ITEM	DESCRIPTION_START	DESCRIPTION_END	LATEST	Description
00001	01FEB1984	31OCT1996	N	Professional attendance at consulting rooms of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 2-- each attendance
00001	01NOV1996	31OCT1997	N	EMERGENCY ATTENDANCE AFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance being an attendance at other than consulting rooms, by a general practitioner on not more than 1 patient on 1 occasion. Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment each attendance
00001	01NOV1997	28FEB2007	N	EMERGENCY ATTENDANCE AFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday
00001	01MAR2007	31DEC9999	Y	URGENT ATTENDANCE AFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment
00002	01FEB1984	31OCT1996	N	Professional attendance at consulting rooms of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00002	01NOV1996	31OCT1997	N	Professional attendance being an attendance at consulting rooms, by a general practitioner on not more than 1 patient on 1 occasion Professional attendance after hours AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance each attendance
00002	01NOV1997	28FEB2007	N	Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday
00002	01MAR2007	31DEC9999	Y	Professional attendance AT CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00003	01DEC1989	30NOV1991	N	Professional attendance at consulting rooms (not being an attendance covered by any other item in this Part) by a vocationally registered general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management  each attendance
00003	01DEC1991	31OCT1993	N	NOTE: Professional attendances by general practitioners cover consultations during which the general practitioner evaluates the patient's problem (which may include certain health screening services - see paragraph 12.3 of the General Explanatory Notes) and formulates a management plan, in relation to one or more conditions present in the patient. The service also includes advice to the patient and/or relatives and the recording of appropriate detail of the particular services - (see paragraphs A.4.6 - A.4.7 of Explanatory Notes to this Category) LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION (Professional attendance at consulting rooms)
00003	01NOV1993	30APR2010	N	LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION (Professional attendance at consulting rooms)
00003	01MAY2010	31DEC9999	Y	Professional attendance at consulting rooms (other than a service to which another item applies) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-each attendance
00004	01DEC1989	31OCT1993	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00004	01NOV1993	31OCT1997	N	HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution)
00004	01NOV1997	31OCT2000	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00004	01NOV2000	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution)
00004	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00004	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00004	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies) that requires a short patient history and, if necessary, limited examination and management-an attendance on one or more patients at one place on one occasion-each patient
00005	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 6-- each attendance
00006	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00007	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 8-- each attendance
00008	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00009	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 10-- each attendance
00010	01FEB1984	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00011	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 12-- each attendance
00012	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00013	01NOV1990	31OCT1993	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00013	01NOV1993	31OCT2000	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00013	01NOV2000	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00014	01DEC1989	31DEC9999	Y	LEVEL A Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management. CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT
00015	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 16-- each attendance
00016	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00017	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 18-- each attendance
00018	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00019	01NOV1990	31OCT1993	N	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00019	01NOV1993	31DEC9999	Y	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00020	01NOV1990	31OCT1993	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a selfcontained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00020	01NOV1993	31OCT2000	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a selfcontained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00020	01NOV2000	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient
00020	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient.
00020	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in a residential aged care facility (other than accommodation in a self-contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00021	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 22-- each attendance
00022	01FEB1984	31DEC9999	Y	Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday
00023	01DEC1989	31OCT1990	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of an attendance of the type otherwise covered by Item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 SURGERY CONSULTATION (Professional attendance at consulting rooms)
00023	01NOV1990	31OCT1993	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms)
00023	01NOV1993	30APR2010	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms)
00023	01MAY2010	31OCT2023	N	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
00023	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in this Schedule applies), lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation
00024	01DEC1989	31OCT1993	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00024	01NOV1993	31OCT1997	N	HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution)
00024	01NOV1997	31OCT2000	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00024	01NOV2000	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution)
00024	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00024	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00024	01JAN2013	31OCT2023	N	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient
00024	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in this Schedule applies), lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient
00025	01NOV1990	31OCT1993	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00025	01NOV1993	31OCT2000	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00025	01NOV2000	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00026	01DEC1989	31DEC9999	Y	LEVEL B Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of an attendance of the type otherwise covered by Items 36, 37, 39, 44, 47 or 49. CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT
00027	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 28-- each attendance where only one in-patient is seen
00028	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where only one in-patient is seen
00029	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-- an attendance on each of two in-patients in the one hospital on the one occasion at a time other than a time covered by Item 30-- each patient who is not a nursing-home type patient
00030	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of two in-patients in the one hospital on the one occasion-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-each patient who is not a nursing-home type patient
00031	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of three or more in-patients in the one hospital on the one occasion-each patient who is not a nursing-home type patient
00032	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of two in-patients in the one hospital on the one occasion where at least one of those in-patients is a nursing-home type patient-each nursing-home type patient
00033	01NOV1990	31OCT1993	N	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00033	01NOV1993	31DEC9999	Y	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00034	01FEB1984	31DEC9999	Y	Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of three or more in-patients in the one hospital on the one occasion where at least one of those in-patients is a nursing-home type patient-each nursing-home type patient
00035	01NOV1990	31OCT1993	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00035	01NOV1993	31OCT2000	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00035	01NOV2000	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient
00035	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient.
00035	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00036	01DEC1989	31OCT1990	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of an attendance of the type otherwise covered by Items 44, 47, 48, 50 or 51 SURGERY CONSULTATION (Professional attendance at consulting rooms)
00036	01NOV1990	31OCT1993	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms)
00036	01NOV1993	30APR2010	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms)
00036	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
00037	01DEC1989	31OCT1993	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00037	01NOV1993	31OCT1997	N	HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution)
00037	01NOV1997	31OCT2000	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00037	01NOV2000	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution)
00037	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00037	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00037	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient
00038	01NOV1990	31OCT1993	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00038	01NOV1993	31OCT2000	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00038	01NOV2000	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00039	01DEC1989	31DEC9999	Y	LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of an attendance of the type otherwise covered by Items 44, 47 or 49 . CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT
00040	01NOV1990	31OCT1993	N	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00040	01NOV1993	31DEC9999	Y	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00041	01FEB1984	29FEB1984	N	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 42-each attendance where only one patient is seen
00041	01MAR1984	31DEC9999	Y	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - each in hours attendance where only one patient is seen
00042	01FEB1984	29FEB1984	N	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where only one patient is seen
00042	01MAR1984	31DEC9999	Y	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - each after hours attendance where only one patient is seen
00043	01NOV1990	31OCT1993	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00043	01NOV1993	31OCT2000	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00043	01NOV2000	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient
00043	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient.
00043	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00044	01DEC1989	31OCT1993	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms)
00044	01NOV1993	30APR2010	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms)
00044	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
00045	01FEB1984	29FEB1984	N	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-an attendance on two patients in the one nursing home or aged persons' accommodation on the one occasion-each patient
00045	01MAR1984	31DEC9999	Y	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - an attendance on two patients in the one nursing home or aged persons' accommodation on the one occasion - each patient
00046	01FEB1984	29FEB1984	N	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-an attendance on three or more patients in the one nursing home or aged persons' accommodation on the one occasion-each patient
00046	01MAR1984	31DEC9999	Y	Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - an attendance on three or more patients in the one nursing home or aged persons' accommodation on the one occasion - each patient
00047	01DEC1989	31OCT1993	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00047	01NOV1993	31OCT1997	N	HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution)
00047	01NOV1997	31OCT2000	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution)
00047	01NOV2000	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution)
00047	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00047	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility.
00047	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient
00048	01NOV1990	31OCT1993	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00048	01NOV1993	31OCT2000	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00048	01NOV2000	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient
00049	01DEC1989	31DEC9999	Y	LEVEL D Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems, and lasting at ast 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan. CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT
00050	01NOV1990	31OCT1993	N	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00050	01NOV1993	31DEC9999	Y	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient
00051	01NOV1990	31OCT1993	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00051	01NOV1993	31OCT2000	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) each patient
00051	01NOV2000	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient
00051	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient.
00051	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00052	01DEC1989	31OCT1993	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration
00052	01NOV1993	31OCT2019	N	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00052	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00053	01DEC1989	31OCT1993	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00053	01NOV1993	31OCT2019	N	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00053	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00054	01DEC1989	31OCT1993	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00054	01NOV1993	31OCT2019	N	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00054	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00055	01FEB1984	31DEC9999	Y	Professional attendance at an institution of not more than 5 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 56-an attendance on each of two or more patients at the one institution on the one occasion-each patient
00056	01FEB1984	31DEC9999	Y	Professional attendance at an institution of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-each patient
00057	01DEC1989	31OCT1993	N	PROLONGED CONSULTATION of more than 45 minutes duration
00057	01NOV1993	31OCT2019	N	Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00057	01NOV2019	31OCT2023	N	Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00057	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 45 minutes, but not more than 60 minutes (other than a service to which any other item applies) by:(a) a medical practitioner who is not a general practitioner; or(b) a Group A1 disqualified general practitioner
00058	01DEC1989	31OCT1993	N	HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration
00058	01NOV1993	31OCT1997	N	HOME VISITS (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration
00058	01NOV1997	31OCT2000	N	HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration
00058	01NOV2000	30APR2010	N	HOME VISITS Professional attendance by a medical practitioner (other than a general practitioner) on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility BRIEF HOME VISIT of not more than 5 minutes duration
00058	01MAY2010	31DEC2012	N	BRIEF CONSULTATION of not more than 5 minutes duration
00058	01JAN2013	31OCT2019	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00058	01NOV2019	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00059	01DEC1989	31OCT1993	N	STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration
00059	01NOV1993	31OCT1997	N	STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration
00059	01NOV1997	30APR2010	N	STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration
00059	01MAY2010	31DEC2012	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00059	01JAN2013	31OCT2019	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00059	01NOV2019	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00060	01DEC1989	31OCT1993	N	LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration
00060	01NOV1993	31OCT1997	N	LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration
00060	01NOV1997	30APR2010	N	LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration
00060	01MAY2010	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00060	01JAN2013	31OCT2019	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00060	01NOV2019	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00061	01FEB1984	31DEC9999	Y	Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 62-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient
00062	01FEB1984	29FEB1984	N	Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient
00062	01MAR1984	31DEC9999	Y	Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) - an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday - each patient
00063	01FEB1984	31DEC9999	Y	Professional attendance at an institution of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 64-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient
00064	01FEB1984	31DEC9999	Y	Professional attendance at an institution of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient
00065	01DEC1989	31OCT1993	N	PROLONGED HOME VISIT of more than 45 minutes duration
00065	01NOV1993	31OCT1997	N	PROLONGED HOME VISIT of more than 45 minutes duration
00065	01NOV1997	30APR2010	N	PROLONGED HOME VISIT of more than 45 minutes duration
00065	01MAY2010	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration
00065	01JAN2013	31OCT2019	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00065	01NOV2019	31OCT2023	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST).
00065	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in this Schedule applies) lasting more than 45 minutes but not more than 60 minutes -an attendance on one or more patients at one place on one occasion-each patient, by:(a) a medical practitioner who is not a general practitioner; or(b) a Group A1 disqualified general practitioner
00066	01DEC1989	31DEC9999	Y	CONSULTATION AT AN INSTITUTION - Professional attendance on two or more patients in the one INSTITUTION on the one occasion - BRIEF CONSULTATION of not more than 5 minutes duration - EACH PATIENT
00067	01FEB1984	31DEC9999	Y	Professional attendance at an institution of more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 68-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient
00068	01FEB1984	31DEC9999	Y	Professional attendance at an institution of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient
00069	01DEC1989	31DEC9999	Y	CONSULTATION AT AN INSTITUTION - Professional attendance on two or more patients in the one INSTITUTION on the one occasion - STANDARD CONSULTATION, of more than 5 minutes duration but not more than 25 minutes duration - EACH PATIENT
00070	01AUG1987	31AUG1989	N	GENERAL PRACTITIONER-EMERGENCY ATTENDANCE-AFTER HOURS (on not more than one patient on the one occasion). Professional attendance after hours AT A PLACE OTHER THAN SURGERY on not more than one patient on the one occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment-each attendance
00070	01SEP1989	31DEC9999	Y	Professional attendance, being an attendance at other than consulting rooms, on not more than one patient on the one occasion-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment
00071	01DEC1989	31DEC9999	Y	CONSULTATION AT AN INSTITUTION -Professional attendance on two or more patients in the one INSTITUTION on the one occasion - LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration - EACH PATIENT
00072	01DEC1989	31DEC9999	Y	CONSULTATION AT AN INSTITUTION - Professional attendance on two or more patients in the one INSTITUTION on the one occasion - PROLONGED CONSULTATION of more than 45 minutes duration - EACH PATIENT
00073	01DEC1989	31DEC9999	Y	CONSULTATION AT HOSPITAL (one in-patient) - Professional attendance at a HOSPITAL where only one in-patient is seen - EACH ATTENDANCE
00074	01DEC1989	31DEC9999	Y	CONSULTATION AT HOSPITAL (two or more in-patients) - Professional attendance on two or more in-patients in the one HOSPITAL on the one occasion - EACH PATIENT who is not a nursing-home type patient
00075	01DEC1989	31DEC9999	Y	CONSULTATION AT HOSPITAL (two in-patients where at least one is a nursing-home type patient) - Professional attendance on two in-patients in the one HOSPITAL on the one occasion where at least one of those in-patients IS a nursing-home type patient - EACH NURSING-HOME TYPE PATIENT
00076	01DEC1989	31DEC9999	Y	CONSULTATION AT HOSPITAL (three or more in-patients where at least one is a nursing-home type patient) - Professional attendance on three or more in-patients in the one HOSPITAL on the one occasion where at least one of those in-patients is a nursing-home type patient - EACH NURSING-HOME TYPE PATIENT
00077	01DEC1989	31DEC9999	Y	CONSULTATION AT NURSING HOME (one patient) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSING HOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) where only ONE PATIENT is seen - EACH ATTENDANCE
00078	01DEC1989	31DEC9999	Y	CONSULTATION AT NURSING HOME (two patients) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSING HOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) - an attendance on TWO PATIENTS in the one nursing home or aged persons' accommodation ON THE ONE OCCASION - EACH PATIENT
00079	01DEC1989	31DEC9999	Y	CONSULTATION AT NURSING HOME (three or more patients) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSING HOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) - an attendance on THREE OR MORE PATIENTS in the one nursing home or aged persons' accommodation ON THE ONE OCCASION - EACH PATIENT
00080	01DEC1989	31DEC9999	Y	EMERGENCY ATTENDANCE - AFTER HOURS (on not more than one patient on the one occasion) - Professional attendance after hours AT A PLACE OTHER THAN SURGERY on not more than one patient on the one occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - EACH ATTENDANCE
00081	01NOV1990	31OCT1993	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration
00081	01NOV1993	31OCT2000	N	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration
00081	01NOV2000	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration
00082	01FEB1984	31OCT1986	N	Pre-operative examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G)
00082	01NOV1986	31AUG1989	N	PRE-OPERATIVE EXAMINATION OF A PATIENT IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at an attendance other than at which the anaesthetic is administered (G)
00082	01SEP1989	31DEC9999	Y	Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G)
00083	01NOV1990	31OCT1993	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00083	01NOV1993	31DEC9999	Y	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00084	01NOV1990	31OCT1993	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00084	01NOV1993	31DEC9999	Y	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00085	01FEB1984	31OCT1986	N	Pre-operative examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S)
00085	01NOV1986	31AUG1989	N	PRE-OPERATIVE EXAMINATION OF A PATIENT IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at an attendance other than at which the anaesthetic is administered (S)
00085	01SEP1989	31DEC9999	Y	Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S)
00086	01NOV1990	31OCT1993	N	PROLONGED CONSULTATION of more than 45 minutes duration
00086	01NOV1993	31DEC9999	Y	PROLONGED CONSULTATION of more than 45 minutes duration
00087	01NOV1990	31OCT1993	N	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration
00087	01NOV1993	31DEC9999	Y	CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration
00088	01FEB1984	31DEC9999	Y	Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at consulting rooms, hospital or nursing home
00089	01NOV1990	31OCT1993	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00089	01NOV1993	31DEC9999	Y	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00090	01NOV1990	31OCT1993	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00090	01NOV1993	31DEC9999	Y	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00091	01NOV1990	31OCT1993	N	PROLONGED CONSULTATION of more than 45 minutes duration
00091	01NOV1993	31DEC9999	Y	PROLONGED CONSULTATION of more than 45 minutes duration
00092	01NOV1990	31OCT1993	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration
00092	01NOV1993	31OCT2000	N	CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration
00092	01NOV2000	31DEC2012	N	BRIEF CONSULTATION of not more than 5 minutes duration
00092	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00093	01NOV1990	31OCT1993	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00093	01NOV1993	31DEC2012	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration
00093	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00094	01FEB1984	31DEC9999	Y	Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- each attendance subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home
00095	01NOV1990	31OCT1993	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00095	01NOV1993	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration
00095	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00096	01NOV1990	31OCT1993	N	PROLONGED CONSULTATION of more than 45 minutes duration
00096	01NOV1993	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration
00096	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies
00097	01NOV1990	31OCT1996	N	EMERGENCY ATTENDANCE AFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment each attendance
00097	01NOV1996	31OCT1997	N	EMERGENCY ATTENDANCE AFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance being an attendance at other than consulting rooms, by a medical practitioner (other than general practitioner) on not more than 1 patient on 1 occasion. Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment each attendance
00097	01NOV1997	28FEB2007	N	(on not more than 1 patient on 1 occasion) Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday
00097	01MAR2007	31DEC9999	Y	Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment
00098	01NOV1990	31OCT1996	N	Professional attendance after hours AT CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance each attendance
00098	01NOV1996	31OCT1997	N	Professional attendance being an attendance at consulting rooms, by a medical practitioner (other than a general practitioner) on not more than 1 patient on 1 occasion Professional attendance after hours AT CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance each attendance
00098	01NOV1997	28FEB2007	N	Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday
00098	01MAR2007	31DEC9999	Y	Professional attendance AT CONSULTING ROOMS, by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00099	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference by a specialist in the practice of his or her specialty, rendered to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 104 or 105.
00099	01NOV2012	31DEC2012	N	Professional attendance on a patient by a specialist practising in his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 104 lasting more than 10 minutes; or (ii) provided with item 105; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
00099	01JAN2013	31OCT2019	N	Professional attendance on a patient by a specialist practising in his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 104 lasting more than 10 minutes; or (ii) provided with item 105; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00099	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a specialist practising in the specialist's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 104 lasting more than 10 minutes; or (ii) provided with item 105; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00100	01FEB1984	31DEC9999	Y	Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at a place other than consulting rooms, hospital or nursing home
00101	01NOV1990	31DEC9999	Y	Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G)
00102	01NOV1990	31DEC9999	Y	Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S)
00103	01FEB1984	31DEC9999	Y	Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- each attendance subsequent to the first in a single course of treatment where that attendance is at a place other than consulting rooms, hospital or nursing home
00104	01NOV1990	30NOV1991	N	SPECIALIST, REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) INITIAL attendance in a single course of treatment
00104	01DEC1991	31OCT2000	N	SPECIALIST, REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 applies
00104	01NOV2000	30APR2006	N	SPECIALIST, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 applies
00104	01MAY2006	31DEC2009	N	SPECIALIST, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 or 109 apply
00104	01JAN2010	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty after referral of the patient to him or her-each attendance, other than a second or subsequent attendance, in a single course of treatment, other than a service to which item 106, 109 or 16401 applies
00104	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist in the practice of the specialist's specialty after referral of the patient to the specialist-each attendance, other than a second or subsequent attendance, in a single course of treatment, other than a service to which item 106, 109 or 16401 applies
00105	01NOV1990	31OCT2017	N	Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital
00105	01NOV2017	31OCT2019	N	Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital, other than a service to which item 16404 applies
00105	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital, other than a service to which item 16404 applies
00106	01DEC1991	31OCT2005	N	- INITIAL ATTENDANCE in a single course of treatment, being an attendance at which refraction is performed by a specialist ophthalmologist, and the attendance results in the issuing of a prescription for spectacles or contact lenses, including any consultation on the same occasion and any other attendance on the same day (other than a service to which items 10801 to 10816 apply)
00106	01NOV2005	30APR2006	N	- INITIAL SPECIALIST OPHTHALMOLOGIST ATTENDANCE in a single course of treatment, being an attendance at which the sole service provided is refraction testing for the issue of a prescription for spectacles or contact lenses not being a service to which items 104 or 10801 to 10816 apply
00106	01MAY2006	30APR2009	N	- INITIAL SPECIALIST OPHTHALMOLOGIST ATTENDANCE in a single course of treatment, being an attendance at which the sole service provided is refraction testing for the issue of a prescription for spectacles or contact lenses not being a service to which items 104, 109 or 10801 to 10816 apply
00106	01MAY2009	31OCT2019	N	Professional attendance by a specialist in the practice of his or her specialty of ophthalmology and following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at which the only service provided is refraction testing for the issue of a prescription for spectacles or contact lenses, if that attendance is at consulting rooms or hospital (other than a service to which any of items 104, 109 and 10801 to 10816 applies)
00106	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of the specialist's specialty of ophthalmology and following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at which the only service provided is refraction testing for the issue of a prescription for spectacles or contact lenses, if that attendance is at consulting rooms or hospital (other than a service to which any of items 104, 109 and 10801 to 10816 applies)
00107	01NOV1990	31OCT2000	N	SPECIALIST, REFERRED CONSULTATION HOME VISITS (Professional attendance at a place other than consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment
00107	01NOV2000	31OCT2019	N	Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment), if that attendance is at a place other than consulting rooms or hospital
00107	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment), if that attendance is at a place other than consulting rooms or hospital
00108	01NOV1990	31OCT2019	N	Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-each attendance after the first in a single course of treatment, if that attendance is at a place other than consulting rooms or hospital
00108	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-each attendance after the first in a single course of treatment, if that attendance is at a place other than consulting rooms or hospital
00109	01MAY2006	30APR2009	N	INITIAL SPECIALIST OPHTHALMOLOGIST PAEDIATRIC ATTENDANCE in a single course of treatment, being an attendance at which a comprehensive eye examination is performed on a child aged 8 years or under, or on a child aged 14 years or under with developmental delay, not being a service to which item 104, 106 or any of items 10801 to 10816 applies
00109	01MAY2009	29FEB2012	N	INITIAL SPECIALIST OPHTHALMOLOGIST PAEDIATRIC ATTENDANCE, REFERRED CONSULTATION in a single course of treatment, being an attendance at which a comprehensive eye examination is performed on a child aged 8 years or under, or on a child aged 14 years or under with developmental delay, not being a service to which item 104, 106 or any of items 10801 to 10816 applies
00109	01MAR2012	31OCT2019	N	Professional attendance by a specialist in the practice of his or her specialty of ophthalmology following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at which a comprehensive eye examination, including pupil dilation, is performed on: (a) a patient aged 9 years or younger; or (b) a patient aged 14 years or younger with developmental delay; (other than a service to which any of items 104, 106 and 10801 to 10816 applies)
00109	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of the specialist's specialty of ophthalmology following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at which a comprehensive eye examination, including pupil dilation, is performed on: (a) a patient aged 9 years or younger; or (b) a patient aged 14 years or younger with developmental delay; (other than a service to which any of items 104, 106 and 10801 to 10816 applies)
00110	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at consulting rooms, hospital or nursing home
00110	01MAR1987	31AUG1989	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment
00110	01SEP1989	31OCT2000	N	Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-initial attendance in a single course of treatment.
00110	01NOV2000	31OCT2011	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment
00110	01NOV2011	31OCT2019	N	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
00110	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-initial attendance in a single course of treatment
00111	01NOV2017	30JUN2019	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day
00111	01JUL2019	31OCT2019	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00111	01NOV2019	30JUN2020	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00111	01JUL2020	30JUN2021	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $309.35 or more For any particular patient, once only on the same day
00111	01JUL2021	30JUN2022	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $312.15 or more For any particular patient, once only on the same day
00111	01JUL2022	30JUN2023	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $317.15 or more For any particular patient, once only on the same day
00111	01JUL2023	31OCT2023	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $328.55 or more For any particular patient, once only on the same day
00111	01NOV2023	30JUN2024	N	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $330.20 or more For any particular patient, once only on the same day
00111	01JUL2024	31DEC9999	Y	Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $341.75 or more For any particular patient, once only on the same day
00112	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference by a consultant physician in the practice of his or her specialty, rendered to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 110, 116, 119, 132 or 133.
00112	01NOV2012	31DEC2012	N	Professional attendance on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) item 110, 116, 119, 132 or 133 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
00112	01JAN2013	31OCT2019	N	Professional attendance on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 110 lasting more than 10 minutes; or (ii) provided with item 116, 119, 132 or 133; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00112	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a consultant physician practising in the consultant physician's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 110 lasting more than 10 minutes; or (ii) provided with item 116, 119, 132 or 133; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00113	01JAN2013	31OCT2019	N	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist in the practice of his or her speciality if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00113	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist in the practice of the specialist's speciality if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00114	01JAN2013	31OCT2019	N	Initial professional attendance of 10 minutes or less in duration on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00114	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a consultant physician practising in the consultant physician's specialty if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00115	01APR2019	30JUN2019	N	Professional attendance at consulting rooms or in hospital by a specialist or consultant physician in the practice of the medical practitioners specialty after referral of the patient to the specialist or consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the specialist or consultant physician performs a scheduled operation on that patient on the same day; and (b) the operation is one to which an item in Group T8 of the general medical service table applies; and (c) the amount as the fee for service is the amount specified in subclause 1.2.3(2)(c) of the general medical services table; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later date. For any particular patient, once only on the same day.
00115	01JUL2019	30JUN2020	N	Professional attendance at consulting rooms or in hospital by a specialist or consultant physician in the practice of the medical practitioners specialty after referral of the patient to the specialist or consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the specialist or consultant physician performs a scheduled operation on that patient on the same day; and (b) the operation is one to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which the item applies is $304.80 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later date. For any particular patient, once only on the same day.
00115	01JUL2020	30JUN2021	N	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $309.35 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00115	01JUL2021	30JUN2022	N	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $312.15 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00115	01JUL2022	30JUN2023	N	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $317.15 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00115	01JUL2023	31OCT2023	N	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $328.55 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00115	01NOV2023	30JUN2024	N	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $330.20 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00115	01JUL2024	31DEC9999	Y	Professional attendance at consulting rooms or in hospital on a day by a medical practitioner (the attending practitioner) who is a specialist or consultant physician in the practice of the attending practitioners specialty after referral of the patient to the attending practitioner by a referring practitioner-an attendance after the initial attendance in a single course of treatment, if: (a) the attending practitioner performs a scheduled operation on the patient on the same day; and (b) the operation is a service to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $341.75 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later day For any particular patient, once only on the same day
00116	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- each attendance subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home
00116	01MAR1987	21DEC1987	N	Each attendance (other than an attendance covered by Item 119) SUBSEQUENT to the first in a single course of treatment
00116	22DEC1987	31AUG1989	N	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 119 applies) after the first in a single course of treatment
00116	01SEP1989	31OCT2019	N	Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-each attendance (other than an attendance covered by item 119) subsequent to the first in a single course of treatment.
00116	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each attendance (other than a service to which item 119 applies) after the first in a single course of treatment
00117	01NOV2017	30JUN2019	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day
00117	01JUL2019	31OCT2019	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00117	01NOV2019	30JUN2020	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00117	01JUL2020	30JUN2021	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $309.35 or more For any particular patient, once only on the same day
00117	01JUL2021	30JUN2022	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $312.15 or more For any particular patient, once only on the same day
00117	01JUL2022	30JUN2023	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $317.15 or more For any particular patient, once only on the same day
00117	01JUL2023	31OCT2023	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $328.55 or more For any particular patient, once only on the same day
00117	01NOV2023	30JUN2024	N	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $330.20 or more For any particular patient, once only on the same day
00117	01JUL2024	31DEC9999	Y	Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $341.75 or more For any particular patient, once only on the same day
00118	01AUG1987	31DEC9999	Y	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION-SURGERY, HOSPITAL OR NURSING HOME Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his speciality (other than in psychiatry) where the patient is referred to him by a medical practitioner - FOURTH OR SUBSEQUENT attendance in a single course of treatment - EACH ATTENDANCE
00119	22DEC1987	31AUG1989	N	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each minor attendance after the first in a single course of treatment
00119	01SEP1989	31OCT2019	N	Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-each minor attendance subsequent to the first in a single course of treatment.
00119	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each minor attendance after the first in a single course of treatment
00120	01NOV2017	30JUN2019	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day
00120	01JUL2019	31OCT2019	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00120	01NOV2019	30JUN2020	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day
00120	01JUL2020	30JUN2021	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $309.35 or more For any particular patient, once only on the same day
00120	01JUL2021	30JUN2022	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $312.15 or more For any particular patient, once only on the same day
00120	01JUL2022	30JUN2023	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $317.15 or more For any particular patient, once only on the same day
00120	01JUL2023	31OCT2023	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $328.55 or more For any particular patient, once only on the same day
00120	01NOV2023	30JUN2024	N	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-minor attendance, if: (a) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the consultant physician subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $330.20 or more For any particular patient, once only on the same day
00120	01JUL2024	31DEC9999	Y	Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-minor attendance, if: (a) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the consultant physician subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $341.75 or more For any particular patient, once only on the same day
00122	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at a place other than consulting rooms, hospital or nursing home
00122	01MAR1987	31AUG1989	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY, REFERRED CONSULTATION HOME VISITS (Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment
00122	01SEP1989	31OCT2000	N	Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-initial attendance in a single course of treatment.
00122	01NOV2000	31OCT2011	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - HOME VISITS (Professional attendance at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment
00122	01NOV2011	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
00122	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-initial attendance in a single course of treatment
00123	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in this Schedule applies), lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation
00124	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in this Schedule applies), lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient
00128	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- each attendance subsequent to the first in a single course of treatment where that attendance is at a place other than consulting rooms, hospital or nursing home
00128	01MAR1987	21DEC1987	N	Each attendance (other than an attendance covered by Item 131) SUBSEQUENT to the first in a single course of treatment
00128	22DEC1987	31AUG1989	N	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 131 applies) after the first in a single course of treatment
00128	01SEP1989	31OCT2019	N	Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-each attendance (other than an attendance covered by item 131) subsequent to the first in a single course of treatment.
00128	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each attendance (other than a service to which item 131 applies) after the first in a single course of treatment
00130	01AUG1987	31DEC9999	Y	"CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - ""HOME VISITS "" Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner - FOURTH OR SUBSEQUENT attendance in a single course of treatment - EACH ATTENDANCE"
00131	22DEC1987	31AUG1989	N	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each minor attendance after the first in a single course of treatment
00131	01SEP1989	31OCT2019	N	Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-each minor attendance subsequent to the * first in a single course of treatment.
00131	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each minor attendance after the first in a single course of treatment
00132	01NOV2007	31OCT2011	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY) REFERRED PATIENT TREATMENT AND MANAGEMENT PLAN - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration for an initial assessment of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), where the patient is referred by a medical practitioner, and where a) assessment is undertaken that covers: - a comprehensive history, including psychosocial history and medication review; - comprehensive multi or detailed single organ system assessment; - the formulation of differential diagnoses; and b) a consultant physician treatment and management plan of significant complexity is developed and provided to the referring practitioner that involves: - an opinion on diagnosis and risk assessment - treatment options and decisions - medication recommendations Not being an attendance on a patient in respect of whom, an attendance under items 110, 116 and 119 has been received on the same day by the same consultant physician. Not being an attendance on the patient in respect of whom, in the preceding 12 months, payment has been made under this item for attendance by the same consultant physician.
00132	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) this item has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician Not being an attendance on the patient in respect of whom, in the preceding 12 months, payment has been made under this item for attendance by the same consultant physician.
00132	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) this item has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician
00133	01NOV2007	28FEB2013	N	CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY) REVIEW OF REFERRED PATIENT TREATMENT AND MANAGEMENT PLAN - SURGERY OR HOSPITAL Professional attendance of at least 20 minutes duration subsequent to the first attendance in a single course of treatment for a review of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), where a) a review is undertaken that covers: - review of initial presenting problem/s and results of diagnostic investigations - review of responses to treatment and medication plans initiated at time of initial consultation comprehensive multi or detailed single organ system assessment, - review of original and differential diagnoses; and b) a modified consultant physician treatment and management plan is provided to the referring practitioner that involves, where appropriate: - a revised opinion on the diagnosis and risk assessment - treatment options and decisions - revised medication recommendations Not being an attendance on a patient in respect of whom, an attendance under item 110, 116 and 119 has been received on the same day by the same consultant physician. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 132 by the same consultant physician, payable no more than twice in any 12 month period.
00133	01MAR2013	31OCT2019	N	Professional attendance of at least 20 minutes duration subsequent to the first attendance in a single course of treatment for a review of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), wherea) a review is undertaken that covers: - review of initial presenting problem/s and results of diagnostic investigations - review of responses to treatment and medication plans initiated at time of initial consultation - comprehensive multi or detailed single organ system assessment, - review of original and differential diagnoses; and b) a modified consultant physician treatment and management plan is provided to the referring practitioner that involves, where appropriate: - a revised opinion on the diagnosis and risk assessment - treatment options and decisions - revised medication recommendations Not being an attendance on a patient in respect of whom, an attendance under item 110, 116 and 119 has been received on the same day by the same consultant physician or locum tenens. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 132. Item 133 can be provided by either the same consultant physician or a locum tenens. Payable no more than twice in any 12 month period.
00133	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) item 132 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132 or a locum tenens; and (f) this item has not applied more than twice in any 12 month period
00134	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of not more than 15 minutes duration where that attendance is at consulting rooms, hospital or nursing home
00134	01MAR1987	31DEC9999	Y	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) An attendance of not more than 15 minutes duration
00135	01JUL2008	30JUN2011	N	CONSULTANT PAEDIATRICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration by a consultant physician in his or her specialty of paediatrics, for assessment, diagnosis and the preparation of a treatment and management plan for a patient aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant paediatrician by a medical practitioner, where the consultant paediatrician: (a) undertakes a comprehensive assessment of the patient and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan that contains: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate care pathways; and (vi) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a patient in respect of whom payment has previously been made under this item or item 289.
00135	01JUL2011	31OCT2011	N	CONSULTANT PAEDIATRICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration at consulting rooms or hospital, by a consultant physician in his or her specialty of paediatrics, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant paediatrician by a medical practitioner, if the consultant paediatrician does the following: (a) undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan which must include the following: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 137, 139 or 289.
00135	01NOV2011	31OCT2019	N	Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139 or 289)
00135	01NOV2019	28FEB2023	N	Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139 or 289)
00135	01MAR2023	31DEC9999	Y	Professional attendance lasting at least 45 minutes by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant paediatrician by a referring practitioner, for a patient aged under 25, if the consultant paediatrician: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of a complex neurodevelopmental disorder (such as autism spectrum disorder) is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139, 289, 92140, 92141, 92142 or 92434) Applicable only once per lifetime
00136	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at consulting rooms, hospital or nursing home
00136	01MAR1987	31DEC9999	Y	An attendance of more than 15 minutes duration but not more than 30 minutes duration
00137	01JUL2011	31OCT2011	N	SPECIALIST OR CONSULTANT PHYSICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR A CHILD WITH AN ELIGIBLE DISABILITY - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a specialist or consultant physician, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with an eligible disability, who has been referred to the specialist or consultant physician by a medical practitioner, if the specialist or consultant physician does the following: (a) undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan which must include the following: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 139 or 289.
00137	01NOV2011	28FEB2023	N	Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a specialist or consultant physician, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with an eligible disability, who has been referred to the specialist or consultant physician by a referring practitioner, if the specialist or consultant physician does the following: (a) undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan which must include the following: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 139 or 289.
00137	01MAR2023	31DEC9999	Y	Professional attendance lasting at least 45 minutes by a specialist or consultant physician (not including a general practitioner), following referral of the patient to the specialist or consultant physician by a referring practitioner, for a patient aged under 25, if the specialist or consultant physician: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of an eligible disability is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 139, 289, 92140, 92141, 92142 or 92434) Applicable only once per lifetime
00138	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at consulting rooms, hospital or nursing home
00138	01MAR1987	31DEC9999	Y	An attendance of more than 30 minutes duration but not more than 45 minutes duration
00139	01JUL2011	28FEB2023	N	Professional attendance of at least 45 minutes in duration at consulting rooms only, by a general practitioner (not including a specialist or consultant physician) for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 289)
00139	01MAR2023	31DEC9999	Y	Professional attendance lasting at least 45 minutes, at a place other than a hospital, by a general practitioner (not including a specialist or consultant physician), for a patient aged under 25, if the general practitioner: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of an eligible disability is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 289, 92140, 92141, 92142 or 92434) Applicable only once per lifetime
00140	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at consulting rooms, hospital or nursing home
00140	01MAR1987	31DEC9999	Y	An attendance of more than 45 minutes duration but not more than 75 minutes duration
00141	01NOV2007	31OCT2011	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician), where the attendance is initiated by the medical practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at consulting rooms or hospital during which: · the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), · the patient's various health problems and care needs are identified and prioritised ('formulation'), · a detailed management plan is developed ('management plan'), · the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, and · the management plan is communicated in writing to the referring medical practitioner. The management plan should include: · the prioritised list of health problems and care needs, · short and longer term management goals, · recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: - likely to improve or maintain health status, - readily available, and - acceptable to the patient, their family and carer(s). Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or item 145 by the same practitioner.
00141	01NOV2011	30JUN2013	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner, where the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at consulting rooms or hospital during which: · the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), · the patient's various health problems and care needs are identified and prioritised ('formulation'), · a detailed management plan is developed ('management plan'), · the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, and · the management plan is communicated in writing to the referring practitioner. The management plan should include: · the prioritised list of health problems and care needs, · short and longer term management goals, · recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: - likely to improve or maintain health status, - readily available, and - acceptable to the patient, their family and carer(s). Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or item 145 by the same practitioner.
00141	01JUL2013	31OCT2019	N	Professional attendance of more than 60 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patient's family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months
00141	01NOV2019	31DEC9999	Y	Professional attendance of more than 60 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patient's family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months
00142	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 75 minutes duration where that attendance is at consulting rooms, hospital or nursing home
00142	01MAR1987	31DEC9999	Y	An attendance of more than 75 minutes duration
00143	01NOV2007	31OCT2011	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under item 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes duration at consulting rooms or hospital where that attendance follows item 141 or 145 and during which: · the patient's health status is reassessed, · a management plan provided under items 141 or 145 is reviewed and revised, · the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring medical practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review.
00143	01NOV2011	30JUN2013	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under item 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice or participating practice nurse. An attendance of more than 30 minutes duration at consulting rooms or hospital where that attendance follows item 141 or 145 and during which: · the patient's health status is reassessed, · a management plan provided under items 141 or 145 is reviewed and revised, · the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review.
00143	01JUL2013	31OCT2019	N	Professional attendance of more than 30 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review
00143	01NOV2019	31DEC9999	Y	Professional attendance of more than 30 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review
00144	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of not more than 15 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00144	01MAR1987	31DEC9999	Y	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION HOME VISITS (Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY where the patient is referred to him or her by a medical practitioner where that attendance is at a place other than consulting rooms, hospital or nursing home) An attendance of not more than 15 minutes duration
00145	01NOV2007	31OCT2011	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and has been referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician), where the attendance is initiated by the medical practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at a place other than consulting rooms or hospital during which: · the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), · the patient's various health problems and care needs are identified and prioritised ('formulation'), · a detailed management plan is developed ('management plan'), · the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, · the management plan is communicated in writing to the referring medical practitioner. The management plan should include: · the prioritised list of health problems and care needs, · short and longer term management goals, · recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: - likely to improve or maintain health status - readily available - acceptable to the patient, their family and carer(s) Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or 141 by the same practitioner.
00145	01NOV2011	30JUN2013	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and has been referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner, where the attendance is initiated by the practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at a place other than consulting rooms or hospital during which: · the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), · the patient's various health problems and care needs are identified and prioritised ('formulation'), · a detailed management plan is developed ('management plan'), · the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, · the management plan is communicated in writing to the referring practitioner. The management plan should include: · the prioritised list of health problems and care needs, · short and longer term management goals, · recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: - likely to improve or maintain health status - readily available - acceptable to the patient, their family and carer(s) Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or 141 by the same practitioner.
00145	01JUL2013	31OCT2019	N	Professional attendance of more than 60 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail utilising appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies, to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient, the patient's family and any carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 141 applies has not been provided to the patient by the same practitioner in the preceding 12 months
00145	01NOV2019	31DEC9999	Y	Professional attendance of more than 60 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail utilising appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies, to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient, the patient's family and any carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 141 applies has not been provided to the patient by the same practitioner in the preceding 12 months
00146	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00146	01MAR1987	31DEC9999	Y	An attendance of more than 15 minutes duration but not more than 30 minutes duration
00147	01NOV2007	31OCT2011	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under items 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes duration at a place other than consulting rooms or hospital where that attendance follows items 141 or 145 and during which: · the patient's health status is reassessed, · a management plan provided under items 141 or 145 is reviewed and revised, · the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the medical practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review.
00147	01NOV2011	30JUN2013	N	CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under items 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice or participating practice nurse. An attendance of more than 30 minutes duration at a place other than consulting rooms or hospital where that attendance follows items 141 or 145 and during which: · the patient's health status is reassessed, · a management plan provided under items 141 or 145 is reviewed and revised, · the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review.
00147	01JUL2013	31OCT2019	N	Professional attendance of more than 30 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under items 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan that was prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or 143 applies has not been provided by the same practitioner in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review
00147	01NOV2019	31DEC9999	Y	Professional attendance of more than 30 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under items 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan that was prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or 143 applies has not been provided by the same practitioner in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review
00148	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00148	01MAR1987	31DEC9999	Y	An attendance of more than 30 minutes duration but not more than 45 minutes duration
00149	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of geriatric medicine to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 141 or 143.
00149	01NOV2012	31DEC2012	N	Professional attendance on a patient by a consultant physician or specialist practising in his or her specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
00149	01JAN2013	31OCT2019	N	Professional attendance on a patient by a consultant physician or specialist practising in his or her specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
00149	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a consultant physician or specialist practising in the consultant physician's or specialist's specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
00150	01FEB1984	28FEB1987	N	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00150	01MAR1987	31DEC9999	Y	An attendance of more than 45 minutes duration but not more than 75 minutes duration
00151	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 60 minutes (other than a service to which any other item applies) by:(a) a medical practitioner who is not a general practitioner; or(b) a Group A1 disqualified general practitioner
00152	01FEB1984	31DEC9999	Y	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00153	01DEC1991	31DEC9999	Y	ELECTROCONVULSIVE THERAPY, including associated consultation (AU 3 - 17903)
00154	01DEC1991	31DEC9999	Y	CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. -GROUP PSYCHOTHERAPY on a group of 2-9 patients OR FAMILY GROUP psychotherapy on a group of more than THREE patients, EACH PATIENT
00155	01DEC1991	31DEC9999	Y	CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - FAMILY GROUP PSYCHOTHERAPY on a group of three patients, EACH PATIENT
00156	01DEC1991	31DEC9999	Y	CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - FAMILY GROUP PSYCHOTHERAPY on a group of two patients, EACH PATIENT
00157	01DEC1991	31DEC9999	Y	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant psychiatrist in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home
00158	01DEC1991	31DEC9999	Y	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant psychiatrist in the practice of his or her recognised specialty of psychiatry where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home
00159	01NOV1992	31DEC9999	Y	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT. Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than twice in any twelve month period.
00160	01FEB1984	28FEB1987	N	Professional attendance for a period of not less than 1 hour but less than 2 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients
00160	01MAR1987	31AUG1989	N	PROLONGED PROFESSIONAL ATTENDANCES (Professional attendance (not being a service to which another item in this Category applies) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients) For a period of not less than 1 hour but less than 2 hours
00160	01SEP1989	30APR1997	N	Professional attendance for a period of not less than 1 hour but less than 2 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients
00160	01MAY1997	30JUN2018	N	Professional attendance for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death
00160	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death
00161	01FEB1984	28FEB1987	N	Professional attendance for a period of not less than 2 hours but less than 3 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients
00161	01MAR1987	31AUG1989	N	For a period of not less than 2 hours but less than 3 hours
00161	01SEP1989	30APR1997	N	Professional attendance for a period of not less than 2 hours but less than 3 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients
00161	01MAY1997	30JUN2018	N	Professional attendance for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death
00161	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death
00162	01FEB1984	28FEB1987	N	Professional attendance for a period of not less than 3 hours but less than 4 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients
00162	01MAR1987	31AUG1989	N	For a period of not less than 3 hours but less than 4 hours
00162	01SEP1989	30APR1997	N	Professional attendance for a period of not less than 3 hours but less than 4 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients
00162	01MAY1997	30JUN2018	N	Professional attendance for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death
00162	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death
00163	01FEB1984	28FEB1987	N	Professional attendance for a period of not less than 4 hours but less than 5 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients
00163	01MAR1987	31AUG1989	N	For a period of not less than 4 hours but less than 5 hours
00163	01SEP1989	30APR1997	N	Professional attendance for a period of not less than 4 hours but less than 5 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients
00163	01MAY1997	30JUN2018	N	Professional attendance for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death
00163	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death
00164	01FEB1984	28FEB1987	N	Professional attendance for a period of 5 hours or more on a patient in a critical condition that requires constant attention to the exclusion of all other patients
00164	01MAR1987	31AUG1989	N	For a period of 5 hours or more
00164	01SEP1989	30APR1997	N	Professional attendance for a period of 5 hours or more (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients
00164	01MAY1997	30JUN2018	N	Professional attendance for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death
00164	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner, specialist or consultant physician for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death
00165	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in this Schedule applies) lasting more than 60 minutes-an attendance on one or more patients at one place on one occasion-each patient, by:(a) a medical practitioner who is not a general practitioner; or(b) a Group A1 disqualified general practitioner
00170	01AUG1987	31AUG1989	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 2 patients
00170	01SEP1989	30JUN2018	N	Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of two patients
00170	01JUL2018	31OCT2019	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her speciality of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 2 patients
00170	01NOV2019	31DEC9999	Y	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 2 patients
00171	01AUG1987	31AUG1989	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 3 patients
00171	01SEP1989	30JUN2018	N	Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of three patients
00171	01JUL2018	31OCT2019	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 3 patients
00171	01NOV2019	31DEC9999	Y	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 3 patients
00172	01AUG1987	31AUG1989	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients
00172	01SEP1989	30JUN2018	N	Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of four or more patients
00172	01JUL2018	31OCT2019	N	Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients
00172	01NOV2019	31DEC9999	Y	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 4 or more patients
00173	01DEC1991	30APR2010	N	ATTENDANCE at which ACUPUNCTURE is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00173	01MAY2010	31DEC9999	Y	Professional attendance at which acupuncture is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture was performed
00177	01APR2019	31OCT2019	N	Professional attendance for a heart health assessment by a medical practitioner (other than a specialist or consultant physician) at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status, cholesterol status (if not performed within the last 12 months) and blood glucose;(b) a physical examination, which must include recording of blood pressure;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors;with appropriate documentation.
00177	01NOV2019	30JUN2021	N	Professional attendance for a heart health assessment by a medical practitioner (other than a specialist or consultant physician) at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status and blood glucose;(b) a physical examination, which must include recording of blood pressure and cholesterol status;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation. Claimable once only in a 12 month period. The heart health assessment item cannot be claimed if a patient has had a health assessment service (items 224, 225, 226, 227, 228) in the previous 12 months.
00177	01JUL2021	31OCT2023	N	Professional attendance on a patient who is 30 years of age or over for a heart health assessment by a medical practitioner at consulting rooms (other than a specialist or consultant physician) lasting at least 20 minutes and including: collection of relevant information, including taking a patient history; and a basic physical examination, which must include recording blood pressure and cholesterol; and initiating interventions and referrals as indicated; and implementing a management plan; and providing the patient with preventative health care advice and information.
00177	01NOV2023	30JUN2024	N	Professional attendance on a patient who is 30 years of age or over for a heart health assessment by a medical practitioner at consulting rooms (other than a specialist or consultant physician) lasting at least 20 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination, which must include recording blood pressure and cholesterol; and (c) initiating interventions and referrals as indicated; and (d) implementing a management plan; and (e) providing the patient with preventative health care advice and information.
00177	01JUL2024	31DEC9999	Y	Professional attendance on a patient who is 30 years of age or over for a heart health assessment by a prescribed medical practitioner at consulting rooms lasting at least 20 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination, which must include recording blood pressure and cholesterol; and (c) initiating interventions and referrals as indicated; and (d) implementing a management plan; and (e) providing the patient with preventative health care advice and information.
00179	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies)-each attendance, by a medical practitioner in an eligible area.
00179	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting not more than 5 minutes (other than a service to which any other item applies) by a prescribed medical practitioner in an eligible area-each attendance
00180	01FEB1984	29FEB1984	N	Professional attendance by a participating optometrist-an attendance that is the sole or first attendance in a single course of attention that commenced on or after the proclaimed date, being-(a) the first or only course of attention of the patient by a participating optometrist since the proclaimed date; or (b) the second or a subsequent course of attention of the patient by a participating optometrist since the proclaimed date, being a course of attention commencing not earlier than 12 months after the commencement of the preceding course of attention
00180	01MAR1984	31AUG1989	N	Professional attendance by a participating optometrist - an attendance that is the sole or first attendance in a single course of attention that commenced on or after 1 July 1975, being - (a) the first or only course of attention of the patient by a participating optometrist since 1 July 1975; or (b) the second or a subsequent course of attention of the patient by a participating optometrist since 1 July 1975, being the sole course of attention in any calender year
00180	01SEP1989	31DEC9999	Y	Professional attendance by a participating optometrist that is the sole or first attendance in a single course of attention of a patient. The Medicare benefit is payable in respect of attendances by a participating optometrist at, or operating from, the same practice location, only once in a period of twenty four consecutive months unless the examining optometrist has certified that, in his professional opinion, the patient had an ocular condition which necessitated a further course of attention being commenced within twenty four months of the previous initial consultation
00181	01JUL2018	31OCT2023	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by a medical practitioner in an eligible area
00181	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item applies) lasting not more than 5 minutes-an attendance on one or more patients at one place on one occasion by a prescribed medical practitioner in an eligible area-each patient
00182	01FEB1984	31AUG1989	N	Professional attendance by a participating optometrist-- an attendance (not being an attendance covered by Item 186) that is the second attendance in a single course of attention in respect of which the first attendance is covered by Item 180
00182	01SEP1989	31DEC9999	Y	Professional attendance by a participating optometrist (not being an attendance relating to the prescription and fitting of contact lenses) that is the second attendance in a single course of attention in respect of which the first attendance is covered by item 180
00183	01JUL2018	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by medical practitioner in an eligible area
00184	01FEB1984	31AUG1989	N	Professional attendance by a participating optometrist-- an attendance (not being an attendance covered by Item 186) that is the third or a subsequent attendance in a single course of attention of a patient, who, in the professional opinion of the attending optometrist, has a need for that attendance, being a course of attention in respect of which the first attendance is covered by Item 180
00184	01SEP1989	31DEC9999	Y	Professional attendance by a participating optometrist (not being an attendance relating to the prescription and fitting of contact lenses) that is the third or a subsequent attendance in a single course of attention of a patient in respect of whom the attending optometrist has certified on the patient's account that, in his professional opinion, there is a need for that attendance, being a course of attention in respect of which the first attendance is covered by item 180
00185	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies)-each attendance, by a medical practitioner in an eligible area
00185	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 5 minutes but not more than 25 minutes (other than a service to which any other item applies) by a prescribed medical practitioner in an eligible area-each attendance
00186	01FEB1984	31AUG1989	N	Professional attendance by a participating optometrist-- all attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is covered by Item 180
00186	01SEP1989	31DEC9999	Y	Professional attendances by a participating optometrist after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is covered by Item 180. The Medicare benefit is payable only once in a period of thirty six consecutive months unless the examining optometrist has certified on the patient's account that, in his professional opinion, the patient had an ocular condition which necessitated a further course of attention being commenced within thirty six months of the previous initial consultation
00187	01JUL2018	31OCT2023	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one place on one occasion-each patient, by a medical practitioner in an eligible area
00187	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item applies) lasting more than 5 minutes but not more than 25 minutes-an attendance on one or more patients at one place on one occasion by a prescribed medical practitioner in an eligible area-each patient
00188	01JUL2018	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area
00189	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies)-each attendance, by a medical practitioner in an eligible area
00189	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 25 minutes but not more than 45 minutes (other than a service to which any other applies) by a prescribed medical practitioner in an eligible area-each attendance
00190	01FEB1984	29FEB1984	N	Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the attendances do not exceed ten-- each attendance
00190	01MAR1984	28FEB1987	N	Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the attendances do not exceed ten - each attendance
00190	01MAR1987	31DEC9999	Y	ANTENATAL CARE (not including any service or services covered by Item 204 or 205) where the attendances do not exceed ten each attendance
00191	01JUL2018	31OCT2023	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one place on one occasion-each patient, by a medical practitioner in an eligible area
00191	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item applies) lasting more than 25 minutes but not more than 45 minutes-an attendance on one or more patients at one place on one occasion by a prescribed medical practitioner in an eligible area-each patient
00192	01FEB1984	29FEB1984	N	Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the attendances exceed ten
00192	01MAR1984	28FEB1987	N	Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the attendances exceed ten
00192	01MAR1987	31DEC9999	Y	ANTENATAL CARE (not including any service or services covered by Item 204 or 205) where attendances exceed ten
00193	01NOV1998	31OCT2003	N	Professional attendance by a general practitioner at a place other than a hospital, involving either: (i) taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii) a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00193	01NOV2003	30APR2010	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i) taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii) a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00193	01MAY2010	31OCT2022	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00193	01NOV2022	31DEC9999	Y	Professional attendance by a medical practitioner who holds endorsement of registration for acupuncture with the Medical Board of Australia or is registered by the Chinese Medicine Board of Australia as an acupuncturist, at a place other than a hospital, for treatment lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the medical practitioner by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00194	01FEB1984	29FEB1984	N	Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the medical practitioner has not given the antenatal care (G)
00194	01MAR1984	31OCT1986	N	Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (G)
00194	01NOV1986	31AUG1989	N	CONFINEMENT AND POSTNATAL CARE for nine days (not including any service or services covered by Item 204 or 205 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (G)
00194	01SEP1989	31DEC9999	Y	Confinement and postnatal care for nine days where the medical practitioner has not given the antenatal care (G)
00195	01NOV1998	31OCT2003	N	Professional attendance by a general practitioner on 1 or more patients at a hospital, on one occasion, involving either: (i) taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii) a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00195	01NOV2003	30APR2010	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, on 1 or more patients at a hospital, on one occasion, involving either: (i) taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii) a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00195	01MAY2010	31DEC2012	N	CONSULTATION AT A HOSPITAL Consultation by a general practitioner, who is a qualified medical acupuncturist at a hospital on one or more patients on one occasion at which ACUPUNCTURE is performed by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed.
00195	01JAN2013	31OCT2022	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, on one or more patients at a hospital, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00195	01NOV2022	31DEC9999	Y	Professional attendance by a medical practitioner who holds endorsement of registration for acupuncture with the Medical Board of Australia or is registered by the Chinese Medicine Board of Australia as an acupuncturist, on one or more patients at a hospital, for treatment lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the medical practitioner by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00196	01FEB1984	29FEB1984	N	Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the medical practitioner has not given the antenatal care (S)
00196	01MAR1984	31AUG1989	N	Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (S)
00196	01SEP1989	31DEC9999	Y	Confinement and postnatal care for nine days where the medical practitioner has not given the antenatal care (S)
00197	01MAY2003	31OCT2003	N	Professional attendance by a general practitioner at a place other than a hospital, involving either: (i) taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes; OR (ii) a professional attendance of at least 20 minutes but less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00197	01NOV2003	30APR2010	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i) taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes; OR (ii) a professional attendance of at least 20 minutes but less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00197	01MAY2010	31OCT2022	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00197	01NOV2022	31DEC9999	Y	Professional attendance by a medical practitioner who holds endorsement of registration for acupuncture with the Medical Board of Australia or is registered by the Chinese Medicine Board of Australia as an acupuncturist, at a place other than a hospital, for treatment lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the medical practitioner by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00198	01FEB1984	31DEC9999	Y	Confinement as an independent procedure, including all related attendances (S)
00199	01MAY2003	31OCT2003	N	Professional attendance by a general practitioner at a place other than a hospital, involving either: (i) taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems and lasting a least 40 minutes; OR (ii) a professional attendance of at least 40 minutes duration for implementation of a management plan AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00199	01NOV2003	30APR2010	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i) taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems and lasting a least 40 minutes; OR (ii) a professional attendance of at least 40 minutes duration for implementation of a management plan AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00199	01MAY2010	31OCT2022	N	Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00199	01NOV2022	31DEC9999	Y	Professional attendance by a medical practitioner who holds endorsement of registration for acupuncture with the Medical Board of Australia or is registered by the Chinese Medicine Board of Australia as an acupuncturist, at a place other than a hospital, for treatment lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the medical practitioner by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed
00200	01FEB1984	29FEB1984	N	Antenatal care, confinement and postnatal care for nine days (not including services covered by Division 2) (G)
00200	01MAR1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days(not including services covered by Division 2 of this Part) (G)
00201	01AUG1987	31AUG1989	N	CONFINEMENT, incomplete, with or without postnatal care for nine-days where the patient is referred to a specialist for completion of the confinement
00201	01SEP1989	31DEC9999	Y	Confinement, incomplete, with or without postnatal care for nine days where the patient is referred to a specialist in the practice of his or her specialty or the patient's care is transferred to another medical practitioner for completion of the delivery
00202	01JUL2018	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area
00203	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies)-each attendance, by a medical practitioner in an eligible area
00203	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 45 minutes but not more than 60 minutes (other than a service to which any other item applies) by a prescribed medical practitioner in an eligible area-each attendance
00204	01AUG1987	31AUG1989	N	ANTENATAL CARE, CONFINEMENT AND POSTNATAL CARE for nine days (G)
00204	01SEP1989	31DEC9999	Y	Antenatal care, confinement with delivery by any means (including Caesarean section) and postnatal care for nine days (G)
00205	01AUG1987	31AUG1989	N	ANTENATAL CARE, CONFINEMENT AND POSTNATAL CARE for nine days (S)
00205	01SEP1989	31DEC9999	Y	Antenatal care, confinement with delivery by any means (including Caesarean section) and postnatal care for nine days (S)
00206	01JUL2018	31OCT2023	N	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by a medical practitioner in an eligible area
00206	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item applies) lasting more than 45 minutes but not more than 60 minutes-an attendance on one or more patients at one place on one occasion by a prescribed medical practitioner in an eligible area-each patient
00207	01FEB1984	29FEB1984	N	Antenatal care, confinement and postnatal care for nine days (not including services covered by Division 2) (S)
00207	01MAR1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days(not including services covered by Division 2 of this Part) (S)
00208	01FEB1984	29FEB1984	N	Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2) (G)
00208	01MAR1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2 of this Part) (G)
00209	01FEB1984	29FEB1984	N	Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2) (S)
00209	01MAR1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2 of this Part) (S)
00210	01AUG1987	31AUG1989	N	CAESAREAN SECTION and postnatal care for nine days where the patient has been referred for management of the confinement and the practitioner does not provide the antenatal care
00210	01SEP1989	31DEC9999	Y	Caesarean section and postnatal care for nine days where the patient has been referred to a specialist in the practice of his or her specialty or the patient's care has been transferred to another medical practitioner for management of the confinement and the practitioner who performed the Caesarean section did not provide the antenatal care
00211	01FEB1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with surgical induction of labour (G)
00212	01JUL2018	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area
00213	01FEB1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with surgical induction of labour (S)
00214	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death
00214	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner for a period of not less than one hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death
00215	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death
00215	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death
00216	01FEB1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with surgical induction of labour; including major regional or field block (G)
00217	01FEB1984	31DEC9999	Y	Antenatal care, confinement and postnatal care for nine days with surgical induction of labour; including major regional or field block (S)
00218	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death
00218	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death
00219	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death
00219	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death
00220	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death
00220	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death
00221	01JUL2018	31OCT2023	N	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family-each Group of 2 patients
00221	01NOV2023	31DEC9999	Y	Professional attendance for the purpose of Group therapy lasting at least one hour given under the direct continuous supervision of a prescribed medical practitioner, involving members of a family and persons with close personal relationships with that family-each Group of 2 patients
00222	01JUL2018	31OCT2023	N	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family-each Group of 3 patients
00222	01NOV2023	31DEC9999	Y	Professional attendance for the purpose of Group therapy lasting at least one hour given under the direct continuous supervision of a prescribed medical practitioner, involving members of a family and persons with close personal relationships with that family-each Group of 3 patients
00223	01JUL2018	31OCT2023	N	Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients
00223	01NOV2023	31DEC9999	Y	Professional attendance for the purpose of Group therapy lasting at least one hour given under the direct continuous supervision of a prescribed medical practitioner, involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients
00224	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information
00224	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner to perform a brief health assessment, lasting not more than 30 minutes and including:(a) collection of relevant information, including taking a patient history; and(b) a basic physical examination; and(c) initiating interventions and referrals as indicated; and(d) providing the patient with preventive health care advice and information
00225	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient
00225	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including:(a) detailed information collection, including taking a patient history; and(b) an extensive physical examination; and(c) initiating interventions and referrals as indicated; and(d) providing a preventive health care strategy for the patient
00226	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patients medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient
00226	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including:(a) comprehensive information collection, including taking a patient history; and(b) an extensive examination of the patients medical condition and physical function; and(c) initiating interventions and referrals as indicated; and(d) providing a basic preventive health care management plan for the patient
00227	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patients medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient
00227	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner to perform a prolonged health assessment, lasting at least 60 minutes, including:(a) comprehensive information collection, including taking a patient history; and(b) an extensive examination of the patients medical condition, and physical, psychological and social function; and(c) initiating interventions and referrals as indicated; and(d) providing a comprehensive preventive health care management plan for the patient
00228	01JUL2018	09DEC2020	N	Professional attendance by a medical practitioner at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-this item or item 715 not more than once in a 9 month period
00228	10DEC2020	31OCT2023	N	Professional attendance by a medical practitioner at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-this item or items 715, 93470 or 93479 not more than once in a 9 month period.
00228	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner at consulting rooms or in a place other than a hospital or a residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-applicable not more than once in a 9 month period and only if the following items are not applicable within the same 9 month period:(a) item 715;(b) item 92004 or 92011 of the Telehealth and Telephone Determination
00229	01JUL2018	31OCT2023	N	Attendance by a medical practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 and items 235 to 240 apply)
00229	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 235 to 240 and 735 to 758 apply)
00230	01JUL2018	31OCT2023	N	Attendance by a medical practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 and items 235 to 240 apply)
00230	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 235 to 240 and 735 to 758 apply)
00231	01JUL2018	31OCT2023	N	Contribution by a medical practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 and items 235 to 240 apply)
00231	01NOV2023	31OCT2024	N	Either:(a) contribution to a multidisciplinary care plan, for a patient, prepared by another provider; or(b) contribution to a review of a multidisciplinary care plan, for a patient, prepared by another provider;by a prescribed medical practitioner, other than a service associated with a service to which any of items 235 to 240 and 735 to 758 apply
00231	01NOV2024	31DEC9999	Y	Either:(a) contribution to a multidisciplinary care plan, for a patient, prepared by another provider; or(b) contribution to a review of a multidisciplinary care plan, for a patient, prepared by another provider;by a prescribed medical practitioner, other than a service associated with a service to which any of items 235 to 240, 735, 739, 743, 747, 750 or 758 apply
00232	01JUL2018	31OCT2023	N	Contribution by a medical practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 and items 235 to 240 apply)
00232	01NOV2023	31OCT2024	N	Either:(a) contribution to a multidisciplinary care plan, for a patient in a residential aged care facility, prepared by that facility, or contribution to a review of a multidisciplinary care plan, for a patient, prepared by such a facility; or(b) contribution to a multidisciplinary care plan, for a patient, prepared by another provider before the patient is discharged from a hospital or contribution to a review of a multidisciplinary care plan, for a patient, prepared by another provider;by a prescribed medical practitioner, other than a service associated with a service to which any of items 235 to 240 and 735 to 758 apply
00232	01NOV2024	31DEC9999	Y	Either:(a) contribution to a multidisciplinary care plan, for a patient in a residential aged care facility, prepared by that facility, or contribution to a review of a multidisciplinary care plan, for a patient, prepared by such a facility; or(b) contribution to a multidisciplinary care plan, for a patient, prepared by another provider before the patient is discharged from a hospital or contribution to a review of a multidisciplinary care plan, for a patient, prepared by another provider;by a prescribed medical practitioner, other than a service associated with a service to which any of items 235 to 240, 735, 739, 743, 747, 750 or 758 apply
00233	01JUL2018	31OCT2023	N	Attendance by a medical practitioner to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 721 or item 229 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 723 or item 230 applies
00233	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner:(a) to review a GP management plan prepared by a medical practitioner (or an associated medical practitioner); or(b) to coordinate a review of team care arrangements which have been coordinated by the medical practitioner (or the associated medical practitioner)
00234	01FEB1984	31DEC9999	Y	Caesarean section and postnatal care for nine days (G) (AU 10)
00235	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00235	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply).
00235	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts for at least 15 minutes but less than 20 minutes, other than a service associated with a service to which any of items 229 to 233 and 721 to 732 apply
00236	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00236	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply).
00236	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts for at least 20 minutes but less than 40 minutes, other than a service associated with a service to which any of items 229 to 233 and 721 to 732 apply
00237	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00237	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply)
00237	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts at least 40 minutes, other than a service associated with a service to which any of items 229 to 233 and 721 to 732 apply
00238	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00238	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply).
00238	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts for at least 15 minutes but less than 20 minutes, other than a service associated with a service to which any of items 229 to 233 and 721 to 732 apply
00239	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00239	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply).
00239	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts for at least 20 minutes but less than 40 minutes, other than a service associated with a service to any of items 229 to 233 and 721 to 732 apply
00240	01JUL2018	09DEC2020	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 or items 229 to 233 apply)
00240	10DEC2020	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732, items 229 to 233 or items 93469 or 93475 apply)
00240	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in:(a) a community case conference; or(b) a multidisciplinary case conference in a residential aged care facility; or(c) a multidisciplinary discharge case conference;if the conference lasts for at least 40 minutes, other than a service associated with a service to which any of items 229 to 233 and 721 to 732 apply
00241	01FEB1984	31DEC9999	Y	Caesarean section and postnatal care for nine days (S) (AU 10)
00242	01FEB1984	31DEC9999	Y	Treatment of habitual miscarriage by injection of hormones-- each injection up to a maximum of twelve injections, where the injection is not administered during a routine antenatal attendance
00243	01JUL2018	31OCT2023	N	Attendance by a medical practitioner, as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00243	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer, to develop a multidisciplinary treatment plan, if the case conference lasts at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00244	01JUL2018	31OCT2023	N	Attendance by a medical practitioner, as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00244	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer, to develop a multidisciplinary treatment plan, if the case conference lasts at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00245	01JUL2018	31OCT2023	N	Participation by a medical practitioner in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the medical practitioner, with the patients consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient-this item or item 900 is applicable not more than once in each 12 month period, except if there has been a significant change in the patients condition or medication regimen requiring a new DMMR
00245	01NOV2023	31DEC9999	Y	Participation by a prescribed medical practitioner in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the prescribed medical practitioner, with the patients consent:(a) assesses the patient as:(i) having a chronic medical condition or a complex medication regimen; and(ii) not having the patients therapeutic goals met; and(b) following that assessment:(i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and(ii) provides relevant clinical information required for the DMMR; and(c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and(d) develops a written medication management plan following discussion with the patient; and(e) provides the written medication management plan to a community pharmacy chosen by the patientFor any particular patient-applicable not more than once in each 12 month period, and only if item 900 does not apply in the same 12 month period, except if there has been a significant change in the patients condition or medication regimen requiring a new DMMR
00246	01FEB1984	31DEC9999	Y	Threatened abortion, threatened miscarriage or hyperemesis gravidarum, requiring admission to hospital, treatment of-- each attendance that is not a routine antenatal attendance
00247	01AUG1987	31AUG1989	N	Intra-uterine growth retardation, polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of two attendances in any seven day period
00247	01SEP1989	31DEC9999	Y	Polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital-each attendance that is not a routine antenatal attendance, to a maximum of two attendances in any seven day period
00248	01AUG1987	31AUG1989	N	Pregnancy complicated by acute intercurrent infection, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of one visit per day
00248	01SEP1989	31DEC9999	Y	Pregnancy complicated by acute intercurrent infection, intrauterine growth retardation, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital-each attendance that is not a routine antenatal attendance, to a maximum of one visit per day
00249	01JUL2018	31OCT2023	N	Participation by a medical practitioner in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item or item 903 has applied, unless there has been a significant change in the residents medical condition or medication management plan requiring a new RMMR
00249	01NOV2023	31DEC9999	Y	Participation by a prescribed medical practitioner in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item or item 903 has applied, unless there has been a significant change in the residents medical condition or medication management plan requiring a new RMMR
00250	01FEB1984	31DEC9999	Y	Cervix, purse string ligation of, for threatened miscarriage (G) (AU 6)
00251	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner in an eligible area at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00252	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00253	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00254	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00255	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00256	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00257	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
00258	01FEB1984	31DEC9999	Y	Cervix, purse string ligation of, for threatened miscarriage (S) (AU 6)
00259	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
00260	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
00261	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the requirements for a cycle of care of a patient with established diabetes mellitus
00262	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes but not more than 45 minutes, in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
00263	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
00264	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
00265	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00266	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00267	01FEB1984	31DEC9999	Y	Cervix, removal of purse string ligature of, under general anaesthesia (AU 5)
00268	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00269	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00270	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00271	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care
00272	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (who has not undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
00272	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (who has not undertaken mental health skills training), lasting at least 20 minutes but less than 40 minutes, for the preparation of a GP mental health treatment plan for a patient
00273	01FEB1984	31DEC9999	Y	Pre-eclampsia, eclampsia or antepartum haemorrhage, treatment of-- each attendance that is not a routine antenatal attendance
00274	01FEB1984	31AUG1989	N	Induction and management of second trimester labour (G)
00274	01SEP1989	31DEC9999	Y	Management of second trimester labour, with or without induction (G)
00275	01FEB1984	31AUG1989	N	Induction and management of second trimester labour (S)
00275	01SEP1989	31DEC9999	Y	Management of second trimester labour, with or without induction (S)
00276	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (who has not undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
00276	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (who has not undertaken mental health skills training), lasting at least 40 minutes, for the preparation of a GP mental health treatment plan for a patient
00277	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan
00277	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner to:(a) review a GP mental health treatment plan which a medical practitioner, or an associated medical practitioner, has prepared; or(b) to review a Psychiatrist Assessment and Management Plan
00278	01FEB1984	31DEC9999	Y	Amnioscopy or amniocentesis
00279	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation
00279	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner, in relation to a mental disorder, lasting at least 20 minutes and involving:(a) taking relevant history and identifying the presenting problem (to the extent not previously recorded); and(b) providing treatment and advice; and(c) if appropriate, referral for other services or treatments; and(d) documenting the outcomes of the consultation
00280	01AUG1988	31DEC9999	Y	Chorionic villus sampling including any associated imaging
00281	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (who has undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
00281	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (who has undertaken mental health skills training), lasting at least 20 minutes but less than 40 minutes, for the preparation of a GP mental health treatment plan for a patient
00282	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (who has undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
00282	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (who has undertaken mental health skills training), lasting at least 40 minutes, for the preparation of a GP mental health treatment plan for a patient
00283	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
00283	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for mental disorders that have been assessed by a medical practitioner; and(b) lasting at least 30 minutes but less than 40 minutes
00284	01FEB1984	31DEC9999	Y	Amnioscopy with surgical induction of labour (AU 6)
00285	01JUL2018	31OCT2023	N	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
00285	01NOV2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for mental disorders that have been assessed by a medical practitioner; and(b) lasting at least 30 minutes but less than 40 minutes
00286	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes
00286	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for mental disorders that have been assessed by a medical practitioner; and(b) lasting at least 40 minutes
00287	01JUL2018	31OCT2023	N	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes
00287	01NOV2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for mental disorders that have been assessed by a medical practitioner; and(b) lasting at least 40 minutes
00288	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a consultant physician practising in the specialty of psychiatry to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352.
00288	01NOV2012	31DEC2012	N	Professional attendance on a patient by a consultant physician practising in his or her specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
00288	01JAN2013	31OCT2019	N	Professional attendance on a patient by a consultant physician practising in his or her specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00288	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a consultant physician practising in the consultant physician's specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00289	01JUL2008	30JUN2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration by a consultant physician in his or her specialty of psychiatry, for assessment, diagnosis and the preparation of a treatment and management plan for a patient aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant psychiatrist by a medical practitioner, where the consultant psychiatrist: (a) undertakes a comprehensive assessment of the patient and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan that contains: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate care pathways; and (vi) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a patient in respect of whom payment has previously been made under this item or item 135.
00289	01JUL2011	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a consultant physician in his or her specialty of psychiatry, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant psychiatrist by a medical practitioner, if the consultant psychiatrist does the following: (a) undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b) develops a treatment and management plan which must include the following: (i) the outcomes of the assessment; (ii) the diagnosis or diagnoses; (iii) opinion on risk assessment; (iv) treatment options and decisions; (v) appropriate medication recommendations, where necessary. (c) provides a copy of the treatment and management plan to the: (i) referring practitioner; and (ii) relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 137 or 139.
00289	01NOV2011	31OCT2019	N	Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty of psychiatry, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant psychiatrist does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 139)
00289	01NOV2019	28FEB2023	N	Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant psychiatrist does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 139)
00289	01MAR2023	31DEC9999	Y	Professional attendance lasting at least 45 minutes, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant psychiatrist by a referring practitioner, for a patient aged under 25, if the consultant psychiatrist: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of a complex neurodevelopmental disorder (such as autism spectrum disorder) is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 92140, 92141, 92142 or 92434) Applicable only once per lifetime
00290	01AUG1986	31DEC9999	Y	ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (not during the course of the confinement)
00291	01MAY2005	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) where the attendance is initiated by that medical practitioner and where the consultant psychiatrist provides the referring medical practitioner with an assessment and management plan to be undertaken by that medical practitioner in general practice for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - The consultant psychiatrist decides that the patient can be appropriately managed by the referring medical practitioner without the need for ongoing treatment by the psychiatrist - A 12 month management plan, appropriate to the diagnosis, is provided to the referring medical practitioner which must: a) comprehensively evaluate biological, psychological and social issues; b) address diagnostic psychiatric issues; c) make management recommendations addressing biological, psychological and social issues; and d) be provided to the medical practitioner within two weeks of completing the assessment of the patient. - The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The diagnosis and management plan is communicated in writing to the referring medical practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item
00291	01NOV2011	31OCT2015	N	CONSULTANT PSYCHIATRIST, REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner, where the attendance is initiated by the referring practitioner and where the consultant psychiatrist provides the referring practitioner with an assessment and management plan to be undertaken by that practitioner for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - The consultant psychiatrist decides that the patient can be appropriately managed by the referring practitioner without the need for ongoing treatment by the psychiatrist - A 12 month management plan, appropriate to the diagnosis, is provided to the referring practitioner which must: a) comprehensively evaluate biological, psychological and social issues; b) address diagnostic psychiatric issues; c) make management recommendations addressing biological, psychological and social issues; and d) be provided to the referring practitioner within two weeks of completing the assessment of the patient. - The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The diagnosis and management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item
00291	01NOV2015	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner, where the attendance is initiated by the referring practitioner and where the consultant psychiatrist provides the referring practitioner with an assessment and management plan to be undertaken by that practitioner for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - The consultant psychiatrist decides that the patient can be appropriately managed by the referring practitioner without the need for ongoing treatment by the psychiatrist - A 12 month management plan, appropriate to the diagnosis, is provided to the referring practitioner which must: a) comprehensively evaluate biological, psychological and social issues; b) address diagnostic psychiatric issues; c) make management recommendations addressing biological, psychological and social issues; and d) be provided to the referring practitioner within two weeks of completing the assessment of the patient. - The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The diagnosis and management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item
00291	01NOV2019	29FEB2024	N	Professional attendance of more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (including a general practitioner, but not a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patient's diagnosis; and (C) comprehensively evaluates the patient's biological, psychological and social issues; and (D) addresses the patient's diagnostic psychiatric issues; and (E) makes management recommendations addressing the patient's biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees
00291	01MAR2024	31DEC9999	Y	Professional attendance lasting more than 45 minutes at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant, by a medical practitioner in general practice (including a general practitioner, but not a specialist or consultant physician) or a participating nurse practitioner, for an assessment or management; and (b) during the attendance, the consultant: (i) if it is clinically appropriate to do so-uses an appropriate outcome tool; and (ii) carries out a mental state examination; and (iii) undertakes a comprehensive diagnostic assessment; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing management by the consultant; and (d) within 2 weeks after the attendance, the consultant prepares and gives to the referring practitioner a written report, which includes: (i) the comprehensive diagnostic assessment of the patient; and (ii) a management plan for the patient for the next 12 months that comprehensively evaluates the patients biopsychosocial factors and makes recommendations to the referring practitioner to manage the patients ongoing care in a biopsychosocial model; and (e) if clinically appropriate, the consultant explains the diagnostic assessment and management plan, and gives a copy, to: (i) the patient; and (ii) the patients carer (if any), if the patient agrees; and (f) in the preceding 12 months, a service to which this item or item 92435 applies has not been provided to the patient
00293	01MAY2005	31OCT2007	N	CONSULTANT PSYCHIATRIST, REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - A management plan provided under Item 291 is reviewed and revised - The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The reviewed management plan is communicated in writing to the referring medical practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, payable no more than once in any 12 month period
00293	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - A management plan provided under Item 291 is reviewed and revised - The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The reviewed management plan is communicated in writing to the referring medical practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, and no payment has been made under item 359, payable no more than once in any 12 month period.
00293	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice or participating nurse practitioner. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: - An outcome tool is used where clinically appropriate - A mental state examination is conducted - A psychiatric diagnosis is made - A management plan provided under Item 291 is reviewed and revised - The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - The reviewed management plan is communicated in writing to the referring medical practitioner or participating nurse practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, and no payment has been made under item 359, payable no more than once in any 12 month period.
00293	01NOV2019	31OCT2020	N	Professional attendance of more than 30 minutes but not more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 applies has not been provided
00293	01NOV2020	31DEC2021	N	Professional attendance of more than 30 minutes but not more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 359 applies has not been provided
00293	01JAN2022	29FEB2024	N	Professional attendance of more than 30 minutes but not more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291 applies has been provided; and (f) in the preceding 12 months, a service to which this item applies has not been provided
00293	01MAR2024	31DEC9999	Y	Professional attendance lasting more than 30 minutes, but not more than 45 minutes, at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291 or item 92435; and (b) the attendance follows referral of the patient to the consultant, by the medical practitioner or participating nurse practitioner managing the patient, for review of the management plan and the associated comprehensive diagnostic assessment; and (c) during the attendance, the consultant: (i) if it is clinically appropriate to do so-uses an appropriate outcome tool; and (ii) carries out a mental state examination; and (iii) reviews the comprehensive diagnostic assessment and undertakes additional assessment as required; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant prepares and gives to the referring practitioner a written report, which includes: (i) the revised comprehensive diagnostic assessment of the patient; and (ii) a revised management plan including updated recommendations to the referring practitioner to manage the patients ongoing care in a biopsychosocial model; and (e) if clinically appropriate, the consultant explains the diagnostic assessment and management plan, and gives a copy, to: (i) the patient; and (ii) the patients carer (if any), if the patient agrees; and (f) in the preceding 12 months, a service to which item 291 or item 92435 applies has been provided to the patient; and (g) in the preceding 12 months, a service to which this item or item 92436 applies has not been provided to the patient
00294	01NOV2022	30JUN2023	N	Professional attendance on a patient by a consultant physician practising in the consultant physician's specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient is bulk billed; and (e) the patient: (i) is located both: (A) within a Modified Monash 2, 3, 4, 5, 6 or 7 area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential aged care facility; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00294	01JUL2023	29FEB2024	N	Professional attendance on a patient by a consultant physician practising in the consultant physicians specialty of psychiatry if: (a) the attendance is by video conference; and (b) except for the requirement for the attendance to be at consulting rooms-item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 would otherwise apply to the attendance; and (c) the patient is not an admitted patient; and (d) the patient is bulk-billed; and (e) the patient: (i) is located: (A) within a Modified Monash 2, 3, 4, 5, 6 or 7 area; and (B) at the time of the attendance-at least 15 km by road from the physician; or (ii) is a care recipient in a residential aged care facility; or (iii) is a patient of: (A) an Aboriginal medical service; or (B) an Aboriginal community controlled health service; for which a direction made under subsection 19(2) of the Act applies
00294	01MAR2024	31DEC9999	Y	Professional attendance on a patient by a consultant physician practising in the consultant physicians specialty of psychiatry if: (a) the attendance is by video conference; and (b) except for the requirement for the attendance to be at consulting rooms-item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318 or 319 would otherwise apply to the attendance; and (c) the patient is not an admitted patient; and (d) the patient is bulk-billed; and (e) the patient: (i) is located: (A) within a Modified Monash 2, 3, 4, 5, 6 or 7 area; and (B) at the time of the attendance-at least 15 km by road from the physician; or (ii) is a care recipient in a residential aged care facility; or (iii) is a patient of: (A) an Aboriginal medical service; or (B) an Aboriginal community controlled health service; for which a direction made under subsection 19(2) of the Act applies
00295	01FEB1984	31DEC9999	Y	Version, external, under general anaesthesia (AU 6)
00296	01NOV2006	31OCT2007	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, CONSULTING ROOMS Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 297 or 299, or any of items 300 to 346 or 353 to 370 in the preceding 24 month period
00296	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, CONSULTING ROOMS Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 297 or 299, or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period
00296	01NOV2011	31OCT2019	N	Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 297 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months
00296	01NOV2019	31DEC2021	N	Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 297 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months
00296	01JAN2022	29FEB2024	N	Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or item 297 or 299 or any of items 300 to 308, has applied in the preceding 24 months
00296	01MAR2024	31OCT2024	N	Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 has applied in the preceding 24 months
00296	01NOV2024	31DEC9999	Y	Professional attendance lasting more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner - an attendance at consulting rooms if the patient: (a) is a new patient for this consultant physician; or (b) has not received a professional attendance from this consultant physician in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 92437 and 92478 to 92483 has applied in the preceding 24 months
00297	01NOV2006	31OCT2007	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOSPITAL Professional attendance of more than 45 minutes at hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 299 or any of items 300 to 346 or 353 to 370 in the preceding 24 month period
00297	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOSPITAL Professional attendance of more than 45 minutes at hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a referring practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 299 or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period
00297	01NOV2011	31OCT2019	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months (H)
00297	01NOV2019	31DEC2021	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months (H)
00297	01JAN2022	29FEB2024	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or item 296 or 299 or any of items 300 to 308, has applied in the preceding 24 months (H)
00297	01MAR2024	31OCT2024	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 296, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 has applied in the preceding 24 months (H)
00297	01NOV2024	31DEC9999	Y	Professional attendance lasting more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner - an attendance at hospital if the patient: (a) is a new patient for this consultant physician; or (b) has not received a professional attendance from this consultant physician in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 296, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 92437 and 92478 to 92483 has applied in the preceding 24 months (H)
00298	01FEB1984	31DEC9999	Y	Version, internal, under general anaesthesia (AU 6)
00299	01NOV2006	31OCT2007	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOME VISITS Professional attendance of more than 45 minutes at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 297, or any of items 300 to 346 or 353 to 370 in the preceding 24 month period
00299	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOME VISITS Professional attendance of more than 45 minutes at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: - is a new patient for this consultant psychiatrist; or - is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 297, or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period
00299	01NOV2011	31OCT2019	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 297, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months
00299	01NOV2019	31DEC2021	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 297, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months
00299	01JAN2022	29FEB2024	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or item 296 or 297 or any of items 300 to 308, has applied in the preceding 24 months
00299	01MAR2024	31OCT2024	N	Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 296, 297, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 has applied in the preceding 24 months
00299	01NOV2024	31DEC9999	Y	Professional attendance lasting more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner - an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant physician; or (b) has not received a professional attendance from this consultant physician in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 296, 297, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 92437 and 92478 to 92483 has applied in the preceding 24 months
00300	01NOV1996	30JUN1998	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period.
00300	01JUL1998	31OCT2006	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00300	01NOV2006	31OCT2007	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00300	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 358 or 361 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00300	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00300	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00300	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 50 attendances in a calendar year for the patient
00300	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year for the patient
00301	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 60 minutes (other than a service to which any other item in this Schedule applies) by a prescribed medical practitioner in an eligible area-each attendance
00302	01NOV1996	30JUN1998	N	An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 304, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period.
00302	01JUL1998	31OCT2006	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00302	01NOV2006	31OCT2007	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00302	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00302	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00302	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 50 attendances in a calendar year for the patient
00302	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year for the patient
00303	01NOV2023	31DEC9999	Y	Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item applies) lasting more than 60 minutes-an attendance on one or more patients at one place on one occasion by a prescribed medical practitioner in an eligible area-each patient
00304	01NOV1996	30JUN1998	N	An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period.
00304	01JUL1998	31OCT2006	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00304	01NOV2006	31OCT2007	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00304	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00304	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00304	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 50 attendances in a calendar year for the patient
00304	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year for the patient
00306	01NOV1996	30JUN1998	N	An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 304 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period.
00306	01JUL1998	31OCT2007	N	- An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00306	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00306	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00306	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 50 attendances in a calendar year for the patient
00306	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year for the patient
00308	01NOV1996	30JUN1998	N	An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 304 or 306 apply have not exceeded the sum of 50 attendances in a 12 month period.
00308	01JUL1998	31OCT2006	N	- An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00308	01NOV2006	31OCT2007	N	- An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year.
00308	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00308	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00308	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 50 attendances in a calendar year for the patient
00308	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year for the patient
00309	01MAR2023	31OCT2023	N	Professional attendance at consulting rooms by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
00309	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and(b) lasting at least 30 minutes but less than 40 minutes
00310	01NOV1996	30JUN1998	N	An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 312, 314, 316 or 318 apply exceed 50 attendances in a 12 month period.
00310	01JUL1998	31OCT2006	N	- An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00310	01NOV2006	31OCT2007	N	- An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00310	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00310	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00310	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies exceed 50 attendances in a calendar year for the patient
00310	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies exceed 50 attendances in a calendar year for the patient
00311	01MAR2023	31OCT2023	N	Professional attendance at a place other than consulting rooms by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
00311	01NOV2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and(b) lasting at least 30 minutes but less than 40 minutes
00312	01NOV1996	30JUN1998	N	An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 314, 316 or 318 apply exceed 50 attendances in a 12 month period.
00312	01JUL1998	31OCT2006	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00312	01NOV2006	31OCT2007	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00312	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00312	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00312	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies exceed 50 attendances in a calendar year for the patient
00312	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies exceed 50 attendances in a calendar year for the patient
00313	01MAR2023	31OCT2023	N	Professional attendance at consulting rooms by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
00313	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and(b) lasting at least 40 minutes
00314	01NOV1996	30JUN1998	N	An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 316 or 318 apply exceed 50 attendances in a 12 month period.
00314	01JUL1998	31OCT2006	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00314	01NOV2006	31OCT2007	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00314	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00314	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00314	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies exceed 50 attendances in a calendar year for the patient
00314	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies exceed 50 attendances in a calendar year for the patient
00315	01MAR2023	31OCT2023	N	Professional attendance at a place other than consulting rooms by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
00315	01NOV2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service:(a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and(b) lasting at least 40 minutes
00316	01NOV1996	30JUN1998	N	An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 314 or 318 apply exceed 50 attendances in a 12 month period.
00316	01JUL1998	31OCT2006	N	- An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00316	01NOV2006	31OCT2007	N	- An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00316	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00316	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00316	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies exceed 50 attendances in a calendar year for the patient
00316	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies exceed 50 attendances in a calendar year for the patient
00318	01NOV1996	30JUN1998	N	An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 314 or 316 apply exceed 50 attendances in a 12 month period.
00318	01JUL1998	31OCT2006	N	- An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00318	01NOV2006	31OCT2007	N	- An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year.
00318	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00318	01NOV2019	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient
00318	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which item 296 or any of items 300 to 308 applies exceed 50 attendances in a calendar year for the patient
00318	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839 and 92437 applies exceed 50 attendances in a calendar year for the patient
00319	01JAN1997	30APR1997	N	- An attendance of more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 or 319 apply exceed 50 but not more than 160 attendances in a 12 month period and where the patient has: (i) a history of severe sexual or physical abuse which has led to psychiatric illness, or has been diagnosed as suffering from borderline personality disorder or anorexia nervosa or bulimia nervosa; and (ii) been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; and (iii) a history of failed related psychiatric treatment.
00319	01MAY1997	31OCT1997	N	- An attendance of more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 or 319 apply exceed 50 but not more than 160 attendances in a 12 month period and where the patient has: (i) a history of severe sexual or physical abuse which has led to psychiatric illness, or has been diagnosed as suffering from borderline personality disorder or anorexia nervosa or bulimia nervosa; and (ii) been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; and (iii) a history of failed related psychiatric treatment.
00319	01NOV1997	30JUN1998	N	- An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii) for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 300 to 308 apply do not exceed 160 attendances in a 12 month period.
00319	01JUL1998	31OCT2006	N	- An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii) for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply do not exceed 160 attendances in a calendar year.
00319	01NOV2006	31OCT2007	N	- An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii) for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply do not exceed 160 attendances in a calendar year.
00319	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for persons 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which any of items 296, 300 to 319, 353 to 358 and 361 to 370 applies have not exceeded 160 attendances in a calendar year for the patient
00319	01NOV2019	30JUN2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for persons 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which any of items 296, 300 to 319, 353 to 358 and 361 to 370 applies have not exceeded 160 attendances in a calendar year for the patient
00319	01JUL2021	31DEC2021	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for patients 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which any of items 296, 300 to 319, 353 to 358 and 361 to 370 applies have not exceeded 160 attendances in a calendar year for the patient
00319	01JAN2022	29FEB2024	N	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for patients 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which item 296 or any of items 300 to 308 applies have not exceeded 160 attendances in a calendar year for the patient
00319	01MAR2024	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance lasting more than 45 minutes at consulting rooms, if: (a) the formulation of the patients clinical presentation indicates intensive psychotherapy is a clinically appropriate and indicated treatment; and (b) that attendance and another attendance to which any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 91873 and 92437 applies have not exceeded 160 attendances in a calendar year for the patient
00320	01NOV1996	31OCT2000	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOSPITAL OR NURSING HOME (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at hospital or nursing home.
00320	01NOV2000	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOSPITAL (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at hospital.
00320	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at hospital
00320	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at hospital
00322	01NOV1996	31OCT2000	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration at hospital or nursing home.
00322	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at hospital
00322	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at hospital
00324	01NOV1996	31OCT2000	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration at hospital or nursing home.
00324	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at hospital
00324	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at hospital
00326	01NOV1996	31OCT2000	N	- An attendance of more than 45 minutes duration but not more than 75 minutes duration at hospital or nursing home.
00326	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at hospital
00326	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at hospital
00328	01NOV1996	31OCT2000	N	- An attendance of more than 75 minutes duration at hospital or nursing home.
00328	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at hospital
00328	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at hospital
00330	01NOV1996	31OCT2000	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOME VISITS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home.
00330	01NOV2000	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOME VISITS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration where that attendance is at a place other than consulting rooms or hospital
00330	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration if that attendance is at a place other than consulting rooms or hospital
00330	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration if that attendance is at a place other than consulting rooms or hospital
00332	01NOV1996	31OCT2000	N	- An attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home.
00332	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00332	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00334	01NOV1996	31OCT2000	N	- An attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home
00334	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00334	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00336	01NOV1996	31OCT2000	N	- An attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home.
00336	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00336	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration if that attendance is at a place other than consulting rooms or hospital
00338	01NOV1996	31OCT2000	N	- An attendance of more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home.
00338	01NOV2000	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration if that attendance is at a place other than consulting rooms or hospital
00338	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration if that attendance is at a place other than consulting rooms or hospital
00340	01NOV1996	31DEC9999	Y	ELECTROCONVULSIVE THERAPY ATTENDANCE FOR ELECTROCONVULSIVE THERAPY, with or without the use of stimulus dosing techniques, including any electroencephalographic monitoring and associated consultation
00341	01MAR2024	31DEC9999	Y	An interview, lasting not more than 15 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner, for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that service and another service to which this item or any of items 343, 345, 347, 349, 91874 to 91878 and 91882 to 91884 applies have not exceeded 15 services in a calendar year in relation to the patient
00342	01NOV1996	31OCT2011	N	CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - GROUP PSYCHOTHERAPY on a group of 2 to 9 unrelated patients OR FAMILY GROUP psychotherapy on a group of more than 3 patients, EACH PATIENT
00342	01NOV2011	31OCT2019	N	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a Group of 2 to 9 unrelated patients or a family Group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00342	01NOV2019	31DEC9999	Y	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a group of 2 to 9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00343	01MAR2024	31DEC9999	Y	An interview, lasting more than 15 minutes but not more than 30 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner, for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that service and another service to which this item or any of items 341, 345, 347, 349, 91874 to 91878 and 91882 to 91884 applies have not exceeded 15 services in a calendar year in relation to the patient
00344	01NOV1996	31OCT2019	N	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a family Group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00344	01NOV2019	31DEC9999	Y	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a family group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00345	01MAR2024	31DEC9999	Y	An interview, lasting more than 30 minutes but not more than 45 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner, for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that service and another service to which this item or any of items 341, 343, 347, 349, 91874 to 91878 and 91882 to 91884 applies have not exceeded 15 services in a calendar year in relation to the patient
00346	01NOV1996	31OCT2019	N	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a family Group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00346	01NOV2019	31DEC9999	Y	Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a family group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient
00347	01MAR2024	31DEC9999	Y	An interview, lasting more than 45 minutes but not more than 75 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner, for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that service and another service to which this item or any of items 341, 343, 345, 349, 91874 to 91878 and 91882 to 91884 applies have not exceeded 15 services in a calendar year in relation to the patient
00348	01NOV1996	31OCT2000	N	CONSULTANT PSYCHIATRIST INTERVIEW OF A PERSON OTHER THAN A PATIENT SURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home
00348	01NOV2000	31OCT2010	N	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility
00348	01NOV2010	31OCT2011	N	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility
00348	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility
00348	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient
00349	01MAR2024	31DEC9999	Y	An interview, lasting more than 75 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner, for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that service and another service to which this item or any of items 341, 343, 345, 347, 91874 to 91878 and 91882 to 91884 applies have not exceeded 15 services in a calendar year in relation to the patient
00350	01NOV1996	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility
00350	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient
00352	01NOV1996	31OCT2011	N	CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - IN THE COURSE OF CONTINUING MANAGEMENT OF A PATIENT Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry, where the patient is referred to him or her by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than 4 times in any 12 month period
00352	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry, where the patient is referred to him or her by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than 4 times in any 12 month period
00352	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item applies have not exceeded 4 in a calendar year for the patient
00353	01NOV2002	30APR2007	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 300 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment, -that consultation and any other consultation to which items 353 to 358 apply, have not exceeded 12 consultations in a calendar year, -a minimum of one face-to-face consultation (items 364 to 370) is conducted with the patient after every fourth telepsychiatry consultation, and -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration.
00353	01MAY2007	31OCT2007	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 358 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration.
00353	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 361 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration.
00353	01NOV2011	31OCT2019	N	A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a referring practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 361 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration.
00353	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of not more than 15 minutes in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00354	01FEB1984	31DEC9999	Y	Surgical induction of labour (AU 5)
00355	01NOV2002	31OCT2019	N	A telepsychiatry consultation of more than 15 minutes duration but not more than 30 minutes duration.
00355	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 15 minutes, but not more than 30 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00356	01NOV2002	31OCT2019	N	A telepsychiatry consultation of more than 30 minutes duration but not more than 45 minutes duration.
00356	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 30 minutes, but not more than 45 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00357	01NOV2002	31OCT2019	N	A telepsychiatry consultation of more than 45 minutes duration but not more than 75 minutes duration
00357	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 45 minutes, but not more than 75 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00358	01NOV2002	31OCT2019	N	A telepsychiatry consultation of more than 75 minutes duration
00358	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 75 minutes in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00359	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT A telepsychiatry consultation of more than 30 minutes but not more than 45 minutes duration by a consultant physician in the practice of his or her specialty of PSYCHIATRY where: - the patient is located in a regional, rural or remote area (RRMA 3-7) - in the preceding 12 months, payment has been made under item 291 - an outcome tool is used where clinically appropriate - a mental state examination is conducted - a psychiatric diagnosis is made - a management plan provided under Item 291 is reviewed and revised - the reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - the reviewed management plan is communicated in writing to the referring medical practitioner Not being an attendance on a patient in respect of whom payment has been made under this item or item 293 in the preceding 12 month period.
00359	01NOV2011	31OCT2019	N	A telepsychiatry consultation of more than 30 minutes but not more than 45 minutes duration by a consultant physician in the practice of his or her specialty of PSYCHIATRY where: - the patient is located in a regional, rural or remote area (RRMA 3-7) - in the preceding 12 months, payment has been made under item 291 - an outcome tool is used where clinically appropriate - a mental state examination is conducted - a psychiatric diagnosis is made - a management plan provided under Item 291 is reviewed and revised - the reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) - the reviewed management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom payment has been made under this item or item 293 in the preceding 12 month period.
00359	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry-a telepsychiatry consultation of more than 30 minutes but not more than 45 minutes in duration, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant physician in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant physician for review of the management plan by the referring practitioner managing the patient; and (c) during the attendance, the consultant physician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant physician: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) the patient is located in a regional, rural or remote area; and (f) in the preceding 12 months, a service to which item 291 applies has been performed; and (g) in the preceding 12 months, a service to which this item or item 293 applies has not been performed
00360	01FEB1984	31DEC9999	Y	Decapitation, craniotomy, cleidotomy or evisceration of foetus or any two or more of those services (AU 8)
00361	01NOV2007	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-a telepsychiatry consultation of more than 45 minutes in duration, if the patient: (a) either: (i) is a new patient for this consultant psychiatrist; or (ii) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; and (b) is located in a regional, rural or remote area; other than attendance on a patient in relation to whom this item, item 296, 297 or 299, or any of items 300 to 346 and 353 to 370, has applied in the preceding 24 month period
00361	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 45 minutes in duration, if the patient: (a) either: (i) is a new patient for this consultant physician; or (ii) has not received a professional attendance from this consultant physician in the preceding 24 months; and (b) is located in a regional, rural or remote area; other than attendance on a patient in relation to whom this item, item 296, 297 or 299, or any of items 300 to 346 and 353 to 370, has applied in the preceding 24 month period
00362	01FEB1984	31AUG1989	N	Evacuation of products of conception (such as retained foetus, placenta, membranes or mole) by intrauterine manual removal or treatment of postpartum haemorrhage by special procedures such as packing of uterus (AU 7)
00362	01SEP1989	31DEC9999	Y	Evacuation of products of conception (such as retained foetus, placenta, membranes or mole) by intrauterine manual removal as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
00363	01AUG1987	31AUG1989	N	Treatment of post-partum haemorrhage by special procedures such as packing of uterus as an independent procedure where the patient has been referred by another medical practitioner for this procedure
00363	01SEP1989	31DEC9999	Y	Treatment of post-partum haemorrhage by special procedures such as packing of uterus as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
00364	01NOV2002	30APR2007	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: -the patient is referred to him or her by a medical practitioner, -that attendance occurs following four telepsychiatry consultations (items 353 to 358), - where that attendance and any other attendance to which items 364 to 370 apply does not exceed three consultations per patient in a calendar year. -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after every fourth telepsychiatry consultation conducted in accordance with items 353 to 358. A face-to-face attendance of not more than 15 minutes duration.
00364	01MAY2007	31OCT2007	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a medical practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 358), - that attendance and any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 358. A face-to-face attendance of not more than 15 minutes duration.
00364	01NOV2007	31OCT2011	N	CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a medical practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 361), - that attendance and any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 361. A face-to-face attendance of not more than 15 minutes duration.
00364	01NOV2011	31OCT2019	N	Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a referring practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 361), - that attendance and any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 361. A face-to-face attendance of not more than 15 minutes duration.
00364	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of not more than 15 minutes in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00365	01FEB1984	31AUG1989	N	Manipulative correction of acute inversion of uterus, by vaginal approach, with or without incision of cervix (AU 8)
00365	01SEP1989	31DEC9999	Y	Manipulative correction of acute inversion of uterus, by vaginal approach, with or without incision of cervix as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
00366	01NOV2002	31OCT2019	N	A face-to-face attendance of more than 15 minutes duration but not more than 30 minutes duration
00366	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 15 minutes, but not more than 30 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00367	01NOV2002	31OCT2019	N	A face-to-face attendance of more than 30 minutes duration but not more than 45 minutes duration.
00367	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 30 minutes, but not more than 45 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00368	01FEB1984	31DEC9999	Y	Manipulative correction of acute inversion of uterus, by abdominal approach, with or without incision of cervix (AU 9)
00369	01NOV2002	31OCT2019	N	A face-to-face attendance of more than 45 minutes duration but not more than 75 minutes duration
00369	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 45 minutes, but not more than 75 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00370	01NOV2002	31OCT2019	N	A face-to-face attendance of more than 75 minutes duration.
00370	01NOV2019	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 75 minutes in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient
00371	01NOV2018	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner.
00372	01NOV2018	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner.
00383	01FEB1984	31AUG1989	N	Third degree tear, repair of, involving anal sphincter muscles (AU 7)
00383	01SEP1989	31DEC9999	Y	Third degree tear, repair of, involving anal sphincter muscles as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
00384	01JAN2013	31OCT2019	N	Initial professional attendance of 10 minutes or less in duration on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00384	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a consultant occupational physician practising in the consultant occupational physician's specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
00385	01JUL1998	31OCT2011	N	CONSULTANT OCCUPATIONAL PHYSICIAN, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine where the patient is referred to him or her by a medical practitioner) -INITIAL attendance in a single course of treatment
00385	01NOV2011	31OCT2019	N	Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
00385	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-initial attendance in a single course of treatment
00386	01JUL1998	31OCT2019	N	Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-each attendance after the first in a single course of treatment
00386	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-each attendance after the first in a single course of treatment
00387	01JUL1998	31OCT2011	N	CONSULTANT OCCUPATIONAL PHYSICIAN, REFERRED CONSULTATION - HOME VISITS (Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment
00387	01NOV2011	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
00387	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-initial attendance in a single course of treatment
00388	01JUL1998	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-each attendance after the first in a single course of treatment
00388	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-each attendance after the first in a single course of treatment
00389	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a consultant occupational physician practising in the specialty of occupational medicine, to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 385 or 386.
00389	01NOV2012	31DEC2012	N	Professional attendance on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) item 385 or 386 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
00389	01JAN2013	31OCT2019	N	Professional attendance on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 385 lasting more than 10 minutes; or (ii) provided with item 386; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00389	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a consultant occupational physician practising in the consultant occupational physician's specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 385 lasting more than 10 minutes; or (ii) provided with item 386; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00401	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 1)
00403	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 2)
00404	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 3)
00405	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 4)
00406	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 5)
00407	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 6)
00408	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 7)
00409	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 8)
00410	01NOV1999	30APR2010	N	PUBLIC HEALTH PHYSICIAN ATTENDANCES - SURGERY (Professional attendance at consulting rooms by a public health physician in the practice of his or her specialty of public health medicine) - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management
00410	01MAY2010	31DEC9999	Y	LEVEL AProfessional attendance at consulting rooms by a public health physician in the practice of his or her specialty of public health medicine for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management.
00411	01NOV1999	30APR2010	N	- Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR an attendance of less than 20 minutes duration involving components of a service to which item 412 applies
00411	01MAY2010	31DEC9999	Y	LEVEL BProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting less than 20 minutes, including any of the following that are clinically relevant: a) taking a patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00412	01NOV1999	30APR2010	N	- Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR an attendance of less than 40 minutes duration involving components of a service to which item 413 applies
00412	01MAY2010	31DEC9999	Y	LEVEL CProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting at least 20 minutes, including any of the following that are clinically relevant: a) taking a detailed patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00413	01NOV1999	30APR2010	N	- Attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR an attendance of at least 40 minutes duration for implementation of a management plan
00413	01MAY2010	31DEC9999	Y	LEVEL DProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting at least 40 minutes, including any of the following that are clinically relevant: a) taking an extensive patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00414	01NOV1999	30APR2010	N	PUBLIC HEALTH PHYSICIAN ATTENDANCES - OTHER THAN AT CONSULTING ROOMS (Professional attendance at other than consulting rooms by a public health physician in the practice of his or her specialty of public health medicine) - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management
00414	01MAY2010	31DEC2012	N	LEVEL A Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management.
00414	01JAN2013	31DEC9999	Y	LEVEL AProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management
00415	01NOV1999	30APR2010	N	- Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR an attendance of less than 20 minutes duration involving components of a service to which item 416 applies
00415	01MAY2010	31DEC2012	N	LEVEL B Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting less than 20 minutes, including any of the following that are clinically relevant: a) taking a patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00415	01JAN2013	31DEC9999	Y	LEVEL BProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms, lasting less than 20 minutes, including any of the following that are clinically relevant: a) taking a patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00416	01NOV1999	30APR2010	N	- Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR an attendance of less than 40 minutes duration involving components of a service to which item 417 applies
00416	01MAY2010	31DEC2012	N	LEVEL C Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting at least 20 minutes, including any of the following that are clinically relevant: a) taking a detailed patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00416	01JAN2013	31DEC9999	Y	LEVEL CProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms lasting at least 20 minutes, including any of the following that are clinically relevant: a) taking a detailed patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00417	01NOV1999	30APR2010	N	- Attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR an attendance of at least 40 minutes duration for implementation of a management plan
00417	01MAY2010	31DEC2012	N	LEVEL D Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting at least 40 minutes, including any of the following that are clinically relevant: a) taking an extensive patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00417	01JAN2013	31OCT2023	N	LEVEL DProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms lasting at least 40 minutes, including any of the following that are clinically relevant: a) taking an extensive patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation.
00417	01NOV2023	31DEC9999	Y	LEVEL D Professional attendance by a public health physician in the practice of the public health physicians specialty of public health medicine at other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: a) taking an extensive patient history; b) performing a clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
00443	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 9)
00444	01MAY2001	31DEC9999	Y	MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - SURGERY LEVEL 1 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management
00445	01MAY2001	31DEC9999	Y	LEVEL 2 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, or an attendance of less than 20 minutes duration involving components of a service to which item 446 applies
00446	01MAY2001	31DEC9999	Y	LEVEL 3 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, or an attendance of less than 40 minutes duration involving components of a service to which item 447 applies
00447	01MAY2001	31DEC9999	Y	LEVEL 4 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking an exhaustive history, an comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, or an attendance of at least 40 minutes duration for implementation of a management plan
00448	01MAY2001	28FEB2007	N	MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - EMERGENCY AFTER HOURS Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday
00448	01MAR2007	31DEC9999	Y	MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - URGENT AFTER-HOURS (on not more than 1 patient on the 1 occasion) Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00449	01MAY2001	28FEB2007	N	Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance, AT CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am
00449	01MAR2007	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS - each attendance between 11pm and 7am if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00450	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 10)
00453	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 11)
00454	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 12)
00457	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 13)
00458	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 14)
00459	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 15)
00460	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 16)
00461	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 17)
00462	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 18)
00463	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 19)
00464	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 20)
00465	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 21)
00466	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 22)
00467	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 23)
00468	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 24)
00469	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 25)
00470	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 26)
00471	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 27)
00472	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 28)
00473	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 29)
00474	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 30)
00475	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 32)
00476	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 36)
00477	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 38)
00478	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 39)
00479	01FEB1984	31AUG1989	N	Administration of an anaesthetic in connection with electroconvulsive therapy
00479	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 40)
00480	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with radio-therapy
00481	01FEB1984	31AUG1989	N	Administration of an anaesthetic in connection with a forceps delivery of a foetus
00481	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with forceps delivery, vacuum extraction delivery, breech delivery by manipulation, delivery of second twin by manipulation, rotation of head followed by delivery-where an epidural needle or catheter has not been inserted earlier in labour
00482	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a dislocation requiring open operation, being a dislocation referred to in Items 7397 to 7472
00483	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Items 7505 to 7798
00484	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring internal fixation or in connection with the treatment of a compound fracture requiring open operation, being in either case a fracture referred to in Items 7505 to 7798
00485	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Items 7505 to 7798
00486	01NOV1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service that does not contain a reference to a number of anaesthetic units
00487	01FEB1984	31DEC9999	Y	Administration of an anaesthetic where the anaesthetic is administered as a therapeutic procedure
00488	01NOV1986	31DEC9999	Y	Administration of an anaesthetic in connection with reamputation of amputation stump referred to in item 5057
00489	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography-brain scan, plain study with or without contrast medium study
00490	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography-body scan, plain study with or without contrast medium study
00492	01APR1985	31AUG1989	N	Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - THIRTY-FOUR UNITS
00492	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 34)
00493	01JUL1985	31AUG1989	N	Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - THIRTY-FOUR UNITS
00493	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 35)
00497	01JUN1985	31AUG1989	N	Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - FORTY-SEVEN UNITS
00497	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 47)
00500	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 1)
00501	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving straightforward medical decision making that requires: (a) taking a problem focussed history; and (b) limited examination; and (c) diagnosis; and (d) initiation of appropriate treatment interventions
00501	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving straightforward medical decision making that requires: (a) taking a problem focussed history; and (b) limited examination; and (c) diagnosis; and (d) initiation of appropriate treatment interventions
00503	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of low complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (d) initiation of appropriate treatment interventions
00503	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of low complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (d) initiation of appropriate treatment interventions
00505	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 2)
00506	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 3)
00507	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions
00507	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions
00509	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 4)
00510	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 5)
00511	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking a detailed history; and (b) detailed examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent
00511	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking a detailed history; and (b) detailed examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent
00513	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 6)
00514	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 7)
00515	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of high complexity that requires: (a) taking a comprehensive history; and (b) comprehensive examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent
00515	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of high complexity that requires: (a) taking a comprehensive history; and (b) comprehensive examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent
00517	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 8)
00518	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 9)
00519	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 30 minutes but less than 1 hour (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00519	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 30 minutes but less than 1 hour (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00520	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 1 hour but less than 2 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00520	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 1 hour but less than 2 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00521	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 10)
00522	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 11)
00523	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 12)
00524	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 13)
00525	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 14)
00526	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 15)
00527	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 16)
00528	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 17)
00529	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 18)
00530	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 2 hours but less than 3 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00530	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 2 hours but less than 3 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00531	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 19)
00532	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 3 hours but less than 4 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00532	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 3 hours but less than 4 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00533	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 20)
00534	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 4 hours but less than 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00534	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 4 hours but less than 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00535	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 21)
00536	01NOV2002	31OCT2019	N	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00536	01NOV2019	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem
00537	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 22)
00538	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 23)
00539	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 24)
00540	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 25)
00541	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 26)
00542	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 27)
00543	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 28)
00544	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 29)
00545	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 30)
00546	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 32)
00547	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 36)
00548	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 38)
00549	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 39)
00550	01FEB1984	31AUG1989	N	Administration of an anaesthetic in connection with electroconvulsive therapy
00550	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 40)
00551	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with radio-therapy
00552	01FEB1984	31AUG1989	N	Administration of an anaesthetic in connection with a forceps delivery of a foetus
00552	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with forceps delivery, vacuum extraction delivery, breech delivery by manipulation, delivery of second twin by manipulation, rotation of head followed by delivery- where an epidural needle or catheter has not been inserted earlier in labour
00553	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a dislocation requiring open operation, being a dislocation referred to in Items 7397 to 7472
00554	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Items 7505 to 7798
00556	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring internal fixation or in connection with the treatment of a compound fracture requiring open operation, being in either case a fracture referred to in Items 7505 to 7798
00557	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with the treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Items 7505 to 7798
00558	01NOV1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service that does not contain a reference to a number of anaesthetic units
00559	01FEB1984	31DEC9999	Y	Administration of an anaesthetic where the anaesthetic is administered as a therapeutic procedure
00560	01OCT1986	31AUG1989	N	- In connection with reamputation of amputation stump referred to in item 5057 DERIVED FEE - 85% of the fee specified for the anaesthetic for the amputation
00560	01SEP1989	31DEC9999	Y	Administration of an anaesthetic in connection with reamputation of amputation stump referred to in item 5057
00561	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography-brain scan, plain study with or without contrast medium study
00562	01FEB1984	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography-body scan, plain study with or without contrast medium study
00563	01NOV1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 34)
00564	01NOV1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 35)
00565	01DEC1984	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 47)
00566	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an anaesthetic, other than an endotracheal anaesthetic, in connection with a dental operation (G)
00567	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an anaesthetic, other than an endotracheal anaesthetic, in connection with a dental operation (S)
00568	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for extraction of a tooth or teeth, not being a service covered by Item 570 (G)
00569	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for extraction of a tooth or teeth, not being a service covered by Item 571 (S)
00570	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for removal of a tooth or teeth requiring incision of soft tissue and removal of bone (G)
00571	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for removal of a tooth or teeth requiring incision of soft tissue and removal of bone (S)
00572	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of not more than 30 minutes duration (G)
00573	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of not more than 30 minutes duration (S)
00574	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of more than 30 minutes duration (G)
00575	01FEB1984	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of more than 30 minutes duration (S)
00576	01JUL1985	31AUG1989	N	ADMINISTRATION BY A MEDICAL PRACTITIONER OF AN ENDOTRACHEAL ANAESTHETIC in connection with a dental operation, not covered by any other item in this Part. Anaesthetic 7 units (G)
00576	01SEP1989	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic in connection with a dental operation, not covered by any other item in this Part (G)
00577	01JUL1985	31AUG1989	N	ADMINISTRATION BY A MEDICAL PRACTITIONER OF AN ENDOTRACHEAL ANAESTHETIC in connection with a dental operation, not covered by any other item in this Part. Anaesthetic 7 units (S)
00577	01SEP1989	31DEC9999	Y	Administration by a medical practitioner of an endotracheal anaesthetic in connection with a dental operation, not covered by any other item in this Part (S)
00585	01MAR2018	31DEC9999	Y	Professional attendance by a general practitioner on one patient on one occasion-each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms-it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00588	01MAR2018	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) on one patient on one occasion-each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment; and (c) the attendance is in an after-hours rural area; and (d) if the attendance is at consulting rooms-it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00591	01MAR2018	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) on one patient on one occasion-each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment; and (c) the attendance is not in an after-hours rural area; and (d) if the attendance is at consulting rooms-it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00594	01MAR2018	31DEC9999	Y	Professional attendance by a medical practitioner-each additional patient at an attendance that qualifies for item 585, 588 or 591 in relation to the first patient
00597	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken urgent after-hours period; b) the patient's condition requires urgent medical treatment; and c) if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00598	01MAY2010	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken urgent after-hours period; b) the patient's condition requires urgent medical treatment; and c) if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00599	01MAY2010	28FEB2018	N	Professional attendance, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b) the patient's condition requires urgent medical treatment; and c) if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to and specially open, the consulting rooms for the attendance.
00599	01MAR2018	31DEC9999	Y	Professional attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms-it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00600	01MAY2010	28FEB2018	N	Professional attendance, by a medical practitioner, (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b) the patient's condition requires urgent medical treatment; and c) if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to and specially open, the consulting rooms for the attendance
00600	01MAR2018	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms-it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance
00601	01NOV1997	28FEB2007	N	Professional attendance, at a place OTHER THAN CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance on any day of the week between 11pm and 7am
00601	01MAR2007	31DEC9999	Y	Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment
00602	01NOV1997	28FEB2007	N	Professional attendance, AT CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am
00602	01MAR2007	31DEC9999	Y	Professional attendance AT CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00603	01NOV2008	31DEC9999	Y	GENERAL PRACTITIONER URGENT ATTENDANCES - TRANSITIONAL HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (between 6pm and 8pm weekdays excluding public holidays and 12pm and 1pm on a Saturday) in a transitional hours, if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b) the patient's medical condition requires urgent treatment
00696	01NOV2008	31DEC9999	Y	OTHER NON-REFERRED URGENT ATTENDANCES - TRANSITIONAL HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a medical practitioner, other than a general practitioner on not more than 1 patient on the 1 occasion - each attendance (between 6pm and 8pm weekdays excluding public holidays and 12pm and 1pm on a Saturday) in a transitional hours, if: a) the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b) the patient's medical condition requires urgent treatment
00697	01NOV1997	28FEB2007	N	Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance on any day of the week between 11pm and 7am
00697	01MAR2007	31DEC9999	Y	Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment
00698	01NOV1997	28FEB2007	N	Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am
00698	01MAR2007	31DEC9999	Y	Professional attendance AT CONSULTING ROOMS, by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and the patient's medical condition requires urgent treatment; and it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance
00699	01APR2019	31OCT2019	N	Professional attendance for a heart health assessment by a general practitioner at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status, cholesterol status (if not performed within the last 12 months) and blood glucose;(b) a physical examination, which must include recording of blood pressure;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation.
00699	01NOV2019	30JUN2021	N	Professional attendance for a heart health assessment by a general practitioner at consulting rooms lasting at least 20 minutes and must include: (a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status and blood glucose;(b) a physical examination, which must include recording of blood pressure and cholesterol status;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation. Claimable once only in a 12 month period. The heart health assessment item cannot be claimed if a patient has had a health assessment service (items 701, 703, 705, 707, 715) in the previous 12 months.
00699	01JUL2021	31DEC9999	Y	Professional attendance on a patient who is 30 years of age or over for a heart health assessment by a general practitioner at consulting rooms lasting at least 20 minutes and including: collection of relevant information, including taking a patient history; and a basic physical examination, which must include recording blood pressure and cholesterol; and initiating interventions and referrals as indicated; and implementing a management plan; and providing the patient with preventative health care advice and information.
00700	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 702, 704 or 706
00700	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 702, 704 or 706
00701	01MAY2010	30JUN2018	N	Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information
00701	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information
00702	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A NURSING HOME, for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 704 or 706
00702	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 704 or 706
00703	01MAY2010	30JUN2018	N	Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient
00703	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient
00704	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 706
00704	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 706
00705	01MAY2010	30JUN2018	N	Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient
00705	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient
00706	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A NURSING HOME, for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 704
00706	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY, for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 704
00707	01MAY2010	30JUN2018	N	Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient
00707	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient
00708	01MAY2006	31DEC9999	Y	ABORIGINAL AND TORRES STRAIT ISLANDER CHILD HEALTH CHECK Attendance by a medical practitioner, other than a specialist or a consultant physician, at consulting rooms or in another place other than a hospital or Residential Aged Care Facility, for a child health check of a patient who is of Aboriginal or Torres Strait Islander descent and aged 0 to 14 years inclusive - not being a child health check of a patient in respect of whom, in the preceding 9 months, a payment has been made under this item
00709	01JUL2008	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS to undertake a health check for a patient who is receiving or has received their four year old immunisation. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 711. Benefits are payable on one occasion only for each eligible patient.
00710	01MAY2004	31DEC9999	Y	ABORIGINAL AND TORRES STRAIT ISLANDER ADULT HEALTH CHECK Attendance by a medical practitioner, other than a specialist or a consultant physician, at consulting rooms or in another place other than a hospital or Residential Aged Care Facility, for an adult health check of a patient who is of Aboriginal or Torres Strait Islander descent and aged at least 15 years old and less than 55 years old - not being an adult health check of a patient in respect of whom, in the preceding 18 months, a payment has been made under this item
00711	01JUL2008	31OCT2008	N	Service provided by a practice nurse being the provision of a health check for a patient who is receiving or has received their four year old immunisation, if : (a) the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b) the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 709. Benefits are payable on one occasion only for each eligible patient.
00711	01NOV2008	31DEC9999	Y	Service provided by a practice nurse or registered Aboriginal Health Worker being the provision of a health check for a patient who is receiving or has received their four year old immunisation, if : (a) the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b) the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 709. Benefits are payable on one occasion only for each eligible patient.
00712	01JUL2004	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A RESIDENTIAL AGED CARE FACILITY OR AT CONSULTING ROOMS for a Comprehensive Medical Assessment (CMA) of a permanent resident of a residential aged care facility - not being a CMA of a resident in respect of whom, in the preceding 12 months, a payment has been made under this item. Benefits under this item are payable in respect of one CMA for new residents on admission to a Residential Aged Care Facility and for continuing residents on an as required basis, with a maximum of one CMA for a resident in any twelve month period.
00713	01JUL2008	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A PLACE OTHER THAN A HOSPITAL to undertake a type 2 diabetes risk evaluation for a patient who is 40 to 49 years of age (inclusive) with a high risk of developing type 2 diabetes as determined by the Australian Type 2 Diabetes Risk Assessment Tool - not being a type 2 diabetes risk evaluation of a patient in respect of whom, in the preceding 3 years, a payment has been made under this item or item 717.
00714	01MAY2006	31DEC9999	Y	HEALTH ASSESSMENT FOR REFUGEES AND OTHER HUMANITARIAN ENTRANTS Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment of a patient that has been granted residency in Australia under the Humanitarian Program, not being a health assessment of a patient in respect of whom, a payment has been made under this item or item 700, 702, 712 or 716. Benefits are payable for a service provided to a patient within 12 months of them arriving in Australia or receiving residency (whichever is the later) Note: Benefits are payable on one occasion only for a service included in this item or item716
00715	01MAY2010	30JUN2018	N	Professional attendance by a medical practitioner (other than a specialist or consultant physician) at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-not more than once in a 9 month period
00715	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-not more than once in a 9 month period
00716	01MAY2006	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY for a health assessment of a patient that has been granted residency in Australia under the Humanitarian Program, not being a health assessment of a patient in respect of whom, a payment has been made under this item or item 700, 702, 712 or 714. Benefits are payable for a service provided to a patient within 12 months of them arriving in Australia or receiving residency (whichever is the later) Note: Benefits are payable on one occasion only for a service included in this item or item 714
00717	01NOV2006	31DEC9999	Y	45 YEAR OLD HEALTH CHECK Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A PLACE OTHER THAN A HOSPITAL to undertake a health check for a patient between the age of 45 and 49 (inclusive) at risk of developing a chronic disease. Benefits are payable on one occasion only for each eligible patient.
00718	01JUL2007	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient with an intellectual disability - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 719.
00719	01JUL2007	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) not being an attendance at consulting rooms, a hospital or residential aged care facility for a health assessment - of a patient with an intellectual disability - not being a health assessment for a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 718.
00720	01NOV1999	30APR2000	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once in any 6 month period
00720	01MAY2000	31OCT2000	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary COMMUNITY CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once in any 6 month period
00720	01NOV2000	31DEC9999	Y	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary COMMUNITY CARE PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply) - payable not more than once in any 6 month period
00721	01JUL2005	31OCT2006	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MANAGEMENT PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or former item 720, or within three months of a claim for items 725, 727, 729 or 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Management Plan.
00721	01NOV2006	30APR2010	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MANAGEMENT PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, or within three months of a claim for items 725, 727, 729 or 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Management Plan.
00721	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 apply)
00721	01JUL2018	31DEC9999	Y	Attendance by a general practitioner for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 apply)
00722	01NOV1999	31OCT2000	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once for each HOSPITAL ADMISSION
00722	01NOV2000	31DEC9999	Y	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary DISCHARGE CARE PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply) - payable not more than once for each HOSPITAL ADMISSION
00723	01JUL2005	31OCT2006	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE the development of TEAM CARE ARRANGEMENTS for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or former item 720, or within three months of a claim for item 727, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of new Team Care Arrangements.
00723	01NOV2006	30APR2010	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE the development of TEAM CARE ARRANGEMENTS for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, or within three months of a claim for item 727, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of new Team Care Arrangements.
00723	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 apply)
00723	01JUL2018	31DEC9999	Y	Attendance by a general practitioner to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 apply)
00724	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary CARE PLAN prepared by that medical practitioner for a patient (not being a payment in respect of a service to which items 740 to 773 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a) in respect of whom, in the preceding 3 months, a payment has been made under item 720; or (b) in respect of whom, in the preceding month, a payment has been made under item 722
00724	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary COMMUNITY CARE PLAN or a DISCHARGE CARE PLAN prepared by that medical practitioner for a patient and claimed for under item 720 or 722 (not being a payment for a service to which items 740 to 773 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a) for whom, in the preceding 3 months, a payment has been made under item 720; or (b) for whom, in the preceding month, a payment has been made under item 722
00724	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary COMMUNITY CARE PLAN or a DISCHARGE CARE PLAN prepared by that medical practitioner for a patient and claimed for under item 720 or 722 (not being a payment for a service to which items 734 to 779 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a) for whom, in the preceding 3 months, a payment has been made under item 720; or (b) for whom, in the preceding month, a payment has been made under item 722
00725	01JUL2005	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW: (a) a GP MANAGEMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 721 applies; or (b) a multidisciplinary community care plan to which former item 720 applied, or a multidisciplinary discharge care plan to which former item 722 applied, prepared by that medical practitioner (or an associated medical practitioner); (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Management Plan.
00726	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary CARE PLAN (not being a payment in respect of a service to which items 740 to 773 apply) - not being an attendance in relation to a patient in respect of whom, in the preceding 6 months, a payment has been made under item 720
00726	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to contribute to a multidisciplinary COMMUNITY CARE PLAN or to a REVIEW of a multidisciplinary COMMUNITY CARE PLAN prepared by another provider (not being a payment for a service to which items 740 to 773 apply) - not being an attendance in relation to a patient for whom, in the preceding 6 months, a payment has been made under item 720
00726	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to contribute to a multidisciplinary COMMUNITY CARE PLAN or to a REVIEW of a multidisciplinary COMMUNITY CARE PLAN prepared by another provider (not being a payment for a service to which items 734 to 779 apply) - not being an attendance in relation to a patient for whom, in the preceding 6 months, a payment has been made under item 720
00727	01JUL2005	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE a REVIEW of (a) TEAM CARE ARRANGEMENTS coordinated by that medical practitioner (or an associated medical practitioner) to which item 723 applies; or (b) a multidisciplinary community care plan to which former item 720 applied or a multidisciplinary discharge care plan to which former item 722 applied, prepared by that medical practitioner (or an associated medical practitioner); (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 723, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of a new review of Team Care Arrangements.
00728	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary DISCHARGE CARE PLAN (not being a service associated with a service to which items 722, 740 to 773 apply)
00728	01MAY2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to CONTRIBUTE to a multidisciplinary DISCHARGE CARE PLAN or to a REVIEW of a multidisciplinary DISCHARGE CARE PLAN prepared by another provider (not being a service associated with a service to which items 722, 734 to 779 apply)
00729	01JUL2005	31OCT2006	N	CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to a multidisciplinary care plan prepared by another provider or to a REVIEW of a multidisciplinary care plan prepared by another provider (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a claim by the same practitioner for item 721 or 723, within three months of a claim for the same item or within three months of a claim for item 725, former item 726, item 727, former item 728 or item 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan.
00729	01NOV2006	30APR2010	N	CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to a multidisciplinary care plan prepared by another provider or to a REVIEW of a multidisciplinary care plan prepared by another provider (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a claim by the same practitioner for item 721 or 723, within three months of a claim for the same item or within three months of a claim for item 725, item 727, or item 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan.
00729	01MAY2010	30JUN2018	N	Contribution by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 apply)
00729	01JUL2018	31OCT2024	N	Contribution by a general practitioner to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 apply)
00729	01NOV2024	31DEC9999	Y	Contribution by a general practitioner (not including a specialist or consultant physician) to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of item 735, 739, 743, 747, 750 or 758 applies)
00730	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary CARE PLAN IN A RESIDENTIAL AGED CARE FACILITY or to a REVIEW of a multidisciplinary CARE PLAN IN A RESIDENTIAL AGED CARE FACILITY prepared by the residential aged care facility (not being a payment in respect of a service to which items 734 to 779 apply)
00731	01JUL2005	31OCT2006	N	CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to: (a) a multidisciplinary care plan for a patient in A RESIDENTIAL AGED CARE FACILITY, prepared by that facility, or to a REVIEW of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a resident by another provider before the resident is discharged from a hospital or an approved day-hospital facility, or to a review of such a plan prepared by another provider; (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, 723, 725, 727, 729 or former item 730, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan.
00731	01NOV2006	30APR2010	N	CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to: (a) a multidisciplinary care plan for a patient in A RESIDENTIAL AGED CARE FACILITY, prepared by that facility, or to a REVIEW of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a resident by another provider before the resident is discharged from a hospital or an approved day-hospital facility, or to a review of such a plan prepared by another provider; (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, 723, 725, 727, 729, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan.
00731	01MAY2010	30JUN2018	N	Contribution by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 apply)
00731	01JUL2018	31OCT2024	N	Contribution by a general practitioner to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 apply)
00731	01NOV2024	31DEC9999	Y	Contribution by a general practitioner (not including a specialist or consultant physician) to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which item 735, 739, 743, 747, 750 or 758 applies)
00732	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 721 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 723 applies
00732	01JUL2018	31DEC9999	Y	Attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 applies
00733	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner-each attendance
00733	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which another item applies) by a prescribed medical practitioner-each attendance
00734	01NOV2000	31DEC9999	Y	CASE CONFERENCE - MEDICAL PRACTITIONER (OTHER THAN A SPECIALIST OR CONSULTANT PHYSICIAN) Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which item 731 applies)
00735	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply)
00735	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply)
00736	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which item 731 applies)
00737	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes in duration (other than a service to which another item applies) by a medical practitioner-each attendance
00737	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes in duration (other than a service to which another item applies) by a prescribed medical practitioner-each attendance
00738	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 45 minutes, (not being a service associated with a service to which item 731 applies)
00739	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00739	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00740	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply)
00740	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply)
00740	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply)
00741	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner-each attendance
00741	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes in duration (other than a service to which another item applies) by a prescribed medical practitioner-each attendance
00742	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00742	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00742	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply)
00743	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00743	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00744	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00744	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00744	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply)
00745	01JUL2018	31OCT2023	N	Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner-each attendance
00745	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration but not more than 60 minutes (other than a service to which another item applies) by a prescribed medical practitioner-each attendance
00746	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00746	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00747	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply)
00747	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply)
00748	01FEB1984	31OCT1986	N	Initial major regional or field block, including abdominal; brachial plexus; caudal; cervical plexus (not including the uterine cervix); epidural (peridural) ; paravertebral (thoracic or lumbar); pudendal; sacral; spinal
00748	01NOV1986	31AUG1989	N	REGIONAL OR FIELD NERVE BLOCK, being one of the following nerve blocks — abdominal (in association with an intra-peritoneal operation), brachial plexus, caudal, cervical plexus (not including the uterine cervix), epidural (peridural), ilio inguinal-ilio hypogastric-genitofemoral, intercostal (involving any four or more nerves, one or both sides), paravertebral (thoracic or lumbar), pudendal; retrobulbar with facial nerve; sacral or spinal (intrathecal)
00748	01SEP1989	31DEC9999	Y	Regional or field nerve block, being one of the following nerve blocks-abdominal (in association with an intraperitoneal operation); brachial plexus, cervical plexus (not including the uterine cervix); epidural (peridural); ilio-inguinal, ilio-hypogastric, genito-femoral, (involving all three nerves); intercostal (involving any four or more nerves, one or both sides); paravertebral (thoracic or lumbar); pudendal; retrobulbar with facial nerve; sacral or spinal (intrathecal)
00749	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00749	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00750	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00750	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00751	01MAR1987	31DEC9999	Y	MAINTENANCE OF A REGIONAL OR FIELD NERVE BLOCK referred to in Item 748 by the administration of local anaesthetic through an in situ needle or catheter when performed other than by the operating surgeon
00752	01FEB1984	31JUL1987	N	Subsequent major regional or field block, including abdominal; brachial plexus; caudal; cervical plexus (not including the uterine cervix); epidural (peridural) ; paravertebral (thoracic or lumbar); pudendal; sacral; spinal
00752	01AUG1987	31DEC9999	Y	INTRODUCTION OF A NARCOTIC, for the control of post-operative pain, into the epidural or intrathecal space in association with an operation
00753	01FEB1984	29FEB1984	N	Epidural injection in lumbar or thoracic region for the control of post-operative pain, in association with general anaesthesia
00753	01MAR1984	31OCT1986	N	Introduction at the end of an operation of a narcotic or local anaesthetic into the lumbar or thoracic epidural space for the control of post-operative pain, in association with general anaesthesia
00753	01NOV1986	31AUG1989	N	INTRODUCTION at the end of an operation OF A NARCOTIC OR LOCAL ANAESTHETIC into the caudal,lumbar or thoracic epidural space for the control of post-operative pain,in association with general anaesthesia
00753	01SEP1989	31DEC9999	Y	Introduction at the end of an operation of a local anaesthetic into the caudal, lumbar or thoracic epidural space for the control of post-operative pain, in association with general anaesthesia
00754	01AUG1987	31DEC9999	Y	MAINTENANCE of narcotic analgesia referred to in Item 752 by the administration of a narcotic through an in situ needle or catheter, when performed other than by the operating surgeon
00755	01FEB1984	31OCT1986	N	Nerve block with local anaesthetic agent of the coeliac plexus, the lumbar sympathetic chain, the thoracic sympathetic chain, the glossopharyngeal nerve or the obturator nerve, with or without X-ray control
00755	01NOV1986	31AUG1989	N	NERVE BLOCK with local anaesthetic agent of the coeliac plexus, lumbar sympathetic chain, thoracic sympathetic chain glossopharyngeal nerve or obturator nerve, with or without x-ray control
00755	01SEP1989	31DEC9999	Y	Nerve block with local anaesthetic agent of the coeliac plexus, the lumbar sympathetic chain, the thoracic sympathetic chain, the glossopharyngeal nerve or the obturator nerve, with or without X-ray control (AU 8)
00756	01FEB1984	31OCT1986	N	Nerve block with alcohol, phenol or other neurolytic agent of the coeliac plexus, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain or a cranial nerve (other than the trigeminal nerve) or an epidural or caudal block with or without X-ray control, localization by electrical stimulator or preliminary block with local anaesthetic
00756	01NOV1986	31AUG1989	N	NERVE BLOCK with alcohol, phenol or other neurolytic agent of the coeliac plexus nerve, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain, or cranial nerve (other than the trigeminal nerve) or an epidural or caudal block With or without x-ray control, localisation by electrical stimulator or preliminary block with local anaesthetic
00756	01SEP1989	31DEC9999	Y	Nerve block with alcohol, phenol or other neurolytic agent of the coeliac plexus, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain or a cranial nerve (other than the trigeminal nerve) or an epidural or caudal block with or without X-ray control, localization by electrical stimulator or preliminary block with local anaesthetic (AU 8)
00757	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00757	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00758	01MAY2010	30JUN2018	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00758	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply)
00759	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE, (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply)
00759	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE, (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply)
00759	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE, (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply)
00760	01FEB1984	28FEB1987	N	Intravenous regional anaesthesia of limb by retrograde perfusion (G)
00760	01MAR1987	31DEC9999	Y	Intravenous regional anaesthesia of limb by retrograde perfusion (G)
00761	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting not more than 5 minutes-an attendance on one or more patients on one occasion-each patient
00761	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting not more than 5 minutes-an attendance on one or more patients on one occasion-each patient
00762	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00762	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00762	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply)
00763	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 5 minutes, but not more than 25 minutes-an attendance on one or more patients on one occasion-each patient
00763	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 5 minutes, but not more than 25 minutes-an attendance on one or more patients on one occasion-each patient
00764	01FEB1984	28FEB1987	N	Intravenous regional anaesthesia of limb by retrograde perfusion (S)
00764	01MAR1987	31DEC9999	Y	Intravenous regional anaesthesia of limb by retrograde perfusion (S)
00765	01NOV1999	30APR2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00765	01MAY2000	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply)
00765	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply)
00766	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 25 minutes, but not more than 45 minutes-an attendance on one or more patients on one occasion-each patient
00766	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 25 minutes, but not more than 45 minutes-an attendance on one or more patients on one occasion-each patient
00767	01FEB1984	31OCT1986	N	Assistance in the administration of an anaesthetic where the administration of the anaesthetic is in connection with a medical service which contains the reference (AU 21), (AU 22), (AU 23), (AU 24), (AU 25), (AU 26), (AU 27), (AU 28), (AU 29), (AU 30), (AU 32), (AU 36), (AU 38) or (AU 39)
00767	01NOV1986	31AUG1989	N	Assistance in the administration of an anaesthetic for which the anaesthetic unit value is not less than 21 units
00767	01SEP1989	31DEC9999	Y	Assistance in the administration of an anaesthetic where the administration of the anaesthetic is in connection with a medical service which contains the reference (AU 21), (AU 22), (AU 23), (AU 24), (AU 25), (AU 26), (AU 27), (AU 28), (AU 29), (AU 30), (AU 32), (AU 34), (AU 35), (AU 36), (AU 38), (AU 39), (AU 40) or (AU 47)
00768	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00768	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00769	01JUL2018	31OCT2023	N	Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 45 minutes-an attendance on one or more patients on one occasion-each patient
00769	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 45 minutes, but not more than 60 minutes-an attendance on one or more patients on one occasion-each patient.
00770	01FEB1984	31OCT1986	N	Blood pressure recording by intravascular cannula (AU 4)
00770	01NOV1986	28FEB1987	N	BLOOD PRESSURE RECORDING by intravascular cannula
00770	01MAR1987	31DEC9999	Y	BLOOD PRESSURE RECORDING by intravascular cannula
00771	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00771	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00772	01JUL2018	31OCT2023	N	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of not more than 5 minutes in duration by a medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00772	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of not more than 5 minutes in duration by a prescribed medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00773	01NOV1999	31OCT2000	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION
00773	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION
00774	01FEB1984	28FEB1987	N	Hyperbaric oxygen therapy where the medical practitioner is not in the chamber
00774	01MAR1987	31DEC9999	Y	Hyperbaric oxygen therapy where the medical practitioner is not in the chamber
00775	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which item 731 applies)
00776	01JUL2018	31OCT2023	N	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 5 minutes in duration but not more than 25 minutes in duration by a medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00776	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes in duration by a prescribed medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00777	01FEB1984	28FEB1987	N	Hyperbaric oxygen therapy where the medical practitioner is confined in the chamber
00777	01MAR1987	31DEC9999	Y	Hyperbaric oxygen therapy where the medical practitioner is confined in the chamber
00778	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which item 731 applies)
00779	01NOV2000	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 45 minutes, (not being a service associated with a service to which item 731 applies)
00780	01MAY1990	31DEC9999	Y	URINE FLOW STUDY including peak urine flow measurement, not associated with Item 786
00781	01MAY1990	31DEC9999	Y	CYSTOMETROGRAPHY, not associated with Items 784, 785, 786, 810817, 839, 5840 or any item in Part 8
00782	01MAY1990	31DEC9999	Y	URETHRAL PRESSURE PROFILOMETRY, not associated with Items 783, 786, 810817, 839, 5840 or any item in Part 8
00783	01MAY1990	31DEC9999	Y	URETHRAL PRESSURE PROFILOMETRY WITH simultaneous measurement of urethral sphincter electromyography, not associated with Items 782, 785, 786, 5840 or any item in Part 8
00784	01MAY1990	31DEC9999	Y	CYSTOMETROGRAPHY with simultaneous measurement of rectal pressure, not associated with Items 781, 785, 786, 810817, 839, 5840 or any item in Part 8
00785	01MAY1990	31DEC9999	Y	CYSTOMETROGRAPHY with simultaneous measurement of urethral sphincter electromyography, not associated with Items 781, 783, 784, 786, 810817, 839, 5840 or any item in Part 8
00786	01MAY1990	31DEC9999	Y	CYSTOMETROGRAPHY with simultaneous measurement of any one or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; and all associated fluoroscopic imaging, not associated with Items 780785, 810817, 839 and 5840
00787	01FEB1984	31OCT1986	N	Administration of a general anaesthetic (including the administration of oxygen) during hyperbaric therapy where the medical practitioner is not confined in the chamber
00787	01NOV1986	28FEB1987	N	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practioner is NOT confined in the chamber
00787	01MAR1987	31DEC9999	Y	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is NOT confined in the chamber
00788	01JUL2018	31OCT2023	N	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00788	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes by a prescribed medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00789	01JUL2018	31OCT2023	N	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 45 minutes in duration by a medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00789	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 45 minutes but not more than 60 minutes in duration by a prescribed medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
00790	01FEB1984	31OCT1986	N	Administration of a general anaesthetic (including the administration of oxygen) during hyperbaric therapy where the medical practitioner is confined in the chamber
00790	01NOV1986	28FEB1987	N	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practioner is confined in the chamber
00790	01MAR1987	31DEC9999	Y	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is confined in the chamber
00791	01FEB1984	28FEB1987	N	Ultrasonic cross-sectional echography, not associated with Item 793, 794 or 913, where the patient is not referred by a medical practitioner for ultrasonic examination each ultrasonic examination not exceeding two examinations in any one pregnancy
00791	01MAR1987	31DEC9999	Y	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not associated with Item 793, 794 or 913 where the patient is not referred by a medical practitioner for ultrasonic examination each ultrasonic examination not exceeding two examinations in any one pregnancy
00792	01JUL2018	31OCT2023	N	Professional attendance of at least 20 minutes in duration at consulting rooms by a medical practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or items 4001, 81000, 81005 or 81010 applies in relation to that pregnancy
00792	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms by a prescribed medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, lasting at least 20 minutes, for the purpose of providing non-directive pregnancy support counselling to a person who:(a) is currently pregnant; or(b) has been pregnant in the 12 months preceding the provision of the first service to which this item, or item 4001, 81000, 81005, 81010, 92136, 92137, 92138, 92139, 93026 or 93029, applies in relation to that pregnancy
00793	01FEB1984	28FEB1987	N	Ultrasonic cross-sectional echography performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 791, 794 or 913 and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member
00793	01MAR1987	31DEC9999	Y	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 791, 794 or 913 and where the referring medical practitioner is not a member of a group of practitioners of which the firstmentioned practitioner is a member
00794	01FEB1984	29FEB1984	N	Ultrasonic echography, unidimensional, not associated with Item 792, 797 or 913
00794	01MAR1984	28FEB1987	N	Ultrasonic echography, unidimensional not associated with Item 791, 793 or 913
00794	01MAR1987	31DEC9999	Y	ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not associated with Item 791, 793 or 913
00795	01AUG1988	31DEC9999	Y	EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) with hard copy recordings of wave forms, involving one of the following techniques Doppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast fourier transform analysis; venous occlusion plethysmography; air plethysmography; straingauge plethysmography; impedance plethysmography; or photo plethysmography; (not associated with Items 798 or 799) one examination and report
00796	01AUG1988	31DEC9999	Y	- two examinations of the kind referred to in Item 795 and report (not associated with Item 798 or 799)
00797	01FEB1984	31JUL1988	N	Ultrasonic cross-sectional echography, bidimensional (excluding real-time scanning covered by Item 792), not associated with Item 792, 794 or 913
00797	01AUG1988	31DEC9999	Y	- three or more examinations of the kind referred to in Item 795 and report (not associated with Item 798 or 799)
00798	01AUG1988	31DEC9999	Y	EXAMINATION OF PERIPHERAL VESSELS and report, involving any of the techniques referred to in Item 795, with hard copy recording of wave forms before measured exercise using a treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral)
00799	01AUG1988	31DEC9999	Y	Measurement of digital temperature, one or more digits, (unilateral or bilateral) and report, with hard copy recording of temperature before and for 10 minutes or more after cold stress testing
00800	01AUG1988	31DEC9999	Y	Examination of carotid vessels (unilateral or bilateral) with hard copy recordings of wave forms, involving one of the following techniques-Doppler real time fast fourier transform analysis; oculoplethysmography, phonoangiography or both; or periorbital Doppler examination (not associated with item 990, 991, 992 or 993)-one examination and report
00801	01AUG1988	31OCT2000	N	-two examinations of the kind referred to in item 800, and report (not associated with item 990, 991, 992 or 993)
00801	01NOV2000	31DEC9999	Y	CASE CONFERENCE - CONSULTANT PHYSICIAN Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00802	01AUG1988	31AUG1989	N	- three or more examinations of the kind referred to in Item 795 and report (not associated with Item 990, 991 or 993)
00802	01SEP1989	31DEC9999	Y	-three examinations of the kind referred to in item 800, and report (not associated with item 990, 991, 992 or 993)
00803	01FEB1984	29FEB1984	N	Electroencephalography, not covered by Item 794, 797, 806 or 809 (AU 6)
00803	01MAR1984	31AUG1989	N	Electroencephalography, not associated with Item 793, 794,806 or 809 (AU 6)
00803	01SEP1989	31OCT2000	N	Electroencephalography, not associated with item 804, 806 or 809 (AU 6)
00803	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00804	01AUG1988	31DEC9999	Y	Electroencephalography, prolonged recording of at least three hours duration, not associated with item 803, 806 or 809
00805	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and to coordinate the conference) of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00806	01FEB1984	31DEC9999	Y	Electroencephalography, temporosphenoidal
00807	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and to coordinate the conference) of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00809	01FEB1984	31OCT2000	N	Electrocorticography
00809	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00810	01FEB1984	31DEC9999	Y	Neuromuscular electrodiagnosis-- conduction studies on one nerve or electromyography of one or more muscles using concentric needle electrodes or both these examinations (not associated with Item 811 or 813)
00811	01FEB1984	31OCT2000	N	Neuromuscular electrodiagnosis-- conduction studies on two or three nerves with or without electromyography (not associated with Item 810 or 813)
00811	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00812	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
00813	01FEB1984	31OCT2000	N	Neuromuscular electrodiagnosis-- conduction studies on four or more nerves with or without electromyography or recordings from single fibres of nerves and muscles or both of these examinations (not associated with Item 810 or 811)
00813	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00814	01FEB1984	31DEC9999	Y	Neuromuscular electrodiagnosis-- repetitive stimulation for study of neuromuscular conduction or electromyography with quantitative computerised analysis or both of these examinations
00815	01NOV2000	31DEC9999	Y	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations)
00816	01FEB1984	31AUG1989	N	Investigation of cortical evoked responses-- 1 or 2 studies
00816	01SEP1989	31DEC9999	Y	Investigation of central nervous system evoked responses by computerised averaging techniques-one or two studies
00817	01FEB1984	31AUG1989	N	Investigation of cortical evoked responses-- 3 or more studies
00817	01SEP1989	31DEC9999	Y	Investigation of central nervous system evoked responses by computerised averaging techniques-three or more studies
00818	01JAN1986	31AUG1989	N	BRAIN stem evoked response audiometry ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S
00818	01SEP1989	31DEC9999	Y	Brain stem evoked response audiometry (AU 6)
00819	01AUG1987	31DEC9999	Y	INSERTION OF ELECTRODES FOR THE PURPOSE OF ELECTROCOCHLEOGRAPHY
00820	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00820	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00821	01FEB1984	31AUG1989	N	Haemodialysis in hospital, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in the one day
00821	01SEP1989	31DEC9999	Y	Supervision in hospital by a medical specialist of-haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in the one day
00822	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00822	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00823	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00823	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00824	01FEB1984	31AUG1989	N	Haemodialysis in hospital, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in the one day
00824	01SEP1989	31DEC9999	Y	Supervision in hospital by a medical specialist of-haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in the one day
00825	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00825	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00826	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00826	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00827	01JUL2018	31DEC9999	Y	Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
00828	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
00828	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
00829	01JUL2018	31DEC9999	Y	Professional attendance of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
00830	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00830	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00831	01FEB1984	31DEC9999	Y	Declotting of an arteriovenous shunt
00832	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00832	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00833	01FEB1984	31AUG1989	N	Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis-- insertion and fixation of
00833	01SEP1989	31DEC9999	Y	Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis-insertion and fixation of (AU 8)
00834	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00834	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines
00835	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00835	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00836	01FEB1984	31DEC9999	Y	Peritoneal dialysis, establishment of by abdominal puncture and insertion of temporary catheter (including associated consultation)
00837	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00837	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00838	01MAY2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00838	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00839	01FEB1984	31DEC9999	Y	Bladder washout test for localization of urinary infection not including bacterial counts for organisms in specimens
00840	01NOV1990	31DEC9999	Y	Assisted reproductive services (such as in vitro fertilisation, gamete intra-fallopian transfer or similar procedures) involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services - but excluding services for treatment involving surrogacy arrangements, transfer of frozen embryos or donated embryos or ova - all such services rendered during the one treatment cycle, where the duration of the treatment cycle is at least nine days from commencement - a maximum of six claims per patient (not associated with item 104, 105, 791, 793, 794, 841, 842, 847, 960, 963, 2021, 2024-2034 or 4194).
00841	01FEB1984	31DEC9999	Y	Urinary flow study
00842	01NOV1990	31DEC9999	Y	Assisted reproductive services (such as in vitro fertilisation, gamete intra-fallopian transfer or similar procedures), using natural (unstimulated) ovulation or ovulation stimulated only by clomiphene citrate, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services - but excluding services for treatment involving surrogacy arrangements, frozen embryo transfer or donated embryos or ova or involving the use of drugs to induce superovulation - all such services rendered during the one treatment cycle - only where rendered in conjunction with item 845 (not associated with item 791, 793, 794, 840, 841, 847, 960, 963, 2021 or 2024-2034)
00843	01FEB1984	31DEC9999	Y	Cystometrography
00844	01FEB1984	29FEB1984	N	Tonography-- in the investigation or management of glaucoma
00844	01MAR1984	31DEC9999	Y	Tonography - in the investigation or management of glaucoma, of one or both eyes - using an electrical tonography machine producing a directly recorded tracing
00845	01NOV1990	31DEC9999	Y	Oocyte retrieval by any means including laparoscopy or ultrasound-guided ova flushing, for the purposes of assisted reproductive technologies including in vitro fertilisation, gamete intra-fallopian transfer and similar procedures, excluding services related to surrogacy arrangements - where rendered in conjunction with item 840 or 842 (not associated with item 104, 105, 841 or 4194) (AU 9)
00846	01NOV1990	31DEC9999	Y	Transfer of embryos or both ova and sperm to the female reproductive system, by any means (including laparoscopy and gamete intra-fallopian transfer) excluding services related to: the transfer of frozen or donated embryos; artificial insemination; or surrogacy arrangements - where rendered in conjunction with item 840 or 842 - all such services rendered in the one treatment cycle (not associated with item 104, 105, 841, 960, 963 or 4194 ). (AU 9)
00847	01NOV1990	31DEC9999	Y	Preparation and transfer of frozen or donated embryos or both ova and sperm, to the female reproductive system, by any means (including laparoscopy) and including quantitative estimation of hormones and all treatment counselling but excluding services provided for the purposes of artificial insemination or surrogacy arrangements - all such services rendered in the one treatment cycle (not associated with item 104, 105, 840, 841, 842, 845, 846, 960, 963, 2021, 2024-2034 or 4194). (AU 9)
00848	01NOV1990	31DEC9999	Y	Preparation of semen for the purposes of assisted reproductive technologies including in vitro fertilisation and gamete intra-fallopian transfer or for artificial insemination using donated or husband's sperm, but excluding services related to surrogacy arrangements (not associated with item 2370-2373, 2377 or 2378).
00849	01FEB1984	31DEC9999	Y	Provocative test or tests for glaucoma, including water drinking
00850	01NOV1990	31DEC9999	Y	Tonography - in the investigation or management of glaucoma, one or both eyes - using an electrical tonography machine producing a directly recorded tracing
00851	01FEB1984	31AUG1989	N	Attendance by a medical practitioner for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-- one attendance in any period of thirtysix consecutive months
00851	01SEP1989	31DEC9999	Y	Investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of thirty six consecutive months
00852	01AUG1987	31DEC9999	Y	REFITTING OF CONTACT LENSES with keratometry and testing with trial lenses and the issue of a prescription being a subsequent fitting of CONTACT LENSES WITHIN A PERIOD OF THIRTY-SIX MONTHS OF THE INITIAL FITTING WHICH IS COVERED BY ITEM 851
00853	01FEB1984	29FEB1984	N	Electroretinography
00853	01MAR1984	31DEC9999	Y	Electroretinography of one or both eyes or electro-oculography of one or both eyes
00854	01FEB1984	31DEC9999	Y	Electroretinography of one or both eyes and electro-oculography of one or both eyes
00855	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00855	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00856	01FEB1984	31DEC9999	Y	Optic fundi, examination of following intravenous dye injection
00857	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00857	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00858	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team
00858	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team
00859	01FEB1984	31DEC9999	Y	Retinal photography, multiple exposures, of one eye with intravenous dye injection
00860	01FEB1984	31DEC9999	Y	Retinal photography, multiple exposures of both eyes with intravenous dye injection
00861	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00861	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00862	01AUG1986	31DEC9999	Y	Non-determinate AUDIOMETRY
00863	01FEB1984	31DEC9999	Y	Audiogram, air conduction
00864	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00864	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00865	01FEB1984	31AUG1989	N	Audiogram, air and bone conduction
00865	01SEP1989	31DEC9999	Y	Audiogram, air and bone conduction or air conduction and speech discrimination
00866	01NOV2002	31OCT2019	N	Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00866	01NOV2019	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
00867	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00868	01JUL2018	31DEC9999	Y	Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
00869	01JUL2018	31DEC9999	Y	Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
00870	01FEB1984	31DEC9999	Y	Audiogram, air and bone conduction and speech
00871	01NOV2006	30JUN2018	N	Attendance by a medical practitioner (including a specialist or consultant physician in the practice of his or her specialty or a general practitioner), as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00871	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, specialist or consultant physician as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00872	01NOV2006	30JUN2018	N	Attendance by a medical practitioner (including a specialist or consultant physician in the practice of his or her specialty or a general practitioner), as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00872	01JUL2018	31DEC9999	Y	Attendance by a general practitioner, specialist or consultant physician as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers
00873	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
00874	01FEB1984	31DEC9999	Y	Audiogram, air and bone conduction and speech, with other cochlear tests
00875	01AUG1986	31AUG1989	N	GLYCEROL INDUCED COCHLEAR FUNCTION CHANGES assessed by a minimum of four air conduction and speech discrimination tests (Klockoff's tests)
00875	01SEP1989	31DEC9999	Y	Glycerol induced cochlear function changes assessed by a minimum of four air conduction and speech discrimination tests (Klockoff's test)
00876	01JUL2018	31DEC9999	Y	Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
00877	01FEB1984	31DEC9999	Y	Impedance audiogram not associated with a service covered by Item 863, 865, 870 or 874
00878	01FEB1984	31DEC9999	Y	Impedance audiogram in association with a service covered by Item 863, 865, 870 or 874
00879	01NOV1990	31DEC9999	Y	Impedance audiogram where the patient is not referred by a medical practitioner - one examination in any four week period
00880	01MAY2006	31AUG2015	N	CASE CONFERENCE - CONSULTANT PHYSICIAN IN GERIATRIC OR REHABILITATION MEDICINE Attendance by a consultant physician in the practice of his or her specialty of GERIATRIC OR REHABILITATION MEDICINE, as a member of a case conference team, to COORDINATE A CASE CONFERENCE ON AN ADMITTED HOSPITAL PATIENT of at least 10 minutes but less than 30 minutes, with a multidisciplinary team of at least two other formal care providers of different disciplines
00880	01SEP2015	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of geriatric or rehabilitation medicine, as a member of a case conference team, to coordinate a case conference of at least 10 minutes but less than 30 minutes-for any particular patient, one attendance only in a 7 day period (other than attendance on the same day as an attendance for which item 832, 834, 835, 837 or 838 was applicable in relation to the patient) (H)
00880	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of geriatric or rehabilitation medicine, as a member of a case conference team, to coordinate a case conference of at least 10 minutes but less than 30 minutes-for any particular patient, one attendance only in a 7 day period (other than attendance on the same day as an attendance for which item 832, 834, 835, 837 or 838 was applicable in relation to the patient) (H)
00881	01JUL2018	31DEC9999	Y	Professional attendance of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
00882	01FEB1984	31DEC9999	Y	Caloric test of labyrinth or labyrinths
00883	01AUG1986	31DEC9999	Y	SIMULTANEOUS BITHERMAL CALORIC TEST OF LABYRINTHS
00884	01FEB1984	31DEC9999	Y	Electronystagmography
00885	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
00886	01FEB1984	31AUG1989	N	Electroconvulsive therapy, including associated consultation
00886	01SEP1989	31DEC9999	Y	Electroconvulsive therapy, including associated consultation (AU 3)
00887	01FEB1984	31DEC9999	Y	Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a group of 2-9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient
00888	01FEB1984	31DEC9999	Y	Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 3 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient
00889	01FEB1984	31DEC9999	Y	Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 2 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient
00890	01FEB1984	31DEC9999	Y	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration in the course of initial diagnostic evaluation of the patient, where that interview is at consulting rooms, hospital or nursing home
00891	01JUL2018	31DEC9999	Y	Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
00892	01JUL2018	31DEC9999	Y	Professional attendance of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
00893	01FEB1984	31DEC9999	Y	Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner, involving an interview of a person other than the patient of not less than 45 minutes duration in the course of initial diagnostic evaluation of the patient, where that interview is at consulting rooms, hospital or nursing home
00894	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner.
00894	10JAN2020	30JUN2020	N	Professional attendance by video conference by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner
00894	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, for providing mental health services to a patient with mental health issues, if the patient is affected by bushfire.
00895	01FEB1984	31AUG1989	N	Umbilical or scalp vein catheterisation with or without infusion
00895	01SEP1989	31DEC9999	Y	Umbilical or scalp vein catheterisation with or without infusion; or cannulation of a vein in a neonate
00896	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner.
00896	10JAN2020	30JUN2020	N	Professional attendance by video conference by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner.
00896	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, for providing mental health services to a patient with mental health issues, if the patient is affected by bushfire.
00897	01FEB1984	31DEC9999	Y	Umbilical artery catheterisation with or without infusion
00898	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a medical practitioner, lasting more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner.
00898	10JAN2020	30JUN2020	N	Professional attendance by video conference by a medical practitioner, lasting more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner
00898	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a medical practitioner, lasting more than 45 minutes, for providing mental health services to a patient with mental health issues if the patient is affected by bushfire.
00899	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, lasting not more than 5 minutes in duration, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
00900	01OCT2001	31OCT2002	N	Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in the community setting, where the medical practitioner: - assesses a patient's medication management needs, and following that assessment, refers the patient to a community pharmacy for a DMMR, and provides relevant clinical information required for the review, with the patient's consent; and - discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and - develops a written medication management plan following discussion with the patient. Benefits under this item are payable not more than once in each 12 month period, except where there has been a significant change in the patient's condition or medication regimen requiring a new DMMR.
00900	01NOV2002	30SEP2011	N	Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in the community setting, where the medical practitioner: - assesses a patient's medication management needs, and following that assessment, refers the patient to a community pharmacy for a DMMR, and provides relevant clinical information required for the review, with the patient's consent; and - discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and - develops a written medication management plan following discussion with the patient. Benefits under this item are payable not more than once in each 12 month period, except where there has been a significant change in the patient's condition or medication regimen requiring a new DMMR.
00900	01OCT2011	31JAN2018	N	Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in a community setting, in which the medical practitioner: (a) assesses a patient's medication management needs and, following that assessment, refers the patient to a community pharmacy or an accredited pharmacist for a DMMR and, with the patient's consent, provides relevant clinical information required for the review; and (b) discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and (c) develops a written medication management plan following discussion with the patient For any particular patient-applicable not more than once in each 12 month period, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR
00900	01FEB2018	30JUN2018	N	Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the medical practitioner, with the patients consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient-applicable not more than once in each 12 month period, except if there has been a significant change in the patients condition or medication regimen requiring a new DMMR
00900	01JUL2018	31OCT2023	N	Participation by a general practitioner in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the general practitioner, with the patients consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient-applicable not more than once in each 12 month period, except if there has been a significant change in the patients condition or medication regimen requiring a new DMMR
00900	01NOV2023	31DEC9999	Y	Participation by a general practitioner (not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the general practitioner, with the patients consent:(a) assesses the patient as:(i) having a chronic medical condition or a complex medication regimen; and(ii) not having their therapeutic goals met; and(b) following that assessment:(i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and(ii) provides relevant clinical information required for the DMMR; and(c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and(d) develops a written medication management plan following discussion with the patient; and(e) provides the written medication management plan to a community pharmacy chosen by the patientFor any particular patient-applicable not more than once in each 12 month period, and only if item 245 does not apply in the same 12 month period, except if there has been a significant change in the patients condition or medication regimen requiring a new DMMR
00901	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
00902	01FEB1984	29FEB1984	N	Blood transfusion with venesection and complete replacement of blood, including collection from donor
00902	01MAR1984	31DEC9999	Y	Blood transfusion with venesection and complete replacement of blood, including collection from donor 904
00903	01NOV2004	31OCT2005	N	Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a collaborative Residential Medication Management Review (RMMR) for a permanent resident of a residential aged care facility, where the medical practitioner: - discusses and seeks consent for an RMMR from the new or existing resident; - initiates the RMMR and collaborates with the reviewing pharmacist regarding the pharmacy component of the review; - provides input from the resident's Comprehensive Medical Assessment (CMA), or if a CMA has not been undertaken, provides relevant clinical information for the resident's RMMR; - discusses findings of the pharmacist review and proposed medication management strategies with the reviewing pharmacist (unless exceptions apply); - develops and/or revises a written medication plan for the resident; and - consults with the resident to discuss the medication mangement plan and its implementation. Benefits under this item are payable for one RMMR service for new residents on admission to a Residential Aged Care Facility and for continuing residents on an as required basis, with a maximum of one RMMR for a resident in any 12 month period, except where there has been a significant change in medical condition or medication regimen requiring a new RMMR.
00903	01NOV2005	30JUN2018	N	Participation by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item has applied, unless there has been a significant change in the resident's medical condition or medication management plan requiring a new RMMR
00903	01JUL2018	31OCT2023	N	Participation by a general practitioner in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item has applied, unless there has been a significant change in the resident's medical condition or medication management plan requiring a new RMMR
00903	01NOV2023	31DEC9999	Y	Participation by a general practitioner (not including a specialist or consultant physician) in a residential medication management review (RMMR) for a patient who is a care recipient in a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item or item 249 has applied, unless there has been a significant change in the residents medical condition or medication management plan requiring a new RMMR.
00904	01FEB1984	31DEC9999	Y	Blood transfusion with venesection and complete replacement of blood, using blood already collected
00905	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
00906	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, lasting more than 45 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
00907	01FEB1984	31DEC9999	Y	Blood for pathology test, collection of, by femoral or external jugular vein puncture in infants
00908	01FEB1984	29FEB1984	N	Electrocardiography, tracing and report, with or without implanted pacemaker testing
00908	01MAR1984	31DEC9999	Y	Twelve-lead electrocardiography, tracing and report
00909	01FEB1984	29FEB1984	N	Electrocardiography, tracing or report only
00909	01MAR1984	31AUG1989	N	Twelve-lead electrocardiography, tracing only, or twelve-lead electrocardiography, report only where the tracing has been forwarded to another medical practitioner, not associated with an attendance item in Part
00909	01SEP1989	31DEC9999	Y	Twelve-lead electrocardiography, report only where the tracing has been forwarded to another medical practitioner, not associated with an attendance item in Part 1, or twelve-lead electrocardiography, tracing only
00910	01NOV1990	31DEC9999	Y	Two Dimensional real time transoesophageal echocardiographic examination of the heart, not associated with any other echocardiographic examination
00911	01NOV1990	31DEC9999	Y	Two Dimensional real time transoesophageal echocardiographic examination of the heart, associated with another echocardiographic examination
00912	01FEB1984	31AUG1989	N	Phonocardiography
00912	01SEP1989	31DEC9999	Y	Phonocardiography with electrocardiograph lead with indirect arterial or venous pulse tracing, with or without apex cardiogram-interpretation and report
00913	01FEB1984	29FEB1984	N	Echocardiography, not covered by Item 792
00913	01MAR1984	31DEC9999	Y	Echocardiography, not covered by Item 791 or 793
00915	01FEB1984	29FEB1984	N	Electrocardiographic monitoring (continuous) of ambulatory patient including resting electrocardiography and the recording of other parameters
00915	01MAR1984	31DEC9999	Y	Continuous ECG monitoring(Holter) of an ambulatory patient for twelve or more hours involving recording, scanning analysis, interpretation and report, including resting ECG and the recording of other parameters
00916	01FEB1984	31AUG1989	N	Electrocardiographic monitoring during exercise with apparatus such as bicycle ergometer or treadmill including resting electrocardiography and the recording of other parameters
00916	01SEP1989	31DEC9999	Y	Electrocardiographic monitoring during exercise, with apparatus such as bicycle ergometer or treadmill, involving the continuous attendance of a medical practitioner for not less than 20 minutes, including resting electrocardiography and with or without recording of other parameters, on premises equipped with mechanical respirator and defibrillator
00917	01FEB1984	31DEC9999	Y	Restoration of cardiac rhythm by electrical stimulation (cardioversion), other than in the course of cardiac surgery (AU4)
00918	01FEB1984	31DEC9999	Y	Bronchospirometry, including gas analysis
00920	01FEB1984	31DEC9999	Y	Estimation of respiratory function requiring complicated techniques-- each attendance at which one or more tests are performed
00921	01FEB1984	31DEC9999	Y	Estimation of respiratory function involving a directly recorded tracing, performed before and after inhalation of a bronchodilator, a cholinergic substance or a sensitising agent, or before and after exercise-- one or more such tests performed on the one occasion
00922	01FEB1984	31DEC9999	Y	Perfusion of limb or organ using heart-lung machine or equivalent
00923	01FEB1984	31DEC9999	Y	Whole body perfusion, cardiac bypass, using heart-lung machine or equivalent
00924	01SEP1989	31DEC9999	Y	Hyperthermic isolated limb perfusion including vascular cannulation by open operation and subsequent removal of catheters (AU 30)
00925	01FEB1984	31DEC9999	Y	Induced controlled hypothermia-- total body
00926	01MAY1990	31DEC9999	Y	MEASUREMENT OF RESPIRATORY FUNCTION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex respiratory function tests; the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital - each occasion at which one or more such tests are performed
00927	01FEB1984	29FEB1984	N	Fluids, intravenous infusion of-- percutaneous
00927	01MAR1984	31DEC9999	Y	Fluids, intravenous drip infusion of - percutaneous
00928	01MAY1990	31DEC9999	Y	CONTINUOUS MEASUREMENT OF THE RELATIONSHIP BETWEEN FLOW AND VOLUME DURING EXPIRATION OR INSPIRATION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex lung function tests; the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital - each occasion at which one or more such tests are performed
00929	01FEB1984	29FEB1984	N	Fluids, intravenous infusion of-- by open exposure
00929	01MAR1984	31DEC9999	Y	Fluids, intravenous drip infusion of - by open exposure
00930	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference, if the conference lasts for at least 15 minutes, but for less than 20 minutes
00931	01JAN1986	31DEC9999	Y	INTRA-ARTERIAL INFUSION or retrograde intra-venous perfusion of a sympatholytic agent
00932	01FEB1984	31AUG1989	N	Intravenous infusion or injection of a substance incorporating a cytotoxic agent
00932	01SEP1989	31DEC9999	Y	Administration of a cytotoxic agent by intravenous drip infusion or by introduction into the bladder
00933	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference, if the conference lasts for at least 20 minutes, but for less than 40 minutes
00934	01FEB1984	29FEB1984	N	Intra-arterial infusion or injection of a substance incorporating a cytotoxic agent, preparation for
00934	01MAR1984	31AUG1989	N	Intra-arterial infusion or injection of a substance incorporating a cytotoxic agent, preparation for 936
00934	01SEP1989	31DEC9999	Y	Intra-arterial infusion or intra-arterial injection of a substance incorporating a cytotoxic agent, preparation for
00935	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference, if the conference lasts for at least 40 minutes
00936	01FEB1984	31AUG1989	N	Intralymphatic infusion or injection of a fluid containing a cytotoxic agent, with or without the incorporation of an opaque medium
00936	01SEP1989	31DEC9999	Y	Intralymphatic infusion or intralymphatic injection of a fluid containing a cytotoxic agent, with or without the incorporation of an opaque medium
00937	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference, if the conference lasts for at least 15 minutes, but for less than 20 minutes
00938	01FEB1984	31DEC9999	Y	Intralymphatic insertion of needle or cannula for the introduction of radio-active material
00939	01FEB1986	31AUG1989	N	HARVESTING OF HOMOLOGOUS (including allogeneic) bone marrow for the purpose of transplantation ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
00939	01SEP1989	31DEC9999	Y	Harvesting of homologous (including allogeneic) or autologous bone marrow for the purpose of transplantation (AU 10)
00940	01FEB1984	29FEB1984	N	Administration of blood including collection from donor
00940	01MAR1984	31DEC9999	Y	Administration of blood including collection from donor 944
00941	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 30 minutes, but less than 40 minutes
00942	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 40 minutes
00943	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference, if the conference lasts for at least 20 minutes, but for less than 40 minutes
00944	01FEB1984	31AUG1989	N	Administration of blood already collected
00944	01SEP1989	31DEC9999	Y	Administration of blood or bone marrow already collected
00945	01JUL2023	31DEC9999	Y	Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference, if the conference lasts for at least 40 minutes
00946	01JUL2023	31OCT2023	N	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of multidisciplinary case conference team, to organise and coordinate a mental health case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00946	01NOV2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00947	01FEB1984	31DEC9999	Y	Intra-uterine foetal blood transfusion using blood already collected, including necessary amniocentesis
00948	01JUL2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00949	01FEB1984	31AUG1989	N	Collection of blood for purposes of transfusion
00949	01SEP1989	31DEC9999	Y	Collection of blood for autologous transfusion or when homologous blood is required for immediate transfusion in emergency situation
00950	01FEB1984	31AUG1989	N	Central vein catheterisation (via jugular or subclavian vein) by open exposure for parenteral alimentation in a person under twelve years of age (AU 12)
00950	01SEP1989	31DEC9999	Y	Central vein catheterisation (via jugular or subclavian vein) by open exposure, in a person under twelve years of age (AU 12)
00951	01FEB1984	31AUG1989	N	Central vein catheterisation (via jugular or subclavian vein) by percutaneous or open exposure for parenteral alimentation not covered by Item 950 (AU 6)
00951	01SEP1989	31DEC9999	Y	Central vein catheterisation (via jugular or subclavian vein) by percutaneous or open exposure, not covered by Item 950 (AU 6)
00952	01FEB1984	31DEC9999	Y	Blood dye-- dilution indicator test
00953	01JAN1986	31DEC9999	Y	RIGHT HEART BALLOON FLOTATION (Swann-Ganz) catheterisation, insertion of catheter and monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry - management on the first day
00954	01JAN1986	31AUG1989	N	RIGHT HEART BALLOON FLOTATION (Swann-Ganz) catheterisation, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry - management on each day subsequent to the first
00954	01SEP1989	31DEC9999	Y	Right heart balloon flotation (Swann-Ganz) catheterisation, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry-management on each day subsequent to the first
00955	01NOV1979	29FEB1984	N	Venepuncture and the collection of blood for the performance by an approved pathology practitioner of a pathology service-- one or more such procedures during the one attendance
00955	01MAR1984	31DEC9999	Y	Venepuncture and the collection of blood for forwarding to an approved pathology practitioner for the performance of a pathology service, where the referring medical practitioner is not a member of a group of practitioners of which the approved pathology practitioner is a member - one or more such procedures during the one attendance
00956	01FEB1984	31DEC9999	Y	Arterial puncture and collection of blood for diagnostic purposes
00957	01FEB1984	31DEC9999	Y	Intra-arterial cannulisation for purpose of taking multiple arterial blood samples for blood gas analysis
00958	01FEB1984	31DEC9999	Y	Collection of specimen of sweat by iontophoresis
00959	01JUL2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference of at least 45 minutes, with the multidisciplinary case conference team
00960	01FEB1984	31DEC9999	Y	Hormone or living tissue implantation-- by incision
00961	01JUL2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to participate in a mental health case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
00962	01JUL2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to participate in a mental health case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
00963	01FEB1984	31DEC9999	Y	Hormone or living tissue implantation-- by cannula
00964	01JUL2023	31DEC9999	Y	Attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry or paediatrics, as a member of a multidisciplinary case conference team, to participate in a mental health case conference of at least 45 minutes, with the multidisciplinary case conference team
00966	01FEB1984	31DEC9999	Y	Oesophageal motility test, manometric
00968	01FEB1984	31DEC9999	Y	Gastric hypothermia by closed circuit circulation of refrigerant in the absence of gastrointestinal haemorrhage
00969	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes
00969	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes
00970	01FEB1984	31DEC9999	Y	Gastric hypothermia by closed circuit circulation of refrigerant for upper gastrointestinal haemorrhage
00971	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes
00971	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes
00972	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 40 minutes
00972	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate a mental health case conference if the conference lasts for at least 40 minutes
00973	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes
00973	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes
00974	01FEB1984	31DEC9999	Y	Gastric lavage in the treatment of ingested poison
00975	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes
00975	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes
00976	01FEB1984	31AUG1989	N	Counterpulsation by intra-aortic balloon-- management on the first day, including initial and subsequent consultations and monitoring of parameters
00976	01SEP1989	31DEC9999	Y	Counterpulsation by intra-aortic balloon-management on the first day, including percutaneous insertion, initial and subsequent consultations and monitoring of parameters
00977	01FEB1984	31DEC9999	Y	Counterpulsation by intra-aortic balloon-- management on each day subsequent to the first, including associated consultations and monitoring of parameters
00978	01AUG1987	31DEC9999	Y	PUVA THERAPY or UVB THERAPY administered in whole body cabinet, not associated with Item 979 including associated consultations other than an initial consultation
00979	01AUG1987	31DEC9999	Y	PUVA THERAPY or UVB THERAPY administered to localised body areas in a hand and foot cabinet not associated with item 978 including associated consultations other than an initial consultation
00980	01FEB1984	29FEB1984	N	Attendance by a medical practitioner at which acupuncture is performed by application of stimuli on or through the surface of the skin by any means, including any associated consultation on the same day
00980	01MAR1984	31DEC9999	Y	Attendance at which acupuncture is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed
00981	01JUL1985	31AUG1989	N	URINARY FLOW STUDY
00981	01SEP1989	31DEC9999	Y	Urine flow study
00982	01JUL1985	31DEC9999	Y	CYSTOMETROGRAPHY
00983	01JUL1985	31AUG1989	N	URETHRAL PRESSURE PROFILE MEASUREMENT
00983	01SEP1989	31DEC9999	Y	Urethral pressure profile
00984	01JUL1985	31AUG1989	N	CYSTOMETROGRAPHY with rectal pressure measurement or bladder sphincter electromyography ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S
00984	01SEP1989	31DEC9999	Y	Cystometrography with rectal pressure measurement or bladder sphincter electromyography (AU 6)
00985	01JAN1986	31AUG1989	N	CYSTOMETROGRAPHY, rectal pressure measurement or sphincter electromyography, urinary flow and retrograde micturating cystourethrography including all associated radiological services
00985	01SEP1989	31DEC9999	Y	Cystometrography, rectal pressure measurement or sphincter electromyography and urine flow study including all associated imaging procedures
00986	01JUL2023	31OCT2023	N	Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 40 minutes
00986	01NOV2023	31DEC9999	Y	Attendance by a prescribed medical practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 40 minutes
00987	01FEB1984	31DEC9999	Y	Skin sensitivity testing for allergens, using one to twenty allergens
00989	01FEB1984	31DEC9999	Y	Skin sensitivity testing for allergens, using more than twenty allergens
00990	01AUG1988	31DEC9999	Y	Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries), peripheral vessels, or intra-thoracic or intra-abdominal vascular vessels (excluding cardiac and pregnancy related studies) (not associated with item 793)-one examination and report-two or more examinations of the kind referred to in item 990 and report (not associated with item 793)
00991	01AUG1988	31DEC9999	Y	- two or more examinations of the kind referred to in item 990 and report (not associated with Item 793)
00992	01AUG1988	31DEC9999	Y	Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not associated with item 793)-examination and report
00993	01AUG1988	31DEC9999	Y	Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels and carotid vessels, with oculoplethysmography (not associated with item 793)-examination and report
00994	01FEB1984	31DEC9999	Y	Multiphasic health screening service involving the performance of ten or more medical services specified in items in Parts 6, 7 and 8 (including any associated consultation)
00995	01AUG1988	31DEC9999	Y	Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by item 795, 796 or 797 (not associated with item 793)-examination and report
00996	01FEB1984	31DEC9999	Y	Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of two patients-- each patient
00997	01FEB1984	31DEC9999	Y	Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of three patients-- each patient
00998	01FEB1984	31DEC9999	Y	Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of four to six patients-- each patient
00999	01AUG1988	31DEC9999	Y	Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels, including any of the investigations covered by item 798 (not associated with item 793-examination and report
01001	01NOV1988	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (SP)
01002	01NOV1988	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (PP)
01003	01NOV1988	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (OP)
01004	01NOV1988	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (RP)
01005	01NOV1988	31DEC9999	Y	Three or more procedures to which item 1001 applies, including any calculation or measurement of erythrocyte or other indices (SP)
01006	01JUL1982	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- one procedure (SP)
01007	01JUL1982	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- one procedure (excluding blood count consisting of haemoglobin estimation or erthrocyte sedimentation rate when not referred by another medical practitioner) (OP)
01008	01FEB1984	31DEC9999	Y	Two procedures to which Item 1006 applies (SP)
01009	01FEB1984	31DEC9999	Y	Two procedures to which Item 1007 applies (OP)
01010	01JUL1982	31DEC9999	Y	Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- 2 procedures (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (HP)
01011	01FEB1984	31DEC9999	Y	Three or more procedures to which Item 1006 applies including calculation of erythrocyte indices where done (SP)
01012	01FEB1984	31DEC9999	Y	Three or more procedures to which Item 1007 applies including calculation of erythrocyte indices where done (OP)
01013	01JUL1982	31DEC9999	Y	Three or more procedures to which Item 1010 applies including calculation of erythrocyte indices where done (HP)
01014	01FEB1984	31DEC9999	Y	Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (SP)
01015	01FEB1984	31DEC9999	Y	Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (OP)
01016	01JUL1982	31DEC9999	Y	Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (HP)
01017	01NOV1988	31DEC9999	Y	Three or more procedures to which item 1002 applies, including any calculation or measurement of erythrocyte or other indices (PP)
01018	01NOV1988	31DEC9999	Y	Three or more procedures to which item 1003 applies, including any calculation or measurement of erythrocyte or other indices (OP)
01019	01JUL1982	31DEC9999	Y	Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances-- one procedure (SP)
01020	01JUL1982	31DEC9999	Y	Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances-- one procedure (OP)
01021	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1019 applies (SP)
01022	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1020 applies (OP)
01023	01NOV1988	31DEC9999	Y	Three or more procedures to which item 1004 applies, including any calculation or measurement of erythrocyte or other indices (RP)
01024	01NOV1988	31DEC9999	Y	Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1041 or 1091 (SP)
01025	01NOV1988	31DEC9999	Y	Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1042 or 1092 (PP)
01026	01NOV1988	31DEC9999	Y	Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1043 or 1093 (OP)
01027	01NOV1988	31DEC9999	Y	Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1046 or 1094 (RP)
01028	01JUL1982	31DEC9999	Y	Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-- one procedure (SP)
01029	01JUL1982	31DEC9999	Y	Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-- one procedure (OP)
01030	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1028 applies (SP)
01032	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1029 applies (OP)
01033	01NOV1988	31DEC9999	Y	Full blood examination, consisting of items 1005 and 1024. (SP)
01034	01NOV1988	31DEC9999	Y	Full blood examination, consisting of items 1017 and 1025. (PP)
01035	01NOV1988	31DEC9999	Y	Full blood examination, consisting of items 1018 and 1026. (OP)
01036	01JUL1982	31DEC9999	Y	Erythrocytes, qualitative assessment of metabolism or haemolysis by-- erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical) , glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria-- one procedure (SP)
01037	01JUL1982	31DEC9999	Y	Erythrocytes, qualitative assessment of metabolism or haemolysis by-- erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical) , glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria-- one procedure (OP)
01038	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1036 applies (SP)
01039	01NOV1988	31DEC9999	Y	Full blood examination, consisting of items 1023 and 1027. (RP)
01040	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1037 applies (OP)
01041	01NOV1988	31DEC9999	Y	Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (SP)
01042	01NOV1988	31DEC9999	Y	Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (PP)
01043	01NOV1988	31DEC9999	Y	Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (OP)
01044	01JUL1982	31DEC9999	Y	Erythrocytes, quantitative assessment of metabolism or haemolysis by-- acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation-- one procedure (SP)
01045	01JUL1982	31DEC9999	Y	Erythrocytes, quantitative assessment of metabolism or haemolysis by-- acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation-- one procedure (OP)
01046	01NOV1988	31DEC9999	Y	Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (RP)
01047	01NOV1988	31DEC9999	Y	Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (SP)
01048	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1044 applies (SP)
01049	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1045 applies (OP)
01050	01NOV1988	31DEC9999	Y	Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (PP)
01051	01NOV1988	31DEC9999	Y	Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (OP)
01052	01JUL1985	31DEC9999	Y	Viscosity of plasma or whole blood, estimation of - each procedure. (SP)
01053	01JUL1985	31DEC9999	Y	Viscosity of plasma or whole blood, estimation of - each procedure. (OP)
01054	01NOV1988	31DEC9999	Y	Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (RP)
01055	01NOV1988	31DEC9999	Y	Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1001, 1005, 1024 and 1033 . (SP)
01056	01NOV1988	31DEC9999	Y	Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1002, 1017, 1025 and 1034 . (PP)
01057	01NOV1988	31DEC9999	Y	Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1003, 1018, 1026 and 1035 . (OP)
01058	01NOV1988	31DEC9999	Y	Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1004, 1023, 1027 and 1039 . (RP)
01059	01NOV1988	31DEC9999	Y	Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1001, 1005, 1024 and 1033, performed on the same day as the biopsy. (SP)
01060	01NOV1988	31DEC9999	Y	Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1002, 1017, 1025 and 1034, performed on the same day as the biopsy. (PP)
01061	01NOV1988	31DEC9999	Y	Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1003, 1018, 1026 and 1035, performed on the same day as the biopsy. (OP)
01062	01JUL1982	31DEC9999	Y	Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-- one procedure (SP)
01063	01JUL1982	31DEC9999	Y	Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-- one procedure (OP)
01064	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1062 applies (SP)
01065	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1063 applies (OP)
01066	01NOV1988	31DEC9999	Y	Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1004, 1023, 1027 and 1039, performed on the same day as the biopsy. (RP)
01067	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (SP)
01068	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (PP)
01069	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (OP)
01070	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (RP)
01071	01NOV1988	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1067. (SP)
01072	01NOV1988	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1068. (PP)
01073	01NOV1988	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1069. (OP)
01074	01NOV1988	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1070. (RP)
01075	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1001, 1005, 1024 and 1033. (SP)
01076	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1002, 1017, 1025 and 1034. (PP)
01077	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1003, 1018, 1026 and 1035. (OP)
01078	01NOV1988	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1004, 1023, 1027 and 1039. (RP)
01079	01NOV1988	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1001, 1005, 1024, 1033, 1067 and 1075 including all testing performed on any one day. (SP)
01080	01JUL1982	31DEC9999	Y	Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) (not covered by Item 1089) (SP)
01081	01JUL1982	31DEC9999	Y	Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) (not covered by Item 1090) (OP)
01082	01NOV1988	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1002, 1017, 1025, 1034, 1068, and 1076 including all testing performed on any one day. (PP)
01083	01NOV1988	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1003, 1018, 1026, 1035, 1069 and 1077 including all testing performed on any one day. (OP)
01084	01NOV1988	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1004, 1023, 1027, 1039, 1070 and 1078 including all testing performed on any one day. (RP)
01085	01NOV1988	31DEC9999	Y	Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (SP)
01086	01NOV1988	31DEC9999	Y	Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (PP)
01087	01NOV1988	31DEC9999	Y	Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (OP)
01088	01NOV1988	31DEC9999	Y	Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (RP)
01089	01JUL1982	31DEC9999	Y	Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) when performed in association with the compatibility testing covered by Item 1112 or 1114 (SP)
01090	01JUL1982	31DEC9999	Y	Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) when performed in association with the compatibility testing covered by Item 1113 or 1116 (OP)
01091	01NOV1988	31DEC9999	Y	Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1024 or 1033. (SP)
01092	01NOV1988	31DEC9999	Y	Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1025 or 1034. (PP)
01093	01NOV1988	31DEC9999	Y	Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1026 or 1035. (OP)
01094	01NOV1988	31DEC9999	Y	Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1027 or 1039. (RP)
01095	01NOV1988	31DEC9999	Y	Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (SP)
01096	01NOV1988	31DEC9999	Y	Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (PP)
01097	01NOV1988	31DEC9999	Y	Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (OP)
01098	01NOV1988	31DEC9999	Y	Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (RP)
01099	01NOV1988	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (SP)
01100	01NOV1988	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (PP)
01101	01JUL1982	31DEC9999	Y	Blood grouping-- Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-- one system (SP)
01102	01JUL1982	31DEC9999	Y	Blood grouping-- Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-- one system (OP)
01103	01NOV1988	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (OP)
01104	01JUL1982	31DEC9999	Y	Two procedures to which Item 1101 applies (SP)
01105	01JUL1982	31DEC9999	Y	Two procedures to which Item 1102 applies (OP)
01106	01JUL1982	29FEB1984	N	Each procedure to which Item
01106	01MAR1984	31DEC9999	Y	Each procedure to which Item 1101 applies in excess of two (SP)
01107	01NOV1988	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (RP)
01108	01JUL1982	29FEB1984	N	Each procedure to which Item
01108	01MAR1984	31DEC9999	Y	Each procedure to which Item 1102 applies in excess of two (OP)
01109	01NOV1988	31DEC9999	Y	Two estimations specified in item 1099. (SP)
01110	01NOV1988	31DEC9999	Y	Two estimations specified in item 1100. (PP)
01111	01FEB1984	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (SP)
01112	01FEB1984	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (OP)
01113	01JUL1982	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (HP)
01114	01FEB1984	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (SP)
01115	01NOV1988	31DEC9999	Y	Two estimations specified in item 1103. (OP)
01116	01FEB1984	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (OP)
01117	01JUL1982	31DEC9999	Y	Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (HP)
01118	01NOV1988	31DEC9999	Y	Two estimations specified in item 1107. (RP)
01119	01NOV1988	31DEC9999	Y	Three estimations specified in item 1099. (SP)
01120	01NOV1988	31DEC9999	Y	Three estimations specified in item 1100. (PP)
01121	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) (SP)
01122	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) (OP)
01123	01NOV1988	31DEC9999	Y	Three estimations specified in item 1103. (OP)
01124	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) and quantitative estimation of one antibody (SP)
01125	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) and quantitative estimation of one antibody (OP)
01126	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of one antibody (SP)
01127	01NOV1988	31DEC9999	Y	Three estimations specified in item 1107. (RP)
01128	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of one antibody (OP)
01129	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of each antibody in excess of one (SP)
01130	01JUL1982	31DEC9999	Y	Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of each antibody in excess of one (OP)
01131	01NOV1988	31DEC9999	Y	Four estimations specified in item 1099. (SP)
01132	01NOV1988	31DEC9999	Y	Four estimations specified in item 1100. (PP)
01133	01NOV1988	31DEC9999	Y	Four estimations specified in item 1103. (OP)
01134	01NOV1988	31DEC9999	Y	Four estimations specified in item 1107. (RP)
01135	01NOV1988	31DEC9999	Y	Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (SP)
01136	01JUL1982	31DEC9999	Y	Coombs test, direct (SP)
01137	01JUL1982	31DEC9999	Y	Coombs test, direct (OP)
01138	01NOV1988	31DEC9999	Y	Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (PP)
01139	01NOV1988	31DEC9999	Y	Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (OP)
01140	01NOV1988	31DEC9999	Y	Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (RP)
01141	01NOV1988	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (SP)
01142	01NOV1988	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (PP)
01143	01NOV1988	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (OP)
01144	01JUL1982	31DEC9999	Y	Coombs test, indirect (not associated with Item 1112, 1114, 1121, 1124, 1126 or 1129, except where part of neo-natal screening or in investigation of haemolytic anaemia) (SP)
01145	01JUL1982	31DEC9999	Y	Coombs test, indirect (not associated with Item 1113, 1116, 1122, 1125, 1128 or 1130, except where part of neo-natal screening or in investigation of haemolytic anaemia) (OP)
01146	01NOV1988	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (RP)
01147	01NOV1988	31DEC9999	Y	Platelet antibodies - one or more estimations. (SP)
01148	01NOV1988	31DEC9999	Y	Platelet antibodies - one or more estimations. (PP)
01149	01NOV1988	31DEC9999	Y	Platelet antibodies - one or more estimations. (OP)
01150	01NOV1988	31DEC9999	Y	Platelet antibodies - one or more estimations. (RP)
01151	01NOV1988	31DEC9999	Y	Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (SP)
01152	01JUL1982	31DEC9999	Y	Examination of serum for blood group haemolysins (SP)
01153	01JUL1982	31DEC9999	Y	Examination of serum for blood group haemolysins (OP)
01154	01NOV1988	31DEC9999	Y	Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (PP)
01155	01NOV1988	31DEC9999	Y	Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (OP)
01156	01NOV1988	31DEC9999	Y	Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (RP)
01157	01NOV1988	31DEC9999	Y	Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1001, 1005, 1024, 1033, 1099, 1135, 1141, 1147 and 1151. (SP)
01158	01NOV1988	31DEC9999	Y	Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1002, 1017, 1025, 1034, 1100, 1138, 1142, 1148 and 1154. (PP)
01159	01JUL1982	31DEC9999	Y	Leucocyte agglutinins, detection of (SP)
01160	01JUL1982	31DEC9999	Y	Leucocyte agglutinins, detection of (OP)
01161	01NOV1988	31DEC9999	Y	Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1003, 1018, 1026, 1035, 1103, 1139, 1143, 1149 and 1155 (OP)
01162	01NOV1988	31DEC9999	Y	Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1004, 1023, 1027, 1039, 1107, 1140, 1146, 1150 and 1156. (RP)
01163	01AUG1989	31DEC9999	Y	Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - 1 or 2 procedures (SP)
01164	01AUG1989	31DEC9999	Y	Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - 1 or 2 procedures (OP)
01166	01JUL1982	31DEC9999	Y	Platelet agglutinins, detection of (SP)
01167	01JUL1982	31DEC9999	Y	Platelet agglutinins, detection of (OP)
01168	01AUG1989	31DEC9999	Y	3 or more procedures to which item 1163 applies, including any calculation or measurement of erythrocyte or other indices(SP)
01169	01AUG1989	31DEC9999	Y	3 or more procedures to which item 1164 applies, including any calculation or measurement of erythrocyte or other indices(OP)
01170	01AUG1989	31DEC9999	Y	Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services - Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1419 (SP)
01171	01AUG1989	31DEC9999	Y	Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services - Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, inlcuding any services specified in item 1420 (OP)
01172	01AUG1989	31DEC9999	Y	Full blood examination consisting of items 1168 and 1170 (SP)
01173	01AUG1989	31DEC9999	Y	Full blood examination consisting of items 1169 and 1171 (OP)
01176	01AUG1989	31DEC9999	Y	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures (SP)
01177	01AUG1989	31DEC9999	Y	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures (OP)
01179	01AUG1989	31DEC9999	Y	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following - examination for HbH, quantitation of HbA2 or HbF, including any service specified in item 1163, 1168, 1170 or 1172 (SP)
01180	01AUG1989	31DEC9999	Y	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following - examination for HbH, quantitation of HbA2 or HbF, including any service specified in item 1164, 1169, 1171 or 1173 (OP)
01181	01AUG1989	31DEC9999	Y	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any service specified in item 1163, 1168, 1170, 1172 or 1183 (SP)
01182	01AUG1989	31DEC9999	Y	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any service specified in item 1164, 1169, 1171, 1173 or 1184 (OP)
01183	01AUG1989	31DEC9999	Y	Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any service specified in, item 1163, 1168, 1170 or 1172 (SP)
01184	01AUG1989	31DEC9999	Y	Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any service specified in item 1164, 1169, 1171 or 1173 (OP)
01187	01AUG1989	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen) (SP)
01188	01AUG1989	31DEC9999	Y	Blood grouping, including back-grouping when performed - ABO and Rh (D antigen) (OP)
01190	01JUL1982	31DEC9999	Y	Heterophile antibodies-- qualitative estimation of (test for infectious mononucleosis) (SP)
01191	01JUL1982	31DEC9999	Y	Heterophile antibodies-- qualitative estimation of (test for infectious mononucleosis) (OP)
01192	01AUG1989	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any service specified in item 1187 (SP)
01193	01AUG1989	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any service specified in item 1188 (OP)
01194	01JUL1982	31DEC9999	Y	Heterophile antibodies-- quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by Item 1190 where performed) (SP)
01195	01JUL1982	31DEC9999	Y	Heterophile antibodies-- quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by Item 1191 where performed) (OP)
01196	01AUG1989	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any service specified in item 1163, 1168, 1170 or 1172 (SP)
01197	01AUG1989	31DEC9999	Y	Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any service specified in item 1164, 1169, 1171 or 1173 (OP)
01198	01AUG1989	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any service specified in item 1163, 1168, 1170, 1172, 1187 or 1196 including all testing performed on any 1 day (SP)
01199	01AUG1989	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any service specified in item 1164, 1169, 1171, 1173, 1188 or 1197 including all testing performed on any 1 day (OP)
01201	01NOV1988	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (SP)
01202	01JUL1982	31DEC9999	Y	Cold agglutinins, qualitative estimation of (SP)
01203	01JUL1982	31DEC9999	Y	Cold agglutinins, qualitative estimation of (OP)
01204	01NOV1988	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (PP)
01205	01NOV1988	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (OP)
01206	01JUL1982	31DEC9999	Y	Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by Item 1202 where performed) (SP)
01207	01JUL1982	31DEC9999	Y	Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by Item 1203 where performed) (OP)
01208	01NOV1988	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (RP)
01209	01NOV1988	31DEC9999	Y	Two estimations specified in item 1201 (SP)
01210	01NOV1988	31DEC9999	Y	Two estimations specified in item 1204 (PP)
01211	01JUL1982	31DEC9999	Y	Blood volume, estimation of by dye method (SP)
01212	01JUL1982	31DEC9999	Y	Blood volume, estimation of by dye method (OP)
01213	01NOV1988	31DEC9999	Y	Two estimations specified in item 1205 (OP)
01214	01NOV1988	31DEC9999	Y	Two estimations specified in item 1208 (RP)
01215	01JUL1982	31DEC9999	Y	Blood, spectroscopic examination of (SP)
01216	01JUL1982	31DEC9999	Y	Blood, spectroscopic examination of (OP)
01217	01NOV1988	31DEC9999	Y	Three estimations specified in item 1201 (SP)
01218	01NOV1988	31DEC9999	Y	Three estimations specified in item 1204 (PP)
01219	01NOV1988	31DEC9999	Y	Three estimations specified in item 1205 (OP)
01220	01NOV1988	31DEC9999	Y	Three estimations specified in item 1208 (RP)
01221	01NOV1988	31DEC9999	Y	Four estimations specified in item 1201 (SP)
01222	01NOV1988	31DEC9999	Y	Four estimations specified in item 1204 (PP)
01223	01NOV1988	31DEC9999	Y	Four estimations specified in item 1205 (OP)
01224	01NOV1988	31DEC9999	Y	Four estimations specified in item 1208 (RP)
01225	01NOV1988	31DEC9999	Y	Five estimations specified in item 1201 (SP)
01226	01NOV1988	31DEC9999	Y	Five estimations specified in item 1204 (PP)
01227	01NOV1988	31DEC9999	Y	Five estimations specified in item 1205 (OP)
01228	01NOV1988	31DEC9999	Y	Five estimations specified in item 1208 (RP)
01229	01NOV1988	31DEC9999	Y	Six estimations specified in item 1201 (SP)
01230	01NOV1988	31DEC9999	Y	Six estimations specified in item 1204 (PP)
01231	01NOV1988	31DEC9999	Y	Six estimations specified in item 1205 (OP)
01232	01NOV1988	31DEC9999	Y	Six estimations specified in item 1208 (RP)
01234	01JUL1982	31DEC9999	Y	Estimation of-- bleeding time; coagulation time (including clot retraction); prothrombin time (one stage); thromboplastin time (partial) with or without kaolin and with or without kaolin clotting time; or thrombotest (Owren)-- one procedure (SP)
01235	01JUL1982	31DEC9999	Y	Estimation of-- bleeding time; coagulation time (including clot retraction); prothrombin time (one stage); thromboplastin time (partial) with or without kaolin and with or without kaolin clotting time; or thrombotest (Owren)-- one procedure (OP)
01236	01JUL1982	31DEC9999	Y	Two procedures to which Item 1234 applies (SP)
01237	01JUL1982	31DEC9999	Y	Two procedures to which Item 1235 applies (OP)
01238	01JUL1982	31DEC9999	Y	Three or more procedures to which Item 1234 applies (SP)
01239	01JUL1982	31DEC9999	Y	Three or more procedures to which Item 1235 applies (OP)
01242	01JUL1982	31DEC9999	Y	Platelet aggregation, qualitative test for (SP)
01243	01JUL1982	31DEC9999	Y	Platelet aggregation, qualitative test for (OP)
01244	01JUL1982	31DEC9999	Y	Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time-- each procedure (SP)
01246	01JUL1982	31DEC9999	Y	Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time-- each procedure (OP)
01247	01JUL1982	31DEC9999	Y	Fibrinogen titre, determination of (SP)
01248	01JUL1982	31DEC9999	Y	Fibrinogen titre, determination of (OP)
01249	01NOV1988	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (SP)
01250	01NOV1988	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (PP)
01251	01JUL1982	31DEC9999	Y	Factor 13, test for presence of (SP)
01252	01JUL1982	31DEC9999	Y	Factor 13, test for presence of (OP)
01253	01NOV1988	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (OP)
01254	01NOV1988	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (RP)
01255	01JUL1982	31DEC9999	Y	Thromboplastin generation screening test (SP)
01256	01JUL1982	31DEC9999	Y	Thromboplastin generation screening test (OP)
01257	01NOV1988	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (SP)
01258	01NOV1988	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (PP)
01259	01JUL1982	31DEC9999	Y	Prothrombin time, estimation of (two stage) (SP)
01260	01JUL1982	31DEC9999	Y	Prothrombin time, estimation of (two stage) (OP)
01261	01JUL1982	31DEC9999	Y	Qualitative, quantitative or qualitative and quantitative estimation of fibrin degeneration products (SP)
01262	01JUL1982	31DEC9999	Y	Qualitative, quantitative or qualitative and quantitative estimation of fibrin degeneration products (OP)
01263	01JUL1982	31DEC9999	Y	Quantitative estimation of-- platelet adhesion, prothrombin consumption or protamine sulphate-- each procedure (SP)
01264	01JUL1982	31DEC9999	Y	Quantitative estimation of-- platelet adhesion, prothrombin consumption or protamine sulphate-- each procedure (OP)
01265	01NOV1988	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (OP)
01266	01NOV1988	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (RP)
01267	01JUL1982	31DEC9999	Y	Euglobulin lysis time, estimation of (SP)
01268	01JUL1982	31DEC9999	Y	Euglobulin lysis time, estimation of (OP)
01269	01NOV1988	31DEC9999	Y	Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (SP)
01270	01NOV1988	31DEC9999	Y	Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (PP)
01271	01JUL1982	31DEC9999	Y	Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)-- each procedure (SP)
01272	01JUL1982	31DEC9999	Y	Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)-- each procedure (OP)
01273	01NOV1988	31DEC9999	Y	Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (OP)
01274	01NOV1988	31DEC9999	Y	Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (RP)
01275	01NOV1988	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (SP)
01276	01NOV1988	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (PP)
01277	01JUL1982	31DEC9999	Y	Platelet aggregation test using-- ADP, collagen, 5HT, ristocetin, or similar substance-- one procedure (SP)
01278	01JUL1982	31DEC9999	Y	Platelet aggregation test using-- ADP, collagen, 5HT, ristocetin, or similar substance-- one procedure (OP)
01279	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1277 applies (SP)
01280	01JUL1982	31DEC9999	Y	Two or more procedures to which Item 1278 applies (OP)
01281	01NOV1988	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (OP)
01282	01NOV1988	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (RP)
01283	01NOV1988	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (SP)
01284	01NOV1988	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (PP)
01285	01NOV1988	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (OP)
01286	01NOV1988	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (RP)
01287	01NOV1988	31DEC9999	Y	One or more estimations of blood gases as specified in item 1283 on two or more specimens within any one day. (SP)
01288	01NOV1988	31DEC9999	Y	One or more estimations of blood gases as specified in item 1284 on two or more specimens within any one day. (PP)
01289	01NOV1988	31DEC9999	Y	One or more estimations of blood gases as specified in item 1285 on two or more specimens within any one day. (OP)
01290	01NOV1988	31DEC9999	Y	One or more estimations of blood gases as specified in item 1286 on two or more specimens within any one day. (RP)
01291	01NOV1988	31DEC9999	Y	Calculus, analysis of one or more. (SP)
01292	01NOV1988	31DEC9999	Y	Calculus, analysis of one or more. (PP)
01293	01NOV1988	31DEC9999	Y	Calculus, analysis of one or more. (OP)
01294	01NOV1988	31DEC9999	Y	Calculus, analysis of one or more. (RP)
01295	01NOV1988	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1329, 134 1 and 1353 - one or more assays within any twenty eight day period. (SP)
01296	01FEB1984	31DEC9999	Y	Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (SP)
01297	01FEB1984	31DEC9999	Y	Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to 1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (OP)
01298	01NOV1983	31DEC9999	Y	Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to 1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (HP)
01299	01NOV1988	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1332, 1344 and 1356 - one or more assays within any twenty eight day period. (PP)
01300	01NOV1988	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1335, 1347 and 1359 - one or more assays within any twenty eight day period. (OP)
01301	01FEB1984	29FEB1984	N	Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1302 and 1303 where the estimation is performed on a multichannel analyser-- one estimation (SP)
01301	01MAR1984	31DEC9999	Y	Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1302 and 1303 where the estimation is performed on a multichannel analyser - one estimation (SP)
01302	01FEB1984	29FEB1984	N	Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1303 where the estimation is performed on a multichannel analyser-- one estimation (OP)
01302	01MAR1984	31DEC9999	Y	Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1303 where the estimation is performed on a multichannel analyser - one estimation (OP)
01303	01JUL1982	29FEB1984	N	Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1302 where the estimation is performed on a multichannel analyser-- one estimation (HP)
01303	01MAR1984	31DEC9999	Y	Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1302 where the estimation is performed on a multichannel analyser - one estimation (HP) 7.70
01304	01FEB1984	31DEC9999	Y	Two estimations of a kind specified in Item 1301 (SP)
01305	01FEB1984	31DEC9999	Y	Two estimations of a kind specified in Item 1302 (OP)
01306	01JUL1982	31DEC9999	Y	Two estimations of a kind specified in Item 1303 (HP)
01307	01FEB1984	31DEC9999	Y	Three to five estimations of a kind specified in Item 1301 (SP)
01308	01FEB1984	31DEC9999	Y	Three to five estimations of a kind specified in Item 1302 (OP)
01309	01JUL1982	31DEC9999	Y	Three to five estimations of a kind specified in Item 1303 (HP)
01310	01FEB1984	31DEC9999	Y	Six or more estimations of a kind specified in Item 1301 (SP)
01311	01FEB1984	31DEC9999	Y	Six or more estimations of a kind specified in Item 1302 (OP)
01312	01JUL1982	31DEC9999	Y	Six or more estimations of a kind specified in Item 1303 (HP)
01313	01JUL1982	31DEC9999	Y	Glycosylated haemoglobin, estimation of, in the management of established diabetes, with a maximum of three estimations in any twelve month period (SP)
01314	01JUL1982	31DEC9999	Y	Glycosylated haemoglobin, estimation of, in the management of established diabetes, with a maximum of three estimations in any twelve month period (OP)
01315	01NOV1988	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1338, 1350 and 1361 - one or more assays within any twenty eight day period. (RP)
01316	01NOV1988	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (SP)
01317	01NOV1988	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (PP)
01318	01NOV1988	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (OP)
01319	01JUL1982	31DEC9999	Y	Qualitative estimation of-- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-- one estimation (SP)
01320	01JUL1982	31DEC9999	Y	Qualitative estimation of-- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-- one estimation (OP)
01321	01NOV1988	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (RP)
01322	01JUL1982	31DEC9999	Y	Two or more estimations to which Item 1319 applies (SP)
01323	01JUL1982	31DEC9999	Y	Two or more estimations to which Item 1320 applies (OP)
01324	01FEB1984	31DEC9999	Y	Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (SP)
01325	01FEB1984	31DEC9999	Y	Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (OP)
01326	01JUL1982	31DEC9999	Y	Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (HP)
01327	01JUL1982	31DEC9999	Y	Qualitative estimation of-- foetoprotein, gastric acidity (by dye method) or porphyrins-- each estimation (SP)
01328	01JUL1982	31DEC9999	Y	Qualitative estimation of-- foetoprotein, gastric acidity (by dye method) or porphyrins-- each estimation (OP)
01329	01NOV1988	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (SP)
01330	01JUL1982	31DEC9999	Y	Chromatography, qualitative estimation of a substance not specified in any other item in this Division (SP)
01331	01JUL1982	31DEC9999	Y	Chromatography, qualitative estimation of a substance not specified in any other item in this Division (OP)
01332	01NOV1988	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (PP)
01333	01JUL1982	31DEC9999	Y	Electrophoresis, qualitative (SP)
01334	01JUL1982	31DEC9999	Y	Electrophoresis, qualitative (OP)
01335	01NOV1988	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (OP)
01336	01JUL1982	31DEC9999	Y	Australia antigen or similar antigen, detection of by any method including radioimmunoassay (SP)
01337	01JUL1982	31DEC9999	Y	Australia antigen or similar antigen, detection of by any method including radioimmunoassay (OP)
01338	01NOV1988	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (RP)
01339	01JUL1982	31DEC9999	Y	Osmolality, estimation of in serum or urine (SP)
01340	01JUL1982	31DEC9999	Y	Osmolality, estimation of in serum or urine (OP)
01341	01NOV1988	31DEC9999	Y	Two estimations specified in item 1329. (SP)
01342	01JUL1982	31DEC9999	Y	Quantitative estimation of-- acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement (total or fraction), any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose-- each estimation (SP)
01343	01JUL1982	31DEC9999	Y	Quantitative estimation of-- acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement (total or fraction), any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose-- each estimation (OP)
01344	01NOV1988	31DEC9999	Y	Two estimations specified in item 1332. (PP)
01345	01JUL1982	29FEB1984	N	Quantitative estimation of-- arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin (direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin, or any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase, urinary or serum HCG (other than in diagnosis of pregnancy), or any other substance not specified in any other item in this Division-- each estimation (SP)
01345	01MAR1984	31DEC9999	Y	Quantitative estimation of - arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin(direct and indirect), cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin or any other porphyrin factor, delta ALA, 5HIAA, iron(including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division - each estimation (SP)
01346	01JUL1982	29FEB1984	N	Quantitative estimation of-- arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin (direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin, or any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase, urinary or serum HCG (other than in diagnosis of pregnancy), or any other substance not specified in any other item in this Division-- each estimation (OP)
01346	01MAR1984	31DEC9999	Y	Quantitative estimation of - arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin(direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin or any other porphyrin factor, delta ALA, 5HIAA, iron(including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division - each estimation (OP)
01347	01NOV1988	31DEC9999	Y	Two estimations specified in item 1335. (OP)
01348	01JUL1982	31DEC9999	Y	Dibucaine number or similar, determination of (SP)
01349	01JUL1982	31DEC9999	Y	Dibucaine number or similar, determination of (OP)
01350	01NOV1988	31DEC9999	Y	Two estimations specified in item 1338. (RP)
01351	01JUL1982	31DEC9999	Y	Indican, qualitative test for (SP)
01352	01JUL1982	31DEC9999	Y	Indican, qualitative test for (OP)
01353	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1329. (SP)
01354	01JUL1982	31DEC9999	Y	Calculus, analysis of (SP)
01355	01JUL1982	31DEC9999	Y	Calculus, analysis of (OP)
01356	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1332. (PP)
01357	01JUL1982	31DEC9999	Y	Amniotic fluid, spectrophotometric analysis of (SP)
01358	01JUL1982	31DEC9999	Y	Amniotic fluid, spectrophotometric analysis of (OP)
01359	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1335. (OP)
01360	01JUL1982	31DEC9999	Y	Electrophoresis, quantitative (including qualitative test) (SP)
01361	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1338. (RP)
01362	01JUL1982	31DEC9999	Y	Electrophoresis, quantitative (including qualitative test) (OP)
01363	01NOV1988	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (SP)
01364	01JUL1982	29FEB1984	N	Quantitative estimation of-- catecholamines (each component), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process-- each estimation (SP)
01364	01MAR1984	31DEC9999	Y	Quantitative estimation of - catecholamines (one or more components), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process - each estimation (SP)
01365	01NOV1988	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (PP)
01366	01JUL1982	29FEB1984	N	Quantitative estimation of-- catecholamines (each component), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process-- each estimation (OP)
01366	01MAR1984	31DEC9999	Y	Quantitative estimation of - catecholamines (one or more components), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process - each estimation (OP)
01367	01NOV1988	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (OP)
01368	01JUL1982	31DEC9999	Y	Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (SP)
01369	01NOV1988	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (RP)
01370	01JUL1982	31DEC9999	Y	Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (OP)
01371	01NOV1988	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1379, but excluding lipoprotein electrophoresis - one or more examinations. (SP)
01372	01JUL1982	29FEB1984	N	Lechithin/sphingomyelin ratio of amniotic fluid, determination of (SP)
01372	01MAR1984	31DEC9999	Y	Lecithin/sphingomyelin ratio of amniotic fluid, determination of (SP)
01373	01NOV1988	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1383, but excluding lipoprotein electrophoresis - one or more examinations. (PP)
01374	01JUL1982	29FEB1984	N	Lechithin/sphingomyelin ratio of amniotic fluid, determination of (OP)
01374	01MAR1984	31DEC9999	Y	Lecithin/sphingomyelin ratio of amniotic fluid, determination of (OP)
01375	01NOV1988	31DEC9999	Y	Electrophoresis, q uantitative or qualitative of serum, unne or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1386, but excluding lipoprotein electrophoresis - one or more examinations. (OP)
01376	01JUL1982	31DEC9999	Y	Drug assays-- qualitative estimations or screening procedures, by colorimetric methods-- one or more estimations or procedures on each specimen (SP)
01377	01NOV1988	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1388, but excluding lipoprotein electrophoresis - one or more examinations. (RP)
01378	01JUL1982	31DEC9999	Y	Drug assays-- qualitative estimations or screening procedures, by colorimetric methods-- one or more estimations or procedures on each specimen (OP)
01379	01NOV1988	31DEC9999	Y	Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (SP)
01380	01JUL1982	29FEB1984	N	Assay by radioimmmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin-- estimation of one substance by one or more methods (SP)
01380	01MAR1984	31DEC9999	Y	Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin - estimation of one substance by one or more methods (SP)
01381	01JUL1982	29FEB1984	N	Assay by radioimmmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin-- estimation of one substance by one or more methods (OP)
01381	01MAR1984	31DEC9999	Y	Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin - estimation of one substance by one or more methods (OP)
01382	01JUL1982	31DEC9999	Y	Estimation of two substances referred to in Item 1380 by using one or more of the methods specified in that item in relation to each (SP)
01383	01NOV1988	31DEC9999	Y	Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (PP)
01384	01JUL1982	31DEC9999	Y	Estimation of two substances referred to in Item 1381 by using one or more of the methods specified in that item in relation to each (OP)
01385	01JUL1982	31DEC9999	Y	Estimation of three or more substances referred to in Item 1380 by using one or more of the methods specified in that item in relation to each (SP)
01386	01NOV1988	31DEC9999	Y	Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (OP)
01387	01JUL1982	31DEC9999	Y	Estimation of three or more substances referred to in Item 1381 by using one or more of the methods specified in that item in relation to each (OP)
01388	01NOV1988	31DEC9999	Y	Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (RP)
01389	01NOV1988	31DEC9999	Y	Quantitative estimation of two or more proteins specified in item 1379. (SP)
01390	01NOV1988	31DEC9999	Y	Quantitative estimation of two or more proteins specified in item 1383. (PP)
01391	01NOV1988	31DEC9999	Y	Quantitative estimation of two or more proteins specified in item 1386. (OP)
01392	01JUL1982	31DEC9999	Y	Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and Item 1393-- estimation of one substance by one or more methods (SP)
01393	01JUL1982	31DEC9999	Y	Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and Item 1392-- estimation of one substance by one or more methods (OP)
01394	01JUL1982	31DEC9999	Y	Estimation of two substances referred to in Item 1392 by using one or more of the methods specified in that item in relation to each (SP)
01395	01JUL1982	31DEC9999	Y	Estimation of two substances referred to in Item 1393 by using one or more of the methods specified in that item in relation to each (OP)
01396	01NOV1988	31DEC9999	Y	Quantitative estimation of two or more proteins specified in item 1388. (RP)
01397	01JUL1982	31DEC9999	Y	Estimation of three or more substances referred to in Item 1392 by using one or more of the methods specified in that item in relation to each (SP)
01398	01JUL1982	31DEC9999	Y	Estimation of three or more substances referred to in Item 1393 by using one or more of the methods specified in that item in relation to each (OP)
01399	01NOV1988	31DEC9999	Y	Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (SP)
01400	01NOV1988	31DEC9999	Y	Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (PP)
01401	01JUL1982	31DEC9999	Y	HDL cholesterol, estimation of, in proven cases of hyperlipidaemia-- one estimation in any twelve month period (SP)
01402	01JUL1982	31DEC9999	Y	HDL cholesterol, estimation of, in proven cases of hyperlipidaemia-- one estimation in any twelve month period (OP)
01403	01NOV1988	31DEC9999	Y	Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (OP)
01404	01NOV1988	31DEC9999	Y	Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (RP)
01405	01NOV1988	31DEC9999	Y	Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (SP)
01406	01NOV1988	31DEC9999	Y	Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (PP)
01407	01NOV1988	31DEC9999	Y	Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (OP)
01408	01NOV1988	31DEC9999	Y	Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (RP)
01409	01NOV1988	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (SP)
01410	01NOV1988	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (PP)
01411	01NOV1988	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (OP)
01412	01NOV1988	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (RP)
01413	01NOV1988	31DEC9999	Y	Vitamin D or D fractions - one or more estimations. (SP)
01414	01NOV1988	31DEC9999	Y	Vitamin D or D fractions - one or more estimations. (PP)
01415	01NOV1988	31DEC9999	Y	Vitamin D or D fractions - one or more estimations. (OP)
01416	01NOV1988	31DEC9999	Y	Vitamin D or D fractions - one or more estimations. (RP)
01417	01AUG1989	31DEC9999	Y	Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected (SP)
01418	01AUG1989	31DEC9999	Y	Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected (OP)
01419	01AUG1989	31DEC9999	Y	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including service specified in item 1170 or 1172 - 1 or more tests (SP)
01420	01AUG1989	31DEC9999	Y	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including service specified in item 1171 or 1173 - 1 or more tests (OP)
01421	01JUL1982	31DEC9999	Y	Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- one estimation (SP)
01422	01JUL1982	31DEC9999	Y	Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- one estimation (OP)
01424	01JUL1982	31DEC9999	Y	Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- two or more estimations (SP)
01425	01JUL1982	31DEC9999	Y	Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- two or more estimations (OP)
01429	01NOV1988	31DEC9999	Y	Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (SP)
01430	01NOV1988	31DEC9999	Y	Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (PP)
01431	01NOV1988	31DEC9999	Y	Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (OP)
01432	01NOV1988	31DEC9999	Y	Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (RP)
01433	01NOV1988	31DEC9999	Y	Two or more estimations specified in item 1429. (SP)
01434	01NOV1988	31DEC9999	Y	Two or more estimations specified in item 1430. (PP)
01435	01NOV1988	31DEC9999	Y	Two or more estimations specified in item 1431. (OP)
01436	01NOV1988	31DEC9999	Y	Two or more estimations specified in item 1432. (RP)
01437	01NOV1988	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (SP)
01438	01NOV1988	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (PP)
01439	01NOV1988	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (OP)
01440	01NOV1988	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (RP)
01445	01NOV1988	31DEC9999	Y	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (SP)
01446	01NOV1988	31DEC9999	Y	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (PP)
01447	01NOV1988	31DEC9999	Y	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (OP)
01448	01NOV1988	31DEC9999	Y	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (RP)
01449	01NOV1988	31DEC9999	Y	Faecal fat - one or more quantitative estimations within any twenty eight day period. (SP)
01450	01NOV1988	31DEC9999	Y	Faecal fat - one or more quantitative estimations within any twenty eight day period. (PP)
01451	01NOV1988	31DEC9999	Y	Faecal fat - one or more quantitative estimations within any twenty eight day period. (OP)
01452	01JUL1982	29FEB1984	N	Hormone assays (including assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH or HPL but not including assay of a thyroid hormone covered by Item 1421 or 1424) using gamma emitting labels or any other unspecified technique-- one estimation of any one hormone (SP)
01452	01MAR1984	31DEC9999	Y	Hormone assays - assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH, HPL but not including assay of a thyroid hormone covered by Item 1421 or 1424, using gamma emitting labels or other unspecified technique - one estimation of any one hormone (SP)
01453	01JUL1982	29FEB1984	N	Hormone assays (including assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH or HPL but not including assay of a thyroid hormone covered by Item 1422 or 1425) using gamma emitting labels or any other unspecified technique-- one estimation of any one hormone (OP)
01453	01MAR1984	31DEC9999	Y	Hormone assays - assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH, HPL but not including assay of a thyroid hormone covered by Item 1422 or 1425, using gamma emitting labels or other unspecified technique - one estimation of any one hormone (OP)
01454	01NOV1988	31DEC9999	Y	Faecal fat - one or more quantitative estimations within any twenty eight day period. (RP)
01455	01JUL1982	31DEC9999	Y	Two estimations of any one hormone using any technique referred to in Item 1452 (SP)
01456	01JUL1982	31DEC9999	Y	Two estimations of any one hormone using any technique referred to in Item 1453 (OP)
01457	01NOV1988	31DEC9999	Y	Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (SP)
01458	01JUL1982	31DEC9999	Y	Three estimations of any one hormone using any technique referred to in Item 1452 (SP)
01459	01JUL1982	31DEC9999	Y	Three estimations of any one hormone using any technique referred to in Item 1453 (OP)
01460	01NOV1988	31DEC9999	Y	Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (PP)
01461	01JUL1982	31DEC9999	Y	Each estimation of any one hormone in excess of three estimations using any technique referred to in Item 1452 (SP)
01462	01JUL1982	31DEC9999	Y	Each estimation of any one hormone in excess of three estimations using any technique referred to in Item 1453 (OP)
01463	01NOV1988	31DEC9999	Y	Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (OP)
01464	01NOV1988	31DEC9999	Y	Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (RP)
01465	01NOV1988	31DEC9999	Y	Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (SP)
01466	01NOV1988	31DEC9999	Y	Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (PP)
01467	01NOV1988	31DEC9999	Y	Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (OP)
01468	01NOV1988	31DEC9999	Y	Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (RP)
01469	01NOV1984	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or in subsequent lesion in the breast - one or more assays (SP)
01470	01NOV1984	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or in subsequent lesion in the breast - one or more assays (OP)
01471	01NOV1988	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (SP)
01472	01NOV1988	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (PP)
01473	01NOV1988	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (OP)
01474	01NOV1988	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (RP)
01475	01JUL1982	31DEC9999	Y	Hormone assays (including assay of progesterone, testosterone, cortisol (tritium labelled), 17-hydroxyprogesterone, oestradiol or aldosterone) using beta emitting labels or bioassay techniques-- one estimation of any one hormone (SP)
01476	01JUL1982	31DEC9999	Y	Hormone assays (including assay of progesterone, testosterone, cortisol (tritium labelled), 17-hydroxyprogesterone, oestradiol or aldosterone) using beta emitting labels or bioassay techniques-- one estimation of any one hormone (OP)
01477	01NOV1988	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (SP)
01478	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- two estimations of any one hormone (SP)
01479	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- two estimations of any one hormone (OP)
01480	01NOV1988	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (PP)
01481	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- three estimations of any one hormone (SP)
01482	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- three estimations of any one hormone (OP)
01483	01NOV1988	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (OP)
01484	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- each estimation of any one hormone in excess of three (SP)
01485	01JUL1982	31DEC9999	Y	Hormone assay using beta emitting labels or bioassay techniques-- each estimation of any one hormone in excess of three (OP)
01486	01NOV1988	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (RP)
01487	01NOV1988	31DEC9999	Y	Two estimations specified in item 1477. (SP)
01488	01NOV1988	31DEC9999	Y	Two estimations specified in item 1480. (PP)
01489	01NOV1988	31DEC9999	Y	Two estimations specified in item 1483. (OP)
01490	01NOV1988	31DEC9999	Y	Two estimations specified in item 1486. (RP)
01491	01NOV1988	31DEC9999	Y	Three estimations specified in item 1477. (SP)
01492	01NOV1988	31DEC9999	Y	Three estimations specified in item 1480. (PP)
01493	01NOV1988	31DEC9999	Y	Three estimations specified in item 1483. (OP)
01494	01NOV1988	31DEC9999	Y	Three estimations specified in item 1486. (RP)
01495	01NOV1988	31DEC9999	Y	Four estimations specified in item 1477 . (SP)
01496	01NOV1988	31DEC9999	Y	Four estimations specified in item 1480 . (PP)
01497	01NOV1988	31DEC9999	Y	Four estimations specified in item 1483 . (OP)
01498	01NOV1988	31DEC9999	Y	Four estimations specified in item 1486 . (RP)
01499	01NOV1988	31DEC9999	Y	Five estimations specified in item 1477. (SP)
01500	01NOV1988	31DEC9999	Y	Five estimations specified in item 1480. (PP)
01501	01NOV1988	31DEC9999	Y	Five estimations specified in item 1483. (OP)
01502	01NOV1988	31DEC9999	Y	Five estimations specified in item 1486. (RP)
01503	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1477. (SP)
01504	01JUL1982	31DEC9999	Y	Procedural service associated with -ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, L-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (SP)
01505	01JUL1982	31DEC9999	Y	Procedural service associated with -ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, L-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (OP)
01506	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1480. (PP)
01507	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1483. (OP)
01508	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1486. (RP)
01509	01NOV1988	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (SP)
01510	01NOV1988	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (PP)
01511	01JUL1982	31DEC9999	Y	Procedural services associated with -tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (SP)
01512	01JUL1982	31DEC9999	Y	Procedural services associated with -tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (OP)
01513	01NOV1988	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (OP)
01514	01NOV1988	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (RP)
01516	01JUL1982	31DEC9999	Y	Procedural services associated with the administration of -thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (SP)
01517	01JUL1982	31DEC9999	Y	Procedural services associated with the administration of -thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (OP)
01521	01AUG1989	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of - fibrinogen degradation products, fibrin monomer or D-dimer - 1 estimation (SP)
01522	01AUG1989	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of - fibrinogen degradation products, fibrin monomer or D-dimer - 1 estimation (OP)
01523	01AUG1989	31DEC9999	Y	2 estimations specified in item 1521 (SP)
01524	01AUG1989	31DEC9999	Y	2 estimations specified in item 1522 (OP)
01525	01AUG1989	31DEC9999	Y	3 estimations specified in item 1521 (SP)
01526	01AUG1989	31DEC9999	Y	3 estimations specified in item 1522 (OP)
01527	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 1521 (SP)
01528	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 1522 (OP)
01529	01JUL1982	31DEC9999	Y	Microscopical examination, wet film, not covered by Item 1536 (SP)
01530	01JUL1982	31DEC9999	Y	Microscopical examination, wet film, not covered by Item 1537 (OP)
01531	01AUG1989	31DEC9999	Y	Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - 1 estimation (SP)
01532	01AUG1989	31DEC9999	Y	Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - 1 estimation (OP)
01533	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 1531 (SP)
01534	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 1532 (OP)
01535	01AUG1989	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - 1 or more estimations (SP)
01536	01JUL1982	31DEC9999	Y	Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP)
01537	01JUL1982	31DEC9999	Y	Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (where the patient is referred by another medical practitioner) (OP)
01538	01AUG1989	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - 1 or more estimations (OP)
01539	01AUG1989	31DEC9999	Y	Heperin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - 1 or more estimations (SP)
01540	01AUG1989	31DEC9999	Y	Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - 1 or more estimations (OP)
01541	01AUG1989	31DEC9999	Y	Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - 1 estimation (SP)
01542	01AUG1989	31DEC9999	Y	Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - 1 estimation (OP)
01543	01AUG1989	31DEC9999	Y	2 estimations as specified in item 1541 (SP)
01544	01AUG1989	31DEC9999	Y	2 estimations as specified in item 1542 (OP)
01545	01JUL1982	31DEC9999	Y	Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- one stain (SP)
01546	01JUL1982	31DEC9999	Y	Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- one stain (OP)
01548	01JUL1982	31DEC9999	Y	Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- two or more stains (SP)
01549	01JUL1982	31DEC9999	Y	Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- two or more stains (OP)
01550	01AUG1989	31DEC9999	Y	3 or more estimations as specified in item 1541 (SP)
01551	01AUG1989	31DEC9999	Y	3 or more estimations as specified in item 1542 (OP)
01556	01JUL1982	31DEC9999	Y	Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)-- one stain (SP)
01557	01JUL1982	31DEC9999	Y	Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)-- one stain (OP)
01558	01AUG1989	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1734), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation (SP)
01559	01AUG1989	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1735), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation (OP)
01560	01AUG1989	31DEC9999	Y	2 estimations specified in item 1558 (SP)
01561	01AUG1989	31DEC9999	Y	2 estimations specified in item 1559 (OP)
01562	01AUG1989	31DEC9999	Y	3 estimations specified in item 1558 (SP)
01563	01AUG1989	31DEC9999	Y	3 estimations specified in item 1559 (OP)
01564	01AUG1989	31DEC9999	Y	4 estimations specified in item 1558 (SP)
01565	01AUG1989	31DEC9999	Y	4 estimations specified in item 1559 (OP)
01566	01JUL1982	31DEC9999	Y	Microscopical examination using two or more stains, one or more of which is a special stain referred to in Item 1556 (SP)
01567	01JUL1982	31DEC9999	Y	Microscopical examination using two or more stains, one or more of which is a special stain referred to in Item 1557 (OP)
01569	01AUG1989	31DEC9999	Y	5 estimations specified in item 1558 (SP)
01570	01AUG1989	31DEC9999	Y	5 estimations specified in item 1559 (OP)
01571	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 1558 (SP)
01572	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 1559 (OP)
01575	01AUG1989	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations (SP)
01576	01AUG1989	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations (OP)
01577	01AUG1989	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of 3 estimations, taken on separate days (SP)
01578	01AUG1989	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of 3 estimations, taken on separate days (OP)
01579	01AUG1989	31DEC9999	Y	Immunological tests for human haemoglobin in faeces performed in any 28 day period, including chemical test if performed - 1 estimation (SP)
01580	01AUG1989	31DEC9999	Y	Immunological tests for human haemoglobin in faeces performed in any 28 day period, including chemical test if performed - 1 estimation (OP)
01581	01AUG1989	31DEC9999	Y	2 or more estimations specified in item 1579 (SP)
01582	01AUG1989	31DEC9999	Y	2 or more estimations specified in item, 1580 (OP)
01583	01AUG1989	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - 1 or more estimations (SP)
01584	01AUG1989	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - 1 or more estimations (OP)
01586	01JUL1982	31DEC9999	Y	Microscopical examination for dermatophytes-- examination of material from one site (SP)
01587	01JUL1982	31DEC9999	Y	Microscopical examination for dermatophytes-- examination of material from one site (OP)
01588	01JUL1982	31DEC9999	Y	Microscopical examination for dermatophytes-- examination of material from two or more sites (SP)
01589	01JUL1982	31DEC9999	Y	Microscopical examination for dermatophytes-- examination of material from two or more sites (OP)
01590	01AUG1989	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (e.g. haemoglobin, potassium) or calculation performed on the same specimen - 1 or more estimation on 1 specimen (SP)
01591	01AUG1989	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (e.g. haemoglobin, potassium) or calculation performed on the same specimen - 1 or more estimation on 1 specimen (OP)
01592	01AUG1989	31DEC9999	Y	1 or more estimations of blood gases as specified in item 1590 on 2 or more specimens within any 1 day (SP)
01593	01AUG1989	31DEC9999	Y	1 or more estimations of blood gases as specified in item 1591 on 2 or more specimens within any 1 day (OP)
01595	01AUG1989	31DEC9999	Y	Calculus, analysis of 1 or more (SP)
01596	01AUG1989	31DEC9999	Y	Calculus, analysis of 1 or more (OP) 30.90 1598 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any service specified in item 1712, 1714 or 1716, but excluding the surveillance of sports people and athletes for performance improving substances - 1 or more assays (SP)
01598	01AUG1989	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 1712, 1714 and 1716, but excluding the surveillance of sports people and athletes for performance improving substances - one or more assays.(S)
01599	01AUG1989	31DEC9999	Y	Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any service specified in item 1713, 1715 or 1717, but excluding the surveillance of sports people and athletes for performance improving substances - 1 or more assays (OP)
01601	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (SP)
01602	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (PP)
01603	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (OP)
01604	01JUL1982	31DEC9999	Y	Microscopical examination of exudate by dark ground illumination for Treponema pallidum (SP)
01605	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (RP)
01606	01JUL1982	31DEC9999	Y	Microscopical examination of exudate by dark ground illumination for Treponema pallidum (OP)
01607	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1629, 1635 or 1671, and including any services specified in item 1601 - one or more examinations. (SP)
01608	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1630, 1639 or 1672, and including any services specified in item 1602 - one or more examinations. (PP)
01609	01FEB1984	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (SP)
01610	01FEB1984	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (OP)
01611	01JUL1982	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (HP)
01612	01FEB1984	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (SP)
01613	01FEB1984	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (OP)
01614	01JUL1982	31DEC9999	Y	Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (HP)
01615	01FEB1984	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (SP)
01616	01FEB1984	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (OP)
01617	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1631, 1642 or 1675, and including any services specified in item 1603 - one or more examinations. (OP)
01618	01JUL1982	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (HP)
01619	01FEB1984	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (SP)
01620	01FEB1984	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (OP)
01621	01JUL1982	31DEC9999	Y	Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (HP)
01622	01JUL1982	31DEC9999	Y	Cultural examination for mycobacteria-- each specimen (SP)
01623	01JUL1982	31DEC9999	Y	Cultural examination for mycobacteria-- each specimen (OP)
01624	01NOV1988	31DEC9999	Y	Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1632, 1643 or 1677, and including any services specified in item 1605 - one or more examinations. (RP)
01627	01AUG1989	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of 4 assays within any 28 day period (SP)
01628	01AUG1989	31DEC9999	Y	Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of 4 assays within any 28 day period (OP)
01629	01NOV1988	31DEC9999	Y	Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (SP)
01630	01NOV1988	31DEC9999	Y	Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (PP)
01631	01NOV1988	31DEC9999	Y	Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (OP)
01632	01NOV1988	31DEC9999	Y	Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (RP)
01633	01FEB1984	31DEC9999	Y	Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (SP)
01634	01FEB1984	31DEC9999	Y	Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (OP)
01635	01NOV1988	31DEC9999	Y	Identification of two or more antigens specified in item 1629. (SP)
01636	01JUL1982	31DEC9999	Y	Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (HP)
01637	01JUL1982	31DEC9999	Y	Screening test for mycoplasma or ureaplasma or both (SP)
01638	01JUL1982	31DEC9999	Y	Screening test for mycoplasma or ureaplasma or both (OP)
01639	01NOV1988	31DEC9999	Y	Identification of two or more antigens specified in item 1630. (PP)
01640	01JUL1982	31DEC9999	Y	Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1644, 1647, 1661 or 1664 that is performed for the purpose of identifying the same organism (SP)
01641	01JUL1982	31DEC9999	Y	Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1645, 1648, 1662 or 1665 that is performed for the purpose of identifying the same organism (OP)
01642	01NOV1988	31DEC9999	Y	Identification of two or more antigens specified in item 1631. (OP)
01643	01NOV1988	31DEC9999	Y	Identification of two or more antigens specified in item 1632. (RP)
01644	01JUL1982	31DEC9999	Y	Identification of pathogenic microorganisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture-- identification of one organism (SP)
01645	01JUL1982	31DEC9999	Y	Identification of pathogenic microorganisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture-- identification of one organism (OP)
01646	01NOV1988	31DEC9999	Y	Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1629 and 1635 - examination of material from one or more sites. (SP)
01647	01JUL1982	31DEC9999	Y	Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1644 (SP)
01648	01JUL1982	31DEC9999	Y	Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1645 (OP)
01649	01NOV1988	31DEC9999	Y	Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1630 and 1639 - examination of material from one or more sites. (PP)
01650	01NOV1988	31DEC9999	Y	Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1631 and 1642 - examination of material from one or more sites. (OP)
01651	01NOV1988	31DEC9999	Y	Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1632 and 1643 - examination of material from one or more sites. (RP)
01652	01NOV1988	31DEC9999	Y	Microbiological examination consisting of items 1607 and 1646. (SP)
01653	01NOV1988	31DEC9999	Y	Microbiological examination consisting of items 1608 and 1649. (PP)
01654	01NOV1988	31DEC9999	Y	Microbiological examination consisting of items 16 17 and 1650. (OP)
01655	01NOV1988	31DEC9999	Y	Microbiological examination consisting of items 1624 and 1651. (RP)
01656	01NOV1988	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (SP)
01657	01NOV1988	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (PP)
01658	01NOV1988	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (OP)
01659	01NOV1988	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (RP)
01661	01JUL1982	31DEC9999	Y	Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic method)- a procedure involving one technique (SP)
01662	01JUL1982	31DEC9999	Y	Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic method)- a procedure involving one technique (OP)
01664	01JUL1982	31DEC9999	Y	Two or more of any procedures of a kind referred to in Item 1661 using different techniques (SP)
01665	01JUL1982	31DEC9999	Y	Two or more of any procedures of a kind referred to in Item 1662 using different techniques (OP)
01668	01FEB1984	31DEC9999	Y	Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (SP)
01669	01FEB1984	31DEC9999	Y	Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (OP)
01670	01JUL1982	31DEC9999	Y	Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (HP)
01671	01NOV1988	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (SP)
01672	01NOV1988	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (PP)
01673	01FEB1984	31DEC9999	Y	Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP)
01674	01FEB1984	31DEC9999	Y	Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP)
01675	01NOV1988	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (OP)
01676	01JUL1982	31DEC9999	Y	Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (HP)
01677	01NOV1988	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (RP)
01678	01NOV1988	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (SP)
01679	01NOV1988	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (PP)
01680	01NOV1988	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (OP)
01681	01NOV1988	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (RP)
01682	01JUL1982	31DEC9999	Y	Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (SP)
01683	01JUL1982	31DEC9999	Y	Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner) (OP)
01684	01NOV1988	31DEC9999	Y	Two estimations specified in item 1678. (SP)
01685	01NOV1988	31DEC9999	Y	Two estimations specified in item 1679. (PP)
01686	01NOV1988	31DEC9999	Y	Two estimations specified in item 1680. (OP)
01687	01JUL1982	31DEC9999	Y	Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP)
01688	01JUL1982	31DEC9999	Y	Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP)
01689	01NOV1988	31DEC9999	Y	Two estimations specified in item 1681. (RP)
01690	01NOV1988	31DEC9999	Y	Three estimations specified in item 1678. (SP)
01691	01NOV1988	31DEC9999	Y	Three estimations specified in item 1679. (PP)
01692	01NOV1988	31DEC9999	Y	Three estimations specified in item 1680. (OP)
01693	01JUL1982	31DEC9999	Y	Identification of helminths (SP)
01694	01JUL1982	31DEC9999	Y	Identification of helminths (OP)
01695	01NOV1988	31DEC9999	Y	Three estimations specified in item 1681. (RP)
01696	01NOV1988	31DEC9999	Y	Four estimations specified in item 1678. (SP)
01697	01NOV1988	31DEC9999	Y	Four estimations specified in item 1679. (PP)
01698	01NOV1988	31DEC9999	Y	Four estimations specified in item 1680. (OP)
01699	01NOV1988	31DEC9999	Y	Four estimations specified in item 1681. (RP)
01700	01NOV1988	31DEC9999	Y	Five estimations specified in item 1678 . (SP)
01701	01NOV1988	31DEC9999	Y	Five estimations specified in item 1679 . (PP)
01702	01JUL1982	31DEC9999	Y	Cultural examination for parasites, other than trichomonas-- culture of one parasite (SP)
01703	01JUL1982	31DEC9999	Y	Cultural examination for parasites, other than trichomonas-- culture of one parasite (OP)
01704	01NOV1988	31DEC9999	Y	Five estimations specified in item 1680 . (OP)
01705	01JUL1982	31DEC9999	Y	Cultural examination for parasites, other than trichomonas-- culture of two or more parasites (SP)
01706	01JUL1982	31DEC9999	Y	Cultural examination for parasites, other than trichomonas-- culture of two or more parasites (OP)
01707	01NOV1988	31DEC9999	Y	Five estimations specified in item 1681 . (RP)
01708	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1678 . (SP)
01709	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1679 . (PP)
01710	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1680 . (OP)
01711	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1681 . (RP)
01712	01AUG1989	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - 1 estimation (SP)
01713	01AUG1989	31DEC9999	Y	Drug assay - quantitative estimation on blood or other body fluid by any method of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - 1 estimation (OP)
01714	01AUG1989	31DEC9999	Y	2 estimations specified in item 1712 (SP)
01715	01AUG1989	31DEC9999	Y	2 estimations specified in item 1713 (OP)
01716	01AUG1989	31DEC9999	Y	3 or more estimations specified in item 1712 (SP)
01717	01AUG1989	31DEC9999	Y	3 or more estimations specified in item 1713 (OP)
01721	01JUL1982	31DEC9999	Y	Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- one organism (SP)
01722	01JUL1982	31DEC9999	Y	Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- one organism (OP)
01724	01JUL1982	31DEC9999	Y	Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- two or more organisms (SP)
01725	01JUL1982	31DEC9999	Y	Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- two or more organisms (OP)
01726	01AUG1989	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - 1 or more examinations or estimations (SP)
01727	01AUG1989	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - 1 or more examinations or estimations (OP)
01728	01NOV1988	31DEC9999	Y	Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1629 and 1635. (SP)
01729	01NOV1988	31DEC9999	Y	Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1630 and 1639. (PP)
01730	01NOV1988	31DEC9999	Y	Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1631 and 1642. (OP)
01731	01NOV1988	31DEC9999	Y	Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1632 and 1642. (RP)
01732	01JUL1982	31DEC9999	Y	Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (SP)
01733	01JUL1982	31DEC9999	Y	Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (OP)
01734	01AUG1989	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - 1 examination to a maximum of 2 examinations in any 12 month period (SP)
01735	01AUG1989	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5 mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - 1 examination to a maximum of 2 examinations in any 12 month period (OP)
01736	01AUG1989	31DEC9999	Y	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - 2 or more examinations (SP)
01737	01AUG1989	31DEC9999	Y	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - 2 or more examinations (OP)
01738	01AUG1989	31DEC9999	Y	Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1752), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphatase, Transferrin (unless specified in item 1752) and, in the follow-up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - 1 estimation (SP)
01739	01AUG1989	31DEC9999	Y	Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1753), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphatase, Transferrin (unless specified in item 1753) and, in the follow up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - 1 estimation (OP)
01740	01AUG1989	31DEC9999	Y	2 or more estimations specified in item 1738 (SP)
01741	01AUG1989	31DEC9999	Y	2 or more estimations specified in item 1739 (OP)
01742	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (SP)
01743	01JUL1982	31DEC9999	Y	Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP)
01744	01JUL1982	31DEC9999	Y	Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (OP)
01745	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (PP)
01746	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (OP)
01747	01NOV1984	31DEC9999	Y	Serological tests for Hepatitis A and Hepatitis B. Each test to a maximum of two tests. (SP)
01748	01NOV1984	31DEC9999	Y	Serological tests for Hepatitis A and Hepatitis B. Each test to a maximum of two tests. (OP)
01749	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (RP)
01752	01AUG1989	31DEC9999	Y	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin (SP)
01753	01AUG1989	31DEC9999	Y	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin (OP)
01754	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1742 - one or more estimations. (SP)
01755	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1745 - one or more estimations. (PP)
01756	01JUL1982	31DEC9999	Y	Agglutination tests (screening)-- one test (SP)
01757	01JUL1982	31DEC9999	Y	Agglutination tests (screening)-- one test (OP)
01758	01JUL1982	31DEC9999	Y	Agglutination tests (screening) -- two or more tests (SP)
01759	01JUL1982	31DEC9999	Y	Agglutination tests (screening) -- two or more tests (OP)
01760	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- one antigen (SP)
01761	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- one antigen (OP)
01762	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1746 - one or more estimations. (OP)
01763	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- second to sixth antigen-- each antigen (SP)
01764	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- second to sixth antigen-- each antigen (OP)
01765	01NOV1988	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1749 - one or more estimations. (RP)
01766	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- each antigen in excess of six (SP)
01767	01JUL1982	31DEC9999	Y	Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- each antigen in excess of six (OP)
01768	01AUG1989	31DEC9999	Y	Serum B12, serum folate - 1 or more estimations within any 28 day period (SP)
01769	01AUG1989	31DEC9999	Y	Serum B12, serum folate - 1 or more estimations within any 28 day period (OP)
01770	01AUG1989	31DEC9999	Y	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period (SP)
01771	01AUG1989	31DEC9999	Y	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period (OP)
01772	01JUL1982	31DEC9999	Y	Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- one test (SP)
01773	01JUL1982	31DEC9999	Y	Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- one test (OP)
01775	01JUL1982	31DEC9999	Y	Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- two or more tests (SP)
01776	01JUL1982	31DEC9999	Y	Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- two or more tests (OP)
01780	01AUG1989	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - 1 or more estimations within any 6 month period (SP)
01781	01JUL1982	31DEC9999	Y	Complement fixation tests-- one test (SP)
01782	01JUL1982	31DEC9999	Y	Complement fixation tests-- one test (OP)
01783	01AUG1989	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - 1 or more estimations within any 6 month period (OP)
01784	01JUL1982	29FEB1984	N	Complement fixation tests-- each test in excess of one (SP)
01784	01MAR1984	31DEC9999	Y	Complement fixation tests - each test in excess of one (SP) 5.10
01785	01JUL1982	29FEB1984	N	Complement fixation tests-- each test in excess of one (OP)
01785	01MAR1984	31DEC9999	Y	Complement fixation tests - each test in excess of one (OP) 3.85
01786	01AUG1989	31DEC9999	Y	Vitamin D or D fractions - 1 or more estimations (SP)
01787	01AUG1989	31DEC9999	Y	Vitamin D or D fractions - 1 or more estimations (OP)
01791	01AUG1989	31DEC9999	Y	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation (SP)
01792	01AUG1989	31DEC9999	Y	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation (OP)
01793	01JUL1982	31DEC9999	Y	Fluorescent serum antibody test (FTA test, FTA-- absorbed test or similar)-- one test (SP)
01794	01JUL1982	31DEC9999	Y	Fluorescent serum antibody test (FTA test, FTA-- absorbed test or similar)-- one test (OP)
01795	01AUG1989	31DEC9999	Y	2 or more estimations specified in item 1791 (SP)
01796	01JUL1982	31DEC9999	Y	Each test referred to in Item 1793 in excess of one (SP)
01797	01JUL1982	31DEC9999	Y	Each test referred to in Item 1794 in excess of one (OP)
01798	01AUG1989	31DEC9999	Y	2 or more estimations specified in item 1792 (OP)
01801	01NOV1988	31DEC9999	Y	Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1371 or 1807), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (SP)
01802	01NOV1988	31DEC9999	Y	Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1373 or 1810), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (PP)
01803	01NOV1988	31DEC9999	Y	Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1375 or 1811), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (OP)
01804	01NOV1988	31DEC9999	Y	Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1377 or 1812), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (RP)
01805	01JUL1982	31DEC9999	Y	Haemagglutination tests-- one test (SP)
01806	01JUL1982	31DEC9999	Y	Haemagglutination tests-- one test (OP)
01807	01NOV1988	31DEC9999	Y	Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (SP)
01808	01JUL1982	31DEC9999	Y	Haemagglutination tests-- each test in excess of one (SP)
01809	01JUL1982	31DEC9999	Y	Haemagglutination tests-- each test in excess of one (OP)
01810	01NOV1988	31DEC9999	Y	Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (PP)
01811	01NOV1988	31DEC9999	Y	Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (OP)
01812	01NOV1988	31DEC9999	Y	Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (RP)
01813	01NOV1988	31DEC9999	Y	Two estimations specified in item 1807. (SP)
01814	01NOV1988	31DEC9999	Y	Two estimations specified in item 1810. (PP)
01815	01NOV1988	31DEC9999	Y	Two estimations specified in item 1811. (OP)
01816	01NOV1988	31DEC9999	Y	Two estimations specified in item 1812. (RP)
01817	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1807. (SP)
01818	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 181. (PP)
01819	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1811. (OP)
01820	01NOV1988	31DEC9999	Y	Three or more estimations specified in item 1812. (RP)
01821	01NOV1988	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (SP)
01822	01NOV1988	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (PP)
01823	01JUL1982	31DEC9999	Y	Haemagglutination inhibition tests-- one test (SP)
01824	01JUL1982	31DEC9999	Y	Haemagglutination inhibition tests-- one test (OP)
01825	01NOV1988	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (OP)
01826	01JUL1982	31DEC9999	Y	Haemagglutination inhibition tests-- each test in excess of one (SP)
01827	01JUL1982	31DEC9999	Y	Haemagglutination inhibition tests-- each test in excess of one (OP)
01828	01NOV1988	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (RP)
01829	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (SP)
01830	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (PP)
01831	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (OP)
01832	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (RP)
01833	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1829, with a maximum of three estimations in any twelve month period. (SP)
01834	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1830, with a maximum of three estimations in any twelve month period. (PP)
01835	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1831, with a maximum of three estimations in any twelve month period. (OP)
01836	01NOV1988	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1832, with a maximum of three estimations in any twelve month period. (RP)
01837	01NOV1988	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (SP)
01838	01NOV1988	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (PP)
01839	01JUL1982	31DEC9999	Y	Antistreptolysin O titre or similar test, qualitative, not associated with Item 1843 or 1846 (SP)
01840	01JUL1982	31DEC9999	Y	Antistreptolysin O titre or similar test, qualitative, not associated with Item 1844 or 1847 (OP)
01841	01NOV1988	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (OP)
01842	01NOV1988	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (RP)
01843	01JUL1982	31DEC9999	Y	Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- one test (SP)
01844	01JUL1982	31DEC9999	Y	Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- one test (OP)
01845	01NOV1988	31DEC9999	Y	Two estimations specified in item 1837. (SP)
01846	01JUL1982	31DEC9999	Y	Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- two or more tests (SP)
01847	01JUL1982	31DEC9999	Y	Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- two or more tests (OP)
01848	01NOV1988	31DEC9999	Y	Two estimations specified in item 1838. (PP)
01849	01NOV1988	31DEC9999	Y	Two estimations specified in item 1841. (OP)
01850	01NOV1988	31DEC9999	Y	Two estimations specified in item 1842. (RP)
01851	01JUL1982	31DEC9999	Y	Total and differential cell count on any body fluid (SP)
01852	01JUL1982	31DEC9999	Y	Total and differential cell count on any body fluid (OP)
01853	01NOV1988	31DEC9999	Y	Three estimations specified in item 1837. (SP)
01854	01NOV1988	31DEC9999	Y	Three estimations specified in item 1838. (PP)
01855	01NOV1988	31DEC9999	Y	Three estimations specified in item 1841. (OP)
01856	01NOV1988	31DEC9999	Y	Three estimations specified in item 1842. (RP)
01857	01NOV1988	31DEC9999	Y	Four estimations specified in item 1837. (SP)
01858	01JUL1982	31DEC9999	Y	Autogenous vaccine, preparation of-- each organism (SP)
01859	01JUL1982	31DEC9999	Y	Autogenous vaccine, preparation of-- each organism (OP)
01860	01NOV1988	31DEC9999	Y	Four estimations specified in item 1838. (PP)
01861	01NOV1988	31DEC9999	Y	Four estimations specified in item 1841. (OP)
01862	01NOV1988	31DEC9999	Y	Four estimations specified in item 1842. (RP)
01863	01NOV1988	31DEC9999	Y	Five estimations specified in item 1837. (SP)
01864	01NOV1988	31DEC9999	Y	Five estimations specified in item 1838. (PP)
01865	01NOV1988	31DEC9999	Y	Five estimations specified in item 1841. (OP)
01866	01NOV1988	31DEC9999	Y	Five estimations specified in item 1842. (RP)
01867	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1837. (SP)
01868	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1838. (PP)
01869	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1841. (OP)
01870	01NOV1988	31DEC9999	Y	Six or more estimations specified in item 1842. (RP)
01871	01AUG1989	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - 1 or more estimations within any 6 month period (SP)
01872	01AUG1989	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - 1 or more estimations within any 6 month period (OP)
01875	01NOV1988	31DEC9999	Y	Complement - total and components - one or two quantitative estimations. (SP)
01876	01NOV1988	31DEC9999	Y	Complement - total and components - one or two quantitative estimations. (PP)
01877	01JUL1982	31DEC9999	Y	Immunoelectrophoresis using polyvalent antisera (SP)
01878	01JUL1982	31DEC9999	Y	Immunoelectrophoresis using polyvalent antisera (OP)
01879	01NOV1988	31DEC9999	Y	Complement - total and components - one or two quantitative estimations. (OP)
01880	01NOV1988	31DEC9999	Y	Complement - total and components - one or two quantitative estimations. (RP)
01881	01NOV1988	31DEC9999	Y	Three or four estimations specified in item 1875. (SP)
01882	01NOV1988	31DEC9999	Y	Three or four estimations specified in item 1876. (PP)
01883	01NOV1988	31DEC9999	Y	Three or four estimations specified in item 1879. (OP)
01884	01JUL1982	31DEC9999	Y	Immunoelectrophoresis using monovalent antiserum-- each antiserum (SP)
01885	01JUL1982	31DEC9999	Y	Immunoelectrophoresis using monovalent antiserum-- each antiserum (OP)
01886	01NOV1988	31DEC9999	Y	Three or four estimations specified in item 1880. (RP)
01887	01NOV1988	31DEC9999	Y	Five or more estimations specified in item 1875. (SP)
01888	01JUL1982	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of one immunoglobulin (SP)
01889	01JUL1982	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of one immunoglobulin (OP)
01890	01NOV1988	31DEC9999	Y	Five or more estimations specified in item 1876. (PP)
01891	01JUL1982	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of each immunoglobulin in excess of one (SP)
01892	01JUL1982	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of each immunoglobulin in excess of one (OP)
01893	01NOV1988	31DEC9999	Y	Five or more estimations specified in item 1879. (OP)
01894	01NOV1988	31DEC9999	Y	Five or more estimations specified in item 1880. (RP)
01895	01AUG1989	31DEC9999	Y	Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period - each estimation (SP)
01896	01AUG1989	31DEC9999	Y	Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period - each estimation (OP)
01897	01JUL1982	31DEC9999	Y	Immunoglobulin E, quantitative estimation of (SP)
01898	01JUL1982	31DEC9999	Y	Immunoglobulin E, quantitative estimation of (OP)
01901	01NOV1988	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (SP)
01902	01NOV1988	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (PP)
01903	01JUL1982	31DEC9999	Y	Radioallergosorbent tests for allergen identification-- identification of one to four allergens-- each allergen (SP)
01904	01JUL1982	29FEB1984	N	Radioallergosorbent tests for allergen identification-- identification of one to four allergens-- each allergen (OP)
01904	01MAR1984	31DEC9999	Y	Radioallergosorbent tests for allergen identification - identification of one to four allergens - each allergen (OP) 7.65
01905	01JUL1982	31DEC9999	Y	Radioallergosorbent tests for allergen identification-- identification of each allergen in excess of four (SP)
01906	01JUL1982	31DEC9999	Y	Radioallergosorbent tests for allergen identification-- identification of each allergen in excess of four (OP)
01907	01NOV1988	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (OP)
01908	01NOV1988	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (RP)
01909	01NOV1988	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (SP)
01910	01NOV1988	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (PP)
01911	01JUL1982	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of one antibody (SP)
01912	01JUL1982	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of one antibody (OP)
01913	01JUL1982	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of each antibody in excess of one (SP)
01914	01JUL1982	29FEB1984	N	Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of each antibody in excess of one (OP)
01914	01MAR1984	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative(not associated with the service specified in Item 1919), detection of each antibody in excess of one (OP) 7.65
01915	01NOV1988	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (OP)
01916	01NOV1988	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (RP)
01917	01NOV1988	31DEC9999	Y	Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (SP)
01918	01JUL1982	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative and quantitative-- detection and estimation of each antibody (SP)
01919	01JUL1982	31DEC9999	Y	Immunofluorescent detection of tissue antibodies, qualitative and quantitative-- detection and estimation of each antibody (OP)
01920	01NOV1988	31DEC9999	Y	Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (PP)
01921	01NOV1988	31DEC9999	Y	Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (OP)
01922	01NOV1988	31DEC9999	Y	Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (RP)
01923	01NOV1988	31DEC9999	Y	Leucocyte surface markers as specified in item 1917 - four or more subset markers. (SP)
01924	01JUL1982	31DEC9999	Y	Complement fixation tests on human tissue antibodies-- one antibody (SP)
01925	01JUL1982	31DEC9999	Y	Complement fixation tests on human tissue antibodies-- one antibody (OP)
01926	01JUL1982	31DEC9999	Y	Complement fixation tests on human tissue antibodies-- each antibody in excess of one (SP)
01927	01JUL1982	29FEB1984	N	Complement fixation tests on human tissue antibodies-- each antibody in excess of one (OP)
01927	01MAR1984	31DEC9999	Y	Complement fixation tests on human tissue antibodies - each antibody in excess of one (OP) 7.65
01928	01NOV1988	31DEC9999	Y	Leucocyte surface markers as specified in item 1920 - four or more subset markers. (PP)
01929	01NOV1988	31DEC9999	Y	Leucocyte surface markers as specified in item 1921 - four or more subset markers. (OP)
01930	01NOV1988	31DEC9999	Y	Leucocyte surface markers as specified in item 1922 - four or more subset markers. (RP)
01931	01NOV1988	31DEC9999	Y	HLA typing comprising A, B and C phenotypes. (SP)
01932	01NOV1988	31DEC9999	Y	HLA typing comprising A, B and C phenotypes. (PP)
01933	01NOV1988	31DEC9999	Y	HLA typing comprising A, B and C phenotypes. (OP)
01934	01NOV1988	31DEC9999	Y	HLA typing comprising A, B and C phenotypes. (RP)
01935	01JUL1982	31DEC9999	Y	Latex flocculation test-- qualitative, quantitative or qualitative and quantitative (SP)
01936	01JUL1982	31DEC9999	Y	Latex flocculation test-- qualitative, quantitative or qualitative and quantitative (OP)
01937	01NOV1988	31DEC9999	Y	HLA typing, DR phenotype. (SP)
01938	01NOV1988	31DEC9999	Y	HLA typing, DR phenotype. (PP)
01939	01NOV1988	31DEC9999	Y	HLA typing, DR phenotype. (OP)
01940	01NOV1988	31DEC9999	Y	HLA typing, DR phenotype. (RP)
01941	01JUL1982	31DEC9999	Y	Rose Waaler test, quantitative, using sheep cells (SP)
01942	01JUL1982	31DEC9999	Y	Rose Waaler test, quantitative, using sheep cells (OP)
01943	01JUL1982	31DEC9999	Y	Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1941 (SP)
01944	01JUL1982	29FEB1984	N	Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1942 (OP)
01944	01MAR1984	31DEC9999	Y	Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1942 (OP) 7.65
01945	01NOV1988	31DEC9999	Y	IILA typing, one or more antigens. (SP)
01946	01NOV1988	31DEC9999	Y	IILA typing, one or more antigens. (PP)
01947	01NOV1988	31DEC9999	Y	IILA typing, one or more antigens. (OP)
01948	01JUL1982	31DEC9999	Y	Lupus erythematosus cells, preparation and examination of film for (SP)
01949	01JUL1982	31DEC9999	Y	Lupus erythematosus cells, preparation and examination of film for (OP)
01950	01NOV1988	31DEC9999	Y	IILA typing, one or more antigens. (RP)
01951	01NOV1988	31DEC9999	Y	Mantoux test. (SP)
01952	01NOV1988	31DEC9999	Y	Mantoux test. (PP)
01953	01NOV1988	31DEC9999	Y	Mantoux test. (OP)
01954	01NOV1988	31DEC9999	Y	Mantoux test. (RP)
01955	01JUL1982	31DEC9999	Y	Tanned erythrocyte haemagglutination test for tissue antibodies-- one antibody (SP)
01956	01JUL1982	31DEC9999	Y	Tanned erythrocyte haemagglutination test for tissue antibodies-- one antibody (OP)
01957	01JUL1982	31DEC9999	Y	Tanned erythrocyte haemagglutination test for tissue antibodies-- each antibody in excess of one (SP)
01958	01JUL1982	31DEC9999	Y	Tanned erythrocyte haemagglutination test for tissue antibodies-- each antibody in excess of one (OP)
01959	01AUG1989	31DEC9999	Y	Porphyrins (1 or more fractions), Catecholamines (1 or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - 1 or more estimations (SP)
01960	01AUG1989	31DEC9999	Y	Porphyrins (1 or more fractions), Catecholamines (1 or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - 1 or more estimations (OP)
01963	01AUG1989	31DEC9999	Y	Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - 1 or more quantitative estimations within any 28 day period (SP)
01964	01AUG1989	31DEC9999	Y	Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - 1 or more quantitative estimations within any 28 day period (OP)
01965	01JUL1982	31DEC9999	Y	Leucocyte fractionation as preliminary test to specific tests of leucocyte function-- by density gradient centrifugation or any other method (SP)
01966	01JUL1982	31DEC9999	Y	Leucocyte fractionation as preliminary test to specific tests of leucocyte function-- by density gradient centrifugation or any other method (OP)
01969	01AUG1989	31DEC9999	Y	Solid tissue or tissues excluding blood elements - assay of 1 or 2 enzymes (SP)
01970	01AUG1989	31DEC9999	Y	Solid tissue or tissues excluding blood elements - assay of 1 or 2 enzymes (OP)
01971	01JUL1982	31DEC9999	Y	Neutrophil or monocyte tests for phagocytic activity-- visual techniques (SP)
01972	01JUL1982	31DEC9999	Y	Neutrophil or monocyte tests for phagocytic activity-- visual techniques (OP)
01973	01JUL1982	31DEC9999	Y	Neutrophil or monocyte function tests for phagocytic activity-- radioactive techniques (SP)
01974	01JUL1982	31DEC9999	Y	Neutrophil or monocyte function tests for phagocytic activity-- radioactive techniques (OP)
01975	01AUG1989	31DEC9999	Y	Assay of 3 to 5 enzymes as specified in item 1969 (SP)
01976	01AUG1989	31DEC9999	Y	Assay of 3 to 5 enzymes as specified in item 1970 (OP)
01977	01AUG1989	31DEC9999	Y	Assay of 6 or more enzymes as specified in item 1969 (SP)
01978	01AUG1989	31DEC9999	Y	Assay of 6 or more enzymes as specified in item 1970 (OP)
01981	01JUL1982	31DEC9999	Y	Lymphocyte cell count-- E. rosette technique or similar (SP)
01982	01JUL1982	31DEC9999	Y	Lymphocyte cell count-- E. rosette technique or similar (OP)
01983	01AUG1989	31DEC9999	Y	Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin (SP)
01984	01AUG1989	31DEC9999	Y	Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin (OP)
01985	01AUG1989	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones (SP)
01986	01AUG1989	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones (OP)
01987	01JUL1982	31DEC9999	Y	B lymphocyte cell count-- by immunofluorescence or immunoperoxidase (SP)
01988	01JUL1982	31DEC9999	Y	B lymphocyte cell count-- by immunofluorescence or immunoperoxidase (OP)
01989	01NOV1990	31DEC9999	Y	Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - 1 or more procedures (SP)
01990	01NOV1990	31DEC9999	Y	Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - one or more procedures. (GP)
01991	01NOV1990	31DEC9999	Y	Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - 1 procedure (SP)
01992	01NOV1990	31DEC9999	Y	Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - one procedure. (GP)
01993	01NOV1990	31DEC9999	Y	Two or more procedures specified in item 1991. (SP)
01994	01NOV1990	31DEC9999	Y	Two or more procedures specified in item 1992. (GP)
01995	01JUL1982	31DEC9999	Y	Lymphocyte function test-- visual transformation (SP)
01996	01JUL1982	31DEC9999	Y	Lymphocyte function test-- visual transformation (OP)
01997	01JUL1982	31DEC9999	Y	Lymphocyte function test-- radioactive techniques (SP)
01998	01JUL1982	31DEC9999	Y	Lymphocyte function test-- radioactive techniques (OP)
02001	01NOV1988	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (SP)
02002	01NOV1988	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (PP)
02003	01NOV1988	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (OP)
02004	01NOV1988	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (RP)
02005	01NOV1988	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (SP)
02006	01JUL1982	31DEC9999	Y	Tissue group typing (HLA phenotyping) (SP)
02007	01JUL1982	31DEC9999	Y	Tissue group typing (HLA phenotyping) (OP)
02008	01NOV1988	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (PP)
02009	01NOV1988	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (OP)
02010	01NOV1988	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (RP)
02011	01NOV1988	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (SP)
02012	01NOV1988	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (PP)
02013	01JUL1982	31DEC9999	Y	Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (SP)
02014	01JUL1982	29FEB1984	N	Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (OP)
02014	01MAR1984	31DEC9999	Y	Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (OP) 7.65
02015	01NOV1988	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (OP)
02016	01NOV1988	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (RP)
02017	01NOV1988	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination. (SP)
02018	01NOV1988	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination. (PP)
02019	01NOV1988	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination. (OP)
02020	01NOV1988	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination. (RP)
02021	01AUG1989	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone) - 1 estimation (SP)
02022	01JUL1982	31DEC9999	Y	Skin sensitivity-- induction and detection of sensitivity to chemical antigens (SP)
02023	01JUL1982	31DEC9999	Y	Skin sensitivity-- induction and detection of sensitivity to chemical antigens (OP)
02024	01AUG1989	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone) - 1 estimation (OP)
02025	01AUG1989	31DEC9999	Y	2 estimations specified in item 2021 (SP)
02026	01AUG1989	31DEC9999	Y	2 estimations specified in item 2024 (OP)
02027	01AUG1989	31DEC9999	Y	3 estimations specified in item 2021 (SP)
02028	01AUG1989	31DEC9999	Y	3 estimations specified in item 2024 (OP)
02029	01AUG1989	31DEC9999	Y	4 estimations specified in item 2021 (SP)
02030	01AUG1989	31DEC9999	Y	4 estimations specified in item 2024 (OP)
02031	01AUG1989	31DEC9999	Y	5 estimations specified in item 2021 (SP)
02032	01AUG1989	31DEC9999	Y	5 estimations specified in item 2024 (OP)
02033	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 2021 (SP)
02034	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 2024 (OP)
02037	01AUG1989	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - 1 or more assays (SP)
02038	01AUG1989	31DEC9999	Y	Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - 1 or more assays (OP)
02039	01AUG1989	31DEC9999	Y	HDL Cholesterol, estimation of, in patients with serum cholesterol 5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of 4 estimations in any 12 month period (SP)
02040	01AUG1989	31DEC9999	Y	HDL cholesterol, estimation of, in patients with serum cholesterol 5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of 4 estimations in any 12 month period (OP)
02041	01JUL1982	31DEC9999	Y	Histopathology examination of biopsy material-- processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP)
02042	01JUL1982	31DEC9999	Y	Histopathology examination of biopsy material-- processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP)
02043	01AUG1989	31DEC9999	Y	Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of 4 estimations in any 12 month period (SP)
02044	01AUG1989	31DEC9999	Y	Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of 4 estimations in any 12 month period (OP)
02048	01JUL1982	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material performed at the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP)
02049	01JUL1982	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material performed at the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP)
02051	01NOV1988	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (SP)
02052	01NOV1988	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (PP)
02053	01NOV1988	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (OP)
02054	01NOV1988	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (RP)
02055	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (SP)
02056	01JUL1982	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP)
02057	01JUL1982	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP)
02058	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (PP)
02059	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (OP)
02060	01JUL1982	31DEC9999	Y	Immunofluorescent investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent investigation was obtained (SP)
02061	01JUL1982	31DEC9999	Y	Immunofluorescent investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent investigation was obtained (OP)
02062	01NOV1984	31DEC9999	Y	Electron microscopy examination of biopsy material including any other histopathology examination of that tissue obtained from the one patient at the one time. (SP)
02063	01NOV1984	31DEC9999	Y	Electron microscopy examination of biopsy material including any other histopathology examination of that tissue obtained from the one patient at the one time. (OP)
02064	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (RP)
02065	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2055 and any histopathological service performed - one or more examinations. (SP)
02066	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2058 and any histopathological service performed - one or more examinations. (PP)
02067	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2059 and any histopathological service performed - one or more examinations. (OP)
02068	01NOV1988	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2064 and any histopathological service performed - one or more examinations. (RP)
02069	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (SP)
02070	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (PP)
02071	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (OP)
02072	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (RP)
02073	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (SP)
02074	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (PP)
02075	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (OP)
02076	01NOV1988	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (RP)
02081	01JUL1982	31DEC9999	Y	Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549-- each examination (SP)
02082	01JUL1982	31DEC9999	Y	Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549-- each examination (OP)
02083	01AUG1989	31DEC9999	Y	Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures - wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - 1 or more examinations (SP)
02084	01AUG1989	31DEC9999	Y	Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures - wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - 1 or more examinations (OP)
02085	01AUG1989	31DEC9999	Y	Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any service specified in item 2083 - each estimation (SP)
02086	01AUG1989	31DEC9999	Y	Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any service specified in item 2084 - each estimation (OP)
02087	01AUG1989	31DEC9999	Y	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083 - 1 or more sites (SP)
02088	01AUG1989	31DEC9999	Y	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084 - 1 or more sites (OP)
02089	01AUG1989	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 2119), including pathogenic identification and antibiotic sensitivity testing, including any service specified in item 2083 or 2087 - 1 or more examinations on 1 or more specimens (SP)
02090	01AUG1989	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites: skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except where part of item 2120), including pathogenic identification and antibiotic sensitivity testing, including any service specified in item 2084 or 2088 - 1 or more examinations on 1 or more specimens (OP)
02091	01JUL1982	31DEC9999	Y	Cytological examination for malignant cells-- examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid-- each examination (SP)
02092	01JUL1982	31DEC9999	Y	Cytological examination for malignant cells-- examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid-- each examination (OP)
02093	01JUL1985	31DEC9999	Y	Cytological examination for malignant cells of material obtained by fine needle aspiration ofsolid tissues. (SP)
02094	01JUL1985	31DEC9999	Y	Cytological examination for malignant cells of material obtained by fine needle aspiration ofsolid tissues. (OP)
02095	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
02096	01JUL1982	31DEC9999	Y	Cytological examination for malignant cells-- examination of gastric washings, duodenal washings, oesophageal washings or colonic washings; including collection of specimen-- each examination (SP)
02097	01JUL1982	31DEC9999	Y	Cytological examination for malignant cells-- examination of gastric washings, duodenal washings, oesophageal washings or colonic washings; including collection of specimen-- each examination (OP)
02098	01AUG1989	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083, 2087 or 2089 - 1 or more sites (SP)
02099	01AUG1989	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084, 2088 or 2090 - 1 or more sites (OP)
02100	01JUL2011	31OCT2012	N	Level A - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, who is not an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
02100	01NOV2012	28FEB2013	N	Level A - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
02100	01MAR2013	31DEC9999	Y	Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
02101	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (SP)
02102	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (PP)
02103	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (OP)
02104	01JUL1982	31DEC9999	Y	Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP)
02105	01JUL1982	31DEC9999	Y	Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP)
02106	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (RP)
02107	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood. (SP)
02108	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood. (PP)
02109	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood. (OP)
02110	01NOV1988	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood. (RP)
02111	01JUL1982	31DEC9999	Y	Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP)
02112	01JUL1982	31DEC9999	Y	Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP)
02113	01NOV1988	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (SP)
02114	01NOV1988	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (PP)
02115	01NOV1988	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (OP)
02116	01NOV1988	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (RP)
02117	01AUG1989	31DEC9999	Y	Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083, to a maximum of 3 specimens in any 7 day period - each examination (SP)
02118	01AUG1989	31DEC9999	Y	Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084, to a maximum of 3 specimens in any 7 day period - each examination (OP)
02119	01AUG1989	31DEC9999	Y	Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any service specified in item 2083 (SP)
02120	01AUG1989	31DEC9999	Y	Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any service specified in item 2084 (OP)
02121	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a general practitioner, lasting less than 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner.
02121	10JAN2020	30JUN2020	N	Professional attendance by video conference by a general practitioner, lasting less than 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner
02121	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a general practitioner, lasting less than 20 minutes, for providing mental health services to a patient with mental health issues, if the patient is affected by bushfire.
02122	01JUL2011	31OCT2012	N	Level A - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02122	01NOV2012	31DEC2012	N	Level A - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) outside an inner metropolitan area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02122	01JAN2013	28FEB2013	N	Level A - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02122	01MAR2013	31DEC9999	Y	Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02123	01AUG1989	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets (SP)
02124	01AUG1989	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets (OP)
02125	01JUL2011	31DEC2012	N	Level A - Telehealth attendance at a residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit) and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02125	01JAN2013	30JUN2018	N	Professional attendance of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02125	01JUL2018	31DEC9999	Y	Professional attendance of at least 5 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02126	01JUL2011	31OCT2012	N	Level B - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, who is not an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies and who is participating in a video consultation with a specialist or consultant physician.
02126	01NOV2012	28FEB2013	N	Level B - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
02126	01MAR2013	31DEC9999	Y	Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
02127	01AUG1989	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item) (SP)
02128	01AUG1989	31DEC9999	Y	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item) (OP)
02129	01AUG1989	31DEC9999	Y	Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 2117 has been performed - 1 or more estimations (SP)
02130	01AUG1989	31DEC9999	Y	Direct detection of the antigens of Heamophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varcella zoster or detection of Clostridium difficile toxin except where item 2118 has been performed - 1 or more estimations (OP)
02131	01JUL1982	31DEC9999	Y	Cytological sex determination from blood film (SP)
02132	01JUL1982	31DEC9999	Y	Cytological sex determination from blood film (OP)
02133	01AUG1989	31DEC9999	Y	Direct detection of Chlamydia from clinical material, not cultures - 1 or more estimations (SP)
02134	01AUG1989	31DEC9999	Y	Direct detection of Chlamydia from clinical material, not cultures - 1 or more estimations (OP)
02135	01AUG1989	31DEC9999	Y	Direct detection of Herpes simplex from clinical material, not cultures - 1 or more estimations (SP)
02136	01AUG1989	31DEC9999	Y	Direct detection of Herpes simplex from clinical material, not cultures - 1 or more estimations (OP)
02137	01JUL2011	31OCT2012	N	Level B - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02137	01NOV2012	31DEC2012	N	Level B - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) outside an inner metropolitan area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02137	01JAN2013	28FEB2013	N	Level B - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02137	01MAR2013	31DEC9999	Y	Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02138	01JUL2011	31OCT2012	N	Level B - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02138	01NOV2012	31DEC2012	N	Level B - Telehealth attendance at residential aged care facility Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02138	01JAN2013	30JUN2018	N	Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02138	01JUL2018	31DEC9999	Y	Professional attendance of less than 20 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02139	01AUG1989	31DEC9999	Y	Investigation for Herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any service specified in item 2133 or 2135 (SP)
02140	01AUG1989	31DEC9999	Y	Investigation for Herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any service specified in item 2134 or 2136 (OP)
02141	01JUL1982	31DEC9999	Y	Cytological sex chromatin studies (Barr or Y bodies)-- other than from blood film-- each tissue examined (SP)
02142	01JUL1982	31DEC9999	Y	Cytological sex chromatin studies (Barr or Y bodies)-- other than from blood film-- each tissue examined (OP)
02143	01JUL2011	31OCT2012	N	Level C - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, who is not an admitted patient; b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
02143	01NOV2012	28FEB2013	N	Level C - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
02143	01MAR2013	31DEC9999	Y	Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies
02144	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, lasting less than 20 minutes, if: (a) the attendance is by video conference; and (b) the patient is located within a flood affected eligible area.
02145	01AUG1989	31DEC9999	Y	Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy - 1 or more assays (SP)
02146	01AUG1989	31DEC9999	Y	Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy - 1 or more assays (OP)
02147	01JUL2011	31OCT2012	N	Level C -Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other items applies) lasting at least 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02147	01NOV2012	31DEC2012	N	Level C - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02147	01JAN2013	28FEB2013	N	Level C - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02147	01MAR2013	31DEC9999	Y	Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02148	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of amniotic fluid (SP)
02149	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP)
02150	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a general practitioner, lasting at least 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner.
02150	10JAN2020	30JUN2020	N	Professional attendance by video conference by a general practitioner, lasting at least 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner
02150	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a general practitioner, lasting at least 20 minutes, for providing mental health services to a patient with mental health issues, if the patient is affected by bushfire.
02151	01NOV1988	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (SP)
02152	01NOV1988	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (PP)
02153	01NOV1988	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (OP)
02154	01NOV1988	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (RP)
02155	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of bone marrow (SP)
02156	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of bone marrow (OP)
02157	01NOV1988	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (SP)
02158	01NOV1988	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (PP)
02159	01NOV1988	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (OP)
02160	01NOV1988	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (RP)
02161	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2148 or 2155-- each study (SP)
02162	01JUL1982	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2149 or 2156-- each study (OP)
02163	01NOV1988	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - one or more tests. (SP)
02164	01NOV1988	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - one or more tests. (PP)
02165	01NOV1988	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - one or more tests. (OP)
02166	01NOV1988	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - one or more tests. (RP)
02167	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (SP)
02168	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (PP)
02169	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (OP)
02170	01JUL1982	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- one method (SP)
02171	01JUL1982	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- one method (OP)
02172	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (RP)
02173	01JUL1982	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- two or more methods (SP)
02174	01JUL1982	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- two or more methods (OP)
02175	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (SP)
02176	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (PP)
02177	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (OP)
02178	01NOV1988	31DEC9999	Y	Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (RP)
02179	01JUL2011	31DEC2012	N	Level C - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 20 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02179	01JAN2013	30JUN2018	N	Professional attendance of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02179	01JUL2018	31DEC9999	Y	Professional attendance of at least 20 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02180	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, lasting at least 20 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
02181	01AUG1989	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of 1 antibody (SP)
02182	01AUG1989	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of 1 antibody (OP)
02183	01AUG1989	31DEC9999	Y	2 estimations specified in item 2181 (SP)
02184	01AUG1989	31DEC9999	Y	2 estimations specified in item 2182 (OP)
02185	01AUG1989	31DEC9999	Y	3 estimations specified in item 2181 (SP)
02186	01AUG1989	31DEC9999	Y	3 estimations specified in item 2182 (OP)
02187	01AUG1989	31DEC9999	Y	4 estimations specified in item 2181 (SP)
02188	01AUG1989	31DEC9999	Y	4 estimations specified in item 2182 (OP)
02189	01AUG1989	31DEC9999	Y	5 estimations specified in item 2181 (SP)
02190	01AUG1989	31DEC9999	Y	5 estimations specified in item 2182 (OP)
02191	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 2181 (SP)
02192	01AUG1989	31DEC9999	Y	6 or more estimations specified in item 2182 (OP)
02193	02MAR2019	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, lasting at least 40 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area.
02195	01JUL2011	31OCT2012	N	Level D - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, who is not an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
02195	01NOV2012	28FEB2013	N	Level D - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
02195	01MAR2013	31DEC9999	Y	Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
02196	01NOV2018	09JAN2020	N	Professional attendance at consulting rooms by a general practitioner, lasting at least 40 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner.
02196	10JAN2020	30JUN2020	N	Professional attendance by video conference by a general practitioner, lasting at least 40 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner
02196	01JUL2020	31DEC9999	Y	Professional attendance by video conference by a general practitioner, lasting at least 40 minutes, for providing mental health services to a patient with mental health issues, if the patient is affected by bushfire.
02197	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms of more than 60 minutes in duration (other than a service to which another item applies) by a prescribed medical practitioner-each attendance.
02198	01NOV2023	31DEC9999	Y	Professional attendance by a prescribed medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 60 minutes-an attendance on one or more patients on one occasion-each patient.
02199	01JUL2011	31OCT2012	N	Level D - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02199	01NOV2012	31DEC2012	N	Level D - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) outside an inner metropolitan area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02199	01JAN2013	28FEB2013	N	Level D - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02199	01MAR2013	31DEC9999	Y	Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient
02200	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 60 minutes in duration by a prescribed medical practitioner-an attendance on one or more patients at one residential aged care facility on one occasion-each patient.
02201	01JUL1982	31DEC9999	Y	Examination of semen for presence of spermatozoa (SP)
02202	01JUL1982	31DEC9999	Y	Examination of semen for presence of spermatozoa (OP)
02203	01NOV1988	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - one procedure.
02204	01NOV1988	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - two procedures.
02205	01NOV1988	31DEC9999	Y	13lood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - three or more procedures.
02206	01NOV1988	31DEC9999	Y	Microscopical examination of urine.
02207	01NOV1988	31DEC9999	Y	Pregnancy test by one or more imnmunochemical methods.
02208	01NOV1988	31DEC9999	Y	Microscopical examination of wet film other than urine.
02209	01NOV1988	31DEC9999	Y	Microscopical examination of gram stained film.
02210	01NOV1988	31DEC9999	Y	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method.
02211	01JUL1982	31DEC9999	Y	Huhner's test (post-coital test)-- collection of sample and examination of wet preparation (SP)
02212	01JUL1982	31DEC9999	Y	Huhner's test (post-coital test)-- collection of sample and examination of wet preparation (OP)
02213	01NOV1988	31DEC9999	Y	Microscopical examination screening for fungi in skin, hair or nails - one or more sites.
02214	01NOV1988	31DEC9999	Y	Mantoux test.
02215	01JUL1982	31DEC9999	Y	Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (SP)
02216	01JUL1982	31DEC9999	Y	Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP)
02217	01NOV1988	31DEC9999	Y	Casoni test for hydatid disease.
02218	01NOV1988	31DEC9999	Y	Schick test.
02219	01NOV1988	31DEC9999	Y	Seminal examination for presence of spermatozoa.
02220	01JUL2011	31DEC2012	N	Level D - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient.
02220	01JAN2013	30JUN2018	N	Professional attendance of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02220	01JUL2018	31DEC9999	Y	Professional attendance of at least 40 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient
02221	01AUG1989	31DEC9999	Y	Hepatitis B surface antigen test (SP)
02222	01AUG1989	31DEC9999	Y	Hepatitis B surface antigen test (OP)
02223	01AUG1989	31DEC9999	Y	Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including service specified in item 2221, 2229 or 2231 (SP)
02224	01AUG1989	31DEC9999	Y	Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including service specified in item 2222, 2230 or 2232 (OP)
02225	01JUL1982	31DEC9999	Y	Chemical analysis of semen-- analysis of one substance (SP)
02226	01JUL1982	31DEC9999	Y	Chemical analysis of semen-- analysis of one substance (OP)
02227	01JUL1982	31DEC9999	Y	Chemical analysis of semen-- analysis of two or more substances (SP)
02228	01JUL1982	31DEC9999	Y	Chemical analysis of semen-- analysis of two or more substances (OP)
02229	01AUG1989	31DEC9999	Y	All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those service specified in item 2221, 2223 or 2231 (SP)
02230	01AUG1989	31DEC9999	Y	All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in item 2222, 2224 or 2232 (OP)
02231	01AUG1989	31DEC9999	Y	All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in item 2221 or 2223 (SP)
02232	01AUG1989	31DEC9999	Y	All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in item 2222 or 2224 (OP)
02235	01AUG1989	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - 1 or more estimations (SP)
02236	01AUG1989	31DEC9999	Y	Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - 1 or more estimations (OP) 25.00
02239	01AUG1989	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - 1 or more procedures (SP)
02240	01AUG1989	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresi or immunofixation - 1 or more procedures (OP)
02241	01AUG1989	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245) on serum and urine concurrently collected - 2 or more procedures (SP)
02242	01AUG1989	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246) on serum and urine concurrently collected - 2 or more procedures (OP)
02245	01AUG1989	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method - estimation of 1 immunoglobin (SP)
02246	01AUG1989	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method - estimation of 1 immunoglobin (OP)
02247	01JUL1982	31DEC9999	Y	Spermagglutinating and immobilising antibodies, test for-- one test (SP)
02248	01JUL1982	31DEC9999	Y	Spermagglutinating and immobilising antibodies, test for-- one test (OP)
02249	01JUL1982	31DEC9999	Y	Two or more tests referred to in Item 2247 (SP)
02250	01JUL1982	31DEC9999	Y	Two or more tests referred to in Item 2248 (OP)
02251	01AUG1989	31DEC9999	Y	2 estimations specified in item 2245 (SP)
02252	01AUG1989	31DEC9999	Y	2 estimations specified in item 2246 (OP)
02253	01AUG1989	31DEC9999	Y	3 or more estimations specified in item 2245 (SP)
02254	01AUG1989	31DEC9999	Y	3 or more estimations specified in item 2246 (OP)
02255	01AUG1989	31DEC9999	Y	Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - 1 or more estimation (SP)
02256	01AUG1989	31DEC9999	Y	Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - 1 or more estimation (OP)
02257	01AUG1989	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period (SP)
02258	01AUG1989	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period (OP)
02259	01AUG1989	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - 1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period (SP)
02260	01AUG1989	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens - 1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period (SP)
02261	01AUG1989	31DEC9999	Y	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required (SP)
02262	01AUG1989	31DEC9999	Y	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required (OP)
02263	01AUG1989	31DEC9999	Y	Measurment of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained (SP)
02264	01JUL1982	31DEC9999	Y	Sperm penetrability, one or more tests for-- not associated with Item 2211 (SP)
02265	01JUL1982	31DEC9999	Y	Sperm penetrability, one or more tests for-- not associated with Item 2212 (OP)
02266	01AUG1989	31DEC9999	Y	Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained (OP)
02267	01AUG1989	31DEC9999	Y	Antibodies to extractable nuclear antigens, detection of in serum or other body fluids (SP)
02268	01AUG1989	31DEC9999	Y	Antibodies to extractable nuclear antigens, detection of in serum or other body fluids (OP)
02269	01AUG1989	31DEC9999	Y	Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2267 (SP)
02270	01AUG1989	31DEC9999	Y	Charaterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2268 (OP)
02271	01AUG1989	31DEC9999	Y	Antibodies to tissue antigens that are not elsewhere specified in an item in the Schedule - estimation of 1 antibody (SP)
02272	01JUL1982	29FEB1984	N	Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods including estimation of beta-HCG in serum or urine (SP)
02272	01MAR1984	31DEC9999	Y	Chorionic gonadotrophin(beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (SP)
02273	01JUL1982	29FEB1984	N	Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods including estimation of beta-HCG in serum or urine (OP)
02273	01MAR1984	31DEC9999	Y	Chorionic gonadotrophin(beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (OP)
02274	01AUG1989	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of 1 antibody (OP)
02275	01AUG1989	31DEC9999	Y	2 estimations specified in item 2271 (SP)
02276	01AUG1989	31DEC9999	Y	2 estimations specified in item 2274 (OP)
02277	01AUG1989	31DEC9999	Y	3 estimations specified in item 2271 (SP)
02278	01AUG1989	31DEC9999	Y	3 estimations specified in item 2274 (OP)
02279	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 2271 (SP)
02280	01AUG1989	31DEC9999	Y	4 or more estimations specified in item 2274 (OP)
02281	01AUG1989	31DEC9999	Y	Rheumatoid factor, detection of by any technique (SP)
02282	01AUG1989	31DEC9999	Y	Rheumatoid factor, detection of by any technique (OP)
02283	01AUG1989	31DEC9999	Y	Quantitation of Rheumatoid factor where detected, including services specified in item 2281 (SP)
02284	01AUG1989	31DEC9999	Y	Quantitation of Rheumatoid factor where detected, including services specified in item 2282 (OP)
02285	01JUL1982	29FEB1984	N	Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in Item 2272) (SP)
02285	01MAR1984	31DEC9999	Y	Chorionic gonadotrophin quantitative estimation of(including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (SP)
02286	01JUL1982	29FEB1984	N	Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in Item 2273) (OP)
02286	01MAR1984	31DEC9999	Y	Chorionic gonadotrophin quantitative estimation of(including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (OP)
02287	01JUL1985	31DEC9999	Y	PREGNANCY PATHOLOGY ASSESSMENT - comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphillis, test for rubella antibodies, microscopic examination of uring and culture - one assessment in any one pregnancy. (SP)
02288	01JUL1985	31DEC9999	Y	PREGNANCY PATHOLOGY ASSESSMENT - comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphillis, test for rubella antibodies, microscopic examination of uring and culture - one assessment in any one pregnancy. (OP)
02289	01AUG1989	31DEC9999	Y	Complement - total and components - 1 quantitative estimation (SP)
02290	01AUG1989	31DEC9999	Y	Complement - total and components - 1 quantitative estimation (OP)
02291	01AUG1989	31DEC9999	Y	2 estimations as specified in item 2289 (SP)
02292	01AUG1989	31DEC9999	Y	2 estimations as specified in item 2290 (OP)
02293	01AUG1989	31DEC9999	Y	3 or more estimations as specified in item 2289 (SP)
02294	01NOV1983	31DEC9999	Y	Pathology examination of any body fluid or tissue not covered by any other item in this Part (SP)
02295	01NOV1983	31DEC9999	Y	Pathology examination of any body fluid or tissue not covered by any other item in this Part (OP)
02296	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02297	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02298	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02299	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02300	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02301	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02302	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02303	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02304	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02305	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02306	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02307	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02308	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02310	01DEC1987	31DEC9999	Y	[Unidentified item - pathology]
02312	01AUG1989	31DEC9999	Y	3 or more estimations as specified in item 2290 (OP)
02313	01AUG1989	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests (SP)
02314	01AUG1989	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests (OP)
02315	01AUG1989	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1 - Haematology in the Schedule (SP)
02316	01AUG1989	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1 - Haematology in the Schedule (OP)
02317	01AUG1989	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any services in item 2319 - 1 or more estimations (SP)
02318	01AUG1989	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any service in item 2320 - 1 or more estimations (OP)
02319	01AUG1989	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any services in item 2317 - 1 or more estimations (SP)
02320	01AUG1989	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any service in item 2318 - 1 or more estimations (OP)
02321	01AUG1989	31DEC9999	Y	HLA typing comprising A, B, C and DR phenotypes (SP)
02322	01AUG1989	31DEC9999	Y	HLA typing comprising A, B, C and DR phenotypes (OP)
02323	01AUG1989	31DEC9999	Y	HLA typing, excluding any service specified in item 2321 - 1 or more antigens (SP)
02324	01AUG1989	31DEC9999	Y	HLA typing, excluding any service specified in item 2322 - 1 or more antigens (OP)
02325	01AUG1989	31DEC9999	Y	Mantoux test (SP)
02326	01AUG1989	31DEC9999	Y	Mantoux test (OP)
02327	01AUG1989	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions (SP)
02328	01AUG1989	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions (OP)
02329	01AUG1989	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination (SP)
02330	01AUG1989	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination (OP)
02331	01AUG1989	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination (SP)
02332	01AUG1989	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination (OP)
02333	01AUG1989	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination (SP) 141.40
02334	01JUL1982	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- one procedure
02335	01JUL1982	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- two procedures
02336	01JUL1982	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- three or more procedures
02337	01AUG1989	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination (OP) 106.05
02338	01AUG1989	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - 1 or more examinations (SP) 20.50
02339	01AUG1989	31DEC9999	Y	Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - 1 or more examinations (OP)
02340	01AUG1989	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - 1 or more examinations (SP)
02341	01AUG1989	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - 1 or more examinations (OP)
02342	01JUL1982	31DEC9999	Y	Microscopical examination of urine
02343	01AUG1989	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2340 and any histopathological service performed on that cytology specimen - 1 or more examinations (SP) 40.10
02344	01AUG1989	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2341 and any histopathological service performed on that cytology specimen - 1 or more examinations (OP)
02346	01JUL1982	31DEC9999	Y	Pregnancy test by one or more immunochemical methods
02348	01AUG1989	31DEC9999	Y	Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells (SP)
02349	01AUG1989	31DEC9999	Y	Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells (OP)
02350	01AUG1989	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues (SP)
02351	01AUG1989	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues (OP)
02352	01JUL1982	31DEC9999	Y	Microscopical examination of wet film other than urine
02355	01AUG1989	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance (SP)
02356	01AUG1989	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance (OP)
02357	01JUL1982	31DEC9999	Y	Microscopical examination of gram stained film
02360	01AUG1989	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - 1 or more estimations (SP) 181.50
02361	01AUG1989	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - 1 or more estimations (OP)
02362	01JUL1982	31DEC9999	Y	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method
02363	01AUG1989	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood (SP)
02364	01AUG1989	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood (OP)
02365	01AUG1989	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis) or by fragile X-site determination - 1 or more identifications (SP)
02366	01AUG1989	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis) or by fragile X-site determination - 1 or more identifications (OP)
02369	01JUL1982	31DEC9999	Y	Microscopical examination screening for fungi in skin, hair or nails-- one or more sites
02370	01AUG1989	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) (SP)
02371	01AUG1989	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) (OP)
02372	01AUG1989	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period (SP)
02373	01AUG1989	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period (OP)
02374	01JUL1982	31DEC9999	Y	Mantoux test
02377	01AUG1989	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - 1 or more tests (SP)
02378	01AUG1989	31DEC9999	Y	Sperm antibodies, sperm penetrating ability - 1 or more tests (OP)
02379	01AUG1989	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy - 1 or more estimations (SP)
02380	01AUG1989	31DEC9999	Y	Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy - 1 or more estimations (OP)
02382	01JUL1982	31DEC9999	Y	Casoni test for hydatid disease
02384	01AUG1989	31DEC9999	Y	Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion (SP)
02385	01AUG1989	31DEC9999	Y	Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion (OP)
02387	01AUG1989	31DEC9999	Y	Seminal examination for presence of spermatozoa
02388	01JUL1982	31DEC9999	Y	Schick test
02389	01AUG1989	31DEC9999	Y	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - 1 procedure
02390	01AUG1989	31DEC9999	Y	2 procedures specified in item 2389
02391	01AUG1989	31DEC9999	Y	3 or more procedures specified in item 2389 8.25
02392	01JUL1982	31DEC9999	Y	Seminal examination for presence of spermatozoa
02393	01AUG1989	31DEC9999	Y	Microscopical examination of urine
02394	01AUG1989	31DEC9999	Y	Pregnancy test by 1 or more immunochemical methods
02395	01AUG1989	31DEC9999	Y	Microscopical examination of wet film other than urine
02396	01AUG1989	31DEC9999	Y	Microscopical examination of gram-stained film
02397	01AUG1989	31DEC9999	Y	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method
02398	01AUG1989	31DEC9999	Y	Microscopical examination screening for fungi in skin, hair or nails - 1 or more sites
02399	01AUG1989	31DEC9999	Y	Mantoux test 10.15
02400	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditory nneatus without intravenous contrast medium (not covered by item 2447 or 2450)
02400	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (not covered by item 2447 or 2450)
02401	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditory meatus with intravenous contrast medium (not covered by item 2448 or 2451)
02401	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain with or without scan of internal auditory meatus with intravenous contrast medium (not covered by item 2448 or 2451)
02402	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditor/ meatus without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2449 or 2452)
02402	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2449 or 2452)
02403	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF PITUITARY FOSSA by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan
02403	01SEP1989	31DEC9999	Y	Computerised tomography-scan of pituitary fossa by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan
02404	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF ORBITS by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain Scan
02404	01SEP1989	31DEC9999	Y	Computerised tomography-scan of orbits by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan
02405	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF MIDDLE EAR AND TEMPORAL BONE, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan
02405	01SEP1989	31DEC9999	Y	Computerised tomography-scan of middle ear and temporal bone, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan
02406	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF TEMPORAL BONES WITH AIR STUDY (including reconstructions) and including intrathecal injection, not including an associated brain scan
02406	01SEP1989	31DEC9999	Y	Computerised tomography-scan of temporal bones with air study (including reconstructions) and including intrathecal injection, not including an associated brain scan
02407	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-Scan of one or more regions without intravenous contrast medium
02407	01SEP1989	31DEC9999	Y	Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions without intravenous contrast medium
02408	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-scan of one or more regions with intravenous contrast medium
02408	01SEP1989	31DEC9999	Y	Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions with intravenous contrast medium
02409	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-scan of one or more regions without and with intravenous contrast medium
02409	01SEP1989	31DEC9999	Y	Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions without and with intravenous contrast medium
02410	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without intravenous contrast medium (not covered by item 2444)
02410	01SEP1989	31DEC9999	Y	Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without intravenous contrast medium (not covered by item 2444)
02411	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK including lan/nx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions with intravenous contrast medium (not covered by item 2445)
02411	01SEP1989	31DEC9999	Y	Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions with intravenous contrast medium (not covered by item 2445)
02412	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without and with intravenous contrast medium (not covered by item 2446)
02412	01SEP1989	31DEC9999	Y	Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without and with intravenous contrast medium (not covered by item 2446)
02413	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-25 slices or less without intravenous contrast medium
02413	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-25 slices or less without intravenous contrast medium
02414	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-25 slices or less with intravenous contrast medium
02414	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-25 slices or less with intravenous contrast medium
02415	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF S.PINE,;one or more regions-25 slices Sr less without and with intravenous contrast medium
02415	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-25 slices or less without and with intravenous contrast medium
02416	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices without intravenous contrast medium
02416	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-26 or more slices without intravenous contrast medium
02417	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices with intravenous contrast medium
02417	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-26 or more slices with intravenous contrast medium
02418	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices without and with intravenous contrast medium
02418	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions-26 or more slices without and with intravenous contrast medium
02419	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions with intrathecal contrast medium (not including the preparation by intrathecal injection of contrast medium)
02419	01SEP1989	31DEC9999	Y	Computerised tomography-scan of spine, one or more regions with intrathecal contrast medium (not including the preparation by intrathecal injection of contrast medium)
02420	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (including lungs, mediastinum and pleura) with-out intravenous contrast medium (not covered by item 2438, 2441, 2444, 2447 or 2450)
02420	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest (including lungs, mediastinum and pleura) without intravenous contrast medium (not covered by item 2438, 2441, 2444, 2447 or 2450)
02421	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (irtcl.uding lungs, mediastinum and pleura) with intravenous contrast medium (not covered by item 2439, 2442, 2445, 2448 or 2451)
02421	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest (including lungs, mediastinum and pleura) with intravenous contrast medium (not covered by item 2439, 2442, 2445, 2448 or 2451)
02422	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (including lungs, mediastinum and pleura) with-out intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446, 2449 or 2452)
02422	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest (including lungs, mediastinum and pleura) without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440 2443, 2446, 2449 or 2452)
02423	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451)
02423	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450)
02424	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451)
02424	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451)
02425	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452)
02425	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452)
02426	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450)
02426	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen and pelvis without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450)
02427	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS with intravenous con-trast medium (not covered by item 2439, 2442, 2445 or 2451)
02427	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen and pelvis with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451)
02428	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452)
02428	01SEP1989	31DEC9999	Y	Computerised tomography-scan of upper abdomen and pelvis without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452)
02429	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES. ONE OR MORE REGIONS involving up to 20 slices without intravenous contrast medium
02429	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving up to 20 slices without intravenous contrast medium
02430	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving up to 20 slices with intravenous contrast medium
02430	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving up to 20 slices with intravenous contrast medium
02431	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving up to 20 slices without and with intravenous contrast medium
02431	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving up to 20 slices without and with intravenous contrast medium
02432	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices without intravenous contrast medium
02432	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices without intravenous contrast medium
02433	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES. ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices with intravenous contrast medium
02433	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices with intravenous contrast medium
02434	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium
02434	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium
02435	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices without intravenous contrast medium
02435	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 40 slices without intravenous contrast medium
02436	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices with intravenous contrast medium
02436	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 40 slices with intravenous contrast medium
02437	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices without and with intravenous contrast medium
02437	01SEP1989	31DEC9999	Y	Computerised tomography-scan of extremities, one or more regions involving more than 40 slices without and with intravenous contrast medium
02438	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without intravenous contrast medium (not covered by item 2441, 2444 or 2450)
02438	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) without intravenous contrast medium (not covered by item 2441, 2444 or 2450)
02439	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) with intravenous contrast medium (not covered by item 2442, 2445 or 2451)
02439	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) with intravenous contrast medium (not covered by item 2442, 2445 or 2451)
02440	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without and with intravenous contrast medium (not covered by item 2443, 2446 or 2452)
02440	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) without and with intravenous contrast medium (not covered by item 2443 2446 or 2452)
02441	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (not covered by item 2444)
02441	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest, abdomen and pelvis without intravenous contrast medium (not covered by item 2444)
02442	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (not covered by item 2445)
02442	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest, abdomen and pelvis with intravenous contrast medium (not covered by item 2445)
02443	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS without and with intravenous contrast, medium (not covered by item 2446)
02443	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest, abdomen and pelvis without and with intravenous contrast medium (not covered by item 2446)
02444	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without intra-venous contrast medium
02444	01SEP1989	31DEC9999	Y	Computerised tomography-scan of neck, chest, abdomen and pelvis without intravenous contrast medium
02445	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF NECK. CHEST, ABDOMEN AND PELVIS with intrave-nous contrast medium
02445	01SEP1989	31DEC9999	Y	Computerised tomography-scan of neck, chest, abdomen and pelvis with intravenous contrast medium
02446	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium
02446	01SEP1989	31DEC9999	Y	Computerised tomography-scan of neck, chest, abdomen and pelvis without and with intravenous contrast medium
02447	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST without intravenous contrast medium
02447	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain and chest without intravenous contrast medium
02448	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST with intravenous contrast medium
02448	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain and chest with intravenous contrast medium
02449	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST without and with intravenous contrast medium
02449	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain and chest without and with intravenous contrast medium
02450	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without intravenous contrast medium
02450	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain without intravenous contrast medium
02451	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER fBDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN with intravenous contrast mediuni .
02451	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain with intravenous contrast medium
02452	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without and with intravenous contrast medium
02452	01SEP1989	31DEC9999	Y	Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain without and with intravenous contrast medium
02453	01AUG1987	31DEC9999	Y	COMPUTERISED TOMOGRAPHY PELVIMETRY
02454	01AUG1987	31AUG1989	N	COMPUTERISED TQMOGRAPHY-DYNAMIC SCAN OF REGION not associated with any other item in this part
02454	01SEP1989	31DEC9999	Y	Computerised tomography-dynamic scan of region not associated with any other item in this part
02455	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-DYNAMIC SCAN OR REGION when associated with another itenn in this part DERIVED FEE-The fee for computerised tomography of the area and report plus an amount of $88
02455	01SEP1989	31DEC9999	Y	Computerised tomography-dynamic scan of region when associated with another item in this Part
02458	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN without intravenous contrast medium
02458	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain without intravenous contrast medium
02459	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with intravenous contrast medium
02459	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain with intravenous contrast medium
02460	01AUG1987	31AUG1989	N	COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN without and with intravenous contrast medium
02460	01SEP1989	31DEC9999	Y	Computerised tomography-scan of brain without and with intravenous contrast medium
02461	01NOV2019	31DEC9999	Y	Professional attendance by video conference by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management, only if: the patient is not an admitted patient; and the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02463	01NOV2019	31DEC9999	Y	Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting less than 20 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; (arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02464	01NOV2019	31DEC9999	Y	Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting at least 20 minutes but less than 40 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02465	01NOV2019	31DEC9999	Y	Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting at least 40 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02471	01NOV2019	31DEC9999	Y	Professional attendance by video conference of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02472	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 5 minutes in duration but not more than 25 minutes (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02475	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 25 minutes in duration but not more than 45 minutes (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02478	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02480	01NOV2019	31DEC9999	Y	Professional attendance by video conference of not more than 5 minutes in duration by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02481	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 5 minutes in duration but not more than 25 minutes by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02482	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02483	01NOV2019	31DEC9999	Y	Professional attendance by video conference of more than 45 minutes in duration by a medical practitioner, only if:(a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months.
02497	01MAY2005	31OCT2006	N	LEVEL 'A' Professional attendance involving taking a short patient history and, if required, limited examination and management AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999 SURGERY CONSULTATION (Professional attendance at consulting rooms)
02497	01NOV2006	30APR2010	N	LEVEL 'A' Professional attendance involving taking a short patient history and, if required, limited examination and management AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999 SURGERY CONSULTATION (Professional attendance at consulting rooms)
02497	01MAY2010	30NOV2017	N	Professional attendance at consulting rooms by a general practitioner: (a) involving taking a short patient history and, if required, limited examination and management; and (b) at which a cervical smear is taken from a person between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years
02497	01DEC2017	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner: (a) involving taking a short patient history and, if required, limited examination and management; and (b) at which a specimen for a cervical screening service is collected from the patient; if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years.
02501	01NOV2001	30APR2005	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years SURGERY CONSULTATION (Professional attendance at consulting rooms)
02501	01MAY2005	31OCT2006	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02501	01NOV2006	30APR2010	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02501	01MAY2010	30NOV2017	N	Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02501	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years.
02502	01FEB1984	31DEC9999	Y	Digits or phalanges-- all or any of either hand or either foot (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02503	01NOV2001	30APR2005	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02503	01MAY2005	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999.
02503	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02503	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02503	01JAN2013	30NOV2017	N	Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02503	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years.
02504	01NOV2001	30APR2005	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02504	01MAY2005	31OCT2006	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02504	01NOV2006	30APR2010	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02504	01MAY2010	30NOV2017	N	Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02504	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02505	01FEB1984	31DEC9999	Y	Digits or phalanges-- all or any of either hand or either foot (when the service is rendered by a specialist in the practice of his specialty)
02506	01NOV2001	30APR2005	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02506	01MAY2005	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999.
02506	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02506	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02506	01JAN2013	30NOV2017	N	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02506	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02507	01NOV2001	30APR2005	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years SURGERY CONSULTATION (Professional attendance at consulting rooms)
02507	01MAY2005	31OCT2006	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02507	01NOV2006	30APR2010	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02507	01MAY2010	30NOV2017	N	Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02507	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02508	01FEB1984	31DEC9999	Y	Hand, wrist, forearm, elbow or arm (elbow to shoulder) (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02509	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999.
02509	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02509	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02509	01JAN2013	30NOV2017	N	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years
02509	01DEC2017	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02512	01FEB1984	31DEC9999	Y	Hand, wrist, forearm, elbow or arm (elbow to shoulder) (when the service is rendered by a specialist in the practice of his specialty)
02516	01FEB1984	31DEC9999	Y	Hand, wrist and lower forearm; upper forearm and elbow; or elbow and arm (elbow to shoulder) (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02517	01NOV2001	30APR2002	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01MAY2002	31OCT2002	N	Note: Benefits are payable for only one service included in Subgroup 2 or A19, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BM*I: At least once every six months - Measure blood pressure: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height wieght and calculate BMI as part of the initial assessment. Subsequent visits: measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01NOV2002	30APR2005	N	Note: Benefits are payable for only one service included in Subgroup 2 or A19, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least once every six months - Measure blood pressure: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01MAY2005	31OCT2005	N	The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least once every six months - Measure blood pressure: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01NOV2005	31OCT2006	N	The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least twice every cycle of care - Measure blood pressure: At least twice every cycle of care - Examine feet: At least twice every cycle of care - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01NOV2006	30JUN2009	N	The minimum requirements of care needed to be assessed to complete a cycle of care for patients with established diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out* At least once every two years - Measure weight and height and calculate BMI** At least twice every cycle of care - Measure blood pressure At least twice every cycle of care - Examine feet*** At least twice every cycle of care - Measure total cholesterol, triglycerides and HDL cholesterol At least once every year - Test for microalbuminuria At least once every year - Provide self-care education Patient education regarding diabetes management - Review diet Reinforce information about appropriate dietary choices - Review levels of physical activity Reinforce information about appropriate levels of physical activity - Check smoking status Encourage cessation of smoking (if relevant) - Review of medication Medication review * Not required if the patient is blind or does not have both eyes. ** Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. *** Not required if the patient does not have both feet. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01JUL2009	30APR2010	N	The minimum requirements of care to complete an annual Diabetes Cycle of Care for patients with established diabetes mellitus must be completed over a period of at least 11 months and up to 13 months, and must include: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out* At least once every two years - Measure weight and height and calculate BMI** At least twice every cycle of care - Measure blood pressure At least twice every cycle of care - Examine feet*** At least twice every cycle of care - Measure total cholesterol, triglycerides and HDL cholesterol At least once every year - Test for microalbuminuria At least once every year - Provide self-care education Patient education regarding diabetes management - Review diet Reinforce information about appropriate dietary choices - Review levels of physical activity Reinforce information about appropriate levels of physical activity - Check smoking status Encourage cessation of smoking (if relevant) - Review of medication Medication review * Not required if the patient is blind or does not have both eyes. ** Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. *** Not required if the patient does not have both feet. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02517	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02518	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02518	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02518	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02518	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02520	01FEB1984	31DEC9999	Y	Hand, wrist and lower forearm; upper forearm and elbow; or elbow and arm (elbow to shoulder) (when the service is rendered by a specialist in the practice of his specialty)
02521	01NOV2001	31OCT2006	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02521	01NOV2006	30APR2010	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02521	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02522	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02522	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02522	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02522	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02524	01FEB1984	31DEC9999	Y	Foot, ankle, lower leg, upper leg, knee or thigh (femur) (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02525	01NOV2001	31OCT2006	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02525	01NOV2006	30APR2010	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms)
02525	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02526	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02526	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02526	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02526	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02528	01FEB1984	31DEC9999	Y	Foot, ankle, lower leg, upper leg, knee or thigh (femur) (when the service is rendered by a specialist in the practice of his specialty)
02532	01FEB1984	31DEC9999	Y	Foot, ankle and lower leg; or upper leg and knee (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02537	01FEB1984	31DEC9999	Y	Foot, ankle and lower leg; or upper leg and knee (when the service is rendered by a specialist in the practice of his specialty)
02539	01FEB1984	31DEC9999	Y	Shoulder or scapula (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02541	01FEB1984	31DEC9999	Y	Shoulder or scapula (when the service is rendered by a specialist in the practice of his specialty)
02543	01FEB1984	31DEC9999	Y	Clavicle (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02545	01FEB1984	31DEC9999	Y	Clavicle (when the service is rendered by a specialist in the practice of his specialty)
02546	01NOV2001	30APR2002	N	At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - at least two of these consultations to have been planned recalls - diagnosis and assessment of severity - review of asthma related medication - provision of written asthma action plan and education to patient LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms
02546	01MAY2002	31OCT2002	N	Note: Benefits are payable for one service included in Subgroup 3 or A19, Subgroup 3 only in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - planned recalls for at least two of these consultations - documented diagnosis and assessment of severity - review of the patient's use of asthma related medication - provision of a written asthma action plan and self-management education to the patient - review of asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02546	01NOV2002	31OCT2006	N	Note: Benefits are payable for only one service included in Subgroup 3 or A19, Subgroup 3 in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - documented diagnosis and assessment of severity - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - review of the patient's use of asthma related medication - planned recalls for at least two of these consultations - provision of a written asthma action plan and self-management education to the patient, (if the patient is unable to use a written action plan, alternative patient education may be provided and documented in the medical record). - review of asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02546	01NOV2006	30APR2010	N	Note: Benefits are payable for only one service included in Subgroup 3 or A19, Subgroup 3 in a 12-month period, unless a further Asthma Cycle of Care is clinically indicated. At a minimum the Asthma Cycle of Care must include: - at least 2 asthma related consultations within 12 months for a patient with moderate to severe asthma (at least 1 of which (the review consultation) is a consultation that was planned at a previous consultation) - documented diagnosis and assessment of level of asthma control and severity of asthma - review of the patient's use of and access to asthma related medication and devices - provision to the patient of a written asthma action plan (if the patient is unable to use a written asthma action plan - discussion with the patient about an alternative method of providing an asthma action plan, and documentation of the discussion in the patient's medical records) - provision of asthma self-management education to the patient - review of the written or documented asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02546	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02547	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02547	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms)
02547	01MAY2010	31DEC2011	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02547	01JAN2012	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02547	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02548	01FEB1984	31DEC9999	Y	Hip joint
02551	01FEB1984	31DEC9999	Y	Pelvic girdle
02552	01NOV2001	30APR2002	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02552	01MAY2002	31OCT2006	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02552	01NOV2006	30APR2010	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02552	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02553	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02553	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms)
02553	01MAY2010	31DEC2012	N	CONSULTATION AT A PLACE OTHER CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02553	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02554	01FEB1984	31DEC9999	Y	Sacro-iliac joints
02557	01FEB1984	31AUG1989	N	Smith-Petersen nail-- insertion or similar procedure
02557	01SEP1989	31DEC9999	Y	Femur, internal fixation of neck or intertrochanteric (pertrochanteric) fracture
02558	01NOV2001	30APR2002	N	LEVEL 'D' Professional attendance involving taking a exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02558	01MAY2002	31OCT2006	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02558	01NOV2006	30APR2010	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02558	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02559	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02559	01NOV2006	30APR2010	N	OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms)
02559	01MAY2010	31DEC2012	N	CONSULTATION AT A APLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms.
02559	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care
02560	01FEB1984	31DEC9999	Y	Skull (calvarium)
02563	01FEB1984	31DEC9999	Y	Sinuses
02566	01FEB1984	31DEC9999	Y	Mastoids
02569	01FEB1984	31DEC9999	Y	Petrous temporal bones
02573	01FEB1984	31DEC9999	Y	Facial bones-- orbit, maxilla or malar-- any or all
02574	30JUL2002	31OCT2002	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least two of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2) LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02574	01NOV2002	30APR2005	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least two of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2) LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02574	01MAY2005	31OCT2005	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 Step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least 2 of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials. LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02574	01NOV2005	31DEC9999	Y	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 Step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least one of the consultations to have been a planned visit which must include the review step; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials. LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02575	30JUL2002	31OCT2002	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02575	01NOV2002	31DEC9999	Y	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02576	01FEB1984	31DEC9999	Y	Mandible
02577	30JUL2002	31OCT2002	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02577	01NOV2002	31DEC9999	Y	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02578	30JUL2002	31OCT2002	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02578	01NOV2002	31DEC9999	Y	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02579	01FEB1984	31DEC9999	Y	Salivary calculus
02581	01FEB1984	31DEC9999	Y	Nose
02583	01FEB1984	31DEC9999	Y	Eye
02585	01FEB1984	31DEC9999	Y	Temporo-mandibular joints
02587	01FEB1984	31DEC9999	Y	Teeth-- single area
02589	01FEB1984	31DEC9999	Y	Teeth-- full mouth
02590	01SEP1989	31DEC9999	Y	Teeth-orthopantomography
02591	01FEB1984	31DEC9999	Y	Palato-pharyngeal studies with fluoroscopic screening
02593	01FEB1984	31DEC9999	Y	Palato-pharyngeal studies without fluoroscopic screening
02595	01FEB1984	31DEC9999	Y	Larynx
02597	01FEB1984	31DEC9999	Y	Spine-- cervical
02598	01MAY2005	31OCT2006	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999
02598	01NOV2006	31DEC2011	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999
02598	01JAN2012	30JUN2013	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years.
02598	01JUL2013	30NOV2017	N	Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner who practices in general practice (other than a general practitioner) at which a cervical smear is taken from a person between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years
02598	01DEC2017	31DEC9999	Y	Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner who practices in general practice (other than a general practitioner) at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02599	01FEB1984	31DEC9999	Y	Spine-- thoracic
02600	01NOV2001	30APR2005	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years
02600	01MAY2005	31OCT2006	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02600	01NOV2006	31DEC2011	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02600	01JAN2012	30JUN2013	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years.
02600	01JUL2013	30NOV2017	N	Professional attendance at consulting rooms of more than 5, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02600	01DEC2017	31DEC9999	Y	Professional attendance at consulting rooms of more than 5, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02601	01FEB1984	31DEC9999	Y	Spine-- lumbo-sacral
02603	01NOV2001	30APR2005	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years
02603	01MAY2005	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02603	01NOV2006	31DEC2011	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02603	01JAN2012	30JUN2013	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years.
02603	01JUL2013	30NOV2017	N	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02603	01DEC2017	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02604	01FEB1984	31DEC9999	Y	Spine-- sacro-coccygeal
02606	01NOV2001	30APR2005	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive who has not had a cervical smear in the last 4 years
02606	01MAY2005	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02606	01NOV2006	31DEC2011	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02606	01JAN2012	30JUN2013	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years.
02606	01JUL2013	30NOV2017	N	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02606	01DEC2017	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02607	01FEB1984	31DEC9999	Y	Spine-- two regions
02609	01FEB1984	31DEC9999	Y	Spine-- three or more regions
02610	01NOV2001	30APR2005	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years
02610	01MAY2005	31OCT2006	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02610	01NOV2006	31DEC2011	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02610	01JAN2012	31DEC2012	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years.
02610	01JAN2013	30JUN2013	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02610	01JUL2013	30NOV2017	N	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02610	01DEC2017	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02611	01FEB1984	31DEC9999	Y	Spine-- functional views of one area
02613	01NOV2001	30APR2005	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years
02613	01MAY2005	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02613	01NOV2006	31DEC2011	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02613	01JAN2012	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years.
02613	01JAN2013	30JUN2013	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02613	01JUL2013	30NOV2017	N	Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02613	01DEC2017	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02614	01FEB1984	31DEC9999	Y	Bone age study, wrist and knee
02616	01NOV2001	30APR2005	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive who has not had a cervical smear in the last 4 years
02616	01MAY2005	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999.
02616	01NOV2006	31DEC2011	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999.
02616	01JAN2012	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years.
02616	01JAN2013	30JUN2013	N	PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount
02616	01JUL2013	30NOV2017	N	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years
02616	01DEC2017	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years
02617	01FEB1984	31DEC9999	Y	Bone age study, wrist
02620	01NOV2001	30APR2002	N	SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02620	01MAY2002	31OCT2002	N	Note: Benefits are payable for one service included in Subgroup 2 or A18, Subgroup 2 only in a 12-month period The minimum requirements of care needed to be assesed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once per year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once per year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02620	01NOV2002	30APR2005	N	Note: Benefits are payable for only one service included in Subgroup 2 or A18, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least once every six months - Measure blood pressure: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02620	01MAY2005	31OCT2005	N	The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least once every six months - Measure blood pressure: At least once every six months - Examine feet: At least once every six months - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus.
02620	01NOV2005	31OCT2006	N	The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out: At least once every two years - Measure weight and height and calculate BMI*: At least twice every cycle of care - Measure blood pressure: At least twice every cycle of care - Examine feet: At least twice every cycle of care - Measure total cholesterol, triglycerides and HDL cholesterol: At least once every year - Test for microalbuminuria: At least once every year - Provide self-care education: Patient education regarding diabetes management - Review diet: Reinforce information about appropriate dietary choices - Review levels of physical activity: Reinforce information about appropriate levels of physical activity - Check smoking status: Encourage cessation of smoking (if relevant) - Review of medication: Medication review * Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus.
02620	01NOV2006	30JUN2009	N	The minimum requirements of care needed to be assessed to complete a cycle of care for patients with established diabetes mellitus are: - Assess diabetes control by measuring HbA1c At least once every year - Ensure that a comprehensive eye examination is carried out* At least once every two years - Measure weight and height and calculate BMI** At least twice every cycle of care - Measure blood pressure At least twice every cycle of care - Examine feet*** At least twice every cycle of care - Measure total cholesterol, triglycerides and HDL cholesterol At least once every year - Test for microalbuminuria At least once every year - Provide self-care education Patient education regarding diabetes management - Review diet Reinforce information about appropriate dietary choices - Review levels of physical activity Reinforce information about appropriate levels of physical activity - Check smoking status Encourage cessation of smoking (if relevant) - Review of medication Medication review * Not required if the patient is blind or does not have both eyes. ** Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. *** Not required if the patient does not have both feet. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus.
02620	01JUL2009	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
02621	01FEB1984	31DEC9999	Y	Skeletal survey involving four or more regions
02622	01NOV2001	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02622	01NOV2006	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the requirements for a cycle of care of a patient with established diabetes mellitus
02624	01NOV2001	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02624	01NOV2006	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
02625	01FEB1984	31DEC9999	Y	Chest (lung fields) by direct radiography (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02627	01FEB1984	31DEC9999	Y	Chest (lung fields) by direct radiography (when the service is rendered by a specialist in the practice of his specialty)
02630	01FEB1984	31DEC9999	Y	Chest (lung fields) by direct radiography with fluoroscopic screening
02631	01NOV2001	31OCT2006	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02631	01NOV2006	31DEC2012	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02631	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
02633	01NOV2001	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02633	01NOV2006	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02633	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes but not more than 45 minutes, in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
02634	01FEB1984	31DEC9999	Y	Thoracic inlet or trachea
02635	01NOV2001	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus
02635	01NOV2006	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus
02635	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus
02638	01FEB1984	31DEC9999	Y	Chest by miniature radiography
02642	01FEB1984	31DEC9999	Y	Cardiac examination (including barium swallow) (when the service is rendered otherwise than by a specialist in the practice of his specialty)
02646	01FEB1984	31DEC9999	Y	Cardiac examination (including barium swallow) (when the service is rendered by a specialist in the practice of his specialty)
02655	01FEB1984	31DEC9999	Y	Sternum or ribs on one side
02656	01FEB1984	31DEC9999	Y	Sternum and ribs on one side, or ribs on both sides
02657	01FEB1984	31DEC9999	Y	Sternum and ribs on both sides
02664	01NOV2001	30APR2002	N	At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - at least two of these consultations to have been planned recalls - diagnosis and assessment of severity - review of asthma related medication - provision of written asthma action plan and education to patient SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02664	01MAY2002	31OCT2002	N	Note: Benefits are payable for one service included in Subgroup 3 or A18, Subgroup 3 only in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - planned recalls for at least two of these consultations - documented diagnosis and assessment of severity - review of the patient's use of asthma related medication - provision of a written asthma action plan and self-management education to the patient - review of asthma action plan SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02664	01NOV2002	31OCT2006	N	Note: Benefits are payable for only one service included in Subgroup 3 or A18, Subgroup 3 in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - documented diagnosis and assessment of severity - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - review of the patient's use of asthma related medication - planned recalls for at least two of these consultations - provision of a written asthma action plan and self-management education to the patient, (if the patient is unable to use a written action plan, alternative patient education may be provided and documented in the medical record) - review of asthma action plan SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02664	01NOV2006	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02665	01FEB1984	31DEC9999	Y	Plain renal only
02666	01NOV2001	30APR2002	N	LONG CONSULTATION or more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02666	01MAY2002	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02666	01NOV2006	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02668	01NOV2001	30APR2002	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02668	01MAY2002	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02668	01NOV2006	31DEC9999	Y	Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02672	01FEB1984	31DEC9999	Y	Drip-infusion pyelography
02673	01NOV2001	30APR2002	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02673	01MAY2002	31OCT2006	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02673	01NOV2006	31DEC2012	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care.
02673	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02675	01NOV2001	30APR2002	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02675	01MAY2002	31OCT2006	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02675	01NOV2006	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care.
02675	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02676	01FEB1984	31DEC9999	Y	Intravenous pyelography, including preliminary plain film
02677	01NOV2001	30APR2002	N	PROLONGED CONSULTATION of more 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan.
02677	01MAY2002	31OCT2006	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan.
02677	01NOV2006	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care.
02677	01JAN2013	31DEC9999	Y	Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care
02678	01FEB1984	31DEC9999	Y	Intravenous pyelography, including preliminary plain film and limited tomography involving up to three tomographic cuts
02681	01FEB1984	31DEC9999	Y	Intravenous pyelography, including preliminary plain film with delayed examination for the cysto-ureteric reflex
02687	01FEB1984	31DEC9999	Y	Antegrade or retrograde pyelography including preliminary plain film
02690	01FEB1984	31DEC9999	Y	Retrograde cystography or retrograde urethrography
02694	01FEB1984	31DEC9999	Y	Retrograde micturating cysto-urethrography
02697	01FEB1984	31DEC9999	Y	Retro-peritoneal pneumogram
02699	01FEB1984	31DEC9999	Y	Plain abdominal only (when the service is rendered otherwise than by a specialist in the practice of his specialty) not associated with Item 2709, 2711, 2714 or 2720
02700	01NOV2011	30JUN2018	N	Professional attendance by a medical practitioner (including a general practitioner who has not undertaken mental health skills training, but not including a specialist or consultant physician) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02700	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner (including a general practitioner who has not undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02701	01NOV2011	30JUN2018	N	Professional attendance by a medical practitioner (including a general practitioner who has not undertaken mental health skills training, but not including a specialist or consultant physician) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02701	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner (including a general practitioner who has not undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02702	01JAN2010	31DEC9999	Y	PREPARATION by a medical practitioner who has not undertaken mental health skills training (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or item 2710 or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan.
02703	01FEB1984	31DEC9999	Y	Plain abdominal only (when the service is rendered by a specialist in the practice of his specialty) not associated with Item 2709, 2711, 2714 or 2720
02704	30JUL2002	31OCT2002	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least two of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2). SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. AND which completes the requirements of the 3 Step Mental Health Process.
02704	01NOV2002	30APR2005	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least two of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2). SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02704	01MAY2005	31OCT2005	N	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least 2 of the consultations to have been planned visits; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02704	01NOV2005	31DEC9999	Y	Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: - at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; - at least one of the consultations to have been a planned visit which must include the review step; - an assessment and formulation or diagnosis of the mental health disorder/s; - provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); - a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and - utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to Medicare Australia as having the required credentials. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02705	30JUL2002	31OCT2002	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02705	01NOV2002	31DEC9999	Y	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02706	01FEB1984	31DEC9999	Y	Oesophagus, with or without examination for foreign body or barium swallow
02707	30JUL2002	31OCT2002	N	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02707	01NOV2002	31DEC9999	Y	OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02708	30JUL2002	31OCT2002	N	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02708	01NOV2002	31DEC9999	Y	PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process.
02709	01FEB1984	31DEC9999	Y	Barium or other opaque meal of oesophagus, stomach and duodenum, with or without screening of chest and with or without preliminary plain film
02710	01NOV2006	30APR2007	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH CARE PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, within twelve months of a claim for a 3 Step Mental Health Process (items 2574, 2575, 2577, 2578 and 2704, 2705, 2707, 2708) or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Care Plan.
02710	01MAY2007	30JUN2009	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH CARE PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, within twelve months of a claim for a former 3 Step Mental Health Process (items 2574, 2575, 2577, 2578 and 2704, 2705, 2707, 2708) or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Care Plan.
02710	01JUL2009	31DEC2009	N	PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan.
02710	01JAN2010	31DEC9999	Y	PREPARATION by a medical practitioner who has undertaken mental health skills training (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or item 2702 or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan.
02711	01FEB1984	31DEC9999	Y	Barium or other opaque meal of oesophagus, stomach, duodenum and follow through to colon, with or without screening of chest and with or without preliminary plain film
02712	01NOV2006	30JUN2009	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH CARE PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Care Plan.
02712	01JUL2009	31DEC2009	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan.
02712	01JAN2010	31OCT2011	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2702 or 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2702 or 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan.
02712	01NOV2011	29FEB2012	N	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2700, 2701, 2715 or 2717 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 735 to 758 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2700, 2701, 2715 or 2717, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan.
02712	01MAR2012	30JUN2018	N	Professional attendance by a medical practitioner (not including a specialist or consultant physician) to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan
02712	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner to review a GP mental health treatment plan which he or she, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan
02713	01NOV2006	31DEC2009	N	Professional ATTENDANCE by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) involving taking relevant history, identifying presenting problem(s), providing treatment, advice and/or referral for other services or treatments and documenting the outcomes of the consultation, on a patient in relation to a mental disorder and lasting at least 20 minutes (not being a service associated with a service to which items 2710 or 2712 apply). SURGERY CONSULTATION (Professional attendance at consulting rooms)
02713	01JAN2010	31OCT2011	N	Professional ATTENDANCE by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) involving taking relevant history, identifying presenting problem(s), providing treatment, advice and/or referral for other services or treatments and documenting the outcomes of the consultation, on a patient in relation to a mental disorder and lasting at least 20 minutes (not being a service associated with a service to which items 2702, 2710 or 2712 apply). SURGERY CONSULTATION (Professional attendance at consulting rooms)
02713	01NOV2011	30JUN2018	N	Professional attendance by a medical practitioner (not including a specialist or consultant physician) in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation
02713	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation
02714	01FEB1984	31DEC9999	Y	Barium or other opaque meal, small bowel series only, with or without preliminary plain film
02715	01NOV2011	30JUN2018	N	Professional attendance by a medical practitioner (including a general practitioner who has undertaken mental health skills training, but not including a specialist or consultant physician) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02715	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner (including a general practitioner who has undertaken mental health skills training of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02716	01FEB1984	31DEC9999	Y	Opaque enema
02717	01NOV2011	30JUN2018	N	Professional attendance by a medical practitioner (including a general practitioner who has undertaken mental health skills training, but not including a specialist or consultant physician) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02717	01JUL2018	31DEC9999	Y	Professional attendance by a general practitioner (including a general practitioner who has undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
02718	01FEB1984	31DEC9999	Y	Opaque enema, including air contrast study
02719	01NOV2011	31DEC9999	Y	Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which former items 2702 or 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 735 to 758 apply). A rebate will not be paid within three months of a previous claim for the same item, within three months following the review of a GP mental health treatment plan for the patient under item 2712 or within four weeks following a claim for item 2700, 2701, 2715, 2717, 2702 or 2710 except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan.
02720	01FEB1984	31DEC9999	Y	Graham's test (cholecystography) , with or without preliminary abdominal radiograph
02721	01NOV2002	31OCT2006	N	MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note: These services may only be provided by a medical practitioner who is registered with Medicare Australia as meeting the requirements to participate in the Better Outcomes in Mental Health Care Initiative. The medical practitioner must provide the service in a general practice participating in the PIP or which is accredited. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 6 planned sessions. In some instances, following review by the practitioner managing the 3 Step Mental Health Process, up to a further 6 sessions may be approved in any 12 month period to an individual patient. Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental health disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02721	01NOV2006	30APR2007	N	MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note: These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service. The medical practitioner must provide the service in a general practice participating in the PIP or which is accredited. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 12 planned sessions comprising two groups of up to six sessions. In exceptional circumstances, following review by the practitioner managing either the 3 Step Mental Health Process, the GP Mental Health Care Plan or the Psychiatric Assessment and Management Plan, up to a further 6 sessions may be approved in a calendar year to an individual patient. Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02721	01MAY2007	31OCT2011	N	MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note: These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 12 planned sessions comprising two groups of up to six sessions. In exceptional circumstances, following review by the practitioner managing either the former 3 Step Mental Health Process, the GP Mental Health Care Plan or the Psychiatric Assessment and Management Plan, up to a further 6 sessions may be approved in a calendar year to an individual patient. Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02721	01NOV2011	29FEB2012	N	MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note: These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in up to ten planned sessions per calendar year. Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms)
02721	01MAR2012	30JUN2018	N	Professional attendance at consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
02721	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
02722	01FEB1984	31DEC9999	Y	Cholegraphy direct-operative or post-operative
02723	01NOV2002	31DEC2012	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02723	01JAN2013	30JUN2018	N	Professional attendance at a place other than consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
02723	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes
02724	01FEB1984	31DEC9999	Y	Cholegraphy-intravenous
02725	01NOV2002	30JUN2018	N	Professional attendance at consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes
02725	01JUL2018	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes
02726	01FEB1984	31DEC9999	Y	Cholegraphy-percutaneous transhepatic
02727	01NOV2002	31DEC2012	N	OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms)
02727	01JAN2013	30JUN2018	N	Professional attendance at a place other than consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes
02727	01JUL2018	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes
02728	01FEB1984	31DEC9999	Y	Cholegraphy-drip infusion
02729	01NOV2018	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner.
02729	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms, by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, to provide focussed psychological strategies for assessed mental disorders, if: (a) the attendance is by video conference and lasts at least 30 minutes but less than 40 minutes; and (b) the patient is not an admitted patient; and (c) the patient is located within a Modified Monash 4, 5, 6 or 7 area and, at the time of the attendance, is at least 15 kilometres by road from the general practitioner
02730	01FEB1984	31DEC9999	Y	Foreign body in eye (special method, Sweet's or other)
02731	01NOV2018	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner
02731	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms, by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, to provide focussed psychological strategies for assessed mental disorders, if: (a) the attendance is by video conference and lasts at least 40 minutes; and (b) the patient is not an admitted patient; and (c) the patient is located within a Modified Monash 4, 5, 6 or 7 area and, at the time of the attendance, is at least 15 kilometres by road from the general practitioner
02732	01FEB1984	31DEC9999	Y	Foreign body, localization of and report, not covered by any other item in this Part
02733	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 30 minutes, but less than 40 minutes
02734	01FEB1984	31DEC9999	Y	Radiographic examination of both breasts (with or without thermography) and report where the patient is referred with a specific request for this procedure and there is reason to suspect the presence of malignancy in the breasts because of the past occurrence of breast malignancy in the patient or members of the patient's family or because symptoms or indications of malignancy were found on an examination of the patient by a medical practitioner (S)
02735	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 40 minutes
02736	01FEB1984	31DEC9999	Y	Radiographic examination of one breast (with or without thermography) and report where the patient is referred with a specific request for this procedure and there is reason to suspect the presence of malignancy in the breast because of the past occurrence of breast malignancy in the patient or members of the patient's family or because symptoms or indications of malignancy were found on an examination of the patient by a medical practitioner (S)
02738	01FEB1984	31DEC9999	Y	Pregnant uterus
02739	01MAR2023	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician) registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes, but less than 40 minutes
02740	01FEB1984	31DEC9999	Y	Pelvimetry or placentography
02741	01MAR2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician) registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes, but less than 40 minutes
02742	01FEB1984	31DEC9999	Y	Control X-rays associated with intrauterine foetal blood transfusion
02743	01MAR2023	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician) registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
02744	01FEB1984	31DEC9999	Y	Serial angiocardiography (rapid cassette changing)-each series (AU 8)
02745	01MAR2023	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician) registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
02746	01FEB1984	31DEC9999	Y	Serial angiocardiography (single plane-direct roll-film method)-each series (AU 8)
02748	01FEB1984	31DEC9999	Y	Serial angiocardiography (bi-plane-direct roll-film method)-each series (AU 8)
02750	01FEB1984	31DEC9999	Y	Serial angiocardiography (indirect roll-film method)-each series (AU 8)
02751	01FEB1984	31DEC9999	Y	Selective coronary arteriography
02752	01FEB1984	31DEC9999	Y	Discography-one disc
02754	01FEB1984	31DEC9999	Y	Dacryocystography-one side
02756	01FEB1984	31DEC9999	Y	Encephalography
02758	01FEB1984	31DEC9999	Y	Cerebral angiography-one side
02760	01FEB1984	31DEC9999	Y	Cerebral ventriculography
02762	01FEB1984	31DEC9999	Y	Hysterosalpingography
02764	01FEB1984	31DEC9999	Y	Bronchography-one side
02766	01FEB1984	31DEC9999	Y	Arteriography, peripheral-one side
02768	01FEB1984	31DEC9999	Y	Phlebography-one side
02770	01FEB1984	31DEC9999	Y	Aortography
02772	01FEB1984	31DEC9999	Y	Splenography
02773	01FEB1984	31DEC9999	Y	Myelography, one region
02774	01FEB1984	31DEC9999	Y	Myelography, two regions
02775	01FEB1984	31DEC9999	Y	Myelography, three regions
02776	01FEB1984	31DEC9999	Y	Selective arteriography per injection and film run
02778	01FEB1984	31DEC9999	Y	Sialography-one side
02780	01FEB1984	31DEC9999	Y	Vasoepididymography-one side
02782	01FEB1984	31DEC9999	Y	Sinuses and fistulae
02784	01FEB1984	31DEC9999	Y	Laryngography with contrast media
02786	01FEB1984	31AUG1989	N	Pneumarthrography
02786	01SEP1989	31DEC9999	Y	Pneumoarthrography
02788	01FEB1984	31DEC9999	Y	Arthrography-contrast
02790	01FEB1984	31DEC9999	Y	Arthrography-double contrast
02792	01FEB1984	31DEC9999	Y	Lymphangiography, including follow up radiography
02794	01FEB1984	31DEC9999	Y	Pneumomediastinum
02796	01FEB1984	31DEC9999	Y	Tomography, any part and report
02798	01FEB1984	31DEC9999	Y	Stereoscopic examination of any area and report
02799	01JAN2013	31OCT2019	N	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
02799	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of pain medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
02800	01FEB1984	31AUG1989	N	Examination with general anaesthesia (AU 7)
02800	01SEP1989	31DEC9999	Y	Examination with general anaesthesia (not associated with a radiographic examination) (AU 7)
02801	01MAY2006	31OCT2011	N	MEDICAL PRACTITIONER (PAIN MEDICINE SPECIALIST) ATTENDANCE - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist practising in the specialty of pain medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment
02801	01NOV2011	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
02801	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment
02802	01FEB1984	31AUG1989	N	Examination without general anaesthesia
02802	01SEP1989	31DEC9999	Y	Examination without general anaesthesia (not associated with a radiographic examination)
02804	01FEB1984	31DEC9999	Y	Radiographic examination of any part and report not covered by any item in this Part
02805	01FEB1984	31DEC9999	Y	Encephalography (AU 10)
02806	01MAY2006	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 2814 applies) after the first in a single course of treatment
02806	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 2814 applies) after the first in a single course of treatment
02807	01FEB1984	31DEC9999	Y	Cerebral angiography, one side-percutaneous, catheter or open exposure (AU 10)
02811	01FEB1984	31DEC9999	Y	Cerebral ventriculography (AU 10)
02813	01FEB1984	31DEC9999	Y	Dacryocystography-one side
02814	01MAY2006	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
02814	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
02815	01FEB1984	31DEC9999	Y	Bronchography-one or both sides (AU 8)
02817	01FEB1984	31DEC9999	Y	Aortography (AU 8)
02819	01FEB1984	31DEC9999	Y	Arteriography (peripheral) or phlebography-one vessel (AU 6)
02820	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of pain medicine to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 2801, 2806 or 2814.
02820	01NOV2012	31DEC2012	N	Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a) the attendance is by video conference; and (b) item 2801, 2806 or 2814 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
02820	01JAN2013	31OCT2019	N	Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 2801 lasting more than 10 minutes; or (ii) provided with item 2806 or 2814; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
02820	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of pain medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 2801 lasting more than 10 minutes; or (ii) provided with item 2806 or 2814; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
02823	01FEB1984	31DEC9999	Y	Splenography (AU 6)
02824	01MAY2006	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
02824	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment
02825	01FEB1984	31DEC9999	Y	Retroperitoneal pneumogram
02827	01FEB1984	31DEC9999	Y	Selective arteriogram or phlebogram (AU 6)
02831	01FEB1984	31DEC9999	Y	Percutaneous injection of radioopaque material into renal pelvis or into a renal cyst (including aspiration of the cyst) for antegrade pyelography
02832	01MAY2006	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 2840 applies) after the first in a single course of treatment
02832	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 2840 applies) after the first in a single course of treatment
02833	01FEB1984	31DEC9999	Y	Pneumoarthrography or pneumoperitoneum
02834	01SEP1989	31DEC9999	Y	Preparation for contrast arthrography or double contrast arthrography excluding arthrography of the joints between articular processes of the vertebrae
02837	01FEB1984	31DEC9999	Y	Drip-infusion pyelography or dripinfusion cholegraphy
02839	01FEB1984	31DEC9999	Y	Retrograde micturating cystourethrography
02840	01MAY2006	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
02840	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
02841	01FEB1984	31DEC9999	Y	Hysterosalpingography (AU 6)
02843	01FEB1984	31DEC9999	Y	Discography-one disc (AU 5)
02844	01SEP1989	31DEC9999	Y	Preparation for discography using Metrizamide contrast medium
02845	01FEB1984	31DEC9999	Y	Intraosseous venography
02847	01FEB1984	31AUG1989	N	Myelography (AU 11)
02847	01SEP1989	31DEC9999	Y	Myelography, not covered by item 2848 (AU 11)
02848	01NOV1984	31DEC9999	Y	Myelography, using Metrizamide (Amipaque) contrast medium (AU 11)
02849	01FEB1984	31DEC9999	Y	Cisternal puncture
02851	01FEB1984	31DEC9999	Y	Sinus or fistula injection into
02852	01SEP1989	31DEC9999	Y	Preparation for sialography
02853	01FEB1984	31DEC9999	Y	Lymphangiography-one side
02855	01FEB1984	31DEC9999	Y	Laryngography
02857	01FEB1984	31DEC9999	Y	Pneumomediastinum
02859	01FEB1984	31AUG1989	N	Cholegram, percutaneous transhepatic
02859	01SEP1989	31DEC9999	Y	Cholegram, percutaneous transhepatic (AU 11)
02861	01FEB1984	31AUG1989	N	Radiotherapy, superficial-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only
02861	01SEP1989	31DEC9999	Y	Radiotherapy, superficial (including treatment with x-rays, radium rays or other radioactive substances) not covered by any other item in this Part-each attendance at which fractionated treatment is given-one field
02863	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02865	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only
02867	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02869	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-attendance in relation to a condition for the treatment of which a single dose to one field only is given
02871	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-attendance in relation to a condition for the treatment of which a single dose is given separately to each of two or more fields
02873	01FEB1984	31DEC9999	Y	Radiotherapy, superficial-each attendance at which treatment is given to an eye
02875	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only
02877	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02879	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only
02881	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02883	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-attendance in relation to a condition for the treatment of which a single dose to one field only is given (not being an attendance covered by any other item in this Part)
02885	01FEB1984	31DEC9999	Y	Radiotherapy, deep or orthovoltage-attendance in relation to a condition for the treatment of which only a single dose is separately given to each of two or more fields (not being an attendance covered by any other item in this Part)
02887	01FEB1984	31AUG1989	N	Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only
02887	01SEP1989	31DEC9999	Y	Radiation oncology treatment, using a linear accelerator-each attendance at which treatment is given-one field
02889	01FEB1984	31AUG1989	N	Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02889	01SEP1989	31DEC9999	Y	-two or more fields up to a maximum of five additional fields (rotational therapy being three fields)
02891	01FEB1984	31AUG1989	N	Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only
02891	01SEP1989	31DEC9999	Y	Radiation oncology treatment, using cobalt unit or caesium teletherapy unit-each attendance at which treatment is given-one field
02893	01FEB1984	31AUG1989	N	Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields
02893	01SEP1989	31DEC9999	Y	-two or more fields up to a maximum of five additional fields (rotational therapy being three fields)
02894	01SEP1989	31DEC9999	Y	Intrauterine insertion alone (AU 5)
02895	01FEB1984	31DEC9999	Y	Radiotherapy, megavoltage or teletherapy ( not covered by any other item in this Part)-attendance in relation to a condition for the treatment of which a single dose to one field only is given
02896	01SEP1989	31DEC9999	Y	Intravaginal insertion alone (AU 4)
02897	01FEB1984	31DEC9999	Y	Radiotherapy, megavoltage or teletherapy (not covered by any other item in this Part)-attendance in relation to a condition for the treatment of which only a single dose is given separately to each of two or more fields
02898	01SEP1989	31DEC9999	Y	Combined intrauterine and intravaginal insertion (AU 5)
02899	01FEB1984	31DEC9999	Y	Intrauterine insertion alone (AU 5)
02900	01SEP1989	31DEC9999	Y	Implantation of a region necessitating a major anaesthetic and surgical exposure (including implantation in an eye or in an intra-abdominal organ, bladder or prostate) (AU 7)
02901	01FEB1984	31DEC9999	Y	Intravaginal insertion alone (AU 4)
02902	01SEP1989	31DEC9999	Y	Complex implantation of a site not requiring separate surgical exposure but necessitating a major anaesthetic (including implantation in the mouth, in the tongue, in a salivary gland, in the neck, in the axilla, in the groin or in any subcutaneous region) (AU 6)
02903	01SEP1989	31DEC9999	Y	Simple implantation of a site not requiring separate surgical exposure, but necessitating a major anaesthetic (AU 5)
02904	01FEB1984	31DEC9999	Y	Combined intrauterine and intravaginal insertion (AU 5)
02905	01SEP1989	31DEC9999	Y	Implantation of a site not requiring separate surgical exposure or a major anaesthetic (including implantation in skin and implantation in a lip) (AU 4)
02906	01SEP1989	31DEC9999	Y	Preparation of a patient to receive sources for gynaecological irradiation and supervision of the patient during the subsequent irradiation (but not including insertion of the radiation source)
02907	01FEB1984	31DEC9999	Y	Implantation of a region necessitating a major anaesthetic and surgical exposure (including implantation in an eye or in an intra-abdominal organ, bladder or prostate) (AU 7)
02908	01SEP1989	31DEC9999	Y	Removal of sealed radioactive sources under a major anaesthetic (AU 4)
02909	01SEP1989	31DEC9999	Y	Removal of sealed radioactive sources without a major anaesthetic
02910	01FEB1984	31DEC9999	Y	Complex implantation of a site not requiring separate surgical exposure but necessitating a major anaesthetic (including implantation in the mouth, in the tongue, in a salivary gland, in the neck, in the axilla, in the groin or in any subcutaneous region) (AU 6)
02911	01SEP1989	31DEC9999	Y	Construction and first application of a radioactive mould to an intracavitary, an intraoral or an intranasal site
02912	01SEP1989	31DEC9999	Y	Attendance upon a patient to apply a radioactive mould constructed for application to an intracavitary, intraoral or intranasal site other than an attendance which is the first attendance to apply the mould-each attendance
02913	01FEB1984	31DEC9999	Y	Simple implantation of a site not requiring separate surgical exposure, but necessitating a major anaesthetic (AU 5)
02914	01SEP1989	31DEC9999	Y	Construction and first application of a radioactive mould not exceeding 5 cm in diameter to an external surface
02915	01FEB1984	31DEC9999	Y	Implantation of a site not requiring separate surgical exposure or a major anaesthetic (including implantation in skin and implantation in a lip) (AU 4)
02916	01SEP1989	31DEC9999	Y	Construction and first application of a radioactive mould more than 5 cm in diameter to an external surface
02917	01FEB1984	31DEC9999	Y	Preparation of a patient to receive sources for gynaecological irradiation and supervision of the patient during the subsequent irradiation (but not including insertion of the radiation source)
02918	01SEP1989	31DEC9999	Y	Attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould-each attendance
02919	01FEB1984	31DEC9999	Y	Removal of sealed radioactive sources under a major anaesthetic (AU 4)
02920	01SEP1989	31DEC9999	Y	Oral administration of a therapeutic dose of a radioisotope, being an administration not covered by item 2937
02921	01SEP1989	31DEC9999	Y	Oral administration of a therapeutic dose of radioiodine for hyperthyroidism or thyroid cancer by single dose technique
02922	01FEB1984	31DEC9999	Y	Removal of sealed radioactive sources without a major anaesthetic
02923	01SEP1989	31DEC9999	Y	Intravenous administration of a therapeutic dose of a radioisotope
02924	01FEB1984	31DEC9999	Y	Construction and first application of a radioactive mould to an intracavitary, an intraoral or an intranasal site
02925	01SEP1989	31DEC9999	Y	Intracavitary administration of a therapeutic dose of a radioisotope (not including preliminary paracentesis) (AU 5)
02926	01FEB1984	31DEC9999	Y	Attendance upon a patient to apply a radioactive mould constructed for application to an intracavitary, intraoral or intranasal site other than an attendance which is the first attendance to apply the mould-each attendance
02927	01SEP1989	31DEC9999	Y	Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of a single area for treatment by a single field or parallel opposed fields (not associated with Item 2932)
02928	01FEB1984	31DEC9999	Y	Construction and first application of a radioactive mould not exceeding 5 cm in diameter to an external surface
02929	01SEP1989	31DEC9999	Y	Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 2934)
02930	01SEP1989	31DEC9999	Y	Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 2936)
02931	01FEB1984	31DEC9999	Y	Construction and first application of a radioactive mould more than 5 cm in diameter to an external surface
02932	01SEP1989	31DEC9999	Y	Radiation field setting using a diagnostic x-ray unit of a single area for treatment by a single field or parallel opposed fields (not associated with Item 2927)
02933	01FEB1984	31DEC9999	Y	Attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould-each attendance
02934	01SEP1989	31DEC9999	Y	Radiation field setting using a diagnostic x-ray unit of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 2929)
02935	01FEB1984	31DEC9999	Y	Oral administration of a therapeutic dose of a radioisotope, being an administration not covered by Item 2937
02936	01SEP1989	31DEC9999	Y	Radiation field setting using a diagnostic x-ray unit of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 2930)
02937	01FEB1984	31DEC9999	Y	Oral administration of a therapeutic dose of radioiodine for hyperthyroidism or thyroid cancer by single dose technique
02938	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane
02939	01FEB1984	31DEC9999	Y	Intravenous administration of a therapeutic dose of a radioisotope
02940	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
02941	01FEB1984	31DEC9999	Y	Intracavitary administration of a therapeutic dose of a radioisotope (not including preliminary paracentesis) (AU 5)
02942	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons
02943	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane
02944	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
02945	01SEP1989	31DEC9999	Y	Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields, or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons
02946	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes
02946	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes
02949	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes
02949	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes
02951	01FEB1984	31AUG1989	N	Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees exceeds $124.00 but does not exceed $
02951	01SEP1989	31DEC9999	Y	Assistance at any operation for which the fee exceeds $160 but does not exceed $285 or at a series or a combination of operations where the fee for at least one of the operations exceeds $160 but where the fee for the series or combination of operations does not exceed $285
02953	01FEB1984	29FEB1984	N	Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees, specified is $118.00 or more
02953	01MAR1984	31AUG1989	N	Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees, specified exceeds $
02953	01SEP1989	31DEC9999	Y	Assistance at any operation for which the fee exceeds $285 or at a combination of operations for which the aggregate fee exceeds $285 provided that the fee for at least one of the operations exceeds $160
02954	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes
02954	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes
02955	01AUG1988	31DEC9999	Y	Assistance at a delivery involving Caesarean section, not in association with item 201 when itemised by the same practitioner
02957	01AUG1988	31DEC9999	Y	Assistance at a series or combination of operations, one of which is a delivery involving Caesarean section, not in association with item 201 when itemised by the same practitioner
02958	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes
02958	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes
02960	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a brain scanner, plain study (OR)
02961	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a brain scanner, plain study (HR)
02962	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a brain scanner, plain study and contrast medium study (OR)
02963	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a brain scanner, plain study and contrast medium study (HR)
02964	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a body scanner, plain study (OR)
02965	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a body scanner, plain study (HR)
02966	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a body scanner, plain study and contrast medium study (OR)
02967	01FEB1984	31DEC9999	Y	Computerised axial tomography-brain scan on a body scanner, plain study and contrast medium study (HR)
02968	01FEB1984	31DEC9999	Y	Computerised axial tomography-body scan on a body scanner, plain study (OR)
02969	01FEB1984	31DEC9999	Y	Computerised axial tomography-body scan on a body scanner, plain study (HR)
02970	01FEB1984	31DEC9999	Y	Computerised axial tomography-body scan on a body scanner, plain study and intravenous contrast medium study (OR)
02971	01FEB1984	31DEC9999	Y	Computerised axial tomography-body scan on a body scanner, plain study and intravenous contrast medium study (HR)
02972	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes
02972	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes
02974	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes
02974	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes
02978	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
02978	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
02980	01JUN1986	31AUG1989	N	MAGNETIC RESONANCE IMAGING - examination of any parts or parts of the body (HR)
02980	01SEP1989	31DEC9999	Y	Magnetic resonance imaging-examination of any part or parts of body (HR)
02981	01JUL1985	31DEC9999	Y	MAGNETIC RESONANCE IMAGING - examination of any part of parts of the body using a scanner with magnetic filed strength of one Tesla or less. (HR)
02984	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
02984	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
02988	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H)
02988	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H)
02992	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
02992	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
02996	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
02996	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
03000	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H)
03000	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H)
03003	01JAN2013	31OCT2019	N	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
03003	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
03004	01JAN1984	31DEC9999	Y	Operative procedure on tissue, organ or region not covered by any other item in this Part, including any consultation on the same occasion
03005	01MAY2006	31OCT2011	N	MEDICAL PRACTITIONER (PALLIATIVE MEDICINE SPECIALIST) ATTENDANCE - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist practising in the specialty of palliative medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment
03005	01NOV2011	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
03005	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment
03006	01FEB1984	31DEC9999	Y	Dressing of localized burns (not involving grafting)-each attendance at which the procedure is performed, including any associated consultation
03010	01MAY2006	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 3014 applies) after the first in a single course of treatment
03010	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 3014 applies) after the first in a single course of treatment
03012	01FEB1984	31DEC9999	Y	Dressing of burns, extensive, without anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation
03014	01MAY2006	31OCT2019	N	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
03014	01NOV2019	31DEC9999	Y	Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
03015	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of palliative medicine to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 3005, 3010 or 3014.
03015	01NOV2012	31DEC2012	N	Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a) the attendance is by video conference; and (b) item 3005, 3010 or 3014 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
03015	01JAN2013	31OCT2019	N	Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 3005 lasting more than 10 minutes; or (ii) provided with item 3010 or 3014; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
03015	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 3005 lasting more than 10 minutes; or (ii) provided with item 3010 or 3014; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
03016	01FEB1984	31DEC9999	Y	Dressing of localized burns under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (G) (AU 7)
03018	01MAY2006	31OCT2011	N	MEDICAL PRACTITIONER (PALLIATIVE MEDICINE SPECIALIST) ATTENDANCE - HOME VISIT Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist practising in the specialty of pallitive medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment
03018	01NOV2011	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
03018	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment
03022	01FEB1984	31DEC9999	Y	Dressing of localized burns under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (S) (AU 7)
03023	01MAY2006	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 3028 applies) after the first in a single course of treatment
03023	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 3028 applies) after the first in a single course of treatment
03027	01FEB1984	31DEC9999	Y	Dressing of burns, extensive, under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (G) (AU 10)
03028	01MAY2006	31OCT2019	N	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
03028	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment
03032	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes
03032	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes
03033	01FEB1984	31DEC9999	Y	Dressing of burns, extensive, under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (S) (AU 10)
03038	01FEB1984	31DEC9999	Y	Excision, under general anaesthesia, of burns involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation (AU 10)
03039	01FEB1984	31DEC9999	Y	Excision, under general anaesthesia, of burns involving more than 10 per cent of body surface, where grafting is not carried out during the same operation (AU 15)
03040	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes
03040	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes
03041	01FEB1984	29FEB1984	N	Debridement, under general anaesthesia, of deep or extensive contaminated wound of soft tissue (AU 10)
03041	01MAR1984	31AUG1989	N	Debridement, under general anaesthesia, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed(AU 10)
03041	01SEP1989	31DEC9999	Y	Debridement, under general anaesthesia or major regional or field block, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed (AU 10)
03044	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes
03044	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes
03046	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, small (not more than 7 centimetres long), superficial, not covered by any item in Part 2 (AU 5)
03050	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, small (not more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (AU 6)
03051	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes
03051	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes
03055	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
03055	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines
03058	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), superficial (AU 7)
03059	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), superficial (D) (AU 7)
03062	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes
03062	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes
03063	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), involving deeper tissue (AU 7)
03068	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), involving deeper tissue (D) (AU 7)
03069	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
03069	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
03073	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), superficial, not covered by any item in Part 2 (AU 6)
03074	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
03074	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
03078	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H)
03078	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H)
03082	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (G) (AU 7)
03083	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
03083	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H)
03087	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (S) (AU 7)
03088	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
03088	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H)
03092	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), superficial (AU 7)
03093	01MAY2006	31OCT2019	N	Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H)
03093	01NOV2019	31DEC9999	Y	Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H)
03095	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), superficial (D) (AU 7)
03098	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (G) (AU 8)
03101	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (S) (AU 8)
03103	01FEB1984	31DEC9999	Y	Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (D) (AU 8)
03104	01FEB1984	31DEC9999	Y	Repair of full thickness laceration of ear, eyelid or nose with accurate apposition of each layer of tissue (AU 10)
03106	01FEB1984	31DEC9999	Y	Dressing and removal of sutures requiring a general anaesthetic, not associated with any other item in this Part (AU 5)
03110	01FEB1984	31DEC9999	Y	Control of post-operative haemorrhage under general anaesthesia following perineal or vaginal operations (AU 6)
03113	01FEB1984	31DEC9999	Y	Superficial foreign body, removal of, as an independent procedure (AU 5)
03114	01FEB1984	31DEC9999	Y	Superficial foreign body, removal of, as an independent procedure (D) (AU 5)
03116	01FEB1984	31DEC9999	Y	Subcutaneous foreign body, removal of, requiring incision and suture, as an independent procedure (AU 6)
03117	01FEB1984	31DEC9999	Y	Subcutaneous foreign body, removal of, as an independent procedure (D) (AU 6)
03120	01FEB1984	31DEC9999	Y	Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (G) (AU 7)
03124	01FEB1984	31DEC9999	Y	Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (S) (AU 7)
03128	01FEB1984	31DEC9999	Y	Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (D) (AU 7)
03130	01FEB1984	31DEC9999	Y	Biopsy of skin or mucous membrane, as an independent procedure (AU 5)
03134	01FEB1984	31DEC9999	Y	Biopsy of skin or mucous membrane, as an independent procedure (D) (AU 5)
03135	01FEB1984	31DEC9999	Y	Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (G) (AU 6)
03142	01FEB1984	31DEC9999	Y	Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (S) (AU 6)
03147	01FEB1984	31DEC9999	Y	Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (D) (AU 6)
03148	01FEB1984	31AUG1989	N	Aspiration biopsy of lymph gland, deep tissue or organ, as an independent procedure (AU 5)
03148	01SEP1989	31DEC9999	Y	Drill biopsy of lymph gland, deep tissue or organ, as an independent procedure (AU 5)
03157	01FEB1984	31DEC9999	Y	Biopsy of bone marrow by trephine using an open approach (AU 5)
03158	01FEB1984	31DEC9999	Y	Biopsy of bone marrow by trephine using a percutaneous approach with a Jamshidi needle or similar device (AU 5)
03159	01MAY1990	31DEC9999	Y	BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S
03160	01FEB1984	31DEC9999	Y	Biopsy of bone marrow by aspiration or punch biopsy of synovial membrane or pleura (AU 5)
03161	01MAY1990	31DEC9999	Y	BIOPSY OF PLEURA, PERCUTANEOUS - one or more biopsies on anyone occasion ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S
03162	01AUG1988	31DEC9999	Y	Needle biopsy of vertebra (AU 8)
03168	01FEB1984	31DEC9999	Y	Scalene node biopsy (AU 5)
03173	01FEB1984	31DEC9999	Y	Sinus, excision of, involving superficial tissue only (AU 6)
03175	01FEB1984	31DEC9999	Y	Sinus, excision of, involving superficial tissue only (D) (AU 6)
03178	01FEB1984	31DEC9999	Y	Sinus, excision of, involving muscle and deep tissue (G) (AU 7)
03183	01FEB1984	31DEC9999	Y	Sinus, excision of, involving muscle and deep tissue (S) (AU 7)
03187	01FEB1984	31DEC9999	Y	Sinus, excision of, involving muscle and deep tissue (D) (AU 7)
03194	01FEB1984	31DEC9999	Y	Ganglion or small bursa, excision of (G) (AU 6)
03199	01FEB1984	31DEC9999	Y	Ganglion or small bursa, excision of (S) (AU 6)
03208	01FEB1984	31DEC9999	Y	Bursa (large), including olecranon, calcaneum or patella, excision of (G) (AU 6)
03213	01FEB1984	31DEC9999	Y	Bursa (large), including olecranon, calcaneum or patella, excision of (S) (AU 6)
03217	01FEB1984	31DEC9999	Y	Bursa, semimembranosus (Baker's cyst), excision of (AU 7)
03219	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3221, 3223, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 6)
03219	01MAR1984	31AUG1989	N	Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3221, 3223, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 6)
03219	01SEP1989	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3221, 3223, 3225, 3226 or 3349 (G) (AU 6)
03220	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3222, 3224, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 6)
03220	01MAR1984	31AUG1989	N	Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3222, 3224, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 6)
03220	01SEP1989	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3222, 3224, 3225, 3226 or 3349 (S) (AU 6)
03221	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 9)
03221	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 9)
03221	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by item 3349 (G) (AU 9)
03222	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 9)
03222	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 9)
03222	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by item 3349 (S) (AU 9)
03223	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 13)
03223	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 13)
03223	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by item 3349 (G) (AU 13)
03224	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 13)
03224	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 13)
03224	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by item 3349 (S) (AU 13)
03225	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 15)
03225	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 15)
03225	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by item 3349 (AU 15)
03226	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 17)
03226	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 17)
03226	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by item 3349 (AU 17)
03229	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3230 or 3331 (D) (AU 6)
03229	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3230 or 3331 (D) (AU 6)
03229	01SEP1989	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3230 (D) (AU 6)
03230	01FEB1984	29FEB1984	N	Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3331 (D) (AU 9)
03230	01MAR1984	31AUG1989	N	Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3331 (D) (AU 9)
03230	01SEP1989	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions (D) (AU 9)
03233	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (G) (AU 6)
03233	01MAR1984	31DEC9999	Y	Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (G) (AU 6)
03237	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (S) (AU 6)
03237	01MAR1984	31DEC9999	Y	Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (S) (AU 6)
03245	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (D) (AU 6)
03245	01MAR1984	31DEC9999	Y	Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (D) (AU 6)
03247	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (G) (AU 8)
03247	01MAR1984	31DEC9999	Y	Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (G)(AU 8)
03253	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (S) (AU 8)
03253	01MAR1984	31DEC9999	Y	Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (S)(AU 8)
03258	01FEB1984	29FEB1984	N	Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (D) (AU 8)
03258	01MAR1984	31DEC9999	Y	Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (D)(AU 8)
03261	01FEB1984	29FEB1984	N	Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (G) (AU 8)
03261	01MAR1984	31DEC9999	Y	Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (G) (AU 8)
03265	01FEB1984	29FEB1984	N	Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (S) (AU 8)
03265	01MAR1984	31DEC9999	Y	Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (S) (AU 8)
03268	01FEB1984	29FEB1984	N	Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (D) (AU 8)
03268	01MAR1984	31DEC9999	Y	Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (D) (AU 8)
03271	01FEB1984	29FEB1984	N	Malignant tumour, removal of, from skin, requiring wide and deep excision (AU 8)
03271	01MAR1984	31DEC9999	Y	Malignant tumour, removal of, from skin, requiring wide and deep excision, other than removal of basal cell carcinoma(AU 8)
03276	01FEB1984	31DEC9999	Y	Malignant tumour, removal of, from skin, requiring wide and deep excision with immediate block dissection of lymph glands (AU 13)
03281	01FEB1984	31DEC9999	Y	Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin graft (AU 8)
03284	01FEB1984	31DEC9999	Y	Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin graft (D) (AU 8)
03289	01FEB1984	31DEC9999	Y	Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin graft (AU 10)
03290	01FEB1984	31DEC9999	Y	Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin graft (D) (AU 10)
03295	01FEB1984	31DEC9999	Y	Malignant tumour, removal of, from any region involving a radical operation (not being an operation covered by any other item in this Part) (AU 13)
03301	01FEB1984	29FEB1984	N	Malignant tumour, removal of, from any region involving a limited operation (not being an operation covered by any other item in this Part) (AU 8)
03301	01MAR1984	31DEC9999	Y	Malignant tumour, removal of, from any region involving a limited operation, other than removal of basal cell carcinoma(not being an operation covered by any other item in this Part) (AU 8)
03306	01FEB1984	31DEC9999	Y	Lipectomy-- transverse wedge excision of abdominal apron (AU 10)
03307	01FEB1984	31DEC9999	Y	Lipectomy-- wedge excision of skin or fat not covered by Item 3306-- one excision (AU 10)
03308	01FEB1984	31AUG1989	N	Lipectomy-- wedge excision of skin or fat not covered by Item 3306-- two or more excisions (AU 10)
03308	01SEP1989	31DEC9999	Y	Lipectomy-wedge excision of skin or fat not covered by item 3306-two or more excisions (AU 12)
03310	01FEB1984	31DEC9999	Y	Lipectomy-- subumbilical excision with undermining of skin edges and strengthening of musculo-aponeurotic wall (AU 12)
03311	01FEB1984	31DEC9999	Y	Lipectomy-- radical abdominoplasty (Pitanguy type or similar) with excision of skin and subcutaneous tissue, repair of musculo-aponeurotic layer and transposition of umbilicus (AU 18)
03314	01FEB1984	31DEC9999	Y	Axillary hyperidrosis, wedge excision for (AU 7)
03315	01NOV1986	31AUG1989	N	AXILLARY HYPERHIDROSIS, total excision of sweat gland bearing area ANAESTHETIC 10 UNITS-ITEM NOS 450G/521S
03315	01SEP1989	31DEC9999	Y	Axillary hyperhidrosis, total excision of sweat gland bearing area (AU 10)
03320	01FEB1984	31DEC9999	Y	Plantar wart, removal of (AU 5)
03330	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on not more than 5 lesions (including any associated consultation) (AU 4)
03331	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on not more than 5 lesions (including any associated consultation) (D) (AU 4)
03332	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 5 but not more than 10 lesions (including any associated consultation) (AU 5)
03338	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 10 but not more than 15 lesions (including any associated consultation) (AU 6)
03342	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 15 but not more than 20 lesions (including any associated consultation) (AU 7)
03346	01FEB1984	31DEC9999	Y	Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 20 lesions (including any associated consultation) (AU 8)
03347	01AUG1988	31DEC9999	Y	Warts, removal of, by any method (other than by chemical means) under general anaesthesia or under a regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day hospital facility, not associated with any other item in this Part (AU 6)
03348	01NOV1990	31DEC9999	Y	Premalignant skin lesions, treatment of, by galvanocautery or electrodesiccation or cryocautery (10 or more lesions) (AU 4)
03349	01FEB1984	31DEC9999	Y	Cutaneous neoplastic lesions, treatment by electrosurgical destruction, chemotherapy, simple curettage or shaving-- one or more lesions (AU 4)
03350	01FEB1984	31DEC9999	Y	Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349) (AU 6)
03351	01FEB1984	31DEC9999	Y	Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349)-- more than 3 but not more than 10 lesions (AU 9)
03352	01FEB1984	31DEC9999	Y	Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349)-more than 10 lesions (AU 13)
03356	01FEB1984	31DEC9999	Y	Skin lesions, multiple injections with hydrocortisone or similar preparations
03363	01FEB1984	31DEC9999	Y	Keloid, extensive, multiple injections of hydrocortisone or similar preparations under general anaesthesia (AU 5)
03366	01FEB1984	31DEC9999	Y	Haematoma, aspiration of (AU 4)
03371	01FEB1984	31DEC9999	Y	Haematoma, furuncle, small abscess or similar lesion not requiring a general anaesthetic, incision with drainage of (excluding after-care)
03379	01FEB1984	31DEC9999	Y	Large haematoma, large abscess, (including ischio-rectal abscess), carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (G) (AU 5)
03384	01FEB1984	31DEC9999	Y	Large haematoma, large abscess, (including ischio-rectal abscess), carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (S) (AU 5)
03386	01FEB1984	31DEC9999	Y	Large haematoma, large abscess, carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (D) (AU 5)
03391	01FEB1984	31AUG1989	N	Muscle, excision of (limited) (AU 6)
03391	01SEP1989	31DEC9999	Y	Muscle, excision of (limited) or fasciotomy (AU 6)
03393	01FEB1984	31DEC9999	Y	Muscle, excision of (limited) (D) (AU 6)
03399	01FEB1984	31DEC9999	Y	Muscle, excision of (extensive) (AU 7)
03400	01FEB1984	31DEC9999	Y	Muscle, excision of (extensive) (D) (AU 7)
03404	01FEB1984	31DEC9999	Y	Muscle, ruptured, repair of (limited) , not associated with external wound (AU 7)
03407	01FEB1984	31DEC9999	Y	Muscle, ruptured, repair of (extensive) , not associated with external wound (AU 7)
03417	01FEB1984	31DEC9999	Y	Fascia, deep, repair of, for herniated muscle (AU 7)
03425	01FEB1984	31DEC9999	Y	Bone tumour, innocent, excision of, not covered by any other item in this Part (AU 7)
03427	01FEB1984	31DEC9999	Y	Bone tumour, innocent, excision of, not covered by any other item in this Part (D) (AU 7)
03431	01FEB1984	31DEC9999	Y	Styloid process of temporal bone, removal of (AU 7)
03437	01FEB1984	31DEC9999	Y	Parotid gland, total extirpation of (AU 15)
03444	01FEB1984	31DEC9999	Y	Parotid gland, total extirpation of with preservation of facial nerve (AU 18)
03450	01FEB1984	31DEC9999	Y	Parotid gland, superficial lobectomy or removal of tumour from, with exposure of facial nerve (AU 14)
03455	01FEB1984	31DEC9999	Y	Submandibular gland, extirpation of (AU 8)
03456	01FEB1984	31DEC9999	Y	Submandibular gland, extirpation of (D) (AU 8)
03459	01FEB1984	31DEC9999	Y	Sublingual gland, extirpation of (AU 7)
03462	01FEB1984	31DEC9999	Y	Sublingual gland, extirpation of (D) (AU 7)
03465	01FEB1984	31DEC9999	Y	Salivary gland, dilatation or diathermy of duct (AU 6)
03466	01FEB1984	31DEC9999	Y	Salivary gland, dilatation or diathermy of duct (D) (AU 6)
03468	01FEB1984	31AUG1989	N	Salivary gland, removal of calculus from duct (G) (AU 7)
03468	01SEP1989	31DEC9999	Y	Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one more such procedures (G) (AU 7)
03472	01FEB1984	31AUG1989	N	Salivary gland, removal of calculus from duct (S) (AU 7)
03472	01SEP1989	31DEC9999	Y	Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one or more such procedures (S) (AU 7)
03475	01FEB1984	31AUG1989	N	Salivary gland, removal of calculus from duct (D) (AU 7)
03475	01SEP1989	31DEC9999	Y	Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one or more such procedures (D) (AU 7)
03477	01FEB1984	31DEC9999	Y	Salivary gland, repair of cutaneous fistula of (AU 7)
03480	01FEB1984	31DEC9999	Y	Tongue, partial excision of (AU 7)
03483	01FEB1984	31DEC9999	Y	Tongue, partial excision of (D) (AU 7)
03495	01FEB1984	31DEC9999	Y	Radical excision of intra-oral tumour involving resection of mandible and lymph glands of neck (commando-type operation) (AU 18)
03496	01FEB1984	31DEC9999	Y	Tongue tie, repair of, not covered by any other item in this Part (AU 6)
03500	01FEB1984	31DEC9999	Y	Tongue tie, repair of, not covered by any other item in this Part (D) (AU 6)
03505	01FEB1984	31AUG1989	N	Tongue tie or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (AU 6)
03505	01SEP1989	31DEC9999	Y	Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (AU 6)
03507	01FEB1984	31AUG1989	N	Tongue tie or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (D) (AU 6)
03507	01SEP1989	31DEC9999	Y	Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (D) (AU 6)
03509	01FEB1984	31DEC9999	Y	Ranula or mucous cyst of mouth, removal of (G) (AU 9)
03516	01FEB1984	31DEC9999	Y	Ranula or mucous cyst of mouth, removal of (S) (AU 9)
03521	01FEB1984	31DEC9999	Y	Ranula or mucous cyst of mouth, removal of (D) (AU 9)
03526	01FEB1984	31DEC9999	Y	Branchial cyst, removal of (AU 9)
03530	01FEB1984	31DEC9999	Y	Branchial fistula, removal of (AU 9)
03532	01FEB1984	31DEC9999	Y	Cystic hygroma, removal of massive lesion requiring extensive excision-- with or without thoracotomy (AU 11)
03542	01FEB1984	31AUG1989	N	Thyroidectomy, total (AU 14)
03542	01SEP1989	31DEC9999	Y	Thyroidectomy, total or thyroidectomy following previous hemithyroidectomy or following previous unilateral or bilateral sub-total thyroidectomy (AU 14)
03547	01FEB1984	31DEC9999	Y	Parathyroid tumour, removal of (AU 13)
03555	01FEB1984	31DEC9999	Y	Parathyroid glands, removal of, other than for tumour (AU 16)
03557	01AUG1987	31AUG1989	N	CERVICAL RE-EXPLORATION for recurrent or persistent hyperparathyroidism ANAESTHETIC 20 UNITS-ITEM NOS 464G/533S
03557	01SEP1989	31DEC9999	Y	Cervical re-exploration for recurrent or persistent hyperparathyroidism (AU 20)
03560	01DEC1991	31DEC9999	Y	[Unidentified item]
03563	01FEB1984	31AUG1989	N	Hemithyroidectomy or sub-total thyroidectomy with or without exposure of recurrent laryngeal nerve (AU 12)
03563	01SEP1989	31DEC9999	Y	Total hemithyroidectomy or bilateral sub-total thyroidectomy, with or without exposure of recurrent laryngeal nerve (AU 12)
03576	01FEB1984	31AUG1989	N	Thyroid, excision of localized tumour of (AU 10)
03576	01SEP1989	31DEC9999	Y	Thyroid, excision of localised tumour of, or unilateral sub-total thyroidectomy (AU 10)
03581	01FEB1984	31DEC9999	Y	Thyroglossal cyst, removal of (AU 10)
03591	01FEB1984	31DEC9999	Y	Thyroglossal cyst and fistula, removal of (AU 10)
03597	01FEB1984	31DEC9999	Y	Cervical oesophagostomy; or closure of cervical oesophagostomy with or without plastic repair (AU 13)
03616	01FEB1984	31DEC9999	Y	Cervical oesophagectomy with tracheostomy and oesophagostomy, with or without plastic reconstruction; or laryngopharyngectomy with tracheostomy and plastic reconstruction (AU 22)
03618	01FEB1984	31DEC9999	Y	Lymph glands of neck, limited excision of (AU 9)
03622	01FEB1984	31DEC9999	Y	Lymph glands of neck, radical excision of (AU 20)
03634	01FEB1984	31DEC9999	Y	Lymph glands of groin or axilla, limited excision of (AU 9)
03638	01FEB1984	31DEC9999	Y	Lymph glands of groin or axilla, radical excision of (AU 13)
03647	01FEB1984	31DEC9999	Y	Simple mastectomy with or without frozen section biopsy (G) (AU 9)
03652	01FEB1984	31DEC9999	Y	Simple mastectomy with or without frozen section biopsy (S) (AU 9)
03654	01FEB1984	31DEC9999	Y	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason (G) (AU 7)
03664	01FEB1984	31DEC9999	Y	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason (S) (AU 7)
03668	01FEB1984	31AUG1989	N	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed (G) (AU 8)
03668	01SEP1989	31DEC9999	Y	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used (G) (AU 8)
03673	01FEB1984	31AUG1989	N	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed (S) (AU 8)
03673	01SEP1989	31DEC9999	Y	Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used (S) (AU 8)
03678	01FEB1984	31DEC9999	Y	Partial mastectomy involving more than one quarter of the breast tissue with or without frozen section biopsy (G) (AU 8)
03683	01FEB1984	31DEC9999	Y	Partial mastectomy involving more than one quarter of the breast tissue with or without frozen section biopsy (S) (AU 8)
03698	01FEB1984	31DEC9999	Y	Breast, extended simple mastectomy with or without frozen section biopsy (AU 12)
03700	01FEB1984	31DEC9999	Y	Subcutaneous mastectomy with or without frozen section biopsy (AU 12)
03702	01FEB1984	31DEC9999	Y	Breast, radical or modified radical mastectomy with or without frozen section biopsy (AU 16)
03707	01FEB1984	31DEC9999	Y	Nipple, inverted, surgical eversion of (AU 7)
03713	01FEB1984	31DEC9999	Y	Laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed (G) (AU 9)
03718	01FEB1984	31DEC9999	Y	Laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed (S) (AU 9)
03719	01NOV1990	31DEC9999	Y	Liver biopsy by wedge excision when performed in association with another intra-abdominal procedure (AU 11)
03722	01FEB1984	31AUG1989	N	Laparotomy involving caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel's diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus or pyloroplasty (adult) (AU 11)
03722	01SEP1989	31DEC9999	Y	Laparotomy involving caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel's diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus, pyloroplasty (adult) or drainage of pancreas (AU 11)
03726	01FEB1984	31DEC9999	Y	Laparotomy involving division of peritoneal adhesions (where no other listed intra abdominal procedure is performed) (AU 11)
03727	01NOV1990	31DEC9999	Y	Laparotomy involving division of adhesions in association with another intra-abdominal procedure where the time taken to divide the adhesions exceeds 45 minutes (AU 14)
03728	01NOV1990	31DEC9999	Y	Laparotomy with division of extensive adhesions (duration greater than 2 hours) with or without insertion of long intestinal tube (AU 20)
03730	01FEB1984	31DEC9999	Y	Laparotomy for grading of lymphoma, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy (AU 14)
03734	01FEB1984	31DEC9999	Y	Laparotomy for control of postoperative haemorrhage, where no other procedure is performed (AU 11)
03739	01FEB1984	31DEC9999	Y	Laparotomy involving operation on abdominal viscera, not covered by any other item in this Part (G) (AU 12)
03745	01FEB1984	31DEC9999	Y	Laparotomy involving operation on abdominal viscera, not covered by any other item in this Part (S) (AU 12)
03750	01FEB1984	31DEC9999	Y	Subphrenic abscess, drainage of (AU 10)
03752	01FEB1984	31DEC9999	Y	Liver biopsy, percutaneous (AU 6)
03754	01FEB1984	31DEC9999	Y	Liver tumour, removal of other than by biopsy (AU 13)
03759	01FEB1984	31DEC9999	Y	Liver, massive resection of or lobectomy (AU 18)
03764	01FEB1984	31DEC9999	Y	Liver abscess, abdominal drainage of (AU 11)
03783	01FEB1984	31DEC9999	Y	Hydatid cyst of liver, peritoneum or viscus, drainage procedure for (AU 11)
03789	01FEB1984	31DEC9999	Y	Operative cholangiography (including one or more cholegrams performed during the one operation) or operative pancreatography (AU 10)
03793	01FEB1984	31DEC9999	Y	Cholecystectomy (G) (AU 11)
03798	01FEB1984	31DEC9999	Y	Cholecystectomy (S) (AU 11)
03818	01NOV1984	31DEC9999	Y	Choledochoscopy (AU 7)
03820	01FEB1984	31DEC9999	Y	Choledochotomy (with or without cholecystectomy), including dilatation of sphincter of Oddi and removal of calculi (AU 13)
03822	01FEB1984	31DEC9999	Y	Choledochotomy (with or without cholecystectomy), including dilatation of sphincter of Oddi and removal of calculi with choledochoduodenostomy, choledochogastrostomy or choledochoenterostomy (AU 18)
03825	01FEB1984	31DEC9999	Y	Transduodenal operation on sphincter of Oddi, including dilatation, removal of calculi, sphincterotomy and sphincteroplasty with or without choledochotomy, with or without cholecystectomy (AU 15)
03831	01FEB1984	31DEC9999	Y	Cholecystoduodenostomy, cholecystogastrostomy or cholecystoenterostomy with or without enteroenterostomy (AU 15)
03834	01FEB1984	31DEC9999	Y	Operation for reconstruction of hepatic duct or common bile duct for correction of strictures or atresia including all necessary anastomoses, not associated with Item 3793, 3798, 3820, 3822, 3825 or 3831 (AU 19)
03847	01FEB1984	31AUG1989	N	Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) (AU 6)
03847	01SEP1989	31DEC9999	Y	Oesophagoscopy (not covered by item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with or without biopsy (AU 6)
03849	01FEB1984	31AUG1989	N	Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with biopsy or with endoscopic sclerosing injection of oesophageal or gastric varices (AU 7)
03849	01SEP1989	31DEC9999	Y	Oesophagoscopy (not covered by item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with endoscopic sclerosing injection of oesophageal or gastric varices (AU 7)
03851	01FEB1984	29FEB1984	N	Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with polypectomy, with or without removal of foreign body, with or without diathermy coagulation of bleeding oesophageal, gastric or duodenal lesions (AU 7)
03851	01MAR1984	31DEC9999	Y	Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy(one or more such procedures) with one or more of the following procedures - polypectomy, removal of foreign body, diathermy coagulation of bleeding upper gastrointestinal lesions (AU 7)
03853	01NOV1990	31DEC9999	Y	Oesophageal prosthesis, insertion of, including endoscopy and dilatation (AU 9)
03860	01FEB1984	31DEC9999	Y	Endoscopic pancreatocholangiography (AU 8)
03862	01FEB1984	31DEC9999	Y	Endoscopic sphincterotomy with or without extraction of stones from common bile duct (AU 8)
03864	01NOV1990	31DEC9999	Y	Biliary manometry (AU 9)
03866	01NOV1990	31DEC9999	Y	Endoscopic biliary dilatation (AU 11)
03867	01NOV1990	31DEC9999	Y	Bile duct, endoscopic stenting of (including endoscopy and dilatation) (AU 11)
03868	01NOV1990	31DEC9999	Y	Percutaneous endoscopic gastrostomy (initial procedure) (AU 10)
03869	01NOV1990	31DEC9999	Y	Percutaneous endoscopic gastrostomy (repeat procedure) (AU 10)
03870	01NOV1990	31DEC9999	Y	Endoscopic laser therapy for malignancy of upper or lower gastrointestinal tract (AU 12)
03875	01FEB1984	31DEC9999	Y	Vagotomy-- trunkal (AU 11)
03882	01FEB1984	31DEC9999	Y	Vagotomy-- selective (AU 12)
03889	01FEB1984	31DEC9999	Y	Vagotomy, highly selective; or vagotomy, trunkal or selective, with pyloroplasty or gastroenterostomy (AU 13)
03891	01FEB1984	31AUG1989	N	Vagotomy, highly selective with pyloroplasty or gastroenterostomy (AU 13)
03891	01SEP1989	31DEC9999	Y	Vagotomy, highly selective, with pyloroplasty, gastroenterostomy or dilatation of pylorus (AU 13)
03892	01FEB1984	31DEC9999	Y	Gastric reduction or gastroplasty for obesity, by any method (AU 13)
03893	01FEB1984	31DEC9999	Y	Gastric by-pass for obesity, including an anastomosis, by any method (AU 21)
03894	01FEB1984	31DEC9999	Y	Gastro-enterostomy (including gastroduodenostomy) or enterocolostomy or entero-enterostomy (G) (AU 12)
03898	01FEB1984	31DEC9999	Y	Gastro-enterostomy (including gastroduodenostomy) or enterocolostomy or entero-enterostomy (S) (AU 12)
03900	01FEB1984	31DEC9999	Y	Gastro-enterostomy or gastroduodenostomy, reconstruction of (AU 14)
03902	01FEB1984	31DEC9999	Y	Pancreatic cyst-anastomosis to stomach or duodenum (AU 13)
03922	01FEB1984	31DEC9999	Y	Partial gastrectomy, with or without gastro-jejunostomy (AU 15)
03930	01FEB1984	31DEC9999	Y	Gastrectomy, total, for benign disease (AU 19)
03937	01NOV1986	31AUG1989	N	GASTRECTOMY, RADICAL SUB-TOTAL, for carcinoma ANAESTHETIC 19 UNITS-ITEM NOS 463G/531S
03937	01SEP1989	31DEC9999	Y	Gastrectomy, sub-total radical, for carcinoma (AU 19)
03938	01FEB1984	31DEC9999	Y	Gastrectomy, total radical, for carcinoma (AU 21)
03952	01FEB1984	31DEC9999	Y	Pyloroplasty, infant or pyloromyotomy (Ramstedt's operation) (AU 9)
03976	01FEB1984	31DEC9999	Y	Enterostomy or colostomy, extraperitoneal closure of (G) (AU 11)
03981	01FEB1984	31DEC9999	Y	Enterostomy or colostomy, extraperitoneal closure of (S) (AU 11)
03986	01FEB1984	31DEC9999	Y	Enterostomy or colostomy, intraperitoneal closure, not involving resection (AU 11)
03988	01SEP1989	31DEC9999	Y	Colostomy, refashioning of (AU 10)
04001	01NOV2006	31DEC2013	N	MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF NON-DIRECTIVE PREGNANCY SUPPORT COUNSELLING SERVICES Professional attendance for the purpose of providing non-directive pregnancy support counselling to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 20 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may not be provided by a medical practitioner who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of 3 non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 4001, 81000, 81005 and 81010 (see Explanatory note M.8). SURGERY CONSULTATION (professional attendance at consulting rooms)
04001	01JAN2014	30JUN2018	N	Professional attendance of at least 20 minutes in duration at consulting rooms by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 81000, 81005 or 81010 applies in relation to that pregnancy Note: For items 81000, 81005 and 81010, see the determination about allied health services under subsection 3C(1) of the Act.
04001	01JUL2018	30JUN2021	N	Professional attendance of at least 20 minutes in duration at consulting rooms by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 81000, 81005 or 81010 applies in relation to that pregnancy Note: For items 81000, 81005 and 81010, see the determination about allied health services under subsection 3C(1) of the Act.
04001	01JUL2021	31DEC9999	Y	Professional attendance of at least 20 minutes in duration at consulting rooms by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a patient who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 81000, 81005 or 81010 applies in relation to that pregnancy Note: For items 81000, 81005 and 81010, see the determination about allied health services under subsection 3C(1) of the Act.
04003	01FEB1984	31DEC9999	Y	Intussusception, reduction of, by fluid
04012	01FEB1984	31DEC9999	Y	Intussusception, laparotomy and resection of (AU 14)
04018	01FEB1984	31DEC9999	Y	Transverse or sigmoid colectomy with or without anastomosis (AU 15)
04038	01NOV1990	31DEC9999	Y	Small intestine, resection of, without anastomosis (including formation of stoma) (AU 17)
04039	01FEB1984	31DEC9999	Y	Bowel, segmental resection of, with or without anastomosis, not covered by any other item in this Part (G) (AU 15)
04042	01NOV1990	31DEC9999	Y	Small intestine, resection of, with anastomosis (AU 18)
04043	01FEB1984	31DEC9999	Y	Bowel, segmental resection of, with or without anastomosis, not covered by any other item in this Part (S) (AU 15)
04044	01NOV1990	31DEC9999	Y	Large intestine, resection of, without anastomosis, including right hemicolectomy (including formation of stoma) (AU 18)
04045	01NOV1990	31DEC9999	Y	Large intestine, resection of, with anastomosis, including right hemicolectomy (AU 20)
04046	01FEB1984	31DEC9999	Y	Hemicolectomy, right or left (AU 15)
04047	01NOV1990	31DEC9999	Y	Total colectomy and ileostomy (AU 22)
04048	01FEB1984	31DEC9999	Y	Total colectomy with ileo-rectal anastomosis or ileostomy (AU 20)
04052	01FEB1984	31DEC9999	Y	Total colectomy with excision of rectum and ileostomy-one surgeon (AU 20)
04054	01FEB1984	31DEC9999	Y	Total colectomy with excision of rectum and ileostomy, combined synchronous operation; abdominal resection (including after-care) (AU 17)
04059	01FEB1984	31DEC9999	Y	Total colectomy with excision of rectum and ileostomy, combined synchronous operation; perineal resection
04065	01NOV1990	31DEC9999	Y	Rectum, high restorative anterior resection with intraperitoneal anastomosis (of the rectum) greater than 10 centimetres from the anal verge - excluding resection of sigmoid colon alone (AU 22)
04067	01NOV1990	31DEC9999	Y	Rectum, low restorative anterior resection with extraperitoneal anastomosis (of the rectum) less than 10 centimetres from the anal verge (AU 26)
04068	01FEB1984	31DEC9999	Y	Rectum, restorative anterior resection of, with rectosigmoidectomy (AU 16)
04070	01SEP1989	31DEC9999	Y	Rectosigmoidectomy, anterior (Hartman's operation) (AU 15)
04071	01SEP1989	31DEC9999	Y	Restoration of bowel continuity following Hartman's procedure, including dismantling of colostomy (AU 15)
04074	01FEB1984	31DEC9999	Y	Appendicectomy, not covered by Item 4084 (G) (AU 8)
04080	01FEB1984	31DEC9999	Y	Appendicectomy, not covered by Item 4084 (S) (AU 8)
04084	01FEB1984	31DEC9999	Y	Appendicectomy, when performed in conjunction with any other intra-abdominal procedure and through the same incision (AU 5)
04087	01FEB1984	31AUG1989	N	Drainage of appendiceal abscess or for ruptured appendix or for peritonitis with or without appendicectomy (G) (AU 10)
04087	01SEP1989	31DEC9999	Y	Laparotomy for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause-with or without appendicectomy (G) (AU 10)
04093	01FEB1984	31AUG1989	N	Drainage of appendiceal abscess or for ruptured appendix or for peritonitis with or without appendicectomy (S) (AU 10)
04093	01SEP1989	31DEC9999	Y	Laparotomy for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause-with or without appendicectomy (S) (AU 10)
04099	01FEB1984	31DEC9999	Y	Small bowel intubation with biopsy
04104	01FEB1984	31DEC9999	Y	Small bowel intubation, as an independent procedure
04109	01FEB1984	31DEC9999	Y	Pancreatectomy, partial (AU 15)
04115	01FEB1984	31DEC9999	Y	Pancreatico-duodenectomy, Whipple's operation (AU 30)
04130	01NOV1979	31DEC9999	Y	Pancreas, drainage of (AU 11)
04131	01JAN1986	31AUG1989	N	PANCREATIC ABSCESS, drainage of, excluding after-care ANAESTHETIC 11 UNITS - ITEM NOS 453G / 522S
04131	01SEP1989	31DEC9999	Y	Pancreatic abscess, drainage of, excluding after-care (AU 11)
04133	01FEB1984	31DEC9999	Y	Anastomosis of pancreatic duct to bowel (AU 18)
04139	01JAN1986	31AUG1989	N	SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S
04139	01SEP1989	31DEC9999	Y	Splenorrhaphy or partial splenectomy for trauma (AU 13)
04141	01FEB1984	31DEC9999	Y	Splenectomy for trauma (AU 13)
04144	01FEB1984	31DEC9999	Y	Splenectomy, other than for trauma (AU 13)
04165	01FEB1984	31DEC9999	Y	Multiple ruptured viscera (including liver, kidney, spleen or hollow viscus) major repair or removal of (AU 18)
04173	01FEB1984	31DEC9999	Y	Retroperitoneal tumour, removal of (AU 15)
04179	01FEB1984	31DEC9999	Y	Sacrococcygeal and presacral tumour-- excision of (AU 13)
04185	01FEB1984	31DEC9999	Y	Retroperitoneal abscess, drainage of, not involving laparotomy (AU 9)
04191	01NOV1979	31DEC9999	Y	Peritoneoscopy (AU 6)
04192	01NOV1984	31DEC9999	Y	Laparoscopy, diagnostic (AU 7)
04193	01NOV1984	31DEC9999	Y	Laparoscopy, with biopsy (AU 7)
04194	01NOV1984	31DEC9999	Y	Laparoscopy, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedure-one or more procedures with or without biopsy-not associated with item 4193, 6611 or 6612 (AU 7)
04197	01FEB1984	31DEC9999	Y	Paracentesis abdominis
04202	01FEB1984	31DEC9999	Y	Rectum and anus, abdomino-perineal resection of-- one surgeon (AU 17)
04209	01FEB1984	31DEC9999	Y	Rectum and anus, abdomino-perineal resection of, combined synchronous operation-- abdominal resection (AU 16)
04214	01FEB1984	31DEC9999	Y	Rectum and anus, abdomino-perineal resection of, combined synchronous operation-- perineal resection
04217	01FEB1984	31DEC9999	Y	Abdomino-perineal pull through resection with colo-anal anastomosis (one or two stages), including associated colostomy (AU 30)
04218	01NOV1990	31DEC9999	Y	Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy - one surgeon (AU 36)
04219	01NOV1990	31DEC9999	Y	Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy - conjoint surgery, abdominal surgeon (including aftercare) (AU 30)
04220	01NOV1990	31DEC9999	Y	Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir - conjoint surgery, perineal surgeon
04222	01FEB1984	31DEC9999	Y	Femoral or inguinal hernia or infantile hydrocele, repair of, not covered by Item 4233, 4258 or 4262 (G) (AU 8)
04227	01FEB1984	31DEC9999	Y	Femoral or inguinal hernia or infantile hydrocele, repair of, not covered by Item 4233, 4258 or 4262 (S) (AU 8)
04228	01NOV1990	31DEC9999	Y	Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - one surgeon (AU 30)
04229	01NOV1990	31DEC9999	Y	Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - conjoint surgery, abdominal surgeon (including aftercare) (AU 26)
04230	01NOV1990	31DEC9999	Y	Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - conjoint surgery, perineal surgeon
04231	01NOV1990	31DEC9999	Y	Ileostomy reservoir, continent type, creation of, including conversion of existing ileostomy where appropriate (AU 30)
04233	01FEB1984	31DEC9999	Y	Strangulated, incarcerated or obstructed hernia, repair of, without bowel resection (AU 10)
04238	01FEB1984	31DEC9999	Y	Diaphragmatic hernia, traumatic, repair of (AU 17)
04241	01FEB1984	31AUG1989	N	Diaphragmatic hernia, other than traumatic, repair of (abdominal approach) (AU 14)
04241	01SEP1989	31DEC9999	Y	Diaphragmatic hernia, congential, repair of, by thoracic or adbominal approach) (AU 14)
04242	01NOV1984	31DEC9999	Y	Antireflux operation involving insertion of prosthetic device-not associated with Item 4241, 4243, 4244 or 4245 (AU 11)
04243	01NOV1984	31DEC9999	Y	Antireflux operation by fundoplasty via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus-not covered by item 4241 or 4242 (AU 18)
04244	01DEC1984	31DEC9999	Y	Oesophagogastric myotomy (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus (AU 17)
04245	01DEC1984	31DEC9999	Y	Oesophagogastric myotomy (Heller's operation) via abdominal or thoracic approach, with fundoplasty, with or without closure of the diaphragmatic hiatus (AU 18)
04246	01FEB1984	31DEC9999	Y	Umbilical, epigastric or linea alba hernia, repair of, in a person under ten years of age (G) (AU 8)
04249	01FEB1984	31DEC9999	Y	Umbilical, epigastric or linea alba hernia, repair of, in a person under ten years of age (S) (AU 8)
04251	01FEB1984	31DEC9999	Y	Umbilical, epigastric or linea alba hernia, repair of, in a person ten years of age or over (G) (AU 8)
04254	01FEB1984	31DEC9999	Y	Umbilical, epigastric or linea alba hernia, repair of, in a person ten years of age or over (S) (AU 8)
04258	01FEB1984	31DEC9999	Y	Ventral, incisional, lumbar or recurrent hernia or burst abdomen, repair of (G) (AU 10)
04262	01FEB1984	31DEC9999	Y	Ventral, incisional, lumbar or recurrent hernia or burst abdomen, repair of (S) (AU 10)
04265	01FEB1984	31DEC9999	Y	Hydrocele, tapping of
04266	01SEP1989	31DEC9999	Y	Hydrocele, removal of (AU 7)
04269	01FEB1984	31AUG1989	N	Varicocele or hydrocele, removal of (G) (AU 7)
04269	01SEP1989	31DEC9999	Y	Varicocele, surgical correction of when not associated with items 4288, 4293 and 4296, one procedure (G) (AU 7)
04273	01FEB1984	31AUG1989	N	Varicocele or hydrocele, removal of (S) (AU 7)
04273	01SEP1989	31DEC9999	Y	Varicocele, surgical correction of when not associated with items 4288, 4293 and 4296 one procedure (S) (AU 7)
04288	01FEB1984	31AUG1989	N	Orchidectomy (simple) (G) (AU 7)
04288	01SEP1989	31DEC9999	Y	Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (G) (AU 7)
04293	01FEB1984	31AUG1989	N	Orchidectomy (simple) (S) (AU 7)
04293	01SEP1989	31DEC9999	Y	Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (S) (AU 7)
04296	01FEB1984	31AUG1989	N	Orchidectomy and complete excision of spermatic cord (AU 8)
04296	01SEP1989	31DEC9999	Y	Exploration of spermatic cord, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis (AU 8)
04307	01FEB1984	31DEC9999	Y	Undescended testis, orchidopexy or transplantation of, with or without associated hernial repair (AU 8)
04313	01FEB1984	31DEC9999	Y	Secondary detachment of testis from thigh (AU 6)
04319	01FEB1984	31AUG1989	N	Circumcision of a person under four weeks of age (AU 6)
04319	01SEP1989	31DEC9999	Y	Circumcision of a person under six months of age, where medically indicated (AU 6)
04327	01FEB1984	31AUG1989	N	Circumcision of a person under ten years of age but not less than four weeks of age (AU 6)
04327	01SEP1989	31DEC9999	Y	Circumcision of a person under ten years of age but not less than six months of age (AU 6)
04338	01FEB1984	31DEC9999	Y	Circumcision of a person ten years of age or over (G) (AU 6)
04345	01FEB1984	31DEC9999	Y	Circumcision of a person ten years of age or over (S) (AU 6)
04351	01FEB1984	31AUG1989	N	Paraphimosis, reduction of, under anaesthesia, with or without dorsal incision, not associated with any other item in this Part (AU 5)
04351	01SEP1989	31DEC9999	Y	Paraphimosis, reduction of, under general anaesthesia, with or without dorsal incision, not associated with any other item in this Part (AU 5)
04354	01FEB1984	31DEC9999	Y	Sigmoidoscopic examination (with rigid sigmoidoscope), with or without biopsy
04363	01FEB1984	31DEC9999	Y	Sigmoidoscopic examination (with rigid sigmoidoscope), under general anaesthesia, with or without biopsy, not associated with any other item in this Part (AU 5)
04365	01NOV1990	31DEC9999	Y	Sigmoidoscopic examination with diathermy or resection of one or more polyps where the time taken is less than or equal to 45 minutes (AU 7)
04366	01FEB1984	31DEC9999	Y	Sigmoidoscopic examination with diathermy or resection of one or more rectal polyps or tumours (G) (AU 7)
04367	01FEB1984	31DEC9999	Y	Sigmoidoscopic examination with diathermy or resection of one or more rectal polyps or tumours (S) (AU 7)
04368	01NOV1990	31DEC9999	Y	Sigmoidoscopic examination with diathermy or resection of one or more polyps where the time taken is greater than 45 minutes (AU 10)
04380	01FEB1984	31DEC9999	Y	Full or partial thickness rectal biopsy under general anaesthesia (AU 6)
04383	01FEB1984	31AUG1989	N	Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure (AU 6)
04383	01SEP1989	31DEC9999	Y	Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to hepatic flexure, with or without biopsy (AU 6)
04385	01NOV1979	31DEC9999	Y	Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure, with biopsy (AU 7)
04386	01FEB1984	31AUG1989	N	Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure, with removal of one or more colonic polyps, not covered by Item 4366 or 4367 (AU 8)
04386	01SEP1989	31DEC9999	Y	Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure with removal of one or more polyps, not covered by item 4366 or 4367 (AU 8)
04388	01FEB1984	29FEB1984	N	Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure (AU 8)
04388	01MAR1984	31AUG1989	N	Fibreoptic colonoscopy examination of colon up to and beyond splenic flexure (long colonoscopy) (AU 8)
04388	01SEP1989	31DEC9999	Y	Fibreoptic colonoscopy-examination of colon beyond the hepatic flexure with or without biopsy (AU 8)
04389	01NOV1979	29FEB1984	N	Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure with biopsy (AU 9)
04389	01MAR1984	31DEC9999	Y	Fibreoptic colonoscopy - examination of colon up to and beyond splenic flexure (long colonoscopy) with biopsy (AU 9)
04394	01FEB1984	31AUG1989	N	Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure (long colonoscopy) with removal of one or more colonic polyps (AU 10)
04394	01SEP1989	31DEC9999	Y	Fibreoptic colonoscopy-examination of colon beyond the hepatic flexure with removal of one or more polyps (AU 10)
04395	01NOV1990	31DEC9999	Y	Rectal tumour of five centimetres or less in diameter, per anal submucosal excision of (excluding snare diathermy) (AU 10)
04397	01FEB1984	31DEC9999	Y	Villous tumour of rectum, greater than 3 centimetres in diameter, local excision (AU 9)
04398	01NOV1990	31DEC9999	Y	Anorectal carcinoma - per anal full thickness excision of (AU 13)
04399	01FEB1984	29FEB1984	N	Rectal tumour, excision of, via trans-sphincteric approach (AU 12)
04399	01MAR1984	31DEC9999	Y	Rectal tumour, excision of, via trans-sphincteric approach(AU 13)
04410	01SEP1989	31DEC9999	Y	Rectal prolapse, Delorme procedure for (AU 10)
04411	01NOV1990	31DEC9999	Y	Rectal stricture, per anal release of (AU 8)
04413	01FEB1984	31DEC9999	Y	Rectum, radical operation for prolapse of, involving laparotomy (AU 13)
04455	01FEB1984	31DEC9999	Y	Anus, dilatation of, under general anaesthesia, with or without disimpaction of faeces, not associated with any other item in this Part (AU 4)
04467	01FEB1984	31DEC9999	Y	Anal prolapse-- circum-anal suture (AU 6)
04482	01FEB1984	31DEC9999	Y	Anal stricture, repair of (AU 7)
04490	01FEB1984	31DEC9999	Y	Anal sphincterotomy as an independent procedure for Hirschsprung's disease (AU 6)
04492	01FEB1984	29FEB1984	N	Anal incontinence, operation for, by Parkes intersphincteric procedure or by direct repair of anal sphincters, not covered by Item 383 in Part 2 (AU 11)
04492	01MAR1984	31DEC9999	Y	Anal incontinence, operation for, by Parkes intersphincteric procedure or by direct repair of anal sphincters, not covered by Item 383 in Part 2 (AU 12)
04493	01NOV1990	31DEC9999	Y	Anal sphincter, direct repair of (AU 12)
04507	01NOV1990	31DEC9999	Y	Haemorrhoids or rectal prolapse - sclerotherapy for (AU 6)
04509	01FEB1984	31DEC9999	Y	Haemorrhoids, rubber band ligation of, or incision of thrombosed external haemorrhoids (AU 5)
04510	01SEP1989	31DEC9999	Y	Cryosurgery to haemorrhoids (AU 5)
04523	01FEB1984	31AUG1989	N	Haemorrhoidectomy, radical (G) (AU 7)
04523	01SEP1989	31DEC9999	Y	Haemorrhoidectomy, radical (G) (AU 8)
04527	01FEB1984	31AUG1989	N	Haemorrhoidectomy, radical (S) (AU 7)
04527	01SEP1989	31DEC9999	Y	Haemorrhoidectomy, radical (S) (AU 8)
04533	01NOV1990	31DEC9999	Y	Anal polyps, excision of one or more of (AU 5)
04534	01FEB1984	31DEC9999	Y	Removal of external haemorrhoids, removal of anal skin tags, injection of rectal prolapse or injection of anal prolapse-- under general anaesthesia-- one or more of these procedures (AU 5)
04535	01NOV1990	31DEC9999	Y	Anal skin tags, excision of one or more of (AU 7)
04536	01NOV1990	31DEC9999	Y	Perianal thrombosis, incision of (AU 7)
04537	01FEB1984	31DEC9999	Y	Operation for fissure-in-ano including excision, posterior sphincterotomy or lateral sphincterotomy but excluding dilatation only (G) (AU 6)
04544	01FEB1984	31DEC9999	Y	Operation for fissure-in-ano including excision, posterior sphincterotomy or lateral sphincterotomy but excluding dilatation only (S) (AU 6)
04552	01FEB1984	31DEC9999	Y	Fistula in ano, subcutaneous, excision of (G) (AU 7)
04557	01FEB1984	31DEC9999	Y	Fistula in ano, subcutaneous, excision of (S) (AU 7)
04568	01FEB1984	31DEC9999	Y	Fistula in ano, excision of (involving incision of external sphincter) (G) (AU 7)
04572	01NOV1990	31DEC9999	Y	Anal fistula, excision of, involving lower half of the anal sphincter mechanism (AU 7)
04573	01FEB1984	31DEC9999	Y	Fistula in ano, excision of (involving incision of external sphincter) (S) (AU 7)
04574	01NOV1990	31DEC9999	Y	Anal fistula, excision of, involving the upper half of the anal sphincter mechanism (AU 11)
04575	01NOV1990	31DEC9999	Y	Anal fistula, repair of by mucosal flap advancement (AU 15)
04576	01NOV1990	31DEC9999	Y	Fistula wound - review of, under general anaesthetic (AU 7)
04578	01NOV1990	31DEC9999	Y	Anorectal examination, with or without biopsy, under general anaesthetic, not associated with any other item in this Part (AU 6)
04580	01NOV1990	31DEC9999	Y	Intra-anal, perianal or ischio-rectal abscess, drainage of (excluding aftercare) (AU 8)
04583	01NOV1990	31DEC9999	Y	Anal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day-hospital facility, where the time taken is less than or equal to 45 minutes (AU 6)
04584	01NOV1990	31DEC9999	Y	Anal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day-hospital facility, where the time taken is greater than 45 minutes (AU 11)
04586	01NOV1990	31DEC9999	Y	Intestinal sling procedure prior to radiotherapy (AU 15)
04588	01NOV1990	31DEC9999	Y	Colonic lavage, total, intra operative (AU 12)
04590	01FEB1984	31DEC9999	Y	Faecal fistula, repair of (AU 12)
04606	01FEB1984	31DEC9999	Y	Coccyx, excision of (AU 8)
04611	01FEB1984	31DEC9999	Y	Pilonidal sinus or cyst or sacral sinus or cyst, excision of in a person ten years of age or over (G) (AU 8)
04617	01FEB1984	31DEC9999	Y	Pilonidal sinus or cyst or sacral sinus or cyst, excision of in a person ten years of age or over (S) (AU 8)
04618	01MAY1991	31DEC9999	Y	PILONIDAL SINUS, injection of sclerosant fluid under anaesthesia (AU 6 - 407/513)
04619	01MAY1991	31DEC9999	Y	TELANGIECTASES OR STARBURST VESSELS, diathenny or sclerosant injection of, including associated consultation
04620	01MAY1991	31DEC9999	Y	VARICOSE VEINS, multiple simultaneous injections by continuous compression techniques including associated consultation - ONE OR BOTH LEGS - not associated with any other varicose veins operation on the same leg (excluding after-care)
04621	01MAY1991	31DEC9999	Y	VARICOSE VEINS, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of one or more deep perforating veins through separate incisions - ONE LEG - not associated with item 4624, 4625 or 4632 on the same leg (AU 7 - 408/514)
04622	01FEB1984	31DEC9999	Y	Pilonidal sinus, injection of sclerosant fluid under anaesthesia (AU 6)
04623	01MAY1991	31DEC9999	Y	VARICOSE VEINS, complete dissection at SAPHENO-FEMORAL JUNCTION, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction - ONE LEG (AU 6 - 407/513)
04624	01MAY1991	31DEC9999	Y	VARICOSE VEINS, high ligation and complete or partial stripping or excision of long or short saphenous vein or its major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - one leg (AU 10 - 450/521)
04625	01MAY1991	31DEC9999	Y	VARICOSE VEINS, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - one leg (AU 12 - 454/523)
04626	01MAY1991	31DEC9999	Y	LONG SAPHENOUS VEIN, complete dissection and ligation of, at the saphenofemoral junction, for migrating thrombosis of long saphenous vein (AU 11 - 453/522)
04627	01MAY1991	31DEC9999	Y	VARICOSE VEINS, complete dissection at sapheno-popliteal junction, with or without ligation of the short saphenous vein, with or without ligation of the major tributaries at the sapheno-popliteal junction - one leg (AU 6 - 407/513)
04628	01MAY1991	31DEC9999	Y	VARICOSE VEINS, sub-fascial ligation of single deep perforating vein not associated with any other varicose vein operation on the same leg - ONE LEG (AU 6 - 407/513)
04629	01FEB1984	31DEC9999	Y	Varicose veins, injection into-- one or more injections, including any associated consultation
04630	01AUG1988	31DEC9999	Y	Telangiectases or starburst vessels, subcutaneous diathermy or sclerosant injection of, including associated consultation
04631	01MAY1991	31DEC9999	Y	GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-popliteal incompetence - one leg (AU 12 - 454/523)
04632	01MAY1991	31DEC9999	Y	GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-femoral incompetence or recurrent sapheno-popliteal incompetence with one or more of the following - multiple ligations, local stripping or excision of minor veins or sclerotherapy of minor veins - one leg (AU 13 - 457/524)
04633	01FEB1984	31AUG1989	N	Varicose veins, multiple simultaneous injections by continuous compression techniques (excluding after-care)
04633	01SEP1989	31DEC9999	Y	Varicose veins, multiple simultaneous injections by continuous compression techniques including associated consultation-one or both legs-not associated with any other varicose veins operation on the same leg (excluding after-care)
04634	01MAY1991	31DEC9999	Y	BYPASS OR ANASTOMOSIS FOR OCCLUSIVE ARTERIAL DISEASE ARTERY OF NECK, bypass using vein or synthetic material (AU 19 - 463/531)
04636	01MAY1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, transection and reanastomosis of, or resection of small length and reanastomosis of - with or without endarterectomy (AU 18 - 462/529)
04637	01FEB1984	31AUG1989	N	Varicose veins, multiple ligations, with or without local stripping or excision, not covered by any other item in this Part (AU 8)
04637	01SEP1989	31DEC9999	Y	Varicose veins, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of one or or more deep perforating veins through separate incisions-one leg-not associated with item 4641, 4649 or 4664 on the same leg (AU 7)
04638	01MAY1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with by-pass by graft of vein or synthetic material (AU 19 - 463/531)
04639	01MAY1991	31DEC9999	Y	AORTO-ILIAC OR AORTO-FEMORAL GRAFTING, straight or bifurcated (AU 21 - 465/535)
04640	01FEB1984	31DEC9999	Y	Varicose veins, high ligation and complete stripping or excision of long saphenous vein (AU 7)
04641	01JUL1985	31AUG1989	N	VARICOSE VEINS, high ligation and stripping or excision of LONG OR SHORT saphenous vein or its major tributaries, WITH OR WITHOUT MULTIPLE LIGATIONS, local stripping or excision of minor veins - ONE LEG ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
04641	01SEP1989	31DEC9999	Y	Varicose veins, high ligation and stripping or excision of long or short saphenous vein or its major tributaries, with or without multiple ligations, local stripping or excision of minor veins-one leg (AU 10)
04642	01MAY1991	31DEC9999	Y	AXILLARY or SUBCLAVIAN TO FEMORAL BYPASS GRAFTING to one or both FEMORAL ARTERIES (AU 19 - 463/531)
04643	01FEB1984	31DEC9999	Y	Varicose veins, high ligation and complete stripping or excision of short saphenous vein (AU 7)
04644	01MAY1991	31DEC9999	Y	RENAL ARTERY, bypass grafting to (AU 22 - 466/537)
04645	01MAY1991	31DEC9999	Y	RENAL ARTERIES (both), bypass grafting to (AU 26- 470/541)
04646	01MAY1991	31DEC9999	Y	SPLENO-RENAL ARTERIAL BYPASS GRAFTING (AU 21- 465/535)
04647	01MAY1991	31DEC9999	Y	MESENTERIC VESSEL (single), bypass grafting to (AU 18 - 462/529)
04648	01MAY1991	31DEC9999	Y	MESENTERIC VESSELS (multiple), bypass grafting to (AU 21 - 465/535)
04649	01FEB1984	31AUG1989	N	Varicose veins, high ligation and complete stripping or excision of both long and short saphenous systems (AU 10)
04649	01SEP1989	31DEC9999	Y	Varicose veins, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with or without multiple ligations, local stripping or excision of minor veins-one leg (AU 12)
04650	01MAY1991	31DEC9999	Y	INFERIOR MESENTERIC ARTERY, operation on, when performed in association with another intra-abdominal vascular operation (AU 17 - 461/528)
04651	01FEB1984	31AUG1989	N	Varicose veins, high ligation of long saphenous vein at saphenous femoral junction (AU 6)
04651	01SEP1989	31DEC9999	Y	Varicose veins, complete dissection at sapheno-femoral junction, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction-one leg (AU 6)
04652	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with above knee anastomosis (AU 19 - 463/531)
04653	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to below knee popliteal artery (AU 20 - 464/533)
04654	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to tibio peroneal trunk or tibial or peroneal artery (AU 21 - 465/535)
04655	01FEB1984	31AUG1989	N	Varicose veins, high ligation of short saphenous vein at saphenous popliteal junction (AU 6)
04655	01SEP1989	31DEC9999	Y	Varicose veins, high ligation of short saphenous vein at saphenous popliteal junction-one leg (AU 6)
04656	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis within 5cms of the ankle joint (AU 22 - 466/537)
04657	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using synthetic graft, with lower anastomosis above or below the knee (AU 18 - 462/529)
04658	01FEB1984	31AUG1989	N	Varicose veins, sub-fascial ligation of single deep perforation (AU 6)
04658	01SEP1989	31DEC9999	Y	Varicose veins, sub-fascial ligation of single deep perforating vein-one leg-not associated with any other varicose operation on the same leg (AU 6)
04659	01MAY1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING, using a composite graft (synthetic material and vein) with lower anastomosis above or below the knee, including use of a cuff or sleeve of vein at one or both anastomoses (AU 20 - 464/533)
04660	01MAY1991	31DEC9999	Y	FEMORAL ARTERY SEQUENTIAL BYPASS GRAFTING, (using a vein or synthetic material) where an additional anastomosis is made to separately revascularise more than one artery - each additional artery revascularised beyond a femoral bypass (AU 16 - 460/527)
04661	01MAY1991	31DEC9999	Y	VEIN, harvesting of from leg or arm for bypass or replacement graft when not performed through same incision as operation - each vein (AU 9 - 443/518)
04662	01FEB1984	31DEC9999	Y	Varicose veins, sub-fascial ligation of multiple deep perforating veins (Cockett's operation) (AU 7)
04663	01MAY1991	31DEC9999	Y	ARTERIAL BVP ASS GRAFTING, using vein or synthetic material, not covered by any other item in this Part (AU 18 - 462/529)
04664	01NOV1984	31DEC9999	Y	Re-operation for recurrent sapheno-femoral or sapheno-popliteal incompetence, with or without multiple ligations, local stripping or excision-one leg (AU 13)
04665	01FEB1984	31DEC9999	Y	Cross-leg by-pass graft-- saphenous to femoral vein (AU 11)
04666	01MAY1991	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS, not covered by any other item in this Part, as an independent procedure (AU 15 - 459/526)
04667	01MAY1991	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS not covered by any other item in this Part, when performed in combination with another vascular operation (including graft to graft anastomosis) (AU 15 - 459/526)
04668	01MAY1991	31DEC9999	Y	BYPASS, REPLACEMENT, LIGATION OF ANEURYSMS ANEURYSM OF COMMON OR INTERNAL CAROTID ARTERY, OR BOTH, replacement by graft of vein or synthetic material (AU 20 - 464/533)
04669	01MAY1991	31DEC9999	Y	THORACIC ANEURYSM, replacement by graft (AU 35 - 493/564)
04670	01FEB1984	31DEC9999	Y	Intra-arterial oxygen injection
04671	01MAY1991	31DEC9999	Y	SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft including re-implantation of arteries (AU 35 - 493/564)
04672	01MAY1991	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft (AU 26 - 470/541)
04673	01MAY1991	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms) (AU 29 - 473/544)
04674	01MAY1991	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both femoral arteries (with or without excision or bypass of common iliac aneurysms) (AU 29 - 473/544)
04675	01MAY1991	31DEC9999	Y	ANEURYSM OF ILIAC ARTERY (common, external or internal), replacement by graftunilateral (AU 18 - 462/529)
04676	01FEB1984	29FEB1984	N	Ligation of medium artery, medium vein or medium artery and medium vein by elective operation (including repair of artifical arterio-venous fistula) (AU 6)
04676	01MAR1984	31DEC9999	Y	Ligation of medium artery, medium vein or medium artery and medium vein by elective operation, or repair of artificial arterio-venous fistula (AU 6)
04677	01MAY1991	31DEC9999	Y	ANEURYSM OF VISCERAL ARTERY, excision and repair by direct anastomosis or replacement by graft (AU 18 - 462/529)
04678	01FEB1984	31DEC9999	Y	Ligation of large artery, large vein or large artery and large vein by elective operation (AU 7)
04679	01MAY1991	31DEC9999	Y	FALSE ANEURYSM, repair of, at aortic anastomosis following previous aortic surgery (AU 25 - 469/540)
04680	01MAY1991	31DEC9999	Y	FALSE ANEURYSM, repair of, in iliac artery and restoration of arterial continuity (AU 19 - 463/531)
04681	01MAY1991	31DEC9999	Y	FALSE ANEURYSM, repair of, in femoral artery and restoration of arterial continuity (AU 18 - 462/529)
04682	01MAY1991	31DEC9999	Y	RUPTURED THORACIC AORTIC ANEURYSM, replacement by graft (AU 38 - 477 /548)
04683	01MAY1991	31DEC9999	Y	RUPTURED THORACO-ABDOMINAL AORTIC ANEURYSM, replacement by graft (AU 40 - 479/550)
04684	01MAY1991	31DEC9999	Y	RUPTURED SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft (AU 38 - 477/548)
04685	01MAY1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft (AU 28 - 472/543)
04686	01MAY1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision or bypass of common iliac aneurysms) (AU 30 - 474/545)
04687	01MAY1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both femoral arteries (AU 30 - 474/545)
04688	01JUL1985	31AUG1989	N	ARTERY or VEIN or ARTERY AND VEIN (including brachial, radial, ulnar ortibial), ligation of, by elective operation OR repair of surgically created fistula ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S
04688	01SEP1989	31DEC9999	Y	Artery or vein or artery and vein (including brachial, radial, ulnar or tibial), ligation of, by elective operation or repair of surgically created fistula (AU 7)
04689	01MAY1991	31DEC9999	Y	RUPTURED ILIAC ARTERY ANEURYSM, replacement by graft (AU 22 - 466/537)
04690	01FEB1984	31DEC9999	Y	Great artery or great vein (including jugular, subclavian, axillary, iliac, femoral or popliteal) ligation of (AU 8)
04691	01MAY1991	31DEC9999	Y	RUPTURED ANEURYSM OF VISCERAL ARTERY, replacement by anastomosis or graft (AU 22 - 466/537)
04692	01MAY1991	31DEC9999	Y	RUPTURED ANEURYSM OF VISCERAL ARTERY, simple ligation of (AU 18 - 462/529)
04693	01FEB1984	31DEC9999	Y	Major artery or vein of neck or extremity, repair of wound of, with restoration of continuity (AU 13)
04694	01MAY1991	31DEC9999	Y	ANEURYSM OF MAJOR ARTERY, replacement by graft, not covered by any other item in this Part (AU 21 - 465/535)
04695	01FEB1984	31DEC9999	Y	Microvascular repair using operating microscope with restoration of continuity of artery or vein of distal extremity or digit (AU 14)
04696	01FEB1984	31DEC9999	Y	Major artery or vein of abdomen including aorta and vena cava, repair of wound of, with restoration of continuity (AU 16)
04697	01MAY1991	31DEC9999	Y	ENDARTERECTOMY AND ARTERIAL PATCH ARTERY OR ARTERIES OF NECK, endarterectomy of, including closure by suture (where endarterectomy of one or more arteries is undertaken through one arteriotomy incision) (AU 17 - 461/528)
04698	01MAY1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with endarterectomy and closure by suture (AU 19 - 463/531)
04699	01FEB1984	31AUG1989	N	Arterio-venous fistula, dissection and repair of, with restoration of continuity (AU 10)
04699	01SEP1989	31DEC9999	Y	Arterio-venous fistula, dissection and repair of, with restoration of continuity (not in association with haemodialysis) (AU 10)
04700	01MAY1991	31DEC9999	Y	INNOMINATE OR SUBCLAVIAN ARTERY, endarterectomy of, including closure by suture (AU 18 - 462/529)
04701	01MAY1991	31DEC9999	Y	AORTIC ENDARTERECTOMY, including closure by suture, not associated with another procedure on the aorta (AU 18 - 462/529)
04702	01FEB1984	31AUG1989	N	Arterio-venous fistula, dissection and ligation of (AU 10)
04702	01SEP1989	31DEC9999	Y	Arterio-venous fistula, dissection and ligation of (not in association with haemodialysis) (AU 10)
04703	01MAY1991	31DEC9999	Y	AORTD-ILIAC ENDARTERECTOMY (one or both iliac arteries), including closure by suture not associated with Item 4704 (AU 19 - 463/531)
04704	01MAY1991	31DEC9999	Y	AORTD-FEMORAL ENDARTERECTOMY (one or both femoral arteries) or BILATERAL ILID-FEMORAL ENDARTERECTOMY, including closure by suture, not in association with Item 4703 (AU 20 - 464/533)
04705	01FEB1984	31AUG1989	N	Innominate, subclavian or any intraabdominal artery, endarterectomy of (AU 19)
04705	01SEP1989	31DEC9999	Y	Innominate, subclavian or any intra-abdominal artery, endarterectomy of, with closure by simple suture or patch graft, including harvesting of vein (AU 19)
04706	01MAY1991	31DEC9999	Y	ILIAC ENDARTERECTOMY, including closure by suture, not associated with another procedure on the iliac artery (AU 17 - 461/528)
04707	01MAY1991	31DEC9999	Y	ILIO-FEMORAL ENDARTERECTOMY (one side), including closure by suture (AU 17 - 461/528)
04708	01MAY1991	31DEC9999	Y	RENAL ARTERY, endarterectomy of (AU 19 - 463/531)
04709	01FEB1984	31AUG1989	N	Artery of neck or extremities, endarterectomy of (AU 15)
04709	01SEP1989	31DEC9999	Y	Artery of neck or extremities, endarterectomy of, with closure by simple suture or patch graft, including harvesting of vein (AU 15)
04710	01MAY1991	31DEC9999	Y	RENAL ARTERIES (both), endarterectomy of (AU 21 - 465/535)
04711	01MAY1991	31DEC9999	Y	COELIAC OR SUPERIOR MESENTERIC ARTERY, endarterectomy of (AU 19 - 463/531)
04712	01MAY1991	31DEC9999	Y	COELIAC AND SUPERIOR MESENTERIC ARTERY, endarterectomy of (AU 20 - 464/533)
04713	01MAY1991	31DEC9999	Y	INFERIOR MESENTERIC ARTERY, endarterectomy of, not associated with any other item in this Part (AU 19 - 463/531)
04714	01MAY1991	31DEC9999	Y	ARTERY OF EXTREMmES, endarterectomy of, including closure by suture (AU 12 - 454/523)
04715	01FEB1984	31DEC9999	Y	Great artery or great vein (including carotid, jugular, subclavian, axillary, iliac, femoral or popliteal) ligation of involving gradual occlusion by mechanical device (AU 10)
04716	01MAY1991	31DEC9999	Y	EXTENDED DEEP FEMORAL ENDARTERECTOMY where the endarterectomy is at least 7cms long (AU 17 - 461/528)
04717	01MAY1991	31DEC9999	Y	ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long (AU 13 - 457/524)
04718	01MAY1991	31DEC9999	Y	ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is 3cm long or greater (AU 14 - 458/525)
04719	01MAY1991	31DEC9999	Y	ARTERY OR VEIN BYPASS GRAFf, patch grafting to using vein or synthetic material, not associated with any other vascular operation (AU 14 - 458/525)
04720	01MAY1991	31DEC9999	Y	VEIN, harvesting of from leg or arm for patch when not performed through same incision as operation (AU 9 - 443/518)
04721	01FEB1984	31DEC9999	Y	Inferior vena cava, plication or ligation of (AU 12)
04722	01MAY1991	31DEC9999	Y	ENDARTERECTOMY, in association with an arterial bypass operation to prepare the site for anastomosis - each site (AU 16 - 460/527)
04723	01MAY1991	31DEC9999	Y	EMBOLECTOMY, THROMBECTOMY AND VASCULAR TRAUMA EMBOLUS, removal of, from artery of neck (AU 15 - 459/526)
04724	01MAY1991	31DEC9999	Y	EMBOLECTOMY or THROMBECTOMY, by abdominal approach, of an artery or bypass graft of trunk (AU 16 - 460/527)
04725	01MAY1991	31DEC9999	Y	EMBOLECTOMY OR THROMBECTOMY, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery (AU 11 - 453/522)
04726	01MAY1991	31DEC9999	Y	INFERIOR VENA CAVA OR ILIAC VEIN, thrombectomy of (AU 12 - 454/523)
04727	01MAY1991	31DEC9999	Y	THROMBUS, removal of, from femoral or other similar large vein (AU 10 - 450/521)
04728	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by lateral suture (AU 12 - 454/523)
04729	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by direct anastomosis (AU 13 - 457/524)
04730	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein (AU 15 - 459/526)
04731	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by lateral suture (AU 13 - 457/524)
04732	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by direct anastomosis (AU 14 - 458/525)
04733	01FEB1984	31DEC9999	Y	Internal carotid artery, repositioning of (AU 13)
04734	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein (AU 16 - 460/527)
04735	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by lateral suture (AU 16 - 460/527)
04736	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by direct anastomosis (AU 17 - 461/528)
04737	01MAY1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by means of interposition graft (AU 18 - 462/529)
04738	01FEB1984	31AUG1989	N	Arterial patch graft (AU 12)
04738	01SEP1989	31DEC9999	Y	Arterial patch graft including harvesting of vein (AU 12)
04739	01MAY1991	31DEC9999	Y	ARTERY OF NECK, re-operation for bleeding or thrombosis after carotid or vertebral artery surgery (AU 12 - 454/523)
04740	01MAY1991	31DEC9999	Y	LAPAROTOMY for control of post operative bleeding or thrombosis after intraabdominal vascular procedure, where no other procedure is performed (AU 14 - 458/525)
04741	01MAY1991	31DEC9999	Y	EXTREMITY, re-operation on, for control of bleeding or thrombosis after vascular procedure, where no other procedure is performed (AU 12 - 454/523)
04742	01MAY1991	31DEC9999	Y	LIGATION, EXCISION, ELECTIVE REPAffi, DECOMPRESSION OF VESISELS I MAJOR ARTERY OF NECK, elective ligation or exploration of, not associated o/ith any other vascular procedure (AU 11 - 453/522)
04743	01MAY1991	31DEC9999	Y	GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not associated with any other vascular procedure (AU 13 - 457/524)
04744	01FEB1984	31AUG1989	N	Aorto-iliac or aorto-femoral bifurcate graft (AU 19)
04744	01SEP1989	31DEC9999	Y	Aorto-iliac or aorto-femoral or other intra-abdominal straight or bifurcate graft, with or without local endarterectomy to prepare artery for anastomosis (AU 19)
04746	01MAY1991	31DEC9999	Y	ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not associated with any other vascular procedure (AU 9 - 443/518)
04747	01MAY1991	31DEC9999	Y	TEMPORAL ARTERY, biopsy of (AU 7 - 408/514)
04748	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and ligation (AU 14 - 458/525) 458/525)
04749	01FEB1984	31AUG1989	N	Axillary-femoral by-pass graft or subclavian-femoral by-pass graft (AU 16)
04749	01SEP1989	31DEC9999	Y	Axillary or subclavian to femoral by-pass graft or other extra-abdominal arterial by-pass graft, using a synthetic graft, with or without local endarterectomy to prepare artery for anastomosis (AU 16)
04750	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE NECK, dissection and ligation (AU 17 - 461/528)
04751	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and ligation (AU 19- 463/531)
04752	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and repair of, with restoration of continuity (AU 18 - 462/529)
04753	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE NECK, dissection and repair of, with restoration of continuity (AU 18 - 462/529)
04754	01FEB1984	31AUG1989	N	Arterial or venous graft or by-pass not included in any other item (AU 20)
04754	01SEP1989	31DEC9999	Y	Arterial by-pass graft using synthetic graft, with or without local endarterectomy (AU 16)
04755	01JUL1985	31AUG1989	N	FEMORAL ARTERY BY-PASS GRAFT using synthetic or vein graft, including harvesting of vein, with below knee anastomosis ANAESTHETIC 20 UNITS - ITEM NOS 464G / 533S
04755	01SEP1989	31DEC9999	Y	Femoral artery by-pass graft using synthetic or vein graft, including harvesting of vein, with below knee anastomosis (AU 20)
04756	01FEB1984	31DEC9999	Y	Micro-arterial or micro-venous graft using operating microscope (AU 22)
04757	01MAY1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE ABOOMEN, dissection and repair of, with restoration of continuity (AU 22 - 466/537)
04758	01MAY1991	31DEC9999	Y	SURGICALLY CREATED ARTERIO-VENOUS FISTULA OF AN EXTREMITY, closure of (AU 10 - 450/521)
04759	01MAY1991	31DEC9999	Y	SCALENOTOMY (AU 10 - 450/521)
04760	01MAY1991	31DEC9999	Y	FIRST RIB, resection of portion of (AU 13 - 457/524)
04761	01MAY1991	31DEC9999	Y	CERVICAL RIB, removal of, or other operation for removal of thoracic outlet compression, not covered by any other item in this Part (AU 13 - 457/524)
04762	01FEB1984	31AUG1989	N	Arterial anastomosis (AU 16)
04762	01SEP1989	31DEC9999	Y	Arterial anastomosis not associated with any other arterial operation, with or without local endarterectomy to prepare artery for anastomosis (AU 16)
04763	01MAY1991	31DEC9999	Y	COELIAC ARTERY, decompression of, for coeliac artery compression syndrome, as an independent procedure (AU 19 - 463/531)
04764	01FEB1984	31DEC9999	Y	Microvascular anastomosis of artery or vein using operating microscope, for reimplantation of limb or digit or free transfer of tissue (AU 38)
04765	01MAY1991	31DEC9999	Y	POPLITEAL ARTERY, exploration of, for popliteal entrapment, with or without division of fibrous tissue and muscle (AU 13 - 457/524)
04766	01FEB1984	31DEC9999	Y	Portal hypertension, vascular anastomosis for (AU 21)
04767	01MAY1991	31DEC9999	Y	CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is less that 4cm in maximum diameter (AU 19 - 463/531)
04768	01MAY1991	31DEC9999	Y	CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter (AU 19 - 463/531)
04769	01MAY1991	31DEC9999	Y	RECURRENT CAROTID BODY TUMOUR, resection of, with or without repair or
04770	01MAY1991	31DEC9999	Y	NECK, excision of infected bypass graft, including closure of vessel or vessels (AU 15 - 459/526)
04771	01MAY1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by suture of aorta and repair of duodenum (AU 24 - 468/539)
04772	01MAY1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by insertion of aortic graft and repair of duodenum (AU 26 - 470/541)
04773	01MAY1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by oversewing of abdominal aorta, repair
04774	01MAY1991	31DEC9999	Y	lNFECTED BYPASS GRAFT FROM TRUNK, excision of, including closure of arteries (AU 20 - 464/533)
04775	01MAY1991	31DEC9999	Y	lNFECTED AXILLO-FEMORAL OR FEMORO-FEMORAL GRAFT, excision of, including closure of arteries (AU 15 - 459/526)
04776	01MAY1991	31DEC9999	Y	lNFECTED BYPASS GRAFT FROM EXTREMITIES, excision of including closure of arteries (AU 15 - 459/526)
04777	01MAY1991	31DEC9999	Y	OPERATIONS FOR VASCULAR DISEASE ARTERIOVENOUS SHUNT, EXTERNAL, insertion of (AU 9 - 443/518)
04778	01FEB1984	31AUG1989	N	Embolus, removal of, from artery of neck or extremities (AU 12)
04778	01SEP1989	31DEC9999	Y	Embolus, removal of, from an artery or by-pass graft of neck or extremities (AU 12)
04779	01MAY1991	31DEC9999	Y	ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, in association with another venous or arterial operation (AU 14 - 458/525)
04780	01MAY1991	31DEC9999	Y	ARTERIOVENOUS SHUNT, EXTERNAL, removal of (AU 5 - 406/510)
04781	01MAY1991	31DEC9999	Y	ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, not in association with another venous or arterial operation (AU 14 - 458/525)
04782	01MAY1991	31DEC9999	Y	ARTERIOVENOUS ACCESS DEVICE, insertion of (AU 14 - 458/525)
04783	01MAY1991	31DEC9999	Y	ARTERIOVENOUS ACCESS DEVICE, thrombectomy of (AU 11 - 453/522)
04784	01FEB1984	31AUG1989	N	Embolus, removal of, from artery of trunk (AU 15)
04784	01SEP1989	31DEC9999	Y	Embolus or thrombus, removal of, from artery or prosthetic graft of trunk (AU 15)
04785	01MAY1991	31DEC9999	Y	STENOSIS OF ARTERIOVENOUS FISTULA OR PROSTHETIC ARTERIOVENOUS ACCESS DEVICE, correction of (AU 14 - 458/525)
04786	01MAY1991	31DEC9999	Y	INTRA-ABDOMINAL ARTERY OR VEIN, cannulation of for infusion chemotherapy, by open operation (excluding aftercare) (AU 11 - 453/522)
04787	01MAY1991	31DEC9999	Y	ARTERIAL CANNULATION for infusion chemotherapy by open operation, not covered by Item 4786 (excluding after-care) (AU 10 - 450/521)
04788	01MAY1991	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device (AU 11 - 453/522)
04789	01FEB1984	31DEC9999	Y	Thrombus, removal of, from femoral, iliac or other similar large vein (AU 12)
04790	01MAY1991	31DEC9999	Y	HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of (AU 10 - 450/521)
04791	01FEB1984	31DEC9999	Y	Abdominal aortic aneurysm, excision of and insertion of graft (AU 26)
04792	01JUL1985	31AUG1989	N	THORACO-ABDOMINAL ANEURYSM, excision of and insertion of graft, including reanastomosis of visceral vessels ANAESTHETIC 40 UNITS - ITEM NOS 479G / 550S
04792	01SEP1989	31DEC9999	Y	Thoraco-abdominal aneurysm, excision of and insertion of graft, including reanastomosis of visceral vessels (AU 40)
04793	01MAY1991	31DEC9999	Y	ISOLA TED LIMB PERFUSION, including cannulation of artery and vein at commencement of procedure, regional perfusion for chemotherapy, or other therapy, repair of arteriotomy and venotomy at conclusion of procedure (excluding aftercare) (AU 18 - 462/529)
04794	01FEB1984	31AUG1989	N	Ruptured abdominal aortic aneurysm, excision of and insertion of graft (AU 26)
04794	01SEP1989	31DEC9999	Y	Ruptured abdominal aortic aneurysm, excision of and insertion of graft, or repair of aorto-duodenal fistula, including repair of aorta and duodenum (AU 26)
04795	01MAY1991	31DEC9999	Y	ENDOVASCULAR INTERVENTION PROCEDURES INFERIOR VENA CAVAL FILTER, insertion of, by percutaneous method using interventional imaging techniques (AU 11 - 453/522)
04796	01MAY1991	31DEC9999	Y	INFERIOR VENA CAVAL FILTER, insertion of, by open operation (AU 12 - 454/523)
04797	01MAY1991	31DEC9999	Y	INFERIOR VENA CAVA, plication, ligation, or application of caval clip (AU 13 - 457/524)
04798	01FEB1984	31DEC9999	Y	Aneurysm of major artery, excision of and insertion of graft (AU 18)
04799	01MAY1991	31DEC9999	Y	INFERIOR VENA CAVA, reconstruction of or bypass by vein or synthetic material (AU 24 - 468/539)
04800	01FEB1984	31DEC9999	Y	Transluminal arterioplasty including associated radiological services and preparation (AU 12)
04801	01JUL1985	31AUG1989	N	EXCISION OF INFECTED PROSTHETIC BY-PASS GRAFT from NECK or EXTREMITIES, including closure of vessel or vessels ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S
04801	01SEP1989	31DEC9999	Y	Excision of infected prosthetic by-pass graft from neck or extremities, including closure of vessel or vessels (AU 14)
04802	01AUG1985	31AUG1989	N	EXCISION OF INFECTED PROSTHETIC BY-PASS GRAFT from TRUNK, including closure of vessel or vessels ANAESTHETIC 18 UNITS - ITEM NOS 462G / 529S
04802	01SEP1989	31DEC9999	Y	Excision of infected prosthetic by-pass graft from trunk, including closure of vessel or vessels (AU 18)
04803	01MAY1991	31DEC9999	Y	CROSS LEG BYPASS GRAFTING, saphenous to iliac or femoral vein (AU 14 - 458/525)
04804	01MAY1991	31DEC9999	Y	SAPHENOUS VEIN ANASTOMOSIS to femoral or popliteal vein for femoral vein bypass (AU 14 - 458/525)
04805	01MAY1991	31DEC9999	Y	VENOUS STENOSIS OR OCCLUSION, vein bypass for, using vein or synthetic material, not associated with items 4803 or 4804 (AU 13 - 457/524)
04806	01FEB1984	31AUG1989	N	Intra-aortic balloon for counterpulsation, operation for insertion by arteriotomy or removal of and arterioplasty (AU 14)
04806	01SEP1989	31DEC9999	Y	Intra-aortic balloon for counterpulsation, operation for insertion by arteriotomy, or removal of and arterioplasty (excluding repair by patch graft) (AU 14)
04807	01MAY1991	31DEC9999	Y	VEIN STENOSIS, patch angioplasty for, (excluding vein graft stenosis)-using vein or synthetic material (AU 15 - 459/526)
04808	01FEB1984	31DEC9999	Y	Arteriovenous shunt, external, insertion of (AU 9)
04809	01MAY1991	31DEC9999	Y	VENOUS VALVE, plica tion or repair to restore valve competency (AU 25 - 469/540)
04810	01MAY1991	31DEC9999	Y	VEIN TRANSPLANT to restore valvular function (AU 15 - 459/526)
04811	01MAY1991	31DEC9999	Y	EXTERNAL STENT, application of, to restore venous valve competency to superficial vein - one stent (AU 10 - 450/521)
04812	01FEB1984	31DEC9999	Y	Arteriovenous shunt, external, removal of (AU 5)
04813	01MAY1990	31DEC9999	Y	TRANS LUMINAL BALLOON ANGIOPLASTY OF CORONORY ARTERY AND DILATATION OF VESSEL, using interventional imaging techniques ANAESTHETIC 12 UNITS - ITEM NOS 454G I 523S
04814	01MAY1990	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventional imaging techniques ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
04815	01MAY1991	31DEC9999	Y	EXTERNAL STENTS, application of, to restore venous valve competency to superficial vein or veins - more than one stent (AU 11 - 453/522)
04816	01MAY1991	31DEC9999	Y	EXTERNAL STENT, application of, to restore venous valve competency to deep vein (one stent) (AU 11 - 453/522)
04817	01FEB1984	31DEC9999	Y	Arteriovenous anastomosis, direct, of upper or lower limb (AU 14)
04818	01MAY1991	31DEC9999	Y	EXTERNAL STENTS, application of, to restore venous valve competency to deep vein or veins (more than one stent) (AU 12 - 454/523)
04819	01MAY1991	31DEC9999	Y	PORTAL HYPERTENSION, vascular decompression operation for (including splenorenal, porto-caval and mesenterico-caval anastomosis) (AU 24 - 468/539)
04820	01MAY1991	31DEC9999	Y	SYMPATHECTOMY LUMBAR SYMPATHEOUMY (AU 11 - 453/522)
04821	01MAY1991	31DEC9999	Y	CERVICAL OR UPPER THORACIC SYMPATHECTOMY by any surgical approach (AU 16 - 460/527)
04822	01FEB1984	31AUG1989	N	Intra-arterial infusion of arteries of neck, thorax or abdomen, including initial operation and all postoperative management (AU 13)
04822	01SEP1989	31DEC9999	Y	Cannulation of intra-abdominal artery or vein for infusion chemotherapy, by open operation (excluding after-care) (AU 13)
04823	01NOV1985	31AUG1989	N	ARTERIAL CANNULATION for infusion chemotherapy by open operation, not covered by Item 4822 (excluding after-care) ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
04823	01SEP1989	31DEC9999	Y	Arterial cannulation for infusion chemotherapy, by open operation, not covered by item 4822 (excluding after-care) (AU 10)
04824	01JUL1985	31AUG1989	N	CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter not covered by item 4825 ANAESTHETIC 8 UNITS - ITEM NOS 409G / 514S
04824	01SEP1989	31DEC9999	Y	Central vein catheterisation by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter, not covered by item 4825 (AU 8)
04825	01NOV1986	31AUG1989	N	CENTRAL VEIN CATHETERISATION by open exposure using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter in children under the age of 12 years ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
04825	01SEP1989	31DEC9999	Y	Central vein catheterisation by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter, in children under the age or 12 years (AU 12)
04826	01MAY1991	31DEC9999	Y	CERVICAL OR UPPER THORACIC SYMPATHECTOMY, where operation is a reoperation for previous incomplete sympathectomy by any surgical approach (AU 13 - 457/524)
04827	01MAY1991	31DEC9999	Y	LUMBAR SYMPATHECTOMY, where operation is following chemical sympathectomy or for previous incomplete surgical sympathectomy (AU 11 - 453/522)
04828	01MAY1991	31DEC9999	Y	DEBRIDEMENT AND AMPUTATIONS FOR VASCULAR DISEASE ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, slough in, in the operating theatre of a hospital, when debridement includes muscle, tendon or bone (AU 8 - 409/517)
04829	01SEP1989	31DEC9999	Y	Percutaneous epidural implant for chronic pain-insertion of (one or two stages), not involving laminectomy (AU 8)
04830	01SEP1989	31DEC9999	Y	Percutaneous epidural implant for chronic pain-removal of (AU 7)
04831	01MAY1991	31DEC9999	Y	ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, superficial tissue only (AU 9 - 443/518)
04832	01FEB1984	31DEC9999	Y	Operation on phalanx (AU 7)
04834	01MAY1991	31DEC9999	Y	MISCELLANEOUS VASCULAR PROCEDURES OPERATIVE ARTERIOGRAPHY OR VENOGRAPHY, one or more of, performed during the course of an operative prodedure on an artery or vein on one leg (AU 8 - 409/517)
04835	01MAY1991	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLAS1Y OF CORONARY ARTERY AND DILATATION OF VESSEL, using interventionaI imaging techniques (AU 12 - 454/523)
04836	01MAY1991	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLAS1Y OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventionaI imaging techniques (AU 12 - 454/523)
04837	01MAY1991	31DEC9999	Y	OPERATIONS FOR ACUTE OSTEOMYELITIS OPERATION ON PHALANX (AU 7 - 408/514)
04838	01FEB1984	31DEC9999	Y	Operation on sternum, clavicle, rib, ulna, radius, carpus, tibia, fibula, tarsus, skull, mandible or maxilla (other than alveolar margins)-- one bone (AU 10)
04841	01FEB1984	31DEC9999	Y	Operation on mandible or maxilla (other than alveolar margins)-- one bone (D) (AU 10)
04844	01FEB1984	31DEC9999	Y	Operation on humerus or femur-- one bone (AU 10)
04853	01FEB1984	31DEC9999	Y	Operation on spine or pelvic bones-- one bone (AU 13)
04860	01FEB1984	31DEC9999	Y	Operation on scapula, sternum, clavicle, rib, ulna, radius, metacarpus, carpus, phalanx, tibia, fibula, metatarsus, tarsus, mandible or maxilla (other than alveolar margins)-- one bone or any combination of adjoining bones (AU 12)
04862	01FEB1984	31DEC9999	Y	Operation on mandible or maxilla or mandible and maxilla (other than alveolar margins) (D) (AU 12)
04864	01FEB1984	31DEC9999	Y	Operation on humerus or femur-- one bone (AU 11)
04867	01FEB1984	31DEC9999	Y	Operation on spine or pelvic bones-- one bone (AU 12)
04870	01FEB1984	31DEC9999	Y	Operation on skull (AU 12)
04877	01FEB1984	31DEC9999	Y	Operation on any combination of adjoining bones, being bones referred to in Item 4864, 4867 or 4870 (AU 12)
04927	01FEB1984	31DEC9999	Y	One digit of hand (G) (AU 6)
04930	01FEB1984	31DEC9999	Y	One digit of hand (S) (AU 6)
04934	01FEB1984	31DEC9999	Y	Two digits of one hand (G) (AU 7)
04940	01FEB1984	31DEC9999	Y	Two digits of one hand (S) (AU 7)
04943	01FEB1984	31DEC9999	Y	Three digits of one hand (G) (AU 8)
04948	01FEB1984	31DEC9999	Y	Three digits of one hand (S) (AU 8)
04950	01FEB1984	31DEC9999	Y	Four digits of one hand (G) (AU 9)
04954	01FEB1984	31DEC9999	Y	Four digits of one hand (S) (AU 9)
04957	01FEB1984	31DEC9999	Y	Five digits of one hand (G) (AU 10)
04961	01FEB1984	31DEC9999	Y	Five digits of one hand (S) (AU 10)
04965	01FEB1984	31DEC9999	Y	Finger or thumb, including metacarpal or part of metacarpal-- each digit (G) (AU 6)
04969	01FEB1984	31DEC9999	Y	Finger or thumb, including metacarpal or part of metacarpal-- each digit (S) (AU 6)
04972	01FEB1984	31DEC9999	Y	Hand, midcarpal or transmetacarpal (G) (AU 7)
04976	01FEB1984	28FEB1985	N	Hand, midcarpal or transmetacarpal (S) (AU 7)
04976	01MAR1985	31DEC9999	Y	HAND, MIDCARPAL OR TRANSMETACARPAL ANAESTHETIC 7 UNITS (S) - ITEM NOS 408G / 514S
04979	01FEB1984	31DEC9999	Y	Hand, forearm or through arm (AU 8)
04983	01FEB1984	31DEC9999	Y	At shoulder (AU 12)
04987	01FEB1984	31DEC9999	Y	Interscapulothoracic (AU 15)
04990	01FEB1984	31DEC9999	Y	One digit of foot (G) (AU 6)
04993	01FEB1984	31DEC9999	Y	One digit of foot (S) (AU 6)
04995	01FEB1984	31DEC9999	Y	Two digits of one foot (G) (AU 7)
04997	01FEB1984	31DEC9999	Y	Two digits of one foot (S) (AU 7)
04999	01FEB1984	28FEB1985	N	Three digits of one foot (G) (AU 8)
04999	01MAR1985	31DEC9999	Y	THREE DIGITS of one foot (G) ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S
05000	01JAN2005	30APR2010	N	LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05000	01MAY2010	31DEC9999	Y	Professional attendance at consulting rooms (other than a service to which another item applies) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-each attendance
05001	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of ordinary complexity
05002	01FEB1984	31DEC9999	Y	Three digits of one foot (S) (AU 8)
05003	01JAN2005	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05003	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05003	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05003	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies) that requires a short patient history and, if necessary, limited examination and management-an attendance on one or more patients on one occasion-each patient
05004	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of ordinary complexity
05006	01FEB1984	31DEC9999	Y	Four digits of one foot (G) (AU 9)
05007	01JAN2005	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05009	01FEB1984	31DEC9999	Y	Four digits of one foot (S) (AU 9)
05010	01JAN2005	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05010	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6 pm on any other day.
05010	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is accommodated in a residential aged care facility (other than accommodation in a self-contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05011	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of ordinary complexity
05012	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of complexity that is more than ordinary but is not high
05013	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of complexity that is more than ordinary but is not high
05014	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of complexity that is more than ordinary but is not high
05015	01FEB1984	31DEC9999	Y	Five digits of one foot (G) (AU 10)
05016	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of high complexity
05017	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of high complexity
05018	01FEB1984	31DEC9999	Y	Five digits of one foot (S) (AU 10)
05019	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine involving medical decision-making of high complexity
05020	01JAN2005	30APR2010	N	LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 5040, 5043, 5046, 5049, 5060, 5063, 5064 or 5067 applies SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05020	01MAY2010	31OCT2023	N	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
05020	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in this Schedule applies), lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation
05021	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of ordinary complexity
05022	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of ordinary complexity
05023	01JAN2005	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05023	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05023	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05023	01JAN2013	31OCT2023	N	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient
05023	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in this Schedule applies), lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient
05024	01FEB1984	31DEC9999	Y	Toe, including metatarsal or part of metatarsal-- each toe (G) (AU 7)
05026	01JAN2005	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05027	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of ordinary complexity
05028	01JAN2005	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05028	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05028	01JAN2013	31OCT2023	N	Professional attendance by a general practitioner (other than a service to which another item in the table applies), at a residential aged care facility to residents of the facility, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05028	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner (other than a service to which another item in this Schedule applies), on care recipients in a residential aged care facility, lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05029	01FEB1984	31DEC9999	Y	Toe, including metatarsal or part of metatarsal-- each toe (S) (AU 7)
05030	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of complexity that is more than ordinary but is not high
05031	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of complexity that is more than ordinary but is not high
05032	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of complexity that is more than ordinary but is not high
05033	01MAR2020	31DEC9999	Y	Professional attendance, on a patient 4 years or over but under 75 years old, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of high complexity
05034	01FEB1984	31DEC9999	Y	Foot at ankle (Syme, Pirogoff types) (AU 8)
05035	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged under 4 years, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of high complexity
05036	01MAR2020	31DEC9999	Y	Professional attendance, on a patient aged 75 years or over, at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) involving medical decision-making of high complexity
05038	01FEB1984	31DEC9999	Y	Foot, midtarsal or transmetatarsal (AU 7)
05039	01MAR2020	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine for preparation of goals of care by the specialist for a gravely ill patient lacking current goals of care if: (a) the specialist takes overall responsibility for the preparation of the goals of care for the patient; and (b) the attendance is the first attendance by the specialist for the preparation of the goals of care for the patient following the presentation of the patient to the emergency department; and (c) the attendance is in conjunction with, or after, an attendance on the patient by the specialist that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
05040	01JAN2005	30APR2010	N	LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 5060, 5063, 5064 or 5067 applies. SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05040	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
05041	01MAR2020	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialists specialty of emergency medicine for preparation of goals of care by the specialist for a gravely ill patient lacking current goals of care if: (a) the specialist takes overall responsibility for the preparation of the goals of care for the patient; and (b) the attendance is the first attendance by the specialist for the preparation of the goals of care for the patient following the presentation of the patient to the emergency department; and (c) the attendance is not in conjunction with, or after, an attendance on the patient by the specialist that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019; and (d) the attendance is for at least 60 minutes
05042	01MAR2020	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) for preparation of goals of care by the practitioner for a gravely ill patient lacking current goals of care if: (a) the practitioner takes overall responsibility for the preparation of the goals of care for the patient; and (b) the attendance is the first attendance by the practitioner for the preparation of the goals of care for the patient following the presentation of the patient to the emergency department; and (c) the attendance is in conjunction with, or after, an attendance on the patient by the practitioner that is described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
05043	01JAN2005	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution). The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05043	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital or residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05043	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital or residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05043	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient
05044	01MAR2020	31DEC9999	Y	Professional attendance at a recognised emergency department of a private hospital by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) for preparation of goals of care by the practitioner for a gravely ill patient lacking current goals of care if: (a) the practitioner takes overall responsibility for the preparation of the goals of care for the patient; and (b) the attendance is the first attendance by the practitioner for the preparation of the goals of care for the patient following the presentation of the patient to the emergency department; and (c) the attendance is not in conjunction with, or after, an attendance on the patient by the practitioner that is described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (d) the attendance is for at least 60 minutes
05045	01NOV1979	31DEC9999	Y	Through leg or at knee (AU 8)
05046	01JAN2005	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05048	01NOV1979	31DEC9999	Y	Through thigh (AU 10)
05049	01JAN2005	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05049	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05049	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05050	01JUL1985	31AUG1989	N	THROUGH THIGH, AT KNEE OR BELOW KNEE ANAESTHETIC 10 UNITS - ITEM NOS 450G / 5218
05050	01SEP1989	31DEC9999	Y	Through thigh, at knee or below knee (AU 10)
05051	01FEB1984	31DEC9999	Y	At hip (AU 14)
05055	01FEB1984	31DEC9999	Y	Hindquarter (AU 17)
05057	01NOV1986	31AUG1989	N	AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover DERIVED FEE - 75% of the original amputation fee ANAESTHETIC - ITEM NOS 488G / 5608
05057	01SEP1989	31DEC9999	Y	Amputation stump, reamputation of, to provide adequate skin and muscle cover
05059	01FEB1984	31DEC9999	Y	Ear, removal of foreign body in, otherwise than by simple syringing (AU 4)
05060	01JAN2005	30APR2010	N	LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05060	01MAY2010	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance
05062	01FEB1984	31DEC9999	Y	Ear, removal of foreign body in, involving incision of external auditory canal (AU 6)
05063	01JAN2005	30APR2010	N	HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05063	01MAY2010	31OCT2011	N	HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05063	01NOV2011	31DEC2012	N	CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05063	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient
05064	01JAN2005	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05066	01FEB1984	31DEC9999	Y	Aural polyp, removal of (AU 4)
05067	01JAN2005	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.)
05067	01MAY2010	31DEC2012	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05067	01JAN2013	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05068	01FEB1984	31DEC9999	Y	External auditory meatus, surgical removal of keratosis obturans from, not covered by any other item in this Part (AU 9)
05069	01AUG1986	31AUG1989	N	MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone not covered by Item 5070 ANAESTHETIC 9 UNITS - ITEM NOS 443G / 5188
05069	01SEP1989	31DEC9999	Y	Meatoplasty involving removal of cartilage or bone or both cartilage and bone not covered by item 5070 (AU 9)
05070	01AUG1986	31AUG1989	N	MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone associated with Items 5078, 5091, 5095, 5098 or 5100 ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S
05070	01SEP1989	31DEC9999	Y	Meatoplasty involving removal of cartilage or bone or both cartilage and bone associated with items 5078, 5091, 5095, 5098 or 5100 (AU 7)
05071	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in this Schedule applies), lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation
05072	01FEB1984	31DEC9999	Y	External auditory meatus, removal of exostoses in (AU 12)
05073	01SEP1986	31AUG1989	N	Correction of AUDITORY CANAL STENOSIS, including meatoplasty, with or without grafting ANAESTHETIC 12 UNITS - ITEM NOS 454G / 5238
05073	01SEP1989	31DEC9999	Y	Correction of auditory canal stenosis, including meatoplasty, with or without grafting (AU 12)
05074	01OCT1986	31AUG1989	N	RECONSTRUCTION OF EXTERNAL AUDITORY CANAL in association with Items 5095, 5098, 5100 ANAESTHETIC 9 UNITS - ITEM NOS 443G / 5188
05074	01SEP1989	31DEC9999	Y	Reconstruction of external auditory canal in association with items 5095, 5098, 5100 (AU 9)
05075	01FEB1984	31DEC9999	Y	Myringoplasty, trans-canal approach (Rosen incision) (AU 11)
05076	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in this Schedule applies), lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient
05077	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner, on care recipients in a residential aged care facility, other than a service to which another item in this Schedule applies, lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05078	01FEB1984	31DEC9999	Y	Myringoplasty, post-aural or endaural approach with or without mastoid inspection (AU 12)
05079	01AUG1986	31AUG1989	N	ATTICOTOMY without reconstruction of the bony defect, with or without myringoplasty ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
05079	01SEP1989	31DEC9999	Y	Atticotomy without reconstruction of the bony defect, with or without myringoplasty (AU 12)
05080	01AUG1986	31AUG1989	N	ATTICOTOMY with reconstruction of the bony defect, with or without myringoplasty ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S
05080	01SEP1989	31DEC9999	Y	Atticotomy with reconstruction of the bony defect with or without myringoplasty (AU 14)
05081	01FEB1984	31DEC9999	Y	Ossicular chain reconstruction (AU 12)
05085	01FEB1984	31DEC9999	Y	Ossicular chain reconstruction and myringoplasty (AU 13)
05087	01FEB1984	31DEC9999	Y	Mastoidectomy (cortical) (AU 12)
05091	01FEB1984	31DEC9999	Y	Obliteration of the mastoid cavity (AU 10)
05093	01AUG1986	31AUG1989	N	MASTOIDECTOMY, intact wall technique, with myringoplasty ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S
05093	01SEP1989	31DEC9999	Y	Mastoidectomy, intact wall technique, with myringoplasty (AU 16)
05094	01AUG1986	31AUG1989	N	MASTOIDECTOMY, intact wall technique, with myringoplasty and ossicular chain reconstruction ANAESTHETIC 18 UNITS - ITEM NOS 462G / 529S
05094	01SEP1989	31DEC9999	Y	Mastoidectomy, intact wall technique, with myringoplasty and ossicular chain reconstruction (AU 18)
05095	01FEB1984	31DEC9999	Y	Mastoidectomy (radical or modified radical) (AU 13)
05098	01FEB1984	31DEC9999	Y	Mastoidectomy ( radical or modified radical) and myringoplasty (AU 13)
05100	01FEB1984	31DEC9999	Y	Mastoidectomy (radical or modified radical), myringoplasty and ossicular chain reconstruction (AU 14)
05101	01AUG1986	31AUG1989	N	REVISION OF MASTOIDECTOMY (radical, modified radical or intact wall), including myringoplasty ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S
05101	01SEP1989	31DEC9999	Y	Revision of mastoidectomy (radical, modified radical or intact wall), including myringoplasty (AU 16)
05102	01FEB1984	31DEC9999	Y	Decompression of facial nerve in its mastoid portion (AU 13)
05104	01FEB1984	31DEC9999	Y	Decompression of facial nerve in its intracranial portion by intracranial or intrapetrous approach (AU 18)
05106	01FEB1984	31DEC9999	Y	Labyrinthotomy or destruction of labyrinth (AU 12)
05108	01FEB1984	31DEC9999	Y	Cerebello-pontine angle tumour, removal of by two surgeons operating conjointly, by transmastoid, translabyrinthine approach-- transmastoid, translabyrinthine procedure (including after-care) (AU 39)
05112	01FEB1984	31DEC9999	Y	Cerebello-pontine angle tumour, removal of by two surgeons operating conjointly, by transmastoid, translabyrinthine approach-- intracranial procedure (including aftercare)
05113	01AUG1987	31AUG1989	N	SKULL BASE TUMOUR, removal of by infra-temporal approach ANAESTHETIC 40 UNITS-ITEM NOS 479G/550S
05113	01SEP1989	31DEC9999	Y	Skull base tumour, removal of by infratemporal approach (AU 40)
05114	01AUG1987	31AUG1989	N	PARTIAL TEMPORAL BONE RESECTION for removal of tumour involving mastoidectomy with or without decompression of facial nerve. ANAESTHETIC 28 UNITS-ITEM NOS 472G/543S
05114	01SEP1989	31DEC9999	Y	Partial temporal bone resection for removal of tumour involving mastoidectomy with or without decompression of facial nerve (AU 28)
05115	01AUG1987	31AUG1989	N	TOTAL TEMPORAL BONE RESECTION for removal of tumour ANAESTHETIC 32 UNITS-ITEM NOS 475G/546S
05115	01SEP1989	31DEC9999	Y	Total temporal bone resection for removal of tumour (AU 32)
05116	01FEB1984	31DEC9999	Y	Endolymphatic sac, transmastoid decompression with or without drainage of (AU 12)
05117	01AUG1987	31AUG1989	N	TRANSLABYRINTHINE VESTIBULAR NERVE SECTION ANAESTHETIC 22 UNITS-ITEM NOS 466G/537S
05117	01SEP1989	31DEC9999	Y	Translabyrinthine vestibular nerve section (AU 22)
05118	01AUG1987	31AUG1989	N	RETROLABYRINTHINE VESTIBULAR and/or COCHLEAR NERVE SECTION ANAESTHETIC 26 UNITS-ITEM NOS 470G/541S
05118	01SEP1989	31DEC9999	Y	Retrolabyrinthine vestibular and/or cochlear nerve section (AU 26)
05119	01AUG1987	31AUG1989	N	INTERNAL AUDITORY MEATUS, exploration by middle cranial fossa approach with cranial nerve decompression ANAESTHETIC 23 UNITS-ITEM NOS 467G/538S
05119	01SEP1989	31DEC9999	Y	Internal auditory meatus, exploration by middle cranial fossa approach with cranial nerve decompression (AU 23)
05122	01FEB1984	31DEC9999	Y	Internal auditory meatus, exploration of, by middle cranial fossa approach with or without removal of tumour (AU 21)
05127	01FEB1984	31DEC9999	Y	Fenestration operation-- each ear (AU 11)
05131	01FEB1984	31DEC9999	Y	Venous graft to fenestration cavity (AU 12)
05138	01FEB1984	31DEC9999	Y	Stapedectomy (AU 11)
05143	01FEB1984	31DEC9999	Y	Stapes mobilisation (AU 10)
05147	01FEB1984	31AUG1989	N	Repair of round window (AU11)
05147	01SEP1989	31DEC9999	Y	Round window surgery including repair or cochleotomy (AU 11)
05148	01AUG1986	31AUG1989	N	COCHLEAR IMPLANT, insertion of, including mastoidectomy ANAESTHETIC 23 UNITS-ITEM NOS 467G/538S
05148	01SEP1989	31DEC9999	Y	Cochlear implant, insertion of, including mastoidectomy (AU 23)
05152	01FEB1984	31DEC9999	Y	Glomus tumour, transtympanic removal of (AU 12)
05158	01FEB1984	31DEC9999	Y	Glomus tumour, transmastoid removal of, including mastoidectomy (AU 13)
05162	01FEB1984	31DEC9999	Y	Abscess or inflammation of middle ear, operation for (excluding aftercare) (AU 7)
05166	01FEB1984	31DEC9999	Y	Middle ear, exploration of (AU 9)
05172	01FEB1984	31DEC9999	Y	Middle ear, insertion of tube for drainage of (including myringotomy) (AU 7)
05173	01AUG1986	31AUG1989	N	CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, one or more, with or without myringoplasty ANAESTHETIC 10 UNITS-ITEM NOS 450G/521S
05173	01SEP1989	31DEC9999	Y	Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty (AU 10)
05174	01AUG1986	31AUG1989	N	CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, one or more, with or without myringoplasty with ossicular chain reconstruction ANAESTHETIC 16 UNITS-ITEM NOS 460G/527S
05174	01SEP1989	31DEC9999	Y	Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty with ossicular chain reconstruction (AU 16)
05176	01FEB1984	31DEC9999	Y	Perforation of tympanum, cauterisation or diathermy of (AU 6)
05177	01AUG1986	31AUG1989	N	EXCISION OF RIM OF EARDRUM PERFORATION, not associated with mynngoplasty ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S
05177	01SEP1989	31DEC9999	Y	Excision of rim of eardrum perforation, not associated with myringoplasty (AU 6)
05182	01FEB1984	31DEC9999	Y	Ear toilet requiring use of operating microscope and microinspection of tympanic membrane with or without general anaesthesia (AU 7)
05186	01FEB1984	31DEC9999	Y	Tympanic membrane, microinspection of one or both ears under general anaesthesia, not associated with any other item in this Part (AU 7)
05192	01FEB1984	31DEC9999	Y	Examination of nasal cavity or postnasal space or nasal cavity and post-nasal space, under general anaesthesia, not associated with any other item in this Part (AU 6)
05196	01FEB1984	31DEC9999	Y	Nasal haemorrhage, posterior, arrest of, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding after-care) (AU 8)
05200	01JAN2005	31DEC9999	Y	Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance
05201	01FEB1984	31DEC9999	Y	Nose, removal of foreign body in, other than by simple probing (AU 6)
05203	01JAN2005	31DEC9999	Y	Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance
05205	01FEB1984	31DEC9999	Y	Nasal polyp or polypi (simple), removal of
05207	01JAN2005	31DEC9999	Y	Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance
05208	01JAN2005	31OCT2023	N	Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance
05208	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 45 minutes, but not more than 60 minutes, (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)
05209	01NOV2023	31DEC9999	Y	Professional attendance at consulting rooms lasting more than 60 minutes (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)
05210	01FEB1984	31DEC9999	Y	Nasal polyp or polypi (requiring admission to hospital), removal of (G) (AU 7)
05214	01FEB1984	31DEC9999	Y	Nasal polyp or polypi (requiring admission to hospital), removal of (S) (AU 7)
05217	01FEB1984	31AUG1989	N	Nasal septum, septoplasty or submucous resection of (AU 9)
05217	01SEP1989	31DEC9999	Y	Nasal septum, septoplasty, submucous resection or closure of septal perforation (AU 9)
05220	01JAN2005	30APR2010	N	HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) BRIEF HOME VISIT of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05220	01MAY2010	31DEC2012	N	BRIEF CONSULTATION in an after hours period of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day
05220	01JAN2013	31DEC9999	Y	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting not more than 5 minutes-an attendance on one or more patients on one occasion-each patient
05223	01JAN2005	30APR2010	N	STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05223	01MAY2010	31DEC2012	N	STANDARD CONSULTATION in an after hours period of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day.
05223	01JAN2013	31DEC9999	Y	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 5 minutes, but not more than 25 minutes-an attendance on one or more patients on one occasion-each patient
05227	01JAN2005	30APR2010	N	LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05227	01MAY2010	31DEC2012	N	LONG CONSULTATION in an after hours period of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day.
05227	01JAN2013	31DEC9999	Y	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 25 minutes, but not more than 45 minutes-an attendance on one or more patients on one occasion-each patient
05228	01JAN2005	30APR2010	N	PROLONGED HOME VISIT of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05228	01MAY2010	31DEC2012	N	PROLONGED CONSULTATION in an after hours period of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day.
05228	01JAN2013	31OCT2023	N	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 45 minutes-an attendance on one or more patients on one occasion-each patient
05228	01NOV2023	31DEC9999	Y	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in this Schedule applies), lasting more than 45 minutes, but not more than 60 minutes-an attendance on one or more patients on one occasion-each patient
05229	01FEB1984	29FEB1984	N	Cauterisation or diathermy of any or all of septum, turbinates or pharynx -each attendance at which the procedure is performed, including any associated consultation (AU 6)
05229	01MAR1984	31AUG1989	N	Cauterisation (other than by chemical means) or diathermy of septum, turbinates or pharynx - one or more of these procedures (including any consultation on the same occasion) not associated with any other operation on the nose (AU 6)
05229	01SEP1989	31DEC9999	Y	Cauterisation (other than by chemical means) or cauterisation by chemical means when performed under general anaesthesia or diathermy of septum, turbinates or pharynx-one or more of these procedures (including any consultation on the same occasion) not associated with any other operation on the nose (AU 6)
05230	01FEB1984	29FEB1984	N	Cauterisation of blood vessels in nose during epistaxis (AU 7)
05230	01MAR1984	31AUG1989	N	Cauterisation (other than by chemical means) of blood vessels in nose during an episode of epistaxis, one or both sides (AU 7)
05230	01SEP1989	31DEC9999	Y	Nasal haemorrhage, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both (AU 7)
05233	01FEB1984	31DEC9999	Y	Cryotherapy to nose in the treatment of nasal haemorrhage (AU 7)
05234	01AUG1986	31AUG1989	N	DIVISION OF NASAL ADHESIONS, with or without stenting not associated with any other operation on the nose and not perfornned during the post-operative period of a nasal operation ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S
05234	01SEP1989	31DEC9999	Y	Division of nasal adhesions, with or without stenting not associated with any other operation on the nose and not performed during the post-operative period of a nasal operation (AU 6)
05235	01FEB1984	31DEC9999	Y	Dislocation of turbinate or turbinates, one or both sides, not associated with any other item in this Part (AU 6)
05237	01FEB1984	31AUG1989	N	Turbinectomy (AU 6)
05237	01SEP1989	31DEC9999	Y	Turbinectomy or turbinectomies, partial or total, unilateral (AU 6)
05240	01JAN2005	31DEC9999	Y	CONSULTATION AT AN INSTITUTION OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05241	01FEB1984	31AUG1989	N	Turbinates, submucous resection of (AU 8)
05241	01SEP1989	31DEC9999	Y	Turbinates, submucous resection of, unilateral (AU 8)
05242	01SEP1989	31DEC9999	Y	Nasal turbinates, cryotherapy to (AU 6)
05243	01JAN2005	31DEC9999	Y	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05245	01FEB1984	31DEC9999	Y	Maxillary antrum, proof puncture and lavage of (AU 6)
05247	01JAN2005	31DEC9999	Y	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05248	01JAN2005	31DEC9999	Y	PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05249	01FEB1984	31DEC9999	Y	Maxillary antrum, proof puncture and lavage of (D) (AU 6)
05254	01FEB1984	31AUG1989	N	Maxillary antrum, proof puncture and lavage of-- under general anaesthesia (requiring admission to hospital) (AU 6)
05254	01SEP1989	31DEC9999	Y	Maxillary antrum, proof puncture and lavage of-under general anaesthesia (requiring admission to hospital), not associated with any other item in this Part (AU 6)
05259	01FEB1984	31DEC9999	Y	Maxillary antrum, proof puncture and lavage of-- under general anaesthesia (D) (AU 6)
05260	01JAN2005	30APR2010	N	CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05260	01MAY2010	31DEC2012	N	BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05260	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of not more than 5 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05261	01NOV2023	31DEC9999	Y	Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in this Schedule applies), lasting more than 60 minutes-an attendance on one or more patients on one occasion-each patient
05262	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is a care recipient at the facility and is not a resident of a self-contained unit, lasting more than 60 minutes by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05263	01JAN2005	30APR2010	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05263	01MAY2010	31DEC2012	N	STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05263	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05264	01FEB1984	31DEC9999	Y	Maxillary antrum, lavage of-- each attendance at which the procedure is performed, including any associated consultation (AU 6)
05265	01JAN2005	30APR2010	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05265	01MAY2010	31DEC2012	N	LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05265	01JAN2013	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05267	01JAN2005	30APR2010	N	PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.
05267	01MAY2010	31DEC2012	N	PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day.
05267	01JAN2013	31OCT2023	N	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 45 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05267	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is a care recipient in the facility who is not a resident of a self-contained unit, lasting more than 45 minutes, but not more than 60 minutes, by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
05268	01FEB1984	31DEC9999	Y	Maxillary artery, transantral ligation of (AU 9)
05270	01FEB1984	31DEC9999	Y	Antrostomy (radical) (AU 9)
05274	01FEB1984	31DEC9999	Y	Antrostomy (radical) (D) (AU 9)
05277	01FEB1984	31DEC9999	Y	Antrostomy (radical) with transantral ethmoidectomy or transantral vidian neurectomy (AU 10)
05280	01FEB1984	31DEC9999	Y	Antrum, intranasal operation on or removal of foreign body from (AU 8)
05282	01FEB1984	31DEC9999	Y	Antrum, intranasal operation on or removal of foreign body from (D) (AU 8)
05284	01FEB1984	31DEC9999	Y	Antrum, drainage of, through tooth socket (AU 7)
05286	01FEB1984	31DEC9999	Y	Antrum, drainage of, through tooth socket (D) (AU 7)
05288	01FEB1984	31DEC9999	Y	Oro-antral fistula, plastic closure of (AU 11)
05291	01FEB1984	31DEC9999	Y	Oro-antral fistula, plastic closure of (D) (AU 11)
05292	01SEP1986	31AUG1989	N	ETHMOIDAL ARTERY OR ARTERIES, transorbital ligation of (unilateral) ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
05292	01SEP1989	31DEC9999	Y	Ethmoidal artery or arteries, transorbital ligation of (unilateral) (AU 10)
05293	01AUG1986	31AUG1989	N	LATERAL RHINOTOMY with removal of tumour ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
05293	01SEP1989	31DEC9999	Y	Lateral rhinotomy with removal of tumour (AU 12)
05295	01FEB1984	31DEC9999	Y	Fronto-nasal ethmoidectomy with or without sphenoidectomy (AU 9)
05298	01FEB1984	31DEC9999	Y	Radical fronto-ethmoidectomy with osteoplastic flap (AU 13)
05301	01FEB1984	31DEC9999	Y	Frontal sinus or ethmoidal sinuses, intranasal operation on (AU 9)
05305	01FEB1984	31DEC9999	Y	Frontal sinus, catheterisation of (AU 6)
05308	01FEB1984	31DEC9999	Y	Frontal sinus, trephine of (AU 6)
05318	01FEB1984	31DEC9999	Y	Frontal sinus, radical obliteration of (AU 10)
05320	01FEB1984	31DEC9999	Y	Ethmoidal sinuses, external operation on (AU 10)
05330	01FEB1984	31DEC9999	Y	Sphenoidal sinus, intranasal operation on (AU 10)
05343	01FEB1984	31DEC9999	Y	Eustachian tube, catheterisation of (AU 6)
05345	01FEB1984	31DEC9999	Y	Division of pharyngeal adhesions (AU 7)
05348	01FEB1984	31AUG1989	N	Post-nasal spaces, direct examination of, with biopsy nasendoscopy or sinoscopy (unilateral) (AU 7)
05348	01SEP1989	31DEC9999	Y	Post nasal space, direct examination of, with or without biopsy (AU 7)
05349	01AUG1986	31AUG1989	N	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S
05349	01SEP1989	31DEC9999	Y	Nasendoscopy or sinoscopy or fibreoptic examination of nasopharynx and larynx (AU 7)
05350	01AUG1986	31AUG1989	N	NASOPHARYNGEAL ANGIOFIBROMA, transpalatal removal ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
05350	01SEP1989	31DEC9999	Y	Nasopharyngeal angiofibroma, transpalatal removal (AU 12)
05354	01FEB1984	31AUG1989	N	Pharyngeal pouch, removal of (AU 16)
05354	01SEP1989	31DEC9999	Y	Pharyngeal pouch, removal of, with or without cricopharyngeal myotomy (AU 16)
05357	01FEB1984	31DEC9999	Y	Pharyngeal pouch, endoscopic resection of (Dohlman's operation) (AU 14)
05358	01AUG1986	31AUG1989	N	CRICOPHARYNGEAL MYOTOMY with or without inversion of pharyngeal pouch ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
05358	01SEP1989	31DEC9999	Y	Cricopharyngeal myotomy with or without inversion of pharyngeal pouch (AU 10)
05360	01FEB1984	31DEC9999	Y	Pharyngotomy (lateral), with or without total excision of tongue (AU 6)
05361	01OCT1986	31AUG1989	N	PARTIAL PHARYNGECTOMY via PHARYNGOTOMY ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
05361	01SEP1989	31DEC9999	Y	Partial pharyngectomy via pharyngotomy (AU 12)
05362	01SEP1986	31AUG1989	N	PARTIAL PHARYNGECTOMY via PHARYNGOTOMY with partial or total glossectomy ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S
05362	01SEP1989	31DEC9999	Y	Partial pharyngectomy via pharyngotomy with partial or total glossectomy (AU 14)
05363	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a person aged less than twelve years (G) (AU 7)
05366	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a person aged less than twelve years (S) (AU 7)
05389	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a person twelve years of age or over (G) (AU 8)
05392	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a person twelve years of age or over (S) (AU 8)
05396	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, arrest of haemorrhage requiring general anaesthesia, following removal of (G) (AU 9)
05401	01FEB1984	31DEC9999	Y	Tonsils or tonsils and adenoids, arrest of haemorrhage requiring general anaesthesia, following removal of (S) (AU 9)
05407	01FEB1984	31DEC9999	Y	Adenoids, removal of (G) (AU 6)
05411	01FEB1984	31DEC9999	Y	Adenoids, removal of (S) (AU 6)
05431	01FEB1984	31DEC9999	Y	Lingual tonsil or lateral pharyngeal bands, removal of (AU 7)
05445	01FEB1984	31DEC9999	Y	Peritonsillar abscess (quinsy) , incision of (AU 7)
05449	01FEB1984	31DEC9999	Y	Uvulotomy (AU 6)
05456	01FEB1984	31DEC9999	Y	Vallecular or pharyngeal cysts, removal of (AU 8)
05464	01FEB1984	31DEC9999	Y	Oesophagoscopy (with rigid oesophagoscope) (AU 6)
05470	01FEB1984	31DEC9999	Y	Oesophagoscopy with dilatation or insertion of prosthesis-- each occasion (AU 7)
05480	01FEB1984	31DEC9999	Y	Oesophagoscopy (with rigid oesophagoscope) with biopsy (AU 7)
05486	01FEB1984	31DEC9999	Y	Oesophagoscopy (with rigid oesophagoscope) with removal of foreign body (AU 7)
05490	01FEB1984	31DEC9999	Y	Oesophageal stricture, dilatation of, without oesophagoscopy (AU 6)
05492	01FEB1984	31AUG1989	N	Oesophagus, pneumatic dilatation of (AU 8)
05492	01SEP1989	31DEC9999	Y	Oesophagus, endoscopic pneumatic dilatation of (AU 8)
05498	01FEB1984	31DEC9999	Y	Laryngectomy (total) (AU 20)
05499	01AUG1986	31AUG1989	N	VERTICAL HEMI-LARYNGECTOMY including tracheostomy ANAESTHETIC 17 UNITS - ITEM NOS 461G / 528S
05499	01SEP1989	31DEC9999	Y	Vertical hemi-laryngectomy including tracheostomy (AU 17)
05500	01DEC1986	31AUG1989	N	SUPRAGLOTTIC LARYNGECTOMY including tracheostomy ANAESTHETIC 21 UNITS - ITEM NOS 465G / 535S
05500	01SEP1989	31DEC9999	Y	Supraglottic laryngectomy including tracheostomy (AU 21)
05508	01FEB1984	31DEC9999	Y	Laryngopharyngectomy or primary restoration of alimentary continuity after laryngopharyngectomy using stomach or bowel (AU 20)
05520	01FEB1984	31AUG1989	N	Larynx, direct examination of, as an independent procedure (AU 8)
05520	01SEP1989	31DEC9999	Y	Larynx, direct examination of the supraglottic, glottic and subglottic regions, not associated with any other procedure on the larynx nor with the administration of a general anaesthetic (AU 8)
05524	01FEB1984	31DEC9999	Y	Larynx, direct examination of, with biopsy (AU 8)
05530	01FEB1984	31DEC9999	Y	Larynx, direct examination of, with removal of tumour (AU 9)
05534	01FEB1984	31DEC9999	Y	Microlaryngoscopy (AU 8)
05538	01AUG1986	31AUG1989	N	MICROLARYNGOSCOPY with removal of juvenile papillomata ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
05538	01SEP1989	31DEC9999	Y	Microlaryngoscopy with removal of juvenile papillomata (AU 10)
05539	01AUG1986	31AUG1989	N	MICROLARYNGOSCOPY with removal of papillomata by laser surgery ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S
05539	01SEP1989	31DEC9999	Y	Microlaryngoscopy with removal of papillomata by laser surgery (AU 13)
05540	01FEB1984	31DEC9999	Y	Microlaryngoscopy with removal of tumour (AU 9)
05541	01AUG1986	31AUG1989	N	MICROLARYNGOSCOPY with arytenoidectomy ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S
05541	01SEP1989	31DEC9999	Y	Microlaryngoscopy with arytenoidectomy (AU 13)
05542	01FEB1984	31DEC9999	Y	Teflon injection into vocal cord (AU 9)
05545	01FEB1984	31DEC9999	Y	Larynx, fractured, operation for (AU 15)
05556	01FEB1984	31AUG1989	N	Larynx, external operation on or laryngofissure (AU 13)
05556	01SEP1989	31DEC9999	Y	Larynx, external operation on, or laryngofissure, with or without cordectomy (AU 13)
05557	01OCT1986	31AUG1989	N	LARYNGOPLASTY or TRACHEOPLASTY, including tracheostomy ANAESTHETIC 17 UNITS - ITEM NOS 461G / 528S
05557	01SEP1989	31DEC9999	Y	Laryngoplasty or tracheoplasty, including tracheostomy (AU 17)
05572	01FEB1984	31DEC9999	Y	Tracheostomy (G) (AU 10)
05598	01FEB1984	31DEC9999	Y	Tracheostomy (S) (AU 10)
05601	01FEB1984	31DEC9999	Y	Trachea, removal of foreign body in (AU 7)
05605	01FEB1984	31DEC9999	Y	Bronchoscopy, as an independent procedure (AU 7)
05611	01FEB1984	31DEC9999	Y	Bronchoscopy with biopsy or other diagnostic or therapeutic procedure (AU 8)
05613	01FEB1984	31DEC9999	Y	Bronchus, removal of foreign body in (AU 9)
05615	01MAY1990	31DEC9999	Y	FIBREOPTIC BRONCHOSCOPY with one or more transbronchial lung biopsies, with or without bronchial or broncho- alveolar lavage, with or without the use of interventional imaging ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S
05617	01MAY1990	31DEC9999	Y	ENDOSCOPIC LASER RESECTION OF ENDOBRONCHIAL TUMOURS for relief of obstruction including any associated endoscopic procedures ANAESTHETIC 15 UNITS - ITEM NOS 459G / 526S
05619	01FEB1984	31DEC9999	Y	Bronchoscopy with dilatation of tracheal stricture (AU 7)
05636	01FEB1984	31AUG1989	N	Adrenal gland, biopsy or removal of (AU 12)
05636	01SEP1989	31DEC9999	Y	Adrenal gland, excision of-partial or total (AU 12)
05642	01FEB1984	31DEC9999	Y	Renal transplant, not covered by Items 5644 and 5645 (AU 24)
05644	01FEB1984	31DEC9999	Y	Renal transplant, performed by vascular surgeon and urologist operating together-- vascular anastomosis, including aftercare (AU 24)
05645	01FEB1984	31DEC9999	Y	Renal transplant, performed by vascular surgeon and urologist operating together-- ureterovesical anastomosis, including after-care
05647	01FEB1984	29FEB1984	N	Donor nephrectomy (cadaver)
05647	01MAR1984	31DEC9999	Y	Donor nephrectomy (cadaver) , one or both kidneys
05654	01FEB1984	31DEC9999	Y	Nephrectomy, complete (G) (AU 11)
05661	01FEB1984	31DEC9999	Y	Nephrectomy, complete (S) (AU 11)
05663	01FEB1989	31DEC9999	Y	Nephrectomy, complete, complicated by previous surgery on the same kidney (AU 13)
05665	01FEB1984	31AUG1989	N	Partial nephrectomy, nephrectomy complicated by previous surgery on the same kidney or nephroureterectomy (AU 13)
05665	01SEP1989	31DEC9999	Y	Nephrectomy, partial (AU 13)
05666	01FEB1989	31DEC9999	Y	Nephrectomy, partial, complicated by previous surgery on the same kidney (AU 15)
05667	01NOV1984	31DEC9999	Y	Nephrectomy, radical, with enbloc dissection of lymph nodes, with or without adrenalectomy (AU 17)
05675	01FEB1984	31AUG1989	N	Nephro-ureterectomy, complete, with bladder repair (AU 17)
05675	01SEP1989	31DEC9999	Y	Nephro-ureterectomy, complete, including associated bladder repair and any associated endoscopic procedure (AU 17)
05679	01FEB1984	31DEC1984	N	Kidney, fused, symphysiotomy for (AU 14)
05679	01JAN1985	31AUG1989	N	KIDNEY, FUSED, symphysiotomy for ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S
05679	01SEP1989	31DEC9999	Y	Kidney, fused, renal symphysiotomy for (AU 14)
05683	01FEB1984	31AUG1989	N	Kidney, exploration of, with any procedure, not covered by any other item in this Part (AU 10)
05683	01SEP1989	31DEC9999	Y	Kidney or perinephric area, exploration of, with or without drainage of, by open exposure, not covered by any other item in this Part (AU 10)
05691	01FEB1984	31AUG1989	N	Nephrolithotomy or pyelolithotomy (AU 12)
05691	01SEP1989	31DEC9999	Y	Nephrolithotomy or pyelolithotomy, or both, through the same skin incision, for one or two stones (AU 12)
05699	01FEB1984	31AUG1989	N	Nephrolithotomy or pyelolithotomy, where complicated by previous surgery on the same kidney or for large staghorn calculus filling renal pelvis and calyces (AU 12)
05699	01SEP1989	31DEC9999	Y	Nephrolithotomy or pyelolithotomy, or both, extended, for staghorn stone or 3 or more stones, including one or more of the following: nephrostomy, pyelostomy, pedicle control with or without freezing, calyorrhaphy or pyeloplasty (AU 12)
05700	01AUG1986	31AUG1989	N	EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY and post-operative care for three days, including pre-operative consultation In hospital for assessment for lithotripsy ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
05700	01SEP1989	31DEC9999	Y	Extracorporeal shock wave lithotripsy (ESWL) to urinary tract and post-treatment care for three days, including pre-treatment consultation (AU 12)
05705	01FEB1984	31DEC9999	Y	Ureterolithotomy (AU 11)
05715	01FEB1984	31AUG1989	N	Nephrostomy, nephrotomy or pyelostomy with drainage (AU 11)
05715	01SEP1989	31DEC9999	Y	Nephrostomy or pyelostomy, open, as an independent procedure (AU 11)
05721	01FEB1984	31DEC9999	Y	Nephropexy, as an independent procedure (AU 9)
05724	01FEB1984	31DEC9999	Y	Renal cyst or cysts, excision or unroofing of (AU 11)
05726	01FEB1984	31DEC9999	Y	Renal biopsy (closed) (AU 6)
05729	01FEB1984	31DEC9999	Y	Pyonephrosis, drainage of (AU 11)
05732	01FEB1984	31DEC9999	Y	Perinephric abscess, drainage of (AU 9)
05734	01FEB1984	31AUG1989	N	Pyeloplasty (AU 14)
05734	01SEP1989	31DEC9999	Y	Pyeloplasty,by open exposure (AU 14)
05737	01FEB1984	31AUG1989	N	Pyeloplasty, complicated by previous surgery on same kidney or by congenital kidney abnormality or by the operation being on a solitary kidney (AU 14)
05737	01SEP1989	31DEC9999	Y	Pyeloplasty in congenitally abnormal kidney or solitary kidney, by open exposure (AU 14)
05738	01FEB1989	31DEC9999	Y	Pyeloplasty, complicated by previous surgery on the same kidney, by open exposure (AU 15)
05741	01FEB1984	31DEC9999	Y	Divided ureter, repair of (AU 13)
05744	01FEB1984	31AUG1989	N	Repair of kidney, wound or injury (AU 13)
05744	01SEP1989	31DEC9999	Y	Kidney, exposure and exploration of, including repair or nephrectomy, for trauma, not associated with any other procedure performed on the kidney, renal pelvis or renal pedicle (AU 13)
05747	01FEB1984	31AUG1989	N	Ureterectomy, complete or partial, with bladder repair (AU 12)
05747	01SEP1989	31DEC9999	Y	Ureterectomy, complete or partial, with or without associated bladder repair, not associated with item 5889 (AU 12)
05753	01FEB1984	31AUG1989	N	Replacement of ureter by bowel-- unilateral (AU 12)
05753	01SEP1989	31DEC9999	Y	Ureter, replacement of, by bowel (AU 12)
05757	01FEB1984	31DEC9999	Y	Replacement of ureter by bowel-- bilateral (AU 17)
05763	01FEB1984	31AUG1989	N	Ureter (unilateral), transplantation of, into skin (AU 10)
05763	01SEP1989	31DEC9999	Y	Ureter, transplantation of, into skin (AU10)
05769	01FEB1984	31DEC9999	Y	Ureters (bilateral), transplantation of, into skin (AU 12)
05773	01FEB1984	31AUG1989	N	Ureter (unilateral), transplantation of, into bladder (AU 12)
05773	01SEP1989	31DEC9999	Y	Ureter, reimplantation into bladder (AU 12)
05777	01FEB1984	31DEC9999	Y	Ureters (bilateral), transplantation of, into bladder (AU 14)
05780	01FEB1984	31AUG1989	N	Ureter, transplantation of, into bladder with bladder plastic procedure (Boari flap) (AU 12)
05780	01SEP1989	31DEC9999	Y	Ureter, reimplantation into bladder with psoas hitch or Boari flap or both (AU 12)
05785	01FEB1984	31AUG1989	N	Ureter (unilateral), transplantation of, into intestine (AU 12)
05785	01SEP1989	31DEC9999	Y	Ureter, transplantation of, into intestine (AU 12)
05792	01FEB1984	31DEC9999	Y	Ureters (bilateral), transplantation of, into intestine (AU 14)
05799	01FEB1984	31AUG1989	N	Ureter, transplantation of, into other ureter (AU 12)
05799	01SEP1989	31DEC9999	Y	Ureter, transplantation of, into another ureter (AU 12)
05804	01FEB1984	31AUG1989	N	Ureter (unilateral), transplantation of, into isolated intestinal loop (AU 14)
05804	01SEP1989	31DEC9999	Y	Ureter, transplantation of, into isolated intestinal segment, unilateral (AU 14)
05807	01FEB1984	31AUG1989	N	Ureters (bilateral), transplantation of, into isolated intestinal loop (AU 16)
05807	01SEP1989	31DEC9999	Y	Ureters, transplantation of, into isolated intestinal segment, bilateral (AU 16)
05808	01FEB1989	31DEC9999	Y	Intestinal urinary reservoir, continent, formation of, including formation of nonreturn valves and implantation of ureters (one or both) into reservoir (AU 27)
05809	01FEB1989	31DEC9999	Y	Intestinal urinary conduit or ureterostomy, revision of (AU 13)
05812	01FEB1984	31AUG1989	N	Ureterotomy, with exploration or drainage, as an independent procedure (AU 11)
05812	01SEP1989	31DEC9999	Y	Ureter, exploration of, with or without drainage of, as an independent procedure (AU 11)
05816	01FEB1984	31DEC9999	Y	Ureterotomy, with exploration or drainage for tumour, as an independent procedure (AU 11)
05821	01FEB1984	31AUG1989	N	Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition-- unilateral (AU 11)
05821	01SEP1989	31DEC9999	Y	Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition (AU 11)
05827	01FEB1984	31DEC9999	Y	Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition-- bilateral (AU 13)
05831	01FEB1984	31AUG1989	N	Reduction ureteroplasty, unilateral (AU 14)
05831	01SEP1989	31DEC9999	Y	Reduction ureteroplasty (AU 14)
05836	01FEB1984	31DEC9999	Y	Reduction ureteroplasty, bilateral (AU 17)
05837	01FEB1984	31AUG1989	N	Closure of cutaneous ureterostomy-- unilateral (AU 9)
05837	01SEP1989	31DEC9999	Y	Closure of cutaneous ureterostomy (AU 9)
05840	01FEB1984	31AUG1989	N	Bladder, catheterisation of-- where no other surgical procedure is performed (AU 4)
05840	01SEP1989	31DEC9999	Y	Bladder, catheterisation of , where no other procedure is performed (AU 4)
05841	01JAN1986	31AUG1989	N	CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter (not associated with a service covered by Items 5842 to 5888) ANAESTHETIC 5 UNITS - ITEM NOS 406G / 51 OS
05841	01SEP1989	31DEC9999	Y	Ureteroscopy, with or without any one or more of; cystoscopy, ureteric meatotomy, ureteric dilatation and pyeloscopy, not associated with item 5842, 5843, 5845, 5851, 5878 or 5885 (AU 7)
05842	01JAN1986	31AUG1989	N	CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter with one or more of the following procedures in the ureter or renal pelvis - biopsy, diathermy, calculus extraction (not associated with a service covered by Item 5841 and Items 5843 to 5888) ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S
05842	01SEP1989	31DEC9999	Y	Ureteroscopy as described in item 5841, plus one or more of extraction of stone, biopsy or diathermy (AU 9)
05843	01JAN1986	31AUG1989	N	CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter with ultrasonic or electrohydraulic pulse disintegration of stone in the ureter or renal pelvis (not associated with Items 5841,5842 and 5845 to 5888) ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S
05843	01SEP1989	31DEC9999	Y	Ureteroscopy as described in item 5841, plus destruction of stone with ultrasound, electrohydraulic shock waves, or laser, with extraction of fragments (AU 11)
05845	01FEB1984	31AUG1989	N	Cystoscopy, with or without urethral dilatation (AU 5)
05845	01SEP1989	31DEC9999	Y	Cystoscopy with urethroscopy, with or without urethral dilatation, not associated with any other urological endoscopic procedure on the lower urinary tract except item 6070 (AU 5)
05846	01DEC1989	31DEC9999	Y	CYSTOSCOPY, with or without urethroscopy, for the treatment of penile warts or uretheral warts, not associated with Item 3347 ANAESTHETIC 6 UNIITS - ITEM NOS 407G/513S
05847	01FEB1989	31DEC9999	Y	Cystoscopy with ureteric catheterisation including imaging of the upper urinary tract, unilateral or bilateral, not associated with item 5851 or 5855 (AU 6)
05849	01FEB1989	31DEC9999	Y	Cystoscopy with one or more of; ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or of renal pelvis, unilateral, not associated with item 5851 or 5855 (AU 6)
05851	01FEB1984	31AUG1989	N	Cystoscopy, with ureteric catheterisation, with or without introduction of opaque medium (AU 5)
05851	01SEP1989	31DEC9999	Y	Cystoscopy with ureteric catheterisation, unilateral or bilateral, not associated with item 5847 or 5849 (AU 5)
05853	01FEB1984	31DEC9999	Y	Cystoscopy, with controlled hydrodilatation of the bladder (AU 5)
05855	01FEB1989	31DEC9999	Y	Cystoscopy, with ureteric meatotomy (AU 5)
05861	01FEB1984	31DEC9999	Y	Ascending cysto-urethrography (AU 5)
05864	01FEB1984	31AUG1989	N	Cystoscopic removal of foreign body (AU 6)
05864	01SEP1989	31DEC9999	Y	Cystoscopy with removal of foreign body (AU 6)
05868	01FEB1984	31AUG1989	N	Cystoscopy, with biopsy of bladder tumours (AU 6)
05868	01SEP1989	31DEC9999	Y	Cystoscopy with biopsy of bladder, not associated with item 5845, 5855, 5871, 5875, 5878, 5881, 6005, 6006 or 6027 (AU 6)
05871	01FEB1984	31AUG1989	N	Cystoscopy, with diathermy or resection of superficial bladder tumours or with other diathermy of bladder or prostate (AU 6)
05871	01SEP1989	31DEC9999	Y	Cystoscopy with resection or diathermy of bladder tumour or other lesion of the bladder or prostate, not associated with item 5875 (AU 6)
05872	01DEC1989	31DEC9999	Y	CYSTOSCOPY, with lavage of blood clots from bladder including any associated diathermy of prostate or bladder and not associated with Item 5845 and Items 5853 to 5888 and Items 6005 and 6006 ANAESTHETIC 8 UNITS - ITEM NOS 409G I 517S
05875	01FEB1984	31AUG1989	N	Cystoscopy with diathermy or resection of invasive bladder tumours or solitary tumour over 2 centimetres in diameter (AU 6)
05875	01SEP1989	31DEC9999	Y	Cystoscopy with diathermy or resection of multiple bladder tumours in more than two quadrants of the bladder or solitary tumour greater than 2 centimetres in diameter (AU 6)
05878	01FEB1984	29FEB1984	N	Cystoscopy, with ureteric meatotomy or with resection of ureterocoele (AU 5)
05878	01MAR1984	31AUG1989	N	Cystoscopy, with ureteric meatotomy or with resection of ureterocele(AU 5)
05878	01SEP1989	31DEC9999	Y	Cystoscopy with resection of ureterocele (AU 5)
05879	01FEB1989	31DEC9999	Y	Cystoscopy with injection into bladder wall (AU 5)
05881	01FEB1984	29FEB1984	N	Cystoscopy with endoscopic resection bladder neck or cystoscopy with endoscopic incision of bladder neck or both of these procedures (AU 7)
05881	01MAR1984	31AUG1989	N	Cystoscopy with endoscopic resection of bladder neck or cystoscopy with endoscopic incision of bladder neck or both of these procedures (AU 7)
05881	01SEP1989	31DEC9999	Y	Cystoscopy with endoscopic incision or resection of external sphincter, bladder neck or both (AU 7)
05883	01FEB1984	31DEC9999	Y	Endoscopic external sphincterotomy for neurogenic bladder neck obstruction not associated with Item 5881 (AU 7)
05885	01FEB1984	31AUG1989	N	Cystoscopy, with endoscopic removal or manipulation of ureteric calculus (AU 6)
05885	01SEP1989	31DEC9999	Y	Endoscopic manipulation or extraction of ureteric calculus (AU 6)
05886	01FEB1989	31DEC9999	Y	Endoscopic examination of intestinal conduit or reservoir (AU 5)
05888	01FEB1984	29FEB1984	N	Litholapaxy, with or without cystoscopy (AU 7)
05888	01MAR1984	31DEC9999	Y	Litholapaxy, with or without cystoscopy (AU 7) 235.00 235.00 235.00 235.00 235.00 235.00 Operations on the Bladder (Open)
05889	01FEB1989	31DEC9999	Y	Bladder, partial excision of (AU 13)
05891	01FEB1984	31AUG1989	N	Bladder, repair of rupture of, or partial excision of, or plastic repair of (G) (AU 13)
05891	01SEP1989	31DEC9999	Y	Bladder, repair of rupture (G) (AU 13)
05894	01FEB1984	31AUG1989	N	Bladder, repair of rupture of, or partial excision of, or plastic repair of (S) (AU 13)
05894	01SEP1989	31DEC9999	Y	Bladder, repair of rupture (S) (AU 13)
05897	01FEB1984	31AUG1989	N	Cystostomy or cystotomy, suprapubic (not covered by Item 5903) (G) (AU 8)
05897	01SEP1989	31DEC9999	Y	Cystostomy or cystotomy, suprapubic, not covered by item 5903 and not associated with other open bladder procedure (G) (AU 8)
05901	01FEB1984	31AUG1989	N	Cystostomy or cystotomy, suprapubic (not covered by Item 5903) (S) (AU 8)
05901	01SEP1989	31DEC9999	Y	Cystostomy or cystotomy, suprapubic, not covered by item 5903 and not associated with other open bladder procedure (S) (AU 8)
05903	01FEB1984	31DEC9999	Y	Suprapubic stab cystotomy (AU 6)
05905	01FEB1984	31DEC9999	Y	Bladder, total excision of (AU 29)
05906	01NOV2006	31DEC9999	Y	Professional attendance of not more than 5 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms)
05908	01NOV2006	31DEC9999	Y	Professional attendance of more than 5 minutes duration but not more than 20 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms)
05910	01NOV2006	31DEC9999	Y	Professional attendance of more than 20 minutes duration but not more than 40 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms)
05912	01NOV2006	31DEC9999	Y	Professional attendance of more than 40 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms)
05916	01FEB1984	31DEC9999	Y	Bladder neck contracture, operation for (AU 9)
05919	01FEB1984	31DEC9999	Y	Bladder tumours, suprapubic diathermy of (AU 10)
05929	01FEB1984	31AUG1989	N	Diverticulum of bladder, excision or obliteration of (AU 10)
05929	01SEP1989	31DEC9999	Y	Bladder diverticulum, excision or obliteration of (AU 10)
05935	01FEB1984	31DEC9999	Y	Vesical fistula, cutaneous, operation for (AU 12)
05936	01FEB1989	31DEC9999	Y	Cutaneous vesicostomy, establishment of (AU 9)
05941	01FEB1984	31DEC9999	Y	Vesico-vaginal fistula, closure of by abdominal approach (AU 12)
05942	01FEB1989	31DEC9999	Y	Vesico-vaginal fistula, closure of, synchronous combined approach, abdominal component, including aftercare (AU 12)
05943	01FEB1989	31DEC9999	Y	Vesico-vaginal fistula, closure of, synchronous combined approach, vaginal component, including aftercare
05947	01FEB1984	31AUG1989	N	Vesico-colic fistula, closure of, excluding bowel resection (AU 11)
05947	01SEP1989	31DEC9999	Y	Vesico-intestinal fistula, closure of, excluding bowel resection (AU 11)
05956	01FEB1984	31DEC9999	Y	Vesico-rectal fistula, closure of (AU 13)
05964	01FEB1984	31DEC9999	Y	Bladder aspiration, by needle
05968	01FEB1984	31DEC9999	Y	Cystotomy, with removal of calculus, as an independent procedure (AU 8)
05977	01FEB1984	31AUG1989	N	Urethropexy (Marshall-Marchetti operation) (AU 9)
05977	01SEP1989	31DEC9999	Y	Bladder stress incontinence, suprapubic procedure for, not covered by item 6406 (AU 9)
05981	01FEB1984	31AUG1989	N	Bladder enlargement using intestine or segment of bowel (AU 23)
05981	01SEP1989	31DEC9999	Y	Bladder enlargement using intestine (AU 23)
05982	01FEB1989	31DEC9999	Y	Bladder extrophy closure, not involving sphincter reconstruction (AU 14)
05984	01FEB1984	31DEC9999	Y	Correction of vesico-ureteric reflux-- operation for-- unilateral (AU 12)
05993	01FEB1984	31DEC9999	Y	Correction of vesico-ureteric reflux-- operation for-- bilateral (AU 14)
06001	01FEB1984	31AUG1989	N	Prostatectomy (suprapubic, perineal or retropubic) (AU 13)
06001	01SEP1989	31DEC9999	Y	Prostatectomy, open (AU13)
06004	01JAN2013	31DEC9999	Y	Initial professional attendance of 10 minutes or less in duration on a patient by a specialist practising in his or her specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
06005	01FEB1984	31AUG1989	N	Prostatectomy (endoscopic), with or without cystoscopy (AU 10)
06005	01SEP1989	31DEC9999	Y	Prostatectomy (endoscopic), with or without cystoscopy, and with or without urethroscopy, and including services covered by item 6039, 6066 or 6069 (AU 10)
06006	01FEB1989	31DEC9999	Y	Prostatectomy (endoscopic), with or without cystoscopy, and with or without urethroscopy, and including services covered by items 6039, 6066 and 6069, continuation of, within 10 days of initial procedure which had to be discontinued for medical reasons (AU 9)
06007	01NOV2006	31OCT2019	N	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at consulting rooms or hospital
06007	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at consulting rooms or hospital
06009	01NOV2006	31OCT2019	N	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-a minor attendance after the first in a single course of treatment at consulting rooms or hospital
06009	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment at consulting rooms or hospital
06010	01FEB1984	31DEC9999	Y	Median bar, endoscopic resection of, with or without cystoscopy (AU 9)
06011	01NOV2006	31OCT2019	N	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving an extensive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration at consulting rooms or hospital
06011	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving an extensive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration at consulting rooms or hospital
06013	01NOV2006	31OCT2019	N	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving a detailed and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration at consulting rooms or hospital
06013	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving a detailed and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration at consulting rooms or hospital
06015	01NOV2006	31OCT2019	N	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving an exhaustive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration at consulting rooms or hospital
06015	01NOV2019	31DEC9999	Y	Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving an exhaustive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration at consulting rooms or hospital
06016	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a specialist practising in the specialty of neurosurgery to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or b) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 6007, 6009, 6011, 6013 or 6015.
06016	01NOV2012	31DEC2012	N	Professional attendance on a patient by a specialist practising in his or her specialty of neurosurgery if: (a) the attendance is by video conference; and (b) item 6007, 6009, 6011, 6013 or 6015 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
06016	01JAN2013	31OCT2019	N	Professional attendance on a patient by a specialist practising in his or her specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6007 lasting more than 10 minutes; or (ii) provided with item 6009, 6011, 6013 or 6015; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
06016	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a specialist practising in the specialist's specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6007 lasting more than 10 minutes; or (ii) provided with item 6009, 6011, 6013 or 6015; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies
06017	01FEB1984	31DEC9999	Y	Prostate, total excision of (AU 13)
06018	01NOV2016	31OCT2019	N	Professional attendance by an addiction medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided
06018	01NOV2019	31DEC9999	Y	Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty following referral of the patient to the addiction medicine specialist by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided
06019	01NOV2016	31OCT2019	N	Professional attendance by an addiction medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6018 in a single course of treatment; or (b) that follows an initial assessment under item 6023 in a single course of treatment; or (c) that follows a review under item 6024 in a single course of treatment
06019	01NOV2019	31DEC9999	Y	Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty following referral of the patient to the addiction medicine specialist by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6018 in a single course of treatment; or (b) that follows an initial assessment under item 6023 in a single course of treatment; or (c) that follows a review under item 6024 in a single course of treatment
06022	01FEB1984	31AUG1989	N	Prostate, open perineal biopsy of (AU 6)
06022	01SEP1989	31DEC9999	Y	Prostate, open perineal biopsy or open drainage of abscess (AU 6)
06023	01NOV2016	31OCT2019	N	Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) an addiction medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same addiction medicine specialist
06023	01NOV2019	31DEC9999	Y	Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to the addiction medicine specialist by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) an addiction medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same addiction medicine specialist
06024	01NOV2016	30APR2017	N	Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 20 minutes after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06024	01MAY2017	31OCT2019	N	Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 20 minutes, after the first attendance in a single course of treatment, for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06024	01NOV2019	31DEC9999	Y	Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty of at least 20 minutes, after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06025	01NOV2016	31OCT2019	N	Initial professional attendance of 10 minutes or less, on a patient by an addiction medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
06025	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less, on a patient by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
06026	01NOV2016	31OCT2019	N	Professional attendance on a patient by an addiction medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6018 or 6019 and lasting more than 10 minutes; or (ii) provided with item 6023 or 6024; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
06026	01NOV2019	31DEC9999	Y	Professional attendance on a patient by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6018 or 6019 and lasting more than 10 minutes; or (ii) provided with item 6023 or 6024; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
06027	01FEB1984	31DEC9999	Y	Prostate, biopsy of, endoscopic, with or without cystoscopy (AU 6)
06028	01NOV2016	31OCT2019	N	Group therapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour, given under the continuous direct supervision of an addiction medicine specialist in the practice of his or her specialty for a group of 2 to 9 unrelated patients, or a family group of more than 2 patients, each of whom is referred to the addiction medicine specialist by a referring practitioner-for each patient
06028	01NOV2019	31DEC9999	Y	Group therapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour, given under the continuous direct supervision of an addiction medicine specialist in the practice of the addiction medicine specialist's specialty for a group of 2 to 9 unrelated patients, or a family group of more than 2 patients, each of whom is referred to the addiction medicine specialist by a referring practitioner-for each patient
06029	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team
06029	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team
06030	01FEB1984	31DEC9999	Y	Prostate, needle biopsy of, or injection into (AU 5)
06031	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06031	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06032	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06032	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06033	01FEB1984	31AUG1989	N	Prostatic abscess, retropubic or endoscopic drainage of (AU 7)
06033	01SEP1989	31DEC9999	Y	Prostatic abscess, endoscopic drainage of (AU 7)
06034	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate the multidisciplinary case conference of at least 45 minutes, with the multidisciplinary case conference team
06034	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate the multidisciplinary case conference of at least 45 minutes, with the multidisciplinary case conference team
06035	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team
06035	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team
06036	01FEB1984	31DEC9999	Y	Urethral sounds, passage of, as an independent procedure (AU 5)
06037	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06037	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06038	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06038	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06039	01FEB1984	31DEC9999	Y	Urethral stricture, dilatation of (AU 5)
06040	01FEB1989	31DEC9999	Y	Urethra, repair of rupture of distal section (AU 9)
06041	01FEB1984	31AUG1989	N	Urethra, repair of rupture of (AU 10)
06041	01SEP1989	31DEC9999	Y	Urethra, repair of rupture of prostatic or membranous segment (AU 10)
06042	01NOV2016	31OCT2019	N	Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
06042	01NOV2019	31DEC9999	Y	Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
06044	01FEB1984	31DEC9999	Y	Urethral fistula, closure of (AU 8)
06047	01FEB1984	31DEC9999	Y	Urethroscopy, as an independent procedure (AU 5)
06050	01DEC1991	31DEC9999	Y	[Unidentified item]
06051	01NOV2016	31OCT2019	N	Professional attendance by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided
06051	01NOV2019	31DEC9999	Y	Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided
06052	01NOV2016	31OCT2019	N	Professional attendance by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6051 in a single course of treatment; or (b) that follows an initial assessment under item 6057 in a single course of treatment; or (c) that follows a review under item 6058 in a single course of treatment
06052	01NOV2019	31DEC9999	Y	Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6051 in a single course of treatment; or (b) that follows an initial assessment under item 6057 in a single course of treatment; or (c) that follows a review under item 6058 in a single course of treatment
06053	01FEB1984	31AUG1989	N	Urethroscopy, with diathermy of tumour (AU 7)
06053	01SEP1989	31DEC9999	Y	Urethroscopy, with any one or more of; biopsy, diathermy or removal of foreign body or stone (AU 7)
06056	01FEB1984	31DEC9999	Y	Urethroscopy, with removal of stone or foreign body (AU 6)
06057	01NOV2016	31OCT2019	N	Professional attendance by a sexual health medicine specialist in the practice of his or her specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a sexual health medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same sexual health medicine specialist
06057	01NOV2019	31DEC9999	Y	Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to the sexual health medicine specialist by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a sexual health medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same sexual health medicine specialist
06058	01NOV2016	30APR2017	N	Professional attendance by sexual health medicine specialist in the practice of his or her specialty of at least 20 minutes after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06058	01MAY2017	31OCT2019	N	Professional attendance by a sexual health medicine specialist in the practice of his or her specialty of at least 20 minutes, after the first attendance in a single course of treatment, for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06058	01NOV2019	31DEC9999	Y	Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty of at least 20 minutes, after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period
06059	01NOV2016	31OCT2019	N	Initial professional attendance of 10 minutes or less, on a patient by a sexual health medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
06059	01NOV2019	31DEC9999	Y	Initial professional attendance of 10 minutes or less, on a patient by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment
06060	01NOV2016	31OCT2019	N	Professional attendance on a patient by a sexual health medicine specialist in the practice of his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6051 or 6052 and lasting more than 10 minutes; or (ii) provided with item 6057 or 6058; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
06060	01NOV2019	31DEC9999	Y	Professional attendance on a patient by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6051 or 6052 and lasting more than 10 minutes; or (ii) provided with item 6057 or 6058; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
06061	01FEB1984	31DEC9999	Y	Urethra, examination of, involving the use of urethroscope, with cystoscopy (AU 5)
06062	01NOV2016	31OCT2019	N	Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment
06062	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner-initial attendance in a single course of treatment
06063	01NOV2016	31OCT2019	N	Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-each attendance after the attendance under item 6062 in a single course of treatment
06063	01NOV2019	31DEC9999	Y	Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner-each attendance after the attendance under item 6062 in a single course of treatment
06064	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team
06064	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team
06065	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06065	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06066	01FEB1984	31DEC9999	Y	Urethral meatotomy, external (AU 4)
06067	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06067	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06068	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team
06068	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team
06069	01FEB1984	31AUG1989	N	Urethrotomy, external or internal (AU 5)
06069	01SEP1989	31DEC9999	Y	Urethrotomy or urethrostomy, internal or external (AU 5)
06070	01FEB1989	31DEC9999	Y	Urethrotomy, optical, for urethral stricture (AU 5)
06071	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team
06071	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team
06072	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06072	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team
06074	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06074	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team
06075	01NOV2016	31OCT2019	N	Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
06075	01NOV2019	31DEC9999	Y	Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team
06077	01FEB1984	31DEC9999	Y	Urethrectomy, partial or complete, for removal of tumour (AU 9)
06079	01FEB1984	31DEC9999	Y	Urethro-vaginal fistula, closure of (AU 9)
06080	01NOV2017	31DEC9999	Y	Coordination of a TAVI Case Conference by a TAVI Practitioner where the TAVI Case Conference has a duration of 10 minutes or more. (Not payable more than once per patient in a five year period.)
06081	01NOV2017	31DEC9999	Y	Attendance at a TAVI Case Conference by a specialist or consultant physician who does not also perform the service described in item 6080 for the same case conference where the TAVI Case Conference has a duration of 10 minutes or more. (Not payable more than twice per patient in a five year period.)
06082	01JUL2021	31DEC9999	Y	Attendance at a TMVr suitability case conference, by a cardiothoracic surgeon or an interventional cardiologist, to coordinate the conference, if: (a) the attendance lasts at least 10 minutes; and (b) the surgeon or cardiologist is accredited by the TMVr accreditation committee to perform the service Applicable once each 5 years
06083	01FEB1984	31DEC9999	Y	Urethro-rectal fistula, closure of (AU 10)
06084	01JUL2021	31DEC9999	Y	Attendance at a TMVr suitability case conference, by a specialist or consultant physician, other than to coordinate the conference, if the attendance lasts at least 10 minutes Applicable once each 5 years
06085	01JUL1985	31AUG1989	N	PERIURETHRAL TEFLON INJECTION for urinary incontinence including cystoscopy and urethroscopy ANAESTHETIC 5 UNITS - ITEM NOS 406G / 51 OS
06085	01SEP1989	31DEC9999	Y	Peri-urethral injection of Teflon, including urethroscopy and cystoscopy (AU 5)
06086	01FEB1984	31DEC9999	Y	Urethroplasty-- single stage operation (AU 10)
06087	01OCT2017	31DEC9999	Y	A professional attendance, including by telephone or videoconference, on a patient participating in the Health Care Homes Program by or on behalf of a medical practitioner (including a general practitioner but not including a specialist or consultant physician) or participating nurse practitioner employed or otherwise engaged by the Health Care Home trial site at which the patient is enrolled - each patient. The service must be provided to the patient for the purposes of the Health Care Homes Program and the service may be provided to the patient individually or as part of a group.
06089	01FEB1984	31DEC9999	Y	Urethroplasty-- two stage operation-- first stage (AU 9)
06091	01DEC1991	31DEC9999	Y	[Unidentified item]
06092	01FEB1984	31DEC9999	Y	Urethroplasty-- two stage operation-- second stage (AU 9)
06093	01DEC1991	31DEC9999	Y	[Unidentified item]
06094	01DEC1991	31DEC9999	Y	[Unidentified item]
06095	01FEB1984	31DEC9999	Y	Urethroplasty, not covered by any other item in this Part (AU 9)
06098	01FEB1984	31DEC9999	Y	Hypospadias, meatotomy and hemicircumcision (AU 7)
06100	01FEB1989	31DEC9999	Y	Hypospadias, glanuloplasty incorporating meatal advancement (AU 8)
06105	01FEB1984	31DEC9999	Y	Hypospadias, correction of chordee (AU 10)
06107	01FEB1984	31AUG1989	N	Hypospadias, correction of chordee with transplantation of prepuce (AU 10)
06107	01SEP1989	31DEC9999	Y	Hypospadias or epispadias, with or without chordee, correction of, as a staged procedure, first stage (AU 10)
06110	01FEB1984	31AUG1989	N	Hypospadias, urethral reconstruction for, with or without urinary diversion (AU 11)
06110	01SEP1989	31DEC9999	Y	Hypospadias or epispadias, with or without chordee, correction of, as a staged procedure, second stage (AU 11)
06118	01FEB1984	31AUG1989	N	Hypospadias, urethral reconstruction and correction of chordee, complete, one stage including urinary diversion (AU 13)
06118	01SEP1989	31DEC9999	Y	Hypospadias or epispadias, with or without chordee, correction of, as one stage procedure, not covered by item 6100 (AU 13)
06122	01FEB1984	31DEC9999	Y	Hypospadias, secondary correction of (AU 9)
06130	01FEB1984	31DEC9999	Y	Epispadias, repair of, not involving sphincter-- each stage (AU 9)
06135	01FEB1984	31DEC9999	Y	Epispadias, repair of, including bladder neck closure (AU 10)
06140	01FEB1984	31DEC9999	Y	Urethra, diathermy of (AU 4)
06146	01FEB1984	31DEC9999	Y	Urethra, excision of prolapse of (AU 7)
06152	01FEB1984	31AUG1989	N	Urethra, excision of diverticulum of (AU 8)
06152	01SEP1989	31DEC9999	Y	Urethral diverticulum, excision of (AU 8)
06155	01FEB1989	31DEC9999	Y	Urethral sphincter, reconstruction by bladder tubularisation technique or similar procedure (AU 16)
06157	01FEB1984	31AUG1989	N	Urethra, operation for correction of male urinary incontinence (AU 9)
06157	01SEP1989	31DEC9999	Y	Urethra, operation for correction of male urinary incontinence, not covered by item 6158 or 6161 (AU 9)
06158	01FEB1989	31DEC9999	Y	Artificial urinary sphincter, insertion of cuff, perineal approach (AU 10)
06159	01FEB1989	31DEC9999	Y	Artificial urinary sphincter, insertion of cuff, abdominal approach (AU 16)
06160	01FEB1989	31DEC9999	Y	Artificial urinary sphincter, insertion of pressure regulating balloon and pump (AU 8)
06161	01FEB1989	31DEC9999	Y	Artificial urinary sphincter, revision or removal of, with or without replacement (AU 12)
06162	01FEB1984	31AUG1989	N	Priapism, decompression operation for, under general anaesthesia (AU 7)
06162	01SEP1989	31DEC9999	Y	Priapism, decompression by glanular stab cavernosospongiosum shunt (AU 7)
06166	01FEB1984	31AUG1989	N	Priapism, decompression shunt operation for (AU 10)
06166	01SEP1989	31DEC9999	Y	Priapism, shunt operation for, not covered by item 6162 (AU 10)
06175	01FEB1984	31AUG1989	N	Urethral valves or urethral membrane, endoscopic resection of (AU 7)
06175	01SEP1989	31DEC9999	Y	Urethral valve, destruction of, including cystoscopy and urethroscopy (AU 7)
06179	01FEB1984	31DEC9999	Y	Penis, partial amputation of (AU 8)
06184	01FEB1984	31DEC9999	Y	Penis, complete or radical amputation of (AU 12)
06189	01FEB1984	31AUG1989	N	Penis, repair of laceration or fracture involving cavernous tissue (AU 8)
06189	01SEP1989	31DEC9999	Y	Penis, repair of laceration of cavernous tissue, or fracture involving cavernous tissue (AU 8)
06194	01FEB1984	30NOV1985	N	Penis, repair of avulsion (AU 12)
06194	01DEC1985	31DEC9999	Y	PENIS, repair of avulsion ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
06199	01FEB1984	29FEB1984	N	Penis, Peyronie's disease, injection procedure for
06199	01MAR1984	31AUG1989	N	Penis, Peyronie's disease, injection procedure for 6204
06199	01SEP1989	31DEC9999	Y	Penis, injection of, for investigation or treatment of impotence, priapism or Peyronie's plaque
06204	01FEB1984	31AUG1989	N	Penis, Peyronie's disease, operation for (AU 8)
06204	01SEP1989	31DEC9999	Y	Penis, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting (AU 8)
06205	01FEB1989	31DEC9999	Y	Penis, surgery to inhibit rapid penile drainage causing impotence, by ligation of deep veins to Bucks fascia including one or deep cavernosal veins, with or without pharmological test (AU 7)
06207	01FEB1989	31DEC9999	Y	Penis, lengthening by translocation of corpora (AU 14)
06208	01FEB1984	31AUG1989	N	Penis, plastic implantion of (AU 8)
06208	01SEP1989	31DEC9999	Y	Penis, artificial erection device, insertion of, into one or both corpora (AU 8)
06210	01FEB1984	31DEC9999	Y	Penis, lengthening of by translocation of corpora, as an independent procedure (AU 8)
06212	01FEB1984	31DEC9999	Y	Scrotum, partial excision of (AU 7)
06213	01FEB1989	31DEC9999	Y	Penis, artificial erection device, insertion of pump and pressure regulating reservoir (AU 11)
06214	01FEB1989	31DEC9999	Y	Penis, artificial erection device, complete or partial revision or removal of components, with or without replacement (AU 11)
06215	01FEB1989	31DEC9999	Y	Penis, frenuloplasty as an independent procedure (AU 5)
06216	01FEB1989	31DEC9999	Y	Scrotum, partial excision of (AU 7)
06218	01FEB1984	31DEC9999	Y	Testicular biopsy (AU 6)
06221	01FEB1984	31AUG1989	N	Spermatocele or epididymal cysts, excision of (G) (AU 6)
06221	01SEP1989	31DEC9999	Y	Spermatocele or epididymal cyst, excision of, one or both (G) (AU 6)
06224	01FEB1984	31AUG1989	N	Spermatocele or epididymal cysts, excision of (S) (AU 6)
06224	01SEP1989	31DEC9999	Y	Spermatocele or epididymal cyst, excision of, one or both (S) (AU 6)
06228	01FEB1984	31AUG1989	N	Exploration of the testis, with or without fixation for torsion (AU 5)
06228	01SEP1989	31DEC9999	Y	Exploration of scrotal contents, with or without fixation and with or without biopsy (AU 5)
06231	01FEB1984	31AUG1989	N	Retroperitoneal lymph node dissection following orchidectomy (unilateral) (AU 12)
06231	01SEP1989	31DEC9999	Y	Retroperitoneal lymph node dissection, unilateral, as an independent procedure (AU 12)
06232	01FEB1984	31DEC9999	Y	Retroperitoneal lymph node dissection following nephrectomy for tumour (AU 12)
06233	01NOV1979	31DEC9999	Y	Orchidoplasty (AU 8)
06234	01FEB1989	31DEC9999	Y	Retroperitoneal lymph node dissection, unilateral, as an independent procedure, following previous similar retroperitoneal dissection, retroperitoneal irradiation or chemotherapy (AU 24)
06236	01FEB1984	31DEC9999	Y	Epididymectomy (AU 8)
06245	01FEB1984	29FEB1984	N	Vaso-vasostomy or vaso-epididymostomy, unilateral, using operating microscope (AU 14)
06245	01MAR1984	31DEC9999	Y	Vaso-vasostomy or vaso-epididymostomy, unilateral, using the operating microscope(AU 14)
06246	01FEB1984	31DEC9999	Y	Vasoepididymography and vasovesiculography, preparation for, by open operation, as an independent procedure (AU 5)
06247	01FEB1984	31DEC9999	Y	Vaso-vasostomy or vaso-epididymostomy (unilateral) (AU 9)
06249	01FEB1984	31DEC9999	Y	Vasotomy or vasectomy (unilateral or bilateral) (G) (AU 5)
06253	01FEB1984	31DEC9999	Y	Vasotomy or vasectomy (unilateral or bilateral) (S) (AU 5)
06258	01FEB1984	31DEC9999	Y	Gynaecological examination under anaesthesia, not associated with any other item in this Part (AU 5)
06262	01FEB1984	29FEB1984	N	Intra-uterine contraceptive device, introduction of, not associated with any other item in this Part, or removal of under general anaesthesia, not associated with any other item in this Part (AU 5)
06262	01MAR1984	31DEC9999	Y	Intra-uterine contraceptive device, introduction of, not associated with any other item in this Part (AU 5)
06264	01FEB1984	31DEC9999	Y	Intra-uterine contraceptive device, removal of under general anaesthesia, not associated with any other item in this Part (AU 5)
06271	01FEB1984	31DEC9999	Y	Hymenectomy (AU 5)
06274	01FEB1984	31DEC9999	Y	Bartholin's cyst, excision of (G) (AU 7)
06277	01FEB1984	31DEC9999	Y	Bartholin's cyst, excision of (S) (AU 7)
06278	01FEB1984	31DEC9999	Y	Bartholin's cyst or gland, marsupialisation of (G) (AU 6)
06280	01FEB1984	31DEC9999	Y	Bartholin's cyst or gland, marsupialisation of (S) (AU 6)
06284	01FEB1984	31DEC9999	Y	Bartholin's abscess, incision of (AU 5)
06290	01FEB1984	31DEC9999	Y	Urethra or urethral caruncle, cauterisation of (AU 4)
06292	01FEB1984	31DEC9999	Y	Urethral caruncle, excision of (G) (AU 6)
06296	01FEB1984	31DEC9999	Y	Urethral caruncle, excision of (S) (AU 6)
06299	01FEB1984	31AUG1989	N	Clitoris, amputation of (AU 7)
06299	01SEP1989	31DEC9999	Y	Clitoris, amputation of, where medically indicated (AU 7)
06301	01SEP1989	31DEC9999	Y	Vulvoplasty or labioplasty, where medically indicated, not associated with Item 6302 (AU 9)
06302	01FEB1984	31AUG1989	N	Vulvectomy (simple), vulvoplasty or labioplasty (AU 9)
06302	01SEP1989	31DEC9999	Y	Vulva, wide local excision of suspected malignancy; or hemivulvecomy; or superficial vulvectomy, (including colposcopically directed CO2 laser), one or more procedures (AU 9)
06303	01AUG1988	31DEC9999	Y	Colposcopically directed CO2 laser therapy for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies-one anatomical site (AU 5)
06304	01AUG1988	31DEC9999	Y	Colposcopically directed CO2 laser therapy for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies-two or more anatomical sites (AU 6)
06305	01AUG1988	31DEC9999	Y	Colposcopically directed CO2 laser therapy for condylomata, unsuccessfully treated by other methods (AU 6)
06306	01FEB1984	31DEC9999	Y	Vulvectomy (radical) (AU 16)
06307	01SEP1989	31DEC9999	Y	Vulvectomy (radical) for malignancy (AU 17)
06308	01FEB1984	31DEC9999	Y	Pelvic lymph glands, excision of (radical) (AU 15)
06313	01FEB1984	31DEC9999	Y	Vagina, dilatation of, as an independent procedure including any associated consultation (AU 4)
06321	01FEB1984	31DEC9999	Y	Vagina, removal of simple tumour-- (including Gartner duct cyst) (AU 8)
06325	01FEB1984	29FEB1984	N	Vagina, complete removal of (AU 13)
06325	01MAR1984	31DEC9999	Y	Vagina, partial or complete removal of(AU 13)
06327	01FEB1984	31DEC9999	Y	Vaginal reconstruction for congenital absence, gynatresia or urogenital sinus (AU 18)
06332	01FEB1984	31DEC9999	Y	Vaginal septum, excision of, for correction of double vagina (AU 12)
06336	01FEB1984	31DEC9999	Y	Plastic repair to enlarge vaginal orifice (AU 9)
06342	01FEB1984	31AUG1989	N	Colpotomy or colporrhaphy, not covered by any other item in this Part (AU 6)
06342	01SEP1989	31DEC9999	Y	Colpotomy, not covered by any other item in this Part (AU 6)
06347	01FEB1984	29FEB1984	N	Cystocele or rectocele, repair of, not covered by Item 6358, 6363, 6367 or 6373 (G) (AU 10)
06347	01MAR1984	31DEC9999	Y	Anterior vaginal repair or posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6358, 6363, 6367 or 6373 (G)(AU 10)
06352	01FEB1984	29FEB1984	N	Cystocele or rectocele, repair of, not covered by Item 6358, 6363, 6367 or 6373 (S) (AU 10)
06352	01MAR1984	31DEC9999	Y	Anterior vaginal repair or posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6358, 6363, 6367 or 6373 (S)(AU 10)
06358	01FEB1984	29FEB1984	N	Cystocele and rectocele, repair of, not covered by Item 6367 or 6373 (G) (AU 10)
06358	01MAR1984	31DEC9999	Y	Anterior vaginal repair and posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6367 or 6373 (G) (AU 10)
06363	01FEB1984	29FEB1984	N	Cystocele and rectocele, repair of, not covered by Item 6367 or 6373 (S) (AU 10)
06363	01MAR1984	31DEC9999	Y	Anterior vaginal repair and posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6367 or 6373 (S) (AU 10)
06367	01FEB1984	29FEB1984	N	Colpoplasty, Donald-Fothergill or Manchester operation (operation for genital prolapse) (G) (AU 10)
06367	01MAR1984	31DEC9999	Y	Donald-Fothergill or Manchester operation for genital prolapse (G)(AU 10)
06373	01FEB1984	29FEB1984	N	Colpoplasty, Donald-Fothergill or Manchester operation (operation for genital prolapse) (S) (AU 10)
06373	01MAR1984	31DEC9999	Y	Donald-Fothergill or Manchester operation for genital prolapse (S)(AU 10)
06389	01FEB1984	31DEC9999	Y	Urethrocele, operation for (AU 9)
06396	01FEB1984	31DEC9999	Y	Operation involving abdominal approach for repair of enterocoele or suspension of vaginal vault or enterocoele and suspension of vaginal vault (AU 9)
06398	01FEB1989	31DEC9999	Y	Vaginal repair of enterocele with or without repair of rectocele, not associated with item 6347, 6352, 6358, 6363, 6367, 6373, 6396, 6518, 6519 or 6544, and where on a previous occasion there had been performed surgery reflected by a procedure in item 6347, 6352, 6458, 6363, 6367, 6373, 6396, 6518, 6519 or 6544 (AU 8)
06401	01FEB1984	31DEC9999	Y	Fistula between genital and urinary or alimentary tracts, repair of, not covered by Item 5941, 6079 or 6083 (AU 13)
06406	01FEB1984	31DEC9999	Y	Stress incontinence, sling operation for (AU 12)
06407	01FEB1984	31DEC9999	Y	Stress incontinence, combined synchronous abdomino-vaginal operation for; abdominal procedure (including after-care) (AU 12)
06408	01FEB1984	31DEC9999	Y	Stress incontinence, combined synchronous abdomino-vaginal operation for; vaginal procedure (including after-care)
06411	01FEB1984	29FEB1984	N	Cervix, cauterisation, ionisation, diathermy or biopsy of, with or without removal of cervical polyp and with or without dilatation of cervix (AU 5)
06411	01MAR1984	31AUG1989	N	Cervix, cauterisation(other than by by chemical means) ionisation, diathermy or biopsy of, with or without removal of cervical polyp, and with or without dilatation of cervix (AU 5)
06411	01SEP1989	31DEC9999	Y	Cervix, cauterisation (other than by chemical means), ionisation, diathermy or biopsy of, with or without dilatation of cervix (AU 5)
06413	01NOV1986	31AUG1989	N	CERVIX, removal of polyp or polypi, with or without dilatation of cervix, not associated with item 6411 ANAESTHETIC 5 UNITS - ITEM NOS 406G / 5108
06413	01SEP1989	31DEC9999	Y	Cervix, removal of polyp or polypi, with or without dilatation of cervix, not associated with item 6411 (AU 5)
06415	01FEB1984	29FEB1984	N	Examination of the uterine cervix by a magnifying colposcope of the Hinselmann type or similar instrument (AU 5)
06415	01MAR1984	31DEC9999	Y	Examination of lower female genital tract by a Hinselmann-type colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner (AU 5)
06430	01FEB1984	29FEB1984	N	Cervix, cone biopsy, amputation or repair of, not covered by Item 6367 or 6373 (G) (AU 7)
06430	01MAR1984	31DEC9999	Y	Cervix, cone biopsy, amputation or repair of, not covered by Item 6367
06431	01FEB1984	31DEC9999	Y	Cervix, cone biopsy, amputation or repair of, not covered by Item 6367 or 6373 (S) (AU 7)
06446	01FEB1984	31DEC9999	Y	Cervix, dilatation of, under general anaesthesia, not covered by Item 6460,6464 or 6469 (AU 5)
06447	01SEP1989	31DEC9999	Y	Endometrial biopsy where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding (AU 5)
06451	01FEB1984	31AUG1989	N	Hysteroscopy under general anaesthesia or culdoscopy (AU 7)
06451	01SEP1989	31DEC9999	Y	Hysteroscopy with dilatation of cervix under general anaesthesia (AU 7)
06452	01SEP1989	31DEC9999	Y	Hysteroscopy with endometrial biopsy or suction curettage, or both (AU 7)
06453	01SEP1989	31DEC9999	Y	Hysteroscopy with uterine adhesiolysis or polypectomy or tubal catheterization or removal of IUD which cannot be removed by other means, one or more of (AU 8)
06454	01SEP1989	31DEC9999	Y	Hysteroscopy and laparoscopy under general anaesthesia involving either myomectomy or resection of uterine septum, or both (AU 10)
06460	01FEB1984	31AUG1989	N	Uterus, curettage of, under general anaesthesia, with or without dilatation (including curettage for incomplete miscarriage) (G) (AU 5)
06460	01SEP1989	31DEC9999	Y	Uterus, curettage of, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day-hospital facility (G) (AU 5)
06464	01FEB1984	31AUG1989	N	Uterus, curettage of, under general anaesthesia, with or without dilatation (including curettage for incomplete miscarriage) (S) (AU 5)
06464	01SEP1989	31DEC9999	Y	Uterus, curettage of, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day-hospital facility (S) (AU 5)
06469	01FEB1984	31DEC9999	Y	Evacuation of the contents of the gravid uterus by curettage or suction curettage not covered by Item 6460 or 6464 (AU 5)
06483	01FEB1984	31AUG1989	N	Uterus, curettage of, with colposcopy, cervical biopsy and radical diathermy (AU 8)
06483	01SEP1989	31DEC9999	Y	Uterus-colposcopy, cervical biopsy and radical diathermy of (AU 8)
06508	01FEB1984	31AUG1989	N	Hysterectomy or uterine myomectomy (AU 10)
06508	01SEP1989	31DEC9999	Y	Hysterotomy or uterine myomectomy, abdominal (AU 10)
06513	01FEB1984	31AUG1989	N	Hysterectomy, sub-total or total, by any route (G) (AU 11)
06513	01SEP1989	31DEC9999	Y	Hysterectomy, abdominal, subtotal or total, with or without removal of uterine adnexae (G) (AU 11)
06517	01FEB1984	31AUG1989	N	Hysterectomy, sub-total or total, by any route (S) (AU 11)
06517	01SEP1989	31DEC9999	Y	Hysterectomy, vaginal, with or without uterine curettage, not covered by item 6544 (S) (AU 11)
06518	01FEB1989	31DEC9999	Y	HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 6544 ANAESTHETIC]] UNITS - ITEM NOS 453G / 522S (G)
06519	01FEB1989	31DEC9999	Y	HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 6544 ANAESTHETIC]] UNITS - ITEM NOS 453G / 522S (S)
06532	01FEB1984	31AUG1989	N	Hysterectomy, abdominal, with enucleation of ovarian cyst, one or both sides (G) (AU 12)
06532	01SEP1989	31DEC9999	Y	Hysterectomy, abdominal, with excision of ovarian, para-ovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries (G) (AU 12)
06533	01FEB1984	31AUG1989	N	Hysterectomy, abdominal, with enucleation of ovarian cyst, one or both sides (S) (AU 12)
06533	01SEP1989	31DEC9999	Y	Hysterectomy, abdominal, with excision of ovarian, para-ovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries (S) (AU 12)
06536	01FEB1984	31AUG1989	N	Hysterectomy and dissection of pelvic glands (AU 17)
06536	01SEP1989	31DEC9999	Y	Radical hysterectomy with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any one more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum (AU 17)
06542	01FEB1984	31AUG1989	N	Radical hysterectomy without gland dissection (AU 12)
06542	01SEP1989	31DEC9999	Y	Radical hysterectomy without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum (AU 17)
06543	01SEP1989	31DEC9999	Y	Hysterectomy, abdominal, with radical excision of pelvic lymph glands, with or without removal of uterine adnexae (AU 19)
06544	01FEB1984	31AUG1989	N	Hysterectomy, vaginal, with removal of uterine adnexae (AU 12)
06544	01SEP1989	31DEC9999	Y	Hysterectomy, vaginal, (with or without uterine curettage) with salpingectomy, oophorectomy or excision of ovarian cyst, one or more, one or both sides (AU 12)
06553	01FEB1984	31DEC9999	Y	Ectopic gestation, removal of (G) (AU 9)
06557	01FEB1984	31DEC9999	Y	Ectopic gestation, removal of (S) (AU 9)
06570	01FEB1984	31DEC9999	Y	Bicornuate uterus, plastic reconstruction for (AU 14)
06585	01FEB1984	31DEC9999	Y	Uterus, suspension or fixation of, as an independent procedure (G) (AU 8)
06594	01FEB1984	31DEC9999	Y	Uterus, suspension or fixation of, as an independent procedure (S) (AU 8)
06604	01NOV1979	31DEC9999	Y	Laparoscopy, diagnostic, as a diagnostic procedure performed in gynaecology (AU 7)
06607	01NOV1979	31DEC9999	Y	Laparoscopy involving one or more of biopsy, puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedure-- not associated with Item 6611 or 6612 (AU 7)
06611	01FEB1984	31DEC9999	Y	Sterilisation by transection or resection of fallopian tubes, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method (G) (AU 8)
06612	01FEB1984	31DEC9999	Y	Sterilisation by transection or resection of fallopian tubes, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method (S) (AU 8)
06613	01MAY1990	31DEC9999	Y	STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S
06631	01FEB1984	31AUG1989	N	Tuboplasty (salpingostomy, salpingolysis, or tubal implantation into uterus), unilateral or bilateral (AU 11)
06631	01SEP1989	31DEC9999	Y	Tuboplasty (salpingostomy, salpingolysis or tubal implantation into uterus), unilateral or bilateral, one or more procedures (AU 11)
06632	01AUG1987	31AUG1989	N	MICROSURGICAL TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, one or more procedures ANAESTHETIC 16 UNITS-ITEM NOS 460G/527S
06632	01SEP1989	31DEC9999	Y	Microsurgical tuboplasty (salpingostomy, salpingolysis or tubal implantation into uterus), unilateral or bilateral, one or more procedures (AU 16)
06633	01FEB1984	31DEC9999	Y	Fallopian tubes, unilateral microsurgical anastomosis of, using operating microscope (AU 18)
06638	01FEB1984	29FEB1984	N	Fallopian tubes, hydrotubation of, as an isolated procedure, or Rubin test for patency of (AU 7)
06638	01MAR1984	31AUG1989	N	Rubin test for patency of Fallopian tubes, or hydrotubation of Fallopian tubes, as a non-repetitive procedure not associated with any other item in this Part (AU 7)
06638	01SEP1989	31DEC9999	Y	Hydrotubation of Fallopian tubes as a non-repetitive procedure not associated with any other item in this Part or Rubin test for patency of Fallopian tubes (AU 7)
06639	01MAY1990	31DEC9999	Y	RUBINS TEST FOR PATENCY OF FALLOPIAN TUBES ANAESTHETIC 7 UNITS - ITEM NOS 408G I 514S
06641	01FEB1984	31DEC9999	Y	Fallopian tubes, hydrotubation of, as a repetitive post-operative procedure (AU 7)
06643	01FEB1984	29FEB1984	N	Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- one such procedure not associated with hysterectomy (G) (AU 9)
06643	01MAR1984	31DEC9999	Y	Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - one such procedure not associated with hysterectomy (G) (AU 9)
06644	01FEB1984	29FEB1984	N	Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- one such procedure not associated with hysterectomy (S) (AU 9)
06644	01MAR1984	31DEC9999	Y	Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - one such procedure not associated with hysterectomy (S) (AU 9)
06648	01FEB1984	29FEB1984	N	Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- two or more such procedures, unilateral or bilateral, not associated with hysterectomy (G) (AU 10)
06648	01MAR1984	31DEC9999	Y	Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - two or more such procedures, unilateral or bilateral, not associated with hysterectomy (G) (AU 10)
06649	01FEB1984	29FEB1984	N	Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- two or more such procedures, unilateral or bilateral, not associated with hysterectomy (S) (AU 10)
06649	01MAR1984	31DEC9999	Y	Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - two or more such procedures, unilateral or bilateral, not associated with hysterectomy (S) (AU 10)
06655	01FEB1984	31AUG1989	N	Radical or debulking operation for ovarian tumour including omentectomy (AU 16)
06655	01SEP1989	31DEC9999	Y	Radical or debulking operation for advanced gynaecological malignancy, with or without omentectomy (AU 16)
06657	01AUG1987	31DEC9999	Y	LAPAROTOMY, FOR REASSESSMENT ('second look') in the management of ovarian cancer, including associated biopsies and other procedures ANAESTHETIC 13 UNITS-ITEM NOS 457G/524S
06658	01SEP1989	31DEC9999	Y	Retro-peritoneal lymph node biopsies from above the level of the aortic bifurcation, for staging or restaging of gynaecological malignancy (AU 19)
06659	01SEP1989	31DEC9999	Y	Infra-colic omentectomy with multiple peritoneal biopsies for staging or restaging of gynaecological malignancy (AU 19)
06677	01NOV1979	31DEC9999	Y	Pelvic abscess, suprapubic drainage of (G) (AU 8)
06681	01NOV1979	31DEC9999	Y	Pelvic abscess, suprapubic drainage of (S) (AU 8)
06686	01FEB1984	31DEC9999	Y	Ophthalmological examination under general anaesthesia, not associated with any other item in this Part (AU 5)
06688	01FEB1984	31DEC9999	Y	Eye, enucleation of, with or without sphere implant (AU 8)
06692	01FEB1984	31DEC9999	Y	Eye, enucleation of, with insertion of integrated implant (AU 9)
06697	01FEB1984	31DEC9999	Y	Globe, evisceration of (AU 8)
06699	01FEB1984	31DEC9999	Y	Globe, evisceration of, and insertion of intrascleral ball or cartilage (AU 9)
06701	01FEB1984	31DEC9999	Y	Anophthalmic orbit, insertion of cartilage or artificial implant as a delayed procedure, or removal of implant from socket (AU 9)
06703	01FEB1984	31DEC9999	Y	Orbit, skin graft to, as a delayed procedure (AU 7)
06705	01FEB1984	31DEC9999	Y	Contracted socket, reconstruction including mucous membrane grafting and stent mould (AU 11)
06707	01FEB1984	31DEC9999	Y	Orbit, exploration with or without biopsy, requiring removal of bone (AU 9)
06709	01FEB1984	31DEC9999	Y	Orbit, exploration of, with drainage or biopsy not requiring removal of bone (AU 8)
06715	01FEB1984	31DEC9999	Y	Orbit, exenteration of, with or without skin graft and with or without temporalis muscle transplant (AU 11)
06722	01FEB1984	31DEC9999	Y	Orbit, exploration of, with removal of tumour or foreign body, requiring removal of bone (AU 12)
06724	01FEB1984	31DEC9999	Y	Orbit, exploration of, with removal of tumour or of foreign body (AU 10)
06728	01FEB1984	29FEB1984	N	Eyeball, perforating wound of, not involving intraocular structures-- repair (AU 10)
06728	01MAR1984	31DEC9999	Y	Eyeball, perforating wound of, not involving intraocular structures - repair involving suture of cornea or sclera, or both, not covered by Item 6807 (AU 10)
06730	01FEB1984	31DEC9999	Y	Eyeball, perforating wound of, with incarceration or prolapse of uveal tissue-- repair (AU 12)
06736	01FEB1984	31DEC9999	Y	Eyeball, perforating wound of, with incarceration of lens or vitreous-- repair (AU 12)
06740	01FEB1984	31DEC9999	Y	Intraocular foreign body, magnetic removal from anterior segment (AU 10)
06742	01FEB1984	31DEC9999	Y	Intraocular foreign body, nonmagnetic removal from anterior segment (AU 11)
06744	01FEB1984	31DEC9999	Y	Intraocular foreign body, magnetic removal from posterior segment (AU 10)
06747	01FEB1984	31DEC9999	Y	Intraocular foreign body, nonmagnetic removal from posterior segment (AU 12)
06752	01FEB1984	31DEC9999	Y	Abscess (intraorbital), drainage of (AU 6)
06754	01FEB1984	31DEC9999	Y	Tarsal cyst, extirpation of (AU 6)
06758	01FEB1984	31DEC9999	Y	Tarsal cartilage, excision of (AU 8)
06762	01FEB1984	29FEB1984	N	Ectropion, tarsal cauterisation for
06762	01MAR1984	31DEC9999	Y	Ectropion, tarsal cauterisation for 6766
06766	01FEB1984	31DEC9999	Y	Tarsorrhaphy (AU 8)
06767	01FEB1984	31AUG1989	N	Electrolysis epilation for trichiasis, each treatment (AU 6)
06767	01SEP1989	31DEC9999	Y	Cryotherapy or electrolysis epilation for trichiasis-each treatment (AU 6)
06768	01FEB1984	31DEC9999	Y	Canthoplasty, medial or lateral (AU 9)
06772	01FEB1984	31DEC9999	Y	Lacrimal gland, excision of palpebral lobe (AU 8 )
06774	01FEB1984	31DEC9999	Y	Lacrimal sac, excision of, or operation on (AU 8)
06778	01FEB1984	31DEC9999	Y	Dacryocystorhinostomy (AU 11)
06786	01FEB1984	31DEC9999	Y	Conjunctivorhinostomy including dacryocystorhinostomy and fashioning of conjunctival flaps (AU 12)
06792	01FEB1984	31AUG1989	N	Lacrimal canalicular system, reconstruction of (AU 8)
06792	01SEP1989	31DEC9999	Y	Lacrimal canalicular system, establishment of patency by open operation (AU 8)
06796	01FEB1984	31DEC9999	Y	Lacrimal canaliculus, immediate repair of (AU 8)
06799	01FEB1984	31AUG1989	N	Naso-lacrimal duct, probing for obstruction, one or both ducts (AU 4)
06799	01SEP1989	31DEC9999	Y	Nasolacrimal tube (unilateral) replacement of, under general anaesthesia, or lacrimal passages, probing for obstruction, unilateral or bilateral, with or without lavage (AU 4)
06802	01FEB1984	31AUG1989	N	Lacrimal passages, lavage of (excluding after-care) (AU 4)
06802	01SEP1989	31DEC9999	Y	Lacrimal passages, lavage of, unilateral, not associated with item 6799 (excluding after-care) (AU 4)
06805	01FEB1984	31DEC9999	Y	Punctum snip operation (AU 4)
06807	01FEB1984	31DEC9999	Y	Conjunctival peritomy or repair of corneal laceration by conjunctival flap (AU 6)
06810	01FEB1984	31DEC9999	Y	Conjunctival graft over cornea (AU 7)
06816	01NOV1979	31DEC9999	Y	Cornea or sclera, removal of superficial foreign body from (excluding after-care) (AU 6)
06818	01FEB1984	31DEC9999	Y	Cornea or sclera, removal of imbedded foreign body from (excluding after-care) (AU 8)
06820	01FEB1984	31DEC9999	Y	Corneal scars, removal of, by partial keratectomy (AU 8)
06824	01FEB1984	31AUG1989	N	Cornea, epithelial debridement for dendritic ulcer (excluding after-care) (AU 8)
06824	01SEP1989	31DEC9999	Y	Cornea, epithelial debridement for corneal ulcer or corneal erosion (excluding after-care) (AU 8)
06828	01FEB1984	31DEC9999	Y	Cornea, transplantation of, full thickness, including collection of implant (AU 13)
06832	01FEB1984	31DEC9999	Y	Cornea, transplantation of, superficial or lamellar, including collection of transplant (AU 11)
06833	01NOV1984	31DEC9999	Y	Refractive keratoplasty (excluding radial keratotomy) following corneal grafting or intraocular operation including any measurements and calculations associated with the procedure (AU 10)
06835	01FEB1984	31DEC9999	Y	Conjunctiva, cautery of, including treatment of pannus-- each attendance at which treatment is given including any associated consultation (AU 4)
06837	01FEB1984	31DEC9999	Y	Pterygium, removal of (AU 6)
06842	01FEB1984	31DEC9999	Y	Pinguecula, removal of (AU 6)
06846	01FEB1984	31DEC9999	Y	Limbic tumour, removal of (AU 7)
06848	01FEB1984	31DEC9999	Y	Lens extraction (AU 11)
06852	01FEB1984	31DEC9999	Y	Artificial lens, insertion of (AU 11)
06857	01FEB1984	31AUG1989	N	Artificial lens, removal of (AU 9)
06857	01SEP1989	31DEC9999	Y	Artificial lens, removal or repositioning of by open operation-not associated with item 6852 (AU 9)
06858	01NOV1984	31DEC9999	Y	Artificial lens, removal of and replacement with a different lens (AU 12)
06859	01FEB1984	31DEC9999	Y	Cataract, juvenile, removal of, including subsequent needlings (AU 11)
06861	01FEB1984	31AUG1989	N	Capsulectomy, or removal of, vitreous via the anterior chamber (AU 9)
06861	01SEP1989	31DEC9999	Y	Capsulectomy or removal of vitreous via the anterior chamber by any method, not associated with any other intraocular operation on that eye (AU 9)
06862	01JUL1985	31AUG1989	N	CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye - one or both procedures. (See Explanatory Notes covering this Item) ANAESTHETIC 15 UNITS - ITEM NOS 459G / 526S
06862	01SEP1989	31DEC9999	Y	Capsulectomy by posterior chamber sclerotomy or removal of vitreous or vitreous bands from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye-one or both procedures (AU 15)
06863	01FEB1984	29FEB1984	N	Virectomy via posterior chamber sclerotomy with removal of vitreous by cutting and suction and replacement by saline, Hartmann's or similar solution (AU 25)
06863	01MAR1984	31AUG1989	N	Vitrectomy via posterior chamber sclerotomy with removal of vitreous by cutting and suction and replacement by saline, Hartmann's or similar solution (AU 25)
06863	01SEP1989	31DEC9999	Y	Vitrectomy by posterior chamber sclerotomy-including the removal of vitreous, division of bands or removal of pre-retinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye (AU 25)
06864	01JUL1985	31AUG1989	N	CAPSULECTOMY or LENSECTOMY by posterior chamber sclerotomy associated with the removal of vitreous or division of vitreous bands or removal of pre-retinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation. (See Explanatory Notes covering this Item) ANAESTHETIC 25 UNITS - ITEM NOS 469G / 540S
06864	01SEP1989	31DEC9999	Y	Capsulectomy or lensectomy by posterior chamber sclerotomy associated with the removal of vitreous or division of vitreous bands or removal of pre-retinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation (AU 25)
06865	01FEB1984	31DEC9999	Y	Capsulotomy, needling or paracentesis for diagnosis or relief of tension (AU 7)
06871	01FEB1984	31DEC9999	Y	Anterior chamber, irrigation of blood from, as an independent procedure (AU 7)
06873	01FEB1984	31DEC9999	Y	Glaucoma, filtering and allied operations in the treatment of (AU 10)
06879	01FEB1984	31DEC9999	Y	Goniotomy (AU 10)
06881	01FEB1984	31DEC9999	Y	Division of anterior or posterior synechiae, as an independent procedure (AU 9)
06885	01FEB1984	31DEC9999	Y	Iridectomy (including excision of tumour of iris) or iridotomy, as an independent procedure (AU 10)
06889	01FEB1984	31DEC9999	Y	Iris, light coagulation of (AU 6)
06894	01FEB1984	31DEC9999	Y	Tumour, involving ciliary body or ciliary body and iris, excision of (AU 12)
06898	01FEB1984	31DEC9999	Y	Cyclodiathermy or cyclocryotherapy (AU 8)
06900	01FEB1984	31AUG1989	N	Detached retina, diathermy or cryotherapy for (AU 11)
06900	01SEP1989	31DEC9999	Y	Detached retina, diathermy or cryotherapy for, not associated with item 6902 (AU 11)
06902	01FEB1984	31DEC9999	Y	Detached retina, resection of, or buckling operation for, or revision operation for (AU 15)
06904	01FEB1984	31AUG1989	N	Photocoagulation, each attendance at which treatment is given (AU 10)
06904	01SEP1989	31DEC9999	Y	Photocoagulation, treatment to one or both eyes (AU 10)
06906	01FEB1984	31DEC9999	Y	Detached retina, removal of encircling silicone band from (AU 8)
06908	01FEB1984	31DEC9999	Y	Retina, cryotherapy to, as an independent procedure (AU 13)
06914	01FEB1984	31DEC9999	Y	Retrobulbar transillumination, as an independent procedure (AU 5)
06918	01FEB1984	31DEC9999	Y	Retrobulbar injection of alcohol or other drug, as an independent procedure
06920	01SEP1989	31DEC9999	Y	Injection of botulinus toxin for blepharospasm or strabismus
06922	01FEB1984	31DEC9999	Y	Squint, operation for, on one or both eyes, the operation involving a total of one or two muscles (AU 8)
06924	01FEB1984	31AUG1989	N	Squint, operation for, on one or both eyes, the operation involving a total of three or four muscles (AU 9)
06924	01SEP1989	31DEC9999	Y	Squint, operation for, on one or both eyes, the operation involving a total of three or more muscles (AU 9)
06928	01NOV1979	31DEC9999	Y	Squint, operation for, on one or both eyes, the operation involving a total of more than four muscles (AU 10)
06929	01JUL1985	31AUG1989	N	READJUSTMENT OF ADJUSTABLE SUTURES, one or both eyes, as an independent procedure following an operation for correction of squint ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S
06929	01SEP1989	31DEC9999	Y	Readjustment of adjustable sutures, one or both eyes, as an independent procedure following an operation for correction of squint (AU 6)
06930	01FEB1984	31DEC9999	Y	Squint, muscle transplant for (Hummelsheim type, etc.) (AU 9)
06931	01JUL1985	31AUG1989	N	RECURRENT SQUINT OPERATION, one or both eyes, being an operation referred to in Item 6922,6924 or 6930 where there has been two or more previous squint operations on the eye or eyes DERIVED FEE - The fee specified for Item 6922,6924 or 6930 plus one-quarter of that fee ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
06931	01SEP1989	31DEC9999	Y	Recurrent squint operation, one or both eyes, being an operation referred to in item 6922, 6924 or 6930 where there has been two or more previous squint operations on the eye or eyes (AU 10)
06932	01FEB1984	31DEC9999	Y	Ruptured medial palpebral ligament or ruptured extra-ocular muscle, repair of (AU 9)
06938	01FEB1984	31DEC9999	Y	Resuturing of wound following intraocular procedures with or without excision of prolapsed iris (AU 9)
06939	01MAY1990	31DEC9999	Y	THORACIC CAVITY, aspiration of, for diagnostic purposes, not associated with Item 6941
06940	01FEB1984	31DEC9999	Y	Thoracic cavity, aspiration or paracentesis of, or both (excluding after-care)
06941	01MAY1990	31DEC9999	Y	THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample
06942	01FEB1984	31DEC9999	Y	Pericardium, paracentesis of (excluding after-care) (AU 6)
06953	01FEB1984	31DEC9999	Y	Intercostal drain, insertion of, not involving resection of rib (excluding after-care) (AU 7)
06954	01SEP1989	31DEC9999	Y	Percutaneous needle biopsy of lung (AU 7)
06955	01FEB1984	31DEC9999	Y	Empyema, radical operation for, involving resection of rib (AU 13)
06958	01FEB1984	31DEC9999	Y	Thoracotomy, exploratory, with or without biopsy (AU 11)
06962	01FEB1984	31DEC9999	Y	Thoracotomy with pulmonary decortication (AU 17)
06964	01FEB1984	31DEC9999	Y	Thoracotomy for pleurectomy or pleurodesis; or enucleation of hydatid cysts (AU 16)
06966	01FEB1984	31DEC9999	Y	Thoracoplasty (complete) (AU 21)
06968	01FEB1984	31DEC9999	Y	Thoracoplasty (in stages)-- each stage (AU 14)
06972	01FEB1984	31DEC9999	Y	Pectus excavatum or pectus carinatum, radical correction of (AU 16)
06974	01FEB1984	31DEC9999	Y	Thoracoscopy, with or without division of pleural adhesions (AU 7)
06980	01FEB1984	31DEC9999	Y	Pneumonectomy or lobectomy (AU 18)
06986	01FEB1984	31DEC9999	Y	Oesophagectomy with direct anastomosis or with stomach transposition (AU 23)
06988	01FEB1984	31DEC9999	Y	Oesophagectomy with interposition of small or large bowel (AU 27)
06992	01FEB1984	31DEC9999	Y	Mediastinum, cervical exploration of, with or without biopsy (AU 10)
06995	01FEB1984	31DEC9999	Y	Pericardium, transthoracic drainage of (other than for treatment of constrictive pericarditis) (AU 14)
06997	01NOV1979	31DEC9999	Y	Hernia, hiatus or other diaphragmatic, transthoracic repair of (AU 15)
06999	01FEB1984	31DEC9999	Y	Intrathoracic operation on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum or on more than one of those organs, not covered by any other item in this Part (AU 28)
07001	01FEB1984	29FEB1984	N	Right heart catheterisation-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test (AU 12)
07001	01MAR1984	31DEC9999	Y	Measurement of intracardiac conduction times or right heart catheterisation, including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test(AU 12)
07002	01FEB1984	31DEC9999	Y	Intracardiac electrophysiological investigations not covered by Item 7001 (AU 16)
07003	01FEB1984	31DEC9999	Y	Left heart catheterisation by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test (AU 12)
07006	01FEB1984	31DEC9999	Y	Right heart catheterisation with left heart catheterisation via the right heart or by any other procedure-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test (AU 14)
07007	01DEC1989	31DEC9999	Y	CARDIAC ELECTRO PHYSIOLOGICAL STUDY - up to and including 3 catheter investigation of anyone or more of - syncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not in association with Item 7008 ANAESTHETIC 19 UNITS - ITEM NOS 463G / 531S
07008	01DEC1989	31DEC9999	Y	CARDIAC ELECTRO PHYSIOLOGICAL STUDY - 4 or more catheter supraventricular tachycardia invcstigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, multiple catheter mapping, or acute intravenous anti-arryhthmic drug testing with pre and post drug inductions; or catheter ablation; or intra-operative mapping; or clectrophysiological services during defibrillator implantation or testing - not in association with Item 7007 ANAESTHETIC 27 UNITS - ITEM NOS 471G / 542S
07011	01FEB1984	31DEC9999	Y	Selective coronary arteriography-- placement of catheters and injection of opaque material (AU 14)
07013	01FEB1984	31DEC9999	Y	Selective coronary arteriography-- placement of catheters and injection of opaque material with right or left heart catheterisation, or both (AU 16)
07015	01MAY1991	31DEC9999	Y	INTRA-AORTIC BALLOON FOR COUNTERPULSATION, operation for insertion by arteriotomy, or removal and arterioplasty (excluding repair by patch graft) (AU 14 - 458/525)
07021	01FEB1984	31DEC9999	Y	Permanent internal pacemaker and myocardial electrodes, insertion or replacement of by thoracotomy (AU 11)
07028	01FEB1984	31DEC9999	Y	Permanent transvenous electrode, insertion or replacement of (AU 12)
07033	01FEB1984	31DEC9999	Y	Permanent pacemaker, insertion or replacement of (AU 12)
07042	01FEB1984	31DEC9999	Y	Temporary transvenous pacemaking electrode, insertion of (AU 11)
07044	01FEB1984	31DEC9999	Y	Open heart surgery for congenital heart disease in children up to two years, excluding patent ductus arteriosus (AU 38)
07046	01FEB1984	31DEC9999	Y	Open heart surgery for single valve replacement, atrial septal defect, pulmonary valvotomy, congenital heart disease (not covered by Item 7044) or any other open heart operation not covered by any other item in this Part (AU 32)
07057	01FEB1984	31DEC9999	Y	Open heart surgery on more than one valve or involving more than one chamber (AU 38)
07066	01FEB1984	31DEC9999	Y	Coronary artery or arteries, direct surgery to, employing cardiopulmonary by-pass (AU 36)
07070	01MAY1991	31DEC9999	Y	LUMBAR PUNCTURE, or spinal or epidural injection not covered by Item 748 (AU 5 - 406/510)
07071	01MAY1991	31DEC9999	Y	CISTERNAL PUNCTURE
07072	01MAY1991	31DEC9999	Y	DIAGNOSTIC PROCEDURES VENTRICULAR PUNCfURE (not including burr-hole)
07073	01MAY1991	31DEC9999	Y	SUBDURAL HAEMORRHAGE, tap for, each tap (AU 6 - 407/513)
07074	01MAY1991	31DEC9999	Y	BURR-HOLE, single, preparatory to ventricular puncture or for inspection purpose - not included in any other Items (AU 11 - 453/522)
07075	01MAY1991	31DEC9999	Y	VENTRICULAR RESERVOIR or intracranial pressure monitoring device, insertion of - including burr-hole (excluding after-care) (AU 12 - 454/523)
07076	01MAY1991	31DEC9999	Y	CEREBROSPINAL FLUID reservoir, insertion of (AU 10 - 450/521)
07077	01MAY1991	31DEC9999	Y	PROCEDURES FOR PAIN RELIEF INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance (AU 8 - 409/517)
07078	01MAY1991	31DEC9999	Y	INTRATHECAL INJECfION of alcohol or phenol
07079	01FEB1984	31AUG1989	N	Injection into trigeminal ganglion or primary branch of trigeminal nerve with alcohol
07079	01SEP1989	31DEC9999	Y	Injection into trigeminal ganglion or primary branch of trigeminal nerve with alcohol, cortisone, phenol, etc. (AU 8)
07080	01MAY1991	31DEC9999	Y	NEURECTOMY, INTRACRANIAL, for trigeminal neuralgia (AU 16 - 460/527)
07081	01FEB1984	31DEC9999	Y	Intrathecal injection of alcohol or phenol
07082	01MAY1991	31DEC9999	Y	TRIGEMINAL GANGLIOTOMY by radiofrequency, balloon or glycerol (AU 8 - 409/517)
07083	01MAY1991	31DEC9999	Y	CRANIAL NERVE, intracranial decompression of, using microsurgical techniques (AU 25 - 469/540)
07084	01MAY1991	31DEC9999	Y	PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy (AU 6 - 407/513)
07085	01FEB1984	31AUG1989	N	Lumbar puncture; or spinal or epidural injection not covered by Item 748 or 752
07085	01SEP1989	31DEC9999	Y	Lumbar puncture, or spinal or epidural injection not covered by item 748 or 752 (AU 5)
07086	01MAY1991	31DEC9999	Y	PERCUTANEOUS NEUROTOMY for facet joint denervation by radio-frequency probe or cryoprobe using radiological imaging control (AU 7 - 408/514)
07087	01MAY1991	31DEC9999	Y	PERCUTANEOUS CORDOTOMY (AU 9 - 443/518)
07088	01MAY1991	31DEC9999	Y	CORDOTMY OR MYELOTOMY, laminectomy for, or operation for dorsal root entry zone (Drez) lesion (AU 13 - 457/524)
07089	01FEB1984	31DEC9999	Y	Cisternal puncture
07090	01MAY1991	31DEC9999	Y	SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER FOR PAIN, insertion of (AU 8 - 409/517)
07091	01MAY1991	31DEC9999	Y	PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, insertion of (one or two stages), not involving laminectomy (AU 8 - 409/517)
07092	01MAY1991	31DEC9999	Y	EPIDURAL STIMULATOR or INTRATHECAL INFUSION DEVICE, revision of (AU 7 - 408/514)
07093	01MAY1991	31DEC9999	Y	PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, removal of (AU 7 - 408/514)
07094	01MAY1991	31DEC9999	Y	EPIDURAL IMPLANT FOR PAIN, laminectomy and insertion of, including implantation of pulse generator (one or two stages) (AU 18 - 462/529)
07095	01MAY1991	31DEC9999	Y	PERIPHERAL NERVES CUTANEOUS NERVE (including digi tal nerve), primary repair of, using microsurgical techniques (AU 9 - 443/518)
07096	01MAY1991	31DEC9999	Y	CUTANEOUS NERVE (including digital nerve), secondary repair of, using microsurgical techniques (AU 10 - 450/521)
07097	01MAY1991	31DEC9999	Y	NERVE 1RUNK, primary repair of, using microsurgical techniques (AU 11 - 453/522)
07098	01MAY1991	31DEC9999	Y	NERVE 1RUNK, secondary repair of, using microsurgical techniques (AU 12 - 454/523)
07099	01FEB1984	31DEC9999	Y	Ventricular puncture (not including burr-hole)
07100	01MAY1991	31DEC9999	Y	NERVE TRUNK, internal (interfasicular), neurolysis of, using microsurgical techniques (AU 11 - 453/522)
07101	01MAY1991	31DEC9999	Y	NERVE 1RUNK, nerve graft to, (cable graft) including harvesting of nerve graft using microsurgical techniques (AU 16 - 460/527)
07102	01MAY1991	31DEC9999	Y	CUTANEOUS NERVE (including digital nerve), nerve graft to, using microsurgical techniques (AU 12 - 454/523)
07103	01MAY1991	31DEC9999	Y	NERVE, transposition of (AU 8 - 409/517)
07104	01MAY1991	31DEC9999	Y	NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve (AU 8 - 409/517)
07105	01MAY1991	31DEC9999	Y	NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve (AU 10 - 450/521)
07106	01FEB1984	31DEC9999	Y	Cutaneous or digital nerve, primary suture of (G) (AU 8)
07107	01MAY1991	31DEC9999	Y	BRACHIAL PLEXUS, exploration of not covered by any other item in this Part (AU 11 - 453/522)
07108	01MAY1991	31DEC9999	Y	CRANIAL NERVES VESTIBULAR NERVE, section of, via posterior fossa (AU 24 - 468/539)
07109	01MAY1991	31DEC9999	Y	FACIO-HYPOGLOSSAL nerve or FACIO-ACCESSORY nerve, anastomosis of (AU 28 - 472/543)
07110	01MAY1991	31DEC9999	Y	CRANIO-CEREBRAL INJURIES Intracranial haemorrhage, burr-hole craniotomy for - including burr holes (AU 11 - 453/522)
07111	01FEB1984	31DEC9999	Y	Cutaneous or digital nerve, primary suture of (S) (AU 8)
07112	01FEB1984	29FEB1984	N	Cutaneous nerve (other than digital nerve) primary suture of by microsurgical techniques (AU 9)
07112	01MAR1984	31DEC9999	Y	Cutaneous nerve (other than digital nerve), primary suture of, using the operating microscope(AU 9)
07113	01MAY1991	31DEC9999	Y	FRACTURED SKULL, compound, without dural penetration, operation for (AU 12 - 454/523)
07114	01MAY1991	31DEC9999	Y	FRACTURED SKULL, compound or complicated, with dural penetration and brain laceration, operation for (AU 14 - 458/525)
07115	01MAY1991	31DEC9999	Y	FRACTURED SKULL with rhinorrhoea or otorrhoea, cranioplasty and repair of (AU 16 - 460/527)
07116	01FEB1984	31DEC9999	Y	Repair of divided digital nerve to thumb or finger (G) (AU 8)
07117	01FEB1984	31DEC9999	Y	Repair of divided digital nerve to thumb or finger (S) (AU 8)
07118	01JAN1986	31AUG1989	N	CUTANEOUS NERVE (including digital nerve), primary repair of ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S
07118	01SEP1989	31DEC9999	Y	Cutaneous nerve (including digital nerve), primary repair of (AU 8)
07119	01JAN1986	31AUG1989	N	CUTANEOUS NERVE (including digital nerve), secondary repair of ANAESTHETIC 9 UNITS - ITEM NOS 443G / 518S
07119	01SEP1989	31DEC9999	Y	Cutaneous nerve (including digital nerve), secondary repair of (AU 9)
07120	01FEB1984	29FEB1984	N	Repair of divided digital nerve to thumb or finger by microsurgical techniques, primary repair (AU 9)
07120	01MAR1984	31AUG1989	N	Repair of divided digital nerve to thumb or finger using the operating microscope - primary repair (AU 9)
07120	01SEP1989	31DEC9999	Y	Cutaneous nerve (including digital nerve), primary repair of, using the operating microscope (AU 9)
07121	01FEB1984	29FEB1984	N	Repair of divided digital nerve to thumb or finger by microsurgical techniques, secondary repair (AU 10)
07121	01MAR1984	31AUG1989	N	Repair of divided digital nerve to thumb or finger using the operating microscope - secondary repair (AU 10)
07121	01SEP1989	31DEC9999	Y	Cutaneous nerve (including digital nerve), secondary repair of, using the operating microscope (AU 10)
07122	01MAY1991	31DEC9999	Y	INTRACRANIAL tumour, biopsy or decompression of via osteoplastic flap OR biopsy and decompression of via osteoplastic flap (AU 18 - 462/529)
07123	01MAY1991	31DEC9999	Y	CRANIOTOMY for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem - not covered by any other Item in this Part (AU 25 - 469/540)
07124	01FEB1984	31AUG1989	N	Nerve trunk, primary suture of (AU 8)
07124	01SEP1989	31DEC9999	Y	Nerve trunk, primary repair of (AU 8)
07125	01MAY1991	31DEC9999	Y	CRANIOTOMY FOR REMOVAL OF MENINGIOMA, pinealoma, cranio-pharyngioma, intraventricular tumour or any other intracranial tumour not covered by any other item in this Part (AU 25 - 469/540)
07126	01MAY1991	31DEC9999	Y	PITUITARY TUMOUR, hypophysectomy or removal of by transcranial or transphenoidal approach (AU 25 - 469/540)
07128	01FEB1984	31AUG1989	N	Nerve trunk, primary suture of (D) (AU 8)
07128	01SEP1989	31DEC9999	Y	Nerve trunk, primary repair of (D) (AU 8)
07129	01FEB1984	29FEB1984	N	Nerve trunk, primary suture of, by microsurgical techniques (AU 11)
07129	01MAR1984	31AUG1989	N	Nerve trunk, primary suture of, using the operating microscope (AU 11)
07129	01SEP1989	31DEC9999	Y	Nerve trunk, primary repair of, using the operating microscope (AU 11)
07130	01MAY1991	31DEC9999	Y	ARACHNOIDAL CYST, craniotomy for (AU 15 - 459/526)
07132	01FEB1984	31AUG1989	N	Nerve trunk, secondary suture of (AU 9)
07132	01SEP1989	31DEC9999	Y	Nerve trunk, secondary repair of (AU 9)
07133	01FEB1984	31DEC9999	Y	Neurolysis of nerve trunk, internal(interfascicular), using the operating microscope (AU 11)
07134	01FEB1984	31AUG1989	N	Nerve trunk, secondary suture of (D) (AU 9)
07134	01SEP1989	31DEC9999	Y	Nerve trunk, secondary repair of (D) (AU 9)
07135	01MAY1991	31DEC9999	Y	CRANIOTOMY, involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc (AU 16 - 460/527)
07136	01MAY1991	31DEC9999	Y	CEREBROVASCULAR DISEASE ANEURYSM, clipping or reinforcement of sac (AU 28 - 472/543)
07137	01MAY1991	31DEC9999	Y	INTRACRANIAL ARTERIOVENOUS MALFORMATION, excision of (AU 32 - 475/546)
07138	01FEB1984	29FEB1984	N	Nerve trunk, secondary suture of, by microsurgical techniques (AU 12)
07138	01MAR1984	31AUG1989	N	Nerve trunk, secondary suture of, using the operating microscope(AU 12)
07138	01SEP1989	31DEC9999	Y	Nerve trunk, secondary repair of, using the operating microscope (AU 12)
07139	01FEB1984	31AUG1989	N	Nerve graft performed with magnification (AU 9)
07139	01SEP1989	31DEC9999	Y	Nerve graft to nerve trunk (cable graft) including harvesting of nerve graft (AU 9)
07140	01JUL1985	31AUG1989	N	NERVE GRAFT to cutaneous nerve (including digital nerve) ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
07140	01SEP1989	31DEC9999	Y	Nerve graft to cutaneous nerve (including digital nerve) (AU 12)
07141	01NOV1986	31AUG1989	N	NERVE GRAFT to nerve trunk (cable graft) including harvesting of nerve graft using microsurgical techniques ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S
07141	01SEP1989	31DEC9999	Y	Nerve graft to nerve trunk (cable graft) including harvesting of nerve graft using microsurgical techniques (AU 16)
07143	01FEB1984	31DEC9999	Y	Nerve, transposition of (AU 8)
07146	01FEB1984	31DEC9999	Y	Nerve, transposition of (D) (AU 8)
07147	01MAY1991	31DEC9999	Y	ANEURYSM, or arteriovenous malformation, intracranial proximal artery clipping of (AU 24 - 468/539)
07148	01FEB1984	31AUG1989	N	Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve, including multiple percutaneous neurotomy of posterior division of spinal nerves (G) (AU 8)
07148	01SEP1989	31DEC9999	Y	Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve (G) (AU 8)
07149	01MAY1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION, craniotomy and direct embolisation of (AU 32 - 475/546)
07150	01MAY1991	31DEC9999	Y	INTRACRANIAL ANEURYSM or arteriovenous fistula, ligation of cervical vessel or vessels (AU 10 - 450/521)
07151	01MAY1991	31DEC9999	Y	CAROTID-CA VERNOUS FISTULA, obliteration of - combined cervical and intracranial procedure (AU 40 - 479/550)
07152	01FEB1984	31AUG1989	N	Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve, including multiple percutaneous neurotomy of posterior division of spinal nerves (S) (AU 8)
07152	01SEP1989	31DEC9999	Y	Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve (S) (AU 8)
07153	01JUL1985	31AUG1989	N	PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S
07153	01SEP1989	31DEC9999	Y	Percutaneous neurotomy of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy (AU 6)
07154	01MAY1991	31DEC9999	Y	EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery or saphenous vein graft (AU 32 - 475/546)
07155	01MAY1991	31DEC9999	Y	INFECTION INTRACRANIAL INFECfION, drainage of, via burr-hole - including burr-hole (AU 10 - 450/521)
07156	01FEB1984	31DEC9999	Y	Neurectomy, neurotomy or removal of tumour from deep peripheral nerve (AU 10)
07157	01FEB1984	31DEC9999	Y	Radiofrequency trigeminal gangliotomy (AU 8)
07158	01MAY1991	31DEC9999	Y	INTRACRANIAL ABSCESS, excision of (AU 17 - 461/528)
07159	01MAY1991	31DEC9999	Y	OSTEOMYELITIS OF SKULL or removal of infected bone flap, craniectomy for (AU 10 - 450/521)
07160	01MAY1991	31DEC9999	Y	CEREBRO-SPINAL FLUID CIRCULATION DISORDERS VENTRICULO-CISTERNOSTOMY (Torkildsen's operation) (AU 15 - 459/526)
07161	01MAY1991	31DEC9999	Y	CRANIAL OR CISTERNAL SHUNT DIVERSION, insertion of (AU 14 - 458/525)
07162	01MAY1991	31DEC9999	Y	LUMBAR SHUNT DIVERSION, insertion of (AU 13 - 457/524)
07163	01MAY1991	31DEC9999	Y	CRANIAL, CISTERNAL OR LUMBAR SHUNT, revision or removal of (AU 12 - 454/523)
07164	01MAY1991	31DEC9999	Y	THIRD VENTRICULOSTOMY (AU 15 - 459/526)
07165	01MAY1991	31DEC9999	Y	SUBTEMPORAL DECOMPRESSION (AU 26 - 470/541)
07166	01MAY1991	31DEC9999	Y	LUMBAR CEREBROSPINAL FLUID DRAIN, insertion of (AU 6 - 407/513)
07167	01MAY1991	31DEC9999	Y	CONGENITAL DISORDERS MENINGOCELE, excision and closure of (AU 13 - 457/524)
07168	01MAY1991	31DEC9999	Y	MYELOMENINGOCELE, excision and closure of, including skin flaps or Z plasty where performed (AU 15 - 459/526)
07169	01MAY1991	31DEC9999	Y	ARNOLD-CHIARI MALFORMATION, decompression of (AU 35 - 493/564)
07170	01FEB1984	31DEC9999	Y	Neurectomy, intracranial or radical as in tic douloureux (AU 16)
07171	01FEB1984	31DEC9999	Y	Intracranial microsurgical decompression of cranial nerve, posterior cranial fossa approach including Jannetta's operation (AU 25)
07172	01MAY1991	31DEC9999	Y	ENCEPHALOCOELE, excision and closure of (AU 34 - 492/563)
07173	01MAY1991	31DEC9999	Y	TETHERED CORD, release of, including lipomeningocoele or diastematomyelia (AU 35 - 493/564)
07174	01MAY1991	31DEC9999	Y	CRANIOSTENOSIS, operation for - single suture (AU 17 - 461/528)
07175	01FEB1984	31DEC9999	Y	Exploration of brachial plexus, not covered by any other item in this Part (AU 11)
07176	01MAY1991	31DEC9999	Y	CRANIOSTENOSIS, operation for - more than one suture (AU 20 - 464/533)
07177	01MAY1991	31DEC9999	Y	SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for exploration or removal of (AU 12 - 454/523)
07178	01FEB1984	31AUG1989	N	Neurolysis by open operation, without transposition (G) (AU 7)
07178	01SEP1989	31DEC9999	Y	Neurolysis by open operation without transposition, not associated with item 7133 (G) (AU 7)
07179	01MAY1991	31DEC9999	Y	RECURRENT DISC LESION OR SPINAL STENOSIS, laminectomy for - one level (AU 13 - 457/524)
07180	01MAY1991	31DEC9999	Y	SPINAL CANAL STENOSIS, laminectomy (multi-level), for treatment of (AU 16- 460/527)
07181	01MAY1991	31DEC9999	Y	EXTRADURAL TUMOUR OR ABSCESS, laminectomy for (AU 12 - 454/523)
07182	01FEB1984	31AUG1989	N	Neurolysis by open operation, without transposition (S) (AU 7)
07182	01SEP1989	31DEC9999	Y	Neurolysis by open operation without transposition, not associated with item 7133 (S) (AU 7)
07183	01MAY1991	31DEC9999	Y	SPINAL RHIZOLYSIS involving exposure of spinal nerve roots, with or without laminectomy (AU 16 - 460/527)
07184	01FEB1984	31DEC9999	Y	Subdural haemorrhage, tap for, each tap (AU 6)
07185	01MAY1991	31DEC9999	Y	INTRADURAL LESION, laminectomy for, not covered by any other item in this Part (AU 13 - 457/524)
07186	01FEB1984	31DEC9999	Y	Burr-hole, single preparatory to ventricular puncture or for inspection purpose-- not included in any other items (AU 11)
07187	01MAY1991	31DEC9999	Y	CRANIOCERVICAL JUNCTION LESION, transoral approach for (AU 29 - 473/544)
07188	01MAY1991	31DEC9999	Y	INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, laminectomy and radical excision of (AU 14 - 458/525)
07189	01MAY1991	31DEC9999	Y	POSTERIOR SPINAL FUSION, not covered by items 7191 and 7193 (AU 18 - 462/529)
07190	01FEB1984	31DEC9999	Y	Insertion of ventricular reservoir, or insertion of intracranial pressure monitoring device, including burr-hole, as an independent procedure(excluding after-care)(AU 12)
07191	01MAY1991	31DEC9999	Y	LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare (AU 18 - 462/529)
07192	01FEB1984	31DEC9999	Y	Intracranial tumour, biopsy of, or intracranial cyst, drainage of via burr-hole-- including burr-hole (AU 10)
07193	01MAY1991	31DEC9999	Y	LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare
07194	01FEB1984	31DEC9999	Y	Intracranial tumour, biopsy or decompression of via osteoplastic flap or biopsy and decompression of via osteoplastic flap (AU 18)
07195	01MAY1991	31DEC9999	Y	ANTERIOR INTERBODY SPINAL FUSION TO CERVICAL SPINE - one level (AU 14 - 458/525)
07196	01MAY1991	31DEC9999	Y	CERVICAL DISCEcrOMY (ANTERIOR), without fusion (AU 19 - 463/531)
07197	01MAY1991	31DEC9999	Y	SPINE (EXCLUDING SACRUM), treatment of fracture of vertebral body, without involvement of cord, requiring immobilisation in plaster or traction by skull calipers (AU 9 - 443/518)
07198	01FEB1984	31AUG1989	N	Intracerebral tumour, craniotomy and removal; or temporal lobectomy for any reason (AU 25)
07198	01SEP1989	31DEC9999	Y	Craniotomy for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem-not covered by any other item in this Part (AU 25)
07199	01MAY1991	31DEC9999	Y	SPINE (EXCLUDING SACRUM), treatment of fracture of vertebral body, with involvement of cord (AU 9 - 443/518)
07200	01MAY1991	31DEC9999	Y	INTRADISCAL INJECTION OF CHYMOPAPAIN (DISCASE) - one disc (AU 8- 409/517) (See para 10.33 of explanatory notes to this Part)
07203	01FEB1984	29FEB1984	N	Intracranial extracerebral tumour, craniotomy and removal; or hemispherectomy for any reason (AU 25)
07203	01MAR1984	31AUG1989	N	Intracranial extracerebral tumour, craniotomy and removal; or hemispherectomy for any reason, not associated with Item 7204(AU 25)
07203	01SEP1989	31DEC9999	Y	Craniotomy for removal of meningioma pinealoma, cranio-pharyngioma or any other intracranial tumour-not covered by any other item in this Part (AU 25)
07204	01FEB1984	31DEC9999	Y	Hypophysectomy or removal of pituitary tumour by transcranial or transphenoidal approach(AU 25)
07208	01MAY1991	31DEC9999	Y	BONE GRAFT TO SPINE with laminectomy and posterior interbody fusion - one level (AU 15 - 459/526)
07209	01MAY1991	31DEC9999	Y	BONE GRAFT TO SPINE with laminectomy and posterior interbody fusion - more than one level (AU 18 - 462/529)
07211	01MAY1991	31DEC9999	Y	BONE GRAFT TO SPINE, postero-lateral fusion (AU 14 - 458/525)
07212	01FEB1984	31DEC9999	Y	Intracranial haemorrhage, burr-hole craniotomy for-- including burrholes (AU 11)
07213	01MAY1991	31DEC9999	Y	ANTERIOR INTERBODY SPINAL FUSION TO LUMBAR OR THORACIC SPINE - one level (AU 15 - 459/526)
07214	01MAY1991	31DEC9999	Y	ANTERIOR INTERBODY SPINAL FUSION TO LUMBAR OR THORACIC SPINE - more than one level (AU 15 - 459/526)
07216	01FEB1984	31DEC9999	Y	Intracranial haemorrhage, osteoplastic craniotomy or extensive craniectomy and removal of haematoma (AU 18)
07217	01MAY1991	31DEC9999	Y	HYDROMELIA, plugging of obex for, with or without duroplasty (AU 25 - 469/540)
07218	01MAY1991	31DEC9999	Y	HYDROMELIA, craniotomy and laminectomy for, with cavity packing and CSF shunt (AU 25 - 469/540)
07219	01MAY1991	31DEC9999	Y	SKULL RECONSTRUCTION CRANIOPLASTY, reconstructive (AU 16 - 460/527)
07222	01MAY1991	31DEC9999	Y	EPILEPSY CORPUS CALLOSUM, anterior section of, for epilepsy (AU 25 - 469/540)
07223	01MAY1991	31DEC9999	Y	CORTICECfOMY, TOPECfOMY or PARTIAL LOBECTOMY for epilepsy (AU 23 - 467/538)
07224	01MAY1991	31DEC9999	Y	HEMISPHERECTOMY for intractible epilepsy (AU 40 - 479/550)
07225	01MAY1991	31DEC9999	Y	BURR-HOLE PLACEMENT of intracranial depth or surface electrodes (AU 15 - 459/526)
07226	01MAY1991	31DEC9999	Y	INTRACRANIAL ELECTRODE PLACEMENT via craniotomy (AU 21 - 465/535)
07227	01MAY1991	31DEC9999	Y	STEREOTACTIC PROCEDURES STEREOTACTIC ANATOMICAL LOCALISATION in association with an intracranial operative procedure (AU 17 - 461/528)
07228	01MAY1991	31DEC9999	Y	INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not covered by any other item in this Part (AU 17 - 461/528)
07229	01MAY1991	31DEC9999	Y	MISCELLANEOUS LEUCOTOMY for psychiatric disorder (AU 15 - 459/526)
07231	01FEB1984	31DEC9999	Y	Fracture of skull, depressed or comminuted, operation for (AU 12)
07232	01MAY1991	31DEC9999	Y	OPTIC NERVE MENINGES, incision of (AU 14 - 458/525)
07240	01FEB1984	31DEC9999	Y	Fractured skull, compound, without dural penetration, operation for (AU 12)
07244	01FEB1984	31DEC9999	Y	Fractured skull, compound or complicated, with dural penetration and brain damage, operation for (AU 14)
07248	01FEB1984	31DEC9999	Y	Fractured skull with rhinorrhoea or otorrhea, cranioplasty and repair of (AU 16)
07251	01FEB1984	31DEC9999	Y	Reconstructive cranioplasty (AU 16)
07265	01FEB1984	31DEC9999	Y	Aneurysm or arteriovenous malformation, clipping or reinforcement of sac (AU 28)
07270	01FEB1984	31DEC9999	Y	Aneurysm or arteriovenous malformation, intracranial proximal artery clipping (AU 24)
07274	01FEB1984	31DEC9999	Y	Aneurysm or arteriovenous fistula, cervical carotid ligation for (AU 10)
07279	01FEB1984	31DEC9999	Y	Craniotomy involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc. (AU 16)
07283	01FEB1984	31DEC9999	Y	Intracranial abscess, excision of (AU 17)
07287	01FEB1984	31DEC9999	Y	Intracranial infection, drainage of, via burr-hole-- including burr-hole (AU 10)
07291	01FEB1984	31DEC9999	Y	Craniectomy for osteomyelitis of skull (AU 10)
07298	01FEB1984	31DEC9999	Y	Leucotomy or lobotomy for psychiatric causes (AU 15)
07312	01FEB1984	29FEB1984	N	Chemopallidectomy or other stereotactic procedure including burrhole and air studies (AU 17)
07312	01MAR1984	31DEC9999	Y	Intracranial stereotactic procedure by any method, including burr-holes, preparation for ventriculography and localisation of lesion(AU 17)
07314	01FEB1984	31DEC9999	Y	Ventriculo-cisternostomy (Torkildsen's operation) (AU 15)
07316	01FEB1984	31DEC9999	Y	Ventriculo-atrial or ventriculoperitoneal valvular shunt for hydrocephalus or other lesions (AU 14)
07318	01FEB1984	31DEC9999	Y	Ventriculo-atrial or ventriculoperitoneal valvular shunt, revision or removal of (AU 12)
07320	01FEB1984	31DEC9999	Y	Spino-ureteral, spino-peritoneal, spino-pleural or similar spinal shunt for hydrocephalus (AU 13)
07324	01FEB1984	31DEC9999	Y	Craniostenosis, operation for-- single suture (AU 17)
07326	01FEB1984	31DEC9999	Y	Craniostenosis, operation for-- more than one suture (AU 20)
07328	01FEB1984	31DEC9999	Y	Arachnoidal cyst, operation for (AU 15)
07331	01FEB1984	31DEC9999	Y	Laminectomy for exploration or removal of intervertebral disc or discs (AU 12)
07336	01FEB1984	31DEC9999	Y	Laminectomy for recurrent disc lesion or spinal stenosis (AU 13)
07338	01AUG1988	31DEC9999	Y	Laminectomy, multi-level, for the treatment of spinal canal stenosis (AU 16)
07341	01FEB1984	31DEC9999	Y	Laminectomy for extradural tumour or abscess (AU 12)
07346	01FEB1984	31DEC9999	Y	Laminectomy for intradural lesion or open cordotomy (AU 13)
07353	01FEB1984	31DEC9999	Y	Laminectomy and radical excision of intra-medullary tumour or arteriovenous malformation (AU 14)
07355	01FEB1984	31DEC9999	Y	Laminectomy followed by posterior fusion-- not covered by Items 7361 and 7365 (AU 18)
07361	01FEB1984	31DEC9999	Y	Laminectomy followed by posterior fusion performed by neuro-surgeon and orthopaedic surgeon operating together-- laminectomy including after-care (AU 18)
07365	01FEB1984	31DEC9999	Y	Laminectomy followed by posterior fusion performed by neuro-surgeon and orthopaedic surgeon operating together-- posterior fusion including after-care
07370	01FEB1984	31DEC9999	Y	Spinal rhizolysis involving exposure of spinal nerve roots, with or without laminectomy (AU 16)
07373	01AUG1987	31AUG1989	N	INTRADISCAL INJECTION of chymopapain (DISCASE)-ONE DISC ANAESTHETIC 8 UNITS-ITEM NOS 409G/517S
07373	01SEP1989	31DEC9999	Y	Intradiscal injection of chymopapain (Discase)-one disc (AU 8)
07376	01FEB1984	31DEC9999	Y	Sympathectomy (cervical, lumbar, thoracic, sacral or presacral) (AU 10)
07381	01FEB1984	31DEC9999	Y	Percutaneous cordotomy (AU 9)
07397	01FEB1984	31DEC9999	Y	Mandible (AU 4)
07402	01FEB1984	31DEC9999	Y	Mandible (D) (AU 4)
07410	01FEB1984	31DEC9999	Y	Clavicle (AU 4)
07412	01FEB1984	31DEC9999	Y	Shoulder-first or second dislocation (AU 4)
07416	01FEB1984	31DEC9999	Y	Shoulder-third or subsequent dislocation -requiring anaesthesia (AU 4)
07419	01FEB1984	31DEC9999	Y	Shoulder-third or subsequent dislocation-not requiring anaesthesia
07423	01FEB1984	31DEC9999	Y	Elbow (AU 4)
07426	01FEB1984	31DEC9999	Y	Carpus (AU 4)
07430	01FEB1984	31DEC9999	Y	Carpus on radius and ulna (G)(AU 4)
07432	01FEB1984	31DEC9999	Y	Carpus on radius and ulna (S) (AU 4)
07435	01FEB1984	31DEC9999	Y	Finger (AU 4)
07436	01FEB1984	31DEC9999	Y	Metacarpo-phalangeal joint of thumb (AU 4)
07440	01FEB1984	31DEC9999	Y	Hip (G) (AU 5)
07443	01FEB1984	31DEC9999	Y	Hip (S) (AU 5)
07446	01FEB1984	31DEC9999	Y	Knee (G) (AU 4)
07451	01FEB1984	31DEC9999	Y	Knee (S) (AU 4)
07457	01FEB1984	31DEC9999	Y	Patella (AU 4)
07461	01FEB1984	31DEC9999	Y	Ankle (AU 5)
07464	01FEB1984	31DEC9999	Y	Toe (AU 4)
07468	01FEB1984	31DEC9999	Y	Tarsus (AU 4)
07472	01FEB1984	31DEC9999	Y	Spine (cervical or lumbar), without fracture (AU 7)
07480	01FEB1984	31DEC9999	Y	Treatment of a dislocation requiring open operation, being a dislocation referred to in Item 7397, 7410, 7416, 7419, 7426, 7435, 7457 or 7464
07483	01FEB1984	31DEC9999	Y	Treatment of a dislocation requiring open operation, being a dislocation referred to in an item (other than an item referred to in Item 7480 or an item that includes the symbol (D)) under the heading Dislocations not requiring Open Operation in this Division
07485	01FEB1984	31DEC9999	Y	Treatment of a dislocation of the mandible requiring open operation (D)
07505	01FEB1984	31DEC9999	Y	Terminal phalanx of finger or thumb (AU 4)
07508	01FEB1984	31DEC9999	Y	Proximal phalanx of finger or thumb (G) (AU 4)
07512	01FEB1984	31DEC9999	Y	Proximal phalanx of finger or thumb (S) (AU 4)
07516	01FEB1984	31DEC9999	Y	Middle phalanx of finger (AU 4)
07520	01FEB1984	31DEC9999	Y	One or more metacarpals, not involving base of first carpometacarpal joint (G) (AU 4)
07524	01FEB1984	31DEC9999	Y	One or more metacarpals, not involving base of first carpometacarpal joint (S) (AU 4)
07527	01FEB1984	31DEC9999	Y	First metacarpal involving carpometacarpal joint (Bennett's fracture) (G) (AU 4)
07530	01FEB1984	31DEC9999	Y	First metacarpal involving carpometacarpal joint (Bennett's fracture) (S) (AU 4)
07533	01FEB1984	31DEC9999	Y	Carpus (excluding navicular) (AU 5)
07535	01FEB1984	31DEC9999	Y	Navicular or carpal scaphoid (G) (AU 5)
07538	01FEB1984	31DEC9999	Y	Navicular or carpal scaphoid (S) (AU 5)
07539	01SEP1989	31DEC9999	Y	Carpal scaphoid, fracture of, reduction and screw fixation (AU 10)
07540	01FEB1984	31DEC9999	Y	Colles' fracture of wrist (G) (AU 5)
07544	01FEB1984	31DEC9999	Y	Colles' fracture of wrist (S) (AU 5)
07547	01FEB1984	31DEC9999	Y	Distal end of radius or ulna, involving wrist (AU 5)
07550	01FEB1984	31DEC9999	Y	Radius (G) (AU 5)
07552	01FEB1984	31DEC9999	Y	Radius (S) (AU 5)
07559	01FEB1984	31DEC9999	Y	Ulna (G) (AU 5)
07563	01FEB1984	31DEC9999	Y	Ulna (S) (AU 5)
07567	01FEB1984	31DEC9999	Y	Humerus or both shafts of forearm (G) (AU 6)
07572	01FEB1984	31DEC9999	Y	Humerus or both shafts of forearm (S) (AU 6)
07588	01FEB1984	31DEC9999	Y	Clavicle or sternum (G) (AU 6)
07593	01FEB1984	31DEC9999	Y	Clavicle or sternum (S) (AU 6)
07597	01FEB1984	31DEC9999	Y	Scapula (AU 6)
07601	01FEB1984	31DEC9999	Y	One or more ribs-- each attendance (G) (AU 7)
07605	01FEB1984	31DEC9999	Y	One or more ribs-- each attendance (S) (AU 7)
07608	01FEB1984	31DEC9999	Y	Pelvis (excluding symphysis pubis) or sacrum (G) (AU 8)
07610	01FEB1984	31DEC9999	Y	Pelvis (excluding symphysis pubis) or sacrum (S) (AU 8)
07615	01FEB1984	31DEC9999	Y	Symphysis pubis (G) (AU 7)
07619	01FEB1984	31DEC9999	Y	Symphysis pubis (S) (AU 7)
07624	01FEB1984	31DEC9999	Y	Femur (G) (AU 8)
07627	01FEB1984	31DEC9999	Y	Femur (S) (AU 8)
07632	01FEB1984	31DEC9999	Y	Fibula or tarsus (excepting os calcis or os talus) (G) (AU 6)
07637	01FEB1984	31DEC9999	Y	Fibula or tarsus (excepting os calcis or os talus) (S) (AU 6)
07641	01FEB1984	31DEC9999	Y	Tibia or patella (G) (AU 6)
07643	01FEB1984	31DEC9999	Y	Tibia or patella (S) (AU 6)
07647	01FEB1984	31DEC9999	Y	Ankle (Pott's fracture) with or without dislocation, os calcis (calcaneus), os talus or both shafts of leg (G) (AU 7)
07652	01FEB1984	31DEC9999	Y	Ankle (Pott's fracture) with or without dislocation, os calcis (calcaneus), os talus or both shafts of leg (S) (AU 7)
07673	01FEB1984	31DEC9999	Y	Metatarsals-- one or more (G) (AU 5)
07677	01FEB1984	31DEC9999	Y	Metatarsals-- one or more (S) (AU 5)
07681	01FEB1984	31DEC9999	Y	Phalanx of toe (other than great toe) (AU 4)
07683	01FEB1984	31DEC9999	Y	More than one phalanx of toe (other than great toe) (AU 4)
07687	01FEB1984	31DEC9999	Y	Distal phalanx of great toe (AU 4)
07691	01FEB1984	31DEC9999	Y	Proximal phalanx of great toe (AU 4)
07694	01FEB1984	31DEC9999	Y	Skull, not requiring operation-- each attendance (G)
07697	01FEB1984	31DEC9999	Y	Skull, not requiring operation-- each attendance (S)
07701	01FEB1984	31DEC9999	Y	Nasal bones, not requiring reduction-- each attendance (G)
07706	01FEB1984	31DEC9999	Y	Nasal bones, not requiring reduction-each attendance (S)
07709	01FEB1984	31DEC9999	Y	Nasal bones, requiring reduction (G) (AU 6)
07712	01FEB1984	31DEC9999	Y	Nasal bones, requiring reduction (S) (AU 6)
07715	01FEB1984	31DEC9999	Y	Nasal bones, requiring reduction and involving osteotomies (AU 8)
07718	01NOV1979	31DEC9999	Y	Maxilla-not requiring splinting (G)
07719	01NOV1984	31DEC9999	Y	Maxilla or mandible, unilateral or bilateral, not requiring splinting
07720	01NOV1984	31DEC9999	Y	Maxilla or mandible, unilateral or bilateral, not requiring splinting (D)
07721	01NOV1979	31DEC9999	Y	Maxilla-not requiring splinting (S)
07722	01NOV1984	31DEC9999	Y	Maxilla or mandible, requiring splinting or wiring of teeth, not associated with item 7725-each procedure to a maximum of three such procedures (AU 13)
07723	01NOV1984	31DEC9999	Y	Maxilla or mandible, requiring splinting or wiring of teeth, not associated with item 7726-each procedure to a maximum of three such procedures (D) (AU 13)
07724	01NOV1979	31DEC9999	Y	Maxilla-not requiring splinting (D)
07725	01NOV1984	31DEC9999	Y	Maxilla or mandible, circumosseous fixation of-each procedure to a maximum of three such procedures (AU 15)
07726	01NOV1984	31DEC9999	Y	Maxilla or mandible, circumosseous fixation of-each procedure to a maximum of three such procedures (D) (AU 15)
07727	01NOV1979	31DEC9999	Y	Maxilla-with external fixation, wiring of teeth or internal fixation (AU 11)
07728	01NOV1984	31DEC9999	Y	Maxilla or mandible, external skeletal fixation of-each procedure to a maximum of three such procedures (AU 15)
07729	01NOV1984	31DEC9999	Y	Maxilla or mandible, external skeletal fixation of-each procedure to a maximum of three such procedures (D) (AU 15)
07731	01NOV1979	31DEC9999	Y	Maxilla-with external fixation, wiring of teeth or internal fixation (D) (AU 11)
07739	01NOV1979	31DEC9999	Y	Mandible-not requiring splinting (G)
07743	01NOV1979	31DEC9999	Y	Mandible-not requiring splinting (S)
07745	01NOV1979	31DEC9999	Y	Mandible-not requiring splinting (D)
07749	01NOV1979	31DEC9999	Y	Mandible-with wiring of teeth, internal fixation or skeletal pinning with external fixation (AU 12)
07753	01NOV1979	31DEC9999	Y	Mandible-with wiring of teeth, internal fixation or skeletal pinning with external fixation (D) (AU 12)
07764	01FEB1984	31DEC9999	Y	Zygoma (G) (AU 7)
07766	01FEB1984	31DEC9999	Y	Zygoma (S) (AU 7)
07770	01FEB1984	31DEC9999	Y	Zygoma (D) (AU 7)
07774	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), transverse process or bone other than vertebral body, not requiring immobilisation in plaster-each attendance (G)
07777	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), transverse process or bone other than vertebral body, not requiring immobilisation in plaster-each attendance (S)
07781	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), vertebral body, without involvement of cord, not requiring immobilisation in plaster-each attendance (G)
07785	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), vertebral body, without involvement of cord, not requiring immobilisation in plaster-each attendance (S)
07789	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), transverse process or bone other than vertebral body requiring immobilisation in plaster or traction by skull calipers (AU 9)
07793	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), vertebral body, without involvement of cord, requiring immobilisation in plaster or traction by skull calipers (AU 9)
07798	01FEB1984	31DEC9999	Y	Spine (excluding sacrum), vertebral body, with involvement of cord (AU 9)
07802	01FEB1984	28FEB1987	N	Treatment of a simple and uncomplicated fracture requiring open operation being a fracture referred to in Item 7505, 7508, 7516, 7533, 7601, 7605, 7681, 7683, 7687, 7691, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785
07802	01MAR1987	31DEC9999	Y	TREATMENT OF A SIMPLE AND UNCOMPLICATED FRACTURE REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505, 7508,7516,7533, 7601. 7605, 7681,7683,7687,7691,7694,7697, 7701, 7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 483G / 554S
07803	01FEB1984	31DEC9999	Y	Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7802 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07804	01FEB1984	31AUG1989	N	Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D)
07804	01SEP1989	31DEC9999	Y	Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D)
07808	01FEB1984	28FEB1987	N	Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in Item 7505, 7516, 7533, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785
07808	01MAR1987	31DEC9999	Y	TREATMENT OF A SIMPLE AND UNCOMPLICATED FRACTURE REQUIRING INTERNAL FIXATION, being a fracture referred to in Item - 7505,7516,7533, 7601,7605,7681, 7683, 7694,7697, 7701,7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 484G / 556S
07809	01FEB1984	31DEC9999	Y	Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in an item (other than an item referred to in Item 7808 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07812	01FEB1984	31AUG1989	N	Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D)
07812	01SEP1989	31DEC9999	Y	Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D)
07815	01FEB1984	28FEB1987	N	Treatment of a compound fracture requiring open operation, being a fracture referred to in Item 7505, 7516, 7533, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785
07815	01MAR1987	31DEC9999	Y	TREATMENT OF A COMPOUND FRACTURE REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505,7516, 7533,7601,7605, 7681, 7683,7694, 7697,7701,7706,7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 484G / 556S
07817	01FEB1984	31DEC9999	Y	Treatment of a compound fracture requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7815 or an item that includes the symbol (D) ) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07818	01FEB1984	31AUG1989	N	Treatment of a compound fracture requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D)
07818	01SEP1989	31DEC9999	Y	Treatment of a compound fracture requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D)
07821	01FEB1984	28FEB1987	N	Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Item 7505, 7516, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785
07821	01MAR1987	31DEC9999	Y	TREATMENT OF A COMPLICATED FRACTURE INVOLVING VISCERA, BLOOD VESSELS OR NERVES AND REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505, 7516, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 485G / 557S
07823	01FEB1984	31DEC9999	Y	Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7821 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07824	01FEB1984	31AUG1989	N	Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D)
07824	01SEP1989	31DEC9999	Y	Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D)
07828	01FEB1984	31DEC9999	Y	Initial reduction (without full postoperative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07831	01FEB1984	31AUG1989	N	Initial reduction (without full postoperative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D)
07831	01SEP1989	31DEC9999	Y	Initial reduction (without full post-operative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D)
07834	01FEB1984	31DEC9999	Y	Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol(D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07836	01FEB1984	31AUG1989	N	Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D)
07836	01SEP1989	31DEC9999	Y	Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D)
07839	01FEB1984	28FEB1987	N	Final reduction (including full postoperative treatment) in a series, being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07839	01MAR1987	31DEC9999	Y	FINAL REDUCTION (including full post-operative treatment) in a series being a reduction that would, but for this item, be covered by an item under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division DERIVED FEE - The fee specified for the administration of the anaesthetic for the reduction of this fracture
07841	01FEB1984	31AUG1989	N	Final reduction (including full post-operative treatment) in a series, being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D)
07841	01SEP1989	31DEC9999	Y	Final reduction (including full post-operative treatment) in a series, being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D)
07844	01FEB1984	31DEC9999	Y	Treatment of avulsion of epiphysis of any part referred to in an item under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07847	01FEB1984	31DEC9999	Y	Treatment of a closed fracture, involving a joint surface, being a fracture referred to in an item (other than an item that includes the symbol(D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division
07849	01FEB1984	31AUG1989	N	Treatment of a closed fracture, involving a joint surface, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D)
07849	01SEP1989	31DEC9999	Y	Treatment of a closed fracture, involving a joint surface, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D)
07853	01FEB1984	31DEC9999	Y	Accessory or sesamoid bone, removal of (AU 6)
07855	01NOV1984	31DEC9999	Y	Bone cysts, injection of steroids into (AU 8)
07857	01FEB1984	31DEC9999	Y	Epicondylitis, open operation for (AU 6)
07861	01FEB1984	31DEC9999	Y	Digital nail, removal of (AU 5)
07864	01FEB1984	31DEC9999	Y	Incision for pulp space infection, paronychia or other acute infection of hands or feet, not covered by any other item in this Part (excluding after-care) (AU 5)
07868	01FEB1984	31DEC9999	Y	Middle palmar, thenar or hypothenar spaces, drainage of (AU 6)
07872	01FEB1984	31DEC9999	Y	Ingrowing toenail, excision of nail bed (G) (AU 6)
07874	01SEP1989	31DEC9999	Y	Nail bed, excision or wedge resection of (G) (AU 6)
07875	01SEP1989	31DEC9999	Y	Nail bed, excision or wedge resection of (S) (AU 6)
07878	01FEB1984	31DEC9999	Y	Ingrowing toenail, excision of nail bed (S) (AU 6)
07883	01FEB1984	31DEC9999	Y	Insertion of orthopaedic pin or wire, as an independent procedure (AU 5)
07886	01FEB1984	31DEC9999	Y	Removal of buried wire, pin, screw, rod, nail or plate requiring incision under regional or general anaesthesia (AU 8)
07888	01FEB1984	31DEC9999	Y	Insertion of orthopaedic pin or wire where no other surgical procedure is performed (D) (AU 5)
07898	01FEB1984	31AUG1989	N	Osteosynthesis by Smith-Petersen nail (AU 11)
07898	01SEP1989	31DEC9999	Y	Femur, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (AU 11)
07902	01FEB1984	31DEC9999	Y	Temporo-mandibular meniscectomy (AU 9)
07907	01FEB1984	31DEC9999	Y	Temporo-mandibular meniscectomy (D) (AU 9)
07911	01FEB1984	31DEC9999	Y	Manipulation of joint, joints, spine, joint and spine or joints and spine, under general anaesthesia, not associated with any other item in this Part (G) (AU 4)
07915	01FEB1984	31DEC9999	Y	Manipulation of joint, joints, spine, joint and spine or joints and spine, under general anaesthesia, not associated with any other item in this Part (S) (AU 4)
07926	01FEB1984	31DEC9999	Y	Spine, application of plaster jacket (AU 6)
07928	01FEB1984	31DEC9999	Y	Risser jacket, localizer or turn-buckle jacket, application of, body only
07932	01FEB1984	31DEC9999	Y	Risser jacket, localizer or turn-buckle jacket, application of, body and head
07934	01FEB1984	31DEC9999	Y	Scoliosis, spinal fusion for (AU 23)
07937	01FEB1984	31DEC9999	Y	Scoliosis, re-exploration for adjustment or removal of Harrington rods or similar devices (AU 12)
07938	01FEB1984	29FEB1984	N	Spinal fusion for scoliosis or kyphosis by use of Harrington distraction rod or by anterior correction (Dwyer procedure) of not more than four spaces (AU 23)
07938	01MAR1984	31DEC9999	Y	Anterior correction of scoliosis (Dwyer procedure) of not more than four spaces; or spinal fusion for scoliosis or kyphosis with use of Harrington distraction rod (AU 23)
07939	01FEB1984	29FEB1984	N	Spinal fusion for scoliosis or kyphosis by use of Harrington distraction rod and compression rod or by anterior correction (Dwyer procedure) of more than four spaces (AU 29)
07939	01MAR1984	31DEC9999	Y	Anterior correction of scoliosis (Dwyer procedure) of more than four spaces; or spinal fusion for scoliosis or kyphosis with use of Harrington distraction and compression rods(AU 29)
07940	01FEB1984	31DEC9999	Y	Application of halo for spinal fusion in the treatment of scoliosis, not covered by Item 7934 (AU 8)
07942	01FEB1984	31DEC9999	Y	Bone graft to spine, posterior, not covered by Item 7945, 7967 or 7969 (AU 14)
07945	01FEB1984	31DEC9999	Y	Bone graft to spine, postero-lateral fusion (AU 14)
07947	01FEB1984	31DEC9999	Y	Anterior interbody spinal fusion to cervical spine-- one level (AU 14)
07951	01FEB1984	31DEC9999	Y	Anterior interbody spinal fusion to cervical spine-- more than one level (AU 15)
07957	01FEB1984	31DEC9999	Y	Anterior interbody spinal fusion to lumbar or thoracic spine-- one level (AU 15)
07961	01FEB1984	31DEC9999	Y	Anterior interbody spinal fusion to lumbar or thoracic spine-- more than one level (AU 15)
07967	01FEB1984	31DEC9999	Y	Bone graft to spine with laminectomy and posterior interbody fusion-- one level (AU 15)
07969	01FEB1984	31DEC9999	Y	Bone graft to spine with laminectomy and posterior interbody fusion-- more than one level (AU 18)
07975	01FEB1984	31DEC9999	Y	Bone graft to femur (AU 11)
07977	01FEB1984	31DEC9999	Y	Bone graft to tibia (AU 10)
07980	01MAY1990	31DEC9999	Y	CARPAL SCAPHOID, fracture of, reduction and screw fixation ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
07983	01FEB1984	31DEC9999	Y	Bone graft to humerus or to radius and ulna (AU 10)
07993	01FEB1984	31DEC9999	Y	Bone graft to radius or ulna (AU 8)
07999	01FEB1984	31DEC9999	Y	Bone graft to scaphoid (AU 9)
08001	01FEB1984	31DEC9999	Y	Bone graft to other bones, not covered by any other item in this Part (AU 8)
08003	01FEB1984	31DEC9999	Y	Carpal bone, replacement of, by silicone or other implant, including any necessary tendon transfers (AU 9)
08006	01FEB1984	31DEC9999	Y	Bone graft not covered by any other item in this Part (D) (AU 8)
08009	01FEB1984	31DEC9999	Y	Shoulder-- removal of calcium deposit from cuff (AU 8)
08014	01FEB1984	31DEC9999	Y	Shoulder-- arthrotomy (AU 7)
08017	01FEB1984	31DEC9999	Y	Shoulder-- arthroplasty or plastic reconstruction (AU 11)
08019	01FEB1984	31DEC9999	Y	Shoulder-- arthrodesis or arthrectomy (AU 11)
08022	01FEB1984	31DEC9999	Y	Finger or other small joint-- arthrodesis, arthrectomy or arthroplasty (AU 5)
08023	01SEP1989	31DEC9999	Y	Finger joint, prosthetic replacement of (AU 5)
08024	01FEB1984	31AUG1989	N	Metacarpo-phalangeal joint, prosthetic athroplasty (AU 5)
08024	01SEP1989	31DEC9999	Y	Metacarpo-phalangeal joint, prosthetic arthroplasty (AU 5)
08026	01FEB1984	31DEC9999	Y	Small joint-- arthrotomy (AU 5)
08028	01FEB1984	31DEC9999	Y	Zygapophyseal joints, arthrectomy (AU 8)
08032	01FEB1984	31DEC9999	Y	Sacro-iliac joint-- arthrodesis (AU 12)
08036	01FEB1984	31DEC9999	Y	Other large joint-- arthrodesis, arthrectomy, arthroplasty or total synovectomy of (AU 10)
08040	01FEB1984	31DEC9999	Y	Other large joint-- arthrotomy (AU 8)
08044	01FEB1984	31DEC9999	Y	Hip-- arthrodesis (AU 15)
08048	01FEB1984	31DEC9999	Y	Hip-- arthrectomy (AU 15)
08053	01FEB1984	31DEC9999	Y	Hip-- arthroplasty (Austin Moore, Girdlestone or similar procedure) (AU 10)
08064	01MAR1987	31DEC9999	Y	Historical item included for item mapping purposes
08069	01FEB1984	31AUG1989	N	Joint-- arthroplasty, total replacement of hip (McKee-Farrer, Charnley or similar procedure), knee, elbow, shoulder or ankle (AU 17)
08069	01SEP1989	31DEC9999	Y	Joint - arthroplasty, total replacement of hip (McKee-Farrer, Charnley or similar procedure), wrist, knee, elbow, shoulder or ankle (AU 17)
08070	01FEB1984	31DEC9999	Y	Joint-- arthroplasty, revision operation for total replacement of hip, knee, elbow, shoulder or ankle with removal of prosthesis and replacement with new prosthesis (AU 20)
08072	01AUG1988	31DEC9999	Y	Shoulder, elbow, wrist, hip or ankle-arthroscopic examination of (AU 6)
08074	01FEB1984	31DEC9999	Y	Hip-- arthrotomy including removal of prosthesis (AU 9)
08080	01FEB1984	29FEB1984	N	Knee-- diagnostic arthroscopy not associated with a procedure performed through the arthroscope (AU 5)
08080	01MAR1984	31DEC9999	Y	Knee - diagnostic arthroscopy not associated with a procedure performed through the arthroscope(AU 6)
08082	01FEB1984	31DEC9999	Y	Knee-- arthrotomy, including one or more of, removal of loose body, removal of foreign body, biopsy or lateral capsular release, not associated with Item 8085, 8088, 8090 or 8092 (AU 6)
08085	01FEB1984	29FEB1984	N	Knee-- single meniscectomy, repair of one collateral ligament, patellectomy, operation for recurrent dislocation of patella, single transfer of ligament for rotary instablity, single transfer of tendon for rotary instability or any other single procedure not covered by any other item in this Part-- one procedure (AU 7)
08085	01MAR1984	31DEC9999	Y	Knee - single meniscectomy, repair of one collateral ligament, patellectomy, operation for recurrent dislocation of patella, single transfer of ligament for rotary instability, single transfer of tendon for rotary instability or any other single procedure not covered by any other item in this Part - one procedure(AU 8)
08088	01FEB1984	31DEC9999	Y	Knee-- total synovectomy, arthrectomy, arthrodesis,repair of cruciate ligaments, replacement of cruciate ligaments, reconstruction of cruciate ligaments, arthroscopic surgery for meniscectomy, chondroplasty, removal of loose body or removal of foreign body-- one procedure (AU 9)
08090	01FEB1984	31DEC9999	Y	Knee-- operation comprising two or more procedures covered by Item 8082, 8085 or 8088, but not covered by Item 8092 (AU 11)
08092	01FEB1984	31DEC9999	Y	Knee-- three or more procedures for correction of rotary instability involving injury to cruciate ligaments, comprising as a minimum, medial, lateral and intra-articular procedures (AU 12)
08105	01FEB1984	31DEC9999	Y	Joint or other synovial cavity-- aspiration of, injection into, or both of these procedures (AU 5)
08113	01FEB1984	31DEC9999	Y	Joint, repair of capsule or ligament of, or internal fixation of to stabilize joint (AU 7)
08116	01FEB1984	31DEC9999	Y	Foot or ankle region-- triple arthrodesis (AU 9)
08120	01FEB1984	31DEC9999	Y	Calcanean spur, removal of (AU 6)
08131	01FEB1984	31DEC9999	Y	Hallux valgus or rigidus, correction of, with osteotomy or osteectomy of phalanx or metatarsal (Keller's arthroplasty); or total replacement of the first metatarsophalangeal joint (AU 7)
08135	01FEB1984	31DEC9999	Y	Hallux valgus, correction of, with osteotomy or osteectomy of phalanx or metatarsal and transplantation of adductor hallucis tendon (AU 8)
08151	01FEB1984	31DEC9999	Y	Hammer toe, correction of (G) (AU 6)
08153	01FEB1984	31DEC9999	Y	Hammer toe, correction of (S) (AU 6)
08158	01FEB1984	31DEC9999	Y	Cervical rib, removal of (AU 11)
08159	01JUL1985	31AUG1989	N	REMOVAL OF FIRST RIB by axillary approach ANAESTHETIC 13 UNITS - ITEM NOS 457G / 5248
08159	01SEP1989	31DEC9999	Y	Removal of the first rib by axillary approach (AU 13)
08161	01FEB1984	31DEC9999	Y	Scalenotomy (AU 8)
08166	01FEB1984	31DEC9999	Y	Acromion or coraco-acromion ligament, removal of (AU 7)
08169	01FEB1984	31DEC9999	Y	Excision of exostosis of small bone including simple removal of bunion (G) (AU 6)
08173	01FEB1984	31DEC9999	Y	Excision of exostosis of small bone including simple removal of bunion (S) (AU 6)
08175	01FEB1984	31DEC9999	Y	Excision of exostosis of small bone (D) (AU 6)
08179	01FEB1984	31AUG1989	N	Excision of exostosis of large bone (G) (AU 6)
08179	01SEP1989	31DEC9999	Y	Excision of exostosis of large bone or excision of osteoma of palate (G) (AU 6)
08182	01FEB1984	31AUG1989	N	Excision of exostosis of large bone (S) (AU 6)
08182	01SEP1989	31DEC9999	Y	Excision of exostosis of large bone or excision of osteoma of palate (S) (AU 6)
08185	01FEB1984	31DEC9999	Y	Osteotomy or osteectomy of phalanx, metacarpal or metatarsal (AU 6)
08187	01FEB1984	31DEC9999	Y	Osteotomy of phalanx, metacarpal or metatarsal, with internal fixation (AU 6)
08190	01FEB1984	31DEC9999	Y	Osteotomy or osteectomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus (AU 7)
08193	01FEB1984	31DEC9999	Y	Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus, with internal fixation (AU 7)
08195	01FEB1984	31DEC9999	Y	Osteotomy or osteectomy of tibia or humerus (AU 7)
08198	01FEB1984	31DEC9999	Y	Osteotomy or osteectomy of femur or pelvic bone (AU 8)
08201	01FEB1984	31DEC9999	Y	Osteotomy of tibia, humerus, femur or pelvic bone, with internal fixation (AU 11)
08206	01FEB1984	31DEC9999	Y	Osteotomy of femur-- sub-trochanteric (AU 11)
08209	01FEB1984	31AUG1989	N	Osteectomy of vertebral bodies (AU 10)
08209	01SEP1989	31DEC9999	Y	Vertebral body, total or sub-total excision of, including bone graft or other form of fixation (AU 26)
08211	01FEB1984	31DEC9999	Y	Osteotomy and distraction for lengthening of limb (AU 8)
08214	01FEB1984	31DEC9999	Y	Removal of distracting apparatus from limb, without internal fixation (AU 6)
08217	01FEB1984	31DEC9999	Y	Removal of distracting apparatus from limb, with internal fixation (AU 7)
08219	01FEB1984	31DEC9999	Y	Flexor tendon of hand, primary suture of (G) (AU 8)
08222	01FEB1984	31DEC9999	Y	Flexor tendon of hand, primary suture of (S) (AU 8)
08225	01FEB1984	31DEC9999	Y	Flexor tendon of hand, secondary suture of (AU 9)
08227	01FEB1984	31DEC9999	Y	Extensor tendon of hand, primary suture of (G) (AU 8)
08230	01FEB1984	31DEC9999	Y	Extensor tendon of hand, primary suture of (S) (AU 8)
08233	01FEB1984	31DEC9999	Y	Extensor tendon of hand, secondary suture of (AU 9)
08235	01FEB1984	31DEC9999	Y	Achilles tendon or other large tendon, suture of (G) (AU 9)
08238	01FEB1984	31DEC9999	Y	Achilles tendon or other large tendon, suture of (S) (AU 9)
08241	01FEB1984	31DEC9999	Y	Tendon of foot, primary suture of (AU 8)
08243	01FEB1984	31DEC9999	Y	Tendon of foot, secondary suture of (AU 8)
08246	01FEB1984	31DEC9999	Y	Tenotomy, subcutaneous, one or more tendons (AU 4)
08249	01FEB1984	31DEC9999	Y	Tenotomy, open, with or without tenoplasty (AU 7)
08251	01FEB1984	31DEC9999	Y	Tendon or ligament transplantation, not covered by any other item in this Part (AU 8)
08257	01FEB1984	31DEC9999	Y	Tendon graft (AU 8)
08259	01FEB1984	31DEC9999	Y	Insertion of artificial tendon prosthesis in preparation for tendon grafting (AU 10)
08262	01FEB1984	31DEC9999	Y	Achilles tendon or other large tendon-- operation for lengthening (AU 9)
08267	01FEB1984	31DEC9999	Y	Tendon sheath, incision of, or open operation for stenosing tendovaginitis (AU 6)
08275	01FEB1984	31DEC9999	Y	Tenolysis of flexor tendon following tendon injury, repair or graft (AU 8)
08279	01FEB1984	31DEC9999	Y	Tenolysis of extensor tendon following tendon injury, repair or graft (AU 7)
08282	01FEB1984	31DEC9999	Y	Tendon sheath of finger or thumb, synovectomy of (AU 8)
08283	01FEB1984	31AUG1989	N	Synovectomy of metacarpophalangeal joint (AU 8)
08283	01SEP1989	31DEC9999	Y	Synovectomy of metacarpophalangeal or metatarsophalangeal joint (AU 8)
08287	01FEB1984	31DEC9999	Y	Synovectomy of interphalangeal joint (AU 8)
08290	01FEB1984	31DEC9999	Y	Synovectomy of wrist, extensor or flexor tendon of wrist, carpometacarpal joint or inferior radio ulnar joint (AU 11)
08294	01FEB1984	31DEC9999	Y	Cicatricial flexion contracture of joint, correction of, involving tissues deeper than skin and subcutaneous tissue (AU 9)
08296	01FEB1984	31DEC9999	Y	Dupuytren's contracture, subcutaneous fasciotomy (AU 8)
08298	01FEB1984	31DEC9999	Y	Dupuytren's contracture, radical operation for (AU 9)
08302	01FEB1984	31DEC9999	Y	Fragmentation and rodding in fragilitas ossium-- humerus, radius or ulna (AU 11)
08304	01FEB1984	31DEC9999	Y	Fragmentation and rodding in fragilitas ossium-- tibia (AU 10)
08306	01FEB1984	31DEC9999	Y	Fragmentation and rodding in fragilitas ossium-- femur (AU 12)
08310	01FEB1984	31DEC9999	Y	Epiphyseodesis-- femur (AU 7)
08312	01FEB1984	31DEC9999	Y	Epiphyseodesis-- tibia and fibula (AU 7)
08314	01FEB1984	31DEC9999	Y	Epiphyseodesis-- femur, tibia and fibula (AU 10)
08316	01FEB1984	31DEC9999	Y	Staple arrest of hemi-epiphysis (AU 7)
08318	01FEB1984	31DEC9999	Y	Operation for the prevention of closure of epiphysial plate (AU 8)
08320	01FEB1984	31DEC9999	Y	Radical plantar fasciotomy (Steindler's operation) (AU 7)
08322	01FEB1984	31DEC9999	Y	Talipes equinovarus-- posterior release procedure (AU 7)
08324	01FEB1984	31DEC9999	Y	Talipes equinovarus-- medial release procedure (AU 7)
08326	01FEB1984	31DEC9999	Y	Subtalar arthrodesis (extra-articular) (AU 10)
08328	01FEB1984	31DEC9999	Y	Calcaneal osteotomy (AU 8)
08330	01FEB1984	31DEC9999	Y	Calcaneal osteotomy with bone graft (AU 10)
08332	01FEB1984	31DEC9999	Y	Congenital dislocation of hip-- manipulation and plaster (one hip) (AU 6)
08334	01FEB1984	31DEC9999	Y	Talipes equinovarus, calcaneus valgus, pes planus, metatarsus varus, genu varum or genu valgum-- manipulation under general anaesthesia (AU 5)
08336	01FEB1984	31DEC9999	Y	Talipes equinovarus, calcaneus valgus, pes planus, metatarsus varus, genu varum or genu valgum-- manipulation and plaster under general anaesthesia (AU 6)
08349	01FEB1984	31DEC9999	Y	Epiphysitis (Perthes' Calve's or Scheuermann's) plaster for (AU 5)
08351	01FEB1984	31DEC9999	Y	Epiphysitis (Sever's, Kohler's, Keinbock's or Schlatter's) plaster for (AU 5)
08352	01FEB1984	31DEC9999	Y	Contractures, manipulation under general anaesthesia, not covered by any other item in this Part (AU 5)
08354	01FEB1984	31DEC9999	Y	Contractures, manipulation and plaster under general anaesthesia, not covered by any other item in this Part (AU 5)
08356	01FEB1984	31DEC9999	Y	Spastic paralysis-- manipulation and plaster (one limb) (AU 5)
08378	01FEB1984	31DEC9999	Y	Hypertelorism, correction of (AU 14)
08380	01FEB1984	31DEC9999	Y	Choanal atresia, plastic repair of (AU 16)
08382	01FEB1984	31DEC9999	Y	Choanal atresia, repair of by puncture and dilatation (AU 11)
08384	01FEB1984	31DEC9999	Y	Macrocheilia, macroglossia or macrostomia, operation for (AU 13)
08386	01FEB1984	31DEC9999	Y	Torticollis, operation for (AU 7)
08388	01FEB1984	31DEC9999	Y	Oesophagus, correction of congenital stenosis by oesophagectomy and anastomosis (AU 21)
08390	01FEB1984	31DEC9999	Y	Tracheo-oesophageal fistula (with or without atresia), ligation and division of (AU 20)
08392	01FEB1984	31DEC9999	Y	Oesophageal atresia, with or without fistula, correction of (AU 23)
08394	01FEB1984	31DEC9999	Y	Neonatal alimentary obstruction, laparotomy for, with or without resection, including reduction of volvulus (AU 15)
08397	01NOV1990	31DEC9999	Y	Anal sphincterotomy as an independent procedure for Hirchsprung's disease (AU 6)
08398	01FEB1984	31DEC9999	Y	Hirschsprung's disease, rectosigmoidectomy for (AU 22)
08400	01FEB1984	31DEC9999	Y	Exomphalos or gastroschisis, operation for (AU 13)
08402	01FEB1984	29FEB1984	N	Exomphalos or gastroschisis, operaation for, by plastic flap (AU 14)
08402	01MAR1984	31DEC9999	Y	Exomphalos or gastroschisis, operation for, by plastic flap(AU 14)
08406	01FEB1984	31DEC9999	Y	Ano-rectal malformation, perineal anoplasty, primary or secondary repair (AU 10)
08408	01FEB1984	31DEC9999	Y	Ano-rectal malformation, rectoplasty, primary or secondary repair, not covered by Item 8406 (AU 18)
08410	01FEB1984	31DEC9999	Y	Contracted bladder neck (congenital) , wedge excision or perurethral resection of (AU 11)
08412	01FEB1984	31DEC9999	Y	Urachal fistula, operation for (AU 11)
08414	01FEB1984	31DEC9999	Y	Sphincter reconstruction for ectopia vesicae, ectopia cloacae or congenital incontinence (AU 12)
08418	01FEB1984	31DEC9999	Y	Urethral valves or urethral membrane, open removal of (AU 12)
08422	01FEB1984	31DEC9999	Y	Lymphangiectasis of limb (Milroy's disease)-- limited excision of (AU 14)
08424	01FEB1984	31DEC9999	Y	Lymphangiectasis of limb (Milroy's disease)-- radical excision of (AU 18)
08428	01FEB1984	31DEC9999	Y	Extra digit, ligation of pedicle (AU 4)
08430	01FEB1984	31DEC9999	Y	Extra digit, amputation of (AU 6)
08432	01FEB1984	31DEC9999	Y	Dermoid, periorbital or superficial nasal, excision of (G) (AU 8)
08434	01FEB1984	31DEC9999	Y	Dermoid, periorbital or superficial nasal, excision of (S) (AU 8)
08436	01FEB1984	31DEC9999	Y	Dermoid, orbital, excision of (AU 8)
08440	01FEB1984	31DEC9999	Y	Dermoid of nose, excision of, with intranasal extension (AU 8)
08442	01FEB1984	31DEC9999	Y	Myelomeningocele-- excision of sac (AU 13)
08444	01FEB1984	29FEB1984	N	Myelomeningocele, extensive, requiing formal repair with skin flaps or Z plasty (AU 15)
08444	01MAR1984	31DEC9999	Y	Myelomeningocele, extensive, requiring formal repair with skin flaps or Z plasty(AU 15)
08445	01MAY1991	31DEC9999	Y	METICULOUS REPAIR DESIGNED TO OBTAIN MAXIMUM FUNCTIONAL AND AESTHETIC RESULTS INCLUDING THE PREPARATION OF THE DEFECT REQUIRING REPAIR SINGLE STAGE LOCAL MUSCLE FLAP REP AIR, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 7 - 408/514)
08446	01MAY1991	31DEC9999	Y	SINGLE STAGE LOCAL MYOCUT ANEOUS FLAP REP AIR to one defect, simple and small (AU 11 - 453/522)
08447	01MAY1991	31DEC9999	Y	SINGLE STAGE LARGE MYOCUT ANEOUS FLAP REP AIR to one defect, (pectoralis major, latissimus dorsi, or similar large muscle) (AU 16 - 460/527)
08448	01FEB1984	31DEC9999	Y	Single stage local muscle flap repair, simple, small (AU 11)
08449	01FEB1984	31DEC9999	Y	Single stage large muscle flap repair, (pectoralis major, gastrocnemius, gracilis or similar large muscle) (AU 17)
08450	01FEB1984	31DEC9999	Y	Dermo-fat or fascia graft (including transplant or muscle flap) (AU 12)
08451	01MAY1991	31DEC9999	Y	MUSCLE OR MYOCUTANEOUS FLAP, delay of (AU 8 - 409/517)
08452	01FEB1984	31DEC9999	Y	Abrasive therapy, limited area (AU 6)
08453	01MAY1991	31DEC9999	Y	DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) (AU 12 - 454/523)
08454	01FEB1984	31DEC9999	Y	Abrasive therapy, extensive area (AU 7)
08455	01MAY1991	31DEC9999	Y	ABRASIVE THERAPY, limited to one aesthetic area (AU 6 - 407/513)
08456	01MAY1991	31DEC9999	Y	ABRASIVE THERAPY to more than one aesthetic area (AU 7 - 408/514)
08458	01FEB1984	31DEC9999	Y	Angioma, cauterisation of or injection into, under general anaesthetic (AU 7)
08460	01FEB1984	31DEC9999	Y	Angioma, cauterisation of or injection into, under general anaesthetic (D) (AU 7)
08462	01FEB1984	31DEC9999	Y	Angioma of skin, and subcutaneous tissue or mucous surface, small, excision and repair of (AU 7)
08464	01FEB1984	31DEC9999	Y	Angioma of skin and subcutaneous tissue or mucous surface, small, excision and repair of (D) (AU 7)
08466	01FEB1984	31DEC9999	Y	Angioma of skin and subcutaneous tissue or mucous surface, large, excision and repair of (AU 9)
08467	01MAY1991	31DEC9999	Y	ANGIOMA OF NECK, deep, excision of (AU 10 - 450/521)
08468	01FEB1984	31DEC9999	Y	Angioma of skin and subcutaneous tissue or mucous surface, large, excision and repair of (D) (AU 9)
08470	01FEB1984	31DEC9999	Y	Angioma, involving deeper tissue, small, excision and repair of (AU 9)
08471	01MAY1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION (3 centimetres or less) of superficial tissue, excision of (AU 11 - 453/522)
08472	01FEB1984	31DEC9999	Y	Angioma, involving deeper tissue, large, excision and repair of (AU 10)
08473	01MAY1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION, (greater than 3 centimetres), excision of (AU 16 - 460/527)
08474	01FEB1984	31DEC9999	Y	Haemangioma of neck, deep-seated, excision of (AU 10)
08475	01MAY1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, neck,hand, thumb, finger or genitals, excision of (AU 16 - 460/527)
08476	01FEB1984	31DEC9999	Y	Major excision and grafting for lymphoedema (AU 15)
08478	01FEB1984	31AUG1989	N	Foreign implants for contour reconstruction (AU 10)
08478	01SEP1989	31DEC9999	Y	Foreign implants, insertion of, for contour reconstruction (AU 10)
08479	01FEB1984	31AUG1989	N	Foreign implants for contour reconstruction (D) (AU 10)
08479	01SEP1989	31DEC9999	Y	Foreign implants, insertion of, for contour reconstruction (D) (AU 10)
08480	01FEB1984	31DEC9999	Y	Single stage local flap repair, simple, small, excluding flap for male pattern baldness (AU 7)
08481	01MAY1991	31DEC9999	Y	SINGLE STAGE LOCAL FLAP, where indicated to repair one defect, complicated or large, excluding flap for male pattern baldness (AU 10 - 450/521)
08482	01FEB1984	31DEC9999	Y	Single stage local flap repair, simple, small (D) (AU 7)
08483	01MAY1991	31DEC9999	Y	SINGLE STAGE LOCAL FLAP where indicated to repair one defect, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 12 - 454/523)
08484	01FEB1984	31DEC9999	Y	Single stage local flap repair, complicated or large, excluding flap for male pattern baldness (AU 10)
08485	01FEB1984	31DEC9999	Y	Direct flap repair (cross arm, abdominal or similar), first stage (AU 11)
08486	01FEB1984	31DEC9999	Y	Direct flap repair (cross arm, abdominal or similar), second stage (AU 9)
08487	01FEB1984	31DEC9999	Y	Direct flap repair, cross leg, first stage (AU 13)
08488	01FEB1984	31DEC9999	Y	Direct flap repair, cross leg, second stage (AU 10)
08490	01FEB1984	31DEC9999	Y	Direct flap repair, small (cross finger or similar), first stage (AU 7)
08492	01FEB1984	31DEC9999	Y	Direct flap repair, small (cross finger or similar), second stage (AU 7)
08494	01FEB1984	31DEC9999	Y	Indirect flap or tubed pedicle, formation of (AU 10)
08496	01FEB1984	31DEC9999	Y	Indirect flap or tubed pedicle, delay of (AU 8)
08498	01FEB1984	31DEC9999	Y	Indirect flap or tubed pedicle, preparation of intermediate or final site and attachment to the site (AU 10)
08500	01FEB1984	31DEC9999	Y	Indirect flap or tubed pedicle, spreading of pedicle, as a separate procedure (AU 8)
08502	01FEB1984	31DEC9999	Y	Direct, indirect or local flap repair, revision of graft (AU 7)
08504	01FEB1984	31DEC9999	Y	Free grafts (split skin or pinch grafts) on granulating areas, small (AU 7)
08506	01FEB1984	31DEC9999	Y	Free grafts (split skin or pinch grafts) on granulating areas, small (D) (AU 7)
08508	01FEB1984	31DEC9999	Y	Free grafts (split skin) on granulating areas, extensive (AU 11)
08509	01FEB1984	31DEC9999	Y	Free grafts (split skin) to burns, including excision of burned tissue-- involving not more than 2.5 per centum of total body surface (AU 8)
08510	01FEB1984	31DEC9999	Y	Free grafts (split skin) to burns, including excision of burned tissue-- involving more than 2.5 per centum of total body surface (AU 14)
08511	01FEB1984	31DEC9999	Y	Free grafts (homograft split skin) to burns, including excision of burned tissue-- involving more than 2.5 per centum of total body surface (AU 13)
08512	01FEB1984	31DEC9999	Y	Free grafts (split skin) including elective dissection, small (AU 8)
08514	01FEB1984	31DEC9999	Y	Free grafts (split skin) including elective dissection, small (D) (AU 8)
08515	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to one defect, including elective dissection, extensive (AU 11 - 453/522)
08516	01FEB1984	31DEC9999	Y	Free grafts (split skin) including elective dissection, extensive; or inlay graft using a mould, insertion of and removal of mould (AU 11)
08517	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to one defect, including elective dissection on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, not covered by Items 8515 or 8516 (AU 8 - 409/517)
08518	01FEB1984	31DEC9999	Y	Free full thickness grafts, excluding grafts for male pattern baldness (AU 9)
08519	01MAY1991	31DEC9999	Y	MICROVASCULAR REPAIR using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit (AU 14 - 458/525)
08520	01FEB1984	31DEC9999	Y	Free full thickness grafts (D) (AU 9)
08521	01MAY1991	31DEC9999	Y	MICRO-ARTERIAL OR MICRO-VENOUS GRAFf using microsurgical techniques (AU 22 - 466/537)
08522	01FEB1984	31DEC9999	Y	Revision under general anaesthesia of facial or neck scar not more than 3 cm. in length (AU 8)
08523	01MAY1991	31DEC9999	Y	MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue (AU 38 - 477/548)
08524	01FEB1984	31DEC9999	Y	Revision under general anaesthesia of facial or neck scar more than 3 cm. in length (AU 9)
08525	01MAY1991	31DEC9999	Y	SCAR, other than on face or neck, not more than 7 centimetres in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure (AU 10 - 450/521)
08526	01MAY1991	31DEC9999	Y	SCAR, other than on face or neck, more than 7 centimetres in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure (AU 12 - 454/523)
08527	01MAY1991	31DEC9999	Y	BREAST PROSTHESIS, removal of, as an independent procedure (AU 11 - 453/522)
08528	01FEB1984	29FEB1984	N	Mammaplasty, reduction including repositioning of nipple (unilateral) (AU 10)
08528	01MAR1984	31DEC9999	Y	Mammaplasty, reduction (unilateral) , with or without repositioning of nipple (AU 10)
08529	01MAY1991	31DEC9999	Y	FIBROUS CAPSULE SURROUNDING BREAST PROSTHESIS, excision or multiple incisions to, as an independent procedure (AU 10 - 450/521)
08530	01FEB1984	29FEB1984	N	Augumentation mammaplasty for significant breast asymmetry or following mastectomy, where the mammaplasty is limited to one breast (AU 10)
08530	01MAR1984	31AUG1989	N	Augmentation mammaplasty for significant breast asymmetry or following mastectomy, where the mammaplasty is limited to one breast (AU 10)
08530	01SEP1989	31DEC9999	Y	Augmentation mammaplasty for significant breast asymmetry where the augmentation is limited to one breast (AU 10)
08531	01NOV1986	31AUG1989	N	Augmentation mammoplasty following mastectomy-unilateral (AU 9)
08531	01SEP1989	31DEC9999	Y	Augmentation mammaplasty (unilateral), following mastectomy (AU 9)
08532	01NOV1986	31AUG1989	N	Breast reconstruction using a latissimus dorsi or other large myocutaneous flap,including repair of secondary skin defect (AU 20)
08532	01SEP1989	31DEC9999	Y	Breast reconstruction (unilateral), using a latissimus dorsi or other large myocutaneous flap, including repair of secondary skin defect (AU 20)
08533	01FEB1987	31DEC9999	Y	Breast reconstruction using breast sharing technique(first stage)including breast reduction, transfer of complex skin and breast tissue flap,split skin graft to pedicle of flap or other similar procedure (AU 15)
08534	01NOV1986	31DEC9999	Y	Breast reconstruction using breast sharing technique (second stage) including division of pedicle, insetting of breast flap, with closure of donor site or other similar procedure (AU 12)
08535	01FEB1984	31DEC9999	Y	Hair transplantation for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not covered by any other item in this Part (AU 11)
08536	01NOV1986	31AUG1989	N	Breast reconstruction using tissue expansion-insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 9)
08536	01SEP1989	31DEC9999	Y	Breast reconstruction (unilateral), following mastectomy, using tissue expansion -insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 9)
08537	01NOV1986	31AUG1989	N	Breast reconstruction using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis (AU 9)
08537	01SEP1989	31DEC9999	Y	Breast reconstruction (unilateral), following mastectomy, using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis (AU 9)
08538	01NOV1986	31DEC9999	Y	Nipple or areola or both,reconstruction of by any technique (AU 10)
08539	01MAY1991	31DEC9999	Y	BREAST PROSTHESIS, replacement of, following medical complications, (including rupture, migration, or capsule formation) where new pocket is formed (AU 15 - 459/526)
08540	01FEB1984	31DEC9999	Y	Digit, transplantation of-- complete procedure (AU 16)
08541	01MAY1991	31DEC9999	Y	HAIR TRANSPLANTATION for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not covered by any other item in this Part (AU 11 - 453/522)
08542	01FEB1984	31AUG1989	N	Neurovascular island flap, including repair of secondary defect, excluding flap for male pattern baldness (AU 15)
08542	01SEP1989	31DEC9999	Y	Neurovascular island flap, or free transfer of tissue with vascular or neurovascular pedicle, including repair of secondary defect excluding flap for male pattern baldness (AU 15)
08543	01NOV1986	31DEC9999	Y	Tissue expansion not covered by Items 8536/8537-insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 10)
08544	01FEB1984	31DEC9999	Y	Macrodactyly, plastic reduction of, each finger (AU 8)
08545	01MAY1991	31DEC9999	Y	INTRA OPERATIVE TISSUE EXPANSION performed during an operation when combined with any other Item in Part 10 including expansion injections and excluding treatment of male pattern baldness (AU 13 - 457/524)
08546	01FEB1984	31DEC9999	Y	Facial nerve paralysis, free fascia graft for (AU 12)
08548	01FEB1984	31DEC9999	Y	Facial nerve paralysis, muscle transfer or graft for (AU 13)
08549	01MAY1991	31DEC9999	Y	FACIAL NERVE PALSY, excision of tissue for (AU 12 - 454/523)
08550	01MAY1991	31DEC9999	Y	LIPOSUCTION (suction assisted lipolysis) to one regional area (thigh, buttock, or similar), for treatment of post-traumatic pseudolipoma (AU 13 - 457/524)
08551	01FEB1984	31DEC9999	Y	Meloplasty for correction of facial asymmetry due to soft tissue abnormality where the meloplasty is limited to one side of the face (AU 14)
08552	01FEB1984	31AUG1989	N	Orbital cavity, reconstruction of floor or roof of (AU 12)
08552	01SEP1989	31DEC9999	Y	Orbital cavity, reconstruction of walls or floor or both walls and floor with or without foreign implant (AU 12)
08553	01AUG1987	31DEC9999	Y	Orbital cavity, bone or cartilage graft to orbital walls or floor or both walls and floor including reduction of prolapsed or entrapped orbital contents (AU 14)
08554	01FEB1984	31DEC9999	Y	Maxilla, resection of (AU 17)
08556	01FEB1984	31DEC9999	Y	Mandible, resection of (AU 15)
08557	01MAY1991	31DEC9999	Y	MANDIBLE, including lower border, OR MAXILLA, sub-total resection of (AU 19 - 463/531)
08558	01FEB1984	31DEC9999	Y	Mandible, resection of (D) (AU 15)
08560	01FEB1984	31DEC9999	Y	Mandible, segmental resection of, for tumours (AU 13)
08562	01FEB1984	31DEC9999	Y	Mandible, segmental resection of, for tumours (D) (AU 13)
08564	01NOV1979	31DEC9999	Y	Mandible, section-fixation for prognathism or retrognathism (AU 14)
08566	01NOV1979	31DEC9999	Y	Mandible, section-fixation for prognathism or retrognathism (D) (AU 14)
08568	01FEB1984	31DEC9999	Y	Mandible, hemi-mandibular reconstruction with bone graft, not associated with Item 8556 (AU 15)
08570	01FEB1984	31DEC9999	Y	Mandible, condylectomy (AU 11)
08572	01FEB1984	31DEC9999	Y	Mandible, condylectomy (D) (AU 11)
08574	01NOV1979	31DEC9999	Y	Osteotomy or osteectomy of mandible (other than alveolar margins) for congenital or post-traumatic malformation, not covered by any other item in this Part (AU 11)
08576	01NOV1979	31DEC9999	Y	Osteotomy or osteectomy of mandible (other than alveolar margins) for congenital or post-traumatic malformation, not covered by any other item in this Part (D) (AU 11)
08578	01NOV1979	31DEC9999	Y	Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (AU 11)
08580	01NOV1979	31DEC9999	Y	Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (D) (AU 11)
08582	01FEB1984	31DEC9999	Y	Whole thickness reconstruction of eyelid other than by direct suture only (AU 10)
08584	01FEB1984	31DEC9999	Y	Reduction of upper eyelid for skin redundancy obscuring vision, herniation of orbital fat in exophthalmos, facial nerve palsy or post traumatic scarring, or, in respect of one of these conditions, the restoration of symmetry of the contralateral upper eyelid (AU 7)
08585	01FEB1984	31DEC9999	Y	Reduction of lower eyelid for herniation of orbital fat in exophthalmos, facial nerve palsy or post traumatic scarring, or, in respect of one of these conditions, the restoration of symmetry of the contralateral lower eyelid (AU 8)
08586	01FEB1984	31DEC9999	Y	Correction of ptosis (unilateral) (AU 12)
08588	01FEB1984	31DEC9999	Y	Ectropion or entropion, correction of (unilateral) (AU 9)
08592	01FEB1984	31DEC9999	Y	Symblepharon, grafting for (AU 8)
08594	01FEB1984	31AUG1989	N	Rhinoplasty, correction of lateral or alar cartilages or both (AU 10)
08594	01SEP1989	31DEC9999	Y	Rhinoplasty, correction of lateral or alar cartilages or columella, one or more (AU 10)
08596	01FEB1984	31DEC9999	Y	Rhinoplasty, correction of bony vault only (AU 10)
08598	01FEB1984	31DEC9999	Y	Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose (AU 12)
08599	01MAY1991	31DEC9999	Y	RHINOPLASTY involving nasal or septal cartilage graft (AU 14 - 458/525)
08600	01FEB1984	31AUG1989	N	Rhinoplasty or similar contour restoration of the face, involving autogenous bone or costal cartilage graft (AU 13)
08600	01SEP1989	31DEC9999	Y	Rhinoplasty involving autogenous bone or cartilage graft (excluding nasal or septal cartilage) (AU 13)
08601	01NOV1986	31DEC9999	Y	Contour restoration of one region of face using autogenous bone or cartilage graft (not covered by item 8600) (AU 18)
08602	01FEB1984	31DEC9999	Y	Rhinoplasty, secondary revision of (AU 10)
08604	01FEB1984	31DEC9999	Y	Rhinophyma, correction of (AU 9)
08605	01MAY1991	31DEC9999	Y	FACE, contour restoration of one region, using autogenous bone or cartilage graft (not covered by Item 8600) (AU 18 - 462/529)
08606	01FEB1984	31DEC9999	Y	Composite graft (chondrocutaneous or chondro-mucosal) to nose, ear or eyelid (AU 11)
08608	01FEB1984	31DEC9999	Y	Lop ear, bat ear or similar deformity, correction of (AU 8)
08612	01FEB1984	31DEC9999	Y	Congenital atresia, reconstruction of external auditory canal (AU 11)
08614	01FEB1984	31DEC9999	Y	Full thickness wedge excision of lip or eyelid, with repair by direct sutures (AU 8)
08616	01FEB1984	31DEC9999	Y	Vermilionectomy (AU 8)
08618	01FEB1984	31DEC9999	Y	Lip or eyelid reconstruction using full thickness flap (Abbe or similar), first stage (AU 11)
08620	01FEB1984	31DEC9999	Y	Lip or eyelid reconstruction using full thickness flap (Abbe or similar), second stage (AU 4)
08622	01FEB1984	31DEC9999	Y	Cleft lip, unilateral-- primary repair, (AU 12)
08623	01MAY1991	31DEC9999	Y	CLEFT LIP, unilateral - primary repair, one stage, with anterior palate repair (AU 14 - 458/525)
08624	01FEB1984	31DEC9999	Y	Cleft lip, complete primary repair, one stage, bilateral (AU 14)
08625	01MAY1991	31DEC9999	Y	CLEFT LIP, bilateral - primary repair, one stage, with anterior palate repair (AU 16 - 460/527)
08627	01MAY1991	31DEC9999	Y	CLEFT LIP, lip adhesion procedure, unilateral or bilateral (AU 10 - 450/521)
08628	01FEB1984	31DEC9999	Y	Cleft lip, secondary correction, partial or incomplete (AU 10)
08630	01FEB1984	31DEC9999	Y	Cleft lip, secondary correction, complete revision (AU 12)
08631	01MAY1991	31DEC9999	Y	CLEFT LIP, primary columella lengthening procedure, bilateral (AU 10 - 450/521)
08632	01FEB1984	31DEC9999	Y	Cleft lip, secondary correction, Abbe flap (AU 12)
08633	01MAY1991	31DEC9999	Y	CLEFT LIP reconstruction using full thickness flap (Abbe or similar), second stage (AU 8 - 409/517)
08634	01FEB1984	31DEC9999	Y	Cleft lip, secondary correction of nostril or nasal tip (AU 10)
08636	01FEB1984	31DEC9999	Y	Cleft palate, primary repair, partial cleft (AU 13)
08638	01FEB1984	31DEC9999	Y	Cleft palate, primary repair, partial cleft (D) (AU 13)
08640	01FEB1984	31DEC9999	Y	Cleft palate, primary repair, complete cleft or cleft requiring major repair (AU 14)
08642	01FEB1984	31DEC9999	Y	Cleft palate, primary repair, complete cleft or cleft requiring major repair (D) (AU 14)
08644	01FEB1984	31DEC9999	Y	Cleft palate, secondary repair, closure of fistula (AU 13)
08646	01FEB1984	31DEC9999	Y	Cleft palate, secondary repair, closure of fistula (D) (AU 13)
08648	01FEB1984	31DEC9999	Y	Cleft palate, secondary repair, lengthening procedure (AU 12)
08650	01FEB1984	31DEC9999	Y	Cleft palate, secondary repair, lengthening procedure (D) (AU 12)
08652	01FEB1984	31DEC9999	Y	Cleft palate, partial repair, complex cleft (AU 13)
08654	01FEB1984	31DEC9999	Y	Cleft palate, partial repair, complex cleft (D) (AU 13)
08655	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 16 - 460/527)
08656	01FEB1984	31AUG1989	N	Pharyngeal flap or pharyngoplasty (AU 15)
08656	01SEP1989	31DEC9999	Y	Pharyngeal flap or pharyngoplasty, with or without tonsillectomy (AU 15)
08657	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 20 - 464/533)
08658	01NOV1984	31DEC9999	Y	Unilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (AU 14)
08659	01NOV1984	31DEC9999	Y	Unilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 14)
08660	01NOV1984	31DEC9999	Y	Bilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (AU 18)
08661	01NOV1984	31DEC9999	Y	Bilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 18)
08662	01DEC1984	31DEC9999	Y	Osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures on the one jaw, including transposition of nerves and vessels and bone grafts taken from the same site (AU 22)
08663	01NOV1984	31DEC9999	Y	Osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures on the one jaw, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 22)
08664	01DEC1984	31DEC9999	Y	Bilateral osteotomies or osteectomies of mandible or maxilla involving two such procedures of each jaw including transposition of nerves and vessels and bone grafts taken from the same site (AU 26)
08665	01NOV1984	31DEC9999	Y	Bilateral osteotomies or osteectomies of mandible or maxilla involving two such procedures of each jaw including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 26)
08666	01APR1985	31DEC9999	Y	Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of one jaw and two such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (AU 32)
08667	01NOV1984	31DEC9999	Y	Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of one jaw and two such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 32)
08668	01DEC1984	31DEC9999	Y	Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (AU 34)
08669	01NOV1984	31DEC9999	Y	Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 34)
08670	01NOV1984	31DEC9999	Y	Genioplasty not associated with item 8658, 8660, 8662, 8664, 8666, or 8668 including transposition of nerves and vessels and bone grafts taken from the site (AU 10)
08671	01NOV1984	31DEC9999	Y	Genioplasty not associated with item 8659, 8661, 8663, 8665, 8667 or 8669 including transposition of nerves and vessels and bone grafts taken from the site (D) (AU 10)
08672	01DEC1984	31DEC9999	Y	Genioplasty associated with item 8658, 8660, 8662 or 8664 (AU 8)
08673	01NOV1984	31DEC9999	Y	Genioplasty associated with item 8659, 8661, 8663 or 8665 (D) (AU 8)
08674	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving three or more such procedures on the ONE JAW, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 24 - 468/539)
08675	01NOV1984	31DEC9999	Y	Hypertelorism, correction of, intra-cranial (AU 47)
08676	01MAY1985	31DEC9999	Y	Hypertelorism, correction of, sub-cranial (AU 26)
08677	01APR1986	31DEC9999	Y	Peri-orbital correction of Treacher Collins Syndrome, with rib and iliac bone grafts (AU 30)
08678	01MAR1985	31DEC9999	Y	Correction of unilateral orbital dystopia - total repositioning of one orbit intra-cranial (AU 35)
08679	01NOV1984	31DEC9999	Y	Correction of unilateral orbital dystopia-sub-total repositioning of one orbit, extra-cranial (AU 18)
08680	01NOV1984	31DEC9999	Y	Unilateral fronto-orbital advancement (AU 19)
08681	01DEC1984	31DEC9999	Y	Cranial vault reconstruction for oxycephaly, brachycephaly, turricephaly or similar condition-(bilateral frontoorbital advancement) (AU 39)
08682	01APR1985	31DEC9999	Y	Reconstruction of glenoid fossa, zygomatic arch and temporal bone (Obwegeser technique) (AU 19)
08683	01MAR1987	31DEC9999	Y	Construction of absent condyle and ascending ramus in hemifacial microsomia (AU 15)
08684	01MAY1991	31DEC9999	Y	OSSEO-INTEGRA TION PROCEDURE - extra oral, implantation of titanium fixture (AU 20 - 464/533)
08685	01MAY1991	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment (AU 16- 460/527)
08686	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, osteotomies or oteectomies of, involving TWO such procedures of EACH JAW, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 28 - 472/543)
08687	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving THREE or MORE such procedures of ONE JAW and TWO such procedures of the OTHER JAW, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid screws or both (AU 34 - 492/563)fixation by bone plates,
08688	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving not more than 3 per cent of total body surface (AU 8 - 409/517)
08689	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface (AU 10 - 450/521)
08690	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface (AU 12 - 454/523)
08691	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface (AU 14 - 458/525)
08692	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more of total body surface (AU 16 - 460/527)
08693	01MAY1991	31DEC9999	Y	FREE GRAFTING (split skin) to bums, including excision of burnt tissue, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 18 - 462/529)
08694	01MAY1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving not more than 3 per cent of total body surface (AU 13 - 457/524)
08695	01MAY1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent Qf total body surface (AU 15 - 459/526)
08696	01MAY1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface (AU 17 - 461/528)
08697	01MAY1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface (AU 19 - 463/531)
08698	01MAY1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 12 per cent or more of total body surface (AU 21 - 465/535)
08699	01MAY1991	31DEC9999	Y	MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving THREE or MORE such procedures of EACH JAW, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 36 - 476/547)
08700	01FEB1984	31DEC9999	Y	Erythrocyte radioactive uptake survival time test
08701	01SEP1989	31DEC9999	Y	Blood volume estimation
08702	01FEB1984	31DEC9999	Y	Blood volume estimation using radioactive chromium
08703	01SEP1989	31DEC9999	Y	Erythrocyte radioactive uptake survival time test or iron kinetic test
08704	01FEB1984	31DEC9999	Y	Gastrointestinal blood loss estimation with radioactive chromium involving serial examinations of stool specimens
08705	01SEP1989	31DEC9999	Y	Gastrointestinal blood loss estimation involving examination of stool specimens
08706	01FEB1984	31DEC9999	Y	Radioiodine, urinary estimation
08707	01SEP1989	31DEC9999	Y	Gastrointestinal protein loss
08708	01FEB1984	31DEC9999	Y	Protein bound radioactive iodine test
08710	01FEB1984	31DEC9999	Y	Radioactive B12 absorption test (Schilling test)-- one isotope
08711	01FEB1984	31DEC9999	Y	Radioactive B12 absorption test (Schilling test)-- two isotopes
08712	01FEB1984	31DEC9999	Y	Thallium myocardial study or thallium myocardial redistribution study (C)
08713	01FEB1984	31DEC9999	Y	Thallium myocardial study or thallium myocardial redistribution study (NC)
08714	01SEP1989	31DEC9999	Y	Radioactive B12 absorption test-one isotope
08715	01SEP1989	31DEC9999	Y	Radioactive B12 absorption test-two isotopes
08716	01FEB1984	31DEC9999	Y	Myocardial infarct avid imaging study, cardiac blood pool study or cardiac output estimation (C)
08717	01FEB1984	31DEC9999	Y	Myocardial infarct avid imaging study, cardiac blood pool study or cardiac output estimation (NC)
08718	01SEP1989	31DEC9999	Y	Thyroid uptake (using probe)
08719	01SEP1989	31DEC9999	Y	Perchlorate discharge study
08720	01FEB1984	31DEC9999	Y	Gated cardiac blood pool (equilibrium) study (C)
08721	01FEB1984	31DEC9999	Y	Gated cardiac blood pool (equilibrium) study (NC)
08722	01SEP1989	31DEC9999	Y	Renal function test (without imaging procedure)
08723	01FEB1984	31DEC9999	Y	Gated cardiac blood pool study with intervention (C)
08724	01FEB1984	31DEC9999	Y	Cardiac first pass blood flow study (gated or ungated) or cardiac shunt study (C)
08725	01SEP1989	31DEC9999	Y	Renal function test (associated with imaging and at least 2 blood samples)
08726	01SEP1989	31DEC9999	Y	Whole body count-not associated with any other item
08727	01SEP1989	31DEC9999	Y	Myocardial perfusion study using thallium-single study for stress OR reperfusion (C)
08728	01SEP1989	31DEC9999	Y	Myocardial perfusion study using thallium-single study for stress OR reperfusion (NC)
08730	01FEB1984	31DEC9999	Y	Lung perfusion study, lung ventilation study or lung aerosol study (C)
08731	01FEB1984	31DEC9999	Y	Lung perfusion study, lung ventilation study or lung aerosol study (NC)
08732	01SEP1989	31DEC9999	Y	Myocardial perfusion study using thallium-combined study for stress AND reperfusion (C)
08733	01SEP1989	31DEC9999	Y	Myocardial perfusion study using thallium-combined study for stress AND reperfusion (NC)
08734	01SEP1989	31DEC9999	Y	Myocardial infarct-avid imaging study (C)
08735	01SEP1989	31DEC9999	Y	Myocardial infarct-avid imaging study (NC)
08736	01FEB1984	31DEC9999	Y	Liver and spleen study, hepato biliary study or Meckel's diverticulum study (C)
08737	01FEB1984	31DEC9999	Y	Liver and spleen study, hepato biliary study or Meckel's diverticulum study (NC)
08738	01FEB1984	31DEC9999	Y	Spleen study, red blood cell spleen study, pancreas study, gastrooesophageal reflux study, salivary study or bowel haemorrhage study (C)
08739	01FEB1984	31DEC9999	Y	Spleen study, red blood cell spleen study, pancreas study, gastrooesophageal reflux study, salivary study or bowel haemorrhage study (NC)
08740	01SEP1989	31DEC9999	Y	Gated cardiac blood pool (equilibrium) study (C)
08741	01SEP1989	31DEC9999	Y	Gated cardiac blood pool study with intervention (C)
08742	01FEB1984	31DEC9999	Y	Liver and lung study (C)
08743	01FEB1984	31DEC9999	Y	Liver and lung study (NC)
08744	01SEP1989	31DEC9999	Y	Cardiac first pass blood flow study, cardiac shunt study or cardiac output study (not part of other investigation) (C)
08745	01SEP1989	31DEC9999	Y	Cardiac first pass blood flow study, cardiac shunt study or cardiac output study (not part of other investigation) (NC)
08746	01FEB1984	31DEC9999	Y	Le Veen shunt study (C)
08747	01FEB1984	31DEC9999	Y	Le Veen shunt study (NC)
08748	01SEP1989	31DEC9999	Y	Cardiac first pass blood flow study, cardiac shunt study or cardiac output study when associated with another item in this Part (C)
08749	01SEP1989	31DEC9999	Y	Cardiac first pass blood flow study, cardiac shunt study or cardiac output study when associated with another item in this Part (NC)
08750	01FEB1984	31DEC9999	Y	Gastric emptying study
08751	01SEP1989	31DEC9999	Y	Lung perfusion study (C)
08752	01SEP1989	31DEC9999	Y	Lung perfusion study (NC)
08753	01SEP1989	31DEC9999	Y	Lung ventilation study using Xe127 gas (C)
08754	01SEP1989	31DEC9999	Y	Lung ventilation study using Xe127 gas (NC)
08755	01FEB1984	31DEC9999	Y	Renal study (static) or placental study (C)
08756	01FEB1984	31DEC9999	Y	Renal study (static) or placental study (NC)
08757	01SEP1989	31DEC9999	Y	Lung ventilation study using Xe133 gas (C)
08758	01SEP1989	31DEC9999	Y	Lung ventilation study using Xe133 gas (NC)
08759	01FEB1984	31DEC9999	Y	Cystoureterogram or quantitative renogram (C)
08760	01FEB1984	31DEC9999	Y	Cystoureterogram or quantitative renogram (NC)
08761	01SEP1989	31DEC9999	Y	Lung ventilation study using aerosol (C)
08762	01SEP1989	31DEC9999	Y	Lung ventilation study using aerosol (NC)
08763	01FEB1984	31DEC9999	Y	Testicular study (C)
08764	01FEB1984	31DEC9999	Y	Testicular study (NC)
08765	01SEP1989	31DEC9999	Y	Lung perfusion study and lung ventilation study using either Xe127 or Xe133 gas (C)
08766	01SEP1989	31DEC9999	Y	Lung perfusion study and lung ventilation study using either Xe127 or Xe133 gas (NC)
08767	01SEP1989	31DEC9999	Y	Lung perfusion study and lung ventilation study using aerosol (C)
08768	01SEP1989	31DEC9999	Y	Lung perfusion study and lung ventilation study using aerosol (NC)
08769	01FEB1984	31DEC9999	Y	Brain study (static) or cerebro spinal fluid study (static) (C)
08770	01FEB1984	31DEC9999	Y	Brain study (static) or cerebro spinal fluid study (static) (NC)
08771	01SEP1989	31DEC9999	Y	Liver and spleen study (colloid) (C)
08772	01SEP1989	31DEC9999	Y	Liver and spleen study (colloid) (NC)
08773	01FEB1984	31DEC9999	Y	Shunt patency study (C)
08774	01FEB1984	31DEC9999	Y	Shunt patency study (NC)
08775	01SEP1989	31DEC9999	Y	Red blood cell spleen study (C)
08776	01SEP1989	31DEC9999	Y	Red blood cell spleen study (NC)
08777	01SEP1989	31DEC9999	Y	Hepatobiliary study (C)
08778	01SEP1989	31DEC9999	Y	Hepatobiliary study (NC)
08779	01FEB1984	31DEC9999	Y	Dynamic flow study or regional blood volume quantitative study (C)
08780	01FEB1984	31DEC9999	Y	Dynamic flow study or regional blood volume quantitative study (NC)
08781	01SEP1989	31DEC9999	Y	Bowel haemorrhage study (C)
08782	01SEP1989	31DEC9999	Y	Bowel haemorrhage study (NC)
08783	01FEB1984	31DEC9999	Y	Venography, lymphoscintigraphy, labelled platelets thrombus study or labelled white cell study (C)
08784	01FEB1984	31DEC9999	Y	Venography, lymphoscintigraphy, labelled platelets thrombus study or labelled white cell study (NC)
08785	01SEP1989	31DEC9999	Y	Meckel's diverticulum study (C)
08786	01SEP1989	31DEC9999	Y	Meckel's diverticulum study (NC)
08787	01FEB1984	31DEC9999	Y	Peripheral perfusion study (C)
08788	01FEB1984	31DEC9999	Y	Peripheral perfusion study (NC)
08789	01SEP1989	31DEC9999	Y	Salivary study (C)
08790	01SEP1989	31DEC9999	Y	Salivary study (NC)
08791	01SEP1989	31DEC9999	Y	Gastro-oesophageal reflux study (C)
08792	01SEP1989	31DEC9999	Y	Gastro-oesophageal reflux study (NC)
08793	01FEB1984	31DEC9999	Y	Bone study-- 4 or more areas (C)
08794	01FEB1984	31DEC9999	Y	Bone study-- 4 or more areas (NC)
08795	01SEP1989	31DEC9999	Y	Oesophageal clearance study (C)
08796	01SEP1989	31DEC9999	Y	Oesophageal clearance study (NC)
08797	01FEB1984	31DEC9999	Y	Bone study-- less than 4 areas (C)
08798	01FEB1984	31DEC9999	Y	Bone study-- less than 4 areas (NC)
08799	01FEB1984	31DEC9999	Y	Joint study of two or more joints (C)
08800	01FEB1984	31DEC9999	Y	Joint study of two or more joints (NC)
08801	01SEP1989	31DEC9999	Y	Gastric emptying study using single tracer (C)
08802	01SEP1989	31DEC9999	Y	Gastric emptying study using dual tracer (C)
08803	01FEB1984	31DEC9999	Y	Tumour seeking study-- 3 or more areas (C)
08804	01FEB1984	31DEC9999	Y	Tumour seeking study-- 3 or more areas (NC)
08805	01SEP1989	31DEC9999	Y	Renal study involving dynamic flow study and computer extraction of functional parameters (C)
08807	01FEB1984	31DEC9999	Y	Tumour seeking study-- less than 3 areas (C)
08808	01FEB1984	31DEC9999	Y	Tumour seeking study-- less than 3 areas (NC)
08809	01SEP1989	31DEC9999	Y	Renal study with intervention (C)
08810	01SEP1989	31DEC9999	Y	Renal study with intervention (NC)
08811	01SEP1989	31DEC9999	Y	Cystoureterogram (C)
08812	01SEP1989	31DEC9999	Y	Cystoureterogram (NC)
08813	01FEB1984	29FEB1984	N	Thyroid study (using technetium, iodine or caesium) perchlorate discharge study (C)
08813	01MAR1984	31DEC9999	Y	Thyroid study (using technetium, iodine or caesium) or perchlorate discharge study (C)
08814	01FEB1984	29FEB1984	N	Thyroid study (using technetium, iodine or caesium) perchlorate discharge study (NC)
08814	01MAR1984	31DEC9999	Y	Thyroid study (using technetium, iodine or caesium) or perchlorate discharge study (NC)
08815	01SEP1989	31DEC9999	Y	Testicular study (C)
08816	01SEP1989	31DEC9999	Y	Testicular study (NC)
08817	01FEB1984	31DEC9999	Y	Thyroid uptake study (C)
08818	01FEB1984	31DEC9999	Y	Thyroid uptake study (NC)
08819	01SEP1989	31DEC9999	Y	Brain study with blood brain barrier agent (C)
08820	01SEP1989	31DEC9999	Y	Brain study with blood brain barrier agent (NC)
08821	01FEB1984	31DEC9999	Y	Parathyroid study
08822	01SEP1989	31DEC9999	Y	Cerebro-spinal fluid transport study (C)
08823	01SEP1989	31DEC9999	Y	Cerebro-spinal fluid transport study (NC)
08824	01FEB1984	31DEC9999	Y	Adrenal study (C)
08825	01FEB1984	31DEC9999	Y	Adrenal study (NC)
08826	01SEP1989	31DEC9999	Y	Cerebro-spinal fluid shunt patency study (C)
08827	01SEP1989	31DEC9999	Y	Cerebro-spinal fluid shunt patency study (NC)
08828	01FEB1984	31DEC9999	Y	Study of region or organ not covered by any other item in this Part (C)
08829	01FEB1984	31DEC9999	Y	Study of region or organ not covered by any other item in this Part (NC)
08830	01SEP1989	31DEC9999	Y	Dynamic blood flow study or regional blood volume quantitative study (not associated with any other item in this Part) (C)
08831	01SEP1989	31DEC9999	Y	Dynamic blood flow study or regional blood volume quantitative study (not associated with any other item in this Part) (NC)
08832	01SEP1989	31DEC9999	Y	Bone study-whole body (C)
08833	01SEP1989	31DEC9999	Y	Bone study-whole body (NC)
08834	01SEP1989	31DEC9999	Y	Bone study-whole body and dynamic blood flow or regional blood volume quantitative study (C)
08835	01SEP1989	31DEC9999	Y	Bone study-whole body and dynamic blood flow or regional blood volume quantitative study (NC)
08836	01SEP1989	31DEC9999	Y	Whole body study using iodine (C)
08837	01SEP1989	31DEC9999	Y	Whole body study using iodine (NC)
08838	01SEP1989	31DEC9999	Y	Whole body study using gallium (C)
08839	01SEP1989	31DEC9999	Y	Whole body study using gallium (NC)
08840	01SEP1989	31DEC9999	Y	Whole body study using cells labelled with technetium (C)
08841	01SEP1989	31DEC9999	Y	Whole body study using cells labelled with technetium (NC)
08842	01SEP1989	31DEC9999	Y	Bone marrow study-whole body (C)
08843	01SEP1989	31DEC9999	Y	Bone marrow study-whole body (NC)
08844	01SEP1989	31DEC9999	Y	Repeat whole body study on different occasion using same administration of radiopharmaceutical (C)
08845	01SEP1989	31DEC9999	Y	Repeat whole body study on different occasion using same administration of radiopharmaceutical (NC)
08846	01SEP1989	31DEC9999	Y	Localised bone or joint study including flow and blood pool studies (C)
08847	01SEP1989	31DEC9999	Y	Localised bone or joint study including flow and blood pool studies (NC)
08848	01SEP1989	31DEC9999	Y	Localised bone, joint, tumour, infection or inflammation seeking study using gallium (C)
08849	01SEP1989	31DEC9999	Y	Localised bone, joint, tumour, infection or inflammation seeking study using gallium (NC)
08850	01NOV1984	31DEC9999	Y	Procedure service associated with the administration of a radionucletide in relation to a service covered by an item in Part 8A or Part 11.
08851	01SEP1989	31DEC9999	Y	Localised bone, joint, tumour, infection or inflammation seeking study using technetium (C)
08852	01SEP1989	31DEC9999	Y	Localised bone, joint, tumour, infection or inflammation seeking study using technetium (NC)
08853	01SEP1989	31DEC9999	Y	Repeat localised bone, joint, tumour, infection or inflammation seeking study on different occasion using same administration of radiopharmaceutical (C)
08854	01SEP1989	31DEC9999	Y	Repeat localised bone, joint, tumour, infection or inflammation seeking study on different occasion using same administration of radiopharmaceutical (NC)
08855	01SEP1989	31DEC9999	Y	Venography (including blood pool study, active uptake study or dynamic blood flow study) (C)
08856	01SEP1989	31DEC9999	Y	Venography (including blood pool study, active uptake study or dynamic blood flow study) (NC)
08857	01SEP1989	31DEC9999	Y	Lymphoscintigraphy (C)
08858	01SEP1989	31DEC9999	Y	Lymphoscintigraphy (NC)
08859	01SEP1989	31DEC9999	Y	Thyroid Study (C)
08860	01SEP1989	31DEC9999	Y	Thyroid Study (NC)
08861	01SEP1989	31DEC9999	Y	Thyroid uptake study performed on gamma camera (C)
08862	01SEP1989	31DEC9999	Y	Thyroid uptake study performed on gamma camera (NC)
08863	01SEP1989	31DEC9999	Y	Parathyroid (C)
08864	01SEP1989	31DEC9999	Y	Adrenal Study using Selenocholesterol (C)
08865	01SEP1989	31DEC9999	Y	Adrenal Study using Selenocholesterol (NC)
08866	01SEP1989	31DEC9999	Y	Adrenal Study (not covered by Item 8864/8865) (C)
08867	01SEP1989	31DEC9999	Y	Adrenal Study (not covered by Item 8864/8865) (NC)
08868	01SEP1989	31DEC9999	Y	Single photon emission tomography when associated with another item in this Part (C)
08869	01SEP1989	31DEC9999	Y	Tear Duct Study (C)
08870	01SEP1989	31DEC9999	Y	Tear Duct Study (NC)
08871	01SEP1989	31DEC9999	Y	Particle perfusion study (intra-arterial) or Le Veen Shunt study (C)
08872	01SEP1989	31DEC9999	Y	Particle perfusion study (intra-arterial) or Le Veen Shunt study (NC)
08873	01SEP1989	31DEC9999	Y	Study of region or organ not covered by any other item in this Part (C)
08874	01SEP1989	31DEC9999	Y	Study of region or organ not covered by any other item in this Part (NC)
08875	01SEP1989	31DEC9999	Y	Procedural service associated with the administration of a radionuclide in relation to a service covered by any item in Part 8A or Part 11
08878	01NOV1990	31DEC9999	Y	Administration of a therapeutic dose of a radioisotope - not covered by any other item in this Part
08880	01NOV1990	31DEC9999	Y	Intra-cavitary administration of a therapeutic dose of Yttrium 90 (not including preliminary paracentesis) (AU 5)
08882	01NOV1990	31DEC9999	Y	Administration of a therapeutic dose of Iodine 131 for thyroid cancer by single dose technique
08884	01NOV1990	31DEC9999	Y	Administration of a therapeutic dose of Iodine 131 for thyrotoxicosis by single dose technique
08886	01NOV1990	31DEC9999	Y	Intravenous administration of a therapeutic dose of Phosphorous 32
08901	01FEB1984	31DEC9999	Y	Professional attendance not covered by Item 8902 (AO)
08902	01FEB1984	31DEC9999	Y	Professional attendance and treatmentplanning where treatment is deferred (AO)
08903	01FEB1984	31DEC9999	Y	Production of dental study models not associated with Item 8902 or with a service covered by Item 8914, 8915, 8917, 8918, 8919, 8922, 8923, 8924, 8925, or 8928 (AO)
08905	01FEB1984	31DEC9999	Y	Orthodontic radiography-- orthopantomography (AO)
08906	01FEB1984	31DEC9999	Y	Orthodontic radiography-- anteroposterior cephalometric radiography with cephalometric tracings or lateral cephalometric radiography with cephalometric tracings (AO)
08907	01FEB1984	31DEC9999	Y	Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings (AO)
08908	01FEB1984	31DEC9999	Y	Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings and orthopantomography (AO)
08909	01FEB1984	31DEC9999	Y	Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings, orthopantomography and hand-wrist studies (including growth prediction) (AO)
08914	01FEB1984	31DEC9999	Y	Pre-surgical infant maxillary arch repositioning, including supply of appliances and all associated consultations-- where one appliance is used (AO)
08915	01FEB1984	31DEC9999	Y	Pre-surgical infant maxillary arch repositioning, including supply of appliances and all associated consultations-- where two appliances are used (AO)
08917	01FEB1984	31DEC9999	Y	Deciduous dentition treatment-- maxillary arch expansion, including supply of appliances and all associated consultations, treatmentplanning and retention services beyond the period of active treatment (AO)
08918	01FEB1984	31DEC9999	Y	Deciduous and permanent dentition treatment-incisor alignment using fixed appliances in maxillary arch, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment (AO)
08919	01FEB1984	31DEC9999	Y	Deciduous and permanent dentition treatment (not being treatment associated with treatment covered by Item 8918)-- lateral arch expansion and incisor alignment using fixed appliances in maxillary arch, including supply of appliances and all associated attendances, treatment-planning and retention services beyond the period of active treatment (AO)
08922	01FEB1984	31DEC9999	Y	Permanent dentition treatment (not being treatment associated with treatment covered by Item 8924 or 8925)-- single arch (mandibular or maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- initial three months of active treatment (AO)
08923	01FEB1984	31DEC9999	Y	Permanent dentition treatment (not being treatment associated with treatment covered by Item 8924 or 8925)-- single arch (mandibular or maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- each three months of active treatment after the first for a maximum of a further 33 months (AO)
08924	01FEB1984	31DEC9999	Y	Permanent dentition treatment (not being treatment associated with treatment covered by Item 8922 or 8923)-- two-arch (mandibular and maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- initial three months of active treatment (AO)
08925	01FEB1984	31DEC9999	Y	Permanent dentition treatment (not being treatment associated with treatment covered by Item 8922 or 8923)-- two-arch (mandibular and maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- each three months of active treatment after the first for a maximum of a further 33 months (AO)
08928	01FEB1984	29FEB1984	N	Pre-sugical or post-sugrical jaw growth guidance using removable appliances, including supply of appliances and all associated consultations and treatment-planning (AO)
08928	01MAR1984	31DEC9999	Y	Pre-surgical or post-surgical jaw growth guidance using removable appliances, including supply of appliances and all associated consultations and treatment-planning (AO)
08931	01FEB1984	29FEB1984	N	Removal of tooth or tooth fragment (not being treatment covered by Item 8936, 8937, 8938, 8939, 8940 or 8941), where the patient is referred by a recognized orthodontist (AD)
08931	01MAR1984	31DEC9999	Y	Removal of tooth or tooth fragment (not being treatment covered by Item 8936, 8937, 8938, 8939, 8940 or 8941), where the patient is referred by a recognized orthodonist (AD)
08932	01FEB1984	31DEC9999	Y	Removal of tooth or tooth fragment under general anaesthesia, where the patient is referred by a recognized orthodontist (AD)
08933	01FEB1984	31DEC9999	Y	Removal of each additional tooth or tooth fragment at the same attendance at which a service referred to in Item 8931 or 8932 is rendered (AD)
08936	01FEB1984	31DEC9999	Y	Surgical removal of erupted tooth, where the patient is referred by a recognized orthodontist (AOS)
08937	01FEB1984	31DEC9999	Y	Surgical removal of tooth with soft tissue impaction, where the patient is referred by a recognized orthodontist (AOS)
08938	01FEB1984	31DEC9999	Y	Surgical removal of tooth with partial bone impaction, where the patient is referred by a recognized orthodontist (AOS)
08939	01FEB1984	31DEC9999	Y	Surgical removal of tooth with complete bone impaction, where the patient is referred by a recognized orthodontist (AOS)
08940	01FEB1984	31DEC9999	Y	Surgical removal of tooth fragment requiring incision of soft tissue only, where the patient is referred by a recognized orthodontist (AOS)
08941	01FEB1984	31DEC9999	Y	Surgical removal of tooth fragment requiring removal of bone, where the patient is referred by a recognized orthodontist (AOS)
08945	01FEB1984	31DEC9999	Y	Surgical exposure, stimulation and packing of unerupted tooth, where the patient is referred by a recognized orthodontist (AOS)
08946	01FEB1984	31DEC9999	Y	Surgical exposure of unerupted tooth for the purpose of fitting a traction device, where the patient is referred by a recognized orthodontist (AOS)
08947	01FEB1984	31DEC9999	Y	Surgical repositioning of unerupted tooth, where the patient is referred by a recognized orthodontist (AOS)
08948	01FEB1984	31DEC9999	Y	Transplantation of tooth bud, where the patient is referred by a recognized orthodontist (AOS)
08960	01FEB1984	31AUG1989	N	Attendance comprising consultation, preventive treatment and prophylaxis, of not more than thirty minutes duration-- each attendance to a maximum of three attendances in any period of twelve months (AD)
08960	01SEP1989	31DEC9999	Y	Attendance comprising consultation, preventive treatment and prophylaxis, of not less than thirty minutes duration-each attendance to a maximum of three attendances in any period of twelve months (AD)
08961	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- one tooth (AD)
08962	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- two teeth (AD)
08963	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- three teeth (AD)
08964	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- four teeth (AD)
08965	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- five to nine teeth (AD)
08966	01FEB1984	31DEC9999	Y	Provision and fitting of acrylic base partial denture, including retainers-- ten to twelve teeth (AD)
08971	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-- one tooth (AD)
08972	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-- two teeth (AD)
08973	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-three teeth (AD)
08974	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-four teeth (AD)
08975	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-five to nine teeth (AD)
08976	01FEB1984	31DEC9999	Y	Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-ten to twelve teeth (AD)
08980	01FEB1984	31DEC9999	Y	Provision and fitting of retainers (not being treatment associated with treatment covered by Item 8961, 8962, 8963, 8964, 8965, 8966, 8971, 8972, 8973, 8974, 8975 or 8976)-each retainer (AD)
08982	01FEB1984	31DEC9999	Y	Adjustment of partial denture (not being treatment associated with treatment covered by Item 8961, 8962, 8963, 8964, 8965, 8966, 8971, 8972, 8973, 8974, 8975 or 8976) (AD)
08984	01FEB1984	29FEB1984	N	Relining of partial denture by laboratory process and associated fitting (AD)
08984	01MAR1984	31DEC9999	Y	Reclining of partial denture by laboratory process and associated fitting (AD)
08986	01FEB1984	31DEC9999	Y	Remodelling and fitting of partial denture of more than four teeth (AD)
08988	01FEB1984	31DEC9999	Y	Repair to cast metal base of partial denture-one or more points (AD)
08990	01FEB1984	31DEC9999	Y	Addition of a tooth or teeth to a partial denture to replace extracted tooth or teeth, including taking of necessary impression (AD)
09011	01JUL1985	31DEC9999	Y	ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (for services from 1 July 1985 to 31 July 1986)
09021	01NOV1986	31DEC9999	Y	ANAESTHETICS ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with removal of phaeochromocytoma - SIXTEEN UNITS (G)
09022	01NOV1986	31DEC9999	Y	ANAESTHETICS ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with removal of phaeochromocytoma - SIXTEEN UNITS (S)
09023	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with insertion of peripheral venous cannula - FOUR UNITS (G)
09024	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with insertion of peripheral venous cannula - FOUR UNITS (S)
09025	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with peripheral venous cannulation by open exposure - FIVE UNITS (G)
09026	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with peripheral venous cannulation by open exposure - FIVE UNITS (S)
09027	01SEP1986	31OCT1986	N	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation - FIVE UNITS (G)
09027	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation — FIVE UNITS (G)
09028	01OCT1986	31OCT1986	N	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation - FIVE UNITS (S)
09028	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation — FIVE UNITS (S)
09029	01MAR1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation OVER TWELVE YEARS of age - EIGHT UNITS (G)
09030	01MAR1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation OVER TWELVE YEARS of age - EIGHT UNITS (S)
09031	01OCT1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation UNDER TWELVE YEARS of age - TWELVE UNITS (G)
09032	01NOV1986	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation UNDER TWELVE YEARS of age - TWELVE UNITS (S)
09033	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with electrocochleography (insertion of electrodes and brain stem evoked response audiometry) - ELEVEN UNITS (G)
09034	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with electrocochleography (insertion of electrodes and brain stem evoked response audiometry) - ELEVEN UNITS (S)
09035	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manual removal of products of conception, treatment of postpartum haemorrhage or repair of third degree tear - SEVEN UNITS (G)
09036	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manual removal of products of conception, treatment of postpartum haemorrhage or repair of third degree tear - SEVEN UNITS (S)
09037	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manipulative correction of acute inversion of uterus - EIGHT UNITS (G)
09038	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manipulative correction of acute inversion of uterus - EIGHT UNITS (S)
09039	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with caesarean section - TEN UNITS (G)
09040	01AUG1987	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with caesarean section - TEN UNITS (S)
09041	01AUG1988	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with repair of episiotomy - FIVE UNITS (G)
09042	01AUG1988	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with repair of episiotomy - FIVE UNITS (S)
09061	01JUL1985	31DEC9999	Y	ADMINISTRATION OF CYTOTOXIC AGENT by intravenous drip infusion (for services from 1 July 1985 to 31 July 1986)
09062	01AUG1988	31DEC9999	Y	MISCELLANEOUS PROCEDURES PULMONARY ARTERY pressure monitoring during open heart surgery, in a person under 12 years of age
09063	01AUG1988	31DEC9999	Y	PULMONARY ARTERY pressure monitoring during open heart surgery, in a person over 12 years of age
09065	01AUG1989	31DEC9999	Y	ASSISTED REPRODUCTIVE TECHNOLOGIES involving handling of both human ova and sperm including invitro fertilisation or gamete intra-faiIopian transfer or similar techniques, when rendered in conjunction with
09066	01DEC1989	31DEC9999	Y	M-MODE AND TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST TWO THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not associated with Items 791, 793 or 913
09067	01DEC1989	31DEC9999	Y	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST EIGHT HOURS DURATION, involving continuous morutoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG, with continuous technician attendance, under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine, where the patient is referred to him or her by a medical practitioner, including interpretation by physician of recordings; payable not more than three times in any twelve month period
09341	01AUG1988	31DEC9999	Y	ORTHOPANTOMOGRAPHY and report
09342	01AUG1988	31DEC9999	Y	PREPARATION FOR DISCOGRAPHY using Metrizarnide contrast medium
09343	01AUG1988	31DEC9999	Y	PREPARATION FOR CONTRAST ARTHROGRAPHY or double contrast arthrography excluding arthrography of the joints between articular processes of the vertebrae
09344	01AUG1988	31DEC9999	Y	PREPARATION FOR SIALOGRAPHY
09381	01FEB1988	31DEC9999	Y	RADIATION FIELD SETTING using a simulator or isocentric x-ray or megavoliage machine of a single area for treatment by a single field or parallel opposed fields (not associated with Item 9384)
09382	01FEB1988	31DEC9999	Y	RADIATION FIELD SETTING using a simulator or isocentric x-ray or megavolt age machine of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 9385)
09383	01MAR1988	31DEC9999	Y	RADIATION FIELD SETTING usining simulator or isocentric x-ray or megavoltage machine of three or more areas, or of total body or half body irradiatigrt, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 9386)
09384	01FEB1988	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic x-ray unit of a single area for treatment by a single field or parallel opposed fields (not associated with Item 9381)
09385	01FEB1988	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic x-ray unit of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 9382)
09386	01FEB1988	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic x-ray unit of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 9383)
09387	01FEB1988	31DEC9999	Y	"RADIATION DOSIMETRY by a CT interfacing computer for ""megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane"
09388	01FEB1988	31DEC9999	Y	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy adiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or here wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
09389	01FEB1988	31DEC9999	Y	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy o three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons
09390	01FEB1988	31DEC9999	Y	RADIATION DOSIMETRY by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane
09391	01FEB1988	31DEC9999	Y	RADIATION DOSIMETRY by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single Ii area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
09392	01FEB1988	31DEC9999	Y	RADIATION DOSIMETRY by a non-CT interfac planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane of more than 10 sources or ribbons
09401	01SEP1986	31DEC9999	Y	OPERATIONS HAEMORRHAGE, arrest of, following circumcision requiring general anaes-thesia
09402	01MAR1987	31DEC9999	Y	AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover. ANAESTHETIC - ITEM NOS 488G/560S (for services from 31 July 1986 to 31 October 1986)
09403	01OCT1986	31DEC9999	Y	NASAL SEPTUM BUTTON, insertion of
09404	01AUG1988	31DEC9999	Y	PERCUTANEOUS NEEDLE BIOPSY of lung ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S
09405	01AUG1988	31DEC9999	Y	NASAL TURBINATES, cryotherapy to ANAESTHETIC 6 UNIT - ITEM NOS 407G / 5I3S
09406	01AUG1988	31DEC9999	Y	PERCUTANEOUS EPIDURAL IMPLANCT FOR CHRONIC PAIN -insertion of (one or two stages), not involving laminectomy ANAESTHETIC 8 ITS - ITEM NOS 409G / 5l7S
09407	01AUG1988	31DEC9999	Y	PERCUTANEOUS EPIDURAL IMPLANCT FOR CHRONIC PAIN - removal of ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S
09408	01AUG1988	31DEC9999	Y	POSTERIOR MOBILISATION (release), operaiion for scoliosis ANAESTHETIC 21 UNITS - ITEM NOS 4650 / 535S
09409	01AUG1988	31DEC9999	Y	FINGER JOINT, prosthetic replacement of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S
09410	01AUG1988	31DEC9999	Y	ARGON LASER THERAPY for vascular lesions of the Skin - session up to one half hour
09411	01AUG1988	31DEC9999	Y	ARGON LASER THERAPY for vascular lesions of the skin - session taking more than one half hour but less than one hour
09412	01AUG1988	31DEC9999	Y	ARGON LASER THERAPY for vascular lesions of the skin - session taking more than one hour but less than two hours
09413	01AUG1988	31DEC9999	Y	ARGON LASER THERAPY for vascular lesions of the skin - session taking more than two hours but less than three hours
09414	01AUG1988	31DEC9999	Y	ARGON LASER THERAPY for vascular lesions of the skin - session taking more than three hours
09415	01AUG1988	31DEC9999	Y	CRYOSURGERY to haemorrhoids ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S
09416	01AUG1988	31DEC9999	Y	WRIST, total replacement ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S
09417	01AUG1988	31DEC9999	Y	CARPAL SCAPHOID, internal fixation of ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
09418	01AUG1988	31DEC9999	Y	HYPERTHERMIC ISOLATED LIMB PERFUSION including vascular cannulation by operation and subsequent removal of catheteters ANAESTHETIC 30 UNITS - ITEM NOS 474G / 545S
09419	01AUG1988	31DEC9999	Y	ARTERIAL BYPASS GRAFT USING SYNTHETIC GRAFT,with or without local endarterectomy ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S
09420	01AUG1988	31DEC9999	Y	LAPAROTOMY WITH INSERTION OF PORTACATH for administration of cytotoxic therapy including placement of reservoir ' ANAESTHETIC II UNITS - ITEM NOS 4530 / 522S
09421	01AUG1988	31DEC9999	Y	NAIL BED, excision or wedge resection of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S (G)
09422	01AUG1988	31DEC9999	Y	NAIL BED, excision or wedge resection of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S (S)
09423	01AUG1988	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR, with or without creation of temporary ileostomy: one surgeon ANAESTHETIC 36 UNITS - ITEM NOS 4760 / 547S
09424	01AUG1988	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR, with or without creation of temporary ileostomy: conjoint surgery abdominal surgeon (including after-care) ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S
09425	01AUG1988	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR: conjoint surgery perineal surgeon
09426	01AUG1988	31DEC9999	Y	ILEOSTOMY closure with rectal resection and mucosectomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: one surgeon ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S
09427	01AUG1988	31DEC9999	Y	ILEOSTOMY closure with rectal resection and mucoscctomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: abdominal surgeon (including aftercare) ANAESTHETIC 26 UNITS - ITEM NOS 4700 /541S
09428	01AUG1988	31DEC9999	Y	ILEOSTOMY closure with rectal resection and mucoscctomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: conjoint surgery perineal surgeon
09429	01AUG1988	31DEC9999	Y	ILEOSTOMY reservoir, continent type, creation of including conversion of existing ileostomy where appropriate ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S
09430	01AUG1988	31DEC9999	Y	RECTOSIGMOIDECTOMY, anterior (Hartman's peration) ANAESTHETIC 15 UNITS - ITEM NOS 459G 526S
09431	01AUG1988	31DEC9999	Y	Restoration of bowel continuity following Hartman's procedure, including dismantling of colostomy ANAESTHETIC 15 UNITS - ITEM NO 459G / 526S
09432	01AUG1988	31DEC9999	Y	RECTAL PROLAPSE - Delorme procedure for ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
09433	01AUG1988	31DEC9999	Y	COLOSTOMY, refashioning of ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
09434	01AUG1988	31DEC9999	Y	Injection of botulinus toxin fo blepharospasm or strabismus
09435	01AUG1988	31DEC9999	Y	LAPAROTOMY with division of bowel adhesions and introduction of Dennis tube ANAESTHETIC 14 UNITS - ITEM NOS 4580 / 525S
09436	01AUG1988	31DEC9999	Y	CENTRAL VEIN ATHETERISATION (via jugular or subclavian vein) or by open exposure in a person under 12 years of age ANAESTHETI 12 UNITS - ITEM NOS 454G / 523S
09437	01AUG1988	31DEC9999	Y	CENTRAL VEIN CATHETERISATION (via jugular or subclavian vein) by percutaneous or open exposure, not covered by item 9430 ANAESTHETIC 6 UNITS - ITEM NOS 407G / 5l3S
09438	19OCT1988	31DEC9999	Y	TEMPORO-MANDIBULAR JOINT, arthroplasty ANAESTHETIC 6 UNITS - ITEM NOS 4070 / 513S
09439	19OCT1988	31DEC9999	Y	TEMPORO-MANDIBULAR JOINT, arthroplasty (D) ANAESTHETIC 6 UNITS - ITEM NOS 407G /513S
09441	01FEB1989	31DEC9999	Y	NEPHROSTOMY, percutaneous, including associated imaging ANAESTHETIC 9 UNITS - ITEM NOS 443G / 518S
09442	01FEB1989	31DEC9999	Y	NEPHROSCOPY, percutaneous, with or without anyone or more of; stone extraction, biopsy or diathermy, not covered by Items 9446, 9447, 9448 or 9449 ANAESTHETIC II UNITS - ITEM NOS 453G / 522S
09443	01FEB1989	31DEC9999	Y	The services covered by Item 9442 where, after a substantial portion of the procedure has been performed, it is necessary to discontinue the operation due to bleeding ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S
09444	01FEB1989	31DEC9999	Y	NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, not in association with Items 9442,9446, 9447, 9448 or 9449 ANAESTHETIC II UNITS - ITEM NOS 453G / 522S
09445	01FEB1989	31AUG1989	N	NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, in association with Items 9442, 9446, 9447, 9448 or 9449 ANAESTHETIC 13 UNITS - ITEM N
09445	01SEP1989	31DEC9999	Y	NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, in association with Items 9442, 9446, 9447, 9448 or 9449 ANAESTHETIC 13 UNITS - ITEM N<?S 457G / 524S
09446	01FEB1989	31DEC9999	Y	NEPHROSCOPY, percutaneous, with destruction and extraction of one or two stones using ultrasound or electrohydraulic shock waves or lasers (not covered by Items 9448 or 9449) ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S
09447	01FEB1989	31DEC9999	Y	The services covered by Item 9446 where, after a substantial portion of the procedure has been performed, it is necessary to discontinue the operation due to bleeding ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S
09448	01FEB1989	31DEC9999	Y	NEPHROSCOPY, percutaneous, with removal or destruction of a stone greater than 3 cms in any dimension, or for three or more stones ANAESTHETIC 17 UNITS - ITEM NOS 461G / 528S
09449	01FEB1989	31DEC9999	Y	The services covered by Item 9448 where, after a substantial portion of the procedure has been performed, it is necessary to discontinue the operation ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S
09450	01FEB1989	31DEC9999	Y	HYPERBARIC TREATMENT including oxygen therapy for a period of more than two hours (including examination immediately pre and post treatment) - per hour
09451	01FEB1989	31DEC9999	Y	Historical item included for item mapping purposes
09452	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wavc length of 510-600 nanometres in the treatment of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least 60 minutes duration
09453	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wave length of 510-600 nanometres in the treatmcnt of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least I hour and 15 minutes duration
09454	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wave length of 510-600 nanometres in the trcatment of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least I hour and 30 minutes duration
09455	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least I hour and 45 minutes duration
09456	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least 2 hours duration
09457	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION of the head or neck using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains and other severely disfiguring vascular lesions of the skin where individual abnormal vessels are visible at a distance of two metres, including any associated consultation - session of at least 2 hours and 15 minutes duration
09458	01FEB1989	31DEC9999	Y	[Unidentified item]
09459	01SEP1989	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY- automated absolute static threshold) performed by a specialist in the practice of his/her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral - to a maximum of two examinations (including examinations covered by Item 9460) in any twelve month period
09460	01SEP1989	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY(automated absolute static threshold) performed by a specialist in the practice of his/her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral - to a maximum of two examinations (including examinations covered by Item 9459) in any twelve month period
09461	01SEP1989	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY(automated absolute static threshold) performed by a specialist in the practice of his/her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, an examination covered by either Item 9459 or Item 9460, being the third or subsequent examination in a twelve month period
09462	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometrps in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9463, 9464, 9465,9466, 9467and 9468) in any twelve month period - session of at least 30 minutes duration
09463	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9464, 9465,9466, 9467and 9468) in any twelve month period - session of at least 60 minutes duration
09464	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9463, 9465,9466, 9467and 9468) in any twelve month period - session of at least 1 hour and 15 minutes duration
09465	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9463, 9464,9466, 9467and 9468) in any twelve month period - session of at least 1 hour and 30 minutes duration
09466	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9463, 9464,9465, 9467and 9468) in any twelve month period - session of at least 1 hour and 45 minutes duration
09467	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9463, 9464,9465, 9466and 9468) in any twelve month period - session of at least 2 hours duration
09468	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of two metres, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9462, 9463, 9464,9465, 9466and 9467) in any twelve month period - session of at least 2 hours and 15 minutes duration
09469	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9470, 9471, 9472, 9473, 9474, and 9475) in any twelve month period - session of at least 30 minutes duration
09470	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469, 9471, 9472, 9473, 9474, and 9475) in any twelve month period - session of at least 60 minutes duration
09471	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469, 9470, 9472, 9473, 9474, and 9475) in any twelve month period - session of at least I hour and 15 minutes duration
09472	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469, 9470, 9471, 9473, 9474, and 9475) in any twelve month period - session of at least 1 hour and 30 minutes duration
09473	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469,9470,9471,9472,9474, and 9475) in any twelve month period - session of at least I hour and 45 minutes duration
09474	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469,9470,9471,9472,9473, and 9475) in any twelve month period - session of at least 2 hours duration
09475	01FEB1989	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of twelve sessions (including any sessions under items 9469, 9470, 9471, 9472, 9473, and 9474) in any twelve month period - session of at least 2 hours and 15 minutes duration
09476	01DEC1989	31DEC9999	Y	BLADDER TRANSECTION AND RE-ANASTOMOSIS TO TRIGONE ANAESTHETIC 16 UNITS - ITEM NOS 460G/527S
09477	01DEC1989	31DEC9999	Y	PENIS ERECTION TEST FOR HYPOSPADIAS AND CHORDEE when performed under general anaesthesia, as an independent procedure ANAESTHETIC 5 UNITS - ITEM NOS 406G/51OS
09478	01DEC1989	31DEC9999	Y	URETEROLITHOTOMY COMPLICATED BY PREVIOUS SURGERY at the same site of the same ureter ANAESTHETIC 12 UNITS - ITEM NOS 454G/523S
10660	18JUN2021	28JUN2021	N	Professional attendance by a general practitioner, if all of the following apply: (a) the service is associated with a service to which item 93624, 93625, 93634, 93635, 93644, 93645, 93653 or 93654 applies; (b) the service is provided to a patient who is at least 50 years of age; (c) the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (d) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (e) the service is bulk-billed
10660	29JUN2021	29JUN2021	N	Professional attendance by a general practitioner, if all of the following apply: (a) the service is associated with a service to which item 93624, 93625, 93634, 93635, 93644, 93645, 93653 or 93654 applies; (b) the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed Note: Effective 29 June 2021, age restrictions on the use of this item have been removed.
10660	30JUN2021	31JAN2023	N	Professional attendance by a general practitioner, if all of the following apply: (a) the service is associated with a service to which item 93624, 93625, 93634, 93635, 93644, 93645, 93653 or 93654 applies; (b) the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed Note: Effective 29 June2021, age restrictions on the use of this item have been removed.
10660	01FEB2023	31DEC9999	Y	Professional attendance by a general practitioner, if all of the following apply: (a) the service is associated with a service to which item 93644, 93645, 93653 or 93654 applies; (b) the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed
10661	18JUN2021	28JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply: (a) the service is associated with a service to which item 93626, 93627, 93636, 93637, 93646, 93647, 93655 or 93656 applies; (b) the service is provided to a patient who is at least 50 years of age; (c) the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (d) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (e) the service is bulk-billed
10661	29JUN2021	29JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply: (a) the service is associated with a service to which item 93626, 93627, 93636, 93637, 93646, 93647, 93655 or 93656 applies; (b) the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed Note: Effective 29 June 2021, age restrictions on the use of this item have been removed.
10661	30JUN2021	31JAN2023	N	Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply: (a) the service is associated with a service to which item 93626, 93627, 93636, 93637, 93646, 93647, 93655 or 93656 applies; (b) the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed Note: Effective 29 June2021, age restrictions on the use of this item have been removed.
10661	01FEB2023	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply: (a) the service is associated with a service to which item 93646, 93647, 93655 or 93656 applies; (b) the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine; (c) one or both of the following is undertaken, where clinically relevant: (i) a detailed patient history; (ii) complex examination and management; (d) the service is bulk-billed
10801	01DEC1991	31OCT1997	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS Note: Benefits may not be claimed under Item 10809 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons ATTENDANCE FOR THE INVESTIGATION and EVALUATION of a patient for the fitting of CONTACT LENSES, with keratometry and testing with trial lenses and the issue of a prescription - 1 SERVICE IN ANY PERIOD OF 36 CONSECUTIVE MONTHS - patients with myopia of 4.0 dioptres or greater (spherical equivalent) in 1 eye
10801	01NOV1997	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with myopia of 5.0 dioptres or greater (spherical equivalent) in one eye
10802	01DEC1991	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in one eye
10803	01DEC1991	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with astigmatism of 3.0 dioptres or greater in one eye
10804	01DEC1991	31OCT1997	N	- patients with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is less than 6/12 and if that corrected acuity would be improved by an additional 1 line on the Snellen chart by the use of a contact lens
10804	01NOV1997	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is worse than 0.3 logMAR (6/12) and if that corrected acuity would be improved by an additional 0.1 logMAR by the use of a contact lens
10805	01DEC1991	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with anisometropia of 3.0 dioptres or greater (difference between spherical equivalents)
10806	01DEC1991	31OCT1997	N	- patients with subnormal corrected visual acuity of not greater than 6/30 in either eye, being patients for whom a contact lens is prescribed as part of a telescopic system
10806	01NOV1997	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with corrected visual acuity of 0.7 logMAR (6/30) or worse in both eyes and for whom a contact lens is prescribed as part of a telescopic system
10807	01DEC1991	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient for whom a wholly or segmentally opaque contact lens is prescribed for the alleviation of dazzle, distortion or diplopia caused by pathological mydriasis, aniridia, coloboma of the iris, pupillary malformation or distortion, significant ocular deformity or corneal opacity-whether congenital, traumatic or surgical in origin
10808	01DEC1991	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient who, because of physical deformity, are unable to wear spectacles
10809	01DEC1991	31OCT1997	N	- patients who have a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition to which item 10806, 10807 or 10808 applies) requiring the use of a contact lens for correction and which condition must be specified on the patient's account
10809	01NOV1997	31DEC9999	Y	Attendance for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of 36 months-patient with a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition to which item 10806, 10807 or 10808 applies) requiring the use of a contact lens for correction, if the condition is specified on the patient's account
10815	01DEC1991	31DEC9999	Y	ATTENDANCE FOR REFITTING of CONTACT LENSES with keratometry and testing with trial lenses and the issue of a prescription being a subsequent fitting of contact lenses within a period of 36 months of the initial fitting to which items 10801 to 10809 apply
10816	19JUN1997	31OCT1997	N	ATTENDANCE FOR THE REFITTING OF CONTACT LENSES with keratometry and testing with trial lenses and the issue of a prescription, where the patient requires a change in contact lens material or basic lens parameters, other than simple power change, because of a structural or functional change in the eye or an allergic response within 36 months of the fitting of a contact lens to which Items 10801 to 10809 apply
10816	01NOV1997	31DEC9999	Y	Attendance for the refitting of contact lenses with keratometry and testing with trial lenses and the issue of a prescription, if the patient requires a change in contact lens material or basic lens parameters, other than simple power change, because of a structural or functional change in the eye or an allergic response within 36 months after the fitting of a contact lens to which items 10801 to 10809 apply
10900	01DEC1991	31OCT1994	N	INITIAL CONSULTATION Professional attendance that is the SOLE or FIRST attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location - once only in a period of 24 months.
10900	01NOV1994	31OCT1997	N	INITIAL STANDARD CONSULTATION Professional attendance, not being an attendance covered by item 10906, that is the SOLE or FIRST attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location - once only in a period of 24 months.
10900	01NOV1997	31OCT2003	N	COMPREHENSIVE INITIAL CONSULTATION Professional attendance of more than 15 minutes duration, being the first in a course of attention - not payable within 24 months of an attendance to which item 10900, 10905, 10907, 10912, 10913 or 10914 applied
10900	01NOV2003	31DEC9999	Y	COMPREHENSIVE INITIAL CONSULTATION Professional attendance of more than 15 minutes duration, being the first in a course of attention - not payable within 24 months of an attendance to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10915 applies
10901	01DEC1991	31DEC9999	Y	INITIAL CONSULTATION WITHIN 24 MONTHS OF THE PREVIOUS INITIAL CONSULTATION Professional attendance that is the SOLE or FIRST attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location, where the patient has an ocular condition which necessitated a further course of attention within twenty-four months of the previous initial consultation covered by Item 10900 or 10901 NOTE: Benefits may only be claimed where certain criteria are met - see paragraph O8.4 of Notes for Guidance (Section 1)
10902	01JUL1992	31OCT1994	N	INITIAL CONSULTATION WITHIN 24 MONTHS OF THE PREVIOUS INITIAL CONSULTATION Professional attendance that is the SOLE or FIRST attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location, where the patient has a visual or ocular condition which necessitates a comprehensive optometric consultation within 24 months of the previous initial or comprehensive consultation to which item 10900, 10902, 10903 or 10904 applies - patients with a significant change of visual function requiring complete reassessment
10902	01NOV1994	31DEC9999	Y	STANDARD CONSULTATION WITHIN 24 MONTHS OF AN INITIAL STANDARD CONSULTATION Professional attendance, not being an attendance covered by item 10906, that is the SOLE or FIRST attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location, where the patient has a visual or ocular condition which necessitates a comprehensive optometric consultation within 24 months of the previous initial or comprehensive consultation to which item 10900, 10902, 10903, 10904 or 10906 applies - patients with a significant change of visual function requiring complete reassessment
10903	01JUL1992	31DEC9999	Y	Professional attendance that is the sole or first attendance in a single course of attention of a patient by a participating optometrist at, or operating from, the same practice location, where the patient has new signs or symptoms, unrelated to the earlier course of attention, requiring complete reassessment which necessitates a comprehensive optometric consultation within 24 months of the previous initial or comprehensive consultation to which item 10900, 10902, 10903 or 10904 applies
10904	01JUL1992	31DEC9999	Y	Professional attendance that is the sole or first attendance in single course of attention of a patient by a participating optometrist at, or operating from, the same practice location, where the patient has a progressive disorder (excluding presbyopia) requiring complete reassessment which necessitates a comprehensive optometric consultation within 24 months of the previous initial or comprehensive consultation to which item 10900, 10902, 10903 or 10904 applies
10905	01NOV1997	31DEC9999	Y	REFERRED COMPREHENSIVE INITIAL CONSULTATION Professional attendance of more than 15 minutes duration, being the first in a course of attention, where the patient has been referred by another optometrist who is not associated with the optometrist to whom the patient is referred
10906	01NOV1994	31OCT1995	N	INITIAL SHORT CONSULTATION Professional attendance, which would otherwise be covered by items 10900, 10902, 10903 or 10904, where the duration of the attendance is not more than 15 minutes
10906	01NOV1995	31DEC9999	Y	SHORT CONSULTATION Professional attendance, which would otherwise be covered by items 10900, 10902, 10903 or 10904, where the duration of the attendance is not more than 15 minutes
10907	01NOV1997	31OCT2003	N	COMPREHENSIVE INITIAL CONSULTATION BY ANOTHER PRACTITIONER WITHIN 24 MONTHS OF A PREVIOUS COMPREHENSIVE CONSULTATION Professional attendance of more than 15 minutes duration being the first in a course of attention where the patient has attended another optometrist within the previous 24 months for an attendance to which item 10900, 10905, 10907, 10912, 10913 or 10914 applied
10907	01NOV2003	31DEC2014	N	COMPREHENSIVE INITIAL CONSULTATION BY ANOTHER PRACTITIONER WITHIN 24 MONTHS OF A PREVIOUS COMPREHENSIVE CONSULTATION Professional attendance of more than 15 minutes duration being the first in a course of attention where the patient has attended another optometrist within the previous 24 months for an attendance to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10915 applies
10907	01JAN2015	31DEC9999	Y	COMPREHENSIVE INITIAL CONSULTATION BY ANOTHER PRACTITIONER Professional attendance of more than 15 minutes in duration, being the first in a course of attention if the patient has attended another optometrist for an attendance to which this item or item 10905, 10910, 10911, 10912, 10913, 10914 or 10915 applies, or to which old item 10900 applied: (a) for a patient who is less than 65 years of age-within the previous 36 months; or (b) for a patient who is at least 65 years or age-within the previous 12 months
10908	01DEC1991	30JUN1992	N	SECOND CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the second attendance in a single course of attention in respect of which the first attendance is covered by Item 10900 or Item 10901.
10908	01JUL1992	31OCT1994	N	SECOND CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the second attendance in a single course of attention in respect of which the first attendance is a service to which item 10900, 10902, 10903 or 10904 applies
10908	01NOV1994	31DEC9999	Y	SECOND CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the second attendance in a single course of attention in respect of which the first attendance is a service to which item 10900, 10902, 10903, 10904 or 10906 applies
10909	01DEC1991	30JUN1992	N	THIRD OR SUBSEQUENT CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the third or subsequent attendance in a single course of attention of a patient in respect of whom the attending optometrist has certified that, in his/her professional opinion, there is a need for that attendance, being a course of attention in respect of which the first attendance is covered by Item 10900 or Item 10901.
10909	01JUL1992	31OCT1994	N	THIRD OR SUBSEQUENT CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the third or subsequent attendance in a single course of attention of a patient in respect of whom the attending optometrist has certified that, in his or her professional opinion, there is a need for that attendance, being a course of attention in respect of which the first attendance is a service to which item 10900, 10902, 10903 or 10904 applies
10909	01NOV1994	31DEC9999	Y	THIRD OR SUBSEQUENT CONSULTATION Professional attendance (not being an attendance relating to the prescription and fitting of contact lenses) that is the third or subsequent attendance in a single course of attention of a patient in respect of whom the attending optometrist has certified that, in his or her professional opinion, there is a need for that attendance, and the attendance follows an attendance covered by item 10908 or 10909
10910	01JAN2015	31DEC9999	Y	COMPREHENSIVE INITIAL CONSULTATION - PATIENT IS LESS THAN 65 YEARS OF AGE Professional attendance of more than 15 minutes in duration, being the first in a course of attention, if: (a) the patient is less than 65 years of age; and (b) the patient has not, within the previous 36 months, received a service to which: (i) this item or item 10905, 10907, 10912, 10913, 10914 or 10915 applies; or (ii) old item 10900 applied
10911	01JAN2015	31DEC9999	Y	COMPREHENSIVE INITIAL CONSULTATION - PATIENT IS AT LEAST 65 YEARS OF AGE Professional attendance of more than 15 minutes in duration, being the first in a course of attention, if: (a) the patient is at least 65 years of age; and (b) the patient has not, within the previous 12 months, received a service to which: (i) this item, or item 10905, 10907, 10910, 10912, 10913, 10914 or 10915 applies; or (ii) old item 10900 applied
10912	01NOV1997	31DEC2014	N	OTHER COMPREHENSIVE CONSULTATIONS Professional attendance of more than 15 minutes duration, being the first in a course of attention, where the patient has suffered a significant change of visual function requiring comprehensive reassessment within 24 months of an initial consultation to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10915 at the same practice applies
10912	01JAN2015	31DEC9999	Y	OTHER COMPREHENSIVE CONSULTATIONS Professional attendance of more than 15 minutes in duration, being the first in a course of attention, if the patient has suffered a significant change of visual function requiring comprehensive reassessment: (a) for a patient who is less than 65 years of age-within 36 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10913, 10914 or 10915 at the same practice applies; or (ii) old item 10900 at the same practice applied; or (b) for a patient who is at least 65 years of age-within 12 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10911, 10913, 10914 or 10915 at the same practice applies; or (ii) old item 10900 at the same practice applied
10913	01NOV1997	31DEC2014	N	Professional attendance of more than 15 minutes duration, being the first in a course of attention, where the patient has new signs or symptoms, unrelated to the earlier course of attention, requiring comprehensive reassessment within 24 months of an initial consultation to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10915 at the same practice applies
10913	01JAN2015	31DEC9999	Y	Professional attendance of more than 15 minutes in duration, being the first in a course of attention, if the patient has new signs or symptoms, unrelated to the earlier course of attention, requiring comprehensive reassessment: (a) for a patient who is less than 65 years of age-within 36 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10912, 10914 or 10915 at the same practice applies; or (ii) old item 10900 at the same practice applied; or (b) for a patient who is at least 65 years of age-within 12 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10911, 10912, 10914 or 10915 at the same practice applies; or (ii) old item 10900 at the same practice applied
10914	01NOV1997	31OCT2003	N	Professional attendance of more than 15 minutes duration, being the first in a course of attention, where the patient has a progressive disorder (excluding presbyopia) requiring comprehensive reassessment within 24 months of initial consultation to which item 10900, 10905, 10907, 10912, 10913 or 10914 applied
10914	01NOV2003	31DEC2014	N	Professional attendance of more than 15 minutes duration, being the first in a course of attention, where the patient has a progressive disorder (excluding presbyopia) requiring comprehensive reassessment within 24 months of an initial consultation to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10915 applies
10914	01JAN2015	31DEC9999	Y	Professional attendance of more than 15 minutes in duration, being the first in a course of attention, if the patient has a progressive disorder (excluding presbyopia) requiring comprehensive reassessment: (a) for a patient who is less than 65 years of age-within 36 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10912, 10913 or 10915 applies; or (ii) old item 10900 applied; or (b) for a patient who is at least 65 years of age-within 12 months of an initial consultation to which: (i) this item, or item 10905, 10907, 10910, 10911, 10912, 10913 or 10915 applies; or (ii) old item 10900 applied
10915	01NOV2003	31DEC9999	Y	Professional attendance of more than 15 minutes duration, being the first in a course of attention involving the examination of the eyes, with the instillation of a mydriatic, of a patient with diabetes mellitus requiring comprehensive reassessment.
10916	01NOV1997	31OCT2003	N	BRIEF INITIAL CONSULTATION Professional attendance, being the first in a course of attention, of not more than 15 minutes duration
10916	01NOV2003	30APR2005	N	BRIEF INITIAL CONSULTATION Professional attendance, being the first in a course of attention, of not more than 15 minutes duration, not to be used in association with item 10940 or 10941
10916	01MAY2005	31OCT2005	N	BRIEF INITIAL CONSULTATION Professional attendance, being the first in a course of attention, of not more than 15 minutes duration, not to be used in association with item 10940, 10941 or 10942
10916	01NOV2005	31DEC9999	Y	BRIEF INITIAL CONSULTATION Professional attendance, being the first in a course of attention, of not more than 15 minutes duration, not being a service associated with a service to which item 10931, 10932, 10933, 10940, 10941, 10942 or 10943 applies
10918	01NOV1997	31OCT2003	N	SUBSEQUENT CONSULTATION Professional attendance being the second or subsequent in a course of attention not related to the prescription and fitting of contact lenses
10918	01NOV2003	31OCT2005	N	SUBSEQUENT CONSULTATION Professional attendance being the second or subsequent in a course of attention not related to the prescription and fitting of contact lenses, not to be used in association with item 10940 or 10941
10918	01NOV2005	31DEC9999	Y	SUBSEQUENT CONSULTATION Professional attendance being the second or subsequent in a course of attention not related to the prescription and fitting of contact lenses, not being a service associated with a service to which item 10940 or 10941 applies
10921	01DEC1991	30JUN1992	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS Note: Benefits may not be claimed where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O8.10 of Notes for Guidance (Section 1) All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is covered by Item 10900 or Item 10901. The Medicare benefit is payable once only in a period of thirty-six months for any of these items, unless the examining optometrist has certified on the patient's account that, in his/her professional opinion the patient had an ocular condition which necessitated a further course of attention being commenced within thirty-six months of the previous initial consultation. - patients with myopia of 4.0 dioptres or greater in one eye
10921	01JUL1992	31OCT1994	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS Note: Benefits may not be claimed under Item 10929 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O8.10 of Notes for Guidance (Section 1) All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is a service to which item 10900, 10902, 10903 or 10904 applies The Medicare benefit is payable once only in a period of 36 months for any of these items, unless the examining optometrist has certified on the patient's account that, in his or her professional opinion the patient had an ocular condition that necessitated a further course of attention being commenced within 36 months of the previous initial consultation - patients with myopia of 4.0 dioptres or greater (spherical equivalent) in 1 eye
10921	01NOV1994	31OCT1997	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS Note: Benefits may not be claimed under Item 10929 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O8.10 of Notes for Guidance (Section 1) All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is a service to which item 10900, 10902, 10903, 10904 or 10906 applies The Medicare benefit is payable once only in a period of 36 months for any of these items, unless the examining optometrist has certified on the patient's account that, in his or her professional opinion the patient had an ocular condition that necessitated a further course of attention being commenced within 36 months of the previous initial consultation - patients with myopia of 4.0 dioptres or greater (spherical equivalent) in 1 eye
10921	01NOV1997	31OCT2003	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS Note: Benefits may not be claimed under Item 10929 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O8.10 of Notes for Guidance (Section 1) All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is a service to which item 10900, 10905, 10907, 10912, 10913, 10914 or 10916 applies - payable only once in a period of 36 months - patients with myopia of 5.0 dioptres or greater (spherical equivalent) in 1 eye
10921	01NOV2003	31DEC2014	N	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS Note: Benefits may not be claimed under Item 10929 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O8 - O8 of explanatory notes to this category. All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is a service to which item 10900, 10905, 10907, 10912, 10913, 10914, 10915 or 10916 applies - payable only once in a period of 36 months - patients with myopia of 5.0 dioptres or greater (spherical equivalent) in 1 eye
10921	01JAN2015	31DEC9999	Y	CONTACT LENSES FOR SPECIFIED CLASSES OF PATIENTS - BULK ITEMS FOR ALL SUBSEQUENT CONSULTATIONS All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with myopia of 5.0 dioptres or greater (spherical equivalent) in one eye
10922	01DEC1991	30JUN1992	N	- patients with manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in one eye
10922	01JUL1992	31OCT2013	N	- patients with manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in 1 eye
10922	01NOV2013	31DEC2014	N	- patients with manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in 1 eye
10922	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with manifest hyperopia of 5.0 dioptres or greater (spherical equivalent) in one eye
10923	01DEC1991	30JUN1992	N	- patients with astigmatism of 3.0 dioptres or greater in one eye
10923	01JUL1992	31DEC2014	N	- patients with astigmatism of 3.0 dioptres or greater in 1 eye
10923	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with astigmatism of 3.0 dioptres or greater in one eye
10924	01DEC1991	30JUN1992	N	- patients with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is less than 6/12 and if that corrected acuity would be improved by an additional one line on the Snellen chart by the use of a contact lens
10924	01JUL1992	31OCT1997	N	- patients with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is less than 6/12 and if that corrected acuity would be improved by an additional 1 line on the Snellen chart by the use of a contact lens
10924	01NOV1997	31DEC2014	N	- patients with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is worse than 0.3 logMAR (6/12) and if that corrected acuity would be improved by an additional 0.1 logMAR by the use of a contact lens
10924	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with irregular astigmatism in either eye, being a condition the existence of which has been confirmed by keratometric observation, if the maximum visual acuity obtainable with spectacle correction is worse than 0.3 logMAR (6/12) and if that corrected acuity would be improved by an additional 0.1 logMAR by the use of a contact lens
10925	01DEC1991	30JUN1992	N	- patients with anisometropia of 3.0 dioptres or greater (difference between spherical equivalents)
10925	01JUL1992	31OCT1997	N	- patients with anisometropia of 3.0 dioptres or greater (difference between spherical equivalents)
10925	01NOV1997	31DEC2014	N	- patients with anisometropia of 3.0 dioptres or greater (difference between spherical equivalents)
10925	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with anisometropia of 3.0 dioptres or greater (difference between spherical equivalents)
10926	01DEC1991	30JUN1992	N	- patients with subnormal corrected visual acuity of not greater than 6/30 in either eye, being patients for whom a contact lens is prescribed as part of a telescopic system
10926	01JUL1992	31OCT1997	N	- patients with subnormal corrected visual acuity of not greater than 6/30 in either eye, being patients for whom a contact lens is prescribed as part of a telescopic system
10926	01NOV1997	31DEC2014	N	- patients with corrected visual acuity of 0.7 logMAR (6/30) or worse in both eyes, being patients for whom a contact lens is prescribed as part of a telescopic system
10926	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients with corrected visual acuity of 0.7 logMAR (6/30) or worse in both eyes, being patients for whom a contact lens is prescribed as part of a telescopic system
10927	01DEC1991	30JUN1992	N	- patients for whom a wholly or segmentally opaque contact lens is prescribed for the alleviation of dazzle, distortion or diplopia caused by: (i) pathological mydriasis; or (ii) aniridia; or (iii) coloboma of the iris; or (iv) pupillary malformation or distortion; or (v) significant ocular deformity or corneal opacity whether congenital, traumatic or surgical in origin
10927	01JUL1992	31OCT1997	N	- patients for whom a wholly or segmentally opaque contact lens is prescribed for the alleviation of dazzle, distortion or diplopia caused by: (i) pathological mydriasis; or (ii) aniridia; or (iii) coloboma of the iris; or (iv) pupillary malformation or distortion; or (v) significant ocular deformity or corneal opacity whether congenital, traumatic or surgical in origin
10927	01NOV1997	31DEC2014	N	- patients for whom a wholly or segmentally opaque contact lens is prescribed for the alleviation of dazzle, distortion or diplopia caused by: (i) pathological mydriasis; or (ii) aniridia; or (iii) coloboma of the iris; or (iv) pupillary malformation or distortion; or (v) significant ocular deformity or corneal opacity whether congenital, traumatic or surgical in origin
10927	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients for whom a wholly or segmentally opaque contact lens is prescribed for the alleviation of dazzle, distortion or diplopia caused by: i. pathological mydriasis; or ii. aniridia; or iii. coloboma of the iris; or iv. pupillary malformation or distortion; or v. significant ocular deformity or corneal opacity -whether congenital, traumatic or surgical in origin
10928	01DEC1991	30JUN1992	N	- patients who, by reason of physical deformity, are unable to wear spectacles
10928	01JUL1992	31OCT1997	N	- patients who, by reason of physical deformity, are unable to wear spectacles
10928	01NOV1997	31DEC2014	N	- patients who, by reason of physical deformity, are unable to wear spectacles
10928	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for -patients who, because of physical deformity, are unable to wear spectacles
10929	01DEC1991	30JUN1992	N	- patients who have a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition covered by Items 10926 - 10928) requiring the use of a contact lens for correction and which condition must be specified on the patient's account
10929	01JUL1992	31OCT1997	N	- patients who have a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition to which item 10926, 10927 or 10928 applies) requiring the use of a contact lens for correction and which condition must be specified on the patient's account
10929	01NOV1997	31DEC2014	N	- patients who have a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition to which item 10926, 10927 or 10928 applies) requiring the use of a contact lens for correction, where the condition is specified on the patient's account
10929	01JAN2015	31DEC9999	Y	All professional attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention for which the first attendance is a service to which: (a) item 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915 or 10916 applies; or (b) old item 10900 applied Payable once in a period of 36 months for - patients who have a medical or optical condition (other than myopia, hyperopia, astigmatism, anisometropia or a condition to which item 10926, 10927 or 10928 applies) requiring the use of a contact lens for correction, if the condition is specified on the patient's account Note: Benefits may not be claimed under Item 10929 where the patient wants the contact lenses for appearance, sporting, work or psychological reasons - see paragraph O6 of explanatory notes to this category.
10930	01NOV1997	31DEC9999	Y	All professional attendances regarded as a single service in a single course of attention involving the prescription and fitting of contact lenses where the patient meets the requirements of an item in the range 10921-10929 and requires a change in contact lens material or basic lens parameters, other than a simple power change, because of a structural or functional change in the eye or an allergic response within 36 months of the fitting of a contact lens covered by item 10921 to 10929
10931	01NOV2005	31DEC9999	Y	DOMICILIARY VISITS An optometric service to which an item in Group A10 of this table (other than this item or item 10916, 10932, 10933, 10940 or 10941) applies (the applicable item) if the service is: a) rendered at a place other than consulting rooms, being at: (i) a patient's home: or (ii) residential aged care facility: or (iii) an institution; and b) performed on one patient at a single location on one occasion, and c) either: (i) bulk-billed in respect of the fees for both: - this item; and - the applicable item; or (ii) not bulk-billed in respect of the fees for both: - this item; and - the applicable item
10932	01NOV2005	31DEC9999	Y	An optometric service to which an item in Group A10 of this table (other than this item or item 10916, 10931, 10933, 10940 or 10941) applies (the applicable item) if the service is: a) rendered at a place other than consulting rooms, being at: (i) a patient's home: or (ii) residential aged care facility: or (iii) an institution; and b) performed on two patients at the same location on one occasion, and c) either: (i) bulk-billed in respect of the fees for both: - this item; and - the applicable item; or (ii) not bulk-billed in respect of the fees for both: - this item; and - the applicable item
10933	01NOV2005	31DEC9999	Y	An optometric service to which an item in Group A10 of this table (other than this item or item 10916, 10931, 10932, 10940 or 10941) applies (the applicable item) if the service is: a) rendered at a place other than consulting rooms, being at: (i) a patient's home: or (ii) residential aged care facility: or (iii) an institution; and b) performed on three patients at the same location on one occasion, and c) either: (i) bulk-billed in respect of the fees for both: - this item; and - the applicable item; or (ii) not bulk-billed in respect of the fees for both: - this item; and - the applicable item
10940	01NOV2003	31OCT2005	N	COMPUTERISED PERIMETRY Full quantitative computerised perimetry (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by an optometrist, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral - to a maximum of 2 examinations (including examinations to which item 10941 applies) in any 12 month period, not being a service associated with a service to which item 10916 or 10918 applies
10940	01NOV2005	31DEC9999	Y	COMPUTERISED PERIMETRY Full quantitative computerised perimetry (automated absolute static threshold), with bilateral assessment and report, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain that: (a) is not a service involving multifocal multi channel objective perimetry; and (b) is performed by an optometrist; not being a service associated with a service to which item 10916, 10918, 10931, 10932 or 10933 applies To a maximum of 2 examinations per patient (including examinations to which item 10941 applies) in any 12 month period.
10941	01NOV2003	31OCT2005	N	Full quantitative computerised perimetry (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by an optometrist, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral - to a maximum of 2 examinations (including examinations to which item 10940 applies) in any 12 month period, not being a service associated with a service to which item 10916 or 10918 applies
10941	01NOV2005	31DEC9999	Y	COMPUTERISED PERIMETRY Full quantitative computerised perimetry (automated absolute static threshold) with unilateral assessment and report, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain that: (a) is not a service involving multifocal multichannel objective perimetry; and (b) is performed by an optometrist; not being a service associated with a service to which item 10916, 10918 10931, 10932 or 10933 applies To a maximum of 2 examinations per patient (including examinations to which item 10940 applies) in any 12 month period.
10942	01MAY2005	31OCT2005	N	LOW VISION ASSESSMENT Testing of residual vision to provide optimum visual performance involving one or more of spectacle correction, determination of contrast sensitivity, determination of glare sensitivity and prescription of magnification aids in a patient who has best corrected visual acuity of 6/15 or N.12 in the better eye, or horizontal visual field of less than 120 degrees and within 10 degrees above and below the horizontal meridian, not to be used in association with items 10916 or 10921 - 10930, payable twice in a 12 month period
10942	01NOV2005	31DEC9999	Y	LOW VISION ASSESSMENT Testing of residual vision to provide optimum visual performance for a patient who has best corrected visual acuity of 6/15 or N.12 or worse in the better eye or a horizontal visual field of less than 120 degrees and within 10 degrees above and below the horizontal midline, involving 1 or more of the following: (a) spectacle correction; (b) determination of contrast sensitivity; (c) determination of glare sensitivity; (d) prescription of magnification aids; not being a service associated with a service to which item 10916, 10921, 10922, 10923, 10924, 10925, 10926, 10927, 10928, 10929 or 10930 applies Not payable more than twice per patient in a 12 month period.
10943	01NOV2005	31DEC9999	Y	CHILDREN'S VISION ASSESSMENT Additional testing to confirm diagnosis of, or establish a treatment regime for, a significant binocular or accommodative dysfunction, in a patient aged 3 to 14 years, including assessment of 1 or more of the following: (a) accommodation; (b) ocular motility; (c) vergences; (d) fusional reserves; (e) cycloplegic refraction; not being a service to which item 10916, 10921, 10922, 10923, 10924, 10925, 10926, 10927, 10928, 10929 or 10930 applies Not to be used for the assessment of learning difficulties or learning disabilities. Not payable more than once per patient in a 12 month period.
10944	01SEP2015	31AUG2017	N	CORNEA, complete removal of embedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare) The item is not to be billed on the same occasion as MBS items 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915, 10916 or 10918. Where the embedded foreign body has not been completely removed, benefits are only payable under item 10916
10944	01SEP2017	31DEC9999	Y	CORNEA, complete removal of embedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare) The item is not to be billed on the same occasion as MBS items 10905, 10907, 10910, 10911, 10912, 10913, 10914, 10915, 10916 or 10918. If the embedded foreign body is not completely removed, this item does not apply but item 10916 may apply.
10945	01SEP2015	31MAR2016	N	A professional attendance of less than 15 minutes (whether or not continuous) by a participating optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient; and (c) either: (i) is located within a telehealth eligible area and, at the time of the attendance, is at least 15 kilometres by road from the specialist mentioned in paragraph (a); or (ii) is a patient of an Aboriginal Medical Service, or an Aboriginal Community Controlled Health Service, for which a direction under subsection 19(2) of the Act applies
10945	01APR2016	31DEC2021	N	A professional attendance of less than 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient; and (c) either: (i) is located within a telehealth eligible area and, at the time of the attendance, is at least 15 kilometres by road from the specialist mentioned in paragraph (a); or (ii) is a patient of an Aboriginal Medical Service, or an Aboriginal Community Controlled Health Service, for which a direction under subsection 19(2) of the Act applies
10945	01JAN2022	31DEC9999	Y	A professional attendance of less than 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient
10946	01SEP2015	31MAR2016	N	A professional attendance of at least 15 minutes (whether or not continuous) by a participating optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient; and (c) either: (i) is located within a telehealth eligible area and, at the time of the attendance, is at least 15 kilometres by road from the specialist mentioned in paragraph (a); or (ii) is a patient of an Aboriginal Medical Service, or an Aboriginal Community Controlled Health Service, for which a direction under subsection 19(2) of the Act applies
10946	01APR2016	31DEC2021	N	A professional attendance of at least 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient; and (c) either: (i) is located within a telehealth eligible area and, at the time of the attendance, is at least 15 kilometres by road from the specialist mentioned in paragraph (a); or (ii) is a patient of an Aboriginal Medical Service, or an Aboriginal Community Controlled Health Service, for which a direction under subsection 19(2) of the Act applies
10946	01JAN2022	29FEB2024	N	A professional attendance of at least 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and (b) is not an admitted patient
10946	01MAR2024	31DEC9999	Y	A professional attendance of at least 15 minutes (whether or not continuous) by an optometrist providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist practising in the speciality of ophthalmology; and (b) is not an admitted patient
10947	01SEP2015	31MAR2016	N	A professional attendance (not being a service to which any other item applies) of less than 15 minutes (whether or not continuous) by a participating optometrist that requires the provision of clinical support to a patient who: a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and b) at the time of the attendance, is located at a residential aged care facility (whether or not at consulting rooms situated within the facility); and c) is a care recipient in the facility; and d) is not a resident of a self-contained unit; for an attendance on one occasion-each patient
10947	01APR2016	31DEC9999	Y	A professional attendance (not being a service to which any other item applies) of less than 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and b) at the time of the attendance, is located at a residential aged care facility (whether or not at consulting rooms situated within the facility); and c) is a care recipient in the facility; and d) is not a resident of a self-contained unit; for an attendance on one occasion-each patient
10948	01SEP2015	31MAR2016	N	A professional attendance (not being a service to which any other item applies) of at least 15 minutes (whether or not continuous) by a participating optometrist that requires the provision of clinical support to a patient who: a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and b) at the time of the attendance, is located at a residential aged care facility (whether or not at consulting rooms situated within the facility); and c) is a care recipient in the facility; and d) is not a resident of a self-contained unit; for an attendance on one occasion-each patient
10948	01APR2016	31DEC9999	Y	A professional attendance (not being a service to which any other item applies) of at least 15 minutes (whether or not continuous) by an attending optometrist that requires the provision of clinical support to a patient who: a) is participating in a video conferencing consultation with a specialist practising in his or her speciality of ophthalmology; and b) at the time of the attendance, is located at a residential aged care facility (whether or not at consulting rooms situated within the facility); and c) is a care recipient in the facility; and d) is not a resident of a self-contained unit; for an attendance on one occasion-each patient
10950	01JUL2004	31OCT2005	N	Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible Aboriginal health worker by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substanially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10950	01NOV2005	31OCT2007	N	ABORIGINAL HEALTH WORKER SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible Aboriginal health worker by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10950	01NOV2007	31OCT2009	N	ABORIGINAL HEALTH WORKER SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible Aboriginal health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10950	01NOV2009	30JUN2012	N	ABORIGINAL HEALTH WORKER SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible Aboriginal health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10950	01JUL2012	30SEP2017	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10950	01OCT2017	09DEC2020	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10950	10DEC2020	29FEB2024	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE Aboriginal or Torres Strait Islander health service provided to a person by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10950	01MAR2024	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a patient by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10951	01NOV2004	31OCT2005	N	Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10951	01NOV2005	31OCT2007	N	DIABETES EDUCATION SERVICE Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has a chronic and complex condition being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10951	01NOV2007	31OCT2009	N	DIABETES EDUCATION SERVICE Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10951	01NOV2009	30SEP2017	N	DIABETES EDUCATION SERVICE Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10951	01OCT2017	09DEC2020	N	DIABETES EDUCATION SERVICE Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10951	10DEC2020	29FEB2024	N	DIABETES EDUCATION SERVICE Diabetes education health service provided to a person by an eligible diabetes educator if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10951	01MAR2024	31DEC9999	Y	Diabetes education health service provided to a patient by an eligible diabetes educator if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10952	01JUL2004	31OCT2005	N	Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10952	01NOV2005	31OCT2007	N	AUDIOLGY Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefitin respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10952	01NOV2007	31OCT2009	N	AUDIOLOGY Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10952	01NOV2009	30SEP2017	N	AUDIOLOGY Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10952	01OCT2017	09DEC2020	N	AUDIOLOGY Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared can plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10952	10DEC2020	29FEB2024	N	AUDIOLOGY Audiology health service provided to a person by an eligible audiologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared can plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10952	01MAR2024	31DEC9999	Y	Audiology health service provided to a patient by an eligible audiologist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10953	01JAN2006	31OCT2007	N	EXERCISE PHYSIOLOGY Exercise physiology service provided to a person by an eligible exercise physiologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10953	01NOV2007	31OCT2009	N	EXERCISE PHYSIOLOGY Exercise physiology service provided to a person by an eligible exercise physiologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10953	01NOV2009	30SEP2017	N	EXERCISE PHYSIOLOGY Exercise physiology service provided to a person by an eligible exercise physiologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10953	01OCT2017	09DEC2020	N	EXERCISE PHYSIOLOGY Exercise physiology service provided to a person by an eligible exercise physiologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10953	10DEC2020	29FEB2024	N	EXERCISE PHYSIOLOGY Exercise physiology service provided to a person by an eligible exercise physiologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10953	01MAR2024	31DEC9999	Y	Exercise physiology health service provided to a patient by an eligible exercise physiologist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or items 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10954	01JUL2004	31OCT2005	N	Dietetics health service provided to a person by an eligible dietitian if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible dietitian by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10954	01NOV2005	31OCT2007	N	DIETETICS SERVICES Dietetics health service provided to a person by an eligible dietitian if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complexcondition; and (c) the person is referred to the eligible dietitian by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in respect of a service for which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10954	01NOV2007	31OCT2009	N	DIETETICS SERVICES Dietetics health service provided to a person by an eligible dietitian if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible dietitian by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10954	01NOV2009	30SEP2017	N	DIETETICS SERVICES Dietetics health service provided to a person by an eligible dietician if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible dietician by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietician gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10954	01OCT2017	09DEC2020	N	DIETETICS SERVICES Dietetics health service provided to a person by an eligible dietician if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible dietician by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietician gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10954	10DEC2020	29FEB2024	N	DIETETICS SERVICES Dietetics health service provided to a person by an eligible dietician if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible dietician by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible dietician gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10954	01MAR2024	31DEC9999	Y	Dietetics health service provided to a patient by an eligible dietitian if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10955	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which another item in this Group applies)
10956	01JUL2004	31OCT2005	N	Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10956	01NOV2005	31OCT2007	N	MENTAL HEALTH SERVICE Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10956	01NOV2007	31OCT2009	N	MENTAL HEALTH SERVICE Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10956	01NOV2009	30SEP2017	N	MENTAL HEALTH SERVICE Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10956	01OCT2017	09DEC2020	N	MENTAL HEALTH SERVICE Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10956	10DEC2020	29FEB2024	N	MENTAL HEALTH SERVICE Mental health service provided to a person by an eligible mental health worker if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10956	01MAR2024	31DEC9999	Y	Mental health service provided to a patient by an eligible mental health worker if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10957	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which another item in this Group applies)
10958	01JUL2004	31OCT2005	N	Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10958	01NOV2005	31OCT2007	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10958	01NOV2007	31OCT2009	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10958	01NOV2009	30SEP2017	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10958	01OCT2017	09DEC2020	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10958	10DEC2020	29FEB2024	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a person by an eligible occupational therapist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10958	01MAR2024	31DEC9999	Y	Occupational therapy health service provided to a patient by an eligible occupational therapist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10959	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; if the conference lasts for at least 40 minutes (other than a service associated with a service to which another item in this Group applies)
10960	01JUL2004	31OCT2005	N	Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10960	01NOV2005	31OCT2007	N	PHYSIOTHERAPY Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10960	01NOV2007	31OCT2009	N	PHYSIOTHERAPY Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10960	01NOV2009	30SEP2017	N	PHYSIOTHERAPY Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10960	01OCT2017	09DEC2020	N	PHYSIOTHERAPY Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10960	10DEC2020	29FEB2024	N	PHYSIOTHERAPY Physiotherapy health service provided to a person by an eligible physiotherapist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10960	01MAR2024	31DEC9999	Y	Physiotherapy health service provided to a patient by an eligible physiotherapist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10962	01JUL2004	31OCT2005	N	Chiropody health service provided to a person by an eligible chiropodist, or podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible chiropidist or eligible podiatrist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropodist or eligible podiatrist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10962	01NOV2005	31OCT2007	N	CHIROPODY OR PODIATRY Chiropody health service provided to a person by an eligible chiropodist, or podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible chiropodist or eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropodist or eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10962	01NOV2007	31OCT2009	N	PODIATRY Podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10962	01NOV2009	30SEP2017	N	PODIATRY Podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10962	01OCT2017	09DEC2020	N	PODIATRY Podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10962	10DEC2020	29FEB2024	N	PODIATRY Podiatry health service provided to a person by an eligible podiatrist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10962	01MAR2024	31DEC9999	Y	Podiatry health service provided to a patient by an eligible podiatrist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10964	01JUL2004	31OCT2005	N	Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10964	01NOV2005	31OCT2007	N	CHIROPRACTIC SERVICE Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital (or day-hospital facility); and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10964	01NOV2007	31OCT2009	N	CHIROPRACTIC SERVICE Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10964	01NOV2009	30SEP2017	N	CHIROPRACTIC SERVICE Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10964	01OCT2017	09DEC2020	N	CHIROPRACTIC SERVICE Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10964	10DEC2020	29FEB2024	N	CHIROPRACTIC SERVICE Chiropractic health service provided to a person by an eligible chiropractor if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10964	01MAR2024	31DEC9999	Y	Chiropractic health service provided to a patient by an eligible chiropractor if: (a) the service is provided to a patient who has: (i) a chronic condition; and(ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10966	01JUL2004	31OCT2005	N	Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10966	01NOV2005	31OCT2007	N	OSTEOPATHY Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10966	01NOV2007	31OCT2009	N	OSTEOPATHY Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10966	01NOV2009	30SEP2017	N	OSTEOPATHY Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10966	01OCT2017	09DEC2020	N	OSTEOPATHY Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10966	10DEC2020	29FEB2024	N	OSTEOPATHY Osteopathy health service provided to a person by an eligible osteopath if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10966	01MAR2024	31DEC9999	Y	Osteopathy health service provided to a patient by an eligible osteopath if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10968	01JUL2004	31OCT2005	N	Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10968	01NOV2005	31OCT2007	N	PSYCHOLOGY Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10968	01NOV2007	31OCT2009	N	PSYCHOLOGY Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10968	01NOV2009	30SEP2017	N	PSYCHOLOGY Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10968	01OCT2017	09DEC2020	N	PSYCHOLOGY Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10968	10DEC2020	29FEB2024	N	PSYCHOLOGY Psychology health service provided to a person by an eligible psychologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10968	01MAR2024	31DEC9999	Y	Psychology health service provided to a patient by an eligible psychologist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10970	01JUL2004	31OCT2005	N	Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form issued by the Commission; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a 12 month period
10970	01NOV2005	31OCT2007	N	SPEECH PATHOLOGY Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10970	01NOV2007	31OCT2009	N	SPEECH PATHOLOGY Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 5 services (including any services to which items 10950 to 10970 apply) in a calendar year
10970	01NOV2009	30SEP2017	N	SPEECH PATHOLOGY Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has a chronic condition and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements or multidisciplinary care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10970	01OCT2017	09DEC2020	N	SPEECH PATHOLOGY Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970 apply) in a calendar year
10970	10DEC2020	29FEB2024	N	SPEECH PATHOLOGY Speech pathology health service provided to a person by an eligible speech pathologist if: (a) the service is provided to a person who has: a chronic condition; and complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the person's medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the person's Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 20 minutes duration; and (g) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters; and (h) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of five services (including any services to which items 10950 to 10970, 93000, 93013, 93501 to 93513 and 93524 to 93538 apply) in a calendar year
10970	01MAR2024	31DEC9999	Y	Speech pathology health service provided to a patient by an eligible speech pathologist if: (a) the service is provided to a patient who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the service is of at least 20 minutes duration; to a maximum of 5 services (including any services to which this item or any other item in this Subgroup or item 93000 or 93013 in the Telehealth and Telephone Determination applies) in a calendar year
10975	01JUL2004	31OCT2005	N	Dental assessment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form issued by the Commission;and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) after the assessment, the eligible dental practitioner gives a written report to the referring medical practitioner; and (f) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10976 or 10977 applies) in a 12 month period
10975	01NOV2005	31OCT2007	N	Dental assessment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital or day-hospital facility; and (e) after the assessment, the eligible dental practitioner gives a written report to the referring medical practitioner; and (f) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10976 or 10977 applies) in a calendar year
10975	01NOV2007	31DEC9999	Y	Dental assessment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic condition being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) after the assessment, the eligible dental practitioner gives a written report to the referring medical practitioner; and (f) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10976 or 10977 applies) in a calendar year
10976	01JUL2004	31OCT2005	N	Dental treatment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person; and (d) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form issued by the Commission; and (e) the person is not an admitted patient of a hospital or day-hospital facility; and (f) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10977 applies) in a 12 month period
10976	01NOV2005	31OCT2007	N	Dental treatment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person; and (d) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (e) the person is not an admitted patient of a hospital or day-hospital facility; and (f) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10977 applies) in a calendar year
10976	01NOV2007	31DEC9999	Y	Dental treatment provided to a person by an eligible dental practitioner if: (a) the service is provided to a person whose dental condition is exacerbating a chronic condition being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person; and (d) the person is referred to the eligible dental practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (e) the person is not an admitted patient of a hospital; and (f) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10977 applies) in a calendar year
10977	01JUL2004	31OCT2005	N	Dental service provided to a person by an eligible dental practitioner or an eligible dental specialist (the providing dentist) if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC multidisciplinary care plan; and (b) the service is recommended in the person's EPC multidisciplinary care plan as part of the management of the person's chronic and complex condition; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person by another eligible dental practitioner; and (d) the person is referred to the providing dentist by the eligible dental practitioner who provided the service described in item 10975 using a referral form issued by the Commission; and (e) the person is not an admitted patient of a hospital or day-hospital facility; and (f) after the service, the providing dentist gives a written report to the referring eligible dental practitioner and the medical practitioner mentioned in paragraph (a); and (g) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10976 applies) in a 12 month period
10977	01NOV2005	31OCT2007	N	Dental service provided to a person by an eligible dental practitioner or an eligible dental specialist (the providing dentist) if: (a) the service is provided to a person whose dental condition is exacerbating a chronic and complex condition that is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic and complex condition; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person by another eligible dental practitioner; and (d) the person is referred to the providing dentist by the eligible dental practitioner who provided the service described in item 10975 using a referral form that has been issued by the Department (of Health and Ageing) or a referral form that substantially complies with the form issued by the Department; and (e) the person is not an admitted patient of a hospital or day-hospital facility; and (f) after the service, the providing dentist gives a written report to the referring eligible dental practitioner and the medical practitioner mentioned in paragraph (a); and (g) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10976 applies) in a calendar year
10977	01NOV2007	31DEC9999	Y	Dental service provided to a person by an eligible dental practitioner or an eligible dental specialist (the providing dentist) if: (a) the service is provided to a person whose dental condition is exacerbating a chronic condition being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under an EPC plan; and (b) the service is recommended in the person's EPC plan as part of the management of the person's chronic condition and complex care needs; and (c) the service is associated with a service of the kind described in item 10975 previously provided to the person by another eligible dental practitioner; and (d) the person is referred to the providing dentist by the eligible dental practitioner who provided the service described in item 10975 using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (e) the person is not an admitted patient of a hospital; and (f) after the service, the providing dentist gives a written report to the referring eligible dental practitioner and the medical practitioner mentioned in paragraph (a); and (g) for a service for which a private health insurance benefit is payable - the person who incurred the medical expenses for the service has elected to claim the Medicare benefit for the service, and not the private health insurance benefit; - to a maximum of 3 services (including any services to which this item or item 10975 or 10976 applies) in a calendar year
10981	20APR2020	31DEC9999	Y	A medical service to which an item of the general medical services table (other than this item, item 10982 or item 10990, 10991 or 10992 of the general medical services table) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is a patient at risk of COVID-19 virus; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in the general medical services table applying to the service (e) the service is not provided at, or from, a practice location in an eligible area.
10982	20APR2020	31DEC9999	Y	A medical service to which an item of the general medical services table (other than this item, item 10981 or item 10990, 10991 or 10992 of the general medical services table) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is a patient at risk of COVID-19 virus; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in the general medical services table applying to the service; and (e) the service is provided at, or from, a practice location in an eligible area.
10983	01JUL2011	30JUN2012	N	Service by a practice nurse or Aboriginal health worker provided on behalf of, and under the supervision of, a medical practitioner that requires the provision of clinical support to a patient who is: a) located at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or b) located outside an inner metropolitan area, not being an admitted patient; and who is participating in a video consultation with a specialist or consultant physician.
10983	01JUL2012	31OCT2012	N	Attendance by a practice nurse, an Aboriginal health worker or an Aboriginal and Torres Strait Islander health practitioner on behalf of, and under the supervision of, a medical practitioner, to provide clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (i) is a patient of: (A) an Aboriginal Medical Service; or an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
10983	01NOV2012	31DEC2021	N	Attendance by a practice nurse, an Aboriginal health worker or an Aboriginal and Torres Strait Islander health practitioner on behalf of, and under the supervision of, a medical practitioner, to provide clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
10983	01JAN2022	31DEC9999	Y	Attendance by a practice nurse, an Aboriginal health worker or an Aboriginal and Torres Strait Islander health practitioner on behalf of, and under the supervision of, a medical practitioner, to provide clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient
10984	01JUL2011	30JUN2012	N	Service by a practice nurse or Aboriginal health worker provided on behalf of, and under the supervision of, a medical practitioner that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a self-contained unit); or b) at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician.
10984	01JUL2012	31DEC9999	Y	Service by a practice nurse or Aboriginal health worker or Aboriginal and Torres Strait Islander health practitioner provided on behalf of, and under the supervision of, a medical practitioner that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a self-contained unit); or b) at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician.
10985	01MAY2010	31DEC9999	Y	A medical service to which item 597, 598, 599 or 600 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas; and: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10986	01MAY2010	30JUN2012	N	Service provided by a practice nurse or registered Aboriginal health worker being the provision of a health assessment for a patient who is receiving or has received their four year old immunisation, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b) the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 701, 703, 705, 707. Benefits are payable on one occasion only for each eligible patient
10986	01JUL2012	31DEC9999	Y	Service provided by a practice nurse or Aboriginal and Torres Strait Islander health practitioner being the provision of a health assessment for a patient who is receiving or has received their four year old immunisation, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b) the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 701, 703, 705, 707. Benefits are payable on one occasion only for each eligible patient
10987	01NOV2008	31OCT2009	N	Follow up service provided by a practice nurse or registered Aboriginal health worker, on behalf of a GP, for an Indigenous person who has received a health check if: a) The service is provided on behalf of and under the supervision of a medical practitioner; and b) the person is not an admitted patient of a hospital; and c) the service is consistent with the needs identified through the health check; - to a maximum of 5 services per patient in a calendar year
10987	01NOV2009	30JUN2012	N	Follow up service provided by a practice nurse or registered Aboriginal health worker, on behalf of a medical practitioner, for an Indigenous person who has received a health assessment if: a) The service is provided on behalf of and under the supervision of a medical practitioner; and b) the person is not an admitted patient of a hospital; and c) the service is consistent with the needs identified through the health assessment; - to a maximum of 10 services per patient in a calendar year
10987	01JUL2012	31DEC9999	Y	Follow up service provided by a practice nurse or Aboriginal and Torres Strait Islander health practitioner, on behalf of a medical practitioner, for an Indigenous person who has received a health assessment if: a) The service is provided on behalf of and under the supervision of a medical practitioner; and b) the person is not an admitted patient of a hospital; and c) the service is consistent with the needs identified through the health assessment; - to a maximum of 10 services per patient in a calendar year
10988	01MAY2006	31OCT2007	N	Immunisation provided to a person by a registered Aboriginal Health Worker if: (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility
10988	01NOV2007	30JUN2012	N	Immunisation provided to a person by a registered Aboriginal Health Worker if: (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital.
10988	01JUL2012	31DEC9999	Y	Immunisation provided to a person by an Aboriginal and Torres Strait Islander health practitioner if: (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital.
10989	01MAY2006	31OCT2007	N	Treatment of a person's wound (other than normal aftercare) provided by a registered Aboriginal Health Worker if: (a) the treatment is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility
10989	01NOV2007	30JUN2012	N	Treatment of a person's wound (other than normal aftercare) provided by a registered Aboriginal Health Worker if: (a) the treatment is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital.
10989	01JUL2012	31DEC9999	Y	Treatment of a person's wound (other than normal aftercare) provided by an Aboriginal and Torres Strait Islander health practitioner if: (a) the treatment is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital.
10990	01FEB2004	31OCT2007	N	A medical service to which an item in this table (other than this item or item 10991) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital or day-hospital facility; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
10990	01NOV2007	30JUN2021	N	A medical service to which an item in this table (other than this item or item 10991) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
10990	01JUL2021	31DEC2021	N	A medical service to which an item in this Schedule (other than this item or item 10991 or 10992) applies if: (a) the service is an unreferred service; and (b) the service is provided to a patient who is under the age of 16 or is a concessional beneficiary; and (c) the patient is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service
10990	01JAN2022	31OCT2023	N	A medical service to which an item in this Schedule (other than this item or item 10991, 10992, 75855, 75856, 75857 or 75858) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service
10990	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service;other than a service associated with a service:(e) to which another item in this Group applies; or(f) that is a general practice support service; or(g) that is a MyMedicare service
10991	01MAY2004	31AUG2004	N	A medical service to which an item in this table (other than this item OR ITEM 10990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital or day-hospital facility: and (d) the service is bulk-billed in respect of the fees for: (i) this item: and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania
10991	01SEP2004	31OCT2007	N	A medical service to which an item in this table (other than this item or item 10990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital or day-hospital facility; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service: and (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M)Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC)
10991	01NOV2007	31DEC2019	N	A medical service to which an item in this table (other than this item or item 10990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item: and (ii) the other item in this table applying to the service (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) a geographical area included in any of the following ssd spatial units: (a) Beaudesert Shire Part a (b) Belconnen (c) Darwin City (d) Eastern Outer Melbourne (e) East Metropolitan, Perth (f) Frankston City (g) Gosford-Wyong (h) Greater Geelong City Part a (i) Gungahlin-Hall (j) Ipswich City (part in bsd) (k) Litchfield Shire (l) Melton-Wyndham (m) Mornington Peninsula Shire (n)Newcastle (o) North Canberra (p) Palmerston-East Arm (q) Pine Rivers Shire (r) Queanbeyan (s) South Canberra (t) South Eastern Outer Melbourne (u) Southern Adelaide (v) South West Metropolitan, Perth (w) Thuringowa City Part a (x) Townsville City Part a (y) Tuggeranong (z) Weston Creek-Stromlo (za) Woden Valley (zb)Yarra Ranges Shire Part a; or (iv) the geographical area included in the sla spatial unit of Palm Island (ac)
10991	01JAN2020	29MAR2020	N	A medical service to which an item in this table (other than this item or item 10990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii) the other item in this table applying to the service: and (e) the service is provided at, or from, a practice location in a regional, rural or remote area.
10991	30MAR2020	30JUN2021	N	A medical service to which an item in this table (other than this item or item 10990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in a regional, rural or remote area.
10991	01JUL2021	31DEC2021	N	A medical service to which an item in this Schedule (other than this item or item 10990 or 10992) applies if: (a) the service is an unreferred service; and (b) the service is provided to a patient who is under the age of 16 or is a concessional beneficiary; and (c) the patient is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
10991	01JAN2022	31OCT2023	N	A medical service to which an item in this Schedule (other than this item or item 10990, 10992, 75855, 75856, 75857 or 75858) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 2 area
10991	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service; and(e) the service is provided at, or from, a practice location in a Modified Monash 2 area;other than a service associated with a service:(f) to which another item in this Group applies; or(g) that is a general practice support service; or(h) that is a MyMedicare service
10992	01JAN2005	31OCT2007	N	A medical service to which item 1, 97, 601, 697, 5003, 5007, 5010, 5023, 5026, 5028, 5043, 5046, 5049, 5063, 5064, 5067, 5220, 5223, 5227, 5228, 5240, 5243, 5247, 5248, 5260, 5263, 5265 or 5267 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital or approved day-hospital facility; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01NOV2007	31DEC2008	N	A medical service to which item 1, 97, 601, 697, 5003, 5007, 5010, 5023, 5026, 5028, 5043, 5046, 5049, 5063, 5064, 5067, 5220, 5223, 5227, 5228, 5240, 5243, 5247, 5248, 5260, 5263, 5265 or 5267 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01JAN2009	30JUN2010	N	A medical service to which item 1, 97, 601, 603, 696, 697, 5003, 5007, 5010, 5023, 5026, 5028, 5043, 5046, 5049, 5063, 5064, 5067, 5220, 5223, 5227, 5228, 5240, 5243, 5247, 5248, 5260, 5263, 5265 or 5267 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01JUL2010	28FEB2018	N	A medical service to which item 597. 598, 599, 600, 5003, 5010, 5023, 5028, 5043, 5049, 5063, 5067, 5220, 5223, 5227, 5228, 5260, 5263, 5265 or 5267 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01MAR2018	31DEC2019	N	A medical service to which item 585, 588, 591, 594, 599, 600, 761, 763, 766, 769, 772, 776, 788, 789, 5003, 5010, 5023, 5028, 5043, 5049, 5063, 5067, 5220, 5223, 5227, 5228, 5260, 5263, 5265 or 5267 applies if:(a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following eligible areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an eligible area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01JAN2020	30JUN2021	N	A medical service to which item 585, 588, 591, 594, 599, 600, 761, 763, 766, 769, 772, 776, 788, 789, 5003, 5010, 5023, 5028, 5043, 5049, 5063, 5067, 5220, 5223, 5227, 5228, 5260, 5263, 5265 or 5267 applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is not provided in consulting rooms; and (e) the service is provided in one of the following designated areas: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC) (f) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in a designated area; and (g) the service is bulk billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service.
10992	01JUL2021	31DEC2021	N	A medical service to which: (a) item 585, 588, 591, 594, 599, 600, 5003, 5010, 5023, 5028, 5043, 5049, 5063, 5067, 5220, 5223, 5227, 5228, 5260, 5263, 5265 or 5267 applies; or (b) item 761, 763, 766, 769, 772, 776, 788 or 789 of a Schedule (within the meaning of the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018) applies; if: (c) the service is an unreferred service; and (d) the service is provided to a patient who is under the age of 16 or is a concessional beneficiary; and (e) the patient is not an admitted patient of a hospital; and (f) the service is not provided in consulting rooms; and (g) the service is provided in a designated area; and (h) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in a designated area; and (i) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item mentioned in paragraph (a) or (b) applying to the service
10992	01JAN2022	31OCT2023	N	A medical service to which: (a) item 585, 588, 591, 594, 599, 600, 5003, 5010, 5023, 5028, 5043, 5049, 5063, 5067, 5220, 5223, 5227, 5228, 5260, 5263, 5265 or 5267 applies; or (b) item 761, 763, 766, 769, 772, 776, 788 or 789 of a Schedule (within the meaning of the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018) applies; if: (c) the service is an unreferred service; and (d) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (e) the person is not an admitted patient of a hospital; and (f) the service is not provided in consulting rooms; and (g) the service is provided in any of the following areas: (i) a Modified Monash 2 area; (ii) a Modified Monash 3 area; (iii) a Modified Monash 4 area; (iv) a Modified Monash 5 area; (v) a Modified Monash 6 area; (vi) a Modified Monash 7 area; and (h) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an area mentioned in paragraph (g); and (i) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item mentioned in paragraph (a) or (b) applying to the service
10992	01NOV2023	31DEC9999	Y	A medical service to which: (a) item 585, 588, 591, 594, 599, 600, 5003, 5010, 5220 or 5260 applies; or(b) item 761 or 772 applies (see the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018); if: (c) the service is an unreferred service; and (d) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (e) the person is not an admitted patient of a hospital; and (f) the service is not provided in consulting rooms; and (g) the service is provided in any of the following areas: (i) a Modified Monash 2 area; (ii) a Modified Monash 3 area; (iii) a Modified Monash 4 area; (iv) a Modified Monash 5 area; (v) a Modified Monash 6 area; (vi) a Modified Monash 7 area; and (h) the service is provided by, or on behalf of, a medical practitioner whose practice location is not in an area mentioned in paragraph (g); and (i) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item mentioned in paragraph (a) or (b) applying to the service
10993	01FEB2004	30APR2006	N	Immunisation provided to a person by a practice nurse: if (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner: and (b) the immunisation is provided: (i) in the consulting rooms of a general practice; or (ii) in a residential aged facility: or (iii) during a home visit to the person: or (iv) in an institution (other than a hospital or day-hospital facility)
10993	01MAY2006	31OCT2007	N	Immunisation provided to a person by a practice nurse if: (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner: and (b) the person is not an admitted patient of a hospital or approved day hospital facility
10993	01NOV2007	31DEC9999	Y	Immunisation provided to a person by a practice nurse if: (a) the immunisation is provided on behalf of, and under the supervision of, a medical practitioner: and (b) the person is not an admitted patient of a hospital.
10994	01NOV2006	31OCT2007	N	Services provided by a practice nurse, being the taking of a cervical smear and preventive checks, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility. This item cannot be claimed with items 2497-2509, 2598-2616, 10995, 10998 or 10999.
10994	01NOV2007	31DEC9999	Y	Services provided by a practice nurse, being the taking of a cervical smear and preventive checks, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital. This item cannot be claimed with items 2497-2509, 2598-2616, 10995, 10998 or 10999.
10995	01NOV2006	31OCT2007	N	Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years, and preventive checks if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility. This item cannot be claimed with items 2497-2509, 2598-2616, 10994, 10998 or 10999.
10995	01NOV2007	31DEC9999	Y	Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years, and preventive checks if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital. This item cannot be claimed with items 2497-2509, 2598-2616, 10994, 10998 or 10999.
10996	01FEB2004	31OCT2007	N	Treatment of a person's wound (other than normal aftercare) provided by a practice nurse if: (a) the treatment is provided on behalf of, and under the supervision of, a medical practitioner: and (b) the person is not an admitted patient of a hospital or day-hospital facility
10996	01NOV2007	31DEC9999	Y	Treatment of a person's wound (other than normal aftercare) provided by a practice nurse if: (a) the treatment is provided on behalf of, and under the supervision of, a medical practitioner: and (b) the person is not an admitted patient of a hospital.
10997	01JUL2007	30JUN2012	N	Service provided to a person with a chronic disease by a practice nurse or registered Aboriginal Health Worker if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the person is not an admitted patient of a hospital; and (c) the person has a GP Management Plan, Team Care Arrangements or Multidisciplinary Care Plan in place; and (d) the service is consistent with the GP Management Plan, Team Care Arrangements or Multidisciplinary Care Plan to a maximum of 5 services per patient in a calendar year
10997	01JUL2012	31DEC9999	Y	Service provided to a person with a chronic disease by a practice nurse or an Aboriginal and Torres Strait Islander health practitioner if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the person is not an admitted patient of a hospital; and (c) the person has a GP Management Plan, Team Care Arrangements or Multidisciplinary Care Plan in place; and (d) the service is consistent with the GP Management Plan, Team Care Arrangements or Multidisciplinary Care Plan to a maximum of 5 services per patient in a calendar year
10998	01JAN2005	31OCT2006	N	Service provided by a practice nurse, being the taking of a cervical smear from a person, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the person is not an admitted patient of a hospital or approved day hospital facility.
10998	01NOV2006	31OCT2007	N	Service provided by a practice nurse, being the taking of a cervical smear from a person, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility. This item cannot be claimed with items 2497-2509, 2598-2616, 10994, 10995 or 10999.
10998	01NOV2007	31DEC9999	Y	Service provided by a practice nurse, being the taking of a cervical smear from a person, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital. This item cannot be claimed with items 2497-2509, 2598-2616, 10994, 10995 or 10999.
10999	01MAY2005	31OCT2006	N	Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the person is not an admitted patient of a hospital or approved day hospital facility. this item cannot be claimed with items 2497-2509 and 2598-2616
10999	01NOV2006	31OCT2007	N	Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital or approved day hospital facility. This item cannot be claimed with items 2497-2509 and 2598-2616, 10994, 10995 or 10998.
10999	01NOV2007	31DEC9999	Y	Service provided by a practice nurse, being the taking of a cervical smear from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the person is not an admitted patient of a hospital. This item cannot be claimed with items 2497-2509 and 2598-2616, 10994, 10995 or 10998.
11000	01DEC1991	30JUN1995	N	ELECTROENCEPHALOGRAPHY, not being a service associated with a service to which item 11003, 11006 or 11009 applies
11000	01JUL1995	31OCT2020	N	ELECTROENCEPHALOGRAPHY, not being a service: (a) associated with a service to which item 11003, 11006 or 11009 applies; or (b) involving quantitative topographic mapping using neurometrics or similar devices
11000	01NOV2020	31DEC9999	Y	ELECTROENCEPHALOGRAPHY, not being a service: (a) associated with a service to which item 11003 or 11009 applies; or (b) involving quantitative topographic mapping using neurometrics or similar devices
11003	01DEC1991	30JUN1995	N	ELECTROENCEPHALOGRAPHY, prolonged recording of at least 3 hours duration, not being a service associated with a service to which item 11000, 11006 or 11009 applies
11003	01JUL1995	31OCT2003	N	ELECTROENCEPHALOGRAPHY, prolonged recording of at least 3 hours duration, not being a service: (a) associated with a service to which item 11000, 11006 or 11009 applies; or (b) involving quantitative topographic mapping using neurometrics or similar devices
11003	01NOV2003	31OCT2020	N	ELECTROENCEPHALOGRAPHY, prolonged recording of at least 3 hours duration, not being a service: (a) associated with a service to which item 11000, 11004, 11005, 11006 or 11009 applies; and (b) involving quantitative topographic mapping using neurometrics or similar devices
11003	01NOV2020	31DEC9999	Y	Electroencephalography, prolonged recording lasting at least 3 hours, that requires multi-channel recording using: (a) for a service not associated with a service to which an item in Group T8 applies-standard 10-20 electrode placement; or (b) for a service associated with a service to which an item in Group T8 applies-either standard 10-20 electrode placement or a different electrode placement and number of recorded channels; other than a service: (c) associated with a service to which item 11000, 11004 or 11005 applies; or (d) involving quantitative topographic mapping using neurometrics or similar devices.
11004	01NOV2003	31OCT2020	N	ELECTROENCEPHALOGRAPHY, ambulatory or video, prolonged recording of at least 3 hours duration up to 24 hours duration, recording on the first day, not being a service: (a) associated with a service to which item 11000, 11003, 11005, 11006 or 11009 applies; and (b) involving quantitative topographic mapping using neurometrics or similar devices
11004	01NOV2020	31DEC9999	Y	Electroencephalography, ambulatory or video, prolonged recording lasting at least 3 hours and up to 24 hours, that requires multi channel recording using standard 10-20 electrode placement, first day, other than a service:(a) associated with a service to which item 11000, 11003 or 11005 applies; or(b) involving quantitative topographic mapping using neurometrics or similar devices.
11005	01NOV2003	31OCT2020	N	ELECTROENCEPHALOGRAPHY, ambulatory or video, prolonged recording of at least 3 hours duration up to 24 hours duration, recording on each day subsequent to the first day, not being a service: (a) associated with a service to which item 11000, 11003, 11004, 11006 or 11009 applies; or (b) involving quantitative topographic mapping using neurometrics or similar devices
11005	01NOV2020	31DEC9999	Y	Electroencephalography, ambulatory or video, prolonged recording lasting at least 3 hours and up to 24 hours, that requires multi channel recording using standard 10-20 electrode placement, each day after the first day, other than a service:(a) associated with a service to which item 11000, 11003 or 11004 applies; or(b) involving quantitative topographic mapping using neurometrics or similar devices.
11006	01DEC1991	30JUN1995	N	ELECTROENCEPHALOGRAPHY, temporosphenoidal
11006	01JUL1995	31DEC9999	Y	ELECTROENCEPHALOGRAPHY, temporosphenoidal, not being a service involving quantitative topographic mapping using neurometrics or similar devices
11009	01DEC1991	31DEC9999	Y	ELECTROCORTICOGRAPHY
11012	01DEC1991	31DEC9999	Y	NEUROMUSCULAR ELECTRODIAGNOSIS conduction studies on 1 nerve OR ELECTROMYOGRAPHY of 1 or more muscles using concentric needle electrodes OR both these examinations (not being a service associated with a service to which item 11015 or 11018 applies)
11015	01DEC1991	31DEC9999	Y	NEUROMUSCULAR ELECTRODIAGNOSIS conduction studies on 2 or 3 nerves with or without electromyography (not being a service associated with a service to which item 11012 or 11018 applies)
11018	01DEC1991	31DEC9999	Y	NEUROMUSCULAR ELECTRODIAGNOSIS conduction studies on 4 or more nerves with or without electromyography OR recordings from single fibres of nerves and muscles OR both of these examinations (not being a service associated with a service to which item 11012 or 11015 applies)
11021	01DEC1991	31DEC9999	Y	NEUROMUSCULAR ELECTRODIAGNOSIS repetitive stimulation for study of neuromuscular conduction OR electromyography with quantitative computerised analysis OR both of these examinations
11024	01DEC1991	30JUN1995	N	INVESTIGATION OF CENTRAL NERVOUS SYSTEM EVOKED RESPONSES by computerised averaging techniques 1 or 2 studies
11024	01JUL1995	30APR2003	N	CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised averaging techniques, not being a service involving quantitative topographic mapping of event-related potentials - 1 or 2 studies
11024	01MAY2003	31DEC9999	Y	CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised averaging techniques, not being a service involving quantitative topographic mapping of event-related potentials or multifocal multichannel objective perimetry - 1 or 2 studies
11027	01DEC1991	30JUN1995	N	INVESTIGATION OF CENTRAL NERVOUS SYSTEM EVOKED RESPONSES by computerised averaging techniques 3 or more studies
11027	01JUL1995	30APR2003	N	CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised averaging techniques, not being a service involving quantitative topographic mapping of event-related potentials - 3 or more studies
11027	01MAY2003	31DEC9999	Y	CENTRAL NERVOUS SYSTEM EVOKED RESPONSES, INVESTIGATION OF, by computerised averaging techniques, not being a service involving quantitative topographic mapping of event-related potentials or multifocal multichannel objective perimetry - 3 or more studies
11200	01DEC1991	31OCT2012	N	PROVOCATIVE TEST OR TESTS FOR GLAUCOMA, including water drinking
11200	01NOV2012	31DEC9999	Y	PROVOCATIVE TEST OR TESTS FOR OPEN ANGLE GLAUCOMA, including water drinking
11203	01DEC1991	31DEC9999	Y	TONOGRAPHY in the investigation or management of glaucoma, 1 or both eyes using an electrical tonography machine producing a directly recorded tracing
11204	01NOV2001	31OCT2017	N	ELECTRORETINOGRAPHY of one or both eyes by computerised averaging techniques, including 3 or more studies performed according to current professional guidelines or standards
11204	01NOV2017	31DEC9999	Y	ELECTRORETINOGRAPHY of one or both eyes by computerised averaging techniques, including 3 or more studies performed according to current professional guidelines or standards, performed by or on behalf of a specialist or consultant physician in the practice of his or her speciality.
11205	01NOV2001	31OCT2017	N	ELECTROOCULOGRAPHY of one or both eyes performed according to current professional guidelines or standards
11205	01NOV2017	31DEC9999	Y	ELECTROOCULOGRAPHY of one or both eyes performed according to current professional guidelines or standards, performed by or on behalf of a specialist or consultant physician in the practice of his or her speciality.
11206	01DEC1991	31DEC9999	Y	ELECTRORETINOGRAPHY of 1 or both eyes OR ELECTROOCULOGRAPHY of 1 or both eyes
11209	01DEC1991	31DEC9999	Y	ELECTRORETINOGRAPHY of 1 or both eyes AND ELECTROOCULOGRAPHY of 1 or both eyes
11210	01NOV2001	31DEC9999	Y	PATTERN ELECTRORETINOGRAPHY of one or both eyes by computerised averaging techniques, including 3 or more studies performed according to current professional guidelines or standards
11211	01NOV2001	31DEC9999	Y	DARK ADAPTOMETRY of one or both eyes with a quantitative (log cd/m2) estimation of threshold in log lumens at 45 minutes of dark adaptations
11212	01DEC1991	31DEC9999	Y	OPTIC FUNDI, examination of, following intravenous dye injection
11215	01DEC1991	31OCT2016	N	RETINAL PHOTOGRAPHY, multiple exposures of 1 eye with intravenous dye injection
11215	01NOV2016	31DEC9999	Y	RETINAL ANGIOGRAPHY, multiple exposures of 1 eye with intravenous dye injection
11218	01DEC1991	31OCT2016	N	RETINAL PHOTOGRAPHY, multiple exposures of both eyes with intravenous dye injection
11218	01NOV2016	31DEC9999	Y	RETINAL ANGIOGRAPHY, multiple exposures of both eyes with intravenous dye injection
11219	01NOV2016	30NOV2016	N	Optical coherence tomography to determine if the requirements relating to: a) age related macular degeneration for access to initial treatment with ranibizumab or aflibercept, or b) diabetic macular oedema for access to initial treatment with ranibizumab, aflibercept or dexamethasone, or c) central retinal vein occlusion for access to initial treatment with ranibizumab or aflibercept, or d) branch retinal vein occlusion for access to initial treatment with ranibizumab under the pharmaceutical benefits scheme are fulfilled. Maximum of one service in a 12 month period
11219	01DEC2016	31OCT2018	N	OPTICAL COHERENCE TOMOGRAPHY to determine if the requirements relating to: a) age related macular degeneration for access to initial treatment with ranibizumab or aflibercept; or b) diabetic macular oedema for access to initial treatment with ranibizumab, aflibercept or dexamethasone; or c) central or branch retinal vein occlusion for access to initial treatment with ranibizumab or aflibercept; or d) vitreomacular traction for access to initial treatment with ocriplasmin; under the pharmaceutical benefits scheme are fulfilled. Maximum of one service in a 12 month period
11219	01NOV2018	28FEB2021	N	OPTICAL COHERENCE TOMOGRAPHY for diagnosis of ocular conditions for which a medication is listed on the Pharmaceutical Benefits Scheme for intraocular administration Maximum of one service in a 12 month period
11219	01MAR2021	31DEC9999	Y	Optical coherence tomography for diagnosis of an ocular condition for the treatment of which there is a medication that is: (a) listed on the pharmaceutical benefits scheme; and (b) indicated for intraocular administration Applicable only once in any 12 month period
11220	01DEC2016	31DEC9999	Y	OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. Maximum of one service per eye per lifetime.
11221	01DEC1991	30APR2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral - to a maximum of 2 examinations (including examinations to which item 11224 applies) in any 12 month period
11221	01MAY2003	31OCT2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold but not including multifocal multichannel objective perimetry), performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral - to a maximum of 2 examinations (including examinations to which item 11224 applies) in any 12 month period
11221	01NOV2003	31OCT2018	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral - to a maximum of 2 examinations (including examinations to which item 11224 applies) in any 12 month period
11221	01NOV2018	31DEC9999	Y	Full quantitative computerised perimetry (automated absolute static threshold), other than a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, if indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, bilateral-to a maximum of 3 examinations (including examinations to which item 11224 applies) in any 12 month period
11222	19JUN1997	31OCT1997	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, bilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which Item 11221 applies due to presence of 1 of the following conditions:- . established glaucoma (where surgery is being considered or has been performed) where there has been definite progression of damage over a 12 month period; . progressive neurologic disease; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11222	01NOV1997	31OCT2001	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, bilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which Item 11221 applies due to presence of 1 of the following conditions:- . established glaucoma (where surgery is being considered or has been performed) where there has been definite progression of damage over a 12 month period; . progressive neurologic disease; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11222	01NOV2001	30APR2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, bilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which Item 11221 applies due to presence of 1 of the following conditions:- . established glaucoma (where surgery is being considered) where there has been definite progression of damage over a 12 month period; established neurologic disease which may be progressive; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11222	01MAY2003	31OCT2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY (automated absolute static threshold but not including multifocal multichannel objective perimetry), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, bilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which Item 11221 applies due to presence of 1 of the following conditions:- . established glaucoma (where surgery is being considered) where there has been definite progression of damage over a 12 month period; . established neurological disease which may be progressive and where a visual field is necessary for the management of the patient; or . for monitoring ocular disease caused by systemic drug toxicity, where there is also other disease such as glaucoma or neurological disease - each additional examination
11222	01NOV2003	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, bilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which Item 11221 applies due to presence of one of the following conditions:- . established glaucoma (where surgery may be required within a six month period) where there has been definite progression of damage over a 12 month period; . established neurological disease which may be progressive and where a visual field is necessary for the management of the patient; or . monitoring for ocular disease or disease of the visual pathways which may be caused by systemic drug toxicity, where there may also be other disease such as glaucoma or neurological disease - each additional examination
11224	01DEC1991	30APR2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral - to a maximum of 2 examinations (including examinations to which item 11221 applies) in any 12 month period
11224	01MAY2003	31OCT2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold but not including multifocal multichannel objective perimetry), performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral - to a maximum of 2 examinations (including examinations to which item 11221 applies) in any 12 month period
11224	01NOV2003	31OCT2018	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral - to a maximum of 2 examinations (including examinations to which item 11221 applies) in any 12 month period
11224	01NOV2018	31DEC9999	Y	Full quantitative computerised perimetry (automated absolute static threshold), other than a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, if indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, unilateral-to a maximum of 3 examinations (including examinations to which item 11221 applies) in any 12 month period
11225	19JUN1997	31OCT1997	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, unilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which item 11224 applies due to presence of one of the following conditions:- . established glaucoma (where surgery is being considered or has been performed) where there has been definite progression of damage over a 12 month period; . progressive neurologic disease; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11225	01NOV1997	31OCT2001	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, unilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which item 11224 applies due to presence of one of the following conditions:- . established glaucoma (where surgery is being considered or has been performed) where there has been definite progression of damage over a 12 month period; . progressive neurologic disease; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11225	01NOV2001	30APR2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, unilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which item 11224 applies due to presence of one of the following conditions:- . established glaucoma (where surgery is being considered) where there has been definite progression of damage over a 12 month period; . established neurologic disease which may be progressive; or . for the monitoring of systemic drug toxicity, where there is also other disease such as glaucoma or neurologic disease - each additional examination
11225	01MAY2003	31OCT2003	N	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold but not including multifocal multichannel objective perimetry), performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, unilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which item 11224 applies due to presence of one of the following conditions:- . established glaucoma (where surgery is being considered) where there has been definite progression of damage over a 12 month period; . established neurological disease which may be progressive and where a visual field is necessary for the management of the patient; or . for monitoring ocular disease caused by systemic drug toxicity, where there is also other disease such as glaucoma or neurological disease - each additional examination
11225	01NOV2003	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) not being a service involving multifocal multichannel objective perimetry, performed by or on behalf of a specialist in the practice of his or her specialty, with assessment and report, unilateral, where it can be demonstrated that a further examination is indicated in the same 12 month period to which item 11224 applies due to presence of one of the following conditions:- . established glaucoma (where surgery may be required within a 6 month period) where there has been definite progression of damage over a 12 month period; . established neurological disease which may be progressive and where a visual field is necessary for the management of the patient; or . monitoring for ocular disease or disease of the visual pathways which may be caused by systemic drug toxicity, where there may also be other disease such as glaucoma or neurological disease - each additional examination
11227	01DEC1991	31DEC9999	Y	FULL QUANTITATIVE COMPUTERISED PERIMETRY - (automated absolute static threshold) performed by a specialist in the practice of his or her specialty, where indicated by the presence of relevant ocular disease or suspected pathology of the visual pathways or brain with assessment and report, an examination to which item 11221 or 11224 applies, being the third or subsequent examination in a 12 month period
11235	01NOV1996	31DEC9999	Y	EXAMINATION OF THE EYE BY IMPRESSION CYTOLOGY OF CORNEA for the investigation of ocular surface dysplasia, including the collection of cells, processing and all cytological examinations and preparation of report
11237	01NOV2003	31DEC9999	Y	OCULAR CONTENTS, simultaneous ultrasonic echography by both unidimensional and bidimensional techniques, for the diagnosis, monitoring or measurement of choroidal and ciliary body melanomas, retinoblastoma or suspicious naevi or simulating lesions, one eye, not being a service associated with a service to which items in Group I1 of Category 5 apply
11240	01MAR1999	31OCT2001	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, not being a service associated with a service to which items in Group I1 apply
11240	01NOV2001	31OCT2002	N	ORBITAL CONTENTS, ultrasonic echography of, for one eye, not being a service associated with a service to which items in Group I1 apply
11240	01NOV2002	31OCT2003	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for one eye, not being a service associated with a service to which items in Group I1 apply
11240	01NOV2003	31OCT2004	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for the measurement of one eye prior to lens surgery on that eye, not being a service associated with a service to which items in Group I1 apply
11240	01NOV2004	31DEC9999	Y	ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence interferometry of, for the measurement of one eye prior to lens surgery on that eye, not being a service associated with a service to which items in Group I1 of Category 5 apply.
11241	01NOV2001	31OCT2002	N	ORBITAL CONTENTS, ultrasonic echography of, for both eyes, not being a service associated with a service to which items in Group I1 apply
11241	01NOV2002	31OCT2003	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for both eyes, not being a service associated with a service to which items in Group I1 apply
11241	01NOV2003	31OCT2004	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for bilateral eye measurement prior to lens surgery on both eyes, not being a service associated with a service to which items in Group I1 apply
11241	01NOV2004	31DEC9999	Y	ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence interferometry of, for bilateral eye measurement prior to lens surgery on both eyes, not being a service associated with a service to which items in Group I1 apply
11242	01NOV2001	31OCT2002	N	ORBITAL CONTENTS, ultrasonic echography of, for the measurement of an eye previously measured and lens surgery has been performed, and where further lens surgery is contemplated in that eye, not being a service associated with a service to which items in Group I1 apply
11242	01NOV2002	31OCT2004	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for the measurement of an eye previously measured and on which lens surgery has been performed, and where further lens surgery is contemplated in that eye, not being a service associated with a service to which items in Group I1 apply
11242	01NOV2004	31DEC9999	Y	ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence interferometry of, for the measurement of an eye previously measured and on which lens surgery has been performed, and where further lens surgery is contemplated in that eye, not being a service associated with a service to which items in Group I1 apply
11243	01NOV2001	31OCT2002	N	ORBITAL CONTENTS, ultrasonic echography of, for the measurement of the second eye where surgery for the first eye has resulted in more than 1 dioptre of error or where more than 3 years have elapsed, not being a serivce associated with a service to which items in Group I1 apply
11243	01NOV2002	31OCT2004	N	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, for the measurement of a second eye where surgery for the first eye has resulted in more than 1 dioptre of error or where more than 3 years have elapsed since the surgery for the first eye, not being a service associated with a service to which items in Group I1 apply
11243	01NOV2004	31DEC9999	Y	ORBITAL CONTENTS, unidimensional ultrasonic echography or partial coherence interferometry of, for the measurement of a second eye where surgery for the first eye has resulted in more than 1 dioptre of error or where more than 3 years have elapsed since the surgery for the first eye, not being a service associated with a service to which items in Group I1 apply
11244	01MAR2013	30APR2013	N	Orbital contents, diagnostic B-scan of, not being a service associated with a service to which an item in Group I1 of the diagnostic imaging services table applies.
11244	01MAY2013	31DEC9999	Y	Orbital contents, diagnostic B-scan of, by a specialist practising in his or her speciality of ophthalmology, not being a service associated with a service to which an item in Group I1 of the diagnostic imaging services table applies.
11300	01DEC1991	28FEB2023	N	BRAIN stem evoked response audiometry
11300	01MAR2023	30JUN2024	N	Brain stem evoked response audiometry if: (a) the service is not for the purposes of programming either an auditory implant or the sound processor of an auditory implant; and(b) a service to which item 82300 applies has not been performed on the patient on the same day other than a service associated with a service to which item 11340, 11341 or 11343 applies
11300	01JUL2024	31DEC9999	Y	Brain stem evoked response audiometry, if: (a) the service is not for the purposes of programming either an auditory implant or the sound processor of an auditory implant; and (b) a service to which item 82300 applies has not been performed on the patient on the same day
11302	01MAR2023	31DEC9999	Y	Programming an auditory implant or the sound processor of an auditory implant, unilateral, performed by or on behalf of a medical practitioner, if a service to which item 82301, 82302 or 82304 applies has not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 11342 or item 11345 applies on the same day
11303	01DEC1991	31OCT1993	N	INSERTION OF ELECTRODES for the purpose of ELECTROCOCHLEOGRAPHY
11303	01NOV1993	31OCT1994	N	ELECTROCOCHLEOGRAPHY including the insertion of electrodes
11303	01NOV1994	31DEC9999	Y	ELECTROCOCHLEOGRAPHY, extratympanic method, 1 or both ears
11304	01NOV1994	31DEC9999	Y	ELECTROCOCHLEOGRAPHY, transtympanic membrane insertion technique, 1 or both ears
11306	01DEC1991	28FEB2023	N	Nondeterminate AUDIOMETRY
11306	01MAR2023	31DEC9999	Y	Non determinate audiometry, if a service to which item 82306 applies has not been performed on the patient on the same day.
11309	01DEC1991	28FEB2023	N	AUDIOGRAM, air conduction
11309	01MAR2023	31DEC9999	Y	Audiogram, air conduction, if a service to which item 82309 applies has not been performed on the patient on the same day.
11312	01DEC1991	28FEB2023	N	AUDIOGRAM, air and bone conduction or air conduction and speech discrimination
11312	01MAR2023	31DEC9999	Y	Audiogram, air and bone conduction or air conduction and speech discrimination, if a service to which item 82312 applies has not been performed on the patient on the same day.
11315	01DEC1991	28FEB2023	N	AUDIOGRAM, air and bone conduction and speech
11315	01MAR2023	31DEC9999	Y	Audiogram, air and bone conduction and speech, if a service to which item 82315 applies has not been performed on the patient on the same day
11318	01DEC1991	28FEB2023	N	AUDIOGRAM, air and bone conduction and speech, with other Cochlear tests
11318	01MAR2023	31DEC9999	Y	Audiogram, air and bone conduction and speech, with other cochlear tests, if a service to which item 82318 applies has not been performed on the patient on the same day
11321	01DEC1991	31DEC9999	Y	GLYCEROL INDUCED COCHLEAR FUNCTION CHANGES assessed by a minimum of 4 air conduction and speech discrimination tests (Klockoff's tests)
11324	01DEC1991	28FEB2023	N	IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed by, or on behalf of, a specialist in the practice of his or her specialty, where the patient is referred by a medical practitioner - not being a service associated with a service to which item 11309, 11312, 11315 or 11318 applies
11324	01MAR2023	31DEC9999	Y	Impedance audiogram involving tympanometry and measurement of static compliance and acoustic reflex performed by, or on behalf of, a medical practitioner, if a service to which item 82324 applies has not been performed on the patient on the same day
11327	01DEC1991	31DEC9999	Y	IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed by, or on behalf of, a specialist in the practice of his or her specialty, where the patient is referred by a medical practitioner - being a service associated with a service to which item 11309, 11312, 11315 or 11318 applies
11330	01DEC1991	31DEC9999	Y	IMPEDANCE AUDIOGRAM where the patient is not referred by a medical practitioner - 1 examination in any 4 week period
11332	01MAY2000	28FEB2023	N	OTO-ACOUSTIC EMISSION AUDIOMETRY for the detection of permanent congenital hearing impairment, performed by or on behalf of a specialist or consultant physician, on an infant or child who is at risk due to one or more of the following factors:- (i) admission to a neonatal intensive care unit; or (ii) family history of hearing impairment; or (iii) intra-uterine or perinatal infection (either suspected or confirmed); or (iv) birthweight less than 1.5kg; or (v) craniofacial deformity: or (vi) birth asphyxia; or (vii) chromosomal abnormality, including Down's Syndrome; or (viii) exchange transfusion; and where:- - the patient is referred by another medical practitioner; and - middle ear pathology has been excluded by specialist opinion
11332	01MAR2023	31OCT2023	N	Oto-acoustic emission audiometry for the detection of outer hair cell functioning in the cochlear, performed by or on behalf of a specialist or consultant physician, when middle ear pathology has been excluded, if: (a) the service is performed: (i) on an infant or child who is at risk of permanent hearing impairment; or (ii) on an individual who is at risk of oto-toxicity due to medications or medical intervention; or (iii) on an individual at risk of noise induced hearing loss; or (iv) to assist in the diagnosis of auditory neuropathy; and (b) a service to which item 82332 applies has not been performed on the patient on the same day
11332	01NOV2023	31DEC9999	Y	Oto-acoustic emission audiometry for the detection of outer hair cell functioning in the cochlea, performed by or on behalf of a specialist or consultant physician, when middle ear pathology has been excluded, if:(a) the service is performed:(i) on an infant or child who is at risk of permanent hearing impairment; or(ii) on an individual who is at risk of oto-toxicity due to medications or medical intervention; or(iii) on an individual at risk of noise induced hearing loss; or(iv) to assist in the diagnosis of auditory neuropathy; and(b) a service to which item 82332 applies has not been performed on the patient on the same day
11333	01DEC1991	31DEC9999	Y	CALORIC TEST OF LABYRINTH OR LABYRINTHS
11336	01DEC1991	31DEC9999	Y	SIMULTANEOUS BITHERMAL CALORIC TEST OF LABYRINTHS
11339	01DEC1991	31DEC9999	Y	ELECTRONYSTAGMOGRAPHY
11340	01MAR2023	30JUN2024	N	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using up to 2 clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 11300 applies
11340	01JUL2024	31DEC9999	Y	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using up to 2 clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027 or 11205 applies
11341	01MAR2023	30JUN2024	N	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using 3 or 4 clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 11300 applies
11341	01JUL2024	31DEC9999	Y	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using 3 or 4 clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027 or 11205 applies
11342	01MAR2022	28FEB2023	N	Programming by telehealth of an auditory implant, or the sound processor of an auditory implant, unilateral, performed by or on behalf of a medical practitioner, if a service to which item 82300, 82302 or 82304 applies has not been performed on the patient on the same day. Applicable up to a total of 4 services to which this item or item 11300 or 11345 apply on the same day
11342	01MAR2023	31DEC9999	Y	Programming by telehealth of an auditory implant, or the sound processor of an auditory implant, unilateral, performed by or on behalf of a medical practitioner, if a service to which items 82301, 82302 or 82304 applies has not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 11302 or item 11345 applies on the same day
11343	01MAR2023	30JUN2024	N	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using 5 or more clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027, 11205 or 11300 applies
11343	01JUL2024	31DEC9999	Y	Investigation of the vestibular function to assist in the diagnosis, treatment or management of a vestibular or related disorder, performed by or on behalf of a medical practitioner: (a) to assess one or more of the following: (i) the organs of the peripheral vestibular system (utricle, saccule, lateral, superior and posterior semicircular canals, and vestibular nerve); (ii) muscular or eye movement responses elicited by vestibular stimulation; (iii) static signs of vestibular dysfunction; (iv) the central ocular-motor function; and (b) using 5 or more clinically recognised tests; other than a service associated with a service to which item 11015, 11021, 11024, 11027 or 11205 applies
11345	01MAR2022	28FEB2023	N	Programming by phone of an auditory implant, or the sound processor of an auditory implant, unilateral, performed by or on behalf of a medical practitioner, if a service to which item 82300, 82302 or 82304 applies has not been performed on the patient on the same day. Applicable up to a total of 4 services to which this item or item 11300 or 11342 apply on the same day
11345	01MAR2023	31DEC9999	Y	Programming by phone of an auditory implant, or the sound processor of an auditory implant, unilateral, performed by or on behalf of a medical practitioner, if a service to which items 82301, 82302 or 82304 applies has not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 11302 or item 11342 applies on the same day
11500	01DEC1991	31DEC9999	Y	BRONCHOSPIROMETRY, including gas analysis
11503	01DEC1991	30JUN1993	N	MEASUREMENT OF THE MECHANICAL OR GAS EXCHANGE FUNCTION OF THE RESPIRATORY SYSTEM, or of respiratory muscle function, or of ventilatory control mechanisms, using measurements of various parameters including pressures, volumes, flow, gas concentrations in inspired or expired air, alveolar gas or blood, electrical activity of muscles each occasion at which 1 or more such tests are performed
11503	01JUL1993	31OCT2005	N	MEASUREMENT OF THE MECHANICAL OR GAS EXCHANGE FUNCTION OF THE RESPIRATORY SYSTEM, OR OF RESPIRATORY MUSCLE FUNCTION, OR OF VENTILATORY CONTROL MECHANISMS, using measurements of various parameters including pressures, volumes, flow, gas concentrations in inspired or expired air, alveolar gas or blood, electrical activity of muscles (the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital) - each occasion at which 1 or more such tests are performed
11503	01NOV2005	28FEB2013	N	MEASUREMENT OF THE MECHANICAL OR GAS EXCHANGE FUNCTION OF THE RESPIRATORY SYSTEM, OR OF RESPIRATORY MUSCLE FUNCTION, OR OF VENTILATORY CONTROL MECHANISMS, using measurements of various parameters including pressures, volumes, flow, gas concentrations in inspired or expired air, alveolar gas or blood, electrical activity of muscles (the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital) - each occasion at which 1 or more such tests are performed, not being a service associated with a service to which item 22018 applies
11503	01MAR2013	31OCT2018	N	Measurement of the: (a) mechanical or gas exchange function of the respiratory system; or (b) respiratory muscle function; or (c) ventilatory control mechanisms. Various measurement parameters may be used including any of the following: (a) pressures; (b) volumes; (c) flow; (d) gas concentrations in inspired or expired air; (e) alveolar gas or blood; (f) electrical activity of muscles. The tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital. Each occasion at which 1 or more such tests are performed, not being a service associated with a service to which item 22018 applies.
11503	01NOV2018	31OCT2021	N	Complex measurement of properties of the respiratory system, including the lungs and respiratory muscles, that is performed: (a) in a respiratory laboratory; and (b) under the supervision of a consultant respiratory physician who is responsible for staff training, supervision, quality assurance and the issuing of written reports on tests performed; and (c) using any of the following tests: (i) measurement of absolute lung volumes by any method; (ii) measurement of carbon monoxide diffusing capacity by any method; (iii) measurement of airway or pulmonary resistance by any method; (iv) inhalation provocation testing, including pre-provocation spirometry and the construction of a dose response curve, using a recognised direct or indirect bronchoprovocation agent and post-bronchodilator spirometry; (v) provocation testing involving sequential measurement of lung function at baseline and after exposure to specific sensitising agents, including drugs, or occupational asthma triggers; (vi) spirometry performed before and after simple exercise testing undertaken as a provocation test for the investigation of asthma, in premises equipped with resuscitation equipment and personnel trained in Advanced Life Support; (vii) measurement of the strength of inspiratory and expiratory muscles at multiple lung volumes; (viii) simulated altitude test involving exposure to hypoxic gas mixtures and oxygen saturation at rest and/or during exercise with or without an observation of the effect of supplemental oxygen; (ix) calculation of pulmonary or cardiac shunt by measurement of arterial oxygen partial pressure and haemoglobin concentration following the breathing of an inspired oxygen concentration of 100% for a duration of 15 minutes or greater; (x) if the measurement is for the purpose of determining eligibility for pulmonary arterial hypertension medications subsidised under the Pharmaceutical Benefits Scheme or eligibility for the provision of portable oxygen-functional exercise test by any method (including 6 minute walk test and shuttle walk test); each occasion at which one or more tests are performed Not applicable to a service performed in association with a spirometry or sleep study service to which item 11505, 11506, 11507, 11508, 11512, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Not applicable to a service to which item 11507 applies
11503	01NOV2021	31DEC9999	Y	Complex measurement of properties of the respiratory system, including the lungs and respiratory muscles, that is performed: (a) in a respiratory laboratory; and (b) under the supervision of a specialist or consultant physician who is responsible for staff training, supervision, quality assurance and the issuing of written reports on tests performed; and (c) using any of the following tests: (i) measurement of absolute lung volumes by any method; (ii) measurement of carbon monoxide diffusing capacity by any method; (iii) measurement of airway or pulmonary resistance by any method; (iv) inhalation provocation testing, including pre-provocation spirometry and the construction of a dose response curve, using a recognised direct or indirect bronchoprovocation agent and post-bronchodilator spirometry; (v) provocation testing involving sequential measurement of lung function at baseline and after exposure to specific sensitising agents, including drugs, or occupational asthma triggers; (vi) spirometry performed before and after simple exercise testing undertaken as a provocation test for the investigation of asthma, in premises equipped with resuscitation equipment and personnel trained in Advanced Life Support; (vii) measurement of the strength of inspiratory and expiratory muscles at multiple lung volumes; (viii) simulated altitude test involving exposure to hypoxic gas mixtures and oxygen saturation at rest and/or during exercise with or without an observation of the effect of supplemental oxygen; (ix) calculation of pulmonary or cardiac shunt by measurement of arterial oxygen partial pressure and haemoglobin concentration following the breathing of an inspired oxygen concentration of 100% for a duration of 15 minutes or greater; (x) if the measurement is for the purpose of determining eligibility for pulmonary arterial hypertension medications subsidised under the Pharmaceutical Benefits Scheme or eligibility for the provision of portable oxygen-functional exercise test by any method (including 6 minute walk test and shuttle walk test); each occasion at which one or more tests are performed Not applicable to a service performed in association with a spirometry or sleep study service to which item 11505, 11506, 11507, 11508, 11512, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Not applicable to a service to which item 11507 applies
11505	01NOV2018	31DEC9999	Y	Measurement of spirometry, that: (a) involves a permanently recorded tracing, performed before and after inhalation of a bronchodilator; and (b) is performed to confirm diagnosis of: (i) asthma; or (ii) chronic obstructive pulmonary disease (COPD); or (iii) another cause of airflow limitation; each occasion at which 3 or more recordings are made Applicable only once in any 12 month period
11506	01DEC1991	31OCT2018	N	MEASUREMENT OF RESPIRATORY FUNCTION involving a permanently recorded tracing performed before and after inhalation of bronchodilator - each occasion at which 1 or more such tests are performed
11506	01NOV2018	31DEC9999	Y	Measurement of spirometry, that: (a) involves a permanently recorded tracing, performed before and after inhalation of a bronchodilator; and (b) is performed to: (i) confirm diagnosis of chronic obstructive pulmonary disease (COPD); or (ii) assess acute exacerbations of asthma; or (iii) monitor asthma and COPD; or (iv) assess other causes of obstructive lung disease or the presence of restrictive lung disease; each occasion at which recordings are made
11507	01NOV2018	31OCT2019	N	Measurement of spirometry: (a) that includes continuous measurement of the relationship between flow and volume during expiration or during expiration and inspiration, performed before and after inhalation of a bronchodilator; and (b) fractional exhaled nitric oxide (FeNO) concentration in exhaled breath; if: (c) the measurement is performed: (i) under the supervision of a specialist or consultant physician; and (ii) with continuous attendance by a respiratory scientist; and (iii) in a respiratory laboratory equipped to perform complex lung function tests; and (d) a permanently recorded tracing and written report is provided; and (e) 3 or more spirometry recordings are performed unless difficult to achieve for clinical reasons; each occasion at which one or more such tests are performed Not applicable to a service associated with a service to which item 11503, 11512 or 22018 applies
11507	01NOV2019	31DEC9999	Y	Measurement of spirometry: (a) that includes continuous measurement of the relationship between flow and volume during expiration or during expiration and inspiration, performed before and after inhalation of a bronchodilator; and (b) fractional exhaled nitric oxide (FeNO) concentration in exhaled breath; if: (c) the measurement is performed: (i) under the supervision of a specialist or consultant physician; and (ii) with continuous attendance by a respiratory scientist; and (iii) in a respiratory laboratory equipped to perform complex lung function tests; and (d) a permanently recorded tracing and written report is provided; and (e) 3 or more spirometry recordings are performed unless difficult to achieve for clinical reasons; each occasion at which one or more such tests are performed Not applicable to a service associated with a service to which item 11503 or 11512 applies
11508	01NOV2018	31OCT2019	N	Maximal symptom-limited incremental exercise test using a calibrated cycle ergometer or treadmill, if: (a) the test is performed for the evaluation of: (i) breathlessness of uncertain cause from tests performed at rest; or (ii) breathlessness out of proportion with impairment due to known conditions; or (iii) functional status and prognosis in a patient with significant cardiac or pulmonary disease for whom complex procedures such as organ transplantation are considered; or (iv) anaesthetic and peri-operative risks in a patient undergoing major surgery who is assessed as substantially above average risk after standard evaluation; and (b) the test has been requested by a specialist or consultant physician following professional attendance on the patient by the specialist or consultant physician; and (c) a respiratory scientist and a medical practitioner are in constant attendance during the test; and (d) the test is performed in a respiratory laboratory equipped with airway management and defibrillator equipment; and (e) there is continuous measurement of at least the following: (i) work rate; (ii) pulse oximetry; (iii) respired oxygen and carbon dioxide partial pressures and respired volumes; (iv) ECG; (v) heart rate and blood pressure; and (f) interpretation and preparation of a permanent report is provided by a consultant respiratory physician who is also responsible for the supervision of technical staff and quality assurance
11508	01NOV2019	31OCT2021	N	Maximal symptom-limited incremental exercise test using a calibrated cycle ergometer or treadmill, if: (a) the test is performed for the evaluation of: (i) breathlessness of uncertain cause from tests performed at rest; or (ii) breathlessness out of proportion with impairment due to known conditions; or (iii) functional status and prognosis in a patient with significant cardiac or pulmonary disease for whom complex procedures such as organ transplantation are considered; or (iv) anaesthetic and perioperative risks in a patient undergoing major surgery who is assessed as substantially above average risk after standard evaluation; and (b) the test has been requested by a specialist or consultant physician following professional attendance on the patient by the specialist or consultant physician; and (c) a respiratory scientist and a medical practitioner are in constant attendance during the test; and (d) the test is performed in a respiratory laboratory equipped with airway management and defibrillator equipment; and (e) there is continuous measurement of at least the following: (i) work rate; (ii) pulse oximetry; (iii) respired oxygen and carbon dioxide partial pressures and respired volumes; (iv) ECG; (v) heart rate and blood pressure; and (f) interpretation and preparation of a permanent report is provided by a consultant respiratory physician who is also responsible for the supervision of technical staff and quality assurance
11508	01NOV2021	31DEC9999	Y	Maximal symptom-limited incremental exercise test using a calibrated cycle ergometer or treadmill, if: (a) the test is performed for the evaluation of: (i) breathlessness of uncertain cause from tests performed at rest; or (ii) breathlessness out of proportion with impairment due to known conditions; or (iii) functional status and prognosis in a patient with significant cardiac or pulmonary disease for whom complex procedures such as organ transplantation are considered; or (iv) anaesthetic and perioperative risks in a patient undergoing major surgery who is assessed as substantially above average risk after standard evaluation; and (b) the test has been requested by a specialist or consultant physician following professional attendance on the patient by the specialist or consultant physician; and (c) a respiratory scientist and a medical practitioner are in constant attendance during the test; and (d) the test is performed in a respiratory laboratory equipped with airway management and defibrillator equipment; and (e) there is continuous measurement of at least the following: (i) work rate; (ii) pulse oximetry; (iii) respired oxygen and carbon dioxide partial pressures and respired volumes; (iv) ECG; (v) heart rate and blood pressure; and (f) interpretation and preparation of a permanent report is provided by a specialist or consultant physician who is also responsible for the supervision of technical staff and quality assurance
11509	01DEC1991	31DEC9999	Y	MEASUREMENT OF RESPIRATORY FUNCTION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex respiratory function tests (the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital) - each occasion at which 1 or more such tests are performed
11512	01DEC1991	31OCT2018	N	CONTINUOUS MEASUREMENT OF THE RELATIONSHIP BETWEEN FLOW AND VOLUME DURING EXPIRATION OR INSPIRATION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex lung function tests (the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital) - each occasion at which 1 or more such tests are performed
11512	01NOV2018	31OCT2019	N	Measurement of spirometry: (a) that includes continuous measurement of the relationship between flow and volume during expiration or during expiration and inspiration, performed before and after inhalation of a bronchodilator; and (b) that is performed with a respiratory scientist in continuous attendance; and (c) that is performed in a respiratory laboratory equipped to perform complex lung function tests; and (d) that is performed under the supervision of a consultant physician practising respiratory medicine who is responsible for staff training, supervision, quality assurance and the issuing of written reports; and (e) for which a permanently recorded tracing and written report is provided; and (f) for which 3 or more spirometry recordings are performed; each occasion at which one or more such tests are performed Not applicable for a service associated with a service to which item 11503, 11507 or 22018 applies
11512	01NOV2019	31OCT2021	N	Measurement of spirometry: (a) that includes continuous measurement of the relationship between flow and volume during expiration or during expiration and inspiration, performed before and after inhalation of a bronchodilator; and (b) that is performed with a respiratory scientist in continuous attendance; and (c) that is performed in a respiratory laboratory equipped to perform complex lung function tests; and (d) that is performed under the supervision of a consultant physician practising respiratory medicine who is responsible for staff training, supervision, quality assurance and the issuing of written reports; and (e) for which a permanently recorded tracing and written report is provided; and (f) for which 3 or more spirometry recordings are performed; each occasion at which one or more such tests are performed Not applicable for a service associated with a service to which item 11503 or 11507 applies
11512	01NOV2021	31DEC9999	Y	Measurement of spirometry: (a) that includes continuous measurement of the relationship between flow and volume during expiration or during expiration and inspiration, performed before and after inhalation of a bronchodilator; and (b) that is performed with a respiratory scientist in continuous attendance; and (c) that is performed in a respiratory laboratory equipped to perform complex lung function tests; and (d) that is performed under the supervision of a specialist or consultant physician who is responsible for staff training, supervision, quality assurance and the issuing of written reports; and (e) for which a permanently recorded tracing and written report is provided; and (f) for which 3 or more spirometry recordings are performed; each occasion at which one or more such tests are performed Not applicable for a service associated with a service to which item 11503 or 11507 applies
11600	01DEC1991	30JUN1993	N	BLOOD PRESSURE MONITORING by intravascular cannula
11600	01JUL1993	30APR1994	N	BLOOD PRESSURE MONITORING by intravascular cannula (not being a service associated with a service to which item 13818 or 13819 applies)
11600	01MAY1994	31OCT2002	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - each day of monitoring for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies)
11600	01NOV2002	31OCT2008	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - each day of monitoring for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies and where not performed in association with the administration of anaesthesia)
11600	01NOV2008	31DEC9999	Y	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - once only for each type of pressure on any calendar day up to a maximum of 4 pressures (not being a service to which item 13876 applies and where not performed in association with the administration of general anaesthesia)
11601	01MAY1994	30APR2002	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) performed in association with the administration of an anaesthetic relating to another discrete operation on the same day
11601	01MAY2002	31DEC9999	Y	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies)
11602	01NOV2003	28FEB2013	N	INVESTIGATION OF VENOUS REFLUX OR OBSTRUCTION in one or more limbs at rest by CW Doppler or pulsed Doppler involving examination at multiple sites along the limb(s) using intermittent limb compression and/or Valsava manoeuvres to detect prograde and retrograde flow, not being a service associated with a service to which item 32500 or 32501 applies - hard copy trace and report, maximum of two examinations in a 12 month period.
11602	01MAR2013	31OCT2018	N	Investigation of venous reflux or obstruction in one or more limbs at rest by CW Doppler or pulsed Doppler involving examination at multiple sites along each limb using intermittent limb compression or Valsava manoeuvres, or both, to detect prograde and retrograde flow, other than a service associated with a service to which item 32500 or 32501 applies - hard copy trace and written report, the report component of which must be performed by a medical practitioner, maximum of two examinations in a 12 month period, not to be used in conjunction with sclerotherapy.
11602	01NOV2018	31DEC9999	Y	Investigation of venous reflux or obstruction in one or more limbs at rest by CW Doppler or pulsed Doppler involving examination at multiple sites along each limb using intermittent limb compression or Valsalva manoeuvres, or both, to detect prograde and retrograde flow, other than a service associated with a service to which item 32500 applies-hard copy trace and written report, the report component of which must be performed by a medical practitioner, maximum of 2 examinations in a 12 month period, not to be used in conjunction with sclerotherapy
11603	01DEC1991	30JUN1996	N	EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) with hard copy recordings of wave forms, involving 1 of the following techniques Doppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast fourier transform analysis; venous occlusion plethysmography; air plethysmography; straingauge plethysmography; impedance plethysmography; or photo plethysmography; (not being a service associated with a service to which item 11612 or 11615 applies) 1 examination and report
11603	01JUL1996	31OCT1996	N	EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) excluding the cavernosal artery and dorsal artery of the penis, with had copy recordings of wave forms, involving 1 of the following techniques Doppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast fourier transform analysis; venous occlusion plethysmography; air plethysmography; straingauge plethysmography; impedance plethysmography; or photo plethysmography; (not being a service associated with a service to which item 11612 or 11615 applies) 1 examination and report
11603	01NOV1996	30APR2003	N	EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) excluding the cavernosal artery and dorsal artery of the penis, with hard copy recordings of wave forms, involving 1 of the following techniques Doppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast fourier transform analysis; venous occlusion plethysmography; strain-gauge plethysmography; impedance plethysmography; or photo plethysmography; (not being a service to which item 11612 or 11615 applies) - 1 examination and report
11603	01MAY2003	31DEC9999	Y	EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) excluding the cavernosal artery and dorsal artery of the penis, with hard copy recordings of wave forms, involving 1 of the following techniques: Doppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast Fourier transform analysis; venous occlusion plethysmography; strain-gauge plethysmography; impedance plethysmography; or photo plethysmography; (not being a service to which item 11612 or 11615 applies and not to be used in conjunction with items 32500 and 32501) - 1 examination and report
11604	01NOV2003	28FEB2013	N	PLETHYSMOGRAPHIC ASSESSMENT OF CHRONIC VENOUS DISEASE, assessment of chronic venous disease in the lower and upper extremities, or in the lower or upper extremities (unilateral or bilateral) using venous occlusion plethysmography, strain gauge plethysmography or air plethysmography, not being a service associated with a service to which item 32500 or 32501 applies - examination hard copy trace and report.
11604	01MAR2013	31OCT2018	N	Investigation of chronic venous disease in the upper and lower extremities, one or more limbs, by plethysmography (excluding photoplethysmography) - examination, hard copy trace and written report, not being a service associated with a service to which item 32500 or 32501 applies.
11604	01NOV2018	31DEC9999	Y	Investigation of chronic venous disease in the upper and lower extremities, one or more limbs, by plethysmography (excluding photoplethysmography)-examination, hard copy trace and written report, not being a service associated with a service to which item 32500 applies
11605	01NOV2003	28FEB2013	N	INFRARED PHOTOPLETHYSMOGRAPHIC ASSESSMENT OF COMPLEX CHRONIC LOWER LIMB VENOUS DISEASE, assessment of chronic venous disease in the lower extremities (unilateral or bilateral) using infrared photoplethysmography, examination during and following exercise with and without superficial venous occlusion, to assess venous function (reflux and/or obstruction) to determine surgical intervention or the conservative management of deep venous thrombotic disease, not being a service associated with a service to which item 32500 or 32501 applies - hard copy trace, calculation of 90% Recovery time and report.
11605	01MAR2013	31OCT2018	N	Investigation of complex chronic lower limb reflux or obstruction, in one or more limbs, by infrared photoplethysmography, during and following exercise to determine surgical intervention or the conservative management of deep venous thrombotic disease, hard copy trace, calculation of 90% recovery time and written report, not being a service associated with a service to which item 32500 or 32501 applies.
11605	01NOV2018	31DEC9999	Y	Investigation of complex chronic lower limb reflux or obstruction, in one or more limbs, by infrared photoplethysmography, during and following exercise to determine surgical intervention or the conservative management of deep venous thrombotic disease-hard copy trace, calculation of 90% recovery time and written report, not being a service associated with a service to which item 32500 applies
11606	01DEC1991	30JUN1996	N	- 2 examinations of the kind referred to in item 11603 and report (not being a service associated with a service to which item 11612 or 11615 applies)
11606	01JUL1996	30APR2003	N	- 2 examinations of the kind referred to in item 11603 and report (not being a service associated with a service to which item 11612 or 11615 applies)
11606	01MAY2003	31DEC9999	Y	- 2 examinations of the kind referred to in item 11603 and report (not being a service associated with a service to which item 11612 or 11615 applies and not to be used in conjunction with items 32500 and 32501)
11607	01NOV2021	30JUN2022	N	Continuous ambulatory blood pressure recording for 24 hours or more for a patient if: (a) the patient has a clinic blood pressure measurement (using a sphygmomanometer or a validated oscillometric blood pressure monitoring device) of either or both of the following measurements: (i) systolic blood pressure greater than or equal to 140 mmHg and less than or equal to 180 mmHg; (ii) diastolic blood pressure greater than or equal to 90 mmHg and less than or equal to 110 mmHg; and (b) the patient has not commenced anti-hypertensive therapy; and (c) the recording includes the patients resting blood pressure; and (d) the recording is conducted using microprocessor-based analysis equipment; and (e) the recording is interpreted by a medical practitioner and a report is prepared by the same medical practitioner; and (f) a treatment plan is provided for the patient; and (g) the service: (i) is not provided in association with ambulatory electrocardiogram recording, and (ii) is not associated with a service to which any of the following items apply: (A) 177; (B) 224 to 228; (C) 229 to 244; (D) 699; (E) 701 to 707; (F) 721 to 732; (G) 735 to 758. Applicable only once in any 12 month period
11607	01JUL2022	31DEC9999	Y	Continuous ambulatory blood pressure recording for 24 hours or more for a patient if: (a) the patient has a clinic blood pressure measurement (using a sphygmomanometer or a validated oscillometric blood pressure monitoring device) of either or both of the following measurements: (i) systolic blood pressure greater than or equal to 140 mmHg and less than or equal to 180 mmHg; (ii) diastolic blood pressure greater than or equal to 90 mmHg and less than or equal to 110 mmHg; and (b) the patient has not commenced anti-hypertensive therapy; and (c) the recording includes the patients resting blood pressure; and (d) the recording is conducted using microprocessor-based analysis equipment; and (e) the recording is interpreted by a medical practitioner and a report is prepared by the same medical practitioner; and (f) a treatment plan is provided for the patient; and (g) the service: (i) is not provided in association with ambulatory electrocardiogram recording, and (ii) is not associated with a service to which any of the following items apply: (A) 177; (B) 224 to 228; (C) 229 to 244; (D) 699; (E) 701 to 707; (F) 715; (G) 721 to 732; (H) 735 to 758. Applicable only once in any 12 month period
11609	01DEC1991	30JUN1996	N	- 3 or more examinations of the kind referred to in item 11603 and report (not being a service associated with a service to which item 11612 or 11615 applies)
11609	01JUL1996	30APR2003	N	- 3 or more examinations of the kind referred to in item 11603 and report (not being a service to which item 11612 or 11615 applies)
11609	01MAY2003	31DEC9999	Y	- 3 or more examinations of the kind referred to in item 11603 and report (not being a service to which item 11612 or 11615 applies and not to be used in conjunction with items 32500 and 32501)
11610	01NOV2003	31DEC9999	Y	MEASUREMENT OF ANKLE: BRACHIAL INDICES AND ARTERIAL WAVEFORM ANALYSIS, measurement of posterior tibial and dorsalis pedis (or toe) and brachial arterial pressures bilaterally using Doppler or plethysmographic techniques, the calculation of ankle (or toe) brachial systolic pressure indices and assessment of arterial waveforms for the evaluation of lower extremity arterial disease, examination, hard copy trace and report.
11611	01NOV2003	31DEC9999	Y	MEASUREMENT OF WRIST: BRACHIAL INDICES AND ARTERIAL WAVEFORM ANALYSIS, measurement of radial and ulnar (or finger) and brachial arterial pressures bilaterally using Doppler or plethysmographic techniques, the calculation of the wrist (or finger ) brachial systolic pressure indices and assessment of arterial waveforms for the evaluation of upper extremity arterial disease, examination, hard copy trace and report.
11612	01DEC1991	31OCT2003	N	EXAMINATION OF PERIPHERAL VESSELS and report, involving any of the techniques referred to in item 11603, with hard copy recording of wave forms before measured exercise using a treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral)
11612	01NOV2003	31DEC9999	Y	EXERCISE STUDY FOR THE EVALUATION OF LOWER EXTREMITY ARTERIAL DISEASE, measurement of posterior tibial and dorsalis pedis (or toe) and brachial arterial pressures bilaterally using Doppler or plethysmographic techniques, the calculation of ankle (or toe) brachial systolic pressure indices for the evaluation of lower extremity arterial disease at rest and following exercise using a treadmill or bicycle ergometer or other such equipment where the exercise workload is quantifiably documented, examination and report.
11614	01NOV2003	31OCT2022	N	TRANSCRANIAL DOPPLER, examination of the intracranial arterial circulation using CW Doppler or pulsed Doppler with hard copy recording of waveforms, examination and report, not associated with a service to which items 55229 or 55280 in Group I1 of Category 5 apply.
11614	01NOV2022	31DEC9999	Y	Transcranial doppler, examination of the intracranial arterial circulation using CW Doppler or pulsed Doppler with hard copy recording of waveforms, examination and report, other than a service associated with a service to which item 55280 of the diagnostic imaging services table applies
11615	01DEC1991	31DEC9999	Y	MEASUREMENT OF DIGITAL TEMPERATURE, 1 or more digits, (unilateral or bilateral) and report, with hard copy recording of temperature before and for 10 minutes or more after cold stress testing.
11618	01DEC1991	31OCT1992	N	EXAMINATION OF CAROTID VESSELS (unilateral or bilateral) with hard copy recordings of wave forms, involving one of the following techniques Doppler real time fast fourier transform analysis; oculoplethysmography, phonoangiography or both; or periorbital Doppler examination (not associated with Item 55012, 55015, 55018 or 55021) one examination and report
11618	01NOV1992	31OCT1996	N	EXAMINATION OF CAROTID VESSELS (unilateral or bilateral) with hard copy recordings of wave forms, involving 1 of the following techniques Doppler real time fast fourier transform analysis; oculoplethysmography, phonoangiography or both; or periorbital Doppler examination (not being a service associated with a service to which item 55201, 55204, 55225 or 55231 applies) 1 examination and report
11618	01NOV1996	31DEC9999	Y	EXAMINATION OF CAROTID OR VERTEBRAL VESSELS, or both (unilateral or bilateral) with hard copy recordings of wave forms, involving 1 of the following techniques Doppler real time fast Fourier transform analysis; oculoplethysmography, phonoangiography or both; or periorbital Doppler examination (not being a service associated with a service to which item 55274, 55288 or 55290 applies) - 1 examination and report
11621	01DEC1991	31OCT1992	N	two examinations of the kind referred to in Item 11618 and report (not associated with Item 55012, 55015, 55018 or 55021)
11621	01NOV1992	31DEC9999	Y	- 2 examinations of the kind referred to in item 11618 and report (not being a service associated with a service to which item 55274, 55288 or 55290 applies)
11624	01DEC1991	31OCT1992	N	- three or more examinations of the kind referred to in Item 11618 and report (not associated with Item 55012, 55015, 55018 or 55021)
11624	01NOV1992	31DEC9999	Y	- 3 or more examinations of the kind referred to in item 11618 and report (not being a service associated with a service to which item 55274, 55288 or 55290 applies)
11627	01DEC1991	30JUN2021	N	PULMONARY ARTERY pressure monitoring during open heart surgery, in a person under 12 years of age
11627	01JUL2021	31DEC9999	Y	PULMONARY ARTERY pressure monitoring during open heart surgery, in a patient under 12 years of age
11630	01DEC1991	31DEC9999	Y	PULMONARY ARTERY pressure monitoring during open heart surgery, in a person over 12 years of age
11700	01DEC1991	31DEC9999	Y	TWELVE-LEAD ELECTROCARDIOGRAPHY, tracing and report
11701	01JUL1993	31OCT1998	N	TWELVE-LEAD ELECTROCARDIOGRAPHY, report only where the tracing has been forwarded to another medical practitioner, including any consultation on the same day
11701	01NOV1998	31DEC9999	Y	TWELVE-LEAD ELECTROCARDIOGRAPHY, report only where the tracing has been forwarded to another medical practitioner, not in association with a consultation on the same occasion
11702	01JUL1993	31DEC9999	Y	TWELVE-LEAD ELECTROCARDIOGRAPHY, tracing only
11703	01DEC1991	31DEC9999	Y	12 LEAD ELECTROCARDIOGRAPHY, report only where the tracing has been forwarded to another medical practitioner, not being a service associated with a service to which an attendance item in Category 1 applies, OR 12 lead electrocardiography, tracing only
11704	01AUG2020	14SEP2020	N	Twelve-lead electrocardiography to produce a trace and a formal report, by a specialist or a consultant physician, if: (a) the service is requested by a requesting practitioner; and (b) a copy of formal report is provided to the requesting practitioner; and (c) the service does not apply if: (i) the patient is an admitted patient (ii) the specialist or consultant physician who renders the service has a financial relationship with the requesting practitioner (iii) the specialist or consultant physician who performs the service has performed a service to which an attendance applies for the same patient on the same day
11704	15SEP2020	31OCT2020	N	Twelve-lead electrocardiography to produce a trace and a formal report, by a specialist or a consultant physician, if: (a) the service is requested by a requesting practitioner; and (b) a copy of formal report is provided to the requesting practitioner; and (c) the service does not apply if: (i) the patient is an admitted patient; and (ii) the specialist or consultant physician who renders the service has a financial relationship with the requesting practitioner; and (iii) the specialist or consultant physician who performs the service has performed a service to which an attendance applies for the same patient on the same day; and (d) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies
11704	01NOV2020	28FEB2021	N	Twelve-lead electrocardiography to produce a trace and a formal report, by a specialist or a consultant physician, if: (a) the service is requested by a requesting practitioner; and (b) a copy of formal report is provided to the requesting practitioner; and (c) the service does not apply if: (i) the patient is an admitted patient (including for the purposes of pre-admission assessment); and (ii) the specialist or consultant physician who renders the service has a financial relationship with the requesting practitioner; and (iii) the specialist or consultant physician who performs the service has performed a service to which an attendance applies for the same patient on the same day; and (d) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies
11704	01MAR2021	31DEC9999	Y	Twelve-lead electrocardiography, trace and formal report, by a specialist or a consultant physician, if the service: (a) is requested by a requesting practitioner; and (b) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies. Note: the following are also requirements of the service: a formal report is completed; and a copy of the formal report is provided to the requesting practitioner; and the service is not provided to the patient as part of an episode of hospital treatment or hospital-substitute treatment; and is not provided in association with an attendance item (Part 2 of the schedule); and the specialist or consultant physician who renders the service does not have a financial relationship with the requesting practitioner.
11705	01AUG2020	14SEP2020	N	Preparing a formal report only on an electrocardiography trace, by a specialist or a consultant physician, if:(a) the service is requested by a requesting practitioner; and (b) the formal report uses a trace provided from twelve-lead electrocardiography for the patient which has: (i) been provided with the request from the requesting practitioner; and (ii) has not been previously been reported on; and (c) a copy of the formal report is provided to the requesting practitioner; and (d) the service does not apply if: (i) the specialist or consultant physician who renders the service has a financial relationship with the requesting practitioner; and (ii) the specialist or consultant physician who performs the service has performed a service to which an attendance applies for the same patient on the same day, unless exceptional circumstances exist For any particular patient, applicable no more than twice on the same day
11705	15SEP2020	28FEB2021	N	Preparing a formal report only on an electrocardiography trace, by a specialist or a consultant physician, if: (a) the service is requested by a requesting practitioner; and (b) the formal report uses a trace provided from twelve-lead electrocardiography for the patient which has: (i) been provided with the request from the requesting practitioner; and (ii) has not been previously been reported on; and (c) a copy of the formal report is provided to the requesting practitioner; and (d) the service does not apply if: (i) the specialist or consultant physician who renders the service has a financial relationship with the requesting practitioner; and (ii) the specialist or consultant physician who performs the service has performed a service to which an attendance applies for the same patient on the same day, unless exceptional circumstances exist; and (e) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than twice on the same day
11705	01MAR2021	31DEC9999	Y	Twelve-lead electrocardiography, formal report only, by a specialist or a consultant physician, if the service: (a) is requested by a requesting practitioner; and (b) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable not more than twice on the same day Note: the following are also requirements of the service: a formal report is completed; and a copy of the formal report is provided to the requesting practitioner; and the specialist or consultant physician who renders the service does not have a financial relationship with the requesting practitioner.
11706	01DEC1991	31DEC9999	Y	PHONOCARDIOGRAPHY with electrocardiograph lead with indirect arterial or venous pulse tracing, with or without apex cardiogram - interpretation and report
11707	01AUG2020	14SEP2020	N	Twelve-lead electrocardiography to produce a trace only, by a medical practitioner, if the trace: (a) is required to inform clinical decision making; and (b) is reviewed in a clinically appropriate timeframe to identify potentially serious or life-threatening abnormalities; and (c) does not need to be fully interpreted or reported on; and (d) the service does not apply if: (i) the patient is an admitted patient. For any particular patient, applicable no more than twice on the same day.
11707	15SEP2020	31OCT2020	N	Twelve-lead electrocardiography to produce a trace only, by a medical practitioner, if the trace: (a) is required to inform clinical decision making; and (b) is reviewed in a clinically appropriate timeframe to identify potentially serious or life-threatening abnormalities; and (c) does not need to be fully interpreted or reported on; and (d) the service does not apply if the patient is an admitted patient; and (e) the services is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than twice on the same day.
11707	01NOV2020	28FEB2021	N	Twelve-lead electrocardiography to produce a trace only, by a medical practitioner, if the trace: (a) is required to inform clinical decision making; and (b) is reviewed in a clinically appropriate timeframe to identify potentially serious or life-threatening abnormalities; and (c) does not need to be fully interpreted or reported on; and (d) the service does not apply if the patient is an admitted patient (including for the purposes of pre-admission assessment); and (e) the services is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than twice on the same day.
11707	01MAR2021	31DEC9999	Y	Twelve-lead electrocardiography, trace only, by a medical practitioner, if: (a) the trace: (i) is required to inform clinical decision making; and (ii) is reviewed in a clinically appropriate timeframe to identify potentially serious or life-threatening abnormalities; and (iii) does not need to be fully interpreted or reported on; and (b) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable not more than twice on the same day Note: the service is not provided to the patient as part of an episode of: hospital treatment; or hospital-substitute treatment.
11708	01JUL1993	31OCT1994	N	CONTINUOUS ECG RECORDING of ambulatory patient for 12 or more hours, including microprocessor based analysis, interpretation and report of recordings, not being a service to which item 11709 applies
11708	01NOV1994	28FEB2013	N	CONTINUOUS ECG RECORDING of ambulatory patient for 12 or more hours (including resting ECG and the recording of parameters), NOT IN ASSOCIATION WITH AMBULATORY BLOOD PRESSURE MONITORING, involving microprocessor based analysis equipment, interpretation and report of recordings by a specialist physician or consultant physician, not being a service to which item 11709 applies
11708	01MAR2013	31DEC9999	Y	Continuous ECG recording of ambulatory patient for 12 or more hours (including resting ECG and the recording of parameters), not in association with ambulatory blood pressure monitoring, involving microprocessor based analysis equipment, interpretation and report of recordings by a specialist physician or consultant physician. Not being a service to which item 11709 applies. The changing of a tape or batteries does not constitute a separate service. Where a recording is analysed and reported on and a decision is made to undertake a further period of monitoring, the second episode is regarded as a separate service.
11709	01DEC1991	31OCT1992	N	CONTINUOUS ECG MONITORING (Holter) of ambulatory patient for twelve or more hours involving recording, scanning analysis, interpretation and report, INCLUDING RESTING ECG and the recording of other parameters
11709	01NOV1992	30JUN1993	N	CONTINUOUS ECG RECORDING (Holter) of ambulatory patient for 12 or more hours involving recording, scanning analysis, interpretation and report, INCLUDING RESTING ECG and the recording of other parameters
11709	01JUL1993	31OCT1994	N	CONTINUOUS ECG RECORDING (Holter) of ambulatory patient for 12 or more hours involving recording and storage on a device, utilising a system capable of superimposition and full disclosure printout of at least 12 hours of recorded ECG data, microprocessor based scanning analysis, interpretation and report, including resting ECG and the recording of parameters
11709	01NOV1994	28FEB2013	N	CONTINUOUS ECG RECORDING (Holter) of ambulatory patient for 12 or more hours (including resting ECG and the recording of parameters), NOT IN ASSOCIATION WITH AMBULATORY BLOOD PRESSURE MONITORING, utilising a system capable of superimposition and full disclosure printout of at least 12 hours of recorded ECG data, microprocessor based scanning analysis, with interpretation and report by a specialist physician or consultant physician
11709	01MAR2013	31DEC9999	Y	Continuous ECG recording (Holter) of ambulatory patient for 12 or more hours (including resting ECG and the recording of parameters), not in association with ambulatory blood pressure monitoring, utilising a system capable of superimposition and full disclosure printout of at least 12 hours of recorded ECG data, microprocessor based scanning analysis, with interpretation and report by a specialist physician or consultant physician. The changing of a tape or batteries does not constitute a separate service. Where a recording is analysed and reported on and a decision is made to undertake a further period of monitoring, the second episode is regarded as a separate service.
11710	01JUL1992	31OCT1992	N	CONTINUOUS AMBULATORY ECG monitoring for a minimum of twelve hours and for up to seven days by a device with facility for the patient to activate permanent recording from magnetic tape or solid state memory for at least twenty seconds prior to each activation of recording and for at least fifteen seconds after each activation, including analysis, interpretation and report of recordings (Ministerial Determination)
11710	01NOV1992	30JUN1993	N	CONTINUOUS AMBULATORY ECG monitoring for a minimum of 12 hours and for up to 7 days by a device with facility for the patient to activate permanent recording from magnetic tape or solid state memory for at least 20 seconds prior to each activation of recording and for at least 15 seconds after each activation, including analysis, interpretation and report of recordings
11710	01JUL1993	31DEC9999	Y	AMBULATORY ECG MONITORING, patient activated, single or multiple event recording, utilising a looping memory recording device which is connected continuously to the patient for 12 hours or more and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation, including transmission, analysis, interpretation and report - payable once in any 4 week period
11711	01JUL1993	31DEC9999	Y	AMBULATORY ECG MONITORING for 12 hours or more, patient activated, single or multiple event recording, utilising a memory recording device which is capable of recording for at least 30 seconds after each activation, including transmission, analysis, interpretation and report - payable once in any 4 week period
11712	01DEC1991	31OCT1992	N	ELECTROCARDIOGRAPHIC MONITORING during exercise (bicycle ergometer or treadmill) involving the continuous attendance of a medical practitioner for not less than 20 minutes, with resting ECG and with or without recording of other parameters, on premises equipped with mechanical respirator and defibrillator
11712	01NOV1992	31OCT1994	N	ELECTROCARDIOGRAPHIC MONITORING during exercise (bicycle ergometer or treadmill) or pharmacological stress, involving the continuous attendance of a medical practitioner for not less than 20 minutes, with resting ECG and with or without recording of other parameters, on premises equipped with mechanical respirator and defibrillator
11712	01NOV1994	31DEC9999	Y	MULTI CHANNEL ECG MONITORING AND RECORDING during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, involving the continuous attendance of a medical practitioner for not less than 20 minutes, with resting ECG, and with or without continuous blood pressure monitoring and the recording of other parameters, on premises equipped with mechanical respirator and defibrillator
11713	01JUL1992	31OCT1992	N	SIGNAL AVERAGED ELECTROCARDIOGRAPHIC RECORDING involving not more than 100 beats, using at least three leads with data acquisition at not less than 110Hz of at least 100 QRS complexes, including analysis, interpretation and report of recording (Ministerial Determination)
11713	01NOV1992	31OCT1994	N	SIGNAL AVERAGED ELECTROCARDIOGRAPHIC RECORDING involving not more than 300 beats, using at least 3 leads with data acquisition at not less than 1000Hz of at least 100 QRS complexes, including analysis, interpretation and report of recording
11713	01NOV1994	31DEC9999	Y	SIGNAL AVERAGED ECG RECORDING involving not more than 300 beats, using at least 3 leads with data acquisition at not less than 1000Hz of at least 100 QRS complexes, including analysis, interpretation and report of recording by a specialist physician or consultant physician
11714	01AUG2020	14SEP2020	N	Twelve-lead electrocardiography to produce a trace and a clinical note, by a specialist or consultant physician, if a copy of the clinical note is provided to the medical practitioner managing the patients care, if appropriate; and (a) the service does not apply if: (i) the patient is an admitted patient For any particular patient, applicable no more than twice on the same day.
11714	15SEP2020	31OCT2020	N	Twelve-lead electrocardiography to produce a trace and a clinical note, by a specialist or consultant physician, if: (a) a copy of the clinical note is provided to the medical practitioner managing the patients care, if appropriate; and (b) the service does not apply if the patient is an admitted patient; and (c) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than twice on the same day
11714	01NOV2020	28FEB2021	N	Twelve-lead electrocardiography to produce a trace and a clinical note, by a specialist or consultant physician, if: (a) a copy of the clinical note is provided to the medical practitioner managing the patients care, if appropriate; and (b) the service does not apply if the patient is an admitted patient (including for the purposes of pre-admission assessment); and (c) the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than twice on the same day
11714	01MAR2021	31DEC9999	Y	Twelve-lead electrocardiography, trace and clinical note, by a specialist or consultant physician, if the service is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable not more than twice on the same day Note: the service is not provided to the patient as part of an episode of: hospital treatment; or hospital-substitute treatment.
11715	01DEC1991	31DEC9999	Y	BLOOD DYE DILUTION INDICATOR TEST
11716	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous electrocardiogram recording of ambulatory patient for 12 or more hours with interpretation and report, by a specialist or consultant physician, if the service: (a) is indicated for the evaluation of a patient for: (i) syncope; or (ii) pre-syncopal episodes; or (iii) palpitations where episodes are occurring greater than once a week; or (iv) another asymptomatic arrhythmia is suspected with an expected frequency of greater than once a week; or (v) surveillance following cardiac surgical procedures that have an established risk of causing dysrhythmia; and (b) utilises a system capable of superimposition and full disclosure printout of at least 12 hours of recorded electrocardiogram data, (including resting electrocardiogram and the recording of parameters) microprocessor based scanning analysis; and (c) is not in association with ambulatory blood pressure monitoring; and (d) is other than a service on a patient in relation to whom this item and any of the items 11704, 11705, 11707 or 11714 are rendered by a single medical practitioner on a single patient on a single day; and (e) is applicable once in a 4 week period (f) the service does not apply if: (i) the patient is an admitted patient.
11716	15SEP2020	31OCT2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous electrocardiogram recording of ambulatory patient for 12 or more hours with interpretation and report, by a specialist or consultant physician, if the service: (a) is indicated for the evaluation of a patient for: (i) syncope; or (ii) pre-syncopal episodes; or (iii) palpitations where episodes are occurring greater than once a week; or (iv) another asymptomatic arrhythmia is suspected with an expected frequency of greater than once a week; or (v) surveillance following cardiac surgical procedures that have an established risk of causing dysrhythmia; and (b) utilises a system capable of superimposition and full disclosure printout of at least 12 hours of recorded electrocardiogram data, (including resting electrocardiogram and the recording of parameters) microprocessor based scanning analysis; and (c) is not in association with ambulatory blood pressure monitoring; and (d) is other than a service on a patient in relation to whom this item and any of the items 11704, 11705, 11707 or 11714 are rendered by a single medical practitioner on a single patient on a single day; and (e) is applicable once in a 4 week period; and (f) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11717, 11723 or 11735 applies
11716	01NOV2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous electrocardiogram recording of ambulatory patient for 12 or more hours with interpretation and report, by a specialist or consultant physician, if the service: (a) is indicated for the evaluation of a patient for: (i) syncope; or (ii) pre-syncopal episodes; or (iii) palpitations where episodes are occurring greater than once a week; or (iv) another asymptomatic arrhythmia is suspected with an expected frequency of greater than once a week; or (v) surveillance following cardiac surgical procedures that have an established risk of causing dysrhythmia; and (b) utilises a system capable of superimposition and full disclosure printout of at least 12 hours of recorded electrocardiogram data, (including resting electrocardiogram and the recording of parameters) microprocessor based scanning analysis; and (c) is not in association with ambulatory blood pressure monitoring; and (d) is other than a service on a patient in relation to whom this item and any of the items 11704, 11705, 11707 or 11714 are rendered by a single medical practitioner on a single patient on a single day; and (e) is applicable once in a 4 week period; and (f) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11717, 11723 or 11735 applies Note: The service does not apply if the patient is an admitted patient.
11716	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous ambulatory electrocardiogram recording for 12 or more hours, by a specialist or consultant physician, if the service: (a) is indicated for the evaluation of any of the following: (i) syncope; (ii) pre-syncopal episodes; (iii) palpitations where episodes are occurring more than once a week; (iv) another asymptomatic arrhythmia is suspected with an expected frequency of greater than once a week; (v) surveillance following cardiac surgical procedures that have an established risk of causing dysrhythmia; and (b) utilises a system capable of superimposition and full disclosure printout of at least 12 hours of recorded electrocardiogram data (including resting electrocardiogram and the recording of parameters) and microprocessor based scanning analysis; and (c) includes interpretation and report; and (d) is not provided in association with ambulatory blood pressure monitoring; and (e) is not associated with a service to which item 11704, 11705, 11707, 11714, 11717, 11723, 11735, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable only once in any 4 week period Note: this services does not apply if the patient is being provided with the service as part of an episode of: hospital treatment; or hospital-substitute treatment.
11717	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event memory recording device which is connected continuously to the patient for between 7 and 30 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and reporting (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) the service does not apply if: (i) the patient is an admitted patient.
11717	15SEP2020	31OCT2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event memory recording device which is connected continuously to the patient for between 7 and 30 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and reporting (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11716, 11723 or 11735 applies
11717	01NOV2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event memory recording device which is connected continuously to the patient for between 7 and 30 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and reporting (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11716, 11723 or 11735 applies Note: The service does not apply if the patient is an admitted patient.
11717	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram monitoring, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event memory recording device that: (i) is connected continuously to the patient for between 7 and 30 days; and (ii) is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and reporting (including the indication for the investigation); and (c) is for the investigation of recurrent episodes of: unexplained syncope; or palpitation; or other symptoms where a cardiac rhythm disturbance is suspected and where infrequent episodes have occurred; and (d) is not associated with a service to which item 11716, 11723, 11735, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable only once in any 3 month period Note: the service does not apply if the patient is being provided with the service as part of an episode of: hospital treatment; or hospital-substitute treatment.
11718	01JUL1992	31OCT1992	N	IMPLANTED PACEMAKER TESTING involving electrocardiography, measurement of rate, width and amplitude stimulus, including reprogramming when required, not associated with item 11700 or 11721 (Ministerial Determination)
11718	01NOV1992	31AUG2015	N	IMPLANTED PACEMAKER TESTING involving electrocardiography, measurement of rate, width and amplitude of stimulus, including reprogramming when required, not being a service associated with a service to which item 11700 or 11721 applies
11718	01SEP2015	31JUL2020	N	IMPLANTED PACEMAKER TESTING involving electrocardiography, measurement of rate, width and amplitude of stimulus, including reprogramming when required, not being a service associated with a service to which item 11700, 11719, 11720, 11721, 11725 or 11726 applies
11718	01AUG2020	31DEC9999	Y	IMPLANTED PACEMAKER TESTING involving electrocardiography, measurement of rate, width and amplitude of stimulus, including reprogramming when required, not being a service associated with a service to which item 11719, 11720, 11721, 11725 or 11726 applies
11719	01SEP2015	31DEC9999	Y	IMPLANTED PACEMAKER (including cardiac resynchronisation pacemaker) REMOTE MONITORING involving reviews (without patient attendance) of arrhythmias, lead and device parameters, if at least one remote review is provided in a 12 month period. Payable only once in any 12 month period
11720	01SEP2015	30JUN2021	N	IMPLANTED PACEMAKER TESTING, with patient attendance, following detection of abnormality by remote monitoring involving electrocardiography, measurement of rate, width and amplitude of stimulus including reprogramming when required, not being a service associated with a service to which item 11718 or 11721 applies.
11720	01JUL2021	31DEC9999	Y	IMPLANTED PACEMAKER TESTING, with patient attendance, following detection of abnormality by remote monitoring involving electrocardiography, measurement of rate, width and amplitude of stimulus including reprogramming when required, not being a service associated with a service to which item 11721 applies.
11721	01JUL1992	31OCT1992	N	IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate responsive, or antitachycardia pacemakers, including reprogramming when required, not associated with item 11700 or 11718 (Ministerial Determination)
11721	01NOV1992	31AUG2015	N	IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate responsive, or antitachycardia pacemakers, including reprogramming when required, not being a service associated with a service to which Item 11700 or 11718 applies
11721	01SEP2015	31JUL2020	N	IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate responsive, or antitachycardia pacemakers, including reprogramming when required, not being a service associated with a service to which Item 11700, 11718 11719, 11720, 11725 or 11726 applies
11721	01AUG2020	30JUN2021	N	IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate responsive, or antitachycardia pacemakers, including reprogramming when required, not being a service associated with a service to which Item 11718, 11719, 11720, 11725 or 11726 applies
11721	01JUL2021	31DEC9999	Y	IMPLANTED PACEMAKER TESTING of atrioventricular (AV) sequential, rate responsive, or antitachycardia pacemakers, including reprogramming when required, not being a service associated with a service to which Item 11704, 11719, 11720, 11725 or 11726 applies
11722	01NOV2004	31DEC9999	Y	IMPLANTED ECG LOOP RECORDING, for the investigation of recurrent unexplained syncope if: (a) a diagnosis has not been achieved through all other available cardiac investigations; and (b) a neurogenic cause is not suspected; and (c) the patient to whom the service is provided does not have a structural heart defect associated with a high risk of sudden cardiac death; including reprogramming when required, retrieval of stored data, analysis, interpretation and report, not being a service to which item 38285 applies
11723	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Conducting ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event recording, on a memory recording device which is connected continuously to the patient for up to 7 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and formal report (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) the service does not apply if: (i) the patient is an admitted patient.
11723	15SEP2020	31OCT2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Conducting ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event recording, on a memory recording device which is connected continuously to the patient for up to 7 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and formal report (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11716, 11717 or 11735 applies
11723	01NOV2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Conducting ambulatory electrocardiogram monitoring of a patient, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event recording, on a memory recording device which is connected continuously to the patient for up to 7 days and is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and formal report (including the indication for the investigation); and (c) is for investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where episodes are infrequent has occurred; and (d) is applicable once in a 3 month period; and (e) is not associated with a service to which item 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217, 12250, 11716, 11717 or 11735 applies Note: The service does not apply if the patient is an admitted patient.
11723	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Ambulatory electrocardiogram monitoring, by a specialist or consultant physician, if the service: (a) utilises a patient activated, single or multiple event recording, on a memory recording device that: (i) is connected continuously to the patient for up to 7 days; and (ii) is capable of recording for at least 20 seconds prior to each activation and for 15 seconds after each activation; and (b) includes transmission, analysis, interpretation and formal report (including the indication for the investigation); and (c) is for the investigation of recurrent episodes of: (i) unexplained syncope; or (ii) palpitation; or (iii) other symptoms where a cardiac rhythm disturbance is suspected and where infrequent episodes have occurred; and (d) is not associated with a service to which item 11716, 11717, 11735, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable only once in any 3 month period Note: The service does not apply if the patient is an admitted patient.
11724	01JUL1995	31DEC9999	Y	UP-RIGHT TILT TABLE TESTING for the investigation of syncope of suspected cardiothoracic origin, including blood pressure monitoring, continuous ECG monitoring and the recording of the parameters, and involving an established intravenous line and the continuous attendance of a specialist or consultant physician - on premises equipped with a mechanical respirator and defibrillator
11725	01SEP2015	31DEC9999	Y	IMPLANTED DEFIBRILLATOR (including cardiac resynchronisation defibrillator) REMOTE MONITORING involving reviews (without patient attendance) of arrhythmias, lead and device parameters, if at least 2 remote reviews are provided in a 12 month period. Payable only once in any 12 month period
11726	01SEP2015	31DEC9999	Y	IMPLANTED DEFIBRILLATOR TESTING with patient attendance following detection of abnormality by remote monitoring involving electrocardiography, measurement of rate, width and amplitude of stimulus, not being a service associated with a service to which item 11727 applies.
11727	01NOV2006	31AUG2015	N	IMPLANTED DEFIBRILLATOR TESTING involving electrocardiography, assessment of pacing and sensing thresholds for pacing and defibrillation electrodes, download and interpretation of stored events and electrograms, including programming when required, not being a service associated with a service to which item 11700, 11718 or 11721 applies
11727	01SEP2015	31JUL2020	N	IMPLANTED DEFIBRILLATOR TESTING involving electrocardiography, assessment of pacing and sensing thresholds for pacing and defibrillation electrodes, download and interpretation of stored events and electrograms, including programming when required, not being a service associated with a service to which item 11700, 11718, 11719, 11720, 11721, 11725 or 11726 applies
11727	01AUG2020	30JUN2021	N	IMPLANTED DEFIBRILLATOR TESTING involving electrocardiography, assessment of pacing and sensing thresholds for pacing and defibrillation electrodes, download and interpretation of stored events and electrograms, including programming when required, not being a service associated with a service to which item 11718, 11719, 11720, 11721, 11725 or 11726 applies
11727	01JUL2021	31DEC9999	Y	IMPLANTED DEFIBRILLATOR TESTING involving electrocardiography, assessment of pacing and sensing thresholds for pacing and defibrillation electrodes, download and interpretation of stored events and electrograms, including programming when required, not being a service associated with a service to which item 11719, 11720, 11721, 11725 or 11726 applies
11728	01MAY2018	31DEC9999	Y	Implanted loop recording for the investigation of atrial fibrillation if the patient to whom the service is provided has been diagnosed as having had an embolic stroke of undetermined source, including reprogramming when required, retrieval of stored data, analysis, interpretation and report, other than a service to which item 38288 applies For any particular patient-applicable not more than 4 times in any 12 months
11729	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is aged 17 years or more; and: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relatives with suspected heritable arrhythmia; and (b) the exercise or pharmacological stress monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (iii) is performed on premises equipped with standard resuscitation equipment; and (iv) a person trained in exercise testing and cardiopulmonary resuscitation is in continuous attendance during the monitoring and recording; and (v) a second person trained in cardiopulmonary resuscitation is located at the premise where the testing is performed and is immediately available to respond at the time the exercise test is performed on the patient, if required; and (c) a written report is produced by a medical practitioner that includes interpretation of the exercise or pharmacological stress monitoring and recording data, commenting on the significance of the data, and their relationship to clinical decision making for the patient in their clinical context; and (d) other than a service: (i) provided on the same occasion as a service described in any of items 11704, 11705, 11707 or 11714 of the general medical services table; or (ii) performed within 24 months of a service to which any of items 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349 or 61357 of the diagnostic imaging services tables has applied Applicable once in a 24 month period
11729	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is aged 17 years or more; and: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (b) the exercise or pharmacological stress monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (iii) is performed on premises equipped with standard resuscitation equipment; and (iv) a person trained in exercise testing and cardiopulmonary resuscitation is in continuous attendance during the monitoring and recording; and (v) a second person trained in cardiopulmonary resuscitation is located at the premise where the testing is performed and is immediately available to respond at the time the exercise test is performed on the patient, if required; and (c) a written report is produced by a medical practitioner that includes interpretation of the exercise or pharmacological stress monitoring and recording data, commenting on the significance of the data, and their relationship to clinical decision making for the patient in their clinical context; and (d) other than a service: (i) provided on the same occasion as a service described in any of items 11704, 11705, 11707 or 11714 of the general medical services table; or (ii) performed within 24 months of a service to which any of items 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 of the diagnostic imaging services table has applied Applicable once in a 24 month period
11729	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is 17 years or more; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 applies Applicable only once in any 24 month period
11729	01JUL2021	31JUL2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is 17 years or more; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61311, 61324, 61329, 61332, 61345, 61349, 61357, 61365, 61377, 61380, 61394, 61398, 61406, 61410, 61414 or 61418 applies
11729	01AUG2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is 17 years or more; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61311, 61324, 61329, 61332, 61345, 61349, 61357, 61365, 61377, 61380, 61394, 61398, 61406, 61410, 61414 or 61418 applies Applicable only once in any 24 month period
11729	01NOV2023	31DEC9999	Y	Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts) or pharmacological stress, if: (a) the patient is 17 years or more; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 applies Applicable only once in any 24 month period
11730	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.2 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), if: (a) the patient is aged under 17 years; and: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relatives with suspected heritable arrhythmia; and (b) the exercise or pharmacological stress monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (iii) is performed on premises equipped with standard resuscitation equipment; and (iv) a person trained in exercise testing and cardiopulmonary resuscitation is in continuous attendance during the monitoring and recording; and (v) a second person trained in cardiopulmonary resuscitation is located at the premise where the testing is performed and is immediately available to respond at the time the exercise test is performed on the patient, if required; and (c) a written report is produced by a medical practitioner that includes interpretation of the exercise or pharmacological stress monitoring and recording data, commenting on the significance of the data, and their relationship to clinical decision making for the patient in their clinical context; and (d) other than a service: (i) provided on the same occasion as a service described in any of items 11704, 11705, 11707 or 11714 of the general medical services table; or (ii) performed within 24 months of a service to which any of items 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349 or 61357 of the diagnostic imaging services tables has applied Applicable once in a 24 month period
11730	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.3 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), if: (a) the patient is aged under 17 years; and: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (b) the exercise or pharmacological stress monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (iii) is performed on premises equipped with standard resuscitation equipment; and (iv) a person trained in exercise testing and cardiopulmonary resuscitation is in continuous attendance during the monitoring and recording; and (v) a second person trained in cardiopulmonary resuscitation is located at the premise where the testing is performed and is immediately available to respond at the time the exercise test is performed on the patient, if required; and (c) a written report is produced by a medical practitioner that includes interpretation of the exercise or pharmacological stress monitoring and recording data, commenting on the significance of the data, and their relationship to clinical decision making for the patient in their clinical context; and (d) other than a service: (i) provided on the same occasion as a service described in any of items 11704, 11705, 11707 or 11714 of the general medical services table; or (ii) performed within 24 months of a service to which any of items 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 of the diagnostic imaging services table has applied Applicable once in a 24 month period
11730	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.3 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), if: (a) the patient is less than 17 years; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 applies Applicable only once in any 24 month period
11730	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements in note DR.1.3 Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), if: (a) the patient is less than 17 years; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61311, 61324, 61329, 61332, 61345, 61349, 61357, 61365, 61377, 61380, 61394, 61398, 61406, 61410, 61414 or 61418 applies Applicable only once in any 24 month period
11730	01NOV2023	31DEC9999	Y	Multi channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), if: (a) the patient is less than 17 years; and (b) the patient: (i) has symptoms consistent with cardiac ischemia; or (ii) has other cardiac disease which may be exacerbated by exercise; or (iii) has a first degree relative with suspected heritable arrhythmia; and (c) the monitoring and recording: (i) is not less than 20 minutes in duration; and (ii) includes resting electrocardiogram; and (d) a written report is produced by a medical practitioner that includes interpretation of the monitoring and recording data, commenting on the significance of the data, and the relationship of the data to clinical decision making for the patient in the clinical context; and (e) the service is not a service: (i) provided on the same occasion as a service to which item 11704, 11705, 11707 or 11714 applies; or (ii) performed within 24 months of a service to which item 55141, 55143, 55145, 55146, 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 or 61414 applies Applicable only once in any 24 month period
11731	01AUG2020	28FEB2021	N	Implanted electrocardiogram loop recording, by a medical practitioner, including reprogramming when required; retrieval of stored data, analysis, interpretation and report by a medical practitioner, if the service is: (a) an investigation for a patient with: (i) cryptogenic stroke; or (ii) recurrent unexplained syncope; and (b) not a service to which item 38285 of the general medical services table applies; and Applicable once in a 4 week period.
11731	01MAR2021	31DEC9999	Y	Implanted electrocardiogram loop recording, by a medical practitioner, including reprogramming (if required), retrieval of stored data, analysis, interpretation and report, if the service is: (a) an investigation for a patient with: (i) cryptogenic stroke; or (ii) recurrent unexplained syncope; and (b) not a service to which item 38285 applies Applicable only once in any 4 week period
11732	01MAR2024	31DEC9999	Y	Multi-channel electrocardiogram monitoring and recording during exercise (motorised treadmill or cycle ergometer capable of quantifying external workload in watts), performed by a cardiologist with relevant expertise in genetic heart disease, if: (a) the patient is: (i) under investigation or treatment for long QT syndrome, catecholaminergic polymorphic ventricular tachycardia or arrhythmogenic cardiomyopathy; or (ii) a first degree relative of a person with confirmed long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, arrhythmogenic cardiomyopathy or unexplained sudden cardiac death at 40 years of age or younger; and (b) the monitoring and recording: (i) is for at least 20 minutes; and (ii) includes resting electrocardiogram; and (c) the cardiologist produces a report that includes interpretation of the monitoring and recording data (commenting on the significance of the data) and discussion of the relationship of the data to clinical decision making for the patient in the clinical context; and (d) the service is not provided on the same occasion as a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies Applicable once per day
11735	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous electrocardiogram recording of an ambulatory patient for 7 days with interpretation and report, by a specialist or consultant physician, if the service: utilises intelligent microprocessor based monitoring, with patient triggered recording and symptom reporting capability, real time analysis of electrocardiograms and alerts, and daily or live data uploads; and is not in association with ambulatory blood pressure monitoring; and is for the investigation of: episodes of suspected intermittent cardiac arrhythmia or episodes of syncope; or suspected intermittent cardiac arrhythmia in patients who: have had a previous cerebrovascular accident; or are at risk of cerebrovascular accident; or have had a previous transient ischemic attack/s; and is not associated with a service to which item 11716, 11717, 11723, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies For any particular patient, applicable no more than four times in a 12 month period. Note: The service does not apply if the patient is an admitted patient.
11735	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements in Note: DR.1.1 Continuous ambulatory electrocardiogram recording for 7 days, by a specialist or consultant physician, if the service: (a) utilises intelligent microprocessor based monitoring, with patient triggered recording and symptom reporting capability, real time analysis of electrocardiograms and alerts and daily or live data uploads; and (b) is for the investigation of: (i) episodes of suspected intermittent cardiac arrhythmia or episodes of syncope; or (ii) suspected intermittent cardiac arrhythmia in a patient who has had a previous cerebrovascular accident, is at risk of cerebrovascular accident or has had one or more previous transient ischemic attacks; and (c) includes interpretation and report; and (d) is not a service: (i) provided in association with ambulatory blood pressure monitoring; or (ii) associated with a service to which item 11716, 11717, 11723, 12203, 12204, 12205, 12207, 12208, 12210, 12213, 12215, 12217 or 12250 applies Applicable not more than 4 times in any 12 month period Note: The service does not apply if the patient is an admitted patient.
11736	01NOV2022	31DEC9999	Y	Implanted loop recording via remote monitoring (including reprogramming (if required), retrieval of stored data, analysis, interpretation and report), for the investigation of atrial fibrillation, if the service: (a) is provided to a patient who has been diagnosed as having had an embolic stroke of undetermined source; and (b) is not a service to which item 38288 applies Applicable not more than 4 times in any 12 month period
11737	01NOV2022	31DEC9999	Y	Implanted electrocardiogram loop recording via remote monitoring (including reprogramming (if required), retrieval of stored data, analysis, interpretation and report), by a medical practitioner, if the service is: (a) an investigation for a patient with: (i) cryptogenic stroke; or (ii) recurrent unexplained syncope; and (b) not a service to which item 38285 applies Applicable only once in any 4 week period
11800	01DEC1991	31DEC9999	Y	OESOPHAGEAL MOTILITY TEST, manometric
11801	01SEP2015	31DEC9999	Y	CLINICAL ASSESSMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE that involves 48 hour catheter-free wireless ambulatory oesophageal pH monitoring including administration of the device and associated endoscopy procedure for placement, analysis and interpretation of the data and all attendances for providing the service, if (a) a cathetter-based ambulatory oesophageal pH-mnitoring: (i) has been attempted on the patient but failed due to clinical complications, or (ii) is not clinically appropriate for the patient due to anatomical reasons (nasopharyngeal anatomy) preventing the use of catheter-based pH monitoring; and (b) the services is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy. Not in association with another item in Category 2, sub-group 7
11810	01JUL1992	31OCT1992	N	CLINICAL ASSESSMENT of GASTRO-OESOPHAGEAL REFLUX DISEASE involving 24 hour pH monitoring, including analysis, interpretation and report and including any associated consultation (Ministerial Determination)
11810	01NOV1992	31DEC9999	Y	CLINICAL ASSESSMENT of GASTRO-OESOPHAGEAL REFLUX DISEASE involving 24 hour pH monitoring, including analysis, interpretation and report and including any associated consultation
11820	01MAY2004	30APR2005	N	CAPSULE ENDOSCOPY to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (b) the patient to whom the service is provided: (i) is aged 18 years or over; and (ii) has recurrent or persistent bleeding; and (iii) is anaemic or has active bleeding; and (c) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (d) the service is performed within 6 months of the upper gastrointestinal endoscopy and colonoscopy
11820	01MAY2005	30JUN2007	N	CAPSULE ENDOSCOPY to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered), if: (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (b) the patient to whom the service is provided: (i) is aged 10 years or over; and (ii) has recurrent or persistent bleeding; and (iii) is anaemic or has active bleeding; and (c) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (d) the service is performed within 6 months of the upper gastrointestinal endoscopy and colonoscopy
11820	01JUL2007	28FEB2013	N	CAPSULE ENDOSCOPY to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered), (not being a service associated with double balloon enteroscopy), if: (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (b) the patient to whom the service is provided: (i) is aged 10 years or over; and (ii) has recurrent or persistent bleeding; and (iii) is anaemic or has active bleeding; and (c) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (d) the service is performed within 6 months of the upper gastrointestinal endoscopy and colonoscopy
11820	01MAR2013	28FEB2014	N	Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered), (not being a service associated with double balloon enteroscopy), if: (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (b) the patient to whom the service is provided: (i) is aged 10 years or over; and (ii) has recurrent or persistent bleeding; and (iii) is anaemic or has active bleeding; and (c) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (d) the service is performed within 6 months of the upper gastrointestinal endoscopy and colonoscopy (e) the service is not associated with double balloon enteroscopy (f) the service has not been provided to the same patient: (i) more than once in an episode of bleeding, being bleeding occurring within 6 months of the prerequisite upper gastrointestinal endoscopy and colonoscopy (any bleeding after that time is considered to be a new episode); or (ii) on more than 2 occasions in any 12 month period.
11820	01MAR2014	31DEC2014	N	Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device (including administration of the capsule, associated endoscopy procedure if required for placement, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the patient to whom the service is provided: (i) has recurrent or persistent bleeding; and (ii) is anaemic or has active bleeding; and (b) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (c) the service has not been provided to the same patient on more than 2 occasions in the preceding 12 months; and (d) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for Recognition of Training in Gastrointestinal Endoscopy; and (e) the service is not associated with balloon enteroscopy.
11820	01JAN2015	30JUN2016	N	Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device (including administration of the capsule, associated endoscopy procedure if required for placement, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the patient to whom the service is provided: (i) has recurrent or persistent bleeding; and (ii) is anaemic or has active bleeding; and (b) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (c) the service has not been provided to the same patient on more than 2 occasions in the preceding 12 months; and (d) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by The Conjoint Committee for Recognition of Training in Gastrointestinal Endoscopy; and (e) the service is not associated with balloon enteroscopy. (f) the service has not been provided to the same patient: (i) more than once in an episode of bleeding, being bleeding occurring within 6 months of the prerequisite upper gastrointestinal endoscopy and colonoscopy (any bleeding after that time is considered to be a new episode); or (ii) on more than 2 occasions in any 12 month period
11820	01JUL2016	31OCT2017	N	Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device (including administration of the capsule, associated endoscopy procedure if required for placement, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the patient to whom the service is provided: (i) has recurrent or persistent bleeding; and (ii) is anaemic or has active bleeding; and (b) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (c) the service has not been provided to the same patient on more than 2 occasions in the preceding 12 months; and (d) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by the Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (e) the service is not associated with balloon enteroscopy
11820	01NOV2017	31DEC9999	Y	Capsule endoscopy to investigate an episode of obscure gastrointestinal bleeding, using a capsule endoscopy device (including administration of the capsule, associated endoscopy procedure if required for placement, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the service is provided to a patient who: (i) has overt gastrointestinal bleeding; or (ii) has gastrointestinal bleeding that is recurrent or persistent, and iron deficiency anaemia that is not due to coeliac disease, and, if the patient also has menorrhagia, has had the menorrhagia considered and managed; and (b) an upper gastrointestinal endoscopy and a colonoscopy have been performed on the patient and have not identified the cause of the bleeding; and (c) the service has not been provided to the same patient on more than 2 occasions in the preceding 12 months; and (d) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by the Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (e) the service is not associated with a service to which item 30680, 30682, 30684 or 30686 applies
11823	01MAR2009	28FEB2014	N	CAPSULE ENDOSCOPY to conduct small bowel surveillance of a patient diagnosed with Peutz-Jeghers syndrome, using a capsule endoscopy device approved by the Therapeutic Goods Administration. The procedure includes the administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered (not being a service associated with double balloon enteroscopy). Medicare benefits are only payable for this item if: 1. the service has been performed by a specialist or consultant physician with endoscopic training that is recognised by the Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and 2. the patient to whom the service is provided has been conclusively diagnosed with Peutz-Jeghers syndrome (PJS) This item is available once in any two year period.
11823	01MAR2014	31DEC9999	Y	Capsule endoscopy to conduct small bowel surveillance of a patient diagnosed with Peutz-Jeghers Syndrome, using a capsule endoscopy device approved by the Therapeutic Goods Administration (including administration of the capsule, imaging, image reading and interpretation, and all attendances for providing the service on the day the capsule is administered) if: (a) the service is performed by a specialist or consultant physician with endoscopic training that is recognised by the Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy; and (b) the item is performed only once in any 2 year period; and (c) the service is not associated with balloon enteroscopy.
11830	01JUL1992	31OCT1992	N	DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR involving anal manometry or measurement of anorectal sensation or measurement of the rectosphincteric reflex (Ministerial Determination)
11830	01NOV1992	31DEC9999	Y	DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR involving anal manometry or measurement of anorectal sensation or measurement of the rectosphincteric reflex
11833	01JUL1992	31OCT1992	N	DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR and sphincter muscles involving electromyography or measurement of pudendal and spinal nerve motor latency (Ministerial Determination)
11833	01NOV1992	31DEC9999	Y	DIAGNOSIS of ABNORMALITIES of the PELVIC FLOOR and sphincter muscles involving electromyography or measurement of pudendal and spinal nerve motor latency
11900	01DEC1991	30APR2003	N	URINE FLOW STUDY including peak urine flow measurement, not being a service associated with a service to which item 11918 applies
11900	01MAY2003	28FEB2022	N	URINE FLOW STUDY including peak urine flow measurement, not being a service associated with a service to which item 11919 applies
11900	01MAR2022	31DEC9999	Y	Urine flow study, including peak urine flow measurement, not being a service associated with a service to which item 11912, 11917 or 11919 applies
11903	01DEC1991	30APR2003	N	CYSTOMETROGRAPHY, not being a service associated with a service to which item 11912, 11915, 11918, 11012-11027, 11921, 36800 or any item in Group I3 applies
11903	01MAY2003	31DEC9999	Y	CYSTOMETROGRAPHY, not being a service associated with a service to which any of items 11012-11027, 11912, 11915, 11919, 11921 and 36800 or any item in Group I3 of Category 5 applies
11906	01DEC1991	30APR2003	N	URETHRAL PRESSURE PROFILOMETRY, not being a service associated with a service to which item 11909, 11918, 11012-11027, 11921, 36800 or any item in Group I3 applies
11906	01MAY2003	31DEC9999	Y	URETHRAL PRESSURE PROFILOMETRY, not being a service associated with a service to which any of items 11012-11027, 11909, 11919, 11921 and 36800 or any item in Group I3 of Category 5 applies
11909	01DEC1991	30APR2003	N	URETHRAL PRESSURE PROFILOMETRY WITH simultaneous measurement of urethral sphincter electromyography, not being a service associated with a service to which item 11906, 11915, 11918, 36800 or any item in Group I3 applies
11909	01MAY2003	31DEC9999	Y	URETHRAL PRESSURE PROFILOMETRY WITH simultaneous measurement of urethral sphincter electromyography, not being a service associated with a service to which item 11906, 11915, 11919, 36800 or any item in Group I3 of Category 5 applies
11912	01DEC1991	30APR2003	N	CYSTOMETROGRAPHY with simultaneous measurement of rectal pressure, not being a service associated with a service to which item 11903, 11915, 11918, 11012-11027, 11921, 36800 or any item in Group I3 applies
11912	01MAY2003	28FEB2022	N	CYSTOMETROGRAPHY with simultaneous measurement of rectal pressure, not being a service associated with a service to which any of items 11012-11027, 11903, 11915, 11919, 11921 and 36800 or any item in Group I3 of Category 5 applies
11912	01MAR2022	31DEC9999	Y	Cystometrography:(a) with measurement of any one or more of the following: (i) urine flow rate; (ii) urethral pressure profile; (iii) urethral sphincter electromyography; and(b) with simultaneous measurement of: (i) rectal pressure; or (ii) stomal or vaginal pressure if rectal pressure is not possible;not being a service associated with a service to which any of items 11012 to 11027, 11900, 11917, 11919 and 36800 or an item in Group I3 of the diagnostic imaging services table applies
11915	01DEC1991	30APR2003	N	CYSTOMETROGRAPHY with simultaneous measurement of urethral sphincter electromyography, not being a service associated with a service to which item 11903, 11909, 11912, 11918, 11012-11027, 11921, 36800 or any item in Group I3 applies
11915	01MAY2003	31DEC9999	Y	CYSTOMETROGRAPHY with simultaneous measurement of urethral sphincter electromyography, not being a service associated with a service to which any of items 11012-11027, 11903, 11909, 11912, 11919, 11921 and 36800 or any item in Group I3 of Category 5 applies
11917	01NOV2002	30APR2003	N	CYSTOMETROGRAPHY IN CONJUNCTION WITH ULTRASOUND OF 1 OR MORE COMPONENTS OF THE URINARY TRACT, with measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; including all associated imaging by any approach, not being a service associated with a service to which items 11012-11027, 11900-11915, 11918,11921 and 36800 apply.
11917	01MAY2003	28FEB2022	N	CYSTOMETROGRAPHY IN CONJUNCTION WITH ULTRASOUND OF 1 OR MORE COMPONENTS OF THE URINARY TRACT, with measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; including all imaging associated with cystometrography, not being a service associated with a service to which items 11012-11027, 11900-11915, 11919, 11921 and 36800 apply.
11917	01MAR2022	31DEC9999	Y	Cystometrography, in conjunction with real time ultrasound of one or more components of the urinary tract:(a) with measurement of any one or more of the following: (i) urine flow rate; (ii) urethral pressure profile; (iii) urethral sphincter electromyography; and(b) with simultaneous measurement of: (i) rectal pressure; or (ii) stomal or vaginal pressure if rectal pressure is not possible;including all imaging associated with cystometrography, not being a service associated with a service to which any of items 11012 to 11027, 11900, 11912, 11919 and 36800 or an item in Group I3 of the diagnostic imaging services table applies
11918	01DEC1991	31OCT1994	N	CYSTOMETROGRAPHY with simultaneous measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; and all associated fluoroscopic imaging, not being a service associated with a service to which items 1190011915, 1101211027, 11921 and 36800 apply
11918	01NOV1994	30JUN1996	N	CYSTOMETROGRAPHY with simultaneous measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; and all associated imaging, not being a service associated with a service to which items 1190011915, 1101211027, 11921 and 36800 apply
11918	01JUL1996	31OCT2002	N	CYSTOMETROGRAPHY IN CONJUNCTION WITH IMAGING, with measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; including all imaging associated with cystometrography, not being a service associated with a service to which items 11012-11027, 11900-11915, 11921 and 36800 apply
11918	01NOV2002	31DEC9999	Y	CYSTOMETROGRAPHY IN CONJUNCTION WITH CONTRAST MICTURATING CYSTOURETHROGRAPHY, with measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; including all associated imaging by any approach, not being a service associated with a service to which items 11012-11027, 11900-11917, 11921 and 36800 apply
11919	01MAY2003	31OCT2020	N	CYSTOMETROGRAPHY IN CONJUNCTION WITH CONTRAST MICTURATING CYSTOURETHROGRAPHY, with measurement of any 1 or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; including all imaging associated with cystometrography, not being a service associated with a service to which items 11012-11027, 11900-11917, 11921 and 36800 apply
11919	01NOV2020	28FEB2022	N	CYSTOMETROGRAPHY IN CONJUNCTION WITH CONTRAST MICTURATING CYSTOURETHROGRAPHY, with measurement of any one or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography, being a service associated with a service to which items 60506 or 60509 applies; other than a service associated with a service to which items 11012-11027, 11900-11917, 11921 and 36800 apply
11919	01MAR2022	31DEC9999	Y	CYSTOMETROGRAPHY IN CONJUNCTION WITH CONTRAST MICTURATING CYSTOURETHROGRAPHY, with measurement of any one or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography, being a service associated with a service to which items 60506 or 60509 applies; other than a service associated with a service to which items 11012-11027, 11900-11917 and 36800 apply
11921	01DEC1991	31DEC9999	Y	BLADDER WASHOUT TEST for localisation of urinary infection not including bacterial counts for organisms in specimens
12000	01DEC1991	30JUN1993	N	SKIN SENSITIVITY TESTING for allergens, USING 1 TO 20 ALLERGENS, not being a service associated with a service to which item 12006 applies
12000	01JUL1993	31OCT1995	N	SKIN SENSITIVITY TESTING for allergens, USING 1 TO 20 ALLERGENS, not being a service associated with a service to which item 12006 or 12009 applies
12000	01NOV1995	31OCT2016	N	SKIN SENSITIVITY TESTING for allergens, USING 1 TO 20 ALLERGENS, not being a service associated with a service to which item 12012, 12015, 12018 or 12021 applies
12000	01NOV2016	30APR2017	N	Skin sensitivity testing for allergens, using one to 20 allergens, other than a service associated with a service to which item 12012, 12017, 12021, 12022, 12024, 12025, 12026 or 12027 applies
12000	01MAY2017	31OCT2018	N	Skin sensitivity testing for allergens, using one to 20 allergens, other than a service associated with a service to which item 12012, 12017, 12021, 12022 or 12024 applies
12000	01NOV2018	31DEC9999	Y	Skin prick testing for aeroallergens by a specialist or consultant physician in the practice of the specialist or consultant physicians specialty, including all allergens tested on the same day, not being a service associated with a service to which item 12001, 12002, 12005, 12012, 12017, 12021, 12022 or 12024 applies
12001	01NOV2018	31DEC9999	Y	Skin prick testing for aeroallergens, including all allergens tested on the same day, not being a service associated with a service to which item 12000, 12002, 12005, 12012, 12017, 12021, 12022 or 12024 applies. Applicable only once in any 12 month period
12002	01NOV2018	31DEC9999	Y	Repeat skin prick testing of a patient for aeroallergens, including all allergens tested on the same day, if: (a) further testing for aeroallergens is indicated in the same 12 month period to which item 12001 applies to a service for the patient; and (b) the service is not associated with a service to which item 12000, 12001, 12005, 12012, 12017, 12021, 12022 or 12024 applies Applicable only once in any 12 month period
12003	01DEC1991	30JUN1993	N	SKIN SENSITIVITY TESTING for allergens, USING MORE THAN 20 ALLERGENS, not being a service associated with a service to which item 12009 applies
12003	01JUL1993	31OCT1995	N	SKIN SENSITIVITY TESTING for allergens, USING MORE THAN 20 ALLERGENS, not being a service associated with a service to which item 12006 or 12009 applies
12003	01NOV1995	31OCT2016	N	SKIN SENSITIVITY TESTING for allergens, USING MORE THAN 20 ALLERGENS, not being a service associated with a service to which item 12012, 12015, 12018 or 12021 applies
12003	01NOV2016	30APR2017	N	Skin sensitivity testing for allergens, using more than 20 allergens, other than a service associated with a service to which item 12012, 12017, 12021, 12022, 12024, 12025, 12026 or 12027 applies
12003	01MAY2017	31OCT2018	N	Skin sensitivity testing for allergens, using more than 20 allergens, other than a service associated with a service to which item 12012, 12017, 12021, 12022 or 12024 applies
12003	01NOV2018	31DEC9999	Y	Skin prick testing for food and latex allergens, including all allergens tested on the same day, not being a service associated with a service to which item 12012, 12017, 12021, 12022 or 12024 applies
12004	01NOV2018	31DEC9999	Y	Skin testing for medication allergens (antibiotics or non general anaesthetics agents) and venoms (including prick testing and intradermal testing with a number of dilutions), including all allergens tested on the same day, not being a service associated with a service to which item 12012, 12017, 12021, 12022 or 12024 applies
12005	01NOV2018	31DEC9999	Y	Skin testing: (a) performed by or on behalf of a specialist or consultant physician in the practice of the specialist or consultant physicians specialty; and (b) for agents used in the perioperative period (including prick testing and intradermal testing with a number of dilutions), to investigate anaphylaxis in a patient with a history of prior anaphylactic reaction or cardiovascular collapse associated with the administration of an anaesthetic; and (c) including all allergens tested on the same day; and (d) not being a service associated with a service to which item 12000, 12001, 12002, 12003, 12012, 12017, 12021, 12022 or 12024 applies
12006	01DEC1991	31DEC9999	Y	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis, using 1 to 20 ALLERGENS
12009	01DEC1991	31DEC9999	Y	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis, using more than 20 ALLERGENS
12012	01NOV1995	31OCT2016	N	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis using less than the number of allergens included in a standard patch test battery
12012	01NOV2016	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis using not more than 25 allergens
12015	01NOV1995	31DEC9999	Y	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis using all of the allergens in a standard patch test battery
12017	01NOV2016	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis using more than 25 allergens but not more than 50 allergens
12018	01NOV1995	31DEC9999	Y	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis using all of the allergens in a standard patch test battery and additional allergens to a total of up to and including 50 allergens
12021	01NOV1995	31OCT2016	N	EPICUTANEOUS PATCH TESTING in the investigation of allergic dermatitis, performed by or on behalf of a specialist in the practice of his or her specialty, using more than 50 allergens
12021	01NOV2016	30APR2017	N	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist in the practice of his or her specialty, using more than 50 allergens but not more than 75 allergens
12021	01MAY2017	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist, or consultant physician, in the practice of his or her specialty, using more than 50 allergens but not more than 75 allergens
12022	01NOV2016	30APR2017	N	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist in the practice of his or her specialty, using more than 75 allergens but not more than 100 allergens
12022	01MAY2017	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist, or consultant physician, in the practice of his or her specialty, using more than 75 allergens but not more than 100 allergens
12024	01NOV2016	30APR2017	N	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist in the practice of his or her specialty, using more than 100 allergens
12024	01MAY2017	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a specialist, or consultant physician, in the practice of his or her specialty, using more than 100 allergens
12025	01NOV2016	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 50 allergens but not more than 75 allergens
12026	01NOV2016	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 75 allergens but not more than 100 allergens
12027	01NOV2016	31DEC9999	Y	Epicutaneous patch testing in the investigation of allergic dermatitis, performed by or on behalf of a consultant physician in the practice of his or her specialty, using more than 100 allergens
12100	01DEC1991	31DEC9999	Y	ARTERIAL PUNCTURE and collection of blood for diagnostic purposes
12103	01DEC1991	31DEC9999	Y	INTRAARTERIAL CANNULISATION for the purpose of taking multiple arterial blood samples for blood gas analysis
12106	01DEC1991	31DEC9999	Y	COUNTERPULSATION BY INTRAAORTIC BALLOON management on the first day, including percutaneous insertion, initial and subsequent consultations and monitoring of parameters
12109	01DEC1991	31DEC9999	Y	COUNTERPULSATION BY INTRAAORTIC BALLOON management on each day subsequent to the first, including associated consultations and monitoring of parameters
12112	31OCT1992	31DEC9999	Y	CIRCULATORY SUPPORT DEVICE, management of, on first day
12115	31OCT1992	31DEC9999	Y	CIRCULATORY SUPPORT DEVICE, management of, on each day subsequent to the first
12200	01DEC1991	31DEC9999	Y	COLLECTION OF SPECIMEN OF SWEAT by iontophoresis
12201	01MAY2004	31DEC9999	Y	Administration, by a specialist or consultant physician in the practice of the specialists or consultant physicians specialty, of thyrotropin alfa-rch (recombinant human thyroid-stimulating hormone), and arranging services to which both items 61426 and 66650 apply, for the detection of recurrent well-differentiated thyroid cancer in a patient if: (a) the patient has had a total thyroidectomy and 1 ablative dose of radioactive iodine; and (b) the patient is maintained on thyroid hormone therapy; and (c) the patient is at risk of recurrence; and (d) on at least 1 previous whole body scan or serum thyroglobulin test when withdrawn from thyroid hormone therapy, the patient did not have evidence of well-differentiated thyroid cancer; and (e) either: (i) withdrawal from thyroid hormone therapy resulted in severe psychiatric disturbances when hypothyroid; or (ii) withdrawal is medically contra-indicated because the patient has: (a) unstable coronary artery disease; or (b) hypopituitarism; or (c) a high risk of relapse or exacerbation of a previous severe psychiatric illness applicable once only in a 12 month period
12203	01DEC1991	30JUN1995	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, involving continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG, with continuous technician attendance, under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine or under the supervision of a specialist in a sleep laboratory of a recognised hospital, where the patient is referred to him or her by a medical practitioner, including interpretation by physician of recordings; payable no more than 3 times in any 12 month period (Ministerial Determination)
12203	01JUL1995	31OCT1996	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION: (a) involving continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG; and (b) with continuous attendance of a technician; and (c) under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine, or under the supervision of a specialist in a sleep laboratory of a recognised hospital; and (d) where the patient is referred to the consultant physician or specialist by a medical practitioner; and (e) including interpretation of recordings by the consultant physician or specialist; payable only in relation to each of the first 3 times the investigation is performed in any 12 month period
12203	01NOV1996	28FEB1999	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION WHERE: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of a consultant physician in thoracic medicine, or a specialist where the investigation is performed in the sleep laboratory of a recognised hospital; (c) the patient is referred by a medical practitioner; (d) the necessity for the investigation is determined by the supervising medical practitioner prior to the investigation; (e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report ; and (f) interpretation and report are provided by the supervising medical practitioner based on reviewing the direct original recording of polygraphic data from the patient - payable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period.
12203	01MAR1999	31OCT2018	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, FOR AN ADULT AGED 18 YEARS AND OVER WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; b) a technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified adult sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report ; and f) interpretation and report are provided by a qualified adult sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient - payable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period.
12203	01NOV2018	31JUL2020	N	Overnight diagnostic assessment of sleep, for a period of at least 8 hours duration, for a patient aged 18 years or more, to confirm diagnosis of a sleep disorder, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified sleep medicine practitioner or a consultant respiratory physician, the qualified sleep medicine practitioner or consultant respiratory physician determines that assessment is necessary to confirm the diagnosis of a sleep disorder; and (b) the overnight diagnostic assessment is performed to investigate: (i) suspected obstructive sleep apnoea syndrome where the patient is assessed as not suitable for an unattended sleep study; or (ii) suspected central sleep apnoea syndrome; or (iii) suspected sleep hypoventilation syndrome; or (iv) suspected sleep-related breathing disorders in association with non-respiratory co-morbid conditions including heart failure, significant cardiac arrhythmias, neurological disease, acromegaly or hypothyroidism; or (v) unexplained hypersomnolence which is not attributed to inadequate sleep hygiene or environmental factors; or (vi) suspected parasomnia or seizure disorder where clinical diagnosis cannot be established on clinical features alone (including associated atypical features, vigilance behaviours or failure to respond to conventional therapy); or (vii) suspected sleep related movement disorder, where the diagnosis of restless legs syndrome is not evident on clinical assessment; and (c) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (d) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the overnight diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12203	01AUG2020	30SEP2020	N	Overnight diagnostic assessment of sleep, for a period of at least 8 hours duration, for a patient aged 18 years or more, to confirm diagnosis of a sleep disorder, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified sleep medicine practitioner or a consultant respiratory physician, the qualified sleep medicine practitioner or consultant respiratory physician determines that assessment is necessary to confirm the diagnosis of a sleep disorder; and (b) the overnight diagnostic assessment is performed to investigate: (i) suspected obstructive sleep apnoea syndrome where the patient is assessed as not suitable for an unattended sleep study; or (ii) suspected central sleep apnoea syndrome; or (iii) suspected sleep hypoventilation syndrome; or (iv) suspected sleep-related breathing disorders in association with non-respiratory co-morbid conditions including heart failure, significant cardiac arrhythmias, neurological disease, acromegaly or hypothyroidism; or (v) unexplained hypersomnolence which is not attributed to inadequate sleep hygiene or environmental factors; or (vi) suspected parasomnia or seizure disorder where clinical diagnosis cannot be established on clinical features alone (including associated atypical features, vigilance behaviours or failure to respond to conventional therapy); or (vii) suspected sleep related movement disorder, where the diagnosis of restless legs syndrome is not evident on clinical assessment; and (c) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (d) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the overnight diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12203	01OCT2020	28FEB2021	N	Overnight diagnostic assessment of sleep, for at least 8 hours, for a patient aged 18 years or more, to confirm diagnosis of a sleep disorder, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified adult sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified adult sleep medicine practitioner or a consultant respiratory physician, the qualified adult sleep medicine practitioner or consultant respiratory physician determines that assessment is necessary to confirm the diagnosis of a sleep disorder; and (b) the overnight diagnostic assessment is performed to investigate: (i) suspected obstructive sleep apnoea syndrome where the patient is assessed as not suitable for an unattended sleep study; or (ii) suspected central sleep apnoea syndrome; or (iii) suspected sleep hypoventilation syndrome; or (iv) suspected sleep-related breathing disorders in association with non-respiratory co-morbid conditions including heart failure, significant cardiac arrhythmias, neurological disease, acromegaly or hypothyroidism; or (v) unexplained hypersomnolence which is not attributed to inadequate sleep hygiene or environmental factors; or (vi) suspected parasomnia or seizure disorder where clinical diagnosis cannot be established on clinical features alone (including associated atypical features, vigilance behaviours or failure to respond to conventional therapy); or (vii) suspected sleep related movement disorder, where the diagnosis of restless legs syndrome is not evident on clinical assessment; and (c) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (d) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the overnight diagnostic assessment is not provided to the patient on the same occasion that a service described in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12203	01MAR2021	31DEC9999	Y	Overnight diagnostic assessment of sleep, for at least 8 hours, for a patient aged 18 years or more, to confirm diagnosis of a sleep disorder, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified adult sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 3 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified adult sleep medicine practitioner or a consultant respiratory physician, the qualified adult sleep medicine practitioner or consultant respiratory physician determines that assessment is necessary to confirm the diagnosis of a sleep disorder; and (b) the overnight diagnostic assessment is performed to investigate: (i) suspected obstructive sleep apnoea syndrome where the patient is assessed as not suitable for an unattended sleep study; or (ii) suspected central sleep apnoea syndrome; or (iii) suspected sleep hypoventilation syndrome; or (iv) suspected sleep-related breathing disorders in association with non-respiratory co-morbid conditions including heart failure, significant cardiac arrhythmias, neurological disease, acromegaly or hypothyroidism; or (v) unexplained hypersomnolence which is not attributed to inadequate sleep hygiene or environmental factors; or (vi) suspected parasomnia or seizure disorder where clinical diagnosis cannot be established on clinical features alone (including associated atypical features, vigilance behaviours or failure to respond to conventional therapy); or (vii) suspected sleep related movement disorder, where the diagnosis of restless legs syndrome is not evident on clinical assessment; and (c) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (d) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the overnight diagnostic assessment is not provided to the patient on the same occasion that a service described in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to the patient Applicable only once in any 12 month period
12204	01NOV2018	31JUL2020	N	Overnight assessment of positive airway pressure, for a period of at least 8 hours duration, for a patient aged 18 years or more, if: (a) the necessity for an intervention sleep study is determined by a qualified sleep medicine practitioner or consultant respiratory physician where a diagnosis of a sleep-related breathing disorder has been made; and (b) the patient has not undergone positive airway pressure therapy in the previous 6 months; and (c) following professional attendance on the patient by a qualified sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), the qualified sleep medicine practitioner or consultant respiratory physician establishes that the sleep-related breathing disorder is responsible for the patients symptoms; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement; (ix) position; and (f) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (g) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (h) the overnight assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12204	01AUG2020	30SEP2020	N	Overnight assessment of positive airway pressure, for a period of at least 8 hours duration, for a patient aged 18 years or more, if: (a) the necessity for an intervention sleep study is determined by a qualified sleep medicine practitioner or consultant respiratory physician where a diagnosis of a sleep-related breathing disorder has been made; and (b) the patient has not undergone positive airway pressure therapy in the previous 6 months; and (c) following professional attendance on the patient by a qualified sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), the qualified sleep medicine practitioner or consultant respiratory physician establishes that the sleep-related breathing disorder is responsible for the patients symptoms; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement; (ix) position; and (f) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (g) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (h) the overnight assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12204	01OCT2020	28FEB2021	N	Overnight assessment of positive airway pressure, for at least 8 hours, for a patient aged 18 years or more, if: (a) the necessity for an intervention sleep study is determined by a qualified adult sleep medicine practitioner or consultant respiratory physician where a diagnosis of a sleep-related breathing disorder has been made; and (b) the patient has not undergone positive airway pressure therapy in the previous 6 months; and (c) following professional attendance on the patient by a qualified adult sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), the qualified adult sleep medicine practitioner or consultant respiratory physician establishes that the sleep-related breathing disorder is responsible for the patients symptoms; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement; (ix) position; and (f) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (g) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (h) the overnight assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12204	01MAR2021	31DEC9999	Y	Overnight assessment of positive airway pressure, for at least 8 hours, for a patient aged 18 years or more, if: (a) the necessity for an intervention sleep study is determined by a qualified adult sleep medicine practitioner or consultant respiratory physician where a diagnosis of a sleep-related breathing disorder has been made; and (b) the patient has not undergone positive airway pressure therapy in the previous 6 months; and (c) following professional attendance on the patient by a qualified adult sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), the qualified adult sleep medicine practitioner or consultant respiratory physician establishes that the sleep-related breathing disorder is responsible for the patients symptoms; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement; (ix) position; and (f) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (g) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (h) the overnight assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to the patient Applicable only once in any 12 month period
12205	01NOV2018	31OCT2019	N	Follow-up study for a patient aged 18 years or more with a sleep-related breathing disorder, following professional attendance on the patient by a qualified sleep medicine practitioner or consultant respiratory physician (either face-to-face or by video conference), if:(a) either: (i) there has been a recurrence of symptoms not explained by known or identifiable factors such as inadequate usage of treatment, sleep duration or significant recent illness; or (ii) there has been a significant change in weight or changes in co-morbid conditions that could affect sleep-related breathing disorders and other means of assessing treatment efficacy (including review of data stored by a therapy device used by the patient) are unavailable, or have been equivocal; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) the follow-up study is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12205	01NOV2019	31JUL2020	N	Follow-up study for a patient aged 18 years or more with a sleep-related breathing disorder, following professional attendance on the patient by a qualified sleep medicine practitioner or consultant respiratory physician (either face-to-face or by video conference), if: (a) any of the following subparagraphs applies: (i) there has been a recurrence of symptoms not explained by known or identifiable factors such as inadequate usage of treatment, sleep duration or significant recent illness; (ii) there has been a significant change in weight or changes in co-morbid conditions that could affect sleep-related breathing disorders, and other means of assessing treatment efficacy (including review of data stored by a therapy device used by the patient) are unavailable or have been equivocal; (iii) the patient has undergone a therapeutic intervention (including, but not limited to, positive airway pressure, upper airway surgery, positional therapy, appropriate oral appliance, weight loss of more than 10% in the previous 6 months or oxygen therapy), and there is either clinical evidence of sub-optimal response or uncertainty about control of sleep-disordered breathing; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) the follow-up study is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12205	01AUG2020	30SEP2020	N	Follow-up study for a patient aged 18 years or more with a sleep-related breathing disorder, following professional attendance on the patient by a qualified sleep medicine practitioner or consultant respiratory physician (either face-to-face or by video conference), if: (a) any of the following subparagraphs applies: (i) there has been a recurrence of symptoms not explained by known or identifiable factors such as inadequate usage of treatment, sleep duration or significant recent illness; (ii) there has been a significant change in weight or changes in co-morbid conditions that could affect sleep-related breathing disorders, and other means of assessing treatment efficacy (including review of data stored by a therapy device used by the patient) are unavailable or have been equivocal; (iii) the patient has undergone a therapeutic intervention (including, but not limited to, positive airway pressure, upper airway surgery, positional therapy, appropriate oral appliance, weight loss of more than 10% in the previous 6 months or oxygen therapy), and there is either clinical evidence of sub-optimal response or uncertainty about control of sleep-disordered breathing; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) the follow-up study is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713, or 12250 is provided to the patient Applicable only once in any 12 month period
12205	01OCT2020	28FEB2021	N	Follow-up study for a patient aged 18 years or more with a sleep-related breathing disorder, following professional attendance on the patient by a qualified adult sleep medicine practitioner or consultant respiratory physician (either face-to-face or by video conference), if: (a) any of the following subparagraphs applies: (i) there has been a recurrence of symptoms not explained by known or identifiable factors such as inadequate usage of treatment, sleep duration or significant recent illness; (ii) there has been a significant change in weight or changes in co-morbid conditions that could affect sleep-related breathing disorders, and other means of assessing treatment efficacy (including review of data stored by a therapy device used by the patient) are unavailable or have been equivocal; (iii) the patient has undergone a therapeutic intervention (including, but not limited to, positive airway pressure, upper airway surgery, positional therapy, appropriate oral appliance, weight loss of more than 10% in the previous 6 months or oxygen therapy), and there is either clinical evidence of sub-optimal response or uncertainty about control of sleep-disordered breathing; and (b) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (c) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (e) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) the follow-up study is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12205	01MAR2021	31DEC9999	Y	Follow-up study for a patient aged 18 years or more with a sleep-related breathing disorder, following professional attendance on the patient by a qualified adult sleep medicine practitioner or consultant respiratory physician (either face-to-face or by video conference), if: (a) any of the following subparagraphs applies: (i) there has been a recurrence of symptoms not explained by known or identifiable factors such as inadequate usage of treatment, sleep duration or significant recent illness; (ii) there has been a significant change in weight or changes in co-morbid conditions that could affect sleep-related breathing disorders, and other means of assessing treatment efficacy (including review of data stored by a therapy device used by the patient) are unavailable or have been equivocal; (iii) the patient has undergone a therapeutic intervention (including, but not limited to, positive airway pressure, upper airway surgery, positional therapy, appropriate oral appliance, weight loss of more than 10% in the previous 6 months or oxygen therapy), and there is either clinical evidence of sub-optimal response or uncertainty about control of sleep-disordered breathing; and (b) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (c) there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (e) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) the follow-up study is not provided to the patient on the same occasion that a service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to the patient Applicable only once in any 12 month period
12206	01FEB1992	30JUN1995	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, involving continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG, with continuous technician attendance, under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine or under the supervision of a specialist in a sleep laboratory of a recognised hospital, where the patient is referred to him or her by a medical practitioner, including interpretation by physician of recordings; being the fourth or subsequent investigation in a 12 month period (Ministerial Determination)
12206	01JUL1995	31OCT1996	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION: (a) involving continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG; and (b) with the continuous attendance of a technician; and (c) under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine, or under the supervision of a specialist in a sleep laboratory of a recognised hospital; and (d) where the patient is referred to the consultant physician or specialist by a medical practitioner; and (e) including interpretation of recordings by the consultant physician or specialist; payable only in relation to the fourth investigation, and each subsequent investigation, performed in a 12 month period identified for the purposes of item 12203
12206	01NOV1996	31DEC9999	Y	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION WHERE: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of a consultant physician in thoracic medicine, or a specialist where the investigation is performed in the sleep laboratory of a recognised hospital; (c) the patient is referred by a medical practitioner: (d) the necessity for the investigation is determined by the supervising medical practitioner prior to the investigation; (e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; and (f) interpretation and report are provided by the supervising medical practitioner based on reviewing the direct original recording of polygraphic data from the patient - payable only in relation to each of the fourth, and each subsequent, occasion the investigation is performed in any 12 month period identified for the purposes of item 12203
12207	19JUN1997	31OCT1997	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, WHERE: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of a consultant physician in thoracic medicine, or a specialist where the investigation is performed in the sleep laboratory of a recognised hospital; (c) the patient is referred by a medical practitioner; (d) the necessity for the investigation is determined by the supervising medical practitioner prior to the investigation; (e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; and (f) interpretation and report are provided by the supervising medical practitioner based on reviewing the direct original recording of polygraphic data from the patient where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12203 applies for the adjustment and/or testing of the effectiveness of a positive pressure ventilatory support device (other than nasal continuous positive airway pressure) in sleep, in a patient with severe cardio-respiratory failure, and where previous studies have demonstrated failure of continuous positive airway pressure or oxygen - each additional investigation
12207	01NOV1997	28FEB1999	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, WHERE: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of a consultant physician in thoracic medicine, or a specialist where the investigation is performed in the sleep laboratory of a recognised hospital; (c) the patient is referred by a medical practitioner; (d) the necessity for the investigation is determined by the supervising medical practitioner prior to the investigation; (e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; and (f) interpretation and report are provided by the supervising medical practitioner based on reviewing the direct original recording of polygraphic data from the patient where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12203 applies for the adjustment and/or testing of the effectiveness of a positive pressure ventilatory support device (other than nasal continuous positive airway pressure) in sleep, in a patient with severe cardio-respiratory failure, and where previous studies have demonstrated failure of continuous positive airway pressure or oxygen - each additional investigation
12207	01MAR1999	31OCT2001	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, WHERE: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; (c) the patient is referred by a medical practitioner; (d) the necessity for the investigation is determined by the supervising medical practitioner prior to the investigation; (e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; and (f) interpretation and report are provided by the supervising medical practitioner based on reviewing the direct original recording of polygraphic data from the patient where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12203 applies for the adjustment and/or testing of the effectiveness of a positive pressure ventilatory support device (other than nasal continuous positive airway pressure) in sleep, in a patient with severe cardio-respiratory failure, and where previous studies have demonstrated failure of continuous positive airway pressure or oxygen - each additional investigation
12207	01NOV2001	31OCT2018	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS DURATION, FOR AN ADULT AGED 18 YEARS AND OVER WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; b) a technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified adult sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; and f) interpretation and report are provided by a qualified adult sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12203 applies for the adjustment and/or testing of the effectiveness of a positive pressure ventilatory support device (other than nasal continuous positive airway pressure) in sleep, in a patient with severe cardio-respiratory failure, and where previous studies have demonstrated failure of continuous positive airway pressure or oxygen - each additional investigation
12207	01NOV2018	31OCT2019	N	Overnight investigation, for a patient aged 18 years or more, for a sleep-related breathing disorder, following professional attendance by a qualified sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient; and (h) previous studies have demonstrated failure of continuous positive airway pressure or oxygen; and (i) if the patient has severe cardio-respiratory failure-a further investigation is indicated in the same 12 month period to which items 12204 and 12205 apply to a service for the patient, for the adjustment or testing, or both, of the effectiveness of a positive pressure ventilatory support device (other than continuous positive airway pressure) in sleep Applicable only once in the same 12 month period to which item 12204 or 12205 applies
12207	01NOV2019	31JUL2020	N	Overnight investigation, for a patient aged 18 years or more, for a sleep-related breathing disorder, following professional attendance by a qualified sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient; and (h) previous studies have demonstrated failure of continuous positive airway pressure or oxygen; and (i) if the patient has severe respiratory failure-a further investigation is indicated in the same 12 month period to which items 12204 and 12205 apply to a service for the patient, for the adjustment or testing, or both, of the effectiveness of a positive pressure ventilatory support device (other than continuous positive airway pressure) in sleep Applicable only once in the same 12 month period to which item 12204 or 12205 applies
12207	01AUG2020	30SEP2020	N	Overnight investigation, for a patient aged 18 years or more, for a sleep-related breathing disorder, following professional attendance by a qualified sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient; and (h) previous studies have demonstrated failure of continuous positive airway pressure or oxygen; and (i) if the patient has severe respiratory failure-a further investigation is indicated in the same 12 month period to which items 12204 and 12205 apply to a service for the patient, for the adjustment or testing, or both, of the effectiveness of a positive pressure ventilatory support device (other than continuous positive airway pressure) in sleep Applicable only once in the same 12 month period to which item 12204 or 12205 applies
12207	01OCT2020	28FEB2021	N	Overnight investigation, for a patient aged 18 years or more, for a sleep-related breathing disorder, following professional attendance by a qualified adult sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified adult sleep medicine practitioner before the investigation; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient; and (h) previous studies have demonstrated failure of continuous positive airway pressure or oxygen; and (i) if the patient has severe respiratory failure-a further investigation is indicated in the same 12 month period to which items 12204 and 12205 apply to a service for the patient, for the adjustment or testing, or both, of the effectiveness of a positive pressure ventilatory support device (other than continuous positive airway pressure) in sleep Applicable only once in any 12 month period
12207	01MAR2021	31DEC9999	Y	Overnight investigation, for a patient aged 18 years or more, for a sleep-related breathing disorder, following professional attendance by a qualified adult sleep medicine practitioner or a consultant respiratory physician (either face-to-face or by video conference), if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified adult sleep medicine practitioner before the investigation; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen) (ix) position; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate and limb movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to the patient; and (h) previous studies have demonstrated failure of continuous positive airway pressure or oxygen; and (i) if the patient has severe respiratory failure-a further investigation is indicated in the same 12 month period to which items 12204 and 12205 apply to a service for the patient, for the adjustment or testing, or both, of the effectiveness of a positive pressure ventilatory support device (other than continuous positive airway pressure) in sleep Applicable only once in any 12 month period
12208	01NOV2018	31OCT2019	N	Overnight investigation for sleep apnoea for a period of at least 8 hours duration, for a patient aged 18 years or more, if: (a) a qualified sleep medicine practitioner or consultant respiratory physician has determined that the investigation is necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) a further investigation is indicated in the same 12 month period to which item 12203 applies to a service for the patient because insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or less, during the previous investigation to which that item applied; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in the same 12 month period to which item 12203 applies
12208	01NOV2019	31JUL2020	N	Overnight investigation for sleep apnoea for a period of at least 8 hours duration, for a patient aged 18 years or more, if: (a) a qualified sleep medicine practitioner or consultant respiratory physician has determined that the investigation is necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) a further investigation is indicated in the same 12 month period to which item 12203 applies to a service for the patient because insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or less, during the previous investigation to which that item applied; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12208	01AUG2020	30SEP2020	N	Overnight investigation for sleep apnoea for a period of at least 8 hours duration, for a patient aged 18 years or more, if: (a) a qualified sleep medicine practitioner or consultant respiratory physician has determined that the investigation is necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (e) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) a further investigation is indicated in the same 12 month period to which item 12203 applies to a service for the patient because insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or less, during the previous investigation to which that item applied; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12208	01OCT2020	28FEB2021	N	Overnight investigation, for sleep apnoea for at least 8 hours, for a patient aged 18 years or more, if: (a) a qualified adult sleep medicine practitioner or consultant respiratory physician has determined that the investigation is necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (e) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) a further investigation is indicated in the same 12 month period to which item 12203 applies to a service for the patient because insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or less, during the previous investigation to which that item applied; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 or 12250 is provided to the patient Applicable only once in any 12 month period
12208	01MAR2021	31DEC9999	Y	Overnight investigation, for sleep apnoea for at least 8 hours, for a patient aged 18 years or more, if: (a) a qualified adult sleep medicine practitioner or consultant respiratory physician has determined that the investigation is necessary to confirm the diagnosis of a sleep disorder; and (b) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (c) there is continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (d) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (e) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (f) a further investigation is indicated in the same 12 month period to which item 12203 applies to a service for the patient because insufficient sleep was acquired, as evidenced by a sleep efficiency of 25% or less, during the previous investigation to which that item applied; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11713, 11714, 11716, 11717, 11723, 11735 or 12250 is provided to the patient Applicable only once in any 12 month period
12209	01JUL1996	31DEC9999	Y	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA for a period of at least 8 hours duration where: (a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG. EOG, submental EMG. anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG are performed; (b) a technician is in continuous attendance under the supervision of medical practitioner specified in the Attachment; (c) the patient is referred to the specified medical practitioner by a consultant physician, specialist in otolaryngology or paediatric surgery, or another specified medical practitioner; (d) polygraphic records are analysed epoch by epoch with manual scoring, or manual correction of computerised scoring, and stored for interpretation and preparation of report; where such analysis requires assessment of sleep stage, arousals, respiratory events and clinically significant alterations in heart rate and limb movement; and (e) interpretation and report is provided by the specified medical practitioner based on reviewing the direct original of polygraphic data from the patient - payable on not more than 3 occasions in any 12 month period. (Ministerial Determination)
12210	01NOV2001	31OCT2018	N	OVERNIGHT PAEDIATRIC INVESTIGATION FOR A PERIOD OF AT LEAST 8 HOURS DURATION FOR A CHILD AGED 0 - 12 YEARS, WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG (minimum of 4 EEG leads with facility to increase to 6 in selected investigations), EOG, EMG submental +/- diaphragm, respiratory movement must include rib and abdomen (+/- sum) airflow detection, measurement of CO2 either end-tidal or transcutaneous, oxygen saturation and ECG are performed; b) a technician or registered nurse with sleep technology training is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and the assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; f) the interpretation and report to be provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient. payable only in relation to the first 3 occasions the investigation is performed in a 12 month period.
12210	01NOV2018	30SEP2020	N	Overnight paediatric investigation, for a period of at least 8 hours in duration, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12210	01OCT2020	28FEB2021	N	Overnight paediatric investigation, for at least 8 hours, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12210	01MAR2021	31DEC9999	Y	Overnight paediatric investigation, for at least 8 hours, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service to which item 11704, 11705, 11707, 11714, 11716, 11717, 11723 or 11735 applies is provided to the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12212	01MAR1999	31DEC9999	Y	Historical item included for item mapping purposes
12213	01NOV2001	31OCT2018	N	OVERNIGHT PAEDIATRIC INVESTIGATION FOR A PERIOD OF AT LEAST 8 HOURS DURATION FOR A CHILD AGED BETWEEN 12 AND 18 YEARS, WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG (minimum of 4 EEG leads with facility to increase to 6 in selected investigations), EOG, EMG submental +/- diaphragm, respiratory movement must include rib and abdomen (+/- sum) airflow detection, measurement of CO2 either end-tidal or transcutaneous, oxygen saturation and ECG are performed; b) a technician or registered nurse with sleep technology training is in continuous attendance under the supervision of a qualified sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and the assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; f) the interpretation and report to be provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient. payable only in relation to the first 3 occasions the investigation is performed in a 12 month period.
12213	01NOV2018	30SEP2020	N	Overnight paediatric investigation, for a period of at least 8 hours in duration, for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12213	01OCT2020	28FEB2021	N	Overnight paediatric investigation, for at least 8 hours, for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12213	01MAR2021	31DEC9999	Y	Overnight paediatric investigation, for at least 8 hours, for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service to which item 11704, 11705, 11707, 11714, 11716, 11717, 11723 or 11735 applies is provided to the patient For each particular patient-applicable only in relation to each of the first 3 occasions the investigation is performed in any 12 month period
12215	01NOV2001	31OCT2018	N	OVERNIGHT PAEDIATRIC INVESTIGATION FOR A PERIOD OF AT LEAST 8 HOURS DURATION FOR CHILDREN AGED 0 - 12 YEARS, WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG (minimum of 4 EEG leads with facility to increase to 6 in selected investigations), EOG, EMG submental +/- diaphragm, respiratory movement must include rib and abdomen (+/- sum) airflow detection, measurement of CO2 either end-tidal or transcutaneous, oxygen saturation and ECG are performed; b) a technician or registered nurse with sleep technology training is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and the assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; f) the interpretation and report to be provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient. where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12210 applies, for therapy with Continuous Positive Airway Pressure (CPAP), bilevel pressure support and/or ventilation is instigated or in the presence of recurring hypoxia and supplemental oxygen is required - each additional investigation.
12215	01NOV2018	30SEP2020	N	Overnight paediatric investigation, for a period of at least 8 hours in duration, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12210 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12210 applied for the patient, and further titration of respiratory support is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12210 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support Applicable only once in the same 12 month period to which item 12210 applies
12215	01OCT2020	28FEB2021	N	Overnight paediatric investigation, for at least 8 hours, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12210 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12210 applied for the patient, and further titration of respiratory support is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12210 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support Applicable only once in the same 12 month period to which item 12210 applies
12215	01MAR2021	31DEC9999	Y	Overnight paediatric investigation, for at least 8 hours, for a patient less than 12 years of age, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified paediatric sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified paediatric sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12210 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12210 applied for the patient, and further titration of respiratory support is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12210 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support; and (h) the investigation is not provided to the patient on the same occasion that a service to which item 11704, 11705, 11707, 11714, 11716, 11717, 11723 or 11735 applies is provided to the patient Applicable only once in the same 12 month period to which item 12210 applies
12217	01NOV2001	31OCT2018	N	OVERNIGHT PAEDIATRIC INVESTIGATION FOR A PERIOD OF AT LEAST 8 HOURS DURATION FOR CHILDREN AGED BETWEEN 12 AND 18 YEARS, WHERE: a) continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recording of EEG (minimum of 4 EEG leads with facility to increase to 6 in selected investigations), EOG, EMG submental +/- diaphragm, respiratory movement must include rib and abdomen (+/- sum) airflow detection, measurement of CO2 either end-tidal or transcutaneous, oxygen saturation and ECG are performed; b) a technician or registered nurse with sleep technology training is in continuous attendance under the supervision of a qualified sleep medicine practitioner; c) the patient is referred by a medical practitioner; d) the necessity for the investigation is determined by a qualified sleep medicine practitioner prior to the investigation; e) polygraphic records are analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and the assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute, and stored for interpretation and preparation of report; f) the interpretation and report to be provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient. where it can be demonstrated that a further investigation is indicated in the same 12 month period to which item 12213 applies, for therapy with Continuous Positive Airway Pressure (CPAP), bilevel pressure support and/or ventilation is instigated or in the presence of recurring hypoxia and supplemental oxygen is required - each additional investigation.
12217	01NOV2018	30SEP2020	N	Overnight paediatric investigation for a period of at least 8 hours in duration for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12213 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12213 applied for the patient, and further titration is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12213 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support Applicable only once in the same 12 month period to which item 12213 applies
12217	01OCT2020	28FEB2021	N	Overnight paediatric investigation, for at least 8 hours, for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12213 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12213 applied for the patient, and further titration is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12213 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support Applicable only once in the same 12 month period to which item 12213 applies
12217	01MAR2021	31DEC9999	Y	Overnight paediatric investigation, for at least 8 hours, for a patient aged at least 12 years but less than 18 years, if: (a) the patient is referred by a medical practitioner; and (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner before the investigation; and (c) there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (d) a sleep technician, or registered nurse with sleep technology training, is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and report are provided by a qualified sleep medicine practitioner based on reviewing the direct original recording of polygraphic data from the patient; and (g) a further investigation is indicated in the same 12 month period to which item 12213 applies to a service for the patient, for a patient using Continuous Positive Airway Pressure (CPAP) or non-invasive or invasive ventilation, or supplemental oxygen, in either or both of the following circumstances: (i) there is ongoing hypoxia or hypoventilation on the third study to which item 12213 applied for the patient, and further titration is needed to optimise therapy; (ii) there is clear and significant change in clinical status (for example lung function or functional status) or an intervening treatment that may affect ventilation in the period since the third study to which item 12213 applied for the patient, and repeat study is therefore required to determine the need for or the adequacy of respiratory support; and (h) the investigation is not provided to the patient on the same occasion that a service to which item 11704, 11705, 11707, 11714, 11716, 11717, 11723 or 11735 applies is provided to the patient Applicable only once in the same 12 month period to which item 12213 applies
12250	01OCT2008	30JUN2011	N	OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST 8 HOURS' DURATION, WHERE: (a) the patient is referred for the investigation by a medical practitioner; (b) the necessity for the investigation is determined by a qualified sleep medicine practitioner (as defined in explanatory note D1.25) prior to the investigation; (c) a qualified sleep medicine practitioner has: (i) established quality assurance procedures for the data acquisition; and (ii) personally analysed the data and written the report; (d) the investigation must include, during a period of sleep, a continuous recording of an electrocardiograph (ECG); a continuous recording of an electroencephalograph (EEG); and respiratory function testing (including oro-nasal airflow, rib cage/abdominal movement, body position, oximetry); (e) interpretation and report of the investigation (with analysis of sleep stage, arousals, respiratory events and assessment of clinically significant alterations in heart rate) are provided by a qualified sleep medicine practitioner based on reviewing the parameters recorded under (d) above. Payable only once in a 12 month period.
12250	01JUL2011	31OCT2014	N	Overnight investigation for sleep apnoea for a period of at least 8 hours duration for a patient aged 18 years or more, if all of the following requirements are met: (a) the patient has, before the overnight investigation, been referred to a qualified adult sleep medicine practitioner by a medical practitioner whose clinical opinion is that there is a high probability that the patient has obstructive sleep apnoea; and (b) the investigation takes place after the qualified adult sleep medicine practitioner has: (i) confirmed the necessity for the investigation; and (ii) communicated this confirmation to the referring medical practitioner; and (c) during a period of sleep, the investigation involves recording a minimum of seven physiological parameters which must include: (i) continuous electro-encephalogram (EEG); and (ii) continuous electro-cardiogram (ECG; and (iii) airflow; and (iv) thoraco-abdominal movement; and (v) oxygen saturation; and (vi) 2 or more of the following: (A) electro-oculogram (EOG); (B) chin electro-myogram (EMG); (C) body position; and (d) in the report on of the investigation, the qualified adult sleep medicine practitioner uses the data specified in paragraph (c) to: (i) analyse sleep stage, arousals and respiratory events; and (ii) assess clinically significant alteration in heart rate; and (e) the qualified adult sleep medicine practitioner: (i) before the investigation takes place, establishes quality assurance procedures for data acquisition; and (ii) personally analyses the data and writes the report on the results of the investigation. Payable only once in a 12 month period.
12250	01NOV2014	31OCT2018	N	Overnight investigation for sleep apnoea for a period of at least 8 hours duration for a patient aged 18 years or more, if all of the following requirements are met: (a) the patient has, before the overnight investigation, been referred to a qualified adult sleep medicine practitioner by a medical practitioner whose clinical opinion is that there is a high probability that the patient has obstructive sleep apnoea; and (b) the investigation takes place after the qualified adult sleep medicine practitioner has: (i) confirmed the necessity for the investigation; and (ii) communicated this confirmation to the referring medical practitioner; and (c) during a period of sleep, the investigation involves recording a minimum of seven physiological parameters which must include: (i) continuous electro-encephalogram (EEG); and (ii) continuous electro-cardiogram (ECG; and (iii) airflow; and (iv) thoraco-abdominal movement; and (v) oxygen saturation; and (vi) 2 or more of the following: (A) electro-oculogram (EOG); (B) chin electro-myogram (EMG); (C) body position; and (d) in the report on of the investigation, the qualified adult sleep medicine practitioner uses the data specified in paragraph (c) to: (i) analyse sleep stage, arousals and respiratory events; and (ii) assess clinically significant alteration in heart rate; and (e) the qualified adult sleep medicine practitioner: (i) before the investigation takes place, establishes quality assurance procedures for data acquisition; and (ii) personally analyses the data and writes the report on the results of the investigation; (f) the investigation is not provided to the patient on the same occasion as a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 and 12203 is provided to the patient Payable only once in a 12 month period
12250	01NOV2018	31JUL2020	N	Overnight investigation of sleep for a period of at least 8 hours of a patient aged 18 years or more to confirm diagnosis of obstructive sleep apnoea, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified sleep medicine practitioner or a consultant respiratory physician, the qualified sleep medicine practitioner or consultant respiratory physician determines that investigation is necessary to confirm the diagnosis of obstructive sleep apnoea; and (b) during a period of sleep, there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) continuous ECG; (iv) continuous EEG; (v) EOG; (vi) oxygen saturation; (vii) respiratory effort; and (c) the investigation is performed under the supervision of a qualified sleep medicine practitioner; and (d) either: (i) the equipment is applied to the patient by a sleep technician; or (ii) if this is not possible-the reason it is not possible for the sleep technician to apply the equipment to the patient is documented and the patient is given instructions on how to apply the equipment by a sleep technician supported by written instructions; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and cardiac abnormalities) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11700 to 11709, 11713 and 12203 is provided to the patient Applicable only once in any 12 month period
12250	01AUG2020	30SEP2020	N	Overnight investigation of sleep for a period of at least 8 hours of a patient aged 18 years or more to confirm diagnosis of obstructive sleep apnoea, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified sleep medicine practitioner or a consultant respiratory physician, the qualified sleep medicine practitioner or consultant respiratory physician determines that investigation is necessary to confirm the diagnosis of obstructive sleep apnoea; and (b) during a period of sleep, there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) continuous ECG; (iv) continuous EEG; (v) EOG; (vi) oxygen saturation; (vii) respiratory effort; and (c) the investigation is performed under the supervision of a qualified sleep medicine practitioner; and (d) either: (i) the equipment is applied to the patient by a sleep technician; or (ii) if this is not possible-the reason it is not possible for the sleep technician to apply the equipment to the patient is documented and the patient is given instructions on how to apply the equipment by a sleep technician supported by written instructions; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and cardiac abnormalities) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 and 12203 is provided to the patient Applicable only once in any 12 month period
12250	01OCT2020	28FEB2021	N	Overnight investigation of sleep for at least 8 hours of a patient aged 18 years or more to confirm diagnosis of obstructive sleep apnoea, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified adult sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 4 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified adult sleep medicine practitioner or a consultant respiratory physician, the qualified adult sleep medicine practitioner or consultant respiratory physician determines that investigation is necessary to confirm the diagnosis of obstructive sleep apnoea; and (b) during a period of sleep, there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) continuous ECG; (iv) continuous EEG; (v) EOG; (vi) oxygen saturation; (vii) respiratory effort; and (c) the investigation is performed under the supervision of a qualified adult sleep medicine practitioner; and (d) either: (i) the equipment is applied to the patient by a sleep technician; or (ii) if this is not possible-the reason it is not possible for the sleep technician to apply the equipment to the patient is documented and the patient is given instructions on how to apply the equipment by a sleep technician supported by written instructions; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and cardiac abnormalities) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000 to 11005, 11503, 11713 and 12203 is provided to the patient Applicable only once in any 12 month period
12250	01MAR2021	31DEC9999	Y	Overnight investigation of sleep for at least 8 hours of a patient aged 18 years or more to confirm diagnosis of obstructive sleep apnoea, if: (a) either: (i) the patient has been referred by a medical practitioner to a qualified adult sleep medicine practitioner or a consultant respiratory physician who has determined that the patient has a high probability for symptomatic, moderate to severe obstructive sleep apnoea based on a STOP-Bang score of 3 or more, an OSA50 score of 5 or more or a high risk score on the Berlin Questionnaire, and an Epworth Sleepiness Scale score of 8 or more; or (ii) following professional attendance on the patient (either face-to-face or by video conference) by a qualified adult sleep medicine practitioner or a consultant respiratory physician, the qualified adult sleep medicine practitioner or consultant respiratory physician determines that investigation is necessary to confirm the diagnosis of obstructive sleep apnoea; and (b) during a period of sleep, there is continuous monitoring and recording, performed in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) continuous ECG; (iv) continuous EEG; (v) EOG; (vi) oxygen saturation; (vii) respiratory effort; and (c) the investigation is performed under the supervision of a qualified adult sleep medicine practitioner; and (d) either: (i) the equipment is applied to the patient by a sleep technician; or (ii) if this is not possible-the reason it is not possible for the sleep technician to apply the equipment to the patient is documented and the patient is given instructions on how to apply the equipment by a sleep technician supported by written instructions; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events and cardiac abnormalities) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the investigation is not provided to the patient on the same occasion that a service mentioned in any of items 11000, 11003, 11004, 11005, 11503, 11704, 11705, 11707, 11714, 11716, 11717, 11723, 11735 and 12203 is provided to the patient Applicable only once in any 12 month period
12254	01NOV2018	30SEP2020	N	Multiple sleep latency test for the assessment of unexplained hypersomnolence in a patient aged 18 years or more, if: (a) a qualified sleep medicine practitioner or neurologist determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria for drugs relevant to treat that condition under the Pharmaceutical Benefits Scheme are fulfilled; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration is performed, with continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (c) immediately following the overnight investigation a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12203, 12204, 12205, 12208, 12250 or 12258 is provided to the patient Applicable only once in a 12 month period
12254	01OCT2020	31DEC9999	Y	Multiple sleep latency test for the assessment of unexplained hypersomnolence in a patient aged 18 years or more, if: (a) a qualified adult sleep medicine practitioner or neurologist determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria under the pharmaceutical benefits scheme for drugs relevant to treat that condition are met; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (c) immediately following the overnight investigation a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12203, 12204, 12205, 12208, 12250 or 12258 is provided to the patient Applicable only once in a 12 month period
12258	01NOV2018	30SEP2020	N	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness in a patient aged 18 years or more, if: (a) a qualified sleep medicine practitioner or neurologist determines that testing is necessary to objectively confirm the ability to maintain wakefulness; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration is performed, with continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12203, 12204, 12205, 12208, 12250 or 12254 is provided to the patient Applicable only once in a 12 month period
12258	01OCT2020	31DEC9999	Y	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness in a patient aged 18 years or more, if: (a) a qualified adult sleep medicine practitioner or neurologist determines that testing is necessary to objectively confirm the ability to maintain wakefulness; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring and recording, in accordance with current professional guidelines, of the following measures: (i) airflow; (ii) continuous EMG; (iii) anterior tibial EMG; (iv) continuous ECG; (v) continuous EEG; (vi) EOG; (vii) oxygen saturation; (viii) respiratory movement (chest and abdomen); (ix) position; and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified adult sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified adult sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12203, 12204, 12205, 12208, 12250 or 12254 is provided to the patient Applicable only once in a 12 month period
12261	01NOV2018	30SEP2020	N	Multiple sleep latency test for the assessment of unexplained hypersomnolence in a patient aged at least 12 years but less than 18 years, if: (a) a qualified sleep medicine practitioner determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria for drugs relevant to treat that condition under the Pharmaceutical Benefits Scheme are fulfilled; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration where continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12213, 12217 or 12265 is provided to the patient Applicable only once in a 12 month period
12261	01OCT2020	31DEC9999	Y	Multiple sleep latency test for the assessment of unexplained hypersomnolence in a patient aged at least 12 years but less than 18 years, if: (a) a qualified sleep medicine practitioner determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria under the pharmaceutical benefits scheme for drugs relevant to treat that condition are met; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, and maturation of sleep indices, arousals, respiratory events and assessment of clinically significant alterations in heart rate and body movement) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12213, 12217 or 12265 is provided to the patient Applicable only once in a 12 month period
12265	01NOV2018	30SEP2020	N	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness in a patient aged at least 12 years but less than 18 years, if: (a) a qualified sleep medicine practitioner determines that testing to objectively confirm the ability to maintain wakefulness is necessary; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration where continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12213, 12217 or 12261 or is provided to the patient Applicable only once in a 12 month period
12265	01OCT2020	31DEC9999	Y	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness in a patient aged at least 12 years but less than 18 years, if: (a) a qualified sleep medicine practitioner determines that testing to objectively confirm the ability to maintain wakefulness is necessary; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12213, 12217 or 12261 is provided to the patient Applicable only once in a 12 month period
12268	01NOV2018	30SEP2020	N	Multiple sleep latency test for the assessment of unexplained hypersomnolence for a patient less than 12 years of age, if: (a) a qualified sleep medicine practitioner determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria for drugs relevant to treat that condition under the Pharmaceutical Benefits Scheme are fulfilled; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration where there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12210, 12215 or 12272 is provided to the patient Applicable only once in a 12 month period
12268	01OCT2020	31DEC9999	Y	Multiple sleep latency test for the assessment of unexplained hypersomnolence for a patient less than 12 years of age, if: (a) a qualified paediatric sleep medicine practitioner determines that testing is necessary to confirm the diagnosis of a central disorder of hypersomnolence or to determine whether the eligibility criteria under the pharmaceutical benefits scheme for drugs relevant to treat that condition are met; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 nap periods are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified paediatric sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12210, 12215 or 12272 is provided to the patient Applicable only once in a 12 month period
12272	01NOV2018	30SEP2020	N	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness for a patient less than 12 years of age, if: (a) a qualified sleep medicine practitioner determines that testing to objectively confirm the ability to maintain wakefulness is necessary; and (b) an overnight diagnostic assessment of sleep, for a period of at least 8 hours duration where there is continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following are made, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of report; and (f) interpretation and preparation of a permanent report is provided by a qualified sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service mentioned in any of items 11003, 12210, 12215 or 12268 is provided to the patient Applicable only once in a 12 month period
12272	01OCT2020	31DEC9999	Y	Maintenance of wakefulness test for the assessment of the ability to maintain wakefulness for a patient less than 12 years of age, if: (a) a qualified paediatric sleep medicine practitioner determines that testing to objectively confirm the ability to maintain wakefulness is necessary; and (b) an overnight diagnostic assessment of sleep is performed for at least 8 hours, with continuous monitoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of the following, in accordance with current professional guidelines: (i) airflow; (ii) continuous EMG; (iii) ECG; (iv) EEG (with a minimum of 4 EEG leads or, in selected investigations, a minimum of 6 EEG leads); (v) EOG; (vi) oxygen saturation; (vii) respiratory movement of rib and abdomen (whether movement of rib is recorded separately from, or together with, movement of abdomen); (viii) measurement of carbon dioxide (either end-tidal or transcutaneous); and (c) immediately following the overnight investigation, a daytime investigation is performed where at least 4 wakefulness trials are conducted, during which there is continuous recording of EEG, EMG, EOG and ECG; and (d) a sleep technician is in continuous attendance under the supervision of a qualified paediatric sleep medicine practitioner; and (e) polygraphic records are: (i) analysed (for assessment of sleep stage, arousals, respiratory events, cardiac abnormalities and limb movements) with manual scoring, or manual correction of computerised scoring in epochs of not more than 1 minute; and (ii) stored for interpretation and preparation of a report; and (f) interpretation and preparation of a permanent report is provided by a qualified paediatric sleep medicine practitioner with personal direct review of raw data from the original recording of polygraphic data from the patient; and (g) the diagnostic assessment is not provided to the patient on the same occasion that a service described in item 11003, 12210, 12215 or 12268 is provided to the patient Applicable only once in a 12 month period
12300	01MAR1994	31DEC9999	Y	BONE DENSITOMETRY (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry or quantitative computerised tomography, for the confirmation of a presumptive diagnosis of osteoporosis made on the basis of 1 or more fractures occurring after minimal trauma or for the monitoring of osteoporosis proven by previous bone densitometry - measurement of 1 or more sites - 1 service only in a period of 24 consecutive months - interpretation and report (Ministerial Determination)
12303	01MAR1994	31DEC9999	Y	BONE DENSITOMETRY (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry or quantitative computerised tomography, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions - prolonged glucocorticoid therapy, conditions associated with excess glucocorticoid secretion, male hypogonadism, amenorrhea lasting more than 6 months before the age of 40, primary hyperparathyroidism, chronic liver disease, chronic renal disease, proven malabsorptive disorders, rheumatoid arthritis, or conditions associated with thyroxine excess, where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 1 or more sites - 1 service only in a period of 24 consecutive months - interpretation and report (Ministerial Determination)
12306	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for: . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma; or . for the monitoring of low bone mineral density proven by bone densitometry at least 12 months previously. Measurement of 2 or more sites - 1 service only in a period of 24 months - including interpretation and report; not being a service associated with a service to which item 12309, 12312, 12315, 12318 or 12321 applies (Ministerial Determination)
12306	01AUG1996	31OCT2017	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for: . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma; or . for the monitoring of low bone mineral density proven by bone densitometry at least 12 months previously. Measurement of 2 or more sites - 1 service only in a period of 24 months - including interpretation and report; not being a service associated with a service to which item 12309, 12312, 12315, 12318 or 12321 applies (Ministerial Determination)
12306	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting), for: (a) confirmation of a presumptive diagnosis of low bone mineral density made on the basis of one or more fractures occurring after minimal trauma; or (b) monitoring of low bone mineral density proven by bone densitometry at least 12 months previously; other than a service associated with a service to which item 12312, 12315 or 12321 applies For any particular patient, once only in a 24 month period
12309	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using quantitative computerised tomography, for: . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma; or . for the monitoring of low bone mineral density proven by bone densitometry at least 12 months previously. Measurement of 2 or more sites - 1 service only in a period of 24 months - including interpretation and report; not being a service associated with a service to which item 12306, 12312, 12315, 12318 or 12321 applies (Ministerial Determination)
12309	01AUG1996	31DEC9999	Y	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using quantitative computerised tomography, for: . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma; or . for the monitoring of low bone mineral density proven by bone densitometry at least 12 months previously. Measurement of 2 or more sites - 1 service only in a period of 24 months - including interpretation and report; not being a service associated with a service to which item 12306, 12312, 12315, 12318 or 12321 applies (Ministerial Determination)
12312	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . prolonged glucocorticoid therapy; . conditions associated with excess glucocorticoid secretion; . male hypogonadism; or . female hypogonadism lasting more than 6 months before the age of 45. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 12 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12315, 12318 or 12321 applies (Ministerial Determination)
12312	01AUG1996	31OCT2017	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . prolonged glucocorticoid therapy; . conditions associated with excess glucocorticoid secretion; . male hypogonadism; or . female hypogonadism lasting more than 6 months before the age of 45. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 12 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12315, 12318 or 12321 applies (Ministerial Determination)
12312	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following: (a) prolonged glucocorticoid therapy; (b) any condition associated with excess glucocorticoid secretion; (c) male hypogonadism; (d) female hypogonadism lasting more than 6 months before the age of 45; other than a service associated with a service to which item 12306, 12315 or 12321 applies For any particular patient, once only in a 12 month period
12315	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . primary hyperparathyroidism; . chronic liver disease; . chronic renal disease; . proven malabsorptive disorders; . rheumatoid arthritis; or . conditions associated with thyroxine excess. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 24 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12318 or 12321 applies (Ministerial Determination)
12315	01AUG1996	31OCT2017	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . primary hyperparathyroidism; . chronic liver disease; . chronic renal disease; . proven malabsorptive disorders; . rheumatoid arthritis; or . conditions associated with thyroxine excess. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 24 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12318 or 12321 applies (Ministerial Determination)
12315	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following conditions: (a) primary hyperparathyroidism; (b) chronic liver disease; (c) chronic renal disease; (d) any proven malabsorptive disorder; (e) rheumatoid arthritis; (f) any condition associated with thyroxine excess; other than a service associated with a service to which item 12306, 12312 or 12321 applies For any particular patient, once only in a 24 month period
12318	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using quantitative computerised tomography, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . prolonged glucocorticoid therapy; . conditions associated with excess glucocorticoid secretion; . male hypogonadism; . female hypogonadism lasting more than 6 months before the age of 45; . primary hyperparathyroidism; . chronic liver disease; . chronic renal disease; . proven malabsorptive disorders; . rheumatoid arthritis; or . conditions associated with thyroxine excess. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 24 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315 or 12321 applies (Ministerial Determination)
12318	01AUG1996	31DEC9999	Y	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using quantitative computerised tomography, for the diagnosis and monitoring of bone loss associated with 1 or more of the following conditions: . prolonged glucocorticoid therapy; . conditions associated with excess glucocorticoid secretion; . male hypogonadism; . female hypogonadism lasting more than 6 months before the age of 45; . primary hyperparathyroidism; . chronic liver disease; . chronic renal disease; . proven malabsorptive disorders; . rheumatoid arthritis; or . conditions associated with thyroxine excess. Where the bone density measurement will contribute to the management of a patient with any of the above conditions - measurement of 2 or more sites - 1 service only in a period of 24 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315 or 12321 applies (Ministerial Determination)
12320	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry or quantitative computed tomography, involving the measurement of 2 or more sites (including interpretation and reporting) for measurement of bone mineral density, if:(a) the patient is 70 years of age or over, and (b) either: (i) the patient has not previously had bone densitometry; or (ii) the t-score for the patient's bone mineral density is -1.5 or more; other than a service associated with a service to which item 12306, 12312, 12315, 12321 or 12322 applies For any particular patient, once only in a 5 year period
12321	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the measurement of bone density 12 months following a significant change in therapy for: . established low bone mineral density; or . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma. Measurement of 2 or more sites - 1 service only in a period of 12 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315 or 12318 applies (Ministerial Determination).
12321	01AUG1996	31OCT2017	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the measurement of bone density 12 months following a significant change in therapy for: . established low bone mineral density; or . the confirmation of a presumptive diagnosis of low bone mineral density made on the basis of 1 or more fractures occurring after minimal trauma. Measurement of 2 or more sites - 1 service only in a period of 12 consecutive months - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315 or 12318 applies (Ministerial Determination).
12321	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry, involving the measurement of 2 or more sites at least 12 months after a significant change in therapy (including interpretation and reporting), for: (a) established low bone mineral density; or (b) confirming a presumptive diagnosis of low bone mineral density made on the basis of one or more fractures occurring after minimal trauma; other than a service associated with a service to which item 12306, 12312 or 12315 applies For any particular patient, once only in a 12 month period
12322	01NOV2017	31DEC9999	Y	Bone densitometry, using dual energy X-ray absorptiometry or quantitative computed tomography, involving the measurement of 2 or more sites (including interpretation and reporting) for measurement of bone mineral density, if:(a) the patient is 70 years of age or over; and (b) the t-score for the patient's bone mineral density is less than -1.5 but more than -2.5; other than a service associated with a service to which item 12306, 12312, 12315, 12320 or 12321 applies For any particular patient, once only in a 2 year period
12323	01APR2007	30NOV2007	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry, for the measurement of bone density, for the measurement of bone mineral density, for a person aged 70 years or over. Measurement of 2 or more sites - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315, 12318 or 12321 applies (Ministerial Determination).
12323	01DEC2007	31DEC9999	Y	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry or quantitative computerised tomography, for the measurement of bone mineral density, for a person aged 70 years or over. Measurement of 2 or more sites - including interpretation and report; not being a service associated with a service to which item 12306, 12309, 12312, 12315, 12318 or 12321 applies (Ministerial Determination).
12324	31OCT1995	31JUL1996	N	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry or quantitative computerised tomography, for the monitoring of bone loss associated with clinical conditions not specified in items 12306, 12309, 12312, 12315, 12318 and 12321 or for an additional test in excess of that defined in the period specified in items 12306, 12309, 12312, 12315, 12318, and 12321 - measurement of 2 or more sites - including interpretation and report; not being a service associated with a service to which item 12306,12309, 12312, 12315, 12318, or 12321 applies (Ministerial Determination).
12324	01AUG1996	31DEC9999	Y	Bone densitometry (performed by a specialist or consultant physician where the patient is referred by another medical practitioner), using dual energy X-ray absorptiometry or quantitative computerised tomography, for the monitoring of bone loss associated with clinical conditions not specified in items 12306, 12309, 12312, 12315, 12318 and 12321 or for an additional test in excess of that defined in the period specified in items 12306, 12309, 12312, 12315, 12318, and 12321 - measurement of 2 or more sites - including interpretation and report; not being a service associated with a service to which item 12306,12309, 12312, 12315, 12318, or 12321 applies (Ministerial Determination).
12325	01NOV2016	31DEC9999	Y	Assessment of visual acuity and bilateral retinal photography with a non mydriatic retinal camera, including analysis and reporting of the images for initial or repeat assessment for presence or absence of diabetic retinopathy, in a patient with medically diagnosed diabetes, if: (a) the patient is of Aboriginal and Torres Strait Islander descent; and (b) the assessment is performed by the medical practitioner (other than an optometrist or ophthalmologist) providing the primary glycaemic management of the patient's diabetes; and (c) this item and item 12326 have not applied to the patient in the preceding 12 months; and (d) the patient does not have: (i) an existing diagnosis of diabetic retinopathy; or (ii) visual acuity of less than 6/12 in either eye; or (iii) a difference of more than 2 lines of vision between the 2 eyes at the time of presentation
12326	01NOV2016	31DEC9999	Y	Assessment of visual acuity and bilateral retinal photography with a non-mydriatic retinal camera, including analysis and reporting of the images for initial or repeat assessment for presence or absence of diabetic retinopathy, in a patient with medically diagnosed diabetes, if: (a) the assessment is performed by the medical practitioner (other than an optometrist or ophthalmologist) providing the primary glycaemic management of the patient's diabetes; and (b) this item and item 12325 have not applied to the patient in the preceding 24 months; and (c) the patient does not have: (i) an existing diagnosis of diabetic retinopathy; or (ii) visual acuity of less than 6/12 in either eye; or (iii) a difference of more than 2 lines of vision between the 2 eyes at the time of presentation
12500	01DEC1991	31DEC9999	Y	BLOOD VOLUME ESTIMATION
12503	01DEC1991	31DEC9999	Y	ERYTHROCYTE RADIOACTIVE UPTAKE SURVIVAL TIME TEST OR IRON KINETIC TEST
12506	01DEC1991	31DEC9999	Y	GASTROINTESTINAL BLOOD LOSS ESTIMATION involving examination of stool specimens
12509	01DEC1991	31DEC9999	Y	GASTROINTESTINAL PROTEIN LOSS
12512	01DEC1991	31DEC9999	Y	RADIOACTIVE B12 ABSORPTION TEST 1 isotope
12515	01DEC1991	31DEC9999	Y	RADIOACTIVE B12 ABSORPTION TEST 2 isotopes
12518	01DEC1991	31DEC9999	Y	THYROID UPTAKE (using probe)
12521	01DEC1991	31DEC9999	Y	PERCHLORATE DISCHARGE STUDY
12524	01DEC1991	31DEC9999	Y	RENAL FUNCTION TEST (without imaging procedure)
12527	01DEC1991	31DEC9999	Y	RENAL FUNCTION TEST (with imaging and at least 2 blood samples)
12530	01DEC1991	31DEC9999	Y	WHOLE BODY COUNT not being a service associated with a service to which another item applies
12533	01JUL1995	31OCT1995	N	C-14 UREA BREATH TEST using oral C-14 urea, including the measurement of exhaled 14CO2, performed by a specialist or a consultant physician (to whom the patient has been referred by another medical practitioner), for (a) the monitoring of the success of eradication therapy for Helicobactor pylori; or (b) the confirmation of Helicobactor pylori colonisation
12533	01NOV1995	30APR1997	N	CARBON-LABELLED urea breath test using oral C-13 or C-14 urea, including the measurement of exhaled 13CO2 or 14CO2 performed by a specialist or a consultant physician where the patient is referred by another medical practitioner, for (a) the monitoring of the success of eradication therapy for Helicobactor pylori; or (b) the confirmation of Helicobactor pylori colonisation
12533	01MAY1997	30JUN1998	N	CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, including the measurement of exhaled 13CO2 or 14CO2, performed by a specialist or a consultant physician where the patient is referred by another medical practitioner, for either:- (a) the confirmation of Helicobactor pylori colonisation, where: (i) suitable biopsy material for diagnosis cannot be obtained at endoscopy in patients with peptic ulceration, or where the diagnosis of peptic ulcer has been made on barium meal; or (ii) in patients with past history of peptic ulceration, gastric ulceration or gastric lymphoma, where endoscopy is not indicated, OR (b) the monitoring of the success of eradication of Helicobactor pylori in patients with peptic ulceration
12533	01JUL1998	31OCT2006	N	CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, performed by a specialist or consultant physician, including the measurement of exhaled 13CO2 or 14CO2, for either:- (a) the confirmation of Helicobacter pylori colonisation, where: (i) suitable biopsy material for diagnosis cannot be obtained at endoscopy in patients with peptic ulcer disease, or where the diagnosis of peptic ulcer has been made on barium meal; or (ii) in patients with past history of duodenal ulcer, gastric ulcer or gastric neoplasia, where endoscopy is not indicated, OR (b) the monitoring of the success of eradication of Helicobacter pylori in patients with peptic ulcer disease - where any request for the test by another medical practitioner who collects the breath sample specifically identifies in writing one or more of the clinical indications for the test
12533	01NOV2006	30JUN2009	N	CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, performed by a specialist or consultant physician, including the measurement of exhaled 13CO2 or 14CO2, for either:- (a) the confirmation of Helicobacter pylori colonisation, OR (b) the monitoring of the success of eradication of Helicobacter pylori.
12533	01JUL2009	31DEC9999	Y	CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, performed by a specialist or consultant physician, including the measurement of exhaled 13CO2 or 14CO2, for either:- (a)the confirmation of Helicobacter pylori colonisation, OR (b)the monitoring of the success of eradication of Helicobacter pylori in patients with peptic ulcer disease. not being a service to which 66900 applies
13000	01DEC1991	31DEC9999	Y	HYPERBARIC OXYGEN THERAPY where the medical practitioner is NOT in the chamber
13003	01DEC1991	31DEC9999	Y	HYPERBARIC OXYGEN THERAPY where the medical practitioner is confined in the chamber
13006	01DEC1991	31DEC9999	Y	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is not confined in the chamber
13009	01DEC1991	31DEC9999	Y	ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is confined in the chamber
13012	01DEC1991	30JUN1995	N	HYPERBARIC TREATMENT including oxygen therapy for a period of more than 2 hours (including examination immediately pre and post treatment) - per hour (Ministerial Determination)
13012	01JUL1995	31DEC9999	Y	HYPERBARIC TREATMENT, including oxygen therapy, for a period of more than 2 hours (including examination immediately before and after treatment) - per hour
13015	01NOV2001	31OCT2009	N	HYPERBARIC OXYGEN THERAPY, for treatment of soft tissue radionecrosis or chronic or recurring wounds where hypoxia can be demonstrated, performed in a comprehensive hyperbaric facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance
13015	01NOV2009	31OCT2012	N	HYPERBARIC OXYGEN THERAPY, for treatment of soft tissue radionecrosis or chronic or recurring wounds where hypoxia can be demonstrated, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance
13015	01NOV2012	31DEC9999	Y	HYPERBARIC, OXYGEN THERAPY, for treatment of localised non-neurological soft tissue radiation injuries excluding radiation-induced soft tissue lymphoedema of the arm after treatment for breast cancer, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance.
13020	01JUL1996	31OCT2001	N	HYPERBARIC OXYGEN THERAPY performed in a comprehensive hyperbaric medicine facility for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance
13020	01NOV2001	30APR2002	N	HYPERBARIC OXYGEN THERAPY, for treatment of decompression illness, gas gangrene, air or gas embolism; diabetic wounds including diabetic gangrene and diabetic foot ulcers; necrotising soft tissue infections including necrotising fasciitis, Fournier's gangrene or osteoradionecrosis, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance
13020	01MAY2002	31DEC9999	Y	HYPERBARIC OXYGEN THERAPY, for treatment of decompression illness, gas gangrene, air or gas embolism; diabetic wounds including diabetic gangrene and diabetic foot ulcers; necrotising soft tissue infections including necrotising fasciitis or Fournier's gangrene; or for the prevention and treatment of osteoradionecrosis, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber of between 1 hour 30 minutes and 3 hours, including any associated attendance
13025	01JUL1996	31OCT2001	N	HYPERBARIC OXYGEN THERAPY performed in a comprehensive hyperbaric medicine facility for a period in the hyperbaric chamber greater than 3 hours, including any associated attendance - per hour (or part of an hour)
13025	01NOV2001	31DEC9999	Y	HYPERBARIC OXYGEN THERAPY for treatment of decompression illness, air or gas embolism, performed in a comprehensive hyperbaric medicine facility, under the supervision of a medical practitioner qualified in hyperbaric medicine, for a period in the hyperbaric chamber greater than 3 hours, including any associated attendance - per hour (or part of an hour)
13030	01JUL1996	31DEC9999	Y	HYPERBARIC OXYGEN THERAPY performed in a comprehensive hyperbaric medicine facility where the medical practitioner is pressurised in the hyperbaric chamber for the purpose of providing continuous life saving emergency treatment, including any associated attendance - per hour (or part of an hour)
13100	01DEC1991	31DEC9999	Y	SUPERVISION IN HOSPITAL by a medical specialist of haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in 1 day
13103	01DEC1991	31DEC9999	Y	SUPERVISION IN HOSPITAL by a medical specialist of haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in 1 day
13104	01NOV2005	31DEC9999	Y	Planning and management of home dialysis (either haemodialysis or peritoneal dialysis), by a consultant physician in the practice of his or her specialty of renal medicine, for a patient with end-stage renal disease, and supervision of that patient on self-administered dialysis, to a maximum of 12 claims per year
13105	01NOV2018	31DEC9999	Y	Haemodialysis for a patient with end-stage renal disease if: (a) the service is provided by a registered nurse, an Aboriginal health worker or an Aboriginal and Torres Strait Islander health practitioner on behalf of a medical practitioner; and (b) the service is supervised by the medical practitioner (either in person or remotely); and (c) the patients care is managed by a nephrologist; and (d) the patient is treated or reviewed by the nephrologist every 3 to 6 months (either in person or remotely); and (e) the patient is not an admitted patient of a hospital; and (f) the service is provided in a Modified Monash 7 area
13106	01DEC1991	31DEC9999	Y	DECLOTTING OF AN ARTERIOVENOUS SHUNT
13109	01DEC1991	31DEC9999	Y	INDWELLING PERITONEAL CATHETER (Tenckhoff or similar) FOR DIALYSIS INSERTION AND FIXATION OF
13110	01MAY1997	31OCT2018	N	TENCKHOFF PERITONEAL DIALYSIS CATHETER, removal of (including catheter cuffs)
13110	01NOV2018	31DEC9999	Y	INDWELLING PERITONEAL CATHETER (Tenckhoff or similar) FOR DIALYSIS , removal of (including catheter cuffs)
13112	01DEC1991	31DEC9999	Y	PERITONEAL DIALYSIS, establishment of, by abdominal puncture and insertion of temporary catheter (including associated consultation)
13200	01DEC1991	30NOV1992	N	ASSISTED REPRODUCTIVE SERVICES (such as in vitro fertilisation, gamete intrafallopian transfer or similar procedures) involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service provided under Item 13203, 13206 or 13218 - being services rendered during one treatment cycle, if the duration of the treatment cycle is at least nine days - a maximum of six claims per patient
13200	01DEC1992	31OCT2000	N	ASSISTED REPRODUCTIVE SERVICES (such as in vitro fertilisation, gamete intrafallopian transfer or similar procedures) involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13203, 13206 or 13218 applies - being services rendered during 1 treatment cycle, if the duration of the treatment cycle is at least 9 days - a maximum of 6 claims per patient
13200	01NOV2000	31DEC2009	N	ASSISTED REPRODUCTIVE SERVICES (such as in vitro fertilisation, gamete intrafallopian transfer or similar procedures) involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13203, 13206 or 13218 applies - being services rendered during 1 treatment cycle, if the duration of the treatment cycle is at least 9 days
13200	01JAN2010	28FEB2022	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, semen preparation, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13201, 13202, 13203, 13206, 13218 applies - being services rendered during 1 treatment cycle - INITIAL cycle in a single calendar year
13200	01MAR2022	31DEC2023	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, semen preparation, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13201, 13202, 13203, 13218 applies - being services rendered during 1 treatment cycle - INITIAL cycle in a single calendar year
13200	01JAN2024	31DEC9999	Y	Assisted reproductive technologies superovulated treatment cycle proceeding to oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13201, 13202, 13203 or 13218 applies, being services rendered during one treatment cycle-initial cycle in a single calendar year
13201	01JAN2010	28FEB2022	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, semen preparation, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13202, 13203, 13206, 13218 applies - being services rendered during 1 treatment cycle - each cycle SUBSEQUENT to the first in a single calendar year
13201	01MAR2022	31DEC2023	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE PROCEEDING TO OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, semen preparation, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13202, 13203, 13218 applies - being services rendered during 1 treatment cycle - each cycle SUBSEQUENT to the first in a single calendar year
13201	01JAN2024	31DEC9999	Y	Assisted reproductive technologies superovulated treatment cycle proceeding to oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13202, 13203 or 13218 applies, being services rendered during one treatment cycle-each cycle after the first in a single calendar year
13202	01JAN2010	28FEB2022	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE THAT IS CANCELLED BEFORE OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, semen preparation, ultrasound examinations, but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which Item 13200, 13201, 13203, 13206, 13218, applies being services rendered during 1 treatment cycle
13202	01MAR2022	31DEC2023	N	ASSISTED REPRODUCTIVE TECHNOLOGIES SUPEROVULATED TREATMENT CYCLE THAT IS CANCELLED BEFORE OOCYTE RETRIEVAL, involving the use of drugs to induce superovulation and including quantitative estimation of hormones, semen preparation, ultrasound examinations, but excluding artificial insemination or transfer of frozen embryos or donated embryos or ova or a service to which Item 13200, 13201, 13203, 13218, applies being services rendered during 1 treatment cycle
13202	01JAN2024	31DEC9999	Y	Assisted reproductive technologies superovulated treatment cycle that is cancelled before oocyte retrieval, involving the use of drugs to induce superovulation and including quantitative estimation of hormones and ultrasound examinations, but excluding artificial insemination, transfer of frozen embryos or donated embryos or ova or a service to which item 13200, 13201, 13203 or 13218 applies, being services rendered during one treatment cycle
13203	01DEC1991	31DEC2009	N	OVULATION MONITORING SERVICES, for superovulated treatment cycles of less than 9 days duration and artificial insemination - including quantitative estimation of hormones and ultrasound examinations, being services rendered during 1 treatment cycle but excluding a service to which item 13200, 13206, 13212, 13215 or 13218 applies
13203	01JAN2010	28FEB2022	N	OVULATION MONITORING SERVICES, for artificial insemination - including quantitative estimation of hormones and ultrasound examinations, being services rendered during 1 treatment cycle but excluding a service to which Item 13200, 13201, 13202, 13206, 13212, 13215, 13218, applies
13203	01MAR2022	31DEC9999	Y	Ovulation monitoring services for artificial insemination or gonadotrophin, stimulated ovulation induction, including quantitative estimation of hormones and ultrasound examinations, being services rendered during one treatment cycle but excluding a service to which item 13200, 13201, 13202, 13212, 13215 or 13218 applies
13206	01DEC1991	31DEC2009	N	ASSISTED REPRODUCTIVE SERVICES (such as in vitro fertilisation, gamete intrafallopian transfer or similar procedures), using unstimulated ovulation or ovulation stimulated only by clomiphene citrate, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, frozen embryo transfer or donated embryos or ova or treatment involving the use of drugs to induce superovulation being services rendered during 1 treatment cycle but only if rendered in conjunction with a service to which item 13212 applies
13206	01JAN2010	31DEC9999	Y	ASSISTED REPRODUCTIVE TECHNOLOGIES TREATMENT CYCLE using either the natural cycle or oral medication only to induce oocyte growth and development, and including quantitative estimation of hormones, semen preparation, ultrasound examinations, all treatment counselling and embryology laboratory services but excluding artificial insemination, frozen embryo transfer or donated embryos or ova or treatment involving the use of injectable drugs to induce superovulation being services rendered during 1 treatment cycle but only if rendered in conjunction with a service to which item 13212 applies
13207	01NOV2021	31DEC9999	Y	Biopsy of an embryo, from a patient who is eligible for a service described in item 73384 under clause 2.7.3A of the pathology services table (see PR.7.1), for the purpose of providing a sample for pre-implantation genetic testing-applicable to one or more tests performed in one assisted reproductive treatment cycle
13209	01DEC1991	31DEC2009	N	PLANNING and MANAGEMENT of a referred patient by a specialist for the purpose of treatment by assisted reproductive technologies including in vitro fertilisation, gamete intrafallopian transfer and similar procedures, or for artificial insemination payable once only during 1 treatment cycle
13209	01JAN2010	31DEC2023	N	PLANNING and MANAGEMENT of a referred patient by a specialist for the purpose of treatment by assisted reproductive technologies or for artificial insemination payable once only during 1 treatment cycle
13209	01JAN2024	31DEC9999	Y	Planning and management of a referred patient by a specialist for the purpose of treatment by assisted reproductive technologies or for artificial insemination-applicable once during a treatment cycle
13210	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a specialist practising in his or her specialty to a patient who is: a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 13209.
13210	01NOV2012	31DEC9999	Y	Professional attendance on a patient by a specialist practising in his or her specialty if: (a) the attendance is by video conference; and (b) item 13209 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
13212	01DEC1991	31DEC2009	N	OOCYTE RETRIEVAL by any means including laparoscopy or ultrasoundguided ova flushing, for the purposes of assisted reproductive technologies including in vitro fertilisation, gamete intra-fallopian transfer or similar procedures - only if rendered in conjunction with a service to which item 13200 or 13206 applies
13212	01JAN2010	31OCT2014	N	OOCYTE RETRIEVAL for the purposes of assisted reproductive technologies - only if rendered in conjunction with a service to which Item 13200, 13201 or 13206 applies
13212	01NOV2014	28FEB2022	N	Oocyte retrieval for the purpose of assisted reproductive technologies-only if rendered in connection with a service to which item 13200, 13201 or 13206 applies
13212	01MAR2022	31DEC2023	N	Oocyte retrieval for the purpose of assisted reproductive technologies-only if rendered in connection with a service to which item 13200 or 13201 applies
13212	01JAN2024	31DEC9999	Y	Oocyte retrieval for the purpose of assisted reproductive technologies-only if rendered in connection with a service to which item 13200 or 13201 applies
13215	01DEC1991	31DEC2009	N	TRANSFER of EMBRYOS or both ova and sperm to the female reproductive system, by any means but excluding artificial insemination or the transfer of frozen or donated embryos - only if rendered in conjunction with a service to which item 13200 or 13206 applies, being services rendered in 1 treatment cycle
13215	01JAN2010	31DEC2013	N	TRANSFER OF EMBRYOS or both ova and sperm to the female reproductive system, excluding artificial insemination - only if rendered in conjunction with a service to which item 13200, 13201, 13206 or 13218 applies, being services rendered in 1 treatment cycle
13215	01JAN2014	31OCT2014	N	TRANSFER OF EMBRYOS or both ova and sperm to the uterus or fallopian tubes, excluding artificial insemination - only if rendered in conjunction with a service to which item 13200, 13201, 13206 or 13218 applies, being services rendered in 1 treatment cycle
13215	01NOV2014	28FEB2022	N	Transfer of embryos or both ova and sperm to the uterus or fallopian tubes, excluding artificial insemination-only if rendered in connection with a service to which item 13200, 13201, 13206 or 13218 applies, being services rendered in one treatment cycle
13215	01MAR2022	31DEC2023	N	Transfer of embryos or both ova and sperm to the uterus or fallopian tubes, excluding artificial insemination-only if rendered in connection with a service to which item 13200, 13201 or 13218 applies, being services rendered in one treatment cycle
13215	01JAN2024	31DEC9999	Y	Transfer of embryos or both ova and sperm to the uterus or fallopian tubes, excluding artificial insemination-only if rendered in connection with a service to which item 13200, 13201 or 13218 applies, being services rendered in one treatment cycle
13218	01DEC1991	31DEC2009	N	PREPARATION AND TRANSFER of frozen or donated embryos or both ova and sperm, to the female reproductive system, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in 1 treatment cycle and excluding a service to which item 13200, 13203, 13206, 13212 or 13215 applies
13218	01JAN2010	31DEC2013	N	PREPARATION of frozen or donated embryos or donated oocytes for transfer to the female reproductive system, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in 1 treatment cycle and excluding a service to which item 13200, 13201, 13202, 13203, 13206, 13212 applies
13218	01JAN2014	28FEB2022	N	PREPARATION of frozen or donated embryos or donated oocytes for transfer to the uterus or fallopian tubes, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in 1 treatment cycle and excluding a service to which item 13200, 13201, 13202, 13203, 13206, 13212 applies
13218	01MAR2022	31DEC2023	N	PREPARATION of frozen or donated embryos or donated oocytes for transfer to the uterus or fallopian tubes, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in 1 treatment cycle and excluding a service to which item 13200, 13201, 13202, 13203, 13212 applies
13218	01JAN2024	31DEC9999	Y	Preparation of frozen or donated embryos or donated oocytes for transfer to the uterus or fallopian tubes, by any means and including quantitative estimation of hormones and all treatment counselling but excluding artificial insemination services rendered in one treatment cycle and excluding a service to which item 13200, 13201, 13202, 13203 or 13212 applies
13221	01DEC1991	31DEC2009	N	PREPARATION OF SEMEN for the purposes of assisted reproductive technologies or for artificial insemination
13221	01JAN2010	31OCT2014	N	PREPARATION OF SEMEN for the purposes of artificial insemination - only if rendered in conjunction with a service to which item 13203 applies
13221	01NOV2014	31DEC2023	N	Preparation of semen for the purpose of artificial insemination-only if rendered in connection with a service to which item 13203 applies
13221	01JAN2024	31DEC9999	Y	Preparation of semen for the purpose of artificial insemination-only if rendered in connection with a service to which item 13203 applies
13241	01MAR2022	31DEC9999	Y	Open surgical testicular sperm retrieval, unilateral, using operating microscope, including the exploration of scrotal contents, with biopsy, for the purposes of intracytoplasmic sperm injection, for male factor infertility, not being a service associated with a service to which item 13218 or 37604 applies (H)
13251	01MAY2007	31DEC2009	N	INTRACYTOPLASMIC SPERM INJECTION for the purposes of assisted reproductive technologies, for male factor infertility, excluding a service to which item 13218 applies.
13251	01JAN2010	31DEC2023	N	INTRACYTOPLASMIC SPERM INJECTION for the purposes of assisted reproductive technologies, for male factor infertility, excluding a service to which Item 13203 or 13218 applies
13251	01JAN2024	31DEC9999	Y	Intracytoplasmic sperm injection for the purpose of assisted reproductive technologies, for male factor infertility, excluding a service to which item 13203 or 13218 applies
13260	01NOV2018	31DEC9999	Y	Processing and cryopreservation of semen for fertility preservation treatment before or after completion of gonadotoxic treatment for malignant or non-malignant conditions, in a post-pubertal male in Tanner stages II-V, up to 60 years old, if the patient is referred by a specialist or consultant physician, initial cryopreservation of semen (not including storage) - one of a maximum of two semen collection cycles per patient in a lifetime.
13290	01MAY1997	31DEC9999	Y	SEMEN, collection of, from a patient with spinal injuries or medically induced impotence, for the purposes of analysis, storage or assisted reproduction, by a medical practitioner using a vibrator or electro-ejaculation device including catheterisation and drainage of bladder where required
13292	01MAY1997	31DEC9999	Y	SEMEN, collection of, from a patient with spinal injuries or medically induced impotence, for the purposes of analysis, storage or assisted reproduction, by a medical practitioner using a vibrator or electro-ejaculation device including catheterisation and drainage of bladder where required, under general anaesthetic, in a hospital
13300	01DEC1991	31DEC9999	Y	UMBILICAL OR SCALP VEIN CATHETERISATION in a NEONATE with or without infusion; or cannulation of a vein in a neonate
13303	01DEC1991	31DEC9999	Y	UMBILICAL ARTERY CATHETERISATION with or without infusion
13306	01DEC1991	31DEC9999	Y	BLOOD TRANSFUSION with venesection and complete replacement of blood, including collection from donor
13309	01DEC1991	31DEC9999	Y	BLOOD TRANSFUSION with venesection and complete replacement of blood, using blood already collected
13312	01DEC1991	31DEC9999	Y	BLOOD for pathology test, collection of, BY FEMORAL OR EXTERNAL JUGULAR VEIN PUNCTURE IN INFANTS
13315	01DEC1991	31DEC9999	Y	INTRAUTERINE FOETAL BLOOD TRANSFUSION using blood already collected, INCLUDING NECESSARY AMNIOCENTESIS
13318	01DEC1991	30JUN2012	N	CENTRAL VEIN CATHETERISATION (via jugular or subclavian vein) - by open exposure in a person under 12 years of age
13318	01JUL2012	30JUN2021	N	CENTRAL VEIN CATHETERISATION - by open exposure in a person under 12 years of age
13318	01JUL2021	31DEC9999	Y	CENTRAL VEIN CATHETERISATION - by open exposure in a patient under 12 years of age
13319	01MAY1997	31DEC9999	Y	CENTRAL VEIN CATHETERISATION in a neonate via peripheral vein
13400	01DEC1991	30JUN2021	N	RESTORATION OF CARDIAC RHYTHM by electrical stimulation (cardioversion), other than in the course of cardiac surgery
13400	01JUL2021	31DEC9999	Y	Restoration of cardiac rhythm by electrical stimulation (cardioversion), other than in the course of cardiac surgery (H)
13500	01DEC1991	31DEC9999	Y	GASTRIC HYPOTHERMIA by closed circuit circulation of refrigerant IN THE ABSENCE OF GASTROINTESTINAL HAEMORRHAGE
13503	01DEC1991	31DEC9999	Y	GASTRIC HYPOTHERMIA by closed circuit circulation of refrigerant FOR UPPER GASTROINTESTINAL HAEMORRHAGE
13506	01MAY1994	31DEC2013	N	GASTRO-OESOPHAGEAL balloon intubation, Minnesota, Sengstaken-Blakemore or similar, for control of bleeding from gastric oesophageal varices
13506	01JAN2014	31DEC9999	Y	GASTRO-OESOPHAGEAL balloon intubation, for control of bleeding from gastric oesophageal varices
13600	01DEC1991	31DEC9999	Y	PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent
13603	01DEC1991	31DEC9999	Y	WHOLE BODY PERFUSION, CARDIAC BYPASS, using heartlung machine or equivalent
13604	01NOV1997	31DEC9999	Y	PROLONGED WHOLE BODY PERFUSION, CARDIAC BY-PASS, using heart-lung machine or equivalent, where the time for the procedure exceeds 6 hours
13606	01DEC1991	31DEC9999	Y	INDUCED CONTROLLED HYPOTHERMIA total body
13609	01MAY1994	31OCT1997	N	CARDIOPLEGIA, retrograde administration of, involving crystalloid or blood, via a roller pump or pump-oxygenator
13609	01NOV1997	31DEC9999	Y	CARDIOPLEGIA, blood or crystalloid, administration by any route
13612	01NOV1998	31DEC9999	Y	DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22°c, including management of retrograde cerebral perfusion if performed
13700	01DEC1991	31DEC9999	Y	HARVESTING OF HOMOLOGOUS (including allogeneic) or AUTOLOGOUS bone marrow for the purpose of transplantation
13703	01DEC1991	31DEC2014	N	ADMINISTRATION OF BLOOD, including collection from donor
13703	01JAN2015	31OCT2020	N	TRANSFUSION OF BLOOD, including collection from donor
13703	01NOV2020	29FEB2024	N	Transfusion of blood, including collection from donor, when used for intra-operative normovolaemic haemodilution
13703	01MAR2024	31DEC9999	Y	Transfusion of blood including collection from donor, when used for intra-operative normovolaemic haemodilution, other than a service associated with a service to which item 22052 applies
13706	01DEC1991	31DEC2014	N	ADMINISTRATION OF BLOOD or bone marrow already collected
13706	01JAN2015	31DEC9999	Y	TRANSFUSION OF BLOOD or bone marrow already collected
13709	01DEC1991	31DEC9999	Y	COLLECTION OF BLOOD for autologous transfusion or when homologous blood is required for immediate transfusion in emergency situation
13750	01JUL1996	31DEC9999	Y	THERAPEUTIC HAEMAPHERESIS for the removal of plasma or cellular (or both) elements of blood, utilising continuous or intermittent flow techniques; including morphological tests for cell counts and viability studies, if performed; continuous monitoring of vital signs, fluid balance, blood volume and other parameters with continuous registered nurse attendance under the supervision of a consultant physician, not being a service associated with a service to which item 13755 applies -payable once per day
13755	01JUL1996	31DEC9999	Y	DONOR HAEMAPHERESIS for the collection of blood products for transfusion, utilising continuous or intermittent flow techniques; including morphological tests for cell counts and viability studies; continuous monitoring of vital signs, fluid balance, blood volume and other parameters; with continuous registered nurse attendance under the supervision of a consultant physician; not being a service associated with a service to which item 13750 applies - payable once per day
13757	01MAY1997	31OCT1997	N	THERAPEUTIC VENESECTION for the management of haemochromatosis or polycythemia vera
13757	01NOV1997	31DEC9999	Y	THERAPEUTIC VENESECTION for the management of haemochromatosis, polycythemia vera or porphyria cutanea tarda
13760	01JUL1996	31OCT1996	N	IN VITRO PROCESSING (and cryopreservation) of bone marrow or peripheral blood for autologous stem cell transplantation as an adjunct to high dose chemotherapy for: . chemosensitive intermediate or high grade non-Hodgkin's lymphoma at high risk of relapse following first line chemotherapy, or . Hodgkin's disease which has relapsed following, or is refractory to, chemotherapy; performed under the supervision of a consultant physician. - payable once per day.
13760	01NOV1996	30APR1997	N	IN VITRO PROCESSING (and cryopreservation) of bone marrow or peripheral blood for autologous stem cell transplantation as an adjunct to high dose chemotherapy for: . chemosensitive intermediate or high grade non-Hodgkin's lymphoma at high risk of relapse following first line chemotherapy; or . Hodgkin's disease which has relapsed following, or is refractory to, chemotherapy; or . acute myelogenous leukaemia in first remission, where suitable genotypically matched sibling donor is not available for allogeneic bone marrow transplant; or . multiple myeloma in remission (complete or partial) following standard dose chemotherapy. - performed under the supervision of a consultant physician - each day.
13760	01MAY1997	31OCT2020	N	IN VITRO PROCESSING (and cryopreservation) of bone marrow or peripheral blood for autologous stem cell transplantation as an adjunct to high dose chemotherapy for: . chemosensitive intermediate or high grade non-Hodgkin's lymphoma at high risk of relapse following first line chemotherapy; or . Hodgkin's disease which has relapsed following, or is refractory to, chemotherapy; or . acute myelogenous leukaemia in first remission, where suitable genotypically matched sibling donor is not available for allogeneic bone marrow transplant; or . multiple myeloma in remission (complete or partial) following standard dose chemotherapy; or . small round cell sarcomas; or . primitive neuroectodermal tumour; or . germ cell tumours which have relapsed following, or are refractory to, chemotherapy; . germ cell tumours which have had an incomplete response to first line therapy. - performed under the supervision of a consultant physician - each day.
13760	01NOV2020	31DEC9999	Y	In vitro processing with cryopreservation of bone marrow or peripheral blood, for autologous stem cell transplantation for a patient receiving high-dose chemotherapy for management of: (a) aggressive malignancy; or (b) malignancy that has proven refractory to prior treatment
13761	01MAR2022	30JUN2023	N	Extracorporeal photopheresis for the treatment of chronic graft-versus-host disease, if: (a) the person is: (i) has received allogeneic haematopoietic stem cell transplantation; and (ii) has been diagnosed with chronic graft versus host disease following the transplantation; and (iii) steroid treatment is clinically unsuitable as the disease is steroid refractory or the person is steroid-dependent or steroid-intolerant; and (b) the person has not previously received an extracorporeal photopheresis treatment cycle; and (c) the service is delivered using an integrated, closed extracorporeal photopheresis system; and (d) the service is provided in combination with the use of methoxalen that is listed on the Pharmaceutical Benefits Scheme; and (e) the service is provided by, or on behalf of, a specialist or consultant physician who: (i) is practising in the speciality of haematology or oncology; and (ii) has experience with allogeneic bone marrow transplantation. Applicable once per treatment cycle
13761	01JUL2023	31DEC9999	Y	Extracorporeal photopheresis for the treatment of chronic graft-versus-host disease, if: (a) the person is: (i) has received allogeneic haematopoietic stem cell transplantation; and (ii) has been diagnosed with chronic graft versus host disease following the transplantation; and (iii) steroid treatment is clinically unsuitable as the disease is steroid refractory or the person is steroid-dependent or steroid-intolerant; and (b) the person has not previously received extracorporeal photopheresis treatment; and (c) the service is delivered using an integrated, closed extracorporeal photopheresis system; and (d) the service is provided in combination with the use of methoxsalen that is listed on the Pharmaceutical Benefits Scheme; and (e) the service is provided by, or on behalf of, a specialist or consultant physician who: (i) is practising in the speciality of haematology or oncology; and (ii) has experience with allogeneic bone marrow transplantation. Applicable once per treatment session
13762	01MAR2022	30JUN2023	N	Extracorporeal photopheresis for the treatment of chronic graft-versus-host disease, if: (a) the person is: (i) has received allogeneic haematopoietic stem cell transplantation; and (ii) has been diagnosed with chronic graft versus host disease following the transplantation; and (iii) steroid treatment is clinically unsuitable as the disease is steroid refractory or the person is steroid-dependent or steroid-intolerant; and (b) the person has previously received an extracorporeal photopheresis treatment cycle and had a partial or complete response in at least one organ in response to treatment; and (c) the person requires further extracorporeal photopheresis; and (d) the service is delivered using an integrated, closed extracorporeal photopheresis system; and (e) the service is provided in combination with the use of methoxalen that is listed on the Pharmaceutical Benefits Scheme; and (f) the service is provided by, or on behalf of, a specialist or consultant physician who: (i) is practising in the speciality of haematology or oncology; and (ii) has experience with allogeneic bone marrow transplantation. Applicable once per treatment cycle
13762	01JUL2023	31DEC9999	Y	Extracorporeal photopheresis for the treatment of chronic graft-versus-host disease, if: (a) the person is: (i) has received allogeneic haematopoietic stem cell transplantation; and (ii) has been diagnosed with chronic graft versus host disease following the transplantation; and (iii) steroid treatment is clinically unsuitable as the disease is steroid refractory or the person is steroid-dependent or steroid-intolerant; and (b) the person has previously received an extracorporeal photopheresis treatment cycle and had a partial or complete response in at least one organ in response to treatment; and (c) the person requires further extracorporeal photopheresis; and (d) the service is delivered using an integrated, closed extracorporeal photopheresis system; and (e) the service is provided in combination with the use of methoxsalen that is listed on the Pharmaceutical Benefits Scheme; and (f) the service is provided by, or on behalf of, a specialist or consultant physician who: (i) is practising in the speciality of haematology or oncology; and (ii) has experience with allogeneic bone marrow transplantation. Applicable once per treatment session
13800	01DEC1991	31DEC9999	Y	CENTRAL VEIN CATHETERISATION (via jugular or subclavian vein) by percutaneous or open exposure not being a service to which item 13318 applies
13803	01DEC1991	31DEC9999	Y	RIGHT HEART BALLOON FLOTATION using pulmonary artery catheter, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry management on the first day
13806	01DEC1991	31DEC9999	Y	RIGHT HEART BALLOON FLOTATION using pulmonary artery catheter, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry management on each day subsequent to the first
13809	01JUL1993	31DEC9999	Y	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including initial and subsequent attendances, electrocardiograms, arterial sampling, bladder catheterisation and blood sampling - management on the first day
13812	01JUL1993	31DEC9999	Y	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including all attendances, electrocardiograms, arterial sampling, bladder catheterisation and blood sampling - management on each day subsequent to the first day
13815	01JUL1993	31OCT1993	N	CENTRAL VEIN CATHETERISATION (via jugular or subclavian vein) by percutaneous or open exposure not being a service to which item 13318 applies
13815	01NOV1993	30JUN2012	N	CENTRAL VEIN CATHETERISATION (via jugular, subclavian or femoral vein) by percutaneous or open exposure not being a service to which item 13318 applies
13815	01JUL2012	29FEB2020	N	CENTRAL VEIN CATHETERISATION by percutaneous or open exposure not being a service to which item 13318 applies
13815	01MAR2020	31DEC9999	Y	Central vein catheterisation, including under ultrasound guidance where clinically appropriate, by percutaneous or open exposure other than a service to which item 13318 applies (Anaes.) No separate ultrasound item is payable with this item.
13818	01JUL1993	30APR1994	N	RIGHT HEART BALLOON FLOTATION using a pulmonary artery catheter, including pulmonary wedge pressure and cardiac output measurement and including monitoring of pulmonary arterial and central venous pressures on the day of insertion - management on the first day
13818	01MAY1994	31DEC9999	Y	RIGHT HEART BALLOON CATHETER, insertion of, including pulmonary wedge pressure and cardiac output measurement
13819	01JUL1993	31DEC9999	Y	CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure, continuous monitoring by indwelling catheter by a specialist or consultant physician in an Intensive Care Unit - each day of monitoring for each pressure up to a maximum of 4 pressures (not being a service to which item 11600 or 13818 applies)
13821	01JUL1993	31DEC9999	Y	MECHANICAL VENTILATION, initiation of, by a specialist or consultant physician in conjunction with subsequent management of ventilatory support on the first day, in an Intensive Care Unit
13824	01JUL1993	31OCT1993	N	VENTILATORY SUPPORT in an Intensive Care Unit, management of, by a specialist or consultant physician - not being a service to which item 13809 applies - each day
13824	01NOV1993	31DEC9999	Y	VENTILATORY SUPPORT in an Intensive Care Unit, management of, by a specialist or consultant physician - not being a service to which item 13821 applies - each day
13827	01JUL1993	31DEC9999	Y	GASTRO-OESOPHAGEAL balloon intubation, Minnesota, Sengstaken-Blakemore or similar, for control of bleeding from gastric oesophageal varices
13830	01JUL1993	31DEC9999	Y	INTRACRANIAL PRESSURE, monitoring of, by intraventricular or subdural catheter, subarachnoid bolt or similar, by a specialist or consultant physician - each day
13832	01MAR2020	31DEC9999	Y	Peripheral cannulation, including under ultrasound guidance where clinically appropriate, for veno-arterial cardiopulmonary extracorporeal life support No separate ultrasound item is payable with this item
13833	01JUL1993	31DEC9999	Y	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, management by a specialist or consultant physician - on the first day in an Intensive Care Unit
13834	01MAR2020	31DEC9999	Y	Veno-arterial cardiopulmonary extracorporeal life support, management of-the first day
13835	01MAR2020	31DEC9999	Y	Veno-arterial cardiopulmonary extracorporeal life support, management of-each day after the first
13836	01JUL1993	31DEC9999	Y	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, management by a specialist or consultant physician - on each day subsequent to the first day in an Intensive Care Unit
13837	01MAR2020	31DEC9999	Y	Veno-venous pulmonary extracorporeal life support, management of-the first day
13838	01MAR2020	31DEC9999	Y	Veno-venous pulmonary extracorporeal life support, management of-each day after the first
13839	01MAY1994	31DEC9999	Y	ARTERIAL PUNCTURE and collection of blood for diagnostic purposes
13840	01MAR2020	31DEC9999	Y	Peripheral cannulation, including under ultrasound guidance where clinically appropriate, for veno-venous pulmonary extracorporeal life support No separate ultrasound item is payable with this item
13842	01MAY1994	29FEB2020	N	INTRAARTERIAL CANNULATION for the purpose of taking multiple arterial blood samples for blood gas analysis
13842	01MAR2020	31DEC9999	Y	Intra-arterial cannulation, including under ultrasound guidance where clinically appropriate, for the purpose of intra-arterial pressure monitoring or arterial blood sampling (or both) No separate ultrasound item is payable with this item
13845	01MAY1994	31DEC9999	Y	COUNTERPULSATION BY INTRAAORTIC BALLOON management on the first day, including percutaneous insertion, initial and subsequent consultations and monitoring of parameters
13847	01NOV2005	31DEC9999	Y	COUNTERPULSATION BY INTRAAORTIC BALLOON management on the first day including initial and subsequent consultations and monitoring of parameters
13848	01MAY1994	29FEB2020	N	COUNTERPULSATION BY INTRAAORTIC BALLOON management on each day subsequent to the first, including associated consultations and monitoring of parameters
13848	01MAR2020	31DEC9999	Y	Counterpulsation by intra-aortic balloon-management including associated consultations and monitoring of parameters by means of full haemodynamic assessment and management on several occasions on a day - each day
13851	01MAY1994	29FEB2020	N	CIRCULATORY SUPPORT DEVICE, management of, on first day
13851	01MAR2020	31DEC9999	Y	Ventricular assist device, management of, for a patient admitted to an intensive care unit for implantation of the device or for complications arising from implantation or management of the device - first day
13854	01MAY1994	29FEB2020	N	CIRCULATORY SUPPORT DEVICE, management of, on each day subsequent to the first
13854	01MAR2020	31DEC9999	Y	Ventricular assist device, management of, for a patient admitted to an intensive care unit, including management of complications arising from implantation or management of the device - each day after the first day
13857	01NOV1994	31OCT2005	N	MECHANICAL VENTILATION, initiation of (other than initiation of ventilation in the context of an anaesthetic for surgery), outside of an Intensive Care Unit, where subsequent management of ventilatory support is undertaken in an Intensive Care Unit
13857	01NOV2005	31DEC9999	Y	AIRWAY ACCESS, ESTABLISHMENT OF AND INITIATION OF MECHANICAL VENTILATION (other than in the context of an anaesthetic for surgery), outside an Intensive Care Unit, for the purpose of subsequent ventilatory support in an Intensive Care Unit
13870	01MAY1994	31OCT1994	N	(Note: See para T1.5 of Explanatory Notes to this Category for definition of an Intensive Care Unit) MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including initial and subsequent attendances, electrocardiograms, arterial sampling, bladder catheterisation and blood sampling - management on the first day
13870	01NOV1994	31OCT2005	N	(Note: See para T1.7 of Explanatory Notes to this Category for definition of an Intensive Care Unit) MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including initial and subsequent attendances, electrocardiographic monitoring, arterial sampling, bladder catheterisation and blood sampling - management on the first day
13870	01NOV2005	31DEC2014	N	(Note: See para T1.8 of Explanatory Notes to this Category for definition of an Intensive Care Unit) MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - including initial and subsequent attendances, electrocardiographic monitoring, arterial sampling and bladder catheterisation - management on the first day
13870	01JAN2015	31DEC9999	Y	(Note: See para T1.8 of Explanatory Notes to this Category for definition of an Intensive Care Unit) MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - including initial and subsequent attendances, electrocardiographic monitoring, arterial sampling and bladder catheterisation - management on the first day (H)
13873	01MAY1994	31OCT1994	N	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including all attendances, electrocardiograms, arterial sampling, bladder catheterisation and blood sampling - management on each day subsequent to the first day
13873	01NOV1994	31OCT2005	N	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician - including all attendances, electrocardiographic monitoring, arterial sampling, bladder catheterisation and blood sampling - management on each day subsequent to the first day
13873	01NOV2005	31DEC2014	N	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - including all attendances, electrocardiographic monitoring, arterial sampling and bladder catheterisation - management on each day subsequent to the first day
13873	01JAN2015	31DEC9999	Y	MANAGEMENT of a patient in an Intensive Care Unit by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - including all attendances, electrocardiographic monitoring, arterial sampling and bladder catheterisation - management on each day subsequent to the first day (H)
13876	01MAY1994	31OCT2005	N	CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure, continuous monitoring by indwelling catheter by a specialist or consultant physician in an Intensive Care Unit - each day of monitoring for each type of pressure up to a maximum of 4 pressures
13876	01NOV2005	31OCT2008	N	CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure, continuous monitoring by indwelling catheter in an intensive care unit and managed by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - each day of monitoring for each type of pressure up to a maximum of 4 pressures
13876	01NOV2008	31DEC2014	N	CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure, continuous monitoring by indwelling catheter in an intensive care unit and managed by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - once only for each type of pressure on any calendar day (up to a maximum of 4 pressures)
13876	01JAN2015	31DEC9999	Y	CENTRAL VENOUS PRESSURE, pulmonary arterial pressure, systemic arterial pressure or cardiac intracavity pressure, continuous monitoring by indwelling catheter in an intensive care unit and managed by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - once only for each type of pressure on any calendar day (up to a maximum of 4 pressures) (H)
13879	01MAY1994	31OCT1994	N	MECHANICAL VENTILATION, initiation of, by a specialist or consultant physician in conjunction with subsequent management of ventilatory support on the first day, in an Intensive Care Unit
13879	01NOV1994	31DEC9999	Y	MECHANICAL VENTILATION, initiation of, by a specialist or consultant physician, in an Intensive Care Unit, including subsequent management of ventilatory support on the first day
13881	01NOV2005	31DEC2014	N	AIRWAY ACCESS, ESTABLISHMENT OF AND INITIATION OF MECHANICAL VENTILATION, in an Intensive Care Unit, not in association with any anaesthetic service, by a specialist or consultant physician for the purpose of subsequent ventilatory support
13881	01JAN2015	31DEC9999	Y	AIRWAY ACCESS, ESTABLISHMENT OF AND INITIATION OF MECHANICAL VENTILATION, in an Intensive Care Unit, not in association with any anaesthetic service, by a specialist or consultant physician for the purpose of subsequent ventilatory support (H)
13882	01MAY1994	31OCT2005	N	VENTILATORY SUPPORT in an Intensive Care Unit, management of, by a specialist or consultant physician - not being a service to which item 13879 applies - each day
13882	01NOV2005	31DEC2014	N	VENTILATORY SUPPORT in an Intensive Care Unit, management of, by invasive means, or by non-invasive means where the only alternative to non-invasive ventilatory support would be invasive ventilatory support, by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care, each day
13882	01JAN2015	31DEC9999	Y	VENTILATORY SUPPORT in an Intensive Care Unit, management of, by invasive means, or by non-invasive means where the only alternative to non-invasive ventilatory support would be invasive ventilatory support, by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care, each day (H)
13885	01MAY1994	31OCT2005	N	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, management by a specialist or consultant physician - on the first day in an Intensive Care Unit
13885	01NOV2005	31DEC2014	N	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care unit, management by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - on the first day
13885	01JAN2015	31DEC9999	Y	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care unit, management by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - on the first day (H)
13888	01MAY1994	31OCT2005	N	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, management by a specialist or consultant physician - on each day subsequent to the first day in an Intensive Care Unit
13888	01NOV2005	31DEC2014	N	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care unit, management by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - on each day subsequent to the first day
13888	01JAN2015	31DEC9999	Y	CONTINUOUS ARTERIO VENOUS OR VENO VENOUS HAEMOFILTRATION, in an intensive care unit, management by a specialist or consultant physician who is immediately available and exclusively rostered for intensive care - on each day subsequent to the first day (H)
13899	01MAR2020	31DEC9999	Y	Preparation of Goals of Care is provided outside of an intensive care unit. Refer to explanatory note TN.1.11 for further information about Goals of Care attendance Professional attendance, outside an intensive care unit, for at least 60 minutes spent in preparation of goals of care for a gravely ill patient lacking current goals of care, by a specialist in the specialty of intensive care who takes overall responsibility for the preparation of the goals of care for the patient Item 13899 cannot be co-claimed with item 13870 or item 13873 on the same day
13900	01DEC1991	31DEC9999	Y	INTRAARTERIAL INFUSION or retrograde intravenous perfusion of a sympatholytic agent
13903	01DEC1991	31DEC9999	Y	ADMINISTRATION OF CYTOTOXIC AGENT by intravenous drip infusion or by introduction into the bladder
13906	01DEC1991	31DEC9999	Y	INTRAARTERIAL INFUSION or INTRAARTERIAL INJECTION of a substance incorporating a CYTOTOXIC AGENT, PREPARATION FOR
13909	01DEC1991	31DEC9999	Y	INTRALYMPHATIC INFUSION or INTRALYMPHATIC INJECTION of a fluid containing a CYTOTOXIC AGENT, with or without the incorporation of an opaque medium
13912	01DEC1991	31DEC9999	Y	INTRALYMPHATIC INSERTION OF NEEDLE OR CANNULA for the introduction of radioactive material
13915	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, either by intravenous push technique (directly into a vein, or a butterfly needle, or the side-arm of an infusion) or by intravenous infusion of not more than 1 hours duration - payable once only on the same day
13915	01MAR1999	31OCT2002	N	CYTOTOXIC CHEMOTHERAPY, administration of, either by intravenous push technique (directly into a vein, or a butterfly needle, or the side-arm of an infusion) or by intravenous infusion of not more than 1 hours duration - payable once only on the same day
13915	01NOV2002	30APR2006	N	CYTOTOXIC CHEMOTHERAPY, administration of, either by intravenous push technique (directly into a vein, or a butterfly needle, or the side-arm of an infusion) or by intravenous infusion of not more than 1 hours duration - payable once only on the same day, not being a service associated with photodynamic therapy with verteporfin
13915	01MAY2006	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, either by intravenous push technique (directly into a vein, or a butterfly needle, or the side-arm of an infusion) or by intravenous infusion of not more than 1 hours duration - payable once only on the same day, not being a service associated with photodynamic therapy with verteporfin or for the administration of drugs used immediately prior to, or with microwave (UHF radiowave) cancer therapy alone
13918	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intravenous infusion of more than 1 hours duration but not more than 6 hours duration - payable once only on the same day
13918	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intravenous infusion of more than 1 hours duration but not more than 6 hours duration - payable once only on the same day
13921	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intravenous infusion of more than 6 hours duration - for the first day of treatment
13921	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intravenous infusion of more than 6 hours duration - for the first day of treatment
13924	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intravenous infusion of more than 6 hours duration - on each day subsequent to the first in the same continuous treatment episode
13924	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intravenous infusion of more than 6 hours duration - on each day subsequent to the first in the same continuous treatment episode
13927	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, either by intra-arterial push technique (directly into an artery, a butterfly needle or the side-arm of an infusion) or by intra-arterial infusion of not more than 1 hours duration - payable once only on the same day
13927	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, either by intra-arterial push technique (directly into an artery, a butterfly needle or the side-arm of an infusion) or by intra-arterial infusion of not more than 1 hours duration - payable once only on the same day
13930	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 1 hours duration but not more than 6 hours duration - payable once only on the same day
13930	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 1 hours duration but not more than 6 hours duration - payable once only on the same day
13933	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 6 hours duration - for the first day of treatment
13933	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 6 hours duration - for the first day of treatment
13936	01JUL1993	28FEB1999	N	CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 6 hours duration - on each day subsequent to the first in the same continuous treatment episode
13936	01MAR1999	31DEC9999	Y	CYTOTOXIC CHEMOTHERAPY, administration of, by intra-arterial infusion of more than 6 hours duration - on each day subsequent to the first in the same continuous treatment episode
13939	01JUL1993	31OCT1998	N	IMPLANTED PUMP OR RESERVOIR, loading of, with a therapeutic agent or agents, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13939	01NOV1998	28FEB1999	N	IMPLANTED PUMP OR RESERVOIR, loading of, with a chemotherapeutic agent or agents, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13939	01MAR1999	31OCT1999	N	IMPLANTED PUMP OR RESERVOIR, loading of, with a cytotoxic chemotherapeutic agent or agents, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13939	01NOV1999	31DEC9999	Y	IMPLANTED PUMP OR RESERVOIR, loading of, with a cytotoxic agent or agents, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933, 13936 or 13945 applies
13942	01JUL1993	31OCT1998	N	AMBULATORY DRUG DELIVERY DEVICE, loading of, with a therapeutic agent or agents for the infusion of the agent or agents via the intravenous, intra-arterial or spinal routes, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13942	01NOV1998	28FEB1999	N	AMBULATORY DRUG DELIVERY DEVICE, loading of, with a chemotherapeutic agent or agents for the infusion of the agent or agents via the intravenous, intra-arterial or spinal routes, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13942	01MAR1999	31OCT1999	N	AMBULATORY DRUG DELIVERY DEVICE, loading of, with a cytotoxic agent or agents for the infusion of the agent or agents via the intravenous, intra-arterial or spinal routes, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933 or 13936 applies
13942	01NOV1999	31DEC9999	Y	AMBULATORY DRUG DELIVERY DEVICE, loading of, with a cytotoxic agent or agents for the infusion of the agent or agents via the intravenous, intra-arterial or spinal routes, not being a service associated with a service to which item 13915, 13918, 13921, 13924, 13927, 13930, 13933, 13936 or 13945 applies
13945	01JUL1993	28FEB1999	N	LONG-TERM IMPLANTED DRUG DELIVERY DEVICE, accessing of
13945	01MAR1999	31DEC9999	Y	LONG-TERM IMPLANTED DRUG DELIVERY DEVICE FOR CYTOTOXIC CHEMOTHERAPY, accessing of
13948	01JUL1993	31DEC9999	Y	CYTOTOXIC AGENT, instillation of, into a body cavity
13950	01NOV2020	31DEC9999	Y	Parenteral administration of one or more antineoplastic agents, including agents used in cytotoxic chemotherapy or monoclonal antibody therapy but not agents used in anti-resorptive bone therapy or hormonal therapy, by or on behalf of a specialist or consultant physician-attendance for one or more episodes of administration Note: The fee for item 13950 contains a component which covers the accessing of a long-term drug delivery device. TN.1.27 refers
14050	01DEC1991	31OCT2018	N	PUVA THERAPY or UVB THERAPY administered in whole body cabinet, not being a service associated with a service to which item 14053 applies including associated consultations other than an initial consultation
14050	01NOV2018	31DEC9999	Y	UVA or UVB phototherapy administered in a whole body cabinet or hand and foot cabinet including associated consultations other than the initial consultation, if treatment is initiated and supervised by a specialist in the specialty of dermatology Applicable not more than 150 times in a 12 month period
14053	01DEC1991	31DEC9999	Y	PUVA THERAPY or UVB THERAPY administered to localised body areas in hand and foot cabinet not being a service associated with a service to which item 14050 applies including associated consultations other than an initial consultation
14056	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14059, 14062, 14065, 14068, 14071 and 14074 apply) in any 12 month period - session of at least 30 minutes duration (Ministerial Determination)
14056	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation - session with a duration of at least 30 minutes but less than 60 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14059, 14062, 14065, 14068, 14071 or 14074) in any 12 month period
14059	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14062, 14065, 14068, 14071 and 14074 apply) in any 12 month period - session of at least 60 minutes duration (Ministerial Determination)
14059	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation - session with a duration of at least 60 minutes but less than 1 hour - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14062, 14065, 14068, 14071 or 14074) in any 12 month period
14062	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14059, 14065, 14068, 14071 and 14074 apply) in any 12 month period - session of at least 1 hour and 15 minutes duration (Ministerial Determination)
14062	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation - session with a duration of at least 1 hour and 15 minutes but less than 1 hour and 30 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14059, 14065, 14068, 14071 or 14074) in any 12 month period
14065	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14059, 14062, 14068, 14071 and 14074 apply) in any 12 month period - session of at least 1 hour and 30 minutes duration (Ministerial Determination)
14065	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation - session with a duration of at least 1 hour and 30 minutes but less than 1 hour and 45 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14059, 14062, 14068, 14071 or 14074) in any 12 month period
14068	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14059, 14062, 14065, 14071 and 14074 apply) in any 12 month period - session of at least 1 hour and 45 minutes duration (Ministerial Determination)
14068	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation -session with a duration of at least 1 hour and 45 minutes but less than 2 hours - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14059, 14062, 14065, 14071 or 14074) in any 12 month period
14071	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14059, 14062, 14065, 14068 and 14074 apply) in any 12 month period - session of at least 2 hours duration (Ministerial Determination)
14071	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation -session with a duration of at least 2 hours but less than 2 hours and 15 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14059, 14062, 14065, 14068 or 14074) in any 12 month period
14074	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14056, 14059, 14062, 14065, 14068 and 14071 apply) in any 12 month period - session of at least 2 hours and 15 minutes duration (Ministerial Determination)
14074	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of severely disfiguring vascular lesions of the head or neck where the individual abnormal vessels are visible at a distance of 2 metres, including any associated consultation -session with a duration of at least 2 hours and 15 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14056, 14059, 14062, 14065, 14068 or 14071) in any 12 month period
14077	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14080, 14083, 14086, 14089, 14092 and 14095 apply) in any 12 month period - session of at least 30 minutes duration (Ministerial Determination)
14077	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 30 minutes but less than 60 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14080, 14083, 14086, 14089, 14092 or 14095) in any 12 month period
14080	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14083, 14086, 14089, 14092 and 14095 apply) in any 12 month period - session of at least 60 minutes duration (Ministerial Determination)
14080	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 60 minutes but less than 1 hour and 15 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14083, 14086, 14089, 14092 or 14095) in any 12 month period
14083	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14080, 14086, 14089, 14092 and 14095 apply) in any 12 month period - session of at least 1 hour and 15 minutes duration (Ministerial Determination)
14083	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 1 hour 15 minutes but less than 1 hour and 30 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14080, 14086, 14089, 14092 or 14095) in any 12 month period
14086	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14080, 14083, 14089, 14092, and 14095 apply) in any 12 month period - session of at least 1 hour and 30 minutes duration (Ministerial Determination)
14086	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 1 hour 30 minutes but less than 1 hour and 45 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14080, 14083, 14089, 14092 or 14095) in any 12 month period
14089	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14080, 14083, 14086, 14092, and 14095 apply) in any 12 month period - session of at least 1 hour and 45 minutes duration (Ministerial Determination)
14089	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 1 hour 45 minutes but less than 2 hours - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14080, 14083, 14086, 14092 or 14095) in any 12 month period
14092	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14080, 14083, 14086, 14089, and 14095 apply) in any 12 month period - session of at least 2 hours duration (Ministerial Determination)
14092	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 2 hours but less than 2 hours and 15 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14080, 14083, 14086, 14089 or 14095) in any 12 month period
14095	01DEC1991	30JUN1995	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation, up to a maximum of 12 sessions (including any sessions to which items 14077, 14080, 14083, 14086, 14089, and 14092 apply) in any 12 month period - session of at least 2 hours and 15 minutes duration (Ministerial Determination)
14095	01JUL1995	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600 nanometres in the treatment of port wine stains, including any associated consultation -session with a duration of at least 2 hours and 15 minutes - payable not more than 12 times (including any times payment is made in respect of the patient for a service described in item 14077, 14080, 14083, 14086, 14089 or 14092) in any 12 month period
14100	01NOV1995	31OCT1996	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 6 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - session of at least 30 minutes duration
14100	01NOV1996	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - session of at least 30 minutes duration
14100	01NOV2004	31OCT2018	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of vascular lesions of the head or neck where abnormality is visible from 3 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period
14100	01NOV2018	31DEC9999	Y	Laser photocoagulation using laser radiation in the treatment of vascular abnormalities of the head or neck, including any associated consultation, if: (a) the abnormality is visible from 3 metres; and (b) photographic evidence demonstrating the need for this service is documented in the patient notes; to a maximum of 4 sessions (including any sessions to which this item or any of items 14106 to 14118 apply) in any 12 month period
14103	01NOV1995	31OCT1996	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 6 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - session of at least 60 minutes duration
14103	01NOV1996	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - session of at least 60 minutes duration
14106	01NOV1995	30APR1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of port wine stains and haemangiomas, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment up to 50cm2
14106	01MAY1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment up to 50cm2
14106	01NOV2004	30APR2005	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment up to 50cm2 where abnormality is visible from 3 metres
14106	01MAY2005	31OCT2018	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), where the abnormality is visible from 3 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment up to 50cm2
14106	01NOV2018	31DEC9999	Y	Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café au lait macules and naevi of Ota, other than melanocytic naevi (common moles), if the abnormality is visible from 3 metres, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14118 apply) in any 12 month period-area of treatment less than 150 cm2
14109	01NOV1995	30APR1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of port wine stains and haemangiomas, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 50cm2 and up to 100cm2
14109	01MAY1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 50cm2 and up to 100cm2
14109	01NOV2004	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 50cm2 and up to 100cm2
14112	01NOV1995	30APR1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of port wine stains and haemangiomas, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 100cm2 and up to 150cm2
14112	01MAY1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 100cm2 and up to 150cm2
14112	01NOV2004	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 100cm2 and up to 150cm2
14115	01NOV1995	30APR1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of port wine stains and haemangiomas, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 150cm2 and up to 250cm2
14115	01MAY1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 150cm2 and up to 250cm2
14115	01NOV2004	31OCT2018	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 150cm2 and up to 250cm2
14115	01NOV2018	31DEC9999	Y	Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café au lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14118 apply) in any 12 month period-area of treatment 150 cm2 to 300 cm2
14118	01NOV1995	30APR1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of port wine stains and haemangiomas, including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 apply) in any 12 month period - area of treatment more than 250cm2
14118	01MAY1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 250cm2
14118	01NOV2004	31OCT2018	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas of infancy, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - area of treatment more than 250cm2
14118	01NOV2018	31DEC9999	Y	Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café au lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14115 apply) in any 12 month period-area of treatment more than 300 cm2
14120	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation - session of at least 30 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14120	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation - session of at least 30 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14122	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation, session of at least 60 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14122	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-600nm in the treatment of severely disfiguring vascular lesions of the head or neck where abnormality is visible from 4 metres, including any associated consultation, session of at least 60 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment up to 50cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	01NOV1997	31OCT2004	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment up to 50cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	01NOV2004	30APR2005	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of haemangiomas of infancy, including any associated consultation - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	01MAY2005	31JUL2014	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of haemangiomas of infancy, including any associated consultation - where a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	01AUG2014	31OCT2018	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of haemangiomas of infancy, including any associated consultation - where a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14124	01NOV2018	31DEC9999	Y	Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, if: (a) a seventh or subsequent session (including any sessions to which this item or any of items 14100 to 14118 apply) is indicated in a 12 month period commencing on the day of the first session; and (b) photographic evidence demonstrating the need for this service is documented in the patient notes
14126	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 50cm2 and up to 100cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14126	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 50cm2 and up to 100cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14128	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 100cm2 and up to 150cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14128	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 100cm2 and up to 150cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14130	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 150cm2 and up to 250cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14130	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 150cm2 and up to 250cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14132	19JUN1997	31OCT1997	N	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 250cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14132	01NOV1997	31DEC9999	Y	LASER PHOTOCOAGULATION using laser light within the wave length of 510-1064nm in the treatment of port wine stains, haemangiomas, cafe-au-lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation - area of treatment more than 250cm2 - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
14200	01DEC1991	31DEC9999	Y	GASTRIC LAVAGE in the treatment of ingested poison
14201	01JUL2011	31DEC9999	Y	POLY-L-LACTIC ACID, one or more injections of, for the initial session only, for the treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953 - once per patient
14202	01JUL2011	31DEC9999	Y	POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953
14203	01DEC1991	30JUN1993	N	HORMONE OR LIVING TISSUE IMPLANTATION by incision
14203	01JUL1993	31DEC9999	Y	HORMONE OR LIVING TISSUE IMPLANTATION, by direct implantation involving incision and suture
14206	01DEC1991	31DEC9999	Y	HORMONE OR LIVING TISSUE IMPLANTATION by cannula
14209	01JUL1993	31DEC9999	Y	INTRAARTERIAL INFUSION or retrograde intravenous perfusion of a sympatholytic agent
14212	01NOV1994	31DEC9999	Y	INTUSSUSCEPTION, management of fluid or gas reduction for
14215	01MAR1999	31DEC9999	Y	LONG-TERM IMPLANTED RESERVOIR associated with the adjustable gastric band, accessing of to add or remove fluid
14216	01NOV2021	31DEC9999	Y	Professional attendance on a patient by a psychiatrist, who has undertaken training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment mapping for rTMS, if the patient: (a) has not previously received any prior transcranial magnetic stimulation therapy in a public or private setting; and (b) is at least 18 years old; and (c) is diagnosed with a major depressive episode; and (d) has failed to receive satisfactory improvement for the major depressive episode despite the adequate trialling of at least 2 different classes of antidepressant medications, unless contraindicated, and all of the following apply: (i) the patients adherence to antidepressant treatment has been formally assessed; (ii) the trialling of each antidepressant medication has been at the recommended therapeutic dose for a minimum of 3 weeks; (iii) where clinically appropriate, the treatment has been titrated to the maximum tolerated therapeutic dose; and (e) has undertaken psychological therapy, if clinically appropriate
14217	01NOV2021	31DEC9999	Y	Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 35 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS, if the patient has previously received a service under item 14216-each service up to 35 services
14218	01MAR1999	30APR2005	N	IMPLANTED PUMP OR RESERVOIR, LOADING OF, with a therapeutic agent or agents, for infusion to the subarachnoid or epidural space
14218	01MAY2005	28FEB2022	N	IMPLANTED INFUSION PUMP REFILLING OF reservoir, with a therapeutic agent or agents, for infusion to the subarachnoid or epidural space, with or without re-programming of a programmable pump, for the management of chronic intractable pain
14218	01MAR2022	31DEC9999	Y	Implanted infusion pump, refilling of reservoir with a therapeutic agent or agents for infusion to the subarachnoid space or accessing the side port to assess catheter patency, with or without pump reprogramming, for the management of chronic pain, including cancer pain
14219	01NOV2021	31DEC9999	Y	Professional attendance on a patient by a psychiatrist, who has undertaken training in Repetitive Transcranial Magnetic Stimulation (rTMS), for treatment mapping for rTMS, if the patient: (a) is at least 18 years old; and (b) is diagnosed with a major depressive episode; and (c) has failed to receive satisfactory improvement for the major depressive episode despite the adequate trialling of at least 2 different classes of antidepressant medications, unless contraindicated, and all of the following apply: (i) the patients adherence to antidepressant treatment has been formally assessed; (ii) the trialling of each antidepressant medication has been at the recommended therapeutic dose for a minimum of 3 weeks; (iii) where clinically appropriate, the treatment has been titrated to the maximum tolerated therapeutic dose; and (d) has undertaken psychological therapy, if clinically appropriate; and (e) has previously received an initial service under item 14217 and the patient: (i) has relapsed after a remission following the initial service; and (ii) has had a satisfactory clinical response to the service under item 14217 (which has been assessed by a validated major depressive disorder tool at least 4 months after receiving that service)
14220	01NOV2021	31DEC9999	Y	Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of up to 15 services provided by, or on behalf of, a psychiatrist who has undertaken training in rTMS, if the patient has previously received: (a) a service under item 14217 (which was not provided in the previous 4 months); and (b) a service under item 14219 Each service up to 15 services
14221	01MAR1999	31OCT2020	N	LONG-TERM IMPLANTED DEVICE FOR DELIVERY OF THERAPEUTIC AGENTS, accessing of, not being a service associated with a service to which item 13945 applies
14221	01NOV2020	31DEC9999	Y	LONG-TERM IMPLANTED DEVICE FOR DELIVERY OF THERAPEUTIC AGENTS, accessing of, not being a service associated with a service to which item 13950 applies
14224	01MAR1999	29FEB2024	N	ELECTROCONVULSIVE THERAPY, with or without the use of stimulus dosing techniques, including any electroencephalographic monitoring and associated consultation
14224	01MAR2024	31DEC9999	Y	Electroconvulsive therapy, with or without the use of stimulus dosing techniques, including any electroencephalographic monitoring and associated consultation (H)
14227	01MAY2006	31DEC9999	Y	IMPLANTED INFUSION PUMP, REFILLING of reservoir, with baclofen, for infusion to the subarachnoid or epidural space, with or without re-programming of a programmable pump, for the management of severe chronic spasticity
14230	01MAY2006	31DEC9999	Y	Intrathecal or epidural SPINAL CATHETER insertion or replacement of, for connection to a subcutaneous implanted infusion pump, for the management of severe chronic spasticity with baclofen
14233	01MAY2006	31OCT2006	N	INFUSION PUMP, subcutaneous implantation or replacement of, and connection to intrathecal or epidural catheter, and loading of reservoir with analgesic, with or without programming of the pump, for the management of severe chronic spasticity
14233	01NOV2006	31DEC9999	Y	INFUSION PUMP, subcutaneous implantation or replacement of, and connection to intrathecal or epidural catheter, and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity
14234	01NOV2020	31DEC9999	Y	Infusion pump or components of an infusion pump, removal or replacement of, and connection to intrathecal or epidural catheter, and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity
14236	01MAY2006	31DEC9999	Y	INFUSION PUMP, subcutaneous implantation of, AND intrathecal or epidural SPINAL CATHETER insertion, and connection of pump to catheter and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity
14237	01NOV2020	31DEC9999	Y	Infusion pump or components of an infusion pump, subcutaneous implantation of, and intrathecal or epidural spinal catheter insertion, and connection of pump to catheter, and loading of reservoir with baclofen, with or without programming of the pump, for the management of severe chronic spasticity
14239	01MAY2006	31DEC9999	Y	Removal of subcutaneously IMPLANTED INFUSION PUMP, OR removal or repositioning of intrathecal or epidural SPINAL CATHETER, for the management of severe chronic spasticity
14242	01MAY2006	31DEC9999	Y	SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER, insertion of, for the management of severe chronic spasticity
14245	01NOV2006	31OCT2007	N	INFLIXIMAB, administration of, by intravenous infusion for at least 2 hours duration - payable once only on the same day and where infliximab is provided under section 100 of the Pharmaceutical Benefits Scheme
14245	01NOV2007	31DEC9999	Y	IMMUNOMODULATING AGENT, administration of, by intravenous infusion for at least 2 hours duration - payable once only on the same day and where the agent is provided under section 100 of the Pharmaceutical Benefits Scheme
14247	01NOV2020	31DEC9999	Y	Extracorporeal photopheresis for the treatment of erythrodermic stage III-IVa T4 M0 cutaneous T-cell lymphoma; if the service is provided in the initial six months of treatment; and the service is delivered using an integrated, closed extracorporeal photopheresis system; and the patient is 18 years old or over; and the patient has received prior systemic treatment for this condition and experienced either disease progression or unacceptable toxicity while on this treatment; and the service is provided in combination with the use of Pharmaceutical Benefits Scheme-subsidised methoxsalen; and the service is supervised by a specialist or consultant physician in the speciality of haematology. Applicable once per treatment cycle
14249	01NOV2020	31DEC9999	Y	Extracorporeal photopheresis for the continuing treatment of erythrodermic stage III-IVa T4 M0 cutaneous T-cell lymphoma; if in the preceding 6 months:(i) a service to which item 14247 applies has been provided; and(ii) the patient has demonstrated a response to this service; and(iii)the patient requires further treatment; and the service is delivered using an integrated, closed extracorporeal photopheresis system; and the patient is 18 years old or over; and the service is provided in combination with the use of Pharmaceutical Benefits Scheme-subsidised methoxsalen; and the service is supervised by a specialist or consultant physician in the speciality of haematology. Applicable once per treatment cycle
14255	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 30 minutes but less than 1 hour, by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
14256	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 1 hour but less than 2 hours, by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
14257	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 2 hours, by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
14258	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 30 minutes but less than 1 hour, by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
14259	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 1 hour but less than 2 hours, by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
14260	01MAR2020	31DEC9999	Y	Resuscitation of a patient provided for at least 2 hours, by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
14263	01MAR2020	31DEC9999	Y	Minor procedure on a patient by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
14264	01MAR2020	31DEC9999	Y	Procedure (except a minor procedure) on a patient by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019
14265	01MAR2020	31DEC9999	Y	Minor procedure on a patient by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
14266	01MAR2020	31DEC9999	Y	Procedure (except a minor procedure) on a patient by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital, in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036
14270	01MAR2020	31DEC9999	Y	Management, without aftercare, of all fractures and dislocations suffered by a patient that: (a) is provided by a specialist in the practice of the specialist's specialty of emergency medicine in conjunction with an attendance on the patient by the specialist described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017 or 5019; and (b) occurs at a recognised emergency department of a private hospital
14272	01MAR2020	31DEC9999	Y	Management, without aftercare, of all fractures and dislocations suffered by a patient that: (a) is provided by a medical practitioner (except a specialist in the practice of the specialist's specialty of emergency medicine) in conjunction with an attendance on the patient by the practitioner described in item 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (b) occurs at a recognised emergency department of a private hospital
14277	01MAR2020	31DEC9999	Y	Application of chemical or physical restraint of a patient by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital
14278	01MAR2020	31DEC9999	Y	Application of chemical or physical restraint of a patient by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital
14280	01MAR2020	31DEC9999	Y	Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is managed by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies
14283	01MAR2020	31DEC9999	Y	Anaesthesia (whether general anaesthesia or not) of a patient that: (a) is managed by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies
14285	01MAR2020	31DEC9999	Y	Emergent intubation, airway management or both of a patient that: (a) is managed by a specialist in the practice of the specialists specialty of emergency medicine at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies
14288	01MAR2020	31DEC9999	Y	Emergent intubation, airway management or both of a patient that: (a) is managed by a medical practitioner (except a specialist in the practice of the specialists specialty of emergency medicine) at a recognised emergency department of a private hospital; and (b) occurs in conjunction with an attendance on the patient that is described in item 5001, 5004, 5011, 5012, 5013, 5014, 5016, 5017, 5019, 5021, 5022, 5027, 5030, 5031, 5032, 5033, 5035 or 5036; and (c) is not anaesthesia provided by a specialist anaesthetist to which an item in Group T7 or T10 applies
15000	01DEC1991	31DEC9999	Y	(Benefits for administration of general anaesthetic for radiotherapy are payable under Group T10) RADIOTHERAPY, SUPERFICIAL (including treatment with xrays, radium rays or other radioactive substances), not being a service to which another item in this Group applies each attendance at which fractionated treatment is given - 1 field
15003	01DEC1991	31DEC9999	Y	Radiotherapy, superficial (including treatment with x-rays, radium rays or other radioactive substances), not being a service to which another item in this Group applies - each attendance at which fractionated treatment is given - 2 or more fields up to a maximum of 5 additional fields
15006	01DEC1991	31DEC9999	Y	RADIOTHERAPY, SUPERFICIAL, attendance at which single dose technique is applied - 1 field
15009	01DEC1991	31DEC9999	Y	Radiotherapy, superficial attendance at which a single dose technique is applied - 2 or more fields up to a maximum of 5 additional fields
15012	01DEC1991	31DEC9999	Y	RADIOTHERAPY, SUPERFICIAL each attendance at which treatment is given to an eye
15100	01DEC1991	31DEC9999	Y	RADIOTHERAPY, DEEP OR ORTHOVOLTAGE each attendance at which fractionated treatment is given at 3 or more treatments per week - 1 field
15103	01DEC1991	31DEC9999	Y	Radiotherapy, deep or orthovoltage each attendance at which fractionated treatment is given at 3 or more treatments per week - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15106	01DEC1991	31DEC9999	Y	RADIOTHERAPY, DEEP OR ORTHOVOLTAGE each attendance at which fractionated treatment is given at 2 treatments per week or less frequently - 1 field
15109	01DEC1991	31DEC9999	Y	Radiotherapy, deep or orthovoltage each attendance at which fractionated treatment is given at 2 treatments per week or less frequently - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15112	01DEC1991	31DEC9999	Y	RADIOTHERAPY, DEEP OR ORTHOVOLTAGE attendance at which single dose technique is applied 1 field
15115	01DEC1991	31DEC9999	Y	Radiotherapy, deep or orthovoltage attendance at which a single dose technique is applied - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15203	01DEC1991	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field
15204	01DEC1991	31DEC9999	Y	- 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15207	01DEC1991	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of 10 MV photons or greater, with electron facilities - each attendance at which treatment is given - 1 field
15208	01DEC1991	31DEC9999	Y	- 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15211	01DEC1991	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using cobalt unit or caesium teletherapy unit each attendance at which treatment is given - 1 field
15214	01DEC1991	31DEC9999	Y	Radiation oncology treatment, using cobalt unit or caesium teletherapy unit - each attendance at which treatment is given 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields)
15215	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (lung)
15218	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (prostate)
15221	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (breast)
15224	01MAY2003	31OCT2003	N	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site for cancers not covered by items 15215, 15218 and 15221
15224	01NOV2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site for diseases and conditions not covered by items 15215, 15218 and 15221
15227	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to secondary site
15230	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (lung)
15233	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (prostate)
15236	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (breast)
15239	01MAY2003	31OCT2003	N	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site for cancers not covered by items 15230, 15233 or 15236
15239	01NOV2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site for diseases and conditions not covered by items 15230, 15233 or 15236
15242	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a single photon energy linear accelerator with or without electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to secondary site
15245	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (lung)
15248	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (prostate)
15251	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site (breast)
15254	01MAY2003	31OCT2003	N	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of 10MV photons or greater, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site for cancers not covered by items 15245, 15248 or 15251
15254	01NOV2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to primary site for diseases and conditions not covered by items 15245, 15248 or 15251
15257	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 1 field - treatment delivered to secondary site
15260	01MAY2003	31DEC9999	Y	RADIATION ORADIATION ONCOLOGY treatment, using a dual photon energy linear accelerator with a minimum higher energy of at least 10mv photons, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (lung)
15263	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (prostate)
15266	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site (breast)
15269	01MAY2003	31OCT2003	N	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of 10MV photons or greater, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site for cancers not covered by items 15260, 15263 or 15266
15269	01NOV2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to primary site for diseases and conditions not covered by items 15260, 15263 or 15266
15272	01MAY2003	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT, using a dual photon energy linear accelerator with a minimum higher energy of at least 10MV photons, with electron facilities - each attendance at which treatment is given - 2 or more fields up to a maximum of 5 additional fields (rotational therapy being 3 fields) - treatment delivered to secondary site
15275	01JAN2016	30JUN2016	N	RADIATION ONCOLOGY TREATMENT with IGRT imaging facilities undertaken: (a) to implement an IMRT dosimetry plan prepared in accordance with item 15565; and (b) utilising an intensity modulated treatment delivery (fixed or dynamic gantry linear accelerator or non linear accelerator) mode, once only at each attendance at which treatment is given.
15275	01JUL2016	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT with IGRT imaging facilities undertaken: (a) to implement an IMRT dosimetry plan prepared in accordance with item 15565; and (b) utilising an intensity modulated treatment delivery mode (delivered by a fixed or dynamic gantry linear accelerator or by a helical non C-arm based linear accelerator), once only at each attendance at which treatment is given.
15303	01DEC1991	31DEC9999	Y	INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a half-life greater than 115 days using manual afterloading techniques
15304	01DEC1991	31DEC9999	Y	INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a half-life greater than 115 days using automatic afterloading techniques
15307	01DEC1991	31DEC9999	Y	INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using manual afterloading techniques
15308	01DEC1991	31DEC9999	Y	INTRAUTERINE TREATMENT ALONE using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using automatic afterloading techniques
15311	01DEC1991	31DEC9999	Y	INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a half-life greater than 115 days using manual afterloading techniques
15312	01DEC1991	31DEC9999	Y	INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a half-life greater than 115 days using automatic afterloading techniques
15315	01DEC1991	31DEC9999	Y	INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using manual afterloading techniques
15316	01DEC1991	31DEC9999	Y	INTRAVAGINAL TREATMENT ALONE using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using automatic afterloading techniques
15319	01DEC1991	31DEC9999	Y	COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed sources having a half-life greater than 115 days using manual afterloading techniques
15320	01DEC1991	31DEC9999	Y	COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed sources having a half-life greater than 115 days using automatic afterloading techniques
15323	01DEC1991	31DEC9999	Y	COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using manual afterloading techniques
15324	01DEC1991	31DEC9999	Y	COMBINED INTRAUTERINE AND INTRAVAGINAL TREATMENT using radioactive sealed sources having a half-life of less than 115 days including iodine, gold, iridium or tantalum using automatic afterloading techniques
15327	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a region, under general anaesthesia, or epidural or spinal (intrathecal) nerve block, requiring surgical exposure and using manual afterloading techniques
15328	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a region, under general anaesthesia, or epidural or spinal (intrathecal) nerve block, requiring surgical exposure and using automatic afterloading techniques
15331	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a site (including the tongue, mouth, salivary gland, axilla, subcutaneous sites), where the volume treated involves multiple planes but does not require surgical exposure and using manual afterloading techniques
15332	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a site (including the tongue, mouth, salivary gland, axilla, subcutaneous sites), where the volume treated involves multiple planes but does not require surgical exposure and using automatic afterloading techniques
15335	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a site where the volume treated involves only a single plane but does not require surgical exposure and using manual afterloading techniques
15336	01DEC1991	31DEC9999	Y	IMPLANTATION OF A SEALED RADIOACTIVE SOURCE (having a half-life of less than 115 days including iodine, gold, iridium or tantalum) to a site where the volume treated involves only a single plane but does not require surgical exposure and using automatic afterloading techniques
15338	01NOV2001	31OCT2005	N	PROSTATE, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1, T2A or T2B, with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed at an approved site in association with a urologist.
15338	01NOV2005	30JUN2007	N	PROSTATE, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed at an approved site in association with a urologist.
15338	01JUL2007	31OCT2020	N	PROSTATE, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 7 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed at an approved site in association with a urologist.
15338	01NOV2020	31DEC9999	Y	Prostate, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance: (a) for a patient with: (i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and (ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and (b) performed by an oncologist at an approved site in association with a urologist; and (c) being a service associated with: (i) services to which items 37220 and 55603 apply; and (ii) a service to which item 60506 or 60509 applies
15339	01DEC1991	31DEC9999	Y	REMOVAL OF A SEALED RADIOACTIVE SOURCE under general anaesthesia, or under epidural or spinal nerve block
15342	01DEC1991	31DEC9999	Y	CONSTRUCTION AND APPLICATION OF A RADIOACTIVE MOULD using a sealed source having a half-life of greater than 115 days, to treat intracavity, intraoral or intranasal site
15345	01DEC1991	31DEC9999	Y	CONSTRUCTION AND APPLICATION OF A RADIOACTIVE MOULD using a sealed source having a half-life of less than 115 days including iodine, gold, iridium or tantalum to treat intracavity, intraoral or intranasal sites
15348	01DEC1991	31DEC9999	Y	SUBSEQUENT APPLICATIONS OF RADIOACTIVE MOULD referred to in item 15342 or 15345 each attendance
15351	01DEC1991	31OCT2006	N	CONSTRUCTION AND INITIAL APPLICATION OF RADIOACTIVE MOULD not exceeding 5 cm. diameter to an external surface
15351	01NOV2006	31DEC9999	Y	CONSTRUCTION WITH OR WITHOUT INITIAL APPLICATION OF RADIOACTIVE MOULD not exceeding 5 cm. diameter to an external surface
15354	01DEC1991	31DEC9999	Y	CONSTRUCTION AND INITIAL APPLICATION OF RADIOACTIVE MOULD 5 cm. or more in diameter to an external surface
15357	01DEC1991	31DEC2022	N	SUBSEQUENT APPLICATIONS OF RADIOACTIVE MOULD, attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould each attendance
15357	01JAN2023	31DEC9999	Y	SUBSEQUENT APPLICATIONS OF RADIOACTIVE MOULD, attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould each attendance
15360	01NOV2003	31OCT2005	N	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY for the treatment of in-stent restenoses of 1 coronary artery, administration of radioactive sealed sources having a half life of less than 115 days using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 35347, 35350, 35353, or 35356 applies.
15360	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY for the treatment of in-stent restenoses of 1 coronary artery, administration of radioactive sealed sources having a half life of less than 115 days using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 38321, 38324, 38327 or 38330 applies.
15363	01NOV2003	31OCT2005	N	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY for the treatment of in-stent restenoses of 1 coronary artery, administration of radioactive sealed sources having a half life of greater than 115 days using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 35347, 35350, 35353, or 35356 applies.
15363	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY for the treatment of in-stent restenoses of 1 coronary artery, administration of radioactive sealed sources having a half life of greater than 115 days using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 38321, 38324, 38327 or 38330 applies.
15500	01DEC1991	31OCT2003	N	RADIOTHERAPY PLANNING RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine of a single area for treatment by a single field or parallel opposed fields (not being a service associated with a service to which item 15509 applies)
15500	01NOV2003	31DEC9999	Y	RADIOTHERAPY PLANNINGRADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine or CT of a single area for treatment by a single field or parallel opposed fields (not being a service associated with a service to which item 15509 applies)
15503	01DEC1991	31OCT2003	N	RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine of a single area, where views in more than 1 plane are required for treatment by multiple fields, or of 2 areas (not being a service associated with a service to which item 15512 applies)
15503	01NOV2003	31DEC9999	Y	RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine or CT of a single area, where views in more than 1 plane are required for treatment by multiple fields, or of 2 areas (not being a service associated with a service to which item 15512 applies)
15506	01DEC1991	31OCT2003	N	RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine of 3 or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of offaxis fields or several joined fields (not being a service associated with a service to which item 15515 applies)
15506	01NOV2003	31DEC9999	Y	RADIATION FIELD SETTING using a simulator or isocentric xray or megavoltage machine or CT of 3 or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of offaxis fields or several joined fields (not being a service associated with a service to which item 15515 applies)
15509	01DEC1991	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic xray unit of a single area for treatment by a single field or parallel opposed fields (not being a service associated with a service to which item 15500 applies)
15512	01DEC1991	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic xray unit of a single area, where views in more than 1 plane are required for treatment by multiple fields, or of 2 areas (not being a service associated with a service to which item 15503 applies)
15513	01NOV2001	31OCT2003	N	RADIATION SOURCE LOCALISATION using a simulator or x-ray machine of a single area, where views in more than 1 plane are required, for brachytherapy treatment planning for I125 seed implantation of localised prostate cancer, in association with item 15338
15513	01NOV2003	31DEC9999	Y	RADIATION SOURCE LOCALISATION using a simulator or x-ray machine or CT of a single area, where views in more than 1 plane are required, for brachytherapy treatment planning for I125 seed implantation of localised prostate cancer, in association with item 15338
15515	01DEC1991	31DEC9999	Y	RADIATION FIELD SETTING using a diagnostic xray unit of 3 or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of offaxis fields or several joined fields (not being a service associated with a service to which item 15506 applies)
15518	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to 1 area with up to 2 shielding blocks, or for brachytherapy with isodose calculations in a single plane
15518	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to 1 area with up to 2 shielding blocks
15521	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by 3 or more fields, or by a single field or parallel opposed fields to 2 areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
15521	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by 3 or more fields, or by a single field or parallel opposed fields to 2 areas, or where wedges are used
15524	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to 3 or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or offaxis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons
15524	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to 3 or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or offaxis fields, or several joined fields
15527	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a nonCT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to 1 area with up to 2 shielding blocks, or for brachytherapy with isodose calculations in a single plane
15527	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to 1 area with up to 2 shielding blocks
15530	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a nonCT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by 3 or more fields, or by a single field or parallel opposed fields to 2 areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons
15530	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by 3 or more fields, or by a single field or parallel opposed fields to 2 areas, or where wedges are used
15533	01DEC1991	31OCT1993	N	RADIATION DOSIMETRY by a nonCT interfacing planning computer for megavoltage or teletherapy radiotherapy to 3 or more areas, or by mantle fields or inverted Y fields, or tangential fields or irregularly shaped fields using multiple blocks, or offaxis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons
15533	01NOV1993	31DEC9999	Y	RADIATION DOSIMETRY by a non CT interfacing planning computer for megavoltage or teletherapy radiotherapy to 3 or more areas, or by mantle fields or inverted Y fields, or tangential fields or irregularly shaped fields using multiple blocks, or offaxis fields, or several joined fields
15536	01NOV1993	31DEC9999	Y	BRACHYTHERAPY PLANNING, computerised radiation dosimetry
15539	01NOV2001	31DEC9999	Y	BRACHYTHERAPY PLANNING, computerised radiation dosimetry for I125 seed implantation of localised prostate cancer, in association with item 15338
15541	01NOV2003	31OCT2005	N	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY PLANNING: computerised radiation dosimetry. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 35347, 35350, 35353, or 35356 applies.
15541	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY PLANNING: computerised radiation dosimetry. The procedure must be performed by a radiation oncologist in association with a cardiologist and be associated with a service to which item 38321, 38324, 38327 or 38330 applies.
15550	01MAY2006	31DEC9999	Y	SIMULATION FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY without intravenous contrast medium, where: (a) treatment set up and technique specifications are in preparations for three dimensional conformal radiotherapy dose planning; and (b) patient set up and immobilisation techniques are suitable for reliable CT image volume data acquisition and three dimensional conformal radiotherapy treatment; and (c) a high-quality CT-image volume dataset must be acquired for the relevant region of interest to be planned and treated; and (d) the image set must be suitable for the generation of quality digitally reconstructed radiographic images
15553	01MAY2006	31DEC9999	Y	SIMULATION FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY pre and post intravenous contrast medium, where: (a) treatment set up and technique specifications are in preparations for three dimensional conformal radiotherapy dose planning; and (b) patient set up and immobilisation techniques are suitable for reliable CT image volume data acquisition and three dimensional conformal radiotherapy treatment; and (c) a high-quality CT-image volume dataset must be acquired for the relevant region of interest to be planned and treated; and (d) the image set must be suitable for the generation of quality digitally reconstructed radiographic images
15555	01JAN2016	31DEC9999	Y	SIMULATION FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT), with or without intravenous contrast medium, if: 1. treatment set-up and technique specifications are in preparations for three-dimensional conformal radiotherapy dose planning; and 2. patient set-up and immobilisation techniques are suitable for reliable CT-image volume data acquisition and three-dimensional conformal radiotherapy; and 3. a high-quality CT-image volume dataset is acquired for the relevant region of interest to be planned and treated; and 4. the image set is suitable for the generation of quality digitally-reconstructed radiographic images.
15556	01MAY2006	31DEC9999	Y	DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 1 COMPLEXITY where: (a) dosimetry for a single phase three dimensional conformal treatment plan using CT image volume dataset and having a single treatment target volume and organ at risk; and (b) one gross tumour volume or clinical target volume, plus one planning target volume plus at least one relevant organ at risk as defined in the prescription must be rendered as volumes; and (c) the organ at risk must be nominated as a planning dose goal or constraint and the prescription must specify the organ at risk dose goal or constraint; and (d) dose volume histograms must be generated, approved and recorded with the plan; and (e) a CT image volume dataset must be used for the relevant region to be planned and treated; and (f) the CT images must be suitable for the generation of quality digitally reconstructed radiographic images
15559	01MAY2006	31DEC9999	Y	DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 2 COMPLEXITY where: (a) dosimetry for a two phase three dimensional conformal treatment plan using CT image volume dataset(s) with at least one gross tumour volume, two planning target volumes and one organ at risk defined in the prescription; or (b) dosimetry for a one phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, one planning target volume and two organ at risk dose goals or constraints defined in the prescription; or (c) image fusion with a secondary image (CT, MRI or PET) volume dataset used to define target and organ at risk volumes in conjunction with and as specified in dosimetry for three dimensional conformal radiotherapy of level 1 complexity. All gross tumour targets, clinical targets, planning targets and organs at risk as defined in the prescription must be rendered as volumes. The organ at risk must be nominated as planning dose goals or constraints and the prescription must specify the organs at risk as dose goals or constraints. Dose volume histograms must be generated, approved and recorded with the plan. A CT image volume dataset must be used for the relevant region to be planned and treated. The CT images must be suitable for the generation of quality digitally reconstructed radiographic images
15562	01MAY2006	31DEC9999	Y	DOSIMETRY FOR THREE DIMENSIONAL CONFORMAL RADIOTHERAPY OF LEVEL 3 COMPLEXITY - where: (a) dosimetry for a three or more phase three dimensional conformal treatment plan using CT image volume dataset(s) with at least one gross tumour volume, three planning target volumes and one organ at risk defined in the prescription; or (b) dosimetry for a two phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, and (i) two planning target volumes; or (ii) two organ at risk dose goals or constraints defined in the prescription. or (c) dosimetry for a one phase three dimensional conformal treatment plan using CT image volume datasets with at least one gross tumour volume, one planning target volume and three organ at risk dose goals or constraints defined in the prescription; or (d) image fusion with a secondary image (CT, MRI or PET) volume dataset used to define target and organ at risk volumes in conjunction with and as specified in dosimetry for three dimensional conformal radiotherapy of level 2 complexity. All gross tumour targets, clinical targets, planning targets and organs at risk as defined in the prescription must be rendered as volumes. The organ at risk must be nominated as planning dose goals or constraints and the prescription must specify the organs at risk as dose goals or constraints. Dose volume histograms must be generated, approved and recorded with the plan. A CT image volume dataset must be used for the relevant region to be planned and treated. The CT images must be suitable for the generation of quality digitally reconstructed radiographic images
15565	01JAN2016	30APR2018	N	Preparation of an IMRT DOSIMETRY PLAN, which uses one or more CT image volume datasets, if: (a) in preparing the IMRT dosimetry plan: (i) the differential between target dose and normal tissue dose is maximised, based on a review and assessment by a radiation oncologist; and (ii) all gross tumour targets, clinical targets, planning targets and organs at risk are rendered as volumes as defined in the prescription; and (iii) organs at risk are nominated as planning dose goals or constraints and the prescription specifies the organs at risk as dose goals or constraints; and (iv) dose calculations and dose volume histograms are generated in an inverse planned process, using a specialised calculation algorithm, with prescription and plan details approved and recorded in the plan; and (v) a CT image volume dataset is used for the relevant region to be planned and treated; and (vi) the CT images are suitable for the generation of quality digitally reconstructed radiographic images; and (b) the final IMRT dosimetry plan is validated by the radiation therapist and the medical physicist, using robust quality assurance processes that include: (i) determination of the accuracy of the dose fluence delivered by the multi-leaf collimator and gantryposition (static or dynamic); and (ii) ensuring that the plan is deliverable, data transfer is acceptable and validation checks are completed on a linear accelerator; and (iii) validating the accuracy of the derived IMRT dosimetry plan in a known dosimetric phantom; and (iv) determining the accuracy of planned doses in comparison to delivered doses to designated points within the phantom or dosimetry device; and (c) the final IMRT dosimetry plan is approved by the radiation oncologist prior to delivery.
15565	01MAY2018	31DEC9999	Y	Preparation of an IMRT DOSIMETRY PLAN, which uses one or more CT image volume datasets, if: (a) in preparing the IMRT dosimetry plan: (i) the differential between target dose and normal tissue dose is maximised, based on a review and assessment by a radiation oncologist; and (ii) all gross tumour targets, clinical targets, planning targets and organs at risk are rendered as volumes as defined in the prescription; and (iii) organs at risk are nominated as planning dose goals or constraints and the prescription specifies the organs at risk as dose goals or constraints; and (iv) dose calculations and dose volume histograms are generated in an inverse planned process, using a specialised calculation algorithm, with prescription and plan details approved and recorded in the plan; and (v) a CT image volume dataset is used for the relevant region to be planned and treated; and (vi) the CT images are suitable for the generation of quality digitally reconstructed radiographic images; and (b) the final IMRT dosimetry plan is validated by the radiation therapist and the medical physicist, using robust quality assurance processes that include: (i) determination of the accuracy of the dose fluence delivered by the multi-leaf collimator and gantryposition (static or dynamic); and (ii) ensuring that the plan is deliverable, data transfer is acceptable and validation checks are completed on a linear accelerator; and (iii) validating the accuracy of the derived IMRT dosimetry plan; and (c) the final IMRT dosimetry plan is approved by the radiation oncologist prior to delivery.
15600	19JUN1997	31OCT1997	N	STEREOTACTIC RADIOSURGERY, including all radiation oncology consultations, planning, simulation, dosimetry and treatment
15600	01NOV1997	31DEC9999	Y	STEREOTACTIC RADIOSURGERY, including all radiation oncology consultations, planning, simulation, dosimetry and treatment
15700	01JUL2008	30APR2010	N	RADIATION ONCOLOGY TREATMENT VERIFICATION - single projection (with single or double exposures) - each non-contiguous treatment site verified.
15700	01MAY2010	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT VERIFICATION - single projection (with single or double exposures) - when prescribed and reviewed by a radiation oncologist and not associated with item 15705 or 15710 - each attendance at which treatment is verified (ie maximum one per attendance).
15705	01JUL2008	30APR2010	N	RADIATION ONCOLOGY TREATMENT VERIFICATION - multiple projection or volumetric acquisition - each non-contiguous treatment site verified to a maximum of 3 sites per attendance.
15705	01MAY2010	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT VERIFICATION - multiple projection acquisition when prescribed and reviewed by a radiation oncologist and not associated with item 15700 or 15710 - each attendance at which treatment involving three or more fields is verified (ie maximum one per attendance).
15710	01MAY2010	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT VERIFICATION - volumetric acquisition, when prescribed and reviewed by a radiation oncologist and not associated with item 15700 or 15705 - each attendance at which treatment involving three fields or more is verified (ie maximum one per attendance). (see para T2.5 of explanatory notes to this Category)
15715	01JAN2016	31DEC9999	Y	RADIATION ONCOLOGY TREATMENT VERIFICATION of planar or volumetric IGRT for IMRT, involving the use of at least 2 planar image views or projections or 1 volumetric image set to facilitate a 3-dimensional adjustment to radiation treatment field positioning, if: (a) the treatment technique is classified as IMRT; and (b) the margins applied to volumes (clinical target volume or planning target volume) are tailored or reduced to minimise treatment related exposure of healthy or normal tissues; and (c) the decisions made using acquired images are based on action algorithms and are given effect immediately prior to or during treatment delivery by qualified and trained staff considering complex competing factors and using software driven modelling programs; and (d) the radiation treatment field positioning requires accuracy levels of less than 5mm (curative cases) or up to 10mm (palliative cases) to ensure accurate dose delivery to the target; and (e) the image decisions and actions are documented in the patient's record; and (f) the radiation oncologist is responsible for supervising the process, including specifying the type and frequency of imaging, tolerance and action levels to be incorporated in the process, reviewing the trend analysis and any reports and relevant images during the treatment course and specifying action protocols as required; and (g) when treatment adjustments are inadequate to satisfy treatment protocol requirements, replanning is required; and (h) the imaging infrastructure (hardware and software) is linked to the treatment unit and networked to an image database, enabling both on line and off line reviews.
15800	01JUL2008	31DEC9999	Y	BRACHYTHERAPY TREATMENT VERIFICATION - maximum of one only for each attendance.
15850	01JUL2008	31DEC9999	Y	RADIATION SOURCE LOCALISATION using a simulator, x-ray machine, CT or ultrasound of a single area, where views in more than one plane are required, for brachytherapy treatment planning, not being a service to which Item 15513 applies.
15900	01SEP2015	28FEB2021	N	BREAST, MALIGNANT TUMOUR, targeted intraoperative radiotherapy, using an Intrabeam® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who: a) is 45 years of age or more; and b) has a T1 or small T2 (less than or equal to 3cm in diameter) primary tumour; and c) has an histologic Grade 1 or 2 tumour; and d) has an oestrogen-receptor positive tumour; and e) has a node negative malignancy; and f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and g) has no contra-indications to breast irradiation
15900	01MAR2021	30JUN2024	N	BREAST, MALIGNANT TUMOUR, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who: a) is 45 years of age or more; and b) has a T1 or small T2 (less than or equal to 3cm in diameter) primary tumour; and c) has an histologic Grade 1 or 2 tumour; and d) has an oestrogen-receptor positive tumour; and e) has a node negative malignancy; and f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and g) has no contra-indications to breast irradiation Applicable only once per breast per lifetime (H)
15900	01JUL2024	31DEC9999	Y	Breast, malignant tumour, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who: (a) is 45 years of age or over; and (b) has a T1 or small T2 (less than or equal to 3 cm in diameter) primary tumour; and (c) has a histologic grade 1 or 2 tumour; and (d) has an oestrogen-receptor positive tumour; and (e) has a node negative malignancy; and (f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and (g) has no contra-indications to breast irradiation Applicable once per breast per lifetime (H)
15902	01JUL2024	31DEC9999	Y	Megavoltage planning-level 1.1 Simple complexity single-field radiation therapy simulation and dosimetry for treatment planning, without imaging for field setting, if: (a) all of the following apply in relation to the simulation: (i) the simulation is to one site; (ii) localisation is based on clinical mark-up and image-based simulation is not required; (iii) patient set-up and immobilisation techniques are suitable for two-dimensional radiation therapy treatment, with wide margins and allowance for movement; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to deliver a prescribed dose to a point, either at depth or on the surface of the patient; (ii) based on review and assessment by a radiation oncologist, the planning process does not require the differential of dose between target, organs at risk and normal tissue dose; (iii) delineation of structures is not possible or required, and field borders will delineate the treatment volume; (iv) doses are calculated in reference to a point, either at depth or on the surface of the patient, from tables, charts or data from a treatment planning system Applicable once per course of treatment
15904	01JUL2024	31DEC9999	Y	Megavoltage planning-level 1.2 Simple complexity radiation therapy simulation and dosimetry for treatment planning, with imaging for field setting, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for two-dimensional radiation therapy dose planning; (ii) patient set-up and immobilisation techniques are suitable for two-dimensional radiation therapy treatment where interfraction reproducibility is required; (iii) imaging datasets are acquired for the relevant region of interest to be planned; and (b) all of the following apply in relation to the dosimetry: (i) the two-dimensional planning process is required to calculate dose to a volume, however a dose-volume histogram is not required to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the two-dimensional planning process is not required to maximise the differential between target dose and normal tissue dose; (iii) the target (which may include gross, clinical and planning targets as a composite structure or field border outline), as defined in the prescription, is rendered as a two-dimensional structure as field borders or a volume; (iv) organs at risk are delineated if required, and assessment of dose to these structures is derived from dose point calculations, rather than full calculation and inclusion in a dose-volume histogram; (v) dose calculations are calculated using a specialised algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment
15906	01JUL2024	31OCT2024	N	Megavoltage planning-level 2.1 Three-dimensional radiation therapy simulation and dosimetry for treatment planning, without motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for three-dimensional planning without consideration of motion management; (ii) patient set-up and immobilisation techniques are reproducible for treatment; (iii) a high-quality dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three-dimensional planning process is required to calculate dose to three-dimensional volume structures and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three-dimensional planning process (which must include multi-leaf collimator-based shaping to achieve target dose conformity and organs at risk avoidance or dose management or reduction) is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three-dimensional structure on planning outputs (three-dimensional plan review, three-planar sections review or dose-volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from calculation and inclusion in a dose-volume histogram Applicable once per course of treatment
15906	01NOV2024	31DEC9999	Y	Megavoltage planning-level 2.1 Three-dimensional radiation therapy simulation and dosimetry for treatment planning, without motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for three-dimensional planning without consideration of motion management; (ii) patient set-up and immobilisation techniques are reproducible for treatment; (iii) a high-quality dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three-dimensional planning process is required to calculate dose to three-dimensional volume structures and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three-dimensional planning process is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three-dimensional structure on planning outputs (three-dimensional plan review, three-planar sections review or dose-volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from calculation and inclusion in a dose-volume histogram Applicable once per course of treatment
15908	01JUL2024	31OCT2024	N	Megavoltage planning-level 2.2 Three-dimensional radiation therapy simulation and dosimetry for treatment planning with motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for complex three-dimensional planning with consideration of motion management; (ii) patient set-up and immobilisation techniques are reproducible for treatment; (iii) a high-quality three-dimensional or four-dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three-dimensional planning process is required to calculate dose to three-dimensional volume structures (which must include structures moving with physiologic processes) and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three-dimensional planning process (which must include multi-leaf collimator-based shaping to achieve target dose conformity and organs at risk avoidance or dose management or reduction) is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three-dimensional structure on planning outputs (three-dimensional plan review, three-planar sections review or dose-volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from full calculation and inclusion in a dose-volume histogram Applicable once per course of treatment
15908	01NOV2024	31DEC9999	Y	Megavoltage planning-level 2.2 Three-dimensional radiation therapy simulation and dosimetry for treatment planning with motion management, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for complex three-dimensional planning with consideration of motion management; (ii) patient set-up and immobilisation techniques are reproducible for treatment; (iii) a high-quality three-dimensional or four-dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the three-dimensional planning process is required to calculate dose to three-dimensional volume structures (which must include structures moving with physiologic processes) and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the three-dimensional planning process is required to optimise the differential between target dose and normal tissue dose; (iii) the planning target volume is rendered as a three-dimensional structure on planning outputs (three-dimensional plan review, three-planar sections review or dose-volume histogram); (iv) organs at risk are delineated, and assessment of dose to these structures is derived from full calculation and inclusion in a dose-volume histogram Applicable once per course of treatment
15910	01JUL2024	31DEC9999	Y	Megavoltage planning-level 3.1 Standard intensity modulated radiation therapy (IMRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for single-dose level IMRT planning without motion management; (ii) patient set-up and immobilisation techniques are suitable for image volume data acquisition and reproducible IMRT treatment; (iii) a high-quality three-dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the IMRT planning process is required to calculate dose to a single-dose level volume structure and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the IMRT planning process optimises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered as volumes and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose-volume histograms are generated in an inverse planned process using a specialised algorithm, with prescription and plan details approved and recorded with the plan; (vi) a three-dimensional image volume dataset is used for the relevant region to be planned and treated with image verification Applicable once per course of treatment
15912	01JUL2024	31OCT2024	N	Megavoltage re-planning-level 3.1 Additional dosimetry plan for re-planning of standard intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan described in item 15910 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15912	01NOV2024	31DEC9999	Y	Megavoltage re-planning-level 3.1 Additional dosimetry plan for re-planning of standard intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan at a level that is equivalent to or higher than that described in item 15910 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15914	01JUL2024	31DEC9999	Y	Megavoltage planning-level 3.2 Complex intensity modulated radiation therapy (IMRT) simulation and dosimetry for treatment planning, if (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for multiple-dose level IMRT planning or single-dose level IMRT planning requiring motion management; (ii) patient set-up and immobilisation techniques are suitable for image volume data acquisition and reproducible IMRT treatment; (iii) a high-quality three-dimensional or four-dimensional volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification; and (b) all of the following apply in relation to the dosimetry: (i) the IMRT planning process is required to calculate dose to multiple-dose level volume structures or single-dose level volume structures (including structures moving with physiologic processes or requiring precise positioning with respect to beam edges) and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the IMRT planning process optimises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour targets, clinical target volumes, planning target volumes, internal target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose-volume histograms are generated in an inverse planned process using a specialised algorithm, with prescription and plan details approved and recorded with the plan; (vi) a three-dimensional or four-dimensional image volume dataset is used for the relevant region to be planned and treated, with image verification for a multiple-dose level IMRT planning or single-dose level IMRT planning requiring motion management Applicable once per course of treatment
15916	01JUL2024	31OCT2024	N	Megavoltage re-planning-level 3.2 Additional dosimetry plan for re-planning of complex intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan described in item 15914 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15916	01NOV2024	31DEC9999	Y	Megavoltage re-planning-level 3.2 Additional dosimetry plan for re-planning of complex intensity modulated radiation therapy (IMRT) treatment, if: (a) an initial treatment plan at a level that is equivalent to or higher than that described in item 15914 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15918	01JUL2024	31DEC9999	Y	Megavoltage planning-level 4 Intracranial stereotactic radiation therapy (SRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for multiple non-coplanar, rotational or fixed beam stereotactic delivery; (ii) precise personalised patient set-up and immobilisation techniques are suitable for reliable imaging acquisition and reproducible SRT small-field and ablative treatments; (iii) a high-quality three-dimensional image volume dataset is acquired in treatment position for the intracranial lesions to be planned and treated and verified; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to calculate dose to single or multiple target structures and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the planning process maximises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose-volume histograms are generated using a validated stereotactic-type algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment
15920	01JUL2024	31DEC9999	Y	Megavoltage planning-level 4 Stereotactic body radiation therapy (SBRT) simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for inverse planning with multiple non-coplanar, rotational or fixed beam stereotactic delivery or intensity modulated radiation therapy (IMRT) stereotactic delivery; (ii) personalised patient set-up and immobilisation techniques are suitable for reliable imaging acquisition and reproducible, including techniques to minimise motion of organs at risk and targets; (iii) small-field and ablative treatment is used; (iv) a high-quality three-dimensional or four-dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned, treated and verified (through daily planar or volumetric image guidance strategies); and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to calculate dose to single or multiple target structures and requires a dose-volume histogram to complete the planning process; (ii) based on review and assessment by a radiation oncologist, the planning process maximises the differential between target dose, organs at risk and normal tissue dose; (iii) all relevant gross tumour volumes, clinical target volumes, planning target volumes and organs at risk are rendered and nominated with planning dose objectives; (iv) organs at risk are nominated as planning dose constraints; (v) dose calculations and dose-volume histograms are generated using a validated stereotactic-type algorithm, with prescription and plan details approved and recorded with the plan Applicable once per course of treatment
15922	01JUL2024	31OCT2024	N	Megavoltage re-planning-level 4 Additional dosimetry plan for re-planning of intracranial stereotactic radiation therapy (SRT) or stereotactic body radiation therapy (SBRT) treatment, if: (a) an initial treatment plan described in item 15918 or 15920 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15922	01NOV2024	31DEC9999	Y	Megavoltage re-planning-level 4 Additional dosimetry plan for re-planning of intracranial stereotactic radiation therapy (SRT) or stereotactic body radiation therapy (SBRT) treatment, if: (a) an initial treatment plan at a level that is equivalent to or higher than that described in item 15918 or 15920 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15924	01JUL2024	31DEC9999	Y	Megavoltage planning-level 5 Specialised radiation therapy simulation and dosimetry for treatment planning, if both of the following apply in relation to the simulation: (a) treatment set-up and technique specifications are in preparation for a specialised case with general anaesthetic or sedation supervised by an anaesthetist; (b) a high-quality three-dimensional or four-dimensional image volume dataset is acquired in treatment position for the relevant region of interest to be planned and treated with image verification Applicable once per course of treatment
15926	01JUL2024	31DEC9999	Y	Megavoltage planning-level 5 Specialised radiation therapy simulation and dosimetry for treatment planning, if: (a) all of the following apply in relation to the simulation: (i) treatment set-up and technique specifications are in preparation for a specialised application such as total skin electron therapy (TSE) or total body irradiation (TBI); (ii) reproducible personalised patient set-up and immobilisation techniques are suitable to implement three-dimensional radiation therapy, intensity modulated radiation therapy (IMRT) (including multiple non-coplanar, rotational or fixed beam treatment delivery) or a specialised total body treatment delivery method; (iii) a specialised dataset of anatomical dimensions is acquired in the treatment position for TSE or TBI; and (b) all of the following apply in relation to the dosimetry: (i) total TSE, TBI, IMRT or multiple non-coplanar, rotational or fixed beam treatment is used; (ii) the final dosimetry plan is validated by a radiation therapist and a medical physicist, using quality assurance processes; (iii) the final dosimetry plan is approved, prior to treatment delivery, by a radiation oncologist Applicable once per course of treatment
15928	01JUL2024	31DEC9999	Y	Megavoltage re-planning-level 5 Additional dosimetry plan for re-planning of specialised radiation therapy if: (a) an initial treatment plan described in 15924 or 15926 has been prepared; and (b) treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15930	01JUL2024	31OCT2024	N	Megavoltage treatment-level 1.1 Radiation therapy for simple, single-field treatment (including electron beam treatments), if: (a) the treatment does not use imaging for field setting; and (b) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (c) the treatment is delivered with a one-dimensional plan; and (d) a two-dimensional single-field treatment delivery mode is utilised Applicable once per plan per day
15930	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 1.1 Radiation therapy for simple, single-field treatment (including electron beam treatments), if: (a) the treatment does not use imaging for field setting; and (b) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (c) the treatment is delivered with a one-dimensional plan; and (d) a two-dimensional single-field treatment delivery mode is utilised
15932	01JUL2024	31OCT2024	N	Megavoltage treatment-level 1.2 Radiation therapy and image verification for simple treatment, with imaging for field setting, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a two-dimensional plan, and (c) two-dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patients record Applicable once per plan per day
15932	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 1.2 Radiation therapy and image verification for simple treatment, with imaging for field setting, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a two-dimensional plan, and (c) two-dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patients record
15934	01JUL2024	31OCT2024	N	Megavoltage treatment-level 2.1 Radiation therapy and image verification for three-dimensional treatment, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a standard three-dimensional plan; and (c) three-dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patients record Applicable once per plan per day
15934	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 2.1 Radiation therapy and image verification for three-dimensional treatment, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a standard three-dimensional plan; and (c) three-dimensional treatment is delivered; and (d) image verification decisions and actions are documented in the patients record
15936	01JUL2024	31OCT2024	N	Megavoltage treatment-level 2.2 Radiation therapy and image verification for three-dimensional treatment, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a complex three-dimensional plan; and (c) complex three-dimensional treatment is delivered with management of motion; and (d) image decisions and actions are documented in the patients record Applicable once per plan per day
15936	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 2.2 Radiation therapy and image verification for three-dimensional treatment, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a complex three-dimensional plan; and (c) complex three-dimensional treatment is delivered with management of motion; and (d) image decisions and actions are documented in the patients record
15938	01JUL2024	31OCT2024	N	Megavoltage treatment-level 3.1 Standard single-dose level intensity modulated radiation therapy (IMRT) treatment and image verification, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a standard IMRT plan described in item 15910 Applicable once per plan per day
15938	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 3.1 Standard single-dose level intensity modulated radiation therapy (IMRT) treatment and image verification, without motion management, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used to implement a standard IMRT plan at a level that is equivalent to or higher than that described in item 15910
15940	01JUL2024	31OCT2024	N	Megavoltage treatment-level 3.2 Complex multiple-dose level intensity modulated radiation therapy (IMRT) treatment, or single-dose level IMRT treatment requiring motion management, and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used (with motion management functionality if required) to implement a complex IMRT plan described in item 15914; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record Applicable once per plan per day
15940	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 3.2 Complex multiple-dose level intensity modulated radiation therapy (IMRT) treatment, or single-dose level IMRT treatment requiring motion management, and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) imaging is used (with motion management functionality if required) to implement a complex IMRT plan at a level that is equivalent to or higher than that described in item 15914; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record
15942	01JUL2024	31OCT2024	N	Megavoltage treatment-level 4 Intracranial stereotactic radiation therapy treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) or minimally invasive stereotactic frame localisation is used to implement an intracranial stereotactic treatment plan described in item 15918; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record Applicable once per day
15942	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 4 Intracranial stereotactic radiation therapy treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) or minimally invasive stereotactic frame localisation is used to implement an intracranial stereotactic treatment plan at a level that is equivalent to or higher than that described in item 15918; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record
15944	01JUL2024	31OCT2024	N	Megavoltage treatment-level 4 Stereotactic body radiation therapy (SBRT) treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) is used (with motion management functionality if required) to implement a stereotactic body radiation therapy plan described in item 15920; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record Applicable once per day
15944	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 4 Stereotactic body radiation therapy (SBRT) treatment and image verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) image-guided radiation therapy (IGRT) is used (with motion management functionality if required) to implement a stereotactic body radiation therapy plan at a level that is equivalent to or higher than that described in item 15920; and (c) radiation field positioning requires accurate dose delivery to the target; and (d) image decisions and actions are documented in the patients record
15946	01JUL2024	31OCT2024	N	Megavoltage treatment-level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique is used with general anaesthetic or sedation supervised by an anaesthetist Applicable once per plan per day
15946	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique is used with general anaesthetic or sedation supervised by an anaesthetist
15948	01JUL2024	31OCT2024	N	Megavoltage treatment-level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique, such as total skin electron therapy (TSE) or total body irradiation (TBI), is used to implement a treatment plan described in item 15926; and (c) image-guided radiation therapy (IGRT) is used (with motion management functionality, if required) to implement: (i) three-dimensional radiation therapy; or (ii) intensity modulated radiation therapy (IMRT) (including multiple non-coplanar, rotational or fixed beam treatment); or (iii) total skin electrons (TSE) where there is individualised treatment Applicable once per day
15948	01NOV2024	31DEC9999	Y	Megavoltage treatment-level 5 Specialised radiation therapy treatment and verification, if: (a) the treatment is delivered using a device that is included in the Australian Register of Therapeutic Goods; and (b) a specialised technique, such as total skin electron therapy (TSE) or total body irradiation (TBI), is used to implement a treatment plan described in item 15926; and (c) image-guided radiation therapy (IGRT) is used (with motion management functionality, if required) to implement: (i) three-dimensional radiation therapy; or (ii) intensity modulated radiation therapy (IMRT) (including multiple non-coplanar, rotational or fixed beam treatment); or (iii) total skin electrons (TSE) where there is individualised treatment
15950	01JUL2024	31DEC9999	Y	Kilovoltage planning Simple complexity single-field radiation therapy simulation and dosimetry for treatment planning without imaging for field setting, if: (a) both of the following apply in relation to the simulation: (i) localisation is based on clinical mark-up and image-based simulation is not required; (ii) patient set-up and immobilisation techniques are suitable for two-dimensional radiation therapy treatment, with wide margins and allowance for movement; and (b) all of the following apply in relation to the dosimetry: (i) the planning process is required to deliver a prescribed dose to a point, either at depth or on the surface of the patient; (ii) based on review and assessment by a radiation oncologist, the planning process does not require the differential of dose between target, organs at risk and normal tissue dose; (iii) delineation of structures is not possible or required, and field borders will delineate the treatment volume; (iv) doses are calculated in reference to a point, either at depth or on the surface of the patient, from tables, charts or data from a treatment planning system Applicable once per course of treatment
15952	01JUL2024	31OCT2024	N	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to one anatomical site (excluding orbital structures where there is placement of an internal eye shield), other than a service to which item 15954 applies
15952	01NOV2024	31DEC9999	Y	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to one anatomical site (excluding orbital structures where there is placement of an internal eye shield)
15954	01JUL2024	31OCT2024	N	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to 2 or more anatomical sites (excluding orbital structures where there is placement of an internal eye shield)
15954	01NOV2024	31DEC9999	Y	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to each additional anatomical site following delivery to one anatomical site treated under item 15952 (excluding orbital structures where there is placement of an internal eye shield)
15956	01JUL2024	31DEC9999	Y	Delivery of kilovoltage radiation therapy (50 kV to 500 kV range) to orbital structures where there is placement of an internal eye shield
15958	01JUL2024	31DEC9999	Y	Simple placement or insertion of any of the following kinds of brachytherapy device, without image guidance: (a) intracavitary vaginal cylinder, vaginal ovoids, vaginal ring or vaginal mould; (b) surface mould or applicator, with catheters fixed to or embedded into mould or applicator, on external surface of body; including the removal of applicators, catheters or needles
15960	01JUL2024	31OCT2024	N	Complex construction and manufacture of a personalised brachytherapy applicator or mould, derived from three dimensional image volume datasets, to treat intracavitary, intraoral or intranasal site, including the removal of applicators, catheters or needles
15960	01NOV2024	31DEC9999	Y	Complex construction and manufacture of a personalised brachytherapy applicator or mould, derived from three-dimensional image volume datasets, including the removal of applicators, catheters or needles
15962	01JUL2024	31DEC9999	Y	Complex insertion of any of the following kinds of brachytherapy device, with image guidance and if a radiation oncologist is in attendance at the initiation of the service: (a) intrauterine tubes with or without ovoids, ring or cylinder; (b) endocavity applicators; (c) intraluminal catheters for treatment of bronchus, trachea, oesophagus, nasopharynx, bile duct; (d) endovascular catheters for treatment of vessels; including the removal of applicators, catheters or needles
15964	01JUL2024	31DEC9999	Y	Complex insertion and removal of hybrid intracavitary and interstitial brachytherapy applicators, or intracavitary and multi catheter applicators, with image guidance and if a radiation oncologist is in attendance at the initiation of the service
15966	01JUL2024	31DEC9999	Y	Complex insertion of any of the following kinds of interstitial brachytherapy implants not requiring surgical exposure, with image guidance, and if a radiation oncologist is in attendance during the service: (a) catheters or needles for temporary implants; (b) radioactive sources for permanent implants; (c) breast applicators, single channel and multi-channel strut devices; including the removal of applicators, catheters or needles
15968	01JUL2024	31DEC9999	Y	Complex insertion of any of the following interstitial brachytherapy implants requiring surgical exposure (other than a service to which item 15900 applies), if a radiation oncologist is in attendance at the initiation of the service: (a) catheters, needles or applicators to a region requiring surgical exposure; (b) radioactive sources for permanent implants; (c) surface moulds during intraoperative brachytherapy; (d) plastic catheters or stainless steel needles, requiring surgical exposure; including implantation and removal of applicators, catheters or needles
15970	01JUL2024	31OCT2024	N	Simple level dosimetry for brachytherapy plans prescribed to surface or depth from catheter and library plans, if: (a) the planning process is required to deliver a prescribed dose to a three-dimensional volume, and relative to a single line or multiple channel delivery applicator; and (b) the planning process does not require the differential of dose between the target, organs at risk and normal tissue dose; and (c) delineation of structures is not required; and (d) dose calculations are performed in reference to the surface or a point at depth (two-dimensional plan) from tables, charts or data from a treatment planning system library plan Applicable once per course of treatment
15970	01NOV2024	31DEC9999	Y	Simple level dosimetry for brachytherapy plans prescribed to surface or depth from catheter and library plans, if: (a) the planning process is required to deliver a prescribed dose to a three-dimensional volume, and relative to a single line or multiple channel delivery applicator; and (b) the planning process does not require the differential of dose between the target, organs at risk and normal tissue dose; and (c) delineation of structures is not required; and (d) dose calculations are performed in reference to the surface or a point at depth (two-dimensional plan) from tables, charts or data from a treatment planning system library plan
15972	01JUL2024	31OCT2024	N	Simple level dosimetry re-planning of an initial brachytherapy plan described in item 15970 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15972	01NOV2024	31DEC9999	Y	Simple level dosimetry re-planning of an initial brachytherapy plan described in item 15970 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements
15974	01JUL2024	31OCT2024	N	Intermediate level dosimetry calculated on a volumetric dataset for intracavitary or intraluminal or endocavity applicators, for brachytherapy plans that have three-dimensional image datasets acquired as part of simulation, if: (a) the planning process is required to deliver the prescribed dose to a three-dimensional volume, and relative to multiple line for channel delivery applicators (excluding interstitial catheters and needles and multi-catheter devices); and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of dose between target, organs at risk and normal tissue dose using avoidance strategies (which include placement of sources and/or dwell-times or tissue packing); and (c) delineation of structures is required as part of the planning process to produce a dose-volume histogram integral to the avoidance strategies; and (d) dose calculations are performed on a personalised basis, which must include three-dimensional dose calculation to target and organ-at-risk volumes; and (e) dose calculations and the dose-volume histogram are approved and recorded with the plan Applicable once per course of treatment
15974	01NOV2024	31DEC9999	Y	Intermediate level dosimetry calculated on a volumetric dataset for intracavitary or intraluminal or endocavity applicators, for brachytherapy plans that have three-dimensional image datasets acquired as part of simulation, if: (a) the planning process is required to deliver the prescribed dose to a three-dimensional volume, and relative to multiple line for channel delivery applicators (excluding interstitial catheters and needles and multi-catheter devices); and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of dose between target, organs at risk and normal tissue dose using avoidance strategies (which include placement of sources and/or dwell-times or tissue packing); and (c) delineation of structures is required as part of the planning process to produce a dose-volume histogram integral to the avoidance strategies; and (d) dose calculations are performed on a personalised basis, which must include three-dimensional dose calculation to target and organ-at-risk volumes; and (e) dose calculations and the dose-volume histogram are approved and recorded with the plan
15976	01JUL2024	31OCT2024	N	Intermediate level dosimetry re-planning of an initial brachytherapy plan described in item 15974 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15976	01NOV2024	31DEC9999	Y	Intermediate level dosimetry re-planning of an initial brachytherapy plan described in item 15974 if treatment adjustments to that initial plan are inadequate to satisfy treatment protocol requirements
15978	01JUL2024	31OCT2024	N	Complex level dosimetry for brachytherapy plans that contain multiple needles, catheters or radiation sources, calculated on the three-dimensional volumetric dataset, if: (a) the planning process is required to deliver a prescribed dose to a target volume relative to multiple channel delivery applicators, needles or catheters or radiation sources; and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of doses between the target, organs at risk and normal tissue dose using avoidance strategies (which include the placement of sources and/or dwell times or tissue packing; and (c) delineation of structures is required as part of the planning process, in order to produce a dose-volume histogram to review and assess the plan; and (d) dose calculations are performed on a personalised basis, which must include three-dimensional dose calculation to target and organ at risk volumes; and (e) dose calculations and the dose-volume histogram are approved and recorded with the plan Applicable once per course of treatment
15978	01NOV2024	31DEC9999	Y	Complex level dosimetry for brachytherapy plans that contain multiple needles, catheters or radiation sources, calculated on the three-dimensional volumetric dataset, if: (a) the planning process is required to deliver a prescribed dose to a target volume relative to multiple channel delivery applicators, needles or catheters or radiation sources; and (b) based on review and assessment by a radiation oncologist, the planning process requires the differential of doses between the target, organs at risk and normal tissue dose using avoidance strategies (which include the placement of sources and/or dwell times or tissue packing; and (c) delineation of structures is required as part of the planning process, in order to produce a dose-volume histogram to review and assess the plan; and (d) dose calculations are performed on a personalised basis, which must include three-dimensional dose calculation to target and organ at risk volumes; and (e) dose calculations and the dose-volume histogram are approved and recorded with the plan
15980	01JUL2024	31OCT2024	N	Complex level dosimetry re-planning of an initial brachytherapy plan described in item 15978 if treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements Applicable once per course of treatment
15980	01NOV2024	31DEC9999	Y	Complex level dosimetry re-planning of an initial brachytherapy plan described in item 15978 if treatment adjustments to the initial plan are inadequate to satisfy treatment protocol requirements
15982	01JUL2024	31DEC9999	Y	Brachytherapy treatment, if: (a) the service is performed by radiation therapists and medical physicists; and (b) a radiation oncologist is in attendance during the service; and (c) the treatment is to implement a brachytherapy treatment plan described in any of items 15970, 15972, 15974, 15976, 15978 and 15980
15984	01JUL2024	31DEC9999	Y	Verification of position of brachytherapy applicators, needles, catheters or radioactive sources, if: (a) a two-dimensional or three-dimensional volumetric image set, or a validated in-vivo dosimetry measurement, is required to facilitate an adjustment to the applicators, needles, catheters or dosimetry plan; and (b) decisions using the acquired images are based on action algorithms and enacted immediately prior to, or during, treatment, where treatment is preceded by manipulation or adjustment of delivery applicator or adjustment of the dosimetry plan; and (c) the service is associated with a service to which any of the following items apply: (i) items 15958 to 15968; (ii) item 15982
15999	06SEP2004	31DEC9999	Y	Planning and management of a pregnancy that has progressed beyond 20 weeks provided the fee does not include any amount for the management of the labour and/or delivery - payable once only for any pregnancy that has progressed beyond 20 weeks
16000	01DEC1991	31DEC9999	Y	ADMINISTRATION OF A THERAPEUTIC DOSE OF A RADIOISOTOPE not being a service to which another item in this Group applies
16003	01DEC1991	30APR2003	N	INTRACAVITARY ADMINISTRATION OF A THERAPEUTIC DOSE OF YTTRIUM 90 (not including preliminary paracentesis)
16003	01MAY2003	30APR2006	N	INTRACAVITARY ADMINISTRATION OF A THERAPEUTIC DOSE OF YTTRIUM 90 not including preliminary paracentesis and not being a service associated with selective internal radiation therapy
16003	01MAY2006	30JUN2023	N	INTRACAVITY ADMINISTRATION OF A THERAPEUTIC DOSE OF YTTRIUM 90 not including preliminary paracentesis, not being a service associated with selective internal radiation therapy or to which item 35404, 35406 or 35408 applies
16003	01JUL2023	31DEC9999	Y	Intra-cavitary administration of a therapeutic dose of Yttrium 90 (not including preliminary paracentesis and other than a service to which item 35404, 35406 or 35408 applies or a service associated with selective internal radiation therapy)
16006	01DEC1991	30JUN2023	N	ADMINISTRATION OF A THERAPEUTIC DOSE OF IODINE 131 for thyroid cancer by single dose technique
16006	01JUL2023	31DEC9999	Y	Administration of a therapeutic dose of Iodine 131 for thyroid cancer by single dose technique
16009	01DEC1991	30JUN2023	N	ADMINISTRATION OF A THERAPEUTIC DOSE OF IODINE 131 for thyrotoxicosis by single dose technique
16009	01JUL2023	31DEC9999	Y	Administration of a therapeutic dose of Iodine 131 for thyrotoxicosis by single dose technique
16012	01DEC1991	30JUN2023	N	INTRAVENOUS ADMINISTRATION OF A THERAPEUTIC DOSE OF PHOSPHOROUS 32
16012	01JUL2023	31DEC9999	Y	Intravenous administration of a therapeutic dose of Phosphorous 32
16015	01MAY1997	30JUN2023	N	ADMINISTRATION OF STRONTIUM 89 for painful bony metastases from carcinoma of the prostate where hormone therapy has failed and either: (i) the disease is poorly controlled by conventional radiotherapy; or (ii) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain
16015	01JUL2023	31DEC9999	Y	Administration of Strontium 89 for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan), if systemic antineoplastic therapy is unavailable or has failed to control the patients disease and either: a) the disease is poorly controlled by conventional radiotherapy; or b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain.
16018	22DEC1999	30APR2000	N	ADMINISTRATION OF 153 Sm-lexidronam for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan) from either:- (i) carcinoma of the prostate, where hormonal therapy has failed: or (ii) carcinoma of the breast, where both hormonal therapy and chemotherapy have failed; and either (a) the disease is poorly controlled by conventional radiotherapy; or (b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain
16018	01MAY2000	30JUN2008	N	ADMINISTRATION OF 153 SM-LEXIDRONAM for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan) from either:- (i) carcinoma of the prostate, where hormonal therapy has failed; or (ii) carcinoma of the breast, where both hormonal therapy and chemotherapy have failed; and either:- (a) the disease is poorly controlled by conventional radiotherapy; or (b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain
16018	01JUL2008	30JUN2023	N	ADMINISTRATION OF 153 SM-LEXIDRONAM for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan) where hormonal therapy and/or chemotherapy have failed and either the disease is poorly controlled by conventional radiotherapy or conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain.
16018	01JUL2023	31DEC9999	Y	Administration of 153 Sm-lexidronam for the relief of bone pain due to skeletal metastases (as indicated by a positive bone scan), if systemic antineoplastic therapy is unavailable or has failed to control the patients disease, and: a) the disease is poorly controlled by conventional radiotherapy; or b) conventional radiotherapy is inappropriate, due to the wide distribution of sites of bone pain.
16399	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a specialist practising in the specialty of obstetrics to a patient who is a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient being a service associated with item 16401, 16404, 16406, 16500, 16590 or 16591.
16399	01NOV2012	31DEC9999	Y	Professional attendance on a patient by a specialist practising in his or her specialty of obstetrics if: (a) the attendance is by video conference; and (b) item 16401, 16404, 16406, 16500, 16590 or 16591 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies
16400	01NOV2006	30JUN2012	N	ANTENATAL CARE Antenatal service provided by a midwife, nurse or a registered Aboriginal Health Worker if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; (b) the service is provided at, or from, a practice location in a regional, rural or remote area RRMA 3-7; (c) the service is not performed in conjunction with another antenatal attendance item (same patient, same practitioner on the same day); (d) the service is not provided for an admitted patient of a hospital; and to a maximum of 10 service per pregnancy
16400	01JUL2012	31DEC2023	N	ANTENATAL CARE Antenatal service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitionerif: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; (b) the service is provided at, or from, a practice location in a regional, rural or remote area; (c) the service is not performed in conjunction with another antenatal attendance item (same patient, same practitioner on the same day); (d) the service is not provided for an admitted patient of a hospital; and to a maximum of 10 service per pregnancy
16400	01JAN2024	31DEC9999	Y	Antenatal service provided by a practice midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, applicable 10 times for a pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and (d) the service is not provided for an admitted patient of a hospital or approved day facility
16401	01JAN2010	31OCT2017	N	OBSTETRIC SPECIALIST, REFERRED CONSULTATION - SURGERY OR HOSPITAL Professional attendance at consulting rooms or a hospital by a specialist in the practice of his or her specialty of obstetrics, after referral of the patient to him or her - each INITIAL attendance, in a single course of treatment - not being a service to which item 104 applies.
16401	01NOV2017	31DEC2023	N	Professional attendance at consulting rooms or a hospital by a specialist in the practice of his or her specialty of obstetrics, after referral of the patient to him or her - each attendance, other than a second or subsequent attendance in a single course of treatment
16401	01JAN2024	31DEC9999	Y	Professional attendance at consulting rooms or a hospital by a specialist in the practice of the specialists specialty of obstetrics after referral of the patient to the specialist-initial attendance in a single course of treatment
16404	01JAN2010	31DEC2023	N	Professional attendance at consulting rooms or a hospital by a specialist in the practice of his or her specialty of obstetrics after referral of the patient to him or her - each attendance SUBSEQUENT to the first attendance in a single course of treatment.
16404	01JAN2024	31DEC9999	Y	Professional attendance at consulting rooms or a hospital by a specialist in the practice of the specialists specialty of obstetrics after referral of the patient to the specialist-an attendance after the initial attendance in a single course of treatment
16406	01NOV2010	31OCT2017	N	32-36 WEEK OBSTETRIC VISIT Antenatal professional attendance, as part of a single course of treatment, at 32-36 weeks of the patient's pregnancy when the patient is referred by a participating midwife. Payable only once for a pregnancy.
16406	01NOV2017	31DEC2023	N	Antenatal professional attendance, by an obstetrician or general practitioner, as part of a single course of treatment when the patient is referred by a participating midwife. Payable only once for a pregnancy
16406	01JAN2024	31DEC9999	Y	Antenatal professional attendance by an obstetrician or general practitioner, as part of a single course of treatment when the patient is referred by a participating midwife Applicable once for a pregnancy
16407	01NOV2017	31DEC9999	Y	Postnatal professional attendance (other than a service to which any other item applies) if the attendance: (a) is by an obstetrician or general practitioner; and (b) is in hospital or at consulting rooms; and (c) is between 4 and 8 weeks after the birth; and (d) lasts at least 20 minutes; and (e) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (f) is for a pregnancy in relation to which a service to which item 82140 applies is not provided Payable once only for a pregnancy
16408	01NOV2017	31DEC9999	Y	Postnatal attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if the attendance: (a) is by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided Payable once only for a pregnancy
16500	01DEC1991	30APR1994	N	ANTENATAL CARE (not including any service or services to which item 16516 or 16517 applies) where the attendances do not exceed 10 each attendance
16500	01MAY1994	31OCT1995	N	ANTENATAL CARE (not including any service or services to which item 16517 applies) where the attendances do not exceed 10 each attendance
16500	01NOV1995	31DEC2023	N	ANTENATAL ATTENDANCE
16500	01JAN2024	31DEC9999	Y	Antenatal attendance
16501	01NOV2000	31DEC2023	N	EXTERNAL CEPHALIC VERSION for breech presentation, after 36 weeks where no contraindication exists, in a Unit with facilities for Caesarean Section, including pre- and post version CTG, with or without tocolysis, not being a service to which items 55718 to 55728 and 55768 to 55774 apply - chargeable whether or not the version is successful and limited to a maximum of 2 ECV's per pregnancy
16501	01JAN2024	31DEC9999	Y	External cephalic version for breech presentation, after 36 weeks, if no contraindication exists, in a unit with facilities for caesarean section, including pre and post version CTG, with or without tocolysis, other than a service to which items 55718 to 55728 and 55768 to 55774 apply-chargeable whether or not the version is successful and limited to a maximum of 2 ECVs per pregnancy
16502	01NOV1995	31DEC2023	N	POLYHYDRAMNIOS, UNSTABLE LIE, MULTIPLE PREGNANCY, PREGNANCY COMPLICATED BY DIABETES OR ANAEMIA, THREATENED PREMATURE LABOUR treated by bed rest only or oral medication, requiring admission to hospital each attendance that is not a routine antenatal attendance, to a maximum of 1 visit per day
16502	01JAN2024	31DEC9999	Y	Polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital-a professional attendance that is not a routine antenatal attendance, applicable once per day
16503	01DEC1991	30APR1994	N	ANTENATAL CARE (not including any service or services to which item 16516 or 16517 applies) where attendances exceed 10
16503	01MAY1994	31DEC9999	Y	ANTENATAL CARE (not including any service or services to which item 16517 applies) where attendances exceed 10
16504	01NOV1995	31DEC9999	Y	TREATMENT OF HABITUAL MISCARRIAGE by injection of hormones each injection up to a maximum of 12 injections, where the injection is not administered during a routine antenatal attendance
16505	01NOV1995	31DEC2023	N	THREATENED ABORTION, THREATENED MISCARRIAGE OR HYPEREMESIS GRAVIDARUM, requiring admission to hospital, treatment of each attendance that is not a routine antenatal attendance
16505	01JAN2024	31DEC9999	Y	Threatened abortion, threatened miscarriage or hyperemesis gravidarum, requiring admission to hospital, treatment of-an attendance that is not a routine antenatal attendance
16506	01DEC1991	31DEC9999	Y	CONFINEMENT AND POSTNATAL CARE for 9 days where the medical practitioner has not given the antenatal care
16507	01DEC1991	30APR1994	N	CONFINEMENT AND POSTNATAL CARE for 9 days where the medical practitioner has not given the antenatal care
16507	01MAY1994	31DEC9999	Y	CONFINEMENT AND POSTNATAL CARE for 9 days where the medical practitioner has not given the antenatal care
16508	01NOV1995	31OCT2017	N	PREGNANCY COMPLICATED BY acute intercurrent infection, intrauterine growth retardation, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of 1 visit per day
16508	01NOV2017	31DEC2023	N	Pregnancy complicated by acute intercurrent infection, fetal growth restriction, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital - each professional attendance (other than a service to which item 16533 applies) that is not a routine antenatal attendance, to a maximum of one visit per day
16508	01JAN2024	31DEC9999	Y	Pregnancy complicated by acute intercurrent infection, fetal growth restriction, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital-professional attendance (other than a service to which item 16533 applies) that is not a routine antenatal attendance, applicable once per day
16509	01NOV1995	31OCT2017	N	PREECLAMPSIA, ECLAMPSIA OR ANTEPARTUM HAEMORRHAGE, treatment of each attendance that is not a routine antenatal attendance
16509	01NOV2017	31DEC2023	N	Pre-eclampsia, eclampsia or antepartum haemorrhage, treatment of - each professional attendance (other than a service to which item 16534 applies) that is not a routine antenatal attendance
16509	01JAN2024	31DEC9999	Y	Pre-eclampsia, eclampsia or antepartum haemorrhage, treatment of-professional attendance (other than a service to which item 16534 applies) that is not a routine antenatal attendance
16510	01DEC1991	31DEC9999	Y	CONFINEMENT AS AN INDEPENDENT PROCEDURE BY A SPECIALIST in the practice of his or her specialty, where the patient is referred by another medical practitioner including all attendances related to the confinement
16511	01NOV1995	31DEC2023	N	CERVIX, purse string ligation of
16511	01JAN2024	31DEC9999	Y	Cervix, purse string ligation of
16512	01NOV1995	31DEC2023	N	CERVIX, removal of purse string ligature of
16512	01JAN2024	31DEC9999	Y	Cervix, removal of purse string ligature of
16513	01DEC1991	31DEC9999	Y	CONFINEMENT, incomplete, with or without postnatal care for 9 days where the patient is referred to a specialist in the practice of his or her specialty or the patient's care is transferred to another medical practitioner for completion of the delivery
16514	01NOV1995	31DEC2023	N	ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (not during the course of the confinement)
16514	01JAN2024	31DEC9999	Y	Antenatal cardiotocography in the management of high risk pregnancy (not during the course of the confinement)
16515	01NOV1995	31OCT2017	N	MANAGEMENT OF LABOUR AND DELIVERY MANAGEMENT OF VAGINAL DELIVERY as an independent procedure where the patient's care has been transferred by another medical practitioner for management of the delivery and the attending medical practitioner has not provided antenatal care to the patient, including all attendances related to the delivery
16515	01NOV2017	31DEC2023	N	Management of vaginal birth as an independent procedure, if the patient's care has been transferred by another medical practitioner for management of the birth and the attending medical practitioner has not provided antenatal care to the patient, including all attendances related to the birth
16515	01JAN2024	31DEC9999	Y	Management of vaginal birth as an independent procedure, if the patients care has been transferred by another medical practitioner for management of the birth and the attending medical practitioner has not provided antenatal care to the patient, including all attendances related to the birth
16516	01DEC1991	31DEC9999	Y	ANTENATAL CARE, CONFINEMENT with delivery by any means (including Caesarean section) AND POSTNATAL CARE for 9 days
16517	01DEC1991	30APR1994	N	ANTENATAL CARE, CONFINEMENT with delivery by any means (including Caesarean section) AND POSTNATAL CARE for 9 days
16517	01MAY1994	31DEC9999	Y	ANTENATAL CARE, CONFINEMENT with delivery by any means (including Caesarean section) AND POSTNATAL CARE for 9 days
16518	01NOV1995	31OCT2017	N	MANAGEMENT OF LABOUR, incomplete, where the patient's care has been transferred to another medical practitioner for completion of the delivery
16518	01NOV2017	31DEC2023	N	Management of labour, incomplete, if the patient's care has been transferred to another medical practitioner for completion of the birth
16518	01JAN2024	31DEC9999	Y	Management of labour, incomplete, if the patients care has been transferred to another medical practitioner for completion of the birth
16519	01NOV1995	31OCT2017	N	MANAGEMENT OF LABOUR and delivery by any means (including Caesarean section) including post-partum care for 5 days
16519	01NOV2017	31DEC2023	N	Management of labour and birth by any means (including Caesarean section) including post-partum care for 5 days
16519	01JAN2024	31DEC9999	Y	Management of labour and birth by any means (including Caesarean section) including post-partum care for 5 days
16520	01DEC1991	31OCT1995	N	CAESAREAN SECTION and postnatal care for 9 days where the patient has been referred to a specialist in the practice of his or her specialty or the patient's care has been transferred to another medical practitioner for management of the confinement and the practitioner who performs the Caesarean section did not provide the antenatal care
16520	01NOV1995	31OCT2017	N	CAESAREAN SECTION and post-operative care for 7 days where the patient's care has been transferred by another medical practitioner for management of the confinement and the attending medical practitioner has not provided any of the antenatal care
16520	01NOV2017	31DEC9999	Y	Caesarean section and post-operative care for 7 days, if the patients care has been transferred by another medical practitioner for management of the confinement and the attending medical practitioner has not provided any of the antenatal care
16522	01NOV1998	31OCT2017	N	MANAGEMENT OF LABOUR AND DELIVERY, or delivery alone, (including Caesarean section), where in the course of antenatal supervision or intrapartum management 1 or more of the following conditions is present, including postnatal care for 7 days: - multiple pregnancy; - recurrent antepartum haemorrhage from 20 weeks gestation; - grades 2, 3 or 4 placenta praevia; - baby with a birth weight less than or equal to 2500gm; - pre-existing diabetes mellitus dependent on medication, or gestational diabetes requiring at least daily blood glucose monitoring; - trial of vaginal delivery in a patient with uterine scar, or trial of vaginal breech delivery; - pre-existing hypertension requiring antihypertensive medication, or pregnancy induced hypertension of at least 140/90mm Hg associated with at least 1+ proteinuria on urinalysis; - prolonged labour greater than 12 hours with partogram evidence of abnormal cervimetric progress; - fetal distress defined by significant cardiotocograph or scalp pH abnormalities requiring immediate delivery; OR - conditions that pose a significant risk of maternal death.
16522	01NOV2017	31DEC9999	Y	Management of labour and birth, or birth alone, (including caesarean section), on or after 23 weeks gestation, if in the course of antenatal supervision or intrapartum management one or more of the following conditions is present, including postnatal care for 7 days: (a) fetal loss; (b) multiple pregnancy; (c) antepartum haemorrhage that is: (i) of greater than 200 ml; or (ii) associated with disseminated intravascular coagulation; (d) placenta praevia on ultrasound in the third trimester with the placenta within 2 cm of the internal cervical os; (e) baby with a birth weight less than or equal to 2,500 g; (f) trial of vaginal birth in a patient with uterine scar where there has been a planned vaginal birth after caesarean section; (g) trial of vaginal breech birth where there has been a planned vaginal breech birth; (h) prolonged labour greater than 12 hours with partogram evidence of abnormal cervimetric progress as evidenced by cervical dilatation at less than 1 cm/hr in the active phase of labour (after 3 cm cervical dilatation and effacement until full dilatation of the cervix); (i) acute fetal compromise evidenced by: (i) scalp pH less than 7.15; or (ii) scalp lactate greater than 4.0; (j) acute fetal compromise evidenced by at least one of the following significant cardiotocograph abnormalities: (i) prolonged bradycardia (less than 100 bpm for more than 2 minutes); (ii) absent baseline variability (less than 3 bpm); (iii) sinusoidal pattern; (iv) complicated variable decelerations with reduced (3 to 5 bpm) or absent baseline variability; (v) late decelerations; (k) pregnancy induced hypertension of at least 140/90 mm Hg associated with: (i) at least 2+ proteinuria on urinalysis; or (ii) protein-creatinine ratio greater than 30 mg/mmol; or (iii) platelet count less than 150 x 109/L; or (iv) uric acid greater than 0.36 mmol/L; (l) gestational diabetes mellitus requiring at least daily blood glucose monitoring; (m) mental health disorder (whether arising prior to pregnancy, during pregnancy or postpartum) that is demonstrated by: (i) the patient requiring hospitalisation; or (ii) the patient receiving ongoing care by a psychologist or psychiatrist to treat the symptoms of a mental health disorder; or (iii) the patient having a GP mental health treatment plan; or (iv) the patient having a management plan prepared in accordance with item 291; (n) disclosure or evidence of domestic violence; (o) any of the following conditions either diagnosed pre-pregnancy or evident at the first antenatal visit before 20 weeks gestation: (i) pre-existing hypertension requiring antihypertensive medication prior to pregnancy; (ii) cardiac disease (co-managed with a specialist physician and with echocardiographic evidence of myocardial dysfunction); (iii) previous renal or liver transplant; (iv) renal dialysis; (v) chronic liver disease with documented oesophageal varices; (vi) renal insufficiency in early pregnancy (serum creatinine greater than 110 mmol/L); (vii) neurological disorder that confines the patient to a wheelchair throughout pregnancy; (viii) maternal height of less than 148 cm; (ix) a body mass index greater than or equal to 40; (x) pre-existing diabetes mellitus on medication prior to pregnancy; (xi) thyrotoxicosis requiring medication; (xii) previous thrombosis or thromboembolism requiring anticoagulant therapy through pregnancy and the early puerperium; (xiii) thrombocytopenia with platelet count of less than 100,000 prior to 20 weeks gestation; (xiv) HIV, hepatitis B or hepatitis C carrier status positive; (xv) red cell or platelet iso-immunisation; (xvi) cancer with metastatic disease; (xvii) illicit drug misuse during pregnancy
16523	01DEC1991	31DEC9999	Y	TREATMENT OF HABITUAL MISCARRIAGE by injection of hormones each injection up to a maximum of 12 injections, where the injection is not administered during a routine antenatal attendance
16524	18SEP2008	31DEC9999	Y	Historical item included for item mapping purposes
16525	01NOV1995	31DEC9999	Y	MANAGEMENT OF SECOND TRIMESTER LABOUR, with or without induction, for intrauterine fetal death, gross fetal abnormality or life threatening maternal disease, not being a service to which item 35643 applies
16526	01DEC1991	31DEC9999	Y	THREATENED ABORTION, THREATENED MISCARRIAGE OR HYPEREMESIS GRAVIDARUM, requiring admission to hospital, treatment of each attendance that is not a routine antenatal attendance
16527	01NOV2010	31OCT2017	N	MANAGEMENT OF VAGINAL DELIVERY, if the patient's care has been transferred by a participating midwife for management of the delivery, including all attendances related to the delivery. Payable once only for a pregnancy.
16527	01NOV2017	31DEC2023	N	Management of vaginal birth, if the patient's care has been transferred by a participating midwife for management of the birth, including all attendances related to the birth. Payable once only for a pregnancy.
16527	01JAN2024	31DEC9999	Y	Management of vaginal birth, if the patients care has been transferred by a participating midwife for management of the birth, including all attendances related to the birth Applicable once for a pregnancy
16528	01NOV2010	31OCT2017	N	CAESAREAN SECTION and post-operative care for 7 days, if the patient's care has been transferred by a participating midwife for management of the birth. Payable once only for a pregnancy.
16528	01NOV2017	31DEC2023	N	Caesarean section and post-operative care for 7 days, if the patient's care has been transferred by a participating midwife for management of the birth. Payable once only for a pregnancy.
16528	01JAN2024	31DEC9999	Y	Caesarean section and post-operative care for 7 days, if the patients care has been transferred by a participating midwife for management of the birth Applicable once for a pregnancy
16529	01DEC1991	31DEC9999	Y	POLYHYDRAMNIOS, UNSTABLE LIE, MULTIPLE PREGNANCY, PREGNANCY COMPLICATED BY DIABETES OR ANAEMIA, THREATENED PREMATURE LABOUR treated by bed rest only or oral medication, requiring admission to hospital each attendance that is not a routine antenatal attendance, to a maximum of 2 attendances in any 7 day period
16530	01NOV2017	31DEC9999	Y	Management of pregnancy loss, from 14 weeks to 15 weeks and 6 days gestation, other than a service to which item 16531, 35640 or 35643 applies
16531	01NOV2017	31DEC9999	Y	Management of pregnancy loss, from 16 weeks to 22 weeks and 6 days gestation, other than a service to which item 16530, 35640 or 35643 applies
16532	01DEC1991	31DEC9999	Y	PREGNANCY COMPLICATED BY acute intercurrent infection, intrauterine growth retardation, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of 1 visit per day
16533	01NOV2017	31DEC9999	Y	Pregnancy complicated by acute intercurrent infection, fetal growth restriction, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital-each professional attendance lasting at least 40 minutes that is not a routine antenatal attendance, to a maximum of 3 services per pregnancy
16534	01NOV2017	31DEC9999	Y	Pre-eclampsia, eclampsia or antepartum haemorrhage, treatment of-each professional attendance lasting at least 40 minutes that is not a routine antenatal attendance, to a maximum of 3 services per pregnancy
16535	01DEC1991	31DEC9999	Y	CERVIX, purse string ligation of, for threatened miscarriage
16536	01DEC1991	31DEC9999	Y	CERVIX, purse string ligation of, for threatened miscarriage
16539	01DEC1991	31DEC9999	Y	CERVIX, removal of purse string ligature of, under general anaesthesia
16542	01DEC1991	31DEC9999	Y	PREECLAMPSIA, ECLAMPSIA OR ANTEPARTUM HAEMORRHAGE, treatment of each attendance that is not a routine antenatal attendance
16545	01DEC1991	31DEC9999	Y	MANAGEMENT OF SECOND TRIMESTER LABOUR, with or without induction
16546	01DEC1991	31DEC9999	Y	MANAGEMENT OF SECOND TRIMESTER LABOUR, with or without induction
16549	01DEC1991	31DEC9999	Y	AMNIOSCOPY OR AMNIOCENTESIS
16552	01DEC1991	30APR1994	N	CHORIONIC VILLUS SAMPLING including any associated imaging
16552	01MAY1994	31DEC9999	Y	CHORIONIC VILLUS SAMPLING using interventional imaging techniques
16555	01DEC1991	31DEC9999	Y	ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (not during the course of the confinement)
16558	01DEC1991	30APR1994	N	VERSION, EXTERNAL, under general anaesthesia, not being a service to which items 16506 to 16517 apply
16558	01MAY1994	31DEC9999	Y	VERSION, EXTERNAL, under general anaesthesia, not being a service to which items 16507 to 16517 apply
16561	01DEC1991	30APR1994	N	VERSION, INTERNAL, under general anaesthesia, not being a service to which items 16506 to 16517 apply
16561	01MAY1994	31DEC9999	Y	VERSION, INTERNAL, under general anaesthesia, not being a service to which items 16507 to 16517 apply
16564	01DEC1991	31OCT1995	N	EVACUATION OF PRODUCTS OF CONCEPTION (such as retained foetus, placenta, membranes or mole) by intrauterine manual removal as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
16564	01NOV1995	31DEC2023	N	POST-PARTUM CARE EVACUATION OF RETAINED PRODUCTS OF CONCEPTION (placenta, membranes or mole) as a complication of confinement, with or without curettage of the uterus, as an independent procedure
16564	01JAN2024	31DEC9999	Y	Evacuation of retained products of conception (placenta, membranes or mole) as a complication of confinement, with or without curettage of the uterus, as an independent procedure
16567	01DEC1991	31OCT1995	N	TREATMENT OF POSTPARTUM HAEMORRHAGE by special procedures such as packing of uterus as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
16567	01NOV1995	31DEC2023	N	MANAGEMENT OF POSTPARTUM HAEMORRHAGE by special measures such as packing of uterus, as an independent procedure
16567	01JAN2024	31DEC9999	Y	Management of postpartum haemorrhage by special measures such as packing of uterus, as an independent procedure
16570	01DEC1991	31OCT1995	N	MANIPULATIVE CORRECTION OF ACUTE INVERSION OF UTERUS, by vaginal approach, with or without incision of cervix as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
16570	01NOV1995	31DEC2023	N	ACUTE INVERSION OF THE UTERUS, vaginal correction of, as an independent procedure
16570	01JAN2024	31DEC9999	Y	Acute inversion of the uterus, vaginal correction of, as an independent procedure
16571	01NOV1995	31DEC2023	N	CERVIX, repair of extensive laceration or lacerations
16571	01JAN2024	31DEC9999	Y	Cervix, repair of extensive laceration or lacerations
16573	01DEC1991	31OCT1995	N	THIRD DEGREE TEAR, repair of, involving anal sphincter muscles as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances
16573	01NOV1995	31DEC2023	N	THIRD DEGREE TEAR, involving anal sphincter muscles and rectal mucosa, repair of, as an independent procedure
16573	01JAN2024	31DEC9999	Y	Third degree tear, involving anal sphincter muscles and rectal mucosa, repair of, as an independent procedure
16590	01NOV2005	31DEC2009	N	Planning and management of a pregnancy that has progressed beyond 20 weeks provided the fee does not include any amount for the management of the labour and/or delivery - payable once only for any pregnancy that has progressed beyond 20 weeks
16590	01JAN2010	31OCT2017	N	Planning and management of a pregnancy that has progressed beyond 20 weeks provided the fee does not include any amount for the management of the labour and delivery, payable once only for any pregnancy that has progressed beyond 20 weeks where the practitioner intends to undertake the delivery for a privately admitted patient, not being a service to which item 16591 applies.
16590	01NOV2017	31DEC2023	N	Planning and management, by a practitioner, of a pregnancy if: (a) the practitioner intends to take primary responsibility for management of the pregnancy and any complications, and to be available for the birth; and (b) the patient intends to be privately admitted for the birth; and (c) the pregnancy has progressed beyond 28 weeks gestation; and (d) the practitioner has maternity privileges at a hospital or birth centre; and (e) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (f) a service to which item 16591 applies is not provided in relation to the same pregnancy Payable once only for a pregnancy
16590	01JAN2024	31DEC9999	Y	Planning and management, by a practitioner, of a pregnancy if: (a) the practitioner intends to take primary responsibility for management of the pregnancy and any complications, and to be available for the birth; and (b) the patient intends to be privately admitted for the birth; and (c) the pregnancy has progressed beyond 28 weeks gestation; and (d) the practitioner has maternity privileges at a hospital or birth centre; and (e) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (f) a service to which item 16591 applies is not provided in relation to the same pregnancy Applicable once for a pregnancy
16591	01JAN2010	31OCT2017	N	Planning and management of a pregnancy that has progressed beyond 20 weeks provided the fee does not include any amount for the management of the labour and delivery if the care of the patient will be transferred to another medical practitioner, payable once only for any pregnancy that has progressed beyond 20 weeks, not being a service to which item 16590 applies.
16591	01NOV2017	31DEC2023	N	Planning and management, by a practitioner, of a pregnancy if: (a) the pregnancy has progressed beyond 28 weeks gestation; and (b) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (c) a service to which item 16590 applies is not provided in relation to the same pregnancy Payable once only for a pregnancy
16591	01JAN2024	31DEC9999	Y	Planning and management, by a practitioner, of a pregnancy if: (a) the pregnancy has progressed beyond 28 weeks gestation; and (b) the service includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (c) a service to which item 16590 applies is not provided in relation to the same pregnancy Applicable once for a pregnancy
16600	01JUL1995	31DEC2023	N	INTERVENTIONAL TECHNIQUES AMNIOCENTESIS, diagnostic
16600	01JAN2024	31DEC9999	Y	Amniocentesis, diagnostic
16603	01JUL1995	31DEC2023	N	CHORIONIC VILLUS SAMPLING, by any route
16603	01JAN2024	31DEC9999	Y	Chorionic villus sampling, by any route
16606	01JUL1995	31OCT2017	N	FOETAL BLOOD SAMPLING, using interventional techniques from umbilical cord or foetus, including foetal neuromuscular blockade and amniocentesis
16606	01NOV2017	31DEC9999	Y	Fetal blood sampling, using interventional techniques from umbilical cord or fetus, including fetal neuromuscular blockade and amniocentesis
16609	01JUL1995	31DEC2023	N	FOETAL INTRAVASCULAR BLOOD TRANSFUSION, using blood already collected, including neuromuscular blockade, amniocentesis and foetal blood sampling
16609	01JAN2024	31DEC9999	Y	Fetal intravascular blood transfusion, using blood already collected, including neuromuscular blockade, amniocentesis and fetal blood sampling
16612	01JUL1995	31DEC9999	Y	FOETAL INTRAPERITONEAL BLOOD TRANSFUSION, using blood already collected, including neuromuscular blockade, amniocentesis and foetal blood sampling - not performed in conjunction with a service described in item 16609
16615	01JUL1995	31DEC9999	Y	FOETAL INTRAPERITONEAL BLOOD TRANSFUSION, using blood already collected, including neuromuscular blockade, amniocentesis and foetal blood sampling - performed in conjunction with a service described in item 16609
16618	01JUL1995	31DEC2023	N	AMNIOCENTESIS, THERAPEUTIC, when indicated because of polyhydramnios with at least 500ml being aspirated
16618	01JAN2024	31DEC9999	Y	Amniocentesis, therapeutic, when indicated because of polyhydramnios with at least 500 ml being aspirated
16621	01JUL1995	31DEC9999	Y	AMNIOINFUSION, for diagnostic or therapeutic purposes in the presence of severe oligohydramnios
16624	01JUL1995	31DEC2023	N	FOETAL FLUID FILLED CAVITY, drainage of
16624	01JAN2024	31DEC9999	Y	Fetal fluid filled cavity, drainage of
16627	01JUL1995	31DEC2023	N	FETO-AMNIOTIC SHUNT, insertion of, into fetal fluid filled cavity, including neuromuscular blockade and amniocentesis
16627	01JAN2024	31DEC9999	Y	Feto-amniotic shunt, insertion of, into fetal fluid filled cavity, including neuromuscular blockade and amniocentesis
16633	01JUL1995	31OCT1995	N	PROVISION OF A SERVICE specified in any of items 16600 to 16627 in relation to more than 1 foetus in a multiple pregnancy
16633	01NOV1995	31DEC9999	Y	PROCEDURE ON MULTIPLE PREGNANCIES relating to items 16606, 16609, 16612, 16615 and 16627
16636	01NOV1995	31DEC9999	Y	PROCEDURE ON MULTIPLE PREGNANCIES relating to items 16600, 16603, 16618, 16621 and 16624
17500	01DEC1991	31OCT1994	N	Assistance in the administration of an anaesthetic for which the anaesthetic unit value is not less than 21 units
17500	01NOV1994	31DEC9999	Y	Assistance in the administration of an anaesthetic for which the anaesthetic unit value is not less than 21 units
17503	01MAY1997	31DEC9999	Y	Assistance in the administration of an anaesthetic requiring continuous anaesthesia on a patient in imminent danger of death requiring continuous life saving emergency treatment, to the exclusion of all other patients
17506	01JUL1998	31DEC9999	Y	Assistance in the administration of an elective anaesthetic, where: (i) the patient has complex airway problems; or (ii) the patient is a neonate or a complex paediatric case; or (iii) there is anticipated to be massive blood loss (greater than 50% of blood volume) during the procedure; or (iv) the patient is critically ill, with multiple organ failure; and where the anaesthesia time is expected to exceed 6 hours and the assistance is provided to the exclusion of all other patients
17600	01DEC1991	31MAR1992	N	EXAMINATION OF A PATIENT BY OTHER THAN A SPECIALIST IN THE PRACTICE OF HIS OR HER SPECIALITY IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at a place other than an operating theatre or suite adjoining an operating theatre
17600	01APR1992	31DEC9999	Y	EXAMINATION OF A PATIENT BY OTHER THAN A SPECIALIST IN THE PRACTICE OF HIS OR HER SPECIALITY IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at a place other than an operating theatre or an anaesthetic induction room
17603	01DEC1991	31MAR1992	N	EXAMINATION OF A PATIENT BY A SPECIALIST IN THE PRACTICE OF HIS OR HER SPECIALITY IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at an attendance other than that at which the anaesthetic is administered, being an examination carried out at a place other than an operating theatre or a suite adjoining an operating theatre
17603	01APR1992	31OCT1994	N	EXAMINATION OF A PATIENT BY A SPECIALIST IN THE PRACTICE OF HIS OR HER SPECIALTY IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at a place other than an operating theatre or an anaesthetic induction room
17603	01NOV1994	31DEC9999	Y	EXAMINATION OF A PATIENT IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC RELATING TO A CLINICALLY RELEVANT SERVICE, being an examination carried out at a place other than an operating theatre or an anaesthetic induction room
17609	01JUL2011	31OCT2012	N	The initiation of a professional attendance via video conference rendered by a specialist practising in the specialty of anaesthesia to a patient who is a) a care recipient receiving care in a residential aged care service; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c) located outside an inner metropolitan area, not being an admitted patient being a service associated with item 17610, 17615, 17620, 17625, 17640, 17645, 17650, 17655 or 17690.
17609	01NOV2012	31DEC2012	N	Professional attendance on a patient by a specialist practising in his or her specialty of anaesthesia if: (a) the attendance is by video conference; and (b) item 17610, 17615, 17620, 17625, 17640, 17645, 17650, or 17655 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
17609	01JAN2013	31DEC9999	Y	Professional attendance on a patient by a specialist practising in his or her specialty of anaesthesia if: (a) the attendance is by video conference; and (b) item 17610, 17615, 17620, 17625, 17640, 17645, 17650, or 17655 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies
17610	01NOV2006	31DEC9999	Y	ANAESTHETIST, PRE-ANAESTHESIA CONSULTATION (Professional attendance by a medical practitioner in the practice of ANAESTHESIA) - a BRIEF consultation involving a targeted history and limited examination (including the cardio-respiratory system) - AND of not more than 15 minutes s duration, not being a service associated with a service to which items 2801 - 3000 apply
17615	01NOV2006	31DEC9999	Y	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and an extensive examination of multiple systems and the formulation of a written patient management plan documented in the patient notes - and of more than 15 minutes but not more than 30 minutes duration, not being a service associated with a service to which items 2801 - 3000 applies
17620	01NOV2006	31DEC9999	Y	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems involving a detailed history and comprehensive examination of multiple systems and the formulation of a written patient management plan documented in the patient notes - and of more than 30 minutes but not more than 45 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply
17625	01NOV2006	31DEC9999	Y	Professional attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems involving an exhaustive history and comprehensive examination of multiple systems , the formulation of a written patient management plan following discussion with relevant health care professionals and/or the patient, involving medical planning of high complexity documented in the patient notes - and of more than 45 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply
17640	01NOV2006	31DEC9999	Y	ANAESTHETIST, REFERRED CONSULTATION (other than prior to anaesthesia) (Professional attendance by a specialist anaesthetist in the practice of ANAESTHESIA where the patient is referred to him or her) - a BRIEF consultation involving a short history and limited examination - AND of not more than 15 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply
17645	01NOV2006	31DEC9999	Y	-a consultation involving a selective history and examination of multiple systems andthe formulation of a written patient management plan -AND of more than 15 minutes but not more than 30 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply.
17650	01NOV2006	31DEC9999	Y	-a consultation involving a detailed history and comprehensive examination of multiple systems and the formulation of a written patient management plan -AND of more than 30 minutes but not more than 45 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply
17655	01NOV2006	31DEC9999	Y	-a consultation involving an exhaustive history and comprehensive examination of multiple systems andthe formulation of a written patient management plan following discussion with relevant health care professionals and/or the patient, involving medical planning of high complexity, -AND of more than 45 minutes duration, not being a service associated with a service to which items 2801 - 3000 apply.
17680	01NOV2006	31DEC9999	Y	ANAESTHETIST, CONSULTATION, OTHER (Professional attendance by an anaesthetist in the practice of ANAESTHESIA) - a consultation immediately prior to the institution of a major regional blockade in a patient in labour, where no previous anaesthesia consultation has occurred, not being a service associated with a service to which items 2801 - 3000 apply.
17690	01NOV2006	31DEC9999	Y	-Where a pre-anaesthesia consultation covered by an itemin the range 17615-17625 is performed in-rooms if: (a) the service is provided to a patient prior to an admitted patient episode of care involving anaesthesia; and (b) the service is not providedto an admitted patient of a hospital; and (c) the service is not provided on the day of admission to hospital for the subsequent episode of care involving anaesthesia services; and (d) the service is of more than 15 minutes duration not being a service associated with a service to which items 2801 - 3000 apply.
17701	01NOV1994	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC - In connection with a medical service which has been assigned an anaesthetic unit value of - ONE UNIT
17702	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 2
17703	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 3
17704	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 4
17705	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 5
17706	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 6
17707	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 7
17708	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 8
17709	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 9
17710	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 10
17711	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 11
17712	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 12
17713	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 13
17714	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 14
17715	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 15
17716	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 16
17717	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 17
17718	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 18
17719	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 19
17720	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 20
17721	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 21
17722	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 22
17723	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 23
17724	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 24
17725	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 25
17726	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 26
17727	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 27
17728	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 28
17729	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 29
17730	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 30
17731	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 31
17732	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 32
17733	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 33
17734	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 34
17735	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 35
17736	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 36
17737	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 37
17738	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 38
17739	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 39
17740	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 40
17741	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 41
17742	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 42
17743	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 43
17744	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 44
17745	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 45
17746	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 46
17747	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 47
17748	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 48
17749	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 49
17750	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 50
17751	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 51
17752	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 52
17753	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 53
17754	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 54
17755	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 55
17756	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 56
17757	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 57
17758	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 58
17759	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 59
17760	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 60
17761	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 61
17762	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 62
17763	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 63
17764	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 64
17765	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 65
17766	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 66
17767	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 67
17768	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 68
17769	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 69
17770	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 70
17771	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 71
17772	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 72
17773	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 73
17774	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 74
17775	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 75
17776	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 76
17777	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 77
17778	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 78
17779	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 79
17780	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 80
17781	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 81
17782	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 82
17783	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 83
17784	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 84
17785	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 85
17786	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 86
17787	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 87
17788	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 88
17789	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 89
17790	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 90
17791	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 91
17792	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 92
17793	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 93
17794	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 94
17795	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 95
17796	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 96
17797	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 97
17798	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 98
17799	01NOV1994	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which has a combined anaesthetic unit value of 99
17800	19JUN1997	31OCT1997	N	Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 1 hour - applicable to anaesthesia assigned up to 12 anaesthetic time units
17800	01NOV1997	31DEC9999	Y	Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 1 hour - applicable to anaesthesia assigned up to 12 anaesthetic time units
17805	19JUN1997	31OCT1997	N	Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 1 hour and 30 minutes - applicable to anaesthesia assigned 13 to 24 anaesthetic time units
17805	01NOV1997	31DEC9999	Y	Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 1 hour and 30 minutes - applicable to anaesthesia assigned 13 to 24 anaesthetic time units
17810	19JUN1997	31OCT1997	N	- Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 2 hours - applicable to anaesthesia assigned more than 24 anaesthetic time units
17810	01NOV1997	31DEC9999	Y	- Where the anaesthetic time exceeds the normal anaesthetic time for the procedure by more than 2 hours - applicable to anaesthesia assigned more than 24 anaesthetic time units
17901	01DEC1991	31DEC9999	Y	ADMINISTRATION OF AN ANAESTHETIC In connection with a medical service which has been assigned an anaesthetic unit value of ONE UNIT
17902	01DEC1991	31DEC9999	Y	TWO UNITS
17903	01DEC1991	31DEC9999	Y	THREE UNITS
17904	01DEC1991	31DEC9999	Y	FOUR UNITS
17905	01DEC1991	31DEC9999	Y	FIVE UNITS
17906	01DEC1991	31DEC9999	Y	SIX UNITS
17907	01DEC1991	31DEC9999	Y	SEVEN UNITS
17908	01DEC1991	31DEC9999	Y	EIGHT UNITS
17909	01DEC1991	31DEC9999	Y	NINE UNITS
17910	01DEC1991	31DEC9999	Y	TEN UNITS
17911	01DEC1991	31DEC9999	Y	ELEVEN UNITS
17912	01DEC1991	31DEC9999	Y	TWELVE UNITS
17913	01DEC1991	31DEC9999	Y	THIRTEEN UNITS
17914	01DEC1991	31DEC9999	Y	FOURTEEN UNITS
17915	01DEC1991	31DEC9999	Y	FIFTEEN UNITS
17916	01DEC1991	31DEC9999	Y	SIXTEEN UNITS
17917	01DEC1991	31DEC9999	Y	SEVENTEEN UNITS
17918	01DEC1991	31DEC9999	Y	EIGHTEEN UNITS
17919	01DEC1991	31DEC9999	Y	NINETEEN UNITS
17920	01DEC1991	31DEC9999	Y	TWENTY UNITS
17921	01DEC1991	31DEC9999	Y	TWENTYONE UNITS
17922	01DEC1991	31DEC9999	Y	TWENTYTWO UNITS
17923	01DEC1991	31DEC9999	Y	TWENTYTHREE UNITS
17924	01DEC1991	31DEC9999	Y	TWENTYFOUR UNITS
17925	01DEC1991	31DEC9999	Y	TWENTYFIVE UNITS
17926	01DEC1991	31DEC9999	Y	TWENTYSIX UNITS
17927	01DEC1991	31DEC9999	Y	TWENTYSEVEN UNITS
17928	01DEC1991	31DEC9999	Y	TWENTYEIGHT UNITS
17929	01DEC1991	31DEC9999	Y	TWENTYNINE UNITS
17930	01DEC1991	31DEC9999	Y	THIRTY UNITS
17931	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 31)
17932	01DEC1991	31DEC9999	Y	THIRTYTWO UNITS
17933	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 33)
17934	01DEC1991	31DEC9999	Y	THIRTYFOUR UNITS
17935	01DEC1991	31DEC9999	Y	THIRTYFIVE UNITS
17936	01DEC1991	31DEC9999	Y	THIRTYSIX UNITS
17938	01DEC1991	31DEC9999	Y	THIRTYEIGHT UNITS
17939	01DEC1991	31DEC9999	Y	THIRTYNINE UNITS
17940	01DEC1991	31DEC9999	Y	FORTY UNITS
17942	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 42)
17944	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 44)
17946	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 46)
17947	01DEC1991	31DEC9999	Y	FORTYSEVEN UNITS
17950	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 50)
17952	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 52)
17958	01NOV1992	31DEC9999	Y	Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 58)
17959	01DEC1991	31DEC9999	Y	FIFTY-NINE UNITS
17965	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with radiotherapy (Anaes.)
17968	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with forceps delivery, vacuum extraction delivery, breech delivery by manipulation, rotation of head followed by delivery (Anaes.)
17970	01NOV1997	31DEC9999	Y	- In connection with an operative procedure to which Item 30001 applies
17971	01DEC1991	31DEC9999	Y	In connection with a medical service, being a medical service which does not contain a reference to a number of anaesthetic units
17972	01NOV1994	31DEC9999	Y	Administration of an anaesthetic, where the anaesthetic is prolonged
17974	01DEC1991	31DEC9999	Y	Administration of an anaesthetic where the anaesthetic is administered as a therapeutic procedure (Anaes.)
17977	01DEC1991	31DEC9999	Y	- In connection with reamputation of amputation stump referred to in item 44376
17980	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography  brain scan, plain study with or without contrast medium study (Anaes.)
17983	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with computerised axial tomography  body scan, plain study with or without contrast medium study (Anaes.)
17986	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with the removal of phaeochromocytoma (Anaes.)
17989	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with peripheral venous cannulation (Anaes.)
17992	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with peripheral venous cannulation by open exposure (Anaes.)
17995	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with percutaneous central venous cannulation (Anaes.)
17998	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with electrocochleography (insertion of electrodes and brain stem evoked response audiometry) (Anaes.)
18001	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with manual removal of products of conception, treatment of postpartum haemorrhage or repair of third degree tear (Anaes.)
18004	01DEC1991	31OCT1997	N	- In connection with repair of extensive laceration of cervix or manipulative correction of acute inversion of uterus by vaginal approach
18004	01NOV1997	31DEC9999	Y	Administration of an anaesthetic in connection with repair of extensive laceration or lacerations of cervix or manipulative correction of acute inversion of uterus by vaginal approach (Anaes.)
18007	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with Caesarean section (Anaes.)
18010	01DEC1991	31DEC9999	Y	Administration of an anaesthetic in connection with repair of episiotomy (Anaes.)
18013	01JUL1992	31OCT1992	N	ADMINISTRATION of an ANAESTHETIC in connection with magnetic resonance imaging services provided at prescribed locations (Ministerial Determination)
18013	01NOV1992	31AUG1998	N	- In connection with magnetic resonance imaging services provided at prescribed locations
18013	01SEP1998	31OCT2000	N	- In connection with magnetic resonance imaging services covered by Items 63000 to 63946
18013	01NOV2000	31DEC9999	Y	Administration of an anaesthetic in connection with magnetic resonance imaging services covered by items 63000 to 63946 (Anaes.)
18016	11MAY1994	31OCT1994	N	Administration of an anaesthetic in connection with a regional or field nerve block covered by items 18216, 18219, 18230, 18232, 18233, 18234, 18236, 18280, 18284, 18286, 18288, 18290, 18292, 18294, 18296 or 18298, not being an anaesthetic administered in conjunction with an operative procedure
18016	01NOV1994	30APR1997	N	- In connection with a regional or field nerve block covered by items 18216, 18219, 18230, 18232, 18233, 18234, 18236, 18280, 18284, 18286, 18288, 18290, 18292, 18294, 18296 or 18298, not being an anaesthetic administered in conjunction with an operative procedure
18016	01MAY1997	31OCT1997	N	- In connection with a regional or field nerve block covered by items 18216, 18219, 18230, 18232, 18233, 18234, 18236, 18242, 18280, 18284, 18286, 18288, 18290, 18292, 18294, 18296 or 18298, not being an anaesthetic administered in conjunction with an operative procedure
18016	01NOV1997	31DEC9999	Y	- In connection with a regional or field nerve block covered by item 18216, 18219, 18230, 18232, 18233, 18234, 18236, 18242, 18262, 18280, 18284, 18286, 18288, 18290, 18292, 18294, 18296 or 18298, not being an anaesthetic administered in conjunction with an operative procedure
18019	01NOV1994	31DEC9999	Y	Administration of an anaesthetic for incision and drainage of large haematoma, large abscess, cellulitis or similar lesion causing life threatening airway obstruction, or for the relief of life threatening airway obstruction due to epiglottitus (Anaes.)
18021	01JUL1995	31DEC9999	Y	Administration of an anaesthetic in connection with muscle biopsy for malignant hyperpyrexia (Anaes.)
18022	01NOV1994	31OCT1995	N	ADMINISTRATION OF AN ANAESTHETIC in connection with a digital subtraction angiography, not being an anaesthetic administered in conjunction with an operative procedure
18022	01NOV1995	31DEC9999	Y	Administration of an anaesthetic in connection with digital subtraction angiography (Anaes.)
18026	01NOV1995	31DEC9999	Y	Administration of an anaesthetic during hyperbaric therapy where the medical practitioner is not confined in the chamber (including the administration of oxygen) (Anaes.)
18027	01NOV1995	31DEC9999	Y	Administration of an anaesthetic during hyperbaric therapy where the medical practitioner is confined in the chamber (including the administration of oxygen) (Anaes.)
18030	01NOV1995	31DEC9999	Y	- Performed on a person under the age of 10 years in connection with a procedure covered by an item which has not been allocated anaesthetic units where the anaesthesia time is up to and including 30 minutes
18031	01NOV1995	31DEC9999	Y	- Performed on a person under the age of 10 years in connection with a procedure covered by an item which has not been allocated anaesthetic units where the anaesthesia time exceeds 30 minutes and is up to and including 60 minutes
18032	01NOV1995	31DEC9999	Y	- Performed on a person under the age of 10 years in connection with a procedure covered by an item which has not been allocated anaesthetic units where the anaesthesia time exceeds 60 minutes
18033	01JUL1998	31DEC9999	Y	- In connection with a procedure covered by an item which has not been allocated anaesthetic units, not being a service to which item 18030, 18031 or 18032 applies, where it can be demonstrated that there is a clinical need for anaesthesia
18035	01JUL1996	31DEC9999	Y	In connection with a change of dressing or change of plaster undertaken in a hospital or approved day-hospital facility (Anaes.)
18100	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18101	01DEC1991	31DEC9999	Y	(IN CONNECTION WITH A DENTAL SERVICE NOT BEING A MEDICAL SERVICE PRESCRIBED FOR THE PAYMENT OF MEDICARE BENEFITS) ADMINISTRATION by a medical practitioner OF AN ANAESTHETIC, OTHER THAN AN ENDOTRACHEAL ANAESTHETIC, in connection with a dental operation
18102	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner OF AN ANAESTHETIC in connection with a dental operation other than for the extraction of teeth or restorative dental work where the procedure is less than 15 minutes duration
18103	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner OF AN ANAESTHETIC in connection with a dental operation other than for the extraction of teeth or restorative dental work where the procedure is more than 15 minutes duration
18104	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18105	01DEC1991	31OCT1992	N	ADMINISTRATION by a medical practitioner OF AN ENDOTRACHEAL ANAESTHETIC for extraction of a tooth or teeth not covered by item 18108 or 18109
18105	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner OF AN ANAESTHETIC for extraction of a tooth or teeth, not being a service to which item 18109 applies
18108	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18109	01DEC1991	31OCT1992	N	ADMINISTRATION by a medical practitioner of an ENDOTRACHEAL ANAESTHETIC for removal of a tooth or teeth requiring incision of soft tissue and removal of bone
18109	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner of an ANAESTHETIC for removal of a tooth or teeth requiring incision of soft tissue and removal of bone
18112	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18113	01DEC1991	31OCT1992	N	ADMINISTRATION by a medical practitioner of an ENDOTRACHEAL ANAESTHETIC for restorative dental work where the procedure is of not more than 30 minutes duration
18113	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner of an ANAESTHETIC for restorative dental work where the procedure is of not more than 30 minutes duration
18117	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18118	01DEC1991	31OCT1992	N	ADMINISTRATION by a medical practitioner of an ENDOTRACHEAL ANAESTHETIC for restorative dental work where the procedure is of more than 30 minutes duration
18118	01NOV1992	31DEC9999	Y	ADMINISTRATION by a medical practitioner of an ANAESTHETIC for restorative dental work where the procedure is of more than 30 minutes duration
18119	19JUN1997	31OCT1997	N	ADMINISTRATION by a medical practitioner of an ANAESTHETIC in connection with a dental operation where the procedure is of more than 3 hours duration
18119	01NOV1997	31DEC9999	Y	ADMINISTRATION by a medical practitioner of an ANAESTHETIC in connection with a dental operation where the procedure is of more than 3 hours duration
18121	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
18122	01DEC1991	31DEC9999	Y	ADMINISTRATION by a medical practitioner of an ENDOTRACHEAL ANAESTHETIC in connection with a dental operation, not covered by any other item in this Group
18200	01DEC1991	31DEC9999	Y	REGIONAL OR FIELD NERVE BLOCK, being 1 of the following nerve blocks abdominal (in association with an intraperitoneal operation); brachial plexus; caudal; cervical plexus (not including the uterine cervix); epidural (peridural); ilioinguinal, iliohypogastric, genitofemoral (involving all 3 nerves); intercostal (involving any 4 or more nerves, 1 or both sides); paravertebral (thoracic or lumbar); pudendal; retrobulbar with facial nerve; sacral or spinal (intrathecal)
18203	01DEC1991	31DEC9999	Y	MAINTENANCE OF A REGIONAL OR FIELD NERVE BLOCK referred to in item 18200 by the administration of local anaesthetic through an in situ needle or catheter when performed other than by the operating surgeon
18206	01DEC1991	31DEC9999	Y	(Note: Where an anaesthetic combines a regional nerve block with a general anaesthetic for an operative procedure, benefits will be paid only under the anaesthetic item relevant to the operation. The only instance where additional benefits are payable under an item in this Group is in relation to item 18206 or 18209, or for item 18210 to 18212 which apply to post-operative pain management) INTRODUCTION OF A NARCOTIC, for the control of postoperative pain, into the epidural or intrathecal space in conjunction with an operation
18209	01DEC1991	31OCT1994	N	INTRODUCTION at the end of an operation of a local anaesthetic into the caudal, lumbar or thoracic epidural space for the control of postoperative pain, in conjunction with general anaesthesia
18209	01NOV1994	31DEC9999	Y	INTRODUCTION OF LOCAL ANAESTHETIC, for control of postoperative pain, into the epidural or intrathecal space, in conjunction with an operation
18210	01MAY1997	30JUN1998	N	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with knee surgery
18210	01JUL1998	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with knee, ankle or foot surgery
18211	01MAY1997	30JUN1998	N	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with knee surgery
18211	01JUL1998	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with knee, ankle or foot surgery
18212	01DEC1991	30JUN1993	N	MAINTENANCE of narcotic analgesia referred to in item 18206 by the administration of a narcotic through an in situ needle or catheter, when performed other than by the operating surgeon
18212	01JUL1993	30APR1997	N	MAINTENANCE of narcotic analgesia referred to in item 18206 by the administration of a narcotic or MAINTENANCE of local anaesthetic referred to in item 18209 through an in situ needle or catheter, when performed other than by the operating surgeon
18212	01MAY1997	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE block peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the brachial plexus in conjunction with shoulder surgery
18213	01NOV1993	28FEB2022	N	INTRAVENOUS REGIONAL ANAESTHESIA of limb by retrograde perfusion
18213	01MAR2022	31DEC9999	Y	Intravenous regional anaesthesia of limb by retrograde perfusion of local anaesthetic agent
18215	01DEC1991	31DEC9999	Y	NERVE BLOCK with local anaesthetic agent (with or without xray control), of the coeliac plexus, lumbar sympathetic chain, thoracic sympathetic chain, glossopharyngeal nerve or obturator nerve
18216	01NOV1993	30JUN1996	N	INTRATHECAL, EPIDURAL OR CAUDAL INFUSION of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner
18216	01JUL1996	31OCT2019	N	INTRATHECAL OR EPIDURAL INFUSION of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner
18216	01NOV2019	31DEC9999	Y	Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner Applicable once per presentation, per medical practitioner, per complete new procedure
18218	01DEC1991	31DEC9999	Y	NERVE BLOCK with alcohol, phenol or other neurolytic agent (with or without xray control, localisation by electrical stimulator or preliminary block with local anaesthetic) of the coeliac plexus nerve, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain or a cranial nerve (other than the trigeminal nerve); or an epidural or caudal block
18219	01NOV1993	30JUN1996	N	INTRATHECAL, EPIDURAL OR CAUDAL INFUSION of a therapeutic substance, initial injection or commencement of, where continuous attendance by the medical practitioner extends beyond the first hour
18219	01JUL1996	31OCT2019	N	INTRATHECAL or EPIDURAL INFUSION of a therapeutic substance, initial injection or commencement of, where continuous attendance by the medical practitioner extends beyond the first hour
18219	01NOV2019	31DEC9999	Y	Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, if continuous attendance by the medical practitioner extends beyond the first hour
18222	01NOV1993	28FEB2022	N	INFUSION OF A THERAPEUTIC SUBSTANCE to maintain regional anaesthesia or analgesia, subsequent injection or revision of, where the period of continuous medical practitioner attendance is 15 minutes or less
18222	01MAR2022	31DEC9999	Y	Continuous infusion or injection by catheter of a therapeutic substance (not contrast agent) to maintain regional anaesthesia or analgesia, subsequent injection or revision of, if the period of continuous medical practitioner attendance is 15 minutes or less
18224	01DEC1991	31DEC9999	Y	INTRAVENOUS REGIONAL ANAESTHESIA OF LIMB BY RETROGRADE PERFUSION
18225	01NOV1993	28FEB2022	N	INFUSION OF A THERAPEUTIC SUBSTANCE to maintain regional anaesthesia or analgesia, subsequent injection or revision of, where the period of continuous medical practitioner attendance is more than 15 minutes
18225	01MAR2022	31DEC9999	Y	Continuous infusion or injection by catheter of a therapeutic substance (not contrast agent) to maintain regional anaesthesia or analgesia, subsequent injection or revision of, if the period of continuous medical practitioner attendance is more than 15 minutes
18226	01NOV2002	31OCT2019	N	INTRATHECAL OR EPIDURAL INFUSION of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner, for a patient in labour, where the service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or any time on a Saturday, a Sunday or a public holiday.
18226	01NOV2019	31DEC9999	Y	Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, including up to 1 hour of continuous attendance by the medical practitioner, for a patient in labour, where the service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or any time on a Saturday, a Sunday or a public holiday. Applicable once per presentation, per medical practitioner, per complete new procedure
18227	01NOV2002	31OCT2019	N	INTRATHECAL OR EPIDURAL INFUSION of a therapeutic substance, initial injection or commencement of, where continuous attendance by a medical practitioner extends beyond the first hour, for a patient in labour, where the service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or any time on a Saturday, a Sunday or a public holiday.
18227	01NOV2019	31DEC9999	Y	Intrathecal, combined spinal-epidural or epidural infusion of a therapeutic substance, initial injection or commencement of, where continuous attendance by a medical practitioner extends beyond the first hour, for a patient in labour, where the service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or any time on a Saturday, a Sunday or a public holiday.
18228	01NOV1993	28FEB2022	N	INTERPLEURAL BLOCK, initial injection or commencement of infusion of a therapeutic substance
18228	01MAR2022	31DEC9999	Y	Interpleural block, initial injection or commencement of infusion of a therapeutic substance, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18230	01NOV1993	30JUN1996	N	INTRATHECAL, EPIDURAL OR CAUDAL INJECTION of neurolytic substance
18230	01JUL1996	28FEB2022	N	INTRATHECAL or EPIDURAL INJECTION of neurolytic substance
18230	01MAR2022	31DEC9999	Y	Intrathecal or epidural injection of neurolytic substance (not contrast agent) by any route, including transforaminal route
18232	01NOV1993	30JUN1996	N	INTRATHECAL, EPIDURAL OR CAUDAL INJECTION of substance other than anaesthetic, contrast or neurolytic solutions, not being a service to which another item in this Group applies
18232	01JUL1996	28FEB2022	N	INTRATHECAL or EPIDURAL INJECTION of substance other than anaesthetic, contrast or neurolytic solutions, not being a service to which another item in this Group applies
18232	01MAR2022	31DEC9999	Y	Intrathecal or epidural injection (including translaminar and transforaminal approaches) of therapeutic substance or substances (anaesthetic, steroid or chemotherapeutic agents):(a) other than a service to which another item in this Group applies; and (b) not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18233	01NOV1993	31DEC9999	Y	EPIDURAL INJECTION of blood for blood patch
18234	01NOV1993	28FEB2022	N	TRIGEMINAL NERVE, primary division of, injection of an anaesthetic agent
18234	01MAR2022	31DEC9999	Y	Trigeminal nerve, primary branch (ophthalmic, maxillary or mandibular branches, excluding infraorbital nerve), injection of an anaesthetic agent or steroid, but not in association with a service to which an item in Group T8 applies, unless a targeted percutaneous technique is used
18236	01NOV1993	28FEB2022	N	TRIGEMINAL NERVE, peripheral branch of, injection of an anaesthetic agent
18236	01MAR2022	31DEC9999	Y	Trigeminal nerve, peripheral branch (including infraorbital nerve), injection of an anaesthetic agent, but not in association with a service to which an item in Group T8 applies, unless a targeted percutaneous technique is used
18238	01NOV1993	28FEB2022	N	FACIAL NERVE, injection of an anaesthetic agent, not being a service associated with a service to which item 18240 applies
18238	01MAR2022	31DEC9999	Y	Facial nerve, injection of an anaesthetic agent, other than a service associated with a service to which item 18240 applies, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18240	01NOV1993	31DEC9999	Y	RETROBULBAR OR PERIBULBAR INJECTION of an anaesthetic agent
18242	01NOV1993	31DEC9999	Y	GREATER OCCIPITAL NERVE, injection of an anaesthetic agent
18244	01NOV1993	28FEB2022	N	VAGUS NERVE, injection of an anaesthetic agent
18244	01MAR2022	31DEC9999	Y	Vagus nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18246	01NOV1993	31DEC9999	Y	GLOSSOPHARYNGEAL NERVE, injection of an anaesthetic agent
18248	01NOV1993	31DEC9999	Y	PHRENIC NERVE, injection of an anaesthetic agent
18250	01NOV1993	31DEC9999	Y	SPINAL ACCESSORY NERVE, injection of an anaesthetic agent
18252	01NOV1993	28FEB2022	N	CERVICAL PLEXUS, injection of an anaesthetic agent
18252	01MAR2022	31DEC9999	Y	Cervical plexus, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18254	01NOV1993	28FEB2022	N	BRACHIAL PLEXUS, injection of an anaesthetic agent
18254	01MAR2022	31DEC9999	Y	Brachial plexus, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18256	01NOV1993	31DEC9999	Y	SUPRASCAPULAR NERVE, injection of an anaesthetic agent
18258	01NOV1993	31DEC9999	Y	INTERCOSTAL NERVE (single), injection of an anaesthetic agent
18260	01NOV1993	31DEC9999	Y	INTERCOSTAL NERVES (multiple), injection of an anaesthetic agent
18262	01NOV1993	28FEB2022	N	ILIO-INGUINAL, ILIOHYPOGASTRIC OR GENITOFEMORAL NERVES, 1 or more of, injection of an anaesthetic agent
18262	01MAR2022	31DEC9999	Y	Ilio inguinal, iliohypogastric or genitofemoral nerves, one or more of, injections of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18264	01NOV1993	31AUG2015	N	PUDENDAL NERVE, injection of an anaesthetic agent
18264	01SEP2015	28FEB2022	N	PUDENDAL NERVE and or dorsal nerve, injection of anaesthetic agent
18264	01MAR2022	31DEC9999	Y	Pudendal nerve or dorsal nerve (or both), injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18266	01NOV1993	28FEB2022	N	ULNAR, RADIAL OR MEDIAN NERVE, MAIN TRUNK OF, 1 or more of, injection of an anaesthetic agent, not being associated with a brachial plexus block
18266	01MAR2022	31DEC9999	Y	Ulnar, radial or median nerve, main trunk of, one or more of, injections of an anaesthetic agent, not being associated with a brachial plexus block, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18268	01NOV1993	31DEC9999	Y	OBTURATOR NERVE, injection of an anaesthetic agent
18270	01NOV1993	31DEC9999	Y	FEMORAL NERVE, injection of an anaesthetic agent
18272	01NOV1993	31DEC9999	Y	SAPHENOUS, SURAL, POPLITEAL OR POSTERIOR TIBIAL NERVE, MAIN TRUNK OF, 1 or more of, injection of an anaesthetic agent
18274	01NOV1993	31DEC9999	Y	PARAVERTEBRAL, CERVICAL, THORACIC, LUMBAR, SACRAL OR COCCYGEAL NERVES, injection of an anaesthetic agent, (single vertebral level)
18276	01NOV1993	31DEC9999	Y	PARAVERTEBRAL NERVES, injection of an anaesthetic agent, (multiple levels)
18278	01NOV1993	28FEB2022	N	SCIATIC NERVE, injection of an anaesthetic agent
18278	01MAR2022	31DEC9999	Y	Sciatic nerve, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18280	01NOV1993	28FEB2022	N	SPHENOPALATINE GANGLION, injection of an anaesthetic agent
18280	01MAR2022	31DEC9999	Y	Sphenopalatine ganglion, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18282	01NOV1993	31DEC9999	Y	CAROTID SINUS, injection of an anaesthetic agent, as an independent percutaneous procedure
18284	01NOV1993	28FEB2022	N	STELLATE GANGLION, injection of an anaesthetic agent, (cervical sympathetic block)
18284	01MAR2022	31DEC9999	Y	Cervical or thoracic sympathetic chain, injection of an anaesthetic agent
18286	01NOV1993	28FEB2022	N	LUMBAR OR THORACIC NERVES, injection of an anaesthetic agent, (paravertebral sympathetic block)
18286	01MAR2022	31DEC9999	Y	Lumbar or pelvic sympathetic chain, injection of an anaesthetic agent
18288	01NOV1993	28FEB2022	N	COELIAC PLEXUS OR SPLANCHNIC NERVES, injection of an anaesthetic agent
18288	01MAR2022	31DEC9999	Y	Coeliac plexus or splanchnic nerves, injection of an anaesthetic agent, not in association with a service to which an item in Group T8 applies, unless the nerve block is performed using a targeted percutaneous approach
18290	01NOV1993	30APR2003	N	CRANIAL NERVE OTHER THAN TRIGEMINAL, destruction by a neurolytic agent
18290	01MAY2003	28FEB2022	N	CRANIAL NERVE OTHER THAN TRIGEMINAL, destruction by a neurolytic agent, not being a service associated with the injection of botulinum toxin
18290	01MAR2022	31DEC9999	Y	Cranial nerve other than trigeminal, destruction by a neurolytic agent under image guidance, other than a service associated with the injection of botulinum toxin
18292	01NOV1993	30APR2003	N	NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies
18292	01MAY2003	30JUN2008	N	NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies or a service associated with the injection of botulinum toxin
18292	01JUL2008	30JUN2015	N	NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies or a service associated with the injection of botulinum toxin except those services to which items 18354, 18356 and 18358 applies
18292	01JUL2015	28FEB2022	N	NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies or a service associated with the injection of botulinum toxin except those services to which item 18354 applies
18292	01MAR2022	31DEC9999	Y	Nerve branch, destruction by a neurolytic agent under image guidance, other than a service to which another item in this Group applies or a service associated with the injection of botulinum toxin except a service to which item 18354 applies
18294	01NOV1993	28FEB2022	N	COELIAC PLEXUS OR SPLANCHNIC NERVES, destruction by a neurolytic agent
18294	01MAR2022	31DEC9999	Y	Coeliac plexus or splanchnic nerves, destruction by a neurolytic agent under image guidance
18296	01NOV1993	28FEB2022	N	LUMBAR SYMPATHETIC CHAIN, destruction by a neurolytic agent
18296	01MAR2022	31DEC9999	Y	Lumbar or pelvic sympathetic chain, destruction by a neurolytic agent under image guidance
18297	01NOV2019	31DEC9999	Y	Assistance at the administration of an epidural blood patch (a service to which item 18233 applies) by another medical practitioner
18298	01NOV1993	31DEC9999	Y	CERVICAL OR THORACIC SYMPATHETIC CHAIN, destruction by a neurolytic agent
18350	01MAY2003	31OCT2004	N	BOTULINUM TOXIN BOTULINUM TOXIN (Botox), injection of, for hemifacial spasm in a patient over 12 years of age, including all injections on any one day
18350	01NOV2004	31OCT2014	N	BOTULINUM TOXIN BOTULINUM TOXIN (Botox), injection of, for hemifacial spasm in a patient 12 years of age or older, including all injections on any one day
18350	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of hemifacial spasm in a patient who is at least 12 years of age, including all such injections on any one day
18351	01NOV2005	31OCT2014	N	BOTULINUM TOXIN (Dysport), injection of, for the treatment of hemifacial spasm in a patient 18 years of age or older, including all such injections on any one day
18351	01NOV2014	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the treatment of hemifacial spasm in a patient who is at least 18 years of age, including all such injections on any one day
18352	01MAY2003	31OCT2014	N	BOTULINUM TOXIN (Botox or Dysport), injection of, for cervical dystonia (spasmodic torticollis), including all injections on any one day
18352	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutin Complex (Dysport), injection of, for the treatment of cervical dystonia (spasmodic torticollis), including all such injections on any one day
18353	01APR2015	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of cervical dystonia (spasmodic torticollis), including all such injections on any one day
18354	01MAY2003	30APR2010	N	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinus foot deformity due to spasticity in an ambulant cerebral palsy patient, between the ages of 2 and 17 (inclusive), including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18354	01MAY2010	31OCT2014	N	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinus foot deformity due to spasticity in an ambulant cerebral palsy patient, aged two years or older, in accordance with the supply of the drug under instrument PB 122 of 2008 (Arrangements - Botulinum Toxin Program) made under Section 100 (1) (b) of the National Health Act 1953, including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18354	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotixin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport), injection of, for the treatment of dynamic equinus foot deformity (including equinovarus and equinovalgus) due to spasticity in an ambulant cerebral palsy patient, if:(a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each lower limb), including all injections per set
18356	01MAY2003	30APR2010	N	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinovarus foot deformity due to spasticity in an ambulant cerebral palsy patient, between the ages of 2 and 17 (inclusive), including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18356	01MAY2010	31DEC9999	Y	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinovarus foot deformity due to spasticity in an ambulant cerebral palsy patient, aged two years or older, in accordance with the supply of the drug under instrument PB 122 of 2008 (Arrangements - Botulinum Toxin Program) made under Section 100 (1) (b) of the National Health Act 1953, including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18358	01MAY2003	30APR2010	N	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinovalgus foot deformity due to spasticity in an ambulant cerebral palsy patient, between the ages of 2 and 17 (inclusive), including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18358	01MAY2010	31DEC9999	Y	BOTULINUM TOXIN (Botox or Dysport), injection of, for dynamic equinovalgus foot deformity due to spasticity in an ambulant cerebral palsy patient, aged two years or older, in accordance with the supply of the drug under instrument PB 122 of 2008 (Arrangements - Botulinum Toxin Program) made under Section 100 (1) (b) of the National Health Act 1953, including all such injections on any one day for all or any of the muscles subserving one functional activity and supplied by one motor nerve - applicable only to the first two treatments of each limb of the patient on any one day
18359	01SEP2009	31DEC9999	Y	Historical item included for item mapping purposes
18360	01MAY2003	31OCT2005	N	BOTULINUM TOXIN (Botox), injection of, for focal spasticity in adults, including all injections for all or any of the muscles subserving one functional activity, supplied by one motor nerve, with a maximum of 4 treatments per patient on any one day (2 per limb)
18360	01NOV2005	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of focal spasticity in adults, including all injections for all or any of the muscles subserving one functional activity, supplied by one motor nerve, with a maximum of 4 treatments per patient on any one day (2 per limb)
18360	01NOV2014	30JUN2015	N	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18364
18360	01JUL2015	31OCT2018	N	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18365
18360	01NOV2018	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity, if: (a) the patient is at least 18 years of age; and (b) the spasticity is associated with a previously diagnosed neurological disorder; and (c) treatment is provided as: (i) second line therapy when standard treatment for the conditions has failed; or (ii) an adjunct to physical therapy; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set; and (e) the treatment is not provided on the same occasion as a service mentioned in item 18365
18361	01JUL2011	31OCT2014	N	Botulinum toxin (Botox), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy, in a patient who is at least 2 years but less than 18 years, in association with either: (a) physiotherapy or occupational therapy or both; or (b) electrical stimulation or ultrasound for muscle localisation; including all injections for any or all of the muscles sub-serving one functional activity supplied by one motor nerve - with a maximum of four treatments per patient on any one day, and with a maximum of two treatments per limb
18361	01NOV2014	30NOV2020	N	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy if: (a) the patient is at least 2 years of age, and (b) for a patient who is at least 18 years of age - before the patient turned 18, the patient had commenced treatment for the spasticity with botulinum toxin supplied under the pharmaceutical benefits scheme; and (c) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set
18361	01DEC2020	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of moderate to severe upper limb spasticity due to cerebral palsy if: (a) the patient is at least 2 years of age; and (b) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set
18362	01MAY2003	31OCT2005	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of severe primary hyperhidrosis of the axillae, including all such injections on any one day
18362	01NOV2005	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of severe primary hyperhidrosis of the axillae, including all such injections on any one day
18362	01NOV2014	31DEC9999	Y	Botulinum Toxin type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of severe primary axillary hyperhidrosis, including all injections on any one day, if: (a) the patient is at least 12 years of age; and (b) the patient has been intolerant of, or has not responded to, topical aluminium chloride hexahydrate; and (c) the patient has not had treatment with botulinum toxin within the immediately preceding 4 months; and (d) if the patient has had treatment with botulinum toxin within the previous 12 months - the patient had treatment on no more than 2 separate occasions
18364	01MAY2003	31OCT2005	N	BOTULINUM TOXIN (Dysport), injection of, for treatment of spasticity of the arm in adults following a stroke, including all injections for all or any of the muscles subserving one functional activity, supplied by one motor nerve, with a maximum of 4 treatments per patient on any one day (2 per limb)
18364	01NOV2005	31OCT2014	N	BOTULINUM TOXIN (Dysport), injection of, for treatment of spasticity of the arm in adults following a stroke, including all injections for all or any of the muscles subserving one functional activity, supplied by one motor nerve, with a maximum of 4 treatments per patient on any one day (2 per limb)
18364	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutin Complex (Dysport), injection of, for the treatment of moderate to severe spasticity of the upper limb following a stroke, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment
18365	01APR2015	31JUL2020	N	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following a stroke, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment
18365	01AUG2020	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of moderate to severe spasticity of the upper limb following an acute event, if: (a) the patient is at least 18 years of age; and (b) treatment is provided as: (i) second line therapy when standard treatment for the condition has failed; or (ii) an adjunct to physical therapy; and (c) the patient does not have established severe contracture in the limb that is to be treated; and (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each upper limb), including all injections per set; and (e) for a patient who has received treatment on 2 previous separate occasions - the patient has responded to the treatment
18366	01MAY2003	31OCT2005	N	BOTULINUM TOXIN, injection of, for strabismus including all such injections on any one day and associated electromyography
18366	01NOV2005	31OCT2006	N	BOTULINUM TOXIN, injection of, for the treatment of strabismus in children and adults, including all such injections on any one day and associated electromyography
18366	01NOV2006	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of strabismus in children and adults, including all such injections on any one day and associated electromyography
18366	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of strabismus, including all such injections on any one day and associated electromyography
18368	01MAY2003	31OCT2005	N	BOTULINUM TOXIN, injection into vocal cords, including associated consultation
18368	01NOV2005	31OCT2006	N	BOTULINUM TOXIN, injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day
18368	01NOV2006	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day
18368	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of spasmodic dysphonia, including all such injections on any one day
18369	01APR2015	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day
18370	01MAY2003	31OCT2004	N	BOTULINUM TOXIN (Botox), injection of, for blepharospasm, including all such injections on any one day.
18370	01NOV2004	31OCT2006	N	BOTULINUM TOXIN (Botox), injection of, for blepharospasm in a patient 12 years of age or older, including all such injections on any one day.
18370	01NOV2006	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of blepharospasm in a patient 12 years of age or older, including all such injections on any one day.
18370	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 12 years of age, including all such injections on any one day
18371	01NOV2005	31OCT2014	N	BOTULINUM TOXIN (Dysport), injection of, for the treatment of blepharospasm in a patient 18 years of age or older, including all such injections on any one day
18371	01NOV2014	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutin Complex (Dysport), injection of, for the treatment of unilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day
18372	01NOV2006	31OCT2014	N	BOTULINUM TOXIN (Botox), injection of, for the treatment of bilateral blepharospasm in a patient 12 years of age or older, including all such injections on any one day
18372	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of bilateral blepharospasm, in a patient who is at least 12 years of age; including all such injections on any one day
18373	01NOV2006	31OCT2014	N	BOTULINUM TOXIN (Dysport), injection of, for the treatment of bilateral blepharospasm in a patient 18 years of age or older, including all such injections on any one day
18373	01NOV2014	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutin Complex (Dysport), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day
18374	01APR2015	31DEC9999	Y	Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport) or IncobotulinumtoxinA (Xeomin), injection of, for the treatment of bilateral blepharospasm in a patient who is at least 18 years of age, including all such injections on any one day
18375	01OCT2013	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to neurogenic detrusor overactivity as demonstrated by urodynamic study of a patient with: (i) multiple sclerosis; or (ii) spinal cord injury; or (iii) spina bifida and who is at least 18 years of age; and (b) the patient has urinary incontinence that is inadequately controlled by anti-cholinergic therapy, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin type A; and (c) the patient is willing and able to self-catheterise; and (d) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with; and (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient - applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment
18377	01MAR2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), injection of, for the treatment of chronic migraine, including all injections in 1 day, if: (a) the patient is at least 18 years of age; and (b) the patient has experienced an inadequate response, intolerance or contraindication to at least 3 prophylactic migraine medications before commencement of treatment with botulinum toxin, as manifested by an average of 15 or more headache days per month, with at least 8 days of migraine, over a period of at least 6 months, before commencement of treatment with botulinum toxin; and (c) the requirements relating to botulinum toxin type A under the Pharmaceutical Benefits Scheme are complied with For each patient-applicable not more than twice except if the patient achieves and maintains at least a 50% reduction in the number of headache days per month from baseline after 2 treatment cycles (each of 12 weeks duration)
18379	01NOV2014	31DEC9999	Y	Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if: (a) the urinary incontinence is due to idiopathic overactive bladder in a patient: and (b) the patient is at least 18 years of age; and (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti- cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and (d) the patient is willing and able to self-catheterise; and (e) treatment is not provided on the same occasion as a service mentioned in item 104, 105, 110, 116, 119, 11900 or 11919 For each patient-applicable not more than once except if the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment (H)
20100	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, subcutaneous tissue, muscles, salivary glands or superficial vessels of the head including biopsy, not being a service to which another item in this Subgroup applies
20102	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for plastic repair of cleft lip
20104	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for electroconvulsive therapy
20120	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on external, middle or inner ear, including biopsy, not being a service to which another item in this Subgroup applies
20124	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for otoscopy
20140	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on eye, not being a service to which another item in this Group applies
20142	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for lens surgery
20142	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lens surgery
20143	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for retinal surgery
20143	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for retinal surgery
20144	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for corneal transplant
20145	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vitrectomy
20146	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for biopsy of conjunctiva
20147	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for squint repair
20148	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for ophthalmoscopy
20160	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nose or accessory sinuses, not being a service to which another item in this Subgroup applies
20160	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for intranasal or accessory sinuses, not being a service to which another item in this Subgroup applies
20162	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical surgery on the nose and accessory sinuses
20162	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for intranasal surgery for malignancy or for intranasal ablation
20164	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for biopsy of soft tissue of the nose and accessory sinuses
20164	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for biopsy of soft tissue of the nose and accessory sinuses
20170	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for intraoral procedures, including biopsy, not being a service to which another item in this Subgroup applies
20172	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of cleft palate
20174	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision of retropharyngeal tumour
20176	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical intraoral surgery
20190	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on facial bones, not being a service to which another item in this Subgroup applies
20192	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical surgery on facial bones (including prognathism and extensive facial bone reconstruction)
20192	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for extensive surgery on facial bones (including prognathism and extensive facial bone reconstruction)
20210	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for intracranial procedures, not being a service to which another item in this Subgroup applies
20212	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for subdural taps
20214	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for burr holes of the cranium
20216	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for intracranial vascular procedures including those for aneurysms or arterio-venous abnormalities
20220	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for spinal fluid shunt procedures
20222	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for ablation of an intracranial nerve
20225	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for all cranial bone procedures
20230	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the head or face
20300	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the neck not being a service to which another item in this Subgroup applies
20300	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the neck not being a service to which another item in this Subgroup applies
20305	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for incision and drainage of large haematoma, large abscess, cellulitis or similar lesion or epiglottitis causing life threatening airway obstruction
20320	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on oesophagus, thyroid, larynx, trachea, lymphatic system, muscles, nerves or other deep tissues of the neck, not being a service to which another item in this Subgroup applies
20321	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for laryngectomy, hemi laryngectomy, laryngopharyngectomy or pharyngectomy
20330	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for laser surgery to the airway (excluding nose and mouth)
20350	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major vessels of neck, not being a service to which another item in this Subgroup applies
20352	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for simple ligation of major vessels of neck
20355	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the neck
20400	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the anterior part of the chest, not being a service to which another item in this Subgroup applies
20401	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the breast, not being a service to which another item in this Subgroup applies
20402	01NOV2001	28FEB2022	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for reconstructive procedures on breast
20402	01MAR2022	31DEC9999	Y	Initiation of management of anaesthesia for reconstructive procedures on breast including implant reconstruction and exchange
20403	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for removal of breast lump or for breast segmentectomy with axillary node dissection
20403	01MAY2002	28FEB2022	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for removal of breast lump or for breast segmentectomy where axillary node dissection is performed
20403	01MAR2022	31DEC9999	Y	Initiation of management of anaesthesia for axillary dissection or sentinel node biopsy
20404	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for mastectomy
20405	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for reconstructive procedures on the breast using myocutaneous flaps
20406	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical or modified radical procedures on breast with internal mammary node dissection
20410	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for electrical conversion of arrhythmias
20420	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin of the posterior part of the chest
20420	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the posterior part of the chest not being a service to which another item in this Subgroup applies
20440	01MAY2003	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of the sternum
20450	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on clavicle, scapula or sternum, not being a service to which another item in this Subgroup applies
20452	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical surgery on clavicle, scapula or sternum
20470	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for partial rib resection, not being a service to which another item in this Subgroup applies
20472	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracoplasty
20474	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures on chest wall
20475	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the anterior or posterior thorax
20500	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the oesophagus
20520	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for all closed chest procedures (including rigid oesophagoscopy, bronchoscopy or transvenous pacemaker), not being a service to which another item in this Subgroup applies
20520	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for all closed chest procedures (including rigid oesophagoscopy or bronchoscopy), not being a service to which another item in this Subgroup applies
20522	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for needle biopsy of pleura
20524	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for pneumocentesis
20526	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracoscopy
20526	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracoscopy
20528	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for mediastinoscopy
20540	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracotomy procedures involving lungs, pleura, diaphragm, or mediastinum, not being a service to which another item in this Subgroup applies
20542	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for pulmonary decortication
20542	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for pulmonary decortication
20546	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for pulmonary resection with thoracoplasty
20548	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for intrathoracic repair of trauma to trachea and bronchi
20560	01NOV2001	31OCT2017	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the heart, pericardium or great vessels of chest
20560	01NOV2017	31DEC9999	Y	Initiation of the management of anaesthesia for: (a) open procedures on the heart, pericardium or great vessels of the chest; or (b) percutaneous insertion of a valvular prosthesis
20600	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on cervical spine and/or cord, not being a service to which another item in this Subgroup applies (for myelography and discography see Items 21908 and 21914)
20604	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for posterior cervical laminectomy with the patient in the sitting position
20620	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on thoracic spine and/or cord, not being a service to which another item in this Subgroup applies
20622	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for thoracolumbar sympathectomy
20630	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures in lumbar region, not being a service to which another item in this Subgroup applies
20632	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lumbar sympathectomy
20634	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for chemonucleolysis
20670	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for extensive spine and/or spinal cord procedures
20680	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for manipulation of spine when performed in the operating theatre of a hospital
20690	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous spinal procedures, not being a service to which another item in this Subgroup applies
20700	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper anterior abdominal wall, not being a service to which another item in this Subgroup applies
20702	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous liver biopsy
20703	01NOV2005	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures on the nerves, muscles, tendons and fascia of the upper abdominal wall, not being a service to which another item in this Subgroup applies
20704	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the anterior or posterior upper abdomen
20705	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for diagnostic laparoscopy procedures
20706	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for laparoscopic procedures in the upper abdomen, not being a service to which another item in this Subgroup applies
20706	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for laparoscopic procedures in the upper abdomen, including laparoscopic cholecystectomy, not being a service to which another item in this Subgroup applies
20730	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper posterior abdominal wall, not being a service to which another item in this Subgroup applies
20730	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper posterior abdominal wall, not being a service to which another item in this Subgroup applies
20740	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for upper gastrointestinal endoscopic procedures
20745	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for upper gastrointestinal endoscopic procedures in association with acute gastrointestinal haemorrhage
20745	01NOV2019	28FEB2022	N	Initiation of the management of anaesthesia for either or both of the following:(a) upper gastrointestinal endoscopic procedures in association with acute gastrointestinal haemorrhage;(b) endoscopic retrograde cholangiopancreatography
20745	01MAR2022	31DEC9999	Y	Initiation of the management of anaesthesia for any of the following:(a) upper gastrointestinal endoscopic procedures in association with acute gastrointestinal haemorrhage;(b) endoscopic retrograde cholangiopancreatography;(c) upper gastrointestinal endoscopic ultrasound;(d) percutaneous endoscopic gastrostomy;(e) upper gastrointestinal endoscopic mucosal resection of tumour.
20750	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for hernia repairs in upper abdomen, not being a service to which another item in this Subgroup applies
20750	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for hernia repairs to the upper abdominal wall, other than a service to which another item in this Subgroup applies.
20752	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of incisional hernia and/or wound dehiscence
20754	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on an omphalocele
20756	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for transabdominal repair of diaphragmatic hernia
20770	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major upper abdominal blood vessels
20790	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures within the peritoneal cavity in upper abdomen including cholecystectomy, gastrectomy, laparoscopic nephrectomy or bowel shunts
20790	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for procedures within the peritoneal cavity in upper abdomen, including any of the following:(a) open cholecystectomy;(b) gastrectomy;(c) laparoscopically assisted nephrectomy;(d) bowel shunts
20791	01NOV2001	30JUN2013	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for gastric reduction or gastroplasty for the treatment of morbid obesity
20791	01JUL2013	31DEC2013	N	Initiation of the management of anaesthesia for a patient with clinically severe obesity
20791	01JAN2014	31DEC9999	Y	Initiation of the management of anaesthesia for bariatric surgery in a patient with clinically severe obesity
20792	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for partial hepatectomy (excluding liver biopsy)
20793	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for extended or trisegmental hepatectomy
20794	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for pancreatectomy, partial or total
20794	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for pancreatectomy, partial or total
20798	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for neuro endocrine tumour removal in the upper abdomen
20799	01NOV2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous procedures on an intra-abdominal organ in the upper abdomen
20800	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the lower anterior abdominal walls, not being a service to which another item in this Subgroup applies
20802	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lipectomy of the lower abdomen
20803	01NOV2005	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures on the nerves, muscles, tendons and fascia of the lower abdominal wall, not being a service to which another item in this Subgroup applies
20804	01NOV2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the anterior or posterior lower abdomen
20805	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for diagnostic laparoscopic procedures
20806	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for laparoscopic procedures in the lower abdomen
20806	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for laparoscopic procedures in the lower abdomen
20810	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lower intestinal endoscopic procedures
20815	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for extracorporeal shock wave lithotripsy to urinary tract
20815	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for extracorporeal shock wave lithotripsy to urinary tract
20820	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its derivatives or subcutaneous tissue of the lower posterior abdominal wall
20830	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for hernia repairs in lower abdomen, not being a service to which another item in this Subgroup applies
20832	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of incisional herniae and/or wound dehiscence of the lower abdomen
20840	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures within the peritoneal cavity in lower abdomen including appendicectomy, not being a service to which another item in this Subgroup applies
20840	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for all procedures within the peritoneal cavity in lower abdomen including appendicectomy, not being a service to which another item in this Subgroup applies
20840	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for all open procedures within the lower abdominal peritoneal cavity, including appendicectomy, not being a service to which another item in this Subgroup applies
20841	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bowel resection, including laparoscopic bowel resection not being a service to which another item in this Subgroup applies
20842	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for amniocentesis
20844	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for abdominoperineal resection, including pull through procedures, ultra low anterior resection and formation of bowel reservoir
20845	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical prostatectomy
20846	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical hysterectomy
20847	01NOV2005	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for ovarian malignancy
20848	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for pelvic exenteration
20850	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean section
20855	01NOV2001	31OCT2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean hysterectomy
20855	01NOV2002	29NOV2007	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarian hysterectomy or hysterectomy within 24 hours of delivery.
20855	30NOV2007	31OCT2017	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean hysterectomy or hysterectomy within 24 hours of delivery.
20855	01NOV2017	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for Caesarean hysterectomy or hysterectomy within 24 hours of birth
20860	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for extraperitoneal procedures in lower abdomen, including those on the urinary tract, not being a service to which another item in this Subgroup applies
20860	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for extraperitoneal procedures in lower abdomen, including those on the urinary tract, not being a service to which another item in this Subgroup applies
20862	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for renal procedures, including upper 1/3 of ureter
20863	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for nephrectomy
20864	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for total cystectomy
20866	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for adrenalectomy
20867	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for neuro endocrine tumour removal in the lower abdomen
20867	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for neuro endocrine tumour removal in the lower abdomen
20868	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for renal transplantation (donor or recipient)
20880	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on major lower abdominal vessels, not being a service to which another item in this subgroup applies
20882	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for inferior vena cava ligation
20884	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous umbrella insertion
20886	01NOV2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous procedures on an intra-abdominal organ in the lower abdomen
20900	01NOV2001	31DEC2013	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the perineum (including biopsy of male genital system), not being a service to which another item in this Subgroup applies
20900	01JAN2014	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the perineum not being a service to which another item in this Subgroup applies
20902	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for anorectal procedures (including endoscopy and/or biopsy)
20902	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for anorectal procedures (including surgical haemorrhoidectomy, but not banding of haemorrhoids)
20904	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical perineal procedures including radical perineal prostatectomy or radical vulvectomy
20905	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the perineum
20906	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vulvectomy
20910	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral procedures (including urethrocystoscopy), not being a service to which another item in this Subgroup applies
20911	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for endoscopic ureteroscopic surgery including laser procedures
20912	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral resection of bladder tumour(s)
20914	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for transurethral resection of prostate
20916	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bleeding post-transurethral resection
20920	01NOV2001	30JUN2013	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on male external genitalia, not being a service to which another item in this Subgroup applies
20920	01JUL2013	31DEC9999	Y	Initiation of management of anaesthesia for procedures on external genitalia, not being a service to which another item in this Subgroup applies.
20924	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on undescended testis, unilateral or bilateral
20926	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical orchidectomy, inguinal approach
20928	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical orchidectomy, abdominal approach
20930	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for orchiopexy, unilateral or bilateral
20932	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis
20934	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis with bilateral inguinal lymphadenectomy
20936	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for complete amputation of penis with bilateral inguinal and iliac lymphadenectomy
20938	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for insertion of penile prosthesis
20940	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal procedures (including biopsy of labia, vagina, cervix or endometrium), not being a service to which another item in this Subgroup applies
20940	01MAY2002	31DEC2013	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for per vagina and vaginal procedures (including biopsy of labia, vagina, cervix or endometrium), not being a service to which another item in this Subgroup applies
20940	01JAN2014	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for per vagina and vaginal procedures (including biopsy of vagina, cervix or endometrium), not being a service to which another item in this Subgroup applies
20942	01NOV2001	30JUN2008	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for colpotomy, colpectomy or colporrhaphy
20942	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal procedures including repair operations and urinary incontinence procedures (perineal)
20943	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for transvaginal oocyte collection
20943	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for transvaginal assisted reproductive services
20944	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal hysterectomy
20946	01NOV2001	31OCT2017	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal delivery
20946	01NOV2017	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal birth
20948	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for purse string ligation of cervix, or removal of purse string ligature
20950	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for culdoscopy
20952	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for hysteroscopy
20953	01NOV2005	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for endometrial ablation or resection in association with hysteroscopy
20954	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for correction of inverted uterus
20956	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for evacuation of retained products of conception, as a complication of confinement
20958	01MAY2002	31OCT2017	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for manual removal of retained placenta or for repair of vaginal or perineal tear following delivery
20958	01NOV2017	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for manual removal of retained placenta or for repair of vaginal or perineal tear following birth
20960	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for vaginal procedures in the management of post partum haemorrhage (blood loss > 500mls)
21100	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the anterior pelvic region (anterior to iliac crest), except external genitalia
21110	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its derivatives or subcutaneous tissue of the pelvic region (posterior to iliac crest), except perineum
21110	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its derivatives or subcutaneous tissue of the pelvic region (posterior to iliac crest), except perineum
21112	01MAY2003	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of the anterior iliac crest
21114	01MAY2003	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of the posterior iliac crest
21116	01MAY2003	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow harvesting from the pelvis
21120	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the bony pelvis
21130	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for body cast application or revision when performed in the operating theatre of a hospital
21140	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for interpelviabdominal (hind-quarter) amputation
21150	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures for tumour of the pelvis, except hind-quarter amputation
21155	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the anterior or posterior pelvis
21160	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving symphysis pubis or sacroiliac joint when performed in the operating theatre of a hospital
21170	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving symphysis pubis or sacroiliac joint
21195	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper leg
21199	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of the upper leg
21200	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving hip joint when performed in the operating theatre of a hospital
21202	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the hip joint
21210	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving hip joint, not being a service to which another item in this Subgroup applies
21212	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for hip disarticulation
21214	01NOV2001	28FEB2022	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for total hip replacement or revision
21214	01MAR2022	31DEC9999	Y	Initiation of management of anaesthesia for primary total hip replacement.
21215	01MAR2022	31DEC9999	Y	Initiation of management of anaesthesia for revision total hip replacement
21216	01NOV2005	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral total hip replacement
21220	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving upper 2/3 of femur when performed in the operating theatre of a hospital
21230	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving upper 2/3 of femur, not being a service to which another item in this Subgroup applies
21232	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for above knee amputation
21234	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of the upper 2/3 of femur
21260	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving veins of upper leg, including exploration
21270	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving arteries of upper leg, including bypass graft, not being a service to which another item in this Subgroup applies
21272	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery ligation
21274	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery embolectomy
21275	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the upper leg
21280	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of upper leg
21300	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the knee and/or popliteal area
21321	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of knee and/or popliteal area
21340	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower 1/3 of femur when performed in the operating theatre of a hospital
21360	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on lower 1/3 of femur
21380	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on knee joint when performed in the operating theatre of a hospital
21382	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of knee joint
21390	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on upper ends of tibia, fibula, and/or patella when performed in the operating theatre of a hospital
21392	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on upper ends of tibia, fibula, and/or patella
21400	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on knee joint, not being a service to which another item in this Subgroup applies
21402	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for total knee replacement
21402	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for knee replacement
21403	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral knee replacement
21404	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for disarticulation of knee
21420	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for cast application, removal, or repair involving knee joint, undertaken in a hospital
21430	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of knee or popliteal area, not being a service to which another item in this Subgroup applies
21432	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of arteriovenous fistula of knee or popliteal area
21440	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of knee or popliteal area, not being a service to which another item in this Subgroup applies
21445	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the knee and/or popliteal area
21460	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of lower leg, ankle, or foot
21461	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, or fascia of lower leg, ankle, or foot, not being a service to which another item in this Subgroup applies
21462	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower leg, ankle, or foot
21464	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedure of ankle joint
21472	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of Achilles tendon
21474	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for gastrocnemius recession
21480	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on bones of lower leg, ankle, or foot, including amputation, not being a service to which another item in this Subgroup applies
21482	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of bone involving lower leg, ankle or foot
21484	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for osteotomy or osteoplasty of tibia or fibula
21486	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for total ankle replacement
21490	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lower leg cast application, removal or repair, undertaken in a hospital
21500	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of lower leg, including bypass graft, not being a service to which another item in this Subgroup applies
21502	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of the lower leg
21520	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of lower leg, not being a service to which another item in this Subgroup applies
21522	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for venous thrombectomy of the lower leg
21530	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of lower leg, ankle or foot
21532	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of toe
21532	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of toe
21535	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the lower leg
21600	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the shoulder or axilla
21610	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of shoulder or axilla including axillary dissection
21620	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, or shoulder joint when performed in the operating theatre of a hospital
21622	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of shoulder joint
21630	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint, not being a service to which another item in this Subgroup applies
21632	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection involving humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint
21634	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder disarticulation
21636	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for interthoracoscapular (forequarter) amputation
21638	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for total shoulder replacement
21650	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of shoulder or axilla, not being a service to which another item in this Subgroup applies
21652	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures for axillary-brachial aneurysm
21654	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bypass graft of arteries of shoulder or axilla
21656	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for axillary-femoral bypass graft
21670	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of shoulder or axilla
21680	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder cast application, removal or repair, not being a service to which another item in this Subgroup applies, when undertaken in a hospital
21682	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder spica application when undertaken in a hospital
21685	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the shoulder or the axilla
21700	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper arm or elbow
21710	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of upper arm or elbow, not being a service to which another item in this Subgroup applies
21712	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open tenotomy of the upper arm or elbow
21714	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for tenoplasty of the upper arm or elbow
21716	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for tenodesis for rupture of long tendon of biceps
21730	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the upper arm or elbow when performed in the operating theatre of a hospital
21732	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of elbow joint
21740	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the upper arm or elbow, not being a service to which another item in this Subgroup applies
21756	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures on the upper arm or elbow
21760	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for total elbow replacement
21770	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of upper arm, not being a service to which another item in this Subgroup applies
21772	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of arteries of the upper arm
21780	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of upper arm, not being a service to which another item in this Subgroup applies
21785	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the upper arm or elbow
21790	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of upper arm
21800	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the forearm, wrist or hand
21810	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the nerves, muscles, tendons, fascia, or bursae of the forearm, wrist or hand
21820	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the radius, ulna, wrist, or hand bones when performed in the operating theatre of a hospital
21830	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the radius, ulna, wrist, or hand bones, not being a service to which another item in this Subgroup applies
21832	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for total wrist replacement
21834	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the wrist joint
21840	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the arteries of forearm, wrist or hand, not being a service to which another item in this Subgroup applies
21842	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of artery of forearm, wrist or hand
21850	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the veins of forearm, wrist or hand, not being a service to which another item in this Subgroup applies
21860	01NOV2001	30NOV2007	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for forearm, wrist, or hand cast application, removal, or repair when undertaken in a hospital or approved day hospital facility
21860	01DEC2007	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for forearm, wrist, or hand cast application, removal, or repair when rendered to a patient as part of an episode of hospital treatment
21865	01JUL2008	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the forearm, wrist or hand
21870	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of forearm, wrist or hand
21872	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of a finger
21878	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting where the area of burn involves not more than 3% of total body surface
21879	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting,where the area of burn involves more than 3% but less than 10% of total body surface
21880	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 10% or more but less than 20% of total body surface
21881	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 20% or more but less than 30% of total body surface
21882	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 30% or more but less than 40% of total body surface
21883	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 40% or more but less than 50% of total body surface
21884	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 50% or more but less than 60% of total body surface
21885	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 60% or more but less than 70% of total body surface
21886	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 70% or more but less than 80% of total body surface
21887	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 80% or more of total body surface
21900	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for hysterosalpingography
21906	01MAY2001	31OCT2001	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: lumbar or thoracic
21906	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: lumbar or thoracic
21908	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: cervical
21910	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: posterior fossa
21912	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for discography: lumbar or thoracic
21914	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for discography: cervical
21915	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral arteriogram
21916	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for arteriograms: cerebral, carotid or vertebral
21918	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde arteriogram: brachial or femoral
21922	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for computerised axial tomography scanning, magnetic resonance scanning, digital subtraction angiography scanning
21925	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde cystography, retrograde urethrography or retrograde cystourethrography
21926	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for fluoroscopy
21927	01NOV2001	31OCT2012	N	INITIATION OF MANAGEMENT OF ANAESTHESIA forl barium enema or other opaque study of the small bowel
21927	01NOV2012	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for barium enema or other opaque study of the small bowel
21930	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for bronchography
21935	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for phlebography
21936	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for heart, 2 dimensional real time transoesophageal examination
21939	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral venous cannulation
21941	01NOV2001	30APR2002	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac catheterisation including coronary arteriography, ventriculography, or cardiac mapping
21941	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac catheterisation including coronary arteriography, ventriculography, cardiac mapping, insertion of automatic defibrillator or transvenous pacemaker
21942	01MAY2002	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac electrophysiological procedures including radio frequency ablation
21943	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for central vein catheterisation or insertion of right heart balloon catheter (via jugular, subclavian or femoral vein) by percutaneous or open exposure
21945	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for lumbar puncture, cisternal puncture, or epidural injection
21949	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for harvesting of bone marrow for the purpose of transplantation
21952	01NOV2001	31OCT2019	N	INITIATION OF MANAGEMENT OF ANAESTHESIA for muscle biopsy for malignant hyperpyrexia
21952	01NOV2019	31DEC9999	Y	Initiation of the management of anaesthesia for diagnostic muscle biopsy to assess for malignant hyperpyrexia
21955	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for electroencephalography
21959	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for brain stem evoked response audiometry
21962	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for electrocochleography by extratympanic method or transtympanic membrane insertion method
21965	01NOV2001	31OCT2005	N	INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure where it can be demonstrated that there is a clinical need for anaesthesia
21965	01NOV2005	31OCT2018	N	INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure where it can be demonstrated that there is a clinical need for anaesthesia, not for the treatment of headache of any etiology
21965	01NOV2018	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure if there is a clinical need for anaesthesia, not for headache of any etiology
21969	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the medical practitioner is not confined in the chamber (including the administration of oxygen)
21970	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the medical practitioner is confined in the chamber (including the administration of oxygen)
21973	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for brachytherapy using radioactive sealed sources
21976	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for therapeutic nuclear medicine
21980	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for radiotherapy
21981	01JUL2008	30JUN2011	N	ANAESTHETIC AGENT ALLERGY TESTING, using skin sensitivity methods in a patient with a history of prior anaphylactic or anaphylactoid reaction or cardiovascular collapse in association with the administration of anaesthesia agents
21981	01JUL2011	31DEC9999	Y	ANAESTHETIC AGENT ALLERGY TESTING, using skin sensitivity methods in a patient with a history of prior anaphylactic or anaphylactoid reaction or cardiovascular collapse associated with the management of anaesthesia agents
21990	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA when no procedure ensues
21992	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA performed on a person under the age of 10 years in connection with a procedure covered by an item which has not been identified as attracting an anaesthetic
21997	01NOV2001	31OCT2018	N	INITIATION OF MANAGEMENT OF ANAESTHESIA in connection with a procedure covered by an item which has not been identified as attracting an anaesthetic rebate, not being a service to which item 21992 or 21965 applies where it can be demonstrated that there is a clinical need for anaesthesia
21997	01NOV2018	31DEC9999	Y	"INITIATION OF MANAGEMENT OF ANAESTHESIA in connection with a procedure covered by an item that does not include the word ""(Anaes.)"", other than a service to which item 21965 or 21992 applies, if there is a clinical need for anaesthesia"
22001	01NOV2001	31DEC9999	Y	COLLECTION OF BLOOD FOR AUTOLOGOUS TRANSFUSION or when homologous blood is required for immediate transfusion in an emergency situation, when performed in association with the administration of anaesthesia
22002	01NOV2001	31OCT2019	N	ADMINISTRATION OF BLOOD or bone marrow already collected when performed in association with the administration of anaesthesia
22002	01NOV2019	31OCT2024	N	Administration of homologous blood or bone marrow already collected, when performed in association with the management of anaesthesia
22002	01NOV2024	31DEC9999	Y	Administration of blood or bone marrow, when performed in association with the management of anaesthesia (H)
22007	01NOV2001	30JUN2008	N	AWAKE ENDOTRACHEAL INTUBATION with flexible fibreoptic scope associated with difficult airway when performed in association with the administration of anaesthesia
22007	01JUL2008	31DEC9999	Y	ENDOTRACHEAL INTUBATION with flexible fibreoptic scope associated with difficult airway when performed in association with the administration of anaesthesia
22008	01NOV2001	31DEC9999	Y	DOUBLE LUMEN ENDOBRONCHIAL TUBE OR BRONCHIAL BLOCKER, insertion of when performed in association with the administration of anaesthesia
22012	01NOV2001	30APR2002	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - each day of monitoring for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia
22012	01MAY2002	31OCT2008	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia
22012	01NOV2008	31OCT2019	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - once only for each type of pressure on any calendar day, up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia
22012	01NOV2019	31DEC9999	Y	Central venous, pulmonary arterial, systemic arterial or cardiac intracavity blood pressure monitoring by indwelling catheter-once per day for each type of pressure for a patient:(a) when performed in association with the management of anaesthesia for the patient; and(b) other than a service to which item 13876 applies(c) is categorised as having a high risk of complications or during the procedure develops either complications or a high risk of complications
22014	01NOV2001	31OCT2008	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia relating to another discrete operation on the same day
22014	01NOV2008	31OCT2019	N	BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - once only for each type of pressure on any calendar day, up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia relating to another discrete operation on the same day
22014	01NOV2019	31DEC9999	Y	Central venous, pulmonary arterial, systemic arterial or cardiac intracavity blood pressure monitoring by indwelling catheter-once per day for each type of pressure for a patient:(a) when performed in association with the management of anaesthesia for the patient; and(b) relating to another discrete operation on the same day for the patient; and(c) other than a service to which item 13876 applies(d) who is categorised as having a high risk of complications or develops during the current procedure either complications or a high risk of complications
22015	01NOV2001	31DEC9999	Y	RIGHT HEART BALLOON CATHETER, insertion of, including pulmonary wedge pressure and cardiac output measurement, when performed in association with the administration of anaesthesia
22018	01NOV2005	31DEC9999	Y	MEASUREMENT OF THE MECHANICAL OR GAS EXCHANGE FUNCTION OF THE RESPIRATORY SYSTEM, using measurements of parameters, including pressures, volumes, flow, gas concentrations in inspired or expired air, alveolar gas or blood and incorporating serial arterial blood gas analysis and a written record of the results, when performed in association with the administration of anaesthesia, not being a service associated with a service to which item 11503 applies
22020	01NOV2001	30JUN2012	N	CENTRAL VEIN CATHETERISATION (via jugular, subclavian or femoral vein) by percutaneous or open exposure, not being a service to which item 13318 applies, when performed in association with the administration of anaesthesia
22020	01JUL2012	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by percutaneous or open exposure, not being a service to which item 13318 applies, when performed in association with the administration of anaesthesia
22025	01NOV2001	31OCT2019	N	INTRAARTERIAL CANNULATION when performed in association with the administration of anaesthesia
22025	01NOV2019	31DEC9999	Y	Intra-arterial cannulation when performed in association with the management of anaesthesia in a patient who:(a) is categorised as having a high risk of complications; or(b) develops a high risk of complications during the procedure
22030	01NOV2001	31DEC9999	Y	INTRODUCTION OF A NARCOTIC, for the control of postoperative pain, into the epidural or intrathecal space in conjunction with an operation
22031	01NOV2005	31OCT2019	N	INTRATHECAL or EPIDURAL INJECTION (initial) of a therapeutic substance or substances, with or without insertion of a catheter, in association with anaesthesia and surgery, for postoperative pain management, not being a service associated with a service to which 22036 applies
22031	01NOV2019	31DEC9999	Y	Intrathecal or epidural injection (initial) of a therapeutic substance or substances, with or without insertion of a catheter, in association with anaesthesia and surgery, for post-operative pain management, not being a service to which 22036 applies
22035	01NOV2001	31DEC9999	Y	INTRODUCTION OF A LOCAL ANAESTHETIC, for control of postoperative pain, into the epidural or intrathecal space, in conjunction with an operation
22036	01NOV2005	31DEC9999	Y	INTRATHECAL or EPIDURAL INJECTION (subsequent) of a therapeutic substance or substances, using an in-situ catheter, in association with anaesthesia and surgery, for postoperative pain management, not being a service associated with a service to which 22031 applies
22040	01NOV2001	31OCT2003	N	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with knee, ankle or foot surgery
22040	01NOV2003	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with hip, knee, ankle or foot surgery
22041	01NOV2019	31DEC9999	Y	Perioperative introduction of a plexus or nerve block proximal to the lower leg or forearm for post operative pain management
22042	01NOV2019	31DEC9999	Y	Introduction of a nerve block performed via a retrobulbar, peribulbar, or sub Tenons approach, or other complex eye block, when administered by an anaesthetist perioperatively
22045	01NOV2001	31OCT2003	N	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with knee, ankle or foot surgery
22045	01NOV2003	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with hip, knee, ankle or foot surgery
22050	01NOV2001	31DEC9999	Y	INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the brachial plexus in conjunction with shoulder surgery
22051	01NOV2008	31DEC9999	Y	INTRA-OPERATIVE TRANSOESOPHAGEAL ECHOCARDIOGRAPHY - Monitoring in real time of the structure and function of the heart chambers, valves and surrounding structures, including assessment of blood flow, with appropriate permanent recording during procedures on the heart, pericardium or great vessels of the chest (not in association with items 55130, 55135 or 21936)
22052	01MAR2024	31DEC9999	Y	Transfusion of blood by an anaesthetist, including collection from donor, when used for intra-operative normovolaemic haemodilution, where the service is provided on the same occasion as the administration of anaesthesia by the same anaesthetist, other than a service associated with a service to which item 13703 applies
22053	01MAR2024	31DEC9999	Y	Insertion of lumbar cerebrospinal fluid drain, by an anaesthetist at the request of the treating specialist, where the service is provided on the same occasion as the administration of anaesthesia by the same anaesthetist, other than a service associated with a service to which item 40018 applies
22054	01MAR2024	31DEC9999	Y	Intraoperative two-dimensional or three-dimensional real time transoesophageal echocardiography by an anaesthetist, where the service: (a) is provided on the same day as a service to which item 38477, 38484, 38499, 38516 or 38517 applies; and (b) includes Doppler techniques with colour flow mapping and recordings on digital media; and (c) is performed during cardiac valve surgery (replacement or repair); and (d) incorporates sequential assessment of cardiac function and valve competence before and after the surgical procedure; and (e) is not associated with a service to which item 21936, 22051, 55118, 55130 or 55135 applies; and (f) is provided on the same occasion as the administration of anaesthesia by the same anaesthetist
22055	01NOV2001	30APR2009	N	PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent
22055	01MAY2009	30JUN2009	N	PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent, not being a service associated with a service to which an item in Subgroup 21 applies
22055	01JUL2009	31DEC9999	Y	PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent, not being a service associated with anaesthesia to which an item in Subgroup 21 applies
22060	01NOV2001	30APR2009	N	WHOLE BODY PERFUSION, CARDIAC BYPASS, using heart-lung machine or equivalent
22060	01MAY2009	31OCT2015	N	WHOLE BODY PERFUSION, CARDIAC BYPASS, using heart-lung machine or equivalent, not being a service associated with anaesthesia to which an item in Subgroup 21 applies
22060	01NOV2015	28FEB2021	N	WHOLE BODY PERFUSION, CARDIAC BYPASS, where the heart-lung machine or equivalent is continuously operated by a medical perfusionist, other than a service associated with anaesthesia to which an item in Subgroup 21 applies. (20 basic units)
22060	01MAR2021	31DEC9999	Y	WHOLE BODY PERFUSION, CARDIAC BYPASS, where the heart-lung machine or equivalent is continuously operated by a medical perfusionist, other than a service associated with anaesthesia to which an item in Subgroup 21 applies
22065	01NOV2001	30APR2009	N	INDUCED CONTROLLED HYPOTHERMIA total body
22065	01MAY2009	30JUN2009	N	INDUCED CONTROLLED HYPOTHERMIA total body, not being a service associated with a service to which an item in Subgroup 21 applies
22065	01JUL2009	31DEC9999	Y	INDUCED CONTROLLED HYPOTHERMIA total body, being a service to which item 22060 applies, not being a service associated with anaesthesia to which an item in Subgroup 21 applies
22070	01NOV2001	30APR2009	N	CARDIOPLEGIA, blood or crystalloid, administration by any route
22070	01MAY2009	30JUN2009	N	CARDIOPLEGIA, blood or crystalloid, administration by any route, not being a service associated with a service to which an item in Subgroup 21 applies
22070	01JUL2009	31DEC9999	Y	CARDIOPLEGIA, blood or crystalloid, administration by any route, being a service to which item 22060 applies, not being a service associated with anaesthesia to which an item in Subgroup 21 applies
22075	01NOV2001	30APR2009	N	DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22°c, including management of retrograde cerebral perfusion if performed
22075	01MAY2009	30JUN2009	N	DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22°c, including management of retrograde cerebral perfusion if performed, not being a service associated with a service to which an item in Subgroup 21 applies
22075	01JUL2009	31DEC9999	Y	DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22°c, including management of retrograde cerebral perfusion if performed, not being a service associated with anaesthesia to which an item in Subgroup 21 applies
22900	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT BY A MEDICAL PRACTITIONER OF ANAESTHESIA for extraction of tooth or teeth with or without incision of soft tissue or removal of bone
22905	01NOV2001	31DEC9999	Y	INITIATION OF MANAGEMENT OF ANAESTHESIA for restorative dental work
23010	01MAY2001	31OCT2001	N	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS)
23010	01NOV2001	30JUN2008	N	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS)
23010	01JUL2008	31DEC9999	Y	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS)
23021	01MAY2001	31OCT2001	N	16 MINUTES TO 20 MINUTES
23021	01NOV2001	31DEC9999	Y	16 MINUTES TO 20 MINUTES
23022	01MAY2001	31OCT2001	N	21 MINUTES TO 25 MINUTES
23022	01NOV2001	31DEC9999	Y	21 MINUTES TO 25 MINUTES
23023	01MAY2001	31OCT2001	N	26 MINUTES TO 30 MINUTES
23023	01NOV2001	31DEC9999	Y	26 MINUTES TO 30 MINUTES
23025	01NOV2019	31DEC9999	Y	16 MINUTES TO 30 MINUTES
23031	01MAY2001	31OCT2001	N	31 MINUTES TO 35 MINUTES
23031	01NOV2001	31DEC9999	Y	31 MINUTES TO 35 MINUTES
23032	01MAY2001	31OCT2001	N	36 MINUTES TO 40 MINUTES
23032	01NOV2001	31DEC9999	Y	36 MINUTES TO 40 MINUTES
23033	01MAY2001	31OCT2001	N	41 MINUTES TO 45 MINUTES
23033	01NOV2001	31DEC9999	Y	41 MINUTES TO 45 MINUTES
23035	01NOV2019	31DEC9999	Y	31 MINUTES to 45 MINUTES
23041	01MAY2001	31OCT2001	N	46 MINUTES TO 50 MINUTES
23041	01NOV2001	31DEC9999	Y	46 MINUTES TO 50 MINUTES
23042	01MAY2001	31OCT2001	N	51 MINUTES TO 55 MINUTES
23042	01NOV2001	31DEC9999	Y	51 MINUTES TO 55 MINUTES
23043	01MAY2001	31OCT2001	N	56 MINUTES TO 1:00 HOUR
23043	01NOV2001	31DEC9999	Y	56 MINUTES TO 1:00 HOUR
23045	01NOV2019	31DEC9999	Y	46 MINUTES to 1:00 HOUR
23051	01MAY2001	31OCT2001	N	1:01 HOURS TO 1:05 HOURS
23051	01NOV2001	31DEC9999	Y	1:01 HOURS TO 1:05 HOURS
23052	01MAY2001	31OCT2001	N	1:06 HOURS TO 1:10 HOURS
23052	01NOV2001	31DEC9999	Y	1:06 HOURS TO 1:10 HOURS
23053	01MAY2001	31OCT2001	N	1:11 HOURS TO 1:15 HOURS
23053	01NOV2001	31DEC9999	Y	1:11 HOURS TO 1:15 HOURS
23055	01NOV2019	31DEC9999	Y	1:01 HOURS to 1:15 HOURS
23061	01MAY2001	31OCT2001	N	1:16 HOURS TO 1:20 HOURS
23061	01NOV2001	31DEC9999	Y	1:16 HOURS TO 1:20 HOURS
23062	01MAY2001	31OCT2001	N	1:21 HOURS TO 1:25 HOURS
23062	01NOV2001	31DEC9999	Y	1:21 HOURS TO 1:25 HOURS
23063	01MAY2001	31OCT2001	N	1:26 HOURS TO 1:30 HOURS
23063	01NOV2001	31DEC9999	Y	1:26 HOURS TO 1:30 HOURS
23065	01NOV2019	31DEC9999	Y	1:16 HOURS to 1:30 HOURS
23071	01MAY2001	31OCT2001	N	1:31 HOURS TO 1:35 HOURS
23071	01NOV2001	31DEC9999	Y	1:31 HOURS TO 1:35 HOURS
23072	01MAY2001	31OCT2001	N	1:36 HOURS TO 1:40 HOURS
23072	01NOV2001	31DEC9999	Y	1:36 HOURS TO 1:40 HOURS
23073	01MAY2001	31OCT2001	N	1:41 HOURS TO 1:45 HOURS
23073	01NOV2001	31DEC9999	Y	1:41 HOURS TO 1:45 HOURS
23075	01NOV2019	31DEC9999	Y	1:31 HOURS to 1:45 HOURS
23081	01MAY2001	31OCT2001	N	1:46 HOURS TO 1:50 HOURS
23081	01NOV2001	31DEC9999	Y	1:46 HOURS TO 1:50 HOURS
23082	01MAY2001	31OCT2001	N	1:51 HOURS TO 1:55 HOURS
23082	01NOV2001	31DEC9999	Y	1:51 HOURS TO 1:55 HOURS
23083	01MAY2001	31OCT2001	N	1:56 HOURS TO 2:00 HOURS
23083	01NOV2001	31DEC9999	Y	1:56 HOURS TO 2:00 HOURS
23085	01NOV2019	31DEC9999	Y	1:46 HOURS to 2:00 HOURS
23090	01MAY2001	31OCT2001	N	2:01 HOURS TO 2:15 HOURS
23090	01NOV2001	31DEC9999	Y	2:01 HOURS TO 2:15 HOURS
23091	01NOV2005	31DEC9999	Y	2:01 HOURS TO 2:10 HOURS
23100	01MAY2001	31OCT2001	N	2:16 HOURS TO 2:30 HOURS
23100	01NOV2001	31DEC9999	Y	2:16 HOURS TO 2:30 HOURS
23101	01NOV2005	31DEC9999	Y	2:11 HOURS TO 2:20 HOURS
23110	01MAY2001	31OCT2001	N	2:31 HOURS TO 2:45 HOURS
23110	01NOV2001	31DEC9999	Y	2:31 HOURS TO 2:45 HOURS
23111	01NOV2005	31DEC9999	Y	2:21 HOURS TO 2:30 HOURS
23112	01NOV2005	31DEC9999	Y	2:31 HOURS TO 2:40 HOURS
23113	01NOV2005	31DEC9999	Y	2:41 HOURS TO 2:50 HOURS
23114	01NOV2005	31DEC9999	Y	2:51 HOURS TO 3:00 HOURS
23115	01NOV2005	31DEC9999	Y	3:01 HOURS TO 3:10 HOURS
23116	01NOV2005	31DEC9999	Y	3:11 HOURS TO 3:20 HOURS
23117	01NOV2005	31DEC9999	Y	3:21 HOURS TO 3:30 HOURS
23118	01NOV2005	31DEC9999	Y	3:31 HOURS TO 3:40 HOURS
23119	01NOV2005	31DEC9999	Y	3:41 HOURS TO 3:50 HOURS
23120	01MAY2001	31OCT2001	N	2:46 HOURS TO 3:00 HOURS
23120	01NOV2001	31DEC9999	Y	2:46 HOURS TO 3:00 HOURS
23121	01NOV2005	31DEC9999	Y	3:51 HOURS TO 4:00 HOURS
23130	01MAY2001	31OCT2001	N	3:01 HOURS TO 3:15 HOURS
23130	01NOV2001	31DEC9999	Y	3:01 HOURS TO 3:15 HOURS
23140	01MAY2001	31OCT2001	N	3:16 HOURS TO 3:30 HOURS
23140	01NOV2001	31DEC9999	Y	3:16 HOURS TO 3:30 HOURS
23150	01MAY2001	31OCT2001	N	3:31 HOURS TO 3:45 HOURS
23150	01NOV2001	31DEC9999	Y	3:31 HOURS TO 3:45 HOURS
23160	01MAY2001	31OCT2001	N	3:46 HOURS TO 4:00 HOURS
23160	01NOV2001	31DEC9999	Y	3:46 HOURS TO 4:00 HOURS
23170	01MAY2001	31OCT2001	N	4:01 HOURS TO 4:10 HOURS
23170	01NOV2001	31DEC9999	Y	4:01 HOURS TO 4:10 HOURS
23180	01MAY2001	31OCT2001	N	4:11 HOURS TO 4:20 HOURS
23180	01NOV2001	31DEC9999	Y	4:11 HOURS TO 4:20 HOURS
23190	01MAY2001	31OCT2001	N	4:21 HOURS TO 4:30 HOURS
23190	01NOV2001	31DEC9999	Y	4:21 HOURS TO 4:30 HOURS
23200	01MAY2001	31OCT2001	N	4:31 HOURS TO 4:40 HOURS
23200	01NOV2001	31DEC9999	Y	4:31 HOURS TO 4:40 HOURS
23210	01MAY2001	31OCT2001	N	4:41 HOURS TO 4:50 HOURS
23210	01NOV2001	31DEC9999	Y	4:41 HOURS TO 4:50 HOURS
23220	01MAY2001	31OCT2001	N	4:51 HOURS TO 5:00 HOURS
23220	01NOV2001	31DEC9999	Y	4:51 HOURS TO 5:00 HOURS
23230	01MAY2001	31OCT2001	N	5:01 HOURS TO 5:10 HOURS
23230	01NOV2001	31DEC9999	Y	5:01 HOURS TO 5:10 HOURS
23240	01MAY2001	31OCT2001	N	5:11 HOURS TO 5:20 HOURS
23240	01NOV2001	31DEC9999	Y	5:11 HOURS TO 5:20 HOURS
23250	01MAY2001	31OCT2001	N	5:21 HOURS TO 5:30 HOURS
23250	01NOV2001	31DEC9999	Y	5:21 HOURS TO 5:30 HOURS
23260	01MAY2001	31OCT2001	N	5:31 HOURS TO 5:40 HOURS
23260	01NOV2001	31DEC9999	Y	5:31 HOURS TO 5:40 HOURS
23270	01MAY2001	31OCT2001	N	5:41 HOURS TO 5:50 HOURS
23270	01NOV2001	31DEC9999	Y	5:41 HOURS TO 5:50 HOURS
23280	01MAY2001	31OCT2001	N	(5:51 HOURS TO 6:00 HOURS
23280	01NOV2001	31DEC9999	Y	(5:51 HOURS TO 6:00 HOURS
23290	01MAY2001	31OCT2001	N	6:01 HOURS TO 6:10 HOURS
23290	01NOV2001	31DEC9999	Y	6:01 HOURS TO 6:10 HOURS
23300	01MAY2001	31OCT2001	N	6:11 HOURS TO 6:20 HOURS
23300	01NOV2001	31DEC9999	Y	6:11 HOURS TO 6:20 HOURS
23310	01MAY2001	31OCT2001	N	6:21 HOURS TO 6:30 HOURS
23310	01NOV2001	31DEC9999	Y	6:21 HOURS TO 6:30 HOURS
23320	01MAY2001	31OCT2001	N	6:31 HOURS TO 6:40 HOURS
23320	01NOV2001	31DEC9999	Y	6:31 HOURS TO 6:40 HOURS
23330	01MAY2001	31OCT2001	N	6:41 HOURS TO 6:50 HOURS
23330	01NOV2001	31DEC9999	Y	6:41 HOURS TO 6:50 HOURS
23340	01MAY2001	31OCT2001	N	6:51 HOURS TO 7:00 HOURS
23340	01NOV2001	31DEC9999	Y	6:51 HOURS TO 7:00 HOURS
23350	01MAY2001	31OCT2001	N	7:01 HOURS TO 7:10 HOURS
23350	01NOV2001	31DEC9999	Y	7:01 HOURS TO 7:10 HOURS
23360	01MAY2001	31OCT2001	N	7:11 HOURS TO 7:20 HOURS
23360	01NOV2001	31DEC9999	Y	7:11 HOURS TO 7:20 HOURS
23370	01MAY2001	31OCT2001	N	7:21 HOURS TO 7:30 HOURS
23370	01NOV2001	31DEC9999	Y	7:21 HOURS TO 7:30 HOURS
23380	01MAY2001	31OCT2001	N	7:31 HOURS TO 7:40 HOURS
23380	01NOV2001	31DEC9999	Y	7:31 HOURS TO 7:40 HOURS
23390	01MAY2001	31OCT2001	N	7:41 HOURS TO 7:50 HOURS
23390	01NOV2001	31DEC9999	Y	7:41 HOURS TO 7:50 HOURS
23400	01MAY2001	31OCT2001	N	7:51 HOURS TO 8:00 HOURS
23400	01NOV2001	31DEC9999	Y	7:51 HOURS TO 8:00 HOURS
23410	01MAY2001	31OCT2001	N	8:01 HOURS TO 8:10 HOURS
23410	01NOV2001	31DEC9999	Y	8:01 HOURS TO 8:10 HOURS
23420	01MAY2001	31OCT2001	N	8:11 HOURS TO 8:20 HOURS
23420	01NOV2001	31DEC9999	Y	8:11 HOURS TO 8:20 HOURS
23430	01MAY2001	31OCT2001	N	8:21 HOURS TO 8:30 HOURS
23430	01NOV2001	31DEC9999	Y	8:21 HOURS TO 8:30 HOURS
23440	01MAY2001	31OCT2001	N	8:31 HOURS TO 8:40 HOURS
23440	01NOV2001	31DEC9999	Y	8:31 HOURS TO 8:40 HOURS
23450	26JAN2001	31OCT2001	N	8:41 HOURS TO 8:50 HOURS
23450	01NOV2001	31DEC9999	Y	8:41 HOURS TO 8:50 HOURS
23460	01MAY2001	31OCT2001	N	8:51 HOURS TO 9:00 HOURS
23460	01NOV2001	31DEC9999	Y	8:51 HOURS TO 9:00 HOURS
23470	01MAY2001	31OCT2001	N	9:01 HOURS TO 9:10 HOURS
23470	01NOV2001	31DEC9999	Y	9:01 HOURS TO 9:10 HOURS
23480	01MAY2001	31OCT2001	N	9:11 HOURS TO 9:20 HOURS
23480	01NOV2001	31DEC9999	Y	9:11 HOURS TO 9:20 HOURS
23490	01MAY2001	31OCT2001	N	9:21 HOURS TO 9:30 HOURS
23490	01NOV2001	31DEC9999	Y	9:21 HOURS TO 9:30 HOURS
23500	01MAY2001	31OCT2001	N	9:31 HOURS TO 9:40 HOURS
23500	01NOV2001	31DEC9999	Y	9:31 HOURS TO 9:40 HOURS
23510	01MAY2001	31OCT2001	N	9:41 HOURS TO 9:50 HOURS
23510	01NOV2001	31DEC9999	Y	9:41 HOURS TO 9:50 HOURS
23520	01MAY2001	31OCT2001	N	9:51 HOURS TO 10:00 HOURS
23520	01NOV2001	31DEC9999	Y	9:51 HOURS TO 10:00 HOURS
23530	01MAY2001	31OCT2001	N	10:01 HOURS TO 10:10 HOURS
23530	01NOV2001	31DEC9999	Y	10:01 HOURS TO 10:10 HOURS
23540	01MAY2001	31OCT2001	N	10:11 HOURS TO 10:20 HOURS
23540	01NOV2001	31DEC9999	Y	10:11 HOURS TO 10:20 HOURS
23550	01JAN2001	31OCT2001	N	10:21 HOURS TO 10:30 HOURS
23550	01NOV2001	31DEC9999	Y	10:21 HOURS TO 10:30 HOURS
23560	01MAY2001	31OCT2001	N	10:31 HOURS TO 10:40 HOURS
23560	01NOV2001	31DEC9999	Y	10:31 HOURS TO 10:40 HOURS
23570	01MAY2001	31OCT2001	N	10:41 HOURS TO 10:50 HOURS
23570	01NOV2001	31DEC9999	Y	10:41 HOURS TO 10:50 HOURS
23580	01JAN2001	31OCT2001	N	10:51 HOURS TO 11:00 HOURS
23580	01NOV2001	31DEC9999	Y	10:51 HOURS TO 11:00 HOURS
23590	01JAN2001	31OCT2001	N	11:01 HOURS TO 11:10 HOURS
23590	01NOV2001	31DEC9999	Y	11:01 HOURS TO 11:10 HOURS
23600	01MAY2001	31OCT2001	N	11:11 HOURS TO 11:20 HOURS
23600	01NOV2001	31DEC9999	Y	11:11 HOURS TO 11:20 HOURS
23610	01MAY2001	31OCT2001	N	11:21 HOURS TO 11:30 HOURS
23610	01NOV2001	31DEC9999	Y	11:21 HOURS TO 11:30 HOURS
23620	01MAY2001	31OCT2001	N	11:31 HOURS TO 11:40 HOURS
23620	01NOV2001	31DEC9999	Y	11:31 HOURS TO 11:40 HOURS
23630	01MAY2001	31OCT2001	N	11:41 HOURS TO 11:50 HOURS
23630	01NOV2001	31DEC9999	Y	11:41 HOURS TO 11:50 HOURS
23640	01MAY2001	31OCT2001	N	11:51 HOURS TO 12:00 HOURS
23640	01NOV2001	31DEC9999	Y	11:51 HOURS TO 12:00 HOURS
23650	01MAY2001	31OCT2001	N	12:01 HOURS TO 12:10 HOURS
23650	01NOV2001	31DEC9999	Y	12:01 HOURS TO 12:10 HOURS
23660	01MAY2001	31OCT2001	N	12:11 HOURS TO 12:20 HOURS
23660	01NOV2001	31DEC9999	Y	12:11 HOURS TO 12:20 HOURS
23670	01MAY2001	31OCT2001	N	12:21 HOURS TO 12:30 HOURS
23670	01NOV2001	31DEC9999	Y	12:21 HOURS TO 12:30 HOURS
23680	01MAY2001	31OCT2001	N	12:31 HOURS TO 12:40 HOURS
23680	01NOV2001	31DEC9999	Y	12:31 HOURS TO 12:40 HOURS
23690	01MAY2001	31OCT2001	N	12:41 HOURS TO 12:50 HOURS
23690	01NOV2001	31DEC9999	Y	12:41 HOURS TO 12:50 HOURS
23700	01MAY2001	31OCT2001	N	12:51 HOURS TO 13:00 HOURS
23700	01NOV2001	31DEC9999	Y	12:51 HOURS TO 13:00 HOURS
23710	01MAY2001	31OCT2001	N	13:01 HOURS TO 13:10 HOURS
23710	01NOV2001	31DEC9999	Y	13:01 HOURS TO 13:10 HOURS
23720	01MAY2001	31OCT2001	N	13:11 HOURS TO 13:20 HOURS
23720	01NOV2001	31DEC9999	Y	13:11 HOURS TO 13:20 HOURS
23730	01MAY2001	31OCT2001	N	13:21 HOURS TO 13:30 HOURS
23730	01NOV2001	31DEC9999	Y	13:21 HOURS TO 13:30 HOURS
23740	01MAY2001	31OCT2001	N	13:31 HOURS TO 13:40 HOURS
23740	01NOV2001	31DEC9999	Y	13:31 HOURS TO 13:40 HOURS
23750	01MAY2001	31OCT2001	N	13:41 HOURS TO 13:50 HOURS
23750	01NOV2001	31DEC9999	Y	13:41 HOURS TO 13:50 HOURS
23760	01MAY2001	31OCT2001	N	13:51 HOURS TO 14:00 HOURS
23760	01NOV2001	31DEC9999	Y	13:51 HOURS TO 14:00 HOURS
23770	01MAY2001	31OCT2001	N	14:01 HOURS TO 14:10 HOURS
23770	01NOV2001	31DEC9999	Y	14:01 HOURS TO 14:10 HOURS
23780	01MAY2001	31OCT2001	N	14:11 HOURS TO 14:20 HOURS
23780	01NOV2001	31DEC9999	Y	14:11 HOURS TO 14:20 HOURS
23790	01MAY2001	31OCT2001	N	14:21 HOURS TO 14:30 HOURS
23790	01NOV2001	31DEC9999	Y	14:21 HOURS TO 14:30 HOURS
23800	01MAY2001	31OCT2001	N	14:31 HOURS TO 14:40 HOURS
23800	01NOV2001	31DEC9999	Y	14:31 HOURS TO 14:40 HOURS
23810	01MAY2001	31OCT2001	N	14:41 HOURS TO 14:50 HOURS
23810	01NOV2001	31DEC9999	Y	14:41 HOURS TO 14:50 HOURS
23820	01MAY2001	31OCT2001	N	14:51 HOURS TO 15:00 HOURS
23820	01NOV2001	31DEC9999	Y	14:51 HOURS TO 15:00 HOURS
23830	01MAY2001	31OCT2001	N	15:01 HOURS TO 15:10 HOURS
23830	01NOV2001	31DEC9999	Y	15:01 HOURS TO 15:10 HOURS
23840	01MAY2001	31OCT2001	N	15:11 HOURS TO 15:20 HOURS
23840	01NOV2001	31DEC9999	Y	15:11 HOURS TO 15:20 HOURS
23850	01MAY2001	31OCT2001	N	15:21 HOURS TO 15:30 HOURS
23850	01NOV2001	31DEC9999	Y	15:21 HOURS TO 15:30 HOURS
23860	01MAY2001	31OCT2001	N	15:31 HOURS TO 15:40 HOURS
23860	01NOV2001	31DEC9999	Y	15:31 HOURS TO 15:40 HOURS
23870	01MAY2001	31OCT2001	N	15:41 HOURS TO 15:50 HOURS
23870	01NOV2001	31DEC9999	Y	15:41 HOURS TO 15:50 HOURS
23880	01MAY2001	31OCT2001	N	15:51 HOURS TO 16:00 HOURS
23880	01NOV2001	31DEC9999	Y	15:51 HOURS TO 16:00 HOURS
23890	01MAY2001	31OCT2001	N	16:01 HOURS TO 16:10 HOURS
23890	01NOV2001	31DEC9999	Y	16:01 HOURS TO 16:10 HOURS
23900	01MAY2001	31OCT2001	N	16:11 HOURS TO 16:20 HOURS
23900	01NOV2001	31DEC9999	Y	16:11 HOURS TO 16:20 HOURS
23910	01MAY2001	31OCT2001	N	16:21 HOURS TO 16:30 HOURS
23910	01NOV2001	31DEC9999	Y	16:21 HOURS TO 16:30 HOURS
23920	01MAY2001	31OCT2001	N	16:31 HOURS TO 16:40 HOURS
23920	01NOV2001	31DEC9999	Y	16:31 HOURS TO 16:40 HOURS
23930	01MAY2001	31OCT2001	N	16:41 HOURS TO 16:50 HOURS
23930	01NOV2001	31DEC9999	Y	16:41 HOURS TO 16:50 HOURS
23940	01MAY2001	31OCT2001	N	16:51 HOURS TO 17:00 HOURS
23940	01NOV2001	31DEC9999	Y	16:51 HOURS TO 17:00 HOURS
23950	01MAY2001	31OCT2001	N	17:01 HOURS TO 17:10 HOURS
23950	01NOV2001	31DEC9999	Y	17:01 HOURS TO 17:10 HOURS
23960	01MAY2001	31OCT2001	N	17:11 HOURS TO 17:20 HOURS
23960	01NOV2001	31DEC9999	Y	17:11 HOURS TO 17:20 HOURS
23970	01MAY2001	31OCT2001	N	17:21 HOURS TO 17:30 HOURS
23970	01NOV2001	31DEC9999	Y	17:21 HOURS TO 17:30 HOURS
23980	01MAY2001	31OCT2001	N	17:31 HOURS TO 17:40 HOURS
23980	01NOV2001	31DEC9999	Y	17:31 HOURS TO 17:40 HOURS
23990	01MAY2001	31OCT2001	N	17:41 HOURS TO 17:50 HOURS
23990	01NOV2001	31DEC9999	Y	17:41 HOURS TO 17:50 HOURS
24100	01MAY2001	31OCT2001	N	17:51 HOURS TO 18:00 HOURS
24100	01NOV2001	31DEC9999	Y	17:51 HOURS TO 18:00 HOURS
24101	01MAY2001	31OCT2001	N	18:01 HOURS TO 18:10 HOURS
24101	01NOV2001	31DEC9999	Y	18:01 HOURS TO 18:10 HOURS
24102	01MAY2001	31OCT2001	N	18:11 HOURS TO 18:20 HOURS
24102	01NOV2001	31DEC9999	Y	18:11 HOURS TO 18:20 HOURS
24103	01MAY2001	31OCT2001	N	18:21 HOURS TO 18:30 HOURS
24103	01NOV2001	31DEC9999	Y	18:21 HOURS TO 18:30 HOURS
24104	01MAY2001	31OCT2001	N	18:31 HOURS TO 18:40 HOURS
24104	01NOV2001	31DEC9999	Y	18:31 HOURS TO 18:40 HOURS
24105	01MAY2001	31OCT2001	N	18:41 HOURS TO 18:50 HOURS
24105	01NOV2001	31DEC9999	Y	18:41 HOURS TO 18:50 HOURS
24106	01MAY2001	31OCT2001	N	18:51 HOURS TO 19:00 HOURS
24106	01NOV2001	31DEC9999	Y	18:51 HOURS TO 19:00 HOURS
24107	01MAY2001	31OCT2001	N	19:01 HOURS TO 19:10 HOURS
24107	01NOV2001	31DEC9999	Y	19:01 HOURS TO 19:10 HOURS
24108	01MAY2001	31OCT2001	N	19:11 HOURS TO 19:20 HOURS
24108	01NOV2001	31DEC9999	Y	19:11 HOURS TO 19:20 HOURS
24109	01MAY2001	31OCT2001	N	19:21 HOURS TO 19:30 HOURS
24109	01NOV2001	31DEC9999	Y	19:21 HOURS TO 19:30 HOURS
24110	01MAY2001	31OCT2001	N	19:31 HOURS TO 19:40 HOURS
24110	01NOV2001	31DEC9999	Y	19:31 HOURS TO 19:40 HOURS
24111	01MAY2001	31OCT2001	N	19:41 HOURS TO 19:50 HOURS
24111	01NOV2001	31DEC9999	Y	19:41 HOURS TO 19:50 HOURS
24112	01MAY2001	31OCT2001	N	19:51 HOURS TO 20:00 HOURS
24112	01NOV2001	31DEC9999	Y	19:51 HOURS TO 20:00 HOURS
24113	01MAY2001	31OCT2001	N	20:01 HOURS TO 20:10 HOURS
24113	01NOV2001	31DEC9999	Y	20:01 HOURS TO 20:10 HOURS
24114	01MAY2001	31OCT2001	N	20:11 HOURS TO 20:20 HOURS
24114	01NOV2001	31DEC9999	Y	20:11 HOURS TO 20:20 HOURS
24115	01MAY2001	31OCT2001	N	20:21 HOURS TO 20:30 HOURS
24115	01NOV2001	31DEC9999	Y	20:21 HOURS TO 20:30 HOURS
24116	01MAY2001	31OCT2001	N	20:31 HOURS TO 20:40 HOURS
24116	01NOV2001	31DEC9999	Y	20:31 HOURS TO 20:40 HOURS
24117	01MAY2001	31OCT2001	N	20:41 HOURS TO 20:50 HOURS
24117	01NOV2001	31DEC9999	Y	20:41 HOURS TO 20:50 HOURS
24118	01MAY2001	31OCT2001	N	20:51 HOURS TO 21:00 HOURS
24118	01NOV2001	31DEC9999	Y	20:51 HOURS TO 21:00 HOURS
24119	01MAY2001	31OCT2001	N	21:01 HOURS TO 21:10 HOURS
24119	01NOV2001	31DEC9999	Y	21:01 HOURS TO 21:10 HOURS
24120	01MAY2001	31OCT2001	N	21:11 HOURS TO 21:20 HOURS
24120	01NOV2001	31DEC9999	Y	21:11 HOURS TO 21:20 HOURS
24121	01MAY2001	31OCT2001	N	21:21 HOURS TO 21:30 HOURS
24121	01NOV2001	31DEC9999	Y	21:21 HOURS TO 21:30 HOURS
24122	01MAY2001	31OCT2001	N	21:31 HOURS TO 21:40 HOURS
24122	01NOV2001	31DEC9999	Y	21:31 HOURS TO 21:40 HOURS
24123	01MAY2001	31OCT2001	N	21:41 HOURS TO 21:50 HOURS
24123	01NOV2001	31DEC9999	Y	21:41 HOURS TO 21:50 HOURS
24124	01MAY2001	31OCT2001	N	21:51 HOURS TO 22:00 HOURS
24124	01NOV2001	31DEC9999	Y	21:51 HOURS TO 22:00 HOURS
24125	01MAY2001	31OCT2001	N	22:01 HOURS TO 22:10 HOURS
24125	01NOV2001	31DEC9999	Y	22:01 HOURS TO 22:10 HOURS
24126	01MAY2001	31OCT2001	N	22:11 HOURS TO 22:20 HOURS
24126	01NOV2001	31DEC9999	Y	22:11 HOURS TO 22:20 HOURS
24127	01MAY2001	31OCT2001	N	22:21 HOURS TO 22:30 HOURS
24127	01NOV2001	31DEC9999	Y	22:21 HOURS TO 22:30 HOURS
24128	01MAY2001	31OCT2001	N	22:31 HOURS TO 22:40 HOURS
24128	01NOV2001	31DEC9999	Y	22:31 HOURS TO 22:40 HOURS
24129	01MAY2001	31OCT2001	N	22:41 HOURS TO 22:50 HOURS
24129	01NOV2001	31DEC9999	Y	22:41 HOURS TO 22:50 HOURS
24130	01MAY2001	31OCT2001	N	22:51 HOURS TO 23:00 HOURS
24130	01NOV2001	31DEC9999	Y	22:51 HOURS TO 23:00 HOURS
24131	01MAY2001	31OCT2001	N	23:01 HOURS TO 23:10 HOURS
24131	01NOV2001	31DEC9999	Y	23:01 HOURS TO 23:10 HOURS
24132	01MAY2001	31OCT2001	N	23:11 HOURS TO 23:20 HOURS
24132	01NOV2001	31DEC9999	Y	23:11 HOURS TO 23:20 HOURS
24133	01MAY2001	31OCT2001	N	23:21 HOURS TO 23:30 HOURS
24133	01NOV2001	31DEC9999	Y	23:21 HOURS TO 23:30 HOURS
24134	01MAY2001	31OCT2001	N	23:31 HOURS TO 23:40 HOURS
24134	01NOV2001	31DEC9999	Y	23:31 HOURS TO 23:40 HOURS
24135	01MAY2001	31OCT2001	N	23:41 HOURS TO 23:50 HOURS
24135	01NOV2001	31DEC9999	Y	23:41 HOURS TO 23:50 HOURS
24136	01MAY2001	31OCT2001	N	23:51 HOURS TO 24:00 HOURS
24136	01NOV2001	31DEC9999	Y	23:51 HOURS TO 24:00 HOURS
25000	01NOV2001	31DEC9999	Y	ANAESTHESIA, PERFUSION or ASSISTANCE AT ANAESTHESIA (a) for anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) for perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 Where the patient has severe systemic disease equivalent to ASA physical status indicator 3
25005	01NOV2001	31DEC9999	Y	Where the patient has severe systemic disease which is a constant threat to life equivalent to ASA physical status indicator 4
25010	01MAY2001	31OCT2001	N	For a patient who is not expected to survive for 24 hours with or without the operation, equivalent to ASA physical status indicator 5
25010	01NOV2001	31DEC9999	Y	For a patient who is not expected to survive for 24 hours with or without the operation, equivalent to ASA physical status indicator 5
25012	01NOV2019	31DEC9999	Y	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is over 3 years of age but under 4 years of age
25013	01MAY2020	31DEC9999	Y	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged under 4 years
25014	01MAY2020	31DEC9999	Y	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged 75 years or more
25015	01NOV2001	30APR2002	N	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient's age is one year or less or 70 years or greater
25015	01MAY2002	31OCT2019	N	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient is less than 12 months of age or 70 years or greater
25015	01NOV2019	31DEC9999	Y	Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged not more than 3 years or at least 75 years
25020	01NOV2001	31DEC9999	Y	ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient requires immediate treatment without which there would be significant threat to life or body part - not being a service associated with a service to which item 25025 or 25030 or 25050 applies
25025	01MAY2001	31OCT2001	N	EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies Derived Fee: An additional amount of 50% of the fee for the anaesthetic service. That is: (a) an anaesthesia item/s in the range 20100 - 21997 or 22900, plus (b) an item in the range 23010 - 24136, plus (c) where applicable, an item in the range 25000-25015, plus (d) where performed, any associated therapeutic or diagnostic service/s in the range 22001-22050
25025	01NOV2001	31OCT2007	N	EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies Derived Fee: An additional amount of 50% of the fee for the anaesthetic service. That is: (a) an anaesthesia item/s in the range 20100 - 21997 or 22900, plus (b) an item in the range 23010 - 24136, plus (c) where applicable, an item in the range 25000-25015, plus (d) where performed, any associated therapeutic or diagnostic service/s in the range 22001-22050
25025	01NOV2007	30JUN2020	N	EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies
25025	01JUL2020	31DEC9999	Y	Anaesthesia, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday
25030	01MAY2001	31OCT2001	N	ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies
25030	01NOV2001	31OCT2007	N	ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies
25030	01NOV2007	30JUN2020	N	ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies
25030	01JUL2020	31DEC9999	Y	Assistance in the management of anaesthesia, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday
25050	01NOV2001	31OCT2007	N	AFTER HOURS EMERGENCY PERFUSION where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the perfusion service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25030 applies
25050	01NOV2007	30JUN2020	N	AFTER HOURS EMERGENCY PERFUSION where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the perfusion service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25030 applies
25050	01JUL2020	31DEC9999	Y	Perfusion, if the patient requires immediate treatment without which there would be significant threat to life or body part and if more than 50% of the service time occurs between 8 pm to 8 am on any weekday, or on a Saturday, Sunday or public holiday.
25200	01NOV2001	31OCT2023	N	ASSISTANCE IN THE ADMINISTRATION OF ANAESTHESIA on a patient in imminent danger of death requiring continuous life saving emergency treatment, to the exclusion of all other patients
25200	01NOV2023	31DEC9999	Y	Assistance in the management of anaesthesia requiring continuous anaesthesia on a patient in imminent danger of death requiring continuous life saving emergency treatment, to the exclusion of attendance on all other patients
25205	01NOV2001	31OCT2023	N	ASSISTANCE IN THE ADMINISTRATION OF ELECTIVE ANAESTHESIA where: (i) the patient has complex airway problems; or (ii) the patient is a neonate or a complex paediatric case; or (iii) there is anticipated to be massive blood loss (greater than 50% of blood volume) during the procedure; or (iv) the patient is critically ill, with multiple organ failure; or (v) where the anaesthesia time exceeds 6 hours and the assistance is provided to the exclusion of all other patients
25205	01NOV2023	31DEC9999	Y	Assistance in the management of elective anaesthesia, if: (a) the patient has complex airway problems; or (b) the patient is a neonate; or (c) the patient is a paediatric patient and is receiving one or more of the following services: (i) invasive monitoring, either intravascular or transoesophageal; (ii) organ transplantation; (iii) craniofacial surgery; (iv) major tumour resection; (v) separation of conjoint twins; or (d) there is anticipated to be massive blood loss (greater than 50% of blood volume) during the procedure; or (e) the patient is critically ill, with multiple organ failure; or (f) the service time of the management of anaesthesia exceeds 6 hours and the assistance is provided to the exclusion of attendance on all other patients
30000	01DEC1991	31DEC9999	Y	Operative procedure on tissue, organ or region not being a service to which another item in this Group applies, including any consultation on the same occasion
30001	01NOV1997	31DEC9999	Y	OPERATIVE PROCEDURE, not being a service to which any other item in this Group applies, being a service to which an item in this Group would have applied had the procedure not been discontinued on medical grounds
30003	01DEC1991	31OCT1995	N	DRESSING OF LOCALISED BURNS (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30003	01NOV1995	30JUN2023	N	LOCALISED BURNS, dressing of, (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30003	01JUL2023	31DEC9999	Y	Burns, involving 1% or more but less than 3% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present-each attendance at which the procedure is performedNot applicable for skin reactions secondary to radiotherapy
30006	01DEC1991	31OCT1995	N	DRESSING OF BURNS, EXTENSIVE, without anaesthesia (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30006	01NOV1995	30JUN2023	N	EXTENSIVE BURNS, dressing of, without anaesthesia (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30006	01JUL2023	31DEC9999	Y	Burns, involving 3% or more but less than 10% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present-each attendance at which the procedure is performedNot applicable for skin reactions secondary to radiotherapy
30007	01JUL2023	31DEC9999	Y	Burns, involving 10% or more of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, if medical practitioner is present-each attendance at which the procedure is performedNot applicable for skin reactions secondary to radiotherapy
30009	01DEC1991	31OCT1995	N	DRESSING OF LOCALISED BURNS UNDER GENERAL ANAESTHESIA (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30009	01NOV1995	31DEC9999	Y	LOCALISED BURNS, dressing of, under general anaesthesia (not involving grafting)
30010	01DEC1991	31OCT1995	N	DRESSING OF LOCALISED BURNS UNDER GENERAL ANAESTHESIA (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30010	01NOV1995	30JUN2023	N	LOCALISED BURNS, dressing of, under general anaesthesia (not involving grafting)
30010	01JUL2023	31DEC9999	Y	Burns, involving not more than 3% of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H)
30013	01DEC1991	31OCT1995	N	DRESSING OF BURNS, EXTENSIVE, UNDER GENERAL ANAESTHESIA (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30013	01NOV1995	31DEC9999	Y	EXTENSIVE BURNS, dressing of, under general anaesthesia (not involving grafting)
30014	01DEC1991	31OCT1995	N	DRESSING OF BURNS, EXTENSIVE, UNDER GENERAL ANAESTHESIA (not involving grafting) each attendance at which the procedure is performed, including any associated consultation
30014	01NOV1995	30JUN2023	N	EXTENSIVE BURNS, dressing of, under general anaesthesia (not involving grafting)
30014	01JUL2023	31DEC9999	Y	Burns, involving 3% or more but less than 20% of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H)
30015	01JUL2023	31DEC9999	Y	Burns, involving 20% or more but less than 50% of total body surface, or burns of less than 20% of total body surface involving 1% or more of total body surface within the hands or face, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H)
30016	01JUL2023	31DEC9999	Y	Burns, involving 50% or more of total body surface, dressing of (including redressing of any related donor site, if required), in an operating theatre under general anaesthesia or intravenous sedation, if medical practitioner is present (H)
30017	01DEC1991	31OCT1995	N	EXCISION, under general anaesthesia, OF BURNS involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation
30017	01NOV1995	31DEC9999	Y	BURNS, excision of, under general anaesthesia, involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation
30020	01DEC1991	31OCT1995	N	EXCISION, under general anaesthesia, OF BURNS involving more than 10 per cent of body surface, where grafting is not carried out during the same operation
30020	01NOV1995	31DEC9999	Y	BURNS, excision of, under general anaesthesia, involving more than 10 per cent of body surface, where grafting is not carried out during the same operation
30023	01DEC1991	31OCT1995	N	DEBRIDEMENT, under general anaesthesia or major regional or field block, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed
30023	01NOV1995	31OCT2005	N	WOUND OF SOFT TISSUE, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed
30023	01NOV2005	31DEC9999	Y	WOUND OF SOFT TISSUE, traumatic, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed
30024	01NOV2005	31DEC9999	Y	WOUND OF SOFT TISSUE, debridement of extensively infected post-surgical incision or Fournier's Gangrene, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed
30026	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), superficial, not being a service to which another item in Group T4 applies
30026	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 CM LONG), superficial, not being a service to which another item in Group T4 applies
30029	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30029	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30032	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), superficial
30032	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM LONG), superficial
30035	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), involving deeper tissue
30035	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue
30038	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), superficial, not being a service to which another item in Group T4 applies
30038	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, not on face or neck, large (MORE THAN 7 CM LONG), superficial, not being a service to which another item in Group T4 applies
30041	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30041	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, not on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30042	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30042	01JUL1998	31OCT2017	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, other than on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies
30042	01NOV2017	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, other than on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, other than a service to which another item in Group T4 applies
30045	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), superficial
30045	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), superficial
30048	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue
30048	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue
30049	01DEC1991	30JUN1998	N	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue
30049	01JUL1998	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue
30052	01DEC1991	31OCT1995	N	REPAIR OF FULL THICKNESS LACERATION OF EAR, EYELID OR NOSE with accurate apposition of each layer of tissue
30052	01NOV1995	31DEC9999	Y	FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with accurate apposition of each layer of tissue
30055	01DEC1991	31OCT1995	N	DRESSING AND REMOVAL OF SUTURES requiring a general anaesthetic, not being a service associated with a service to which another item in this Group applies
30055	01NOV1995	30JUN2021	N	WOUNDS, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in this Group applies
30055	01JUL2021	31DEC9999	Y	Wounds, dressing of, under general, regional or intravenous sedation, with or without removal of sutures, other than a service associated with a service to which another item in this Group applies
30058	01DEC1991	31OCT1995	N	CONTROL OF POSTOPERATIVE HAEMORRHAGE, under general anaesthesia following perineal or vaginal operations
30058	01NOV1995	31DEC9999	Y	POSTOPERATIVE HAEMORRHAGE, control of, under general anaesthesia, as an independent procedure
30061	01DEC1991	31DEC9999	Y	SUPERFICIAL FOREIGN BODY, REMOVAL OF, (including from cornea or sclera), as an independent procedure
30062	01MAY2007	31DEC9999	Y	Etonogestrel subcutaneous implant, removal of, as an independent procedure
30064	01DEC1991	31OCT1995	N	SUBCUTANEOUS FOREIGN BODY, REMOVAL OF, requiring incision and suture, as an independent procedure
30064	01NOV1995	31DEC9999	Y	SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and exploration, including closure of wound if performed, as an independent procedure
30067	01DEC1991	31DEC9999	Y	FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure
30068	01DEC1991	31DEC9999	Y	FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure
30071	01DEC1991	31OCT2003	N	BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure
30071	01NOV2003	31OCT2016	N	DIAGNOSTIC BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure, where the biopsy specimen is sent for pathological examination
30071	01NOV2016	31DEC9999	Y	Diagnostic biopsy of skin, as an independent procedure, if the biopsy specimen is sent for pathological examination
30072	01NOV2016	31DEC9999	Y	Diagnostic biopsy of mucous membrane, as an independent procedure, if the biopsy specimen is sent for pathological examination
30074	01DEC1991	31OCT2003	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure
30074	01NOV2003	31DEC9999	Y	DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination
30075	01DEC1991	31OCT2003	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure
30075	01NOV2003	31OCT2017	N	DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination
30075	01NOV2017	31OCT2019	N	DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, if the biopsy specimen is sent for pathological examination
30075	01NOV2019	31DEC9999	Y	DIAGNOSTIC BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, if the biopsy specimen is sent for pathological examination
30078	01DEC1991	31OCT2003	N	DRILL BIOPSY OF LYMPH GLAND, DEEP TISSUE OR ORGAN, as an independent procedure
30078	01NOV2003	31OCT2019	N	DIAGNOSTIC DRILL BIOPSY OF LYMPH GLAND, DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination
30078	01NOV2019	31DEC9999	Y	DIAGNOSTIC DRILL BIOPSY OF LYMPH NODE, DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination
30081	01DEC1991	31OCT2003	N	BIOPSY OF BONE MARROW by trephine using open approach
30081	01NOV2003	31DEC9999	Y	DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using open approach, where the biopsy specimen is sent for pathological examination
30084	01DEC1991	31OCT2003	N	BIOPSY OF BONE MARROW by trephine using percutaneous approach with a Jamshidi needle or similar device
30084	01NOV2003	31DEC2013	N	DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using percutaneous approach with a Jamshidi needle or similar device, where the biopsy is sent for pathological examination
30084	01JAN2014	31DEC9999	Y	DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using percutaneous approach where the biopsy is sent for pathological examination
30087	01DEC1991	31OCT2003	N	BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL MEMBRANE
30087	01NOV2003	31DEC9999	Y	DIAGNOSTIC BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL MEMBRANE, where the biopsy is sent for pathological examination
30090	01DEC1991	31OCT2003	N	BIOPSY OF PLEURA, PERCUTANEOUS 1 or more biopsies on any 1 occasion
30090	01NOV2003	31DEC9999	Y	DIAGNOSTIC BIOPSY OF PLEURA, PERCUTANEOUS 1 or more biopsies on any 1 occasion, where the biopsy is sent for pathological examination
30093	01DEC1991	31OCT2003	N	NEEDLE BIOPSY OF VERTEBRA
30093	01NOV2003	31DEC9999	Y	DIAGNOSTIC NEEDLE BIOPSY OF VERTEBRA, where the biopsy is sent for pathological examination
30094	01APR1992	31OCT2003	N	PERCUTANEOUS ASPIRATION BIOPSY of deep organ using interventional imaging techniques - but not including imaging
30094	01NOV2003	31DEC9999	Y	DIAGNOSTIC PERCUTANEOUS ASPIRATION BIOPSY of deep organ using interventional imaging techniques - but not including imaging, where the biopsy is sent for pathological examination
30096	01DEC1991	30APR2004	N	SCALENE NODE BIOPSY
30096	01MAY2004	31DEC9999	Y	DIAGNOSTIC SCALENE NODE BIOPSY, by open procedure, where the specimen excised is sent for pathological examination
30097	01NOV2006	31OCT2018	N	Personal performance of a Synacthen Stimulation Test, including associated consultation; by a medical practitioner with resuscitation training and access to facilities where life support procedures can be implemented.
30097	01NOV2018	31DEC9999	Y	Personal performance of a Synacthen Stimulation Test, including associated consultation; by a medical practitioner with resuscitation training and access to facilities where life support procedures can be implemented, if: serum cortisol at 0830-0930 hours on any day in the preceding month has been measured at greater than 100 nmol/L but less than 400 nmol/L; or in a patient who is acutely unwell and adrenal insufficiency is suspected.
30099	01DEC1991	31DEC9999	Y	SINUS, excision of, involving superficial tissue only
30102	01DEC1991	31DEC9999	Y	SINUS, excision of, involving muscle and deep tissue
30103	01DEC1991	31DEC9999	Y	SINUS, excision of, involving muscle and deep tissue
30104	01NOV1995	31AUG2015	N	PRE-AURICULAR SINUS, excision of
30104	01SEP2015	30JUN2021	N	PRE-AURICULAR SINUS, on a person 10 years of age or over. Excision of,
30104	01JUL2021	31DEC9999	Y	Pre-auricular sinus, excision of, on a patient 10 years of age or over
30105	01SEP2015	30JUN2021	N	PRE-AURICULAR SINUS, on a person under 10 years of age. Excision of,
30105	01JUL2021	31DEC9999	Y	Pre-auricular sinus, excision of, on a patient under 10 years of age
30106	01DEC1991	31OCT1995	N	GANGLION OR SMALL BURSA, excision of
30106	01NOV1995	31DEC9999	Y	GANGLION OR SMALL BURSA, excision of, not being a service associated with a service to which another item in this Group applies
30107	01DEC1991	31OCT1995	N	GANGLION OR SMALL BURSA, excision of
30107	01NOV1995	31OCT2017	N	GANGLION OR SMALL BURSA, excision of, not being a service associated with a service to which another item in this Group applies
30107	01NOV2017	30JUN2021	N	GANGLION OR SMALL BURSA, excision of, other than a service associated with a service to which another item in this Group applies
30107	01JUL2021	31DEC9999	Y	Excision of ganglion, other than a service associated with a service to which another item in this Group applies
30110	01DEC1991	31DEC9999	Y	BURSA (LARGE), INCLUDING OLECRANON, CALCANEUM OR PATELLA, excision of
30111	01DEC1991	31DEC9999	Y	BURSA (LARGE), INCLUDING OLECRANON, CALCANEUM OR PATELLA, excision of
30114	01DEC1991	31DEC9999	Y	BURSA, SEMIMEMBRANOSUS (Baker's cyst), excision of
30116	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30128, 30130, 30134, 30138, 30145, 30149, 30152, 30157 or 30195 apply)
30117	01DEC1991	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 30121/30122, 30125/30126, 30129, 30132 or 30195 applies
30118	01DEC1991	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removalis by surgical excision and suture, not being a service to which item 30121/30122, 30125/30126, 30129, 30132 or 30195 applies
30119	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30130, 30137, 30141, 30146, 30151, 30154, 30158 or 30195 apply)
30120	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30130, 30137, 30142, 30148, 30151, 30155, 30160 or 30195 apply)
30121	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 3 BUT NOT MORE THAN 10 LESIONS, not being a service to which item 30195 applies
30122	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 3 BUT NOT MORE THAN 10 LESIONS, not being a service to which item 30195 applies
30123	01NOV1996	31DEC9999	Y	TUMOURS,(other than viral verrucae[common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which item 30195 applies)
30124	01NOV1996	31DEC9999	Y	TUMOURS,(other than viral verrucae[common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which item 30195 applies)
30125	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 10 BUT NOT MORE THAN 20 LESIONS, not being a service to which item 30195 applies
30126	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 10 BUT NOT MORE THAN 20 LESIONS, not being a service to which item 30195 applies
30127	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from nose, eyelid, lip, ear, digit or genitalia - where removal is by surgical excision and suture (not being a service to which items 30134, 30137, 30149, 30151 or 30195 apply)
30128	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30127, lesion size up to 10mm in diameter - where removal is by surgical excision and suture (not being a service to which items 30138, 30141, 30142, 30152, 30154, 30155 or 30195 apply)
30129	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 20 BUT NOT MORE THAN 50 LESIONS, not being a service to which item 30195 applies
30130	01NOV1996	31DEC9999	Y	TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30127, lesion size more than 10mm in diameter - where removal is by surgical excision and suture (not being a service to which items 30138, 30141, 30142, 30152, 30154, 30155 or 30195 apply)
30131	01NOV1996	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE, extensive excision of, in the treatment of suppurative hydradenitis (excision from axilla, groin or natal cleft) or sycosis barbae or nuchae (excision from face or neck)
30132	01DEC1991	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 50 LESIONS, not being a service to which item 30195 applies
30133	01NOV1996	31DEC9999	Y	GIANT HAIRY OR CONGENITAL PIGMENTED NAEVUS, excision of an area at least 1 percent of body surface where the specimen is sent for histological confirmation of diagnosis
30134	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30135	01DEC1991	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
30136	01DEC1991	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
30137	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, lesion size more than 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30138	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30134, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30139	01DEC1991	31DEC9999	Y	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in this Group applies, involving muscle, bone or other deep tissue
30140	01DEC1991	31DEC9999	Y	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in this Group applies, involving muscle, bone or other deep tissue
30141	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30137, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30142	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30137, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30143	01DEC1991	31DEC9999	Y	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not being a service to which another item in this Group applies
30144	01DEC1991	31DEC9999	Y	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not being a service to which another item in this Group applies
30145	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30134 and 30138, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30146	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30137 and 30141, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30147	01DEC1991	31DEC9999	Y	MALIGNANT TUMOUR, removal of, from skin, requiring wide and deep excision, other than removal of basal cell carcinoma
30148	01NOV1996	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30137 and 30142, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30149	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30150	01DEC1991	31DEC9999	Y	MALIGNANT TUMOUR, removal of, from skin, requiring wide and deep excision with immediate block dissection of lymph glands
30151	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, lesion size more than 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30152	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30149, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30153	01DEC1991	31DEC9999	Y	TUMOUR, removal of, from SOFT TISSUE (INCLUDING MUSCLE, FASCIA AND CONNECTIVE TISSUE), EXTENSIVE EXCISION OF, WITHOUT SKIN GRAFT
30154	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30151, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30155	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30151, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30156	01DEC1991	31DEC9999	Y	TUMOUR, removal of, from SOFT TISSUE (INCLUDING MUSCLE, FASCIA AND CONNECTIVE TISSUE), EXTENSIVE EXCISION OF, WITH SKIN GRAFT
30157	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30158	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30159	01DEC1991	31DEC9999	Y	MALIGNANT TUMOUR, removal of, from any region involving a RADICAL OPERATION (not being an operation to which another item in this Group applies)
30160	01NOV1996	31DEC9999	Y	MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis
30161	01NOV1996	31DEC9999	Y	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, performed in association with excision of malignant tumour of skin covered by items 30134, 30137, 30138, 30141, 30142, 30145, 30146, 30148, 30149, 30151, 30152, 30154, 30155, 30157, 30158 or 30160
30162	01DEC1991	31DEC9999	Y	MALIGNANT TUMOUR, removal of, from any region involving a LIMITED OPERATION, other than removal of basal cell carcinoma (not being an operation to which another item in this Group applies)
30165	01DEC1991	31OCT2003	N	LIPECTOMY transverse wedge excision of abdominal apron
30165	01NOV2003	31OCT2004	N	LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45533 applies
30165	01NOV2004	31DEC2014	N	LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies
30165	01JAN2015	31DEC2015	N	LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies (H)
30165	01JAN2016	31DEC9999	Y	Lipectomy, wedge excision of abdominal apron that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30168, 30171, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the abdominal apron interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H)
30166	01JUL2023	31DEC9999	Y	Removal of redundant abdominal skin and lipectomy, as a wedge excision, for functional problems following significant weight loss equivalent to at least 5 body mass index points and if there has been a stable weight for a period of at least 6 months prior to surgery, other than a service associated with a service to which item 30175, 30176, 30177, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies (H)
30168	01DEC1991	31OCT2003	N	LIPECTOMY wedge excision of skin or fat not being a service to which item 30165 applies 1 EXCISION
30168	01NOV2003	31OCT2004	N	LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45533 and not being a service to which item 30165 applies, 1 EXCISION
30168	01NOV2004	30JUN2009	N	LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION
30168	01JUL2009	31DEC2014	N	LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION
30168	01JAN2015	31DEC2015	N	LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION (H)
30168	01JAN2016	31DEC9999	Y	Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30165, 30171, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 1 excision only (H)
30169	01JUL2023	31DEC9999	Y	Removal of redundant non-abdominal skin and lipectomy for functional problems following significant weight loss equivalent to at least 5 body mass index points and if there has been a stable weight for a period of at least 6 months prior to surgery, one or 2 non-abdominal areas, other than a service associated with a service to which item 30175, 30176, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies (H)
30171	01DEC1991	31OCT2003	N	LIPECTOMY wedge excision of skin or fat not being a service to which item 30165 applies 2 OR MORE EXCISIONS
30171	01NOV2003	31OCT2004	N	LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45533 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS
30171	01NOV2004	30JUN2009	N	LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS
30171	01JUL2009	31DEC2014	N	LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS
30171	01JAN2015	31DEC2015	N	LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS (H)
30171	01JAN2016	31DEC9999	Y	Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30165, 30168, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 2 excisions only (H)
30172	01JAN2016	31DEC9999	Y	Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30165, 30168, 30171, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 3 or more excisions (H)
30174	01DEC1991	31OCT2003	N	LIPECTOMY subumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall
30174	01NOV2003	31OCT2004	N	LIPECTOMY subumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45533
30174	01NOV2004	31DEC2014	N	LIPECTOMY subumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45530
30174	01JAN2015	31DEC9999	Y	LIPECTOMY subumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45530 (H)
30175	01JUL2022	30JUN2023	N	Radical abdominoplasty, with repair of rectus diastasis, excision of skin and subcutaneous tissue, and transposition of umbilicus, not being a laparoscopic procedure, where the patient has an abdominal wall defect as a consequence of pregnancy, if: (a) the patient:(i) has a diastasis of at least 3cm measured by diagnostic imaging prior to this service; and(ii) has symptoms of at least moderate severity of pain or discomfort at the site of the diastasis in the abdominal wall during functional use and/or low back pain or urinary symptoms likely due to rectus diastasis that have been documented in the patients records by the practitioner providing this service; and(iii) has failed to respond to non-surgical conservative treatment including physiotherapy; and(iv) has not been pregnant in the last 12 months (b) the service is not a service associated with a service to which item 30165, 30651, 30655, 30168, 30171, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies Applicable once per lifetime (H)
30175	01JUL2023	31DEC9999	Y	Radical abdominoplasty, with repair of rectus diastasis, excision of skin and subcutaneous tissue, and transposition of umbilicus, not being a laparoscopic procedure, if:(a) the patient has an abdominal wall defect as a consequence of pregnancy; and(b) the patient: (i) has a diastasis of at least 3cm measured by diagnostic imaging prior to this service; and(ii) has either or both of the following: (A) at least moderately severe pain or discomfort at the site of the diastasis in the abdominal wall during functional use and the pain or discomfort has been documented in the patients records by the practitioner providing the service;(B) low back pain or urinary symptoms likely due to rectus diastasis and the pain or symptoms have been documented in the patients records by the practitioner providing the service; and (iii) has failed to respond to non-surgical conservative treatment, that must have included physiotherapy; and(iv) has not been pregnant in the last 12 months; and (c) the service is not a service associated with a service to which item 30166, 30169, 30176, 30177, 30179, 30651, 30655, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 appliesApplicable once per lifetime (H)
30176	01JAN2016	31OCT2018	N	Lipectomy, radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30177, 30179, 45530, 45564 or 45565 applies, if it can be demonstrated that there is an anterior abdominal wall defect that is a consequence of the surgical removal of large intra abdominal or pelvic tumours (H)
30176	01NOV2018	30JUN2023	N	Lipectomy, radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30177, 30179, 45530, 45564 or 45565 applies, if the patient has previously had a massive intra-abdominal or pelvic tumour surgically removed
30176	01JUL2023	31DEC9999	Y	Radical abdominoplasty, with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30166, 30169, 30175, 30177, 30179, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies, if the patient has previously had a massive intra-abdominal or pelvic tumour surgically removed (H)
30177	01DEC1991	31OCT2003	N	LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus
30177	01NOV2003	31OCT2004	N	LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45533 applies
30177	01NOV2004	31DEC2015	N	LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies
30177	01JAN2016	30JUN2023	N	Lipectomy, excision of skin and subcutaneous tissue associated with redundant abdominal skin and fat that is a direct consequence of significant weight loss, in conjunction with a radical abdominoplasty (Pitanguy type or similar), with or without repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H)
30177	01JUL2023	31DEC9999	Y	Lipectomy, excision of skin and subcutaneous tissue associated with redundant abdominal skin and fat that is a direct consequence of significant weight loss, in conjunction with a radical abdominoplasty, with or without repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30166, 30175, 30176, 30179, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non-surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H)
30178	01NOV2003	31OCT2004	N	CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45564, 45565 or 45533
30178	01NOV2004	31DEC9999	Y	CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45564, 45565 or 45530
30179	01JAN2016	30JUN2023	N	Circumferential lipectomy, as an independent procedure, to correct circumferential excess of redundant skin and fat that is a direct consequence of significant weight loss, with or without a radical abdominoplasty (Pitanguy type or similar), not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 45530, 45564 or 45565 applies, if: (a) the circumferential excess of redundant skin and fat is complicated by intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the circumferential excess of redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H)
30179	01JUL2023	31DEC9999	Y	Circumferential lipectomy, as an independent procedure, to correct circumferential excess of redundant skin and fat that is a direct consequence of significant weight loss, with or without a radical abdominoplasty, not being a service associated with a service to which item 30175, 30176, 30177, 45530, 45531, 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070, 46072, 46080, 46082, 46084, 46086, 46088 or 46090 applies, if: (a) the circumferential excess of redundant skin and fat is complicated by intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non-surgical) treatment; and (b) the circumferential excess of redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H)
30180	01DEC1991	31OCT2003	N	AXILLARY HYPERHIDROSIS, wedge excision for
30180	01NOV2003	31DEC9999	Y	AXILLARY HYPERHIDROSIS, partial excision for
30183	01DEC1991	31DEC9999	Y	AXILLARY HYPERHIDROSIS, total excision of sweat gland bearing area
30185	01NOV2003	31DEC9999	Y	PALMAR OR PLANTAR WARTS (10 or more), definitive removal of, excluding ablative methods alone, not being a service to which item 30186 or 30187 applies
30186	01DEC1991	31OCT1995	N	PLANTAR WART, removal of
30186	01NOV1995	31OCT2003	N	PALMAR OR PLANTAR WARTS, removal of, not being a service to which item 30187 applies
30186	01NOV2003	31DEC9999	Y	PALMAR OR PLANTAR WARTS (less than 10), definitive removal of, excluding ablative methods alone, not being a service to which item 30185 or 30187 applies
30187	01NOV1995	30APR2001	N	PALMAR OR PLANTAR WARTS, removal of, by carbon dioxide laser, requiring admission to a hospital or day-hospital facility, or when performed by a specialist in the practice of his/her specialty, where the time taken is greater than 45 minutes (5 or more warts)
30187	01MAY2001	31DEC9999	Y	PALMAR OR PLANTAR WARTS, removal of, by carbon dioxide laser or erbium laser, requiring admission to a hospital, or when performed by a specialist in the practice of his/her specialty, (5 or more warts)
30189	01DEC1991	31OCT2003	N	WARTS or MOLLUSCUM CONTAGIOSUM, removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital or approved day-hospital facility, not being a service associated with a service to which another item in this Group applies
30189	01NOV2003	31DEC2014	N	WARTS or MOLLUSCUM CONTAGIOSUM (one or more), removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies
30189	01JAN2015	31DEC9999	Y	WARTS or MOLLUSCUM CONTAGIOSUM (one or more), removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies (H)
30190	01NOV1995	30APR2001	N	ANGIOFIBROMAS, TRICHOEPITHELIOMAS or other severely disfiguring tumours suitable for laser excision as confirmed by specialist opinion, of the face or neck, removal of, by carbon dioxide laser excision-ablation including associated resurfacing (10 or more tumours)
30190	01MAY2001	31OCT2018	N	ANGIOFIBROMAS, TRICHOEPITHELIOMAS or other severely disfiguring tumours suitable for laser excision as confirmed by specialist opinion, of the face or neck, removal of, by carbon dioxide laser or erbium laser excision-ablation including associated resurfacing (10 or more tumours)
30190	01NOV2018	31DEC9999	Y	Angiofibromas, trichoepitheliomas or other severely disfiguring tumours of the face or neck (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), suitable for laser ablation as confirmed by the opinion of a specialist in the specialty of dermatology-removal of, by carbon dioxide laser or erbium laser ablation, including associated resurfacing (10 or more tumours)
30191	01NOV2018	31DEC9999	Y	Angiofibromas, trichoepithelioma, epidermal naevi, xanthelasma, pyogenic granuloma, genital angiokeratomas, hereditary haemorrhagic telangiectasia and other severely disfiguring or recurrently bleeding tumours (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), treatment of, with carbon dioxide/erbium or other appropriate laser (or curettage and fine point diathermy for pyogenic granuloma only), if confirmed by the opinion of a specialist in the specialty of dermatology, one or more lesions.
30192	01DEC1991	31OCT2003	N	PREMALIGNANT SKIN LESIONS, treatment of, by galvanocautery or electrodesiccation or cryocautery (10 or more lesions)
30192	01NOV2003	31DEC9999	Y	PREMALIGNANT SKIN LESIONS (including solar keratoses), treatment of, by ablative technique (10 or more lesions)
30195	01DEC1991	31OCT1993	N	NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, not being a service to which item 30198, 30201 or 30204 applies (1 or more lesions)
30195	01NOV1993	31OCT1995	N	NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, not being a service associated with a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions)
30195	01NOV1995	30APR2003	N	NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which items 30196, 30197, 30202, 30203 or 30205 apply (1 or more lesions)
30195	01MAY2003	31OCT2003	N	BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which items 30196, 30197, 30202, 30203 or 30205 apply (1 or more lesions)
30195	01NOV2003	31OCT2004	N	BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions)
30195	01NOV2004	30APR2005	N	BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) seborrheic keratoses and skin tags, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions)
30195	01MAY2005	31DEC9999	Y	BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) seborrheic keratoses, cysts and skin tags, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions)
30196	01NOV1993	31OCT1995	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by a specialist opinion, removal of, BY SERIAL CURETTAGE, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies
30196	01NOV1995	30APR2001	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies
30196	01MAY2001	30APR2003	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies
30196	01MAY2003	31OCT2018	N	MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies
30196	01NOV2018	28FEB2021	N	Malignant neoplasm of skin or mucous membrane that has been:(a) proven by histopathology; or (b) confirmed by the opinion of a specialist in the specialty of dermatology where a specimen has been submitted for histologic confirmation; removal of, by serial curettage, or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy
30196	01MAR2021	31DEC9999	Y	Malignant neoplasm of skin or mucous membrane that has been: (a) proven by histopathology; or (b) confirmed by the opinion of a specialist in the specialty of dermatology or plastic surgery where a specimen has been submitted for histologic confirmation; removal of, by serial curettage, or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy
30197	01NOV1993	31OCT1995	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by a specialist opinion, removal of, BY SERIAL CURETTAGE, including any associated cryotherapy or diathermy, (10 OR MORE LESIONS)
30197	01NOV1995	30APR2003	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, (10 or more lesions)
30197	01MAY2003	31DEC9999	Y	MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, (10 OR MORE LESIONS)
30198	01DEC1991	31DEC9999	Y	CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles, not being a service to which item 30201 or 30204 applies
30201	01DEC1991	31DEC9999	Y	CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles (more than 3 but not more than 10 lesions)
30202	01NOV1993	30APR2003	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles, not being a service to which item 30203 applies
30202	01MAY2003	31OCT2018	N	MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles, not being a service to which item 30203 applies
30202	01NOV2018	28FEB2021	N	Malignant neoplasm of skin or mucous membrane proven by histopathology or confirmed by the opinion of a specialist in the specialty of dermatology-removal of, by liquid nitrogen cryotherapy using repeat freeze thaw cycles
30202	01MAR2021	31DEC9999	Y	Malignant neoplasm of skin or mucous membrane proven by histopathology or confirmed by the opinion of a specialist in the specialty of dermatology or plastic surgery-removal of, by liquid nitrogen cryotherapy using repeat freeze thaw cycles
30203	01NOV1993	30APR2003	N	CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles (10 OR MORE LESIONS)
30203	01MAY2003	31DEC9999	Y	MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles (10 OR MORE LESIONS)
30204	01DEC1991	31DEC9999	Y	CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles (more than 10 lesions)
30205	01NOV1993	30APR2003	N	CANCER OF SKIN proven by histopathology, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles WHERE CANCER EXTENDS INTO CARTILAGE
30205	01MAY2003	31DEC9999	Y	MALIGNANT NEOPLASM OF SKIN proven by histopathology, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles WHERE THE MALIGNANT NEOPLASM EXTENDS INTO CARTILAGE
30207	01DEC1991	31OCT2018	N	SKIN LESIONS, multiple injections with hydrocortisone or similar preparations
30207	01NOV2018	31DEC9999	Y	Skin lesions, multiple injections with glucocorticoid preparations
30210	01DEC1991	31OCT2018	N	KELOID and other SKIN LESIONS, EXTENSIVE, MULTIPLE INJECTIONS OF HYDROCORTISONE or similar preparations where undertaken in the operating theatre of a hospital
30210	01NOV2018	31OCT2021	N	Keloid and other skin lesions, extensive, multiple injections of glucocorticoid preparations, if undertaken in the operating theatre of a hospital on a patient less than 16 years of age
30210	01NOV2021	31DEC9999	Y	Keloid and other skin lesions, extensive, multiple injections of glucocorticoid preparations, if undertaken in the operating theatre of a hospital (H)
30213	01DEC1991	30JUN1993	N	TELANGIECTASES OR STARBURST VESSELS, diathermy or sclerosant injection of, including associated consultation - for a session of at least 20 minutes
30213	01JUL1993	31OCT1995	N	TELANGIECTASES OR STARBURST VESSELS on the head or neck, diathermy or sclerosant injection of, including associated consultation - for a session of at least 20 minutes duration
30213	01NOV1995	31OCT1996	N	TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 3 metres, diathermy or sclerosant injection of, including associated consultation - limited to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - for a session of at least 20 minutes duration
30213	01NOV1996	31DEC9999	Y	TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - limited to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - for a session of at least 20 minutes duration
30214	19JUN1997	31OCT1997	N	TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - session of at least 20 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
30214	01NOV1997	31DEC9999	Y	TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - session of at least 20 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period
30216	01DEC1991	31DEC9999	Y	HAEMATOMA, aspiration of
30219	01DEC1991	30APR2000	N	HAEMATOMA, FURUNCLE, SMALL ABSCESS OR SIMILAR LESION not requiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare)
30219	01MAY2000	31DEC9999	Y	HAEMATOMA, FURUNCLE, SMALL ABSCESS OR SIMILAR LESION not requiring admission to a hospital - INCISION WITH DRAINAGE OF (excluding aftercare)
30222	01DEC1991	31DEC9999	Y	LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion requiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare)
30223	01DEC1991	30APR2000	N	LARGE HAEMATOMA, LARGE ABSCESS (including ischiorectal abscess), CARBUNCLE, CELLULITIS or similar lesionrequiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare)
30223	01MAY2000	31DEC9999	Y	LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding aftercare)
30224	01APR1992	31OCT1992	N	PERCUTANEOUS DRAINAGE OF DEEP ABSCESS - but not including imaging
30224	01NOV1992	31DEC9999	Y	PERCUTANEOUS DRAINAGE OF DEEP ABSCESS using interventional imaging techniques - but not including imaging
30225	01APR1992	31OCT1992	N	ABSCESS DRAINAGE TUBE, exchange of - but not including imaging
30225	01NOV1992	31DEC9999	Y	ABSCESS DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging
30226	01DEC1991	31DEC9999	Y	MUSCLE, excision of (LIMITED), or fasciotomy
30229	01DEC1991	31DEC9999	Y	MUSCLE, excision of (EXTENSIVE)
30232	01DEC1991	31DEC9999	Y	MUSCLE, RUPTURED, repair of (limited), not associated with external wound
30235	01DEC1991	31DEC9999	Y	MUSCLE, RUPTURED, repair of (extensive), not associated with external wound
30238	01DEC1991	31DEC9999	Y	FASCIA, DEEP, repair of, FOR HERNIATED MUSCLE
30241	01DEC1991	31DEC9999	Y	BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in this Group applies
30244	01DEC1991	31DEC9999	Y	STYLOID PROCESS OF TEMPORAL BONE, removal of
30246	01JUL1998	31DEC9999	Y	PAROTID DUCT, repair of, using micro-surgical techniques
30247	01DEC1991	28FEB2023	N	PAROTID GLAND, total extirpation of
30247	01MAR2023	31DEC9999	Y	Parotid gland, total extirpation of, including removal of tumour, other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H)
30250	01DEC1991	28FEB2023	N	PAROTID GLAND, total extirpation of, with preservation of facial nerve
30250	01MAR2023	31DEC9999	Y	Parotid gland, total extirpation of, with preservation of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H)
30251	01JUL1998	28FEB2023	N	RECURRENT PAROTID TUMOUR, excision of, with preservation of facial nerve
30251	01MAR2023	31DEC9999	Y	Recurrent parotid tumour, excision of, with preservation of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H)
30253	01DEC1991	30JUN1998	N	PAROTID GLAND, SUPERFICIAL LOBECTOMY OR REMOVAL OF TUMOUR FROM, with exposure of facial nerve
30253	01JUL1998	28FEB2023	N	PAROTID GLAND, SUPERFICIAL LOBECTOMY OF, with exposure of facial nerve
30253	01MAR2023	31DEC9999	Y	Parotid gland, superficial lobectomy of, with exposure of facial nerve, including: (a) removal of tumour; and (b) exposure or mobilisation of facial nerve; other than a service associated with a service to which item 39321, 39324, 39327 or 39330 applies (H)
30255	01MAY1997	30JUN1998	N	SUBMANDIBULAR DUCTS, removal of, for surgical control of drooling
30255	01JUL1998	31DEC9999	Y	SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling
30256	01DEC1991	28FEB2023	N	SUBMANDIBULAR GLAND, extirpation of
30256	01MAR2023	31DEC9999	Y	Submandibular gland, extirpation of, other than a service associated with a service to which item 31423, 31426, 31429, 31432, 31435 or 31438 applies on the same side (H)
30257	01MAR2023	31DEC9999	Y	Sialendoscopy, of submandibular or parotid duct, with or without removal of calculus or treatment of stricture
30259	01DEC1991	31DEC9999	Y	SUBLINGUAL GLAND, extirpation of
30262	01DEC1991	31DEC9999	Y	SALIVARY GLAND, DILATATION OR DIATHERMY of duct
30265	01DEC1991	31DEC9999	Y	SALIVARY GLAND, removal of CALCULUS from duct or meatotomy or marsupialisation, 1 or more such procedures.
30266	01DEC1991	31DEC9999	Y	Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, 1 or more such procedures.
30269	01DEC1991	31DEC9999	Y	SALIVARY GLAND, repair of CUTANEOUS FISTULA OF
30272	01DEC1991	31DEC9999	Y	TONGUE, partial excision of
30275	01DEC1991	31OCT2019	N	RADICAL EXCISION OF INTRAORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH GLANDS OF NECK (commandotype operation)
30275	01NOV2019	28FEB2023	N	RADICAL EXCISION OF INTRAORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH NODES OF NECK (commandotype operation)
30275	01MAR2023	31DEC9999	Y	Radical excision of intra oral tumour, with or without resection of mandible, including dissection of lymph glands of neck, unilateral, other than a service associated with a service to which item 31423, 31426, 31429, 31432, 31435 or 31438 applies on the same side (H)
30278	01DEC1991	28FEB2023	N	TONGUE TIE, repair of, not being a service to which another item in this Group applies
30278	01MAR2023	31DEC9999	Y	Tongue tie, repair of, other than: (a) a service to which another item in this Subgroup applies; or (b) a service associated with a service to which item 45009 applies
30281	01DEC1991	30JUN2021	N	TONGUE TIE, MANDIBULAR FRENULUM or MAXILLARY FRENULUM, repair of, in a person aged 2 years and over, under general anaesthesia
30281	01JUL2021	28FEB2023	N	Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a patient aged 2 years and over, under general anaesthesia
30281	01MAR2023	31DEC9999	Y	Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged 2 years and over, under general anaesthesia, other than a service associated with a service to which item 45009 applies
30282	01DEC1991	31DEC9999	Y	RANULA OR MUCOUS CYST OF MOUTH, removal of
30283	01DEC1991	31DEC9999	Y	RANULA OR MUCOUS CYST OF MOUTH, removal of
30286	01DEC1991	31AUG2015	N	BRANCHIAL CYST, removal of
30286	01SEP2015	30JUN2021	N	BRANCHIAL CYST, on a person 10 years of age or over. Removal of,
30286	01JUL2021	31DEC9999	Y	Branchial cyst, removal of, on a patient 10 years of age or over
30287	01SEP2015	30JUN2021	N	BRANCHIAL CYST, on a person under 10 years of age. Removal of,
30287	01JUL2021	31DEC9999	Y	Branchial cyst, removal of, on a patient under 10 years of age
30289	01DEC1991	31AUG2015	N	BRANCHIAL FISTULA, removal of
30289	01SEP2015	30JUN2021	N	BRANCHIAL FISTULA, on a person 10 years of age or over. Removal of,
30289	01JUL2021	31DEC9999	Y	Branchial fistula, removal of, on a patient 10 years of age or over
30292	01DEC1991	31DEC9999	Y	CYSTIC HYGROMA, removal of massive lesion requiring extensive excision with or without thoracotomy
30293	01NOV1992	31DEC9999	Y	CERVICAL OESOPHAGOSTOMY or CLOSURE OF CERVICAL OESOPHAGOSTOMY with or without plastic repair
30294	01NOV1992	31DEC9999	Y	CERVICAL OESOPHAGECTOMY with tracheostomy and oesophagostomy, with or without plastic reconstruction; or LARYNGOPHARYNGECTOMY with tracheostomy and plastic reconstruction
30295	01DEC1991	31DEC9999	Y	THYROIDECTOMY, total, or THYROIDECTOMY following previous total hemithyroidectomy or following previous unilateral or bilateral subtotal thyroidectomy
30296	01NOV1992	31DEC9999	Y	THYROIDECTOMY, total
30297	01NOV1992	31DEC9999	Y	THYROIDECTOMY following previous thyroid surgery
30298	01DEC1991	31DEC9999	Y	PARATHYROID TUMOUR, removal of
30299	01NOV2005	30JUN2023	N	SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level I axilla, using preoperative lymphoscintigraphy and lymphotropic dye injection, not being a service associated with a service to which item 30300, 30302 or 30303 applies
30299	01JUL2023	31DEC9999	Y	Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection in an axilla, using preoperative lymphoscintigraphy and/or lymphotropic dye injection (H)
30300	01NOV2005	31DEC9999	Y	SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level II/III axilla, using preoperative lymphoscintigraphy and lymphotropic dye injection, not being a service associated with a service to which item 30299, 30302 or 30303 applies
30301	01DEC1991	31DEC9999	Y	PARATHYROID GLANDS, removal of, other than for tumour
30302	01NOV2005	31DEC9999	Y	SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level I axilla, using lymphotropic dye injection, not being a service associated with a service to which item 30299, 30300 or 30303 applies
30303	01NOV2005	31DEC9999	Y	SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level II/III axilla, using lymphotropic dye injection, not being a service associated with a service to which item 30299, 30300 or 30302 applies
30304	01DEC1991	31DEC9999	Y	CERVICAL REEXPLORATION for recurrent or persistent hyperparathyroidism
30305	01JUL2023	31DEC9999	Y	Sentinel lymph node biopsy or biopsies for breast cancer, involving dissection along internal mammary chain (H)
30306	01NOV1992	31DEC9999	Y	TOTAL HEMITHYROIDECTOMY
30307	01DEC1991	31DEC9999	Y	TOTAL HEMITHYROIDECTOMY or BILATERAL SUBTOTAL THYROIDECTOMY, with or without exposure of recurrent laryngeal nerve
30308	01NOV1992	31DEC9999	Y	BILATERAL SUBTOTAL THYROIDECTOMY
30309	01NOV1992	31DEC9999	Y	THYROIDECTOMY, SUBTOTAL for THYROTOXICOSIS
30310	01DEC1991	31OCT1992	N	THYROID, excision of localised tumour of, or unilateral subtotal thyroidectomy
30310	01NOV1992	31OCT2018	N	THYROID, unilateral subtotal thyroidectomy or equivalent partial thyroidectomy
30310	01NOV2018	31DEC9999	Y	Partial or subtotal thyroidectomy
30311	01NOV2021	30JUN2023	N	SENTINEL LYMPH NODE BIOPSY or biopsies for cutaneous melanoma, using preoperative lymphoscintigraphy and lymphotropic dye injection, if: (a) the primary lesion is greater than 1.0 mm in depth (or at least 0.8 mm in depth in the presence of ulceration); and (b) appropriate excision of the primary melanoma has occurred; and (c) the service is not associated with a service to which item 30075, 30078, 30299, 30300, 30302, 30303, 30329, 30332, 30618, 30820,31423, 52025 or 52027 applies. Applicable to only one lesion per occasion on which the service is provided (H)
30311	01JUL2023	31DEC9999	Y	Sentinel lymph node biopsy or biopsies for cutaneous melanoma, using preoperative lymphoscintigraphy and/or lymphotropic dye injection, if: (a) the primary lesion is greater than 1.0 mm in depth (or at least 0.8 mm in depth in the presence of ulceration); and (b) appropriate excision of the primary melanoma has occurred; and (c) the service is not associated with a service to which item 30075, 30078, 30299, 30305, 30329, 30332, 30618, 30820, 31423, 52025 or 52027 appliesApplicable to only one lesion per occasion on which the service is provided (H)
30313	01DEC1991	31DEC9999	Y	THYROGLOSSAL CYST, removal of
30314	01NOV1992	31AUG2015	N	THYROGLOSSAL CYST or FISTULA or both, radical removal of, including thyroglossal duct and portion of hyoid bone
30314	01SEP2015	30JUN2021	N	THYROGLOSSAL CYST or FISTULA or both, on a person 10 years of age or over. Radical removal of, including thyroglossal duct and portion of hyoid bone
30314	01JUL2021	31DEC9999	Y	Thyroglossal cyst or fistula or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a patient 10 years of age or over
30315	01NOV1992	31OCT2018	N	PARATHYROID operation for hyperparathyroidism
30315	01NOV2018	31DEC9999	Y	Minimally invasive parathyroidectomy. Removal of 1 or more parathyroid adenoma through a small cervical incision for an image localised adenoma, including thymectomy. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30318, 30317 or 30320 applies.
30316	01DEC1991	31DEC9999	Y	THYROGLOSSAL CYST AND FISTULA, removal of
30317	01NOV1992	31OCT2018	N	CERVICAL REEXPLORATION for recurrent or persistent hyperparathyroidism
30317	01NOV2018	31DEC9999	Y	Redo parathyroidectomy. Cervical re-exploration for persistent or recurrent hyperparathyroidism, including thymectomy and cervical exploration of the mediastinum. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30318 or 30320 applies.
30318	01NOV1992	31OCT2018	N	MEDIASTINUM, exploration of, via the cervical route, for hyperparathyroidism (including thymectomy)
30318	01NOV2018	31DEC9999	Y	Open parathyroidectomy, exploration and removal of 1 or more adenoma or hyperplastic glands via a cervical incision including thymectomy and cervical exploration of the mediastinum when performed. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30317 or 30320 applies.
30319	01DEC1991	31DEC9999	Y	CERVICAL OESOPHAGOSTOMY or CLOSURE OF CERVICAL OESOPHAGOSTOMY with or without plastic repair
30320	01NOV1992	31OCT2018	N	MEDIASTINUM, exploration of, via mediastinotomy, for hyperparathyroidism (including thymectomy)
30320	01NOV2018	31DEC9999	Y	Removal of a mediastinal parathyroid adenoma via sternotomy or mediastinal thorascopic approach. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30317 or 30318 applies.
30321	01NOV1992	31DEC9999	Y	RETROPERITONEAL NEUROENDOCRINE TUMOUR, removal of
30322	01DEC1991	31DEC9999	Y	CERVICAL OESOPHAGECTOMY with tracheostomy and oesophagostomy, with or without plastic reconstruction; or LARYNGOPHARYNGECTOMY with tracheostomy and plastic reconstruction
30323	01NOV1992	31OCT2018	N	RETROPERITONEAL NEUROENDOCRINE TUMOUR, removal of, requiring complex and extensive dissection
30323	01NOV2018	31DEC9999	Y	Excision of phaeochromocytoma or extraadrenal paraganglioma via endoscopic or open approach.
30324	01NOV1992	31OCT2018	N	ADRENAL GLAND TUMOUR, excision of
30324	01NOV2018	31DEC9999	Y	Excision of an adrenocortical tumour or hyperplasia via endoscopic or open approach.
30325	01DEC1991	31DEC9999	Y	LYMPH GLANDS of NECK, limited excision of
30326	01SEP2015	30JUN2021	N	THYROGLOSSAL CYST or FISTULA or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a person under 10 years of age
30326	01JUL2021	31DEC9999	Y	Thyroglossal cyst or fistula or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a patient under 10 years of age
30328	01DEC1991	31DEC9999	Y	LYMPH GLANDS of NECK, radical excision of
30329	01NOV1992	31OCT2019	N	LYMPH GLANDS of GROIN, limited excision of
30329	01NOV2019	31DEC9999	Y	LYMPH NODES of GROIN, limited excision of
30330	01NOV1992	31OCT2019	N	LYMPH GLANDS of GROIN, radical excision of
30330	01NOV2019	31DEC9999	Y	LYMPH NODES of GROIN, radical excision of
30331	01DEC1991	31DEC9999	Y	LYMPH GLANDS OF GROIN OR AXILLA, limited excision of
30332	01NOV1992	30APR2000	N	LYMPH GLANDS of AXILLA, limited excision of
30332	01MAY2000	30JUN2023	N	LYMPH NODES of AXILLA, limited excision of (sampling)
30332	01JUL2023	31DEC9999	Y	Lymph nodes of axilla, limited excision of (H)
30333	01NOV1992	31DEC9999	Y	LYMPH GLANDS of AXILLA, radical excision of
30334	01DEC1991	31DEC9999	Y	LYMPH GLANDS OF GROIN OR AXILLA, radical excision of
30335	01MAY2000	31DEC9999	Y	LYMPH NODES of AXILLA, complete excision of, to level I
30336	01MAY2000	30JUN2023	N	LYMPH NODES of AXILLA, complete excision of, to level II or level III
30336	01JUL2023	31DEC9999	Y	Lymph nodes of axilla, complete excision of (H)
30337	01DEC1991	31DEC9999	Y	SIMPLE MASTECTOMY with or without frozen section biopsy
30338	01DEC1991	31DEC9999	Y	SIMPLE MASTECTOMY with or without frozen section biopsy
30339	01MAY2000	31DEC9999	Y	BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histology
30340	01MAY2000	31DEC9999	Y	BREAST, BENIGN LESION more than 50mm in diameter, excision of
30341	01DEC1991	31DEC9999	Y	BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason
30342	01DEC1991	31DEC9999	Y	BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason
30343	01MAY2000	31DEC9999	Y	BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of
30344	01MAY2000	31DEC9999	Y	BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology
30345	01DEC1991	31DEC9999	Y	BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used
30346	01DEC1991	31DEC9999	Y	BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used
30347	01MAY2000	31DEC9999	Y	BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology
30348	01MAY2000	31DEC9999	Y	BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour
30349	01DEC1991	31DEC9999	Y	PARTIAL MASTECTOMY, involving more than 25% of the breast tissue, with or without frozen section biopsy
30350	01DEC1991	31DEC9999	Y	PARTIAL MASTECTOMY, involving more than 25% of the breast tissue, with or without frozen section biopsy
30351	01MAY2000	31DEC9999	Y	BREAST (female), total mastectomy
30352	01MAY2000	31DEC9999	Y	BREAST (male), total mastectomy
30353	01DEC1991	31DEC9999	Y	BREAST, extended simple mastectomy with or without frozen section biopsy
30354	01MAY2000	31DEC9999	Y	BREAST (female), subcutaneous mastectomy
30355	01MAY2000	31DEC9999	Y	BREAST (male), subcutaneous mastectomy
30356	01DEC1991	31DEC9999	Y	SUBCUTANEOUS MASTECTOMY with or without frozen section biopsy
30358	01NOV2000	31DEC9999	Y	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a vacuum-assisted breast biopsy device under imaging guidance, for histological examination, where imaging has demonstrated: (a) microcalcification of lesion; or (b) impalpable lesion less than 1cm in diameter - including pre-operative localisation of lesion where performed, not being a service to which item 30363 applies
30359	01DEC1991	31DEC9999	Y	BREAST, radical or modified radical mastectomy with or without frozen section biopsy
30360	01APR1992	30APR2000	N	FINE NEEDLE ASPIRATION of an impalpable breast lesion defected by mammography or ultrasound, imaging guided - but not including imaging
30360	01MAY2000	31DEC9999	Y	FINE NEEDLE ASPIRATION of an impalpable breast lesion detected by mammography or ultrasound, imaging guided - but not including imaging
30361	01APR1992	31OCT1992	N	BREAST, preoperative localisation of lesion by hookwire or similar device - but not including imaging
30361	01NOV1992	31DEC9999	Y	BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging
30362	01DEC1991	31OCT1992	N	NIPPLE, INVERTED, surgical eversion of
30362	01NOV1992	31DEC9999	Y	INVERTED NIPPLE, surgical eversion of
30363	01NOV1992	31OCT2000	N	BREAST, core biopsy of solid tumour or tissue of, using mechanical biopsy device, for histological examination
30363	01NOV2000	31DEC9999	Y	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using mechanical biopsy device, for histological examination, not being a service to which item 30358 applies
30364	01NOV1992	30APR2000	N	BREAST, haematoma, seroma or inflammatory condition including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital or day-hospital facility, excluding aftercare
30364	01MAY2000	31DEC9999	Y	BREAST, HAEMATOMA, SEROMA OR INFLAMMATORY CONDITION including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital or day-hospital facility, excluding aftercare
30365	01DEC1991	31DEC9999	Y	LAPAROTOMY (exploratory), including associated biopsies, where no other intraabdominal procedure is performed
30366	01NOV1992	31DEC9999	Y	BREAST, microdochotomy of, for benign or malignant condition
30367	01NOV1992	31DEC9999	Y	BREAST CENTRAL DUCTS, excision of, for benign condition
30368	01DEC1991	31DEC9999	Y	LAPAROTOMY involving Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas
30369	01NOV1992	31DEC9999	Y	ACCESSORY BREAST TISSUE, excision of
30370	01NOV1992	31DEC9999	Y	INVERTED NIPPLE, surgical eversion of
30371	01DEC1991	31DEC9999	Y	LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed)
30372	01NOV1992	31DEC9999	Y	ACCESSORY NIPPLE, excision of
30373	01NOV1992	31DEC9999	Y	LAPAROTOMY (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed
30374	01DEC1991	31DEC9999	Y	LAPAROTOMY INVOLVING DIVISION OF ADHESIONS in association with another intraabdominal procedure where the time taken to divide the adhesions exceeds 45 minutes
30375	01NOV1992	30APR2005	N	LAPAROTOMY involving Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas
30375	01MAY2005	31AUG2015	N	Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas
30375	01SEP2015	31DEC9999	Y	Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, on a person 10 years of age or over. Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas
30376	01NOV1992	31AUG2015	N	LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed)
30376	01SEP2015	31DEC9999	Y	LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) on a person 10 years of age or over
30377	01DEC1991	31DEC9999	Y	LAPAROTOMY WITH DIVISION OF EXTENSIVE ADHESIONS (duration greater than 2 hours) with or without insertion of long intestinal tube
30378	01NOV1992	30JUN1996	N	LAPAROTOMY INVOLVING DIVISION OF ADHESIONS in conjunction with another intraabdominal procedure where the time taken to divide the adhesions exceeds 45 minutes
30378	01JUL1996	31AUG2015	N	LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours
30378	01SEP2015	31DEC9999	Y	LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours, on a person 10 years of age or over
30379	01NOV1992	31DEC9999	Y	LAPAROTOMY WITH DIVISION OF EXTENSIVE ADHESIONS (duration greater than 2 hours) with or without insertion of long intestinal tube
30380	01DEC1991	31DEC9999	Y	LAPAROTOMY FOR GRADING OF LYMPHOMA, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy
30381	01NOV1992	31DEC9999	Y	FAECAL FISTULA, abdominal repair of, by simple excision of bowel
30382	01NOV1992	30JUN1995	N	ENTEROCUTANEOUS FISTULA, radical repair of involving extensive dissection and resection of bowel (Ministerial Determination)
30382	01JUL1995	30JUN2021	N	ENTEROCUTANEOUS FISTULA, radical repair of, involving extensive dissection and resection of bowel
30382	01JUL2021	31DEC9999	Y	Enterocutaneous fistula, repair of, if dissection and resection of bowel is performed, with or without anastomosis or formation of a stoma (H)
30383	01DEC1991	31DEC9999	Y	LAPAROTOMY FOR CONTROL OF POSTOPERATIVE HAEMORRHAGE, where no other procedure is performed
30384	01NOV1992	30JUN2021	N	LAPAROTOMY FOR GRADING OF LYMPHOMA, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy
30384	01JUL2021	31DEC9999	Y	Open or minimally invasive excision of a retroperitoneal mass, 4 cm or greater in largest dimension, lasting more than 3 hours, other than a service to which another item in this Group applies (H)
30385	01NOV1992	30JUN2021	N	LAPAROTOMY FOR CONTROL OF POSTOPERATIVE HAEMORRHAGE, where no other procedure is performed
30385	01JUL2021	31DEC9999	Y	Unplanned return to theatre for laparotomy or laparoscopy for control or drainage of intra-abdominal haemorrhage following abdominal surgery (H)
30386	01DEC1991	31DEC9999	Y	LAPAROTOMY for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause; with or without appendicectomy
30387	01NOV1992	30JUN2021	N	LAPAROTOMY INVOLVING OPERATION ON ABDOMINAL VISCERA (including pelvic viscera), not being a service to which another item in this Group applies
30387	01JUL2021	31DEC9999	Y	Laparoscopy or laparotomy when an operation is performed on abdominal, retroperitoneal or pelvic viscera, excluding lymph node biopsy, other than a service to which another item in this Group applies (H)
30388	01NOV1992	30JUN1995	N	LAPAROTOMY for trauma involving 3 or more organs (Ministerial Determination)
30388	01JUL1995	30JUN2021	N	LAPAROTOMY for trauma involving 3 or more organs
30388	01JUL2021	31DEC9999	Y	Laparotomy for abdominal trauma, including control of haemorrhage (with or without packing) and containment of contamination (H)
30389	01DEC1991	31DEC9999	Y	LAPAROTOMY INVOLVING OPERATION ON ABDOMINAL VISCERA (including pelvic viscera), not covered by any other Item in this Group
30390	01NOV1992	31OCT2010	N	LAPAROSCOPY, diagnostic
30390	01NOV2010	31AUG2015	N	LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure
30390	01SEP2015	30JUN2021	N	LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure, on a person 10 years of age or over
30390	01JUL2021	31DEC9999	Y	Laparoscopy, diagnostic, with or without aspiration of fluid, on a patient 10 years of age or over, if no other intra-abdominal procedure is performed (H)
30391	01NOV1992	31DEC9999	Y	LAPAROSCOPY with biopsy
30392	01DEC1991	31OCT1997	N	RADICAL OR DEBULKING OPERATION for advanced intra-abdominal malignancy, with or without omentectomy, as an independent procedure
30392	01NOV1997	31DEC9999	Y	RADICAL OR DEBULKING OPERATION for advanced intra-abdominal malignancy, with or without omentectomy, as an independent procedure
30393	01MAY1997	31DEC9999	Y	LAPAROSCOPIC DIVISION OF ADHESIONS in association with another intra-abdominal procedure where the time taken to divide the adhesions exceeds 45 minutes
30394	01NOV1992	31DEC9999	Y	LAPAROTOMY for drainage of subphrenic abscess, pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause, with or without appendicectomy
30395	01DEC1991	31DEC9999	Y	SUBPHRENIC ABSCESS, drainage of
30396	01NOV1992	30JUN1995	N	LAPAROTOMY for gross intra peritoneal sepsis requiring debridement of fibrin, with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity via a major abdominal incision, with or without closure of abdomen and with or without mesh or zipper insertion (Ministerial Determination)
30396	01JUL1995	30JUN2021	N	LAPAROTOMY for gross intra peritoneal sepsis requiring debridement of fibrin, with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity via a major abdominal incision, with or without closure of abdomen and with or without mesh or zipper insertion
30396	01JUL2021	31DEC9999	Y	Laparotomy or laparoscopy for generalised intra-peritoneal sepsis (also known as peritonitis), with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity, with or without closure of the abdomen when performed by laparotomy (H)
30397	01NOV1992	30JUN1995	N	LAPAROSTOMY, via wound previously made and left open or closed with zipper, involving change of dressings or packs, and with or without drainage of loculated collections (Ministerial Determination)
30397	01JUL1995	30JUN2021	N	LAPAROSTOMY, via wound previously made and left open or closed with zipper, involving change of dressings or packs, and with or without drainage of loculated collections
30397	01JUL2021	31DEC9999	Y	Laparostomy, via wound previously made and left open or closed, including change of dressings or packs, with or without drainage of loculated collections (H)
30398	01DEC1991	31DEC9999	Y	LIVER BIOPSY, percutaneous
30399	01NOV1992	30JUN1995	N	LAPAROSTOMY, final closure of wound made at previous operation, after removal of dressings or packs and removal of mesh or zipper if previously inserted(Ministerial Determination)
30399	01JUL1995	30JUN2021	N	LAPAROSTOMY, final closure of wound made at previous operation, after removal of dressings or packs and removal of mesh or zipper if previously inserted
30399	01JUL2021	31DEC9999	Y	Laparostomy, final closure of wound made at previous operation, after removal of dressings or packs
30400	01NOV1992	31DEC9999	Y	LAPAROTOMY WITH INSERTION OF PORTACATH for administration of cytotoxic therapy including placement of reservoir
30401	01DEC1991	31DEC9999	Y	LIVER BIOPSY by wedge excision when performed in association with another intraabdominal procedure
30402	01NOV1992	31DEC9999	Y	RETROPERITONEAL ABSCESS, drainage of, not involving laparotomy
30403	01NOV1992	30APR2005	N	VENTRAL, INCISIONAL, OR RECURRENT HERNIA OR BURST ABDOMEN, repair of
30403	01MAY2005	31DEC9999	Y	VENTRAL, INCISIONAL, OR RECURRENT HERNIA OR BURST ABDOMEN, repair of with or without mesh
30404	01DEC1991	31DEC9999	Y	LIVER TUMOUR, removal of other than by biopsy
30405	01NOV1992	30JUN1995	N	VENTRAL, or incisional hernia, repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel (Ministerial Determination)
30405	01JUL1995	30APR2005	N	VENTRAL OR INCISIONAL HERNIA, repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel
30405	01MAY2005	31DEC9999	Y	VENTRAL OR INCISIONAL HERNIA, (excluding recurrent inguinal or femoral hernia), repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel
30406	01NOV1992	31DEC9999	Y	PARACENTESIS ABDOMINIS
30407	01DEC1991	31DEC9999	Y	LIVER, MASSIVE RESECTION OF, or LOBECTOMY
30408	01NOV1992	30JUN1995	N	PERITONEO venous (Leveen) shunt, insertion of (Ministerial Determination)
30408	01JUL1995	31OCT2010	N	PERITONEO venous (Leveen) shunt, insertion of
30408	01NOV2010	31DEC9999	Y	PERITONEOVENOUS shunt, insertion of
30409	01NOV1992	31DEC9999	Y	LIVER BIOPSY, percutaneous
30410	01DEC1991	31DEC9999	Y	LIVER ABSCESS, ABDOMINAL, drainage of
30411	01NOV1992	31DEC9999	Y	LIVER BIOPSY by wedge excision when performed in conjunction with another intraabdominal procedure
30412	01NOV1992	30JUN1995	N	LIVER BIOPSY by core needle, when performed in conjunction with another intra-abdominal procedure (Ministerial Determination)
30412	01JUL1995	31DEC9999	Y	LIVER BIOPSY by core needle, when performed in conjunction with another intra-abdominal procedure
30413	01DEC1991	31DEC9999	Y	HYDATID CYST OF LIVER, PERITONEUM OR VISCUS, drainage procedure for
30414	01NOV1992	30JUN1995	N	LIVER, subsegmental resection of, (local excision), other than for trauma (Ministerial Determination)
30414	01JUL1995	31DEC9999	Y	LIVER, subsegmental resection of, (local excision), other than for trauma
30415	01NOV1992	30JUN1995	N	LIVER, segmental resection of, other than for trauma (Ministerial Determination)
30415	01JUL1995	31DEC9999	Y	LIVER, segmental resection of, other than for trauma
30416	01DEC1991	31OCT1996	N	LIVER CYST, laparoscopic marsupialisation of, where the size of the cyst is greater than 5cm in diameter
30416	01NOV1996	30JUN2021	N	LIVER CYST, laparoscopic marsupialisation of, where the size of the cyst is greater than 5cm in diameter
30416	01JUL2021	31DEC9999	Y	Liver cysts, greater than 5 cm in diameter, marsupialisation of 4 or less
30417	01APR1992	31OCT1996	N	LIVER CYSTS, laparoscopic marsupialisation of 5 or more, including any cyst greater than 5cm in diameter
30417	01NOV1996	30JUN2021	N	LIVER CYSTS, laparoscopic marsupialisation of 5 or more, including any cyst greater than 5cm in diameter
30417	01JUL2021	31DEC9999	Y	Liver cysts, greater than 5 cm in diameter, marsupialisation of 5 or more
30418	01NOV1992	30JUN1995	N	LIVER, lobectomy of, other than for trauma (Ministerial Determination)
30418	01JUL1995	31DEC9999	Y	LIVER, lobectomy of, other than for trauma
30419	01DEC1991	30APR1997	N	LIVER TUMOURS, destruction of, by hepatic cryotherapy
30419	01MAY1997	30APR2004	N	LIVER TUMOURS, destruction of, by hepatic cryotherapy
30419	01MAY2004	30JUN2021	N	LIVER TUMOURS, destruction of, by hepatic cryotherapy, not being a service associated with a service to which item 50950 or 50952 applies
30419	01JUL2021	31DEC9999	Y	Liver tumour, other than a hepatocellular carcinoma, destruction of one or more, by local ablation, other than a service associated with a service to which item 50950 or 50952 applies
30420	01DEC1991	31DEC9999	Y	CHOLECYSTECTOMY
30421	01NOV1992	30JUN1995	N	LIVER, TRI-SEGMENTAL RESECTION (extended lobectomy) of, other than for trauma (Ministerial Determination)
30421	01JUL1995	30JUN2021	N	LIVER, TRI-SEGMENTAL RESECTION (extended lobectomy) of, other than for trauma
30421	01JUL2021	31DEC9999	Y	Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, other than for trauma
30422	01NOV1992	30JUN1995	N	LIVER, repair of superficial laceration of, for trauma (Ministerial Determination)
30422	01JUL1995	31DEC9999	Y	LIVER, repair of superficial laceration of, for trauma
30423	01DEC1991	31DEC9999	Y	CHOLEDOCHOSCOPY
30424	01APR1992	31DEC9999	Y	BILIARY DRAINAGE TUBE, exchange of - but not including imaging
30425	01NOV1992	30JUN1995	N	LIVER, repair of deep multiple lacerations of, or requiring debridement, for trauma (Ministerial Determination)
30425	01JUL1995	31DEC9999	Y	LIVER, repair of deep multiple lacerations of, or debridement of, for trauma
30426	01DEC1991	31DEC9999	Y	CHOLEDOCHOTOMY (WITH OR WITHOUT CHOLECYSTECTOMY), including dilatation of sphincter of Oddi and removal of calculi
30427	01NOV1992	30JUN1995	N	LIVER, segmental resection of, for trauma (Ministerial Determination)
30427	01JUL1995	31DEC9999	Y	LIVER, segmental resection of, for trauma
30428	01NOV1992	30JUN1995	N	LIVER, lobectomy of, for trauma (Ministerial Determination)
30428	01JUL1995	31DEC9999	Y	LIVER, lobectomy of, for trauma
30429	01DEC1991	31DEC9999	Y	CHOLEDOCHOTOMY (WITH OR WITHOUT CHOLECYSTECTOMY), including dilatation of sphincter of Oddi and removal of calculi WITH CHOLEDOCHODUODENOSTOMY, CHOLEDOCHOGASTROSTOMY OR CHOLEDOCHOENTEROSTOMY
30430	01NOV1992	30JUN1995	N	LIVER, extended lobectomy (tri-segmental resection) of, for trauma (Ministerial Determination)
30430	01JUL1995	30JUN2021	N	LIVER, extended lobectomy (tri-segmental resection) of, for trauma
30430	01JUL2021	31DEC9999	Y	Liver, extended lobectomy of, or central resections of segments 4, 5 and 8, for trauma
30431	01NOV1992	30JUN2021	N	LIVER ABSCESS, open abdominal drainage of
30431	01JUL2021	31DEC9999	Y	Liver abscess, single, open or minimally invasive abdominal drainage of, excluding aftercare
30432	01DEC1991	31DEC9999	Y	TRANSDUODENAL OPERATION ON SPHINCTER OF ODDI, including dilatation, removal of calculi, sphincterotomy and sphincteroplasty with or without choledochotomy, with or without cholecystectomy
30433	01NOV1992	30JUN1995	N	LIVER ABSCESS (multiple), open abdominal drainage of (Ministerial Determination)
30433	01JUL1995	30JUN2021	N	LIVER ABSCESS (multiple), open abdominal drainage of
30433	01JUL2021	31DEC9999	Y	Liver abscess, multiple, open or minimally invasive abdominal drainage of, excluding aftercare
30434	01NOV1992	30JUN1995	N	HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles (Ministerial Determination)
30434	01JUL1995	31DEC9999	Y	HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles
30435	01DEC1991	31DEC9999	Y	CHOLECYSTODUODENOSTOMY, CHOLECYSTOGASTROSTOMY or CHOLECYSTOENTEROSTOMY with or without enteroenterostomy
30436	01NOV1992	30JUN1995	N	HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty (Ministerial Determination)
30436	01JUL1995	31DEC9999	Y	HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty
30437	01NOV1992	30JUN1995	N	HYDATID CYST OF LIVER, total excision of, by cysto-pericystectomy (membrane plus fibrous wall) (Ministerial Determination)
30437	01JUL1995	31DEC9999	Y	HYDATID CYST OF LIVER, total excision of, by cysto-pericystectomy (membrane plus fibrous wall)
30438	01DEC1991	31OCT1996	N	HYDATID CYST OF LIVER, excision of, with drainage and excision of liver tissue
30438	01NOV1996	31DEC9999	Y	HYDATID CYST OF LIVER, excision of, with drainage and excision of liver tissue
30439	01NOV1992	31OCT1996	N	OPERATIVE CHOLANGIOGRAPHY or operative pancreatography or intra operative ultrasound (including 1 or more examinations performed during the 1 operation)
30439	01NOV1996	30JUN2021	N	OPERATIVE CHOLANGIOGRAPHY OR OPERATIVE PANCREATOGRAPHY OR INTRA OPERATIVE ULTRASOUND of the biliary tract (including 1 or more examinations performed during the 1 operation)
30439	01JUL2021	31DEC9999	Y	Intraoperative ultrasound of biliary tract, or operative cholangiography, if the service: (a) is performed in association with an intra-abdominal procedure; and (b) is not associated with a service to which item 30442 or 30445 applies
30440	01NOV1992	30APR2005	N	CHOLANGIOGRAM, percutaneous transhepatic, and biliary drainage, using interventional imaging techniques - but not including imaging
30440	01MAY2005	31DEC9999	Y	CHOLANGIOGRAM, percutaneous transhepatic, and insertion of biliary drainage tube, using interventional imaging techniques - but not including imaging, not being a service associated with a service to which item 30451 applies
30441	01DEC1991	31OCT1996	N	INTRA OPERATIVE ULTRASOUND for staging of intra abdominal tumours
30441	01NOV1996	30JUN2021	N	INTRA OPERATIVE ULTRASOUND for staging of intra abdominal tumours
30441	01JUL2021	31DEC9999	Y	Intraoperative ultrasound for staging of intra-abdominal tumours
30442	01NOV1992	31DEC9999	Y	CHOLEDOCHOSCOPY in conjunction with another procedure
30443	01NOV1992	30JUN2021	N	CHOLECYSTECTOMY
30443	01JUL2021	31DEC9999	Y	Cholecystectomy, by any approach, without cholangiogram
30444	01DEC1991	31DEC9999	Y	OESOPHAGOSCOPY (not covered by Item 41816 or 41822), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (one or more such procedures), with endoscopic sclerosing injection of oesophageal or gastric varices, not associated with Item 30441 or 30447
30445	01NOV1992	30JUN1995	N	LAPAROSCOPIC CHOLECYSTECTOMY (Ministerial Determination)
30445	01JUL1995	30JUN2021	N	LAPAROSCOPIC CHOLECYSTECTOMY
30445	01JUL2021	31DEC9999	Y	Cholecystectomy, by any approach, with attempted or completed cholangiogram or intraoperative ultrasound of the biliary system, when performed via laparoscopic or open approach or when conversion from laparoscopic to open approach is required
30446	01NOV1992	30JUN1995	N	LAPAROSCOPIC CHOLECYSTECTOMY when procedure is completed by laparotomy (Ministerial Determination)
30446	01JUL1995	31DEC9999	Y	LAPAROSCOPIC CHOLECYSTECTOMY when procedure is completed by laparotomy
30447	01DEC1991	31DEC9999	Y	OESOPHAGOSCOPY (not covered by Item 41816, 41822 or 41825), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (one or more such procedures), with one or more of the following procedures polypectomy, removal of foreign body, diathermy coagulation of bleeding upper gastrointestinal lesions, not associated with Item 30441 or 30444
30448	01NOV1992	30JUN1995	N	LAPAROSCOPIC CHOLECYSTECTOMY, involving removal of common duct calculi via the cystic duct (Ministerial Determination)
30448	01JUL1995	30JUN2021	N	LAPAROSCOPIC CHOLECYSTECTOMY, involving removal of common duct calculi via the cystic duct
30448	01JUL2021	31DEC9999	Y	Cholecystectomy, by any approach, involving removal of common duct calculi via the cystic duct, with or without stent insertion
30449	01NOV1992	30JUN1995	N	LAPAROSCOPIC CHOLECYSTECTOMY with removal of common duct calculi via laparoscopic choledochotomy (Ministerial Determination)
30449	01JUL1995	30JUN2021	N	LAPAROSCOPIC CHOLECYSTECTOMY with removal of common duct calculi via laparoscopic choledochotomy
30449	01JUL2021	31DEC9999	Y	Cholecystectomy with removal of common duct calculi via choledochotomy, by any approach, with or without insertion of a stent
30450	01DEC1991	31OCT1996	N	CALCULUS OF BILIARY OR RENAL TRACT, extraction of, using interventional imaging techniques - not being a service associated with a service to which items 36627, 36630, 36645 or 36648 applies
30450	01NOV1996	31OCT2020	N	CALCULUS OF BILIARY OR RENAL TRACT, extraction of, using interventional imaging techniques - not being a service associated with a service to which items 36627, 36630, 36645 or 36648 applies
30450	01NOV2020	30JUN2021	N	Calculus of biliary or renal tract, extraction of, using interventional imaging techniques - other than a service associated with a service to which items 36627 or 36645 applies
30450	01JUL2021	31DEC9999	Y	Calculus of biliary tract, extraction of, using interventional imaging techniques
30451	01NOV1992	30APR2005	N	BILIARY DRAINAGE TUBE, exchange of, using interventional imaging techniques - but not including imaging
30451	01MAY2005	31DEC9999	Y	BILIARY DRAINAGE TUBE, exchange of, using interventional imaging techniques - but not including imaging, not being a service associated with a service to which item 30440 applies
30452	01NOV1992	30JUN1995	N	CHOLEDOCHOSCOPY with balloon dilation of a stricture or passage of stent or extraction of calculi (Ministerial Determination)
30452	01JUL1995	31DEC9999	Y	CHOLEDOCHOSCOPY with balloon dilation of a stricture or passage of stent or extraction of calculi
30453	01DEC1991	31DEC9999	Y	ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
30454	01NOV1992	30JUN2021	N	CHOLEDOCHOTOMY (with or without cholecystectomy), with or without removal of calculi
30454	01JUL2021	31DEC9999	Y	Choledochotomy without cholecystectomy, with or without removal of calculi
30455	01NOV1992	30JUN2021	N	CHOLEDOCHOTOMY (with or without cholecystectomy), with removal of calculi including biliary intestinal anastomosis
30455	01JUL2021	31DEC9999	Y	Choledochotomy with cholecystectomy, with removal of calculi, including biliary intestinal anastomosis
30456	01DEC1991	31DEC9999	Y	ENDOSCOPIC SPHINCTEROTOMY with or without extraction of stones from common bile duct
30457	01NOV1992	30JUN1995	N	CHOLEDOCHOTOMY, intrahepatic, involving removal of intrahepatic bile duct calculi (Ministerial Determination)
30457	01JUL1995	31DEC9999	Y	CHOLEDOCHOTOMY, intrahepatic, involving removal of intrahepatic bile duct calculi
30458	01NOV1992	31DEC9999	Y	TRANSDUODENAL OPERATION ON SPHINCTER OF ODDI, involving 1 or more of, removal of calculi, sphincterotomy, sphincteroplasty, biopsy, local excision of peri-ampullary or duodenal tumour, sphincteroplasty of the pancreatic duct, pancreatic duct septoplasty, with or without choledochotomy
30459	01DEC1991	31DEC9999	Y	BILIARY MANOMETRY
30460	01NOV1992	31DEC9999	Y	CHOLECYSTODUODENOSTOMY, CHOLECYSTOENTEROSTOMY, CHOLEDOCHOJEJUNOSTOMY or Roux-en-Y as a bypass procedure when no prior biliary surgery performed
30461	01NOV1992	31OCT2000	N	RADICAL RESECTION of porta hepatis for gall bladder or common bile duct carcinoma with biliary-enteric anastomoses, not being a service associated with a service to which item 30443, 30454, 30455, 30458 or 30460 applies
30461	01NOV2000	30JUN2021	N	RADICAL RESECTION of porta hepatis with biliary-enteric anastomoses, not being a service associated with a service to which item 30443, 30454, 30455, 30458 or 30460 applies
30461	01JUL2021	31DEC9999	Y	Radical resection of porta hepatis (including associated neuro-lymphatic tissue), for cancer, suspected cancer or choledochal cyst, including bile duct excision and biliary-enteric anastomoses, other than a service associated with a service to which item 30440, 30451 or 31454 applies
30462	01DEC1991	31DEC9999	Y	ENDOSCOPIC BILIARY DILATATION
30463	01NOV1992	30JUN1995	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, with 2 duct anastomoses (Ministerial Determination)
30463	01JUL1995	31OCT2000	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, with 2 duct anastomoses
30463	01NOV2000	30JUN2021	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, with 2 duct anastomoses
30463	01JUL2021	31DEC9999	Y	Radical resection of common hepatic duct and right and left hepatic ducts, with 2 duct anastomoses, for cancer, suspected cancer or choledochal cyst
30464	01NOV1991	30OCT1992	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, involving more than 2 anastomoses or resection of segment or major portion of segment of liver (Ministerial Determination)
30464	31OCT1992	30JUN1995	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, involving more than 2 anastomoses or resection of segment or major portion of segment of liver (Ministerial Determination)
30464	01JUL1995	31OCT2000	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, involving more than 2 anastomoses or resection of segment or major portion of segment of liver
30464	01NOV2000	30JUN2021	N	RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, involving more than 2 anastomoses or resection of segment or major portion of segment of liver
30464	01JUL2021	31DEC9999	Y	Radical resection of common hepatic duct and right and left hepatic ducts, for cancer, suspected cancer or choledochal cyst, involving either or both of the following:(a) more than 2 anastomoses;(b) resection of segment (or major portion of segment) of liver;
30465	01DEC1991	31DEC9999	Y	BILE DUCT, ENDOSCOPIC STENTING OF (including endoscopy and dilatation)
30466	01NOV1992	30JUN1995	N	INTRAHEPATIC biliary bypass of left hepatic ductal system by Roux-en-Y loop to peripheral ductal system (Ministerial Determination)
30466	01JUL1995	31DEC9999	Y	INTRAHEPATIC biliary bypass of left hepatic ductal system by Roux-en-Y loop to peripheral ductal system
30467	01NOV1992	30JUN1995	N	INTRAHEPATIC BYPASS of right hepatic ductal system by Roux-en-Y loop to peripheral ductal system (Ministerial Determination)
30467	01JUL1995	31DEC9999	Y	INTRAHEPATIC BYPASS of right hepatic ductal system by Roux-en-Y loop to peripheral ductal system
30468	01DEC1991	31DEC9999	Y	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (initial procedure)
30469	01NOV1992	30JUN1995	N	BILIARY STRICTURE, repair of, after 1 or more operations on the biliary tree (Ministerial Determination)
30469	01JUL1995	31DEC9999	Y	BILIARY STRICTURE, repair of, after 1 or more operations on the biliary tree
30470	01NOV1992	30JUN1995	N	BILE DUCT FISTULA, repair of, following previous bile duct surgery (Ministerial Determination)
30470	01JUL1995	31DEC9999	Y	BILE DUCT FISTULA, repair of, following previous bile duct surgery
30471	01DEC1991	31DEC9999	Y	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (repeat procedure)
30472	01NOV1992	30JUN1995	N	HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to transection of bile duct or ducts (Ministerial Determination)
30472	01JUL1995	31OCT2000	N	HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to transection of bile duct or ducts
30472	01NOV2000	30JUN2021	N	HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to partial or total transection of bile duct or ducts
30472	01JUL2021	31DEC9999	Y	Repair of bile duct injury, including immediate reconstruction, other than a service associated with a service to which item 30584 applies
30473	01NOV1992	31OCT2017	N	OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with or without biopsy, not being a service associated with a service to which item 30476 or 30478 applies
30473	01NOV2017	28FEB2023	N	Oesophagoscopy (not being a service to which item 41816 or 41822 applies), gastroscopy, duodenoscopy or panendoscopy (1 or more such procedures), with or without biopsy, not being a service associated with a service to which item 30478 or 30479 applies.
30473	01MAR2023	31DEC9999	Y	Oesophagoscopy (not being a service associated with a service to which item 41822 applies), gastroscopy, duodenoscopy or panendoscopy (1 or more such procedures), with or without biopsy, not being a service associated with a service to which item 30478 or 30479 applies.
30474	01DEC1991	31DEC9999	Y	ENDOSCOPIC LASER THERAPY for malignancy of upper or lower gastrointestinal tract
30475	01NOV1992	31OCT2017	N	ENDOSCOPY with balloon dilatation of gastric or gastroduodenal stricture
30475	01NOV2017	31DEC9999	Y	Endoscopic dilatation of stricture of upper gastrointestinal tract (including the use of imaging intensification where clinically indicated)
30476	01NOV1992	31OCT1995	N	OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with endoscopic sclerosing injection of oesophageal or gastric varices, not being a service associated with a service to which item 30473 or 30478 applies
30476	01NOV1995	31DEC9999	Y	OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with endoscopic sclerosing injection or banding of oesophageal or gastric varices, not being a service associated with a service to which item 30473 or 30478 applies
30477	01DEC1991	31DEC9999	Y	VAGOTOMY - TRUNKAL
30478	01NOV1992	31OCT2017	N	OESOPHAGOSCOPY (not being a service to which item 41816, 41822 or 41825 applies), gastroscopy, duodenoscopy or panendoscopy (1 or more such procedures), with 1 or more of the following endoscopic procedures - polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation, or sclerosing injection of bleeding upper gastrointestinal lesions, not being a service associated with a service to which item 30473 or 30476 applies
30478	01NOV2017	28FEB2023	N	Oesophagoscopy (other than a service to which item 41816, 41822 or 41825 applies), gastroscopy, duodenoscopy, panendoscopy or push enteroscopy, one or more such procedures, if: (a) the procedures are performed using one or more of the following endoscopic procedures: (i) polypectomy; (ii) sclerosing or adrenalin injections; (iii) banding; (iv) endoscopic clips; (v) haemostatic powders; (vi) diathermy; (vii) argon plasma coagulation; and (b) the procedures are for the treatment of one or more of the following: (i) upper gastrointestinal tract bleeding; (ii) polyps; (iii) removal of foreign body; (iv) oesophageal or gastric varices; (v) peptic ulcers; (vi) neoplasia; (vii) benign vascular lesions; (viii) strictures of the gastrointestinal tract; (ix) tumorous overgrowth through or over oesophageal stents; other than a service associated with a service to which item 30473 or 30479 applies
30478	01MAR2023	31DEC9999	Y	Oesophagoscopy (other than a service associated with a service to which item 41822 or 41825 applies), gastroscopy, duodenoscopy, panendoscopy or push enteroscopy, one or more such procedures, if: (a) the procedures are performed using one or more of the following endoscopic procedures: (i) polypectomy; (ii) sclerosing or adrenalin injections; (iii) banding; (iv) endoscopic clips; (v) haemostatic powders; (vi) diathermy; (vii) argon plasma coagulation; and (b) the procedures are for the treatment of one or more of the following: (i) upper gastrointestinal tract bleeding; (ii) polyps; (iii) removal of foreign body; (iv) oesophageal or gastric varices; (v) peptic ulcers; (vi) neoplasia; (vii) benign vascular lesions; (viii) strictures of the gastrointestinal tract; (ix) tumorous overgrowth through or over oesophageal stents; other than a service associated with a service to which item 30473 or 30479 applies
30479	01NOV1992	30JUN1993	N	ENDOSCOPIC LASER THERAPY for malignancy of upper or lower gastrointestinal tract
30479	01JUL1993	30APR2010	N	ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the gastrointestinal tract
30479	01MAY2010	31OCT2017	N	ENDOSCOPY with LASER THERAPY or ARGON PLASMA COAGULATION, for the treatment of neoplasia, benign vascular lesions, strictures of the gastrointestinal tract, tumorous overgrowth through or over oesophageal stents, peptic ulcers, angiodysplasia, gastric antral vascular ectasia (GAVE) or post-polypectomy bleeding, 1 or more of
30479	01NOV2017	31DEC9999	Y	Endoscopy with laser therapy, for the treatment of one or more of the following: (a) neoplasia; (b) benign vascular lesions; (c) strictures of the gastrointestinal tract; (d) tumorous overgrowth through or over oesophageal stents; (e) peptic ulcers; (f) angiodysplasia; (g) gastric antral vascular ectasia; (h) post-polypectomy bleeding; other than a service associated with a service to which item 30473 or 30478 applies
30480	01DEC1991	31DEC9999	Y	VAGOTOMY SELECTIVE
30481	01NOV1992	31OCT1997	N	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (initial procedure)
30481	01NOV1997	30APR2018	N	PERCUTANEOUS GASTROSTOMY (initial procedure), including any associated imaging services
30481	01MAY2018	31DEC9999	Y	PERCUTANEOUS GASTROSTOMY (initial procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss
30482	01NOV1992	31OCT1997	N	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (repeat procedure)
30482	01NOV1997	30APR2018	N	PERCUTANEOUS GASTROSTOMY (repeat procedure), including any associated imaging services
30482	01MAY2018	31DEC9999	Y	PERCUTANEOUS GASTROSTOMY (repeat procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss
30483	01DEC1991	31OCT1996	N	GASTROSTOMY BUTTON, non-endoscopic insertion of, or non-endoscopic replacement of
30483	01NOV1996	31AUG2015	N	GASTROSTOMY BUTTON, non-endoscopic insertion of, or non-endoscopic replacement of
30483	01SEP2015	30APR2018	N	GASTROSTOMY BUTTON, CAECOSTOMY ANTEGRADE ENEMA DEVICE (CHAIT etc) or STOMAL INDWELLING DEVICE non-endoscopic insertion of, or non-endoscopic replacement of, on a person 10 years of age or over
30483	01MAY2018	30JUN2021	N	GASTROSTOMY BUTTON, CAECOSTOMY ANTEGRADE ENEMA DEVICE (CHAIT etc.) or STOMAL INDWELLING DEVICE: (a) non-endoscopic insertion of; or (b) non-endoscopic replacement of; on a person 10 years of age or over, excluding the insertion of a device for the purpose of facilitating weight loss
30483	01JUL2021	31DEC9999	Y	Gastrostomy button, caecostomy antegrade enema device (chait etc.) or stomal indwelling device: (a) non-endoscopic insertion of; or (b) non-endoscopic replacement of; on a patient 10 years of age or over, excluding the insertion of a device for the purpose of facilitating weight loss
30484	01NOV1992	29FEB2024	N	ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
30484	01MAR2024	31DEC9999	Y	Endoscopic retrograde cholangiopancreatography, other than a service to which item 30664 or 30665 applies
30485	01NOV1992	31DEC9999	Y	ENDOSCOPIC SPHINCTEROTOMY with or without extraction of stones from common bile duct
30486	01DEC1991	31DEC9999	Y	VAGOTOMY, HIGHLY SELECTIVE with pyloroplasty or gastroenterostomy or dilatation of pylorus
30487	01NOV1992	30JUN2008	N	SMALL BOWEL INTUBATION with biopsy
30487	01JUL2008	31DEC9999	Y	SMALL BOWEL INTUBATION with biopsy, as an independent procedure
30488	01NOV1992	31DEC9999	Y	SMALL BOWEL INTUBATION as an independent procedure
30489	01DEC1991	31DEC9999	Y	GASTRIC REDUCTION OR GASTROPLASTY for obesity, by any method
30490	01NOV1992	31DEC9999	Y	OESOPHAGEAL PROSTHESIS, insertion of, including endoscopy and dilatation
30491	01NOV1992	31DEC9999	Y	BILE DUCT, ENDOSCOPIC STENTING OF (including endoscopy and dilatation)
30492	01DEC1991	30APR2005	N	GASTRIC BYPASS FOR OBESITY, including anastomosis, by any method
30492	01MAY2005	31DEC9999	Y	BILE DUCT, PERCUTANEOUS STENTING OF (including dilatation when performed), using interventional imaging techniques - but not including imaging
30493	01NOV1992	31DEC9999	Y	BILIARY MANOMETRY
30494	01NOV1992	31DEC9999	Y	ENDOSCOPIC BILIARY DILATATION
30495	01DEC1991	30APR2005	N	GASTROENTEROSTOMY (INCLUDING GASTRODUODENOSTOMY) OR ENTEROCOLOSTOMY OR ENTEROENTEROSTOMY
30495	01MAY2005	31DEC9999	Y	PERCUTANEOUS BILIARY DILATATION for biliary stricture, using interventional imaging techniques - but not including imaging
30496	01NOV1992	31DEC9999	Y	VAGOTOMY, truncal or selective, with or without pyloroplasty or gastroenterostomy
30497	01NOV1992	31DEC9999	Y	VAGOTOMY and ANTRECTOMY
30498	01DEC1991	31DEC9999	Y	GASTROENTEROSTOMY or GASTRODUODENOSTOMY, reconstruction of
30499	01NOV1992	31DEC9999	Y	VAGOTOMY, highly selective
30500	01NOV1992	31DEC9999	Y	VAGOTOMY, highly selective with duodenoplasty for peptic stricture
30501	01DEC1991	31DEC9999	Y	PANCREATIC CYST ANASTOMOSIS TO STOMACH OR DUODENUM
30502	01NOV1992	31DEC9999	Y	VAGOTOMY, highly selective, with dilatation of pylorus
30503	01NOV1992	31DEC9999	Y	VAGOTOMY or ANTRECTOMY, or both, for peptic ulcer following previous operation for peptic ulcer
30504	01DEC1991	31DEC9999	Y	PARTIAL GASTRECTOMY, with or without gastrojejunostomy
30505	01NOV1992	31DEC9999	Y	BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision
30506	01NOV1992	31DEC9999	Y	BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision, and vagotomy and pyloroplasty or gastroenterostomy
30507	01DEC1991	31DEC9999	Y	GASTRECTOMY, TOTAL, FOR BENIGN DISEASE
30508	01NOV1992	31DEC9999	Y	BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision, and highly selective vagotomy
30509	01NOV1992	31DEC9999	Y	BLEEDING PEPTIC ULCER, control of, involving gastric resection (other than wedge resection)
30510	01DEC1991	31DEC9999	Y	GASTRECTOMY, RADICAL SUBTOTAL, for carcinoma
30511	01NOV1992	31DEC9999	Y	(see Item 31441 for repair, revision or replacement of implanted reservoir associated with adjustable gastric band) (see Item 14215 for adding or removing fluid via the implanted reservoir to adjust the tightness of the gastric band) MORBID OBESITY, gastric reduction or gastroplasty for, by any method
30512	01NOV1992	31DEC9999	Y	MORBID OBESITY, gastric bypass for, by any method including anastomosis
30513	01DEC1991	31DEC9999	Y	GASTRECTOMY, RADICAL TOTAL, for carcinoma
30514	01NOV1992	30JUN1993	N	MORBID OBESITY, reversal surgical procedure
30514	01JUL1993	30APR2005	N	MORBID OBESITY, surgical reversal of procedure to which item 30511 or 30512 applies
30514	01MAY2005	31DEC9999	Y	MORBID OBESITY, surgical reversal, by any method, of procedure to which item 30511 or 30512 applies
30515	01NOV1992	30JUN2013	N	GASTROENTEROSTOMY (INCLUDING GASTRODUODENOSTOMY) OR ENTEROCOLOSTOMY OR ENTEROENTEROSTOMY
30515	01JUL2013	30JUN2021	N	Gastroenterostomy (including gastroduodenostomy) or enterocolostomy or enteroenterostomy, not being a service to which any of items 31569 to 31581 apply
30515	01JUL2021	31DEC9999	Y	Gastroenterostomy (including gastroduodenostomy), enterocolostomy or enteroenterostomy, as an independent procedure or in combination with another procedure, only if required for irresectable obstruction, other than a service to which any of items 31569 to 31581 apply
30516	01DEC1991	31DEC9999	Y	PYLOROPLASTY, INFANT, OR PYLOROMYOTOMY (RAMSTEDT'S operation)
30517	01NOV1992	30JUN2021	N	GASTROENTEROSTOMY, PYLOROPLASTY or GASTRODUODENOSTOMY, reconstruction of
30517	01JUL2021	31DEC9999	Y	Revision of gastroenterostomy, pyloroplasty or gastroduodenostomy
30518	01NOV1992	30JUN2013	N	PARTIAL GASTRECTOMY
30518	01JUL2013	31DEC9999	Y	Partial gastrectomy, not being a service associated with a service to which any of items 31569 to 31581 apply
30519	01DEC1991	31DEC9999	Y	ENTEROSTOMY or COLOSTOMY, closure of not involving resection of bowel
30520	01NOV1992	30JUN2021	N	GASTRIC TUMOUR, removal of, by local excision, not being a service to which item 30518 applies
30520	01JUL2021	31DEC9999	Y	Gastric tumour, 2 cm or greater in diameter, removal of, by local excision, by laparoscopic or open approach, including any associated anastomosis, excluding polypectomy, other than a service to which item 30518 applies
30521	01NOV1992	31DEC9999	Y	GASTRECTOMY, TOTAL, for benign disease
30522	01DEC1991	31DEC9999	Y	COLOSTOMY OR ILEOSTOMY, refashioning of
30523	01NOV1992	31DEC9999	Y	GASTRECTOMY, SUBTOTAL RADICAL, for carcinoma, (including splenectomy when performed)
30524	01NOV1992	31DEC9999	Y	GASTRECTOMY, TOTAL RADICAL, for carcinoma (including extended node dissection and distal pancreatectomy and splenectomy when performed)
30525	01DEC1991	31DEC9999	Y	INTUSSUSCEPTION, reduction of, by fluid
30526	01NOV1992	30JUN2021	N	GASTRECTOMY, TOTAL, and including lower oesophagus, performed by left thoraco-abdominal incision or opening of diaphragmatic hiatus, (including splenectomy when performed)
30526	01JUL2021	31DEC9999	Y	Gastrectomy, total, and removal of lower oesophagus, performed by open or minimally invasive approach, with anastomosis in the mediastinum, including any of the following (if performed):(a) distal pancreatectomy;(b) nodal dissection;(c) splenectomy
30527	01NOV1992	31DEC9999	Y	ANTIREFLUX OPERATION by fundoplasty, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus not being a service to which item 30601 applies
30528	01DEC1991	31DEC9999	Y	INTUSSUSCEPTION, LAPAROTOMY and resection of
30529	01NOV1992	31DEC9999	Y	ANTIREFLUX operation by fundoplasty, with OESOPHAGOPLASTY for stricture or short oesophagus
30530	01NOV1992	31DEC9999	Y	ANTIREFLUX operation by cardiopexy, with or without fundoplasty
30531	01DEC1991	31DEC9999	Y	SMALL INTESTINE, resection of, without anastomosis (including formation of stoma)
30532	01NOV1992	31OCT2000	N	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus
30532	01NOV2000	30JUN2021	N	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, by laparoscopy or open operation
30532	01JUL2021	31DEC9999	Y	Oesophagogastric myotomy (Hellers operation) by endoscopic, abdominal or thoracic approach, whether performed by open or minimally invasive approach, including fundoplication when performed laparoscopically
30533	01NOV1992	31OCT2000	N	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus
30533	01NOV2000	31DEC9999	Y	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus, by laparoscopy or open operation
30534	01DEC1991	31DEC9999	Y	SMALL INTESTINE, resection of, with anastomosis
30535	01NOV1992	30JUN1993	N	OESOPHAGECTOMY with gastric reconstruction by abdominal mobilisation and right thoracotomy
30535	01JUL1993	31DEC9999	Y	OESOPHAGECTOMY with gastric reconstruction by abdominal mobilisation and thoracotomy
30536	01NOV1992	30JUN1993	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - 1 surgeon
30536	01JUL1993	31OCT2000	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck - 1 surgeon
30536	01NOV2000	31DEC9999	Y	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest - 1 surgeon
30537	01DEC1991	31DEC9999	Y	APPENDICECTOMY, not covered by Item 30543
30538	01NOV1992	30JUN1993	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - conjoint surgery, principal surgeon (including aftercare)
30538	01JUL1993	31OCT2000	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck - conjoint surgery, principal surgeon (including aftercare)
30538	01NOV2000	31DEC9999	Y	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest- conjoint surgery, principal surgeon (including aftercare)
30539	01NOV1992	30JUN1993	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - conjoint surgery, co-surgeon
30539	01JUL1993	31OCT2000	N	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck - conjoint surgery, co-surgeon
30539	01NOV2000	31DEC9999	Y	OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest - conjoint surgery, co-surgeon
30540	01DEC1991	31DEC9999	Y	APPENDICECTOMY, not covered by Item 30543
30541	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - 1 surgeon
30542	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - conjoint surgery, principal surgeon (including aftercare)
30543	01DEC1991	31DEC9999	Y	APPENDICECTOMY, when performed in conjunction with any other intraabdominal procedure through the same incision
30544	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - conjoint surgery, co-surgeon
30545	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - 1 surgeon
30546	01DEC1991	31DEC9999	Y	SMALL BOWEL INTUBATION with biopsy
30547	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - conjoint surgery, principal surgeon (including aftercare)
30548	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - conjoint surgery, co-surgeon
30549	01DEC1991	31DEC9999	Y	SMALL BOWEL INTUBATION as an independent procedure
30550	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - 1 surgeon
30551	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - conjoint surgery, principal surgeon (including aftercare)
30552	01DEC1991	31DEC9999	Y	PANCREATECTOMY, PARTIAL
30553	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - conjoint surgery, co-surgeon
30554	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with reconstruction by free jejunal graft - 1 surgeon
30555	01DEC1991	31DEC9999	Y	PANCREATICODUODENECTOMY, WHIPPLE'S OPERATION
30556	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with reconstruction by free jejunal graft - conjoint surgery, principal surgeon (including aftercare)
30557	01NOV1992	31DEC9999	Y	OESOPHAGECTOMY with reconstruction by free jejunal graft - conjoint surgery, co-surgeon
30558	01DEC1991	31DEC9999	Y	PANCREATIC ABSCESS, drainage of, excluding aftercare
30559	01NOV1992	31DEC9999	Y	OESOPHAGUS, local excision for tumour of
30560	01NOV1992	30JUN2021	N	OESOPHAGEAL PERFORATION, repair of, by thoracotomy
30560	01JUL2021	31DEC9999	Y	Oesophageal perforation, repair of, by abdominal or thoracic approach, including thoracic drainage
30561	01DEC1991	31DEC9999	Y	ANASTOMOSIS OF PANCREATIC DUCT TO BOWEL
30562	01NOV1992	31AUG2015	N	ENTEROSTOMY or COLOSTOMY, closure of not involving resection of bowel
30562	01SEP2015	30JUN2021	N	ENTEROSTOMY or COLOSTOMY, closure of (not involving resection of bowel), on a person 10 years of age or over
30562	01JUL2021	31DEC9999	Y	Enterostomy or colostomy, closure of (not involving resection of bowel), on a patient 10 years of age or over
30563	01NOV1992	31AUG2015	N	COLOSTOMY OR ILEOSTOMY, refashioning of
30563	01SEP2015	31DEC9999	Y	COLOSTOMY OR ILEOSTOMY, refashioning of, on a person 10 years of age or over
30564	01DEC1991	30APR1994	N	SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA
30564	01MAY1994	31DEC9999	Y	SMALL BOWEL STRICTUREPLASTY for chronic inflammatory bowel disease
30565	01NOV1992	31DEC9999	Y	SMALL INTESTINE, resection of, without anastomosis (including formation of stoma)
30566	01NOV1992	31AUG2015	N	SMALL INTESTINE, resection of, with anastomosis
30566	01SEP2015	31DEC9999	Y	SMALL INTESTINE, resection of, with anastomosis, on a person 10 years of age or over
30567	01DEC1991	31DEC9999	Y	SPLENECTOMY FOR TRAUMA
30568	01NOV1992	31DEC9999	Y	INTRAOPERATIVE ENTEROTOMY for visualisation of the small intestine by endoscopy
30569	01NOV1992	31DEC9999	Y	ENDOSCOPIC EXAMINATION of SMALL BOWEL with flexible endoscope passed at laparotomy, with or without biopsies
30570	01DEC1991	31DEC9999	Y	SPLENECTOMY, OTHER THAN FOR TRAUMA
30571	01NOV1992	31AUG2015	N	APPENDICECTOMY, not being a service to which item 30574 applies
30571	01SEP2015	31DEC9999	Y	APPENDICECTOMY, not being a service to which item 30574 applies on a person 10 years of age or over
30572	01NOV1992	31AUG2015	N	LAPAROSCOPIC APPENDICECTOMY
30572	01SEP2015	31DEC9999	Y	LAPAROSCOPIC APPENDICECTOMY, on a person 10 years of age or over
30573	01DEC1991	31DEC9999	Y	RETROPERITONEAL TUMOUR, removal of
30574	01NOV1992	30JUN2021	N	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item APPENDICECTOMY, when performed in conjunction with any other intraabdominal procedure through the same incision
30574	01JUL2021	31DEC9999	Y	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item Appendicectomy, when performed in conjunction with another intra-abdominal procedure and during which a specimen is collected and sent for pathological testing
30575	01NOV1992	31DEC9999	Y	PANCREATIC ABSCESS, laparotomy and external drainage of, not requiring retro-pancreatic dissection
30576	01DEC1991	31DEC9999	Y	RETROPERITONEAL ABSCESS, drainage of, not involving laparotomy
30577	01NOV1992	30JUN2021	N	PANCREATIC NECROSECTOMY for PANCREATIC NECROSIS or ABSCESS FORMATION requiring major pancreatic or retro-pancreatic dissection, excluding aftercare
30577	01JUL2021	31DEC9999	Y	Initial pancreatic necrosectomy by open, laparoscopic or endoscopic approach, excluding aftercare
30578	01NOV1992	31DEC9999	Y	ENDOCRINE TUMOUR, exploration of pancreas or duodenum, followed by local excision of pancreatic tumour
30579	01DEC1991	31DEC9999	Y	LAPAROSCOPY, diagnostic
30580	01NOV1992	31DEC9999	Y	ENDOCRINE TUMOUR, exploration of pancreas or duodenum, followed by local excision of duodenal tumour
30581	01NOV1992	31DEC9999	Y	ENDOCRINE TUMOUR, exploration of pancreas or duodenum for, but no tumour found
30582	01DEC1991	31DEC9999	Y	LAPAROSCOPY with biopsy
30583	01NOV1992	30JUN2021	N	DISTAL PANCREATECTOMY
30583	01JUL2021	31DEC9999	Y	Distal pancreatectomy with splenic preservation, by open or minimally invasive approach
30584	01NOV1992	30JUN2021	N	PANCREATICO-DUODENECTOMY, WHIPPLE'S OPERATION, with or without preservation of pylorus
30584	01JUL2021	31DEC9999	Y	Pancreatico duodenectomy (Whipples procedure), with or without preservation of pylorus, including any of the following (if performed):(a) cholecystectomy;(b) pancreatico-biliary anastomosis;(c) gastro-jejunal anastomosis
30585	01DEC1991	31DEC9999	Y	LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedure one or more procedures with or without biopsy not associated with Item 30582, 35687 or 35688
30586	01NOV1992	31OCT1996	N	PANCREATIC CYST ANASTOMOSIS TO STOMACH OR DUODENUM
30586	01NOV1996	31DEC9999	Y	PANCREATIC CYST ANASTOMOSIS TO STOMACH OR DUODENUM - by open or endoscopic means
30587	01NOV1992	31DEC9999	Y	PANCREATIC CYST, anastomosis to Roux loop of jejunum
30588	01DEC1991	31DEC9999	Y	PARACENTESIS ABDOMINIS
30589	01NOV1992	31DEC9999	Y	PANCREATICO-JEJUNOSTOMY for pancreatitis or trauma
30590	01NOV1992	31DEC9999	Y	PANCREATICO-JEJUNOSTOMY following previous pancreatic surgery
30591	01DEC1991	31DEC9999	Y	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not covered by Items 30595, 30624 or 30625
30592	01DEC1991	31DEC9999	Y	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not covered by Items 30595, 30624 or 30625
30593	01NOV1992	31DEC9999	Y	PANCREATECTOMY, near total or total (including duodenum), with or without splenectomy
30594	01NOV1992	31DEC9999	Y	PANCREATECTOMY for pancreatitis following previously attempted drainage procedure or partial resection
30595	01DEC1991	31DEC9999	Y	STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection
30596	01NOV1992	31OCT2000	N	SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA
30596	01NOV2000	31DEC9999	Y	SPLENORRHAPHY OR PARTIAL SPLENECTOMY
30597	01NOV1992	31DEC9999	Y	SPLENECTOMY
30598	01DEC1991	31DEC9999	Y	DIAPHRAGMATIC HERNIA, TRAUMATIC, repair of
30599	01NOV1992	31DEC9999	Y	SPLENECTOMY, for massive spleen (weighing more than 1500 grams) or involving thoraco-abdominal incision
30600	01NOV1992	30JUN2021	N	DIAPHRAGMATIC HERNIA, TRAUMATIC, repair of
30600	01JUL2021	31DEC9999	Y	Emergency repair of diaphragmatic laceration or hernia, following recent trauma, by any approach, including when performed in conjunction with another procedure indicated as a result of abdominal or chest trauma
30601	01DEC1991	30JUN2013	N	DIAPHRAGMATIC HERNIA, CONGENITAL repair of, by thoracic or abdominal approach
30601	01JUL2013	31AUG2015	N	Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply
30601	01SEP2015	30JUN2021	N	Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply, on a person 10 years of age or over
30601	01JUL2021	31DEC9999	Y	Diaphragmatic hernia, congenital, or delayed presentation of traumatic rupture, repair of, by thoracic or abdominal approach, on a patient 10 years of age or over, other than a service to which any of items 31569 to 31581 apply
30602	01NOV1992	31DEC9999	Y	PORTAL HYPERTENSION, porto-caval shunt for
30603	01NOV1992	31DEC9999	Y	PORTAL HYPERTENSION, meso-caval shunt for
30604	01DEC1991	31DEC9999	Y	ANTIREFLUX OPERATION involving insertion of prosthetic device - not associated with Item 30601, 30607, 30610 or 30613
30605	01NOV1992	31DEC9999	Y	PORTAL HYPERTENSION, selective spleno-renal shunt for
30606	01NOV1992	31DEC9999	Y	PORTAL HYPERTENSION, oesophageal transection via stapler or oversew of gastric varices with or without devascularisation
30607	01DEC1991	31DEC9999	Y	ANTIREFLUX OPERATION by fundoplasty, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus not covered by Item 30601 or 30604
30608	01SEP2015	30JUN2021	N	SMALL INTESTINE, resection of, with anastomosis, on a person under 10 years of age
30608	01JUL2021	31DEC9999	Y	Small intestine, resection of, with anastomosis, on a patient under 10 years of age
30609	01NOV1993	31AUG2015	N	FEMORAL OR INGUINAL HERNIA, laparoscopic repair of, not being a service associated with a service to which item 30612 or 30614 applies
30609	01SEP2015	31DEC9999	Y	FEMORAL OR INGUINAL HERNIA, laparoscopic repair of, not being a service associated with a service to which item 30614 applies
30610	01DEC1991	31DEC9999	Y	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus
30611	01SEP2015	30JUN2021	N	BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata - removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, on a person under 10 years of age , not being a service to which another item in this Group applies
30611	01JUL2021	31DEC9999	Y	Benign tumour of soft tissue (other than tumours of skin, cartilage and bone, simple lipomas covered by item 31345 and lipomata), removal of, by surgical excision, on a patient under 10 years of age, if the specimen excised is sent for histological confirmation of diagnosis, other than a service to which another item in this Group applies
30612	01NOV1992	31DEC9999	Y	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 30615 applies
30613	01DEC1991	31DEC9999	Y	OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus
30614	01NOV1992	31AUG2015	N	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which items 30403 or 30615 applies
30614	01SEP2015	31DEC9999	Y	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 30615 applies, on a person 10 years of age or over
30615	01NOV1992	31AUG2015	N	STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection
30615	01SEP2015	30JUN2021	N	STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection, on a person 10 years of age or over
30615	01JUL2021	31DEC9999	Y	Strangulated, incarcerated or obstructed hernia, repair of, without bowel resection, on a patient 10 years of age or over
30616	01DEC1991	31DEC9999	Y	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person under 10 years of age
30617	01DEC1991	31DEC9999	Y	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person under 10 years of age
30618	01SEP2015	30JUN2021	N	LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a person under 10 years of age
30618	01JUL2021	31DEC9999	Y	Lymph nodes of neck, selective dissection of one or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a patient under 10 years of age
30619	01SEP2015	30JUN2021	N	LAPAROSCOPIC SPLENECTOMY, on a person under 10 years of age
30619	01JUL2021	31DEC9999	Y	Laparoscopic splenectomy, on a patient under 10 years of age
30620	01DEC1991	30APR2016	N	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person 10 years of age or over
30620	01MAY2016	31DEC9999	Y	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other formal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies (G)
30621	01DEC1991	30APR2016	N	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person 10 years of age or over
30621	01MAY2016	31OCT2017	N	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other fromal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies (S)
30621	01NOV2017	30NOV2018	N	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other fromal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies
30621	01DEC2018	30JUN2021	N	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other formal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies
30621	01JUL2021	31DEC9999	Y	Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other repair, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service to which item 30651 or 30655 applies
30622	01SEP2015	30JUN2021	N	Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty or Drainage of pancreas on a person under 10 years of age
30622	01JUL2021	31DEC9999	Y	Caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckels diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus, pyloroplasty or drainage of pancreas, on a patient under 10 years of age
30623	01SEP2015	30JUN2021	N	LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) on a person under 10 years of age
30623	01JUL2021	31DEC9999	Y	Laparotomy involving division of peritoneal adhesions (if no other intra-abdominal procedure is performed), on a patient under 10 years of age
30624	01DEC1991	31DEC9999	Y	VENTRAL, INCISIONAL, LUMBAR OR RECURRENT HERNIA OR BURST ABDOMEN, repair of
30625	01DEC1991	31DEC9999	Y	VENTRAL, INCISIONAL, LUMBAR OR RECURRENT HERNIA OR BURST ABDOMEN, repair of
30626	01SEP2015	30JUN2021	N	LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours, on a person under 10 years of age
30626	01JUL2021	31DEC9999	Y	Laparotomy involving division of adhesions in association with another intra-abdominal procedure if the time taken to divide the adhesions is between 45 minutes and 2 hours, on a patient under 10 years of age
30627	01SEP2015	30JUN2021	N	LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure, on a person under 10 years of age
30627	01JUL2021	31DEC9999	Y	Laparoscopy, diagnostic, if no other intra-abdominal procedure is performed, on a patient under 10 years of age (H)
30628	01DEC1991	31DEC9999	Y	HYDROCELE, tapping of
30629	01NOV2020	31DEC9999	Y	Orchidectomy, radical, including spermatic cord, unilateral, for tumour, inguinal approach, without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635, 30641, 30643 or 30644 applies
30630	01NOV2020	30JUN2023	N	Insertion of testicular prosthesis, at least 6 months following orchidectomy
30630	01JUL2023	31DEC9999	Y	Insertion of testicular prosthesis, at least 6 months following orchidectomy (H)
30631	01DEC1991	30APR2017	N	HYDROCELE, removal of, not being a service associated with a service to which items 30638, 30641 and 30644 apply
30631	01MAY2017	31OCT2017	N	Hydrocele, removal of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies
30631	01NOV2017	31DEC9999	Y	Hydrocele, removal of, other than a service associated with a service to which item 30641, 30642 or 30644 applies
30632	01NOV1992	31DEC9999	Y	PYLOROPLASTY, INFANT, OR PYLOROMYOTOMY (RAMSTEDT'S operation)
30633	01NOV1992	31DEC9999	Y	INTUSSUSCEPTION, reduction of, by fluid
30634	01DEC1991	30APR2017	N	VARICOCELE, surgical correction of, not being a service associated with a service to which items 30638, 30641 and 30644 apply, 1 procedure
30634	01MAY2017	31DEC9999	Y	Varicocele, surgical correction of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies-one procedure
30635	01DEC1991	30APR2017	N	VARICOCELE, surgical correction of, not being a service associated with a service to which items 30638, 30641 and 30644 apply, 1 procedure
30635	01MAY2017	31OCT2017	N	Varicocele, surgical correction of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies-one procedure
30635	01NOV2017	31OCT2020	N	Varicocele, surgical correction of, other than a service associated with a service to which item 30641, 30642 or 30644 applies-one procedure
30635	01NOV2020	31DEC9999	Y	Varicocele, surgical correction of, including microsurgical techniques, other than a service associated with a service to which item 30390, 30627, 30641, 30642 or 30644 applies-one procedure
30636	01SEP2015	30JUN2021	N	GASTROSTOMY BUTTON, caecostomy antegrade enema device (chait etc) and/or stomal indwelling device, non-endoscopic insertion of, or non-endoscopic replacement of, on a person under 10 years of age
30636	01JUL2021	31DEC9999	Y	Gastrostomy button, caecostomy antegrade enema device (chait etc.) or stomal indwelling device, non-endoscopic insertion of, or non-endoscopic replacement of, on a patient under 10 years of age
30637	01SEP2015	30JUN2021	N	ENTEROSTOMY or COLOSTOMY, closure of not involving resection of bowel, on a person under 10 years of age
30637	01JUL2021	31DEC9999	Y	Enterostomy or colostomy, closure of (not involving resection of bowel), on a patient under 10 years of age
30638	01DEC1991	31DEC9999	Y	ORCHIDECTOMY, simple or subscapsular, unilateral with or without insertion of testicular prosthesis
30639	01SEP2015	30JUN2021	N	COLOSTOMY OR ILEOSTOMY, refashioning of, on a person under 10 years of age
30639	01JUL2021	31DEC9999	Y	Colostomy or ileostomy, refashioning of, on a patient under 10 years of age
30640	01MAY2016	31OCT2017	N	Repair of large and irreducible scrotal hernia, where duration of surgery exceeds 2 hours, in a person 10 years of age or over, other than a service to which item 30403, 30405, 30614, 30615, 30620 or 30621 applies
30640	01NOV2017	30JUN2021	N	Repair of large and irreducible scrotal hernia, where duration of surgery exceeds 2 hours, in a person 10 years of age or over, other than a service to which item 30403, 30405, 30614, 30615 or 30621 applies
30640	01JUL2021	31DEC9999	Y	Repair of large and irreducible scrotal hernia, if surgery exceeds 2 hours, in a patient 10 years of age or over, other than a service to which item 30615, 30621, 30648, 30651 or 30655 applies
30641	01DEC1991	31OCT2021	N	ORCHIDECTOMY, simple or subscapsular, unilateral with or without insertion of testicular prosthesis
30641	01NOV2021	31DEC9999	Y	Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (H)
30642	01MAY2017	31OCT2017	N	Orchidectomy, radical, unilateral, with or without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30634, 30635, 30638, 30641, 30643 or 30644 applies
30642	01NOV2017	31OCT2020	N	Orchidectomy, radical, unilateral, with or without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635, 30641, 30643 or 30644 applies
30642	01NOV2020	31DEC9999	Y	Orchidectomy, radical, including spermatic cord, unilateral, for tumour, inguinal approach, with insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635, 30641, 30643, 30644 or 45051 applies
30643	01SEP2015	31OCT2020	N	EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis on a person under 10 years of age
30643	01NOV2020	31DEC9999	Y	Exploration of spermatic cord, inguinal approach, with or without testicular biopsy, with or without excision of spermatic cord lesion, for a patient under 10 years of age, other than a service associated with a service to which item 30629, 30630 or 30642 applies
30644	01DEC1991	31AUG2015	N	EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis
30644	01SEP2015	31OCT2020	N	EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis on a person 10 years of age or over
30644	01NOV2020	31DEC9999	Y	Exploration of spermatic cord, inguinal approach, with or without testicular biopsy, with or without excision of spermatic cord lesion, for a patient at least 10 years of age, other than a service associated with a service to which item 30629, 30630 or 30642 applies
30645	01SEP2015	30JUN2021	N	APPENDICECTOMY, not being a service to which item 30574 applies, on a person under 10 years of age
30645	01JUL2021	31DEC9999	Y	Appendicectomy, on a patient under 10 years of age, other than a service to which item 30574 applies
30646	01SEP2015	30JUN2021	N	LAPAROSCOPIC APPENDICECTOMY, on a person under 10 years of age
30646	01JUL2021	31DEC9999	Y	Laparoscopic appendicectomy, on a patient under 10 years of age
30647	01DEC1991	31DEC9999	Y	UNDESCENDED TESTIS, orchidopexy or transplantation of, with or without associated hernial repair
30648	01JUL2021	31DEC9999	Y	Femoral or inguinal hernia or infantile hydrocele, repair of, by open or minimally invasive approach, on a patient 10 years of age or over, other than a service to which item 30615 or 30651 applies
30649	01SEP2015	30JUN2021	N	HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia on a person under 10 years of age
30649	01JUL2021	31DEC9999	Y	Haemorrhage, arrest of, following circumcision requiring general anaesthesia, on a patient under 10 years of age
30650	01DEC1991	31DEC9999	Y	SECONDARY DETACHMENT OF TESTIS FROM THIGH
30651	01JUL2021	30JUN2023	N	Ventral hernia repair involving primary fascial closure by suture, with or without onlay mesh or insertion of intraperitoneal onlay mesh repair, without closure of the defect or advancement of the rectus muscle toward the midline, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service to which item 30621, 30655 or 30657 applies
30651	01JUL2023	31DEC9999	Y	Ventral hernia repair involving primary fascial closure by suture, with or without onlay mesh or insertion of intraperitoneal onlay mesh repair, without closure of the defect or advancement of the rectus muscle toward the midline, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service associated with a service to which item 30175, 30621, 30655 or 30657 applies (H)
30652	01JUL2021	31DEC9999	Y	Recurrent groin hernia regardless of size of defect, repair of, with or without mesh, by open or minimally invasive approach, in a patient 10 years of age or over
30653	01DEC1991	30JUN1995	N	CIRCUMCISION of person UNDER 6 MONTHS of age
30653	01JUL1995	30JUN2013	N	CIRCUMCISION of person UNDER 6 MONTHS of age
30653	01JUL2013	31DEC9999	Y	Circumcision of the penis, on a person under 6 months of age
30654	01NOV2016	31OCT2020	N	Circumcision of the penis (other than a service to which item 30658 applies)
30654	01NOV2020	31DEC9999	Y	Circumcision of the penis, with topical or local analgesia, other than a service to which item 30658 applies
30655	01JUL2021	30JUN2023	N	Ventral hernia, repair of, with advancement of the rectus muscles to the midline using a retro-rectus, pre-peritoneal or sublay technique, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service to which item 30621 or 30651 applies
30655	01JUL2023	31DEC9999	Y	Ventral hernia, repair of, with advancement of the rectus muscles to the midline using a retro-rectus, pre-peritoneal or sublay technique, by open or minimally invasive approach, in a patient 10 years of age or over, other than a service associated with a service to which item 30175, 30621 or 30651 applies (H)
30656	01DEC1991	30JUN1995	N	CIRCUMCISION of person UNDER 10 YEARS of age but not less than 6 months of age
30656	01JUL1995	30JUN2013	N	CIRCUMCISION of a male UNDER 10 YEARS of age but not less than 6 months of age
30656	01JUL2013	31DEC9999	Y	Circumcision of the penis, on a person under 10 years of age but not less than 6 months of age
30657	01JUL2021	31DEC9999	Y	Unilateral abdominal wall reconstruction with component separation, including transversus abdominus release and external oblique release for abdominal wall closure by mobilising the rectus abdominis muscles to the midline, by open or minimally invasive approach
30658	01NOV2016	31OCT2020	N	Circumcision of the penis, when performed in conjunction with a service to which an item in Group T7 or Group T10 applies
30658	01NOV2020	31DEC9999	Y	Circumcision of the penis, when performed under general or regional anaesthesia and in conjunction with a service to which an item in Group T7 or Group T10 applies
30659	01DEC1991	30JUN1995	N	CIRCUMCISION of person 10 YEARS OF AGE OR OVER
30659	01JUL1995	30JUN2013	N	CIRCUMCISION of a male 10 YEARS OF AGE OR OVER
30659	01JUL2013	31DEC9999	Y	Circumcision of the penis, on a person 10 years of age or over
30660	01DEC1991	30JUN1995	N	CIRCUMCISION of person 10 YEARS OF AGE OR OVER
30660	01JUL1995	30JUN2013	N	CIRCUMCISION of a male 10 YEARS OF AGE OR OVER
30660	01JUL2013	31DEC9999	Y	Circumcision of the penis, on a person 10 years of age or over.
30661	01NOV2022	31DEC9999	Y	Minor surgical repair following a complication from the circumcision of a penis, when performed in conjunction with a service to which an item in Group T7 or Group T10 applies, other than a service associated with a service to which item 45206 applies (H)
30662	01NOV2022	31DEC9999	Y	Complex surgical repair following a complication from the circumcision of a penis, including single stage local flap, if indicated, to repair one defect, on genitals (other than a service associated with a service to which item 37819, 37822, 45200, 45201, 45202, 45203 or 45206 applies) (H)
30663	01DEC1991	31AUG2015	N	HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia
30663	01SEP2015	30JUN2021	N	HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia on a person 10 years of age or over
30663	01JUL2021	31DEC9999	Y	Haemorrhage, arrest of, following circumcision requiring general anaesthesia, on a patient 10 years of age or over
30664	01MAR2024	31DEC9999	Y	Endoscopic retrograde cholangiopancreatography (ERCP), with single operator, single use peroral cholangiopancreatoscopy (POCPS) and biopsy, for the diagnosis of biliary strictures for a patient for whom: (a) a previous ERCP service has been provided; and (b) results from guided brush cytology or intraductal biopsy (or both) are indeterminate Applicable not more than 2 times in a 12 month period, or not more than 3 times in a 12 month period if the patient has been diagnosed with primary sclerosing cholangitis (PSC) (H)
30665	01MAR2024	31DEC9999	Y	Endoscopic retrograde cholangiopancreatography (ERCP), with single operator, single use peroral cholangiopancreatoscopy (POCPS) and electrohydraulic or laser lithotripsy for the removal of biliary stones that are: (a) greater than 10mm in diameter; or (b) proximal to a stricture; for a patient for whom there has been at least one failed attempt at removal via ERCP extraction techniques Applicable not more than 2 times per treatment cycle (H)
30666	01DEC1991	31AUG2015	N	PARAPHIMOSIS, reduction of, under general anaesthesia, with or without dorsal incision, not being a service associated with a service to which another item in this Group applies
30666	01SEP2015	31DEC9999	Y	PARAPHIMOSIS or PHIMOSIS, reduction of, under general anaesthesia, with or without dorsal incision, not being a service associated with a service to which another item in this Group applies
30669	01DEC1991	31DEC9999	Y	FAECAL FISTULA, repair of
30672	01DEC1991	31DEC9999	Y	COCCYX, excision of
30675	01DEC1991	31MAR1992	N	PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of, in a person ten years of age or over
30675	01APR1992	31DEC9999	Y	PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of
30676	01DEC1991	31MAR1992	N	PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of, in a person ten years of age or over
30676	01APR1992	30JUN2021	N	PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of
30676	01JUL2021	31DEC9999	Y	Pilonidal sinus or cyst, or sacral sinus or cyst, definitive excision of
30679	01DEC1991	31DEC9999	Y	PILONIDAL SINUS, injection of sclerosant fluid under anaesthesia
30680	01JUL2007	28FEB2014	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30680	01MAR2014	31DEC9999	Y	Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30682	01JUL2007	28FEB2014	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30682	01MAR2014	31DEC9999	Y	Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30684	01JUL2007	30JUN2009	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (polypectomy, snares, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30684	01JUL2009	28FEB2014	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: l have recurrent or persistent bleeding; and l be anaemic or have active bleeding; and l have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30684	01MAR2014	31DEC9999	Y	Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30686	01JUL2007	30JUN2009	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITH 1 or more of the following procedures (polypectomy, snares, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30686	01JUL2009	28FEB2014	N	DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30686	01MAR2014	31DEC9999	Y	Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii) have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding.
30687	01NOV2012	31DEC9999	Y	ENDOSCOPY with RADIOFREQUENCY ABLATION of mucosal metaplasia for the treatment of Barrett's Oesophagus in a single course of treatment, following diagnosis of high grade dysplasia confirmed by histological examination
30688	01JUL2007	31OCT2017	N	ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis.
30688	01NOV2017	31DEC9999	Y	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis.
30690	01JUL2007	31OCT2017	N	ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis.
30690	01NOV2017	31DEC9999	Y	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, with fine needle aspiration, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis.
30692	01JUL2007	31OCT2017	N	ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis.
30692	01NOV2017	31DEC9999	Y	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis.
30694	01JUL2007	31OCT2017	N	ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis.
30694	01NOV2017	31DEC9999	Y	Endoscopic ultrasound (endoscopy with ultrasound imaging), with or without biopsy, with fine needle aspiration, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup (other than item 30484, 30485, 30491 or 30494) and other than a service associated with the routine monitoring of chronic pancreatitis.
30696	01JUL2009	31DEC9999	Y	ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION BIOPSY(S) (endoscopy with ultrasound imaging) to obtain one or more specimens from either: (a) mediastinal mass(es) or (b) locoregional nodes to stage non-small cell lung carcinoma not being a service associated with another item in this subgroup or to which items 30710 and 55054 apply
30710	01JUL2009	31DEC9999	Y	ENDOBRONCHIAL ULTRASOUND GUIDED BIOPSY(S) (bronchoscopy with ultrasound imaging, with or without associated fluoroscopic imaging) to obtain one or more specimens by either: (a) transbronchial biopsy(s) of peripheral lung lesions; or (b) fine needle aspiration(s) of a mediastinal mass(es); or (c) fine needle aspiration(s) of locoregional nodes to stage non-small cell lung carcinoma not being a service associated with another item in this subgroup or to which items 30696, 41892, 41898, and 60500 to 60509 applies
30720	01JUL2021	31DEC9999	Y	Appendicectomy, on a patient 10 years of age or over, whether performed by:(a) laparoscopy or right iliac fossa open incision; or(b) conversion of a laparoscopy to an open right iliac fossa incision;other than a service to which item 30574 applies
30721	01JUL2021	31DEC9999	Y	Laparotomy or laparoscopy, or laparoscopy converted to laparotomy, with or without associated biopsies, including the division of adhesions (if performed, but only if the time taken to divide adhesions is 45 minutes or less), if no other intra-abdominal procedure is performed
30722	01JUL2021	31DEC9999	Y	Laparotomy or laparoscopy, on a patient 10 years of age or over, including any of the following procedures (if performed, and including division of one or more adhesions, but only if the time taken to divide the adhesions is 45 minutes or less): (a) colostomy; (b) colotomy; (c) cholecystostomy; (d) enterostomy; (e) enterotomy; (f) gastrostomy; (g) gastrotomy; (h) caecostomy; (i) gastric fixation by cardiopexy; (j) reduction of intussusception; (k) simple repair of ruptured viscus (including perforated peptic ulcer); (l) reduction of volvulus; (m) drainage of pancreas
30723	01JUL2021	31DEC9999	Y	Laparotomy, laparoscopy or extra-peritoneal approach, for drainage of an intra-abdominal, pancreatic or retroperitoneal collection or abscess
30724	01JUL2021	31DEC9999	Y	Laparotomy or laparoscopy with division of adhesions, lasting more than 45 minutes but less than 2 hours, performed either:(a) as a primary procedure; or(b) when the division of adhesions is performed in conjunction with another primary procedure-to provide access to a surgical field (but excluding mobilisation or normal anatomical dissection of the organ or structure for which the primary procedure is being carried out)
30725	01JUL2021	31DEC9999	Y	Laparotomy or laparoscopy for intestinal obstruction or division of extensive, complex adhesions, lasting 2 hours or more, performed either:a) as a primary procedure; orb) when the division of adhesions is performed in conjunction with another procedure-to provide access to a surgical field, but excluding mobilisation or normal anatomical dissection of the organ or structure for which the other procedure is being carried out
30730	01JUL2021	31DEC9999	Y	Small intestine, resection of, including either of the following:(a) a small bowel diverticulum (such as Meckels procedure) with anastomosis;(b) stricturoplasty
30731	01JUL2021	31DEC9999	Y	Intraoperative enterotomy for visualisation of the small intestine by endoscopy, including endoscopic examination using a flexible endoscope, with or without biopsies
30732	01JUL2021	31DEC9999	Y	Peritonectomy, lasting more than 5 hours, including hyperthermic intra-peritoneal chemotherapy
30750	01JUL2021	31DEC9999	Y	Oesophagectomy with colon or jejunal interposition graft, by any approach, including:(a) any gastrointestinal anastomoses (except vascular anastomoses); and(b) anastomoses in the chest or neck (if appropriate)One surgeon
30751	01JUL2021	31DEC9999	Y	Oesophagectomy with colon or jejunal interposition graft, by any approach, including:(a) any gastrointestinal anastomoses (except vascular anastomoses); and(b) anastomoses in the chest or neck (if appropriate)Conjoint surgery, principal surgeon
30752	01JUL2021	31DEC9999	Y	Oesophagectomy with colon or jejunal interposition graft, by any approach, including:(a) any gastrointestinal anastomoses (except vascular anastomoses); and(b) anastomoses in the chest or neck (if appropriate)Conjoint surgery, co-surgeon
30753	01JUL2021	31DEC9999	Y	Oesophagectomy, by any approach, including:(a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the neck or chestOne surgeon
30754	01JUL2021	31DEC9999	Y	Oesophagectomy, by any approach, including:(a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the neck or chestConjoint surgery, principal surgeon
30755	01JUL2021	31DEC9999	Y	Oesophagectomy by any approach, including:(a) gastric reconstruction by abdominal mobilisation, thoracotomy or thoracoscopy; and(b) anastomosis in the neck or chestConjoint surgery, co-surgeon
30756	01JUL2021	31DEC9999	Y	Antireflux operation by fundoplasty, with or without cardiopexy, by any approach, with or without closure of the diaphragmatic hiatus, other than a service to which item 30601 applies
30760	01JUL2021	31DEC9999	Y	Vagotomy, with or without gastroenterostomy, pyloroplasty or other drainage procedure
30761	01JUL2021	31DEC9999	Y	Bleeding peptic ulcer, control of, by laparoscopy or laparotomy, involving suture of bleeding point or wedge excision (with or without gastric resection), including either of the following (if performed):(a) vagotomy and pyloroplasty;(b) gastroenterostomy
30762	01JUL2021	31DEC9999	Y	Gastrectomy, subtotal or total radical, for carcinoma, by open or minimally invasive approach, including all necessary anastomoses, including either or both of the following (if performed):(a) extended lymph node dissection;(b) splenectomy
30763	01JUL2021	31DEC9999	Y	Gastric tumour, 2cm or greater in diameter, removal of, by local excision, by endoscopic approach, including any required anastomosis, excluding polypectomy, other than a service to which item 30518 applies
30770	01JUL2021	31DEC9999	Y	Hydatid cyst of liver, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty
30771	01JUL2021	31DEC9999	Y	Portal hypertension, porto-caval, meso-caval or selective spleno-renal shunt for
30780	01JUL2021	31DEC9999	Y	Intrahepatic biliary bypass of left or right hepatic ductal system by Roux-en-Y loop to peripheral ductal system
30790	01JUL2021	31DEC9999	Y	Pancreatic cyst anastomosis to stomach, duodenum or small intestine, by endoscopic, open or minimally invasive approach, with or without the use of endoscopic or intraoperative ultrasound
30791	01JUL2021	31DEC9999	Y	Pancreatic necrosectomy, by open, laparoscopic or endoscopic approach, excluding aftercare, subsequent procedure
30792	01JUL2021	31DEC9999	Y	Distal pancreatectomy with splenectomy, by open or minimally invasive approach
30800	01JUL2021	31DEC9999	Y	Splenectomy, by open or minimally invasive approach, other than a service to which item 30792 applies
30810	01JUL2021	31DEC9999	Y	Exploration of pancreas or duodenum for endocrine tumour, including associated imaging, either: (a) followed by local excision of tumour; or (b) when, after extensive exploration, no tumour is found
30820	01JUL2021	31DEC9999	Y	Lymph node of neck, biopsy of, by open procedure, if the specimen excised is sent for pathological examination
31000	01MAR1992	30JUN1995	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 6 or fewer sections (Ministerial Determination)
31000	01JUL1995	31OCT2018	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 6 or fewer sections
31000	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-6 or fewer sections
31001	01MAR1992	30JUN1995	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 7 to 12 sections (Ministerial Determination)
31001	01JUL1995	31OCT2018	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 7 to 12 sections (inclusive)
31001	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-7 to 12 sections (inclusive)
31002	01MAR1992	30JUN1995	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 13 or more sections (Ministerial Determination)
31002	01JUL1995	31OCT2018	N	MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 13 or more sections
31002	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-13 or more sections
31003	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-6 or fewer sections Not applicable to a service performed in association with a service to which item 31000 applies
31004	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-7 to 12 sections (inclusive) Not applicable to a service performed in association with a service to which item 31001 applies
31005	01NOV2018	31DEC9999	Y	Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon-13 or more sections Not applicable to a service performed in association with a service to which item 31002 applies
31200	01MAY1997	30APR2004	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service to which another item in this Group applies
31200	01MAY2004	30APR2006	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision (other than shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service to which another item in this Group applies
31200	01MAY2006	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision (other than shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service associated with a service to which item 45200, 45203 or 45206 applies and not being a service to which another item in this Group applies
31205	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies)
31205	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31205	01NOV2003	31OCT2005	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31205	01NOV2005	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31206	01NOV2016	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is not more than 10 mm in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination
31210	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies)
31210	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31210	01NOV2003	31OCT2005	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31210	01NOV2005	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to and including 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31211	01NOV2016	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is more than 10 mm, but not more than 20 mm, in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination
31215	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies)
31215	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31215	01NOV2003	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31216	01NOV2016	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is more than 20 mm in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination
31220	01MAY1997	30APR2003	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies)
31220	01MAY2003	31OCT2003	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31220	01NOV2003	31OCT2005	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies)
31220	01NOV2005	31OCT2016	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal of 4 to 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies)
31220	01NOV2016	30JUN2023	N	Tumours (other than viral verrucae (common warts) and seborrheic keratoses), cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of 4 to 10 lesions and suture, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue by surgical excision (other than by shave excision); and (c) all of the specimens excised are sent for histological examination
31220	01JUL2023	31DEC9999	Y	Tumours (other than viral verrucae (common warts) and seborrheic keratoses), lipomas, cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of 4 to 10 lesions and suture, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue by surgical excision (other than by shave excision); and (c) all of the specimens excised are sent for histological examination
31221	01NOV2016	31DEC9999	Y	Tumours, cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of 4 to 10 lesions, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) each site of excision is closed by suture; and (d) all of the specimens excised are sent for histological examination
31225	01MAY1997	30APR2003	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where specimen sent for histological examination (not being a service to which item 30195 applies)
31225	01MAY2003	31OCT2003	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31225	01NOV2003	31OCT2005	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies)
31225	01NOV2005	31OCT2016	N	TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal of more than 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies)
31225	01NOV2016	30JUN2023	N	Tumours (other than viral verrucae (common warts) and seborrheic keratoses), cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of more than 10 lesions, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue or mucous membrane by surgical excision (other than by shave excision); and (c) each site of excision is closed by suture; and (d) all of the specimens excised are sent for histological examination
31225	01JUL2023	31DEC9999	Y	Tumours (other than viral verrucae (common warts) and seborrheic keratoses), lipomas, cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of more than 10 lesions, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue or mucous membrane by surgical excision (other than by shave excision); and (c) each site of excision is closed by suture; and (d) all of the specimens excised are sent for histological examination
31227	01JUL2023	31DEC9999	Y	Tumour, lipoma or cyst, removal of single lesion by excision and suture, where removal is from subcutaneous tissue and the specimen excised is sent for histological examination
31230	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where specimen sent for histological examination (not being a service to which item 30195 applies)
31230	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31230	01NOV2003	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision (other than by shave excision) and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31235	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where specimen sent for histological examination (not being a service to which item 30195 applies)
31235	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31235	01NOV2003	31OCT2005	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31235	01NOV2005	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to and including 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31240	01MAY1997	30APR2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where specimen sent for histological examination (not being a service to which item 30195 applies)
31240	01MAY2003	31OCT2003	N	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31240	01NOV2003	31DEC9999	Y	TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies)
31245	01MAY1997	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE, extensive excision of, in the treatment of SUPPURATIVE HIDRADENITIS (excision from axilla, groin or natal cleft) or SYCOSIS BARBAE or NUCHAE (excision from face or neck)
31250	01MAY1997	30APR2003	N	GIANT HAIRY or COMPOUND NAEVUS, excision of an area at least 1 percent of body surface where the specimen is sent for histological confirmation of diagnosis
31250	01MAY2003	31DEC9999	Y	GIANT HAIRY or COMPOUND NAEVUS, excision of an area at least 1 percent of body surface where the specimen excised is sent for histological confirmation of diagnosis
31255	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31255	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31255	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31255	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31255	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter - where removal is by therapeutic surgical excision (other than by shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31256	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31257	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31258	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from nose, eyelid, lip, ear, digit or genitalia, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies
31260	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31260	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31260	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31260	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31260	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by therapeutic surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31261	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31262	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31263	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from nose, eyelid, lip, ear, digit or genitalia, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies
31265	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31265	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31265	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31265	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter and where removal is by surgical excision (other than shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31265	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck, (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to and including 10mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31266	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31267	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31268	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies
31270	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31270	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31270	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31270	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31270	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck, (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to and including 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31271	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31272	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31273	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies
31275	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31275	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31275	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31275	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31275	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31276	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31277	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31278	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies
31280	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31280	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31280	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31280	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31280	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to and including 10mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31281	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31255 and 31265, where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31282	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31255 and 31265, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31283	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31255 and 31265, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31285	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31285	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31285	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31285	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31285	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to and including 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31286	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31270, where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31287	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31270, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31288	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31260 and 31270, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31290	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31290	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31290	01NOV2003	31OCT2004	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31290	01NOV2004	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31290	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination
31291	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31275, where previous excision was performed by the same practitioner, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31292	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31275, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination
31293	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31260 and 31275, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31295	01MAY1997	30APR2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent ( where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained
31295	01MAY2003	31OCT2003	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent ( where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31295	01NOV2003	30APR2005	N	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31295	01MAY2005	31DEC9999	Y	BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT (where lesion was treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31300	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31300	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31300	01NOV2003	31OCT2005	N	"TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at the site of the primary tumour"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained"
31300	01NOV2005	30APR2007	N	"TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at the site of the primary tumour"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained"
31300	01MAY2007	31DEC9999	Y	"TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at that site of excision"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained"
31305	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31305	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31305	01NOV2003	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE and removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31310	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31310	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31310	01NOV2003	31OCT2005	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31310	01NOV2005	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31315	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31315	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31315	01NOV2003	31OCT2005	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter and where removal is by definitive surgical excision (as defined above in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31315	01NOV2005	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to and including 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31320	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31320	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31320	01NOV2003	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31325	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31325	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31325	01NOV2003	31OCT2005	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31325	01NOV2005	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31330	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31330	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31330	01NOV2003	31OCT2005	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31330	01NOV2005	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to and including 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31335	01MAY1997	30APR2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained
31335	01MAY2003	31OCT2003	N	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained
31335	01NOV2003	31DEC9999	Y	MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained
31340	01MAY1997	30APR2004	N	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, performed in association with excision of malignant tumour of skin covered by item 31255, 31260, 31265, 31270, 31275, 31280, 31285, 31290, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335
31340	01MAY2004	31OCT2005	N	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, where the specimen excised is sent for histological confirmation, performed in association with excision of malignant tumour of skin covered by item 31255, 31260, 31265, 31270, 31275, 31280, 31285, 31290, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335
31340	01NOV2005	31OCT2016	N	NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, where the specimen excised is sent for histological confirmation, performed in association with excision of malignant tumour of skin covered by item 31255, 31256, 31257, 31258, 31260, 31261, 31262, 31263, 31265, 31266, 31267, 31268, 31270, 31271, 31272, 31273, 31275, 31276, 31277, 31278, 31280, 31281, 31282, 31283, 31285, 31286, 31287, 31288, 31290, 31291, 31292, 31293, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335
31340	01NOV2016	30APR2017	N	Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if: (a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375 or 31376 is excised
31340	01MAY2017	31OCT2018	N	Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if:(a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31000, 31001, 31002, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375 or 31376 is excised
31340	01NOV2018	30JUN2023	N	Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if: (a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31000, 31001, 31002, 31003, 31004, 31005, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375 or 31376 is excised
31340	01JUL2023	31DEC9999	Y	Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if: (a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31000, 31001, 31002, 31003, 31004, 31005, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383 is excised
31344	01JUL2023	29FEB2024	N	Lipoma, removal of, by surgical excision or liposuction, if:(a) the lesion:(i) is subcutaneous and 150mm or more in diameter; or(ii) is submuscular, intramuscular or involves dissection of a named nerve or vessel and is 50 mm or more in diameter; and(b) a specimen of the excised lipoma is sent for histological confirmation of diagnosis
31344	01MAR2024	31DEC9999	Y	Lipoma, removal of, by surgical excision or liposuction, if:(a) the lesion:(i) is subcutaneous and 150mm or more in diameter; or(ii) is submuscular, intramuscular or involves dissection of a named nerve or vessel and is 50 mm or more in diameter; and(b) a specimen of the excised lipoma is sent for histological confirmation of diagnosis (H)
31345	01MAY1997	31OCT1997	N	LIPOMA, excision of, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial
31345	01NOV1997	30APR2003	N	LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial, where specimen is sent for histological confirmation of diagnosis
31345	01MAY2003	31OCT2005	N	LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial, where the specimen is sent for histological confirmation of diagnosis
31345	01NOV2005	30JUN2023	N	LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and 50mm or more in diameter, or is sub-fascial, where the specimen is sent for histological confirmation of diagnosis
31345	01JUL2023	31DEC9999	Y	Lipoma, removal of, by surgical excision or liposuction, if:(a) the lesion is: (i) subcutaneous and 50 mm or more in diameter but less than 150 mm in diameter; or(ii) sub fascial; and (b) the specimen excised is sent for histological confirmation of diagnosis
31346	01MAY2003	31OCT2004	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal fat due to repeated insulin injections, where the lesion is subcutaneous and greater than 50mm in diameter
31346	01NOV2004	31OCT2005	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal or upper arm or thigh fat due to repeated insulin injections, where the lesion is subcutaneous and greater than 50mm in diameter
31346	01NOV2005	31OCT2018	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal or upper arm or thigh fat due to repeated insulin injections, where the lesion is subcutaneous and 50mm or more in diameter
31346	01NOV2018	31DEC9999	Y	Liposuction (suction assisted lipolysis) to one regional area for contour problems of abdominal, upper arm or thigh fat because of repeated insulin injections, if: (a) the lesion is subcutaneous; and (b) the lesion is 50 mm or more in diameter; and (c) photographic and/or diagnostic imaging evidence demonstrating the need for this service is documented in the patient notes
31350	01MAY1997	30APR2003	N	BENIGN TUMOUR of SOFT TISSUE, removal of by surgical excision, where specimen is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies
31350	01MAY2003	31OCT2005	N	BENIGN TUMOUR of SOFT TISSUE, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies
31350	01NOV2005	31AUG2015	N	BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies
31350	01SEP2015	30JUN2021	N	BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, on a person 10 years of age or over, not being a service to which another item in this Group applies
31350	01JUL2021	31DEC9999	Y	Benign tumour of soft tissue (other than tumours of skin, cartilage and bone, simple lipomas covered by item 31345 and lipomata), removal of, by surgical excision, on a patient 10 years of age or over, if the specimen excised is sent for histological confirmation of diagnosis, other than a service to which another item in this Group applies
31355	01MAY1997	31OCT2005	N	MALIGNANT TUMOUR of SOFT TISSUE, removal of by surgical excision, where histological proof of malignancy has been obtained, not being a service to which another item in this Group applies
31355	01NOV2005	31DEC9999	Y	MALIGNANT TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage and bone, removal of by surgical excision, where histological proof of malignancy has been obtained, not being a service to which another item in this Group applies
31356	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31356	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31357	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201
31358	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31358	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31359	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision), if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia (the applicable site); and (b) the necessary excision area is at least one third of the surface area of the applicable site; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy (H)
31359	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision), if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia (the applicable site); and (b) the necessary excision area is at least one third of the surface area of the applicable site; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy (H)
31360	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination
31361	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31361	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31362	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201
31363	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31363	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31364	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination
31365	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31369, 31370, 31371, 31372 or 31373), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31365	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31369, 31370, 31371, 31372, 31373, 31377, 31378 or 31379), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31366	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201
31367	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31367	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31368	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is at least 15 mm but not more than 30mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201
31369	01NOV2016	30JUN2023	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31369	01JUL2023	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31370	01NOV2016	31DEC9999	Y	Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination
31371	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31371	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31372	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31372	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with a service to which item 45201 applies
31373	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31373	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31374	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31374	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with a service to which item 45201 applies
31375	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201
31375	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with a service to which item 45201 applies
31376	01NOV2016	31OCT2022	N	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31376	01NOV2022	31DEC9999	Y	Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, including excision of the primary tumour bed, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy
31377	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; not in association with a service to which item 45201 applies
31378	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination
31379	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; not in association with a service to which item 45201 applies
31380	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination
31381	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; not in association with a service to which item 45201 applies
31382	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; not in association with a service to which item 45201 applies
31383	01NOV2022	31DEC9999	Y	Clinically suspected melanoma, surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31377, 31378, 31379 or 31380; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination
31386	01JUL2023	29FEB2024	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the head or neck; and(b) the necessary excision diameter is more than 50 mm; and(c) the excision involves at least 2 critical areas (eyelid, nose, ear, mouth); and(d) the excised specimen is sent for histological examination; and(e) malignancy is confirmed from the excised specimen or previous biopsy; and(f) the service is not covered by item 31387
31386	01MAR2024	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the head or neck; and(b) the necessary excision diameter is more than 50 mm; and(c) the excision involves at least 2 critical areas (eyelid, nose, ear, mouth); and(d) the excised specimen is sent for histological examination; and(e) malignancy is confirmed from the excised specimen or previous biopsy; and(f) the service is not covered by item 31387 (H)
31387	01JUL2023	29FEB2024	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the head or neck; and(b) the necessary excision diameter is more than 70 mm; and(c) the excised specimen is sent for histological examination; and(d) malignancy is confirmed from the excised specimen or previous biopsy; and(e) the service is not covered by item 31386
31387	01MAR2024	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the head or neck; and(b) the necessary excision diameter is more than 70 mm; and(c) the excised specimen is sent for histological examination; and(d) malignancy is confirmed from the excised specimen or previous biopsy; and(e) the service is not covered by item 31386 (H)
31388	01JUL2023	29FEB2024	N	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the trunk or limbs; and(b) the necessary excision diameter is more than 120 mm; and(c) the excised specimen is sent for histological examination; and(d) malignancy is confirmed from the excised specimen or previous biopsy
31388	01MAR2024	31DEC9999	Y	Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375, 31376, 31377, 31378, 31379, 31380, 31381, 31382 or 31383), surgical excision (other than by shave excision) and repair of, if:(a) the lesion is excised from the trunk or limbs; and(b) the necessary excision diameter is more than 120 mm; and(c) the excised specimen is sent for histological examination; and(d) malignancy is confirmed from the excised specimen or previous biopsy (H)
31400	01JUL1998	31OCT2005	N	MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR up to 20mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained
31400	01NOV2005	31DEC9999	Y	MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR up to and including 20mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained
31403	01JUL1998	31OCT2005	N	MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 20mm and up to 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained
31403	01NOV2005	31DEC9999	Y	MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 20mm and up to and including 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained
31406	01JUL1998	31DEC9999	Y	MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained
31409	01JUL1998	31DEC9999	Y	PARAPHARYNGEAL TUMOUR, excision of, by cervical approach
31412	01JUL1998	31DEC9999	Y	RECURRENT OR PERSISTENT PARAPHARYNGEAL TUMOUR, excision of, by cervical approach
31420	01JUL1998	31DEC9999	Y	LYMPH NODE OF NECK, biopsy of
31423	01JUL1998	31AUG2015	N	LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck
31423	01SEP2015	30JUN2021	N	LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a person 10 years of age or over
31423	01JUL2021	28FEB2023	N	Lymph nodes of neck, selective dissection of one or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a patient 10 years of age or over
31423	01MAR2023	31DEC9999	Y	Lymph nodes of neck, selective dissection of one or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a patient 10 years of age or over, other than a service associated with a service to which item 30256 or 30275 applies on the same side
31426	01JUL1998	28FEB2023	N	LYMPH NODES OF NECK, selective dissection of 3 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck
31426	01MAR2023	31DEC9999	Y	Lymph nodes of neck, selective dissection of 3 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, other than a service associated with a service to which item 30256 or 30275 applies on the same side (H)
31429	01JUL1998	28FEB2023	N	LYMPH NODES OF NECK, selective dissection of 4 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve
31429	01MAR2023	31DEC9999	Y	Lymph nodes of neck, selective dissection of 4 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve, other than a service associated with a service to which item 30256 or 30275 applies on the same side (H)
31432	01JUL1998	28FEB2023	N	LYMPH NODES OF NECK, bilateral selective dissection of levels I, II and III (bilateral supraomohyoid dissections)
31432	01MAR2023	31DEC9999	Y	Lymph nodes of neck, bilateral selective dissection of levels I, II and III (bilateral supraomohyoid dissections), other than a service associated with a service to which item 30256 or 30275 applies on the same side (H)
31435	01JUL1998	28FEB2023	N	LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck
31435	01MAR2023	31DEC9999	Y	Lymph nodes of neck, comprehensive dissection of all 5 lymph node levels on one side of the neck, other than a service associated with a service to which item 30256 or 30275 applies on the same side (H)
31438	01JUL1998	28FEB2023	N	LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve
31438	01MAR2023	31DEC9999	Y	Lymph nodes of neck, comprehensive dissection of all 5 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve, other than a service associated with a service to which item 30256 or 30275 applies on the same side (H)
31441	01MAR1999	31DEC9999	Y	(see Item 14215 for adding or removing fluid via the implanted reservoir to adjust the tightness of the gastric band) LONG-TERM IMPLANTED RESERVOIR associated with the adjustable gastric band, repair, revision or replacement of
31450	01NOV1999	31DEC9999	Y	LAPAROSCOPIC DIVISION OF ADHESIONS, as an independent procedure, where the time taken is 1 hour or less
31452	01NOV1999	31DEC9999	Y	LAPAROSCOPIC DIVISION OF ADHESIONS, as an independent procedure, where the time taken in more than 1 hour
31454	01NOV2000	30JUN2021	N	LAPAROSCOPY with drainage of pus, bile or blood, as an independent procedure
31454	01JUL2021	31DEC9999	Y	Laparoscopy or laparotomy with drainage of bile, as an independent procedure (H)
31456	01NOV2000	31DEC9999	Y	GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where blind insertion of the feeding tube has failed or is inappropriate due to the patient's medical condition
31458	01NOV2000	31DEC9999	Y	GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where blind insertion of the feeding tube has failed or is inappropriate due to the patient's medical condition, and where the use of imaging intensification is clinically indicated
31460	01NOV2000	31DEC9999	Y	PERCUTANEOUS GASTROSTOMY TUBE, jejunal extension to, including any associated imaging services
31462	01NOV2000	31DEC9999	Y	OPERATIVE FEEDING JEJUNOSTOMY performed in conjunction with major upper gastro-intestinal resection
31464	01NOV2000	31DEC9999	Y	ANTIREFLUX OPERATION BY FUNDOPLASTY, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, by laparoscopic technique - not being a service to which item 30601 applies
31466	01NOV2000	31DEC9999	Y	ANTIREFLUX OPERATION BY FUNDOPLASTY, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, revision procedure, by laparoscopy or open operation
31468	01NOV2000	30JUN2021	N	PARA-OESOPHAGEAL HIATUS HERNIA, repair of, with complete reduction of hernia, resection of sac and repair of hiatus, with or without fundoplication
31468	01JUL2021	31DEC9999	Y	Para-oesophageal hiatus hernia, repair of, with complete reduction of hernia, resection of sac and repair of hiatus, with or without fundoplication, other than a service associated with a service to which item 30756 or 31466 applies
31470	01NOV2000	31AUG2015	N	LAPAROSCOPIC SPLENECTOMY
31470	01SEP2015	31DEC9999	Y	LAPAROSCOPIC SPLENECTOMY, on a person 10 years of age or over
31472	01NOV2000	30JUN2021	N	CHOLECYSTODUODENOSTOMY, CHOLECYSTOENTEROSTOMY, CHOLEDOCHOJEJUNOSTOMY OR ROUX-EN-Y as a bypass procedure where prior biliary surgery has been performed
31472	01JUL2021	31DEC9999	Y	Cholecystoduodenostomy, cholecystoenterostomy, choledochojejunostomy or Roux-en-y loop to provide biliary drainage or bypass, other than a service associated with a service to which item 30584 applies
31500	01NOV2002	30APR2003	N	BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histolog, not being a service to which items 31539, 31542 or 31545 apply
31500	01MAY2003	31DEC9999	Y	BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histology
31503	01NOV2002	30APR2003	N	BREAST, BENIGN LESION more than 50mm in diameter, excision of, not being a service to which items 31539, 31542 or 31545 apply
31503	01MAY2003	31DEC9999	Y	BREAST, BENIGN LESION more than 50mm in diameter, excision of
31506	01NOV2002	30APR2003	N	BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of, not being a service to which items 31539, 31542 or 31545 apply
31506	01MAY2003	31DEC9999	Y	BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of
31509	01NOV2002	30APR2003	N	BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology, not being a service to which items 31539, 31542 or 31545 apply
31509	01MAY2003	31DEC9999	Y	BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology
31512	01NOV2002	30APR2003	N	BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology, not being a service to which items 31539, 31542 or 31545 apply
31512	01MAY2003	30JUN2023	N	BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology
31512	01JUL2023	31DEC9999	Y	Breast, malignant tumour, complete local excision of, with or without frozen section histology, other than a service associated with a service to which:(a) item 45523 or 45558 applies; and(b) item 31513, 31514, 45520, 45522 or 45556 applies on the same side (if performed by the same medical practitioner)(H)
31513	01JUL2023	31DEC9999	Y	Breast, malignant tumour, complete local excision of, with simultaneous reshaping of the breast parenchyma using techniques such as round block or rotation flaps, other than a service associated with a service to which:(a) item 45523 or 45558 applies; and(b) item 31512, 31514, 45520, 45522 or 45556 applies on the same side(H)
31514	01JUL2023	31DEC9999	Y	Breast, malignant tumour, complete local excision of, with simultaneous ipsilateral pedicled breast reduction, including repositioning of the nipple, other than a service associated with a service to which:(a) item 45523 or 45558 applies; and(b) item 31512, 31513, 45520, 45522 or 45556 applies on the same side(H)
31515	01NOV2002	30APR2003	N	BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour, not being a service to which items 31539, 31542 or 31545 apply
31515	01MAY2003	31DEC9999	Y	BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour
31516	01SEP2015	28FEB2021	N	BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology when targeted intraoperative radiotherapy (using an Intrabeam® device) is performed concurrently, if the requirements of item 15900 are met for the patient
31516	01MAR2021	31DEC9999	Y	BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology when targeted intraoperative radiation therapy (using an Intrabeam® or Xoft® Axxent® device) is performed concurrently, if the patient satisfies the requirements mentioned in paragraphs (a) to (g) of item 15900 Applicable only once per breast per lifetime (H)
31518	01NOV2002	31DEC9999	Y	BREAST (female), total mastectomy
31519	01JUL2014	30JUN2023	N	BREAST, total mastectomy (H)
31519	01JUL2023	31DEC9999	Y	Total mastectomy (unilateral) (H)
31520	01JUL2023	31DEC9999	Y	Total mastectomy (bilateral) (H)
31521	01NOV2002	31OCT2003	N	BREAST (male), total mastectomy
31521	01NOV2003	31DEC9999	Y	BREAST (male), total mastectomy, not being a service associated with a service to which item 45585 applies
31522	01JUL2023	31DEC9999	Y	Skin sparing mastectomy (unilateral) (H)
31523	01JUL2023	31DEC9999	Y	Skin sparing mastectomy (bilateral) (H)
31524	01NOV2002	30JUN2014	N	BREAST (female), subcutaneous mastectomy
31524	01JUL2014	31DEC9999	Y	BREAST, subcutaneous mastectomy (H)
31525	01JUL2014	30JUN2023	N	BREAST, mastectomy for gynecomastia, with or without liposuction (suction assisted lipolysis), not being a service associated with a service to which item 45585 applies (H)
31525	01JUL2023	31DEC9999	Y	Mastectomy for gynaecomastia (unilateral), with or without liposuction (suction assisted lipolysis), if:(a) breast enlargement is not due to obesity and is not proportionate to body habitus; and(b) sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes;not being a service associated with a service to which item 45585 applies (H)
31526	01JUL2023	31DEC9999	Y	Mastectomy for gynaecomastia (bilateral), with or without liposuction (suction assisted lipolysis), if:(a) breast enlargement is not due to obesity and is not proportionate to body habitus; and(b) sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes;not being a service associated with a service to which item 45585 applies (H)
31527	01NOV2002	31OCT2003	N	BREAST (male), subcutaneous mastectomy
31527	01NOV2003	31OCT2012	N	BREAST (male), subcutaneous mastectomy, not being a service associated with a service to which item 45585 applies
31527	01NOV2012	31DEC9999	Y	BREAST (male), SUBCUTANEOUS MASTECTOMY, with or without liposuction (suction assisted lipolysis), not being a service associated with a service to which 45585 applies
31528	01JUL2023	31DEC9999	Y	Nipple sparing mastectomy (unilateral) (H)
31529	01JUL2023	31DEC9999	Y	Nipple sparing mastectomy (bilateral) (H)
31530	01NOV2002	30APR2020	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a vacuum-assisted breast biopsy device under imaging guidance, for histological examination, where imaging has demonstrated: (a) microcalcification of lesion; or (b) impalpable lesion less than 1cm in diameter - including pre-operative localisation of lesion where performed, not being a service to which items 31539, 31545 or 31548 apply
31530	01MAY2020	31DEC9999	Y	Breast, biopsy of solid tumour or tissue of, using a vacuum-assisted breast biopsy device under imaging guidance, for histological examination, if imaging has demonstrated:(a) microcalcification of lesion; or(b) impalpable lesion less than one cm in diameter;including pre-operative localisation of lesion, if performed, other than a service associated with a service to which item 31548 applies
31533	01NOV2002	31DEC9999	Y	FINE NEEDLE ASPIRATION of an impalpable breast lesion detected by mammography or ultrasound, imaging guided - but not including imaging
31536	01NOV2002	30APR2003	N	BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging, not being a service to which item 31542 applies
31536	01MAY2003	30APR2020	N	BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging, not being a service to which item 31539, 31542 or 31545 applies
31536	01MAY2020	31DEC9999	Y	Breast, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques, but not including imaging (Anaes.)
31537	01MAR2024	31DEC9999	Y	Insertion of a marker clip into a breast, including axilla, following a breast biopsy and using imaging (but not including the associated imaging), if additional surgery, neoadjuvant systemic therapy, follow up imaging or radiation may be required and the insertion is for any of the following reasons: (a) to mark the site of a lesion that has been totally or almost completely removed; (b) to confirm biopsy site if multiple lesions are present; (c) to confirm biopsy site of an ill-defined lesion; (d) future surgery or preoperative localisation is considered to be potentially difficult due to lesion conspicuity; (e) preoperative localisation is likely to be carried out using a modality different from the biopsy modality; (f) for correlation across modalities for diagnostic reasons
31539	01NOV2002	30APR2003	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using Advanced Breast Biopsy Instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which items 31530 or 31536 apply
31539	01MAY2003	31DEC2013	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using advanced breast biopsy instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which item 31530, 31536 or 31548 applies
31539	01JAN2014	31DEC9999	Y	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a bore-enbloc stereotactic biopsy, for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which item 31530, 31536 or 31548 applies
31542	01NOV2002	30APR2003	N	BREAST, initial guidewire localisation of lesion, by hookwire, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to Advanced Breast Biopsy Instrumentation (ABBI), - including imaging not being a service to which item 31536 applies
31542	01MAY2003	31DEC2013	N	BREAST, initial guidewire localisation of lesion, by hookwire or similar device, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to advanced breast biopsy instrumentation (ABBI), - including imaging not being a service associated with a service to which item 31536 applies
31542	01JAN2014	31DEC9999	Y	BREAST, initial guidewire localisation of lesion, by hookwire or similar device, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to using a bore-enbloc stereotactic biopsy - including imaging not being a service associated with a service to which item 31536 applies
31545	01NOV2002	30APR2003	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using Advanced Breast Biopsy Instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire, using interventional imaging techniques and including imaging not being a service to which item 31530, 31536 or 31548 apply
31545	01MAY2003	31DEC2013	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using advanced breast biopsy instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons; where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire or similar device, using interventional imaging techniques and including imaging not being a service associated with a service to which item 31530, 31536 or 31548 applies
31545	01JAN2014	31DEC9999	Y	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a bore-enbloc stereotactic biopsy, for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons; where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire or similar device, using interventional imaging techniques and including imaging not being a service associated with a service to which item 31530, 31536 or 31548 applies
31548	01NOV2002	30APR2020	N	BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using mechanical biopsy device, for histological examination, not being a service to which items 31530, 31539 or 31545 apply
31548	01MAY2020	31DEC9999	Y	Breast, biopsy of solid tumour or tissue of, using mechanical biopsy device, for histological examination, other than a service associated with a service to which item 31530 applies (Anaes.)
31551	01NOV2002	31DEC9999	Y	BREAST, HAEMATOMA, SEROMA OR INFLAMMATORY CONDITION including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital, excluding aftercare
31554	01NOV2002	31DEC9999	Y	BREAST, microdochotomy of, for benign or malignant condition
31557	01NOV2002	31DEC9999	Y	BREAST CENTRAL DUCTS, excision of, for benign condition
31560	01NOV2002	31DEC9999	Y	ACCESSORY BREAST TISSUE, excision of
31563	01NOV2002	30JUN2023	N	INVERTED NIPPLE, surgical eversion of
31563	01JUL2023	31DEC9999	Y	Inverted nipple, surgical eversion of, with or without flap repair, if the nipple cannot readily be everted manually
31566	01NOV2002	31DEC9999	Y	ACCESSORY NIPPLE, excision of
31569	01JUL2013	31DEC9999	Y	Adjustable gastric band, placement of, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity
31572	01JUL2013	31DEC9999	Y	Gastric bypass by Roux-en-Y including associated anastomoses, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity not being associated with a service to which item 30515 applies
31575	01JUL2013	31DEC9999	Y	Sleeve gastrectomy, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity
31578	01JUL2013	31DEC9999	Y	Gastroplasty (excluding by gastric plication), with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity
31581	01JUL2013	31DEC9999	Y	Gastric bypass by biliopancreatic diversion with or without duodenal switch including gastric resection and anastomoses, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity
31584	01JUL2013	30JUN2021	N	Surgical reversal of adjustable gastric banding (removal or replacement of gastric band), gastric bypass, gastroplasty (excluding by gastric plication) or biliopancreatic diversion being services to which items 31569 to 31581 apply
31584	01JUL2021	31DEC9999	Y	Surgical reversal of previous bariatric procedure, including revision or conversion, if:a) the previous procedure involved any of the following:(i) placement of adjustable gastric banding;(ii) gastric bypass;(iii) sleeve gastrectomy;(iv) gastroplasty (excluding gastric plication);(v) biliopancreatic diversion; and(b) any of items 31569 to 31581 applied to the previous procedureother than a service associated with a service to which item 31585 applies
31585	01JUL2021	31DEC9999	Y	Removal of adjustable gastric band
31587	01JUL2013	31DEC9999	Y	Adjustment of gastric band as an independent procedure including any associated consultation
31590	01JUL2013	31DEC9999	Y	Adjustment of gastric band reservoir, repair, revision or replacement of
31591	16NOV2017	31DEC9999	Y	Surgical reversal of an existing bariatric procedure performed in association with a service to which items 31569 to 31581 apply.
32000	01DEC1991	31DEC9999	Y	LARGE INTESTINE, resection of, without anastomosis, including right hemicolectomy (including formation of stoma)
32003	01DEC1991	31DEC9999	Y	LARGE INTESTINE, resection of, with anastomosis, including right hemicolectomy
32004	01NOV1992	31OCT1993	N	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) without anastomosis, not being a service associated with a service to which another item in this Group applies
32004	01NOV1993	30JUN2022	N	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) without anastomosis, not being a service associated with a service to which item 32000, 32003, 32005 or 32006 applies
32004	01JUL2022	31DEC9999	Y	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) without anastomosis, not being a service associated with a service to which item 32000, 32003, 32005, 32006 or 32030 applies (H)
32005	01NOV1992	31OCT1993	N	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) with anastomosis, not being a service associated with a service to which another item in this Group applies
32005	01NOV1993	30JUN2022	N	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) with anastomosis, not being a service associated with a service to which item 32000, 32003, 32004 or 32006 applies
32005	01JUL2022	31DEC9999	Y	LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) with anastomosis, not being a service associated with a service to which item 32000, 32003, 32004, 32006 or 32030 applies (H)
32006	01DEC1991	30JUN2022	N	LEFT HEMICOLECTOMY, including the descending and sigmoid colon (including formation of stoma)
32006	01JUL2022	31JUL2022	N	Left hemicolectomy, including the descending and sigmoid colon (including formation of stoma), if associated with a service to which item 32024, 32025, 32026 or 32028 applies (H)
32006	01AUG2022	31DEC9999	Y	Left hemicolectomy, including the descending and sigmoid colon (including formation of stoma), other than a service associated with a service to which item 32024, 32025, 32026 or 32028 applies (H)
32009	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY AND ILEOSTOMY
32012	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY AND ILEORECTAL ANASTOMOSIS
32015	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY 1 surgeon
32018	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS OPERATION; ABDOMINAL RESECTION (including aftercare)
32021	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS OPERATION; PERINEAL RESECTION
32023	01MAR2013	31DEC9999	Y	Endoscopic insertion of stent or stents for large bowel obstruction, stricture or stenosis, including colonoscopy and any image intensification, where the obstruction is due to: a) a pre-diagnosed colorectal cancer, or cancer of an organ adjacent to the bowel; or b) an unknown diagnosis
32024	01DEC1991	30APR2004	N	RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS (of the rectum) greater than 10 centimetres from the anal verge excluding resection of sigmoid colon alone
32024	01MAY2004	30JUN2022	N	RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS (of the rectum) greater than 10 centimetres from the anal verge excluding resection of sigmoid colon alone not being a service associated with a service to which item 32103, 32104 or 32106 applies
32024	01JUL2022	31DEC9999	Y	RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS (of the rectum) greater than 10 centimetres from the anal verge excluding resection of sigmoid colon alone not being a service associated with a service to which item 32000, 32030, 32106 or 32232 applies (H)
32025	01MAY1994	30APR2004	N	RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge, with or without covering stoma
32025	01MAY2004	30JUN2022	N	RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge, with or without covering stoma not being a service associated with a service to which item 32103, 32104 or 32106 applies
32025	01JUL2022	31DEC9999	Y	RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge, with or without covering stoma not being a service associated with a service to which item 32000, 32030, 32106 or 32232 applies (H)
32026	01MAY1994	30JUN2022	N	RECTUM, ULTRA LOW RESTORATIVE RESECTION, with or without covering stoma, where the anastomosis is sited in the anorectal region and is 6cm or less from the anal verge
32026	01JUL2022	31DEC9999	Y	Rectum, ultra-low restorative resection, with or without covering stoma and with or without colonic reservoir, if the anastomosis is sited in the anorectal region and is 6 cm or less from the anal verge, not being a service associated with a service to which item 32000, 32030, 32106, 32117 or 32232 applies (H)
32027	01DEC1991	31DEC9999	Y	RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge
32028	01MAY1994	30JUN2022	N	RECTUM, LOW OR ULTRA LOW RESTORATIVE RESECTION, with peranal sutured coloanal anastomosis, with or without covering stoma
32028	01JUL2022	31DEC9999	Y	Rectum, low or ultra-low restorative resection, with per anal sutured coloanal anastomosis, with or without covering stoma and with or without colonic reservoir, not being a service associated with a service to which item 32000, 32030, 32106, 32117 or 32232 applies (H)
32029	01MAY1994	31DEC9999	Y	COLONIC RESERVOIR, construction of, being a service associated with a service to which any other item in this Subgroup applies
32030	01DEC1991	30JUN2022	N	RECTOSIGMOIDECTOMY (Hartmann's operation)
32030	01JUL2022	31DEC9999	Y	RECTOSIGMOIDECTOMY, including formation of stoma (H)
32033	01DEC1991	31OCT1992	N	RESTORATION OF BOWEL continuity following Hartmann's operation including dismantling of colostomy
32033	01NOV1992	30JUN2022	N	RESTORATION OF BOWEL following Hartmann's or similar operation, including dismantling of the stoma
32033	01JUL2022	31DEC9999	Y	RESTORATION OF BOWEL continuity following rectosigmoidectomy or similar operation, including dismantling of the stoma (H)
32036	01DEC1991	31DEC9999	Y	SACROCOCCYGEAL AND PRESACRAL TUMOUR excision of
32039	01DEC1991	31DEC9999	Y	RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF 1 surgeon
32042	01DEC1991	31DEC9999	Y	RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS OPERATION abdominal resection
32045	01DEC1991	31DEC9999	Y	RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS OPERATION perineal resection
32046	01NOV1992	31DEC9999	Y	RECTUM and ANUS, abdomino-perineal resection of, combined synchronous operation - perineal resection where the perineal surgeon also provides assistance to the abdominal surgeon
32047	01NOV1992	31DEC9999	Y	PERINEAL PROCTECTOMY
32048	01DEC1991	31DEC9999	Y	ABDOMINOPERINEAL PULL-THROUGH RESECTION with coloanal anastomosis (1 or 2 stages), including associated colostomy
32051	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy 1 surgeon
32054	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy conjoint surgery, abdominal surgeon (including aftercare)
32057	01DEC1991	31DEC9999	Y	TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoir conjoint surgery, perineal surgeon
32060	01DEC1991	30JUN2022	N	ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy 1 surgeon
32060	01JUL2022	31DEC9999	Y	Restorative proctectomy, involving rectal resection with formation of ileal reservoir and ileoanal anastomosis, including ileostomy mobilisation, with or without mucosectomy or temporary loop ileostomy, 1 surgeon (H)
32063	01DEC1991	31DEC9999	Y	ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy conjoint surgery, abdominal surgeon (including aftercare)
32066	01DEC1991	31DEC9999	Y	ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy conjoint surgery, perineal surgeon
32069	01DEC1991	31DEC9999	Y	ILEOSTOMY RESERVOIR, continent type, creation of, including conversion of existing ileostomy where appropriate
32072	01DEC1991	31DEC9999	Y	SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), with or without biopsy
32075	01DEC1991	31DEC9999	Y	SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), UNDER GENERAL ANAESTHESIA, with or without biopsy, not being a service associated with a service to which another item in this Group applies
32078	01DEC1991	31DEC9999	Y	SIGMOIDOSCOPIC EXAMINATION with diathermy OR resection of 1 or more polyps where the time taken is less than or equal to 45 minutes
32081	01DEC1991	31DEC9999	Y	SIGMOIDOSCOPIC EXAMINATION with diathermy OR resection of 1 or more polyps where the time taken is greater than 45 minutes
32084	01DEC1991	31OCT2017	N	FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY up to the hepatic flexure, WITH or WITHOUT BIOPSY
32084	01NOV2017	31OCT2019	N	Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure, with or without biopsy, other than a service associated with a service to which item 32090 or 32093 applies.
32084	01NOV2019	30APR2020	N	Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure, with or without biopsy, other than a service associated with a service to which any of items 32222 to 32228 applies.
32084	01MAY2020	31DEC9999	Y	Sigmoidoscopy or colonoscopy up to the hepatic flexure, with or without biopsy, other than a service associated with a service to which any of items 32222 to 32228 applies.
32087	01DEC1991	30APR2010	N	FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY up to the hepatic flexure WITH REMOVAL OF 1 OR MORE POLYPS not being a service to which item 32078 applies
32087	01MAY2010	30JUN2016	N	Endoscopic examination of the colon up to the hepatic flexure by FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of, not being a service to which item 32078 applies
32087	01JUL2016	31OCT2017	N	Endoscopic examination of the colon up to the hepatic flexure by FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of
32087	01NOV2017	31OCT2019	N	Endoscopic examination of the colon up to the hepatic flexure by flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy for the removal of 1 or more polyps or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by argon plasma coagulation, one or more of, other than a service associated with a service to which item 32090 or 32093 applies
32087	01NOV2019	30APR2020	N	Endoscopic examination of the colon up to the hepatic flexure by flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy for the removal of 1 or more polyps or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by argon plasma coagulation, one or more of, other than a service associated with a service to which any of items 32222 to 32228 applies
32087	01MAY2020	31DEC9999	Y	Endoscopic examination of the colon up to the hepatic flexure by sigmoidoscopy or colonoscopy for the removal of one or more polyps, other than a service associated with a service to which any of items 32222 to 32228 applies (Anaes.)
32088	01MAY2016	31DEC9999	Y	FIBREOPTIC COLONOSCOPY examination of the colon beyond the hepatic flexure WITH or WITHOUT BIOPSY, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program.
32089	01MAY2016	31DEC9999	Y	Endoscopic examination of the colon beyond the hepatic flexure by FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program.
32090	01DEC1991	31DEC9999	Y	FIBREOPTIC COLONOSCOPY examination of colon beyond the hepatic flexure WITH or WITHOUT BIOPSY
32093	01DEC1991	30APR2010	N	FIBREOPTIC COLONOSCOPY examination of colon beyond the hepatic flexure WITH REMOVAL OF 1 OR MORE POLYPS
32093	01MAY2010	31DEC9999	Y	Endoscopic examination of the colon beyond the hepatic flexure by FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS, or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of
32094	01NOV1992	31DEC9999	Y	ENDOSCOPIC DILATATION OF COLORECTAL STRICTURES including colonoscopy
32095	01NOV1992	31DEC9999	Y	ENDOSCOPIC EXAMINATION of SMALL BOWEL with flexible endoscope passed by stoma, with or without biopsies
32096	01DEC1991	30JUN2022	N	RECTAL BIOPSY, full thickness, under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital
32096	01JUL2022	31DEC9999	Y	RECTAL BIOPSY, full thickness, to diagnose or exclude Hirschsprung's Disease, under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital
32099	01DEC1991	31OCT1992	N	RECTAL TUMOUR of five centimetres or less in diameter, per anal submucosal excision of (excluding snare diathermy)
32099	01NOV1992	31DEC9999	Y	RECTAL TUMOUR of 5 centimetres or less in diameter, per anal submucosal excision of
32102	01DEC1991	31OCT1992	N	RECTAL TUMOUR of greater than five centimetres in diameter, per anal submucosal excision of
32102	01NOV1992	31DEC9999	Y	RECTAL TUMOUR of greater than 5 centimetres in diameter, indicated by pathological examination, per anal submucosal excision of
32103	01MAY2004	31OCT2012	N	RECTAL TUMOUR, of less than 4cm in diameter, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy or by local excision not being a service associated with a service to which item 32024, 32025, 32104 or 32106 applies
32103	01NOV2012	31DEC9999	Y	RECTAL TUMOUR, of less than 4 cm in diameter, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy or by local excision, other than a service associated with a service to which item 32024, 32025, 32104 or 32106 applies
32104	01MAY2004	31OCT2012	N	RECTAL TUMOUR, of 4cm or greater in diameter, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy or by local excision not being a service associated with a service to which item 32024, 32025, 32103 or 32106 applies
32104	01NOV2012	31DEC9999	Y	RECTAL TUMOUR, of 4 cm or greater in diameter, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy or by local excision, other than a service associated with a service to which item 32024, 32025, 32103 or 32106 applies
32105	01DEC1991	31DEC9999	Y	ANORECTAL CARCINOMA per anal full thickness excision of
32106	01MAY2004	31OCT2012	N	ANTEROLATERAL INTRAPERITONEAL RECTAL TUMOUR, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy and where removal requires dissection within the peritoneal cavity not being a service associated with a service to which item 32024, 32025, 32103 or 32104 applies
32106	01NOV2012	30JUN2022	N	ANTEROLATERAL INTRAPERITONEAL RECTAL TUMOUR, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy and if removal requires dissection within the peritoneal cavity, other than a service associated with a service to which item 32024, 32025, 32103 or 32104 applies
32106	01JUL2022	31DEC9999	Y	Anterolateral intraperitoneal rectal tumour, per anal excision of, using rectoscopy digital viewing system and pneumorectum, if:(a) clinically appropriate; and(b) removal requires dissection within the peritoneal cavity;excluding use of a colonoscope as the operating platform and not being a service associated with a service to which item 32024, 32025 or 32232 applies
32108	01DEC1991	31DEC9999	Y	RECTAL TUMOUR, transsphincteric excision of (Kraske or similar operation)
32111	01DEC1991	31DEC9999	Y	RECTAL PROLAPSE Delorme procedure for
32112	01MAY1994	31DEC9999	Y	RECTAL PROLAPSE, perineal recto-sigmoidectomy for
32114	01DEC1991	31DEC9999	Y	RECTAL STRICTURE, per anal release of
32115	01MAY1997	31DEC9999	Y	RECTAL STRICTURE, dilatation of
32117	01DEC1991	30APR1994	N	RECTAL PROLAPSE, abdominal repair of
32117	01MAY1994	30JUN2022	N	RECTAL PROLAPSE, abdominal rectopexy of
32117	01JUL2022	31DEC9999	Y	Rectal prolapse, abdominal rectopexy of, excluding ventral mesh rectopexy, not being a service associated with a service to which item 32025 or 32026 applies (H)
32118	06JUL2022	29FEB2024	N	Rectal prolapse, ventral mesh rectopexy of, not being a service associated with a service to which item 32025, 32026 or 32117 applies (H)
32118	01MAR2024	31DEC9999	Y	Treatment of external rectal prolapse, or of symptomatic high grade rectal intussusception (the rectum descends to the level of or into the anal canal, confirmed by diagnostic imaging): (a) by minimally invasive surgery involving: (i) ventral dissection of the extra-peritoneal rectum; and (ii) suspension of the rectum from the sacral promontory by means of a prosthesis; and (b) including suspension of the vagina if performed, and any associated repair; other than a service associated with a service to which item 30390, 35595 or 35597 applies (H)
32120	01DEC1991	31DEC9999	Y	RECTAL PROLAPSE, perineal repair of
32123	01DEC1991	31DEC9999	Y	ANAL STRICTURE, anoplasty for
32126	01DEC1991	31DEC9999	Y	ANAL INCONTINENCE, Parks' intersphincteric procedure for
32129	01DEC1991	30JUN2022	N	ANAL SPHINCTER, direct repair of
32129	01JUL2022	31DEC9999	Y	ANAL SPHINCTER, repair (H)
32131	01MAY1994	30APR2001	N	RECTOCELE, perineal repair of
32131	01MAY2001	31DEC9999	Y	RECTOCELE, transanal repair of rectocele
32132	01DEC1991	31DEC9999	Y	HAEMORRHOIDS OR RECTAL PROLAPSE sclerotherapy for
32135	01DEC1991	31OCT2003	N	HAEMORRHOIDS OR RECTAL PROLAPSE rubber band ligation of, with or without sclerotherapy, cryosurgery or infra red therapy for
32135	01NOV2003	30JUN2022	N	HAEMORRHOIDS OR RECTAL PROLAPSE rubber band ligation of, with or without sclerotherapy, cryotherapy or infra red therapy for
32135	01JUL2022	31OCT2024	N	Treatment of haemorrhoids or rectal prolapse, including rubber band ligation or sclerotherapy for, not being a service to which item 32139 applies
32135	01NOV2024	31DEC9999	Y	Treatment of haemorrhoids or rectal prolapse, including rubber band ligation or sclerotherapy or topical energy therapies for, not being a service to which item 32139 applies
32138	01DEC1991	30JUN1995	N	HAEMORRHOIDECTOMY
32138	01JUL1995	31DEC9999	Y	HAEMORRHOIDECTOMY including excision of anal skin tags when performed
32139	01MAY1997	30JUN2022	N	HAEMORRHOIDECTOMY involving third or fourth degree haemorrhoids, including excision of anal skin tags when performed
32139	01JUL2022	31OCT2024	N	Operative treatment of haemorrhoids involving third-degree or fourth-degree haemorrhoids, including excision of anal skin tags when performed, not being a service associated with a service to which item 32135 or 32233 applies (H)
32139	01NOV2024	31DEC9999	Y	Operative treatment of symptomatic haemorrhoids, including excision of anal skin tags when performed, not being a service associated with a service to which item 32135 or 32233 applies (H)
32141	01DEC1991	31DEC9999	Y	ANAL POLYPS, excision of one or more of
32142	01NOV1992	31DEC9999	Y	ANAL SKIN TAGS or ANAL POLYPS, excision of 1 or more of
32144	01DEC1991	31DEC9999	Y	ANAL SKIN TAGS, excision of one or more of
32145	01NOV1992	31DEC9999	Y	ANAL SKIN TAGS or ANAL POLYPS, excision of 1 or more of, undertaken in the operating theatre of a hospital
32147	01DEC1991	31DEC9999	Y	PERIANAL THROMBOSIS, incision of
32150	01DEC1991	30JUN2022	N	OPERATION FOR FISSUREINANO, including excision or sphincterotomy, but excluding dilatation only
32150	01JUL2022	31DEC9999	Y	Operation for anal fissure, including excision, injection of Botulinum toxin or sphincterotomy, excluding dilatation
32153	01DEC1991	31DEC9999	Y	ANUS, DILATATION OF, under general anaesthesia, with or without disimpaction of faeces, not being a service associated with a service to which another item in this Group applies
32156	01DEC1991	30JUN2022	N	FISTULA-IN-ANO, SUBCUTANEOUS, excision of
32156	01JUL2022	31DEC9999	Y	Anal fistula, subcutaneous, excision of
32159	01DEC1991	30APR2004	N	ANAL FISTULA, excision of, involving lower half of the anal sphincter mechanism
32159	01MAY2004	31DEC9999	Y	ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a combination of both procedures, involving the lower half of the anal sphincter mechanism
32162	01DEC1991	30APR2004	N	ANAL FISTULA, excision of, involving the upper half of the anal sphincter mechanism
32162	01MAY2004	31DEC9999	Y	ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a combination of both procedures, involving the upper half of the anal sphincter mechanism
32165	01DEC1991	30JUN2022	N	ANAL FISTULA, repair of, by mucosal flap advancement
32165	01JUL2022	31DEC9999	Y	Operative treatment of anal fistula, repair by mucosal advancement flap, including ligation of inter-sphincteric fistula tract (LIFT) or other complex sphincter sparing surgery
32166	01NOV1992	31DEC9999	Y	ANAL FISTULA - readjustment of Seton
32168	01DEC1991	31OCT1992	N	FISTULA WOUND, review of, under general anaesthetic
32168	01NOV1992	30APR1994	N	FISTULA WOUND, review of, under general or regional anaesthetic, as an independent procedure
32168	01MAY1994	31DEC9999	Y	FISTULA WOUND, review of, under general or regional anaesthetic, as an independent procedure
32171	01DEC1991	30JUN2022	N	ANORECTAL EXAMINATION, with or without biopsy, under general anaesthetic, not being a service associated with a service to which another item in this Group applies
32171	01JUL2022	31DEC9999	Y	Anorectal examination, with or without biopsy, under general anaesthetic, with or without faecal disimpaction, other than a service associated with a service to which another item in this Group applies (H)
32174	01DEC1991	31DEC9999	Y	INTR-AANAL, perianal or ischiorectal abscess, drainage of (excluding aftercare)
32175	01NOV1992	31DEC9999	Y	INTRA-ANAL, PERIANAL or ISCHIO-RECTAL ABSCESS, draining of, undertaken in the operating theatre of a hospital (excluding aftercare)
32177	01DEC1991	31MAR1992	N	ANAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved dayhospital facility, where the time taken is less than or equal to 45 minutes
32177	01APR1992	31DEC9999	Y	ANAL WARTS, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is less than or equal to 45 minutes - not being a service associated with a service to which item 35507 or 35508 applies
32180	01DEC1991	31MAR1992	N	ANAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved dayhospital facility, where the time taken is greater than 45 minutes
32180	01APR1992	31DEC9999	Y	ANAL WARTS, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is greater than 45 minutes - not being a service associated with a service to which item 35507 or 35508 applies
32183	01DEC1991	31DEC9999	Y	INTESTINAL SLING PROCEDURE prior to radiotherapy
32186	01DEC1991	31DEC9999	Y	COLONIC LAVAGE, total, intra operative
32200	01MAY1997	31DEC9999	Y	DISTAL MUSCLE, devascularisation of
32203	01MAY1997	31DEC9999	Y	ANAL OR PERINEAL GRACILOPLASTY
32206	01MAY1997	31DEC9999	Y	STIMULATOR AND ELECTRODES, insertion of, following previous graciloplasty
32209	01MAY1997	31DEC9999	Y	ANAL OR PERINEAL GRACILOPLASTY with insertion of stimulator and electrodes
32210	19JUN1997	31OCT1997	N	GRACILIS NEOSPHINCTER PACEMAKER, replacement of
32210	01NOV1997	31DEC9999	Y	GRACILIS NEOSPHINCTER PACEMAKER, replacement of
32212	01MAY1997	31DEC9999	Y	ANO-RECTAL APPLICATION OF FORMALIN in the treatment of radiation proctitis, where performed in the operating theatre of a hospital, excluding aftercare
32213	01NOV2005	31DEC2014	N	SACRAL NERVE LEAD(S), placement of, percutaneous using fluoroscopic guidance, or open, and intraoperative test stimulation, for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment
32213	01JAN2015	30APR2017	N	SACRAL NERVE LEAD(S), placement of, percutaneous using fluoroscopic guidance, or open, and intraoperative test stimulation, for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment. Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32213	01MAY2017	30JUN2022	N	Sacral nerve lead or leads, percutaneous placement using fluoroscopic guidance (or open placement) and intraoperative test stimulation, to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non-surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months
32213	01JUL2022	31DEC9999	Y	Sacral nerve lead or leads, placement of, percutaneous or open, including intraoperative test stimulation and programming, for the management of faecal incontinence (H)
32214	01NOV2005	31AUG2015	N	NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, using fluoroscopic guidance
32214	01SEP2015	30APR2017	N	NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, using fluoroscopic guidance. Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32214	01MAY2017	31DEC9999	Y	Neurostimulator or receiver, subcutaneous placement of, involving placement and connection of an extension wire to a sacral nerve electrode using fluoroscopic guidance, to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non-surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months
32215	01NOV2005	31AUG2015	N	SACRAL NERVE ELECTRODE(S), management, adjustment, and electronic programming of neurostimulator by a medical practitioner, for the management of faecal incontinence - each day
32215	01SEP2015	30APR2017	N	SACRAL NERVE ELECTRODE(S), management, adjustment, and electronic programming of neurostimulator by a medical practitioner, for the management of faecal incontinence - each day. Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32215	01MAY2017	30JUN2022	N	Sacral nerve electrode or electrodes, management, adjustment and electronic programming of the neurostimulator by a medical practitioner, to manage faecal incontinence, other than in a patient who: a) is medically unfit for surgery; or b) is pregnant or planning pregnancy; or c) has irritable bowel syndrome; or d) has congenital anorectal malformations; or e) has active anal abscesses or fistulas; or f) has anorectal organic bowel disease, including cancer; or g) has functional effects of previous pelvic irradiation; or h) has congenital or acquired malformations of the sacrum; or i) has had rectal or anal surgery within the previous 12 months -each day
32215	01JUL2022	31DEC9999	Y	Sacral nerve electrode or electrodes, management, adjustment and electronic programming of the neurostimulator by a medical practitioner, to manage faecal incontinence, not being a service associated with a service to which item 32213, 32216, 32218 or 32237 applies. Applicable once per day for the same patient by the same practitioner
32216	01NOV2005	31AUG2015	N	SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, surgical repositioning of, percutaneous using fluoroscopic guidance, or open, to correct displacement or unsatisfactory positioning, and intraoperative test stimulation, not being a service to which item 32213 applies
32216	01SEP2015	30APR2017	N	SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, surgical repositioning of, percutaneous using fluoroscopic guidance, or open, to correct displacement or unsatisfactory positioning, and intraoperative test simulation, not being a service to which item 32213 applies. Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32216	01MAY2017	30JUN2022	N	Sacral nerve lead or leads, percutaneous surgical repositioning of, using fluoroscopic guidance (or open surgical repositioning of) and interoperative test stimulation, to correct displacement or unsatisfactory positioning, if the lead was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non-surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months other than a service to which item 32213 applies
32216	01JUL2022	31DEC9999	Y	Sacral nerve lead or leads, inserted for the management of faecal incontinence in a patient with faecal incontinence refractory to conservative non-surgical treatment, either:(a) percutaneous surgical repositioning of the lead or leads, using fluoroscopic guidance; or(b) open surgical repositioning of the lead or leads; to correct displacement or unsatisfactory positioning (including intraoperative test stimulation), not being a service associated with a service to which item 32213 applies (H)
32217	01NOV2005	31AUG2015	N	NEUROSTIMULATOR or RECEIVER, inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of
32217	01SEP2015	30APR2017	N	NEUROSTIMULATOR or RECEIVER, inserted for the management of faecal incontinence in a patient who had an anatomically intact but funcionaly deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of. Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32217	01MAY2017	31DEC9999	Y	Neurostimulator or receiver, removal of, if the neurostimulator or receiver was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non-surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months
32218	01NOV2005	31DEC2014	N	SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of
32218	01JAN2015	30APR2017	N	SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of Contraindicated in: (a) patients under 18 years of age; and (b) patients 18 years of age or older who: (i) are medically unfit for surgery; or (ii) are pregnant or planning pregnancy; or (iii) have irritable bowel syndrome; or (iv) have congenital anorectal malformations; or (v) have active anal abscesses or fistulas; or (vi) have anorectal organic bowel disease, including cancer; or (vii) have functional effects of previous pelvic irradiation; or (viii) have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months.
32218	01MAY2017	30JUN2022	N	Sacral nerve lead or leads, removal of, if the lead was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non-surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months
32218	01JUL2022	31DEC9999	Y	Sacral nerve lead or leads, removal (H)
32220	01MAR2009	31DEC2014	N	Insertion of an artificial bowel sphincter for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed
32220	01JAN2015	31DEC9999	Y	Insertion of an artificial bowel sphincter for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed. Contraindicated in: (a) patients with inflammatory bowel disease, pelvic sepsis, pregnancy, progressive degenerative diseases or a scarred or fragile perineum; and (b) patients who have had an adverse reaction or radiopaque solution; and (c) patients who enage in receptive anal intercourse
32221	01MAR2009	31DEC2014	N	Removal or revision of an artificial bowel sphincter (with or without replacement) for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed
32221	01JAN2015	30JUN2023	N	Removal or revision of an artificial bowel sphincter (with or without replacement) for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed. Contraindicated in: (a) patients with inflammatory bowel disease, pelvic sepsis, pregnancy, progressive degenerative diseases or a scarred or fragile perineum; and (b) patients who have had an adverse reaction to radiopaque solution; and (c) patients who engage in receptive anal intercourse
32221	01JUL2023	31DEC9999	Y	Removal or revision of an artificial bowel sphincter (with or without replacement) for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed.
32222	01NOV2019	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) following a positive faecal occult blood test; or (b) who has symptoms consistent with pathology of the colonic mucosa; or (c) with anaemia or iron deficiency; or (d) for whom diagnostic imaging has shown an abnormality of the colon; or (e) who is undergoing the first examination following surgery for colorectal cancer; or (f) who is undergoing pre-operative evaluation; or (g) for whom a repeat colonoscopy is required due to inadequate bowel preparation for the patients previous colonoscopy; or (h) for the management of inflammatory bowel disease Applicable only once on a day under a single episode of anaesthesia or other sedation
32222	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) following a positive faecal occult blood test; or (b) who has symptoms consistent with pathology of the colonic mucosa; or (c) who has anaemia or iron deficiency; or (d) for whom diagnostic imaging has shown an abnormality of the colon; or (e) who is undergoing the first examination following surgery for colorectal cancer; or (f) who is undergoing pre-operative evaluation; or (g) for whom a repeat colonoscopy is required due to inadequate bowel preparation for the patients previous colonoscopy; or (h) for the management of inflammatory bowel disease; other than a service associated with a service to which item 32230 applies Applicable once on a day under a single episode of anaesthesia or other sedation
32223	01NOV2019	28FEB2021	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) who has had a colonoscopy that revealed 1 to 4 adenomas, each of which were less than 10mm in diameter, had no villous features and had no high grade dysplasia; or (b) with a moderate risk of colorectal cancer due to family history; or (c) with a history of colorectal cancer, who has had an initial post-operative colonoscopy that did not reveal any adenomas or colorectal cancer Applicable only once in any 5 year period
32223	01MAR2021	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) who has had a colonoscopy that revealed: (i) 1 to 4 adenomas, each of which was less than 10 mm in diameter, had no villous features and had no high grade dysplasia; or (ii) 1 or 2 sessile serrated lesions, each of which was less than 10 mm in diameter, and without dysplasia; or (b) with a moderate risk of colorectal cancer due to family history; or (c) with a history of colorectal cancer, who has had an initial post-operative colonoscopy that did not reveal any adenomas or colorectal cancer Applicable only once in any 5 year period
32223	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) who has had a colonoscopy that revealed: (i) one to 4 adenomas, each of which was less than 10 mm in diameter, had no villous features and had no high grade dysplasia; or (ii) one or 2 sessile serrated lesions, each of which was less than 10 mm in diameter, and without dysplasia; or (b) who has a moderate risk of colorectal cancer due to family history; or (c) who has a history of colorectal cancer and has had an initial post-operative colonoscopy that did not reveal any adenomas or colorectal cancer; other than a service associated with a service to which item 32230 applies Applicable once in any 5 year period
32224	01NOV2019	30APR2020	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a moderate risk of colorectal cancer due to: (a) a history of adenomas, including an adenoma that: (i) was greater than 10mm in diameter; or (ii) had villous features; or (iii) had high grade dysplasia; or (iv) was an advanced serrated adenoma; or (b) having had a previous colonoscopy that revealed 5 to 9 adenomas, each of which was less than 10mm in diameter, had no villous features and had no high grade dysplasia Applicable only once in any 3 year period
32224	01MAY2020	28FEB2021	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a moderate risk of colorectal cancer due to: (a) a history of adenomas, including an adenoma that: (i) was greater than or equal to 10mm in diameter; or (ii) had villous features; or (iii) had high grade dysplasia; or (iv) was an advanced serrated adenoma; or (b) having had a previous colonoscopy that revealed 5 to 9 adenomas, each of which was less than 10mm in diameter, had no villous features and had no high grade dysplasia Applicable only once in any 3 year period
32224	01MAR2021	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a moderate risk of colorectal cancer due to: (a) a history of adenomas, including an adenoma that: (i) was 10 mm or greater in diameter; or (ii) had villous features; or (iii) had high grade dysplasia; or (b) having had a previous colonoscopy that revealed: (i) 5 to 9 adenomas, each of which was less than 10 mm in diameter, had no villous features and had no high grade dysplasia; or (ii) 1 or 2 sessile serrated lesions, each of which was 10 mm or greater in diameter or had dysplasia; or (iii) a hyperplastic polyp that was 10 mm or greater in diameter; or (iv) 3 or more sessile serrated lesions, each of which was less than 10 mm in diameter and had no dysplasia; or (v) 1 or 2 traditional serrated adenomas, of any size Applicable only once in any 3 year period (Anaes.)
32224	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient who has a moderate risk of colorectal cancer due to: (a) a history of adenomas, including an adenoma that: (i) was 10 mm or greater in diameter; or (ii) had villous features; or (iii) had high grade dysplasia; or (b) having had a previous colonoscopy that revealed: (i) 5 to 9 adenomas, each of which was less than 10 mm in diameter, had no villous features and had no high grade dysplasia; or (ii) one or 2 sessile serrated lesions, each of which was 10 mm or greater in diameter or had dysplasia; or (iii) a hyperplastic polyp that was 10 mm or greater in diameter; or (iv) 3 or more sessile serrated lesions, each of which was less than 10 mm in diameter and had no dysplasia; or (v) one or 2 traditional serrated adenomas, of any size; other than a service associated with a service to which item 32230 applies Applicable once in any 3 year period
32225	01NOV2019	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a high risk of colorectal cancer due to having had a previous colonoscopy that: (a) revealed 10 or more adenomas; or (b) included a piecemeal, or possibly incomplete, excision of a large, sessile polyp Applicable not more than 4 times in any 12 month period
32225	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient who has a high risk of colorectal cancer due to having had a previous colonoscopy that: (a) revealed 10 or more adenomas; or (b) included a piecemeal, or possibly incomplete, excision of a large, sessile polyp; other than a service associated with a service to which item 32230 applies Applicable 4 times in any 12 month period
32226	01NOV2019	28FEB2021	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a high risk of colorectal cancer due to: (a) a known or suspected familial condition, such as familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome; or (b) a genetic mutation associated with hereditary colorectal cancer Applicable only once in any 12 month period
32226	01MAR2021	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient who has a high risk of colorectal cancer due to: (a) having either: (i) a known or suspected familial condition, such as familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome; or (ii) a genetic mutation associated with hereditary colorectal cancer; or (b) having had a previous colonoscopy that revealed: (i) 5 or more sessile serrated lesions, each of which was less than 10 mm in diameter and had no dysplasia; or (ii) 3 or more sessile serrated lesions, 1 or more of which was 10 mm or greater in diameter or had dysplasia; or (iii) 3 or more traditional serrated adenomas, of any size Applicable only once in any 12 month period (Anaes.)
32226	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, for a patient who has a high risk of colorectal cancer due to: (a) having either: (i) a known or suspected familial condition, such as familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome; or (ii) a genetic mutation associated with hereditary colorectal cancer; or (b) having had a previous colonoscopy that revealed: (i) 5 or more sessile serrated lesions, each of which was less than 10 mm in diameter and had no dysplasia; or (ii) 3 or more sessile serrated lesions, one or more of which was 10 mm or greater in diameter or had dysplasia; or (iii) 3 or more traditional serrated adenomas, of any size; other than a service associated with a service to which item 32230 applies Applicable once in any 12 month period
32227	01NOV2019	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy: (a) for the treatment of bleeding, including one or more of the following: (i) radiation proctitis; (ii) angioectasia; (iii) post-polypectomy bleeding; or (b) for the treatment of colonic strictures with balloon dilatation Applicable only once on a day under a single episode of anaesthesia or other sedation
32228	01NOV2019	30JUN2024	N	Endoscopic examination of the colon to the caecum by colonoscopy, other that a service to which item 32222, 32223, 32224, 32225, or 32226 applies. Applicable only once
32228	01JUL2024	31DEC9999	Y	Endoscopic examination of the colon to the caecum by colonoscopy, other than: (a) a service to which item 32222, 32223, 32224, 32225 or 32226 applies; or (b) a service associated with a service to which item 32230 applies Applicable once
32229	01NOV2019	31DEC9999	Y	Removal of one or more polyps during colonoscopy, in association with a service to which item 32222, 32223, 32224, 32225, 32226, or 32228 applies
32230	01NOV2021	31DEC2021	N	Endoscopic mucosal resection using electrocautery of a non-invasive sessile or flat superficial colorectal neoplasm which is at least 25mm in diameter, if the service is: (a) provided by a specialist gastroenterologist or surgical endoscopist; and (b) supported by photographic evidence to confirm the size of the polyp in situ, and (c) performed in association with a service to which item 32222, 32223, 32224, 32225, 32226 or 32228 applies. Applicable only once per polyp (H)
32230	01JAN2022	30JUN2024	N	Endoscopic mucosal resection using electrocautery of a non-invasive sessile or flat superficial colorectal neoplasm which is at least 25mm in diameter, if the service is: (a) provided by a specialist gastroenterologist or surgical endoscopist; and (b) supported by photographic evidence to confirm the size of the polyp in situ, and (c) performed within 6 months after a service to which item 32222, 32223, 32224, 32225, 32226 or 32228 applies has been performed Applicable only once per polyp (H)
32230	01JUL2024	31DEC9999	Y	Endoscopic mucosal resection using electrocautery of a non-invasive sessile or flat superficial colorectal neoplasm which is at least 25mm in diameter, if the service is supported by photographic evidence to confirm the size of the polyp in situ Applicable once per polyp (H)
32231	01JUL2022	31DEC9999	Y	Rectal tumour, per anal excision of (H)
32232	01JUL2022	31DEC9999	Y	Rectal tumour, per anal excision of, using a rectoscopy digital viewing system and pneumorectum if clinically appropriate and excluding use of a colonoscope as the operating platform, not being a service associated with a service to which item 32024, 32025 or 32106 applies (H)
32233	01JUL2022	31DEC9999	Y	Perineal repair of rectal prolapse, not being a service associated with a service to which item 32139 applies (H)
32234	01JUL2022	31DEC9999	Y	Rectal stricture, treatment of (H)
32235	01JUL2022	31DEC9999	Y	Anal skin tags or anal polyps, excision of one or more of
32236	01JUL2022	31DEC9999	Y	Anal warts, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block), not being a service associated with a service to which item 35507 or 35508 applies (H)
32237	01JUL2022	31DEC9999	Y	Neurostimulator or receiver, subcutaneous placement of, replacement of, or removal of, including programming and placement and connection of an extension wire or wires to sacral nerve electrode(s), for the management of faecal incontinence (H)
32500	01DEC1991	30APR1994	N	VARICOSE VEINS VARICOSE VEINS, multiple simultaneous injections by continuous compression techniques including associated consultation - 1 OR BOTH LEGS - not being a service associated with any other varicose veins operation on the same leg (excluding after-care)
32500	01MAY1994	31OCT1994	N	VARICOSE VEINS VARICOSE VEINS, (excluding telangiectases, starburst vessels, spider nevi or similar), multiple injections using continuous compression techniques including associated consultation - 1 or both legs - not being a service associated with any other varicose veins operation on the same leg (excluding after-care)
32500	01NOV1994	30APR2003	N	VARICOSE VEINS VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg (excluding after-care) - to a maximum of 6 treatments in a 12 month period
32500	01MAY2003	31OCT2021	N	VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections of sclerosant using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg (excluding after-care) - to a maximum of 6 treatments in a 12 month period
32500	01NOV2021	31DEC9999	Y	Varicose veins, multiple injections of sclerosant using continuous compression techniques, including associated consultation, one or both legs, if: (a) proximal reflux of 0.5 seconds or longer has been demonstrated; and (b) the service is not for cosmetic purposes; and (c) the service is not associated with: (i) any other varicose vein operation on the same leg (excluding aftercare); or (ii) a service on the same leg (excluding aftercare) to which any of the following items apply: (A) 35200; (B) 59970 to 60078; (C) 60500 to 60509; (D) 61109 Applicable to a maximum of 6 treatments in a 12 month period
32501	19JUN1997	31OCT1997	N	VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) - where it can be demonstrated that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period
32501	01NOV1997	30APR2003	N	VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) - where it can be demonstrated that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period
32501	01MAY2003	31DEC9999	Y	VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections of sclerosant using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) where it can be demonstrated that truncal reflux in the long or short saphenous veins has been excluded by duplex examination - and that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period
32503	01DEC1991	31DEC9999	Y	VARICOSE VEINS, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of 1 or more deep perforating veins through separate incisions - 1 LEG - not being a service associated with a service to which item 32506, 32509 or 32530 applies on the same leg
32504	01NOV1994	31OCT2002	N	VARICOSE VEINS, multiple excision of tributaries, with or without division of 1 or more perforating veins - 1 leg - not being a service associated with a service to which item 32507, 32508, 32511, 32514 or 32517 applies
32504	01NOV2002	31DEC9999	Y	VARICOSE VEINS, multiple excision of tributaries, with or without division of 1 or more perforating veins - 1 leg - not being a service associated with a service to which item 32507, 32508, 32511, 32514 or 32517 applies on the same leg
32505	01NOV1994	31DEC9999	Y	VARICOSE VEINS, sub-fascial ligation of 1 or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies
32506	01DEC1991	31DEC9999	Y	VARICOSE VEINS, high ligation and complete or partial stripping or excision of long or short saphenous vein or its major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - 1 leg
32507	01JUL1998	31OCT2002	N	VARICOSE VEINS, sub-fascial surgical exploration of one or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies
32507	01NOV2002	31OCT2021	N	VARICOSE VEINS, sub-fascial surgical exploration of one or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies on the same leg
32507	01NOV2021	31DEC9999	Y	Varicose veins, sub-fascial ligation of one or more incompetent perforating veins in one leg of a patient, if the service: (a) is performed by open surgical technique (not including endoscopic ligation) and the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; and (b) is not associated with: (i) any other varicose vein operation on the same leg; or (ii) a service (on the same leg) to which item 35200, 60072, 60075 or 60078 applies (H)
32508	01NOV1994	31OCT2002	N	VARICOSE VEINS, complete dissection at the sapheno-femoral OR sapheno-popliteal junction, with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time, including excision or injection of either tributaries or incompetent perforating veins, or both
32508	01NOV2002	31OCT2021	N	VARICOSE VEINS, complete dissection at the sapheno-femoral OR sapheno-popliteal junction - 1 leg - with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both
32508	01NOV2021	31DEC9999	Y	Varicose veins, complete dissection at the sapheno-femoral or sapheno-popliteal junction, with or without either ligation or stripping, or both, of the great or small saphenous veins in one leg of a patient, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both, if the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) discomfort; (j) any other signs or symptoms attributable to venous dysfunction (H)
32509	01DEC1991	31DEC9999	Y	VARICOSE VEINS, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - 1 leg -
32511	01NOV1994	31OCT2002	N	VARICOSE VEINS, complete dissection at the sapheno-femoral AND sapheno-popliteal junction, with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time, including excision or injection of either tributaries or incompetent perforating veins, or both
32511	01NOV2002	31OCT2021	N	VARICOSE VEINS, complete dissection at the sapheno-femoral AND sapheno-popliteal junction - 1 leg - with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both
32511	01NOV2021	31DEC9999	Y	Varicose veins, complete dissection at the sapheno-femoral and sapheno-popliteal junction, with or without either ligation or stripping, or both, of the great or small saphenous veins in one leg of a patient, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both, if the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) discomfort; (j) any other signs or symptoms attributable to venous dysfunction (H)
32512	01DEC1991	31DEC9999	Y	LONG SAPHENOUS VEIN, complete dissection and ligation of, at the sapheno-femoral junction, for migrating thrombosis of long saphenous vein
32514	01NOV1994	31OCT2002	N	VARICOSE VEINS, ligation of the long or short saphenous vein, with or without stripping, by re-operation for recurrent veins in the same territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both
32514	01NOV2002	31OCT2021	N	VARICOSE VEINS, ligation of the long or short saphenous vein on the same leg, with or without stripping, by re-operation for recurrent veins in the same territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both
32514	01NOV2021	31DEC9999	Y	Varicose veins, ligation of the great or small saphenous vein in the same leg of a patient, with or without stripping, by re-operation for recurrent veins in the same territory-one leg-including excision or injection of either tributaries or incompetent perforating veins, or both, if the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) discomfort; (j) any other signs or symptoms attributable to venous dysfunction (H)
32515	01DEC1991	31DEC9999	Y	VARICOSE VEINS, complete dissection at SAPHENO-FEMORAL JUNCTION, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction - 1 leg
32517	01NOV1994	31OCT2002	N	VARICOSE VEINS, ligation of the long and short saphenous vein, with or without stripping, by re-operation for recurrent veins in either territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both
32517	01NOV2002	31OCT2021	N	VARICOSE VEINS, ligation of the long and short saphenous vein on the same leg, with or without stripping, by re-operation for recurrent veins in either territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both
32517	01NOV2021	31DEC9999	Y	Varicose veins, ligation of the great and small saphenous vein in the same leg of a patient, with or without stripping, by re-operation for recurrent veins in either territory-one leg-including excision or injection of either tributaries or incompetent perforating veins, or both, if the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (a) ache; (b) pain; (c) tightness; (d) skin irritation; (e) heaviness; (f) muscle cramps; (g) limb swelling; (h) discolouration; (i) discomfort; (j) any other signs or symptoms attributable to venous dysfunction (H)
32518	01DEC1991	31DEC9999	Y	VARICOSE VEINS, complete dissection at sapheno-popliteal junction, with or without ligation of the short saphenous vein, with or without ligation of the major tributaries at the sapheno-popliteal junction - 1 leg
32520	01NOV2011	30JUN2012	N	VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare but not including radiofrequency diathermy or radiofrequency ablation.
32520	01JUL2012	30APR2013	N	VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) OR small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 of the general medical services table.
32520	01MAY2013	30APR2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507
32520	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32520	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32520	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a laser probe introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) of the patient demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32520	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a laser probe introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) of the patient demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32521	01DEC1991	31DEC9999	Y	VARICOSE VEINS, sub-fascial ligation of single deep perforating vein not being a service associated with any other varicose vein operation on the same leg - 1 leg
32522	01NOV2011	30JUN2012	N	VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare but not including radiofrequency diathermy or radiofrequency ablation.
32522	01JUL2012	30APR2013	N	VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) AND small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 of the general medical services table.
32522	01MAY2013	30APR2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507
32522	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32522	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation, and not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32522	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a laser probe introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins of the patient demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32522	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a laser probe introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins of the patient demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32523	01MAY2013	30APR2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both), but not including endovenous laser therapy, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507
32523	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32523	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32523	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a radiofrequency catheter introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include endovenous laser therapy or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32523	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a radiofrequency catheter introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include endovenous laser therapy or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32524	01DEC1991	31DEC9999	Y	VARICOSE VEINS, sub-fascial ligation of multiple deep perforating veins - 1 leg (Cockett's operation, Linton's operation or similar procedure)
32526	01MAY2013	30APR2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both), but not including endovenous laser therapy, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507
32526	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a)including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32526	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32526	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a radiofrequency catheter introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include endovenous laser therapy or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32526	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using a radiofrequency catheter introduced by an endovenous catheter, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include endovenous laser therapy or cyanoacrylate adhesive; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32527	01DEC1991	31DEC9999	Y	GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-popliteal incompetence - 1 leg
32528	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32528	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32528	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using cyanoacrylate adhesive, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service include all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32528	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great or small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using cyanoacrylate adhesive, if all of the following apply: (a) it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service include all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32529	01MAY2018	31OCT2018	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507
32529	01NOV2018	31OCT2021	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507
32529	01NOV2021	31OCT2022	N	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using cyanoacrylate adhesive, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60078; (iv) 60500 to 60509; (v) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32529	01NOV2022	31DEC9999	Y	Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great and small saphenous vein (and major tributaries of saphenous veins as necessary) in one leg of a patient, using cyanoacrylate adhesive, if all of the following apply: (a) it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer; (b) the patient has significant signs or symptoms (including one or more of the following signs or symptoms) attributable to venous reflux: (i) ache; (ii) pain; (iii) tightness; (iv) skin irritation; (v) heaviness; (vi) muscle cramps; (vii) limb swelling; (viii) discolouration; (ix) discomfort; (x) any other signs or symptoms attributable to venous dysfunction; (c) the service does not include radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; (d) the service is not associated with a service (on the same leg) to which any of the following items apply: (i) 32500 to 32507; (ii) 35200; (iii) 59970 to 60021; (iv) 60036 to 60045; (v) 60060 to 60078; (vi) 60500 to 60509; (vii) 61109 The service includes all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both)
32530	01DEC1991	31DEC9999	Y	GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-femoral incompetence or recurrent sapheno-popliteal incompetence with 1 or more of the following - multiple ligations, local stripping or excision of minor veins or sclerotherapy of minor veins - 1 leg
32700	01DEC1991	31DEC9999	Y	ARTERY OF NECK, bypass using vein or synthetic material
32703	01DEC1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, transection and reanastomosis of, or resection of small length and reanastomosis of - with or without endarterectomy
32706	01DEC1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with bypass by graft of vein or synthetic material
32708	01JUL1996	31DEC9999	Y	AORTIC BYPASS for occlusive disease using a straight non-bifurcated graft
32709	01DEC1991	31DEC9999	Y	AORTO-ILIAC OR AORTO-FEMORAL GRAFTING, straight or bifurcated
32710	01JUL1996	31DEC9999	Y	AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both anastomoses to the iliac arteries
32711	01JUL1996	31DEC9999	Y	AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both anastomoses to the common femoral or profunda femoris arteries
32712	01DEC1991	31DEC9999	Y	ILIO-FEMORAL BYPASS GRAFTING
32715	01DEC1991	31DEC9999	Y	AXILLARY or SUBCLAVIAN TO FEMORAL BYPASS GRAFTING to 1 or both FEMORAL ARTERIES
32718	01DEC1991	31DEC9999	Y	FEMORO-FEMORAL OR ILIO-FEMORAL CROSS-OVER BYPASS GRAFTING
32721	01DEC1991	31DEC9999	Y	RENAL ARTERY, bypass grafting to
32724	01DEC1991	31DEC9999	Y	RENAL ARTERIES (both), bypass grafting to
32727	01DEC1991	31DEC9999	Y	SPLENO-RENAL ARTERIAL BYPASS GRAFTING
32730	01DEC1991	31DEC9999	Y	MESENTERIC VESSEL (single), bypass grafting to
32733	01DEC1991	31DEC9999	Y	MESENTERIC VESSELS (multiple), bypass grafting to
32736	01DEC1991	31DEC9999	Y	INFERIOR MESENTERIC ARTERY, operation on, when performed in conjunction with another intra-abdominal vascular operation
32739	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with above knee anastomosis
32742	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to below knee popliteal artery
32745	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to tibio peroneal trunk or tibial or peroneal artery
32748	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis within 5cms of the ankle joint
32751	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING using synthetic graft, with lower anastomosis above or below the knee
32754	01DEC1991	31DEC9999	Y	FEMORAL ARTERY BYPASS GRAFTING, using a composite graft (synthetic material and vein) with lower anastomosis above or below the knee, including use of a cuff or sleeve of vein at 1 or both anastomoses
32757	01DEC1991	31DEC9999	Y	FEMORAL ARTERY SEQUENTIAL BYPASS GRAFTING, (using a vein or synthetic material) where an additional anastomosis is made to separately revascularise more than 1 artery - each additional artery revascularised beyond a femoral bypass
32760	01DEC1991	30JUN1993	N	VEIN, harvesting of from leg or arm for bypass or replacement graft when not performed through same incision as operation - each vein
32760	01JUL1993	31DEC9999	Y	VEIN, HARVESTING OF, FROM LEG OR ARM for bypass or replacement graft when not performed on the limb which is the subject of the bypass or graft - each vein
32763	01DEC1991	31DEC9999	Y	ARTERIAL BYPASS GRAFTING, using vein or synthetic material, not being a service to which another item in this Sub-group applies
32766	01DEC1991	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS, not being a service to which another item in this Sub-group applies, as an independent procedure
32769	01DEC1991	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item in this Sub-group applies, when performed in combination with another vascular operation (including graft to graft anastomosis)
33050	01JUL1996	31DEC9999	Y	BYPASS GRAFTING to replace a popliteal aneurysm using vein, including harvesting vein (when it is the ipsilateral long saphenous vein)
33055	01JUL1996	31DEC9999	Y	BYPASS GRAFTING to replace a popliteal aneurysm using a synthetic graft
33070	01JUL1996	31DEC9999	Y	ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, without bypass grafting
33075	01JUL1996	31DEC9999	Y	ANEURYSM IN THE NECK, ligation, suture closure or excision of, without bypass grafting
33080	01JUL1996	31DEC9999	Y	INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or excision of, without bypass grafting
33100	01DEC1991	31DEC9999	Y	ANEURYSM OF COMMON OR INTERNAL CAROTID ARTERY, OR BOTH, replacement by graft of vein or synthetic material
33103	01DEC1991	31DEC9999	Y	THORACIC ANEURYSM, replacement by graft
33106	01DEC1991	31DEC9999	Y	ARTERY OR VEIN BYPASS GRAFT, patch grafting to using vein or synthetic material, not being a service associated with any other vascular operation
33109	01DEC1991	31DEC9999	Y	THORACO-ABDOMINAL ANEURYSM, replacement by graft including re-implantation of arteries
33112	01DEC1991	31DEC9999	Y	SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft including re-implantation of arteries
33115	01DEC1991	31OCT1999	N	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft
33115	01NOV1999	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft, not being a service associated with a service to which item 33116 applies
33116	01NOV1999	31OCT2007	N	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft using endovascular repair procedure, excluding associated radiological services (Ministerial Determination)
33116	01NOV2007	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft using endovascular repair procedure, excluding associated radiological services
33118	01DEC1991	31OCT1999	N	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms)
33118	01NOV1999	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms) not being a service associated with a service to which item 33119 applies
33119	01NOV1999	31OCT2007	N	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both iliac arteries using endovascular repair procedure, excluding associated radiological services (Ministerial Determination)
33119	01NOV2007	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both iliac arteries using endovascular repair procedure, excluding associated radiological services
33121	01DEC1991	31DEC9999	Y	INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 1 or both femoral arteries (with or without excision or bypass of common iliac aneurysms)
33124	01DEC1991	31DEC9999	Y	ANEURYSM OF ILIAC ARTERY (common, external or internal), replacement by graft - unilateral
33127	01DEC1991	31DEC9999	Y	ANEURYSMS OF ILIAC ARTERIES (common, external or internal), replacement by graft - bilateral
33130	01DEC1991	31DEC9999	Y	ANEURYSM OF VISCERAL ARTERY, excision and repair by direct anastomosis or replacement by graft
33133	01DEC1991	31DEC9999	Y	ANEURYSM OF VISCERAL ARTERY, dissection and ligation of arteries without restoration of continuity
33136	01DEC1991	31DEC9999	Y	FALSE ANEURYSM, repair of, at aortic anastomosis following previous aortic surgery
33139	01DEC1991	31DEC9999	Y	FALSE ANEURYSM, repair of, in iliac artery and restoration of arterial continuity
33142	01DEC1991	31DEC9999	Y	FALSE ANEURYSM, repair of, in femoral artery and restoration of arterial continuity
33145	01DEC1991	31DEC9999	Y	RUPTURED THORACIC AORTIC ANEURYSM, replacement by graft
33148	01DEC1991	31DEC9999	Y	RUPTURED THORACO-ABDOMINAL AORTIC ANEURYSM, replacement by graft
33151	01DEC1991	31DEC9999	Y	RUPTURED SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft
33154	01DEC1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft
33157	01DEC1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision or bypass of common iliac aneurysms)
33160	01DEC1991	31DEC9999	Y	RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 1 or both femoral arteries
33163	01DEC1991	31DEC9999	Y	RUPTURED ILIAC ARTERY ANEURYSM, replacement by graft
33166	01DEC1991	31DEC9999	Y	RUPTURED ANEURYSM OF VISCERAL ARTERY, replacement by anastomosis or graft
33169	01DEC1991	31DEC9999	Y	RUPTURED ANEURYSM OF VISCERAL ARTERY, simple ligation of
33172	01DEC1991	31DEC9999	Y	ANEURYSM OF MAJOR ARTERY, replacement by graft, not being a service to which another item in this Sub-group applies
33175	01JUL1996	31DEC9999	Y	RUPTURED ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, without bypass grafting
33178	01JUL1996	31DEC9999	Y	RUPTURED ANEURYSM IN THE NECK, ligation, suture closure or excision of, without bypass grafting
33181	01JUL1996	31DEC9999	Y	RUPTURED INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or excision of, without bypass grafting
33500	01DEC1991	31DEC9999	Y	ARTERY OR ARTERIES OF NECK, endarterectomy of, including closure by suture (where endarterectomy of 1 or more arteries is undertaken through 1 arteriotomy incision)
33503	01DEC1991	31DEC9999	Y	INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with endarterectomy and closure by suture
33506	01DEC1991	31DEC9999	Y	INNOMINATE OR SUBCLAVIAN ARTERY, endarterectomy of, including closure by suture
33509	01DEC1991	31DEC9999	Y	AORTIC ENDARTERECTOMY, including closure by suture, not being a service associated with another procedure on the aorta
33512	01DEC1991	31DEC9999	Y	AORTO-ILIAC ENDARTERECTOMY (1 or both iliac arteries), including closure by suture not being a service associated with a service to which item 33515 applies
33515	01DEC1991	31DEC9999	Y	AORTO-FEMORAL ENDARTERECTOMY (1 or both femoral arteries) or BILATERAL ILIO-FEMORAL ENDARTERECTOMY, including closure by suture, not being a service associated with a service to which item 33512 applies
33518	01DEC1991	31DEC9999	Y	ILIAC ENDARTERECTOMY, including closure by suture, not being a service associated with another procedure on the iliac artery
33521	01DEC1991	31DEC9999	Y	ILIO-FEMORAL ENDARTERECTOMY (1 side), including closure by suture
33524	01DEC1991	31DEC9999	Y	RENAL ARTERY, endarterectomy of
33527	01DEC1991	31DEC9999	Y	RENAL ARTERIES (both), endarterectomy of
33530	01DEC1991	31DEC9999	Y	COELIAC OR SUPERIOR MESENTERIC ARTERY, endarterectomy of
33533	01DEC1991	31DEC9999	Y	COELIAC AND SUPERIOR MESENTERIC ARTERY, endarterectomy of
33536	01DEC1991	31DEC9999	Y	INFERIOR MESENTERIC ARTERY, endarterectomy of, not being a service associated with a service to which another item in this Sub-group applies
33539	01DEC1991	31DEC9999	Y	ARTERY OF EXTREMITIES, endarterectomy of, including closure by suture
33542	01DEC1991	31DEC9999	Y	EXTENDED DEEP FEMORAL ENDARTERECTOMY where the endarterectomy is at least 7cms long
33545	01DEC1991	31OCT1997	N	ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long
33545	01NOV1997	28FEB1999	N	ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long
33545	01MAR1999	31DEC9999	Y	ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material where patch is less than 3cm long
33548	01DEC1991	31OCT1997	N	ARTERY OR VEIN, patch grafting to by vein or synthetic material in conjunction with another arterial or venous operation where patch is 3cm long or greater
33548	01NOV1997	28FEB1999	N	ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material in conjunction with another arterial or venous operation where patch is 3cm long or greater
33548	01MAR1999	31DEC9999	Y	ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material where patch is 3cm long or greater
33551	01DEC1991	31DEC9999	Y	VEIN, harvesting of from leg or arm for patch when not performed through same incision as operation
33554	01DEC1991	31DEC9999	Y	ENDARTERECTOMY, in conjunction with an arterial bypass operation to prepare the site for anastomosis - each site
33800	01DEC1991	31DEC9999	Y	EMBOLUS, removal of, from artery of neck
33803	01DEC1991	31DEC9999	Y	EMBOLECTOMY or THROMBECTOMY, by abdominal approach, of an artery or bypass graft of trunk
33806	01DEC1991	31OCT2002	N	EMBOLECTOMY OR THROMBECTOMY, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery
33806	01NOV2002	28FEB2013	N	EMBOLECTOMY OR THROMBECTOMY, including the infusion of thrombolytic or other agents, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery
33806	01MAR2013	31DEC9999	Y	Embolectomy or thrombectomy (including the infusion of thrombolytic or other agents) from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery, item to be claimed once per extremity, regardless of the number of incisions required to access the artery or bypass graft
33809	01DEC1991	31DEC9999	Y	INFERIOR VENA CAVA OR ILIAC VEIN, thrombectomy of
33810	01JUL1996	31DEC9999	Y	INFERIOR VENA CAVA OR ILIAC VEIN, closed thrombectomy by catheter via the femoral vein
33811	01JUL1996	31DEC9999	Y	INFERIOR VENA CAVA OR ILIAC VEIN, open removal of thrombus or tumour
33812	01DEC1991	31DEC9999	Y	THROMBUS, removal of, from femoral or other similar large vein
33815	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by lateral suture
33818	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by direct anastomosis
33821	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein
33824	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by lateral suture
33827	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by direct anastomosis
33830	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein
33833	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by lateral suture
33836	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by direct anastomosis
33839	01DEC1991	31DEC9999	Y	MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by means of interposition graft
33842	01DEC1991	31DEC9999	Y	ARTERY OF NECK, re-operation for bleeding or thrombosis after carotid or vertebral artery surgery
33845	01DEC1991	31DEC9999	Y	LAPAROTOMY for control of post operative bleeding or thrombosis after intra-abdominal vascular procedure, where no other procedure is performed
33848	01DEC1991	31DEC9999	Y	EXTREMITY, re-operation on, for control of bleeding or thrombosis after vascular procedure, where no other procedure is performed
34100	01DEC1991	31DEC9999	Y	MAJOR ARTERY OF NECK, elective ligation or exploration of, not being a service associated with any other vascular procedure
34103	01DEC1991	30JUN1998	N	GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not being a service associated with any other vascular procedure
34103	01JUL1998	31OCT2016	N	GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not being a service associated with any other vascular procedure except those services to which items 32508, 32511, 32514 or 32517 apply
34103	01NOV2016	30APR2018	N	Great artery (aorta or pulmonary artery) or great vein (superior or inferior vena cava), ligation or exploration of immediate branches or tributaries, or ligation or exploration of the subclavian, axillary, iliac, femoral or popliteal arteries or veins, if the service is not associated with item 32508, 32511, 32520, 32522, 32523 or 32526-for a maximum of 2 services provided to the same patient on the same occasion (H)
34103	01MAY2018	31DEC9999	Y	Great artery (aorta or pulmonary artery) or great vein (superior or inferior vena cava), ligation or exploration of immediate branches or tributaries, or ligation or exploration of the subclavian, axillary, iliac, femoral or popliteal arteries or veins, if the service is not associated with item 32508, 32511, 32520, 32522, 32523, 32526, 32528 or 32529 - for a maximum of 2 services provided to the same patient on the same occasion (H)
34106	01DEC1991	30JUN1998	N	ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not being a service associated with any other vascular procedure
34106	01JUL1998	31DEC9999	Y	ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not being a service associated with any other vascular procedure except those services to which items 32508, 32511, 32514 or 32517 apply
34109	01DEC1991	31DEC9999	Y	TEMPORAL ARTERY, biopsy of
34112	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and ligation
34115	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE NECK, dissection and ligation
34118	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and ligation
34121	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and repair of, with restoration of continuity
34124	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE NECK, dissection and repair of, with restoration of continuity
34127	01DEC1991	31DEC9999	Y	ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and repair of, with restoration of continuity
34130	01DEC1991	31DEC9999	Y	SURGICALLY CREATED ARTERIO-VENOUS FISTULA OF AN EXTREMITY, closure of
34133	01DEC1991	31DEC9999	Y	SCALENOTOMY
34136	01DEC1991	31DEC9999	Y	FIRST RIB, resection of portion of
34139	01DEC1991	31DEC9999	Y	CERVICAL RIB, removal of, or other operation for removal of thoracic outlet compression, not being a service to which another item in this Sub-group applies
34142	01DEC1991	31DEC9999	Y	COELIAC ARTERY, decompression of, for coeliac artery compression syndrome, as an independent procedure
34145	01DEC1991	31DEC9999	Y	POPLITEAL ARTERY, exploration of, for popliteal entrapment, with or without division of fibrous tissue and muscle
34148	01DEC1991	30JUN1998	N	CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is less that 4cm in maximum diameter
34148	01JUL1998	31DEC9999	Y	CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is 4cm or less in maximum diameter
34151	01DEC1991	30JUN1998	N	CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter
34151	01JUL1998	31DEC9999	Y	CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter
34154	01DEC1991	30JUN1998	N	RECURRENT CAROTID BODY TUMOUR, resection of, with or without repair or replacement of portion of common or internal carotid arteries
34154	01JUL1998	31DEC9999	Y	RECURRENT CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or replacement of portion of internal or common carotid arteries
34157	01DEC1991	31DEC9999	Y	NECK, excision of infected bypass graft, including closure of vessel or vessels
34160	01DEC1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by suture of aorta and repair of duodenum
34163	01DEC1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by insertion of aortic graft and repair of duodenum
34166	01DEC1991	31DEC9999	Y	AORTO-DUODENAL FISTULA, repair of, by oversewing of abdominal aorta, repair of duodenum and axillo-bifemoral grafting
34169	01DEC1991	31DEC9999	Y	INFECTED BYPASS GRAFT FROM TRUNK, excision of, including closure of arteries
34172	01DEC1991	31DEC9999	Y	INFECTED AXILLO-FEMORAL OR FEMORO-FEMORAL GRAFT, excision of, including closure of arteries
34175	01DEC1991	31DEC9999	Y	INFECTED BYPASS GRAFT FROM EXTREMITIES, excision of including closure of arteries
34500	01DEC1991	31DEC9999	Y	ARTERIOVENOUS SHUNT, EXTERNAL, insertion of
34503	01DEC1991	31DEC9999	Y	ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, in conjunction with another venous or arterial operation
34506	01DEC1991	31DEC9999	Y	ARTERIOVENOUS SHUNT, EXTERNAL, removal of
34509	01DEC1991	31DEC9999	Y	ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, not in conjunction with another venous or arterial operation
34512	01DEC1991	31DEC9999	Y	ARTERIOVENOUS ACCESS DEVICE, insertion of
34515	01DEC1991	31DEC9999	Y	ARTERIOVENOUS ACCESS DEVICE, thrombectomy of
34518	01DEC1991	31DEC9999	Y	STENOSIS OF ARTERIOVENOUS FISTULA OR PROSTHETIC ARTERIOVENOUS ACCESS DEVICE, correction of
34521	01DEC1991	31DEC9999	Y	INTRA-ABDOMINAL ARTERY OR VEIN, cannulation of, for infusion chemotherapy, by open operation (excluding aftercare)
34524	01DEC1991	31DEC9999	Y	ARTERIAL CANNULATION for infusion chemotherapy by open operation, not being a service to which item 34521 applies (excluding after-care)
34527	01DEC1991	30JUN1996	N	CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device
34527	01JUL1996	31DEC2013	N	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation
34527	01JAN2014	31AUG2015	N	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation
34527	01SEP2015	30JUN2021	N	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterization, on a person 10 years of age or over
34527	01JUL2021	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation, on a patient 10 years of age or over
34528	01JUL1996	31DEC2013	N	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device
34528	01JAN2014	31AUG2015	N	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device
34528	01SEP2015	30JUN2021	N	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a person 10 years of age or over
34528	01JUL2021	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a patient 10 years of age or over
34529	01SEP2015	30JUN2021	N	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterization, on a person under 10 years of age
34529	01JUL2021	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation, on a patient under 10 years of age
34530	01DEC1991	30JUN1995	N	HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of
34530	01JUL1995	30JUN1996	N	HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of by open surgical procedure
34530	01JUL1996	31DEC2013	N	HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital or approved day-hospital
34530	01JAN2014	31AUG2015	N	CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital or approved day-hospital
34530	01SEP2015	30JUN2021	N	CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital on a person 10 years of age or over
34530	01JUL2021	31DEC9999	Y	CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital on a patient 10 years of age or over
34533	01DEC1991	31DEC9999	Y	ISOLATED LIMB PERFUSION, including cannulation of artery and vein at commencement of procedure, regional perfusion for chemotherapy, or other therapy, repair of arteriotomy and venotomy at conclusion of procedure (excluding aftercare)
34534	01SEP2015	30JUN2021	N	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a person under 10 years of age
34534	01JUL2021	31DEC9999	Y	CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a patient under 10 years of age
34538	01MAY2004	31DEC9999	Y	CENTRAL VEIN CATHERTERISATION by percutaneous technique, using subcutaneous tunnelled cuffed catheter or similar device, for the administration of haemodialysis or parenteral nutrition
34539	01MAY2004	30APR2016	N	TUNNELLED CUFFED CATHETER, OR SIMILAR DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital
34539	01MAY2016	31DEC9999	Y	TUNNELLED CUFFED CATHETER, OR SIMILAR DEVICE, removal of, by open surgical procedure
34540	01SEP2015	30JUN2021	N	CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital, on a person under 10 years of age
34540	01JUL2021	31DEC9999	Y	CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital, on a patient under 10 years of age
34700	01DEC1991	31DEC9999	Y	ENDOVASCULAR INTERVENTION PROCEDURES INFERIOR VENA CAVAL FILTER, insertion of, by percutaneous method using interventional imaging techniques
34703	01DEC1991	31DEC9999	Y	INFERIOR VENA CAVAL FILTER, insertion of, by open operation
34800	01DEC1991	31DEC9999	Y	INFERIOR VENA CAVA, plication, ligation, or application of caval clip
34803	01DEC1991	31DEC9999	Y	INFERIOR VENA CAVA, reconstruction of or bypass by vein or synthetic material
34806	01DEC1991	31DEC9999	Y	CROSS LEG BYPASS GRAFTING, saphenous to iliac or femoral vein
34809	01DEC1991	31DEC9999	Y	SAPHENOUS VEIN ANASTOMOSIS to femoral or popliteal vein for femoral vein bypass
34812	01DEC1991	31DEC9999	Y	VENOUS STENOSIS OR OCCLUSION, vein bypass for, using vein or synthetic material, not being a service associated with a service to which item 34806 or 34809 applies
34815	01DEC1991	31DEC9999	Y	VEIN STENOSIS, patch angioplasty for, (excluding vein graft stenosis)-using vein or synthetic material
34818	01DEC1991	31DEC9999	Y	VENOUS VALVE, plication or repair to restore valve competency
34821	01DEC1991	31DEC9999	Y	VEIN TRANSPLANT to restore valvular function
34824	01DEC1991	31DEC9999	Y	EXTERNAL STENT, application of, to restore venous valve competency to superficial vein - 1 stent
34827	01DEC1991	31DEC9999	Y	EXTERNAL STENTS, application of, to restore venous valve competency to superficial vein or veins - more than 1 stent
34830	01DEC1991	31DEC9999	Y	EXTERNAL STENT, application of, to restore venous valve competency to deep vein (1 stent)
34833	01DEC1991	31DEC9999	Y	EXTERNAL STENTS, application of, to restore venous valve competency to deep vein or veins (more than 1 stent)
34836	01DEC1991	31DEC9999	Y	PORTAL HYPERTENSION, vascular decompression operation for (including spleno-renal, porto-caval and mesenterico-caval anastomosis)
35000	01DEC1991	31DEC9999	Y	LUMBAR SYMPATHECTOMY
35003	01DEC1991	31DEC9999	Y	CERVICAL OR UPPER THORACIC SYMPATHECTOMY by any surgical approach
35006	01DEC1991	31DEC9999	Y	CERVICAL OR UPPER THORACIC SYMPATHECTOMY, where operation is a reoperation for previous incomplete sympathectomy by any surgical approach
35009	01DEC1991	31DEC9999	Y	LUMBAR SYMPATHECTOMY, where operation is following chemical sympathectomy or for previous incomplete surgical sympathectomy
35012	01MAY1994	31DEC9999	Y	SACRAL or PRE-SACRAL SYMPATHECTOMY
35100	01DEC1991	31DEC9999	Y	ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, when debridement includes muscle, tendon or bone
35103	01DEC1991	31DEC9999	Y	ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, superficial tissue only
35200	01DEC1991	31DEC9999	Y	OPERATIVE ARTERIOGRAPHY OR VENOGRAPHY, 1 or more of, performed during the course of an operative procedure on an artery or vein, 1 site
35202	01JUL1996	31DEC9999	Y	MAJOR ARTERIES OR VEINS IN THE NECK, ABDOMEN OR EXTREMITIES, access to, as part of RE-OPERATION after prior surgery on these vessels
35203	01DEC1991	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY OF CORONARY ARTERY AND DILATATION OF VESSEL, using interventional imaging techniques
35206	01DEC1991	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventional imaging techniques
35300	01APR1992	31OCT1993	N	ENDOVASCULAR INTERVENTIONAL PROCEDURES TRANSLUMINAL BALLOON ANGIOPLASTY of 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35300	01NOV1993	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35303	01APR1992	31OCT1993	N	TRANSLUMINAL BALLOON ANGIOPLASTY of aortic arch branches, aortic visceral branches, or more than 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35303	01NOV1993	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of aortic arch branches, aortic visceral branches, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35304	01NOV1992	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35305	01NOV1992	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of more than 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation and excluding aftercare
35306	01APR1992	31OCT1993	N	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35306	01NOV1993	30APR2016	N	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35306	01MAY2016	31DEC9999	Y	TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon dilatation for 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare.
35307	01NOV2005	31DEC9999	Y	TRANSLUMINAL STENT INSERTION, 1 or more stents (not drug-eluting), with or without associated balloon dilatation, for 1 carotid artery, percutaneous (not direct), with or without the use of an embolic protection device, in patients who: - meet the indications for carotid endarterectomy; and - have medical or surgical comorbidities that would make them at high risk of perioperative complications from carotid endarterectomy, excluding associated radiological services or preparation, and excluding aftercare
35309	01APR1992	31OCT1993	N	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35309	01NOV1993	30APR2016	N	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35309	01MAY2016	31DEC9999	Y	TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare.
35310	01NOV1992	31DEC9999	Y	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare
35312	01APR1992	31OCT1993	N	PERIPHERAL ARTERIAL ATHERECTOMY including associated balloon dilatation, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35312	01NOV1993	31DEC9999	Y	PERIPHERAL ARTERIAL ATHERECTOMY including associated balloon dilatation of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35315	01APR1992	31OCT1993	N	PERIPHERAL LASER ANGIOPLASTY including associated balloon dilatation, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35315	01NOV1993	31DEC9999	Y	PERIPHERAL LASER ANGIOPLASTY including associated balloon dilatation of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35317	01JUL1996	31OCT2002	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY CONTINUOUS INFUSION, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35319 or 35320 applies)
35317	01NOV2002	31DEC9999	Y	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY CONTINUOUS INFUSION, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35319 or 35320 applies and not being a service associated with photodynamic therapy with verteporfin)
35318	01APR1992	31DEC9999	Y	PERIPHERAL ARTERIAL or VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which item 13915 applies)
35319	01JUL1996	31OCT2002	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY PULSE SPRAY TECHNIQUE, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35320 applies)
35319	01NOV2002	31DEC9999	Y	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY PULSE SPRAY TECHNIQUE, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35320 applies and not being a service associated with photodynamic therapy with verteporfin)
35320	01JUL1996	31OCT2002	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY OPEN EXPOSURE, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35319 applies)
35320	01NOV2002	31DEC9999	Y	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY OPEN EXPOSURE, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35319 applies and not being a service associated with photodynamic therapy with verteporfin)
35321	01APR1992	31OCT1999	N	PERIPHERAL ARTERIAL CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35321	01NOV1999	31OCT2002	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35321	01NOV2002	30APR2004	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin
35321	01MAY2004	30APR2009	N	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, (but not for the treatment of uterine fibroids) percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin
35321	01MAY2009	31DEC9999	Y	PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, (but not for the treatment of uterine fibroids or varicose veins) percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin
35324	01APR1992	31DEC9999	Y	ANGIOSCOPY not combined with any other procedure, excluding associated radiological services or preparation, and excluding aftercare
35327	01APR1992	31DEC9999	Y	ANGIOSCOPY combined with any other procedure, excluding associated radiological services or preparation, and excluding aftercare
35330	01APR1992	31DEC9999	Y	INSERTION of INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
35331	01MAY2005	31DEC9999	Y	RETRIEVAL OF INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare
35335	01MAY2003	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with no stent insertion, where: - no lesion of the coronary artery has been stented; and - each lesion of the coronary artery is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
35338	01MAY2003	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with insertion of 1 or more stents, where: - no lesion of the coronary artery has been stented; and - each lesion of the coronary artery is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
35341	01MAY2003	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty with no stent insertion, where: - no lesion of the coronary arteries has been stented; and - each lesion of the coronary arteries is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
35344	01MAY2003	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty, with insertion of 1 or more stents, where: - no lesion of the coronary arteries has been stented; and - each lesion of the coronary arteries is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable, excluding associated radiological services or preparation, and excluding aftercare
35347	01NOV2003	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
35350	01NOV2003	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
35353	01NOV2003	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - percutaneous transluminal rotational artherectomy using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
35356	01NOV2003	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - percutaneous transluminal rotational artherectomy - intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
35360	01MAY2005	31DEC9999	Y	Retrieval of foreign body in PULMONARY ARTERY, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered)
35361	01MAY2005	31DEC9999	Y	Retrieval of foreign body in RIGHT ATRIUM, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered)
35362	01MAY2005	31DEC9999	Y	Retrieval of foreign body in INFERIOR VENA CAVA or AORTA, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered)
35363	01MAY2005	31DEC9999	Y	Retrieval of foreign body in PERIPHERAL VEIN or PERIPHERAL ARTERY, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered)
35400	01NOV2005	30APR2006	N	Vertebroplasty, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345, performed on an admitted patient in a hospital or day hospital facility.
35400	01MAY2006	31OCT2006	N	VERTEBROPLASTY, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345 performed on an admitted patient in a hospital or day hospital facility.
35400	01NOV2006	31DEC9999	Y	VERTEBROPLASTY, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345.
35401	01NOV2021	31OCT2024	N	Vertebroplasty, for one or more fractures in one or more vertebrae, performed by an interventional radiologist, for the treatment of a painful osteoporotic thoracolumbar vertebral compression fracture of the thoracolumbar spinal segment (T11, T12, L1 or L2), if: (a) pain is severe (numeric rated pain score greater than or equal to 7 out of 10); and (b) symptoms are poorly controlled by opiate therapy; and (c) severe pain duration is 3 weeks or less; and (d) there is MRI (or SPECT-CT if MRI unavailable) evidence of acute vertebral fracture Applicable only once for the same fracture, but is applicable for a new fracture of the same vertebra or vertebrae (H)
35401	01NOV2024	31DEC9999	Y	Vertebroplasty, for one or more fractures in one or more vertebrae, for the treatment of a painful osteoporotic thoracolumbar vertebral compression fracture of the thoracolumbar spinal segment (T11, T12, L1 or L2), if: (a) the service is performed by a specialist or consultant physician practicing in the specialist's or consultant physician's speciality of diagnostic radiology, neurosurgery, neurology or orthopaedic surgery; and (b) the specialist or consultant physician has undertaken appropriate training in the vertebroplasty procedure; and (c) pain is severe (numeric rated pain score greater than or equal to 7 out of 10); and (d) the symptoms are poorly controlled by opiate therapy; and (e) the severe pain duration is 3 weeks or less; and (f) there is MRI (or SPECT-CT if MRI unavailable) evidence of acute vertebral fracture Applicable only once for the same fracture, but is applicable for a new fracture of the same vertebra or vertebrae (H)
35402	01NOV2005	30APR2006	N	Vertebroplasty, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345, performed on an admitted patient in a hospital or day hospital facility.
35402	01MAY2006	31OCT2006	N	VERTEBROPLASTY, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345 performed on an admitted patient in a hospital or day hospital facility..
35402	01NOV2006	31DEC9999	Y	VERTEBROPLASTY, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345.
35404	01MAY2006	31DEC9999	Y	DOSIMETRY, HANDLING AND INJECTION OF SIR-SPHERES for selective internal radiation therapy of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies The procedure must be performed by a specialist or consultant physician recognised in the specialties of nuclear medicine or radiation oncology on an admitted patient in a hospital. To be claimed once in the patient's lifetime only.
35406	01MAY2006	31DEC9999	Y	Trans-femoral catheterisation of the hepatic artery to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies excluding associated radiological services or preparation, and excluding aftercare
35408	01MAY2006	31DEC9999	Y	Catheterisation of the hepatic artery via a permanently implanted hepatic artery port to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies excluding associated radiological services or preparation, and excluding aftercare
35410	01NOV2006	31DEC9999	Y	UTERINE ARTERY CATHETERISATION with percutaneous administration of occlusive agents, for the treatment of symptomatic uterine fibroids in a patient who has been referred for uterine artery embolisation by a specialist gynaecologist, excluding associated radiological services or preparation, and excluding aftercare
35412	01NOV2006	31DEC2014	N	Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling if performed, with parent artery preservation, not for use with liquid embolics only, including intra-operative imaging, but in association with pre-operative diagnostic imaging items 60009 and either 60072, 60075 or 60078, including aftercare
35412	01JAN2015	31OCT2022	N	Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling if performed, with parent artery preservation, not for use with liquid embolics only, including aftercare, including intra-operative imaging, but in association with the following pre-operative diagnostic imaging items: - either 60009 or 60010; and - either 60072, 60073, 60075, 60076, 60078 or 60079
35412	01NOV2022	29FEB2024	N	Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling (if performed), with parent artery preservation, not for use with liquid embolics only, including intra-operative imaging, but in association with pre-operative diagnostic imaging under item 60009, 60072, 60075 or 60078, including aftercare
35412	01MAR2024	31DEC9999	Y	Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling (if performed), with parent artery preservation, not for use with liquid embolics only, including intra-operative imaging, but in association with pre-operative diagnostic imaging under item 60009 and one of items 60072, 60075 and 60078, including aftercare
35414	01NOV2017	31DEC9999	Y	Mechanical thrombectomy, in a patient with a diagnosis of acute ischaemic stroke caused by occlusion of a large vessel of the anterior cerebral circulation, including intra-operative imaging and aftercare, if: (a) the diagnosis is confirmed by an appropriate imaging modality such as computed tomography, magnetic resonance imaging or angiography; and (b) the service is performed by a specialist or consultant physician with appropriate training that is recognised by the Conjoint Committee for Recognition of Training in Interventional Neuroradiology; and (c) the service is provided in an eligible stroke centre. For any particular patient - applicable once per presentation by the patient at an eligible stroke centre, regardless of the number of times mechanical thrombectomy is attempted during that presentation
35500	01DEC1991	31DEC9999	Y	GYNAECOLOGICAL EXAMINATION UNDER ANAESTHESIA, not being a service associated with a service to which another item in this Group applies
35502	01NOV2004	31DEC9999	Y	INTRAUTERINE DEVICE, INTRODUCTION OF, for the control of idiopathic menorrhagia, AND ENDOMETRIAL BIOPSY to exclude endometrial pathology, not being a service associated with a service to which another item in this Group applies
35503	01DEC1991	31OCT2014	N	INTRAUTERINE CONTRACEPTIVE DEVICE, INTRODUCTION OF, not being a service associated with a service to which another item in this Group applies
35503	01NOV2014	28FEB2022	N	Intra uterine contraceptive device, introduction of, if the service is not associated with a service to which another item in this Group applies (other than a service mentioned in item 30062)
35503	01MAR2022	31DEC9999	Y	Introduction of an intra-uterine device for abnormal uterine bleeding or contraception or for endometrial protection during oestrogen replacement therapy, if the service is not associated with a service to which another item in this Group applies (other than a service described in item 30062, 35506 or 35620)
35506	01DEC1991	28FEB2022	N	INTRAUTERINE CONTRACEPTIVE DEVICE, REMOVAL OF UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies
35506	01MAR2022	31DEC9999	Y	Intra-uterine device, removal of under general anaesthesia, for a retained or embedded device, not being a service associated with a service to which another item in this Group applies (other than a service described in item 35503)
35507	01APR1992	30JUN2022	N	VULVAL OR VAGINAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is less than or equal to 45 minutes - not being a service associated with a service to which item 32177 or 32180 applies
35507	01JUL2022	31DEC9999	Y	Vulval or vaginal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block), if the time taken is less than or equal to 45 minutes-other than a service associated with a service to which item 32236 applies (H)
35508	01APR1992	30JUN2022	N	VULVAL OR VAGINAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is greater than 45 minutes - not being a service associated with a service to which item 32177 or 32180 applies
35508	01JUL2022	31DEC9999	Y	Vulval or vaginal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block), if the time taken is greater than 45 minutes-other than a service associated with a service to which item 32236 applies (H)
35509	01DEC1991	31DEC9999	Y	HYMENECTOMY
35512	01DEC1991	31DEC9999	Y	BARTHOLIN'S CYST, excision of
35513	01DEC1991	28FEB2022	N	BARTHOLIN'S CYST, excision of
35513	01MAR2022	31DEC9999	Y	Bartholin's abscess, cyst or gland, excision of
35516	01DEC1991	31DEC9999	Y	BARTHOLIN'S CYST OR GLAND, marsupialisation of
35517	01DEC1991	28FEB2022	N	BARTHOLIN'S CYST OR GLAND, marsupialisation of
35517	01MAR2022	31DEC9999	Y	Bartholin's abscess, cyst or gland, marsupialisation of
35518	01JUL1995	31DEC2013	N	OVARIAN CYST ASPIRATION, for cysts of at least 4cm in diameter in premenopausal women and at least 2cm in diameter in postmenopausal women, by abdominal or vaginal route, using interventional imaging techniques and not associated with services provided for assisted reproductive techniques
35518	01JAN2014	28FEB2022	N	OVARIAN CYST ASPIRATION, for cysts of at least 4cm in diameter in a premenopausal person and at least 2cm in diameter in a postmenopausal person, by abdominal or vaginal route, using interventional imaging techniques and not associated with services provided for assisted reproductive techniques
35518	01MAR2022	31DEC9999	Y	Ovarian cyst aspiration, for cysts of at least 4 cm in diameter in a premenopausal patient and at least 2 cm in diameter in a postmenopausal patient, by abdominal or vaginal route, using interventional imaging techniques and not associated with services provided for assisted reproductive techniques, and not in cases of suspected or possible malignancy
35520	01DEC1991	31DEC9999	Y	BARTHOLIN'S ABSCESS, incision of
35523	01DEC1991	31DEC9999	Y	URETHRA OR URETHRAL CARUNCLE, cauterisation of
35526	01DEC1991	31DEC9999	Y	URETHRAL CARUNCLE, excision of
35527	01DEC1991	28FEB2022	N	URETHRAL CARUNCLE, excision of
35527	01MAR2022	31DEC9999	Y	Urethral caruncle, symptomatic excision of, if:(a) conservative management has failed; or(b) there is a suspicion of malignancy
35530	01DEC1991	31DEC9999	Y	CLITORIS, amputation of, where medically indicated
35533	01DEC1991	31OCT2014	N	VULVOPLASTY or LABIOPLASTY, where medically indicated, not being a service associated with a service to which item 35536 applies
35533	01NOV2014	31OCT2018	N	VULVOPLASTY or LABIOPLASTY, for repair of: (a) female genital mutilation; or (b) anomalies associated with major congenital anomalies of the uro-gynaecological tract other than a service associated with a service to which item 35536, 37050, 37836, 37842, 37851 or 43882 applies (H)
35533	01NOV2018	31DEC9999	Y	Vulvoplasty or labioplasty, for repair of: (a) female genital mutilation; or (b) an anomaly associated with a major congenital anomaly of the uro-gynaecological tract other than a service associated with a service to which item 35536, 37836, 37050, 37842, 37851 or 43882 applies
35534	01NOV2014	31OCT2018	N	VULVOPLASTY or LABIOPLASTY, for localised gigantism if it can be demonstrated that: (a) the structural abnormality is causing significant functional impairment; and (b) non-surgical treatments have failed (H)
35534	01NOV2018	31DEC9999	Y	Vulvoplasty or labioplasty, in a patient aged 18 years or more, performed by a specialist in the practice of the specialist's specialty, for a structural abnormality that is causing significant functional impairment, if the patient's labium extends more than 8 cm below the vaginal introitus while the patient is in a standing resting position
35536	01DEC1991	31MAR1992	N	VULVA, wide local excision of suspected malignancy; or hemivulvectomy; or superficial vulvectomy, (including colposcopically directed CO2 laser), one or more procedures
35536	01APR1992	28FEB2022	N	VULVA, wide local excision of suspected malignancy or hemivulvectomy, 1 or both procedures
35536	01MAR2022	31DEC9999	Y	Vulva, wide local excision or hemivulvectomy, one or both procedures, for suspected malignancy or vulval lesions with a high risk of malignancy
35539	01DEC1991	31MAR1992	N	COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies one anatomical site
35539	01APR1992	28FEB2022	N	COLPOSCOPICALLY DIRECTED CO² LASER THERAPY for previously confirmed intraepithelial neoplastic changes of the cervix, vagina, vulva, urethra or anal canal, including any associated biopsies 1 anatomical site
35539	01MAR2022	31DEC9999	Y	Colposcopically directed laser therapy for histologically-confirmed high grade intraepithelial neoplastic changes of the vagina, vulva, urethra or anal canal, including any associated biopsies-one anatomical site
35542	01DEC1991	31MAR1992	N	COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies two or more anatomical sites
35542	01APR1992	31DEC9999	Y	COLPOSCOPICALLY DIRECTED CO² LASER THERAPY for previously confirmed intraepithelial neoplastic changes of the cervix, vagina, vulva, urethra or anal canal, including any associated biopsies 2 or more anatomical sites
35545	01DEC1991	28FEB2022	N	COLPOSCOPICALLY DIRECTED CO² LASER THERAPY for condylomata, unsuccessfully treated by other methods
35545	01MAR2022	31DEC9999	Y	Colposcopically directed laser therapy for condylomata, unsuccessfully treated by other methods
35548	01DEC1991	31OCT1992	N	VULVECTOMY (RADICAL) for malignancy
35548	01NOV1992	28FEB2022	N	VULVECTOMY, radical, for malignancy
35548	01MAR2022	31DEC9999	Y	VULVECTOMY, radical, for malignancy (H)
35551	01DEC1991	31OCT2019	N	PELVIC LYMPH GLANDS, excision of (radical)
35551	01NOV2019	31OCT2020	N	PELVIC LYMPH NODES, excision of (radical)
35551	01NOV2020	31DEC9999	Y	Pelvic lymph nodes, radical excision of, unilateral, or sentinel node dissection (including any pre-operative injection)
35552	01NOV2020	28FEB2022	N	Pelvic lymph nodes, radical excision of, unilateral, following similar previous dissection, radiation or chemotherapy
35552	01MAR2022	31DEC9999	Y	Pelvic lymph nodes, radical excision of, unilateral or sentinel node dissection, following similar previous dissection, radiation or chemotherapy (H)
35554	01DEC1991	31DEC9999	Y	VAGINA, DILATATION OF, as an independent procedure including any associated consultation
35557	01DEC1991	28FEB2022	N	VAGINA, removal of simple tumour (including Gartner duct cyst)
35557	01MAR2022	31DEC9999	Y	Vagina, complete excision of benign tumour (including Gartner duct cyst), with histological documentation
35560	01DEC1991	28FEB2022	N	VAGINA, partial or complete removal of
35560	01MAR2022	31DEC9999	Y	Partial or complete vaginectomy, for either or both of the following:(a) deeply infiltrating vaginal endometriosis, if accompanied by histological confirmation from excised tissue;(b) pre-invasive or invasive lesionsNot being a service associated with hysterectomy for non invasive indications (H)
35561	01NOV1992	28FEB2022	N	VAGINECTOMY, radical, for proven invasive malignancy - 1 surgeon
35561	01MAR2022	31DEC9999	Y	VAGINECTOMY, radical, for proven invasive malignancy - 1 surgeon (H)
35562	01NOV1992	28FEB2022	N	VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - abdominal surgeon (including aftercare)
35562	01MAR2022	31DEC9999	Y	VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - abdominal surgeon (including aftercare) (H)
35563	01DEC1991	31DEC9999	Y	VAGINAL RECONSTRUCTION for congenital absence, gynatresia or urogenital sinus
35564	01NOV1992	28FEB2022	N	VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - perineal surgeon
35564	01MAR2022	31DEC9999	Y	VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - perineal surgeon (H)
35565	01NOV1992	31DEC9999	Y	VAGINAL RECONSTRUCTION for congenital absence, gynatresia or urogenital sinus
35566	01DEC1991	31DEC9999	Y	VAGINAL SEPTUM, excision of, for correction of double vagina
35567	01NOV1992	30APR1994	N	VAGINAL REPAIR (involving repair of enterocele) with transvaginal sacrospinus ligament colposuspension
35567	01MAY1994	31DEC9999	Y	VAGINAL REPAIR including 1 or more of anterior, posterior or entrocele repair, with sacrospinous colpopexy
35568	01MAY2005	28FEB2022	N	SACROSPINOUS COLPOPEXY FOR MANAGEMENT OF UPPER VAGINAL PROLAPSE
35568	01MAR2022	31DEC9999	Y	Procedures for the management of symptomatic upper vaginal (vault or cervical) prolapse by sacrospinous or ilococcygeus fixation (H)
35569	01DEC1991	31DEC9999	Y	PLASTIC REPAIR TO ENLARGE VAGINAL ORIFICE
35570	01MAY2005	30JUN2018	N	ANTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving repair of urethrocoele and cystocoele) with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies
35570	01JUL2018	28FEB2021	N	Anterior vaginal compartment repair by vaginal approach for pelvic organ prolapse (involving repair of urethrocele and cystocele), using native tissue without graft, other than a service associated with a service to which item 35573, 35577 or 35578 applies.
35570	01MAR2021	31DEC9999	Y	Anterior vaginal compartment repair by vaginal approach for pelvic organ prolapse: (a) involving repair of urethrocele and cystocele; and (b) using native tissue without graft; other than a service associated with a service to which item 35573, 35577 or 35578 applies
35571	01MAY2005	30JUN2018	N	POSTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving one or more of the following; repair of perineum, rectocoele or enterocoele) with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies
35571	01JUL2018	28FEB2021	N	Posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse involving repair of one or more of the following: (a) perineum; (b) rectocoele; (c) enterocoele; using native tissue without graft, other than a service associated with a service to which item 35573, 35577 or 35578 applies.
35571	01MAR2021	31DEC9999	Y	Posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse: (a) involving repair of one or more of the following: (i) perineum; (ii) rectocoele; (iii) enterocoele; and (b) using native tissue without graft; other than a service associated with a service to which item 35573, 35577 or 35578 applies
35572	01DEC1991	31DEC9999	Y	COLPOTOMY not being a service to which another item in this Group applies
35573	01MAY2005	30JUN2018	N	ANTERIOR AND POSTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving both anterior and posterior compartment defects) with or without mesh, not being a service associated with a service to which item 35577 or 35578 applies
35573	01JUL2018	28FEB2021	N	Anterior and posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse (involving anterior and posterior compartment defects), using native tissue without graft, other than a service associated with a service to which item 35577 or 35578 applies.
35573	01MAR2021	31DEC9999	Y	Anterior and posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse: (a) involving anterior and posterior compartment defects; and (b) using native tissue without graft; other than a service associated with a service to which item 35577 or 35578 applies
35575	01DEC1991	31DEC9999	Y	ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35579, 35580, 35583 or 35584 applies
35576	01DEC1991	31OCT1998	N	ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35579, 35580, 35583 or 35584 applies
35576	01NOV1998	30APR2004	N	ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35580 or 35584 applies
35576	01MAY2004	31DEC9999	Y	ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) with or without mesh, not being a service associated with a service to which item 30405, 35580 or 35584 applies
35577	01MAY2005	30JUN2018	N	MANCHESTER (DONALD FOTHERGILL) OPERATION for genital prolapse, with or without mesh
35577	01JUL2018	28FEB2021	N	Manchester (Donald Fothergill) operation for pelvic organ prolapse (includes cervical amputation, anterior and posterior native tissue vaginal wall repairs without graft).
35577	01MAR2021	31DEC9999	Y	Manchester (Donald Fothergill) operation for pelvic organ prolapse, involving either or both of the following: (a) cervical amputation; (b) anterior and posterior native tissue vaginal wall repairs without graft
35578	01MAY2005	28FEB2022	N	LE FORT OPERATION for genital prolapse, not being a service associated with a service to which another item in this Subgroup applies
35578	01MAR2022	31DEC9999	Y	Colpocleisis for pelvic organ prolapse, not being a service associated with a service to which another item (other than item 35599) in this Subgroup applies (H)
35579	01DEC1991	31DEC9999	Y	ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35583 or 35584 applies
35580	01DEC1991	31OCT1998	N	ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35584 applies
35580	01NOV1998	30APR2004	N	ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35584 applies
35580	01MAY2004	31DEC9999	Y	ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) with or without mesh, not being a service associated with a service to which item 30405 or 35584 applies
35581	01JUL2018	28FEB2021	N	Vaginal procedure for excision of graft material in symptomatic patients with graft related complications, including graft related pain or discharge and bleeding related to graft exposure, less than 2cm2 in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35582 or 35585 applies.
35581	01MAR2021	31DEC9999	Y	Vaginal procedure for excision of graft material in symptomatic patients with graft related complications (including graft related pain or discharge and bleeding related to graft exposure), less than 2cm2 in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35582 or 35585 applies
35582	01JUL2018	28FEB2021	N	Vaginal procedure for excision of graft material in symptomatic patients with graft related complications, including graft related pain or discharge and bleeding related to graft exposure, more than 2cm2 in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35581 or 35585 applies.
35582	01MAR2021	31DEC9999	Y	Vaginal procedure for excision of graft material in symptomatic patients with graft related complications (including graft related pain or discharge and bleeding related to graft exposure), 2cm2 or more in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35581 or 35585 applies
35583	01DEC1991	31OCT1997	N	DONALDFOTHERGILL OR MANCHESTER OPERATION FOR GENITAL PROLAPSE
35583	01NOV1997	31DEC9999	Y	Manchester (DonaldFothergill) operation or le fort opeartion for genital prolapse (Anaes.) (Assist.)
35584	01DEC1991	31OCT1997	N	DONALDFOTHERGILL OR MANCHESTER OPERATION FOR GENITAL PROLAPSE
35584	01NOV1997	30APR2004	N	MANCHESTER (DONALDFOTHERGILL) OPERATION OR LE FORT OPERATION for genital prolapse
35584	01MAY2004	31DEC9999	Y	MANCHESTER (DONALDFOTHERGILL) OPERATION OR LE FORT OPERATION for genital prolapse, with or without mesh, not being a service associated with a service to which item 30405 applies
35585	01JUL2018	28FEB2021	N	Abdominal procedure either open, laparoscopic or robotic, for removal of graft material in patients symptomatic with graft related complications, including graft related pain or discharge and bleeding related to graft exposure or where the graft has penetrated adjacent organs such as the bladder (including urethra) or bowel, including retroperitoneal dissection and mobilisation of bladder and/or bowel, other than a service associated with a service to which item 35581 or 35582 applies.
35585	01MAR2021	31DEC9999	Y	Abdominal procedure, by open, laparoscopic or robot-assisted approach, if the service: (a) is for the removal of graft material: (i) in symptomatic patients with graft related complications (including graft related pain or discharge and bleeding related to graft exposure); or (ii) where the graft has penetrated adjacent organs such as the bladder (including urethra) or bowel; and (b) if required-includes retroperitoneal dissection, and mobilisation, of either or both of the bladder and bowel; other than a service associated with a service to which item 35581 or 35582 applies
35587	01DEC1991	31DEC9999	Y	URETHROCELE, operation for
35590	01DEC1991	30APR2004	N	Operation involving ABDOMINAL APPROACH for repair of ENTEROCELE OR SUSPENSION OF VAGINAL VAULT OR ENTEROCELE AND SUSPENSION OF VAGINAL VAULT
35590	01MAY2004	31DEC9999	Y	Operation involving ABDOMINAL APPROACH for repair of ENTEROCELE OR SUSPENSION OF VAGINAL VAULT OR ENTEROCELE AND SUSPENSION OF VAGINAL VAULT, with or without mesh, not being a service associated with a service to which item 30405 applies
35591	01MAR2022	31DEC9999	Y	Rectovaginal fistula repair of, by vaginal route approach, not being a service associated with a service to which item 35592, 35596, 37029, 37333 or 37336 applies (H)
35592	01MAR2022	31DEC9999	Y	Vesicovaginal fistula closure of, by vaginal approach, not being a service associated with a service to which item 35591, 35596, 37029, 37333 or 37336 applies (H)
35593	01DEC1991	30APR1997	N	VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35575, 35576, 35579, 35580, 35583, 35584, 35590, 35657 or 35673 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35575, 35576, 35579, 35580, 35583, 35584, 35590, 35657 or 35673 applies
35593	01MAY1997	31OCT1998	N	VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies
35593	01NOV1998	30APR2004	N	VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies
35593	01MAY2004	31DEC9999	Y	VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, with or without mesh, not being a service associated with a service to which item 30405, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies
35595	01MAY2005	28FEB2022	N	LAPAROSCOPIC OR ABDOMINAL PELVIC FLOOR REPAIR INCORPORATING THE FIXATION OF THE UTEROSACRAL AND CARDINAL LIGAMENTS TO RECTOVAGINAL AND PUBOCERVICAL FASCIA for symptomatic upper vaginal vault prolapse
35595	01MAR2022	31DEC9999	Y	Procedure for the management of symptomatic vaginal vault or cervical prolapse, by uterosacral ligament suspension, by any approach, without graft, if the uterosacral ligaments are separately identified, transfixed and then incorporated into rectovaginal and pubocervical fascia of the vaginal vault, including cystoscopy to check ureteric integrity (H)
35596	01DEC1991	28FEB2022	N	FISTULA BETWEEN GENITAL AND URINARY OR ALIMENTARY TRACTS, repair of, not being a service to which item 37029, 37333 or 37336 applies
35596	01MAR2022	31DEC9999	Y	Fistula between genital and urinary or alimentary tracts, repair of, other than a service to which item 35591, 35592, 37029, 37333 or 37336 applies (H)
35597	01MAY2005	28FEB2022	N	SACRAL COLPOPEXY, laparoscopic or open procedure where graft or mesh secured to vault, anterior and posterior compartment and to sacrum for correction of symptomatic upper vaginal vault prolapse
35597	01MAR2022	31DEC9999	Y	Sacral colpopexy, by any approach where graft or mesh is secured to vault, anterior and posterior compartments and to sacrum for correction of symptomatic upper vaginal vault prolapse (H)
35599	01DEC1991	30APR2004	N	STRESS INCONTINENCE, sling operation for
35599	01MAY2004	31OCT2004	N	STRESS INCONTINENCE, sling operation for, with or without mesh, not being a service associated with a service to which item 30405 applies
35599	01NOV2004	31OCT2020	N	STRESS INCONTINENCE, sling operation for, with or without mesh or tape, not being a service associated with a service to which item 30405 applies
35599	01NOV2020	12AUG2021	N	Stress incontinence, procedure using a female synthetic mid-urethral sling, with diagnostic cystoscopy to assess the integrity of the lower urinary tract, other than a service associated with a service to which item 30405 or 36812 applies
35599	13AUG2021	31DEC9999	Y	Stress incontinence, procedure using a female synthetic mid-urethral sling, with diagnostic cystoscopy to assess the integrity of the lower urinary tract, other than a service associated with a service to which item 36812 applies (H)
35600	01MAY1997	30APR2004	N	STRESS INCONTINENCE, VAGINAL PROCEDURE FOR
35600	01MAY2004	31DEC9999	Y	STRESS INCONTINENCE, VAGINAL PROCEDURE FOR, with or without mesh, not being a service associated with a service to which item 30405 applies
35602	01DEC1991	30APR2004	N	STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; abdominal procedure (including aftercare)
35602	01MAY2004	12AUG2021	N	STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; abdominal procedure, with or without mesh, (including aftercare), not being a service associated with a service to which item 30405 applies
35602	13AUG2021	31DEC9999	Y	Stress incontinence, combined synchronous abdomino-vaginal operation for-abdominal procedure, with or without mesh, (including after care) (H)
35605	01DEC1991	30APR2004	N	STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; vaginal procedure (including aftercare)
35605	01MAY2004	12AUG2021	N	STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; vaginal procedure, with or without mesh, (including aftercare), not being a service associated with a service to which item 30405 applies
35605	13AUG2021	31DEC9999	Y	Stress incontinence, combined synchronous abdomino-vaginal operation for-vaginal procedure, with or without mesh, (including after care)
35608	01DEC1991	28FEB2022	N	CERVIX, cauterisation (other than by chemical means), ionisation, diathermy or biopsy of, with or without dilatation of cervix
35608	01MAR2022	31DEC9999	Y	Cervix, one or more biopsies, cauterisation (other than by chemical means), ionisation, diathermy or endocervical curettage of, with or without dilatation of cervix
35609	01MAR2022	31DEC9999	Y	Cervix, cone biopsy or amputation
35610	01MAR2022	31DEC9999	Y	Cervix, cone biopsy for histologically proven malignancy
35611	01DEC1991	28FEB2022	N	CERVIX, removal of polyp or polypi, with or without dilatation of cervix, not being a service associated with a service to which item 35608 applies
35611	01MAR2022	31DEC9999	Y	Removal of cervical or vaginal polyp or polypi, with or without dilatation of cervix, not being a service associated with a service to which item 35608 applies
35612	01MAY1997	28FEB2022	N	CERVIX, RESIDUAL STUMP, removal of, by abdominal approach
35612	01MAR2022	31DEC9999	Y	Cervix, residual stump, removal of, by abdominal approach for non-malignant lesions
35613	01MAY1997	31DEC9999	Y	CERVIX, RESIDUAL STUMP, removal of, by vaginal approach
35614	01DEC1991	31DEC2013	N	EXAMINATION OF LOWER FEMALE GENITAL TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner
35614	01JAN2014	30NOV2017	N	EXAMINATION OF LOWER TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner
35614	01DEC2017	28FEB2022	N	EXAMINATION OF LOWER TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear screen result or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner
35614	01MAR2022	31DEC9999	Y	Examination of the lower genital tract using a colposcope in a patient who:(a) has a human papilloma virus related gynaecology indication; or(b) has symptoms or signs suspicious of lower genital tract malignancy; or(c) is undergoing follow-up treatment of lower genital tract malignancy; or(d) is undergoing assessment or surveillance of a vulvovaginal pre-malignant or malignant disease; or(e) is undergoing assessment or surveillance as part of an identified at risk population
35615	01APR1992	28FEB2022	N	VULVA, biopsy of, when performed in conjunction with a service to which item 35614 applies
35615	01MAR2022	31DEC9999	Y	Vulva or vagina, biopsy of, when performed in conjunction with a service to which item 35614 applies
35616	01MAY2001	31OCT2003	N	ENDOMETRIUM, endoscopic examination of and ablation of, by microwave, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage
35616	01NOV2003	30APR2006	N	ENDOMETRIUM, endoscopic examination of and ablation of, by microwave or thermal balloon, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage
35616	01MAY2006	28FEB2022	N	ENDOMETRIUM, endoscopic examination of and ablation of, by microwave or thermal balloon or radiofrequency electrosurgery, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage
35616	01MAR2022	31DEC9999	Y	Endometrial ablation by thermal balloon or radiofrequency electrosurgery, for abnormal uterine bleeding, with or without endometrial sampling, including any hysteroscopy performed on the same day (H)
35617	01DEC1991	30APR2005	N	CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35584 applies
35617	01MAY2005	31DEC9999	Y	CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35577 or 35578 applies
35618	01DEC1991	31OCT2017	N	CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35584 applies
35618	01NOV2017	31DEC9999	Y	CERVIX, cone biopsy, amputation or repair of, other than a service to which item 35577 or 35578 applies
35619	01MAY1994	31DEC9999	Y	CERVIX, dilatation of, under general anaesthesia, not being a service to which item 35639, 35640 or 35643 applies
35620	01MAY1994	28FEB2022	N	ENDOMETRIAL BIOPSY where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding
35620	01MAR2022	31DEC9999	Y	Endometrial biopsy for pathological assessment in women with abnormal uterine bleeding or post-menopausal bleeding
35621	01DEC1991	31DEC9999	Y	CERVIX, dilatation of, under general anaesthesia, not being a service to which item 35639, 35640 or 35643 applies
35622	01MAY1994	28FEB2022	N	ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage, not being a service associated with a service to which item 30390 applies
35622	01MAR2022	31DEC9999	Y	Endometrial ablation, using hysteroscopically guided electrosurgery or laser energy for abnormal uterine bleeding, with or without endometrial sampling, not being a service associated with a service to which item 30390 applies (H)
35623	01MAY1994	31OCT2000	N	HYSTEROSCOPIC RESECTION of myoma or uterine septum followed by endometrial ablation by laser or diathermy
35623	01NOV2000	28FEB2022	N	HYSTEROSCOPIC RESECTION of myoma, or myoma and uterine septum resection (where both are performed), followed by endometrial ablation by laser or diathermy
35623	01MAR2022	31DEC9999	Y	Endometrial ablation and resection of myoma or uterine septum (or both), using hysteroscopic guided electrosurgery or laser energy, for abnormal uterine bleeding, with or without endometrial sampling (H)
35624	01DEC1991	31DEC9999	Y	ENDOMETRIAL BIOPSY where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding
35625	01APR1992	31OCT1992	N	ENDOMETRIUM, endoscopic ablation of, by laser or diathermy resection, for chronic refractory menorrhagia including any hysteroscopy or laparoscopy performed on the same day but excluding services covered by Item 30582 or 35637
35625	01NOV1992	30JUN1993	N	ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, not being a service associated with a service to which item 30390 applies
35625	01JUL1993	31DEC9999	Y	ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage, not being a service associated with a service to which item 30390 applies
35626	01APR1992	31OCT1992	N	HYSTEROSCOPY, including biopsy, for the investigation of suspected intrauterine pathology (with or without local anaesthetic), where the patient is referred by a medical practitioner who is not a member of a group of practitioners of which the practitioner who ordered the service is a member - not in association with Item 35630
35626	01NOV1992	31OCT1994	N	HYSTEROSCOPY, including biopsy, performed by a specialist in the practice of his or her specialty where the patient is referred to him or her for the investigation of suspected intrauterine pathology (with or without local anaesthetic), not being a service associated with a service to which item 35627 or 35630 applies and including procedures to which item 35639, 35640 or 35643 applies, where performed
35626	01NOV1994	28FEB2022	N	HYSTEROSCOPY, including biopsy, performed by a specialist in the practice of his or her specialty where the patient is referred to him or her for the investigation of suspected intrauterine pathology (with or without local anaesthetic), not being a service associated with a service to which item 35627 or 35630 applies
35626	01MAR2022	31DEC9999	Y	Hysteroscopy for investigation of suspected intrauterine pathology, with or without local anaesthesia, including any associated endometrial biopsy, not being a service associated with a service to which item 35630 applies
35627	01DEC1991	31MAR1992	N	HYSTEROSCOPY with dilatation of cervix under general anaesthesia
35627	01APR1992	31OCT1992	N	HYSTEROSCOPY with dilatation of cervix performed in the operating theatre of a hospital or approved day-hospital facility
35627	01NOV1992	31OCT1994	N	HYSTEROSCOPY with dilatation of the cervix performed in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which item 35626 or 35630 applies, and including procedures to which item 35639, 35640 or 35643 applies, where performed
35627	01NOV1994	31DEC9999	Y	HYSTEROSCOPY with dilatation of the cervix performed in the operating theatre of a hospital - not being a service associated with a service to which item 35626 or 35630 applies
35630	01DEC1991	31MAR1992	N	HYSTEROSCOPY with endometrial biopsy or suction curettage, or both
35630	01APR1992	31OCT1992	N	HYSTEROSCOPY, with or without endometrial biopsy, performed in the operating theatre of a hospital or approved day-hospital facility - not covered by Item 35626 and including procedures covered by Item 35639, 35640 or 35643 where performed
35630	01NOV1992	31OCT1994	N	HYSTEROSCOPY, with endometrial biopsy, performed in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which item 35626 or 35627 applies, and including procedures to which item 35639, 35640 or 35643 applies, where performed
35630	01NOV1994	28FEB2022	N	HYSTEROSCOPY, with endometrial biopsy, performed in the operating theatre of a hospital - not being a service associated with a service to which item 35626 or 35627 applies
35630	01MAR2022	31DEC9999	Y	Hysteroscopy for investigation of suspected intrauterine pathology if performed under general anaesthesia, including any associated endometrial biopsy, not being a service associated with a service to which item 35626 applies (H)
35631	01MAR2022	31JUL2022	N	Operative laparoscopy, including any of the following:(a) unilateral or bilateral ovarian cystectomy;(b) salpingo-oophorectomy;(c) salpingectomy for tubal pathology (including ectopic pregnancy by tubal removal or salpingostomy, but excluding sterilisation);(d) excision of stage II (mild) endometriosis;not being a service associated with a service to which any other intraperitoneal or retroperitoneal procedure item (other than item 30724 or 30725) applies (H)
35631	01AUG2022	31DEC9999	Y	Operative laparoscopy, including any of the following:(a) unilateral or bilateral ovarian cystectomy;(b) salpingo-oophorectomy;(c) salpingectomy for tubal pathology (including ectopic pregnancy by tubal removal or salpingostomy, but excluding sterilisation);(d) excision of mild endometriosis;not being a service associated with a service to which any other intraperitoneal or retroperitoneal procedure item (other than item 30724 or 30725) applies (H)
35632	01MAR2022	31JUL2022	N	Complicated operative laparoscopy, including either or both of the following:(a) excision of stage III endometriosis;(b) laparoscopic myomectomy for a myoma of at least 4cm, including incision and repair of the uterus;not being a service associated with a service to which any other intraperitoneal or retroperitoneal procedure item (other than item 30724 or 30725 or 35658) applies (H)
35632	01AUG2022	31DEC9999	Y	Complicated operative laparoscopy, including either or both of the following:(a) excision of moderate endometriosis;(b) laparoscopic myomectomy for a myoma of at least 4cm, including incision and repair of the uterus;not being a service associated with a service to which any other intraperitoneal or retroperitoneal procedure item (other than item 30724 or 30725 or 35658) applies (H)
35633	01DEC1991	30APR2002	N	HYSTEROSCOPY with uterine adhesiolysis or polypectomy or tubal catheterisation or removal of IUD which cannot be removed by other means, 1 or more of
35633	01MAY2002	28FEB2022	N	HYSTEROSCOPY with uterine adhesiolysis or polypectomy or tubal catheterisation (including for insertion of device for sterilisation) or removal of IUD which cannot be removed by other means, 1 or more of
35633	01MAR2022	31JUL2022	N	Hysteroscopy, under visual guidance, including any of the following:(a) removal of an intra-uterine device;(b) removal of polyps by any method;(c) division of minor adhesions (ESH Grade 1)
35633	01AUG2022	31DEC9999	Y	Hysteroscopy, under visual guidance, including any of the following:(a) removal of an intra-uterine device;(b) removal of polyps by any method;(c) division of minor intrauterine adhesions
35634	01NOV2000	31DEC9999	Y	HYSTEROSCOPIC RESECTION of uterine septum followed by endometrial ablation by laser or diathermy
35635	01NOV2000	28FEB2022	N	HYSTEROSCOPY involving resection of the uterine septum
35635	01MAR2022	31JUL2022	N	Hysteroscopy involving division of:(a) a uterine septum; or(b) intrauterine adhesions ESH Grade 2 or higher (H)
35635	01AUG2022	31DEC9999	Y	Hysteroscopy involving division of:(a) a uterine septum; or(b) moderate to severe intrauterine adhesions (H)
35636	01DEC1991	30APR1994	N	HYSTEROSCOPY AND LAPAROSCOPY under general anaesthesia involving either myomectomy or resection of uterine septum, or both
35636	01MAY1994	31OCT2000	N	HYSTEROSCOPY, and laparoscopy where performed, under general anaesthesia involving either myomectomy or resection of uterine septum or both
35636	01NOV2000	28FEB2022	N	HYSTEROSCOPY, involving resection of myoma, or resection of myoma and uterine septum (where both are performed)
35636	01MAR2022	31DEC9999	Y	Hysteroscopy, resection of myoma or myoma and uterine septum (if both are performed) (H)
35637	01APR1992	31OCT1992	N	LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other gynaecological procedure - one or more procedures with or without biopsy - not associated with Item 30582, 35687 or 35688
35637	01NOV1992	31OCT1993	N	LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or similar procedure - 1 or more procedures with or without biopsy - not being a service associated with any other laparoscopic procedure
35637	01NOV1993	28FEB2022	N	LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or similar procedure - 1 or more procedures with or without biopsy - not being a service associated with any other laparoscopic procedure or hysterectomy
35637	01MAR2022	31JUL2022	N	Operative laparoscopy, including any of the following:(a) excision or ablation of stage l (minor) endometriosis;(b) division of pathological adhesions;(c) sterilisation by application of clips, division, destruction or removal of tubes;not being a service associated with a service to which any other item in this Group applies (H) NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
35637	01AUG2022	31DEC9999	Y	Operative laparoscopy, including any of the following: (a) excision or ablation of minimal endometriosis; (b) division of pathological adhesions; (c) sterilisation by application of clips, division, destruction or removal of tubes; not being a service associated with another laparoscopic procedure (H) NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
35638	01APR1992	30APR1994	N	COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, division of adhesions requiring more than 1 hours operating time or division of utero-sacral ligaments for significant dysmenorrhoea
35638	01MAY1994	31OCT2000	N	COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, division of adhesions requiring more than 1 hours operating time or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal procedure
35638	01NOV2000	30APR2001	N	COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal procedure except item 30393
35638	01MAY2001	31OCT2021	N	COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal or retroperitoneal procedure except item 30393
35638	01NOV2021	31DEC9999	Y	Complicated operative laparoscopy, including use of laser when required, for one or more of the following procedures: (a) oophorectomy; (b) ovarian cystectomy; (c) myomectomy; (d) salpingectomy; (e) salpingostomy; (f) ablation of moderate or severe endometriosis requiring more than 1 hours operating time; (g) division of utero-sacral ligaments for significant dysmenorrhoea; other than a service associated with another intraperitoneal or retroperitoneal procedure except item 30724 (H)
35639	01DEC1991	31OCT1994	N	UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day hospital facility
35639	01NOV1994	31DEC9999	Y	UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital, including procedures to which item 35626, 35627 or 35630 applies, where performed
35640	01DEC1991	31OCT1994	N	UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day hospital facility
35640	01NOV1994	31OCT2017	N	UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital, including procedures to which item 35626, 35627 or 35630 applies, where performed
35640	01NOV2017	28FEB2022	N	UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block, including procedures to which item 35626, 35627 or 35630 applies, if performed
35640	01MAR2022	31DEC9999	Y	Uterus, curettage of, with or without dilation (including curettage for incomplete miscarriage), if performed under:(a) general anaesthesia; or(b) epidural or spinal (intrathecal) nerve block; or(c) sedation;including procedures (if performed) to which item 35626 or 35630 applies
35641	01NOV2000	30APR2001	N	ENDOMETRIOSIS LEVEL 4 OR 5, LAPAROSCOPIC RESECTION OF, involving any two of the following procedures, resection of the pelvic side wall with ureterolysis, resection of the Pouch of Douglas, resection of an ovarian endometrioma greater than 2 cms in diameter, dissection of bowel from uterus from the level of the endocervical junction or above: where the operating time exceeds 90 minutes
35641	01MAY2001	28FEB2022	N	ENDOMETRIOSIS LEVEL 4 OR 5, LAPAROSCOPIC RESECTION OF, involving any two of the following procedures, resection of the pelvic side wall including dissection of endometriosis or scar tissue from the ureter, resection of the Pouch of Douglas, resection of an ovarian endometrioma greater than 2 cms in diameter, dissection of bowel from uterus from the level of the endocervical junction or above: where the operating time exceeds 90 minutes
35641	01MAR2022	31JUL2022	N	Endometriosis rAFS stage IV, laparoscopic resection of, involving 2 of the following procedures:(a) resection of the pelvic side wall including dissection of endometriosis or scar tissue from the ureter;(b) resection of the Pouch of Douglas; (c) resection of an ovarian endometrioma greater than 2 cm in diameter;(d) dissection of bowel from uterus from the level of the endocervical junction or above (H)
35641	01AUG2022	31DEC9999	Y	Severe endometriosis, laparoscopic resection of, involving 2 of the following procedures:(a) resection of the pelvic side wall including dissection of endometriosis or scar tissue from the ureter;(b) resection of the Pouch of Douglas; (c) resection of an ovarian endometrioma greater than 2 cm in diameter;(d) dissection of bowel from uterus from the level of the endocervical junction or above (H)
35643	01DEC1991	31OCT1994	N	EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE not being a service to which item 35639/35640 applies
35643	01NOV1994	31OCT2017	N	EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE not being a service to which item 35639/35640 applies, including procedures to which item 35626, 35627 or 35630 applies, where performed
35643	01NOV2017	28FEB2022	N	EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE other than a service to which item 35640 applies, including procedures to which item 35626, 35627 or 35630 applies, if performed
35643	01MAR2022	31DEC9999	Y	Evacuation of the contents of the gravid uterus by curettage or suction curettage, if performed under:(a) local anaesthesia; or(b) general anaesthesia; or(c) epidural or spinal (intrathecal) nerve block; or(d) sedation;including procedures (if performed) to which item 35626 or 35630 applies
35644	01APR1992	31OCT1992	N	CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not associated with Item 35647
35644	01NOV1992	31OCT2017	N	CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not being a service associated with a service to which item 35639, 35640 or 35647 applies
35644	01NOV2017	28FEB2022	N	CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, other than a service associated with a service to which item 35640 or 35647 applies
35644	01MAR2022	31DEC9999	Y	Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with colposcopy, including any local anaesthesia and biopsies, for previously biopsy confirmed HSIL (CIN 2/3) in a patient with a Type 1 or 2 (completely visible) transformation zone, if there is:(a) no evidence of invasive or glandular disease; and(b) no discordance between cytology and previous histology;not being a service associated with a service to which item 35647 or 35648 applies
35645	01APR1992	28FEB2022	N	CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, in conjunction with ablative therapy of additional areas of intraepithelial change in 1 or more sites of vagina, vulva, urethra or anus, not being a service associated with a service to which item 35648 applies
35645	01MAR2022	31DEC9999	Y	Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with colposcopy, including any local anaesthesia or biopsies, in conjunction with ablative therapy of additional areas of biopsy proven high grade intraepithelial lesions of one or more sites of the vagina, vulva, urethra or anus, for previously biopsy confirmed HSIL (CIN2/3) in a patient with a Type 1 of 2 (completely visible) transformation zone, if there is:(a) no evidence of invasive or glandular disease; and(b) no discordance between cytology and previous histology;not being a service associated with a service to which item 35647 or 35648 applies
35646	01DEC1991	31MAR1992	N	UTERUS COLPOSCOPY with cervical biopsy and radical diathermy of cervix
35646	01APR1992	31OCT1992	N	CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix
35646	01NOV1992	30APR2016	N	CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix, where performed in the operating theatre of a hospital
35646	01MAY2016	31DEC9999	Y	CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix
35647	01APR1992	28FEB2022	N	CERVIX, large loop excision of transformation zone together with colposcopy for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not being a service associated with a service to which item 35644 applies
35647	01MAR2022	31DEC9999	Y	Cervix, complete excision of the endocervical transformation zone, using large loop or laser therapy, including any local anaesthesia and biopsies
35648	01APR1992	28FEB2022	N	CERVIX, large loop excision diathermy for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, in conjunction with ablative treatment of additional areas of intraepithelial change of 1 or more sites of vagina, vulva, urethra or anus, not being a service associated with a service to which item 35645 applies
35648	01MAR2022	31DEC9999	Y	Cervix, complete excision of the endocervical transformation zone, using large loop or laser therapy, including any local anaesthesia and biopsies, in conjunction with ablative treatment of additional areas of biopsy-proven high grade intraepithelial lesions of one or more sites of the vagina, vulva, urethra or anus
35649	01DEC1991	28FEB2022	N	HYSTEROTOMY or UTERINE MYOMECTOMY, abdominal
35649	01MAR2022	31DEC9999	Y	Myomectomy, one or more myomas, when undertaken by an open abdominal approach (H)
35652	01DEC1991	31DEC9999	Y	HYSTERECTOMY, ABDOMINAL, SUBTOTAL or TOTAL, with or without removal of uterine adnexae
35653	01DEC1991	28FEB2022	N	HYSTERECTOMY, ABDOMINAL, SUBTOTAL or TOTAL, with or without removal of uterine adnexae
35653	01MAR2022	31DEC9999	Y	Hysterectomy, abdominal, with or without removal of fallopian tubes and ovaries (H)
35656	01DEC1991	31DEC9999	Y	HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 35673
35657	01DEC1991	30APR2002	N	HYSTERECTOMY, VAGINAL, with or without uterine curettage, not being a service to which item 35673 applies
35657	01MAY2002	28FEB2022	N	HYSTERECTOMY, VAGINAL, with or without uterine curettage, not being a service to which item 35673 applies NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
35657	01MAR2022	31OCT2022	N	Hysterectomy, vaginal, with or without uterine curettage, inclusive of posterior culdoplasty, not being a service to which item 35673 applies (H)
35657	01NOV2022	31DEC9999	Y	Hysterectomy, vaginal, with or without uterine curettage, inclusive of posterior culdoplasty, not being a service associated with a service to which item 35673 applies (H)
35658	01NOV1995	28FEB2022	N	UTERUS (at least equivalent in size to a 10 week gravid uterus), debulking of, prior to vaginal removal at hysterectomy
35658	01MAR2022	31DEC9999	Y	Uterus (at least equivalent in size to a 10 week gravid uterus), debulking of, prior to vaginal or laparoscopic removal at hysterectomy or myoma of at least 4 cm removed by laparoscopy when retrieved from the abdomen (H)
35660	01DEC1991	31DEC9999	Y	HYSTERECTOMY, ABDOMINAL, with excision of ovarian, paraovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries
35661	01DEC1991	31OCT1992	N	HYSTERECTOMY, ABDOMINAL, with excision of ovarian, paraovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries
35661	01NOV1992	28FEB2022	N	HYSTERECTOMY, ABDOMINAL, requiring extensive retroperitoneal dissection, with or without exposure of 1 or both ureters, for the management of severe endometriosis, pelvic inflammatory disease or benign pelvic tumours, with or without conservation of the ovaries
35661	01MAR2022	31DEC9999	Y	Hysterectomy, abdominal, that concurrently requires extensive retroperitoneal dissection with exposure of one or both ureters and complex side wall dissection, including when performed with one or more of the following procedures:(a) salpingectomy;(b) oophorectomy;(c) excision of ovarian cyst(H)
35664	01DEC1991	31OCT1992	N	RADICAL HYSTERECTOMY with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum
35664	01NOV1992	31OCT2019	N	RADICAL HYSTERECTOMY with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed
35664	01NOV2019	31DEC9999	Y	RADICAL HYSTERECTOMY with radical excision of pelvic lymph nodes (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed
35667	01DEC1991	31OCT1992	N	RADICAL HYSTERECTOMY without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum
35667	01NOV1992	28FEB2022	N	RADICAL HYSTERECTOMY without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed
35667	01MAR2022	31DEC9999	Y	Radical hysterectomy or radical trachelectomy (with or without excision of uterine adnexae) for proven malignancy, including excision of any one or more of the following:(a) parametrium;(b) paracolpos;(c) upper vagina;(d) contiguous pelvic peritoneum;utilising nerve sparing techniques and involving ureterolysis, if performed (H)
35668	01MAR2022	31DEC9999	Y	Hysterectomy, radical (with or without excision of uterine adnexae) including excision of any one or more of the following:(a) parametrium;(b) paracolpos;(c) upper vagina;(d) contiguous pelvic peritoneum;utilising nerve sparing techniques and involving ureterolysis, if performed in a patient with malignancy and previous pelvic radiation or chemotherapy treatment (H)
35669	01MAR2022	31DEC9999	Y	Hysterectomy, peripartum, performed for histologically proven placenta increta or percreta, or placenta accreta, if the patient has been referred to another practitioner for the management of severe intractable peripartum haemorrhage (H)
35670	01DEC1991	31OCT2019	N	HYSTERECTOMY, abdominal, with radical excision of pelvic lymph glands, with or without removal of uterine adnexae
35670	01NOV2019	31DEC9999	Y	HYSTERECTOMY, abdominal, with radical excision of pelvic lymph nodes, with or without removal of uterine adnexae
35671	01MAR2022	31DEC9999	Y	Hysterectomy, peripartum, for ongoing intractable haemorrhage where other haemorrhage control techniques have failed, for the purpose of providing lifesaving emergency treatment, not being a service associated with a service to which item 35667, 35668 or 35669 applies (H)
35673	01DEC1991	28FEB2022	N	HYSTERECTOMY, VAGINAL (with or without uterine curettage) with salpingectomy, oophorectomy or excision of ovarian cyst, 1 or more, 1 or both sides
35673	01MAR2022	31OCT2022	N	Hysterectomy, vaginal, with or without uterine curettage, with salpingectomy, oophorectomy or excision of ovarian cyst, one or more, one or both sides, inclusive of a posterior culdoplasty, not being a service to which item 35657 applies (H)
35673	01NOV2022	31DEC9999	Y	Hysterectomy, vaginal, with or without uterine curettage, with salpingectomy, oophorectomy or excision of ovarian cyst, one or more, one or both sides, inclusive of a posterior culdoplasty, not being a service associated with a service to which item 35657 applies (H)
35674	01JUL1995	31DEC9999	Y	ULTRASOUND GUIDED NEEDLING and injection of ectopic pregnancy
35676	01DEC1991	31DEC9999	Y	ECTOPIC PREGNANCY, removal of
35677	01DEC1991	31DEC9999	Y	ECTOPIC PREGNANCY, removal of
35678	01APR1992	31DEC9999	Y	ECTOPIC PREGNANCY, laparoscopic removal of
35680	01DEC1991	31DEC9999	Y	BICORNUATE UTERUS, plastic reconstruction for
35683	01DEC1991	31DEC9999	Y	UTERUS, SUSPENSION OR FIXATION OF, as an independent procedure
35684	01DEC1991	31DEC9999	Y	UTERUS, SUSPENSION OR FIXATION OF, as an independent procedure
35687	01DEC1991	30APR2002	N	STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method.
35687	01MAY2002	31DEC9999	Y	STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method. NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
35688	01DEC1991	30APR2002	N	STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method
35688	01MAY2002	31DEC9999	Y	STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
35691	01DEC1991	30APR2002	N	STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section
35691	01MAY2002	31DEC9999	Y	STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explantory note before submitting a claim.
35694	01DEC1991	28FEB2022	N	TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures
35694	01MAR2022	31DEC9999	Y	Tuboplasty (salpingostomy or salpingolysis), unilateral or bilateral, one or more procedures (H)
35697	01DEC1991	28FEB2022	N	MICROSURGICAL TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures
35697	01MAR2022	31DEC9999	Y	Microsurgical or laparoscopic tuboplasty (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures
35700	01DEC1991	31OCT1996	N	FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope
35700	01NOV1996	30JUN2008	N	FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope for other than reversal of previous sterilisation
35700	01JUL2008	28FEB2022	N	FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope
35700	01MAR2022	31DEC9999	Y	FALLOPIAN TUBES, unilateral microsurgical or laparoscopic anastomosis of (H)
35703	01DEC1991	28FEB2022	N	HYDROTUBATION OF FALLOPIAN TUBES as a nonrepetitive procedure not being a service associated with a service to which another item in this Sub-group applies
35703	01MAR2022	31DEC9999	Y	HYDROTUBATION OF FALLOPIAN TUBES as a nonrepetitive procedure
35706	01DEC1991	31DEC9999	Y	RUBIN TEST FOR PATENCY OF FALLOPIAN TUBES
35709	01DEC1991	31DEC9999	Y	FALLOPIAN TUBES, hydrotubation of, as a repetitive postoperative procedure
35710	01MAY1997	31DEC9999	Y	FALLOPOSCOPY, unilateral or bilateral, including hysteroscopy and tubal catheterization
35712	01DEC1991	31DEC9999	Y	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 1 such procedure, not being a service associated with hysterectomy
35713	01DEC1991	31OCT2017	N	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST one such procedure, not associated with hysterectomy
35713	01NOV2017	31DEC9999	Y	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGO-OOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - one such procedure, other than a service associated with hysterectomy
35716	01DEC1991	31DEC9999	Y	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 2 or more such procedures, unilateral or bilateral, not being a service associated with hysterectomy
35717	01DEC1991	31OCT2017	N	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST 2 or more such procedures, unilateral or bilateral, not being a service associated with hysterectomy
35717	01NOV2017	28FEB2022	N	LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGO-OOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 2 or more such procedures, unilateral or bilateral, other than a service associated with hysterectomy
35717	01MAR2022	31DEC9999	Y	Laparotomy, involving oophorectomy, salpingectomy, salpingo-oophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-one or more such procedures, unilateral or bilateral, including adhesiolysis, for benign disease (including ectopic pregnancy by tubal removal or salpingostomy), not being a service associated with hysterectomy (H)
35720	01DEC1991	28FEB2022	N	RADICAL OR DEBULKING OPERATION for advanced gynaecological malignancy, with or without omentectomy
35720	01MAR2022	31DEC9999	Y	Radical debulking, involving the radical excision of a macroscopically disseminated gynaecological malignancy from the pelvic cavity, including resection of peritoneum from the following:(a) the pelvic side wall;(b) the pouch of Douglas;(c) the bladder;for macroscopic disease confined to the pelvis, not being a service associated with a service to which item 35721 applies (H)
35721	01MAR2022	31DEC9999	Y	Radical debulking, involving the radical excision of a macroscopically disseminated gynaecological malignancy from the abdominal and pelvic cavity, where cancer has extended beyond the pelvis, including any of the following:(a) resection of peritoneum over any of the following: (i) the diaphragm; (ii) the paracolic gutters; (iii) the greater or lesser omentum; (iv) the porta hepatis;(b) cytoreduction of recurrent gynaecological malignancy from the abdominal cavity following previous abdominal surgery, radiation or chemotherapy;(c) cytoreduction of recurrent gynaecological malignancy from the pelvic cavity following previous pelvic surgery, radiation or chemotherapy;not being a service to which a service associated with a service to which item 35720 or 35726 applies (H)
35723	01DEC1991	28FEB2022	N	RETROPERITONEAL LYMPH NODE BIOPSIES from above the level of the aortic bifurcation, for staging or restaging of gynaecological malignancy
35723	01MAR2022	31DEC9999	Y	Para-aortic lymph node dissection from above the level of the aortic bifurcation (unilateral), for staging or restaging of gynaecological malignancy (H)
35724	01MAR2022	31DEC9999	Y	Para-aortic lymph node dissection (pelvic or above the aortic bifurcation) after prior similar dissection, radiotherapy or chemotherapy for malignancy (H)
35726	01DEC1991	28FEB2022	N	INFRACOLIC OMENTECTOMY with multiple peritoneal biopsies for staging or restaging of gynaecological malignancy
35726	01MAR2022	31OCT2022	N	Infra-colic omentectomy, with or without multiple peritoneal biopsies, for staging or restaging of gynaecological malignancy, not being a service to which item 35721 applies (H)
35726	01NOV2022	31DEC9999	Y	Infra-colic omentectomy, with or without multiple peritoneal biopsies, for staging or restaging of gynaecological malignancy, not being a service associated with a service to which item 35721 applies (H)
35729	01NOV1992	31DEC9999	Y	OVARIAN TRANSPOSITION out of the pelvis, in conjunction with radical hysterectomy for invasive malignancy
35730	01MAY2017	31DEC9999	Y	Ovarian repositioning for one or both ovaries to preserve ovarian function, prior to gonadotoxic radiotherapy when the treatment volume and dose of radiation have a high probability of causing infertility
35750	01MAY1997	28FEB2022	N	LAPAROSCOPICALLY ASSISTED HYSTERECTOMY, including any associated laparoscopy
35750	01MAR2022	30JUN2022	N	Hysterectomy, laparoscopic assisted vaginal, by any approach, including any endometrial sampling, with or without removal of the tubes or ovarian cystectomy or removal of the ovaries and tubes due to other pathology, not being a service associated with a service to which item 35595 or 35673 applies.
35750	01JUL2022	31DEC9999	Y	Hysterectomy, laparoscopic assisted vaginal, by any approach, including any endometrial sampling, with or without removal of the tubes or ovarian cystectomy or removal of the ovaries and tubes due to other pathology, not being a service associated with a service to which item 35595 or 35673 applies. (H)
35751	01MAR2022	31DEC9999	Y	Hysterectomy, laparoscopic, by any approach, including any endometrial sampling, with or without removal of the tubes, not being a service associated with a service to which item 35595 applies (H)
35753	01MAY1997	30APR2001	N	LAPAROSCOPICALLY ASSISTED HYSTERECTOMY with one or more of the following procedures: salpingectomy, oophorectomy, excision of ovarian cyst or treatment of moderate endometriosis, one or both sides, including any associated laparoscopy
35753	01MAY2001	28FEB2022	N	LAPAROSCOPICALLY ASSISTED HYSTERECTOMY with one or more of the following procedures: salpingectomy, oophorectomy, excision of ovarian cyst or treatment of moderate endometriosis, one or both sides, including any associated laparoscopy
35753	01MAR2022	31DEC9999	Y	Hysterectomy, complex laparoscopic, by any approach, including endometrial sampling, with either or both of the following procedures:(a) unilateral or bilateral salpingo-oophorectomy (excluding salpingectomy);(b) excision of moderate endometriosis or ovarian cyst;including any associated laparoscopy, not being a service associated with a service to which item 35595 applies (H)
35754	01MAY2001	28FEB2022	N	LAPAROSCOPICALLY ASSISTED HYSTERECTOMY which requires dissection of endometriosis, or other pathology, from the ureter, one or both sides, including any associated laparoscopy, including when performed with one or more of the following procedures: salpingectomy, oophorectomy, excision of ovarian cyst, or treatment of endometriosis, not being a service to which item 35641 applies
35754	01MAR2022	31JUL2022	N	Hysterectomy, laparoscopic, by any approach, including any of the following procedures:(a) salpingectomy;(b) oophorectomy;(c) excision of ovarian cyst;(d) any endometrial sampling that concurrently requires complex side wall dissection;(e) any associated laparoscopy;other than a service to which item 35595 or 35641 applies (H)
35754	01AUG2022	31DEC9999	Y	Hysterectomy, complex laparoscopic, by any approach, that concurrently requires either extensive retroperitoneal dissection or complex side wall dissection, or both, with any of the following procedures (if performed):(a) endometrial sampling; (b) unilateral or bilateral salpingectomy, oophorectomy or salpingo-oophorectomy;(c) excision of ovarian cyst; (d) any other associated laparoscopy; not being a service associated with a service to which item 35595 or 35641 applies (H)
35756	01MAY1997	28FEB2022	N	LAPAROSCOPICALLY ASSISTED HYSTERECTOMY, when procedure is completed by open hysterectomy, including any associated laparoscopy
35756	01MAR2022	31DEC9999	Y	Hysterectomy, laparoscopic, by any approach, if the procedure is completed by open hysterectomy for control of bleeding or extensive pathology, including any associated laparoscopy, not being a service associated with a service to which item 35595 or 35641 applies (H)
35759	01NOV2000	31OCT2013	N	Procedure for the control of POST OPERATIVE HAEMORRHAGE following gynaecological surgery, under general anaesthesia, utilising a vaginal or abdominal and vaginal approach where no other procedure is performed
35759	01NOV2013	28FEB2022	N	Procedure for the control of POST OPERATIVE HAEMORRHAGE following gynaecological surgery, under general anaesthesia, utilising a vaginal or abdominal and vaginal approach where no other procedure is performed
35759	01MAR2022	31DEC9999	Y	Procedure for the control of post operative haemorrhage following gynaecological surgery, under general anaesthesia, utilising a vaginal, abdominal or laparoscopic approach if no other procedure is performed (H)
36500	01DEC1991	31DEC9999	Y	ADRENAL GLAND, excision of partial or total
36502	01NOV1997	31DEC9999	Y	PELVIC LYMPHADENECTOMY, open or laparoscopic, or both, unilateral or bilateral
36503	01DEC1991	31DEC9999	Y	RENAL TRANSPLANT (not being a service to which item 36506 or 36509 applies)
36504	01MAY2019	29FEB2024	N	RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with biopsy of bladder, not being a service associated with a service to which item 36505, 36507, 36508, 36812, 36830, 36836, 36840, 36845, 36848, 36854, 37203, 37206, 37215, 37230 or 37233 applies.
36504	01MAR2024	31DEC9999	Y	Rigid cystoscopy using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with biopsy of bladder, not being a service associated with a service to which item 36505, 36507, 36508, 36812, 36830, 36836, 36840, 36845, 36848, 36854, 37203 or 37215 applies
36505	01MAY2019	31DEC9999	Y	RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with urethroscopy with or without urethral dilatation, not being a service associated with any other urological endoscopic procedure on the lower urinary tract except a service to which item 37327 applies.
36506	01DEC1991	31DEC9999	Y	RENAL TRANSPLANT, performed by vascular surgeon and urologist operating together vascular anastomosis including aftercare
36507	01MAY2019	31DEC9999	Y	RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder, not being a service to which item 36840 or 36845 applies.
36508	01MAY2019	31DEC9999	Y	RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with diathermy, resection or visual laser destruction of multiple tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter, not being a service to which item 36845 applies.
36509	01DEC1991	31DEC9999	Y	RENAL TRANSPLANT, performed by vascular surgeon and urologist operating together ureterovesical anastomosis including aftercare
36512	01DEC1991	31DEC9999	Y	DONOR NEPHRECTOMY (cadaver) one or both kidneys
36515	01DEC1991	31DEC9999	Y	NEPHRECTOMY, complete
36516	01DEC1991	31OCT2020	N	NEPHRECTOMY, complete
36516	01NOV2020	31DEC9999	Y	Nephrectomy, complete, by open, laparoscopic or robot-assisted approach, other than a service associated with a service to which item 30390 or 30627 applies
36519	01DEC1991	31OCT2020	N	NEPHRECTOMY, complete, complicated by previous surgery on the same kidney
36519	01NOV2020	31DEC9999	Y	Nephrectomy, complete, by open, laparoscopic or robot-assisted approach, complicated by previous surgery on the same kidney, other than a service associated with a service to which item 30390 or 30627 applies
36522	01DEC1991	31OCT2020	N	NEPHRECTOMY, partial
36522	01NOV2020	31DEC9999	Y	Nephrectomy, partial, by open, laparoscopic or robot-assisted approach, other than a service associated with a service to which item 30390 or 30627 applies
36525	01DEC1991	31OCT2020	N	NEPHRECTOMY, partial, complicated by previous surgery on the same kidney
36525	01NOV2020	31DEC9999	Y	Nephrectomy, partial, by open, laparoscopic or robot-assisted approach: (a) if complicated by previous surgery or ablative procedure on the same kidney; or (b) for a patient with a solitary functioning kidney; or (c) for a patient with an estimated glomerular filtration rate (eGFR) of less than 60ml/min/1.73m2; other than a service associated with a service to which item 30390 or 30627 applies
36526	01MAY2004	31DEC9999	Y	NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour less than 10cms in diameter, where performed if malignancy is clinically suspected but not confirmed by histopathological examination
36527	01MAY2004	31DEC9999	Y	NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour 10cms or more in diameter, or complicated by previous open or laparoscopic surgery on the same kidney, where performed if malignancy is clinically suspected but not confirmed by histopathological examination
36528	01DEC1991	30APR2001	N	NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy
36528	01MAY2001	31OCT2020	N	NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour less than 10 cms in diameter
36528	01NOV2020	31DEC9999	Y	Nephrectomy, radical, by open, laparoscopic or robot-assisted approach, with or without en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour less than 10 cm in diameter, other than a service associated with a service to which item 30390 or 30627 applies
36529	01MAY2001	31OCT2020	N	NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour 10 cms or more in diameter, or complicated by previous open or laparoscopic surgery on the same kidney
36529	01NOV2020	31DEC9999	Y	Nephrectomy, radical, by open, laparoscopic or robot-assisted approach, with or without en bloc dissection of lymph nodes, with or without adrenalectomy: (a) for a tumour 10 cm or more in diameter; or (b) if complicated by previous open or laparoscopic surgery on the same kidney; other than a service associated with a service to which item 30390 or 30627 applies
36530	01NOV2022	31DEC9999	Y	Renal cell carcinoma, not more than 4 cm in diameter, destruction of, by percutaneous, laparoscopic or open cryoablation (including any associated imaging services), if: (a) malignancy has previously been confirmed by histopathological examination; and (b) a multi-disciplinary team has reviewed treatment options for the patient and assessed that partial nephrectomy is not suitable; and (c) the service is not a service associated with a service to which item 36522 or 36525 applies (H)
36531	01DEC1991	31OCT2020	N	NEPHROURETERECTOMY, complete, including associated bladder repair and any associated endoscopic procedures
36531	01NOV2020	31DEC9999	Y	Nephroureterectomy, complete, by open, laparoscopic or robot-assisted approach, including associated bladder repair and any associated endoscopic procedure, other than a service associated with a service to which item 30390 or 30627 applies
36532	01MAY2001	31OCT2020	N	NEPHRO-URETERECTOMY, for tumour, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures
36532	01NOV2020	31DEC9999	Y	Nephroureterectomy, for tumour, by open, laparoscopic or robot-assisted approach, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures, other than a service to which item 36533 applies or a service associated with a service to which item 30390 or 30627 applies
36533	01MAY2001	31OCT2020	N	NEPHRO-URETERECTOMY, for tumour, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures, complicated by previous open or laparoscopic surgery on the same kidney or ureter
36533	01NOV2020	31DEC9999	Y	Nephroureterectomy, for tumour, by open, laparoscopic or robot-assisted approach, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures, if complicated by previous open or laparoscopic surgery on the same kidney or ureter, other than a service associated with a service to which item 30390 or 30627 applies
36534	01DEC1991	31DEC9999	Y	KIDNEY, FUSED, renal symphysiotomy for
36537	01DEC1991	31DEC9999	Y	KIDNEY OR PERINEPHRIC AREA, EXPLORATION OF, with or without drainage of, by open exposure, not being a service to which another item in this Sub-group applies
36540	01DEC1991	31DEC9999	Y	NEPHROLITHOTOMY OR PYELOLITHOTOMY, or both, through the same skin incision, for 1 or 2 stones
36543	01DEC1991	31OCT2020	N	NEPHROLITHOTOMY OR PYELOLITHOTOMY, or both, extended, for staghorn stone or 3 or more stones, including 1 or more of the following: nephrostomy, pyelostomy, pedicle control with or without freezing, calyorrhaphy or pyeloplasty
36543	01NOV2020	31DEC9999	Y	Nephrolithotomy or pyelolithotomy, or both, extended, for one or more renal stones, including one or more of nephrostomy, pyelostomy, pedicle control with or without freezing, calyorrhaphy or pyeloplasty
36546	01DEC1991	31DEC9999	Y	EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) to urinary tract and posttreatment care for 3 days, including pretreatment consultation, unilateral
36549	01DEC1991	31OCT2020	N	URETEROLITHOTOMY
36549	01NOV2020	31DEC9999	Y	Ureterolithotomy, by open, laparoscopic or robot-assisted approach
36552	01DEC1991	31DEC9999	Y	NEPHROSTOMY or pyelostomy, open, as an independent procedure
36555	01DEC1991	31DEC9999	Y	NEPHROPEXY, as an independent procedure
36558	01DEC1991	31DEC9999	Y	RENAL CYST OR CYSTS, excision or unroofing of
36561	01DEC1991	31OCT2020	N	RENAL BIOPSY (closed)
36561	01NOV2020	31DEC9999	Y	Renal biopsy, performed under image guidance (closed)
36564	01DEC1991	30APR2004	N	PYELOPLASTY, by open exposure
36564	01MAY2004	31OCT2020	N	PYELOPLASTY, (plastic reconstruction of the pelvi-ureteric junction) by open exposure, laparoscopy or laparoscopic assisted techniques
36564	01NOV2020	31DEC9999	Y	Pyeloplasty, (plastic reconstruction of the pelvi-ureteric junction) by open, laparoscopic or robot-assisted approach, with or without the use of a retroperitoneal approach
36567	01DEC1991	30APR2001	N	PYELOPLASTY in congenitally abnormal kidney or solitary kidney, by open exposure
36567	01MAY2001	31OCT2020	N	PYELOPLASTY in a kidney that is congenitally abnormal in addition to the presence of PUJ obstruction, or in a solitary kidney, by open exposure
36567	01NOV2020	31DEC9999	Y	Pyeloplasty in a kidney that is congenitally abnormal (in addition to the presence of pelvi-ureteric junction obstruction), or in a solitary kidney, by open, laparoscopic or robot-assisted approach, with or without the use of a retroperitoneal approach
36570	01DEC1991	31OCT2020	N	PYELOPLASTY, complicated by previous surgery on the same kidney, by open exposure
36570	01NOV2020	31DEC9999	Y	Pyeloplasty, complicated by previous surgery on the same kidney, by open, laparoscopic or robot-assisted approach, with or without the use of a retroperitoneal approach
36573	01DEC1991	31DEC9999	Y	DIVIDED URETER, repair of
36576	01DEC1991	31OCT2020	N	KIDNEY, exposure and exploration of, including repair or nephrectomy, for trauma, not being a service associated with any other procedure performed on the kidney, renal pelvis or renal pedicle
36576	01NOV2020	31DEC9999	Y	Kidney, exposure and exploration of, including repair or nephrectomy, for trauma, by open, laparoscopic or robot-assisted approach, other than a service associated with: (a) any other procedure performed on the kidney, renal pelvis or renal pedicle; or (b) a service to which item 30390 or 30627 applies
36579	01DEC1991	31OCT2020	N	URETERECTOMY, COMPLETE OR PARTIAL, with or without associated bladder repair, not being a service associated with a service to which item 37000 applies
36579	01NOV2020	31DEC9999	Y	Ureterectomy, complete or partial: (a) for a tumour within the ureter, proven by histopathology at the time of surgery; or (b) for congenital anomaly; with or without associated bladder repair
36582	01DEC1991	31DEC9999	Y	URETER, replacement of, by bowel
36585	01DEC1991	31DEC9999	Y	URETER, transplantation of, into skin
36588	01DEC1991	31DEC9999	Y	URETER, reimplantation into bladder
36591	01DEC1991	31DEC9999	Y	URETER, reimplantation into bladder with psoas hitch or Boari flap or both
36594	01DEC1991	31DEC9999	Y	URETER, transplantation of, into intestine
36597	01DEC1991	31DEC9999	Y	URETER, transplantation of, into another ureter
36600	01DEC1991	31DEC9999	Y	URETER, transplantation of, into isolated intestinal segment, unilateral
36603	01DEC1991	31DEC9999	Y	URETERS, transplantation of, into isolated intestinal segment, bilateral
36604	01MAY1997	31OCT2020	N	URETERIC STENT, passage of through percutaneous nephrostomy tube, using interventional imaging techniques
36604	01NOV2020	31DEC9999	Y	Ureteric stent, passage of through percutaneous nephrostomy tube, using interventional radiology techniques, but not including imaging
36605	01MAY2005	31DEC9999	Y	URETERIC STENT, insertion of, with removal of calculus from: (a) the pelvicalyceal system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a nephrostomy tube using interventional imaging techniques
36606	01DEC1991	31DEC9999	Y	INTESTINAL URINARY RESERVOIR, continent, formation of, including formation of nonreturn valves and implantation of ureters (1 or both) into reservoir
36607	01MAY2005	31OCT2020	N	URETERIC STENT insertion of, with baloon dilatation of: (a) the pelvicalyceal system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a nephrostomy tube using interventional imaging techniques
36607	01NOV2020	31DEC9999	Y	Ureteric stent insertion of, with balloon dilatation of: (a) the pelvicalyceal system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a nephrostomy tube using interventional radiology techniques, but not including imaging
36608	01MAY2005	31OCT2020	N	URETERIC STENT, exchange of, percutaneously through either the ileal conduit or bladder, using interventional imaging techniques, not being a service associated with a service to which items 36811 to 36854 apply
36608	01NOV2020	31DEC9999	Y	Ureteric stent, exchange of, percutaneously through either the ileal conduit or bladder, using interventional radiology techniques, but not including imaging, not being a service associated with a service to which items 36811 to 36854 apply
36609	01DEC1991	31OCT2020	N	INTESTINAL URINARY CONDUIT OR URETEROSTOMY, revision of
36609	01NOV2020	31DEC9999	Y	Intestinal urinary conduit, reservoir or ureterostomy, revision of
36610	01NOV2020	31DEC9999	Y	Intestinal urinary conduit, incontinent, formation of (including associated small bowel resection and anastomosis), including implantation of one or both ureters into reservoir
36611	01NOV2020	31DEC9999	Y	Intestinal urinary reservoir, continent, formation of (including associated small bowel resection and anastomosis), including formation of non-return valves and implantation of one or both ureters into reservoir, performed by open, laparoscopic or robot-assisted approach
36612	01DEC1991	31DEC9999	Y	URETER, exploration of, with or without drainage of, as an independent procedure
36615	01DEC1991	30APR2001	N	URETEROLYSIS, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition
36615	01MAY2001	31OCT2020	N	URETEROLYSIS, with or without repositioning of the ureter, for obstruction of the ureter, evident either radiologically or by proximal ureteric dilatation at operation, secondary to retroperitoneal fibrosis, or similar condition
36615	01NOV2020	31DEC9999	Y	Ureterolysis, unilateral, with or without repositioning of the ureter, for obstruction of the ureter, if: (a) the obstruction: (i) is evident either radiologically or by proximal ureteric dilatation at operation; and (ii) is secondary to retroperitoneal fibrosis; and (b) there is biopsy proven fibrosis, endometriosis or cancer at the site of the obstruction at time of surgery
36618	01DEC1991	31DEC9999	Y	REDUCTION URETEROPLASTY
36621	01DEC1991	31DEC9999	Y	CLOSURE OF CUTANEOUS URETEROSTOMY
36624	01DEC1991	30APR1994	N	NEPHROSTOMY, percutaneous, including associated imaging
36624	01MAY1994	31OCT2020	N	NEPHROSTOMY, percutaneous, using interventional imaging techniques
36624	01NOV2020	31DEC9999	Y	Nephrostomy, percutaneous, using interventional radiology techniques, but not including imaging
36627	01DEC1991	31OCT2020	N	NEPHROSCOPY, percutaneous, with or without any 1 or more of; stone extraction, biopsy or diathermy, not being a service to which item 36639, 36642, 36645 or 36648 applies
36627	01NOV2020	31DEC9999	Y	Nephroscopy, percutaneous, with or without any one or more of; stone extraction, biopsy or diathermy, not being a service to which item 36639 or 36645 applies
36630	01DEC1991	31DEC9999	Y	NEPHROSCOPY, BEING A SERVICE TO WHICH ITEM 36627 APPLIES, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION DUE TO BLEEDING
36633	01DEC1991	31OCT2020	N	NEPHROSCOPY, percutaneous, with incision of any 1 or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, not being a service associated with a service to which item 36627, 36639, 36642, 36645 or 36648 applies
36633	01NOV2020	31DEC9999	Y	Nephroscopy, percutaneous, with incision of any one or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, not being a service associated with a service to which item 36627, 36639 or 36645 applies
36636	01DEC1991	31OCT2020	N	NEPHROSCOPY, percutaneous, with incision of any 1 or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, being a service associated with a service to which item 36627, 36639, 36642, 36645 or 36648 applies
36636	01NOV2020	31DEC9999	Y	Nephroscopy, percutaneous, with incision of any one or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, being a service associated with a service to which item 36627, 36639 or 36645 applies
36639	01DEC1991	31OCT2020	N	NEPHROSCOPY, percutaneous, with destruction and extraction of 1 or 2 stones using ultrasound or electrohydraulic shock waves or lasers (not being a service to which item 36645 or 36648 applies)
36639	01NOV2020	31DEC9999	Y	Nephroscopy, percutaneous, with destruction and extraction of one or two stones using ultrasound or electrohydraulic shock waves or lasers, other than a service to which item 36645 applies
36642	01DEC1991	31DEC9999	Y	NEPHROSCOPY, BEING A SERVICE TO WHICH ITEM 36639 APPLIES, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION DUE TO BLEEDING
36645	01DEC1991	31DEC9999	Y	NEPHROSCOPY, percutaneous, with removal or destruction of a stone greater than 3 cm in any dimension, or for 3 or more stones
36648	01DEC1991	31DEC9999	Y	NEPHROSCOPY, being a service to which item 36645 applies, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION
36649	01APR1992	31OCT2020	N	NEPHROSTOMY DRAINAGE TUBE, exchange of - but not including imaging
36649	01NOV2020	31DEC9999	Y	Nephrostomy drainage tube, exchange of, using interventional radiology techniques, but not including imaging
36650	01MAY2005	31OCT2020	N	NEPHROSTOMY TUBE, removal of, if the ureter has been stented with a double J ureteric stent and that stent is left in place, using interventional imaging techniques
36650	01NOV2020	31DEC9999	Y	Nephrostomy tube, removal of, using interventional radiology techniques, but not including imaging, if the ureter has been stented with a double J ureteric stent and that stent is left in place
36652	01MAY2001	31DEC9999	Y	PYELOSCOPY, retrograde, of one collecting system, with or without any one or more of, cystoscopy, ureteric meatotomy, ureteric dilatation, not being a service associated with a service to which item 36803, 36812 or 36824 applies
36654	01MAY2001	31OCT2001	N	PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus 1 or more of extraction of stone from the renal pelvis or calyces, or biopsy or diathermy of the renal pelvis or calyces
36654	01NOV2001	31DEC9999	Y	PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus 1 or more of extraction of stone from the renal pelvis or calyces, or biopsy or diathermy of the renal pelvis or calyces, not being a service associated with a service to which item 36656 applies to a procedure performed in the same collecting system
36656	01MAY2001	31OCT2001	N	PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus extraction of 2 or more stones in the renal pelvis or calyces or destruction of stone with ultrasound, electrohydraulic or kinetic lithotripsy, or laser in the renal pelvis or calyces, with or without extraction of fragments
36656	01NOV2001	31DEC9999	Y	PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus extraction of 2 or more stones in the renal pelvis or calyces or destruction of stone with ultrasound, electrohydraulic or kinetic lithotripsy, or laser in the renal pelvis or calyces, with or without extraction of fragments, not being a service associated with a service to which item 36654 applies to a procedure performed in the same collecting system
36657	01APR2002	31DEC9999	Y	This is a dummy item used for statistical item mapping purposes
36658	01APR2002	31DEC9999	Y	SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal of pulse generator and leads
36660	01APR2002	31DEC9999	Y	SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal and replacement of pulse generator
36662	01APR2002	31DEC9999	Y	SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal and replacement of leads
36663	01MAY2010	30APR2017	N	Sacral nerve lead(s), percutaneous placement using fluoroscopic guidance (or open placement) and intraoperative test stimulation, to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older.
36663	01MAY2017	31DEC9999	Y	Both:(a) percutaneous placement of sacral nerve lead or leads using fluoroscopic guidance, or open placement of sacral nerve lead or leads; and (b) intra-operative test stimulation, to manage: (i) detrusor over-activity that has been refractory to at least 12 months conservative non-surgical treatment; or (ii) non-obstructive urinary retention that has been refractory to at least 12 months conservative non-surgical treatment
36664	01MAY2010	30APR2017	N	Sacral nerve lead(s), percutaneous surgical repositioning of, using fluoroscopic guidance (or open surgical repositioning) and intraoperative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older, not being a service to which item 36663 applies
36664	01MAY2017	31DEC9999	Y	Both:(a) percutaneous repositioning of sacral nerve lead or leads using fluoroscopic guidance, or open repositioning of sacral nerve lead or leads; and (b) intra-operative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of: (i) detrusor over-activity that has been refractory to at least 12 months conservative non-surgical treatment; or (ii) non-obstructive urinary retention that has been refractory to at least 12 months conservative non-surgical treatment -other than a service to which item 36663 applies
36665	01MAY2010	31DEC9999	Y	Sacral nerve electrode or electrodes, management and adjustment of the pulse generator by a medical practitioner, to manage detrusor overactivity or non obstructive urinary retention - each day
36666	01MAY2010	30APR2017	N	Pulse generator, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older.
36666	01MAY2017	31DEC9999	Y	Pulse generator, subcutaneous placement of, and placement and connection of extension wire or wires to sacral nerve electrode or electrodes, for the management of:(a) detrusor over-activity that has been refractory to at least 12 months conservative non-surgical treatment; or (b) non-obstructive urinary retention that has been refractory to at least 12 months conservative non-surgical treatment
36667	01MAY2010	30APR2017	N	Sacral nerve lead(s), removal of, if the lead was inserted to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older.
36667	01MAY2017	31DEC9999	Y	Sacral nerve lead or leads, removal of, if the lead was inserted to manage:(a) detrusor over-activity that has been refractory to at least 12 months conservative non-surgical treatment; or (b) non-obstructive urinary retention that has been refractory to at least 12 months conservative non-surgical treatment
36668	01MAY2010	30APR2017	N	Pulse generator, removal of, if the pulse generator was inserted to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older.
36668	01MAY2017	31DEC9999	Y	Pulse generator, removal of, if the pulse generator was inserted to manage:(a) detrusor over-activity that has been refractory to at least 12 months conservative non-surgical treatment; or (b) non-obstructive urinary retention that has been refractory to at least 12 months conservative non-surgical treatment
36671	01NOV2018	31DEC9999	Y	Percutaneous tibial nerve stimulation, initial treatment protocol, for the treatment of overactive bladder, by a specialist urologist, gynaecologist or urogynaecologist, if: (a) the patient has been diagnosed with idiopathic overactive bladder; and (b) the patient has been refractory to, is contraindicated or otherwise not suitable for conservative treatments (including anti-cholinergic agents); and (c) the patient is contraindicated or otherwise not a suitable candidate for botulinum toxin type A therapy; and (d) the patient is contraindicated or otherwise not a suitable candidate for sacral nerve stimulation; and (e) the patient is willing and able to comply with the treatment protocol; and (f) the initial treatment protocol comprises 12 sessions, delivered over a 3 month period; and (g) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. For each patient-applicable only once, unless the patient achieves at least a 50% reduction in overactive bladder symptoms from baseline at any time during the 3 month treatment period. Not applicable for a service associated with a service to which item 36672 or 36673 applies
36672	01NOV2018	31DEC9999	Y	Percutaneous tibial nerve stimulation, tapering treatment protocol, for the treatment of overactive bladder, including any associated consultation at the time the percutaneous tibial nerve stimulation treatment is administered, if: (a) the patient responded to the percutaneous tibial nerve stimulation initial treatment protocol and has achieved at least a 50% reduction in overactive bladder symptoms from baseline at any time during the treatment period for the initial treatment protocol; and (b) the tapering treatment protocol comprises no more than 5 sessions, delivered over a 3 month period, and the interval between sessions is adjusted with the aim of sustaining therapeutic benefit of the treatment; and (c) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. Not applicable for a service associated with a service to which item 36671 or 36673 applies
36673	01NOV2018	31DEC9999	Y	Percutaneous tibial nerve stimulation, maintenance treatment protocol, for the treatment of overactive bladder, including any associated consultation at the time the percutaneous tibial nerve stimulation treatment is administered, if: (a) the patient responded to the percutaneous tibial nerve stimulation initial treatment protocol and to the tapering treatment protocol, and has achieved at least a 50% reduction in overactive bladder symptoms from baseline at any time during the treatment period for the initial treatment protocol; and (b) the maintenance treatment protocol comprises no more than 12 sessions, delivered over a 12 month period, and the interval between sessions is adjusted with the aim of sustaining therapeutic benefit of the treatment; and (c) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. Not applicable for service associated with a service to which item 36671 or 36672 applies
36800	01DEC1991	31DEC9999	Y	BLADDER, catheterisation of, where no other procedure is performed
36803	01DEC1991	30APR2001	N	URETEROSCOPY, of one ureter, with or without any one or more of; cystoscopy, ureteric meatotomy or ureteric dilatation, not being a service associated with a service to which item 36652, 36654, 36656, 36806, 36809, 36812, 36824, 36848 or 36857 applies
36803	01MAY2001	31OCT2020	N	URETEROSCOPY, of one ureter, with or without any one or more of; cystoscopy, ureteric meatotomy or ureteric dilatation, not being a service associated with a service to which item 36652, 36654, 36656, 36806, 36809, 36812, 36824, 36848 or 36857 applies
36803	01NOV2020	31DEC9999	Y	Ureteroscopy, of one ureter, with or without any one or more of; cystoscopy, ureteric meatotomy or ureteric dilatation, not being a service associated with a service to which item 36652, 36654, 36656, 36806, 36809, 36812, 36824 or 36848 applies
36806	01DEC1991	30APR2001	N	URETEROSCOPY, BEING A SERVICE TO WHICH ITEM 36803 APPLIES, PLUS 1 or more of extraction of stone, biopsy or diathermy
36806	01MAY2001	31OCT2020	N	URETEROSCOPY, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, plus one or more of extraction of stone from the ureter, or biopsy or diathermy of the ureter, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36809, 36824, 36848 or 36857 applies to a procedure performed on the same ureter
36806	01NOV2020	31DEC9999	Y	Ureteroscopy, of one ureter: (a) with or without one or more of the following: (i) cystoscopy; (ii) endoscopic incision of pelviureteric junction or ureteric stricture; (iii) ureteric meatotomy; (iv) ureteric dilatation; and (b) with either or both of the following: (i) extraction of stone from the ureter; (ii) biopsy or diathermy of the ureter; other than: (c) a service associated with a service to which item 36803 or 36812 applies; or (d) a service associated with a service, performed on the same ureter, to which item 36809, 36824 or 36848 applies
36809	01DEC1991	30APR2001	N	URETEROSCOPY, BEING A SERVICE TO WHICH ITEM 36803 APPLIES, PLUS destruction of stone with ultrasound, electrohydraulic shock waves, or laser, with extraction of fragments
36809	01MAY2001	31OCT2020	N	URETEROSCOPY, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, PLUS destruction of stone in the ureter with ultrasound, electrohydraulic or kinetic lithotripsy, or laser, with or without extraction of fragments, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36806, 36824, 36848 or 36857 applies to a procedure performed on the same ureter
36809	01NOV2020	31DEC9999	Y	Ureteroscopy, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, plus destruction of stone in the ureter with ultrasound, electrohydraulic or kinetic lithotripsy, or laser, with or without extraction of fragments, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36806, 36824 or 36848 applies to a procedure performed on the same ureter
36811	01MAY1997	31OCT2020	N	CYSTOSCOPY with insertion of urethral prosthesis
36811	01NOV2020	31DEC9999	Y	Cystoscopy, with insertion of one or more urethral or prostatic prostheses, other than a service associated with a service to which item 37203, 37207 or 37230 applies
36812	01DEC1991	31OCT2020	N	CYSTOSCOPY with urethroscopy with or without urethral dilatation, not being a service associated with any other urological endoscopic procedure on the lower urinary tract except a service to which item 37327 applies
36812	01NOV2020	31DEC9999	Y	Either or both of cystoscopy and urethroscopy, with or without urethral dilatation, other than a service associated with any other urological endoscopic procedure on the lower urinary tract
36815	01DEC1991	31DEC9999	Y	CYSTOSCOPY, with or without urethroscopy, for the treatment of penile warts or uretheral warts, not being a service associated with a service to which item 30189 applies
36818	01DEC1991	31OCT2020	N	CYSTOSCOPY with ureteric catheterisation including fluoroscopic imaging of the upper urinary tract, unilateral or bilateral, not being a service associated with a service to which item 36824 or 36830 applies
36818	01NOV2020	31DEC9999	Y	Cystoscopy, with ureteric catheterisation, unilateral or bilateral, guided by fluoroscopic imaging of the upper urinary tract, other than a service associated with a service to which item 36824 or 36830 applies
36821	01DEC1991	31OCT2020	N	CYSTOSCOPY with 1 or more of; ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or renal pelvis, unilateral, not being a service associated with a service to which item 36824 or 36830 applies
36821	01NOV2020	31DEC9999	Y	Cystoscopy with one or more of; ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or renal pelvis, unilateral
36822	01NOV2020	31DEC9999	Y	Cystoscopy, with ureteric catheterisation, unilateral: (a) guided by fluoroscopic imaging of the upper urinary tract; and (b) including one or more of ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or of renal pelvis; other than a service associated with a service to which item 36818, 36821 or 36830 applies
36823	01NOV2020	31DEC9999	Y	Cystoscopy, with removal of ureteric stent and ureteric catheterisation, unilateral: (a) guided by fluoroscopic imaging of the upper urinary tract; and (b) including either or both of the following: (i) ureteric dilatation; or (ii) insertion of ureteric stent of ureter or of renal pelvis; other than a service associated with a service to which item 36818, 36821, 36830 or 36833 applies
36824	01DEC1991	31OCT2020	N	CYSTOSCOPY, with ureteric catheterisation, unilateral or bilateral, not being a service associated with a service to which item 36818 or 36821 applies
36824	01NOV2020	31DEC9999	Y	Cystoscopy, with ureteric catheterisation, unilateral or bilateral, other than a service associated with a service to which item 36818 applies
36825	01NOV1997	31DEC9999	Y	CYSTOSCOPY, with endoscopic incision of pelviureteric junction or ureteric stricture, including removal or replacement of ureteric stent, not being a service associated with a service to which item 36818, 36821, 36824, 36830 or 36833 applies
36827	01DEC1991	31OCT2020	N	CYSTOSCOPY, with controlled hydrodilatation of the bladder
36827	01NOV2020	31DEC9999	Y	Cystoscopy, with controlled hydrodilatation of the bladder, other than a service associated with a service to which item 37011 or 37245 applies
36830	01DEC1991	31DEC9999	Y	CYSTOSCOPY, with ureteric meatotomy
36833	01DEC1991	31OCT1997	N	CYSTOSCOPY WITH REMOVAL OF FOREIGN BODY
36833	01NOV1997	31OCT2020	N	CYSTOSCOPY, with removal of ureteric stent or other foreign body
36833	01NOV2020	31DEC9999	Y	Cystoscopy, with removal of ureteric stent or other foreign body in the lower urinary tract, unilateral
36836	01DEC1991	30APR2003	N	CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36839, 36845, 36848, 36854, 37203, 37206 or 37215 applies
36836	01MAY2003	31JAN2019	N	CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203, 37206 or 37215 applies
36836	01FEB2019	29FEB2024	N	CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203, 37206, 37215, 37230 or 37233 applies
36836	01MAR2024	31DEC9999	Y	Cystoscopy, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203 or 37215 applies
36839	01DEC1991	30JUN1995	N	CYSTOSCOPY, with resection or diathermy of bladder tumour or other lesion of the bladder or prostate, not being a service associated with a service to which item 36845 applies
36839	01JUL1995	31DEC9999	Y	CYSTOSCOPY, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder or prostate, not being a service associated with a service to which item 36845 applies
36840	01MAY2003	31OCT2020	N	CYSTOSCOPY, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder, not being a service to which item 36845 applies
36840	01NOV2020	31DEC9999	Y	Cystoscopy, with diathermy, resection or visual laser destruction of bladder tumour or other lesion of the bladder, for: (a) a tumour or lesion in only one quadrant of the bladder; or (b) a solitary tumour of not more than 2 cm in diameter; other than a service associated with a service to which item 36845 applies
36842	01DEC1991	31OCT2020	N	CYSTOSCOPY, with lavage of blood clots from bladder including any associated diathermy of prostate or bladder and not being a service associated with a service to which item 36812, 36827 to 36863, 37203 or 37206 apply
36842	01NOV2020	29FEB2024	N	Cystoscopy, with lavage of blood clots from bladder, including any associated cautery of prostate or bladder, other than a service associated with a service to which any of items 36812, 36827 to 36863, 37203, 37206, 37230 and 37233 apply
36842	01MAR2024	31DEC9999	Y	Cystoscopy, with lavage of blood clots from bladder, including any associated cautery of prostate or bladder, other than a service associated with a service to which any of items 36812, 36827 to 36863 and 37203 apply (H)
36845	01DEC1991	30JUN1995	N	CYSTOSCOPY, with diathermy or resection of multiple bladder tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter
36845	01JUL1995	31OCT2020	N	CYSTOSCOPY, with diathermy, resection or visual laser destruction of multiple tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter
36845	01NOV2020	31DEC9999	Y	Cystoscopy, with diathermy, resection or visual laser destruction of: (a) multiple tumours in 2 or more quadrants of the bladder; or (b) a solitary bladder tumour of more than 2 cm in diameter
36848	01DEC1991	31DEC9999	Y	CYSTOSCOPY, with resection of ureterocele
36851	01DEC1991	26NOV2013	N	CYSTOSCOPY, with injection into bladder wall
36851	27NOV2013	31OCT2014	N	CYSTOSCOPY, with injection into bladder wall, other than a service associated with a service to which item 18375 applies
36851	01NOV2014	31DEC9999	Y	Cystoscopy, with injection into bladder wall, other than a service associated with a service to which item 18375 or 18379 applies (H)
36854	01DEC1991	31DEC9999	Y	CYSTOSCOPY, with endoscopic incision or resection of external sphincter, bladder neck or both
36857	01DEC1991	31DEC9999	Y	ENDOSCOPIC MANIPULATION OR EXTRACTION of ureteric calculus
36860	01DEC1991	31DEC9999	Y	ENDOSCOPIC EXAMINATION of intestinal conduit or reservoir
36863	01DEC1991	31OCT2020	N	LITHOLAPAXY, with or without cystoscopy
36863	01NOV2020	31DEC9999	Y	Litholapaxy, with or without cystoscopy
37000	01DEC1991	31DEC9999	Y	BLADDER, partial excision of
37003	01DEC1991	31DEC9999	Y	BLADDER, repair of rupture
37004	01DEC1991	31DEC9999	Y	BLADDER, repair of rupture
37007	01DEC1991	31DEC9999	Y	CYSTOSTOMY OR CYSTOTOMY, suprapubic, not being a service to which item 37011 applies and not being a service associated with other open bladder procedure
37008	01DEC1991	31OCT2020	N	CYSTOSTOMY OR CYSTOTOMY, suprapubic, not being a service to which item 37011 applies and not being a service associated with other open bladder procedure
37008	01NOV2020	31DEC9999	Y	Open cystostomy or cystotomy, suprapubic, other than: (a) a service to which item 37011 applies; or (b) a service associated with a service to which item 37245 applies; or (c) another open bladder procedure
37011	01DEC1991	31OCT1995	N	SUPRAPUBIC STAB CYSTOTOMY
37011	01NOV1995	31OCT2020	N	SUPRAPUBIC STAB CYSTOTOMY, not being a service associated with a service to which items 37200 to 37221 apply
37011	01NOV2020	31DEC9999	Y	Suprapubic stab cystotomy, other than a service associated with a service to which item 36827 applies
37014	01DEC1991	31DEC9999	Y	BLADDER, total excision of
37015	01NOV2020	31DEC9999	Y	Bladder, total excision of, following previous open, laparoscopic or robot-assisted surgery, or radiation therapy or chemotherapy to the pelvis
37016	01NOV2020	31DEC9999	Y	Cystectomy, including prostatectomy and pelvic lymph node dissection, other than a service associated with a service to which items 37000, 37014, 37015, 37209, 35551 or 36502 applies
37017	01DEC1991	31DEC9999	Y	BLADDER TUMOURS, suprapubic diathermy of
37018	01NOV2020	31DEC9999	Y	Cystectomy, including prostatectomy and pelvic lymph node dissection, following previous open, laparoscopic or robot-assisted surgery, or radiation therapy or chemotherapy to the pelvis, other than a service associated with a service to which items 37000, 37014, 37015, 37016, 37209, 35551 or 36502 applies
37019	01NOV2020	31DEC9999	Y	Cystectomy, including anterior exenteration and pelvic lymph node dissection, other than a service associated with a service to which any of items 37000, 37014, 37015, 35551, 36502, and 35653 to 35756 apply
37020	01DEC1991	31DEC9999	Y	BLADDER DIVERTICULUM, excision or obliteration of
37021	01NOV2020	31DEC9999	Y	Cystectomy, including anterior exenteration and pelvic lymph node dissection, following previous open, laparoscopic or robot-assisted surgery, radiation therapy or chemotherapy to the pelvis, other than a service associated with a service to which any of items 37000, 37014, 37015, 35551, 36502 and 35653 to 35756 apply
37023	01DEC1991	31DEC9999	Y	VESICAL FISTULA, cutaneous, operation for
37026	01DEC1991	31DEC9999	Y	CUTANEOUS VESICOSTOMY, establishment of
37029	01DEC1991	31DEC9999	Y	VESICOVAGINAL FISTULA, closure of, by abdominal approach
37032	01DEC1991	31DEC9999	Y	VESICOVAGINAL FISTULA, closure of, synchronous combined approach, abdominal component, including aftercare
37035	01DEC1991	31DEC9999	Y	VESICOVAGINAL FISTULA, closure of, synchronous combined approach, vaginal component, including aftercare
37038	01DEC1991	31DEC9999	Y	VESICOINTESTINAL FISTULA, closure of, excluding bowel resection
37039	01NOV2020	31DEC9999	Y	Bladder stress incontinence, sling procedure for, using a non-autologous biological sling
37040	01MAY2016	31OCT2020	N	Bladder stress incontinence, sling procedure for, using a non-adjustable synthetic male sling system, with or without mesh, other than a service associated with a service to which item 30405, 35599 or 37042 applies
37040	01NOV2020	12AUG2021	N	Bladder stress incontinence, sling procedure for, using a non-adjustable synthetic male sling system, other than a service associated with a service to which item 30405 or 37042 applies
37040	13AUG2021	31DEC9999	Y	Bladder stress incontinence, sling procedure for, using a non-adjustable synthetic male sling system, other than a service associated with a service to which item 37042 applies (H)
37041	01DEC1991	31DEC9999	Y	BLADDER ASPIRATION by needle
37042	01MAY2001	30APR2004	N	BLADDER STRESS INCONTINENCE, sling procedure for, using autologous fascial sling, including harvesting of sling, not being a service to which item 35599 applies
37042	01MAY2004	31OCT2020	N	BLADDER STRESS INCONTINENCE, sling procedure for, using autologous fascial sling, including harvesting of sling, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies
37042	01NOV2020	12AUG2021	N	Bladder stress incontinence, sling procedure for, using autologous fascial sling, including harvesting of sling, other than a service associated with a service to which item 30405 or 35599 applies
37042	13AUG2021	31DEC9999	Y	Bladder stress incontinence-sling procedure for, using autologous fascial sling, including harvesting of sling, other than a service associated with a service to which item 35599 applies (H)
37043	01MAY2001	30APR2004	N	BLADDER STRESS INCONTINENCE, Stamey or similar type needle colposuspension, not being a service to which item 35599 applies
37043	01MAY2004	31OCT2020	N	BLADDER STRESS INCONTINENCE, Stamey or similar type needle colposuspension, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies
37043	01NOV2020	12AUG2021	N	Bladder stress incontinence, Stamey or similar type needle colposuspension, other than a service associated with a service to which item 30405 or 35599 applies
37043	13AUG2021	31DEC9999	Y	Bladder stress incontinence, Stamey or similar type needle colposuspension, other than a service associated with a service to which item 35599 applies (H)
37044	01DEC1991	30APR2001	N	BLADDER STRESS INCONTINENCE, suprapubic procedure for, e.g. Burch colposuspension, not being a service to which item 35599 applies
37044	01MAY2001	30APR2004	N	BLADDER STRESS INCONTINENCE, suprapubic procedure for, e.g. Burch colposuspension, not being a service to which item 35599 applies
37044	01MAY2004	31OCT2020	N	BLADDER STRESS INCONTINENCE, suprapubic procedure for, eg Burch colposuspension, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies
37044	01NOV2020	12AUG2021	N	Bladder stress incontinence, suprapubic procedure for, eg Burch colposuspension, other than a service associated with a service to which item 30405 or 35599 applies
37044	13AUG2021	28FEB2022	N	Bladder stress incontinence, suprapubic procedure for, e.g., Burch colposuspension, other than a service associated with a service to which item 35599 applies (H)
37044	01MAR2022	31DEC9999	Y	Bladder stress incontinence, suprapubic operation for (such as Burch colposuspension), open or laparoscopic route, using native tissue without graft, with diagnostic cystoscopy to assess the integrity of the lower urinary tract, not being a service associated with a service to which item 35599 or 36812 applies (H)
37045	01MAY1997	31AUG2015	N	MITROFANOFF CONTINENT VALVE, formation of
37045	01SEP2015	31DEC9999	Y	CONTINENT CATHETERISATION BLADDER STOMAS (eg. Mitrofanoff), formation of
37046	01NOV2020	31DEC9999	Y	Suprapubic or perineal procedure for excision of graft material, either singly or in multiple pieces, for a symptomatic patient with graft related complications (including graft related pain or discharge and bleeding related to graft exposure), if not more than one service to which this item applies has been provided to the patient by the same practitioner in the preceding 12 months
37047	01DEC1991	31DEC9999	Y	BLADDER ENLARGEMENT using intestine
37048	01NOV2020	31DEC9999	Y	Bladder neck closure for the management of urinary incontinence
37050	01DEC1991	31DEC9999	Y	BLADDER EXSTROPHY CLOSURE, not involving sphincter reconstruction
37053	01DEC1991	31DEC9999	Y	BLADDER TRANSECTION AND RE-ANASTOMOSIS TO TRIGONE
37200	01DEC1991	31OCT2020	N	PROSTATECTOMY, open
37200	01NOV2020	31DEC9999	Y	Prostatectomy, by open, laparoscopic or robot-assisted approach
37201	01NOV2002	31OCT2003	N	PROSTATE, transurethral radio-frequency needle ablation of the, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies (Ministerial Determination)
37201	01NOV2003	30APR2013	N	PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies
37201	01MAY2013	29FEB2024	N	PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37245, 37303, 37321 or 37324 applies
37201	01MAR2024	31DEC9999	Y	Prostate, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37207, 37208, 37245, 37303, 37321 or 37324 applies (H)
37202	01NOV2002	31OCT2003	N	PROSTATE, transurethral radio-frequency needle ablation of the, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37203,37207, 37201 which had to be discontinued for medical reasons (Ministerial Determination)
37202	01NOV2003	30APR2013	N	PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 which had to be discontinued for medical reasons
37202	01MAY2013	31DEC9999	Y	PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37245, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 which had to be discontinued for medical reasons
37203	01DEC1991	30JUN1995	N	PROSTATECTOMY (endoscopic), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies
37203	01JUL1995	31OCT2002	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37207, 37208, 37303, 37321 or 37324 applies
37203	01NOV2002	30APR2013	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37202, 37207, 37208, 37303, 37321 or 37324 applies
37203	01MAY2013	31OCT2020	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37202, 37207, 37208, 37245, 37303, 37321 or 37324 applies
37203	01NOV2020	29FEB2024	N	Prostatectomy, transurethral resection using cautery, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37202, 37207, 37208, 37245, 37303, 37321 or 37324 applies
37203	01MAR2024	31DEC9999	Y	Prostatectomy, transurethral resection using cautery, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37207, 37208, 37245, 37303, 37321 or 37324 applies (H)
37204	01MAR2024	31DEC9999	Y	Cystoscopy with insertion of prostatic implants for the treatment of benign prostatic hyperplasia
37205	01MAR2024	31DEC9999	Y	Prostate, ablation by water vapour with or without cystoscopy and with or without urethroscopy
37206	01DEC1991	30JUN1995	N	PROSTATECTOMY (endoscopic), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of initial procedure which had to be discontinued for medical reasons
37206	01JUL1995	31OCT2002	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37203 or 37208 which had to be discontinued for medical reasons
37206	01NOV2002	30APR2006	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37208 or which had to be discontinued for medical reasons
37206	01MAY2006	30APR2013	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 or which had to be discontinued for medical reasons
37206	01MAY2013	31OCT2020	N	PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37207 or 37245 which had to be discontinued for medical reasons
37206	01NOV2020	31DEC9999	Y	Prostatectomy, endoscopic, using diathermy or other ablative techniques: (a) with or without cystoscopy and with or without urethroscopy; and (b) including services to which one or more of items 36854, 37303, 37321 and 37324 apply; continuation, within 10 days, of treatment of benign prostatic hyperplasia that had to be discontinued for medical reasons
37207	01JUL1995	31OCT2002	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37203, 37206, 37321 or 37324 applies
37207	01NOV2002	30APR2013	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37201, 37202, 37203, 37206, 37321 or 37324 applies
37207	01MAY2013	30APR2020	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37201, 37202, 37203, 37206, 37245, 37321 or 37324 applies
37207	01MAY2020	29FEB2024	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37201, 37202, 37203, 37206, 37245, 37303, 37321 or 37324 applies
37207	01MAR2024	31DEC9999	Y	Prostate, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37201, 37203, 37245, 37303, 37321 or 37324 applies (H)
37208	01JUL1995	31OCT2002	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37203, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37203 or 37207, which had to be discontinued for medical reasons
37208	01NOV2002	30APR2013	N	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37201, 37203 or 37207 or which had to be discontinued for medical reasons
37208	01MAY2013	31DEC9999	Y	PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37201, 37203, 37207 or 37245 which had to be discontinued for medical reasons
37209	01DEC1991	30APR2001	N	PROSTATE, total excision of
37209	01MAY2001	31DEC9999	Y	PROSTATE, and/or SEMINAL VESICLE/AMPULLA OF VAS, unilateral or bilateral, total excision of, not being a service associated with a service to which item number 37210 or 37211 applies
37210	01NOV1997	31OCT2020	N	PROSTATECTOMY, radical, involving total excision of the prostate, sparing of nerves around the bladder and bladder neck reconstruction, not being a service associated with a service to which item 35551, 36502 or 37375 applies
37210	01NOV2020	31DEC9999	Y	Prostatectomy, radical, involving total excision of the prostate, sparing of nerves around the prostate (where clinically indicated) with or without bladder neck reconstruction, other than a service associated with a service to which item 30390, 30627, 35551, 36502 or 37375 applies
37211	01NOV1997	31OCT2020	N	PROSTATECTOMY, radical, involving total excision of the prostate, sparing of nerves around the bladder and bladder neck reconstruction, with pelvic lymphadenectomy, not being a service associated with a service to which item 35551, 36502 or 37375 applies
37211	01NOV2020	31DEC9999	Y	Prostatectomy, radical, involving total excision of the prostate, sparing of nerves around the prostate (where clinically indicated): (a) with or without bladder neck reconstruction; and (b) with pelvic lymphadenectomy; other than a service associated with a service to which item 30390, 30627, 35551, 36502 or 37375 applies
37212	01DEC1991	31DEC9999	Y	PROSTATE, open perineal biopsy or open drainage of abscess
37213	01NOV2020	31DEC9999	Y	Prostatectomy, radical, involving total excision of the prostate, sparing of nerves around the prostate (where clinically indicated): (a) complicated by: (i) previous radiation therapy (including brachytherapy) on the prostate; or (ii) previous ablative procedures on the prostate; and (b) with bladder neck reconstruction; other than a service associated with a service to which item 30390, 30627, 35551, 36502 or 37375 applies
37214	01NOV2020	31DEC9999	Y	Prostatectomy, radical, involving total excision of the prostate, sparing of nerves around the prostate (where clinically indicated): (a) complicated by: (i) previous radiation therapy (including brachytherapy) on the prostate; or (ii) previous ablative procedures on the prostate; and (b) with bladder neck reconstruction and pelvic lymphadenectomy; other than a service associated with a service to which item 30390, 30627, 35551, 36502 or 37375 applies
37215	01DEC1991	31OCT2020	N	PROSTATE, biopsy of, endoscopic, with or without cystoscopy
37215	01NOV2020	31DEC9999	Y	Prostate, biopsy of, endoscopic, with or without cystoscopy
37216	01NOV2020	31DEC9999	Y	Prostate or prostatic bed, needle biopsy of, by the transrectal route, using prostatic ultrasound guidance and obtaining one or more prostatic specimens, being a service associated with a service to which item 55603 applies
37217	01JUL2011	31DEC2013	N	Prostate, implantation of gold fiducial markers into the prostate gland or prostate surgical bed
37217	01JAN2014	31OCT2020	N	Prostate, implantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed
37217	01NOV2020	31DEC9999	Y	Prostate, implantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed, under ultrasound guidance, being an item associated with a service to which item 55603 applies
37218	01DEC1991	30JUN2011	N	PROSTATE, needle biopsy of, or injection into
37218	01JUL2011	31OCT2020	N	PROSTATE, needle biopsy of, or injection into, excluding for insertion of radiopaque markers
37218	01NOV2020	31DEC9999	Y	Prostate, injection into, one or more, excluding insertion of fiduciary markers
37219	01MAY1994	30JUN2012	N	PROSTATE, transrectal needle biopsy of, using transrectal prostatic ultrasound techniques and obtaining 1 or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies
37219	01JUL2012	31OCT2020	N	PROSTATE, needle biopsy of, using prostatic ultrasound techniques and obtaining 1 or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies
37219	01NOV2020	31DEC9999	Y	Prostate or prostatic bed, needle biopsy of, by the transperineal route, using prostatic ultrasound guidance and obtaining one or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies
37220	01NOV2001	31OCT2005	N	PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1, T2A or T2B, with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies.
37220	01NOV2005	30JUN2007	N	PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies.
37220	01JUL2007	31OCT2020	N	PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 7 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis. The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies.
37220	01NOV2020	30JUN2024	N	Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance: (a) for a patient with: (i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and (ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and (b) performed by a urologist at an approved site in association with a radiation oncologist; and (c) being a service associated with: (i) services to which items 15338 and 55603 apply; and (ii) a service to which item 60506 or 60509 applies
37220	01JUL2024	31DEC9999	Y	Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance: (a) for a patient with: (i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and (ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and (b) performed by a urologist at an approved site in association with a radiation oncologist; and (c) being a service associated with: (i) services to which items 15966 and 55603 apply; and (ii) a service to which item 60506 or 60509 applies (H)
37221	01DEC1991	31OCT2020	N	PROSTATIC ABSCESS, endoscopic drainage of
37221	01NOV2020	31DEC9999	Y	Prostatic abscess, endoscopic drainage of
37222	01NOV2001	31DEC9999	Y	This dummy item created on 5 March 2010 to facilitate the payment of benefits for item 37220 which should have had an (Anaes.) attributed to it from 1 Nov 2001
37223	01MAY1997	31DEC9999	Y	PROSTATIC COIL, insertion of, under ultrasound control
37224	01MAY2003	31OCT2020	N	PROSTATE, diathermy or visual laser destruction of lesion of, not being a service associated with a service to which item 37201, 37202, 37203, 37206, 37207, 37208 or 37215 applies
37224	01NOV2020	29FEB2024	N	Prostate, diathermy or cauterisation, other than a service associated with a service to which item 37201, 37202, 37203, 37206, 37207, 37208 or 37215 applies
37224	01MAR2024	31DEC9999	Y	Prostate, diathermy or cauterisation, other than a service associated with a service to which item 37201, 37203, 37207, 37208 or 37215 applies
37225	01NOV2001	31DEC9999	Y	This dummy item created on 5 March 2010 to facilitate the payment of benefits for item 37220 which should have had an (Anaes.) attributed to it from 1 Nov 2001
37226	01MAY2020	31DEC9999	Y	Prostate or prostatic bed, needle biopsy of, using prostatic magnetic resonance imaging techniques and obtaining 1 or more prostatic specimens. (Anaes.)
37227	01NOV2006	30APR2007	N	PROSTATE, transperineal insertion of catheters into, for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy. The procedure must be performed at an approved site in association with a radiation oncologist, and be associated with a service to which item 15327 or 15328 applies.
37227	01MAY2007	30JUN2024	N	PROSTATE, transperineal insertion of catheters into, for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy. The procedure must be performed at an approved site in association with a radiation oncologist, and be associated with a service to which item 15331 or 15332 applies.
37227	01JUL2024	31DEC9999	Y	Prostate, transperineal insertion of catheters for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy, if performed at an approved site, and being a service associated with a service to which item 15966 applies
37230	01MAY2006	31OCT2020	N	PROSTATE, high-energy transurethral microwave thermotherapy of, with or without cystoscopy and with or without urethroscopy and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies
37230	01NOV2020	31DEC9999	Y	Prostate, ablation by electrocautery or high-energy transurethral microwave thermotherapy, with or without cystoscopy and with or without urethroscopy
37233	01MAY2006	31OCT2020	N	PROSTATE, high-energy transurethral microwave thermotherapy of, with or without cystoscopy and with or without urethroscopy and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37207, 37230 which had to be discontinued for medical reasons
37233	01NOV2020	31DEC9999	Y	Prostate, ablation by electrocautery or high-energy transurethral microwave thermotherapy, with or without cystoscopy and with or without urethroscopy, continuation, within 10 days, of a urological procedure of the prostate that had to be discontinued for medical reasons
37245	01MAR2013	30APR2013	N	Prostate, endoscopic enucleation of, using high powered Holmium:YAG laser and an end-firing, non-contact fibre, with or without tissue morcellation, with or without cystoscopy and with or without urethroscopy, for the treatment of benign prostatic hyperplasia, other than a service associated with a service to which item 36854, 37201, 37202, 37203, 37206, 37207, 37208, 37303, 37321, or 37324 applies.
37245	01MAY2013	31OCT2020	N	Prostate, endoscopic enucleation of, using high powered Holmium:YAG laser and an end-firing, non-contact fibre, with or without tissue morcellation, cystoscopy or urethroscopy, for the treatment of benign prostatic hyperplasia, and other than a service associated with a service to which item 36854, 37201, 37202, 37203, 37206, 37207, 37208, 37303, 37321, or 37324 applies.
37245	01NOV2020	29FEB2024	N	Prostate, endoscopic enucleation of, for the treatment of benign prostatic hyperplasia: (a) with morcellation, including mechanical morcellation or by an endoscopic technique; and (b) with or without cystoscopy; and (c) with or without urethroscopy; and other than a service associated with a service to which item 36827, 36854, 37008, 37201, 37202, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies
37245	01MAR2024	31DEC9999	Y	Prostate, endoscopic enucleation of, for the treatment of benign prostatic hyperplasia: (a) with morcellation, including mechanical morcellation or by an endoscopic technique; and (b) with or without cystoscopy; and (c) with or without urethroscopy; and other than a service associated with a service to which item 36827, 36854, 37008, 37201, 37203, 37207, 37208, 37303, 37321 or 37324 applies (H)
37300	01DEC1991	31DEC9999	Y	URETHRAL SOUNDS, passage of, as an independent procedure
37303	01DEC1991	31DEC9999	Y	URETHRAL STRICTURE, dilatation of
37306	01DEC1991	31DEC9999	Y	URETHRA, repair of rupture of distal section
37309	01DEC1991	31DEC9999	Y	URETHRA, repair of rupture of prostatic or membranous segment
37312	01DEC1991	31DEC9999	Y	URETHRAL FISTULA, closure of
37315	01DEC1991	31DEC9999	Y	URETHROSCOPY, as an independent procedure
37318	01DEC1991	30JUN1995	N	URETHROSCOPY with any 1 or more of; biopsy, diathermy or removal of foreign body or stone
37318	01JUL1995	31OCT2020	N	URETHROSCOPY with any 1 or more of - biopsy, diathermy, visual laser destruction of stone or removal of foreign body or stone
37318	01NOV2020	31DEC9999	Y	Urethroscopy, with or without cystoscopy, with one or more of biopsy, diathermy, visual laser destruction of urethral calculi or removal of foreign body or calculi
37321	01DEC1991	31DEC9999	Y	URETHRAL MEATOTOMY, EXTERNAL
37324	01DEC1991	31OCT2020	N	URETHROTOMY OR URETHROSTOMY, internal or external
37324	01NOV2020	31DEC9999	Y	Urethrotomy or urethrostomy, internal or external
37327	01DEC1991	31DEC9999	Y	URETHROTOMY, optical, for urethral stricture
37330	01DEC1991	31DEC9999	Y	URETHRECTOMY, partial or complete, for removal of tumour
37333	01DEC1991	31DEC9999	Y	URETHROVAGINAL FISTULA, closure of
37336	01DEC1991	31DEC9999	Y	URETHRORECTAL FISTULA, closure of
37338	01MAY2016	31OCT2020	N	Urethral synthetic male sling system, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, other than a service associated with a service to which item 37340 or 37341 applies
37338	01NOV2020	31DEC9999	Y	Urethral synthetic male sling system, division or removal of, for urethral obstruction, sling erosion, pain or infection, following previous surgery for urinary incontinence, other than a service associated with a service to which item 37340 or 37341 applies
37339	01DEC1991	30JUN1995	N	PERIURETHRAL INJECTION of Teflon, including urethroscopy and cystoscopy
37339	01JUL1995	26NOV2013	N	PERIURETHRAL OR TRANSURETHRAL INJECTION of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy
37339	27NOV2013	31OCT2014	N	PERIURETHRAL OR TRANSURETHRAL INJECTION of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy, other than a service associated with a service to which item 18375 applies
37339	01NOV2014	31OCT2020	N	Periurethral or transurethral injection of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy, other than a service associated with a service to which item 18375 or 18379 applies
37339	01NOV2020	31DEC9999	Y	Periurethral or transurethral injection of urethral bulking agents for the treatment of urinary incontinence, including cystoscopy and urethroscopy, other than a service associated with a service to which item 18375 or 18379 applies
37340	01MAY2001	31OCT2020	N	URETHRAL SLING, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, vaginal approach, not being a service associated with a service to which item number 37341 applies
37340	01NOV2020	31DEC9999	Y	Urethral synthetic sling, division or removal of, for urethral obstruction, sling erosion, pain or infection following previous surgery for urinary incontinence, vaginal approach, other than a service associated with a service to which item 37341 or 37344 applies
37341	01MAY2001	31OCT2020	N	URETHRAL SLING, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, suprapubic or combined suprapubic/vaginal approach, not being a service associated with a service to which item number 37340 applies
37341	01NOV2020	31DEC9999	Y	Urethral sling, division or removal of, for urethral obstruction, sling erosion, pain or infection following previous surgery for urinary incontinence, suprapubic, combined suprapubic and vaginal or combined suprapubic and perineal approach, other than a service associated with a service to which item 37340 or 37344 applies
37342	01DEC1991	31DEC9999	Y	URETHROPLASTY single stage operation
37343	01MAY2001	31DEC9999	Y	URETHROPLASTY, single stage operation, transpubic approach via separate incisions above and below the symphysis pubis, excluding laparotomy, symphysectomy and suprapubic cystotomy, with or without re-routing of the urethra around the crura
37344	01NOV2020	31DEC9999	Y	Urethral autologous fascial sling (or other biological sling), division or removal of, for urethral obstruction, sling erosion, pain or infection following previous surgery for urinary incontinence, vaginal approach, other than a service to which 37340 or 37341 applies
37345	01DEC1991	31DEC9999	Y	URETHROPLASTY 2 stage operation first stage
37348	01DEC1991	31DEC9999	Y	URETHROPLASTY 2 stage operation second stage
37351	01DEC1991	31DEC9999	Y	URETHROPLASTY, not being a service to which another item in this Group applies
37354	01DEC1991	31DEC9999	Y	HYPOSPADIAS, meatotomy and hemicircumcision
37357	01DEC1991	31DEC9999	Y	HYPOSPADIAS, glanuloplasty incorporating meatal advancement
37360	01DEC1991	31DEC9999	Y	HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as a staged procedure, first stage
37363	01DEC1991	31DEC9999	Y	HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as a staged procedure, second stage
37366	01DEC1991	31DEC9999	Y	HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as 1 stage procedure, not being a service to which item 37357 applies
37369	01DEC1991	31DEC9999	Y	URETHRA, excision of prolapse of
37372	01DEC1991	31OCT2020	N	URETHRAL DIVERTICULUM, excision of
37372	01NOV2020	31DEC9999	Y	Urethral diverticulum, excision of
37375	01DEC1991	31DEC9999	Y	URETHRAL SPHINCTER, reconstruction by bladder tubularisation technique or similar procedure
37378	01DEC1991	31DEC9999	Y	URETHRA, operation for correction of male urinary incontinence, not being a service to which item 37381 or 37390 applies
37381	01DEC1991	31DEC9999	Y	ARTIFICIAL URINARY SPHINCTER, insertion of cuff, perineal approach
37384	01DEC1991	31DEC9999	Y	ARTIFICIAL URINARY SPHINCTER, insertion of cuff, abdominal approach
37387	01DEC1991	31DEC9999	Y	ARTIFICIAL URINARY SPHINCTER, insertion of pressure regulating balloon and pump
37388	01NOV2020	31DEC9999	Y	Artificial urinary sphincter, sterile, percutaneous adjustment of filling volume
37390	01DEC1991	31DEC9999	Y	ARTIFICIAL URINARY SPHINCTER, revision or removal of, with or without replacement
37393	01DEC1991	31DEC9999	Y	PRIAPISM, decompression by glanular stab cavernosospongiosum shunt or penile aspiration with or without lavage
37396	01DEC1991	31DEC9999	Y	PRIAPISM, shunt operation for, not being a service to which item 37393 applies
37399	01DEC1991	31DEC9999	Y	URETHRAL VALVE, destruction of, including cystoscopy and urethroscopy
37402	01DEC1991	31DEC9999	Y	PENIS, partial amputation of
37405	01DEC1991	31DEC9999	Y	PENIS, complete or radical amputation of
37408	01DEC1991	31DEC9999	Y	PENIS, repair of laceration of cavernous tissue, or fracture involving cavernous tissue
37411	01DEC1991	31DEC9999	Y	PENIS, repair of avulsion
37414	01DEC1991	31DEC9999	Y	PENIS, injection of, for investigation or treatment of impotence, priapism or Peyronie's plaque
37415	01JUL1996	31OCT2020	N	PENIS, injection of, for the investigation and treatment of impotence - 2 services only in a period of 36 consecutive months
37415	01NOV2020	31DEC9999	Y	Penis, injection of, for the investigation and treatment of erectile dysfunction. Applicable not more than twice in a 36-month period
37417	01DEC1991	31OCT2020	N	PENIS, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting
37417	01NOV2020	31DEC9999	Y	Penis, correction of chordee by plication techniques including Nesbits corporoplasty
37418	01MAY2001	31OCT2020	N	PENIS, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting, involving mobilization of the urethra
37418	01NOV2020	31DEC9999	Y	Penis, correction of chordee with incision or excision of fibrous plaque or plaques, with or without mobilisation of one or both of the neuro-vascular bundle and urethra
37420	01DEC1991	31DEC9999	Y	PENIS, surgery to inhibit rapid penile drainage causing impotence, by ligation of veins deep to Buck's fascia including 1 or more deep cavernosal veins with or without pharmacological erection test
37423	01DEC1991	31OCT2020	N	PENIS, lengthening by translocation of corpora
37423	01NOV2020	31DEC9999	Y	Penis, lengthening by translocation of corpora, in conjunction with partial penectomy or penile epispadias secondary repair, either as primary or secondary procedures
37426	01DEC1991	31DEC9999	Y	PENIS, artificial erection device, insertion of, into 1 or both corpora
37429	01DEC1991	31DEC9999	Y	PENIS, artificial erection device, insertion of pump and pressure regulating reservoir
37432	01DEC1991	31DEC9999	Y	PENIS, artificial erection device, complete or partial revision or removal of components, with or without replacement
37435	01DEC1991	31DEC9999	Y	PENIS, frenuloplasty as an independent procedure
37438	01DEC1991	31OCT2020	N	SCROTUM, partial excision of
37438	01NOV2020	31DEC9999	Y	Scrotum, partial excision of, for histologically proven malignancy or infection
37441	01DEC1991	31DEC9999	Y	PENIS ERECTION TEST FOR HYPOSPADIAS AND CHORDEE when performed under general anaesthesia, as an independent procedure
37444	01DEC1991	31DEC9999	Y	URETEROLITHOTOMY COMPLICATED BY PREVIOUS SURGERY at the same site of the same ureter
37600	01DEC1991	31DEC9999	Y	OPERATIONS ON TESTES, VASA OR SEMINAL VESICLES SPERMATOCELE OR EPIDIDYMAL CYST, excision of, 1 or more of, on 1 side
37601	01DEC1991	31DEC9999	Y	SPERMATOCELE OR EPIDIDYMAL CYST, excision of, 1 or more of, on 1 side
37604	01DEC1991	30APR2002	N	EXPLORATION OF SCROTAL CONTENTS, with or without fixation and with or without biopsy, unilateral
37604	01MAY2002	31OCT2020	N	EXPLORATION OF SCROTAL CONTENTS, with or without fixation and with or without biopsy, unilateral, not being a service associated with sperm harvesting for IVF
37604	01NOV2020	31DEC9999	Y	Exploration of scrotal contents, with or without fixation and with or without biopsy, unilateral or bilateral, other than a service associated with sperm harvesting for IVF
37605	01MAY2007	30JUN2013	N	TRANSCUTANEOUS SPERM RETRIEVAL, unilateral, from either the testis or the epididymis, for the purposes of INTRACYTOPLASMIC SPERM INJECTION, in a man with male factor infertility, excluding a service to which item 13218 applies.
37605	01JUL2013	31DEC9999	Y	Transcutaneous sperm retrieval, unilateral, from either the testis or the epididymis, for the purposes of intracytoplasmic sperm injection, for male factor infertility, excluding a service to which item 13218 applies.
37606	01MAY2007	30JUN2013	N	OPEN SURGICAL SPERM RETRIEVAL, unilateral, including the exploration of scrotal contents, with our without biopsy, for the purposes of INTRACYTOPLASMIC SPERM INJECTION, in a man with male factor infertility, performed in a hospital, excluding a service to which item 13218 or 37604 applies.
37606	01JUL2013	31DEC9999	Y	Open surgical sperm retrieval, unilateral, including the exploration of scrotal contents, with our without biopsy, for the purposes of intracytoplasmic sperm injection, for male factor infertility, performed in a hospital, excluding a service to which item 13218 or 37604 applies.
37607	01DEC1991	31OCT2020	N	RETROPERITONEAL LYMPH NODE DISSECTION, unilateral, not being a service associated with a service to which item 36528 applies
37607	01NOV2020	31DEC9999	Y	Bilateral retroperitoneal lymph node dissection, for testicular tumour, other than a service associated with a service to which item 30390 or 30627 applies
37610	01DEC1991	31OCT2020	N	RETROPERITONEAL LYMPH NODE DISSECTION, unilateral, not being a service associated with a service to which item 36528 applies, following previous similar retroperitoneal dissection, retroperitoneal irradiation or chemotherapy
37610	01NOV2020	31DEC9999	Y	Bilateral retroperitoneal lymph node dissection, for testicular tumour, following previous similar retroperitoneal dissection, retroperitoneal radiation therapy or chemotherapy, other than a service associated with a service to which item 30390 or 30627 applies
37613	01DEC1991	31DEC9999	Y	EPIDIDYMECTOMY
37616	01DEC1991	31OCT1996	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope
37616	01NOV1996	30APR2001	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous sterilisation
37616	01MAY2001	30APR2002	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous elective sterilisation
37616	01MAY2002	30JUN2008	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous elective sterilisation, not being a service associated with sperm harvesting for IVF
37616	01JUL2008	31DEC9999	Y	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, not being a service associated with sperm harvesting for IVF
37619	01DEC1991	31OCT1996	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral
37619	01NOV1996	30APR2001	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous sterilisation
37619	01MAY2001	30APR2002	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous elective sterilisation
37619	01MAY2002	30JUN2008	N	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous elective sterilisation, not being a service associated with sperm harvesting for IVF
37619	01JUL2008	31DEC9999	Y	VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, not being a service associated with sperm harvesting for IVF
37622	01DEC1991	30APR2002	N	VASOTOMY OR VASECTOMY, unilateral or bilateral
37622	01MAY2002	31DEC9999	Y	VASOTOMY OR VASECTOMY, unilateral or bilateral NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
37623	01DEC1991	30APR2002	N	VASOTOMY OR VASECTOMY, unilateral or bilateral
37623	01MAY2002	31DEC9999	Y	VASOTOMY OR VASECTOMY, unilateral or bilateral NOTE: Strict legal requirements apply in relation to sterilisation procedures on minors. Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law. Observe the explanatory note before submitting a claim.
37800	01NOV1994	31AUG2015	N	PATENT URACHUS, excision of
37800	01SEP2015	30JUN2021	N	PATENT URACHUS, excision of, on a person 10 years of age or over.
37800	01JUL2021	31DEC9999	Y	PATENT URACHUS, excision of, on a patient 10 years of age or over.
37801	01SEP2015	30JUN2021	N	PATENT URACHUS, excision of, when performed on a person under 10 years of age
37801	01JUL2021	31DEC9999	Y	PATENT URACHUS, excision of, when performed on a patient under 10 years of age
37803	01NOV1994	31AUG2015	N	UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 applies
37803	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 applies, on a person 10 years of age or over.
37803	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 applies, on a patient 10 years of age or over.
37804	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37807 applies, on a person under 10 years of age
37804	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37807 applies, on a patient under 10 years of age
37806	01NOV1994	31AUG2015	N	UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for
37806	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a person 10 years of age or over
37806	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a patient 10 years of age or over
37807	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a person under 10 years of age
37807	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a patient under 10 years of age
37809	01NOV1994	31AUG2015	N	UNDESCENDED TESTIS, revision orchidopexy for
37809	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS, revision orchidopexy for, on a person 10 years of age or over.
37809	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS, revision orchidopexy for, on a patient 10 years of age or over.
37810	01SEP2015	30JUN2021	N	UNDESCENDED TESTIS, revision orchidopexy for, on a person under 10 years of age
37810	01JUL2021	31DEC9999	Y	UNDESCENDED TESTIS, revision orchidopexy for, on a patient under 10 years of age
37812	01NOV1994	31AUG2015	N	IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37803 to 37809 applies
37812	01SEP2015	30JUN2021	N	IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37803, 37806 and 37809 applies, on a person 10 years of age or over.
37812	01JUL2021	31DEC9999	Y	IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37803, 37806 and 37809 applies, on a patient 10 years of age or over.
37813	01SEP2015	30JUN2021	N	IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37804, 37807 and 37810 applies, on a person under 10 years of age
37813	01JUL2021	31DEC9999	Y	IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37804, 37807 and 37810 applies, on a patient under 10 years of age
37815	01NOV1994	31AUG2015	N	HYPOSPADIAS, examination under anaesthesia with erection test
37815	01SEP2015	30JUN2021	N	HYPOSPADIAS, examination under anaesthesia with erection test on a person 10 years of age or over.
37815	01JUL2021	31DEC9999	Y	HYPOSPADIAS, examination under anaesthesia with erection test on a patient 10 years of age or over.
37816	01SEP2015	30JUN2021	N	HYPOSPADIAS, examination under anaesthesia with erection test, on a person under 10 years of age
37816	01JUL2021	31DEC9999	Y	HYPOSPADIAS, examination under anaesthesia with erection test, on a patient under 10 years of age
37818	01NOV1994	31AUG2015	N	HYPOSPADIAS, glanuloplasty incorporating meatal advancement
37818	01SEP2015	30JUN2021	N	HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a person 10 years of age or over
37818	01JUL2021	31DEC9999	Y	HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a patient 10 years of age or over
37819	01SEP2015	30JUN2021	N	HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a person under 10 years of age
37819	01JUL2021	31DEC9999	Y	HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a patient under 10 years of age
37821	01NOV1994	31AUG2015	N	HYPOSPADIAS, distal, 1 stage repair
37821	01SEP2015	30JUN2021	N	HYPOSPADIAS, distal, 1 stage repair, on a person 10 years of age or over.
37821	01JUL2021	31DEC9999	Y	HYPOSPADIAS, distal, 1 stage repair, on a patient 10 years of age or over.
37822	01SEP2015	30JUN2021	N	HYPOSPADIAS, distal, 1 stage repair, on a person under 10 years of age
37822	01JUL2021	31DEC9999	Y	HYPOSPADIAS, distal, 1 stage repair, on a patient under 10 years of age
37824	01NOV1994	31AUG2015	N	HYPOSPADIAS, proximal, 1 stage repair
37824	01SEP2015	30JUN2021	N	HYPOSPADIAS, proximal, 1 stage repair on a person 10 years of age or over.
37824	01JUL2021	31DEC9999	Y	HYPOSPADIAS, proximal, 1 stage repair, on a patient 10 years of age or over
37825	01SEP2015	30JUN2021	N	HYPOSPADIAS, proximal, 1 stage repair, on a person under 10 years of age
37825	01JUL2021	31DEC9999	Y	HYPOSPADIAS, proximal, 1 stage repair, on a patient under 10 years of age
37827	01NOV1994	31AUG2015	N	HYPOSPADIAS, staged repair, first stage
37827	01SEP2015	30JUN2021	N	HYPOSPADIAS, staged repair, first stage, on a person 10 years of age or over.
37827	01JUL2021	31DEC9999	Y	HYPOSPADIAS, staged repair, first stage, on a patient 10 years of age or over
37828	01SEP2015	30JUN2021	N	HYPOSPADIAS, staged repair, first stage, on a person under 10 years of age
37828	01JUL2021	31DEC9999	Y	HYPOSPADIAS, staged repair, first stage, on a patient under 10 years of age
37830	01NOV1994	31OCT2015	N	HYPOSPADIAS, staged repair, second stage
37830	01NOV2015	30JUN2021	N	HYPOSPADIAS, staged repair, second stage, on a person 10 years of age or over.
37830	01JUL2021	31DEC9999	Y	HYPOSPADIAS, staged repair, second stage, on a patient 10 years of age or over
37831	01NOV2015	30JUN2021	N	HYPOSPADIAS, staged repair, second stage, on a person under 10 years of age.
37831	01JUL2021	31DEC9999	Y	HYPOSPADIAS, staged repair, second stage, on a patient under 10 years of age
37833	01NOV1994	31AUG2015	N	HYPOSPADIAS, repair of post operative urethral fistula
37833	01SEP2015	31OCT2020	N	HYPOSPADIAS, repair of post-operative urethral fistula, on a person 10 years of age or over.
37833	01NOV2020	30JUN2021	N	Hypospadias, repair of urethral fistula, on a person 10 years of age or over
37833	01JUL2021	31DEC9999	Y	Hypospadias, repair of urethral fistula, on a patient 10 years of age or over
37834	01SEP2015	31OCT2020	N	HYPOSPADIAS, repair of post-operative urethral fistula, on a person under 10 years of age
37834	01NOV2020	30JUN2021	N	Hypospadias, repair of urethral fistula, on a person under 10 years of age
37834	01JUL2021	31DEC9999	Y	Hypospadias, repair of urethral fistula, on a patient under 10 years of age
37836	01NOV1994	31DEC9999	Y	EPISPADIAS, staged repair, first stage
37839	01NOV1994	31DEC9999	Y	EPISPADIAS, staged repair, second stage
37842	01NOV1994	31OCT2020	N	EXSTROPHY OF BLADDER OR EPISPADIAS, secondary repair with bladder neck tightening, with or without ureteric reimplantation
37842	01NOV2020	31DEC9999	Y	Exstrophy of bladder or epispadias, primary or secondary repair with or without bladder neck tightening, with or without ureteric reimplantation
37845	01NOV1994	31OCT2020	N	AMBIGUOUS GENITALIA WITH UROGENITAL SINUS, reduction clitoroplasty, with or without endoscopy
37845	01NOV2020	31DEC9999	Y	Congenital disorder of sexual differentiation with urogenital sinus, external genitoplasty, with or without endoscopy
37848	01NOV1994	31OCT2020	N	AMBIGUOUS GENITALIA WITH UROGENITAL SINUS, reduction clitoroplasty with endoscopy and vaginoplasty
37848	01NOV2020	31DEC9999	Y	Congenital disorder of sexual differentiation with urogenital sinus, external genitoplasty with endoscopy and vaginoplasty
37851	01NOV1994	31OCT2020	N	CONGENITAL ADRENAL HYPERPLASIA, mixed gonadal dysgenesis or similar condition, vaginoplasty for, with or without endoscopy
37851	01NOV2020	31DEC9999	Y	Congenital disorder of sexual differentiation, vaginoplasty for, with or without endoscopy
37854	01NOV1994	31OCT2020	N	URETHRAL VALVE, destruction of, including cystoscopy and urethroscopy
37854	01NOV2020	31DEC9999	Y	Urethral valve, destruction of, including cystoscopy and urethroscopy
38200	01DEC1991	30APR2007	N	CARDIOLOGY PROCEDURES RIGHT HEART CATHETERISATION, including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test
38200	01MAY2007	30JUN2021	N	RIGHT HEART CATHETERISATION, with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection or exercise stress test
38200	01JUL2021	31DEC9999	Y	Right heart catheterisation with any one or more of the following: (a) fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output measurement by any method; (e) shunt detection; (f) exercise stress test; other than a service associated with a service to which item 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38254 or 38368 applies
38203	01DEC1991	30APR2007	N	LEFT HEART CATHETERISATION by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test
38203	01MAY2007	30JUN2021	N	LEFT HEART CATHETERISATION by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection or exercise stress test
38203	01JUL2021	31DEC9999	Y	Left heart catheterisation by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture, with any one or more of the following: (a) fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output measurements by any method; (e) shunt detection; (f) exercise stress test; other than a service associated with a service to which item 38200, 38206, 38244, 38247, 38248, 38249, 38251, 38252 or 38254 applies
38206	01DEC1991	30APR2007	N	RIGHT HEART CATHETERISATION WITH LEFT HEART CATHETERISATION via the right heart or by any other procedure including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test
38206	01MAY2007	30JUN2021	N	RIGHT HEART CATHETERISATION WITH LEFT HEART CATHETERISATION via the right heart or by any other procedure with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection or exercise stress test
38206	01JUL2021	31DEC9999	Y	Right heart catheterisation with left heart catheterisation via the right heart or by another procedure, with any one or more of the following: (a) fluoroscopy; (b) oximetry; (c) dye dilution curves; (d) cardiac output measurements by any method; (e) shunt detection; (f) exercise stress test; other than a service associated with a service to which item 38200, 38203, 38244, 38247, 38248, 38249, 38251, 38252 or 38254 applies
38209	01DEC1991	31OCT1996	N	CARDIAC ELECTROPHYSIOLOGICAL STUDY up to and including 3 catheter investigation of any 1 or more of syncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not being a service associated with a service to which item 38212 applies
38209	01NOV1996	31DEC9999	Y	CARDIAC ELECTROPHYSIOLOGICAL STUDY up to and including 3 catheter investigation of any 1 or more of syncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not being a service associated with a service to which item 38212 or 38213 applies
38212	01DEC1991	30JUN1995	N	CARDIAC ELECTROPHYSIOLOGICAL STUDY 4 or more catheter supraventricular tachycardia investigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation; or intraoperative mapping; or electrophysiological services during defibrillator implantation or testing not being a service associated with a service to which item 38209 applies
38212	01JUL1995	31OCT1996	N	CARDIAC ELECTROPHYSIOLOGICAL STUDY 4 or more catheter supraventricular tachycardia investigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation to intentionally induce complete AV block; or intraoperative mapping; or electrophysiological services during defibrillator implantation or testing not being a service associated with a service to which item 38209 applies
38212	01NOV1996	30JUN2021	N	CARDIAC ELECTROPHYSIOLOGICAL STUDY 4 or more catheter supraventricular tachycardia investigation; or complex tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation to intentionally induce complete AV block; or intraoperative mapping; or electrophysiological services during defibrillator implantation not being a service associated with a service to which item 38209 or 38213 applies
38212	01JUL2021	31OCT2021	N	Cardiac electrophysiological study involving 4 or more catheters for: (a) supraventricular tachycardia investigation; or (b) complex tachycardia inductions; or (c) multiple catheter mapping; or (d) acute intravenous anti-arrhythmic drug testing with pre and post drug inductions; or (e) catheter ablation to intentionally induce complete atrioventricular block; or (f) intraoperative mapping; other than a service associated with a service to which item 38209 or 38213 applies
38212	01NOV2021	31DEC9999	Y	Cardiac electrophysiological study for: (a) the investigation of supraventricular tachycardia involving 4 or more catheters; or (b) complex tachycardia inductions; or (c) multiple catheter mapping; or (d) acute intravenous anti-arrhythmic drug testing with pre and post drug inductions; or (e) catheter ablation to intentionally induce complete atrioventricular block; or (f) intraoperative mapping; other than a service associated with a service to which item 38209 or 38213 applies
38213	01NOV1996	30JUN2021	N	CARDIAC ELECTROPHYSIOLOGICAL STUDY, for follow-up testing of implanted defibrillator - not being a service associated with a service to which item 38209 or 38212 applies
38213	01JUL2021	31DEC9999	Y	Cardiac electrophysiological study, performed either: (a) during insertion of implantable defibrillator; or (b) for defibrillation threshold testing at a different time to implantation; other than a service associated with a service to which item 38209 or 38212 applies
38215	01DEC1991	31OCT2001	N	SELECTIVE CORONARY ARTERIOGRAPHY placement of catheters and injection of opaque material
38215	01NOV2001	30APR2002	N	SELECTIVE CORONARY ANGIOGRAPHY placement of catheters and injection of opaque material
38215	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries, not being a service associated with a service to which item 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies
38218	01DEC1991	31OCT2001	N	SELECTIVE CORONARY ARTERIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both
38218	01NOV2001	30APR2002	N	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography
38218	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography, not being a service associated with a service to which item 38215, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies
38220	01NOV2001	30APR2002	N	PLACEMENT OF CATHETER(S) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts) (Anaes.)
38220	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY GRAFT ANGIOGRAPHY placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.)
38221	01DEC1991	31DEC9999	Y	INTRA-AORTIC BALLOON FOR COUNTERPULSATION, operation for insertion by arteriotomy, or removal and arterioplasty (excluding repair by patch graft)
38222	01NOV2001	30APR2002	N	PLACEMENT OF CATHETER(S) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts) (Anaes.)
38222	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY GRAFT ANGIOGRAPHY, placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.)
38224	01DEC1991	31DEC9999	Y	PERMANENT INTERNAL PACEMAKER AND MYOCARDIAL ELECTRODES, insertion or replacement of by thoracotomy
38225	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.)
38227	01DEC1991	31DEC9999	Y	PERMANENT TRANSVENOUS ELECTRODE, insertion or replacement of
38228	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.)
38230	01DEC1991	31DEC9999	Y	PERMANENT PACEMAKER, insertion or replacement of
38231	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into the free coronary graft(s) attached to the aorta (irrespective of the number of grafts), and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38234, 38237, 38240 or 38246 applies (Anaes.)
38233	01DEC1991	31DEC9999	Y	TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of
38234	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38237, 38240 or 38246 applies (Anaes.)
38236	01DEC1991	31DEC9999	Y	OPEN HEART SURGERY for congenital heart disease in children up to two years, excluding patent ductus arteriosus
38237	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38240 or 38246 applies (Anaes.)
38239	01DEC1991	31DEC9999	Y	OPEN HEART SURGERY for single valve replacement, atrial septal defect, pulmonary valvotomy, congenital heart disease (not covered by Item 38236) or any other open heart operation not covered by any other item in this Group
38240	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts) and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237 or 38246 applies (Anaes.)
38241	01NOV2006	30JUN2021	N	USE OF A CORONARY PRESSURE WIRE during selective coronary angiography to measure fractional flow reserve (FFR) and coronary flow reserve (CFR) in one or more intermediate coronary artery or graft lesions (stenosis of 30-70%), to determine whether revascularisation should be performed where previous stress testing has either not been performed or the results are inconclusive
38241	01JUL2021	31DEC9999	Y	Use of a coronary pressure wire, if the service is: (a) performed during selective coronary angiography, percutaneous angioplasty or transluminal insertion of one or more stents; and (b) to measure fractional flow reserve, non-hyperaemic pressure ratios or coronary flow reserve in intermediate coronary artery or graft lesions (stenosis of 50 to 70%); and (c) to determine whether revascularisation is appropriate, if previous functional imaging: (i) has not been performed; or (ii) has been performed but the results are inconclusive or do not apply to the vessel being interrogated; and (d) performed on one or more coronary vascular territories
38242	01DEC1991	31DEC9999	Y	OPEN HEART SURGERY on more than one valve or involving more than one chamber
38243	01MAY2002	31DEC9999	Y	PLACEMENT OF CATHETER(S) and injection of opaque material into any coronary vessel(s) or graft(s) prior to any coronary interventional procedure, not being a service associated with a service to which item 38246 applies (Anaes.)
38244	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Selective coronary angiography: (a) for a patient who is eligible for the service under clause 5.10.17A; and (b) with placement of one or more catheters and injection of opaque material into native coronary arteries; and (c) with or without left heart catheterisation, left ventriculography or aortography; and (d) including all associated imaging; other than a service associated with a service to which 38200, 38203, 38206, 38247, 38248, 38249, 38251 or 38252 applies
38244	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Selective coronary angiography: (a) for a patient who is eligible for the service under clause 5.10.17A; and (b) with placement of one or more catheters and injection of opaque material into native coronary arteries; and (c) with or without left heart catheterisation, left ventriculography or aortography; and (d) including all associated imaging; other than a service associated with a service to which 38200, 38203, 38206, 38247, 38248, 38249, 38251 or 38252 applies
38245	01DEC1991	31DEC9999	Y	CORONARY ARTERY OR ARTERIES, direct surgery to, employing cardiopulmonary bypass
38246	01MAY2002	31DEC9999	Y	SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography followed by placement of catheters prior to any coronary interventional procedure, not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38243 applies (Anaes.)
38247	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - graft) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Selective coronary and graft angiography: (a) for a patient who is eligible for the service under clause 5.10.17A; and (b) with placement of one or more catheters and injection of opaque material into the native coronary arteries; and (c) if free coronary grafts attached to the aorta or direct internal mammary artery grafts are present-with placement of one or more catheters and injection of opaque material into those grafts (irrespective of the number of grafts); and (d) with or without left heart catheterisation, left ventriculography or aortography; and (e) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38248, 38249, 38251 or 38252 applies
38247	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - graft) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Selective coronary and graft angiography: (a) for a patient who is eligible for the service under clause 5.10.17A; and (b) with placement of one or more catheters and injection of opaque material into the native coronary arteries; and (c) if free coronary grafts attached to the aorta or direct internal mammary artery grafts are present-with placement of one or more catheters and injection of opaque material into those grafts (irrespective of the number of grafts); and (d) with or without left heart catheterisation, left ventriculography or aortography; and (e) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38248, 38249, 38251 or 38252 applies
38248	01JUL2021	08JUL2021	N	Note: (stable coronary syndrome) the service only applies if the patient meets the requirements of the descriptor and the of Note: TR.8.2 and TR.8.5 Selective coronary angiography: (a) for a patient who is eligible for the service under clause 5.10.17B; and (b) as part of the management of the patient; and (c) with placement of catheters and injection of opaque material into native coronary arteries; and (d) with or without left heart catheterisation, left ventriculography or aortography; and (e) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38249, 38251 or 38252 applies-applicable each 3 months
38248	09JUL2021	31DEC9999	Y	Note: (stable coronary syndrome) the service only applies if the patient meets the requirements of the descriptor and the of Note: TR.8.3 and TR.8.5 Selective coronary angiography: (a) for a patient who is eligible for the service under clause 5.10.17B; and (b) as part of the management of the patient; and (c) with placement of catheters and injection of opaque material into native coronary arteries; and (d) with or without left heart catheterisation, left ventriculography or aortography; and (e) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38249, 38251 or 38252 applies-applicable each 3 months
38249	01JUL2021	08JUL2021	N	Note: (stable coronary syndrome - graft) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Selective coronary and graft angiography: (a) for a patient who is eligible for the service under clause 5.10.17B; and (b) as part of the management of the patient; and (c) with placement of one or more catheters and injection of opaque material into native coronary arteries; and (d) if free coronary grafts attached to the aorta or direct internal mammary artery grafts are present-with placement of one or more catheters and injection of opaque material into those grafts (irrespective of the number of grafts); and (e) with or without left heart catheterisation, left ventriculography or aortography; and (f) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38251 or 38252 applies-applicable once each 3 months
38249	09JUL2021	31DEC9999	Y	Note: (stable coronary syndrome - graft) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Selective coronary and graft angiography: (a) for a patient who is eligible for the service under clause 5.10.17B; and (b) as part of the management of the patient; and (c) with placement of one or more catheters and injection of opaque material into native coronary arteries; and (d) if free coronary grafts attached to the aorta or direct internal mammary artery grafts are present-with placement of one or more catheters and injection of opaque material into those grafts (irrespective of the number of grafts); and (e) with or without left heart catheterisation, left ventriculography or aortography; and (f) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38251 or 38252 applies-applicable once each 3 months
38250	01JUL1993	31DEC9999	Y	SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion of
38251	01JUL2021	31DEC9999	Y	Note: (pre-operative assessment) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.5 Selective coronary angiography: (a) for a symptomatic patient with valvular or other non-coronary structural heart disease; and (b) as part of the management of the patient for: (i) pre-operative assessment for planning non-coronary cardiac surgery, including by transcatheter approaches; or (ii) evaluation of valvular heart disease or other non-coronary structural heart disease where clinical impression is discordant with non-invasive assessment; and (c) with placement of catheters and injection of opaque material into native coronary arteries; and (d) with or without left heart catheterisation, left ventriculography or aortography; and (e) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249 or 38252 applies-applicable once each 12 months
38252	01JUL2021	31DEC9999	Y	Note: (pre-operative assessment - graft) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.5 Selective coronary and graft angiography: (a) for a symptomatic patient with valvular or other non-coronary structural heart disease; and (b) as part of the management of the patient for: (i) pre-operative assessment for planning non-coronary cardiac surgery, including by transcatheter approaches; or (ii) evaluation of valvular heart disease or other non-coronary structural heart disease where clinical impression is discordant with non-invasive assessment; and (c) with placement of one or more catheters and injection of opaque material into the native coronary arteries; and (d) if free coronary grafts attached to the aorta or direct internal mammary artery grafts are present-with placement of one or more catheters and injection of opaque material into those grafts (irrespective of the number of grafts); and (e) with or without left heart catheterisation, left ventriculography or aortography; and (f) including all associated imaging; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249 or 38251 applies-applicable once each 12 months
38253	01JUL1993	30APR1997	N	PERMANENT PACEMAKER, insertion or replacement of
38253	01MAY1997	31DEC9999	Y	PERMANENT PACEMAKER, insertion, removal or replacement of
38254	01JUL2021	31DEC2021	N	Right heart catheterisation: (a) performed at the same time as service to which item 38244, 38247, 38248, 38249, 38251 or 38252 applies; and (b) including any of the following (if performed): (i) fluoroscopy; (ii) oximetry; (iii) dye dilution curves; (iv) cardiac output measurement; (v) shunt detection; (vi) exercise stress test
38254	01JAN2022	31DEC9999	Y	Right heart catheterisation: (a) performed at the same time as a service to which item 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313 or 38314 applies; and (b) including any of the following (if performed): (i) fluoroscopy; (ii) oximetry; (iii) dye dilution curves; (iv) cardiac output measurement; (v) shunt detection; (vi) exercise stress test
38256	01JUL1993	31DEC9999	Y	TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of
38259	01JUL1993	30APR1997	N	PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion of
38259	01MAY1997	31DEC9999	Y	PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion, removal, or replacement of
38270	01MAY1997	31OCT2004	N	BALLOON VALVULOPLASTY OR SEPTOSTOMY, including cardiac catheterisations before and after balloon dilatation
38270	01NOV2004	31DEC9999	Y	BALLOON VALVULOPLASTY OR ISOLATED ATRIAL SEPTOSTOMY, including cardiac catheterisations before and after balloon dilatation
38272	01NOV2005	30JUN2021	N	ATRIAL SEPTAL DEFECT closure, with septal occluder or other similar device, by transcatheter approach
38272	01JUL2021	31DEC9999	Y	Atrial septal defect or patent foramen closure: (a) for congenital heart disease in a patient with documented evidence of right heart overload or paradoxical embolism; and (b) using a septal occluder or similar device, by transcatheter approach; and (c) including right or left heart catheterisation (or both); other than a service associated with a service to which item 38200, 38203, 38206 or 38254 applies
38273	01JUL2014	31DEC9999	Y	Patent ductus arteriosus, transcatheter closure of, including cardiac catheterisation and any imaging associated with the service
38274	01JUL2014	30JUN2021	N	Ventricular septal defect, transcatheter closure of, with imaging and cardiac catheterisation
38274	01JUL2021	31DEC9999	Y	Ventricular septal defect, transcatheter closure of, with cardiac catheterisation, excluding imaging (H)
38275	01MAY1997	31DEC9999	Y	MYOCARDIAL BIOPSY, by cardiac catheterisation
38276	01NOV2017	28FEB2022	N	Transcatheter occlusion of left atrial appendage, and cardiac catheterisation performed by the same practitioner, for stroke prevention in a patient who has non-valvular atrial fibrillation and a contraindication to life-long oral anticoagulation therapy, and is at increased risk of thromboembolism demonstrated by: (a) a prior stroke (whether of an ischaemic or unknown type), transient ischaemic attack or non-central nervous system systemic embolism; or (b) at least 2 of the following risk factors: (i) an age of 65 years or more; (ii) hypertension; (iii) diabetes mellitus; (iv) heart failure or left ventricular ejection fraction of 35% or less (or both); (v) vascular disease (prior myocardial infarction, peripheral artery disease or aortic plaque)
38276	01MAR2022	31DEC9999	Y	Transcatheter occlusion of left atrial appendage, and cardiac catheterisation performed by the same practitioner, for stroke prevention in a patient who has non-valvular atrial fibrillation, if: (a) the patient is at increased risk of thromboembolism demonstrated by: (i) a prior stroke (whether of an ischaemic or unknown type), transient ischaemic attack or non-central nervous system systemic embolism; or (ii) at least 2 of the following risk factors: (A) an age of 65 years or more; (B) hypertension; (C) diabetes mellitus; (D) heart failure or left ventricular ejection fraction of 35% or less (or both); (E) vascular disease (prior myocardial infarction, peripheral artery disease or aortic plaque); and (b) the patient has an absolute and permanent contraindication to oral anticoagulation (confirmed by written documentation that is provided by a medical practitioner, independent of the practitioner rendering the service); and (c) the service is not associated with a service to which item 38200, 38203, 38206 or 38254 applies (H)
38278	01JUL1998	31DEC9999	Y	SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of
38281	01JUL1998	30APR2002	N	PERMANENT PACEMAKER, insertion, removal or replacement of
38281	01MAY2002	31DEC9999	Y	PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of
38284	01JUL1998	31DEC9999	Y	DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of
38285	01NOV2004	30JUN2021	N	IMPLANTABLE ECG LOOP RECORDER, insertion of, for diagnosis of primary disorder in patients with recurrent unexplained syncope where: - a diagnosis has not been achieved through all other available cardiac investigations; and - a neurogenic cause is not suspected; and - it has been determined that the patient does not have structural heart disease associated with a high risk of sudden cardiac death. including initial programming and testing, as an admitted patient in an approved hospital
38285	01JUL2021	31DEC9999	Y	Insertion of implantable ECG loop recorder, by a specialist or consultant physician, for the diagnosis of a primary disorder, including initial programming and testing, if: (a) the patient has recurrent unexplained syncope and does not have a structural heart defect associated with a high risk of sudden cardiac death; and (b) a diagnosis has not been achieved through all other available cardiac investigations; and (c) a neurogenic cause is not suspected
38286	01NOV2004	30JUN2021	N	IMPLANTABLE ECG LOOP RECORDER, removal of, as an admitted patient in an approved hospital
38286	01JUL2021	31DEC9999	Y	Removal of implantable ECG loop recorder
38287	01JUL1998	31DEC9999	Y	ABLATION OF ARRHYTHMIA CIRCUIT OR FOCUS or isolation procedure involving 1 atrial chamber
38288	01MAY2018	31DEC9999	Y	Implantable loop recorder, insertion of, for diagnosis of atrial fibrillation, if: (a) the patient to whom the service is provided has been diagnosed as having had an embolic stroke of undetermined source; and (b) the bases of the diagnosis included the following: (i) the medical history of the patient; (ii) physical examination; (iii) brain and carotid imaging; (iv) cardiac imaging; (v) surface ECG testing including 24-hour Holter monitoring; and (c) atrial fibrillation is suspected; and (d) the patient: (i) does not have a permanent indication for oral anticoagulants; or (ii) does not have a permanent oral anticoagulants contraindication; including initial programming and testing
38290	01JUL1998	31DEC9999	Y	ABLATION OF ARRHYTHMIA CIRCUITS OR FOCI, or isolation procedure involving both atrial chambers and including curative procedures for atrial fibrillation
38293	01JUL1998	31DEC9999	Y	VENTRICULAR ARRHYTHMIA with mapping and ablation, including all associated electrophysiological studies performed on the same day
38300	01NOV2005	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare
38303	01NOV2005	31DEC9999	Y	TRANSLUMINAL BALLOON ANGIOPLASTY of more than 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation and excluding aftercare
38306	01NOV2005	31OCT2006	N	TRANSLUMINAL STENT INSERTION including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare
38306	01NOV2006	23MAY2017	N	TRANSLUMINAL INSERTION OF STENT OR STENTS into 1 occlusional site, including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare
38306	24MAY2017	31DEC9999	Y	Transluminal insertion of stent or stents into one occlusional site, including associated balloon dilatation of coronary artery, percutaneous or by open exposure, excluding associated radiological services, radiological preparation and after-care
38307	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 1 coronary territory with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38307	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 1 coronary territory with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38308	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 2 coronary territories with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38308	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 2 coronary territories with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38309	01NOV2005	30JUN2021	N	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with no stent insertion, where: - no lesion of the coronary artery has been stented; and - each lesion of the coronary artery is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
38309	01JUL2021	31DEC9999	Y	Percutaneous transluminal rotational atherectomy of one or more coronary arteries, including all associated imaging, if: (a) the target stenosis within at least one coronary artery is heavily calcified and balloon angioplasty with or without stenting is not feasible without rotational artherectomy; and (b) the service is performed in conjunction with a service to which item 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies Applicable only once on each occasion the service is performed
38310	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 3 coronary territories with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38310	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 3 coronary territories with selective coronary angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38311	01JUL2021	31DEC9999	Y	Note: (stable multi-vessel disease - 1 coronary territory with selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C for the service and a service to which item 38314 applies; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38312	01NOV2005	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with insertion of 1 or more stents, where: - no lesion of the coronary artery has been stented; and - each lesion of the coronary artery is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
38313	01JUL2021	31DEC9999	Y	Note: (stable multi-vessel disease - 2 coronary territories with selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C for the service and a service to which item 38314 applies; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38314	01JUL2021	31DEC9999	Y	Note: (stable multi-vessel disease - 3 coronary territory with selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17C; and (ii) for whom selective coronary angiography has not been completed in the previous 3 months; and (b) including selective coronary angiography and all associated imaging, catheter and contrast; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38316, 38317, 38319, 38320, 38322 or 38323 applies
38315	01NOV2005	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty with no stent insertion, where: - no lesion of the coronary arteries has been stented; and - each lesion of the coronary arteries is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare
38316	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 1 coronary territory without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38317, 38319, 38320, 38322 or 38323 applies
38316	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 1 coronary territory without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38317, 38319, 38320, 38322 or 38323 applies
38317	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 2 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 3808, 38310, 38311, 38313, 38314, 38316, 38319, 38320, 38322 or 38323 applies
38317	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 2 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 3808, 38310, 38311, 38313, 38314, 38316, 38319, 38320, 38322 or 38323 applies
38318	01NOV2005	31DEC9999	Y	PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty, with insertion of 1 or more stents, where: - no lesion of the coronary arteries has been stented; and - each lesion of the coronary arteries is complex and heavily calcified; and - balloon angioplasty with or without stenting is not suitable, excluding associated radiological services or preparation, and excluding aftercare
38319	01JUL2021	08JUL2021	N	Note: (acute coronary syndrome - 3 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38320, 38322 or 38323 applies
38319	09JUL2021	31DEC9999	Y	Note: (acute coronary syndrome - 3 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.2 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17A; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38320, 38322 or 38323 applies
38320	01JUL2021	31DEC9999	Y	Note: (stable multi-vessel disease - 1 coronary territory without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C for the service and a service to which item 38323 applies; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on one coronary vascular territory; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38322 or 38323 applies
38321	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
38322	01JUL2021	30JUN2024	N	Note: (stable multi-vessel disease - 2 coronary territories with selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C for the service and a service to which item 38323 applies; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320 or 38323 applies
38322	01JUL2024	31DEC9999	Y	Note: (stable multi-vessel disease - 2 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible under clause 5.10.17C for the service and a service to which item 38323 applies; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 2 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320 or 38323 applies
38323	01JUL2021	30JUN2024	N	Note: (stable multi-vessel disease - 3 coronary territories with selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17C; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320 or 38322 applies
38323	01JUL2024	31DEC9999	Y	Note: (stable multi-vessel disease - 3 coronary territories without selective angiography) the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.4 and TR.8.5 Percutaneous coronary intervention: (a) for a patient: (i) eligible for the service under clause 5.10.17C; and (ii) for whom selective coronary angiography has been completed in the previous 3 months; and (b) including any associated coronary angiography; and (c) including either or both: (i) percutaneous angioplasty; and (ii) transluminal insertion of one or more stents; and (d) performed on 3 coronary vascular territories; and (e) excluding aftercare; other than a service associated with a service to which item 38200, 38203, 38206, 38244, 38247, 38248, 38249, 38251, 38252, 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320 or 38322 applies
38324	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
38325	01MAR2024	31DEC9999	Y	Use of intravascular ultrasound (IVUS) during transluminal insertion of stents, to optimise procedural strategy, appropriate stent size and assessment of stent apposition, for a patient documented with: (a) one or more left main coronary artery lesions; or (b) one or more lesions at least 28mm in length in other locations; if performed in association with a service to which item 38307, 38308, 38310, 38311, 38313, 38314, 38316, 38317, 38319, 38320, 38322 or 38323 applies Applicable once per episode of care (for one or more lesions) (H)
38327	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - percutaneous transluminal rotational artherectomy using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
38330	01NOV2005	31DEC9999	Y	CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; - balloon angioplasty - percutaneous transluminal rotational artherectomy - intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies.
38350	01NOV2005	31OCT2010	N	SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of,
38350	01NOV2010	31DEC9999	Y	SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of, including cardiac electrophysiological services where used for pacemaker implantation
38353	01NOV2005	30APR2006	N	PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of
38353	01MAY2006	31OCT2010	N	PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of, not for cardiac resynchronisation therapy
38353	01NOV2010	31DEC9999	Y	PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of, not for cardiac resynchronisation therapy, including cardiac electrophysiological services where used for pacemaker implantation
38356	01NOV2005	31OCT2010	N	DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of
38356	01NOV2010	31DEC9999	Y	DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of, including cardiac electrophysiological services where used for pacemaker implantation
38358	01NOV2005	30JUN2021	N	Extraction of chronically implanted transvenous pacing or defibrillator lead or leads, by percutaneous method where the leads have been in situ for greater than six months and require removal with locking stylets, snares and/or extraction sheaths in a facility where cardiac surgery is available, in association with item 61109 or 60509
38358	01JUL2021	31DEC9999	Y	Extraction of one or more chronically implanted transvenous pacing or defibrillator leads, by percutaneous method, with locking stylets and snares, with extraction sheaths (if any), if: (a) the leads have been in place for more than 6 months and require removal; and (b) the service is performed: (i) in association with a service to which item 61109 or 60509 applies; and (ii) by a specialist or consultant physician who has undertaken the training to perform the service; and (iii) in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and (c) if the service is performed by an interventional cardiologist-a cardiothoracic surgeon is in attendance during the service (H)
38359	01NOV2005	31DEC9999	Y	PERICARDIUM, paracentesis of (excluding aftercare)
38362	01NOV2005	31DEC9999	Y	INTRA-AORTIC BALLOON PUMP, percutaneous insertion of
38365	01MAY2006	30JUN2014	N	PERMANENT CARDIAC SYNCRONISATION DEVICE, insertion, removal or replacement of, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: - sinus rhythm - a left ventricular ejection fraction of less than or equal to 35% - a QRS duration greater than or equal to 120ms.
38365	01JUL2014	30JUN2021	N	Permanent cardiac synchronisation device (including a cardiac synchronisation device that is capable of defibrillation), insertion, removal or replacement of, for a patient who: (a) has: (i) moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 120 ms; or (b) satisfied the requirements mentioned in paragraph (a) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode
38365	01JUL2021	31DEC9999	Y	Insertion, removal or replacement of permanent cardiac synchronisation device, if the patient: (a) has all of the following: (i) chronic heart failure, classified as New York Heart Association class III or IV (despite optimised medical therapy); (ii) left ventricular ejection fraction of less than 35%; (iii) QRS duration of greater than or equal to 130 ms; or (b) has all of the following: (i) chronic heart failure, classified as New York Heart Association class II (despite optimised medical therapy); (ii) left ventricular ejection fraction of less than 35%; (iii) QRS duration of greater than or equal to 150 ms; other than a service associated with a service to which item 38212 applies (H)
38368	01MAY2006	30JUN2014	N	PERMANENT TRANSVENOUS LEFT VENTRICULAR ELECTRODE, insertion, removal or replacement of through the coronary sinus, for the purpose of cardiac resynchronisation therapy, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: - sinus rhythm - a left ventricular ejection fraction of less than or equal to 35% - a QRS duration greater than or equal to 120ms. Where the service includes right heart catheterisation and any associated venogram of left ventricular veins. Not being a service associated with a service to which items 38200 and 35200 apply
38368	01JUL2014	30JUN2021	N	Permanent transvenous left ventricular electrode, insertion, removal or replacement of through the coronary sinus, for the purpose of cardiac resynchronisation therapy, including right heart catheterisation and any associated venogram of left ventricular veins, other than a service associated with a service to which item 35200 or 38200 applies, for a patient who: (a) has: (i) moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 120 ms; or (b) has: (i) mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 150 ms; or (c) satisfied the requirements mentioned in paragraph (a) or (b) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode
38368	01JUL2021	31DEC9999	Y	Insertion, removal or replacement of permanent transvenous left ventricular electrode, through the coronary sinus, for the purpose of cardiac resynchronisation therapy, including right heart catheterisation and any associated venograms, if the patient: (a) has all of the following: (i) chronic heart failure, classified as New York Heart Association class III or IV (despite optimised medical therapy); (ii) left ventricular ejection fraction of less than 35%; (iii) QRS duration of greater than or equal to 130 ms; or (b) has all of the following: (i) chronic heart failure, classified as New York Heart Association class II (despite optimised medical therapy); (ii) left ventricular ejection fraction of less than 35%; (iii) QRS duration of greater than or equal to 150 ms; other than a service associated with a service to which item 35200, 38200 or 38212 applies (H)
38371	01NOV2006	30JUN2014	N	PERMANENT CARDIAC SYNCHRONISATION DEVICE CAPABLE OF DEFIBRILLATION, insertion, removal or replacement of, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy who meet all of the following criteria: - sinus rhythm - a left ventricular ejection fraction of less than or equal to 35% - a QRS duration greater than or equal to 120ms.
38371	01JUL2014	31DEC9999	Y	Permanent cardiac synchronisation device capable of defibrillation, insertion, removal or replacement of, for a patient who: (a) has: (i) moderate to severe chronic heart failure (New York Heart Association ((NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 120 ms; or (b) has: (i) mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 150 ms
38372	01NOV2023	31DEC9999	Y	Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous insertion of, for the treatment of bradycardia, including cardiac electrophysiological services (other than a service associated with a service to which item 38350 applies) (H)
38373	01NOV2023	29FEB2024	N	Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous retrieval and replacement of, including cardiac electrophysiological services, during the same percutaneous procedure, if: (a) the service is performed: (i) by a specialist or consultant physician who has undertaken training to perform the service; and (ii) in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and (b) if the service is performed by an interventional cardiologist at least 4 weeks after the leadless permanent cardiac pacemaker was inserted-a cardiothoracic surgeon is in attendance during the service; other than a service associated with a service to which item 38350 applies (H)
38373	01MAR2024	31DEC9999	Y	Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous retrieval and replacement of, including cardiac electrophysiological services, during the same percutaneous procedure, if: (a) the service is performed by a specialist or consultant physician who has undertaken training to perform the service; and (b) if the service is performed at least 4 weeks after the pacemaker was inserted-the service is performed in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and (c) if the service is performed by an interventional cardiologist at least 4 weeks after the pacemaker was inserted-a cardiothoracic surgeon is in attendance during the service; other than a service associated with a service to which item 38350 applies (H)
38374	01NOV2023	29FEB2024	N	Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous retrieval of, if: (a) the service is performed: (i) by a specialist or consultant physician who has undertaken training to perform the service; and (ii) in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and (b) if the service is performed by an interventional cardiologist at least 4 weeks after the leadless permanent cardiac pacemaker was inserted-a cardiothoracic surgeon is in attendance during the service (H)
38374	01MAR2024	31DEC9999	Y	Leadless permanent cardiac pacemaker, single-chamber ventricular, percutaneous retrieval of, if: (a) the service is performed by a specialist or consultant physician who has undertaken training to perform the service; and (b) if the service is performed at least 4 weeks after the pacemaker was inserted-the service is performed in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and (c) if the service is performed by an interventional cardiologist at least 4 weeks after the pacemaker was inserted-a cardiothoracic surgeon is in attendance during the service (H)
38375	01NOV2023	31DEC9999	Y	Leadless permanent cardiac pacemaker, single-chamber ventricular, explantation of, by open surgical approach (H)
38384	01NOV2006	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for, primary prevention of sudden cardiac death in: - patients with a left ventricular ejection fraction of less than or equal to 30% at least one month after a myocardial infarct when the patient has received optimised medical therapy; or - patients with chronic heart failure associated with mild to moderate symptoms (NYHA II and III) and a left ventricular ejection fraction less than or equal to 35% when the patient has received optimised medical therapy. Not being a service associated with a service to which item 38213 applies
38387	01NOV2006	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of for, primary prevention of sudden cardiac death in: - patients with a left ventricular ejection fraction of less than or equal to 30% at least one month after a myocardial infarct when the patient has received optimised medical therapy; or - patients with chronic heart failure associated with mild to moderate symptoms (NYHA II and III) and a left ventricular ejection fraction less than or equal to 35% when the patient has received optimised medical therapy. Not being a service associated with a service to which item 38213 applies, not for defibrillators capable of cardiac resynchronisation therapy
38390	01NOV2005	31OCT2006	N	AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for - not being a service associated with a service to which item 38213 applies
38390	01NOV2006	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for - not for patients with heart failure or as primary prevention for tachycardia arrhythmias. Not being a service associated with a service to which item 38213 applies
38393	01NOV2005	30APR2006	N	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies
38393	01MAY2006	31OCT2006	N	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies, not for defibrillators capable of cardiac resynchronisation therapy
38393	01NOV2006	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of for - not for patients with heart failure or as primary prevention for tachycardia arrhythmias. Not being a service associated with a service to which item 38213 applies.
38400	01DEC1991	31DEC9999	Y	THORACIC SURGERY THORACIC CAVITY, aspiration of, for diagnostic purposes, not being a service associated with a service to which item 38403 applies
38403	01DEC1991	31DEC9999	Y	THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample
38406	01DEC1991	31DEC9999	Y	THORACIC SURGERY PERICARDIUM, paracentesis of (excluding aftercare)
38409	01DEC1991	31DEC9999	Y	INTERCOSTAL DRAIN, insertion of, not involving resection of rib (excluding aftercare)
38410	01JUL1993	31DEC9999	Y	INTERCOSTAL DRAIN, insertion of, with pleurodesis and not involving resection of rib (excluding aftercare)
38412	01DEC1991	31DEC9999	Y	PERCUTANEOUS NEEDLE BIOPSY of lung
38415	01DEC1991	31DEC9999	Y	EMPYEMA, radical operation for, involving resection of rib
38416	01MAR2021	31DEC9999	Y	Endoscopic ultrasound guided fine needle aspiration biopsy or biopsies (endoscopy with ultrasound imaging) to obtain one or more specimens from either or both of the following: (a) mediastinal masses; (b) locoregional nodes to stage non-small cell lung carcinoma; other than a service associated with a service to which an item in Subgroup 1 of this Group, or item 38417 or 55054, applies
38417	01MAR2021	31DEC9999	Y	Endobronchial ultrasound guided biopsy or biopsies (bronchoscopy with ultrasound imaging, with or without associated fluoroscopic imaging) to obtain one or more specimens by: (a) transbronchial biopsy or biopsies of peripheral lung lesions; or (b) fine needle aspirations of one or more mediastinal masses; or (c) fine needle aspirations of locoregional nodes to stage non-small cell lung carcinoma; other than a service associated with a service to which an item in Subgroup 1 of this Group, item 38416, 38420 or 38423, or an item in Subgroup I5 of Group I3, applies
38418	01DEC1991	31DEC9999	Y	THORACOTOMY, exploratory, with or without biopsy
38419	01MAR2021	31DEC9999	Y	Bronchoscopy, as an independent procedure
38420	01MAR2021	31DEC9999	Y	Bronchoscopy with one or more endobronchial biopsies or other diagnostic or therapeutic procedures
38421	01DEC1991	31DEC9999	Y	THORACOTOMY, with pulmonary decortication
38422	01MAR2021	31DEC9999	Y	Bronchus, removal of foreign body in
38423	01MAR2021	31DEC9999	Y	Fibreoptic bronchoscopy with one or more transbronchial lung biopsies, with or without bronchial or broncho-alveolar lavage, with or without the use of interventional imaging
38424	01DEC1991	31DEC9999	Y	THORACOTOMY, with pleurectomy or pleurodesis, OR ENUCLEATION OF HYDATID cysts
38425	01MAR2021	29FEB2024	N	Endoscopic laser resection of endobronchial tumours for relief of obstruction including any associated endoscopic procedures
38425	01MAR2024	31DEC9999	Y	Endoscopic resection of endobronchial tumours for relief of obstruction including any associated endoscopic procedures, other than a service associated with a service to which another item in Group T8 applies (H)
38426	01MAR2021	31DEC9999	Y	Trachea or bronchus, dilatation of stricture and endoscopic insertion of stent
38427	01DEC1991	31OCT1992	N	THORACOPLASTY (COMPLETE)
38427	01NOV1992	31DEC9999	Y	THORACOPLASTY (complete) - 3 or more ribs
38428	01NOV2021	28FEB2023	N	Bronchoscopy with dilatation of tracheal stricture
38428	01MAR2023	31DEC9999	Y	Bronchoscopy with treatment of tracheal stricture
38429	01MAR2023	31DEC9999	Y	Tracheal excision and repair of, without cardiopulmonary bypass (H)
38430	01DEC1991	31DEC9999	Y	THORACOPLASTY (in stages) each stage
38431	01MAR2023	31DEC9999	Y	Tracheal excision and repair of, with cardiopulmonary bypass (H)
38432	01NOV1992	31DEC9999	Y	PECTUS EXCAVATUM or PECTUS CARINATUM, repair or radical correction of
38433	01DEC1991	31DEC9999	Y	PECTUS EXCAVATUM OR PECTUS CARINATUM, radical correction of
38434	01NOV1992	31DEC9999	Y	PECTUS EXCAVATUM or PECTUS CARINATUM, repair with implantation of subcutaneous prosthesis of
38436	01DEC1991	31OCT1992	N	THORACOSCOPY, with or without division of pleural adhesions
38436	01NOV1992	30APR2004	N	THORACOSCOPY, with or without division of pleural adhesions, including insertion of intercostal catheter, with or without biopsy
38436	01MAY2004	31DEC9999	Y	THORACOSCOPY, with or without division of pleural adhesions, including insertion of intercostal catheter where necessary, with or without biopsy
38438	01NOV1992	30APR1997	N	PNEUMONECTOMY or LOBECTOMY or SEGMENTECTOMY
38438	01MAY1997	31DEC9999	Y	PNEUMONECTOMY or LOBECTOMY or SEGMENTECTOMY not being a service associated with a service to which Item 38418 applies
38439	01DEC1991	31DEC9999	Y	PNEUMONECTOMY or lobectomy
38440	01NOV1992	31DEC9999	Y	LUNG, wedge resection of
38441	01NOV1992	31DEC9999	Y	RADICAL LOBECTOMY or PNEUMONECTOMY including resection of chest wall, diaphragm, pericardium, or formal mediastinal node dissection
38442	01DEC1991	31OCT1992	N	OESOPHAGECTOMY, with direct anastomosis OR WITH STOMACH TRANSPOSITION
38442	01NOV1992	31DEC9999	Y	Oesophagectomy with gastric reconstruction
38445	01DEC1991	31DEC9999	Y	OESOPHAGECTOMY, with interposition of small or large bowel
38446	01NOV1992	31DEC9999	Y	THORACOTOMY or STERNOTOMY, for removal of thymus or mediastinal tumour
38447	01JUL1993	31DEC9999	Y	PERICARDIECTOMY via sternotomy or anterolateral thoracotomy without cardiopulmonary bypass
38448	01DEC1991	31DEC9999	Y	MEDIASTINUM, cervical exploration of, with or without biopsy
38449	01JUL1993	31DEC9999	Y	PERICARDIECTOMY via sternotomy or anterolateral thoracotomy with cardiopulmonary bypass
38450	01NOV1992	31OCT2005	N	PERICARDIUM, transthoracic drainage of
38450	01NOV2005	31DEC9999	Y	PERICARDIUM, transthoracic open surgical drainage of
38451	01DEC1991	31DEC9999	Y	PERICARDIUM, TRANSTHORACIC DRAINAGE OF (other than for treatment of constrictive pericarditis)
38452	01NOV1992	31MAY2017	N	PERICARDIUM, sub-xyphoid drainage of
38452	01JUN2017	31DEC9999	Y	PERICARDIUM, subxiphoid open surgical drainage of
38453	01NOV1992	31DEC9999	Y	TRACHEAL excision and repair without cardiopulmonary bypass
38454	01DEC1991	31DEC9999	Y	INTRATHORACIC OPERATION on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum, or on more than 1 of those organs, not being a service to which another item in this Group applies
38455	01JUL1993	31DEC9999	Y	TRACHEAL EXCISION AND REPAIR OF, with cardiopulmonary bypass
38456	01JUL1993	31DEC9999	Y	INTRATHORACIC OPERATION on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum, or on more than 1 of those organs, not being a service to which another item in this Group applies
38457	01JUL1993	31DEC9999	Y	PECTUS EXCAVATUM or PECTUS CARINATUM, repair or radical correction of
38458	01JUL1993	31DEC9999	Y	PECTUS EXCAVATUM, repair of, with implantation of subcutaneous prosthesis
38460	01JUL1993	31DEC9999	Y	STERNAL WIRE OR WIRES, removal of
38461	01JUL2021	31OCT2024	N	TMVr, by transvenous or transeptal techniques, for permanent coaptation of mitral valve leaflets using one or more Mitraclips™, including intra-operative diagnostic imaging, if: (a) the patient has each of the following risk factors: (i) moderate to severe, or severe, symptomatic degenerative (primary) mitral valve regurgitation (grade 3+ or 4+); (ii) left ventricular ejection fraction of 20% or more; (iii) symptoms of mild, moderate or severe chronic heart failure (New York Heart Association class II, III or IV); and (b) as a result of a TMVr suitability case conference, the patient has been: (i) assessed as having an unacceptably high risk for surgical mitral valve replacement; and (ii) recommended as being suitable for the service; and (c) the service is performed: (i) by a cardiothoracic surgeon, or an interventional cardiologist, accredited by the TMVr accreditation committee to perform the service; and (ii) via transfemoral venous delivery, unless transfemoral venous delivery is contraindicated or not feasible; and (iii) in a hospital that is accredited by the TMVr accreditation committee as a suitable hospital for the service; and (d) a service to which this item, or item 38463, applies has not been provided to the patient in the previous 5 years (H)
38461	01NOV2024	31DEC9999	Y	TMVr, by transvenous or transeptal techniques, for permanent coaptation of mitral valve leaflets using one or more tissue approximation implants, including intra-operative diagnostic imaging, if: (a) the patient has each of the following risk factors: (i) moderate to severe, or severe, symptomatic degenerative (primary) mitral valve regurgitation (grade 3+ or 4+); (ii) left ventricular ejection fraction of 20% or more; (iii) symptoms of mild, moderate or severe chronic heart failure (New York Heart Association class II, III or IV); and (b) as a result of a TMVr suitability case conference, the patient has been: (i) assessed as having an unacceptably high risk for surgical mitral valve replacement; and (ii) recommended as being suitable for the service; and (c) the service is performed: (i) by a cardiothoracic surgeon, or an interventional cardiologist, accredited by the TMVr accreditation committee to perform the service; and (ii) via transfemoral venous delivery, unless transfemoral venous delivery is contraindicated or not feasible; and (iii) in a hospital that is accredited by the TMVr accreditation committee as a suitable hospital for the service; and (d) a service to which this item, or item 38463, applies has not been provided to the patient in the previous 5 years (H)
38462	01JUL1993	31DEC9999	Y	STERNOTOMY WOUND, debridement of, not involving reopening of the mediastinum
38463	01JUL2021	31DEC9999	Y	TMVr, by transvenous or transeptal techniques, for permanent coaptation of mitral valve leaflets using one or more Mitraclips™, including intra-operative diagnostic imaging, if: (a) the patient has each of the following risk factors: (i) moderate to severe, or severe, symptomatic functional (secondary) mitral valve regurgitation (grade 3+ or 4+); (ii) left ventricular ejection fraction of 20% to 50%; (iii) left ventricular end systolic diameter of not more than 70mm; (iv) symptoms of mild, moderate or severe chronic heart failure (New York Heart Association class II, III or IV) that persist despite maximally tolerated guideline directed medical therapy; and (b) as a result of a TMVr suitability case conference, the patient has been: (i) assessed as having an unacceptably high risk for surgical mitral valve replacement; and (ii) recommended as being suitable for the service; and (c) the service is performed: (i) by a cardiothoracic surgeon, or an interventional cardiologist, accredited by the TMVr accreditation committee to perform the service; and (ii) via transfemoral venous delivery, unless transfemoral venous delivery is contraindicated or not feasible; and (iii) in a hospital that is accredited by the TMVr accreditation committee as a suitable hospital for the service; and (d) a service to which this item, or item 38461, applies has not been provided to the patient in the previous 5 years (H)
38464	01JUL1993	31DEC9999	Y	STERNOTOMY WOUND, debridement of, involving curettage of infected bone with or without removal of wires but not involving reopening of the mediastinum
38466	01JUL1993	31DEC9999	Y	STERNUM, reoperation on, for dehiscence or infection involving reopening of the mediastinum, with or without rewiring
38467	01JUL2021	28FEB2023	N	Insertion, removal or replacement of permanent myocardial electrode, by open surgical approach, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38467	01MAR2023	31DEC9999	Y	Insertion, removal or replacement of permanent myocardial electrode, by open surgical approach, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38468	01JUL1993	31DEC9999	Y	STERNUM AND MEDIASTINUM, reoperation for infection of, involving muscle advancement flaps or greater omentum
38469	01JUL1993	31DEC9999	Y	STERNUM AND MEDIASTINUM, reoperation for infection of, involving muscle advancement flaps and greater omentum
38470	01NOV1992	30APR1997	N	PACEMAKER PROCEDURES PERMANENT MYOCARDIAL ELECTRODE, insertion of, by thoracotomy
38470	01MAY1997	31DEC9999	Y	PERMANENT MYOCARDIAL ELECTRODE, insertion of, by thoracotomy or sternotomy
38471	01JUL2021	31DEC9999	Y	Insertion of implantable defibrillator, including insertion of patches for the insertion of one or more transvenous endocardial leads, if the patient has one of the following: (a) a history of haemodynamically significant ventricular arrhythmias in the presence of structural heart disease; (b) documented high-risk genetic cardiac disease; (c) ischaemic heart disease, with a left ventricular ejection fraction of less than 30% at least one month after experiencing a myocardial infarction and while on optimised medical therapy; (d) chronic heart failure, classified as New York Heart Association class II or III, with a left ventricular ejection fraction of less than 35% (despite optimised medical therapy); other than a service to which item 38212 applies (H)
38472	01JUL2021	31DEC9999	Y	Insertion, replacement or removal of implantable defibrillator generator, if the patient has one of the following: (a) a history of haemodynamically significant ventricular arrhythmias in the presence of structural heart disease; (b) documented high-risk genetic cardiac disease; (c) ischaemic heart disease, with a left ventricular ejection fraction of less than 30% at least one month after experiencing a myocardial infarction and while on optimised medical therapy; (d) chronic heart failure, classified as New York Heart Association class II or III, with a left ventricular ejection fraction of less than 35% (despite optimised medical therapy); other than a service to which item 38212 applies (H)
38473	01NOV1992	31OCT2005	N	PERMANENT PACEMAKER ELECTRODE, insertion by sub-xyphoid approach
38473	01NOV2005	31DEC9999	Y	PERMANENT PACEMAKER ELECTRODE, insertion by open surgical approach
38474	01JUL2021	28FEB2023	N	Repair, augmentation or replacement of branch pulmonary arteries-left or right (or both), with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38474	01MAR2023	31DEC9999	Y	Repair, augmentation or replacement of branch pulmonary arteries-left or right (or both), with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38475	01NOV1995	31DEC9999	Y	VALVE ANNULOPLASTY without insertion of ring, not being a service associated with a service to which item 38480 or 38481 applies
38476	01NOV1992	31DEC9999	Y	SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion of
38477	01NOV1995	30JUN2021	N	VALVE ANNULOPLASTY with insertion of ring not being a service to which item 38478 applies
38477	01JUL2021	28FEB2023	N	Valve annuloplasty with insertion of ring, other than: (a) a service to which item 38516 or 38517 applies; or (b) a service associated with a service to which to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38477	01MAR2023	31OCT2023	N	Valve annuloplasty with insertion of ring, other than: (a) a service to which item 38516 or 38517 applies; or (b) a service associated with a service to which to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38477	01NOV2023	31DEC9999	Y	Valve annuloplasty with insertion of ring, other than: (a) a service to which item 38516 or 38517 applies; or (b) a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38478	01NOV1995	31DEC9999	Y	VALVE ANNULOPLASTY with insertion of ring performed in conjunction with item 38480 or 38481
38479	01NOV1992	31DEC9999	Y	PERMANENT PACEMAKER, insertion or replacement of
38480	01NOV1995	31DEC9999	Y	VALVE REPAIR, 1 leaflet
38481	01NOV1995	31DEC9999	Y	VALVE REPAIR, 2 or more leaflets
38482	01NOV1992	31DEC9999	Y	TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of
38483	01NOV1995	31DEC9999	Y	AORTIC VALVE LEAFLET OR LEAFLETS, decalcification of, not being a service to which item 38475, 38477, 38480, 38481, 38488 or 38489 applies
38484	01JUL2021	28FEB2023	N	Aortic or pulmonary valve replacement with bioprosthesis or mechanical prosthesis, including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38484	01MAR2023	31DEC9999	Y	Aortic or pulmonary valve replacement with bioprosthesis or mechanical prosthesis, including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38485	01NOV1992	31OCT1995	N	PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion of
38485	01NOV1995	31DEC9999	Y	MITRAL ANNULUS, reconstruction of, after decalcification, when performed in association with valve surgery
38486	01JUL1993	31DEC9999	Y	AORTIC VALVE, decalcification of
38487	01JUL1993	31DEC9999	Y	MITRAL VALVE, open valvotomy of
38488	01NOV1992	30JUN1993	N	VALVULAR PROCEDURES VALVE REPLACEMENT with BIOPROSTHESIS or MECHANICAL PROSTHESIS
38488	01JUL1993	31OCT1995	N	VALVE REPLACEMENT with BIOPROSTHESIS, MECHANICAL PROSTHESIS or UNSTENTED XENOGRAFT
38488	01NOV1995	31DEC9999	Y	VALVE REPLACEMENT with BIOPROSTHESIS OR MECHANICAL PROSTHESIS
38489	01NOV1995	31DEC9999	Y	VALVE REPLACEMENT with allograft (subcoronary or cylindrical implant), or unstented xenograft
38490	01NOV1995	30JUN2021	N	SUB-VALVULAR STRUCTURES, reconstruction and re-implantation of, associated with mitral and tricuspid valve replacement
38490	01JUL2021	31DEC9999	Y	Reconstruction and re-implantation of sub-valvular structures, if performed in conjunction with a service to which item 38499 applies (H)
38491	01NOV1992	31DEC9999	Y	VALVE REPLACEMENT with ALLOGRAFT or UNSTENTED XENOGRAFT
38492	01JUL1993	31DEC9999	Y	VALVE REPLACEMENT WITH ALLOGRAFT, subcoronary or cylindrical implant
38493	01NOV1998	31DEC9999	Y	OPERATIVE MANAGEMENT of acute infective endocarditis, in association with heart valve surgery
38494	01NOV1992	31DEC9999	Y	VALVE, repair of
38495	01NOV2017	28FEB2022	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, in a TAVI Hospital on a TAVI Patient by a TAVI Practitioner - includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient. (Not payable more than once per patient in a five year period.)
38495	01MAR2022	30JUN2022	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: the TAVI patient is at high risk for surgery; and the service: (i) is performed by a TAVI Practitioner in a TAVI Hospital ; and (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; not being a service which has been rendered within 5 years of a service to which this item or 38514 applies (H)
38495	01JUL2022	31DEC2023	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: the TAVI patient is at high risk for surgery; and the service: (i) is performed by a TAVI Practitioner in a TAVI Hospital ; and (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; not being a service which has been rendered within 5 years of a service to which this item or item 38514 or 38522 applies (H)
38495	01JAN2024	31DEC9999	Y	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: (a) the TAVI Patient is at high risk for surgery; and (b) the service: (i) is performed by a TAVI Practitioner in a TAVI Hospital; and (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and (iii) includes valvuloplasty, if required; not being a service which has been rendered within 5 years of a service to which this item or item 38514 or 38522 applies (H)
38496	01NOV1995	31DEC9999	Y	ARTERY HARVESTING (other than internal mammary), for coronary artery bypass
38497	01NOV1992	31OCT1993	N	SURGERY FOR ISCHAEMIC HEART DISEASE CORONARY ARTERY BYPASS using saphenous vein graft or grafts only
38497	01NOV1993	31OCT1995	N	SURGERY FOR ISCHAEMIC HEART DISEASE CORONARY ARTERY BYPASS using saphenous vein graft or grafts only, including harvesting of graft material where performed
38497	01NOV1995	31OCT2002	N	CORONARY ARTERY BYPASS using saphenous vein graft or grafts only, including harvesting of vein graft material where performed
38497	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with cardiopulmonary bypass, using saphenous vein graft or grafts only, including harvesting of vein graft material where performed, not being a service asociated with a service to which items 38498, 38500, 38501, 38503 or 38504 apply
38498	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using saphenous vein graft or grafts only, including harvesting of vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38500, 38501, 38503, 38504 or 38600 apply
38499	01JUL2021	28FEB2023	N	Mitral or tricuspid valve replacement with bioprothesis or mechanical prosthesis, including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38499	01MAR2023	31DEC9999	Y	Mitral or tricuspid valve replacement with bioprothesis or mechanical prosthesis, including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38500	01NOV1992	31OCT1993	N	CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts
38500	01NOV1993	31OCT1995	N	CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts, including harvesting of graft material where performed
38500	01NOV1995	31OCT2002	N	CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed
38500	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with cardiopulmonary bypass, using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, not being a service associated with a service to which items 38497, 38498, 38501, 38503 or 38504 apply
38501	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38498, 38500, 38503, 38504 or 38600 apply
38502	01JUL2021	28FEB2023	N	Coronary artery bypass, including cardiopulmonary bypass, with or without retrograde cardioplegia, with or without vein grafts, and including at least one of the following: (a) harvesting of left internal mammary artery and vein graft material; (b) harvesting of left internal mammary artery; (c) harvesting of vein graft material; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38502	01MAR2023	31DEC9999	Y	Coronary artery bypass, including cardiopulmonary bypass, with or without retrograde cardioplegia, with or without vein grafts, and including at least one of the following: (a) harvesting of left internal mammary artery and vein graft material; (b) harvesting of left internal mammary artery; (c) harvesting of vein graft material; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38503	01NOV1992	31OCT1993	N	CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts
38503	01NOV1993	31OCT1995	N	CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of graft material where performed
38503	01NOV1995	31OCT2002	N	CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed
38503	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with cardiopulmonary bypass, using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, not being a service associated with a service to which items 38497, 38498, 38500, 38501 or 38504 apply
38504	01NOV2002	31DEC9999	Y	CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38498, 38500, 38501, 38503 or 38600 apply
38505	01NOV1995	31DEC9999	Y	CORONARY ENDARTERECTOMY, by open operation, including repair with 1 or more patch grafts, each vessel
38506	01NOV1992	31OCT1995	N	LEFT VENTRICULAR ANEURYSMECTOMY
38506	01NOV1995	31DEC9999	Y	LEFT VENTRICULAR ANEURYSM, plication of
38507	01NOV1995	31DEC9999	Y	LEFT VENTRICULAR ANEURYSM resection with primary repair
38508	01NOV1995	30JUN2021	N	LEFT VENTRICULAR ANEURYSM resection with patch reconstruction of the left ventricle
38508	01JUL2021	28FEB2023	N	Repair or reconstruction of left ventricular aneurysm, including plication, resection and primary and patch repairs, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38508	01MAR2023	31DEC9999	Y	Repair or reconstruction of left ventricular aneurysm, including plication, resection and primary and patch repairs, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38509	01NOV1992	30JUN2021	N	ISCHAEMIC VENTRICULAR SEPTAL RUPTURE, repair of
38509	01JUL2021	28FEB2023	N	Repair of ischaemic ventricular septal rupture,, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38509	01MAR2023	31DEC9999	Y	Repair of ischaemic ventricular septal rupture,, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38510	01JUL2021	31OCT2022	N	Artery harvesting (other than of the left internal mammary), for coronary artery bypass, if: (a) more than one arterial graft is required; and (b) the service is performed in conjunction with a service to which item 38502 applies (H)
38510	01NOV2022	31DEC9999	Y	Artery harvesting (other than of the left internal mammary), for coronary artery bypass, if: (a) more than one arterial graft is required; and (b) the service is performed in conjunction with coronary artery bypass surgery performed by any medical practitioner (H)
38511	01JUL2021	31DEC9999	Y	Coronary artery bypass, with the aid of tissue stabilisers, if the service is performed: (a) without cardiopulmonary bypass; and (b) in conjunction with a service to which item 38502 applies (H)
38512	01NOV1992	30JUN2021	N	DIVISION OF ACCESSORY PATHWAY, isolation procedure, procedure on atrioventricular node or perinodal tissues involving 1 atrial chamber only
38512	01JUL2021	28FEB2023	N	Division of accessory pathway, isolation procedure, procedure on atrioventricular node or perinodal tissues involving one atrial chamber only, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38512	01MAR2023	31DEC9999	Y	Division of accessory pathway, isolation procedure, procedure on atrioventricular node or perinodal tissues involving one atrial chamber only, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38513	01JUL2021	31OCT2022	N	Creation of graft anastomosis, including Y-graft, T-graft and graft-to-graft extensions, with micro-arterial or micro-venous anastomosis using microsurgical techniques, if the service is performed in conjunction with a service to which item 38502 applies (H)
38513	01NOV2022	31DEC9999	Y	Creation of Y-graft, T-graft and graft-to-graft extensions, with micro-arterial or micro-venous anastomosis using microsurgical techniques, if: (a) the service is for one or more anastomoses; and (b) the service is performed in conjunction with a service to which item 38502 applies (H)
38514	01MAR2022	30JUN2022	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: the TAVI patient is at intermediate risk for surgery; and the service: is performed by a TAVI practitioner in a TAVI Hospital; and includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; not being a service which has been rendered within 5 years of a service to which this item or 38495 applies (H)
38514	01JUL2022	31DEC2023	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: the TAVI patient is at intermediate risk for surgery; and the service: is performed by a TAVI practitioner in a TAVI Hospital; and includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38522 applies (H)
38514	01JAN2024	31OCT2024	N	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: (a) the TAVI Patient is at intermediate risk for surgery; and (b) the service: (i) is performed by a TAVI Practitioner in a TAVI Hospital; and (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and (iii) includes valvuloplasty, if required; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38522 applies (H)
38514	01NOV2024	31DEC9999	Y	TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: (a) the TAVI Patient is at intermediate risk for surgery; and (b) the service: is performed by a TAVI Practitioner in a TAVI Hospital; and includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and includes valvuloplasty, if required; and is performed in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and if performed by an interventional cardiologist, a cardiothoracic surgeon is in attendance during the service; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38522 applies (H)
38515	01NOV1992	30JUN2021	N	DIVISION OF ACCESSORY PATHWAY, isolation procedure, procedure on atrioventricular node or perinodal tissues involving both atrial chambers and including curative surgery for atrial fibrillation
38515	01JUL2021	28FEB2023	N	Division of accessory pathway, isolation procedure, procedure on atrioventricular node or perinodal tissues involving both atrial chambers and including curative surgery for atrial fibrillation, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38515	01MAR2023	31DEC9999	Y	Division of accessory pathway, isolation procedure, procedure on atrioventricular node or perinodal tissues involving both atrial chambers and including curative surgery for atrial fibrillation, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38516	01JUL2021	28FEB2023	N	Simple valve repair: (a) with or without annuloplasty; and (b) including quadrangular resection, cleft closure or alfieri; and (c) including retrograde cardioplegia (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38516	01MAR2023	31DEC9999	Y	Simple valve repair: (a) with or without annuloplasty; and (b) including quadrangular resection, cleft closure or alfieri; and (c) including retrograde cardioplegia (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38517	01JUL2021	28FEB2023	N	Complex valve repair: (a) with or without annuloplasty; and (b) including retrograde cardioplegia (if performed); and (c) including one of the following: (i) neochords; (ii) chordal transfer; (iii) patch augmentation; (iv) multiple leaflets; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38517	01MAR2023	31DEC9999	Y	Complex valve repair: (a) with or without annuloplasty; and (b) including retrograde cardioplegia (if performed); and (c) including one of the following: (i) neochords; (ii) chordal transfer; (iii) patch augmentation; (iv) multiple leaflets; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38518	01NOV1992	30JUN2021	N	VENTRICULAR ARRHYTHMIA with mapping and muscle ablation, with or without aneurysmeotomy
38518	01JUL2021	28FEB2023	N	Ventricular arrhythmia with mapping and muscle ablation, with or without aneurysmeotomy, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38518	01MAR2023	31DEC9999	Y	Ventricular arrhythmia with mapping and muscle ablation, with or without aneurysmeotomy, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38519	01JUL2021	31DEC2021	N	Valve explant of a previous prosthesis, if performed during a service to which item 38484 or 38499 applies, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38519	01JAN2022	28FEB2023	N	Valve explant of a previous prosthesis, if performed during open cardiac surgery, not being a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38519	01MAR2023	31DEC9999	Y	Valve explant of a previous prosthesis, if performed during open cardiac surgery, not being a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38521	01NOV1992	30JUN1998	N	AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrode for - not being a service associated with a service to which item 38213 applies
38521	01JUL1998	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrode for - not being a service associated with a service to which item 38213 applies
38522	01JUL2022	31DEC2023	N	TAVI, for the treatment of symptomatic severe native calcific aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: the TAVI Patient is at low risk for surgery; and the service: is performed by a TAVI Practitioner in a TAVI Hospital; and includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38514 applies (H)
38522	01JAN2024	31OCT2024	N	TAVI, for the treatment of symptomatic severe native calcific aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: (a) the TAVI Patient is at low risk for surgery; and (b) the service: (i) is performed by a TAVI Practitioner in a TAVI Hospital; and (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and (iii) includes valvuloplasty, if required; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38514 applies (H)
38522	01NOV2024	31DEC9999	Y	TAVI, for the treatment of symptomatic severe native calcific aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if: (a) the TAVI Patient is at low risk for surgery; and (b) the service: is performed by a TAVI Practitioner in a TAVI Hospital; and includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and includes valvuloplasty, if required; and is performed in a facility where cardiothoracic surgery is available and a thoracotomy can be performed immediately and without transfer; and if performed by an interventional cardiologist, a cardiothoracic surgeon is in attendance during the service; not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38514 applies (H)
38523	01JUL2022	31DEC9999	Y	Percutaneous transcatheter delivery of dual-filter cerebral embolic protection system during a TAVI procedure, for the reduction of postoperative embolic ischaemic strokes, if: the service is performed upon a TAVI Patient in a TAVI Hospital; and where the service is performed by the practitioner performing the TAVI procedure, the service includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient (H)
38524	01NOV1992	30JUN1998	N	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of
38524	01JUL1998	31DEC9999	Y	AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies
38530	01JUL1995	31DEC9999	Y	ARRHYTHMIA ABLATION ABLATION OF ARRHYTHMIA CIRCUIT OR FOCUS or isolation procedure involving 1 atrial chamber
38533	01JUL1995	31DEC9999	Y	ABLATION OF ARRHYTHMIA CIRCUITS OR FOCI, or isolation procedure involving both atrial chambers and including curative procedures for atrial fibrillation
38536	01JUL1995	31DEC9999	Y	VENTRICULAR ARRHYTHMIA with mapping and ablation, including all associated electrophysiological studies performed on the same day
38550	01NOV1992	30JUN2021	N	ASCENDING THORACIC AORTA, repair or replacement of, not involving valve replacement or repair or coronary artery implantation
38550	01JUL2021	28FEB2023	N	Repair or replacement of ascending thoracic aorta: (a) including: (i) cardiopulmonary bypass; and (ii) retrograde cardioplegia (if performed); and (b) not including valve replacement or repair or implantation of coronary arteries; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38550	01MAR2023	31DEC9999	Y	Repair or replacement of ascending thoracic aorta: (a) including: (i) cardiopulmonary bypass; and (ii) retrograde cardioplegia (if performed); and (b) not including valve replacement or repair or implantation of coronary arteries; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38553	01NOV1992	30JUN2021	N	ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, without implantation of coronary arteries
38553	01JUL2021	28FEB2023	N	Repair or replacement of ascending thoracic aorta: (a) including: (i) aortic valve replacement or repair; and (i) cardiopulmonary bypass; and (ii) retrograde cardioplegia (if performed); and (b) not including implantation of coronary arteries; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38553	01MAR2023	31DEC9999	Y	Repair or replacement of ascending thoracic aorta: (a) including: (i) aortic valve replacement or repair; and (i) cardiopulmonary bypass; and (ii) retrograde cardioplegia (if performed); and (b) not including implantation of coronary arteries; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38554	01JUL2021	28FEB2023	N	Valve sparing aortic root surgery, with reimplantation of aortic valve and coronary arteries and replacement of the ascending aorta, including cardiopulmonary bypass, and including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38554	01MAR2023	31DEC9999	Y	Valve sparing aortic root surgery, with reimplantation of aortic valve and coronary arteries and replacement of the ascending aorta, including cardiopulmonary bypass, and including retrograde cardioplegia (if performed), other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38555	01JUL2021	28FEB2023	N	Simple replacement or repair of aortic arch, performed in conjunction with a service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, including: (a) deep hypothermic circulatory arrest; and (b) peripheral cannulation for cardiopulmonary bypass; and (c) antegrade or retrograde cerebral perfusion (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38603, 38806 or 45503 applies (H)
38555	01MAR2023	31DEC9999	Y	Simple replacement or repair of aortic arch, performed in conjunction with a service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, including: (a) deep hypothermic circulatory arrest; and (b) peripheral cannulation for cardiopulmonary bypass; and (c) antegrade or retrograde cerebral perfusion (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38603, 38816, 38828 or 45503 applies (H)
38556	01NOV1992	30JUN2021	N	ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, and implantation of coronary arteries
38556	01JUL2021	31OCT2022	N	Repair or replacement of ascending thoracic aorta, including: (a) aortic valve replacement or repair; and (b) implantation of coronary arteries; and (c) cardiopulmonary bypass; and (d) retrograde cardioplegia (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38603, 38806 or 45503 applies (H)
38556	01NOV2022	28FEB2023	N	Repair or replacement of ascending thoracic aorta, including: (a) aortic valve replacement or repair; and (b) implantation of coronary arteries; and (c) cardiopulmonary bypass; and (d) retrograde cardioplegia (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38556	01MAR2023	31DEC9999	Y	Repair or replacement of ascending thoracic aorta, including: (a) aortic valve replacement or repair; and (b) implantation of coronary arteries; and (c) cardiopulmonary bypass; and (d) retrograde cardioplegia (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38603, 38816, 38828 or 45503 applies (H)
38557	01JUL2021	28FEB2023	N	Complex replacement or repair of aortic arch, performed in conjunction with a service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, including: (a) debranching and reimplantation of head and neck vessels; and (b) deep hypothermic circulatory arrest; and (c) peripheral cannulation for cardiopulmonary bypass; and (d) antegrade or retrograde cerebral perfusion (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38557	01MAR2023	29FEB2024	N	Complex replacement or repair of aortic arch, performed in conjunction with a service to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, including: (a) debranching and reimplantation of head and neck vessels; and (b) deep hypothermic circulatory arrest; and (c) peripheral cannulation for cardiopulmonary bypass; and (d) antegrade or retrograde cerebral perfusion (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38557	01MAR2024	31DEC9999	Y	Complex replacement or repair of aortic arch, performed in conjunction with a service, performed by any medical practitioner, to which item 38550, 38553, 38554, 38556, 38568 or 38571 applies, including: (a) debranching and reimplantation of head and neck vessels; and (b) deep hypothermic circulatory arrest; and (c) peripheral cannulation for cardiopulmonary bypass; and (d) antegrade or retrograde cerebral perfusion (if performed); other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38558	01JUL2021	28FEB2023	N	Aortic repair involving augmentation of hypoplastic or interrupted aortic arch, if: (a) the patient is a neonate; and (b) the service includes: (i) the use of antegrade cerebral perfusion or deep hypothermic circulatory arrest and associated myocardial preservation; and (ii) retrograde cardioplegia; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38558	01MAR2023	31DEC9999	Y	Aortic repair involving augmentation of hypoplastic or interrupted aortic arch, if: (a) the patient is a neonate; and (b) the service includes: (i) the use of antegrade cerebral perfusion or deep hypothermic circulatory arrest and associated myocardial preservation; and (ii) retrograde cardioplegia; other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38559	01NOV1992	31DEC9999	Y	AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, not involving valve replacement or repair or coronary artery implantation
38562	01NOV1992	31DEC9999	Y	AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, without implantation of coronary arteries
38565	01NOV1992	31DEC9999	Y	AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, and implantation of coronary arteries
38568	01NOV1992	31OCT2006	N	DESCENDING THORACIC AORTA, repair or replacement of, without shunt or cardiopulmonary bypass
38568	01NOV2006	30JUN2021	N	DESCENDING THORACIC AORTA, repair or replacement of, without shunt or cardiopulmonary bypass, by open exposure, percutaneous or endovascular means
38568	01JUL2021	28FEB2023	N	Repair or replacement of descending thoracic aorta, without shunt or cardiopulmonary bypass, by open exposure, percutaneous or endovascular means, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38568	01MAR2023	31DEC9999	Y	Repair or replacement of descending thoracic aorta, without shunt or cardiopulmonary bypass, by open exposure, percutaneous or endovascular means, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38571	01NOV1992	30JUN2021	N	DESCENDING THORACIC AORTA, repair or replacement of, using shunt or cardiopulmonary bypass
38571	01JUL2021	28FEB2023	N	Repair or replacement of descending thoracic aorta, with shunt or cardiopulmonary bypass, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38571	01MAR2023	31DEC9999	Y	Repair or replacement of descending thoracic aorta, with shunt or cardiopulmonary bypass, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38572	01JUL1993	30JUN2021	N	OPERATIVE MANAGEMENT OF ACUTE RUPTURE OR DISSECTION, in conjunction with procedures on the thoracic aorta
38572	01JUL2021	31OCT2022	N	Operative management of acute rupture or dissection, if the service: (a) is performed in conjunction with a service to which item 38550, 38553, 38554, 38555, 38556, 38557, 38558, 38568, 38571, 38706 or 38709 applies; and (b) is not associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38572	01NOV2022	28FEB2023	N	Operative management of acute rupture or dissection, if the service: (a) is performed in conjunction with a service to which item 38550, 38553, 38554, 38555, 38556, 38557, 38558, 38568, 38571, 38706 or 38709 applies; and (b) is not associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38603, 38806 or 45503 applies (H)
38572	01MAR2023	31DEC9999	Y	Operative management of acute rupture or dissection, if the service: (a) is performed in conjunction with a service to which item 38550, 38553, 38554, 38555, 38556, 38557, 38558, 38568, 38571, 38706 or 38709 applies; and (b) is not associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38603, 38816, 38828 or 45503 applies (H)
38573	01JUL1998	31DEC9999	Y	OPERATIVE MANAGEMENT of acute infective endocarditis, in association with heart valve surgery
38574	01NOV1992	30JUN1998	N	DEEP HYPOTHERMIA with cardiac arrest, in conjunction with OPEN HEART SURGERY
38574	01JUL1998	31DEC9999	Y	Deep hypothermia with circulatory arrest, in conjunction with open heart surgery (Assist.)
38577	01NOV1995	31DEC9999	Y	CANNULATION FOR, and supervision and monitoring of, the administration of retrograde cerebral perfusion during deep hypothermic arrest
38588	01NOV1995	31DEC9999	Y	CANNULATION of the coronary sinus for, and supervision of, the retrograde administration of blood or crystalloid for cardioplegia, including pressure monitoring
38600	01NOV1992	30JUN1993	N	CIRCULATORY SUPPORT PROCEDURES CENTRAL CANNULATION for cardiopulmonary bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies
38600	01JUL1993	31DEC9999	Y	CENTRAL CANNULATION for cardiopulmonary bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies
38603	01NOV1992	30JUN1993	N	PERIPHERAL CANNULATION for cardiopulmonary artery bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies
38603	01JUL1993	30JUN2021	N	PERIPHERAL CANNULATION for cardiopulmonary bypass excluding post-operative management
38603	01JUL2021	31DEC9999	Y	Peripheral cannulation for cardiopulmonary bypass, excluding post-operative management, other than a service: (a) in which peripheral cannulation is used in preference to central cannulation for valve or coronary bypass procedures; or (b) associated with a service to which item 38555 or 38572 applies (H)
38606	01NOV1992	31DEC9999	Y	INTRA-AORTIC BALLOON PUMP, percutaneous insertion of
38609	01NOV1992	30JUN1993	N	INTRA-AORTIC BALLOON PUMP, insertion by femoral arteriotomy
38609	01JUL1993	30JUN2021	N	INTRA-AORTIC BALLOON PUMP, insertion of, by arteriotomy
38609	01JUL2021	28FEB2023	N	Insertion of intra-aortic balloon pump, by arteriotomy, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38609	01MAR2023	31DEC9999	Y	Insertion of intra-aortic balloon pump, by arteriotomy, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38612	01NOV1992	30JUN1993	N	INTRA-AORTIC BALLOON PUMP, removal with closure of femoral artery by direct suture
38612	01JUL1993	30JUN2021	N	INTRA-AORTIC BALLOON PUMP, removal of, with closure of artery by direct suture
38612	01JUL2021	28FEB2023	N	Removal of intra-aortic balloon pump, with closure of artery by direct suture, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38612	01MAR2023	31DEC9999	Y	Removal of intra-aortic balloon pump, with closure of artery by direct suture, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 338816, 38828 or 45503 applies (H)
38613	01JUL1993	31DEC9999	Y	INTRA-AORTIC BALLOON PUMP, removal of, with closure of artery by patch graft
38615	01NOV1992	31OCT2015	N	LEFT OR RIGHT VENTRICULAR ASSIST DEVICE, insertion of
38615	01NOV2015	30JUN2021	N	Insertion of a left or right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; not being a service associated with the use of a ventricular assist device as destination therapy in the management of patients with heart failure who are not expected to be suitable candidates for cardiac transplantation
38615	01JUL2021	28FEB2023	N	Insertion of a left or right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; other than a service associated with a service to which: (d) item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies; or (e) another item in this Schedule applies if the service described in the item is for the use of a ventricular assist device as destination therapy in the management of a patient with heart failure who is not expected to be a suitable candidate for cardiac transplantation (H)
38615	01MAR2023	31DEC9999	Y	Insertion of a left or right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; other than a service associated with a service to which: (d) item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies; or (e) another item in this Schedule applies if the service described in the item is for the use of a ventricular assist device as destination therapy in the management of a patient with heart failure who is not expected to be a suitable candidate for cardiac transplantation (H)
38618	01NOV1992	31OCT2015	N	LEFT AND RIGHT VENTRICULAR ASSIST DEVICE, insertion of
38618	01NOV2015	30JUN2021	N	Insertion of a left and right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; not being a service associated with the use of a ventricular assist device as destination therapy in the management of patients with heart failure who are not expected to be suitable candidates for cardiac transplantation
38618	01JUL2021	28FEB2023	N	Insertion of a left and right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; other than a service associated with a service to which: (d) item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies; or (e) another item in this Schedule applies if the service described in the item is for the use of a ventricular assist device as destination therapy in the management of a patient with heart failure who is not expected to be a suitable candidate for cardiac transplantation (H)
38618	01MAR2023	31DEC9999	Y	Insertion of a left and right ventricular assist device, for use as: (a) a bridge to cardiac transplantation in patients with refractory heart failure who are: (i) currently on a heart transplant waiting list, or (ii) expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b) acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c) cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; other than a service associated with a service to which: (d) item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies; or (e) another item in this Schedule applies if the service described in the item is for the use of a ventricular assist device as destination therapy in the management of a patient with heart failure who is not expected to be a suitable candidate for cardiac transplantation (H)
38621	01NOV1992	30JUN2021	N	LEFT OR RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure
38621	01JUL2021	28FEB2023	N	LEFT OR RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38627, 38806 or 45503 applies (H)
38621	01MAR2023	31DEC9999	Y	Left or right ventricular assist device, removal of, as an independent procedure, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38627, 38816, 38828 or 45503 applies (H)
38624	01NOV1992	30JUN2021	N	LEFT AND RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure
38624	01JUL2021	28FEB2023	N	LEFT AND RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38627, 38806 or 45503 applies (H)
38624	01MAR2023	31DEC9999	Y	Left and right ventricular assist device, removal of, as an independent procedure, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38627, 38816, 38828 or 45503 applies (H)
38627	01JUL1998	30JUN2021	N	EXTRA-CORPOREAL MEMBRANE OXYGENATION, BYPASS OR VENTRICULAR ASSIST DEVICE CANNULAE, adjustment and re-positioning of, by open operation, in patients supported by these devices
38627	01JUL2021	28FEB2023	N	EXTRA-CORPOREAL MEMBRANE OXYGENATION, BYPASS OR VENTRICULAR ASSIST DEVICE CANNULAE, adjustment and re-positioning of, by open operation, in patients supported by these devices, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38627, 38806 or 45503 applies (H)
38627	01MAR2023	31DEC9999	Y	Extra-corporeal membrane oxygenation, bypass or ventricular assist device cannulae, adjustment and re-positioning of, by open operation, in patients supported by these devices, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38627, 38816, 38828 or 45503 applies (H)
38637	01NOV1995	30JUN2021	N	PATENT DISEASED coronary artery bypass vein graft or grafts, dissection, disconnection and oversewing of
38637	01JUL2021	28FEB2023	N	PATENT DISEASED coronary artery bypass vein graft or grafts, dissection, disconnection and oversewing of, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38637	01MAR2023	31DEC9999	Y	Patent diseased coronary artery bypass vein graft or grafts, dissection, disconnection and oversewing of, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38640	01NOV1992	31OCT1993	N	RE-OPERATION RE-OPERATION via median sternotomy, for any procedure
38640	01NOV1993	31DEC9999	Y	RE-OPERATION via median sternotomy, for any procedure, including any divisions of adhesions where the time taken to divide the adhesions is 45 minutes or less
38643	01NOV1995	30JUN2021	N	THORACOTOMY OR STERNOTOMY involving division of adhesions where the time taken to divide the adhesions exceeds 45 minutes
38643	01JUL2021	31DEC2021	N	Re-operation via thoracotomy or sternotomy, by any procedure: (a) including any division of adhesions if the time taken to divide the adhesions exceeds 30 minutes; and (b) other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38643	01JAN2022	31DEC9999	Y	Thoracotomy or sternotomy, by any procedure: (a) including any division of adhesions if the time taken to divide the adhesions exceeds 30 minutes; and (b) other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38647	01NOV1995	31DEC9999	Y	THORACOTOMY OR STERNOTOMY involving division of extensive adhesions where the time taken to divide the adhesions exceeds 2 hours
38650	01NOV1992	31DEC9999	Y	MYOMECTOMY or MYOTOMY for hypertrophic obstructive cardiomyopathy
38653	01NOV1992	30JUN2021	N	OPEN HEART SURGERY, not being a service to which another item in this Group applies
38653	01JUL2021	28FEB2023	N	Open heart surgery, other than a service: (a) to which another item in this Group applies; or (b) associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38653	01MAR2023	31DEC9999	Y	Open heart surgery, other than a service: (a) to which another item in this Group applies; or (b) associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38654	01MAY2006	30JUN2014	N	PERMANENT LEFT VENTRICULAR ELECTRODE, insertion, removal or replacement of via open thoracotomy, for the purpose of cardiac resynchronisation therapy, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: - sinus rhythm - a left ventricular ejection fraction of less than or equal to 35% - a QRS duration greater than or equal to 120ms.
38654	01JUL2014	31DEC9999	Y	Permanent left ventricular electrode, insertion, removal or replacement of via open thoracotomy, for the purpose of cardiac resynchronisation therapy, for a patient who: (a) has: (i) moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 120 ms; or (b) has: (i) mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii) sinus rhythm; and (iii) a left ventricular ejection fraction of less than or equal to 35%; and (iv) a QRS duration greater than or equal to 150 ms; or (c) satisfied the requirements mentioned in paragraph (a) or (b) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode
38656	01NOV1992	30JUN2021	N	THORACOTOMY or median sternotomy for post-operative bleeding
38656	01JUL2021	31DEC9999	Y	THORACOTOMY or median sternotomy for post-operative bleeding, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38659	01NOV1992	31DEC9999	Y	THORACOTOMY or STERNOTOMY involving division of adhesions where the time taken to divide the adhesions exceeds 45 minutes
38662	01NOV1992	31DEC9999	Y	CARDIAC TUMOURS THORACOTOMY or STERNOTOMY involving division of extensive adhesions where the time taken to divide the adhesions exceeds 2 hours
38670	01NOV1995	30JUN2021	N	CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, without patch or conduit reconstruction
38670	01JUL2021	28FEB2023	N	CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, without patch or conduit reconstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38670	01MAR2023	31DEC9999	Y	Cardiac tumour, excision of, involving the wall of the atrium or inter-atrial septum, without patch or conduit reconstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38673	01NOV1995	30JUN2021	N	CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, requiring reconstruction with patch or conduit
38673	01JUL2021	28FEB2023	N	CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, requiring reconstruction with patch or conduit, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38673	01MAR2023	31DEC9999	Y	Cardiac tumour, excision of, involving the wall of the atrium or inter-atrial septum, requiring reconstruction with patch or conduit, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38677	01NOV1995	30JUN2021	N	CARDIAC TUMOUR arising from ventricular myocardium, partial thickness excision of
38677	01JUL2021	28FEB2023	N	CARDIAC TUMOUR arising from ventricular myocardium, partial thickness excision of, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38677	01MAR2023	31DEC9999	Y	Cardiac tumour arising from ventricular myocardium, partial thickness excision of, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38680	01NOV1995	30JUN2021	N	CARDIAC TUMOUR arising from ventricular myocardium, full thickness excision of including repair or reconstruction
38680	01JUL2021	28FEB2023	N	CARDIAC TUMOUR arising from ventricular myocardium, full thickness excision of including repair or reconstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38680	01MAR2023	30JUN2023	N	Cardiac tumour arising from ventricular myocardium, full thickness excision of including repair or reconstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies
38680	01JUL2023	31DEC9999	Y	Cardiac tumour arising from ventricular myocardium, full thickness excision of including repair or reconstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38700	01NOV1992	30JUN1995	N	CONGENITAL CARDIAC SURGERY PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38700	01JUL1995	30JUN2021	N	PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease
38700	01JUL2021	28FEB2023	N	PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38700	01MAR2023	31DEC9999	Y	Patent ductus arteriosus, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38703	01NOV1992	30JUN1995	N	PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38703	01JUL1995	30JUN2021	N	PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease
38703	01JUL2021	28FEB2023	N	Patent ductus arteriosus, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38703	01MAR2023	31DEC9999	Y	Patent ductus arteriosus, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38706	01NOV1992	30JUN1995	N	AORTA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38706	01JUL1995	30JUN2021	N	AORTA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease
38706	01JUL2021	28FEB2023	N	AORTA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38706	01MAR2023	31DEC9999	Y	Aorta, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38709	01NOV1992	30JUN1995	N	AORTA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38709	01JUL1995	30JUN2021	N	AORTA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease
38709	01JUL2021	28FEB2023	N	Anastomosis or repair of aorta, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38709	01MAR2023	31DEC9999	Y	Anastomosis or repair of aorta, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38712	01NOV1992	30JUN1995	N	AORTIC INTERRUPTION, repair of, for congenital heart disease (Ministerial Determination)
38712	01JUL1995	31DEC9999	Y	AORTIC INTERRUPTION, repair of, for congenital heart disease
38715	01NOV1992	30JUN1995	N	MAIN PULMONARY ARTERY, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38715	01JUL1995	30JUN2021	N	MAIN PULMONARY ARTERY, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease
38715	01JUL2021	28FEB2023	N	MAIN PULMONARY ARTERY, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38715	01MAR2023	31DEC9999	Y	Main Pulmonary Artery, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38718	01NOV1992	30JUN1995	N	MAIN PULMONARY ARTERY, banding, debanding or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38718	01JUL1995	30JUN2021	N	MAIN PULMONARY ARTERY, banding, debanding or repair of, with cardiopulmonary bypass, for congenital heart disease
38718	01JUL2021	28FEB2023	N	Banding, debanding or repair of main pulmonary artery, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38718	01MAR2023	31DEC9999	Y	Banding, debanding or repair of main pulmonary artery, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38721	01NOV1992	30JUN1995	N	VENA CAVA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38721	01JUL1995	30JUN2021	N	VENA CAVA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease
38721	01JUL2021	28FEB2023	N	VENA CAVA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38721	01MAR2023	31DEC9999	Y	Vena Cava, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38724	01NOV1992	30JUN1995	N	VENA CAVA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38724	01JUL1995	30JUN2021	N	VENA CAVA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease
38724	01JUL2021	28FEB2023	N	Vena cava, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38724	01MAR2023	31DEC9999	Y	Vena cava, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38727	01NOV1992	30JUN1995	N	INTRATHORACIC VESSELS, anastomosis or repair of, without cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease (Ministerial Determination)
38727	01JUL1995	30JUN2021	N	INTRATHORACIC VESSELS, anastomosis or repair of, without cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease
38727	01JUL2021	31JUL2021	N	Anastomosis or repair of intrathoracic vessels, without cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721, 38724, 38806 or 45503 applies (H)
38727	01AUG2021	28FEB2023	N	Anastomosis or repair of intrathoracic vessels, without cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38700, 38703, 38706, 38709, 38715, 38718, 38721, 38724, 38806 or 45503 applies (H)
38727	01MAR2023	31DEC9999	Y	Anastomosis or repair of intrathoracic vessels, without cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38700, 38703, 38706, 38709, 38715, 38718, 38721, 38724, 38816, 38828 or 45503 applies (H)
38730	01NOV1992	30JUN1995	N	INTRATHORACIC VESSELS, anastomosis or repair of, with cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease (Ministerial Determination)
38730	01JUL1995	30JUN2021	N	INTRATHORACIC VESSELS, anastomosis or repair of, with cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease
38730	01JUL2021	31OCT2021	N	Anastomosis or repair of intrathoracic vessels, with cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721, 38724, 38806 or 45503 applies (H)
38730	01NOV2021	28FEB2023	N	Anastomosis or repair of intrathoracic vessels, with cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38700, 38703, 38706, 38709, 38715, 38718, 38721, 38724, 38806 or 45503 applies (H)
38730	01MAR2023	31DEC9999	Y	Anastomosis or repair of intrathoracic vessels, with cardiopulmonary bypass, performed as a primary procedure, other than a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38700, 38703, 38706, 38709, 38715, 38718, 38721, 38724, 38816, 38828 or 45503 applies (H)
38733	01NOV1992	30JUN1995	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38733	01JUL1995	30JUN2021	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, without cardiopulmonary bypass, for congenital heart disease
38733	01JUL2021	28FEB2023	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38733	01MAR2023	31DEC9999	Y	Systemic pulmonary or Cavo-pulmonary shunt, creation of, without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38736	01NOV1992	30JUN1995	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38736	01JUL1995	30JUN2021	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, with cardiopulmonary bypass, for congenital heart disease
38736	01JUL2021	28FEB2023	N	SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38736	01MAR2023	31DEC9999	Y	Systemic pulmonary or Cavo-pulmonary shunt, creation of, with cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38739	01NOV1992	30JUN1995	N	ATRIAL SEPTECTOMY, with or without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination)
38739	01JUL1995	30JUN2021	N	ATRIAL SEPTECTOMY, with or without cardiopulmonary bypass, for congenital heart disease
38739	01JUL2021	28FEB2023	N	Atrial septectomy, with or without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38739	01MAR2023	31DEC9999	Y	Atrial septectomy, with or without cardiopulmonary bypass, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38742	01NOV1992	30JUN1995	N	ATRIAL SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease (Ministerial Determination)
38742	01JUL1995	30APR2002	N	ATRIAL SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease
38742	01MAY2002	30JUN2021	N	ATRIAL SEPTAL DEFECT, closure by open exposure direct suture or patch, for congenital heart disease
38742	01JUL2021	28FEB2023	N	Atrial septal defect, closure by open exposure and direct suture or patch, for congenital heart disease in a patient with documented evidence of right heart overload or paradoxical embolism, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38742	01MAR2023	31DEC9999	Y	Atrial septal defect, closure by open exposure and direct suture or patch, for congenital heart disease in a patient with documented evidence of right heart overload or paradoxical embolism, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38743	01NOV2004	31DEC9999	Y	ATRIAL SEPTAL DEFECT closure, with septal occluder or other similar device, by transcatheter approach
38745	01NOV1992	30JUN1995	N	INTRA-ATRIAL BAFFLE, insertion of, for congenital heart disease (Ministerial Determination)
38745	01JUL1995	30JUN2021	N	INTRA-ATRIAL BAFFLE, insertion of, for congenital heart disease
38745	01JUL2021	28FEB2023	N	INTRA-ATRIAL BAFFLE, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38745	01MAR2023	31DEC9999	Y	Intra-atrial baffle, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38748	01NOV1992	30JUN1995	N	VENTRICULAR SEPTECTOMY, for congenital heart disease (Ministerial Determination)
38748	01JUL1995	30JUN2021	N	VENTRICULAR SEPTECTOMY, for congenital heart disease
38748	01JUL2021	28FEB2023	N	VENTRICULAR SEPTECTOMY, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38748	01MAR2023	31DEC9999	Y	Ventricular septectomy, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38751	01NOV1992	30JUN1995	N	VENTRICULAR SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease (Ministerial Determination)
38751	01JUL1995	30JUN2014	N	VENTRICULAR SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease
38751	01JUL2014	30JUN2021	N	Ventricular septal defect, closure by direct suture or patch
38751	01JUL2021	28FEB2023	N	Ventricular septal defect, closure by direct suture or patch, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38751	01MAR2023	31DEC9999	Y	Ventricular septal defect, closure by direct suture or patch, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38754	01NOV1992	30JUN1995	N	INTRAVENTRICULAR BAFFLE OR CONDUIT, insertion of, for congenital heart disease (Ministerial Determination)
38754	01JUL1995	30JUN2021	N	INTRAVENTRICULAR BAFFLE OR CONDUIT, insertion of, for congenital heart disease
38754	01JUL2021	28FEB2023	N	INTRAVENTRICULAR BAFFLE OR CONDUIT, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38754	01MAR2023	31DEC9999	Y	Intraventricular baffle or conduit, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38757	01NOV1992	30JUN1995	N	EXTRACARDIAC CONDUIT, insertion of, for congenital heart disease (Ministerial Determination)
38757	01JUL1995	30JUN2021	N	EXTRACARDIAC CONDUIT, insertion of, for congenital heart disease
38757	01JUL2021	28FEB2023	N	EXTRACARDIAC CONDUIT, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38757	01MAR2023	31DEC9999	Y	Extracardiac conduit, insertion of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38760	01NOV1992	30JUN1995	N	EXTRACARDIAC CONDUIT, replacement of, for congenital heart disease (Ministerial Determination)
38760	01JUL1995	30JUN2021	N	EXTRACARDIAC CONDUIT, replacement of, for congenital heart disease
38760	01JUL2021	28FEB2023	N	EXTRACARDIAC CONDUIT, replacement of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38760	01MAR2023	31DEC9999	Y	Extracardiac conduit, replacement of, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38763	01NOV1992	30JUN1995	N	VENTRICULAR MYECTOMY, for relief of ventricular obstruction, right or left, for congenital heart disease (Ministerial Determination)
38763	01JUL1995	31DEC9999	Y	VENTRICULAR MYECTOMY, for relief of ventricular obstruction, right or left, for congenital heart disease
38764	01JUL2021	28FEB2023	N	Ventricular myectomy, for relief of right or left ventricular obstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38764	01MAR2023	31DEC9999	Y	Ventricular myectomy, for relief of right or left ventricular obstruction, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38766	01NOV1992	30JUN1995	N	VENTRICULAR AUGMENTATION, right or left, for congenital heart disease (Ministerial Determination)
38766	01JUL1995	30JUN2021	N	VENTRICULAR AUGMENTATION, right or left, for congenital heart disease
38766	01JUL2021	28FEB2023	N	VENTRICULAR AUGMENTATION, right or left, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38418, 38806 or 45503 applies (H)
38766	01MAR2023	31DEC9999	Y	Ventricular augmentation, right or left, for congenital heart disease, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18260, 33824, 38816, 38828 or 45503 applies (H)
38800	01NOV2005	31DEC9999	Y	THORACIC CAVITY, aspiration of, for diagnostic purposes, not being a service associated with a service to which item 38803 applies
38803	01NOV2005	31DEC9999	Y	THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample
38806	01NOV2005	31DEC9999	Y	INTERCOSTAL DRAIN, insertion of, not involving resection of rib (excluding aftercare)
38809	01NOV2005	31DEC9999	Y	INTERCOSTAL DRAIN, insertion of, with pleurodesis and not involving resection of rib (excluding aftercare)
38812	01NOV2005	31DEC9999	Y	PERCUTANEOUS NEEDLE BIOPSY of lung
38815	01MAR2023	29FEB2024	N	Thoracoscopy, with or without division of pleural adhesions, with or without biopsy, including insertion of intercostal catheter where necessary, other than a service associated with a service to which item 18258, 18260, 38816 or 38828 applies (H)
38815	01MAR2024	31DEC9999	Y	Thoracoscopy, with or without division of pleural adhesions, with or without biopsy, including insertion of intercostal catheter where necessary, other than a service associated with: (a) a service to which item 18258, 18260 or 38828 applies; or (b) a service to which item 38816 applies that is performed on the same lung (H)
38816	01MAR2023	29FEB2024	N	Thoracotomy, exploratory, with or without biopsy, including insertion of an intercostal catheter where necessary, other than a service associated with a service to which item 18258, 18260, 38815 or 38828 applies (H)
38816	01MAR2024	31DEC9999	Y	Thoracotomy, exploratory, with or without biopsy, including insertion of an intercostal catheter where necessary, other than a service associated with: (a) a service to which item 18258, 18260 or 38828 applies; or (b) a service to which item 38815 applies that is performed on the same lung (H)
38817	01MAR2023	31DEC9999	Y	Thoracotomy, thoracoscopy or sternotomy, by any procedure: (a) including any division of adhesions if the time taken to divide the adhesions exceeds 30 minutes; and (b) other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18258, 18260, 33824, 38815, 38816, 38818, 38828 or 45503 applies (H)
38818	01MAR2023	31DEC9999	Y	Thoracotomy, thoracoscopy or median sternotomy for post operative bleeding, other than a service associated with a service to which item 11704, 11705, 11707, 11714, 18258, 18260, 33824, 38815, 38816, 38817, 38828 or 45503 applies (H)
38820	01MAR2023	31DEC9999	Y	Lung, wedge resection of, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38820, 38821 or 38828 applies (H)
38821	01MAR2023	31DEC9999	Y	Lung, wedge resection of, 2 or more wedges, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38820 or 38828 applies (H)
38822	01MAR2023	31DEC9999	Y	Pneumonectomy, lobectomy, bilobectomy or segmentectomy, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38823, 38824 or 38828 applies (H)
38823	01MAR2023	31DEC9999	Y	Radical lobectomy, pneumonectomy, bilobectomy, segmentectomy or formal mediastinal node dissection (greater than 4 nodes), other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38822, 38824 or 38828 applies (H)
38824	01MAR2023	31DEC9999	Y	Segmentectomy, lobectomy, bilobectomy or pneumonectomy, including resection of chest wall, diaphragm, pericardium, and formal mediastinal node dissection (greater than 4 nodes), other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38822, 38823 or 38828 applies (H)
38828	01MAR2023	31DEC9999	Y	Intercostal drain, insertion of: (a) not involving resection of rib; and (b) excluding aftercare; and (c) other than a service associated with a service to which item 38815, 38816, 38829, 38830, 38831, 38832, 38833 or 38834 applies
38829	01MAR2023	31DEC9999	Y	Intercostal drain, insertion of, with pleurodesis: (a) not involving resection of rib; and (b) excluding aftercare; and (c) other than a service associated with a service to which item 38815, 38816, 38828, 38830, 38831, 38832, 38833 or 38834 applies
38830	01MAR2023	31DEC9999	Y	Empyema, radical operation for, involving resection of rib, other than a service associated with a service to which item 38828, 38829, 38831, 38832, 38833 or 38834 applies (H)
38831	01MAR2023	31DEC9999	Y	Thoracoscopy or thoracotomy and drainage of paraneumonic effusion and empyema, exploratory, with or without biopsy, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 38832, 38833 or 38834 applies (H)
38832	01MAR2023	31DEC9999	Y	Thoracotomy or thoracoscopy, with pulmonary decortication, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 38831, 38833 or 38834 applies (H)
38833	01MAR2023	31DEC9999	Y	Thoracotomy or thoracoscopy, with pleurectomy or pleurodesis, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 38831, 38832 or 38834 applies (H)
38834	01MAR2023	31DEC9999	Y	Thoracotomy and radical extra pleural pneumonectomy or radical lung preserving decortication and pleurectomy for malignancy, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38829, 38830, 38831, 38832 or 38833 applies (H)
38837	01MAR2023	31DEC9999	Y	Mediastinum, cervical exploration of, with or without biopsy, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38838	01MAR2023	31DEC9999	Y	Thoracotomy or thoracoscopy or sternotomy, for removal of thymus or mediastinal tumour, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38839	01MAR2023	31DEC9999	Y	Pericardium, subxiphoid open surgical drainage of, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38840 applies (H)
38840	01MAR2023	31DEC9999	Y	Pericardium, transthoracic (thoracotomy or thoracoscopy) open surgical drainage of, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38839 applies (H)
38841	01MAR2023	31DEC9999	Y	Pericardiectomy via sternotomy or thoracoscopy or anterolateral thoracotomy without cardiopulmonary bypass, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38842	01MAR2023	31DEC9999	Y	Pericardiectomy via sternotomy or anterolateral thoracotomy with cardiopulmonary bypass, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38845	01MAR2023	31DEC9999	Y	Sternal wire or wires, removal of, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38846	01MAR2023	31DEC9999	Y	Pectus excavatum or pectus carinatum, repair or radical correction of, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38847, 38848 or 38849 applies (H)
38847	01MAR2023	31DEC9999	Y	Pectus excavatum, repair of, with implantation of subcutaneous prosthesis, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38846, 38848 or 38849 applies (H)
38848	01MAR2023	31DEC9999	Y	Pectus excavatum, repair of, with insertion of a concave bar, by any method, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38846 or 38847 applies (H)
38849	01MAR2023	31DEC9999	Y	Pectus excavatum, removal of a concave bar, by any method, not being a service associated with a service to which item 18258, 18260, 38815, 38816, 38828, 38846 or 38847 applies (H)
38850	01MAR2023	31DEC9999	Y	Sternotomy wound, debridement of, not involving reopening of the mediastinum, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38851 applies (H)
38851	01MAR2023	31DEC9999	Y	Sternotomy wound, debridement of, involving curettage of infected bone, with or without removal of wires, but not involving reopening of the mediastinum, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38850 applies (H)
38852	01MAR2023	31DEC9999	Y	Sternum, reoperation on, for dehiscence or infection involving reopening of the mediastinum, with or without rewiring, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38853 applies (H)
38853	01MAR2023	31DEC9999	Y	Sternum and mediastinum, reoperation for infection of, involving muscle advancement flaps and/or greater omentum, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38828 or 38852 applies (H)
38857	01MAR2023	31DEC9999	Y	Chest wall resection, sternum and/or ribs without reconstruction, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38824, 38828 or 38858 applies (H)
38858	01MAR2023	31DEC9999	Y	Chest wall resection, sternum and / or ribs with reconstruction, other than a service associated with a service to which item 18258, 18260, 38815, 38816, 38824, 38828 or 38857 applies (H)
38859	01MAR2023	29FEB2024	N	Plating of multiple ribs for flail segment, other than a service associated with a service to which item 18258, 18260, 33815, 38816 or 38828 applies (H)
38859	01MAR2024	31DEC9999	Y	Plating of multiple ribs for flail segment, other than a service associated with a service to which item 18258, 18260, 38815, 38816 or 38828 applies (H)
38864	01MAR2023	31DEC9999	Y	Intrathoracic operations on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum, or on more than one of those organs, not being a service to which another item in this Group applies, other than a service associated with a service to which item 18258, 18260 or 38828 applies (H)
39000	01DEC1991	31OCT1993	N	GENERAL LUMBAR PUNCTURE, or spinal or epidural injection, not being a service to which item 18200 applies
39000	01NOV1993	31DEC9999	Y	LUMBAR PUNCTURE
39003	01DEC1991	31DEC9999	Y	CISTERNAL PUNCTURE
39006	01DEC1991	31DEC9999	Y	VENTRICULAR PUNCTURE (not including burr-hole)
39007	01NOV2020	31DEC9999	Y	Procedure to obtain access to intracranial space (including subdural space, ventricle or basal cistern), percutaneously or by burr-hole
39009	01DEC1991	31DEC9999	Y	SUBDURAL HAEMORRHAGE, tap for, each tap
39012	01DEC1991	31DEC9999	Y	BURR-HOLE, single, preparatory to ventricular puncture or for inspection purpose - not being a service to which another item applies
39013	01JUL1993	28FEB2022	N	INJECTION UNDER IMAGE INTENSIFICATION with 1 or more of contrast media, local anaesthetic or corticosteroid into 1 or more zygo-apophyseal or costo-transverse joints or 1 or more primary posterior rami of spinal nerves
39013	01MAR2022	31DEC9999	Y	Injection of one or more zygo-apophyseal or costo-transverse joints with one or more of contrast media, local anaesthetic or corticosteroid under image guidance
39014	01MAR2022	31DEC9999	Y	Medial branch block of one or more primary posterior rami, injection of an anaesthetic agent under image guidance
39015	01DEC1991	30JUN1993	N	VENTRICULAR RESERVOIR or intracranial pressure monitoring device, insertion of -including burr-hole (excluding after-care)
39015	01JUL1993	31OCT2020	N	VENTRICULAR RESERVOIR, EXTERNAL VENTRICULAR DRAIN or INTRACRANIAL PRESSURE MONITORING DEVICE, insertion of - including burr-hole (excluding after-care)
39015	01NOV2020	31DEC9999	Y	Intracranial parenchymal pressure monitoring device, insertion of-including burr hole (excluding after care)
39018	01DEC1991	31OCT2020	N	CEREBROSPINAL FLUID reservoir, insertion of
39018	01NOV2020	31DEC9999	Y	Cerebrospinal reservoir, ventricular reservoir or external ventricular drain, insertion of, with or without stereotaxy
39100	01DEC1991	28FEB2022	N	INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance
39100	01MAR2022	31DEC9999	Y	Injection of primary branch of trigeminal nerve (ophthalmic, maxillary or mandibular branches) with alcohol, cortisone, phenol, or similar neurolytic substance, under image guidance
39103	01DEC1991	31DEC9999	Y	INTRATHECAL INJECTION of alcohol or phenol
39106	01DEC1991	31DEC9999	Y	NEURECTOMY, INTRACRANIAL, for trigeminal neuralgia
39109	01DEC1991	31OCT2020	N	TRIGEMINAL GANGLIOTOMY by radiofrequency, balloon or glycerol
39109	01NOV2020	31DEC9999	Y	Trigeminal gangliotomy by radiofrequency, balloon or glycerol, including stereotaxy
39110	01MAR2022	10APR2022	N	Left lumbar percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control, applicable not more than 3 times in a 12 month period
39110	11APR2022	31DEC9999	Y	Left lumbar percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39111	01MAR2022	10APR2022	N	Right lumbar percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control, applicable not more than 3 times in a 12 month period
39111	11APR2022	31DEC9999	Y	Right lumbar percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39112	01DEC1991	31DEC9999	Y	CRANIAL NERVE, intracranial decompression of, using microsurgical techniques
39113	01NOV2020	31DEC9999	Y	Cranial nerve, neurectomy or intracranial decompression of, using microsurgical techniques, including stereotaxy and cranioplasty
39115	01DEC1991	30JUN1993	N	PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on 1 or more occasions within a 30 day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy
39115	01JUL1993	31DEC9999	Y	PERCUTANEOUS NEUROTOMY of posterior divisions (or rami) of spinal nerves by any method, including any associated spinal, epidural or regional nerve block (payable once only in a 30 day period)
39116	01MAR2022	10APR2022	N	Left thoracic percutaneous zygapophyseal joint denervation by radio-frequency probe or cryoprobe using radiological imaging control, applicable not more than 3 times in a 12 month period
39116	11APR2022	31DEC9999	Y	Left thoracic percutaneous zygapophyseal joint denervation by radio-frequency probe or cryoprobe using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39117	01MAR2022	10APR2022	N	Right thoracic percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control, applicable not more than 3 times in a 12 month period
39117	11APR2022	31DEC9999	Y	Right thoracic percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39118	01DEC1991	28FEB2022	N	PERCUTANEOUS NEUROTOMY for facet joint denervation by radio-frequency probe or cryoprobe using radiological imaging control
39118	01MAR2022	10APR2022	N	Left cervical percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control, applicable not more than 3 times in a 12 month period
39118	11APR2022	31DEC9999	Y	Left cervical percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39119	01MAR2022	10APR2022	N	Right cervical percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control, applicable not more than 3 times in a 12 month period
39119	11APR2022	31DEC9999	Y	Right cervical percutaneous zygapophyseal joint denervation by radio-frequency probe, or cryoprobe, using radiological imaging control Applicable to one or more services provided in a single attendance, for not more than 3 attendances in a 12 month period
39121	01DEC1991	31DEC9999	Y	PERCUTANEOUS CORDOTOMY
39124	01DEC1991	31OCT2006	N	CORDOTOMY OR MYELOTOMY, laminectomy for, or operation for dorsal root entry zone (Drez) lesion
39124	01NOV2006	31DEC9999	Y	CORDOTOMY OR MYELOTOMY, partial or total laminectomy for, or operation for dorsal root entry zone (Drez) lesion
39125	01JUL1993	30APR2005	N	SPINAL CATHETER, insertion of - for an automated infusion device
39125	01MAY2005	28FEB2022	N	Intrathecal or epidural SPINAL CATHETER insertion or replacement of, and connection to a subcutaneous implanted infusion pump, for the management of chronic intractable pain
39125	01MAR2022	31DEC9999	Y	Spinal catheter, insertion or replacement of, and connection to a subcutaneous implanted infusion pump, for the management of chronic pain, including cancer pain (H)
39126	01JUL1993	30APR2005	N	AUTOMATED SUBCUTANEOUS INFUSION DEVICE, insertion of
39126	01MAY2005	28FEB2022	N	INFUSION PUMP, subcutaneous implantation or replacement of, and connection of the pump to an intrathecal or epidural catheter, and filling of reservoir with a therapeutic agent or agents, with or without programming the pump, for the management of chronic intractable pain
39126	01MAR2022	31DEC9999	Y	All of the following:(a) infusion pump, subcutaneous implantation or replacement of;(b) connection of the pump to a spinal catheter;(c) filling of reservoir with a therapeutic agent or agents;with or without programming the pump, for the management of chronic pain, including cancer pain (H)
39127	01DEC1991	30APR2005	N	SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER FOR PAIN, insertion of
39127	01MAY2005	28FEB2022	N	SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER, insertion of, for the management of chronic intractable pain
39127	01MAR2022	31DEC9999	Y	Subcutaneous reservoir and spinal catheter, insertion of, for the management of chronic pain, including cancer pain (H)
39128	01JUL1993	30APR2005	N	AUTOMATED SUBCUTANEOUS INFUSION DEVICE AND SPINAL CATHETER, insertion of
39128	01MAY2005	28FEB2022	N	INFUSION PUMP, subcutaneous implantation of, AND intrathecal or epidural SPINAL CATHETER insertion of, and connection of pump to catheter, and filling of reservoir with a therapeutic agent or agents, with or without programming the pump, for the management of chronic intractable pain
39128	01MAR2022	31DEC9999	Y	All of the following:(a) infusion pump, subcutaneous implantation of;(b) spinal catheter, insertion of;(c) connection of pump to catheter;(d) filling of reservoir with a therapeutic agent or agents;with or without programming the pump, for the management of chronic pain, including cancer pain (H)
39129	01MAR2022	31DEC9999	Y	Peripheral lead or leads, percutaneous placement of, including intraoperative test stimulation, for the management of chronic neuropathic pain (H)
39130	01DEC1991	30JUN1993	N	PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, insertion of (1 or 2 stages), not involving laminectomy
39130	01JUL1993	31OCT2004	N	PERCUTANEOUS EPIDURAL ELECTRODE, insertion of 1 or more of - for spinal stimulation
39130	01NOV2004	28FEB2022	N	EPIDURAL LEAD, percutaneous placement of, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, to a maximum of 4 leads
39130	01MAR2022	31DEC9999	Y	Epidural lead or leads, percutaneous placement of, including intraoperative test stimulation, for the management of chronic neuropathic pain or pain from refractory angina pectoris (H)
39131	01JUL1993	31OCT2004	N	PERCUTANEOUS EPIDURAL ELECTRODES, management, adjustment, electronic programming and trial of stimulation of, by a medical practitioner - each day
39131	01NOV2004	28FEB2022	N	ELECTRODES, epidural or peripheral nerve, management of patient and adjustment or reprogramming of neurostimulator by a medical practitioner, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris - each day
39131	01MAR2022	31DEC9999	Y	Epidural or peripheral nerve electrodes (management, adjustment, or reprogramming of neurostimulator), with a medical practitioner attending, for the management of chronic neuropathic pain or pain from refractory angina pectoris-each day
39133	01DEC1991	31OCT2004	N	EPIDURAL STIMULATOR or INTRATHECAL INFUSION DEVICE, revision of
39133	01NOV2004	30APR2005	N	SPINAL INFUSION DEVICE, revision of
39133	01MAY2005	28FEB2022	N	Removal of subcutaneously IMPLANTED INFUSION PUMP OR removal or repositioning of intrathecal or epidural SPINAL CATHETER, for the management of chronic intractable pain
39133	01MAR2022	31DEC9999	Y	Either:(a) subcutaneously implanted infusion pump, removal of; or(b) spinal catheter, removal or repositioning of;for the management of chronic pain, including cancer pain (H)
39134	01JUL1993	31OCT2002	N	SPINAL NEUROSTIMULATOR RECEIVER or pulse generator, subcutaneous placement of
39134	01NOV2002	31OCT2004	N	SPINAL NEUROSTIMULATOR RECEIVER or pulse generator, subcutaneous placement of, not being a service associated with deep brain stimulation for Parkinson's disease
39134	01NOV2004	28FEB2022	N	NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, including placement and connection of extension wires to epidural or peripheral nerve electrodes, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris
39134	01MAR2022	31DEC9999	Y	Neurostimulator or receiver, subcutaneous placement of, including placement and connection of extension wires to epidural or peripheral nerve electrodes, for the management of chronic neuropathic pain or pain from refractory angina pectoris (H)
39135	01NOV2004	28FEB2022	N	NEUROSTIMULATOR or RECEIVER, that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, removal of, performed in the operating theatre of a hospital
39135	01MAR2022	31DEC9999	Y	Neurostimulator or receiver that was inserted for the management of chronic neuropathic pain or pain from refractory angina pectoris, open surgical removal of, performed in the operating theatre of a hospital (H)
39136	01DEC1991	30JUN1993	N	PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, removal of
39136	01JUL1993	31OCT2004	N	PERCUTANEOUS EPIDURAL IMPLANT for management of pain, removal of
39136	01NOV2004	28FEB2022	N	LEAD, epidural or peripheral nerve that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, removal of, performed in the operating theatre of a hospital
39136	01MAR2022	31DEC9999	Y	Epidural or peripheral nerve lead that was implanted for the management of chronic neuropathic pain or pain from refractory angina pectoris, open surgical removal of, performed in the operating theatre of a hospital (H)
39137	01NOV2004	28FEB2022	N	LEAD, epidural or peripheral nerve that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, surgical repositioning to correct displacement or unsatisfactory positioning, including intraoperative test stimulation, not being a service to which item 39130, 39138 or 39139 applies
39137	01MAR2022	31DEC9999	Y	Epidural or peripheral nerve lead that was implanted for the management of chronic neuropathic pain or pain from refractory angina pectoris, open surgical repositioning of, to correct displacement or unsatisfactory positioning, including intraoperative test stimulation, other than a service to which item 39130, 39138 or 39139 applies (H)
39138	01NOV2004	31OCT2005	N	PERIPHERAL NERVE LEAD, surgical placement of one or more, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris
39138	01NOV2005	28FEB2022	N	PERIPHERAL NERVE LEAD, surgical placement of, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, to a maximum of 4 leads
39138	01MAR2022	31DEC9999	Y	Peripheral nerve lead or leads, surgical placement of, including intraoperative test stimulation, for the management of chronic neuropathic pain where the leads are intended to remain in situ long term (H)
39139	01DEC1991	30JUN1993	N	EPIDURAL IMPLANT FOR PAIN, laminectomy and insertion of, including implantation of pulse generator (1 or 2 stages)
39139	01JUL1993	31OCT2004	N	EPIDURAL ELECTRODE for management of pain, insertion of 1 or more of by laminectomy, including implantation of pulse generator (1 or 2 stages)
39139	01NOV2004	31OCT2006	N	EPIDURAL LEAD, surgical placement of one or more by laminectomy, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris
39139	01NOV2006	28FEB2022	N	Epidural lead, surgical placement of one or more by partial or total laminectomy, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris-to a maximum of 4 leads (H)
39139	01MAR2022	31DEC9999	Y	Epidural lead, surgical placement of one or more of by partial or total laminectomy, including intraoperative test stimulation, for the management of chronic neuropathic pain or pain from refractory angina pectoris (H)
39140	01MAY1997	31DEC9999	Y	EPIDURAL CATHETER, insertion of, under imaging control, with epidurogram and epidural therapeutic injection for lysis of adhesions
39141	01NOV2022	31DEC9999	Y	Epidural or peripheral nerve electrodes (management, adjustment, or reprogramming of neurostimulator), with a medical practitioner attending remotely by video conference, for the management of chronic neuropathic pain or pain from refractory angina pectoris-each day
39300	01DEC1991	30JUN2021	N	CUTANEOUS NERVE (including digital nerve), primary repair of, using microsurgical techniques
39300	01JUL2021	31DEC9999	Y	Nerve, digital or cutaneous, primary repair of, using microsurgical techniques, other than a service associated with a service to which item 39330 applies-applicable once per nerve (H)
39303	01DEC1991	30JUN2021	N	CUTANEOUS NERVE (including digital nerve), secondary repair of, using microsurgical techniques
39303	01JUL2021	29FEB2024	N	Nerve, digital or cutaneous, delayed repair of, using microsurgical techniques, including either or both of the following (if performed): (a) neurolysis; (b) transposition of nerve to facilitate repair; other than a service associated with a service to which item 30023 applies-applicable once per nerve (H)
39303	01MAR2024	31DEC9999	Y	Nerve, digital or cutaneous, delayed repair of, using microsurgical techniques, including either or both of the following (if performed): (a) neurolysis; (b) transposition of nerve to facilitate repair; other than a service associated with a service to which item 30023 applies that is performed at the same site-applicable once per nerve (H)
39306	01DEC1991	30JUN2021	N	NERVE TRUNK, primary repair of, using microsurgical techniques
39306	01JUL2021	31DEC9999	Y	Nerve trunk, primary repair of, using microsurgical techniques, other than a service associated with a service to which item 39330 applies (H)
39307	01JUL2021	31DEC9999	Y	Reconstruction of nerve trunk using biological or synthetic nerve conduit, using microsurgical techniques, other than a service associated with a service to which item 39330 applies
39309	01DEC1991	30JUN2021	N	NERVE TRUNK, secondary repair of, using microsurgical techniques
39309	01JUL2021	29FEB2024	N	Nerve trunk, delayed repair of, using microsurgical techniques, including either or both of the following (if performed): (a) neurolysis; (b) transposition of nerve or nerve transfer to facilitate repair; other than a service associated with a service to which item 30023 or 39321 applies (H)
39309	01MAR2024	31DEC9999	Y	Nerve trunk, delayed repair of, using microsurgical techniques, including either or both of the following (if performed): (a) neurolysis; (b) transposition of nerve or nerve transfer to facilitate repair; other than a service associated with: (c) a service to which item 39321 applies; or (d) a service to which item 30023 applies that is performed at the same site (H)
39312	01DEC1991	30JUN2021	N	NERVE TRUNK, (interfascicular), neurolysis of, using microsurgical techniques
39312	01JUL2021	29FEB2024	N	Nerve trunk, internal (interfascicular), neurolysis of, using microsurgical techniques, other than a service associated with a service to which item 30023 applies (H)
39312	01MAR2024	31DEC9999	Y	Nerve trunk, internal (interfascicular), neurolysis of, using microsurgical techniques, other than a service associated with a service to which item 30023 applies that is performed at the same site (H)
39315	01DEC1991	30JUN2021	N	NERVE TRUNK, nerve graft to, (cable graft) including harvesting of nerve graft using microsurgical techniques
39315	01JUL2021	29FEB2024	N	Nerve trunk, nerve graft to, by cable graft, using microsurgical techniques, including any of the following (if performed): (a) harvesting of nerve graft; (b) proximal and distal anastomosis of nerve graft; (c) transposition of nerve to facilitate grafting; (d) neurolysis; other than a service associated with a service to which item 30023 or 39330 applies (H)
39315	01MAR2024	31DEC9999	Y	Nerve trunk, nerve graft to, by cable graft, using microsurgical techniques, including any of the following (if performed): (a) harvesting of nerve graft; (b) proximal and distal anastomosis of nerve graft; (c) transposition of nerve to facilitate grafting; (d) neurolysis; other than a service associated with: (e) a service to which item 39330 applies; or (f) a service to which item 30023 applies that is performed at the same site (H)
39318	01DEC1991	30JUN2021	N	CUTANEOUS NERVE (including digital nerve), nerve graft to, using microsurgical techniques
39318	01JUL2021	31DEC9999	Y	Nerve, digital or cutaneous, nerve graft to, using microsurgical techniques, including either or both of the following (if performed): (a) harvesting of nerve graft from separate donor site; (b) proximal and distal anastomosis of nerve graft; other than a service associated with a service to which item 39330 applies (H)
39319	01JUL2021	31DEC9999	Y	Reconstruction of digital or cutaneous nerve using biological or synthetic nerve conduit, using microsurgical techniques, other than a service associated with a service to which item 39330 applies
39321	01DEC1991	30JUN2021	N	NERVE, transposition of
39321	01JUL2021	14JUL2021	N	Transposition of nerve, excluding the ulnar nerve at the elbow, other than a service associated with a service to which item 39330 applies (H) (Anaes.) (Assist.)
39321	15JUL2021	31DEC9999	Y	Transposition of nerve, excluding the ulnar nerve at the elbow, other than a service associated with a service to which item 39330 applies (H)
39323	01JUL1993	31OCT2003	N	PERCUTANEOUS NEUROTOMY by cryoneurotomy or radiofrequency lesion generator, not being a service to which another item applies
39323	01NOV2003	28FEB2022	N	PERCUTANEOUS NEUROTOMY by cryotherapy or radiofrequency lesion generator, not being a service to which another item applies
39323	01MAR2022	31DEC9999	Y	Percutaneous denervation (excluding medial branch nerve) by cryotherapy or radiofrequency probe, other than a service to which another item applies, applicable not more than 6 times for a given nerve in a 12 month period
39324	01DEC1991	30JUN1993	N	NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve
39324	01JUL1993	30JUN2021	N	NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve, by open operation
39324	01JUL2021	31DEC9999	Y	Neurectomy or removal of tumour or neuroma from superficial peripheral nerve
39327	01DEC1991	30JUN1993	N	NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve
39327	01JUL1993	31OCT2006	N	NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve, by open operation
39327	01NOV2006	31DEC9999	Y	NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral or cranial nerve, by open operation, not being a service to which item 41575, 41576, 41578 or 41579 applies
39328	01JUL2021	31DEC9999	Y	Neurectomy, neurotomy or removal of tumour from deep peripheral nerve, by open operation, for upper limb surgery (H)
39329	01JUL2021	30JUN2023	N	Extensive neurolysis of radial, median or ulnar nerve trunk nerve in the forearm or arm, other than a service associated with a service to which item 30023, 39303, 39309, 39312, 39315, 39318, 39324, 39327 or 39333 applies
39329	01JUL2023	29FEB2024	N	Extensive neurolysis of radial, median or ulnar nerve trunk nerve in the forearm or arm, other than a service associated with a service to which item 30023, 39303, 39309, 39312, 39315, 39318, 39324 or 39327 applies
39329	01MAR2024	31DEC9999	Y	Extensive neurolysis of radial, median or ulnar nerve trunk nerve in the forearm or arm, other than a service associated with: (a) a service to which item 39303, 39309, 39312, 39315, 39318, 39324 or 39327 applies; or (b) a service to which item 30023 applies that is performed at the same site
39330	01DEC1991	30JUN2021	N	NEUROLYSIS by open operation without transposition, not being a service associated with a service to which item 39312 applies
39330	01JUL2021	29FEB2024	N	Neurolysis by open operation without transposition, other than a service associated with a service to which item 30023, 39321, 39328, 39329, 39332, 39336, 39339, 39342, 39345, 49774 or 49775 applies (H)
39330	01MAR2024	31DEC9999	Y	Neurolysis by open operation without transposition, other than a service associated with: (a) a service to which item 39321, 39328, 39329, 39332, 39336, 39339, 39342, 39345, 49774 or 49775 applies; or (b) a service to which item 30023 applies that is performed at the same site (H)
39331	01JUL1993	30JUN2021	N	CARPAL TUNNEL RELEASE (division of transverse carpal ligament), by any method
39331	01JUL2021	29FEB2024	N	Carpal tunnel release, including division of transverse carpal ligament or release of median nerve, by any method, including either or both of the following (if performed): (a) synovectomy; (b) neurolysis Other than a service associated with a service to which item 30023 or 46339 applies
39331	01MAR2024	31DEC9999	Y	Carpal tunnel release, including division of transverse carpal ligament or release of median nerve, by any method, including either or both of the following (if performed): (a) synovectomy; (b) neurolysis; other than a service associated with: (c) a service to which item 46339 applies; or (d) a service to which item 30023 applies that is performed at the same site
39332	01JUL2021	29FEB2024	N	Revision of carpal tunnel release, including division of transverse carpal ligament or release of median nerve, by any method, including either or both of the following (if performed): (a) synovectomy; (b) neurolysis; other than a service associated with a service to which item 30023 or 46339 applies.
39332	01MAR2024	31DEC9999	Y	Revision of carpal tunnel release, including division of transverse carpal ligament or release of median nerve, by any method, including either or both of the following (if performed): (a) synovectomy; (b) neurolysis; other than a service associated with: (c) a service to which item 46339 applies; or (d) a service to which item 30023 applies that is performed at the same site
39333	01DEC1991	31DEC9999	Y	BRACHIAL PLEXUS, exploration of, not being a service to which another item in this Group applies
39336	01JUL2021	29FEB2024	N	Ulnar nerve decompression at elbow or wrist (cubital tunnel or Guyon's canal) without transposition, by any method, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies
39336	01MAR2024	31DEC9999	Y	Ulnar nerve decompression at elbow or wrist (cubital tunnel or Guyons canal) without transposition, by any method, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
39339	01JUL2021	29FEB2024	N	Revision of ulnar nerve decompression at elbow (cubital tunnel) without transposition, by any method, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies
39339	01MAR2024	31DEC9999	Y	Revision of ulnar nerve decompression at elbow (cubital tunnel) without transposition, by any method, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
39342	01JUL2021	29FEB2024	N	Ulnar nerve decompression at elbow (cubital tunnel), including any of the following (if performed): (a) associated transposition; (b) subcutaneous or submuscular transposition of the nerve; (c) medial epicondylectomy; (d) ostetomy and reconstruction of the flexor origin; (e) neurolysis; other than a service associated with a service to which item 30023 applies
39342	01MAR2024	31DEC9999	Y	Ulnar nerve decompression at elbow (cubital tunnel), including any of the following (if performed): (a) associated transposition; (b) subcutaneous or submuscular transposition of the nerve; (c) medial epicondylectomy; (d) ostetomy and reconstruction of the flexor origin; (e) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site
39345	01JUL2021	29FEB2024	N	Localised decompression of radial, median or ulnar nerve, or branches of, in the forearm for compressive neuropathy, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies
39345	01MAR2024	31DEC9999	Y	Localised decompression of radial, median or ulnar nerve, or branches of, in the forearm for compressive neuropathy, including neurolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
39500	01DEC1991	31DEC9999	Y	VESTIBULAR NERVE, section of, via posterior fossa
39503	01DEC1991	31OCT2020	N	FACIO-HYPOGLOSSAL nerve or FACIO-ACCESSORY nerve, anastomosis of
39503	01NOV2020	31DEC9999	Y	Facio-hypoglossal nerve or facio-accessory nerve, anastomosis of
39600	01DEC1991	31DEC9999	Y	INTRACRANIAL HAEMORRHAGE, burr-hole craniotomy for - including burr-holes
39603	01DEC1991	31DEC9999	Y	INTRACRANIAL HAEMORRHAGE, osteoplastic craniotomy or extensive craniectomy and removal of haematoma
39604	01NOV2020	31DEC9999	Y	Any of the following procedures for intracranial haemorrhage or swelling: (a) craniotomy, craniectomy or burr-holes for removal of intracranial haemorrhage, including stereotaxy;(b) craniotomy or craniectomy for brain swelling, stroke, or raised intracranial pressure, including for subtemporal decompression, including stereotaxy; or(c) post-operative re-opening, including for swelling or post-operative cerebrospinal fluid leak.
39606	01DEC1991	31DEC9999	Y	FRACTURED SKULL, depressed or comminuted, operation for
39609	01DEC1991	31DEC9999	Y	FRACTURED SKULL, compound, without dural penetration, operation for
39610	01NOV2020	31DEC9999	Y	Fractured skull, without brain laceration or dural penetration, repair of
39612	01DEC1991	30JUN1993	N	FRACTURED SKULL, compound or complicated, with dural penetration and brain laceration, operation for
39612	01JUL1993	31OCT2020	N	FRACTURED SKULL, compound, depressed or complicated, with dural penetration and brain laceration, operation for
39612	01NOV2020	31DEC9999	Y	Fractured skull, with brain laceration or dural penetration but without cerebrospinal fluid, rhinorrhoea or otorrhoea, repair of
39615	01DEC1991	31OCT2015	N	FRACTURED SKULL with rhinorrhoea or otorrhoea, cranioplasty and repair of
39615	01NOV2015	31OCT2020	N	FRACTURED SKULL with rhinorrhoea or otorrhoea, repair of by cranioplasty or endoscopic approach
39615	01NOV2020	31DEC9999	Y	Fractured skull, after trauma, with cerebrospinal fluid rhinorrhoea or otorrhoea, repair of, including stereotaxy and dermofat graft
39638	01NOV2020	31DEC9999	Y	Anterior or middle cranial fossa or cavernous sinus, tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty-conjoint surgery, principal surgeon
39639	01NOV2020	31DEC9999	Y	Anterior or middle cranial fossa or cavernous sinus, tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty-conjoint surgery, co-surgeon
39640	01JUL1995	31DEC9999	Y	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving craniotomy, radical excision of the skull base, and dural repair
39641	01NOV2020	31DEC9999	Y	Anterior or middle cranial fossa or cavernous sinus, tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty - one surgeon
39642	01JUL1995	31OCT1995	N	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure), conjoint surgery, principal surgeon
39642	01NOV1995	31DEC9999	Y	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure)
39644	01JUL1995	31DEC9999	Y	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure), conjoint surgery, co-surgeon
39646	01JUL1995	31OCT1995	N	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve (intracranial procedure), conjoint surgery, principal surgeon
39646	01NOV1995	31DEC9999	Y	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve, (intracranial procedure)
39648	01JUL1995	31DEC9999	Y	TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve (intracranial procedure), conjoint surgery, co-surgeon
39650	01JUL1995	31OCT1995	N	TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision, with division and reconstruction of zygomatic arch, and disarticulation of temporo-mandibular joint and complete facial nerve mobilisation (intracranial procedure), conjoint surgery, principal surgeon
39650	01NOV1995	31DEC9999	Y	TUMOUR INVOLVING MIDDLE CRANIAL FOSSA AND INFRA-TEMPORAL FOSSA, removal of, craniotomy and radical or sub-total radical excision, with division and reconstruction of zygomatic arch, (intracranial procedure)
39651	01NOV2020	31DEC9999	Y	Petro-clival, clival or foramen magnum tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty - one surgeon
39652	01JUL1995	31DEC9999	Y	TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision, with division and reconstruction of zygomatic arch, and disarticulation of temporo-mandibular joint and complete facial nerve mobilisation (intra cranial procedure), conjoint surgery, co-surgeon
39653	01NOV1995	31DEC9999	Y	PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision (intracranial procedure), not being a service to which item 39654 or 39656 applies
39654	01JUL1995	31OCT1995	N	PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical excision (intracranial procedure), conjoint surgery, principal surgeon
39654	01NOV1995	31OCT2020	N	PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision, (intracranial procedure), conjoint surgery, principal surgeon
39654	01NOV2020	31DEC9999	Y	Petro-clival, clival or foramen magnum tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty-conjoint surgery, principal surgeon
39656	01JUL1995	31OCT1995	N	PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical excision, (intracranial procedure) conjoint surgery, co-surgeon
39656	01NOV1995	31OCT2020	N	PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision, (intracranial procedure) conjoint surgery, co-surgeon
39656	01NOV2020	31DEC9999	Y	Petro clival, clival or foramen magnum tumour or vascular lesion, removal or radical excision of, including stereotaxy and cranioplasty-conjoint surgery, co surgeon
39658	01JUL1995	31OCT1995	N	TUMOUR INVOLVING THE CLIVUS, radical excision of, involving transoral approach and division of palate
39658	01NOV1995	31DEC9999	Y	TUMOUR INVOLVING THE CLIVUS, radical or sub-total radical excision of, involving transoral or transmaxillary approach
39660	01JUL1995	31OCT1995	N	TUMOUR OR VASCULAR LESION OF CAVERNOUS SINUS, radical excision of, involving craniotomy with or without carotid artery exposure
39660	01NOV1995	31DEC9999	Y	TUMOUR OR VASCULAR LESION OF CAVERNOUS SINUS, radical excision of, involving craniotomy with or without intracranial carotid artery exposure
39662	01JUL1995	31DEC9999	Y	TUMOUR OR VASCULAR LESION OF FORAMEN MAGNUM, radical excision of, via transcondylar or far lateral suboccipital approach
39700	01DEC1991	31OCT2020	N	SKULL TUMOUR, benign or malignant, excision of, excluding cranioplasty
39700	01NOV2020	31DEC9999	Y	Skull tumour, benign or malignant, excision of, including stereotaxy and cranioplasty
39703	01DEC1991	30JUN1993	N	INTRACRANIAL tumour or cyst, burr-hole and biopsy of, or drainage of, or both
39703	01JUL1993	31OCT2020	N	INTRACRANIAL tumour, cyst or other brain tissue, burr-hole and biopsy of, or drainage of, or both
39703	01NOV2020	31DEC9999	Y	Intracranial tumour, cyst or other brain tissue, either or both of: (a) burr hole and biopsy of; (b) drainage of; including stereotaxy
39706	01DEC1991	31DEC9999	Y	INTRACRANIAL tumour, biopsy or decompression of via osteoplastic flap OR biopsy and decompression of via osteoplastic flap
39709	01DEC1991	31DEC9999	Y	CRANIOTOMY for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem - not being a service to which another item in this Sub-group applies
39710	01NOV2020	31DEC9999	Y	Intracranial tumour, one or more, biopsy, drainage, decompression or removal of, through a single craniotomy, including stereotaxy and cranioplasty
39712	01DEC1991	31OCT2020	N	CRANIOTOMY FOR REMOVAL OF MENINGIOMA, pinealoma, cranio-pharyngioma, intraventricular tumour or any other intracranial tumour, not being a service to which another item in this Sub-group applies
39712	01NOV2020	31DEC9999	Y	Transcranial tumour removal or biopsy of one or more of any of the following: (a) meningioma; (b) pinealoma; (c) cranio pharyngioma; (d) pituitary tumour; (e) intraventricular lesion; (f) brain stem lesion; (g) any other intracranial tumour; by any means (with or without endoscopy), through a single craniotomy, including stereotaxy and cranioplasty
39715	01DEC1991	30JUN1993	N	PITUITARY TUMOUR, hypophysectomy or removal of by transcranial or transphenoidal approach
39715	01JUL1993	31OCT2020	N	PITUITARY TUMOUR, removal of, by transcranial or transphenoidal approach
39715	01NOV2020	31DEC9999	Y	Pituitary tumour, removal of, by transphenoidal approach, including stereotaxy and dermis, dermofat or fascia grafting, other than a service associated with a service to which item 40600 applies
39718	01DEC1991	31OCT2020	N	ARACHNOIDAL CYST, craniotomy for
39718	01NOV2020	31DEC9999	Y	Arachnoidal cyst, craniotomy for, including stereotaxy and neuroendoscopy
39720	01NOV2020	31DEC9999	Y	Awake craniotomy for functional neurosurgery
39721	01DEC1991	31DEC9999	Y	CRANIOTOMY, involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc
39800	01DEC1991	31DEC9999	Y	ANEURYSM, clipping or reinforcement of sac
39801	01NOV2020	31DEC9999	Y	Aneurysm, clipping, proximal ligation, or reinforcement of sac, including stereotaxy and cranioplasty
39803	01DEC1991	31OCT2020	N	INTRACRANIAL ARTERIOVENOUS MALFORMATION, excision of
39803	01NOV2020	31DEC9999	Y	Intracranial arteriovenous malformation or fistula, treatment through a craniotomy, including stereotaxy, cranioplasty and all angiography
39806	01DEC1991	31DEC9999	Y	ANEURYSM, or arteriovenous malformation, intracranial proximal artery clipping of
39809	01DEC1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION, craniotomy and direct embolisation of
39812	01DEC1991	31DEC9999	Y	INTRACRANIAL ANEURYSM or arteriovenous fistula, ligation of cervical vessel or vessels
39815	01DEC1991	31DEC9999	Y	CAROTID-CAVERNOUS FISTULA, obliteration of - combined cervical and intracranial procedure
39818	01DEC1991	30JUN1995	N	EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery or saphenous vein graft
39818	01JUL1995	31OCT2020	N	EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery
39818	01NOV2020	31DEC9999	Y	Intracranial vascular bypass using indirect techniques, including stereotaxy
39821	01JUL1995	31OCT2020	N	EXTRACRANIAL TO INTRACRANIAL BYPASS using saphenous vein graft
39821	01NOV2020	31DEC9999	Y	Intracranial vascular bypass using direct anastomosis techniques, including stereotaxy
39900	01DEC1991	31OCT2020	N	INTRACRANIAL INFECTION, drainage of, via burr-hole - including burr-hole
39900	01NOV2020	31DEC9999	Y	Intracranial infection, treated by burr hole, including stereotaxy, other than a service associated with a service to which item 40600 applies
39903	01DEC1991	31OCT2020	N	INTRACRANIAL ABSCESS, excision of
39903	01NOV2020	31DEC9999	Y	Intracranial infection, treated by craniotomy, including stereotaxy, other than a service associated with a service to which item 40600 applies
39906	01DEC1991	31OCT2020	N	OSTEOMYELITIS OF SKULL or removal of infected bone flap, craniectomy for
39906	01NOV2020	31DEC9999	Y	Osteomyelitis of skull or removal of infected bone flap, craniectomy for, other than a service associated with a service to which item 40600 applies
40000	01DEC1991	31DEC9999	Y	VENTRICULO-CISTERNOSTOMY (Torkildsen's operation)
40003	01DEC1991	31DEC9999	Y	CRANIAL OR CISTERNAL SHUNT DIVERSION, insertion of
40004	01NOV2020	31DEC9999	Y	Ventricular, lumbar or cisternal shunt diversion, insertion or revision of, including stereotaxy
40006	01DEC1991	31DEC9999	Y	LUMBAR SHUNT DIVERSION, insertion of
40009	01DEC1991	31DEC9999	Y	CRANIAL, CISTERNAL OR LUMBAR SHUNT, revision or removal of
40012	01DEC1991	30JUN1995	N	THIRD VENTRICULOSTOMY
40012	01JUL1995	31OCT2020	N	THIRD VENTRICULOSTOMY (open or endoscopic) with or without endoscopic septum pellucidotomy
40012	01NOV2020	31DEC9999	Y	Endoscopic ventriculostomy for treatment of cerebrospinal fluid circulation disorders, including stereotaxy
40015	01DEC1991	31DEC9999	Y	SUBTEMPORAL DECOMPRESSION
40018	01DEC1991	29FEB2024	N	LUMBAR CEREBROSPINAL FLUID DRAIN, insertion of
40018	01MAR2024	31DEC9999	Y	Lumbar cerebrospinal fluid drain, insertion of, other than a service associated with a service to which item 22053 applies
40100	01DEC1991	31DEC9999	Y	MENINGOCELE, excision and closure of
40103	01DEC1991	31DEC9999	Y	MYELOMENINGOCELE, excision and closure of, including skin flaps or Z plasty where performed
40104	01NOV2020	31DEC9999	Y	Spinal myelomeningocele or spinal meningocele, excision and closure of, other than a service associated with a service to which item 40600 applies
40106	01DEC1991	31OCT2020	N	ARNOLD-CHIARI MALFORMATION, decompression of
40106	01NOV2020	31DEC9999	Y	Chiari malformation, decompression or reconstruction of, including laminectomy, dermofat graft and stereotaxy, other than a service associated with a service to which item 40600 applies
40109	01DEC1991	31OCT2020	N	ENCEPHALOCOELE, excision and closure of
40109	01NOV2020	31DEC9999	Y	Encephalocoele or cranial meningocele, excision and closure of, including stereotaxy and dermofat graft
40112	01DEC1991	31OCT2020	N	TETHERED CORD, release of, including lipomeningocele or diastematomyelia
40112	01NOV2020	31DEC9999	Y	Tethered cord, release of, including lipomeningocele or diastematomyelia, multiple levels, including laminectomy and rhizolysis, other than a service associated with a service to which item 40600 applies
40115	01DEC1991	31DEC9999	Y	CRANIOSTENOSIS, operation for - single suture
40118	01DEC1991	31DEC9999	Y	CRANIOSTENOSIS, operation for - more than 1 suture
40119	01NOV2020	31DEC9999	Y	Craniostenosis, operation for, other than a service associated with a service to which item 40600 applies
40300	01DEC1991	30JUN1993	N	SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for exploration or removal of
40300	01JUL1993	31OCT2006	N	SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for removal of
40300	01NOV2006	31DEC9999	Y	INTERVERTEBRAL DISC OR DISCS, partial or total laminectomy for removal of
40301	01JUL1993	31OCT2006	N	INTERVERTEBRAL DISC OR DISCS, microsurgical discectomy of
40301	01NOV2006	31DEC9999	Y	INTERVERTEBRAL DISC OR DISCS, microsurgical partial or total discectomy of
40303	01DEC1991	30JUN1993	N	RECURRENT DISC LESION OR SPINAL STENOSIS, laminectomy for - 1 level
40303	01JUL1993	31OCT2006	N	RECURRENT DISC LESION OR SPINAL STENOSIS, or both, laminectomy for - 1 level
40303	01NOV2006	31DEC9999	Y	RECURRENT DISC LESION OR SPINAL STENOSIS, or both, partial or total laminectomy for - 1 level
40306	01DEC1991	30JUN1993	N	SPINAL CANAL STENOSIS, laminectomy (multi-level), for treatment of
40306	01JUL1993	31OCT2006	N	SPINAL STENOSIS, laminectomy for, involving more than 1 vertebral interspace (disc level)
40306	01NOV2006	31DEC9999	Y	SPINAL STENOSIS, partial or total laminectomy for, involving more than 1 vertebral interspace (disc level)
40309	01DEC1991	31OCT2006	N	EXTRADURAL TUMOUR OR ABSCESS, laminectomy for
40309	01NOV2006	31DEC9999	Y	EEXTRADURAL TUMOUR OR ABSCESS, partial or total laminectomy for
40312	01DEC1991	31OCT2006	N	INTRADURAL LESION, laminectomy for, not being a service to which another item in this Group applies
40312	01NOV2006	31DEC9999	Y	INTRADURAL LESION, partial or total laminectomy for, not being a service to which another item in this Group applies
40315	01DEC1991	31DEC9999	Y	CRANIOCERVICAL JUNCTION LESION, transoral approach for
40316	01JUL1995	31DEC9999	Y	ODONTOID screw fixation
40318	01DEC1991	31OCT2006	N	INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, laminectomy and radical excision of
40318	01NOV2006	31DEC9999	Y	INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, partial or total laminectomy and radical excision of
40321	01DEC1991	31DEC9999	Y	POSTERIOR SPINAL FUSION, not being a service to which items 40324 and 40327 apply
40324	01DEC1991	31OCT2006	N	LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare
40324	01NOV2006	31DEC9999	Y	PARTIAL OR TOTAL LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare
40327	01DEC1991	31OCT2006	N	LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare
40327	01NOV2006	31DEC9999	Y	PARTIAL OR TOTAL LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare
40330	01DEC1991	30JUN1995	N	SPINAL RHIZOLYSIS involving exposure of spinal nerve roots, with or without laminectomy
40330	01JUL1995	31OCT2006	N	SPINAL RHIZOLYSIS involving exposure of spinal nerve roots - for lateral recess, exit foraminal stenosis, adhesive radiculopathy or extensive epidural fibrosis, at 1 or more levels - with or without laminectomy
40330	01NOV2006	31DEC9999	Y	SPINAL RHIZOLYSIS involving exposure of spinal nerve roots - for lateral recess, exit foraminal stenosis, adhesive radiculopathy or extensive epidural fibrosis, at 1 or more levels - with or without partial or total laminectomy
40331	01JUL1995	31DEC9999	Y	CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, without fusion, 1 level, by any approach, not being a service to which item 40330 applies
40332	01JUL1995	31DEC9999	Y	CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, including anterior fusion, 1 level, not being a service to which item 40330 applies
40333	01DEC1991	31OCT2006	N	CERVICAL DISCECTOMY (ANTERIOR), without fusion
40333	01NOV2006	31DEC9999	Y	CERVICAL PARTIAL OR TOTAL DISCECTOMY (ANTERIOR), without fusion
40334	01JUL1995	31DEC9999	Y	CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, without fusion, more than 1 level, by any approach, not being a service to which item 40330 applies
40335	01JUL1995	31DEC9999	Y	CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, including anterior fusion, more than 1 level, by any approach, not being a service to which item 40330 applies
40336	01DEC1991	31DEC9999	Y	INTRADISCAL INJECTION OF CHYMOPAPAIN (DISCASE) - 1 disc
40339	01DEC1991	31DEC9999	Y	HYDROMYELIA, plugging of obex for, with or without duroplasty
40342	01DEC1991	31OCT2006	N	HYDROMYELIA, craniotomy and laminectomy for, with cavity packing and CSF shunt
40342	01NOV2006	31DEC9999	Y	HYDROMYELIA, craniotomy and partial or total laminectomy for, with cavity packing and CSF shunt
40345	01JUL1995	31DEC9999	Y	THORACIC DECOMPRESSION of spinal cord with or without involvement of nerve roots, via pedicle or costotransversectomy
40348	01JUL1995	31DEC9999	Y	THORACIC DECOMPRESSION of spinal cord via thoracotomy with vertebrectomy, not including stabilisation procedure
40351	01JUL1995	31DEC9999	Y	THORACO-LUMBAR or high lumbar anterior decompression of spinal cord, not including stabilisation procedure
40600	01DEC1991	31OCT2020	N	CRANIOPLASTY, reconstructive
40600	01NOV2020	28FEB2023	N	Cranioplasty, reconstructive, other than a service associated with a service to which item 39113, 39638, 39639, 39641, 39651, 39654, 39656, 39700, 39710, 39712, 39715, 39801, 39803 or 40703 applies
40600	01MAR2023	31DEC9999	Y	Cranioplasty, reconstructive, other than a service associated with a service to which item 39113, 39638, 39639, 39641, 39651, 39654, 39656, 39700, 39710, 39712, 39715, 39801, 39803, 40703 or 41887 applies (H)
40700	01DEC1991	31OCT2020	N	CORPUS CALLOSUM, anterior section of, for epilepsy
40700	01NOV2020	31DEC9999	Y	Corpus callosotomy, for epilepsy, including stereotaxy
40701	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, subcutaneous placement of electrical pulse generator, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery
40702	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery
40703	01DEC1991	31OCT2020	N	CORTICECTOMY, TOPECTOMY or PARTIAL LOBECTOMY for epilepsy
40703	01NOV2020	31DEC9999	Y	Corticectomy, topectomy or partial lobectomy, for epilepsy, including stereotaxy and cranioplasty
40704	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical placement of lead, including connection of lead to left vagus nerve and intra-operative test stimulation, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery
40705	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of lead attached to left vagus nerve for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery
40706	01DEC1991	31OCT2020	N	HEMISPHERECTOMY for intractable epilepsy
40706	01NOV2020	31DEC9999	Y	Hemispherectomy or functional hemispherectomy, for intractable epilepsy, including stereotaxy
40707	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, electrical analysis and programming of vagus nerve stimulation therapy device using external wand, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery
40708	01NOV2017	31DEC9999	Y	Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical replacement of battery in electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treating refractory focal epilepsy not suitable for resective epilepsy surgery
40709	01DEC1991	31OCT2020	N	BURR-HOLE PLACEMENT of intracranial depth or surface electrodes
40709	01NOV2020	31DEC9999	Y	Intracranial electrode placement by burr hole, including stereotaxy
40712	01DEC1991	31OCT2020	N	INTRACRANIAL ELECTRODE PLACEMENT via craniotomy
40712	01NOV2020	31DEC9999	Y	Intracranial electrode placement by craniotomy, single or multiple, including stereotactic EEG, including stereotaxy
40800	01DEC1991	30JUN1993	N	STEREOTACTIC PROCEDURES STEREOTACTIC ANATOMICAL LOCALISATION in association with an intracranial operative procedure
40800	01JUL1993	31DEC9999	Y	STEREOTACTIC ANATOMICAL LOCALISATION, as an independent procedure
40801	01JUL1993	31OCT2002	N	FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts
40801	01NOV2002	30JUN2009	N	FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts, not being a service associated with deep brain stimulation for Parkinson's disease
40801	01JUL2009	31OCT2020	N	FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts, not being a service associated with deep brain stimulation for Parkinson's disease, essential tremor or dystonia
40801	01NOV2020	31DEC9999	Y	Functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation, and lesion production, by any method, in the basal ganglia, brain stem or deep white matter tracts, other than a service associated with deep brain stimulation for Parkinsons disease, essential tremor or dystonia
40803	01DEC1991	30APR1994	N	INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not being a service to which another item in this Group applies
40803	01MAY1994	31OCT2020	N	INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not being a service to which item 40800 or 40801 applies
40803	01NOV2020	31DEC9999	Y	Intracranial stereotactic procedure by any method, other than: (a) a service to which item 40801 applies; or (b) a service associated with a service to which item 39018, 39109, 39113, 39604, 39615, 39638, 39639, 39641, 39651, 39654, 39656, 39700, 39703, 39710, 39712, 39715, 39718, 39720, 39801, 39803, 39818, 39821, 39900, 39903, 40004, 40012, 40106, 40109, 40700, 40703, 40706, 40709 or 40712 applies
40804	01MAR2024	31DEC9999	Y	Magnetic resonance imaging-scan of head (including magnetic resonance angiography if performed) by a radiologist on request by a specialist or consultant physician, for the sole purpose of guiding focused ultrasound for the treatment of medically refractory essential tremor in association with the services described in items 40805 and 40806, including: (a) stereotactic scan of brain, with frame in place; and (b) assistance with computerised planning; and (c) interpretation of intraprocedural imaging Applicable once per patient per lifetime (H)
40805	01MAR2024	31DEC9999	Y	Neurological assessment and evaluation during the treatment of medically refractory essential tremor with magnetic resonance imaging-guided focused ultrasound, performed by a neurologist in association with the services described in items 40804 and 40806, including: (a) assistance with target localisation incorporating anatomical and physiological techniques; and (b) continuous intraprocedural neurological assessment and evaluation Applicable once per patient per lifetime (H)
40806	01MAR2024	31DEC9999	Y	Treatment of medically refractory essential tremor with magnetic resonance imaging-guided focused ultrasound, performed by a neurosurgeon in association with the services described in items 40804 and 40805, including: (a) computer assisted anatomical localisation; and (b) frame placement; and (c) target verification using anatomical and physiological techniques; and (d) delivery of treatment with lesion production in the basal ganglia, brain stem, thalamus or deep white matter tracts Applicable once per patient per lifetime (H)
40850	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes
40850	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes
40850	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability
40851	05MAY2003	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (bilateral), functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes
40851	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (bilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unnaccepatable motor fluctuations functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes
40851	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (bilateral) functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40852	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), subcutaneous placement of neurostimulator receiver or pulse generator
40852	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, subcutaneous placement of neurostimulator receiver or pulse generator
40852	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) subcutaneous placement of neurostimulator receiver or pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40854	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), revision or removal of brain electrode
40854	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, revision or removal of brain electrode
40854	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) revision or removal of brain electrode for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40856	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), removal or replacement of neurostimulator receiver or pulse generator
40856	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, removal or replacement of neurostimulator receiver or pulse generator
40856	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) removal or replacement of neurostimulator receiver or pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40858	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), removal or replacement of extension lead
40858	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, placement, removal or replacement of extension lead
40858	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) placement, removal or replacement of extension lead for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40860	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire
40860	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire
40860	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40862	01FEB2002	31OCT2006	N	DEEP BRAIN STIMULATION for Parkinson's disease, electronic analysis and programming of neaurostimulator pulse generator
40862	01NOV2006	30JUN2009	N	DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, electronic analysis and programming of neurostimulator pulse generator
40862	01JUL2009	31DEC9999	Y	DEEP BRAIN STIMULATION (unilateral) electronic analysis and programming of neurostimulator pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability.
40863	01NOV2022	31DEC9999	Y	Deep brain stimulation (unilateral), remote electronic analysis and programming of neurostimulator pulse generator for the treatment of: (a) Parkinsons disease, if the patients response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or (b) essential tremor or dystonia, if the patients symptoms cause severe disability Applicable not more than 8 times in any 12 month period
40900	01DEC1991	31DEC9999	Y	MISCELLANEOUS LEUCOTOMY for psychiatric disorder
40903	01JUL1995	31DEC9999	Y	NEUROENDOSCOPY, for inspection of an intraventricular lesion, with or without biopsy including burr hole
40905	01MAY2004	31OCT2020	N	CRANIOTOMY, performed in association with items 45767, 45776, 45782 and 45785 for the correction of craniofacial abnormalities
40905	01NOV2020	31DEC9999	Y	Craniotomy, performed by a neurosurgeon in conjunction with the correction of craniofacial abnormalities
41500	01DEC1991	30JUN1996	N	EAR, foreign body in, removal of, otherwise than by simple syringing
41500	01JUL1996	31DEC9999	Y	EAR, foreign body (other than ventilating tube) in, removal of, other than by simple syringing
41501	01NOV2019	29FEB2020	N	Examination of glottal cycles and vibratory characteristics of the vocal folds by a specialist in the practice of the specialists specialty of otolaryngology using videostroboscopy, including capturing audio, video, frequency and intensity, for confirmation of diagnosis , or for confirmation of treatment effectiveness where there is failure to progress or respond as expected, for: dysphonia where non stroboscopic techniques of the visualising the larynx have failed to identify any frank abnormality of the vocal folds; or benign vocal fold lesions; or premalignant or malignant laryngeal lesions; or vocal fold motion impairment or glottal insufficiency; or evaluation of vocal fold function after treatment or phonosurgery other than a service associated with a service to which item 41764 applies or with a services associated with the administration of a general anaesthetic
41501	01MAR2020	31DEC9999	Y	Examination of glottal cycles and vibratory characteristics of the vocal folds by a specialist in the practice of the specialists specialty of otolaryngology using videostroboscopy, including capturing audio, video, frequency and intensity, for confirmation of diagnosis , or for confirmation of treatment effectiveness where there is failure to progress or respond as expected, for: dysphonia where non stroboscopic techniques of the visualising the larynx have failed to identify any frank abnormality of the vocal folds; or benign or malignant vocal fold lesions; or premalignant or malignant laryngeal lesions; or vocal fold motion impairment or glottal insufficiency; or evaluation of vocal fold function after treatment or phonosurgery other than a service associated with a service to which item 41764 applies or with a services associated with the administration of a general anaesthetic
41503	01DEC1991	28FEB2023	N	EAR, foreign body in, removal of, involving incision of external auditory canal
41503	01MAR2023	31DEC9999	Y	Ear, foreign body in (other than ventilating tube), removal of, involving incision of external auditory canal, other than a service associated with a service to which another item in this Subgroup applies
41506	01DEC1991	31DEC9999	Y	AURAL POLYP, removal of
41509	01DEC1991	28FEB2023	N	EXTERNAL AUDITORY MEATUS, surgical removal of keratosis obturans from, not being a service to which another item in this Group applies
41509	01MAR2023	31DEC9999	Y	External auditory meatus, surgical removal of keratosis obturans from, performed under general anaesthesia, other than: (a) a service to which another item in this Subgroup applies; or (b) a service associated with a service to which item 41647 applies (H)
41512	01DEC1991	31DEC9999	Y	MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, not being a service to which item 41515 applies
41515	01DEC1991	31DEC9999	Y	MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, being a service associated with a service to which item 41530, 41548, 41557, 41560 or 41563 applies
41518	01DEC1991	31DEC9999	Y	EXTERNAL AUDITORY MEATUS, removal of EXOSTOSES IN
41521	01DEC1991	28FEB2023	N	Correction of AUDITORY CANAL STENOSIS, including meatoplasty, with or without grafting
41521	01MAR2023	31DEC9999	Y	Correction of auditory canal stenosis, including meatoplasty, with or without grafting, other than a service associated with a service to which an item in Subgroup 18 applies (H)
41524	01DEC1991	28FEB2023	N	RECONSTRUCTION OF EXTERNAL AUDITORY CANAL, being a service associated with a service to which items 41557, 41560 and 41563 apply
41524	01MAR2023	31DEC9999	Y	Reconstruction of external auditory canal (H)
41527	01DEC1991	28FEB2023	N	MYRINGOPLASTY, transcanal approach (Rosen incision)
41527	01MAR2023	31DEC9999	Y	Myringoplasty, by transcanal approach, other than a service associated with a service to which another item in this Subgroup applies (H)
41530	01DEC1991	28FEB2023	N	MYRINGOPLASTY, postaural or endaural approach with or without mastoid inspection
41530	01MAR2023	31DEC9999	Y	Myringoplasty, post-aural or endaural approach, with or without mastoid inspection, other than a service associated with a service to which another item in this Subgroup applies (H)
41533	01DEC1991	28FEB2023	N	ATTICOTOMY without reconstruction of the bony defect, with or without myringoplasty
41533	01MAR2023	31DEC9999	Y	Atticotomy without reconstruction of the bony defect, with or without myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41536	01DEC1991	28FEB2023	N	ATTICOTOMY with reconstruction of the bony defect, with or without myringoplasty
41536	01MAR2023	31DEC9999	Y	Atticotomy with reconstruction of the bony defect, with or without myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41539	01DEC1991	28FEB2023	N	OSSICULAR CHAIN RECONSTRUCTION
41539	01MAR2023	31DEC9999	Y	Ossicular chain reconstruction, other than a service associated with a service to which item 41611 applies (H)
41542	01DEC1991	28FEB2023	N	OSSICULAR CHAIN RECONSTRUCTION AND MYRINGOPLASTY
41542	01MAR2023	31DEC9999	Y	Ossicular chain reconstruction and myringoplasty, other than a service associated with a service to which item 41611 applies (H)
41545	01DEC1991	28FEB2023	N	MASTOIDECTOMY (CORTICAL)
41545	01MAR2023	31DEC9999	Y	Mastoidectomy (cortical), other than a service associated with a service to which another item in this Subgroup applies (H)
41548	01DEC1991	31DEC9999	Y	OBLITERATION OF THE MASTOID CAVITY
41551	01DEC1991	28FEB2023	N	MASTOIDECTOMY, intact wall technique, with myringoplasty
41551	01MAR2023	31DEC9999	Y	Mastoidectomy, intact wall technique, with myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41554	01DEC1991	28FEB2023	N	MASTOIDECTOMY, intact wall technique, with myringoplasty and ossicular chain reconstruction
41554	01MAR2023	31DEC9999	Y	Mastoidectomy, intact wall technique, with myringoplasty and ossicular chain reconstruction, other than a service associated with a service to which item 41603 or another item in this Subgroup applies (H)
41557	01DEC1991	28FEB2023	N	MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL)
41557	01MAR2023	31DEC9999	Y	Mastoidectomy (radical or modified radical), other than a service associated with a service to which another item in this Subgroup applies (H)
41560	01DEC1991	28FEB2023	N	MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL) AND MYRINGOPLASTY
41560	01MAR2023	31DEC9999	Y	Mastoidectomy (radical or modified radical) and myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41563	01DEC1991	28FEB2023	N	MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL), MYRINGOPLASTY AND OSSICULAR CHAIN RECONSTRUCTION
41563	01MAR2023	31DEC9999	Y	Mastoidectomy (radical or modified radical), myringoplasty and ossicular chain reconstruction, other than a service associated with a service to which another item in this Subgroup applies (H)
41564	01MAY1997	28FEB2023	N	MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL), OBLITERATION OF THE MASTOID CAVITY, BLIND SAC CLOSURE OF EXTERNAL AUDITORY CANAL AND OBLITERATION OF EUSTACHIAN TUBE
41564	01MAR2023	31DEC9999	Y	Mastoidectomy (radical or modified radical), obliteration of the mastoid cavity, blind sac closure of external auditory canal and obliteration of eustachian tube, other than a service associated with a service to which another item in this Subgroup applies (H)
41566	01DEC1991	28FEB2023	N	REVISION OF MASTOIDECTOMY (radical, modified radical or intact wall), including myringoplasty
41566	01MAR2023	31DEC9999	Y	Revision of mastoidectomy (radical, modified radical or intact wall), including myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41569	01DEC1991	28FEB2023	N	DECOMPRESSION OF FACIAL NERVE in its mastoid portion
41569	01MAR2023	31DEC9999	Y	Decompression of facial nerve in its mastoid portion, other than a service associated with a service to which item 41617 applies (H)
41572	01DEC1991	31DEC9999	Y	LABYRINTHOTOMY OR DESTRUCTION OF LABYRINTH
41575	01DEC1991	31DEC9999	Y	CEREBELLO PONTINE ANGLE TUMOUR, removal of by 2 surgeons operating conjointly, by transmastoid, translabyrinthine or retromastoid approach transmastoid, translabyrinthine or retromastoid procedure (including aftercare)
41576	01NOV1995	31DEC9999	Y	CEREBELLO - PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach - intracranial procedure (including aftercare) not being a service to which item 41578 or 41579 applies
41578	01DEC1991	30JUN1995	N	CEREBELLO PONTINE ANGLE TUMOUR, removal of by 2 surgeons operating conjointly, by transmastoid, translabyrinthine or retromastoid approach intracranial procedure (including aftercare)
41578	01JUL1995	31DEC9999	Y	CEREBELLO PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach, (intracranial procedure) - conjoint surgery, principal surgeon
41579	01JUL1995	31DEC9999	Y	CEREBELLO-PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach, (intracranial procedure) - conjoint surgery, co-surgeon
41581	01DEC1991	30JUN1995	N	SKULL BASE TUMOUR, removal of by infratemporal approach
41581	01JUL1995	31DEC9999	Y	TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision of
41584	01DEC1991	31DEC9999	Y	PARTIAL TEMPORAL BONE RESECTION for removal of tumour involving mastoidectomy with or without decompression of facial nerve
41587	01DEC1991	31DEC9999	Y	TOTAL TEMPORAL BONE RESECTION for removal of tumour
41590	01DEC1991	31DEC9999	Y	ENDOLYMPHATIC SAC, TRANSMASTOID DECOMPRESSION with or without drainage of
41593	01DEC1991	31DEC9999	Y	TRANSLABYRINTHINE VESTIBULAR NERVE SECTION
41596	01DEC1991	31DEC9999	Y	RETROLABYRINTHINE VESTIBULAR NERVE SECTION or COCHLEAR NERVE SECTION, or BOTH
41599	01DEC1991	31DEC9999	Y	INTERNAL AUDITORY MEATUS, exploration by middle cranial fossa approach with cranial nerve decompression
41602	01DEC1991	31DEC9999	Y	FENESTRATION OPERATION each ear
41603	01NOV2006	28FEB2023	N	OSSEO-INTEGRATION PROCEDURE - implantation of titanium fixture for use with implantable bone conduction hearing system device, in patients: - With a permanent or long term hearing loss; and - Unable to utilise conventional air or bone conduction hearing aid for medical or audiological reasons; and - With bone conduction thresholds that accord to recognised criteria for the implantable bone conduction hearing device being inserted. Not being a service associated with a service to which items 41554, 45794 or 45797
41603	01MAR2023	31DEC9999	Y	Osseo-integration procedure-implantation of bone conduction hearing system device, in a patient: (a) With a permanent or long-term hearing loss; and (b) Unable to utilise conventional air or bone conduction hearing aid for medical or audiological reasons; and (c) With bone conduction thresholds that accord with recognised criteria for the implantable bone conduction hearing device being inserted. other than a service associated with a service to which item 41554, 45794 or 45797 applies
41604	01NOV2006	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE - fixation of transcutaneous abutment implantation of titanium fixture for use with implantable bone conduction hearing system device, in patients: - With a permanent or long term hearing loss; and - Unable to utilise conventional air or bone conduction hearing aid for medical or audiological reasons; and - With bone conduction thresholds that accord to recognised criteria for the implantable bone conduction hearing device being inserted. Not being a service associated with a service to which items 41554, 45794 or 45797
41605	01DEC1991	31DEC9999	Y	VENOUS GRAFT TO FENESTRATION CAVITY
41608	01DEC1991	31DEC9999	Y	STAPEDECTOMY
41611	01DEC1991	28FEB2023	N	STAPES MOBILISATION
41611	01MAR2023	31DEC9999	Y	Stapes mobilisation, other than a service associated with a service to which item 41539, 41542, or an item in Subgroup 18, applies (H)
41614	01DEC1991	28FEB2023	N	ROUND WINDOW SURGERY including repair of cochleotomy
41614	01MAR2023	31DEC9999	Y	Round window surgery including repair of cochleotomy, other than a service associated with a service to which item 41617 applies
41615	01MAY1994	31DEC9999	Y	OVAL WINDOW SURGERY, including repair of fistula, not being a service associated with a service to which any other item in this Group applies
41617	01DEC1991	28FEB2023	N	COCHLEAR IMPLANT, insertion of, including mastoidectomy
41617	01MAR2023	31DEC9999	Y	Cochlear implant, insertion of, including mastoidectomy, cochleotomy and exposure of facial nerve where required, other than a service associated with a service to which item 41569 or 41614 applies (H)
41618	01MAY2017	31DEC9999	Y	Middle ear implant, partially implantable, insertion of, via mastoidectomy, for patients with: (a) stable sensorineural hearing loss; and (b) outer ear pathology that prevents the use of a conventional hearing aid; and (c) a PTA4 of less than 80 dBHL; and (d) bilateral, symmetrical hearing loss with PTA thresholds in both ears within 20 dBHL (0.5-4kHz) of each other; and (e) speech perception discrimination of at least 65% correct for word lists with appropriately amplified sound; and (f) a normal middle ear; and (g) normal tympanometry; and (h) on audiometry, an air-bone gap of less than 10 dBHL (0.5-4kHz) across all frequencies; and (i) no other inner ear disorders
41620	01DEC1991	31DEC9999	Y	GLOMUS TUMOUR, transtympanic removal of
41623	01DEC1991	31DEC9999	Y	GLOMUS TUMOUR, transmastoid removal of, including mastoidectomy
41626	01DEC1991	28FEB2023	N	ABSCESS OR INFLAMMATION OF MIDDLE EAR, operation for (excluding aftercare)
41626	01MAR2023	31DEC9999	Y	Incision of tympanic membrane, or installation of therapeutic agent, to the middle ear through an intact drum: (a) not including local anaesthetic; and (b) excluding aftercare; and (c) other than a service associated with a service to which item 41632 applies
41629	01DEC1991	28FEB2023	N	MIDDLE EAR, EXPLORATION OF
41629	01MAR2023	31DEC9999	Y	Middle ear, exploration of, other than a service associated with a service to which another item in this Subgroup applies (H)
41632	01DEC1991	28FEB2023	N	MIDDLE EAR, insertion of tube for DRAINAGE OF (including myringotomy)
41632	01MAR2023	31DEC9999	Y	Middle ear, insertion of tube for drainage of (including myringotomy), other than a service associated with a service to which item 41626 applies
41635	01DEC1991	28FEB2023	N	CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, 1 or more, with or without myringoplasty
41635	01MAR2023	31DEC9999	Y	Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty, other than a service associated with a service to which another item in this Subgroup applies (H)
41638	01DEC1991	28FEB2023	N	CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, 1 or more, with or without myringoplasty with ossicular chain reconstruction
41638	01MAR2023	31DEC9999	Y	Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty with ossicular chain reconstruction other than a service associated with a service to which another item in this Subgroup applies (H)
41641	01DEC1991	31DEC9999	Y	PERFORATION OF TYMPANUM, cauterisation or diathermy of
41644	01DEC1991	31DEC9999	Y	EXCISION OF RIM OF EARDRUM PERFORATION, not being a service associated with myringoplasty
41647	01DEC1991	28FEB2023	N	EAR TOILET requiring use of operating microscope and microinspection of tympanic membrane with or without general anaesthesia
41647	01MAR2023	31DEC9999	Y	Micro inspection of tympanic membrane and auditory canal, requiring use of operating microscope or endoscope, including any removal of wax, with or without general anaesthesia, other than a service associated with a service to which item 41509 applies. Not applicable for the removal of uncomplicated wax in the absence of other disorders of the ear
41650	01DEC1991	31DEC9999	Y	TYMPANIC MEMBRANE, microinspection of 1 or both ears under general anaesthesia, not being a service associated with a service to which another item in this Group applies
41653	01DEC1991	31DEC9999	Y	EXAMINATION OF NASAL CAVITY or POSTNASAL SPACE, or NASAL CAVITY AND POSTNASAL SPACE, UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies
41656	01DEC1991	31DEC9999	Y	NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding aftercare)
41659	01DEC1991	31DEC9999	Y	NOSE, removal of FOREIGN BODY IN, other than by simple probing
41662	01DEC1991	28FEB2023	N	NASAL POLYP OR POLYPI (SIMPLE), removal of
41662	01MAR2023	31DEC9999	Y	Nasal polyp or polypi (simple), removal of, other than a service associated with a service to which item 41702, 41703 or 41705 applies on the same side
41665	01DEC1991	31DEC9999	Y	NASAL POLYP OR POLYPI (requiring admission to hospital), removal of
41668	01DEC1991	31OCT2017	N	NASAL POLYP OR POLYPI (requiring admission to hospital), removal of
41668	01NOV2017	28FEB2023	N	NASAL POLYP OR POLYPI, removal of
41668	01MAR2023	31DEC9999	Y	Nasal polyp or polypi, removal of
41671	01DEC1991	28FEB2023	N	NASAL SEPTUM, SEPTOPLASTY, SUBMUCOUS RESECTION or closure of septal perforation
41671	01MAR2023	31DEC9999	Y	Septal surgery, including septoplasty, septal reconstruction, septectomy, closure of septal perforation or other modifications of the septum, not including cauterisation, by any approach, other than a service associated with a service to which item 41689, 41692 or 41693 applies (H)
41672	01MAY1997	31DEC9999	Y	NASAL SEPTUM, reconstruction of
41674	01DEC1991	31OCT2017	N	CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES OR PHARYNX - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose
41674	01NOV2017	31DEC9999	Y	Cauterisation (other than by chemical means) or cauterisation by chemical means when performed under general anaesthesia or diathermy of septum or turbinates-one or more of these procedures (including any consultation on the same occasion) other than a service associated with another operation on the nose
41677	01DEC1991	31DEC9999	Y	NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both
41680	01DEC1991	31DEC9999	Y	CRYOTHERAPY TO NOSE in the treatment of nasal haemorrhage
41683	01DEC1991	31DEC9999	Y	DIVISION OF NASAL ADHESIONS, with or without stenting not being a service associated with any other operation on the nose and not performed during the postoperative period of a nasal operation
41686	01DEC1991	31DEC9999	Y	DISLOCATION OF TURBINATE OR TURBINATES, 1 or both sides, not being a service associated with a service to which another item in this Group applies
41689	01DEC1991	28FEB2023	N	TURBINECTOMY or turbinectomies, partial or total, unilateral
41689	01MAR2023	31DEC9999	Y	Turbinate reduction, partial or total, unilateral or bilateral, other than a service associated with a service to which item 41671, 41692 or 41693 applies
41692	01DEC1991	28FEB2023	N	TURBINATES, submucous resection of, unilateral
41692	01MAR2023	31DEC9999	Y	Turbinate, submucous resection with removal of bone, unilateral or bilateral, other than a service associated with a service to which item 41671, 41689 or 41693 applies (H)
41693	01MAR2023	31DEC9999	Y	Septal surgery with submucous resection of turbinates, unilateral or bilateral, other than a service associated with a service to which item 41671, 41689, 41692 or 41764 applies (H)
41695	01DEC1991	31DEC9999	Y	TURBINATES, cryotherapy to
41698	01DEC1991	28FEB2023	N	MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF
41698	01MAR2023	31DEC9999	Y	Maxillary antrum, proof puncture and lavage of, other than a service associated with a service to which item 41702, 41703, 41705, 41710, 41734 or 41737 applies on the same side
41701	01DEC1991	31DEC9999	Y	MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia (requiring admission to hospital) not being a service associated with a service to which another item in this Group applies
41702	01MAR2023	31DEC9999	Y	Functional sinus surgery of the ostiomeatal unit, including ethmoid, unilateral, other than a service associated with a service to which item 41662, 41698, 41703, 41705, 41710 or 41764 applies on the same side (H)
41703	01MAR2023	31DEC9999	Y	Functional sinus surgery, complete dissection of all 5 sinuses and creation of single sinus cavity, unilateral, other than a service associated with a service to which item 41662, 41698, 41702, 41705, 41710, 41734, 41737, 41752 or 41764 applies on the same side (H)
41704	01DEC1991	31DEC9999	Y	MAXILLARY ANTRUM, LAVAGE OF each attendance at which the procedure is performed, including any associated consultation
41705	01MAR2023	31DEC9999	Y	Functional sinus surgery, complete dissection of all 5 sinuses to create a single sinus cavity, with extended drilling of frontal sinuses, unilateral, other than a service associated with a service to which item 41662, 41698, 41702, 41703, 41710, 41734, 41737, 41752 or 41764 applies on the same side (H)
41707	01DEC1991	28FEB2023	N	MAXILLARY ARTERY, transantral ligation of
41707	01MAR2023	31DEC9999	Y	Maxillary or sphenopalatine artery, ligation of (H)
41710	01DEC1991	28FEB2023	N	ANTROSTOMY (RADICAL)
41710	01MAR2023	31DEC9999	Y	Antrostomy by any approach, other than a service associated with a service to which item 41702, 41703, 41705 or 41698 applies on the same side (H)
41713	01DEC1991	28FEB2023	N	ANTROSTOMY (RADICAL) with transantral ethmoidectomy or transantral vidian neurectomy
41713	01MAR2023	31DEC9999	Y	Vidian neurectomy or exposure of vidian canal (H)
41716	01DEC1991	31DEC9999	Y	ANTRUM, intranasal operation on, or removal of foreign body from
41719	01DEC1991	28FEB2023	N	ANTRUM, drainage of, through tooth socket
41719	01MAR2023	31DEC9999	Y	Antrum, drainage of, through tooth socket, other than a service associated with a service to which item 41722 applies
41722	01DEC1991	28FEB2023	N	OROANTRAL FISTULA, plastic closure of
41722	01MAR2023	31DEC9999	Y	Oroantral fistula, plastic closure of, other than a service associated with a service to which item 41719 or 45009 applies
41725	01DEC1991	28FEB2023	N	ETHMOIDAL ARTERY OR ARTERIES, transorbital ligation of (unilateral)
41725	01MAR2023	31DEC9999	Y	Ligation of ethmoidal artery or arteries, anterior, posterior or both, by any approach (unilateral) (H)
41728	01DEC1991	28FEB2023	N	LATERAL RHINOTOMY with removal of tumour
41728	01MAR2023	31DEC9999	Y	Removal of sinonasal or nasopharyngeal tumour, excluding inflammatory nasal polyps, by any approach (H)
41729	01NOV1994	31DEC9999	Y	DERMOID OF NOSE, excision of, with intranasal extension
41731	01DEC1991	31OCT1993	N	FRONTONASAL ETHMOIDECTOMY with or without sphenoidectomy
41731	01NOV1993	31DEC9999	Y	FRONTONASAL ETHMOIDECTOMY by external approach with or without sphenoidectomy
41734	01DEC1991	28FEB2023	N	RADICAL FRONTOETHMOIDECTOMY with osteoplastic flap
41734	01MAR2023	31DEC9999	Y	Endoscopic Lothrop procedure or radical external frontal sinusotomy with osteoplastic flap, unilateral, other than a service associated with a service to which item 41698, 41703, 41705 or 41764 applies on the same side (H)
41737	01DEC1991	31OCT1999	N	FRONTAL SINUS OR ETHMOIDAL SINUSES, intranasal operation on
41737	01NOV1999	28FEB2023	N	FRONTAL SINUS, OR ETHMOIDAL SINUSES ON THE ONE SIDE, intranasal operation on
41737	01MAR2023	31DEC9999	Y	Frontal sinus, unilateral, intranasal operation on, including complete dissection of frontal recess and exposure of frontal sinus ostium (excludes simple probing, dilatation or irrigation of frontal sinus), other than a service associated with a service to which item 41698, 41703, 41705 or 41764 applies on the same side (H)
41740	01DEC1991	28FEB2023	N	FRONTAL SINUS, catheterisation of
41740	01MAR2023	31OCT2023	N	Frontal sinus, catheterisation of, other than a service associated with a service to which item 41749 applies
41740	01NOV2023	31DEC9999	Y	Frontal sinus, catheterisation of, other than a service associated with a service to which item 41749 applies on the same side (H)
41743	01DEC1991	28FEB2023	N	FRONTAL SINUS, trephine of
41743	01MAR2023	31OCT2023	N	Frontal sinus, trephine of, other than a service associated with a service to which item 41749 applies (H)
41743	01NOV2023	31DEC9999	Y	Frontal sinus, trephine of, other than a service associated with a service to which item 41749 applies on the same side (H)
41746	01DEC1991	28FEB2023	N	FRONTAL SINUS, radical obliteration of
41746	01MAR2023	31DEC9999	Y	Paranasal sinus, radical obliteration of, including any graft harvest
41749	01DEC1991	28FEB2023	N	ETHMOIDAL SINUSES, external operation on
41749	01MAR2023	31DEC9999	Y	Paranasal sinus, external operation on, unilateral, other than a service associated with a service to which item 41740 or 41743 applies on the same side (H)
41752	01DEC1991	28FEB2023	N	SPHENOIDAL SINUS, intranasal operation on
41752	01MAR2023	31DEC9999	Y	Sphenoidal sinus, unilateral, intranasal operation on, other than a service associated with a service to which item 41703 or 41705 applies on the same side (H)
41755	01DEC1991	31DEC9999	Y	EUSTACHIAN TUBE, catheterisation of
41758	01DEC1991	31DEC9999	Y	DIVISION OF PHARYNGEAL ADHESIONS
41761	01DEC1991	31DEC9999	Y	POSTNASAL SPACE, direct examination of, with or without biopsy
41764	01DEC1991	31OCT1993	N	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX
41764	01NOV1993	31OCT2006	N	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures
41764	01NOV2006	28FEB2023	N	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures, unilateral or bilateral examination
41764	01MAR2023	31DEC9999	Y	Nasendoscopy or sinoscopy or fibreoptic examination of nasopharynx and larynx, one or more of these procedures, unilateral or bilateral examination, other than a service associated with a service to which item 41693, 41702, 41703, 41705, 41734 or 41737 applies
41767	01DEC1991	30JUN2011	N	NASOPHARYNGEAL ANGIOFIBROMA, transpalatal removal
41767	01JUL2011	31DEC9999	Y	NASOPHARYNGEAL ANGIOFIBROMA, removal of
41768	01JUL2024	31DEC9999	Y	Unilateral insertion of bioabsorbable implant for nasal airway obstruction due to lateral wall insufficiency confirmed by positive modified Cottle manoeuvre, if: (a) the procedure is provided by a specialist in the practice of the specialists specialty of otolaryngology or plastic surgery; and (b) the patient has a self-reported NOSE Scale score of equal to or greater than 55; and (c) NOSE Scale evidence (with or without photographic evidence demonstrating the clinical need for this service) is documented in the patient notes; and (d) the patient has not previously received a service to which item 41769 applies Applicable once per lifetime per nostril
41769	01JUL2024	31DEC9999	Y	Bilateral insertion of bioabsorbable implant for nasal airway obstruction due to lateral wall insufficiency confirmed by positive modified Cottle manoeuvre, if: (a) the procedure is provided by a specialist in the practice of the specialists specialty of otolaryngology or plastic surgery; and (b) the patient has a self-reported NOSE Scale score of equal to or greater than 55; and (c) NOSE Scale evidence (with or without photographic evidence demonstrating the clinical need for this service) is documented in the patient notes; and (d) the patient has not previously received a service to which item 41768 applies Applicable once per lifetime
41770	01DEC1991	31DEC9999	Y	PHARYNGEAL POUCH, removal of, with or without cricopharyngeal myotomy
41773	01DEC1991	31DEC9999	Y	PHARYNGEAL POUCH, ENDOSCOPIC RESECTION OF (Dohlman's operation)
41776	01DEC1991	28FEB2023	N	CRICOPHARYNGEAL MYOTOMY with or without inversion of pharyngeal pouch
41776	01MAR2023	31DEC9999	Y	Cricopharyngeal myotomy by any approach, including open inversion of pharyngeal pouch or endoscopic repair of pharyngeal pouch (H)
41779	01DEC1991	31DEC9999	Y	PHARYNGOTOMY (lateral), with or without total excision of tongue
41782	01DEC1991	31DEC9999	Y	PARTIAL PHARYNGECTOMY via PHARYNGOTOMY
41785	01DEC1991	28FEB2023	N	PARTIAL PHARYNGECTOMY via PHARYNGOTOMY with partial or total glossectomy
41785	01MAR2023	31DEC9999	Y	Partial pharyngectomy, by any approach, with or without partial glossectomy (H)
41786	01DEC1991	31OCT1994	N	PHARYNGEAL FLAP or PHARYNGOPLASTY, with or without tonsillectomy
41786	01NOV1994	31DEC9999	Y	UVULOPALATOPHARYNGOPLASTY, with or without tonsillectomy, by any means
41787	01NOV1994	31DEC9999	Y	UVULECTOMY AND PARTIAL PALATECTOMY WITH LASER INCISION OF THE PALATE, with or without tonsillectomy, 1 or more stages, including any revision procedures within 12 months
41788	01DEC1991	31DEC9999	Y	TONSILS OR TONSILS AND ADENOIDS, removal of, in a person aged LESS THAN 12 YEARS
41789	01DEC1991	31OCT2017	N	TONSILS OR TONSILS AND ADENOIDS, removal of, in a person aged LESS THAN 12 YEARS
41789	01NOV2017	30JUN2021	N	Tonsils or tonsils and adenoids, removal of, in a person aged less than 12 years (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies
41789	01JUL2021	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a patient aged less than 12 years (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies
41792	01DEC1991	31DEC9999	Y	TONSILS OR TONSILS AND ADENOIDS, removal of, in a person 12 YEARS OF AGE OR OVER
41793	01DEC1991	31OCT2017	N	TONSILS OR TONSILS AND ADENOIDS, removal of, in a person 12 YEARS OF AGE OR OVER
41793	01NOV2017	30JUN2021	N	Tonsils or tonsils and adenoids, removal of, in a person 12 years of age or over (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies
41793	01JUL2021	31DEC9999	Y	Tonsils or tonsils and adenoids, removal of, in a patient 12 years of age or over (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies
41796	01DEC1991	31DEC9999	Y	TONSILS OR TONSILS AND ADENOIDS, ARREST OF HAEMORRHAGE requiring general anaesthesia, following removal of
41797	01DEC1991	31DEC9999	Y	TONSILS OR TONSILS AND ADENOIDS, ARREST OF HAEMORRHAGE requiring general anaesthesia, following removal of
41800	01DEC1991	31DEC9999	Y	ADENOIDS, removal of
41801	01DEC1991	31OCT2017	N	ADENOIDS, removal of
41801	01NOV2017	31DEC9999	Y	Adenoids, removal of (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies
41804	01DEC1991	28FEB2023	N	LINGUAL TONSIL OR LATERAL PHARYNGEAL BANDS, removal of
41804	01MAR2023	31DEC9999	Y	Removal of lingual tonsil (H)
41807	01DEC1991	31DEC9999	Y	PERITONSILLAR ABSCESS (quinsy), incision of
41810	01DEC1991	31DEC9999	Y	UVULOTOMY or UVULECTOMY
41813	01DEC1991	31DEC9999	Y	VALLECULAR OR PHARYNGEAL CYSTS, removal of
41816	01DEC1991	31DEC9999	Y	OESOPHAGOSCOPY (with rigid oesophagoscope)
41819	01DEC1991	31OCT2000	N	OESOPHAGEAL AND ANASTOMOTIC STRICTURE, endoscopic dilatation of
41819	01NOV2000	31DEC9999	Y	DILATATION OF STRICTURE OF UPPER GASTRO-INTESTINAL TRACT using bougie or balloon over endoscopically inserted guidewire, including endoscopy with flexible or rigid endoscope
41820	01NOV2000	31DEC9999	Y	DILATATION OF STRICTURE OF UPPER GASTRO-INTESTINAL TRACT using bougie or balloon over endoscopically inserted guidewire, including endoscopy with flexible or rigid endoscope, where the use of imaging intensification is clinically indicated
41822	01DEC1991	28FEB2023	N	OESOPHAGOSCOPY (with rigid oesophagoscope), with biopsy
41822	01MAR2023	31DEC9999	Y	Oesophagoscopy, with rigid oesophagoscope, with or without biopsy, other than a service associated with a service to which item 30473 or 30478 applies (H)
41825	01DEC1991	28FEB2023	N	OESOPHAGOSCOPY (with rigid oesophagoscope), with removal of foreign body
41825	01MAR2023	31DEC9999	Y	Removal of a foreign body from the pharynx, larynx or oesophagus, by any means, other than a service associated with a service to which item 30478 applies (H)
41828	01DEC1991	31DEC9999	Y	OESOPHAGEAL STRICTURE, dilatation of, without oesophagoscopy
41831	01DEC1991	31OCT2017	N	OESOPHAGUS, endoscopic pneumatic dilatation of
41831	01NOV2017	31DEC9999	Y	Oesophagus, endoscopic pneumatic dilatation of, for treatment of achalasia
41832	01MAY1997	31DEC9999	Y	OESOPHAGUS, balloon dilatation of, using interventional imaging techniques
41834	01DEC1991	28FEB2023	N	LARYNGECTOMY (TOTAL)
41834	01MAR2023	31DEC9999	Y	Total laryngectomy, including cricopharyngeal myotomy and tracheo oesophageal puncture (H)
41837	01DEC1991	28FEB2023	N	VERTICAL HEMILARYNGECTOMY including tracheostomy
41837	01MAR2023	31DEC9999	Y	Complete vertical hemi laryngectomy, involving removal of true and false vocal cords, including tracheostomy. Applicable only once per provider per patient per lifetime (H)
41840	01DEC1991	28FEB2023	N	SUPRAGLOTTIC LARYNGECTOMY including tracheostomy
41840	01MAR2023	31DEC9999	Y	Total supraglottic laryngectomy, involving removal of ventricular folds, epiglottis and aryepiglottic folds including tracheostomy. Applicable only once per provider per patient per lifetime (H)
41843	01DEC1991	31DEC9999	Y	LARYNGOPHARYNGECTOMY or PRIMARY RESTORATION OF ALIMENTARY CONTINUITY after laryngopharyngectomy USING STOMACH OR BOWEL
41846	01DEC1991	31DEC9999	Y	LARYNX, direct examination of the supraglottic, glottic and subglottic regions, not being a service associated with any other procedure on the larynx or with the administration of a general anaesthetic
41849	01DEC1991	31DEC9999	Y	LARYNX, direct examination of, with biopsy
41852	01DEC1991	31DEC9999	Y	LARYNX, direct examination of, WITH REMOVAL OF TUMOUR
41855	01DEC1991	28FEB2023	N	MICROLARYNGOSCOPY
41855	01MAR2023	31DEC9999	Y	Microlaryngoscopy, by any approach, with or without biopsy (H)
41858	01DEC1991	31DEC9999	Y	MICROLARYNGOSCOPY with removal of juvenile papillomata
41861	01DEC1991	30JUN2011	N	MICROLARYNGOSCOPY with removal of papillomata by laser surgery
41861	01JUL2011	28FEB2023	N	MICROLARYNGOSCOPY with removal of benign lesions of the larynx by laser surgery
41861	01MAR2023	31DEC9999	Y	Microlaryngoscopy with complete removal of benign or malignant lesions of the larynx, including papillomata, by any approach or technique, unilateral, other than a service associated with a service to which item 41870 applies on the same side (H)
41864	01DEC1991	31DEC9999	Y	MICROLARYNGOSCOPY WITH REMOVAL OF TUMOUR
41867	01DEC1991	28FEB2023	N	MICROLARYNGOSCOPY with arytenoidectomy
41867	01MAR2023	31DEC9999	Y	Microlaryngoscopy, with partial or complete arytenoidectomy or arytenoid repositioning (H)
41868	01MAY1997	31DEC9999	Y	LARYNGEAL WEB, division of, using microlarygoscopic techniques
41869	01MAY1997	31DEC9999	Y	BOTULINUM TOXIN INJECTION INTO VOCAL CORDS, including associated consultation
41870	01DEC1991	31OCT1997	N	INJECTION OF VOCAL CORD BY TEFLON, FAT, COLLAGEN OR GELFOAM
41870	01NOV1997	28FEB2023	N	INJECTION OF VOCAL CORD BY TEFLON, FAT, COLLAGEN OR GELFOAM
41870	01MAR2023	31OCT2023	N	Laryngeal augmentation or modification by injection techniques, other than a service associated with a service to which item 41861 or 41879 applies
41870	01NOV2023	31DEC9999	Y	Laryngeal augmentation or modification by injection techniques, other than a service associated with a service to which item 41879 applies or item 41861 applies on the same side
41873	01DEC1991	28FEB2023	N	LARYNX, FRACTURED, operation for
41873	01MAR2023	31DEC9999	Y	Larynx, fractured, operation for (H)
41876	01DEC1991	31DEC9999	Y	LARYNX, external operation on, OR LARYNGOFISSURE with or without cordectomy
41879	01DEC1991	28FEB2023	N	LARYNGOPLASTY or TRACHEOPLASTY, including tracheostomy
41879	01MAR2023	31DEC9999	Y	Tracheoplasty, laryngoplasty or thyroplasty, not by injection techniques, including tracheostomy, other than a service associated with a service to which item 41870 applies (H)
41880	23NOV1998	28FEB1999	N	TRACHEOSTOMY by a percutaneous technique using sequential dilatation or partial splitting method to allow insertion of a cuffed tracheostomy tube
41880	01MAR1999	28FEB2023	N	TRACHEOSTOMY by a percutaneous technique using sequential dilatation or partial splitting method to allow insertion of a cuffed tracheostomy tube
41880	01MAR2023	31DEC9999	Y	Tracheostomy by a percutaneous technique (H)
41881	01JUL1998	28FEB1999	N	TRACHEOSTOMY by open exposure of the trachea as an independent procedure
41881	01MAR1999	28FEB2023	N	TRACHEOSTOMY by open exposure of the trachea, including separation of the strap muscles or division of the thyroid isthmus, where performed
41881	01MAR2023	31DEC9999	Y	Tracheostomy by open exposure of the trachea (H)
41882	01DEC1991	31DEC9999	Y	TRACHEOSTOMY
41883	01DEC1991	30JUN1998	N	TRACHEOSTOMY
41883	01JUL1998	31DEC9999	Y	TRACHEOSTOMY by open exposure of the trachea in association with another procedure
41884	01JUL1995	30JUN1998	N	CRICOTHYROSTOMY, by direct stab or Seldinger technique, using Minitrach or similar device, for tracheobronchial toilet
41884	01JUL1998	28FEB1999	N	CRICOTHYROSTOMY OR TRACHEOSTOMY, by direct stab or dilation technique, using Minitrach or similar device
41884	01MAR1999	31DEC2013	N	CRICOTHYROSTOMY by direct stab or Seldinger technique, using Minitrach or similar device
41884	01JAN2014	28FEB2023	N	CRICOTHYROSTOMY by direct stab or Seldinger technique, using mini tracheostomy device
41884	01MAR2023	31DEC9999	Y	Cricothyrostomy (H)
41885	01JUL1998	31DEC9999	Y	TRACHE-OESOPHAGEAL FISTULA, formation of, as a secondary procedure following laryngectomy, including associated endoscopic procedures
41886	01DEC1991	31DEC9999	Y	TRACHEA, removal of foreign body in
41887	01MAR2023	31DEC9999	Y	Pituitary tumour, removal of, by trans-sphenoidal approach, including stereotaxy and dermis, dermofat or fascia grafting, as part of conjoint surgery, other than a service associated with a service to which item 40600 applies (H)
41888	01MAR2023	31DEC9999	Y	Fractured skull, after trauma only, or spontaneous defects with cerebrospinal fluid rhinorrhoea or otorrhoea, repair of, including stereotaxy and dermofat graft (H)
41889	01DEC1991	31DEC9999	Y	BRONCHOSCOPY, as an independent procedure
41890	01MAR2023	31DEC9999	Y	Orbit, decompression of, by fenestration of 2 or more walls, or by the removal of intraorbital peribulbar and retrobulbar fat from each quadrant of the orbit, one eye by endonasal approach (H)
41892	01DEC1991	31DEC9999	Y	BRONCHOSCOPY with 1 or more endobronchial biopsies or other diagnostic or therapeutic procedures
41895	01DEC1991	31DEC9999	Y	BRONCHUS, removal of foreign body in
41898	01DEC1991	31DEC9999	Y	FIBREOPTIC BRONCHOSCOPY with 1 or more transbronchial lung biopsies, with or without bronchial or bronchoalveolar lavage, with or without the use of interventional imaging
41901	01DEC1991	31DEC9999	Y	ENDOSCOPIC LASER RESECTION OF ENDOBRONCHIAL TUMOURS for relief of obstruction including any associated endoscopic procedures
41904	01DEC1991	31DEC9999	Y	BRONCHOSCOPY with dilatation of tracheal stricture
41905	01NOV1995	31DEC9999	Y	TRACHEA OR BRONCHUS, dilatation of stricture and endoscopic insertion of stent
41907	01DEC1991	31DEC9999	Y	NASAL SEPTUM BUTTON, insertion of
41910	01JUL1993	31DEC9999	Y	DUCT OF MAJOR SALIVARY GLAND, transposition of
42503	01DEC1991	31DEC9999	Y	OPHTHALMOLOGICAL EXAMINATION under general anaesthesia, not being a service associated with a service to which another item in this Group applies
42504	01MAY2020	31DEC9999	Y	Glaucoma, implantation of a micro-bypass surgery stent system into the trabecular meshwork, if: (a) conservative therapies have failed, are likely to fail, or are contraindicated; and (b) the service is performed by a specialist with training that is recognised by the Conjoint Committee for the Recognition of Training in Micro-Bypass Glaucoma Surgery
42505	01NOV2018	31JAN2019	N	Complete removal from the eye of a trans-trabecular drainage device or devices, with or without replacement, following device related medical complications necessitating complete removal.
42505	01FEB2019	31DEC9999	Y	Complete removal from the eye of a trans-trabecular drainage device or devices, with or without replacement, following device related medical complications necessitating complete removal.
42506	01DEC1991	31DEC9999	Y	EYE, ENUCLEATION OF, with or without sphere implant
42509	01DEC1991	31DEC9999	Y	EYE, ENUCLEATION OF, with insertion of integrated implant
42510	01MAY1994	30JUN1998	N	EYE, enucleation of, with insertion of hydroxy apatite implant (coral implant), by 1 or more stages
42510	01JUL1998	31DEC9999	Y	EYE, enucleation of, with insertion of hydroxy apatite implant or similar coralline implant
42512	01DEC1991	31DEC9999	Y	GLOBE, EVISCERATION OF
42515	01DEC1991	31DEC9999	Y	GLOBE, EVISCERATION OF, AND INSERTION OF INTRASCLERAL BALL OR CARTILAGE
42518	01DEC1991	31OCT1996	N	ANOPHTHALMIC ORBIT, INSERTION OF CARTILAGE OR ARTIFICIAL IMPLANT as a delayed procedure, or REMOVAL OF IMPLANT FROM SOCKET
42518	01NOV1996	31DEC9999	Y	ANOPHTHALMIC ORBIT, INSERTION OF CARTILAGE OR ARTIFICIAL IMPLANT as a delayed procedure, or REMOVAL OF IMPLANT FROM SOCKET, or PLACEMENT OF A MOTILITY INTEGRATING PEG by drilling into an existing orbital implant
42521	01DEC1991	31DEC9999	Y	ANOPHTHALMIC SOCKET, treatment of, by insertion of a wired-in conformer, integrated implant or dermofat graft, as a secondary procedure
42524	01DEC1991	31DEC9999	Y	ORBIT, SKIN GRAFT TO, as a delayed procedure
42527	01DEC1991	31DEC9999	Y	CONTRACTED SOCKET, RECONSTRUCTION INCLUDING MUCOUS MEMBRANE GRAFTING AND STENT MOULD
42530	01DEC1991	31DEC9999	Y	ORBIT, EXPLORATION with or without biopsy, requiring REMOVAL OF BONE
42533	01DEC1991	31DEC9999	Y	ORBIT, EXPLORATION OF, with drainage or biopsy not requiring removal of bone
42536	01DEC1991	31DEC9999	Y	ORBIT, EXENTERATION OF, with or without skin graft and with or without temporalis muscle transplant
42539	01DEC1991	31DEC9999	Y	ORBIT, EXPLORATION OF, with removal of tumour or foreign body, requiring removal of bone
42542	01DEC1991	30JUN1998	N	ORBIT, EXPLORATION OF, with removal of tumour or of foreign body
42542	01JUL1998	31DEC9999	Y	ORBIT, exploration of anterior aspect with removal of tumour or foreign body
42543	01JUL1998	31DEC9999	Y	ORBIT, exploration of retrobulbar aspect with removal of tumour or foreign body
42545	01DEC1991	30JUN1998	N	ORBIT, decompression of, for dysthyroid eye disease, 2 or more walls, 1 eye
42545	01JUL1998	31DEC9999	Y	ORBIT, decompression of, for dysthyroid eye disease, by fenestration of 2 or more walls, or by the removal of intraorbital peribulbar and retrobulbar fat from each quadrant of the orbit, 1 eye
42548	01DEC1991	31DEC9999	Y	OPTIC NERVE MENINGES, incision of
42551	01DEC1991	31OCT2012	N	EYEBALL, PERFORATING WOUND OF, not involving intraocular structures repair involving suture of cornea or sclera, or both, not being a service to which item 42632 applies
42551	01NOV2012	31DEC9999	Y	EYE, PENETRATING WOUND OR RUPTURE OF, not involving intraocular structures repair involving suture of cornea or sclera, or both, not being a service to which item 42632 applies
42554	01DEC1991	31OCT2012	N	EYEBALL, PERFORATING WOUND OF, with incarceration or prolapse of uveal tissue repair
42554	01NOV2012	31DEC9999	Y	EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration or prolapse of uveal tissue repair
42557	01DEC1991	31OCT2012	N	EYEBALL, PERFORATING WOUND OF, with incarceration of lens or vitreous repair
42557	01NOV2012	31DEC9999	Y	EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration of lens or vitreous repair
42560	01DEC1991	31DEC9999	Y	INTRAOCULAR FOREIGN BODY, magnetic removal from anterior segment
42561	01JUL1998	31DEC9999	Y	Historical item included for item mapping purposes
42563	01DEC1991	31OCT2012	N	INTRAOCULAR FOREIGN BODY, nonmagnetic removal from anterior segment
42563	01NOV2012	31DEC9999	Y	INTRAOCULAR FOREIGN BODY, removal from anterior segment
42566	01DEC1991	31DEC9999	Y	INTRAOCULAR FOREIGN BODY, magnetic removal from posterior segment
42569	01DEC1991	31OCT2012	N	INTRAOCULAR FOREIGN BODY, nonmagnetic removal from posterior segment
42569	01NOV2012	31DEC9999	Y	INTRAOCULAR FOREIGN BODY, removal from posterior segment
42572	01DEC1991	31DEC9999	Y	ORBITAL ABSCESS OR CYST, drainage of
42573	01NOV1994	31AUG2015	N	DERMOID, periorbital, excision of
42573	01SEP2015	30JUN2021	N	DERMOID, periorbital, excision of, on a person 10 years of age or over
42573	01JUL2021	31DEC9999	Y	DERMOID, periorbital, excision of, on a patient 10 years of age or over
42574	01NOV1994	31DEC9999	Y	DERMOID, orbital, excision of
42575	01DEC1991	31DEC9999	Y	TARSAL CYST, extirpation of
42576	01SEP2015	30JUN2021	N	DERMOID, periorbital, excision of, on a person under 10 years of age
42576	01JUL2021	31DEC9999	Y	DERMOID, periorbital, excision of, on a patient under 10 years of age
42578	01DEC1991	31DEC9999	Y	TARSAL CARTILAGE, excision of
42581	01DEC1991	31DEC9999	Y	ECTROPION OR ENTROPION, tarsal cauterisation of
42584	01DEC1991	31DEC9999	Y	TARSORRHAPHY
42587	01DEC1991	30APR1994	N	CRYOTHERAPY or ELECTROLYSIS EPILATION for trichiasis - each eyelid
42587	01MAY1994	31OCT2018	N	TRICHIASIS, treatment of by cryotherapy, laser or electrolysis - each eyelid
42587	01NOV2018	31DEC9999	Y	TRICHIASIS (due to causes other than trachoma), treatment of by cryotherapy, laser or electrolysis - each eyelid
42588	01NOV2018	31DEC9999	Y	TRICHIASIS (due to trachoma), treatment of by cryotherapy, laser or electrolysis - each eyelid
42590	01DEC1991	31DEC9999	Y	CANTHOPLASTY, medial or lateral
42593	01DEC1991	31DEC9999	Y	LACRIMAL GLAND, excision of palpebral lobe
42596	01DEC1991	31DEC9999	Y	LACRIMAL SAC, excision of, or operation on
42599	01DEC1991	31DEC9999	Y	LACRIMAL CANALICULAR SYSTEM, establishment of patency by closed operation using silicone tubes or similar, 1 eye
42602	01DEC1991	31DEC9999	Y	LACRIMAL CANALICULAR SYSTEM, establishment of patency by open operation, 1 eye
42605	01DEC1991	31DEC9999	Y	LACRIMAL CANALICULUS, immediate repair of
42608	01DEC1991	31DEC9999	Y	LACRIMAL DRAINAGE by insertion of glass tube, as an independent procedure
42610	01MAY1994	30JUN1998	N	NASOLACRIMAL TUBE (unilateral) replacement of, or lacrimal passages, probing for obstruction, unilateral, with or without lavage - under general anaesthesia
42610	01JUL1998	31DEC9999	Y	NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing for obstruction, unilateral, with or without lavage - under general anaesthesia
42611	01DEC1991	30APR1994	N	NASOLACRIMAL TUBE (unilateral) replacement of, under general anaesthesia, or lacrimal passages, probing for obstruction, unilateral or bilateral, with or without lavage
42611	01MAY1994	30JUN1998	N	NASOLACRIMAL TUBE (bilateral) replacement of, or lacrimal passages, probing for obstruction, bilateral, with or without lavage - under general anaesthesia
42611	01JUL1998	31DEC9999	Y	NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing for obstruction, bilateral, with or without lavage - under general anaesthesia
42614	01DEC1991	30APR1994	N	LACRIMAL PASSAGES, lavage of, unilateral, not being a service associated with a service to which item 42611 applies (excluding aftercare)
42614	01MAY1994	30JUN1998	N	NASOLACRIMAL TUBE (unilateral) replacement of, or lacrimal passages, probing for obstruction, unilateral, with or without lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare)
42614	01JUL1998	31OCT2001	N	NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, unilateral, including lavage, with or without lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare)
42614	01NOV2001	31DEC9999	Y	NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, unilateral, including lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare)
42615	01MAY1994	30JUN1998	N	NASOLACRIMAL TUBE (bilateral) replacement of, or lacrimal passages, probing for obstruction, bilateral, with or without lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare)
42615	01JUL1998	31OCT2001	N	NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or sit of obstruction, bilateral, including lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare)
42615	01NOV2001	31DEC9999	Y	NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, bilateral, including lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare)
42617	01DEC1991	31DEC9999	Y	PUNCTUM SNIP operation
42620	01DEC1991	31DEC9999	Y	PUNCTUM, occlusion of, by use of a plug
42621	01NOV1996	31DEC9999	Y	PUNCTUM, temporary occlusion of, by use of electrical cautery
42622	01NOV1996	31DEC9999	Y	PUNCTUM, permanent occlusion of, by use of electrical cautery
42623	01DEC1991	31DEC9999	Y	DACRYOCYSTORHINOSTOMY
42626	01DEC1991	31DEC9999	Y	DACRYOCYSTORHINOSTOMY where a previous dacryocystorhinostomy has been performed
42629	01DEC1991	31DEC9999	Y	CONJUNCTIVORHINOSTOMY including dacryocystorhinostomy and fashioning of conjunctival flaps
42632	01DEC1991	31DEC9999	Y	CONJUNCTIVAL PERITOMY OR REPAIR OF CORNEAL LACERATION by conjunctival flap
42635	01DEC1991	31DEC9999	Y	CORNEAL PERFORATIONS, sealing of, with tissue adhesive
42638	01DEC1991	31DEC9999	Y	CONJUNCTIVAL GRAFT OVER CORNEA
42641	01DEC1991	31DEC9999	Y	AUTOCONJUNCTIVAL TRANSPLANT, or mucous membrane graft
42644	01DEC1991	30JUN2008	N	CORNEA OR SCLERA, removal of imbedded foreign body from (excluding aftercare)
42644	01JUL2008	31OCT2012	N	CORNEA OR SCLERA, removal of imbedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare)
42644	01NOV2012	31DEC9999	Y	CORNEA OR SCLERA, complete removal of embedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare)
42647	01DEC1991	31DEC9999	Y	CORNEAL SCARS, removal of, by partial keratectomy, not being a service associated with a service to which item 42686 applies
42650	01DEC1991	31DEC9999	Y	CORNEA, epithelial debridement for corneal ulcer or corneal erosion (excluding aftercare)
42651	01JUL1998	31DEC9999	Y	CORNEA, epithelial debridement for eliminating band keratopathy
42652	01MAY2018	30JUN2021	N	Corneal collagen cross linking, on a person with a corneal ectatic disorder, with evidence of progression-per eye.
42652	01JUL2021	31DEC9999	Y	Corneal collagen cross linking, on a patient with a corneal ectatic disorder, with evidence of progression-per eye
42653	01DEC1991	31OCT1993	N	CORNEA, transplantation of, full thickness, including collection of donor material
42653	01NOV1993	30JUN2014	N	CORNEA, transplantation of, full thickness
42653	01JUL2014	31DEC9999	Y	CORNEA transplantation of
42656	01DEC1991	31OCT1993	N	CORNEA, transplantation of, full thickness, including collection of donor material where there have been 2 previous graft operations
42656	01NOV1993	31OCT2003	N	CORNEA, transplantation of, where there have been 2 previous graft operations
42656	01NOV2003	31DEC9999	Y	CORNEA, transplantation of, second and subsequent procedures
42659	01DEC1991	31OCT1993	N	CORNEA, transplantation of, superficial or lamellar, including collection of donor material
42659	01NOV1993	31DEC9999	Y	CORNEA, transplantation of, superficial or lamellar
42662	01DEC1991	31DEC9999	Y	SCLERA, transplantation of, full thickness, including collection of donor material
42665	01DEC1991	31DEC9999	Y	SCLERA, transplantation of, superficial or lamellar, including collection of donor material
42667	01MAY1997	31DEC9999	Y	RUNNING CORNEAL SUTURE, manipulation of, performed within 4 months of corneal grafting, to reduce astigmatism where a reduction of 2 dioptres of astigmatism is obtained, including any associated consultation
42668	01DEC1991	31DEC9999	Y	CORNEAL SUTURES, removal of, not earlier than 6 weeks after operation requiring use of slit lamp or operating microscope
42670	01MAY1997	31DEC9999	Y	PHOTOTHERAPEUTIC KERATECTOMY by excimer laser
42671	01DEC1991	31DEC9999	Y	REFRACTIVE KERATOPLASTY with penetrating incisions (excluding radial keratotomy) following corneal grafting or intraocular operation INCLUDING ANY MEASUREMENTS AND CALCULATIONS associated with the procedure
42672	01NOV2003	31DEC9999	Y	CORNEAL INCISONS, to correct corneal astigmatism of more than 11/2 dioptres following anterior segment surgery, including appropriate measurements and calculations, performed as an independent procedure
42673	01NOV2003	31DEC9999	Y	ADDITIONAL CORNEAL INCISIONS, to correct corneal astigmatism of more than 11/2 dioptres, including appropriate measurements and calculations, performed in conjunction with other anterior segment surgery
42674	01DEC1991	31DEC9999	Y	CORNEAL INCISIONS, non penetrating, for the correction of astigmatism following surgery of anterior chamber or corneal grafting, and including associated ultrasound pachymetry of corneal thickness, with or without compression sutures
42676	01MAY1997	31DEC9999	Y	CONJUNCTIVA, biopsy of, as an independent procedure
42677	01DEC1991	31DEC9999	Y	CONJUNCTIVA, CAUTERY OF, INCLUDING TREATMENT OF PANNUS each attendance at which treatment is given including any associated consultation
42680	01DEC1991	31DEC9999	Y	CONJUNCTIVA, cryotherapy to, for melanotic lesions or similar using CO² or N²0
42683	01DEC1991	31DEC9999	Y	CONJUNCTIVAL CYSTS, removal of, requiring admission to hospital or approved day-hospital facility
42686	01DEC1991	31DEC9999	Y	PTERYGIUM, removal of
42689	01DEC1991	31DEC9999	Y	PINGUECULA, removal of, not being a service associated with the fitting of contact lenses
42692	01DEC1991	31OCT1998	N	LIMBIC TUMOUR, removal of
42692	01NOV1998	31DEC9999	Y	LIMBIC TUMOUR, removal of, excluding Pterygium
42695	01DEC1991	31OCT1998	N	LIMBIC TUMOUR, excision of, requiring keratectomy or sclerectomy
42695	01NOV1998	31DEC9999	Y	LIMBIC TUMOUR, excision of, requiring keratectomy or sclerectomy, excluding Pterygium
42698	01DEC1991	31OCT2000	N	LENS EXTRACTION
42698	01NOV2000	31OCT2001	N	LENS EXTRACTION, excluding surgery performed for the correction of refractive error only
42698	01NOV2001	31DEC9999	Y	LENS EXTRACTION, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42701	01DEC1991	31OCT2000	N	ARTIFICIAL LENS, insertion of
42701	01NOV2000	31OCT2001	N	ARTIFICIAL LENS, insertion of, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42701	01NOV2001	31OCT2012	N	ARTIFICIAL LENS, insertion of, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42701	01NOV2012	31DEC9999	Y	INTRAOCULAR LENS, insertion of, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42702	01NOV1996	31OCT2000	N	LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS
42702	01NOV2000	31OCT2001	N	LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, excluding surgery performed for the correction of refractive error only
42702	01NOV2001	31OCT2012	N	LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42702	01NOV2012	31DEC9999	Y	LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42703	01NOV1996	31OCT2012	N	ARTIFICIAL LENS, insertion of, into the posterior chamber and suture to the iris and sclera
42703	01NOV2012	31DEC9999	Y	INTRAOCULAR LENS or IRIS PROSTHESIS insertion of, into the posterior chamber with fixation to the iris or sclera
42704	01DEC1991	31OCT2012	N	ARTIFICIAL LENS, REMOVAL or REPOSITIONING of by open operation, not being a service associated with a service to which item 42701 applies
42704	01NOV2012	31DEC9999	Y	INTRAOCULAR LENS, REMOVAL or REPOSITIONING of by open operation, not being a service associated with a service to which item 42701 applies
42705	01MAY2017	31DEC9999	Y	LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye, performed in association with insertion of a trans-trabecular drainage device or devices, in a patient diagnosed with open angle glaucoma who is not adequately responsive to topical anti-glaucoma medications or who is intolerant of anti-glaucoma medication.
42707	01DEC1991	31OCT2005	N	ARTIFICIAL LENS, REMOVAL of and REPLACEMENT with a different lens
42707	01NOV2005	31OCT2012	N	ARTIFICIAL LENS, REMOVAL of and REPLACEMENT with a different lens, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42707	01NOV2012	31DEC9999	Y	INTRAOCULAR LENS, REMOVAL of and REPLACEMENT with a different lens, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye
42710	01DEC1991	31OCT2012	N	ARTIFICIAL LENS, removal of, and replacement with a lens inserted into the posterior chamber and sutured to the iris or sclera
42710	01NOV2012	31DEC9999	Y	INTRAOCULAR LENS, removal of, and replacement with a lens inserted into the posterior chamber and fixated to the iris or sclera
42713	01DEC1991	31OCT2012	N	INTRAOCULAR LENSES, repositioning of, by the use of a McCannell suture or similar
42713	01NOV2012	31DEC9999	Y	IRIS SUTURING, McCannell technique or similar, for fixation of intraocular lens or repair of iris defect
42716	01DEC1991	31DEC9999	Y	CATARACT, JUVENILE, removal of, including subsequent needlings
42718	01NOV2009	31DEC9999	Y	COMPLEX LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, with a surgical procedure time of 40 minutes or more, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 diopres following the removal of cataract in the first eye.
42719	01DEC1991	30JUN1998	N	CAPSULECTOMY OR REMOVAL OF VITREOUS via the anterior chamber by any method, not being a service associated with any other intraocular operation on that eye
42719	01JUL1998	31OCT2005	N	CAPSULECTOMY OR REMOVAL OF VITREOUS via the anterior chamber by any method, not being a service associated with a service to which item 42698, 42702 or 42716 applies
42719	01NOV2005	31OCT2012	N	CAPSULECTOMY OR REMOVAL OF VITREOUS, or both, via the anterior chamber by any method, not being a service associated with a service to which item 42698, 42702 or 42716 applies
42719	01NOV2012	31DEC9999	Y	REMOVAL OF VITREOUS, and/or CAPSULAR or LENS MATERIAL, via a limbal approach, not being a service associated with a service to which item 42698, 42702, 42716, 42725 or 42731 applies
42722	01DEC1991	30JUN1998	N	CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation on that eye 1 or both procedures
42722	01JUL1998	31OCT2005	N	CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with a service to which item 42698, 42702 or 42716 applies - 1 or both procedures
42722	01NOV2005	31DEC9999	Y	CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS, or both, from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and infusion, not being a service associated with a service to which item 42698, 42702 or 42716 applies - 1 or both procedures
42725	01DEC1991	30JUN1998	N	VITRECTOMY by posterior chamber sclerotomy including the removal of vitreous, division of bands or removal of preretinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation on that eye, other than a service to which item 42728 applies
42725	01JUL1998	31OCT2005	N	VITRECTOMY by posterior chamber sclerotomy including the removal of vitreous, division of bands or removal of preretinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution
42725	01NOV2005	31OCT2012	N	VITRECTOMY by posterior chamber sclerotomy including the removal of vitreous, division of bands or removal of preretinal membranes where performed, by cutting and suction and infusion
42725	01NOV2012	30APR2017	N	VITRECTOMY via pars plana sclerotomies including the removal of vitreous, division of bands or removal of epiretinal membranes
42725	01MAY2017	31DEC9999	Y	Vitrectomy via pars plana sclerotomy, including one or more of the following:(a) removal of vitreous; (b) division of vitreous bands; (c) removal of epiretinal membranes; (d) capsulotomy
42728	01DEC1991	31DEC9999	Y	CRYOTHERAPY OF RETINA or other intraocular structures with an internal probe, being a service associated with a service to which item 42725 applies
42731	01DEC1991	31OCT2005	N	CAPSULECTOMY or LENSECTOMY by posterior chamber sclerotomy in conjunction with the removal of vitreous or division of vitreous bands or removal of preretinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation
42731	01NOV2005	31OCT2012	N	CAPSULECTOMY or LENSECTOMY, or both, by posterior chamber sclerotomy in conjunction with the removal of vitreous or division of vitreous bands or removal of preretinal membrane from the posterior chamber by cutting and suction and infusion, not being a service associated with any other intraocular operation
42731	01NOV2012	31DEC9999	Y	LIMBAL OR PARS PLANA LENSECTOMY combined with vitrectomy, not being a service associated with items 42698, 42702, 42719, or 42725
42734	01DEC1991	30APR2017	N	CAPSULOTOMY, other than by laser
42734	01MAY2017	31DEC9999	Y	Capsulotomy, other than by laser, and other than a service associated with a service to which item 42725 or 42731 applies
42737	01DEC1991	31DEC9999	Y	NEEDLING OF POSTERIOR CAPSULE
42738	01MAR2012	31DEC9999	Y	PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, 1 or more of, as an independent procedure.
42739	01MAR2012	28FEB2021	N	PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, 1 or more of, as an independent procedure, for a patient requiring anaesthetic services.
42739	01MAR2021	30JUN2021	N	PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, 1 or more of, as an independent procedure, for a patient requiring the administration of anaesthetic by a specialist anaesthetist.
42739	01JUL2021	31DEC9999	Y	PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, one or more of, as an independent procedure, for a patient requiring the administration of anaesthetic by an anaesthetist.
42740	01DEC1991	31OCT2006	N	PARACENTESIS OF ANTERIOR OR POSTERIOR CHAMBER OR BOTH, for the injection of therapeutic substances, or the removal of aqueous or vitreous for diagnostic purposes, 1 or more of
42740	01NOV2006	29FEB2012	N	PARACENTESIS OF ANTERIOR OR POSTERIOR SEGMENT (including the vitreous) OR BOTH, for the injection of therapeutic substances, or the removal of aqueous or vitreous for diagnostic purposes, 1 or more of
42740	01MAR2012	31DEC9999	Y	INTRAVITREAL INJECTION OF THERAPEUTIC SUBSTANCES, or the removal of vitreous humour for diagnostic purposes, 1 or more of, as a procedure associated with other intraocular surgery.
42741	01JUL2008	31DEC9999	Y	Posterior juxtascleral depot injection of a therapeutic substance, for the treatment of subfoveal choroidal neovascularisation due to age-related macular degeneration, 1 or more of
42743	01DEC1991	31DEC9999	Y	ANTERIOR CHAMBER, IRRIGATION OF BLOOD FROM, as an independent procedure
42744	01NOV2005	30JUN2014	N	NEEDLING FOR DRAINAGE OF ENCYSTED BLEB, following trabeculectomy
42744	01JUL2014	31DEC9999	Y	Needle revision of glaucoma filtration bleb, following glaucoma filtering procedure
42746	01DEC1991	31OCT2012	N	GLAUCOMA, filtering operation for
42746	01NOV2012	31DEC9999	Y	GLAUCOMA, filtering operation for, where conservative therapies have failed, are likely to fail, or are contraindicated
42749	01DEC1991	31DEC9999	Y	GLAUCOMA, filtering operation for, where previous filtering operation has been performed
42752	01DEC1991	31OCT2012	N	GLAUCOMA, insertion of Molteno valve for, 1 or more stages
42752	01NOV2012	31DEC9999	Y	GLAUCOMA, insertion of drainage device incorporating an extraocular reservoir for, such as a Molteno device
42755	01DEC1991	31OCT2012	N	GLAUCOMA, removal of Molteno valve
42755	01NOV2012	31DEC9999	Y	GLAUCOMA, removal of drainage device incorporating an extraocular reservoir for, such as a Molteno device
42758	01DEC1991	30APR2017	N	GONIOTOMY
42758	01MAY2017	31DEC9999	Y	Goniotomy for the treatment of primary congenital glaucoma, excluding the minimally invasive implantation of glaucoma drainage devices
42761	01DEC1991	31DEC9999	Y	DIVISION OF ANTERIOR OR POSTERIOR SYNECHIAE, as an independent procedure, other than by laser
42764	01DEC1991	31DEC9999	Y	IRIDECTOMY (including excision of tumour of iris) OR IRIDOTOMY, as an independent procedure, other than by laser
42767	01DEC1991	31DEC9999	Y	TUMOUR, INVOLVING CILIARY BODY OR CILIARY BODY AND IRIS, excision of
42770	01DEC1991	31OCT1996	N	CYCLODIATHERMY OR CYCLOCRYOTHERAPY
42770	01NOV1996	31DEC9999	Y	CYCLODESTRUCTIVE procedures for the treatment of intractable glaucoma, treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42771	01NOV2001	31DEC9999	Y	CYCLODESTRUCTIVE PROCEDURES for the treatment of intractable glaucoma, treatment to one eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which 42770 applies) is indicated in a 2 year period (Anaes.)
42773	01DEC1991	31OCT2012	N	DETACHED RETINA, diathermy or cryotherapy for, not being a service associated with a service to which item 42776 applies
42773	01NOV2012	31DEC9999	Y	DETACHED RETINA, pneumatic retinopexy for, not being a service associated with a service to which item 42776 applies
42776	01DEC1991	31DEC9999	Y	DETACHED RETINA, buckling or resection operation for
42779	01DEC1991	31OCT2012	N	DETACHED RETINA, revision operation for
42779	01NOV2012	31DEC9999	Y	DETACHED RETINA, revision of scleral buckling operation for
42782	01DEC1991	31OCT2012	N	LASER TRABECULOPLASTY - each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period
42782	01NOV2012	31DEC9999	Y	LASER TRABECULOPLASTY, for the treatment of glaucoma. Each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period
42783	19JUN1997	31OCT1997	N	LASER TRABECULOPLASTY - each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period
42783	01NOV1997	31OCT2012	N	LASER TRABECULOPLASTY - each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period
42783	01NOV2012	31DEC9999	Y	LASER TRABECULOPLASTY, for the treatment of glaucoma. Each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period
42785	01DEC1991	31OCT2006	N	LASER IRIDOTOMY - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42785	01NOV2006	31OCT2018	N	LASER IRIDOTOMY - each treatment episode to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42785	01NOV2018	31DEC9999	Y	LASER IRIDOTOMY - each treatment episode to 1 eye, to a maximum of 3 treatments to that eye in a 2 year period
42786	19JUN1997	31OCT1997	N	LASER IRIDOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period
42786	01NOV1997	31OCT2006	N	LASER IRIDOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period
42786	01NOV2006	31DEC9999	Y	LASER IRIDOTOMY - each treatment episode to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period
42788	01DEC1991	31OCT2006	N	LASER CAPSULOTOMY - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42788	01NOV2006	30APR2017	N	LASER CAPSULOTOMY - each treatment episode to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42788	01MAY2017	31DEC9999	Y	Laser capsulotomy-each treatment episode to one eye, to a maximum of 2 treatments to that eye in a 2 year period-other than a service associated with a service to which item 42702 applies
42789	19JUN1997	31OCT1997	N	LASER CAPSULOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period
42789	01NOV1997	31OCT2006	N	LASER CAPSULOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period
42789	01NOV2006	30APR2017	N	LASER CAPSULOTOMY - each treatment episode to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period
42789	01MAY2017	31DEC9999	Y	Laser capsulotomy-each treatment episode to one eye-if it can be demonstrated that a third or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period-other than a service associated with a service to which item 42702 applies
42791	01DEC1991	30APR2017	N	LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS -each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42791	01MAY2017	31OCT2018	N	Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity-each treatment to one eye, to a maximum of 2 treatments to that eye in a 2 year period
42791	01NOV2018	31DEC9999	Y	Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity-each treatment to one eye, to a maximum of 3 treatments to that eye in a 2 year period
42792	19JUN1997	31OCT1997	N	LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period
42792	01NOV1997	30APR2017	N	LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period
42792	01MAY2017	31DEC9999	Y	Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity -each treatment to one eye-if it can be demonstrated that a third or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period
42794	01DEC1991	31OCT1994	N	DIVISION OF SUTURE BY LASER - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42794	01NOV1994	30JUN2014	N	DIVISION OF SUTURE BY LASER following trabeculoplasty, each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42794	01JUL2014	31DEC9999	Y	DIVISION OF SUTURE BY LASER following glaucoma filtration surgery, each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period
42797	01DEC1991	31DEC9999	Y	LASER COAGULATION OF CORNEAL OR SCLERAL BLOOD VESSELS - each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period
42800	01DEC1991	31DEC9999	Y	PTERYGIUM, removal by laser in 1 or more stages
42801	01NOV2006	31DEC9999	Y	EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment of choroidal melanomas, insertion of
42802	01NOV2006	31DEC9999	Y	EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment of choroidal melanomas, removal of
42803	01DEC1991	31DEC9999	Y	PINGUECULA, removal of by laser in 1 or more stages (not for contact lenses)
42805	01NOV2005	31DEC9999	Y	TANTALUM MARKERS, surgical insertion to the sclera to localise the tumour base to assist in planning of radiotherapy of choroidal melanomas, 1 or more
42806	01DEC1991	31DEC9999	Y	IRIS TUMOUR, laser photocoagulation of
42807	01MAY1997	31DEC9999	Y	PHOTOMYDRIASIS, laser
42808	01MAY1997	30JUN2014	N	PHOTOIRIDOSYNERESIS, laser
42808	01JUL2014	31DEC9999	Y	Laser peripheral iridoplasty
42809	01DEC1991	31OCT2002	N	RETINA, photocoagulation of
42809	01NOV2002	31DEC9999	Y	RETINA, photocoagulation of, not being a service associated with photodynamic therapy with verteporfin
42810	01NOV1996	31DEC9999	Y	PHOTOTHERAPEUTIC KERATECTOMY, by laser, for corneal scarring or disease, excluding surgery for refractive error
42811	01NOV2005	31DEC9999	Y	TRANSPUPILLARY THERMOTHERAPY, for treatment of choroidal and retinal tumours or vascular malformations
42812	01DEC1991	31OCT2012	N	DETACHED RETINA, removal of encircling silicone band from
42812	01NOV2012	31DEC9999	Y	Removal of scleral buckling material, from an eye having undergone previous scleral buckling surgery
42815	01DEC1991	31OCT2012	N	POSTERIOR CHAMBER, removal of silicone oil from
42815	01NOV2012	31DEC9999	Y	VITREOUS CAVITY, removal of silicone oil or other liquid vitreous substitutes from, during a procedure other than that in which the vitreous substitute is inserted
42818	01DEC1991	31OCT2012	N	RETINA, CRYOTHERAPY TO, as an independent procedure, with external probe
42818	01NOV2012	31DEC9999	Y	RETINA, CRYOTHERAPY TO, as an independent procedure, or when performed in conjunction with item 42809 or 42770
42821	01DEC1991	31OCT2003	N	RETROBULBAR TRANSILLUMINATION, as an independent procedure
42821	01NOV2003	31OCT2005	N	OCULAR TRANSILLUMINATION, for the diagnosis and measurement of intraocular tumours, as independent procedure
42821	01NOV2005	31DEC9999	Y	OCULAR TRANSILLUMINATION, for the diagnosis and measurement of intraocular tumours
42824	01DEC1991	31DEC9999	Y	RETROBULBAR INJECTION OF ALCOHOL OR OTHER DRUG, as an independent procedure
42827	01DEC1991	31DEC9999	Y	BOTULINUS TOXIN, injection of, for blepharospasm, including all such injections on any 1 day
42830	01DEC1991	31DEC9999	Y	BOTULINUS TOXIN, injection of, for strabismus including all such injections on any 1 day and associated electromyography
42833	01DEC1991	31OCT2006	N	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES
42833	01NOV2006	31DEC9999	Y	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES on a patient aged 15 years or over
42836	01DEC1991	31OCT2006	N	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES where there have been 2 or more previous squint operations on the eye or eyes
42836	01NOV2006	31DEC9999	Y	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES, on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease
42839	01DEC1991	31OCT2006	N	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES
42839	01NOV2006	31DEC9999	Y	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES on a patient aged 15 years or over
42842	01DEC1991	31OCT2006	N	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES where there have been 2 or more previous squint operations on the eye or eyes
42842	01NOV2006	31DEC9999	Y	SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 or MORE MUSCLES, on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease
42845	01DEC1991	31DEC9999	Y	READJUSTMENT OF ADJUSTABLE SUTURES, 1 or both eyes, as an independent procedure following an operation for correction of squint
42848	01DEC1991	31OCT2006	N	SQUINT, muscle transplant for (Hummelsheim type, or similar operation)
42848	01NOV2006	31DEC9999	Y	SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a patient aged 15 years or over
42851	01DEC1991	31OCT2006	N	SQUINT, muscle transplant for (Hummelsheim type, or similar operation) where there have been 2 or more previous squint operations on the eye or eyes
42851	01NOV2006	31DEC9999	Y	SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease
42854	01DEC1991	31DEC9999	Y	RUPTURED MEDIAL PALPEBRAL LIGAMENT or ruptured EXTRAOCULAR MUSCLE, repair of
42857	01DEC1991	31DEC9999	Y	RESUTURING OF WOUND FOLLOWING INTRAOCULAR PROCEDURES with or without excision of prolapsed iris
42860	01DEC1991	30JUN1998	N	LID, upper or lower, scleral graft to, with recession of the lid retractors
42860	01JUL1998	31DEC9999	Y	EYELID (upper or lower), scleral or Goretex or other non-autogenous graft to, with recession of the lid retractors
42863	01DEC1991	30JUN1998	N	EYELID UPPER, recession of
42863	01JUL1998	31DEC9999	Y	EYELID, recession of
42866	01DEC1991	30JUN1998	N	ENTROPION, repair of, by tightening, shortening or repair of inferior retractors by open operation
42866	01JUL1998	31DEC9999	Y	ENTROPION or TARSAL ECTROPION, repair of, by tightening, shortening or repair of inferior retractors by open operation across the entire width of the eyelid
42869	01DEC1991	31DEC9999	Y	EYELID closure in facial nerve paralysis, insertion of foreign implant for
42872	01DEC1991	31OCT2018	N	EYEBROW, elevation of, for paretic states
42872	01NOV2018	31DEC9999	Y	EYEBROW, elevation of, by skin excision, to correct for a reduced field of vision caused by paretic, involutional, or traumatic eyebrow descent/ptosis to a position below the superior orbital rim
42875	01JUN2002	31DEC9999	Y	Photodynamic therapy, first treatment on or after 1 June 2002, one eye, for patients having commenced therapy prior to 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) other than a service to which item 42887 applies.
42878	01JUN2002	31DEC9999	Y	Photodynamic therapy, first treatment on or after 1 June 2002, both eyes, for patients having commenced therapy prior to 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) other than a service to which item 42996 applies.
42881	01JUN2002	31DEC9999	Y	Photodynamic therapy, initial treatment, one eye, for patients commencing therapy after 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; - and with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200).
42884	01JUN2002	31DEC9999	Y	Photodynamic therapy, 2nd to 4th treatments on the same eye where it has been demonstrated that the patient is eligible for further treatments subsequent to item 42875 or 42878 or 42881, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
42887	01JUN2002	31DEC9999	Y	Photodynamic therapy, 5th treatment on the same eye (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
42990	01JUN2002	31DEC9999	Y	Photodynamic therapy, 6th to 10th treatment on the same eye, where it has been demonstrated that the patient is eligible for further treatments subsequent to item 42875 or 42887, as the case may be, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
42991	01NOV2005	31DEC9999	Y	Photodynamic therapy, 11th to 15th treatment on the same eye, subsequent to item 42990 (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
42993	01JUN2002	31DEC9999	Y	Photodynamic therapy, 2nd to 4th treatments on both eyes where it has been demonstrated that the patient is eligible for further treatments on both eyes subsequent to item 42875 or 42878 or 42881, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200).
42996	01JUN2002	31DEC9999	Y	Photodynamic therapy, 5th treatment on both eyes (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration and has received treatment under; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200).
42999	01JUN2002	31DEC9999	Y	Photodynamic therapy, 6th to 10th treatment on both eyes where it has been demonstrated that the patient is eligible for further treatments on both eyes subsequent to item 42878 or item 42996, as the case may be, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
43000	01NOV2005	31DEC9999	Y	Photodynamic therapy, 11th to 15th treatment on both eyes, subsequent to item 42999 (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: - diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and - with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200)
43002	01JUN2002	31DEC9999	Y	Infusion of verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 42875, 42878, 42881, 42884, 42887, 42990, 42993, 42996 or 42999 has been discontinued on medical grounds
43005	01NOV2002	31DEC9999	Y	Photodynamic therapy, one eye, for patients who commenced photodynamic therapy on that eye prior to 1 November 2002, initial treatment after 1 November 2002, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive
43008	01NOV2002	31DEC9999	Y	Photodynamic therapy, one eye, for patients who commenced photodynamic therapy on that eye prior to 1 November 2002, ongoing treatment following item 43005 or 43011, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive
43011	01NOV2002	31DEC9999	Y	Photodynamic therapy, both eyes, for patients who commenced photodynamic therapy prior to 1 November 2002, initial treatment after 1 November 2002, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive
43014	01NOV2002	31DEC9999	Y	Photodynamic therapy, both eyes, for patients who commenced photodynamic therapy prior to 1 November 2002, ongoing treatment following item 43005 or 43011, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive
43017	01NOV2002	31DEC9999	Y	Infusion of verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 43005, 43008, 43011 or 43014 has been discontinued on medical grounds
43021	01AUG2007	31DEC9999	Y	Photodynamic therapy, one eye, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation.
43022	01AUG2007	31DEC9999	Y	Photodynamic therapy, both eyes, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation.
43023	01AUG2007	31DEC9999	Y	Infusion of Verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 43021 or 43022 has been discontinued on medical grounds.
43500	01DEC1991	31DEC9999	Y	OPERATION ON PHALANX
43503	01DEC1991	31DEC9999	Y	OPERATION ON STERNUM, CLAVICLE, RIB, ULNA, RADIUS, CARPUS, TIBIA, FIBULA, TARSUS, SKULL, MANDIBLE OR MAXILLA (other than alveolar margins) 1 BONE
43506	01DEC1991	31DEC9999	Y	OPERATION ON HUMERUS OR FEMUR 1 BONE
43509	01DEC1991	31DEC9999	Y	OPERATION ON SPINE OR PELVIC BONES 1 BONE
43512	01DEC1991	31DEC9999	Y	OPERATION ON SCAPULA, STERNUM, CLAVICLE, RIB, ULNA, RADIUS, METACARPUS, CARPUS, PHALANX, TIBIA, FIBULA, METATARSUS, TARSUS, MANDIBLE OR MAXILLA (other than alveolar margins) 1 BONE or ANY COMBINATION OF ADJOINING BONES
43515	01DEC1991	31DEC9999	Y	OPERATION ON HUMERUS OR FEMUR 1 BONE
43518	01DEC1991	31DEC9999	Y	OPERATION ON SPINE OR PELVIC BONES 1 BONE
43521	01DEC1991	31DEC9999	Y	OPERATION ON SKULL
43524	01DEC1991	31DEC9999	Y	OPERATION ON ANY COMBINATION OF ADJOINING BONES, being bones referred to in item 43515, 43518 or 43521
43527	01JUL2021	31DEC9999	Y	Operation on sternum, clavicle, rib, metacarpus, carpus, phalanx, metatarsus, tarsus, mandible or maxilla (other than alveolar margins), by open or arthroscopic means, for septic arthritis or osteomyelitis-one approach, inclusive of the adjoining joint (H)
43530	01JUL2021	31DEC9999	Y	Operation on scapula, ulna, radius, tibia, fibula, humerus or femur, by open or arthroscopic means, for septic arthritis or osteomyelitis-one approach, inclusive of the adjoining joint
43533	01JUL2021	31DEC9999	Y	Operation on spine or pelvic bones, by open or arthroscopic means, for septic arthritis or osteomyelitis-one approach, inclusive of the adjoining joint
43800	01DEC1991	31DEC9999	Y	OPERATIONS FOR CORRECTION OF CONGENITAL ABNORMALITIES HYPERTELORISM, correction of
43801	01NOV1994	31DEC9999	Y	INTESTINAL MALROTATION with or without volvulus, laparotomy for, not involving bowel resection
43803	01DEC1991	31DEC9999	Y	CHOANAL ATRESIA, plastic repair of
43804	01NOV1994	31DEC9999	Y	INTESTINAL MALROTATION with or without volvulus, laparotomy for, with bowel resection and anastomosis, with or without formation of stoma
43805	01SEP2015	30JUN2021	N	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, on a person under 10 years of age
43805	01JUL2021	31DEC9999	Y	UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, on a patient under 10 years of age
43806	01DEC1991	31DEC9999	Y	CHOANAL ATRESIA, repair of by puncture and dilatation
43807	01NOV1994	31DEC9999	Y	DUODENAL ATRESIA or STENOSIS, duodenoduodenostomy or duodenojejunostomy for
43809	01DEC1991	31DEC9999	Y	MACROCHEILIA, MACROGLOSSIA OR MACROSTOMIA, operation for
43810	01NOV1994	31DEC9999	Y	JEJUNAL ATRESIA, bowel resection and anastomosis for, with or without tapering
43812	01DEC1991	31DEC9999	Y	TORTICOLLIS, operation for
43813	01NOV1994	31DEC9999	Y	MECONIUM ILEUS, laparotomy for, complicated by 1 or more of associated volvulus, atresia, intesinal perforation with or without meconium peritonitis
43815	01DEC1991	31DEC9999	Y	OESOPHAGUS, correction of congenital stenosis by oesophagectomy and anastomosis
43816	01NOV1994	31DEC9999	Y	ILEAL ATRESIA, COLONIC ATRESIA OR MECONIUM ILEUS not being a service associated with a service to which item 43813 applies, laparotomy for
43818	01DEC1991	31DEC9999	Y	TRACHEOOESOPHAGEAL FISTULA (with or without atresia), ligation and division of
43819	01NOV1994	31AUG2015	N	HIRSCHSPRUNG'S DISEASE, laparotomy for, with or without frozen section biopsies and formation of stoma
43819	01SEP2015	31DEC9999	Y	Agangliosis Coli, laparotomy for, with or without frozen section biopsies and formation of stoma
43821	01DEC1991	31DEC9999	Y	OESOPHAGEAL ATRESIA, with or without fistula, correction of
43822	01NOV1994	31DEC9999	Y	ANORECTAL MALFORMATION, laparotomy and colostomy for
43824	01DEC1991	31DEC9999	Y	NEONATAL ALIMENTARY OBSTRUCTION, laparotomy for, with or without resection, including reduction of volvulus
43825	01NOV1994	31DEC9999	Y	NEONATAL ALIMENTARY OBSTRUCTION, laparotomy for, not being a service to which any other item in this Subgroup applies
43827	01DEC1991	31DEC9999	Y	ANAL SPHINCTEROTOMY as an independent procedure for Hirschsprung's disease
43828	01NOV1994	31DEC9999	Y	ACUTE NEONATAL NECROTISING ENTEROCOLITIS, laparotomy for, with resection, including any anastomoses or stoma formation
43830	01DEC1991	31DEC9999	Y	RECTOSIGMOIDECTOMY for Hirschsprung's disease
43831	01NOV1994	31DEC9999	Y	ACUTE NEONATAL NECROTISING ENTEROCOLITIS where no definitive procedure is possible, laparotomy for
43832	01SEP2015	30JUN2021	N	BRANCHIAL FISTULA, on a person under 10 years of age. Removal of,
43832	01JUL2021	31DEC9999	Y	Branchial fistula, removal of, on a patient under 10 years of age
43833	01DEC1991	31DEC9999	Y	EXOMPHALOS OR GASTROSCHISIS, operation for
43834	01NOV1994	31DEC9999	Y	BOWEL RESECTION for necrotising enterocolitis stricture or strictures, including any anastomoses or stoma formation
43835	01SEP2015	30JUN2021	N	STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection, on a person under 10 years of age
43835	01JUL2021	31DEC9999	Y	STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection, on a patient under 10 years of age
43836	01DEC1991	31DEC9999	Y	EXOMPHALOS OR GASTROSCHISIS, operation for, by plastic flap
43837	01NOV1994	31DEC9999	Y	CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, with diagnosis confirmed in the first 24 hours of life
43838	01SEP2015	30JUN2021	N	Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply, on a person under 10 years of age
43838	01JUL2021	31DEC9999	Y	Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply, on a patient under 10 years of age
43839	01DEC1991	31DEC9999	Y	ANORECTAL MALFORMATION, perineal anoplasty, primary or secondary repair
43840	01NOV1994	31DEC9999	Y	CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, diagnosed after the first day of life and before 20 days of age
43841	01SEP2015	30JUN2021	N	Femoral or inguinal hernia or infantile hydrocele, repair of, on a person under 10 years of age, other than a service to which item 30651 or 43835 applies (H)
43841	01JUL2021	06JUL2021	N	FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 43835 applies, on a patient under 10 years of age
43841	07JUL2021	06AUG2021	N	Femoral or inguinal hernia or infantile hydrocele, repair of, on a patient under 10 years of age, other than a service to which item 30651 or 43835 applies (H) (Anaes.) (Assist.)
43841	07AUG2021	31DEC9999	Y	Femoral or inguinal hernia or infantile hydrocele, repair of, on a patient under 10 years of age, other than a service to which item 30651 or 43835 applies (H)
43842	01DEC1991	31DEC9999	Y	ANORECTAL MALFORMATION, rectoplasty, primary or secondary repair, not being a service to which item 43839 applies
43843	01NOV1994	31DEC9999	Y	OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), complete correction of, not being a service to which item 43846 applies
43845	01DEC1991	31DEC9999	Y	CONTRACTED BLADDER NECK (congenital), wedge excision or perurethral resection of
43846	01NOV1994	31DEC9999	Y	OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), complete correction of, in infant of birth weight less than 1500 grams
43848	01DEC1991	31DEC9999	Y	URACHAL FISTULA, operation for
43849	01NOV1994	31DEC9999	Y	OESOPHAGEAL ATRESIA, gastrostomy for
43851	01DEC1991	31DEC9999	Y	SPHINCTER RECONSTRUCTION for ectopia vesicae, ectopia cloacae or congenital incontinence
43852	01NOV1994	31AUG2015	N	OESOPHAGEAL ATRESIA, thoracotomy for, and division of tracheo-oesophageal fistula without anastomosis
43852	01SEP2015	31DEC9999	Y	OESOPHAGEAL ATRESIA, thoracotomy for, and division of tracheo-oesophageal fistula without anastomosis
43854	01DEC1991	31DEC9999	Y	URETHRAL VALVES OR URETHRAL MEMBRANE, open removal of
43855	01NOV1994	31DEC9999	Y	OESOPHAGEAL ATRESIA, delayed primary anastomosis for
43857	01DEC1991	31DEC9999	Y	LYMPHANGIECTASIS OF LIMB (Milroy's disease) limited excision of
43858	01NOV1994	31AUG2015	N	OESOPHAGEAL ATRESIA, cervical oesophagostomy for
43858	01SEP2015	31DEC9999	Y	OESOPHAGEAL ATRESIA, cervical oesophagostomy for
43860	01DEC1991	31DEC9999	Y	LYMPHANGIECTASIS OF LIMB (Milroy's disease) - radical excision of
43861	01NOV1994	31DEC9999	Y	CONGENITAL CYSTADENOMATOID MALFORMATION OR CONGENITAL LOBAR EMPHYSEMA, thoracotomy and lung resection for
43864	01NOV1994	31DEC9999	Y	GASTROSCHISIS, operation for
43867	01NOV1994	31AUG2015	N	GASTROSCHISIS, secondary operation for, with removal of silo and closure of abdominal wall
43867	01SEP2015	31DEC9999	Y	GASTROSCHISIS or Exomphalos, secondary operation for, with removal of silo
43870	01NOV1994	31DEC9999	Y	EXOMPHALOS containing small bowel only, operation for
43873	01NOV1994	31DEC9999	Y	EXOMPHALOS containing small bowel and other viscera, operation for
43876	01NOV1994	31DEC9999	Y	SACROCOCCYGEAL TERATOMA, excision of, by posterior approach
43879	01NOV1994	31DEC9999	Y	SACROCOCCYGEAL TERATOMA, excision of, by combined posterior and abdominal approach
43882	01NOV1994	31OCT2022	N	CLOACAL EXSTROPHY, operation for
43882	01NOV2022	31DEC9999	Y	Cloacal exstrophy, operation for (H)
43900	01NOV1994	31DEC9999	Y	TRACHEO-OESOPHAGEAL FISTULA without atresia, division and repair of
43903	01NOV1994	31DEC9999	Y	OESOPHAGEAL ATRESIA or CORROSIVE OESOPHAGEAL STRICTURE, oesophageal replacement for, utilizing gastric tube, jejunum or colon
43906	01NOV1994	31DEC9999	Y	OESOPHAGUS, resection of congenital, anastomic or corrosive stricture and anastomosis, not being a service to which item 43903 applies
43909	01NOV1994	31DEC9999	Y	TRACHEOMALACIA, aortopexy for
43912	01NOV1994	31DEC9999	Y	THORACOTOMY and excision of 1 or more of bronchogenic or enterogenous cyst or mediastinal teratoma
43915	01NOV1994	31AUG2015	N	EVENTRATION, plication of diaphragm for
43915	01SEP2015	31DEC9999	Y	EVENTRATION, plication of diaphragm for
43930	01NOV1994	31DEC9999	Y	HYPERTROPHIC PYLORIC STENOSIS, pyloromyotomy for
43933	01NOV1994	31DEC9999	Y	IDIOPATHIC INTUSSUSCEPTION, laparotomy and manipulative reduction of
43936	01NOV1994	31DEC9999	Y	INTUSSUSCEPTION, laparotomy and resection with anastomosis
43939	01NOV1994	31DEC9999	Y	VENTRAL HERNIA following neonatal closure of exomphalos or gastroschisis, repair of
43942	01NOV1994	31AUG2015	N	ABDOMINAL WALL VITELLO INTESTINAL REMNANT, excision of
43942	01SEP2015	31DEC9999	Y	ABDOMINAL WALL VITELLO INTESTINAL REMNANT, excision of
43945	01NOV1994	31DEC9999	Y	PATENT VITELLO INTESTINAL DUCT, excision of
43948	01NOV1994	31AUG2015	N	UMBILICAL GRANULOMA, excision of, under general anaesthesia
43948	01SEP2015	31DEC9999	Y	UMBILICAL GRANULOMA, excision of, under general anaesthesia
43951	01NOV1994	31DEC9999	Y	GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and fundoplication for, without gastrostomy
43954	01NOV1994	31DEC9999	Y	GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and fundoplication for, with gastrostomy
43957	01NOV1994	31DEC9999	Y	GASTRO-OESOPHAGEAL REFLUX, LAPAROTOMY AND FUNDOPLICATION for, with or without hiatus hernia, in child with neurological disease, with gastrostomy
43960	01NOV1994	31DEC9999	Y	ANORECTAL MALFORMATION, perineal anoplasty of
43963	01NOV1994	31DEC9999	Y	ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of
43966	01NOV1994	31DEC9999	Y	ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of, with laparotomy
43969	01NOV1994	31DEC9999	Y	PERSISTENT CLOACA, total correction of, with genital repair using posterior sagittal approach, with or without laparotomy
43972	01NOV1994	31DEC9999	Y	CHOLEDOCHAL CYST, resection of, with 1 duct anastomosis
43975	01NOV1994	31DEC9999	Y	CHOLEDOCHAL CYST, resection of, with 2 duct anastomoses
43978	01NOV1994	31DEC9999	Y	BILIARY ATRESIA, portoenterostomy for
43981	01NOV1994	31DEC9999	Y	NEPHROBLASTOMA, NEUROBLASTOMA OR OTHER MALIGNANT TUMOUR, laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed
43984	01NOV1994	31DEC9999	Y	NEPHROBLASTOMA, radical nephrectomy for
43987	01NOV1994	31DEC9999	Y	NEUROBLASTOMA, radical excision of
43990	01NOV1994	31AUG2015	N	HIRSCHSPRUNG'S DISEASE, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends to sigmoid colon
43990	01SEP2015	31DEC9999	Y	Aganglionosis Coli, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends to sigmoid colon
43993	01NOV1994	31AUG2015	N	HIRSCHSPRUNG'S DISEASE, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends into descending or transverse colon with or without resiting of stoma
43993	01SEP2015	31DEC9999	Y	Aganglionosis Coli, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends into descending or transverse colon with or without resiting of stoma
43996	01NOV1994	31AUG2015	N	HIRSCHSPRUNG'S DISEASE, total colectomy for total colonic aganglionosis with ileoanal pull-through, with or without side to side ileocolic anastomosis
43996	01SEP2015	31DEC9999	Y	Aganglionosis Coli, total colectomy for total colonic aganglionosis with ileoanal pull-through, with or without side to side ileocolic anastomosis
43999	01NOV1994	31AUG2015	N	HIRSCHSPRUNG'S DISEASE, anal sphincterotomy as an independent procedure for
43999	01SEP2015	31DEC9999	Y	Aganglionosis Coli, anal sphincterotomy as an independent procedure for
44100	01DEC1991	31DEC9999	Y	OPERATIONS FOR EXCISION OF CONGENITAL ABNORMALITIES EXTRA DIGIT, ligation of pedicle
44101	01SEP2015	30JUN2021	N	RECTUM, examination of, on a person under 2 years of age, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion
44101	01JUL2021	31DEC9999	Y	RECTUM, examination of, on a patient under 2 years of age, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion
44102	01NOV1994	31AUG2015	N	RECTUM, examination of, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion
44102	01SEP2015	30JUN2021	N	RECTUM, examination of, on a person 2 years of age or over, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion
44102	01JUL2021	31DEC9999	Y	RECTUM, examination of, on a patient 2 years of age or over, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion
44103	01DEC1991	31DEC9999	Y	EXTRA DIGIT, amputation of
44104	01SEP2015	30JUN2021	N	RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a person under 2 years of age, under general anaesthesia
44104	01JUL2021	31DEC9999	Y	RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a patient under 2 years of age, under general anaesthesia
44105	01NOV1994	31AUG2015	N	RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, under general anaesthesia
44105	01SEP2015	30JUN2021	N	RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a person 2 years of age or over, under general anaesthesia
44105	01JUL2021	31DEC9999	Y	RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a patient 2 years of age or over, under general anaesthesia
44106	01DEC1991	31DEC9999	Y	DERMOID, periorbital or superficial nasal, excision of
44107	01DEC1991	31DEC9999	Y	DERMOID, periorbital or superficial nasal, excision of
44108	01NOV1994	31AUG2015	N	INGUINAL HERNIA repair at age less than 3 months
44108	01SEP2015	31OCT2022	N	INGUINAL HERNIA repair at age less than 12 months
44108	01NOV2022	31DEC9999	Y	Inguinal hernia, laparoscopic or open repair of, at age less than 12 months (H)
44110	01DEC1991	31DEC9999	Y	DERMOID, ORBITAL, excision of
44111	01NOV1994	31AUG2015	N	OBSTRUCTED OR STRANGULATED INGUINAL HERNIA, repair of, at age less than 3 months, including orchidopexy when performed
44111	01SEP2015	31OCT2022	N	OBSTRUCTED OR STRANGULATED INGUINAL HERNIA, repair, at age, less than 12 months including orchidopexy when performed
44111	01NOV2022	31DEC9999	Y	Obstructed or strangulated inguinal hernia, laparoscopic or open repair of, at age less than 12 months, including orchidopexy when performed (H)
44113	01DEC1991	31DEC9999	Y	DERMOID OF NOSE, excision of, with intranasal extension
44114	01NOV1994	31AUG2015	N	INGUINAL HERNIA repair at age less than 3 months when orchidopexy also required
44114	01SEP2015	31OCT2022	N	INGUINAL HERNIA repair at age less than 12 months when orchidopexy also required
44114	01NOV2022	31DEC9999	Y	Inguinal hernia, laparoscopic or open repair of, at age less than 12 months when orchidopexy also required (H)
44130	01NOV1994	31DEC9999	Y	LYMPHADENECTOMY, for atypical mycobacterial infection or other granulomatous disease
44133	01NOV1994	31DEC9999	Y	TORTICOLLIS, open division of sternomastoid muscle for
44136	01NOV1994	31DEC9999	Y	INGROWN TOE NAIL, operation for, under general anaesthesia
44300	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44301	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44304	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44305	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44308	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44309	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44312	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44313	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44316	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44317	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44320	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44321	01DEC1991	31DEC9999	Y	Historical item included for item mapping purposes
44324	01DEC1991	31DEC9999	Y	HAND, MIDCARPAL OR TRANSMETACARPAL
44325	01DEC1991	31OCT1999	N	HAND, MIDCARPAL OR TRANSMETACARPAL
44325	01NOV1999	30JUN2021	N	HAND, MIDCARPAL OR TRANSMETACARPAL, amputation of
44325	01JUL2021	31DEC9999	Y	Amputation of hand, transcarpal (H)
44328	01DEC1991	31OCT1999	N	HAND, FOREARM OR THROUGH ARM
44328	01NOV1999	30JUN2021	N	HAND, FOREARM OR THROUGH ARM, amputation of
44328	01JUL2021	31DEC9999	Y	Amputation of hand, proximal to wrist radiocarpal joint, through forearm (H)
44331	01DEC1991	31OCT1999	N	AT SHOULDER
44331	01NOV1999	31DEC9999	Y	AMPUTATION AT SHOULDER
44334	01DEC1991	31OCT1999	N	INTERSCAPULOTHORACIC
44334	01NOV1999	31DEC9999	Y	INTERSCAPULOTHORACIC AMPUTATION
44337	01DEC1991	31DEC9999	Y	1 DIGIT of foot
44338	01DEC1991	31OCT1999	N	1 DIGIT of foot
44338	01NOV1999	30JUN2021	N	1 DIGIT of foot, amputation of
44338	01JUL2021	31DEC9999	Y	Amputation of one digit of one foot, distal to metatarsal head, including any of the following (if performed): (a) resection of bone or joint; (b) excision of neuroma; (c) skin cover with homodigital flaps (H)
44341	01DEC1991	31DEC9999	Y	2 DIGITS of 1 foot
44342	01DEC1991	31OCT1999	N	2 DIGITS of 1 foot
44342	01NOV1999	30JUN2021	N	2 DIGITS of 1 foot, amputation of
44342	01JUL2021	31DEC9999	Y	Amputation of 2 digits of one foot, distal to metatarsal head, including any of the following (if performed): (a) resection of bone or joint; (b) excision of neuroma; (c) skin cover with homodigital flaps (H)
44345	01DEC1991	31DEC9999	Y	3 DIGITS of 1 foot
44346	01DEC1991	31OCT1999	N	3 DIGITS of 1 foot
44346	01NOV1999	30JUN2021	N	3 DIGITS of 1 foot, amputation of
44346	01JUL2021	31DEC9999	Y	Amputation of 3 digits of one foot, distal to metatarsal head, including any of the following (if performed): (a) resection of bone or joint; (b) excision of neuroma; (c) skin cover with homodigital flaps (H)
44349	01DEC1991	31DEC9999	Y	4 DIGITS of 1 foot
44350	01DEC1991	31OCT1999	N	4 DIGITS of 1 foot
44350	01NOV1999	30JUN2021	N	4 DIGITS of 1 foot, amputation of
44350	01JUL2021	31DEC9999	Y	Amputation of 4 digits of one foot, distal to metatarsal head, including any of the following (if performed): (a) resection of bone or joint; (b) excision of neuroma; (c) skin cover with homodigital flaps (H)
44353	01DEC1991	31DEC9999	Y	5 DIGITS of 1 foot
44354	01DEC1991	31OCT1999	N	5 DIGITS of 1 foot
44354	01NOV1999	30JUN2021	N	5 DIGITS of 1 foot, amputation of
44354	01JUL2021	31DEC9999	Y	Amputation of 5 digits of one foot, distal to metatarsal head, including any of the following (if performed): (a) resection of bone or joint; (b) excision of neuroma; (c) skin cover with homodigital flaps (H)
44357	01DEC1991	31DEC9999	Y	TOE, including metatarsal or part of metatarsal each toe
44358	01DEC1991	31OCT1999	N	TOE, including metatarsal or part of metatarsal each toe
44358	01NOV1999	30JUN2021	N	TOE, including metatarsal or part of metatarsal each toe , amputation of
44358	01JUL2021	31DEC9999	Y	Amputation of one ray of one foot, proximal to the metatarsal head, including any of the following (if performed): (a) resection of bone; (b) excision of neuromas; (c) skin cover or recontouring with homodigital flaps (H)
44359	01NOV1999	30JUN2021	N	ONE OR MORE TOES OF ONE FOOT, amputation of, including if performed, excision of 1 or more metatarsal bones of the foot, performed for diabetic or other microvascular disease, excluding aftercare
44359	01JUL2021	31DEC9999	Y	Amputation of one or more toes of one foot, or amputation at midfoot or hindfoot of one foot, for diabetic or other microvascular disease; (a) including any of the following (if performed): (i) resection of bone; (ii) excision of neuromas; (iii) excision of one or more bones of the foot; (iv) treatment of underlying infection; (v) skin cover or recontouring with homodigital flaps; and (b) excluding aftercare; -applicable only once per foot per occasion on which the service is performed (H)
44361	01DEC1991	31OCT1999	N	FOOT AT ANKLE (Syme, Pirogoff types)
44361	01NOV1999	30JUN2021	N	FOOT AT ANKLE (Syme, Pirogoff types), amputation of
44361	01JUL2021	31DEC9999	Y	Amputation of foot, at ankle or hindfoot, including any of the following (if performed): (a) resection of bone; (b) excision of neuromas; (c) skin cover; (H)
44364	01DEC1991	31OCT1999	N	FOOT, MIDTARSAL OR TRANSMETATARSAL
44364	01NOV1999	30JUN2021	N	FOOT, MIDTARSAL OR TRANSMETATARSAL, amputation of
44364	01JUL2021	31DEC9999	Y	Amputation of foot, transtarsal, including any of the following (if performed): (a) resection of bone; (b) excision of neuromas; (c) skin cover; (H)
44367	01DEC1991	31OCT1999	N	THROUGH THIGH, AT KNEE OR BELOW KNEE
44367	01NOV1999	30JUN2021	N	AMPUTATION THROUGH THIGH, AT KNEE OR BELOW KNEE
44367	01JUL2021	14JUL2021	N	Amputation through thigh, at knee or below knee (H) (Anaes.) (Assist.)
44367	15JUL2021	31DEC9999	Y	Amputation through thigh, at knee or below knee (H)
44370	01DEC1991	31OCT1999	N	AT HIP
44370	01NOV1999	31DEC9999	Y	AMPUTATION AT HIP
44373	01DEC1991	31OCT1999	N	HINDQUARTER
44373	01NOV1999	31DEC9999	Y	HINDQUARTER, amputation of
44376	01DEC1991	30JUN2021	N	AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover
44376	01JUL2021	14JUL2021	N	Amputation stump, re?amputation of, to provide adequate skin and muscle cover (Anaes.) (Assist.)
44376	15JUL2021	31DEC9999	Y	Amputation stump, re-amputation of, to provide adequate skin and muscle cover
45000	01DEC1991	31OCT2016	N	"METICULOUS REPAIR DESIGNED TO OBTAIN MAXIMUM FUNCTIONAL RESULTS INCLUDING THE PREPARATION OF THE DEFECT REQUIRING REPAIR (Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL MUSCLE FLAP REPAIR, on eyelid, nose, lip, neck, hand, thumb, finger or genitals"
45000	01NOV2016	30JUN2023	N	Single stage local muscle flap repair, on eyelid, nose, lip, neck, hand, thumb, finger or genitals not in association with any of items 31356 to 31376
45000	01JUL2023	31DEC9999	Y	Single stage local muscle flap repair, on eyelid, nose, lip, neck, hand, thumb, finger or genitals not in association with any of items 31356 to 31383
45003	01DEC1991	31OCT2016	N	SINGLE STAGE LOCAL MYOCUTANEOUS FLAP REPAIR to 1 defect, simple and small
45003	01NOV2016	30JUN2023	N	Single stage local myocutaneous flap repair to one defect, simple and small not in association with any of items 31356 to 31376
45003	01JUL2023	31DEC9999	Y	Single stage local myocutaneous flap repair to one defect, simple and small not in association with any of items 31356 to 31383
45006	01DEC1991	30JUN2023	N	SINGLE STAGE LARGE MYOCUTANEOUS FLAP REPAIR to 1 defect, (pectoralis major, latissimus dorsi, or similar large muscle)
45006	01JUL2023	31DEC9999	Y	Single stage large myocutaneous flap repair to one defect (pectoralis major, latissimus dorsi, or similar large muscle), other than a service associated with a service to which any of items 45524 to 45542 apply (H)
45009	01DEC1991	28FEB2023	N	SINGLE STAGE LOCAL muscle flap repair to 1 defect, simple and small
45009	01MAR2023	31DEC9999	Y	Single stage local muscle flap repair to 1 defect, simple and small, other than a service associated with a service to which item 30278, 30281 or 41722 applies (H)
45012	01DEC1991	30JUN2023	N	SINGLE STAGE LARGE MUSCLE FLAP REPAIR to 1 defect, (pectoralis major, gastrocnemius, gracilis or similar large muscle)
45012	01JUL2023	31DEC9999	Y	Single stage large muscle flap repair to one defect (pectoralis major, gastrocnemius, gracilis or similar large muscle), other than a service associated with a service to which any of items 45524 to 45542 apply (H)
45015	01DEC1991	31DEC9999	Y	MUSCLE OR MYOCUTANEOUS FLAP, delay of
45018	01DEC1991	31OCT2016	N	DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection)
45018	01NOV2016	31OCT2018	N	Dermis, dermofat or fascia graft (excluding transfer of fat by injection), if the service is not associated with neurosurgical services for spinal disorders mentioned in any of items 40300 to 40351
45018	01NOV2018	31OCT2020	N	Dermis, dermofat or fascia graft (excluding transfer of fat by injection), if the service is not associated with neurosurgical services for spinal disorders mentioned in any of items 51011 to 51171
45018	01NOV2020	31DEC9999	Y	Dermis, dermofat or fascia graft (other than transfer of fat by injection): (a) if the service is not associated with neurosurgical services for spinal disorders mentioned in any of items 51011 to 51171; and (b) other than a service associated with a service to which item 39615, 39715, 40106 or 40109 applies
45019	19JUN1997	31OCT1997	N	FULL FACE CHEMICAL PEEL for severely sun-damaged skin, where it can be demonstrated that the damage affects 75% of the facial skin surface area involving photodamage (dermatoheliosis) typically consisting of solar keratoses, solar lentigines, freckling, yellowing and leathering of the skin, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital or approved day-hospital facility by a specialist in the practice of his or her specialty - 1 session only in a 12 month period
45019	01NOV1997	31OCT2018	N	FULL FACE CHEMICAL PEEL for severely sun-damaged skin, where it can be demonstrated that the damage affects 75% of the facial skin surface area involving photodamage (dermatoheliosis) typically consisting of solar keratoses, solar lentigines, freckling, yellowing and leathering of the skin, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital by a specialist in the practice of his or her specialty - 1 session only in a 12 month period
45019	01NOV2018	31DEC9999	Y	Full face chemical peel for severely sun-damaged skin, if: (a) the damage affects at least 75% of the facial skin surface area; and (b) the damage involves photo-damage (dermatoheliosis); and (c) the photo-damage involves: (i) a solar keratosis load exceeding 30 individual lesions; or (ii) solar lentigines; or (iii) freckling, yellowing or leathering of the skin; or (iv) solar kertoses which have proven refractory to, or recurred following, medical therapies; and (d) at least medium depth peeling agents are used; and (e) the chemical peel is performed in the operating theatre of a hospital by a medical practitioner recognised as a specialist in the specialty of dermatology or plastic surgery. Applicable once only in any 12 month period
45020	19JUN1997	31OCT1997	N	FULL FACE CHEMICAL PEEL for severe chloasma or melasma refractory to all other treatments, where it can be demonstrated that the chloasma or melasma affects 75% of the facial skin surface area involving diffuse pigmentation visible at a distance of 4 metres, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital or approved day-hospital facility by a specialist in the practice of his or her specialty - 1 session only in a 12 month period
45020	01NOV1997	31DEC9999	Y	FULL FACE CHEMICAL PEEL for severe chloasma or melasma refractory to all other treatments, where it can be demonstrated that the chloasma or melasma affects 75% of the facial skin surface area involving diffuse pigmentation visible at a distance of 4 metres, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital by a specialist in the practice of his or her specialty - 1 session only in a 12 month period
45021	01DEC1991	28FEB1999	N	ABRASIVE THERAPY, limited to 1 aesthetic area
45021	01MAR1999	31OCT1999	N	ABRASIVE THERAPY for serverely scarring resulting from trauma, burns or cystic acne - limited to 1 aesthetic area
45021	01NOV1999	30JUN2023	N	ABRASIVE THERAPY for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area
45021	01JUL2023	31DEC9999	Y	Abrasive therapy for severely disfiguring scarring of face resulting from trauma, burns or acne, if sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes-limited to one claim per patient per episode
45024	01DEC1991	28FEB1999	N	ABRASIVE THERAPY to more than 1 aesthetic area
45024	01MAR1999	31OCT1999	N	ABRASIVE THERAPY for severey disfiguring scarring resulting from trauma, burns or cystic acne - more than 1 aesthetic area
45024	01NOV1999	31DEC9999	Y	ABRASIVE THERAPY for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area
45025	01NOV1995	31OCT1999	N	CARBON DIOXIDE LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or cystic acne - limited to 1 aesthetic area
45025	01NOV1999	31OCT2007	N	CARBON DIOXIDE LASER OR ERBIUM LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area
45025	01NOV2007	31DEC9999	Y	CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area
45026	01NOV1995	31OCT1999	N	CARBON DIOXIDE LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or cystic acne - more than 1 aesthetic area
45026	01NOV1999	31OCT2007	N	CARBON DIOXIDE LASER OR ERBIUM LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area
45026	01NOV2007	31DEC9999	Y	CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area
45027	01DEC1991	30JUN2023	N	ANGIOMA, cauterisation of or injection into, where undertaken in the operating theatre of a hospital
45027	01JUL2023	29FEB2024	N	Vascular anomaly, cauterisation of or injection into, if undertaken in the operating theatre of a hospital
45027	01MAR2024	31DEC9999	Y	Vascular anomaly, cauterisation of or injection into, if undertaken in the operating theatre of a hospital (H)
45030	01DEC1991	31OCT1994	N	ANGIOMA OF SKIN and subcutaneous tissue (excluding facial muscle or breast) or mucous surface, small, excision and suture of
45030	01NOV1994	30JUN2023	N	ANGIOMA (haemangioma or lymphangioma or both) of skin and subcutaneous tissue (excluding facial muscle or breast) or mucous surface, small, excision and suture of
45030	01JUL2023	31DEC9999	Y	Vascular anomaly, of skin, mucous membrane and/or subcutaneous tissue, small, excision and suture of
45033	01DEC1991	30JUN1993	N	ANGIOMA OF FACIAL MUSCLE OR BREAST, large or involving deeper tissue, excision and suture of
45033	01JUL1993	31OCT1994	N	ANGIOMA, large or involving deeper tissue including facial muscle or breast, excision and suture of
45033	01NOV1994	30JUN2023	N	ANGIOMA, (haemangioma or lymphangioma or both), large or involving deeper tissue including facial muscle or breast, excision and suture of
45033	01JUL2023	31DEC9999	Y	Vascular anomaly, large or involving deeper tissue including facial muscle, excision and suture of
45035	01NOV1994	30JUN2023	N	ANGIOMA (haemangioma or lymphangioma or both), large and deep, involving muscles or nerves, excision of
45035	01JUL2023	31DEC9999	Y	Vascular anomaly, large, deep, and involving major neurovascular structures, excision of, including dissection of muscles, nerves or major vessels (H)
45036	01DEC1991	31OCT1994	N	ANGIOMA OF NECK, deep, excision of
45036	01NOV1994	30JUN2023	N	ANGIOMA (haemangioma or lymphangioma or both) of neck, deep, excision of
45036	01JUL2023	31DEC9999	Y	Vascular anomaly, of neck, deep and involving major neurovascular structures, excision of, including dissection of cranial nerves and major vessels (H)
45039	01DEC1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION (3 centimetres or less) of superficial tissue, excision of
45042	01DEC1991	31DEC9999	Y	ARTERIOVENOUS MALFORMATION, (greater than 3 centimetres), excision of
45045	01DEC1991	30JUN1993	N	ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, neck, hand, thumb, finger or genitals, excision of
45045	01JUL1993	30JUN2023	N	ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, excision of
45045	01JUL2023	31DEC9999	Y	Vascular anomaly on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, excision of
45048	01DEC1991	31OCT1994	N	LYMPHOEDEMATOUS TISSUE of lower leg and foot, or thigh, or upper arm, or forearm and hand, major excision of
45048	01NOV1994	31DEC9999	Y	LYMPHOEDEMATOUS tissue or lymphangiectasis, of lower leg and foot, or thigh, or upper arm, or forearm and hand, major excision of
45051	01DEC1991	30JUN1993	N	FOREIGN IMPLANT, (non biological), insertion of, for contour reconstruction for pathological deformity
45051	01JUL1993	31OCT2015	N	CONTOUR RECONSTRUCTION for pathological deformity, insertion of foreign implant (non biological but excluding injection of liquid or semisolid material) by open operation
45051	01NOV2015	31OCT2018	N	Contour reconstruction for open repair of contour defects, due to deformity, requiring insertion of a non-biological implant, if it can be demonstrated that contour reconstructive surgery is indicated because the deformity is secondary to congenital absence of tissue or has arisen from trauma (other than trauma from previous cosmetic surgery), excluding the following: (a) insertion of a non-biological implant that is a component of another service listed in Group T8; (b) injection of liquid or semisolid material; (c) oral and maxillofacial implant services provided under item 52321; (d) services to insert mesh
45051	01NOV2018	31DEC9999	Y	Contour reconstruction by open repair of contour defects, due to deformity, if: (a) contour reconstructive surgery is indicated because the deformity is secondary to congenital absence of tissue or has arisen from trauma (other than trauma from previous cosmetic surgery); and (b) insertion of a non-biological implant is required, other than one or more of the following: (i) insertion of a non-biological implant that is a component of another service specified in Group T8; (ii) injection of liquid or semisolid material; (iii) an oral and maxillofacial implant service to which item 52321 applies; (iv) a service to insert mesh; and (c) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45054	01NOV1999	30JUN2023	N	LIMB OR CHEST, decompression escharotomy of (including all incisions), for acute compartment syndrome secondary to burn
45054	01JUL2023	31DEC9999	Y	Limb or chest, decompression escharotomy of (including all incisions), for acute compartment syndrome secondary to burn (H)
45060	01NOV2018	31DEC9999	Y	Developmental breast abnormality, single stage correction of, if: (a) the correction involves either: (i) bilateral mastopexy for symmetrical tubular breasts; or (ii) surgery on both breasts with a combination of insertion of one or more implants (which must have at least a 10% volume difference), mastopexy or reduction mammaplasty, if there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least 20% in normally shaped breasts, or 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Applicable only once per occasion on which the service is provided
45061	01NOV2018	31DEC9999	Y	Developmental breast abnormality, 2 stage correction of, first stage, involving surgery on both breasts with a combination of insertion of one or more tissue expanders, mastopexy or reduction mammaplasty, if: (a) there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes. Applicable only once per occasion on which the service is provided
45062	01NOV2018	31DEC9999	Y	Developmental breast abnormality, 2 stage correction of, second stage, involving surgery on both breasts with a combination of exchange of one or more tissue expanders for one or more implants (which must have at least a 10% volume difference), mastopexy or reduction mammaplasty, if: (a) there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes. Applicable only once per occasion on which the service is provided
45200	01DEC1991	31OCT2006	N	"SKIN FLAP SURGERY (Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, simple and small, excluding flap for male pattern baldness"
45200	01NOV2006	31OCT2016	N	"(Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, simple and small, excluding flap for male pattern baldness and excluding H-flap or double advancement flap"
45200	01NOV2016	30JUN2023	N	Single stage local flap, if indicated to repair one defect, simple and small, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376
45200	01JUL2023	31DEC9999	Y	Single stage local flap, if indicated to repair one defect, simple and small, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31383
45201	01NOV2016	31OCT2018	N	Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion (only in association with items 31000, 31001, 31002, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373 or 31376)-may be claimed only once per defect
45201	01NOV2018	30JUN2023	N	Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion (only in association with items 31000, 31001, 31002, 31003, 31004, 31005, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373 or 31376)-may be claimed only once per defect
45201	01JUL2023	31DEC9999	Y	Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion (only in association with items 31000, 31001, 31002, 31003, 31004, 31005, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373, 31376, 31378, 31380 or 31383)-may be claimed only once per defect
45202	01NOV2016	31DEC9999	Y	Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion in a patient, if the clinical relevance of the procedure is clearly annotated in the patient's record and either: (a) item 45201 applies and additional flap repair is required for the same defect; or (b) item 45201 does not apply and either: (i) the patient has severe pre-existing scarring, severe skin atrophy or sclerodermoid changes; or (ii) the repair is contiguous with a free margin
45203	01DEC1991	31OCT2006	N	SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, complicated or large, excluding flap for male pattern baldness
45203	01NOV2006	31OCT2016	N	SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, complicated or large, excluding flap for male pattern baldness and excluding H-flap or double advancement flap
45203	01NOV2016	30JUN2023	N	Single stage local flap, if indicated to repair one defect, complicated or large, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376
45203	01JUL2023	31DEC9999	Y	Single stage local flap, if indicated to repair one defect, complicated or large, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31383
45206	01DEC1991	30JUN1993	N	SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, neck, hand, thumb, finger or genitals
45206	01JUL1993	31OCT2006	N	SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals
45206	01NOV2006	31OCT2016	N	SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, and excluding H-flap or double advancement flap
45206	01NOV2016	30JUN2023	N	Single stage local flap if indicated to repair one defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376
45206	01JUL2023	31DEC9999	Y	Single stage local flap if indicated to repair one defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals and excluding H-flap or double advancement flap not in association with any of items 31356 to 31383
45207	01NOV2006	31OCT2016	N	H-FLAP OR DOUBLE ADVANCEMENT FLAP where indicated to repair 1 defect, on eyelid, eyebrow or forehead
45207	01NOV2016	30JUN2023	N	H-flap or double advancement flap if indicated to repair one defect, on eyelid, eyebrow or forehead not in association with any of items 31356 to 31376
45207	01JUL2023	31DEC9999	Y	H-flap or double advancement flap if indicated to repair one defect, on eyelid, eyebrow or forehead not in association with any of items 31356 to 31383
45209	01DEC1991	30JUN2023	N	DIRECT FLAP REPAIR (cross arm, abdominal or similar), first stage
45209	01JUL2023	29FEB2024	N	Pedicled flap repair (forehead, cross arm, cross leg, abdominal or similar), first stage of a multistage procedure
45209	01MAR2024	31DEC9999	Y	Pedicled flap repair (forehead, cross arm, cross leg, abdominal or similar), first stage of a multistage procedure (H)
45212	01DEC1991	30JUN2023	N	DIRECT FLAP REPAIR (cross arm, abdominal or similar), second stage
45212	01JUL2023	31DEC9999	Y	Pedicled flap repair (forehead, cross arm, cross leg, abdominal or similar), subsequent stage of a multistage procedure
45215	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, cross leg, first stage
45218	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, cross leg, second stage
45221	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, small (cross finger or similar), first stage
45224	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, small (cross finger or similar), second stage
45227	01DEC1991	31DEC9999	Y	INDIRECT FLAP OR TUBED PEDICLE, formation of
45230	01DEC1991	31DEC9999	Y	DIRECT OR INDIRECT FLAP OR TUBED PEDICLE, delay of
45233	01DEC1991	31DEC9999	Y	INDIRECT FLAP OR TUBED PEDICLE, preparation of intermediate or final site and attachment to the site
45236	01DEC1991	31DEC9999	Y	INDIRECT FLAP OR TUBED PEDICLE, spreading of pedicle, as a separate procedure
45239	01DEC1991	31OCT2006	N	DIRECT, INDIRECT OR LOCAL FLAP, revision of
45239	01NOV2006	30JUN2023	N	DIRECT, INDIRECT OR LOCAL FLAP, revision of, by incision and suture, not being a service to which item 45240 applies
45239	01JUL2023	31DEC9999	Y	Direct, indirect, free or local flap, revision of, by incision and suture and/or liposuction, applicable once per flap, not being a service associated with a service to which item 45497 applies
45240	01NOV2006	31DEC9999	Y	DIRECT, INDIRECT OR LOCAL FLAP, revision of, by liposuction, not being a service to which item 45239, 45497, 45498 or 45499 applies
45400	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) of a granulating area, small
45403	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) of a granulating area, extensive
45406	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving not more than 3 per cent of total body surface
45409	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface
45412	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface
45415	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface
45418	01DEC1991	31OCT1999	N	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more of total body surface
45418	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more but less than 15 per cent of total body surface
45419	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more of total body surface
45421	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue, on eyelid, nose, lip, neck, hand, thumb, finger or genitals
45424	01DEC1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving not more than 3 per cent of total body surface
45427	01DEC1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface
45430	01DEC1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface
45433	01DEC1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface
45436	01DEC1991	31DEC9999	Y	FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 12 per cent or more of total body surface
45439	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to 1 defect, including elective dissection, small
45440	01JUL2023	31DEC9999	Y	Split thickness skin graft to a small defect that is:(a) less than 40 mm in diameter: (i) on areas below the knee; or(ii) distal to the ulnar styloid; or(iii) on the genital area; or(iv) on areas above the clavicle; or (b) less than 80 mm in diameter on any other part of the body
45442	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to 1 defect, including elective dissection, extensive
45443	01JUL2023	31DEC9999	Y	Split thickness skin graft to a large defect that is:(a) 40 mm or more in diameter: (i) on areas below the knee; or(ii) distal to the ulnar styloid; or(iii) on the genital area; or(iv) on areas above the clavicle; or (b) 80 mm or more in diameter on any other part of the body
45445	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) as inlay graft to 1 defect including elective dissection using a mould (including insertion of, and removal of mould)
45448	01DEC1991	31DEC9999	Y	FREE GRAFTING (split skin) to 1 defect, including elective dissection on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, not being a service to which item 45442 or 45445 applies
45451	01DEC1991	30JUN2023	N	FREE GRAFTING (full thickness), to 1 defect, excluding grafts for male pattern baldness
45451	01JUL2023	31DEC9999	Y	Full thickness skin graft to one defect, with an average diameter of 5 mm or more
45460	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - one surgeon
45461	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - conjoint surgery, principal surgeon
45462	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - conjoint surgery, co- surgeon
45464	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - one surgeon
45465	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - conjoint surgery, principal surgeon
45466	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - conjoint surgery, co-surgeon
45468	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 30 percent or more but less than 40 percent of total body surface - conjoint surgery, principal surgeon
45469	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 30 percent or more but less than 40 percent of total body surface - conjoint surgery, co-surgeon
45471	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 40 percent or more but less than 50 percent of total body surface - conjoint surgery, principal surgeon
45472	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 40 percent or more but less than 50 percent of total body surface - conjoint surgery, co-surgeon
45474	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 50 percent or more but less than 60 percent of total body surface - conjoint surgery, principal surgeon
45475	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 50 percent or more but less than 60 percent of total body surface - conjoint surgery, co-surgeon
45477	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 60 percent or more but less than 70 percent of total body surface - conjoint surgery, principal surgeon
45478	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 60 percent or more but less than 70 percent of total body surface - conjoint surgery, co-surgeon
45480	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 70 percent or more but less than 80 percent of total body surface - conjoint surgery, principal surgeon
45481	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 70 percent or more but less than 80 percent of total body surface - conjoint surgery, co-surgeon
45483	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 80 percent or more of total body surface - conjoint surgery, principal surgeon
45484	01MAY2000	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 80 percent or more of total body surface - conjoint surgery, co-surgeon
45485	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - upper eyelid, nose, lip, ear or palm of the hand
45486	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - forehead, cheek, anterior aspect of the neck, chin, plantar aspect of the foot, heel or genitalia
45487	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - whole of toe
45488	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 1 digit of the hand
45489	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 2 digits of the hand
45490	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 3 digits of the hand
45491	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 4 digits of the hand
45492	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 5 digits of the hand
45493	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - portion of digit of hand
45494	01NOV1999	31DEC9999	Y	FREE GRAFTING (split skin) to burns, including excision of burnt tissue - whole of face (excluding ears)
45496	01MAY2000	31DEC9999	Y	FLAP, free tissue transfer using microvascular techniques - revision of, by open operation
45497	01MAY2000	31OCT2006	N	FLAP, free tissue transfer using microvascular techniques - complete revision of, by liposuction
45497	01NOV2006	30JUN2023	N	FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - complete revision of, by liposuction
45497	01JUL2023	31DEC9999	Y	Flap, free tissue transfer using microvascular techniques or any autologous breast reconstruction, revision of, by liposuction, other than a service associated with a service to which item 45239 applies (H)
45498	01MAY2000	31OCT2006	N	FLAP, free tissue transfer using microvascular techniques - staged revision of, by liposuction - first stage
45498	01NOV2006	31DEC9999	Y	FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - staged revision of, by liposuction - first stage
45499	01MAY2000	31OCT2006	N	FLAP, free tissue transfer using microvascular techniques - staged revision of, by liposuction - second stage
45499	01NOV2006	31DEC9999	Y	FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - staged revision of, by liposuction - second stage
45500	01DEC1991	30JUN2023	N	MICROVASCULAR REPAIR using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit
45500	01JUL2023	31DEC9999	Y	Microvascular repair using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit; cannot be claimed by the same provider for both artery and vein (H)
45501	01MAR1999	30JUN2023	N	MICROVASCULAR ANASTOMOSIS of artery using microsurgical techniques, for re-implantation of limb or digit
45501	01JUL2023	31DEC9999	Y	Microvascular anastomosis of artery or vein using microsurgical techniques, for replantation or revascularisation of limb or digit, if the limb or digit is devitalised and the repair is critical for restoration of blood supply, other than a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies (H)
45502	01JUL1993	28FEB1999	N	MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue
45502	01MAR1999	30JUN2023	N	MICROVASCULAR ANASTOMOSIS of vein using microsurgical techniques, for re-implantation of limb or digit
45502	01JUL2023	31DEC9999	Y	Microvascular anastomoses of artery and vein using microsurgical techniques, for replantation or revascularisation of limb or digit, if the limb or digit is devitalised and the repair is critical for restoration of blood supply, including anastomoses of all required vessels for that extremity or digit, unless a micro-arterial or micro-venous graft is being used, other than a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies (H)
45503	01DEC1991	30JUN2023	N	MICRO-ARTERIAL OR MICRO-VENOUS GRAFT using microsurgical techniques
45503	01JUL2023	31DEC9999	Y	Micro-arterial or micro-venous graft using microsurgical techniques, if the graft is critical for restoration of blood supply, including harvest of graft and suturing of all related anastomoses (not to be claimed in the context of cardiac surgery) (H)
45504	01MAR1999	30JUN2023	N	MICROVASCULAR ANASTOMOSIS of artery using microsurgical techniques, for free transfer of tissue including setting in of free flap
45504	01JUL2023	31DEC9999	Y	Microvascular anastomosis of artery, vein or veins, using microsurgical techniques, for free transfer of tissue, including setting in of free flap, other than:(a) a service for the purpose of breast reconstruction; or(b) a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies(H)
45505	01MAR1999	30JUN2023	N	MICROVASCULAR ANASTOMOSIS of vein using microsurgical techniques, for free transfer of tissue including setting in of free flap
45505	01JUL2023	31DEC9999	Y	Microvascular anastomoses of artery and vein or veins, using microsurgical techniques, for free transfer of tissue, including setting in of free flap, other than:(a) a service for the purpose of breast reconstruction; or(b) a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies(H)
45506	01DEC1991	30JUN1993	N	SCAR, of face or neck, revision of, NOT MORE THAN 3 cms IN LENGTH, where undertaken in the operating theatre of a hospital or approved day-hospital facility
45506	01JUL1993	31DEC9999	Y	SCAR, of face or neck, not more than 3 cm in length, revision of, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her specialty
45507	01JUL2023	31DEC9999	Y	Microvascular repair using microsurgical techniques, with restoration of continuity of artery and vein of distal extremity or digit, including anastomoses of all required vessels for that extremity or digit, other than a service associated with a service to which item 45564, 45565 or 45567 applies (H)
45509	01DEC1991	31DEC9999	Y	MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue
45510	01JUL2023	31DEC9999	Y	Scar, of face or neck, not more than 3 cm in length, revision of, if:(a) undertaken in the operating theatre of a hospital; or(b) performed by a specialist in the practice of the specialists specialty
45512	01DEC1991	30JUN1993	N	SCAR, of face or neck, revision of, MORE THAN 3 cms IN LENGTH, where undertaken in the operating theatre of a hospital or approved day-hospital facility
45512	01JUL1993	31DEC9999	Y	SCAR, of face or neck, more than 3 cm in length, revision of, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her specialty
45515	01DEC1991	30JUN1993	N	SCAR, other than on face or neck, not more than 7 cms in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure
45515	01JUL1993	30JUN2023	N	SCAR, other than on face or neck, not more than 7 cms in length, revision of, as an independent procedure, where undertaken in the operating theatre of a hospital or where performed by a specialist in the practice of his or her specialty
45515	01JUL2023	31DEC9999	Y	Scar, other than on face or neck, not more than 7 cm in length, revision of, if:(a) the service is:(i) undertaken in the operating theatre of a hospital; or(ii) performed by a specialist in the practice of the specialists specialty; and(b) the service is not performed in conjunction with the insertion of breast implants for cosmetic purposes; and(c) the incision made for revision of the scar is not used as an approach for another procedure (including a non rebatable procedure); and(d) sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes
45518	01DEC1991	30JUN1993	N	SCAR, other than on face or neck, more than 7 cms in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure
45518	01JUL1993	30JUN2023	N	SCAR, other than on face or neck, more than 7 cms in length, revision of, as an independent procedure, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her speciality
45518	01JUL2023	31DEC9999	Y	Scar, other than on face or neck, more than 7 cm in length, revision of, if:(a) the service is:(i) undertaken in the operating theatre of a hospital; or(ii) performed by a specialist in the practice of the specialists specialty; and(b) the service is not performed in conjunction with the insertion of breast implants for cosmetic purposes; and(c) the incision made for revision of the scar is not used as an approach for another procedure (including a non rebatable procedure); and(d) sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes
45519	01NOV1996	31DEC9999	Y	EXTENSIVE BURN SCARS OF SKIN (more than 1 percent of body surface area), excision of, for correction of scar contracture
45520	01JUL1998	31OCT2018	N	REDUCTION MAMMAPLASTY (unilateral) with surgical repositioning of nipple
45520	01NOV2018	30JUN2023	N	Reduction mammaplasty (unilateral) with surgical repositioning of nipple, in the context of breast cancer or developmental abnormality of the breast
45520	01JUL2023	31DEC9999	Y	Reduction mammaplasty (unilateral) with surgical repositioning of nipple, in the context of breast cancer or developmental abnormality of the breast, other than a service associated with a service to which item 31512, 31513 or 31514 applies on the same side (H)
45521	01DEC1991	31DEC9999	Y	MAMMAPLASTY, reduction (unilateral), with or without repositioning of nipple
45522	01JUL1998	31OCT2006	N	REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple
45522	01NOV2006	31DEC2014	N	REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple, excluding the treatment of gynaecomastia
45522	01JAN2015	31OCT2018	N	REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple, excluding the treatment of gynaecomastia (H)
45522	01NOV2018	30JUN2023	N	Reduction mammaplasty (unilateral) without surgical repositioning of the nipple: (a) excluding the treatment of gynaecomastia; and (b) not with insertion of any prosthesis
45522	01JUL2023	31DEC9999	Y	Reduction mammaplasty (unilateral) without surgical repositioning of the nipple:(a) excluding the treatment of gynaecomastia; and(b) not with insertion of any prosthesis;other than a service associated with a service to which item 31512, 31513 or 31514 applies on the same side (H)
45523	01NOV2018	30JUN2023	N	Reduction mammaplasty (bilateral) with surgical repositioning of the nipple: (a) for patients with macromastia and experiencing pain in the neck or shoulder region; and (b) not with insertion of any prosthesis
45523	01JUL2023	31DEC9999	Y	Reduction mammaplasty (bilateral) with surgical repositioning of the nipple:(a) for patients with macromastia who are experiencing pain in the neck or shoulder region; and(b) not with insertion of any prosthesis;other than a service associated with a service to which item 31512, 31513 or 31514 applies (H)
45524	01DEC1991	31OCT2018	N	MAMMAPLASTY, AUGMENTATION, for significant breast asymmetry where the augmentation is limited to 1 breast
45524	01NOV2018	30JUN2023	N	Mammaplasty, augmentation (unilateral) in the context of: (a) breast cancer; or (b) developmental abnormality of the breast, if there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds. Applicable only once per occasion on which the service is provided
45524	01JUL2023	31DEC9999	Y	Mammaplasty, augmentation (unilateral) in the context of: (a) breast cancer; or (b) developmental abnormality of the breast, if there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds. Applicable only once per occasion on which the service is provided, other than a service associated with a service to which item 45006 or 45012 applies (H)
45527	01DEC1991	31OCT2018	N	MAMMAPLASTY, AUGMENTATION, (unilateral), following mastectomy
45527	01NOV2018	30JUN2023	N	Breast reconstruction (unilateral), following mastectomy, using a permanent prosthesis
45527	01JUL2023	31DEC9999	Y	Breast reconstruction (unilateral), following mastectomy, using a permanent prosthesis, other than a service associated with a service to which item 45006 or 45012 applies (H)
45528	19JUN1997	31OCT1997	N	MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation
45528	01NOV1997	30APR2001	N	MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation
45528	01MAY2001	30APR2003	N	MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation of the breast
45528	01MAY2003	31OCT2004	N	MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45527 applies, where it can be demonstrated that surgery is indicated because of congenital malformation, disease or trauma of the breast (other than trauma resulting from previous elective cosmetic surgery)
45528	01NOV2004	31OCT2018	N	MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45527 applies, where it can be demonstrated that surgery is indicated because of malformation of breast tissue (excluding hypomastia), disease or trauma of the breast (other than trauma resulting from previous elective cosmetic surgery)
45528	01NOV2018	30JUN2023	N	Mammaplasty, augmentation, bilateral (other than a service to which item 45527 applies), if: (a) reconstructive surgery is indicated because of: (i) developmental malformation of breast tissue (excluding hypomastia); or (ii) disease of or trauma to the breast (other than trauma resulting from previous elective cosmetic surgery); or (iii) amastia secondary to a congenital endocrine disorder; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45528	01JUL2023	31DEC9999	Y	Mammaplasty, augmentation, bilateral (other than a service to which item 45527 applies), if: (a) reconstructive surgery is indicated because of: (i) developmental malformation of breast tissue (excluding hypomastia); or (ii) disease of or trauma to the breast (other than trauma resulting from previous elective cosmetic surgery); or (iii) amastia secondary to a congenital endocrine disorder; and (b) photographic or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes other than a service associated with a service to which item 45006 or 45012 applies (H)
45529	01JUL2023	31DEC9999	Y	Breast reconstruction (bilateral), following mastectomy, using permanent prostheses, other than a service associated with a service to which item 45006 or 45012 applies (H)
45530	01DEC1991	31OCT1995	N	BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large myocutaneous flap, including repair of secondary skin defect, excluding repair of muscular aponeurotic layer
45530	01NOV1995	31OCT2004	N	BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer
45530	01NOV2004	31OCT2006	N	BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, being a service associated with item 30178
45530	01NOV2006	31DEC2015	N	BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, not being a service associated with a service to which items 30165, 30168, 30171, 30174 or 30177 applies
45530	01JAN2016	30JUN2023	N	Breast reconstruction (unilateral), using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177 or 30179 applies (H)
45530	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous (unilateral), using a large muscle or myocutaneous flap, isolated on its vascular pedicle, excluding repair of muscular aponeurotic layer, other than a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45006 or 45012 applies (H)
45531	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous (bilateral), using a large muscle or myocutaneous flap, isolated on its vascular pedicle, excluding repair of muscular aponeurotic layer, other than a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45006 or 45012 applies (H)
45532	01JUL2023	31DEC9999	Y	Revision of post-mastectomy breast reconstruction, other than a service associated with a service to which item 45006 or 45012 applies (H)
45533	01DEC1991	31OCT2003	N	BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure
45533	01NOV2003	31OCT2004	N	BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177 applies
45533	01NOV2004	31OCT2005	N	BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177 and 30178 applies
45533	01NOV2005	31DEC9999	Y	BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure
45534	01NOV2021	30JUN2023	N	Autologous fat grafting, unilateral service (harvesting, preparation and injection of adipocytes) if: (a) the autologous fat grafting is for one or more of the following purposes: (i) the correction of defects arising from treatment and prevention of breast cancer in patients with contour defects, greater than or equal to 20% volume asymmetry, post-treatment pain or poor prosthetic coverage; (ii) the preparation of post mastectomy thin or irradiated skin flaps in patients intending to have breast reconstruction; (iii) breast reconstruction in breast cancer patients; (iv) the correction of developmental disorders of the breast; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Up to a total of 4 services per side (for total treatment of a single breast) (H)
45534	01JUL2023	31DEC9999	Y	Autologous fat grafting, unilateral service (harvesting, preparation and injection of adipocytes) if: (a) the autologous fat grafting is for one or more of the following purposes: (i) the correction of defects arising from treatment and prevention of breast cancer in patients with contour defects, greater than or equal to 20% volume asymmetry, post-treatment pain or poor prosthetic coverage; (ii) the preparation of post mastectomy thin or irradiated skin flaps in patients intending to have breast reconstruction; (iii) breast reconstruction in breast cancer patients; (iv) the correction of developmental disorders of the breast; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Up to a total of 4 services per side (for total treatment of a single breast), other than a service associated with a service to which item 45006 or 45012 applies (H)
45535	01NOV2021	30JUN2023	N	Autologous fat grafting, bilateral service (harvesting, preparation and injection of adipocytes) if: (a) the autologous fat grafting is for one or more of the following purposes: (i) the correction of defects arising from treatment and prevention of breast cancer in patients with contour defects, greater than or equal to 20% volume asymmetry, post-treatment pain or poor prosthetic coverage; (ii) the preparation of post mastectomy thin or irradiated skin flaps in patients intending to have breast reconstruction; (iii) breast reconstruction in breast cancer patients; (iv) the correction of developmental disorders of the breast; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Up to a total of 4 services (H)
45535	01JUL2023	31DEC9999	Y	Autologous fat grafting, bilateral service (harvesting, preparation and injection of adipocytes) if: (a) the autologous fat grafting is for one or more of the following purposes: (i) the correction of defects arising from treatment and prevention of breast cancer in patients with contour defects, greater than or equal to 20% volume asymmetry, post-treatment pain or poor prosthetic coverage; (ii) the preparation of post mastectomy thin or irradiated skin flaps in patients intending to have breast reconstruction; (iii) breast reconstruction in breast cancer patients; (iv) the correction of developmental disorders of the breast; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Up to a total of 4 services, other than a service associated with a service to which item 45006 or 45012 applies (H)
45536	01DEC1991	31DEC9999	Y	BREAST RECONSTRUCTION using breast sharing technique (second stage) including division of pedicle, insetting of breast flap, with closure of donor site or other similar procedure
45537	01JUL2023	31DEC9999	Y	Perforator flap, such as a thoracodorsal artery perforator (TDAP) flap or a lateral intercostal artery perforator (LICAP) flap, or similar, raising on a named source vessel, for reconstruction of a partial mastectomy defect, other than a service associated with a service to which item 45006 or 45012 applies (H)
45538	01JUL2023	31DEC9999	Y	Perforator flap, such as a deep inferior epigastric perforator (DIEP) flap or similar, raising in preparation for microsurgical transfer of a free flap for post mastectomy breast reconstruction, other than a service associated with a service to which item 45006 or 45012 applies (H)
45539	01DEC1991	30JUN2023	N	BREAST RECONSTRUCTION (unilateral), following mastectomy, using tissue expansion - insertion of tissue expansion unit and all attendances for subsequent expansion injections
45539	01JUL2023	31DEC9999	Y	Breast reconstruction (unilateral), following mastectomy, using tissue expansion-insertion of tissue expansion unit and all attendances for subsequent expansion injections, other than a service associated with a service to which item 45006 or 45012 applies (H)
45540	01JUL2023	31DEC9999	Y	Breast reconstruction (bilateral), following mastectomy, using tissue expansion-insertion of tissue expansion unit and all attendances for subsequent expansion injections, other than a service associated with a service to which item 45006 or 45012 applies (H)
45541	01JUL2023	31DEC9999	Y	Breast reconstruction (bilateral), following mastectomy, using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis, other than a service associated with a service to which item 45006 or 45012 applies (H)
45542	01DEC1991	30JUN2023	N	BREAST RECONSTRUCTION (unilateral), following mastectomy, using tissue expansion - removal of tissue expansion unit and insertion of permanent prosthesis
45542	01JUL2023	31DEC9999	Y	Breast reconstruction (unilateral), following mastectomy, using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis, other than a service associated with a service to which item 45006 or 45012 applies (H)
45543	01NOV1999	30APR2001	N	BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast
45543	01MAY2001	31DEC9999	Y	BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast
45544	01NOV1999	30APR2001	N	BREAST PTOSIS, correction of (unilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45544	01MAY2001	31DEC9999	Y	BREAST PTOSIS, correction of (bilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45545	01DEC1991	30JUN1998	N	NIPPLE OR AREOLA or both, reconstruction of by any technique
45545	01JUL1998	31DEC9999	Y	NIPPLE OR AREOLA or both, reconstruction of, by any surgical technique
45546	01NOV1998	31DEC9999	Y	NIPPLE OR AREOLA or both, intradermal colouration of, following breast reconstruction after mastectomy or for congenital absence of nipple
45547	01JUL2023	31DEC9999	Y	Revision of breast prosthesis pocket, if:(a) breast prosthesis or tissue expander has been placed for the purpose of breast reconstruction in the context of breast cancer or for developmental breast abnormality; and(b) the prosthesis or tissue expander has migrated or rotated from its intended position or orientation; and(c) the existing prosthesis is used(H)
45548	01DEC1991	31DEC9999	Y	BREAST PROSTHESIS, removal of, as an independent procedure
45551	01DEC1991	30JUN1993	N	FIBROUS CAPSULE SURROUNDING BREAST PROSTHESIS, excision or multiple incisions to, as an independent procedure
45551	01JUL1993	31OCT1995	N	BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule, as an independent procedure
45551	01NOV1995	31OCT2006	N	BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule
45551	01NOV2006	31OCT2018	N	BREAST PROSTHESIS, removal of, with excision of fibrous capsule
45551	01NOV2018	31DEC9999	Y	Breast prosthesis, removal of, with excision of at least half of the fibrous capsule, not with insertion of any prosthesis. The excised specimen must be sent for histopathology and the volume removed must be documented in the histopathology report
45552	01JUL1993	31OCT2006	N	BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule and replacement of prosthesis
45552	01NOV2006	31DEC9999	Y	BREAST PROSTHESIS, removal of, with excision of fibrous capsule and replacement of prosthesis
45553	01NOV2006	31OCT2018	N	BREAST PROSTHESIS, removal and replacement with another prosthesis, following medical complications (such as rupture, migration of prosthetic material, or capsule formation).
45553	01NOV2018	31DEC9999	Y	Breast prosthesis, removal of and replacement with another prosthesis, following medical complications (for rupture, migration of prosthetic material or symptomatic capsular contracture), if: (a) either: (i) it is demonstrated by intra-operative photographs post-removal that removal alone would cause unacceptable deformity; or (ii) the original implant was inserted in the context of breast cancer or developmental abnormality; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45554	01DEC1991	30JUN1993	N	BREAST PROSTHESIS, replacement of, following medical complications, (including rupture, migration, or capsule formation) where new pocket is formed
45554	01JUL1993	31OCT2006	N	BREAST PROSTHESIS, replacement of, following medical complications (such as rupture, migration of prosthetic material, or capsule formation), where new pocket is formed, including excision of fibrous capsule
45554	01NOV2006	31OCT2018	N	BREAST PROSTHESIS, removal and replacement with another prosthesis, following medical complications (such as rupture, migration of prosthetic material, or capsule formation), where new pocket is formed, including excision of fibrous capsule
45554	01NOV2018	31DEC9999	Y	Breast prosthesis, removal and replacement with another prosthesis, following medical complications (for rupture, migration of prosthetic material or symptomatic capsular contracture), including excision of at least half of the fibrous capsule or formation of a new pocket, or both, if: (a) either: (i) it is demonstrated by intra-operative photographs post-removal that removal alone would cause unacceptable deformity; or (ii) the original implant was inserted in the context of breast cancer or developmental abnormality; and (b) the excised specimen is sent for histopathology and the volume removed is documented in the histopathology report; and (c) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45555	01MAY1997	31DEC9999	Y	SILICONE BREAST PROSTHESIS, removal of and replacement with prosthesis other than silicone gel prosthesis
45556	01NOV2001	31DEC2014	N	BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast
45556	01JAN2015	31OCT2018	N	BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast (H)
45556	01NOV2018	30JUN2023	N	Breast ptosis, correction of (unilateral), in the context of breast cancer or developmental abnormality, if photographic evidence (including anterior, left lateral and right lateral views) and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Applicable only once per occasion on which the service is provided
45556	01JUL2023	31DEC9999	Y	Breast ptosis, correction of (unilateral), in the context of breast cancer or developmental abnormality, if photographic evidence (including anterior, left lateral and right lateral views) and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Applicable only once per occasion on which the service is provided, other than a service associated with a service to which item 31512, 31513 or 31514 applies on the same side (H)
45557	01NOV2001	30APR2003	N	BREAST PTOSIS, correction of (unilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45557	01MAY2003	30JUN2009	N	BREAST PTOSIS, correction of by mastopexy of (unilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45557	01JUL2009	31DEC9999	Y	BREAST PTOSIS, correction of by mastopexy by any means (unilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove, not being a service associated with a service to which item 45522 applies
45558	01NOV2001	30APR2003	N	BREAST PTOSIS, correction of (bilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45558	01MAY2003	30JUN2009	N	BREAST PTOSIS, correction of by mastopexy of (bilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove
45558	01JUL2009	31OCT2018	N	BREAST PTOSIS, correction of by mastopexy by any means (bilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove, not being a service associated with a service to which item 45522 applies
45558	01NOV2018	31OCT2021	N	Breast ptosis, correction by mastopexy of (bilateral), if: (a) at least two-thirds of the breast tissue, including the nipple, lies inferior to the infra-mammary fold where the nipple is located at the most dependent, inferior part of the breast contour; and (b) if the patient has been pregnant-the correction is performed not less than 1 year, or more than 7 years, after completion of the most recent pregnancy of the patient; and (c) photographic evidence (including anterior, left lateral and right lateral views), with a marker at the level of the inframammary fold, demonstrating the clinical need for this service, is documented in the patient notes Applicable only once per lifetime
45558	01NOV2021	30JUN2023	N	Correction of bilateral breast ptosis by mastopexy, if: (a) at least two-thirds of the breast tissue, including the nipple, lies inferior to the inframammary fold where the nipple is located at the most dependent, inferior part of the breast contour; and (b) photographic evidence (including anterior, left lateral and right lateral views), with a marker at the level of the inframammary fold, demonstrating the clinical need for this service, is documented in the patient notes Applicable only once per lifetime (H)
45558	01JUL2023	31DEC9999	Y	Correction of bilateral breast ptosis by mastopexy, if: (a) at least two-thirds of the breast tissue, including the nipple, lies inferior to the inframammary fold where the nipple is located at the most dependent, inferior part of the breast contour; and (b) photographic evidence (including anterior, left lateral and right lateral views), with a marker at the level of the inframammary fold, demonstrating the clinical need for this service, is documented in the patient notes Applicable only once per lifetime, other than a service associated with a service to which item 31512, 31513 or 31514 applies (H)
45559	01NOV2006	31DEC9999	Y	TUBEROUS, TUBULAR OR CONSTRICTED BREAST, where it can be demonstrated, correction of by simultaneous mastopexy and augmentation of (unilateral)
45560	01DEC1991	31DEC9999	Y	HAIR TRANSPLANTATION for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not being a service to which another item in this Group applies
45561	01MAY2007	30JUN2023	N	MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for supercharging of pedicled flaps
45561	01JUL2023	31DEC9999	Y	Microvascular anastomosis of artery and/or vein, if considered necessary to salvage a vascularly compromised pedicled or free flap, either during the primary procedure or at a subsequent return to theatre (H)
45562	01MAR1999	30JUN2023	N	FREE TRANSFER OF TISSUE involving raising of tissue on vascular or neurovascular pedicle, including direct repair of secondary cutaneous defect if performed, excluding flap for male pattern baldness
45562	01JUL2023	29FEB2024	N	Free transfer of tissue (microvascular free flap) for non-breast defect involving raising of tissue on vascular pedicle, including direct repair of secondary cutaneous defect (if performed), other than a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies
45562	01MAR2024	31DEC9999	Y	Free transfer of tissue (microvascular free flap) for non-breast defect involving raising of tissue on vascular pedicle, including direct repair of secondary cutaneous defect (if performed), other than a service associated with a service to which item 45564, 45565, 45567, 46060, 46062, 46064, 46066, 46068, 46070 or 46072 applies (H)
45563	01DEC1991	28FEB1999	N	NEUROVASCULAR ISLAND FLAP, or free transfer of tissue with vascular or neurovascular pedicle, including repair of secondary defect excluding flap for male pattern baldness
45563	01MAR1999	30JUN2023	N	NEUROVASCULAR ISLAND FLAP, including direct repair of secondary cutaneous defect if performed, excluding flap for male pattern baldness
45563	01JUL2023	29FEB2024	N	Neurovascular island flap for restoration of essential sensation in the digits or sole of the foot, or for genital reconstruction, including:(a) direct repair of secondary cutaneous defect (if performed); and(b) formal dissection of the neurovascular pedicle;other than a service performed on simple V-Y flaps or other standard flaps, such as rotation or keystone
45563	01MAR2024	31DEC9999	Y	Neurovascular island flap for restoration of essential sensation in the digits or sole of the foot, or for genital reconstruction, including:(a) direct repair of secondary cutaneous defect (if performed); and(b) formal dissection of the neurovascular pedicle;other than a service performed on simple V-Y flaps or other standard flaps, such as rotation or keystone (H)
45564	01NOV1999	31OCT2003	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon
45564	01NOV2003	30APR2007	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon
45564	01MAY2007	31DEC2015	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon
45564	01JAN2016	30JUN2023	N	Free transfer of tissue reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 applies-conjoint surgery, principal specialist surgeon (H)
45564	01JUL2023	31DEC9999	Y	Free transfer of tissue (reconstructive surgery) for the repair of major tissue defect of the head and neck or other non-breast defect, using microvascular techniques, all necessary elements of the operation including (but not limited to):(a) anastomoses of all required vessels; and(b) raising of tissue on a vascular pedicle; and(c) preparation of recipient vessels; and(d) transfer of tissue; and(e) insetting of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505, 45507, 45562 or 45567 applies-conjoint surgery, principal specialist surgeon (H)
45565	01NOV1999	31OCT2003	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon
45565	01NOV2003	30APR2007	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon
45565	01MAY2007	31DEC2015	N	FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon
45565	01JAN2016	30JUN2023	N	Free transfer of tissue reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 applies-conjoint surgery, conjoint specialist surgeon (H)
45565	01JUL2023	31DEC9999	Y	Free transfer of tissue (reconstructive surgery) for the repair of major tissue defect of the head and neck or other non-breast defect, using microvascular techniques, all necessary elements of the operation including (but not limited to):(a) anastomoses of all required vessels; and(b) raising of tissue on a vascular pedicle; and(c) preparation of recipient vessels; and(d) transfer of tissue; and(e) insetting of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505, 45507, 45562 or 45567 applies-conjoint surgery, conjoint specialist surgeon (H)
45566	01DEC1991	30JUN2023	N	TISSUE EXPANSION not being a service to which item 45539 or 45542 applies - insertion of tissue expansion unit and all attendances for subsequent expansion injections
45566	01JUL2023	31DEC9999	Y	Insertion of a temporary prosthetic tissue expander which requires subsequent removal, including all attendances for subsequent expansion injections, other than a service for breast or post-mastectomy tissue expansion (H)
45567	01JUL2023	31DEC9999	Y	Free transfer of tissue (reconstructive surgery) for the repair of major tissue defect of the head and neck or other non-breast defect, using microvascular techniques, all necessary elements of the operation including (but not limited to):(a) anastomoses of all required vessels; and(b) raising of tissue on a vascular pedicle; and(c) preparation of recipient vessels; and(d) transfer of tissue; and(e) insetting of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505, 45507, 45562, 45564 or 45565 applies-single surgeon (H)
45568	01NOV2003	30JUN2023	N	TISSUE EXPANDER, removal of, with complete excision of fibrous capsule
45568	01JUL2023	31DEC9999	Y	Tissue expander, removal of, including complete excision of fibrous capsule if performed (H)
45569	01NOV2006	31DEC9999	Y	CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45562, 45564, 45565 or 45530
45570	01NOV2006	31DEC9999	Y	CLOSURE OF ABDOMEN, repair of musculoaponeurotic layer, being a service associated with item 45569
45571	01JUL2023	31OCT2023	N	Closure of abdomen with reconstruction of umbilicus, with or without lipectomy, to be used following the harvest of an autologous flap, being a service associated with a service to which item 45530, 45531, 45562, 45564, 45565 or 45567 applies, including repair of the musculoaponeurotic layer of the abdomen (including insertion of prosthetic mesh if used) (H)
45571	01NOV2023	31DEC9999	Y	Closure of abdomen with reconstruction of umbilicus, with or without lipectomy, to be used following the harvest of an autologous flap, being a service associated with a service to which item 45530, 45531, 45562, 45564, 45565, 45567, 46080, 46082, 46084, 46086, 46088 or 46090 applies, including repair of the musculoaponeurotic layer of the abdomen (including insertion of prosthetic mesh if used) (H)
45572	01DEC1991	30JUN2023	N	INTRA OPERATIVE TISSUE EXPANSION performed during an operation when combined with a service to which another item in Group T8 applies including expansion injections and excluding treatment of male pattern baldness
45572	01JUL2023	31DEC9999	Y	Intra-operative tissue expansion using a prosthetic tissue expander, performed under general anaesthetic or intravenous sedation during an operation, if combined with a service to which another item in Group T8 applies (including expansion injections), not to be used for breast tissue expansion
45575	01DEC1991	31DEC9999	Y	FACIAL NERVE PARALYSIS, free fascia graft for
45578	01DEC1991	31DEC9999	Y	FACIAL NERVE PARALYSIS, muscle transfer for
45581	01DEC1991	30JUN2023	N	FACIAL NERVE PALSY, excision of tissue for
45581	01JUL2023	31DEC9999	Y	Facial nerve paralysis, excision of tissue for
45584	01DEC1991	31OCT2018	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area (thigh, buttock, or similar), for treatment of post-traumatic pseudolipoma
45584	01NOV2018	31DEC9999	Y	Liposuction (suction assisted lipolysis) to one regional area (one limb or trunk), for treatment of post traumatic pseudolipoma, if photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45585	19JUN1997	31OCT1997	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (excluding knees), gynaecomastia, lymphoedema or similar conditions
45585	01NOV1997	31OCT1999	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (excluding knees), gynaecomastia, lymphoedema or similar conditions
45585	01NOV1999	30APR2003	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (including knees), gynaecomastia, lymphoedema or similar conditions
45585	01MAY2003	31OCT2003	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 or 45586 apply, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs, including knees (Barraquer-Simon's Syndrome), gynaecomastia, or lymphoedema
45585	01NOV2003	31OCT2006	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs (Barraquer-Simon's Syndrome), gynaecomastia, or lymphoedema
45585	01NOV2006	31OCT2012	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs (Barraquer-Simon's Syndrome), gynaecomastia, lymphoedema or macrodystrophia lipomatosa
45585	01NOV2012	30JUN2014	N	LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for Barraquer-Simon's Syndrome (pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs), lymphoedema or macrodystrophia lipomatosa
45585	01JUL2014	31OCT2018	N	Liposuction (suction assisted lipolysis) to one regional area, other than a service associated with a service to which item 31525 applies, if it can be demonstrated that the treatment is for Barraquer-Simon's syndrome (pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs), lymphoedema or macrodystrophia lipomatosa
45585	01NOV2018	30JUN2023	N	Liposuction (suction assisted lipolysis) to one regional area (one limb or trunk), other than a service associated with a service to which item 31525 applies, if: (a) the liposuction is for: (i) the treatment of Barraquer-Simons syndrome, lymphoedema or macrodystrophia lipomatosa; or (ii) the reduction of a buffalo hump that is secondary to an endocrine disorder or pharmacological treatment of a medical condition; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45585	01JUL2023	31DEC9999	Y	Liposuction (suction assisted lipolysis) to one regional area (one limb or trunk), other than a service associated with a service to which item 31525 or 31526 applies, if: (a) the liposuction is for: (i) the treatment of Barraquer-Simons syndrome, lymphoedema or macrodystrophia lipomatosa; or (ii) the reduction of a buffalo hump that is secondary to an endocrine disorder or pharmacological treatment of a medical condition; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes (H)
45586	01MAY2003	31DEC9999	Y	LIPOSUCTION (suction assisted lipolysis) for reduction of a buffalo hump, where it can be demonstrated that the buffalo hump is secondary to an endocrine disorder or pharmacological treatment of a medical condition
45587	01DEC1991	31OCT2018	N	MELOPLASTY for correction of facial asymmetry due to soft tissue abnormality where the meloplasty is limited to 1 side of the face
45587	01NOV2018	31DEC9999	Y	Meloplasty for correction of facial asymmetry if: (a) the asymmetry is secondary to trauma (including previous surgery), a congenital condition or a medical condition (such as facial nerve palsy); and (b) the meloplasty is limited to one side of the face
45588	19JUN1997	31OCT1997	N	MELOPLASTY, bilateral, not being a service to which Item 45587 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital conditions
45588	01NOV1997	30APR2003	N	MELOPLASTY, bilateral, not being a service to which Item 45587 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital conditions
45588	01MAY2003	31OCT2018	N	MELOPLASTY, (excluding browlifts and chinlift platysmaplasties), bilateral where it can be demonstrated that surgery is indicated because of congenital conditions, disease or trauma (other than trauma resulting from previous elective cosmetic surgery)
45588	01NOV2018	31DEC9999	Y	Meloplasty (excluding browlifts and chinlift platysmaplasties), bilateral, if: (a) surgery is indicated to correct a functional impairment due to a congenital condition, disease (excluding post-acne scarring) or trauma (other than trauma resulting from previous elective cosmetic surgery); and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45589	01NOV2021	31DEC9999	Y	Autologous fat grafting (harvesting, preparation and injection of adipocytes) if: (a) the autologous fat grafting is for either or both of the following purposes: (i) the correction of asymmetry arising from volume and contour defects in craniofacial disorders-up to a total of 4 services if each service is provided at least 3 months after the previous service; (ii) the treatment of burn scar or associated skin graft in the context of scar contracture, contour deformity or neuropathic pain, for patients who have undergone a minimum of 3 months of topical therapies, including silicone and pressure therapy, with an unsatisfactory or minimal level of improvement-up to a total of 4 services per region of the body (upper or lower limbs, trunk, neck or face) if each service provided per region of the body is provided at least 3 months after the previous such service; and (b) both: (i) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes; and (ii) for craniofacial disorders, evidence of diagnosis of the qualifying craniofacial disorder is documented in the patient notes (H)
45590	01DEC1991	30JUN2023	N	ORBITAL CAVITY, reconstruction of a wall or floor, with or without foreign implant
45590	01JUL2023	31DEC9999	Y	Orbital cavity, reconstruction of wall or floor, with or without bone graft, cartilage graft or foreign implant, other than a service associated with a service to which item 45594 applies on the same side (H)
45592	01JUL2023	31DEC9999	Y	Orbital cavity, reconstruction of wall and floor with bone graft, cartilage graft or foreign implant, other than a service associated with a service to which item 45594 applies on the same side (H)
45593	01DEC1991	31DEC9999	Y	ORBITAL CAVITY, bone or cartilage graft to orbital wall or floor including reduction of prolapsed or entrapped orbital contents
45594	01JUL2023	31DEC9999	Y	Orbital cavity, exploration of wall or floor without bone graft, cartilage graft or foreign implant, other than a service associated with a service to which item 45590 or 45592 applies on the same side (H)
45596	01DEC1991	30JUN2023	N	MAXILLA, total resection of
45596	01JUL2023	31DEC9999	Y	Hemimaxillectomy (H)
45597	01APR1992	30JUN2023	N	MAXILLA, total resection of both maxillae
45597	01JUL2023	31DEC9999	Y	Total maxillectomy (bilateral) (H)
45599	01DEC1991	30JUN2023	N	MANDIBLE, total resection of both sides, including condylectomies where performed
45599	01JUL2023	31DEC9999	Y	Mandible, total resection of, other than a service associated with a service to which item 45608 applies (H)
45602	01DEC1991	31DEC9999	Y	MANDIBLE, including lower border, OR MAXILLA, sub-total resection of
45605	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, segmental resection of, for tumours or cysts
45608	01DEC1991	30JUN2023	N	MANDIBLE, hemimandibular reconstruction with bone graft, not being a service associated with a service to which item 45599 applies
45608	01JUL2023	31DEC9999	Y	Mandible, segmental mandibular or maxilla reconstruction with bone graft, not being a service associated with a service to which item 45599 applies (H)
45609	01JUL2023	31DEC9999	Y	Mandible, maxilla or skull base, reconstruction of, using bony free flap, all osteotomies, shaping, inset and fixation by any means, including all necessary 3 dimensional planning, if performed in conjunction with one or more services covered by items 46060 to 46068 (H)
45611	01DEC1991	30JUN2023	N	MANDIBLE, condylectomy
45611	01JUL2023	31DEC9999	Y	Mandible, condylectomy of (H)
45614	01DEC1991	30JUN2023	N	EYELID, WHOLE THICKNESS RECONSTRUCTION OF other than by direct suture only
45614	01JUL2023	29FEB2024	N	Eyelid, reconstruction of a defect (greater than one quarter of the length of the lid) involving all 3 layers of the eyelid, if unable to be closed by direct suture or wedge excision, including all flaps and grafts that may be required
45614	01MAR2024	31OCT2024	N	Eyelid, reconstruction of a defect (greater than one quarter of the length of the lid) involving all 3 layers of the eyelid, if unable to be closed by direct suture or wedge excision, including all flaps and grafts that may be required (H)
45614	01NOV2024	31DEC9999	Y	Eyelid, reconstruction of a defect (greater than one quarter of the length of the lid) involving all 3 layers of the eyelid, if unable to be closed by direct suture or wedge excision, including all flaps and grafts that may be required
45617	01DEC1991	30JUN1998	N	UPPER EYELID, REDUCTION OF, for skin redundancy obscuring vision, herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or, in respect of 1 of these conditions, the restoration of symmetry of the contralateral upper eyelid
45617	01JUL1998	31OCT2018	N	UPPER EYELID, REDUCTION OF, for skin redundancy obscuring vision (as evidenced by upper eyelid skin resting on lashes on straight ahead gaze), herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or the restoration of symmetry of contralateral upper eyelid in respect of 1 of these conditions
45617	01NOV2018	31OCT2022	N	Upper eyelid, reduction of, if: (a) the reduction is for any of the following: (i) skin redundancy that causes a visual field defect (confirmed by an optometrist or ophthalmologist) or intertriginous inflammation of the eyelid; (ii) herniation of orbital fat in exophthalmos; (iii) facial nerve palsy; (iv) post-traumatic scarring; (v) the restoration of symmetry of contralateral upper eyelid in respect of one of the conditions mentioned in subparagraphs (i) to (iv); and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45617	01NOV2022	31DEC9999	Y	Upper eyelid, reduction of, if: (a) the reduction is for any of the following: (i) history of a demonstrated visual impairment; (ii) intertriginous inflammation of the eyelid; (iii) herniation of orbital fat in exophthalmos; (iv) facial nerve palsy; (v) post-traumatic scarring; (vi) the restoration of symmetry of contralateral upper eyelid in respect of one of the conditions mentioned in subparagraphs (i) to (v); and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45620	01DEC1991	31OCT2018	N	LOWER EYELID, REDUCTION OF, for herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or, in respect of 1 of these conditions, the restoration of symmetry of the contralateral lower eyelid
45620	01NOV2018	31DEC9999	Y	Lower eyelid, reduction of, if: (a) the reduction is for: (i) herniation of orbital fat in exophthalmos, facial nerve palsy or post-traumatic scarring; or (ii) the restoration of symmetry of the contralateral lower eyelid in respect of one of these conditions; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes
45623	01DEC1991	30JUN1993	N	PTOSIS (unilateral), correction of
45623	01JUL1993	31OCT2018	N	PTOSIS of eyelid (unilateral), correction of
45623	01NOV2018	31DEC9999	Y	Ptosis of upper eyelid (unilateral), correction of, by: (a) sutured elevation of the tarsal plate on the eyelid retractors (Mullers or levator muscle or levator aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; Not applicable to a service for repair of mechanical ptosis to which item 45617 applies
45624	01JUL1998	31OCT2018	N	PTOSIS of eyelid, correction of, where previous ptosis surgery has been performed on that side
45624	01NOV2018	31DEC9999	Y	Ptosis of upper eyelid, correction of, by: (a) sutured elevation of the tarsal plate on the eyelid retractors (Mullers or levator muscle or levator aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; if a previous ptosis surgery has been performed on that side
45625	01JUL1998	31DEC9999	Y	PTOSIS of eyelid, correction of eyelid height by revision of levator sutures within one week of primary repair by levator resection or advancement, performed in the operating theatre of a hospital
45626	01DEC1991	31OCT2019	N	ECTROPION OR ENTROPION, correction of (unilateral)
45626	01NOV2019	31DEC9999	Y	Ectropion or entropion, not caused by trachoma, correction of (unilateral)
45627	01NOV2019	31DEC9999	Y	Ectropion or entropion, caused by trachoma, correction of (unilateral)
45629	01DEC1991	31DEC9999	Y	SYMBLEPHARON, grafting for
45632	01DEC1991	31OCT2014	N	RHINOPLASTY, correction of lateral or alar cartilages
45632	01NOV2014	31OCT2018	N	RHINOPLASTY, correction of lateral or alar cartilages for correction of nasal obstruction
45632	01NOV2018	31OCT2021	N	Rhinoplasty, partial, involving correction of lateral or alar cartilages, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45632	01NOV2021	31DEC9999	Y	Rhinoplasty, partial, involving correction of one or both lateral cartilages, one or both alar cartilages or one or both lateral cartilages and alar cartilages, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45635	01DEC1991	31OCT2014	N	RHINOPLASTY, correction of bony vault only
45635	01NOV2014	31OCT2018	N	RHINOPLASTY, correction of vault only, for correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both
45635	01NOV2018	31DEC9999	Y	Rhinoplasty, partial, involving correction of bony vault only, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45638	01DEC1991	30JUN1998	N	RHINOPLASTY TOTAL, including correction of all bony and cartilaginous elements of the external nose
45638	01JUL1998	30APR2003	N	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of post-traumatic deformity or nasal obstruction, or both
45638	01MAY2003	31DEC2014	N	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of nasal obstruction or post-traumatic deformity (but not as a result of previous elective cosmetic surgery), or both
45638	01JAN2015	31DEC9999	Y	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of nasal obstruction or post-traumatic deformity (but not as a result of previous elective cosmetic surgery), or both (H)
45639	01JUL1998	31DEC2014	N	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, where it can be demonstrated that there is a need for correction of significant developmental deformity
45639	01JAN2015	31DEC9999	Y	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, where it can be demonstrated that there is a need for correction of significant developmental deformity (H)
45641	01DEC1991	30JUN1998	N	RHINOPLASTY involving nasal or septal cartilage graft
45641	01JUL1998	31OCT2014	N	RHINOPLASTY involving nasal or septal cartilage graft, or nasal bone graft, or nasal bone and nasal cartilage graft
45641	01NOV2014	31OCT2018	N	RHINOPLASTY involving nasal or septal cartilage graft, or nasal bone graft, or nasal bone and nasal cartilage graft for correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both. (H)
45641	01NOV2018	31DEC9999	Y	Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose, with or without autogenous cartilage or bone graft from a local site (nasal), if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45644	01DEC1991	31OCT2014	N	RHINOPLASTY involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft
45644	01NOV2014	31OCT2018	N	RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft For correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both. (H)
45644	01NOV2018	30JUN2023	N	Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45644	01JUL2023	31DEC9999	Y	Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes; other than a service associated with a service to which item 45718 applies (H)
45645	01NOV1994	31DEC9999	Y	CHOANAL ATRESIA, repair of by puncture and dilatation
45646	01NOV1994	31DEC9999	Y	CHOANAL ATRESIA - correction by open operation with bone removal
45647	01DEC1991	31OCT2003	N	FACE, contour restoration of 1 region, using autogenous bone or cartilage graft (not being a service to which item 45644 applies)
45647	01NOV2003	31DEC9999	Y	FACE, contour restoration of 1 region, using autogenous bone or cartilage graft (not being a service to which item 45644 applies)
45650	01DEC1991	31OCT2014	N	RHINOPLASTY, secondary revision of
45650	01NOV2014	31OCT2018	N	RHINOPLASTY, secondary revision of, for correction of nasal obstruction, post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery) or significant developmental deformity
45650	01NOV2018	31DEC9999	Y	Rhinoplasty, revision of, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes
45652	01NOV1995	30APR2001	N	RHINOPHYMA, carbon dioxide laser excision-ablation of
45652	01MAY2001	31OCT2018	N	RHINOPHYMA, carbon dioxide laser or erbium laser excision-ablation of
45652	01NOV2018	31DEC9999	Y	Rhinophyma of a moderate or severe degree, carbon dioxide laser or erbium laser excision - ablation of
45653	01DEC1991	31DEC9999	Y	RHINOPHYMA, shaving of
45656	01DEC1991	31DEC9999	Y	COMPOSITE GRAFT (Chondrocutaneous or chondromucosal) to nose, ear or eyelid
45658	01MAR2021	31DEC9999	Y	Correction of a congenital deformity of the ear if: (a) the congenital deformity is not related to a prominent ear; and (b) the deformity has been clinically diagnosed as a constricted ear, Stahl's ear, or a similar congenital deformity; and (c) photographic evidence demonstrating the clinical need for this service is documented in the patient notes.
45659	01DEC1991	31OCT2018	N	LOP EAR, BAT EAR OR SIMILAR DEFORMITY, correction of
45659	01NOV2018	31DEC9999	Y	Correction of a congenital deformity of the ear if: (a) the patient is less than 18 years of age; and (b) the deformity is characterised by an absence of the antihelical fold and/or large scapha and/or large concha; and (c) photographic evidence demonstrating the clinical need for this service is documented in the patient notes
45660	01NOV2000	30JUN2023	N	EXTERNAL EAR, COMPLEX TOTAL RECONSTRUCTION OF, using multiple costal cartilage grafts to form a framework, including the harvesting and sculpturing of the cartilage and its insertion, for congenital absence, microtia or post-traumatic loss of entire or substantial portion of pinna (first stage) - performed by a specialist in the practice of his or her specialty
45660	01JUL2023	31DEC9999	Y	External ear, complex total reconstruction of, using costal cartilage grafts to form a framework, including the harvesting and sculpturing of the cartilage and its insertion, for congenital absence, microtia or post-traumatic loss of entire or substantial portion of pinna (first stage) - performed by a specialist in the practice of the specialists specialty (H)
45661	01NOV2000	30JUN2023	N	EXTERNAL EAR, COMPLEX TOTAL RECONSTRUCTION OF, elevation of costal cartilage framework using cartilage previously stored in abdominal wall, including the use of local skin and fascia flaps and full thickness skin graft to cover cartilage (second stage) - performed by a specialist in the practice of his or her specialty
45661	01JUL2023	31DEC9999	Y	External ear, complex total reconstruction of, elevation of costal cartilage framework using cartilage previously stored in abdominal wall, including the use of local skin and fascia flaps and skin graft to cover cartilage (second stage) - performed by a specialist in the practice of the specialists specialty (H)
45662	01DEC1991	31DEC9999	Y	CONGENITAL ATRESIA, reconstruction of external auditory canal
45665	01DEC1991	30JUN2023	N	LIP, EYELID OR EAR, FULL THICKNESS WEDGE EXCISION OF, with repair by direct sutures
45665	01JUL2023	31DEC9999	Y	Lip, eyelid or ear, full thickness wedge excision of, with repair by direct sutures, excluding eyelid wedge when performed in conjunction with a cosmetic eyelid procedure
45668	01DEC1991	31OCT1995	N	VERMILIONECTOMY
45668	01NOV1995	31DEC9999	Y	VERMILIONECTOMY, by surgical excision
45669	01NOV1995	30APR2001	N	VERMILIONECTOMY, using carbon dioxide laser excision-ablation
45669	01MAY2001	31OCT2018	N	VERMILIONECTOMY, using carbon dioxide laser or erbium laser excision-ablation
45669	01NOV2018	31DEC9999	Y	Vermilionectomy for biopsy-confirmed cellular atypia, using carbon dioxide laser or erbium laser excision - ablation
45671	01DEC1991	30JUN2023	N	LIP OR EYELID RECONSTRUCTION using full thickness flap (Abbe or similar), first stage
45671	01JUL2023	29FEB2024	N	Lip or eyelid reconstruction, single stage or first stage of a two-stage flap reconstruction of a defect involving all 3 layers of tissue, if the flap is switched from the opposing lip or eyelid respectively
45671	01MAR2024	31DEC9999	Y	Lip or eyelid reconstruction, single stage or first stage of a two-stage flap reconstruction of a defect involving all 3 layers of tissue, if the flap is switched from the opposing lip or eyelid respectively (H)
45674	01DEC1991	30JUN2023	N	LIP OR EYELID RECONSTRUCTION using full thickness flap (Abbe or similar), second stage
45674	01JUL2023	31DEC9999	Y	Lip or eyelid reconstruction, second stage of a two-stage flap reconstruction, division of the pedicle and inset of flap and closure of the donor
45675	01NOV1994	31DEC9999	Y	MACROCHEILIA or macroglossia, operation for
45676	01NOV1994	31DEC9999	Y	MACROSTOMIA, operation for
45677	01DEC1991	30JUN2023	N	CLEFT LIP, unilateral primary repair, 1 stage, without anterior palate repair
45677	01JUL2023	31DEC9999	Y	Cleft lip, unilateral-primary repair of nasolabial complex, one stage, without anterior palate repair (H)
45680	01DEC1991	30JUN2023	N	CLEFT LIP, unilateral - primary repair, 1 stage, with anterior palate repair
45680	01JUL2023	31DEC9999	Y	Cleft lip, unilateral-primary repair of nasolabial complex, one stage, with anterior palate repair (H)
45683	01DEC1991	30JUN2023	N	CLEFT LIP, bilateral - primary repair, 1 stage, without anterior palate repair
45683	01JUL2023	31DEC9999	Y	Cleft lip, bilateral-primary repair of nasolabial complex, one stage, without anterior palate repair (H)
45686	01DEC1991	30JUN2023	N	CLEFT LIP, bilateral - primary repair, 1 stage, with anterior palate repair
45686	01JUL2023	31DEC9999	Y	Cleft lip, bilateral-primary repair of nasolabial complex, one stage, with anterior palate repair (H)
45689	01DEC1991	31DEC9999	Y	CLEFT LIP, lip adhesion procedure, unilateral or bilateral
45692	01DEC1991	31DEC9999	Y	CLEFT LIP, partial revision, including minor flap revision alignment and adjustment, including revision of minor whistle deformity if performed
45695	01DEC1991	31DEC9999	Y	CLEFT LIP, total revision, including major flap revision, muscle reconstruction and revision of major whistle deformity
45698	01DEC1991	31DEC9999	Y	CLEFT LIP, primary columella lengthening procedure, bilateral
45701	01DEC1991	31DEC9999	Y	CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first stage
45704	01DEC1991	31DEC9999	Y	CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second stage
45707	01DEC1991	31DEC9999	Y	CLEFT PALATE, primary repair
45710	01DEC1991	31DEC9999	Y	CLEFT PALATE, secondary repair, closure of fistula using local flaps
45713	01DEC1991	31DEC9999	Y	CLEFT PALATE, secondary repair, lengthening procedure
45714	01NOV1995	30JUN2023	N	ORO-NASAL FISTULA, plastic closure of, including services to which item 45200, 45203 or 45239 applies
45714	01JUL2023	31DEC9999	Y	Oro-nasal fistula, repair of, including a local flap for closure (H)
45716	01DEC1991	31DEC9999	Y	VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for
45717	01JUL2023	31DEC9999	Y	Alveolar cleft (congenital), unilateral, bone grafting of, including local flap closure of associated oro-nasal fistulae and ridge augmentation, other than a service associated with a service to which item 45718 applies (H)
45718	01JUL2023	31DEC9999	Y	Face, contour restoration of one region, for the correction of deformity using autogenous bone or cartilage, if the deformity:(a) is secondary to congenital absence of tissue; or(b) has arisen from:(i) trauma (other than from previous cosmetic surgery); or(ii) a diagnosed pathological process;other than a service associated with a service to which item 45644 or 45717 (alveolar bone grafting) applies (H)
45719	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45720	01JUL1998	30APR2009	N	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
45720	01MAY2009	31OCT2021	N	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and excluding services to which item 47933or 47936 apply
45720	01NOV2021	31DEC9999	Y	Mandible or maxilla, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
45722	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45723	01JUL1998	31OCT2000	N	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45723	01NOV2000	30APR2009	N	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45723	01MAY2009	31OCT2021	N	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45723	01NOV2021	31DEC9999	Y	Mandible or maxilla, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45725	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
45726	01JUL1998	30APR2009	N	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
45726	01MAY2009	31OCT2021	N	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply
45726	01NOV2021	31DEC9999	Y	Mandible or maxilla, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site (H)
45728	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
45729	01JUL1998	31OCT2000	N	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45729	01NOV2000	30APR2009	N	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45729	01MAY2009	31OCT2021	N	MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45729	01NOV2021	31DEC9999	Y	Mandible or maxilla, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45731	01DEC1991	30APR2009	N	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site
45731	01MAY2009	31OCT2021	N	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply
45731	01NOV2021	31DEC9999	Y	Mandible or maxilla, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site (H)
45732	01JUL1998	31OCT2000	N	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45732	01NOV2000	30APR2009	N	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45732	01MAY2009	31OCT2021	N	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45732	01NOV2021	31DEC9999	Y	Mandible or maxilla, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45734	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site
45735	01JUL1998	30APR2009	N	MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site
45735	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply
45735	01NOV2021	31DEC9999	Y	Mandible and maxilla, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site (H)
45737	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site
45738	01JUL1998	31OCT2000	N	MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45738	01NOV2000	30APR2009	N	MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45738	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45738	01NOV2021	31DEC9999	Y	Mandible and maxilla, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45740	01DEC1991	31DEC9999	Y	MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site
45741	01JUL1998	30APR2009	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site
45741	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply
45741	01NOV2021	31DEC9999	Y	Mandible and maxilla, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site (H)
45743	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45744	01JUL1998	31OCT2000	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45744	01NOV2000	30APR2009	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45744	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45744	01NOV2021	31DEC9999	Y	Mandible and maxilla, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45746	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, osteotomies or oteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45747	01JUL1998	30APR2009	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site
45747	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply
45747	01NOV2021	31DEC9999	Y	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site
45749	01DEC1991	31DEC9999	Y	MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45752	01DEC1991	30JUN1998	N	MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45752	01JUL1998	31OCT2000	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45752	01NOV2000	30APR2009	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45752	01MAY2009	31OCT2021	N	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply
45752	01NOV2021	31DEC9999	Y	MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
45753	01JUL1993	31DEC9999	Y	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III(Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site
45754	01JUL1993	31OCT2000	N	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
45754	01NOV2000	31DEC9999	Y	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
45755	01DEC1991	31OCT2006	N	TEMPOROMANDIBULAR MENISCECTOMY
45755	01NOV2006	31DEC9999	Y	TEMPOROMANDIBULAR PARTIAL OR TOTAL MENISCECTOMY
45758	01DEC1991	31DEC9999	Y	TEMPORO-MANDIBULAR JOINT, arthroplasty
45761	01DEC1991	30JUN1998	N	GENIOPLASTY, including transposition of nerves and bone grafts taken from the same site
45761	01JUL1998	30JUN2023	N	GENIOPLASTY, including transposition of nerves and vessels and bone grafts taken from the same site
45761	01JUL2023	31DEC9999	Y	Genioplasty, including transposition of nerves and vessels and bone grafts taken from the same site, if:(a) the deformity: (i) is secondary to congenital absence of tissue; or(ii) has arisen from trauma (other than from previous cosmetic surgery) or a diagnosed pathological process; and (b) the service is required for maintaining lip competency; and(c) sufficient photographic evidence demonstrating the clinical need for the service is included in patient notes(H)
45764	01DEC1991	30JUN1998	N	GENIOPLASTY being a service associated with a service to which item 45719, 45722, 45725, 45728, 45731, 45734, 45743 or 45746 applies
45764	01JUL1998	31DEC9999	Y	GENIOPLASTY being a service associated with a service to which item 45720, 45723, 45726, 45729, 45731, 45732, 45735 or 45738 applies
45767	01DEC1991	30JUN2023	N	HYPERTELORISM, correction of, intracranial
45767	01JUL2023	31DEC9999	Y	Hypertelorism, correction of, using intracranial approach (H)
45770	01DEC1991	31DEC9999	Y	HYPERTELORISM, correction of, subcranial
45773	01DEC1991	30JUN2023	N	TREACHER COLLINS SYNDROME, PERIORBITAL CORRECTION OF, with rib and iliac bone grafts
45773	01JUL2023	31DEC9999	Y	Syndromic orbital dystopia, such as Treacher Collins Syndrome, bilateral facial or periorbital reconstruction, with bone grafts from a distant site (H)
45776	01DEC1991	31DEC9999	Y	ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 orbit, intracranial
45779	01DEC1991	31DEC9999	Y	ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 orbit, extracranial
45782	01DEC1991	30JUN2023	N	FRONTOORBITAL ADVANCEMENT, UNILATERAL
45782	01JUL2023	31DEC9999	Y	Fronto-orbital advancement (H)
45785	01DEC1991	30JUN2023	N	CRANIAL VAULT RECONSTRUCTION for oxycephaly, brachycephaly, turricephaly or similar condition (bilateral frontoorbital advancement)
45785	01JUL2023	31DEC9999	Y	Cranial vault reconstruction for single suture synostosis (H)
45788	01DEC1991	30JUN2023	N	GLENOID FOSSA, ZYGOMATIC ARCH AND TEMPORAL BONE, RECONSTRUCTION OF, (Obwegeser technique)
45788	01JUL2023	31DEC9999	Y	Glenoid fossa, construction of, from bone and cartilage graft, and creation of condyle and ascending ramus of mandible, in hemifacial microsomia, not including harvesting of graft material (H)
45791	01DEC1991	30JUN2023	N	ABSENT CONDYLE AND ASCENDING RAMUS in hemifacial microsomia, CONSTRUCTION OF, not including harvesting of graft material
45791	01JUL2023	31DEC9999	Y	Absent condyle and ascending ramus in craniofacial microsomia, construction of, not including harvesting of graft material (H)
45794	01DEC1991	31OCT2006	N	OSSEO-INTEGRATION PROCEDURE - extra-oral, implantation of titanium fixture
45794	01NOV2006	30JUN2023	N	OSSEO-INTEGRATION PROCEDURE - extra-oral, implantation of titanium fixture, not for implantable bone conduction hearing system device
45794	01JUL2023	31OCT2023	N	Osseo-integration procedure, first stage, implantation of fixture, following congenital absence, tumour or trauma, other than a service associated with a service to which item 41603 or 41604 applies
45794	01NOV2023	31DEC9999	Y	Osseo-integration procedure, first stage, implantation of fixture, following congenital absence, tumour or trauma, other than a service associated with a service to which item 41603 applies
45797	01DEC1991	31OCT2006	N	OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment
45797	01NOV2006	30JUN2023	N	OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment, not for implantable bone conduction hearing system device
45797	01JUL2023	31OCT2023	N	Osseo-integration procedure, second stage, fixation of transcutaneous abutment, following congenital absence, tumour or trauma, other than a service associated with a service to which item 41603 or 41604 applies
45797	01NOV2023	31DEC9999	Y	Osseo-integration procedure, second stage, fixation of transcutaneous abutment, following congenital absence, tumour or trauma, other than a service associated with a service to which item 41603 applies
45799	01NOV2004	31DEC9999	Y	ASPIRATION BIOPSY of 1 or MORE JAW CYSTS as an independent procedure to obtain material for diagnostic purposes and not being a service associated with an operative procedure on the same day
45801	01NOV2004	30JUN2023	N	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation),in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 45803 applies
45801	01JUL2023	31DEC9999	Y	Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), in the oral cavity, removal from mucosa or submucosal tissues, if the removal is by surgical excision and suture
45803	01NOV2004	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions
45805	01NOV2004	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
45807	01NOV2004	31DEC9999	Y	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, removal of, not being a service to which another item in this Subgroup applies, involving muscle, bone, or other deep tissue
45809	01NOV2004	31DEC9999	Y	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), in the oral and maxillofacial region, removal of, requiring wide excision, not being a service to which another item in this Subgroup applies
45811	01NOV2004	31DEC9999	Y	TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft
45813	01NOV2004	31DEC9999	Y	TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft
45815	01NOV2004	30JUN2023	N	OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for chronic osteomyelitis - 1 bone or in combination with adjoining bones
45815	01JUL2023	31DEC9999	Y	Operation on:(a) mandible or maxilla (other than alveolar margins) for chronic osteomyelitis with radiological and laboratory evidence of osteomyelitis; or(b) mandible or maxilla for necrosis of the jaw from any cause including medication or radiation that requires debridement of the alveolar bone or beyond
45817	01NOV2004	31DEC9999	Y	OPERATION on SKULL for OSTEOMYELITIS
45819	01NOV2004	31DEC9999	Y	OPERATION ON ANY COMBINATION OF ADJOINING BONES IN THE ORAL AND MAXILLOFACIAL REGION, being bones referred to in item 45817
45821	01NOV2004	31DEC9999	Y	BONE GROWTH STIMULATOR IN THE ORAL AND MAXILLOFACIAL REGION, insertion of
45823	01NOV2004	30JUN2023	N	ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital
45823	01JUL2023	31DEC9999	Y	Arch bars or similar, one or more, that were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia, if the service is undertaken in the operating theatre of a hospital (H)
45825	01NOV2004	31DEC9999	Y	MANDIBULAR OR PALATAL EXOSTOSIS, excision of
45827	01NOV2004	31DEC9999	Y	MYLOHYOID RIDGE, reduction of
45829	01NOV2004	31DEC9999	Y	MAXILLARY TUBEROSITY, reduction of
45831	01NOV2004	30JUN2023	N	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - less than 5 lesions
45831	01JUL2023	31DEC9999	Y	Papillary hyperplasia of the palate, surgical reduction of-cannot be claimed more than once per occasion of service
45833	01NOV2004	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - 5 to 20 lesions
45835	01NOV2004	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - more than 20 lesions
45837	01NOV2004	31DEC9999	Y	VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral
45839	01NOV2004	31DEC9999	Y	FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral
45841	01NOV2004	31DEC9999	Y	ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral
45843	01NOV2004	31DEC9999	Y	ALVEOLAR RIDGE AUGMENTATION - unilateral, insertion of tissue expanding device into maxillary or mandibular alveolar ridge region for
45845	01NOV2004	30JUN2023	N	OSSEO-INTEGRATION PROCEDURE - intra-oral implantation of titanium fixture to facilitate restoration of the dentition following resection of part of the maxilla or mandible for benign or malignant tumours
45845	01JUL2023	31DEC9999	Y	Osseo-integration procedure, intra-oral implantation of titanium or similar fixture to facilitate restoration of the dentition following:(a) resection of part of the maxilla or mandible for a benign or a malignant tumour; or(b) segmental loss from trauma or congenital absence of a segment of the maxilla or mandible (multiple adjacent teeth)Fixture must be placed at site of the missing segment following appropriate reconstructive procedures
45847	01NOV2004	30JUN2023	N	OSSEO-INTEGRATION PROCEDURE - fixation of transmucosal abutment to fixtures placed following resection of part of the maxilla or mandible for benign or malignant tumours
45847	01JUL2023	31DEC9999	Y	Osseo-integration procedure, fixation of transmucosal abutment to fixtures that are placed following:(a) resection of part of the maxilla or mandible for a benign or a malignant tumour; or(b) segmental loss from trauma or congenital absence of a segment of the maxilla or mandible (multiple adjacent teeth)Fixture must be placed at site of the missing segment following appropriate reconstructive procedures
45849	01NOV2004	30JUN2023	N	MAXILLARY SINUS, BONE GRAFT to floor of maxillary sinus following elevation of mucosal lining (sinus lift procedure), (unilateral)
45849	01JUL2023	31DEC9999	Y	Maxillary sinus, allograft, bone graft or both, to floor of maxillary sinus following elevation of mucosal lining (sinus lift procedure), unilateral
45851	01NOV2004	30JUN2023	N	TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in this Subgroup applies
45851	01JUL2023	31DEC9999	Y	Temporomandibular joint, manipulation of, as an independent procedure performed in the operating theatre of a hospital, other than a service associated with a service to which any other item in this Group applies (H)
45853	01NOV2004	31DEC9999	Y	ABSENT CONDYLE and ASCENDING RAMUS in hemifacial microsomia, construction of, not including harvesting of graft material
45855	01NOV2004	30JUN2023	N	TEMPOROMANDIBULAR JOINT, arthroscopy of, with or without biopsy, not being a service associated with any other arthroscopic procedure of that joint
45855	01JUL2023	29FEB2024	N	Temporomandibular joint, arthroscopy of, with or without biopsy, other than a service associated with another arthroscopic procedure of that joint
45855	01MAR2024	31DEC9999	Y	Temporomandibular joint, arthroscopy of, with or without biopsy, other than a service associated with another arthroscopic procedure of that joint (H)
45857	01NOV2004	30APR2009	N	TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedures
45857	01MAY2009	30JUN2023	N	TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedure of that joint, not being a service associated with any other arthroscopic procedure of the temporomandibular joint
45857	01JUL2023	29FEB2024	N	Temporomandibular joint, arthroscopy of, removal of loose bodies, debridement, or lysis and lavage or biopsy (including repositioning of meniscus where indicated)-one or more such procedures of that joint, other than a service associated with any other arthroscopic or open procedure of the temporomandibular joint
45857	01MAR2024	31DEC9999	Y	Temporomandibular joint, arthroscopy of, removal of loose bodies, debridement, or lysis and lavage or biopsy (including repositioning of meniscus where indicated)-one or more such procedures of that joint, other than a service associated with any other arthroscopic or open procedure of the temporomandibular joint (H)
45859	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthrotomy of, not being a service to which another item in this Subgroup applies
45861	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without microsurgical techniques
45863	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with condylectomy or condylotomy, with or without microsurgical techniques
45865	01NOV2004	31DEC9999	Y	ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 cannuli into the appropriate joint space(s)
45867	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, synovectomy of, not being a service to which another item in this Subgroup applies
45869	01NOV2004	31OCT2006	N	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including meniscectomy when performed, with or without microsurgical techniques
45869	01NOV2006	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including partial or total meniscectomy when performed, with or without microsurgical techniques
45871	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular and condylar head surgery, with or without microsurgical techniques
45873	01NOV2004	30JUN2023	N	TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 45863, 45867, 45869 and 45871 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques
45873	01JUL2023	31DEC9999	Y	Temporomandibular joint, surgery of, involving procedures to which item 45871 applies and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques
45874	01JUL2023	31DEC9999	Y	Temporomandibular joint, including condylar head and glenoid fossa, total alloplastic replacement (H)
45875	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Subgroup applies
45877	01NOV2004	30APR2009	N	TEMPOROMANDIBULAR JOINT, arthrodesis of, not being a service to which another item in this Subgroup applies
45877	01MAY2009	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthrodesis of, with synovectomy if performed, not being a service to which another item in this Subgroup applies
45879	01NOV2004	31DEC9999	Y	TEMPOROMANDIBULAR JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures
45882	01NOV2007	31DEC9999	Y	The treatment of a premalignant lesion of the oral mucosa by a treatment using cryotherapy, diathermy or carbon dioxide laser.
45885	01NOV2007	31DEC9999	Y	Facial, mandibular or lingual artery or vein or artery and vein, ligation of, not being a service to which item 41707 applies
45888	01NOV2007	31DEC9999	Y	FOREIGN BODY, in the oral and maxillofacial region, deep, removal of using interventional imaging techniques
45891	01NOV2007	31DEC9999	Y	SINGLE-STAGE LOCAL FLAP where indicated, repair to 1 defect, using temporalis muscle
45894	01NOV2007	30JUN2023	N	FREE GRAFTING, in the oral and maxillofacial region, (mucosa or split skin) of a granulating area
45894	01JUL2023	31DEC9999	Y	Grafting (mucosa or split skin), in the oral cavity of a mucosal defect
45897	01NOV2007	31DEC9999	Y	ALVEOLAR CLEFT (congenital) unilateral, grafting of, including plastic closure of associated oro-nasal fistulae and ridge augmentation
45900	01NOV2007	31DEC9999	Y	MANDIBLE, fixation by intermaxillary wiring, excluding wiring for obesity
45903	01NOV2007	31DEC9999	Y	MANDIBULAR OR PALATAL EXOSTOSIS, excision of
45906	01NOV2007	31DEC9999	Y	MYLOHYOID RIDGE, reduction of
45909	01NOV2007	31DEC9999	Y	MAXILLARY TUBEROSITY, reduction of
45912	01NOV2007	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of less than 5 lesions
45915	01NOV2007	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of 5 to 20 lesions
45918	01NOV2007	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of more than 20 lesions
45921	01NOV2007	31DEC9999	Y	VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral
45924	01NOV2007	31DEC9999	Y	FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral
45939	01NOV2007	31DEC9999	Y	PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief
45945	01NOV2007	31DEC9999	Y	MANDIBLE, treatment of a dislocation of, requiring open reduction
45975	01NOV2007	31DEC9999	Y	MAXILLA, unilateral or bilateral, treatment of fracture of, not requiring splinting
45978	01NOV2007	31DEC9999	Y	MANDIBLE, treatment of fracture of, not requiring splinting
45981	01NOV2007	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, not requiring surgical reduction
45984	01NOV2007	31DEC9999	Y	MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves requiring open reduction not involving plate(s)
45987	01NOV2007	31DEC9999	Y	MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s)
45990	01NOV2007	31DEC9999	Y	MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves requiring open reduction involving the use of plate(s)
45993	01NOV2007	31DEC9999	Y	MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s)
45996	01NOV2007	31DEC9999	Y	MANDIBLE, treatment of a closed fracture of, involving a joint surface
46050	01JUL2023	31DEC9999	Y	Perforator flap, raising on a named source vessel, for pedicled transfer for head or neck or other non-breast reconstruction (H)
46052	01JUL2023	31DEC9999	Y	Perforator Flap, such as anterolateral thigh flap or similar, raising in preparation for microsurgical transfer of a free flap for head or neck or other non-breast reconstruction (H)
46060	01JUL2023	31DEC9999	Y	Free transfer of tissue with a vascularised bone component (including chimeric/composite flap), for the repair of major defect of the head or neck or other non-breast defect, all necessary elements of the operation, including (but not limited to):(a) anastomoses of all required vessels using microvascular techniques; and(b) harvesting of flap (including osteotomies); and(c) raising of tissue on a vascular pedicle; and(d) preparation of recipient vessels; and(e) transfer of tissue, including fixation of bony element and inset of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than the following:(g) bony reshaping for purposes of reconstruction of maxilla, mandible or skull base;(h) a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesSingle surgeon (H)
46062	01JUL2023	31DEC9999	Y	Free transfer of tissue with a vascularised bone component (including chimeric/composite flap), for the repair of major defect of the head or neck or other non-breast defect, all necessary elements of the operation, including (but not limited to):(a) anastomoses of all required vessels using microvascular techniques; and(b) harvesting of flap (including osteotomies); and(c) raising of tissue on a vascular pedicle; and(d) preparation of recipient vessels; and(e) transfer of tissue, including fixation of bony element and inset of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than the following:(g) bony reshaping for purposes of reconstruction of maxilla, mandible or skull base;(h) a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, principal specialist surgeon (H)
46064	01JUL2023	31DEC9999	Y	Free transfer of tissue with a vascularised bone component (including chimeric/composite flap), for the repair of major defect of the head or neck or other non-breast defect, all necessary elements of the operation, including (but not limited to):(a) anastomoses of all required vessels using microvascular techniques; and(b) harvesting of flap (including osteotomies); and(c) raising of tissue on a vascular pedicle; and(d) preparation of recipient vessels; and(e) transfer of tissue, including fixation of bony element and inset of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than the following:(g) bony reshaping for purposes of reconstruction of maxilla, mandible or skull base;(h) a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, conjoint specialist surgeon (H)
46066	01JUL2023	31DEC9999	Y	Double free flap, including one free transfer of tissue with a vascularized bone component, for the repair of major defect of the head or neck or other non-breast defect, all necessary elements of the operation, including (but not limited to):(a) anastomoses of all required vessels using microvascular techniques; and(b) harvesting of flap (including osteotomies); and(c) raising of tissue on a vascular pedicle; and(d) preparation of recipient vessels; and(e) transfer of tissue, including fixation of bony element and inset of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than the following:(g) bony reshaping for purposes of reconstruction of maxilla, mandible or skull base;(h) a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, principal specialist surgeon (H)
46068	01JUL2023	31DEC9999	Y	Double free flap, including one free transfer of tissue with a vascularized bone component, for the repair of major defect of the head or neck or other non-breast defect, all necessary elements of the operation, including (but not limited to):(a) anastomoses of all required vessels using microvascular techniques; and(b) harvesting of flap (including osteotomies); and(c) raising of tissue on a vascular pedicle; and(d) preparation of recipient vessels; and(e) transfer of tissue, including fixation of bony element and inset of tissue at recipient site; and(f) direct repair of secondary cutaneous defect, if performed;other than the following:(g) bony reshaping for purposes of reconstruction of maxilla, mandible or skull base;(h) a service associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, conjoint specialist surgeon (H)
46070	01JUL2023	31DEC9999	Y	Double free flap, including 2 free transfers of tissue (reconstructive surgery) for the repair of major tissue defect, involving anastomoses of all required vessels using microvascular techniques, all necessary elements of the operation, including (but not limited to):(a) raising each flap of tissue on a separate vascular pedicle; and(b) preparation of recipient vessels; and(c) transfer of tissue; and(d) inset of tissue at recipient site; and(e) direct repair of secondary cutaneous defect, if performed;other than a service:(f) performed in the context of breast reconstruction; or(g) associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, principal specialist surgeon (H)
46072	01JUL2023	31DEC9999	Y	Double free flap, including 2 free transfers of tissue (reconstructive surgery) for the repair of major tissue defect, involving anastomoses of all required vessels using microvascular techniques, all necessary elements of the operation including (but not limited to):(a) raising each flap of tissue on a separate vascular pedicle; and(b) preparation of recipient vessels; and(c) transfer of tissue; and(d) inset of tissue at recipient site; and(e) direct repair of secondary cutaneous defect, if performed;other than a service:(f) performed in the context of breast reconstruction; or(g) associated with a service to which item 30166, 30169, 30175, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 appliesConjoint surgery, conjoint specialist surgeon (H)
46080	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, single surgeon (unilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomosis of artery and one or more veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies (H)
46082	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, single surgeon (bilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomoses of arteries and veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies (H)
46084	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, conjoint surgery (unilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomosis of artery and one or more veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies-conjoint surgery, principal specialist surgeon (H)
46086	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, conjoint surgery (unilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomosis of artery and one or more veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies-conjoint surgery, conjoint specialist surgeon (H)
46088	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, conjoint surgery (bilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomosis of artery and one or more veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies-conjoint surgery, principal specialist surgeon (H)
46090	01JUL2023	31DEC9999	Y	Post-mastectomy breast reconstruction, autologous, conjoint surgery (bilateral) using a myocutaneous or perforator flap, by microsurgical transfer:(a) including anastomoses of arteries and veins (including repair of secondary skin defect); but(b) excluding repair of muscular aponeurotic layer;other than a service associated with a service to which item 30166, 30169, 30175, 30177 or 30179 applies-conjoint surgery, conjoint specialist surgeon (H)
46092	01JUL2023	29FEB2024	N	Lower pole coverage of reconstructive breast prosthesis, following mastectomy, using muscle or fascia turnover flap or autologous dermal flaps, if the service is performed in combination with a service to which item 31522, 31523, 31528, 31529, 45527, 45539 or 45542 applies
46092	01MAR2024	31DEC9999	Y	Lower pole coverage of reconstructive breast prosthesis, following mastectomy, using muscle or fascia turnover flap or autologous dermal flaps, if the service is performed in combination with a service to which item 31522, 31523, 31528, 31529, 45527, 45539 or 45542 applies (H)
46094	01JUL2023	29FEB2024	N	Lower pole coverage or complete implant coverage of reconstructive breast prosthesis, following mastectomy, using allograft or synthetic products
46094	01MAR2024	31DEC9999	Y	Lower pole coverage or complete implant coverage of reconstructive breast prosthesis, following mastectomy, using allograft or synthetic products (H)
46100	01JUL2023	31DEC9999	Y	Excision of burnt tissue, or definitive burn wound closure, if:(a) the area of burn excised involves more than 1% of hands, face or anterior neck; and(b) the service is performed in conjunction with a service (the co-claimed service) to which any of items 46101 to 46135 (other than item 46112 or 46124) apply;other than a service to which item 46136 applies
46101	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves not more than 1% of the total body surface
46102	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves more than 1% but less than 3% of the total body surface (H)
46103	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 3% or more but less than 10% of the total body surface (H)
46104	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 10% or more but less than 20% of the total body surface, excluding aftercare (H)
46105	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 20% or more but less than 30% of total body surface, excluding aftercare (H)
46106	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 30% or more but less than 40% of total body surface, excluding aftercare (H)
46107	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 40% or more but less than 50% of total body surface, excluding aftercare (H)
46108	01JUL2023	31OCT2023	N	Excision of burnt tissue, if the area of burn excised involves 50% or more but less than 60% of total body surface (H)
46108	01NOV2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 50% or more but less than 60% of total body surface, excluding aftercare (H)
46109	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 60% or more but less than 70% of total body surface, excluding aftercare (H)
46110	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 70% or more but less than 80% of total body surface, excluding aftercare (H)
46111	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves 80% or more of total body surface, excluding aftercare (H)
46112	01JUL2023	31DEC9999	Y	Excision of burnt tissue, if the area of burn excised involves whole of face (excluding ears)-may be claimed with any one of items 46101 to 46111, based on the percentage total body surface (excluding the face), other than a service associated with a service to which item 46100 applies and excluding aftercare (H)
46113	01JUL2023	31DEC9999	Y	Excised burn wound closure, or closure of skin defect secondary to burns contracture release, if the defect area is not more than 1% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound
46114	01JUL2023	31DEC9999	Y	Excised burn wound closure, or closure of skin defect secondary to burns contracture release, if the defect area is more than 1% but not more than 3% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound (H)
46115	01JUL2023	31DEC9999	Y	Excised burn wound closure or closure of skin defect secondary to burns contracture release, if the defect area is more than 3% but not more than 10% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound (H)
46116	01JUL2023	31OCT2023	N	Excised burn wound closure or closure of skin defect secondary to burns contracture release, if the defect area is more than 10% but not more than 20% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46116	01NOV2023	31DEC9999	Y	Excised burn wound closure or closure of skin defect secondary to burns contracture release, if the defect area is more than 10% but less than 20% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46117	01JUL2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 20% or more but less than 30% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46118	01JUL2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 30% or more but less than 40% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46119	01JUL2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 40% or more but less than 50% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46120	01JUL2023	31OCT2023	N	Excised burn wound closure, if the defect area is 50% or more but less than 60% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46120	01NOV2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 50% or more but less than 60% of total body surface and if the service: (a) is performed at the same time as the procedure for the primary burn wound excision; and (b) involves: (i) autologous skin grafting for definitive closure; or (ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46121	01JUL2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 60% or more but less than 70% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46122	01JUL2023	31OCT2023	N	Excised burn wound closure, if the defect area is 70% or more but less than 80% of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision or contracture release; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46122	01NOV2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 70% or more but less than 80% of total body surface and if the service: (a) is performed at the same time as the procedure for the primary burn wound excision; and (b) involves: (i) autologous skin grafting for definitive closure; or (ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46123	01JUL2023	31DEC9999	Y	Excised burn wound closure, if the defect area is 80% or more of total body surface and if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare (H)
46124	01JUL2023	31DEC9999	Y	Excised burn wound closure of whole of face, if the service:(a) is performed at the same time as the procedure for the primary burn wound excision; and(b) involves: (i) autologous skin grafting for definitive closure; or(ii) allogenic skin grafting, or biosynthetic skin substitutes, to temporize the excised wound; excluding aftercare, other than a service associated with a service to which item 46100 applies (H)
46125	01JUL2023	31DEC9999	Y	Non-excisional debridement of superficial or mid-dermal partial thickness burns, if the area of burn involves less than 1% of total body surface, and application of skin substitute (skin allograft or biosynthetic epidermal replacements)
46126	01JUL2023	31DEC9999	Y	Non-excisional debridement of superficial or mid-dermal partial thickness burns, if the area of burn involves 1% or more but less than 3% of total body surface, and application of skin substitute (skin allograft or biosynthetic epidermal replacements)
46127	01JUL2023	31DEC9999	Y	Non-excisional debridement of superficial or mid-dermal partial thickness burns, if the area of burn involves 3% or more but less than 10% of total body surface, and application of skin substitute (skin allograft or biosynthetic epidermal replacements) (H)
46128	01JUL2023	31DEC9999	Y	Non-excisional debridement of superficial or mid-dermal partial thickness burns, if the area of burn involves 10% or more but less than 30% of total body surface, and application of skin substitute (skin allograft or biosynthetic epidermal replacements), excluding aftercare (H)
46129	01JUL2023	31DEC9999	Y	Non-excisional debridement of superficial or mid-dermal partial thickness burns, if the area of burn involves 30% or more of total body surface, and application of skin substitute (skin allograft or biosynthetic epidermal replacements), excluding aftercare (H)
46130	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis or secondary to release of burns scar contracture, if the defect area involves less than 1% of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure or simple dressings
46131	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis or secondary to release of burns scar contracture, if the defect area involves 1% or more but less than 3% of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure or simple dressings (H)
46132	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis or secondary to release of burns scar contracture, if the defect area involves 3% or more but less than 10% of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure or simple dressings (H)
46133	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis or secondary to release of burns scar contracture, if the defect area involves 10% or more but less than 20% of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure or simple dressings, excluding aftercare (H)
46134	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis, if the defect area involves 20% or more but less than 30% of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure, excluding aftercare (H)
46135	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis, if the defect area involves 30% or more of total body surface, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure, excluding aftercare (H)
46136	01JUL2023	31DEC9999	Y	Definitive burn wound closure, or closure of skin defect secondary to necrotising fasciitis, of whole of face, using autologous tissue (split skin graft or other) following previous procedure using non-autologous temporary wound closure, excluding aftercare, other than a service associated with a service to which item 46100 applies (H)
46140	01JUL2023	31DEC9999	Y	Burns contracture, release of, by excision or incision of scar, if the defect resulting from surgery is less than 1% of total body surface, including direct repair if performed
46141	01JUL2023	31DEC9999	Y	Burns contracture, release of, by excision or incision of scar, if the defect resulting from surgery is 1% or more but less than 3% of total body surface (H)
46142	01JUL2023	31DEC9999	Y	Burns contracture, release of, by excision or incision of scar, if the defect resulting from surgery is 3% or more but less than 10% of total body surface (H)
46143	01JUL2023	31DEC9999	Y	Burns contracture, release of, by excision or incision of scar, if the defect resulting from surgery is 10% or more but less than 20% of total body surface (H)
46150	01JUL2023	31DEC9999	Y	Mandible or maxilla, procedure for advancement, retrusion or alteration of tilt, by osteotomy in standard planes, including fixation by any means (including application of distractors if used)-one service per patient on the same occasion (H)
46151	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or alteration of tilt, or combination of these, by osteotomies in standard planes, including fixation by any means (including application of distractors if used)-conjoint surgery, principal specialist surgeon, one service per patient on the same occasion (H)
46152	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or alteration of tilt, or combination of these, by osteotomies in standard planes, including fixation by any means (including application of distractors if used)-conjoint surgery, conjoint specialist surgeon, one service per patient on the same occasion (H)
46153	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for advancement, retrusion or alteration of tilt, or combination of these, by osteotomies in standard planes, including fixation by any means (including application of distractors if used)-single surgeon, one service per patient on the same occasion (H)
46154	01JUL2023	31DEC9999	Y	Maxilla, procedure for reshaping arch of, by complex segmental osteotomies, including fixation by any means (including application of distractors if used), one service per patient on the same occasion (H)
46155	01JUL2023	31DEC9999	Y	Mandible, procedure for reshaping arch of, by complex segmental osteotomies, including genioplasty (if performed) and fixation by any means (including application of distractors if used), one service per patient on the same occasion (H)
46156	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for any combination of arch reshaping, advancement, retrusion or tilting of, involving complex segmental osteotomies, with or without standard osteotomies, including genioplasty (if performed) and fixation by any means (including application of distractors if used)-conjoint surgery, principal specialist surgeon, one service per patient on the same occasion (H)
46157	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for any combination of arch reshaping, advancement, retrusion or tilting of, involving complex segmental osteotomies, with or without standard osteotomies, including genioplasty (if performed) and fixation by any means (including application of distractors if used)-conjoint surgery, conjoint specialist surgeon, one service per patient on the same occasion (H)
46158	01JUL2023	31DEC9999	Y	Mandible and maxilla (bimaxillary), procedure for any combination of arch reshaping, advancement, retrusion or tilting of, involving complex segmental osteotomies, with or without standard osteotomies, including genioplasty (if performed) and fixation by any means (including application of distractors if used)-single surgeon, one service per patient on the same occasion (H)
46159	01JUL2023	31DEC9999	Y	Midfacial osteotomies, Le Fort II or Le Fort III-conjoint surgery, principal specialist surgeon (H)
46160	01JUL2023	31DEC9999	Y	Midfacial osteotomies, Le Fort II or Le Fort III-conjoint surgery, conjoint specialist surgeon (H)
46161	01JUL2023	31DEC9999	Y	Midfacial osteotomies, Le Fort II or Le Fort III-single surgeon (H)
46170	01JUL2023	31DEC9999	Y	Decompression of thoracic outlet, primary, for thoracic outlet syndrome, using any approach, including (if performed) division of scalene muscles, cervical rib and/or first rib resection (H)
46171	01JUL2023	31DEC9999	Y	Decompression of thoracic outlet, repeat (revision) procedure, for thoracic outlet syndrome, using any approach, including (if performed) division of scalene muscles, cervical rib and/or first rib resection (H)
46172	01JUL2023	31DEC9999	Y	Removal or debulking of brachial plexus tumour, involving intraneural dissection, either supraclavicular or infraclavicular dissection (H)
46173	01JUL2023	31DEC9999	Y	Removal or debulking of brachial plexus tumour, involving intraneural dissection, both supraclavicular and infraclavicular dissection (H)
46174	01JUL2023	31DEC9999	Y	Exploration of the brachial plexus, either supraclavicular or infraclavicular, including any neurolyses performed and intraoperative neurophysiological recordings, but excluding reconstruction of elements(H)
46175	01JUL2023	31DEC9999	Y	Exploration of the brachial plexus, both supraclavicular and infraclavicular, including any neurolyses performed and intraoperative neurophysiological recordings, but excluding reconstruction of elements(H)
46176	01JUL2023	31DEC9999	Y	Exploration of the brachial plexus, posterior subscapular approach, all necessary elements of the operation including (but not limited to):(a) resection of the first rib and/or second rib; and(b) vertebral laminectomies or facetectomies, if performed; and(c) any neurolyses performed; and(d) intraoperative neurophysiological recordings;excluding the following:(e) reconstruction of elements of the plexus;(f) spinal instrumentation(H)
46177	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, single cord or trunk, by any appropriate method, single surgeon (H)
46178	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, single cord or trunk, by any appropriate method, conjoint surgery, principal surgeon (H)
46179	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, single cord or trunk, by any appropriate method, conjoint surgery, conjoint surgeon (H)
46180	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, more than a single cord or trunk, but less than the whole plexus, by any appropriate method, single surgeon (H)
46181	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, more than a single cord or trunk, but less than the whole plexus, by any appropriate method, conjoint surgery, principal surgeon (H)
46182	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, more than a single cord or trunk, but less than the whole plexus, by any appropriate method, conjoint surgery, conjoint surgeon (H)
46183	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, whole plexus, by any appropriate method, single surgeon (H)
46184	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, whole plexus, by any appropriate method, conjoint surgery, principal surgeon (H)
46185	01JUL2023	31DEC9999	Y	Reconstruction of deficit of the brachial plexus, whole plexus, by any appropriate method, conjoint surgery, conjoint surgeon (H)
46300	01DEC1991	30APR2009	N	Note: Items 46300 to 46534 are restricted to surgery on the hand/s. INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrodesis of
46300	01MAY2009	30JUN2021	N	Note: Items 46300 to 46534 are restricted to surgery on the hand/s. INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrodesis of, with synovectomy if performed
46300	01JUL2021	31DEC9999	Y	Arthrodesis of interphalangeal or metacarpophalangeal joint of hand, including either or both of the following (if performed): (a) joint debridement; (b) synovectomy -one joint (H)
46303	01DEC1991	30APR2009	N	CARPOMETACARPAL JOINT, arthrodesis of
46303	01MAY2009	30JUN2021	N	CARPOMETACARPAL JOINT, arthrodesis of, with synovectomy if performed
46303	01JUL2021	31DEC9999	Y	Arthrodesis of carpometacarpal joint of hand, including either or both of the following (if performed): (a) joint debridement; (b) synovectomy -one joint (H)
46306	01DEC1991	31OCT1994	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, interposition arthroplasty of (including volar plate arthroplasty), and including tendon transfers or realignment on the 1 ray
46306	01NOV1994	31DEC9999	Y	INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, interposition arthroplasty of and including tendon transfers or realignment on the 1 ray
46307	01NOV1994	31DEC9999	Y	INTERPHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT - volar plate arthroplasty for traumatic deformity including tendon transfers or realignment on the 1 ray
46308	01JUL2021	31DEC9999	Y	Volar plate or soft tissue interposition arthroplasty of interphalangeal or metacarpophalangeal joint of hand, including either or both of the following (if performed): (a) realignment procedures; (b) tendon transfer -one joint
46309	01DEC1991	31OCT1996	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 1 joint
46309	01NOV1996	30JUN2021	N	INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 1 joint
46309	01JUL2021	31DEC9999	Y	Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) ligament reconstruction; (b) ligament realignment; (c) synovectomy; (d) tendon transfer -one joint (H)
46312	01DEC1991	31OCT1996	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 2 joints
46312	01NOV1996	30JUN2021	N	INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 2 joints
46312	01JUL2021	31DEC9999	Y	Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) ligament reconstruction; (b) ligament realignment; (c) synovectomy; (d) tendon transfer -2 joints of one hand (H)
46315	01DEC1991	31OCT1996	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 3 joints
46315	01NOV1996	30JUN2021	N	INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 3 joints
46315	01JUL2021	31DEC9999	Y	Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) ligament reconstruction; (b) ligament realignment; (c) synovectomy; (d) tendon transfer -3 joints of one hand (H)
46318	01DEC1991	31OCT1996	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 4 joints
46318	01NOV1996	30JUN2021	N	INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 4 joints
46318	01JUL2021	31DEC9999	Y	Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) ligament reconstruction; (b) ligament realignment; (c) synovectomy; (d) tendon transfer -4 joints of one hand (H)
46321	01DEC1991	31OCT1996	N	INTER-PHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 5 or more joints
46321	01NOV1996	30JUN2021	N	INTERPHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 5 or more joints
46321	01JUL2021	31DEC9999	Y	Prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) ligament reconstruction; (b) ligament realignment; (c) synovectomy; (d) tendon transfer; -5 joints of one hand (H)
46322	01JUL2021	31DEC9999	Y	Revision of prosthetic replacement arthroplasty or hemiarthroplasty of interphalangeal or metacarpal joint of hand, including any of the following (if performed): (a) bone grafting; (b) ligament reconstruction; (c) ligament realignment; (d) synovectomy; (e) tendon or ligament reconstruction; (f) tendon transfer; -one joint (H)
46324	01DEC1991	31OCT1994	N	CARPAL BONE replacement arthroplasty including associated tendon transfer or realignment when performed
46324	01NOV1994	30JUN2021	N	CARPAL BONE REPLACEMENT ARTHROPLASTY including associated tendon transfer or realignment when performed
46324	01JUL2021	29FEB2024	N	Trapezium replacement arthroplasty or prosthetic interpositional replacement of carpometacarpal joint of thumb, including either or both of the following (if performed): (a) ligament and tendon transfers; (b) rebalancing procedures (H)
46324	01MAR2024	31DEC9999	Y	Prosthetic interpositional replacement of carpometacarpal joint, including either or both of the following (if performed): (a) ligament and tendon transfers; (b) rebalancing procedures (H)
46325	01NOV1994	31OCT1996	N	CARPAL BONE REPLACEMENT ARTHROPLASTY using adjacent tendon or other soft tissue including associated tendon transfer or realignment when performed
46325	01NOV1996	30JUN2021	N	CARPAL BONE REPLACEMENT OR RESECTION ARTHROPLASTY using adjacent tendon or other soft tissue including associated tendon transfer or realignment when performed
46325	01JUL2021	29FEB2024	N	Excisional arthroplasty of carpometacarpal joint of thumb, with excision of adjacent trapezoid, including either or both of the following (if performed): (a) ligament and tendon transfers; (b) realignment procedures (H)
46325	01MAR2024	31DEC9999	Y	Excisional arthroplasty of carpometacarpal joint, including any of the following (if performed): (a) ligament and tendon transfers; (b) realignment procedures; (c) excision of adjacent trapezoid (H)
46327	01DEC1991	31DEC9999	Y	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrotomy of
46330	01DEC1991	31OCT2006	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrotomy of, with ligamentous or capsular repair
46330	01NOV2006	30JUN2021	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, ligamentous or capsular repair with or without arthrotomy
46330	01JUL2021	31DEC9999	Y	Ligamentous or capsular repair or reconstruction of interphalangeal or metacarpophalangeal joint of hand, including any of the following (if performed): (a) arthrotomy; (b) joint stabilisation; (c) synovectomy; -one joint (H)
46333	01DEC1991	30JUN2021	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, ligamentous repair of, using free tissue graft or implant
46333	01JUL2021	31DEC9999	Y	Ligamentous or capsular repair or reconstruction of interphalangeal or metacarpophalangeal joint of hand with graft, using graft or implant, including any of the following (if performed): (a) arthrotomy; (b) harvest of graft; (c) joint stabilisation; (d) synovectomy; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 apply-one joint (H)
46335	01JUL2021	29FEB2024	N	Synovectomy of digital extensor tendons of hand, distal to wrist, for diagnosed inflammatory arthritis, including any of the following (if performed): (a) reconstruction of extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with a service to which item 30023, 39331 or 39330 applies-applicable only once per occasion on which the service is performed
46335	01MAR2024	31DEC9999	Y	Synovectomy of digital extensor tendons of hand, distal to wrist, for diagnosed inflammatory arthritis, including any of the following (if performed): (a) reconstruction of extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with: (e) a service to which item 39330 applies; or (f) a service to which item 30023 applies that is performed at the same site Applicable once per hand per occasion on which the service is performed
46336	01DEC1991	30JUN2021	N	INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, synovectomy, capsulectomy or debridement of, not being a service associated with any procedure related to that joint
46336	01JUL2021	31DEC9999	Y	Synovectomy of interphalangeal, metacarpophalangeal or carpometacarpal joint of hand, including any of the following (if performed): (a) capsulectomy; (b) debridement; (c) ligament or tendon realignment (or both); other than a service combined with a service to which item 46495 applies-one joint
46339	01DEC1991	30JUN2021	N	EXTENSOR TENDONS or FLEXOR TENDONS of hand or wrist, synovectomy of
46339	01JUL2021	29FEB2024	N	Synovectomy of digital flexor tendons at wrist level, for diagnosed inflammatory arthritis, including either or both of the following (if performed): (a) tenolysis; (b) release of median nerve and carpal tunnel; other than a service associated with a service to which item 30023, 39331 or 39330 applies-applicable only once per occasion on which the service is performed (H)
46339	01MAR2024	31DEC9999	Y	Synovectomy of digital flexor tendons at wrist level, for diagnosed inflammatory arthritis, including either or both of the following (if performed): (a) tenolysis; (b) release of median nerve and carpal tunnel; other than a service associated with: (c) a service to which item 39330 or 39331 applies; or (d) a service to which item 30023 applies that is performed at the same site Applicable once per wrist per occasion on which the service is performed (H)
46340	01JUL2021	29FEB2024	N	Synovectomy of wrist flexor or extensor tendons of hand or wrist, for diagnosed inflammatory tenosynovitis, including any of the following (if performed): (a) reconstruction of flexor or extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with a service to which item 30023, 39331 or 39330 applies-one or more compartments (H)
46340	01MAR2024	31DEC9999	Y	Synovectomy of wrist flexor or extensor tendons of hand or wrist, for diagnosed inflammatory tenosynovitis, including any of the following (if performed): (a) reconstruction of flexor or extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with: (e) a service to which item 39330 applies; or (f) if this service is performed on the wrist flexor tendons-a service to which item 39331 applies; or (g) a service to which item 30023 applies that is performed at the same site -one or more compartments per limb (H)
46341	01JUL2021	29FEB2024	N	Synovectomy of wrist flexor or extensor tendons of hand or wrist, for non-inflammatory tenosynovitis or post traumatic synovitis, including any of the following (if performed): (a) reconstruction of flexor or extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with a service to which item 30023, 39331 or 39330 applies-one or more compartments (H)
46341	01MAR2024	31DEC9999	Y	Synovectomy of wrist flexor or extensor tendons of hand or wrist, for non-inflammatory tenosynovitis or post traumatic synovitis, including any of the following (if performed): (a) reconstruction of flexor or extensor retinaculum; (b) removal of tendon nodules; (c) tenolysis; (d) tenoplasty; other than a service associated with: (e) a service to which item 39330 applies; or (f) if this service is performed on the wrist flexor tendons-a service to which item 39331 applies; or (g) a service to which item 30023 applies that is performed at the same site -one or more compartments per limb (H)
46342	01DEC1991	30JUN2021	N	DISTAL RADIOULNAR JOINT or CARPOMETACARPAL JOINT OR JOINTS, synovectomy of
46342	01JUL2021	31DEC9999	Y	Synovectomy of distal radioulnar or carpometacarpal joint of hand-one or more joints (H)
46345	01DEC1991	31OCT1996	N	RECONSTRUCTION of DISTAL RADIOULNAR JOINT
46345	01NOV1996	30JUN2021	N	DISTAL RADIOULNAR JOINT, reconstruction or stabilisation of, including fusion, or ligamentous arthroplasty and excision of distal ulna, when performed
46345	01JUL2021	31DEC9999	Y	Resection arthroplasty of distal radioulnar joint of hand, partial or complete, including any of the following (if performed): (a) ligament or tendon reconstruction; (b) joint stabilisation; (c) synovectomy (H)
46348	01DEC1991	30JUN2021	N	DIGIT, synovectomy of flexor tendon or tendons - 1 digit
46348	01JUL2021	29FEB2024	N	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with a service to which item 30023 or 46363 applies-one ray (H)
46348	01MAR2024	31DEC9999	Y	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with: (d) a service to which item 30023 applies that is performed at the same site; or (e) a service to which item 46363 applies that is performed on the same ray -one ray (H)
46351	01DEC1991	30JUN2021	N	DIGIT, synovectomy of flexor tendon or tendons - 2 digits
46351	01JUL2021	29FEB2024	N	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with a service to which item 30023 or 46363 applies-2 rays of one hand (H)
46351	01MAR2024	31DEC9999	Y	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with: (d) a service to which item 30023 applies that is performed at the same site; or (e) a service to which item 46363 applies that is performed on one of the same rays -2 rays of one hand (H)
46354	01DEC1991	30JUN2021	N	DIGIT, synovectomy of flexor tendon or tendons - 3 digits
46354	01JUL2021	29FEB2024	N	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with a service to which item 30023 or 46363 applies-3 rays of one hand (H)
46354	01MAR2024	31DEC9999	Y	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with: (d) a service to which item 30023 applies that is performed at the same site; or (e) a service to which item 46363 applies that is performed on one of the same rays -3 rays of one hand (H)
46357	01DEC1991	30JUN2021	N	DIGIT, synovectomy of flexor tendon or tendons - 4 digits
46357	01JUL2021	29FEB2024	N	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with a service to which item 30023 or 46363 applies-4 rays of one hand (H)
46357	01MAR2024	31DEC9999	Y	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with: (d) a service to which item 30023 applies that is performed at the same site; or (e) a service to which item 46363 applies that is performed on one of the same rays -4 rays of one hand (H)
46360	01DEC1991	30JUN2021	N	DIGIT, synovectomy of flexor tendon or tendons - 5 digits
46360	01JUL2021	29FEB2024	N	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with a service to which item 30023 or 46363 applies-5 rays of one hand (H)
46360	01MAR2024	31DEC9999	Y	Flexor tenosynovectomy of hand, distal to lumbrical origin, including any of the following (if performed): (a) removal of intratendinous nodules; (b) tenolysis; (c) tenoplasty; other than a service associated with: (d) a service to which item 30023 applies that is performed at the same site; or (e) a service to which item 46363 applies that is performed on one of the same rays -5 rays of one hand (H)
46363	01DEC1991	30JUN2021	N	TENDON SHEATH OF HAND OR WRIST, open operation on, for STENOSING TENOVAGINITIS
46363	01JUL2021	29FEB2024	N	Trigger finger release, for stenosing tenosynoviti, including either or both of the following (if performed): (a) synovectomy; (b) synovial biopsy; -one ray
46363	01MAR2024	31DEC9999	Y	Trigger finger release, for stenosing tenosynovitis, including either or both of the following (if performed): (a) synovectomy; (b) synovial biopsy; -one ray
46364	01JUL2021	29FEB2024	N	Digital sympathectomy of hand, using microsurgical techniques, other than a service associated with a service to which item 30023 or 46363 applies-one digit or palmer arch (or both) or radial or ulnar artery (or both)
46364	01MAR2024	31DEC9999	Y	Digital sympathectomy of hand, using microsurgical techniques, other than a service associated with: (a) a service to which item 46363 applies; or (b) a service to which item 30023 applies that is performed at the same site -one digit or palmer arch (or both) or radial or ulnar artery (or both)
46365	01JUL2021	31DEC9999	Y	Excision of rheumatoid nodules of hand -one lesion
46366	01DEC1991	31OCT1994	N	DUPUYTREN'S CONTRACTURE, subcutaneous fasciotomy for - 1 hand
46366	01NOV1994	31DEC9999	Y	DUPUYTREN'S CONTRACTURE, subcutaneous fasciotomy for - each hand
46367	01JUL2021	31DEC9999	Y	De Quervain's release, including any of the following (if performed): (a) synovectomy of extensor pollicis brevis; (b) synovectomy of abductor pollicis longus tendons; (c) retinaculum reconstruction; other than a service associated with a service to which item 46339 applies
46369	01DEC1991	31DEC9999	Y	DUPUYTREN'S CONTRACTURE, palmar fasciectomy for - 1 hand
46370	01JUL2021	31DEC9999	Y	Percutaneous fasciotomy for Dupuytrens contracture, by needle or chemical method, including either or both of the following (if performed): (a) immediate or delayed manipulation; (b) local or regional nerve block; -one ray
46372	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 1 ray, including dissection of nerves - 1 hand
46372	01JUL2021	31DEC9999	Y	Fasciectomy for Dupuytrens contracture, including dissection of nerves (if performed)-one ray (H)
46375	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 2 rays, including dissection of nerves - 1 hand
46375	01JUL2021	31DEC9999	Y	Fasciectomy for Dupuytrens contracture, including dissection of nerves (if performed)-2 rays (H)
46378	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 3 or more rays, including dissection of nerves - 1 hand
46378	01JUL2021	31DEC9999	Y	Fasciectomy for Dupuytrens contracture, including dissection of nerves (if performed)-3 rays (H)
46379	01JUL2021	31DEC9999	Y	Fasciectomy for Dupuytrens contracture, including dissection of nerves (if performed)-4 rays (H)
46380	01JUL2021	31DEC9999	Y	Fasciectomy for Dupuytrens contracture, including dissection of nerves (if performed)-5 rays (H)
46381	01DEC1991	30JUN2021	N	INTER-PHALANGEAL JOINT, joint capsule release when performed in conjunction with operation for Dupuytren's Contracture - each procedure
46381	01JUL2021	31DEC9999	Y	Release of interphalangeal joint of hand, by open procedure, when performed in conjunction with an operation for Dupuytrens contracture-one joint (H)
46384	01DEC1991	30JUN2021	N	Z PLASTY (or similar local flap procedure) when performed in conjunction with operation for Dupuytren's Contracture - 1 such procedure
46384	01JUL2021	31DEC9999	Y	Z-plasty or similar local flap procedure, when performed in conjunction with an operation for Dupuytrens contracture, including raising, transfer in-setting and suturing of both components (flaps)-one Z-plasty or local flap procedure (H)
46387	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 1 ray, including dissection of nerves - operation for recurrence in that ray
46387	01JUL2021	29FEB2024	N	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies-one ray (H)
46387	01MAR2024	31DEC9999	Y	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one ray (H)
46390	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 2 rays, including dissection of nerves - operation for recurrence in those rays
46390	01JUL2021	29FEB2024	N	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies-2 rays (H)
46390	01MAR2024	31DEC9999	Y	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-2 rays (H)
46393	01DEC1991	30JUN2021	N	DUPUYTREN'S CONTRACTURE, fasciectomy for, from 3 or more rays, including dissection of nerves - operation for recurrence in those rays
46393	01JUL2021	29FEB2024	N	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies-3 rays (H)
46393	01MAR2024	31DEC9999	Y	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-3 rays (H)
46394	01JUL2021	29FEB2024	N	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies-4 rays (H)
46394	01MAR2024	31DEC9999	Y	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-4 rays (H)
46395	01JUL2021	29FEB2024	N	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies-5 rays (H)
46395	01MAR2024	31DEC9999	Y	Fasciectomy for recurrence of Dupuytrens contracture, including either or both of the following (if performed): (a) dissection of nerves; (b) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-5 rays (H)
46396	01DEC1991	30APR2009	N	PHALANX OR METACARPAL OF THE HAND, osteotomy or osteectomy of
46396	01MAY2009	31DEC9999	Y	PHALANX OR METACARPAL OF THE HAND, osteotomy or osteectomy of, and excluding services to which item 47933 or 47936 apply
46399	01DEC1991	30JUN2021	N	PHALANX OR METACARPAL OF THE HAND, osteotomy of, with internal fixation
46399	01JUL2021	31DEC9999	Y	Osteotomy of phalanx or metacarpal of hand, with internal fixation-one bone (H)
46401	01JUL2021	31DEC9999	Y	Operative treatment of non-union of phalanx or metacarpal of hand, including internal fixation (if performed)
46402	01DEC1991	31DEC9999	Y	PHALANX or METACARPAL, bone grafting of, for pseudarthrosis (non-union), including obtaining of graft material
46405	01DEC1991	31DEC9999	Y	PHALANX or METACARPAL, bone grafting of, for pseudarthrosis (non-union), involving internal fixation and including obtaining of graft material
46408	01DEC1991	30JUN2021	N	TENDON, reconstruction of, by tendon graft
46408	01JUL2021	29FEB2024	N	Reconstruction of tendon of hand or wrist, by tendon graft, including either or both of the following (if performed): (a) harvest of graft; (b) tenolysis; other than a service associated with a service to which item 30023 applies (H)
46408	01MAR2024	31DEC9999	Y	Reconstruction of tendon of hand or wrist, by tendon graft, including either or both of the following (if performed): (a) harvest of graft; (b) tenolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site (H)
46411	01DEC1991	30JUN2021	N	FLEXOR TENDON PULLEY, reconstruction of, by graft
46411	01JUL2021	31DEC9999	Y	Reconstruction of complete flexor tendon pulley of hand or wrist, with graft, including harvest of graft (if performed)-one pulley (H)
46414	01DEC1991	30JUN2021	N	ARTIFICIAL TENDON PROSTHESIS, INSERTION OF, in preparation for tendon grafting
46414	01JUL2021	29FEB2024	N	Insertion of artificial tendon prosthesis in preparation for grafting of tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies
46414	01MAR2024	31DEC9999	Y	Insertion of artificial tendon prosthesis in preparation for grafting of tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
46417	01DEC1991	30JUN2021	N	TENDON transfer for restoration of hand function, each transfer
46417	01JUL2021	31DEC9999	Y	Transfer of tendon of hand or wrist, for restoration of hand or digit motion, including harvest of donor motor unit (if performed)-one transfer (H)
46420	01DEC1991	30JUN2021	N	EXTENSOR TENDON OF HAND OR WRIST, primary repair of, each tendon
46420	01JUL2021	31DEC9999	Y	Primary repair of extensor tendon of hand or wrist-one tendon
46423	01DEC1991	30JUN2021	N	EXTENSOR TENDON OF HAND OR WRIST, secondary repair of, each tendon
46423	01JUL2021	29FEB2024	N	Delayed repair of extensor tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies
46423	01MAR2024	31DEC9999	Y	Delayed repair of extensor tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
46426	01DEC1991	30JUN2021	N	FLEXOR TENDON OF HAND OR WRIST, primary repair of, proximal to A1 pulley, each tendon
46426	01JUL2021	29FEB2024	N	Primary repair of flexor tendon of hand or wrist, proximal to A1 pulley, other than a service to repair a tendon of a digit if 2 tendons of the same digit have been repaired during the same procedure-one tendon (H)
46426	01MAR2024	31DEC9999	Y	Primary repair of flexor tendon of hand or wrist, proximal to A1 pulley-one tendon (H)
46429	01DEC1991	31DEC9999	Y	FLEXOR TENDON OF HAND OR WRIST, secondary repair of, proximal to A1 pulley, each tendon
46432	01DEC1991	30JUN2021	N	FLEXOR TENDON OF HAND, primary repair of, distal to A1 pulley, each tendon
46432	01JUL2021	29FEB2024	N	Primary repair of flexor tendon of hand or wrist, distal to A1 pulley, other than a service to repair a tendon of a digit if 2 tendons of the same digit have been repaired during the same procedure-one tendon (H)
46432	01MAR2024	31DEC9999	Y	Primary repair of flexor tendon of hand, distal to A1 pulley, other than a service to repair a tendon of a digit if 2 tendons of the same digit have been repaired during the same procedure-one tendon (H)
46434	01JUL2021	29FEB2024	N	Delayed repair of flexor tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies
46434	01MAR2024	31DEC9999	Y	Delayed repair of flexor tendon of hand or wrist, including tenolysis (if performed), other than a service associated with a service to which item 30023 applies that is performed at the same site
46435	01DEC1991	31DEC9999	Y	FLEXOR TENDON OF HAND, secondary repair of, distal to A1 pulley, each tendon
46438	01DEC1991	30JUN2021	N	MALLET FINGER, closed pin fixation of
46438	01JUL2021	31DEC9999	Y	Closed pin fixation of mallet finger
46441	01DEC1991	30JUN2021	N	MALLET FINGER, open repair of, including pin fixation when performed
46441	01JUL2021	31DEC9999	Y	Open reduction of mallet finger, including any of the following (if performed): (a) joint release; (b) pin fixation; (c) tenolysis
46442	01NOV1994	31DEC9999	Y	MALLET FINGER with intra articular fracture involving more than one third of base of terminal phalanx - open reduction
46444	01DEC1991	30JUN2021	N	BOUTONNIERE DEFORMITY without joint contracture, reconstruction of
46444	01JUL2021	31DEC9999	Y	Reconstruction of Boutonniere or swan neck deformity of hand, including either or both of the following (if performed): (a) tendon graft harvest; (b) tendon transfer -one joint (H)
46447	01DEC1991	31DEC9999	Y	BOUTONNIERE DEFORMITY with joint contracture, reconstruction of
46450	01DEC1991	30JUN2021	N	EXTENSOR TENDON, TENOLYSIS OF, following tendon injury, repair or graft
46450	01JUL2021	29FEB2024	N	Tenolysis of extensor tendon of hand or wrist, following tendon injury or graft, other than a service: (a) for acute, traumatic injury; or (b) associated with a service to which item 30023 applies -one ray (H)
46450	01MAR2024	31DEC9999	Y	Tenolysis of extensor tendon of hand or wrist, following tendon injury or graft, other than a service: (a) for acute, traumatic injury; or (b) associated with a service to which item 30023 applies that is performed at the same site; -one ray (H)
46453	01DEC1991	30JUN2021	N	FLEXOR TENDON, TENOLYSIS OF, following tendon injury, repair or graft
46453	01JUL2021	29FEB2024	N	Tenolysis of flexor tendon of hand or wrist, following tendon injury, repair or graft, other than a service: (a) for acute, traumatic injury; or (b) associated with a service to which item 30023 applies (H)
46453	01MAR2024	31DEC9999	Y	Tenolysis of flexor tendon of hand or wrist, following tendon injury, repair or graft, other than a service: (a) for acute, traumatic injury; or (b) associated with a service to which item 30023 applies that is performed at the same site (H)
46456	01DEC1991	30JUN2021	N	FINGER, percutaneous tenotomy of
46456	01JUL2021	31DEC9999	Y	Percutaneous tenotomy of digit of hand
46459	01DEC1991	31DEC9999	Y	OPERATION for OSTEOMYELITIS on distal phalanx
46462	01DEC1991	31DEC9999	Y	OPERATION for OSTEOMYELITIS on middle or proximal phalanx, metacarpal or carpus
46464	01NOV1994	30JUN2021	N	AMPUTATION of a supernumerary complete digit
46464	01JUL2021	31DEC9999	Y	Amputation of a supernumerary complete digit of hand (H)
46465	01DEC1991	30JUN2021	N	AMPUTATION of SINGLE DIGIT, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover
46465	01JUL2021	31DEC9999	Y	Amputation of digit of hand, distal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) resection of bone; (c) skin cover with local flaps -one ray (H)
46468	01DEC1991	30JUN2021	N	AMPUTATION of 2 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover
46468	01JUL2021	31DEC9999	Y	Amputation of digit of hand, distal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) resection of bone; (c) skin cover with local flaps -2 rays (H)
46471	01DEC1991	30JUN2021	N	AMPUTATION of 3 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover
46471	01JUL2021	31DEC9999	Y	Amputation of digit of hand, distal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) resection of bone; (c) skin cover with local flaps -3 rays (H)
46474	01DEC1991	30JUN2021	N	AMPUTATION of 4 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover
46474	01JUL2021	31DEC9999	Y	Amputation of digit of hand, distal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) resection of bone; (c) skin cover with local flaps -4 rays (H)
46477	01DEC1991	30JUN2021	N	AMPUTATION of 5 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover
46477	01JUL2021	31DEC9999	Y	Amputation of digit of hand, distal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) resection of bone; (c) skin cover with local flaps -5 rays (H)
46480	01DEC1991	30JUN2021	N	AMPUTATION of SINGLE DIGIT, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover, including metacarpal
46480	01JUL2021	31DEC9999	Y	Amputation of ray of hand, proximal to metacarpal head, including any of the following (if performed): (a) excision of neuroma; (b) recontouring; (c) resection of bone; (d) skin cover with local flaps -one ray (H)
46483	01DEC1991	30JUN2021	N	REVISION of AMPUTATION STUMP to provide adequate soft tissue cover
46483	01JUL2021	31DEC9999	Y	Revision of amputation stump of hand to provide adequate cover, including any of the following (if performed): (a) bone shortening; (b) excision of nail bed remnants; (c) excision of neuroma (H)
46486	01DEC1991	30JUN2021	N	NAIL BED, accurate reconstruction of nail bed laceration using magnification, undertaken in the operating theatre of a hospital
46486	01JUL2021	31OCT2021	N	Accurate reconstruction of nail bed laceration using magnification (H)
46486	01NOV2021	31DEC9999	Y	Accurate reconstruction of acute nail bed laceration using magnification (H)
46489	01DEC1991	30JUN2021	N	NAIL BED, secondary exploration and accurate repair of nail bed deformity using magnification, undertaken in the operating theatre of a hospital
46489	01JUL2021	31DEC9999	Y	Secondary reconstruction of nail bed deformity using magnification, including removal of nail (if performed), other than a service associated with a service to which item 46513 or 45451 applies (H)
46492	01DEC1991	31OCT1996	N	FLEXION CONTRACTURE of HAND OR DIGIT, correction of, involving tissues deeper than skin and subcutaneous tissue
46492	01NOV1996	30JUN2021	N	CONTRACTURE OF DIGITS OF HAND, flexor or extensor, correction of, involving tissues deeper than skin and subcutaneous tissue
46492	01JUL2021	31DEC9999	Y	Surgical correction of contracture of joint of hand, flexor or extensor tendon, involving tissues deeper than skin and subcutaneous tissue-one joint (H)
46493	01JUL2021	31DEC9999	Y	Resection of boss of metacarpal base of hand, including either or both of the following (if performed): (a) excision of ganglion; (b) synovectomy
46494	01NOV1995	31DEC9999	Y	GANGLION OF HAND, excision of, not being a service associated with a service to which another item in this Group applies
46495	01DEC1991	31OCT2017	N	GANGLION OR MUCOUS CYST OF DISTAL DIGIT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46495	01NOV2017	30JUN2021	N	GANGLION OR MUCOUS CYST OF DISTAL DIGIT, excision of, other than a service associated with a service to which item 30107 applies
46495	01JUL2021	31DEC9999	Y	Complete excision of one or more ganglia or mucous cysts of interphalangeal, metacarpophalangeal or carpometacarpal joint of hand, including any of the following (if performed): (a) arthrotomy; (b) osteophyte resections (c) synovectomy other than a service associated with a service to which item 30107 or 46336 applies-one joint (H)
46498	01DEC1991	31OCT2017	N	GANGLION OF FLEXOR TENDON SHEATH, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46498	01NOV2017	30JUN2021	N	GANGLION OF FLEXOR TENDON SHEATH, excision of, other than a service associated with a service to which item 30107 applies
46498	01JUL2021	31OCT2021	N	Excision of ganglion of flexor tendon sheath of hand, including any of the following (if performed): (a) flexor tenosynovectomy; (b) sheath excision; (c) skin closure by any method other than a service associated with a service to which item 30106, 30107 or 46363 applies
46498	01NOV2021	29FEB2024	N	Excision of ganglion of flexor tendon sheath of hand, including any of the following (if performed): (a) flexor tenosynovectomy; (b) sheath excision; (c) skin closure by any method other than a service associated with a service to which item 30107 or 46363 applies
46498	01MAR2024	31DEC9999	Y	Excision of ganglion of flexor tendon sheath of hand, including any of the following (if performed): (a) flexor tenosynovectomy; (b) sheath excision; (c) skin closure by any method; other than a service associated with: (d) a service to which item 30107 applies; or (e) a service to which item 46363 applies that is performed on the same ray
46500	01NOV1994	31OCT2017	N	GANGLION OF DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46500	01NOV2017	30JUN2021	N	GANGLION OF DORSAL WRIST JOINT, excision of, other than a service associated with a service to which item 30107 applies
46500	01JUL2021	31OCT2021	N	Excision of ganglion of dorsal wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy other than a service associated with a service to which item 30106 or 30107 applies
46500	01NOV2021	31DEC9999	Y	Excision of ganglion of dorsal wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy other than a service associated with a service to which item 30107 applies
46501	01DEC1991	31OCT1994	N	GANGLION OF VOLAR OR DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46501	01NOV1994	31OCT2017	N	GANGLION OF VOLAR WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46501	01NOV2017	30JUN2021	N	GANGLION OF VOLAR WRIST JOINT, excision of, other than a service associated with a service to which item 30107 applies
46501	01JUL2021	31OCT2021	N	Excision of ganglion of volar wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy; other than a service associated with a service to which item 30106, 30107 or 46325 applies
46501	01NOV2021	31DEC9999	Y	Excision of ganglion of volar wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy; other than a service associated with a service to which item 30107 or 46325 applies
46502	01NOV1994	31OCT2017	N	RECURRENT GANGLION OF DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46502	01NOV2017	30JUN2021	N	RECURRENT GANGLION OF DORSAL WRIST JOINT, excision of, other than a service associated with a service to which item 30107 applies
46502	01JUL2021	31DEC9999	Y	Excision of recurrent ganglion of dorsal wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy
46503	01NOV1994	31OCT2017	N	RECURRENT GANGLION OF VOLAR WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies
46503	01NOV2017	30JUN2021	N	RECURRENT GANGLION OF VOLAR WRIST JOINT, excision of, other than a service associated with a service to which item 30107 applies
46503	01JUL2021	31OCT2021	N	Excision of recurrent ganglion of volar wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy; other than a service associated with a service to which item 30106 or 30107 applies
46503	01NOV2021	31DEC9999	Y	Excision of recurrent ganglion of volar wrist joint of hand, including any of the following (if performed): (a) arthrotomy; (b) capsular or ligament repair (or both); (c) synovectomy; other than a service associated with a service to which item 30107 applies
46504	01DEC1991	30JUN2021	N	NEUROVASCULAR ISLAND FLAP, for pulp innervation
46504	01JUL2021	31DEC9999	Y	Neurovascular island flap, heterodigital, for pulp re-innervation and soft tissue cover
46507	01DEC1991	31OCT1995	N	DIGIT, transposition of, complete procedure
46507	01NOV1995	30JUN2021	N	DIGIT OR RAY, transposition or transfer of, on vascular pedicle, complete procedure
46507	01JUL2021	31DEC9999	Y	Transposition or transfer of digit or ray on vascular pedicle of hand, including any of the following (if performed): (a) nerve transfer; (b) skin closure, by any means; (c) rebalancing procedures (H)
46510	01DEC1991	30JUN2021	N	MACRODACTYLY, surgical reduction of enlarged elements - each digit
46510	01JUL2021	31DEC9999	Y	Surgical reduction of enlarged elements resulting from macrodactyly, including any of the following (if performed): (a) nerve transfer; (b) skin closure, by any means; (c) rebalancing procedures -one digit (H)
46513	01NOV1994	30JUN2021	N	DIGITAL NAIL OF FINGER OR THUMB, removal of, not being a service to which item 46516 applies
46513	01JUL2021	31DEC9999	Y	Removal of nail of finger or thumb-one nail
46516	01NOV1994	31DEC9999	Y	DIGITAL NAIL OF FINGER OR THUMB, removal of, in the operating theatre of a hospital
46519	01NOV1994	30JUN2021	N	MIDDLE PALMAR, THENAR OR HYPOTHENAR SPACES OF HAND, drainage of (excluding aftercare)
46519	01JUL2021	31DEC9999	Y	Drainage of midpalmar, thenar or hypothenar spaces or dorsum of hand, excluding aftercare
46522	01NOV1994	30JUN2021	N	FLEXOR TENDON SHEATH OF FINGER OR THUMB, open operation and drainage for infection
46522	01JUL2021	29FEB2024	N	Open operation and drainage of infection for flexor tendon sheath of finger or thumb, including either or both of the following (if performed): (a) synovectomy; (b) tenolysis; other than a service associated with a service to which item 30023 applies-one digit (H)
46522	01MAR2024	31DEC9999	Y	Open operation and drainage of infection for flexor tendon sheath of finger or thumb, including either or both of the following (if performed): (a) synovectomy; (b) tenolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one digit (H)
46525	01NOV1994	31OCT1996	N	PULP SPACE INFECTION, PARONYCHIA OF HAND, incision for, not being a service to which another item in this Group applies (excluding after-care)
46525	01NOV1996	30JUN2021	N	PULP SPACE INFECTION, PARONYCHIA OF HAND, incision for, when performed in an operating theatre of a hospital, not being a service to which another item in this Group applies (excluding after-care)
46525	01JUL2021	29FEB2024	N	Incision for pulp space infection of hand: (a) other than a service: (i) to which another item in this Group applies; or (ii) associated with a service to which item 30023 applies; and (b) excluding aftercare (H)
46525	01MAR2024	31DEC9999	Y	Incision for pulp space infection of hand: (a) other than a service: (i) to which another item in this Group applies; or (ii) associated with a service to which item 30023 applies that is performed at the same site; and (b) excluding aftercare (H)
46528	01NOV1994	30JUN2021	N	INGROWING NAIL OF FINGER OR THUMB, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed
46528	01JUL2021	31DEC9999	Y	Wedge resection for ingrowing nail of finger or thumb: (a) including each of the following: (i) excision and partial ablation of germinal matrix; (ii) removal of segment of nail; (iii) removal of ungual fold; and (b) including phenolisation (if performed)
46531	01NOV1994	30JUN2021	N	INGROWING NAIL OF FINGER OR THUMB, partial resection of nail, including phenolisation but not including excision of nail bed
46531	01JUL2021	31DEC9999	Y	Partial resection of ingrowing nail of finger or thumb, including phenolisation
46534	01NOV1994	30JUN2021	N	NAIL PLATE INJURY OR DEFORMITY, radical excision of nail germinal matrix
46534	01JUL2021	31DEC9999	Y	Complete ablation of nail germinal matrix (H)
47000	01DEC1991	30JUN2021	N	MANDIBLE, treatment of dislocation of, by closed reduction
47000	01JUL2021	30JUN2023	N	Treatment of dislocation of mandible, by closed reduction
47000	01JUL2023	31DEC9999	Y	Mandible, treatment of dislocation of, by closed reduction, requiring general anaesthesia or intravenous sedation, if performed in the operating theatre of a hospital (H)
47003	01DEC1991	30JUN2021	N	CLAVICLE, treatment of dislocation of, by closed reduction
47003	01JUL2021	31DEC9999	Y	Treatment of dislocation of clavicle, by closed reduction
47006	01DEC1991	31DEC9999	Y	CLAVICLE, treatment of dislocation of, by open reduction
47007	01JUL2021	31DEC9999	Y	Repair of acromioclavicular or sternoclavicular joint dislocation (acute or chronic), by open, mini-open or arthroscopic technique, including either or both of the following (if performed): (a) ligament augmentation; (b) tendon transfers
47009	01DEC1991	30JUN2021	N	SHOULDER, treatment of dislocation of, requiring general anaesthesia, not being a service to which item 47012 applies
47009	01JUL2021	31DEC9999	Y	Treatment of dislocation of shoulder, requiring general anaesthesia, other than a service to which item 47012 applies
47012	01DEC1991	30JUN2021	N	SHOULDER, treatment of dislocation of, requiring general anaesthesia, open reduction
47012	01JUL2021	31DEC9999	Y	Treatment of dislocation of shoulder, requiring general anaesthesia, by open reduction (H)
47015	01DEC1991	30JUN2021	N	SHOULDER, treatment of dislocation of, not requiring general anaesthesia
47015	01JUL2021	31DEC9999	Y	Treatment of dislocation of shoulder, not requiring general anaesthesia
47018	01DEC1991	30JUN2021	N	ELBOW, treatment of dislocation of, by closed reduction
47018	01JUL2021	31DEC9999	Y	Treatment of dislocation of elbow, by closed reduction
47021	01DEC1991	30JUN2021	N	ELBOW, treatment of dislocation of, by open reduction
47021	01JUL2021	31DEC9999	Y	Treatment of dislocation of elbow, by open reduction (H)
47024	01DEC1991	30JUN2021	N	RADIOULNAR JOINT, DISTAL or PROXIMAL, treatment of dislocation of, by closed reduction, not being a service associated with fracture or dislocation in the same region
47024	01JUL2021	31DEC9999	Y	Treatment of dislocation of distal or proximal radioulnar joint, by closed reduction, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of treating fracture or dislocation in the same region
47027	01DEC1991	30JUN2021	N	RADIOULNAR JOINT, DISTAL or PROXIMAL, treatment of dislocation of, by open reduction, not being a service associated with fracture or dislocation in the same region
47027	01JUL2021	31DEC9999	Y	Treatment of dislocation of distal or proximal radioulnar joint, by open reduction, including either or both of the following (if performed): (a) styloid fracture; (b) triangular fibrocartilage complex repair; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of treating fracture or dislocation in the same region
47030	01DEC1991	30JUN2021	N	CARPUS, or CARPUS on RADIUS and ULNA, or CARPOMETACARPAL JOINT, treatment of dislocation of, by closed reduction
47030	01JUL2021	31DEC9999	Y	Treatment of dislocation of carpus, carpus on radius and ulna or carpometacarpal joint, by closed reduction
47033	01DEC1991	30JUN2021	N	CARPUS, or CARPUS on RADIUS and ULNA, or CARPOMETACARPAL JOINT, treatment of dislocation of, by open reduction
47033	01JUL2021	31DEC9999	Y	Treatment of dislocation of carpus, carpus on radius and ulna or carpometacarpal joint, by open reduction, including ligament repair (if performed)
47036	01DEC1991	31DEC9999	Y	INTERPHALANGEAL JOINT, treatment of dislocation of, by closed reduction
47039	01DEC1991	31DEC9999	Y	INTERPHALANGEAL JOINT, treatment of dislocation of, by open reduction
47042	01DEC1991	30JUN2021	N	METACARPOPHALANGEAL JOINT, treatment of dislocation of, by closed reduction
47042	01JUL2021	31DEC9999	Y	Treatment of dislocation of interphalangeal or metacarpophalangeal joint, by closed reduction
47045	01DEC1991	30JUN2021	N	METACARPOPHALANGEAL JOINT, treatment of dislocation of, by open reduction
47045	01JUL2021	31DEC9999	Y	Treatment of dislocation of interphalangeal or metacarpophalangeal joint, by open reduction, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) ligament repair; (d) volar plate repair
47047	01JUL2021	31DEC9999	Y	Treatment of dislocation of prosthetic hip, by closed reduction
47048	01DEC1991	31DEC9999	Y	HIP, treatment of dislocation of, by closed reduction
47049	01JUL2021	31DEC9999	Y	Treatment of dislocation of prosthetic hip, by open reduction
47051	01DEC1991	31DEC9999	Y	HIP, treatment of dislocation of, by open reduction
47052	01JUL2021	31DEC9999	Y	Treatment of dislocation of native hip, by closed reduction
47053	01JUL2021	31DEC9999	Y	Treatment of dislocation of native hip, by open reduction, with internal fixation (if performed)
47054	01DEC1991	30JUN2021	N	KNEE, treatment of dislocation of, by closed reduction
47054	01JUL2021	31DEC9999	Y	Treatment of dislocation of knee, by closed reduction, including application of external fixator (if performed)
47057	01DEC1991	30JUN2021	N	PATELLA, treatment of dislocation of, by closed reduction
47057	01JUL2021	31DEC9999	Y	Treatment of dislocation of patella, by closed reduction
47060	01DEC1991	30JUN2021	N	PATELLA, treatment of dislocation of, by open reduction
47060	01JUL2021	31DEC9999	Y	Treatment of dislocation of patella, by open reduction
47063	01DEC1991	30JUN2021	N	ANKLE or TARSUS, treatment of dislocation of, by closed reduction
47063	01JUL2021	31DEC9999	Y	Treatment of dislocation of ankle or tarsus, by closed reduction
47066	01DEC1991	30JUN2021	N	ANKLE or TARSUS, treatment of dislocation of, by open reduction
47066	01JUL2021	31DEC9999	Y	Treatment of dislocation of ankle or tarsus, by open reduction, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint (H)
47069	01DEC1991	30JUN2021	N	TOE, treatment of dislocation of, by closed reduction
47069	01JUL2021	06AUG2021	N	Treatment of dislocation of toe, by open reduction-one toe
47069	07AUG2021	31DEC9999	Y	Treatment of dislocation of toe, by closed reduction-one toe
47072	01DEC1991	31DEC9999	Y	TOE, treatment of dislocation of, by open reduction
47300	01DEC1991	31DEC9999	Y	DISTAL PHALANX of FINGER or THUMB, treatment of fracture of, by closed reduction, including percutaneous fixation where used
47301	01MAY2016	30JUN2021	N	Phalanx, middle or proximal, treatment of fracture of, by closed reduction, requiring anaesthesia, not provided on the same occasion as a service described in item 47304, 47307, 47310, 47313, 47316 or 47319
47301	01JUL2021	31DEC9999	Y	Treatment of fracture of middle or proximal phalanx, by closed reduction, requiring anaesthesia-one bone
47303	01DEC1991	31DEC9999	Y	DISTAL PHALANX of FINGER or THUMB, treatment of intra-articular fracture of, by closed reduction
47304	01MAY2016	30JUN2021	N	Metacarpal, treatment of fracture of, by closed reduction, requiring anaesthesia, not provided on the same occasion as a service described in item 47301, 47307, 47310, 47313, 47316 or 47319
47304	01JUL2021	31DEC9999	Y	Treatment of fracture of metacarpal, by closed reduction, requiring anaesthesia-one bone (H)
47306	01DEC1991	31DEC9999	Y	DISTAL PHALANX of FINGER or THUMB, treatment of fracture of, by open reduction
47307	01MAY2016	30JUN2021	N	Phalanx or metacarpal, treatment of fracture of, by closed reduction with percutaneous K wire fixation
47307	01JUL2021	31DEC9999	Y	Treatment of fracture of phalanx or metacarpal, by closed reduction, including percutaneous K-wire fixation (if performed)-one bone (H)
47309	01DEC1991	31DEC9999	Y	DISTAL PHALANX of FINGER or THUMB, treatment of intra-articular fracture of, by open reduction
47310	01MAY2016	30JUN2021	N	Phalanx or metacarpal, treatment of fracture of, by open reduction with fixation
47310	01JUL2021	31DEC9999	Y	Treatment of fracture of phalanx or metacarpal, by open reduction, with internal fixation (H)
47312	01DEC1991	31DEC9999	Y	MIDDLE PHALANX of FINGER, treatment of fracture of, by closed reduction
47313	01MAY2016	30JUN2021	N	Phalanx or metacarpal, treatment of intra articular fracture of, by closed reduction with percutaneous K wire fixation
47313	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of phalanx or metacarpal, by closed reduction, including: (a) percutaneous K-wire fixation; and (b) external or dynamic fixation (if performed) (H)
47315	01DEC1991	31DEC9999	Y	MIDDLE PHALANX of FINGER, treatment of intra-articular fracture of, by closed reduction
47316	01MAY2016	30JUN2021	N	Phalanx or metacarpal, treatment of intra articular fracture of, by open reduction with fixation, not provided on the same occasion as a service to which item 47319 applies
47316	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of phalanx or metacarpal, by open reduction with fixation, other than a service provided on the same occasion as a service to which item 47319 applies (H)
47318	01DEC1991	31DEC9999	Y	MIDDLE PHALANX OF FINGER, treatment of fracture of, by open reduction
47319	01MAY2016	30JUN2021	N	Middle phalanx, proximal end, treatment of intra articular fracture of, by open reduction with fixation, not provided on the same occasion as a service to which item 47316 applies
47319	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of proximal end of middle phalanx, by open reduction, with fixation, other than a service provided on the same occasion as a service to which item 47316 applies (H)
47321	01DEC1991	31DEC9999	Y	MIDDLE PHALANX OF FINGER, treatment of intra-articular fracture of, by open reduction
47324	01DEC1991	31DEC9999	Y	PROXIMAL PHALANX OF FINGER OR THUMB, treatment of fracture of, by closed reduction
47327	01DEC1991	31DEC9999	Y	PROXIMAL PHALANX OF FINGER OR THUMB, treatment of intra-articular fracture of, by closed reduction
47330	01DEC1991	31DEC9999	Y	PROXIMAL PHALANX OF FINGER OR THUMB, treatment of fracture of, by open reduction
47333	01DEC1991	31DEC9999	Y	PROXIMAL PHALANX OF FINGER OR THUMB, treatment of intra-articular fracture of, by open operation
47336	01DEC1991	31DEC9999	Y	METACARPAL, treatment of fracture of, by closed reduction
47339	01DEC1991	31DEC9999	Y	METACARPAL, treatment of intra-articular fracture of, by closed reduction
47342	01DEC1991	31DEC9999	Y	METACARPAL, treatment of fracture of, by open reduction
47345	01DEC1991	31DEC9999	Y	METACARPAL, treatment of intra-articular fracture of, by open reduction
47348	01DEC1991	30JUN2021	N	CARPUS (excluding scaphoid), treatment of fracture of, not being a service to which item 47351 applies
47348	01JUL2021	31DEC9999	Y	Treatment of fracture of carpus (excluding scaphoid), by cast immobilisation, other than a service associated with a service to which item 47351 applies
47351	01DEC1991	30JUN2021	N	CARPUS (excluding scaphoid), treatment of fracture of, by open reduction
47351	01JUL2021	31DEC9999	Y	Treatment of fracture of carpus (excluding scaphoid), by open reduction, with internal fixation
47354	01DEC1991	30JUN2021	N	CARPAL SCAPHOID, treatment of fracture of, not being a service to which item 47357 applies
47354	01JUL2021	31DEC9999	Y	Treatment of fracture of carpal scaphoid, by cast immobilisation, other than a service associated with a service to which item 47357 applies
47357	01DEC1991	30JUN2021	N	CARPAL SCAPHOID, treatment of fracture of, by open reduction
47357	01JUL2021	29FEB2024	N	Treatment of fracture of carpal scaphoid, by open reduction, with internal or percutaneous fixation
47357	01MAR2024	31DEC9999	Y	Treatment of fracture of carpal scaphoid, by reduction, with fixation by any means
47360	01DEC1991	30JUN1993	N	RADIUS OR ULNA, distal end of, treatment of fracture of, not being a service to which item 47363 or 47366 applies
47360	01JUL1993	31DEC9999	Y	RADIUS OR ULNA, distal end of, treatment of fracture of, by cast immobilisation, not being a service to which item 47363 or 47366 applies
47361	01MAY2016	30JUN2021	N	Radius or ulna, or radius and ulna, distal end of, treatment of fracture of, by cast immobilisation, other than a service associated with a service to which item 47362, 47364, 47367, 47370 or 47373 applies
47361	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius or ulna (or both), by cast immobilisation, other than a service associated with a service to which item 47362, 47364, 47367, 47370 or 47373 applies
47362	01MAY2016	30JUN2021	N	Radius or ulna, or radius and ulna, distal end of, treatment of fracture of, by closed reduction, requiring general or major regional anaesthesia, but excluding local infiltration, other than a service associated with a service to which item 47361, 47364, 47367, 47370 or 47373 applies
47362	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius or ulna (or both), by closed reduction, requiring general or major regional anaesthesia, but excluding local infiltration, other than a service associated with a service to which item 47361, 47364, 47367, 47370 or 47373 applies
47363	01DEC1991	31DEC9999	Y	RADIUS OR ULNA, distal end of, treatment of fracture of, by closed reduction
47364	01MAY2016	30JUN2021	N	Radius or ulna, distal end of, not involving joint surface, treatment of fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies
47364	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius or ulna (not involving joint surface), by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies (H)
47366	01DEC1991	31DEC9999	Y	RADIUS OR ULNA, distal end of, treatment of fracture of, by open reduction
47367	01MAY2016	30JUN2021	N	Radius, distal end of, treatment of fracture of, by closed reduction with percutaneous fixation, other than a service associated with a service to which item 47361 or 47362 applies
47367	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius, by closed reduction with percutaneous fixation, other than a service associated with a service to which item 47361 or 47362 applies (H)
47369	01DEC1991	30JUN1993	N	RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture, not being a service to which item 47372 or 47375 applies
47369	01JUL1993	31DEC9999	Y	RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture of, by cast immobilisation, not being a service to which item 47372 or 47375 applies
47370	01MAY2016	30JUN2021	N	Radius, distal end of, treatment of intra articular fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies
47370	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of distal end of radius, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies (H)
47372	01DEC1991	31DEC9999	Y	RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture, by closed reduction
47373	01MAY2016	30JUN2021	N	Ulna, distal end of, treatment of intra articular fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies
47373	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of distal end of ulna, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies (H)
47375	01DEC1991	31DEC9999	Y	RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture of, by open reduction
47378	01DEC1991	30JUN1993	N	RADIUS OR ULNA, shaft of, treatment of fracture of, not being a service to which item 47381, 47384, 47385 or 47386 applies
47378	01JUL1993	31DEC9999	Y	RADIUS OR ULNA, shaft of, treatment of fracture of, by cast immobilisation, not being a service to which item 47381, 47384, 47385 or 47386 applies
47381	01DEC1991	30JUN2021	N	RADIUS OR ULNA, shaft of, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital
47381	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of radius or ulna, by closed reduction (H)
47384	01DEC1991	30JUN2021	N	RADIUS OR ULNA, shaft of, treatment of fracture of, by open reduction
47384	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of radius or ulna, by open reduction with internal fixation (H)
47385	01DEC1991	30JUN2021	N	RADIUS OR ULNA, shaft of, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by closed reduction undertaken in the operating theatre of a hospital
47385	01JUL2021	31DEC9999	Y	Treatment of: (a) fracture of shaft of radius or ulna; and (b) dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury); by closed reduction (H)
47386	01DEC1991	30JUN2021	N	RADIUS OR ULNA, shaft of, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by open reduction or internal fixation
47386	01JUL2021	31DEC9999	Y	Treatment of: (a) fracture of shaft of radius or ulna; and (b) dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury); by open reduction, with internal fixation, including reduction of dislocation (if performed) (H)
47387	01DEC1991	30JUN1993	N	RADIUS AND ULNA, shafts of, treatment of fracture of, not being a service to which item 47390 or 47393 applies
47387	01JUL1993	30JUN2021	N	RADIUS AND ULNA, shafts of, treatment of fracture of, by cast immobilisation, not being a service to which item 47390 or 47393 applies
47387	01JUL2021	31DEC9999	Y	Treatment of fracture of distal or shaft of radius or ulna (or both), by cast immobilisation, other than a service to which item 47390 or 47393 applies
47390	01DEC1991	30JUN2021	N	RADIUS AND ULNA, shafts of, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital
47390	01JUL2021	31DEC9999	Y	Treatment of fracture of shafts of radius and ulna, by closed reduction (H)
47393	01DEC1991	30JUN2021	N	RADIUS AND ULNA, shafts of, treatment of fracture of, by open reduction
47393	01JUL2021	31DEC9999	Y	Treatment of fracture of shafts of radius and ulna, by open reduction, with internal fixation (H)
47396	01DEC1991	30JUN2021	N	OLECRANON, treatment of fracture of, not being a service to which item 47399 applies
47396	01JUL2021	31DEC9999	Y	Treatment of fracture of olecranon, by closed reduction
47399	01DEC1991	30JUN2021	N	OLECRANON, treatment of fracture of, by open reduction
47399	01JUL2021	31DEC9999	Y	Treatment of fracture of olecranon, by open reduction (H)
47402	01DEC1991	30JUN2021	N	OLECRANON, treatment of fracture of, involving excision of olecranon fragment and reimplantation of tendon
47402	01JUL2021	31DEC9999	Y	Treatment of fracture of olecranon, with excision of olecranon fragment and reimplantation of tendon
47405	01DEC1991	31OCT2006	N	RADIUS, treatment of fracture of head or neck of, closed management of
47405	01NOV2006	30JUN2021	N	RADIUS, treatment of fracture of head or neck of, closed reduction of
47405	01JUL2021	31DEC9999	Y	Treatment of fracture of head or neck of radius, by closed reduction
47408	01DEC1991	31OCT2006	N	RADIUS, treatment of fracture of head or neck of, open management of, including internal fixation and excision where performed
47408	01NOV2006	30JUN2021	N	RADIUS, treatment of fracture of head or neck of, open reduction of, including internal fixation and excision where performed
47408	01JUL2021	31DEC9999	Y	Treatment of fracture of head or neck of radius, by open reduction, including internal fixation and excision (if performed) (H)
47411	01DEC1991	30JUN2021	N	HUMERUS, treatment of fracture of tuberosity of, not being a service to which item 47417 applies
47411	01JUL2021	31DEC9999	Y	Treatment of fracture of tuberosity of humerus, other than a service to which item 47417 applies
47414	01DEC1991	30JUN2021	N	HUMERUS, treatment of fracture of tuberosity of, by open reduction
47414	01JUL2021	31DEC9999	Y	Treatment of fracture of tuberosity of humerus, by open reduction
47417	01DEC1991	30JUN2021	N	HUMERUS, treatment of fracture of tuberosity of, and associated dislocation of shoulder, by closed reduction
47417	01JUL2021	31DEC9999	Y	Treatment of fracture of tuberosity of humerus and associated dislocation of shoulder, by closed reduction
47420	01DEC1991	30JUN2021	N	HUMERUS, treatment of fracture of tuberosity of, and associated dislocation of shoulder, by open reduction
47420	01JUL2021	31DEC9999	Y	Treatment of fracture of tuberosity of humerus and associated dislocation of shoulder, by open reduction (H)
47423	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of fracture of, not being a service to which item 47426, 47429 or 47432 applies
47423	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of fracture of, other than a service to which item 47426, 47429 or 47432 applies
47426	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital
47426	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of fracture of, by closed reduction (H)
47429	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of fracture of, by open reduction
47429	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of fracture of, by open reduction (H)
47432	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of intra-articular fracture of, by open reduction
47432	01JUL2021	14JUL2021	N	Humerus, proximal, treatment of fracture of, by open reduction (H)
47432	15JUL2021	31DEC9999	Y	Humerus, proximal, treatment of intra-articular fracture of, by open reduction (H)
47435	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of fracture of, and associated dislocation of shoulder, by closed reduction
47435	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of fracture of, and associated dislocation of shoulder, by closed reduction
47438	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of fracture of, and associated dislocation of shoulder, by open reduction
47438	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of fracture of, and associated dislocation of shoulder, by open reduction (H)
47441	01DEC1991	30JUN2021	N	HUMERUS, proximal, treatment of intra-articular fracture of, and associated dislocation of shoulder, by open reduction
47441	01JUL2021	31DEC9999	Y	Humerus, proximal, treatment of intra-articular fracture of, and associated dislocation of shoulder, by open reduction (H)
47444	01DEC1991	30JUN2021	N	HUMERUS, shaft of, treatment of fracture of, not being a service to which item 47447 or 47450 applies
47444	01JUL2021	31DEC9999	Y	Humerus, shaft of, treatment of fracture of, other than a service to which item 47447 or 47450 applies
47447	01DEC1991	30JUN2021	N	HUMERUS, shaft of, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital
47447	01JUL2021	31DEC9999	Y	Humerus, shaft of, treatment of fracture of, by closed reduction (H)
47450	01DEC1991	31OCT1996	N	HUMERUS, shaft of, treatment of fracture of, by open reduction
47450	01NOV1996	30JUN2021	N	HUMERUS, shaft of, treatment of fracture of, by internal or external fixation
47450	01JUL2021	31OCT2021	N	Humerus, shaft of, treatment of fracture of, by internal or external (H)
47450	01NOV2021	31DEC9999	Y	Humerus, shaft of, treatment of fracture of, by internal or external fixation (H)
47451	01NOV1996	30JUN2021	N	HUMERUS, shaft of, treatment of fracture of, by intramedullary fixation
47451	01JUL2021	31DEC9999	Y	Humerus, shaft of, treatment of fracture of, by intramedullary fixation (H)
47453	01DEC1991	30JUN2021	N	HUMERUS, distal, (supracondylar or condylar), treatment of fracture of, not being a service to which item 47456 or 47459 applies
47453	01JUL2021	31DEC9999	Y	Humerus, distal, (supracondylar or condylar), treatment of fracture of, other than a service to which item 47456 or 47459 applies
47456	01DEC1991	30JUN2021	N	HUMERUS, distal (supracondylar or condylar), treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital
47456	01JUL2021	31DEC9999	Y	Humerus, distal (supracondylar or condylar), treatment of fracture of, by closed reduction (H)
47459	01DEC1991	30JUN2021	N	HUMERUS, distal (supracondylar or condylar), treatment of fracture of, by open reduction, undertaken in the operating theatre of a hospital
47459	01JUL2021	31DEC9999	Y	Humerus, distal (supracondylar or condylar), treatment of fracture of, by open reduction (H)
47462	01DEC1991	30JUN2021	N	CLAVICLE, treatment of fracture of, not being a service to which item 47465 applies
47462	01JUL2021	31DEC9999	Y	Clavicle, treatment of fracture of, other than a service to which item 47465 applies
47465	01DEC1991	30JUN2021	N	CLAVICLE, treatment of fracture of, by open reduction
47465	01JUL2021	31DEC9999	Y	Clavicle, treatment of fracture of, by open reduction
47466	01DEC1991	30JUN2021	N	STERNUM, treatment of fracture of, not being a service to which item 47467 applies
47466	01JUL2021	31DEC9999	Y	Sternum, treatment of fracture of, other than a service to which item 47467 applies
47467	01DEC1991	30JUN2021	N	STERNUM, treatment of fracture of, by open reduction
47467	01JUL2021	31DEC9999	Y	Sternum, treatment of fracture of, by open reduction (H)
47468	01DEC1991	31DEC9999	Y	SCAPULA, neck or glenoid region of, treatment of fracture of, by open reduction
47471	01DEC1991	30JUN2021	N	RIBS (1 or more), treatment of fracture of - each attendance
47471	01JUL2021	31DEC9999	Y	RIBS (one or more), treatment of fracture of - each attendance
47474	01DEC1991	31OCT1994	N	PELVIC RING, treatment of fracture of, not involving disrupting pelvic ring or acetabulum
47474	01NOV1994	31DEC9999	Y	PELVIC RING, treatment of fracture of, not involving disruption of pelvic ring or acetabulum
47477	01DEC1991	31OCT1994	N	PELVIC RING, treatment of fracture of, with disrupting pelvic ring or acetabulum
47477	01NOV1994	31DEC9999	Y	PELVIC RING, treatment of fracture of, with disruption of pelvic ring or acetabulum
47480	01DEC1991	30JUN2021	N	PELVIC RING, treatment of fracture of, requiring traction
47480	01JUL2021	31DEC9999	Y	PELVIC RING, treatment of fracture of, requiring traction (H)
47483	01DEC1991	30JUN2021	N	PELVIC RING, treatment of fracture of, requiring control by external fixation
47483	01JUL2021	31DEC9999	Y	PELVIC RING, treatment of fracture of, requiring control by external fixation (H)
47486	01DEC1991	30JUN2021	N	PELVIC RING, treatment of fracture of, by open reduction and involving internal fixation of anterior segment, including diastasis of pubic symphysis
47486	01JUL2021	31DEC9999	Y	Treatment of fracture of anterior pelvic ring or sacroiliac joint disruption (or both), by open reduction, with internal fixation (H)
47489	01DEC1991	30JUN2021	N	PELVIC RING, treatment of fracture of, by open reduction and involving internal fixation of posterior segment (including sacro-iliac joint), with or without fixation of anterior segment
47489	01JUL2021	31DEC9999	Y	Treatment of fracture of posterior pelvic ring or sacroiliac joint disruption (or both), by open reduction, with internal fixation (H)
47491	01JUL2021	31DEC9999	Y	Combined anterior and posterior pelvic ring disruption, including sacroiliac joint disruption, treatment of fracture by open reduction and internal fixation of both anterior and posterior ring segments (H)
47492	01DEC1991	31DEC9999	Y	ACETABULUM, treatment of fracture of, and associated dislocation of hip
47495	01DEC1991	30JUN2021	N	ACETABULUM, treatment of fracture of, and associated dislocation of hip, requiring traction
47495	01JUL2021	31DEC9999	Y	Treatment of fracture of acetabulum and associated dislocation of hip, including the application and management of traction (if performed), excluding aftercare
47498	01DEC1991	30JUN2021	N	ACETABULUM, treatment of fracture of, and associated dislocation of hip, requiring internal fixation, with or without traction
47498	01JUL2021	31DEC9999	Y	Treatment of isolated posterior wall fracture of acetabulum and associated dislocation of hip, by open reduction, with internal fixation, including the application and management of traction (if performed) (H)
47501	01DEC1991	30APR2009	N	ACETABULUM, treatment of single column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair
47501	01MAY2009	30JUN2021	N	ACETABULUM, treatment of single column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply
47501	01JUL2021	31DEC9999	Y	Treatment of anterior or posterior column fracture of acetabulum, by open reduction, with internal fixation, including any of the following (if performed): (a) capsular stabilisation; (b) capsulotomy; (c) osteotomy (H)
47504	01DEC1991	30APR2009	N	ACETABULUM, treatment of T-shape fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair
47504	01MAY2009	31DEC9999	Y	ACETABULUM, treatment of T-shape fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply
47507	01DEC1991	30APR2009	N	ACETABULUM, treatment of transverse fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair
47507	01MAY2009	31DEC9999	Y	ACETABULUM, treatment of transverse fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply
47510	01DEC1991	30APR2009	N	ACETABULUM, treatment of double column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair
47510	01MAY2009	31DEC9999	Y	ACETABULUM, treatment of double column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply
47511	01JUL2021	31DEC9999	Y	Treatment of combined column T-Type, transverse, anterior column or posterior hemitransverse fractures of acetabulum, by open reduction, with internal fixation, performed through single or dual approach (including fixation of the posterior wall fracture), including any of the following (if performed): (a) capsular stabilisation; (b) capsulotomy; (c) osteotomy (H)
47513	01DEC1991	31DEC9999	Y	SACRO-ILIAC JOINT DISRUPTION, treatment of, requiring internal fixation, being a service associated with a service to which items 47501 to 47510 apply
47514	01JUL2021	31DEC9999	Y	Treatment of posterior wall fracture of acetabulum and associated femoral head fracture, by open reduction, with internal fixation (H)
47516	01DEC1991	31DEC9999	Y	FEMUR, treatment of fracture of, by closed reduction or traction
47519	01DEC1991	30JUN2021	N	FEMUR, treatment of trochanteric or subcapital fracture of, by internal fixation
47519	01JUL2021	31DEC9999	Y	FEMUR, treatment of trochanteric or subcapital fracture of, by internal fixation (H)
47522	01DEC1991	31DEC9999	Y	FEMUR, treatment of subcapital fracture of, by hemi-arthroplasty
47525	01DEC1991	31DEC9999	Y	FEMUR, treatment of fracture of, for slipped capital femoral epiphysis
47528	01DEC1991	30JUN2021	N	FEMUR, treatment of fracture of, by internal fixation or external fixation
47528	01JUL2021	31DEC9999	Y	FEMUR, treatment of fracture of, by internal fixation or external fixation (H)
47531	01DEC1991	30APR1994	N	FEMUR, treatment of fracture of shaft, by internal fixation and cross fixation
47531	01MAY1994	30JUN2021	N	FEMUR, treatment of fracture of shaft, by intramedullary fixation and cross fixation
47531	01JUL2021	31DEC9999	Y	FEMUR, treatment of fracture of shaft, by intramedullary fixation and cross fixation (H)
47534	01DEC1991	30JUN2021	N	FEMUR, condylar region of, treatment of intra-articular (T-shaped condylar) fracture of, requiring internal fixation, with or without internal fixation of 1 or more osteochondral fragments
47534	01JUL2021	31DEC9999	Y	Femur, condylar region of, treatment of intra-articular (T-shaped condylar) fracture of, requiring internal fixation, with or without internal fixation of one or more osteochondral fragments (H)
47537	01DEC1991	30JUN2021	N	FEMUR, condylar region of, treatment of fracture of, requiring internal fixation of 1 or more osteochondral fragments, not being a service associated with a service to which item 47534 applies
47537	01JUL2021	31DEC9999	Y	Femur, condylar region of, treatment of fracture of, requiring internal fixation of one or more osteochondral fragments, other than a service associated with a service to which item 47534 applies
47540	01DEC1991	30JUN1993	N	HIP SPICA, application of, as an independent procedure
47540	01JUL1993	30JUN2021	N	HIP SPICA OR SHOULDER SPICA, application of, as an independent procedure
47540	01JUL2021	31DEC9999	Y	Hip spica or shoulder spica, application of, as an independent procedure
47543	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of medial or lateral fracture of, not being a service to which item 47546 or 47549 applies
47543	01JUL2021	31DEC9999	Y	Tibia, plateau of, treatment of medial or lateral fracture of, other than a service to which item 47546 or 47549 applies
47546	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of medial or lateral fracture of, by closed reduction
47546	01JUL2021	31DEC9999	Y	Tibia, plateau of, treatment of medial or lateral fracture of, by closed reduction
47549	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of medial or lateral fracture of, by open reduction
47549	01JUL2021	31DEC9999	Y	Treatment of medial or lateral fracture of plateau of tibia, by open reduction, with internal fixation, including any of the following (if performed): (a) arthroscopy; (b) arthrotomy; (c) meniscal repair (H)
47552	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of both medial and lateral fractures of, not being a service to which item 47555 or 47558 applies
47552	01JUL2021	31DEC9999	Y	Tibia, plateau of, treatment of both medial and lateral fractures of, other than a service to which item 47555 or 47558 applies
47555	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of both medial and lateral fractures of, by closed reduction
47555	01JUL2021	31DEC9999	Y	Tibia, plateau of, treatment of both medial and lateral fractures of, by closed reduction (H)
47558	01DEC1991	30JUN2021	N	TIBIA, plateau of, treatment of both medial and lateral fractures of, by open reduction
47558	01JUL2021	31DEC9999	Y	Treatment of medial and lateral fractures of tibia, by open reduction, with internal fixation, including any of the following (if performed): (a) arthroscopy; (b) arthrotomy; (c) meniscal repair (H)
47559	01JUL2021	31DEC9999	Y	Treatment of medial or lateral (or both) fracture of plateau of tibia, with application of a bridging external fixator to the plateau
47561	01DEC1991	30JUN1993	N	TIBIA, shaft of, treatment of fracture of, not being a service to which item 47564, 47567, 47570 or 47573 applies, with or without treatment of fibular fracture
47561	01JUL1993	30JUN2021	N	TIBIA, shaft of, treatment of fracture of, by cast immobilisation, not being a service to which item 47564, 47567, 47570 or 47573 applies
47561	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of tibia, by cast immobilisation, other than a service to which item 47570 or 47573 applies
47564	01DEC1991	31DEC9999	Y	TIBIA, shaft of, treatment of fracture of, by closed reduction, with or without treatment of fibular fracture
47565	01MAY1994	30JUN2021	N	TIBIA, shaft of, treatment of fracture of, by internal fixation or external fixation
47565	01JUL2021	31DEC9999	Y	Tibia, shaft of, treatment of fracture of, by internal fixation or external fixation (H)
47566	01MAY1994	30JUN2021	N	TIBIA, shaft of, treatment of fracture of, by intramedullary fixation and cross fixation
47566	01JUL2021	31DEC9999	Y	Tibia, shaft of, treatment of fracture of, by intramedullary fixation and cross fixation (H)
47567	01DEC1991	31DEC9999	Y	TIBIA, shaft of, treatment of intra-articular fracture of, by closed reduction, with or without treatment of fibular fracture
47568	01JUL2021	31DEC9999	Y	Closed reduction of proximal tibia, distal tibia or shaft of tibia, with or without treatment of fibular fracture
47570	01DEC1991	30JUN2021	N	TIBIA, shaft of, treatment of fracture of, by open reduction, with or without treatment of fibular fracture
47570	01JUL2021	31DEC9999	Y	Tibia, shaft of, treatment of fracture of, by open reduction, with or without treatment of fibular fracture
47573	01DEC1991	30JUN2021	N	TIBIA, shaft of, treatment of intra-articular fracture of, by open reduction, with or without treatment of fibula fracture
47573	01JUL2021	31DEC9999	Y	Treatment of proximal or distal intra-articular fracture of shaft of tibia, by open reduction, with or without treatment of fibular fracture, including any of the following (if performed): (a) arthroscopy; (b) arthrotomy; (c) capsule repair; (d) removal of intervening soft tissue; (e) removal of loose fragments; (f) washout of joint; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of treating a medial malleolus fracture of the distal tibia (H)
47576	01DEC1991	31DEC9999	Y	FIBULA, treatment of fracture of
47577	01MAR2024	31DEC9999	Y	Treatment of fracture of fibula proximal to ankle, by open reduction, with internal fixation, including any of the following (if performed): (a) internal fixation; (b) arthrotomy; (c) capsule repair; (d) removal of loose fragments or intervening soft tissue; (e) washout of joint (H)
47579	01DEC1991	30JUN2021	N	PATELLA, treatment of fracture of, not being a service to which item 47582 or 47585 applies
47579	01JUL2021	31DEC9999	Y	Treatment of fracture of patella, other than a service to which item 47582 or 47585 applies
47582	01DEC1991	30JUN2021	N	PATELLA, treatment of fracture of, by excision of patella or pole with reattachment of tendon
47582	01JUL2021	31DEC9999	Y	Treatment of fracture of patella, with internal fixation, including bone grafting (if performed), other than a service associated with a service to which item 47579 or 47585 applies (H)
47585	01DEC1991	30JUN2021	N	PATELLA, treatment of fracture of, by internal fixation
47585	01JUL2021	31DEC9999	Y	Treatment of proximal or distal fracture of patella, by open reduction, with internal fixation, including any of the following (if performed): (a) arthrotomy; (b) excision of patellar pole, with reattachment of tendon; (c) removal of loose fragments; (d) repair of quadriceps or patellar tendon (or both); (e) stabilisation of patello-femoral joint (H)
47588	01DEC1991	30JUN2021	N	KNEE JOINT, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar or tibial articular surfaces and requiring repair or reconstruction of 1 or more ligaments
47588	01JUL2021	31DEC9999	Y	Knee joint, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar or tibial articular surfaces and requiring repair or reconstruction of one or more ligaments (H)
47591	01DEC1991	30JUN2021	N	KNEE JOINT, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar and tibial articular surfaces and requiring repair or reconstruction of 1 or more ligaments
47591	01JUL2021	31DEC9999	Y	Knee joint, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar and tibial articular surfaces and requiring repair or reconstruction of one or more ligaments (H)
47592	01JUL2021	31DEC9999	Y	Repair or reconstruction (or both) of acute traumatic chondral injury to the distal femoral or proximal tibial articular surfaces of the knee, when chondral or osteochondral implants or transfers are utilised (H)
47593	01JUL2021	31DEC9999	Y	Repair or reconstruction (or both) of acute traumatic chondral injury to the distal femoral and proximal tibial articular surfaces of the knee, using chondral or osteochondral implants or transfers (H)
47594	01DEC1991	31DEC9999	Y	ANKLE JOINT, treatment of fracture of, not being a service to which item 47597 applies
47595	01JUL2021	31DEC9999	Y	Treatment of fracture of ankle joint, hindfoot, midfoot, metatarsals or toes, by non-surgical management-one leg
47597	01DEC1991	30JUN2021	N	ANKLE JOINT, treatment of fracture of, by closed reduction
47597	01JUL2021	31DEC9999	Y	Treatment of fracture of ankle joint, by closed reduction
47600	01DEC1991	30JUN2021	N	ANKLE JOINT, treatment of fracture of, by internal fixation of 1 of malleolus, fibula or diastasis
47600	01JUL2021	31DEC9999	Y	Treatment of fracture of ankle joint: (a) by internal fixation of the malleolus, fibula or diastasis; and (b) including any of the following (if performed): (i) arthrotomy; (ii) capsule repair; (iii) removal of loose fragments or intervening soft tissue; (iv) washout of joint (H)
47603	01DEC1991	30JUN2021	N	ANKLE JOINT, treatment of fracture of, by internal fixation of more than 1 of malleolus, fibula or diastasis
47603	01JUL2021	31DEC9999	Y	Treatment of fracture of ankle joint: (a) by internal fixation of 2 or more of the malleolus, fibula, diastasis and medial tissue interposition; and (b) including any of the following (if performed): (i) arthrotomy; (ii) capsule repair; (iii) removal of loose fragments or intervening soft tissue; (iv) washout of joint (H)
47606	01DEC1991	31DEC9999	Y	CALCANEUM OR TALUS, treatment of fracture of, not being a service to which item 47609, 47612, 47615 or 47618 applies, with or without dislocation
47609	01DEC1991	31DEC9999	Y	CALCANEUM OR TALUS, treatment of fracture of, by closed reduction, with or without dislocation
47612	01DEC1991	30JUN2021	N	CALCANEUM OR TALUS, treatment of intra-articular fracture of, by closed reduction, with or without dislocation
47612	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of hindfoot, by closed reduction, with or without dislocation-one foot
47615	01DEC1991	30JUN2021	N	CALCANEUM OR TALUS, treatment of fracture of, by open reduction, with or without dislocation
47615	01JUL2021	29FEB2024	N	Treatment of fracture of hindfoot, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one foot
47615	01MAR2024	31DEC9999	Y	Treatment of fracture of hindfoot, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one hindfoot bone
47618	01DEC1991	30JUN2021	N	CALCANEUM OR TALUS, treatment of intra-articular fracture of, by open reduction, with or without dislocation
47618	01JUL2021	29FEB2024	N	Treatment of intra-articular fracture of hindfoot, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one foot (H)
47618	01MAR2024	31DEC9999	Y	Treatment of intra-articular fracture of hindfoot, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one hindfoot bone (H)
47621	01DEC1991	30JUN2021	N	TARSO-METATARSAL, treatment of intra-articular fracture of, by closed reduction, with or without dislocation
47621	01JUL2021	31DEC9999	Y	Treatment of intra-articular fracture of midfoot, by closed reduction, with or without dislocation-one foot
47624	01DEC1991	30JUN2021	N	TARSO-METATARSAL, treatment of fracture of, by open reduction, with or without dislocation
47624	01JUL2021	31DEC9999	Y	Treatment of fracture of tarso-metatarsal, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule or ligament repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one joint (H)
47627	01DEC1991	31DEC9999	Y	TARSUS (excluding calcaneum or talus), treatment of fracture of
47630	01DEC1991	30JUN2021	N	TARSUS (excluding calcaneum or talus), treatment of fracture of, by open reduction, with or without dislocation
47630	01JUL2021	31DEC9999	Y	Treatment of fracture of cuneiform, by open reduction, with or without dislocation, including any of the following (if performed): (a) arthrotomy; (b) capsule or ligament repair; (c) removal of loose fragments or intervening soft tissue; (d) washout of joint -one bone
47633	01DEC1991	31DEC9999	Y	METATARSAL, 1 of, treatment of fracture of
47636	01DEC1991	31DEC9999	Y	METATARSAL, 1 of, treatment of fracture of, by closed reduction
47637	01JUL2021	31DEC9999	Y	Treatment of fractures of metatarsal, by closed reduction-one or more metatarsals of one foot
47639	01DEC1991	30JUN2021	N	METATARSAL, 1 of, treatment of fracture of, by open reduction
47639	01JUL2021	29FEB2024	N	Treatment of fracture of metatarsal, by open reduction, including removal of loose fragments or intervening soft tissue (if performed)-one metatarsal
47639	01MAR2024	31DEC9999	Y	Treatment of fracture of metatarsal, by open reduction, including removal of loose fragments or intervening soft tissue (if performed)-one metatarsal of one foot
47642	01DEC1991	31DEC9999	Y	METATARSALS, 2 of, treatment of fracture of
47645	01DEC1991	31DEC9999	Y	METATARSALS, 2 of, treatment of fracture of, by closed reduction
47648	01DEC1991	30JUN2021	N	METATARSALS, 2 of, treatment of fracture of, by open reduction
47648	01JUL2021	31DEC9999	Y	Treatment of fracture of metatarsal, by open reduction, including removal of loose fragments or intervening soft tissue (if performed)-2 metatarsals of one foot (H)
47651	01DEC1991	31DEC9999	Y	METATARSALS, 3 or more of, treatment of fracture of
47654	01DEC1991	31DEC9999	Y	METATARSALS, 3 or more of, treatment of fracture of, by closed reduction
47657	01DEC1991	30JUN2021	N	METATARSALS, 3 or more of, treatment of fracture of, by open reduction
47657	01JUL2021	31DEC9999	Y	Treatment of fracture of metatarsal, by open reduction, including removal of loose fragments or intervening soft tissue (if performed)-3 or more metatarsals of one foot (H)
47660	01DEC1991	31DEC9999	Y	PHALANX OF GREAT TOE, treatment of fracture of
47663	01DEC1991	30JUN2021	N	PHALANX OF GREAT TOE, treatment of fracture of, by closed reduction
47663	01JUL2021	31DEC9999	Y	Treatment of fracture of phalanx of toe, by closed reduction-one toe
47666	01DEC1991	30JUN2021	N	PHALANX OF GREAT TOE, treatment of fracture of, by open reduction
47666	01JUL2021	31DEC9999	Y	Treatment of fracture or dislocation of phalanx of great toe, by open reduction, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments; (d) removal of intervening soft tissue; (e) washout of joint - one great toe
47669	01DEC1991	31DEC9999	Y	PHALANX OF TOE (other than great toe), 1 of, treatment of fracture of
47672	01DEC1991	30JUN2021	N	PHALANX OF TOE (other than great toe), 1 of, treatment of fracture of, by open reduction
47672	01JUL2021	31DEC9999	Y	Treatment of fracture or dislocation of phalanx of toe, by open reduction, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments; (d) removal of intervening soft tissue; (e) washout of joint -one toe (other than great toe) of one foot
47675	01DEC1991	31DEC9999	Y	PHALANX OF TOE (other than great toe), more than 1 of, treatment of fracture of
47678	01DEC1991	30JUN2021	N	PHALANX OF TOE (other than great toe), more than 1 of, treatment of fracture of, by open reduction
47678	01JUL2021	31DEC9999	Y	Treatment of fracture or dislocation of phalanx of toe, by open reduction, including any of the following (if performed): (a) arthrotomy; (b) capsule repair; (c) removal of loose fragments; (d) removal of intervening soft tissue; (e) washout of joint -2 or more toes (other than great toe) of one foot
47681	01DEC1991	31DEC9999	Y	SPINE (excluding sacrum), treatment of fracture of transverse process, vertebral body, or posterior elements - each attendance
47684	01DEC1991	31OCT2005	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, including immobilisation by calipers
47684	01NOV2005	30APR2006	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, with immobilisation by calipers
47684	01MAY2006	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, with immobilisation by calipers or halo
47687	01DEC1991	31OCT2005	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, including immobilisation by calipers, and including up to 14 days post-operative care
47687	01NOV2005	30APR2006	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, with immobilisation by calipers, and including up to 14 days post-operative care
47687	01MAY2006	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, with immobilisation by calipers or halo, and including up to 14 days post-operative care
47690	01DEC1991	31OCT2005	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, including immobilisation by calipers, requiring reduction by closed manipulation
47690	01NOV2005	30APR2006	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, with immobilisation by calipers, requiring reduction by closed manipulation
47690	01MAY2006	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, with immobilisation by calipers or halo, requiring reduction by closed manipulation
47693	01DEC1991	31OCT2005	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, including immobilisation by calipers, requiring reduction by closed manipulation, including up to 14 days post-operative care
47693	01NOV2005	30APR2006	N	SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, with immobilisation by calipers, requiring reduction by closed manipulation, including up to 14 days post-operative care
47693	01MAY2006	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, with immobilisation by calipers or halo, requiring reduction by closed manipulation, including up to 14 days post-operative care
47696	01DEC1991	31DEC9999	Y	SPINE, reduction of fracture or dislocation of, without cord involvement, undertaken in the operating theatre of a hospital
47699	01DEC1991	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, requiring open reduction with or without internal fixation
47702	01DEC1991	31DEC9999	Y	SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, requiring open reduction with or without internal fixation, including up to 14 days post-operative care
47703	01DEC1991	31DEC9999	Y	SKULL, treatment of fracture of, each attendance
47705	01DEC1991	31DEC9999	Y	SKULL CALIPERS, insertion of, as an independent procedure
47708	01DEC1991	31DEC9999	Y	PLASTER JACKET, application of, as an independent procedure
47711	01DEC1991	31DEC9999	Y	HALO, application of, as an independent procedure
47714	01DEC1991	31DEC9999	Y	HALO, application of, in addition to spinal fusion for scoliosis, or other conditions
47717	01DEC1991	31DEC9999	Y	HALO-THORACIC TRACTION - application of both halo and thoracic jacket
47720	01DEC1991	31DEC9999	Y	HALO-FEMORAL TRACTION, as an independent procedure
47723	01DEC1991	31DEC9999	Y	HALO-FEMORAL TRACTION, in conjunction with a major spine operation
47726	01DEC1991	31OCT1992	N	BONE GRAFT, harvesting of, via separate incision, associated with any item in this Group - Autogenous - small quantity
47726	01NOV1992	31DEC9999	Y	BONE GRAFT, harvesting of, via separate incision, in conjunction with another service - autogenous - small quantity
47729	01DEC1991	31OCT1992	N	BONE GRAFT, harvesting of, via separate incision, associated with any item in this Group - Autogenous - large quantity
47729	01NOV1992	31DEC9999	Y	BONE GRAFT, harvesting of, via separate incision, in conjunction with another service - autogenous - large quantity
47732	01DEC1991	31OCT1992	N	VASCULARISED PEDICLE BONE GRAFT, harvesting of, associated with any item in this Group
47732	01NOV1992	31DEC9999	Y	VASCULARISED PEDICLE BONE GRAFT, harvesting of, in conjunction with another service
47735	01DEC1991	31OCT1994	N	NASAL BONES, treatment of fracture of, not being a service to which item 47738 or 47741 applies
47735	01NOV1994	30JUN2021	N	NASAL BONES, treatment of fracture of, not being a service to which item 47738 or 47741 applies - each attendance
47735	01JUL2021	31DEC9999	Y	Nasal bones, treatment of fracture of, other than a service to which item 47738 or 47741 applies-each attendance
47738	01DEC1991	31MAR1992	N	NASAL BONES, treatment of fracture of, by open reduction
47738	01APR1992	30JUN2021	N	NASAL BONES, treatment of fracture of, by reduction
47738	01JUL2021	31DEC9999	Y	Nasal bones, treatment of fracture of, by reduction
47741	01DEC1991	30JUN2021	N	NASAL BONES, treatment of fracture of, by open reduction involving osteotomies
47741	01JUL2021	31DEC9999	Y	Nasal bones, treatment of fracture of, by open reduction involving osteotomies (H)
47744	01DEC1991	31DEC9999	Y	ZYGOMA, treatment of fracture of
47753	01APR1992	30JUN2021	N	MAXILLA, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation
47753	01JUL2021	30JUN2023	N	Maxilla, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation (H)
47753	01JUL2023	31DEC9999	Y	Maxilla or mandible, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation (H)
47756	01APR1992	30JUN2021	N	MANDIBLE, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation
47756	01JUL2021	31DEC9999	Y	Mandible, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation (H)
47762	01APR1992	30JUN2021	N	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach
47762	01JUL2021	30JUN2023	N	Zygomatic bone, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach
47762	01JUL2023	31DEC9999	Y	Zygomatic arch, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach, other than a service associated with a service to which another item in this Group applies
47765	01APR1992	30JUN2021	N	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at 1 site
47765	01JUL2021	30JUN2023	N	Zygomatic bone, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at 1 site (H)
47765	01JUL2023	31DEC9999	Y	Zygomaticomaxillary complex/malar, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at one or more sites (H)
47766	01JUL2023	31DEC9999	Y	Naso-orbital-ethmoidal complex, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at one or more sites (H)
47768	01APR1992	30JUN2021	N	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 2 sites
47768	01JUL2021	31DEC9999	Y	Zygomatic bone, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 2 sites (H)
47771	01APR1992	30JUN2021	N	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 3 sites
47771	01JUL2021	31DEC9999	Y	Zygomatic bone, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 3 sites (H)
47774	01APR1992	30JUN2021	N	MAXILLA, treatment of fracture of, requiring open operation
47774	01JUL2021	31DEC9999	Y	Maxilla, treatment of fracture of, requiring open operation (H)
47777	01APR1992	30JUN2021	N	MANDIBLE, treatment of fracture of, requiring open reduction
47777	01JUL2021	31DEC9999	Y	Mandible, treatment of fracture of, requiring open reduction (H)
47780	01APR1992	30JUN2021	N	MAXILLA, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s)
47780	01JUL2021	31DEC9999	Y	Maxilla, treatment of fracture of, requiring open reduction and internal fixation not involving plate (H)
47783	01APR1992	30JUN2021	N	MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s)
47783	01JUL2021	31DEC9999	Y	Mandible, treatment of fracture of, requiring open reduction and internal fixation not involving plate
47786	01APR1992	30JUN2021	N	MAXILLA, treatment of fracture of, requiring open reduction and internal fixation involving plate(s)
47786	01JUL2021	30JUN2023	N	Maxilla, treatment of fracture of, requiring open reduction and internal fixation involving plate (H)
47786	01JUL2023	31DEC9999	Y	Maxilla, treatment of fracture of, requiring open reduction and internal fixation involving one or more plates (H)
47789	01APR1992	30JUN2021	N	MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation involving plate(s)
47789	01JUL2021	30JUN2023	N	Mandible, treatment of fracture of, requiring open reduction and internal fixation involving plate (H)
47789	01JUL2023	31DEC9999	Y	Mandible, treatment of fracture of, requiring open reduction and internal fixation involving one or more plates (H)
47790	01NOV2022	31DEC9999	Y	Tendon, large, lengthening of, as an independent procedure
47791	01NOV2022	31DEC9999	Y	Tenosynovectomy, not being a service associated with a service to which another item in this Group applies
47792	01NOV2022	29FEB2024	N	Joint stabilisation procedure of acromio-clavicular joint or scapulo-thoracic joint, including any of the following (if performed): (a) arthrotomy; (b) osteotomy, with or without fixation; (c) local tendon transfer; (d) local tendon lengthening or release; (e) ligament repair; (f) joint debridement; not being a service associated with a service to which another item in this Group applies
47792	01MAR2024	31DEC9999	Y	Joint stabilisation procedure of acromioclavicular joint or sternoclavicular joint, including any of the following (if performed): (a) arthrotomy; (b) osteotomy, with or without fixation; (c) local tendon transfer; (d) local tendon lengthening or release; (e) ligament repair; (f) joint debridement; not being a service associated with a service to which another item in this Group applies (H)
47795	01MAR2024	31DEC9999	Y	Joint stabilisation procedure of scapulothoracic joint, other than a service associated with a service to which another item in this Group (other than item 38828 or 48406) applies (H)
47804	01APR1992	31DEC9999	Y	Historical item included for item mapping purposes
47900	01DEC1991	30JUN2021	N	BONE CYST, injection into or aspiration of
47900	01JUL2021	31DEC9999	Y	Injection into, or aspiration of, unicameral bone cyst
47903	01DEC1991	30JUN2021	N	EPICONDYLITIS, open operation for
47903	01JUL2021	31DEC9999	Y	Epicondylitis, open operation for
47904	01DEC1991	31OCT1994	N	DIGITAL NAIL, removal of, not being a service to which item 47906 applies
47904	01NOV1994	30JUN2021	N	DIGITAL NAIL OF TOE, removal of, not being a service to which item 47906 applies
47904	01JUL2021	31DEC9999	Y	Digital nail of toe, removal of, not being a service to which item 47906 applies
47906	01DEC1991	31OCT1994	N	DIGITAL NAIL, removal of, in the operating theatre of a hospital or approved day hospital facility
47906	01NOV1994	30JUN2021	N	DIGITAL NAIL OF TOE, removal of, in the operating theatre of a hospital
47906	01JUL2021	31DEC9999	Y	Digital nail of toe, removal of, in the operating theatre of a hospital (H)
47909	01DEC1991	31DEC9999	Y	MIDDLE PALMAR, THENAR OR HYPOTHENAR SPACES, drainage of (excluding aftercare)
47912	01DEC1991	31OCT1994	N	PULP SPACE INFECTION, PARONYCHIA of HANDS or FEET, incision for, not being a service to which another item in this Group applies (excluding aftercare)
47912	01NOV1994	31DEC9999	Y	PULP SPACE INFECTION, PARONYCHIA of FOOT, incision for, not being a service to which another item in this Group applies (excluding aftercare)
47915	01DEC1991	30JUN1993	N	INGROWING TOENAIL, wedge resection for, not being a service associated with a service to which item 47918 applies
47915	01JUL1993	31OCT1994	N	INGROWING nail of finger or toe, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed
47915	01NOV1994	30JUN2011	N	INGROWING NAIL OF TOE, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed
47915	01JUL2011	30JUN2021	N	INGROWING NAIL OF TOE, wedge resection for, with removal of segment of nail, ungual fold and portion of the nail bed
47915	01JUL2021	31DEC9999	Y	Wedge resection for ingrowing nail of toe: (a) including each of the following: (i) removal of segment of nail; (ii) removal of ungual fold; (iii) excision and partial ablation of germinal matrix and portion of nail bed; and (b) including phenolisation (if performed)
47916	01JUL1993	31OCT1994	N	INGROWING nail of finger or toe, partial resection of nail, including phenolisation but not including excision of nail bed
47916	01NOV1994	30JUN2011	N	INGROWING NAIL OF TOE, partial resection of nail, including phenolisation but not including excision of nail bed
47916	01JUL2011	30JUN2021	N	INGROWING NAIL OF TOE, partial resection of nail, with destruction of nail matrix by phenolisation, electrocautery, laser, sodium hydroxide or acid but not including excision of nail bed
47916	01JUL2021	31DEC9999	Y	Partial resection for ingrowing nail of toe, including phenolisation
47918	01DEC1991	30JUN2021	N	INGROWING TOENAIL, radical excision of nailbed
47918	01JUL2021	31DEC9999	Y	Complete ablation of nail germinal matrix: (a) including each of the following: (i) removal of segment of nail; (ii) removal of ungual fold; (iii) excision and ablation of germinal matrix and portion of nail bed; and (b) including phenolisation (if performed)
47920	01MAY1997	31DEC9999	Y	BONE GROWTH STIMULATOR, insertion of
47921	01DEC1991	30JUN2021	N	ORTHOPAEDIC PIN OR WIRE, insertion of, as an independent procedure
47921	01JUL2021	31DEC9999	Y	Orthopaedic pin or wire, insertion of, as an independent procedure
47924	01DEC1991	30JUN2021	N	BURIED WIRE, PIN OR SCREW, 1 or more of, which were inserted for internal fixation purposes, removal of requiring incision and suture, not being a service to which item 47927 or 47930 applies - per bone
47924	01JUL2021	31DEC9999	Y	Removal of one or more buried wires, pins or screws (inserted for internal fixation purposes), with incision, other than a service associated with a service to which item 47927 or 47929 applies-one bone
47927	01DEC1991	30JUN2021	N	BURIED WIRE, PIN OR SCREW, 1 or more of, which were inserted for internal fixation purposes, removal of, in the operating theatre of a hospital - per bone
47927	01JUL2021	31DEC9999	Y	Removal of one or more buried wires, pins or screws (inserted for internal fixation purposes)-one bone (H)
47929	01JUL2021	31DEC9999	Y	Removal of fixation elements (including plate, rod or nail and associated wires, pins, screws or external fixation), other than a service associated with a service to which item 47924 or 47927 applies-one bone (H)
47930	01DEC1991	31DEC9999	Y	PLATE, ROD OR NAIL AND ASSOCIATED WIRES, PINS OR SCREWS, 1 or more of, all of which were inserted for internal fixation purposes, removal of, not being a service associated with a service to which item 47924 or 47927 applies - per bone
47933	01DEC1991	30APR2009	N	EXOSTOSIS OF SMALL BONE, excision of, including simple removal of bunion and any associated bursa
47933	01MAY2009	31DEC9999	Y	SMALL EXOSTOSIS (NOT MORE THAN 20MM OF GROWTH ABOVE BONE), excision of, or simple removal of bunion and any associated bursa, not being a service associated with a service for removal of bursa
47936	01DEC1991	30APR2009	N	EXOSTOSIS OF LARGE BONE, excision of
47936	01MAY2009	31DEC9999	Y	LARGE EXOSTOSIS (GREATER THAN 20MM GROWTH ABOVE BONE), excision of
47939	01DEC1991	30JUN1993	N	LIMB LENGTHENING (single or first stage) osteotomy for, including application of distracting apparatus
47939	01JUL1993	31DEC9999	Y	LIMB LENGTHENING (first stage), osteotomy for, including application of distracting apparatus
47942	01DEC1991	31DEC9999	Y	LIMB LENGTHENING (second stage) internal fixation with bone grafting, including removal of distracting apparatus
47943	01JUL1993	31DEC9999	Y	LIMB LENGTHENING requiring slow distraction and application of ring fixator, not being a service to which item 47939 applies
47945	01DEC1991	31DEC9999	Y	DISTRACTING APPARATUS, removal of, without internal fixation
47948	01DEC1991	31DEC9999	Y	EXTERNAL FIXATION, removal of, in the operating theatre of a hospital
47951	01DEC1991	31DEC9999	Y	EXTERNAL FIXATION, removal of, in conjunction with operations involving internal fixation or bone grafting or both
47953	01JUL2021	31DEC9999	Y	Repair of distal biceps brachii tendon, by any method, performed as an independent procedure
47954	01DEC1991	31OCT1996	N	TENDON, large rupture, repair of, not being a service to which another item in this Group applies
47954	01NOV1996	30APR2009	N	TENDON, repair of, not being a service to which another item in this Group applies
47954	01MAY2009	30JUN2021	N	TENDON, repair of, as an independent procedure
47954	01JUL2021	14JUL2021	N	Repair of traumatic tear or rupture of tendon, other than a service associated with: (a) a service to which item 39330 applies; or (b) a service to which another item in this Schedule applies if the service decribed in the other item is for the purpose of repairing peripheral nerve items in the same region
47954	15JUL2021	31DEC9999	Y	Repair of traumatic tear or rupture of tendon, other than a service associated with: (a) a service to which item 39330 applies; or (b) a service to which another item in this Schedule applies if the service described in the other item is for the purpose of repairing peripheral nerve items in the same region
47955	01JUL2021	31DEC9999	Y	Repair of gluteal or rectus femoris tendon, by open or arthroscopic means, when performed as an independent procedure, including either or both of the following (if performed): (a) bursectomy; (b) preparation of greater trochanter; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the hip (H)
47956	01JUL2021	31DEC9999	Y	Repair of proximal hamstring tendon, performed as an independent procedure, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the hip (H)
47957	01DEC1991	30APR2009	N	TENDON, large, lengthening of, not being a service to which another item in this Group applies
47957	01MAY2009	31DEC9999	Y	TENDON, large, lengthening of, as an independent procedure
47960	01DEC1991	31DEC9999	Y	TENOTOMY, SUBCUTANEOUS, not being a service to which another item in this Group applies
47963	01DEC1991	31DEC9999	Y	TENOTOMY, OPEN, with or without tenoplasty, not being a service to which another item in this Group applies
47964	01JUL2021	31DEC9999	Y	Iliopsoas tenotomy, by open or arthroscopic means, when performed as an independent procedure, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the hip (H)
47966	01DEC1991	30APR2009	N	TENDON OR LIGAMENT, TRANSFER, not being a service to which another item in this Group applies
47966	01MAY2009	31DEC9999	Y	TENDON OR LIGAMENT, TRANSFER, as an independent procedure
47967	01JUL2021	31OCT2022	N	Restoration of shoulder function by major muscle tendon transfer, including associated dissection of neurovascular pedicle, excluding micro-anastomosis and biceps tenodesis-one transfer (H)
47967	01NOV2022	31DEC9999	Y	Restoration of shoulder or elbow function by major muscle tendon transfer, including associated dissection of neurovascular pedicle, excluding micro-anastomosis and biceps tenodesis-one transfer (H)
47968	01MAR2024	31DEC9999	Y	Open tenotomy of one or more tendons of shoulder, with or without tenoplasty, to restore shoulder function, other than a service to which another item in this Group applies-applicable once per joint per occasion on which this service is performed
47969	01DEC1991	31DEC9999	Y	TENOSYNOVECTOMY, not being a service to which another item in this Group applies
47970	01MAR2024	31DEC9999	Y	Open tenotomy of one or more tendons of scapula, with or without tenoplasty, to restore scapula function, other than a service to which another item in this Group applies-applicable once per joint per occasion on which this service is performed
47972	01DEC1991	31DEC9999	Y	TENDON SHEATH, open operation for teno-vaginitis, not being a service to which another item in this Group applies
47973	01MAR2024	31DEC9999	Y	Open tenotomy of one or more tendons of elbow, with or without tenoplasty, to restore elbow function, other than a service to which another item in this Group applies-applicable once per joint per occasion on which this service is performed
47975	01JUL1993	30JUN2021	N	FOREARM OR CALF, decompression fasciotomy of, for acute compartment syndrome, requiring excision of muscle and deep tissue
47975	01JUL2021	31DEC9999	Y	Forearm or calf, decompression fasciotomy of, for acute compartment syndrome, requiring excision of muscle and deep tissue (H)
47978	01JUL1993	30JUN2021	N	FOREARM OR CALF, decompression fasciotomy of, for chronic compartment syndrome, requiring excision of muscle and deep tissue
47978	01JUL2021	31DEC9999	Y	Forearm or calf, decompression fasciotomy of, for chronic compartment syndrome, requiring excision of muscle and deep tissue (H)
47981	01JUL1993	30JUN2021	N	FOREARM, CALF OR INTEROSSEOUS MUSCLE SPACE OF HAND, decompression fasciotomy of, not being a service to which another item applies
47981	01JUL2021	31DEC9999	Y	Forearm, calf or interosseous muscle space of hand, decompression fasciotomy of, other than a service to which another item in this Group applies
47982	01MAY1997	30JUN2021	N	FORAGE (Drill decompression), of NECK OR HEAD of FEMUR, or BOTH
47982	01JUL2021	31DEC9999	Y	Forage (Drill decompression), of neck or head of femur, or both (H)
47983	01JUL2021	31DEC9999	Y	Stabilisation of slipped capital femoral epiphysis, by internal fixation (H)
47984	01JUL2021	31DEC9999	Y	Open subcapital realignment of slipped capital femoral epiphysis, other than a service associated with a service to which item 48427 applies (H)
48200	01DEC1991	31DEC9999	Y	FEMUR, bone graft to
48203	01DEC1991	31DEC9999	Y	FEMUR, bone graft to, with internal fixation
48206	01DEC1991	31DEC9999	Y	TIBIA, bone graft to
48209	01DEC1991	31DEC9999	Y	TIBIA, bone graft to, with internal fixation
48212	01DEC1991	31DEC9999	Y	HUMERUS, bone graft to
48215	01DEC1991	31DEC9999	Y	HUMERUS, bone graft to, with internal fixation
48218	01DEC1991	31DEC9999	Y	RADIUS AND ULNA, bone graft to
48221	01DEC1991	31DEC9999	Y	RADIUS AND ULNA, bone graft to, with internal fixation of 1 or both bones
48224	01DEC1991	31DEC9999	Y	RADIUS OR ULNA, bone graft to
48227	01DEC1991	31DEC9999	Y	RADIUS OR ULNA, bone graft to, with internal fixation of 1 or both bones
48230	01DEC1991	31DEC9999	Y	SCAPHOID, bone graft to, for non-union
48233	01DEC1991	31DEC9999	Y	SCAPHOID, bone graft to, for non-union, with internal fixation
48236	01DEC1991	31DEC9999	Y	SCAPHOID, bone graft to, for mal-union, including osteotomy, bone graft and internal fixation
48239	01DEC1991	31DEC9999	Y	BONE GRAFT, not being a service to which another item in this Group applies
48242	01DEC1991	31DEC9999	Y	BONE GRAFT, with internal fixation, not being a service to which another item in this Group applies
48245	01JUL2021	31DEC9999	Y	Harvesting and insertion of bone graft (autograft) via separate incisions and at separate surgical fields (H)
48248	01JUL2021	31DEC9999	Y	Harvesting and insertion of bone graft (autograft) via separate incisions, including internal fixation of the graft or fusion fixation (or both) (H)
48251	01JUL2021	31DEC9999	Y	Harvesting and insertion of osteochondral graft (autograft) via separate incisions at the same joint or joint complex (H)
48254	01JUL2021	31DEC9999	Y	Harvesting and insertion of pedicled bone flap (autograft), including internal fixation of the bone flap (if performed), other than a service associated with a service to which item 45562, 45504 or 45505 applies (H)
48257	01JUL2021	31DEC9999	Y	Preparation and insertion of metallic, cortical or other graft substitute (allograft), where substitute is structural cortico-cancellous bone or structural bone (or both), including internal fixation (if performed) (H)
48400	01DEC1991	30APR2009	N	PHALANX, METATARSAL, ACCESSORY BONE OR SESAMOID BONE, osteotomy or osteectomy of, excluding services to which item 49848 or 49851 applies
48400	01MAY2009	30JUN2021	N	PHALANX, METATARSAL, ACCESSORY BONE OR SESAMOID BONE, osteotomy or osteectomy of, excluding services to which item 49848 or 49851 applies, any of items 49848, 49851, 47933 or 47936 apply
48400	01JUL2021	29FEB2024	N	Osteotomy of phalanx or metatarsal of foot, for correction of deformity, excision of accessory bone or sesamoid bone, including any of the following (if performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) synovectomy; (d) joint release; -one bone (H)
48400	01MAR2024	31DEC9999	Y	Operation on foot: (a) with either or both of the following: (i) osteotomy of phalanx or metatarsal for correction of deformity; (ii) excision of accessory bone or sesamoid bone; and (b) including any of the following (if performed): (i) removal of bone; (ii) excision of surrounding osteophytes; (iii) synovectomy; (iv) joint release; -one bone (H)
48403	01DEC1991	30APR2009	N	PHALANX OR METATARSAL, osteotomy or osteectomy of, with internal fixation
48403	01MAY2009	30JUN2021	N	PHALANX OR METATARSAL, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply
48403	01JUL2021	29FEB2024	N	Osteotomy of phalanx or metatarsal of first toe of foot, for correction of deformity, with internal fixation, including any of the following (if performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) synovectomy; (d) joint release; -one bone (H)
48403	01MAR2024	31DEC9999	Y	Osteotomy of phalanx of first toe or metatarsal, for correction of deformity, with internal fixation, including any of the following (if performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) synovectomy; (d) joint release; -one bone (H)
48406	01DEC1991	30APR2009	N	FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of
48406	01MAY2009	30JUN2021	N	FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply
48406	01JUL2021	31DEC9999	Y	Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus, for correction of deformity, including any of the following (if performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) synovectomy; (d) joint release; -one bone (H)
48409	01DEC1991	30APR2009	N	FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than Acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, with internal fixation
48409	01MAY2009	30JUN2021	N	FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than Acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply
48409	01JUL2021	31DEC9999	Y	Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus, for correction of deformity, with internal fixation, including any of the following (if performed): (a) removal of bone; (b) excision of surrounding osteophytes; (c) synovectomy; (d) joint release; -one bone (H)
48412	01DEC1991	30APR2009	N	HUMERUS, osteotomy or osteectomy of
48412	01MAY2009	30JUN2021	N	HUMERUS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply
48412	01JUL2021	31DEC9999	Y	Osteotomy of humerus, without internal fixation (H)
48415	01DEC1991	30APR2009	N	HUMERUS, osteotomy or osteectomy of, with internal fixation
48415	01MAY2009	30JUN2021	N	HUMERUS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply
48415	01JUL2021	31DEC9999	Y	Osteotomy of humerus, with internal fixation (H)
48418	01DEC1991	30APR2009	N	TIBIA, osteotomy or osteectomy of
48418	01MAY2009	31DEC9999	Y	TIBIA, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply
48419	01JUL2021	31DEC9999	Y	Osteotomy of distal tibia, for correction of deformity, without internal or external fixation, including any of the following (if performed): (a) excision of surrounding osteophytes; (b) release of joint; (c) removal of bone; (d) synovectomy; -one bone (H)
48420	01JUL2021	31DEC9999	Y	Osteotomy of distal tibia, for correction of deformity, with internal or external fixation by any method, including any of the following (if performed): (a) excision of surrounding osteophytes; (b) release of joint; (c) removal of bone; (d) synovectomy; -one bone (H)
48421	01DEC1991	30APR2009	N	TIBIA, osteotomy or osteectomy of, with internal fixation
48421	01MAY2009	30JUN2021	N	TIBIA, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply
48421	01JUL2021	31DEC9999	Y	Osteotomy of proximal tibia, to alter lower limb alignment or rotation (or both), with internal or external fixation (or both) (H)
48422	01JUL2021	31DEC9999	Y	Osteotomy of distal femur, to alter lower limb alignment or rotation (or both), with internal or external fixation (or both) (H)
48423	01JUL2021	31DEC9999	Y	Osteotomy of pelvis, in a patient aged 18 years or over, including any of the following (if performed): (a) associated intra-articular procedures; (b) bone grafting; (c) internal fixation (H)
48424	01DEC1991	30APR2009	N	FEMUR OR PELVIS, osteotomy or osteectomy of
48424	01MAY2009	31OCT2016	N	FEMUR OR PELVIS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply
48424	01NOV2016	30JUN2021	N	Femur or pelvis, osteotomy or osteectomy of, other than a service associated with surgery for femoroacetabular impingement, or to which item 47933 or 47936 applies (H)
48424	01JUL2021	31DEC9999	Y	Osteotomy of pelvis, in a patient aged less than 18 years, with application of hip spica, including internal fixation (if performed), other than a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
48426	01JUL2021	31DEC9999	Y	Osteotomy of femur, in a patient aged 18 years or over, including either or both of the following (if performed): (a) bone grafting; (b) internal fixation (H)
48427	01DEC1991	30APR2009	N	FEMUR OR PELVIS, osteotomy or osteectomy of, with internal fixation
48427	01MAY2009	30JUN2021	N	FEMUR OR PELVIS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply
48427	01JUL2021	31DEC9999	Y	Osteotomy of femur, in a patient aged less than 18 years, including internal fixation (if performed), other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
48430	01JUL2021	31DEC9999	Y	Excision of one or more osteophytes of the foot or ankle, or simple removal of bunion, including any of the following (if performed): (a) capsulotomy; (b) excision of surrounding osteophytes; (c) release of ligaments; (d) removal of one or more associated bursae or ganglia; (e) removal of bone; (f) synovectomy; -each incision (H)
48433	01JUL2021	31DEC9999	Y	Treatment of non-union or malunion, with preservation of the joint, for ankle or hindfoot fracture, with internal or external fixation by any method, including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) excision of surrounding osteophytes; (d) osteotomy; (e) release of joint; (f) removal of bone; (g) removal of hardware; (h) synovectomy; -one bone (H)
48435	01JUL2021	31DEC9999	Y	Treatment of non-union or malunion, with preservation of the joint, for midfoot or forefoot fracture, with internal or external fixation by any method, including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) excision of surrounding osteophytes; (d) osteotomy; (e) release of joint; (f) removal of bone; (g) removal of hardware; (h) synovectomy; -one bone (H)
48436	01MAR2024	31DEC9999	Y	Excision of one or more exostoses of the hand, distal to the wrist, including any of the following (if performed): (a) excision of surrounding osteophytes; (b) release of ligaments; (c) removal of one or more associated bursae or ganglia; (d) removal of bone; (e) synovectomy; other than a service associated with a service to which another item in this Schedule applies that: (f) is an arthroscopic procedure, arthrodesis, arthroplasty or osteotomy, or involves the removal of hardware; and (g) is performed on the same joint or bone; -each incision (H)
48438	01MAR2024	31DEC9999	Y	Excision of one or more exostoses in the wrist including any of the following (if performed): (a) capsulotomy; (b) excision of surrounding osteophytes; (c) release of ligaments; (d) removal of one or more associated bursae or ganglia; (e) removal of bone; (f) synovectomy; other than: (g) a service to which 48436 applies; or (h) a service associated with a service to which another item in this Schedule applies that: (i) is an arthroscopic procedure, arthrodesis, arthroplasty or osteotomy, or involves the removal of hardware; and (ii) is performed on the same joint or bone; -each incision (H)
48440	01MAR2024	31DEC9999	Y	Excision of one or more exostoses in the arm or shoulder, including the radius, ulna, humerus, acromion, clavicle, or scapula, including any of the following (if performed): (a) capsulotomy; (b) excision of surrounding osteophytes; (c) release of ligaments; (d) removal of one or more associated bursae or ganglia; (e) removal of bone; (f) synovectomy; other than: (g) a service to which 48438 applies; or (h) a service associated with a service to which another item in this Schedule applies that: (i) is an arthroscopic procedure, arthrodesis, arthroplasty or osteotomy, or involves the removal of hardware; and (ii) is performed on the same joint or bone; -each incision (H)
48442	01MAR2024	31DEC9999	Y	Excision of one or more exostoses in the hip, including pelvis and femur, including any of following (if performed): (a) capsulotomy; (b) excision of surrounding osteophytes; (c) release of ligaments; (d) removal of one or more associated bursae or ganglia; (e) removal of bone; (f) synovectomy; other than: (g) a service to which 48444 applies; or (h) a service associated with a service to which another item in this Schedule applies that: (i) is an arthroscopic procedure, arthrodesis, arthroplasty or osteotomy, or involves the removal of hardware; and (ii) is performed on the same joint or bone; -each incision (H)
48444	01MAR2024	31DEC9999	Y	Excision of one or more exostoses in the knee, tibia or fibula, including any of following (if performed): (a) capsulotomy; (b) excision of surrounding osteophytes; (c) release of ligaments; (d) removal of one or more associated bursae or ganglia; (e) removal of bone; (f) synovectomy; other than: (g) a service to which item 48430 applies; or (h) a service associated with a service to which another item in this Schedule applies that: (i) is an arthroscopic procedure, arthrodesis, arthroplasty or osteotomy, or involves the removal of hardware; and (ii) is performed on the same joint or bone; -each incision (H)
48446	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of pelvis, including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48448	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of femur, including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48450	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of tibia or fibula, proximal to ankle, including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48452	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of humerus, including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48454	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of radius, ulna, or carpus including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48456	01MAR2024	31DEC9999	Y	Treatment of non-union or malunion of fracture of hand, distal to wrist, including bone graft, and including any of the following (if performed): (a) arthrotomy; (b) debridement; (c) osteotomy; (d) removal of hardware; (e) internal fixation; other than a service associated with a service to which item 48245, 48248, 48251, 48254, 48257 or 47929 applies that is performed on the same bone -one bone (H)
48500	01DEC1991	31DEC9999	Y	FEMUR, epiphysiodesis of
48503	01DEC1991	31DEC9999	Y	TIBIA AND FIBULA, epiphysiodesis of
48506	01DEC1991	31DEC9999	Y	FEMUR, TIBIA AND FIBULA, epiphysiodesis of
48507	01JUL2021	31DEC9999	Y	Epiphysiodesis of a long bone, in a patient less than 18 years of age (H)
48509	01DEC1991	30JUN2021	N	EPIPHYSIODESIS, staple arrest of hemiepiphysis
48509	01JUL2021	31DEC9999	Y	Hemiepiphysiodesis, partial growth plate arrest using internal fixation, in a patient less than 18 years of age (H)
48512	01DEC1991	31OCT1992	N	EPIPHYSIODESIS, operation to prevent closure of plate
48512	01NOV1992	30JUN2021	N	EPIPHYSIOLYSIS, operation to prevent closure of plate
48512	01JUL2021	31DEC9999	Y	Epiphysiolysis, release of focal growth plate closure, in a patient less than 18 years of age (H)
48600	01DEC1991	31DEC9999	Y	SPINE, MANIPULATION OF, performed in the operating theatre of a hospital
48603	01DEC1991	31DEC9999	Y	SPINE, manipulation of, under epidural anaesthesia, with or without steroid injection, where the manipulation and the administration of the epidural anaesthetic are performed by the same medical practitioner in the operating theatre of a hospital, not being a service associated with a service to which item 48600 or 50115 applies
48606	01DEC1991	31DEC9999	Y	SCOLIOSIS or KYPHOSIS, spinal fusion for (without instrumentation)
48609	01DEC1991	31DEC9999	Y	SCOLIOSIS or KYPHOSIS, spinal fusion for, using Harrington or other nonsegmental fixation
48612	01DEC1991	31DEC9999	Y	SCOLIOSIS, spinal fusion for, using segmental instrumentation (C D, Zielke, Luque, or similar)
48613	01JUL1998	31DEC9999	Y	SCOLIOSIS OR KYPHOSIS, spinal fusion for, using segmental instrumentation, reconstruction utilising separate anterior and posterior approaches
48615	01DEC1991	31DEC9999	Y	SCOLIOSIS, re-exploration for, involving adjustment or removal of instrumentation or simple bone grafting procedure
48618	01DEC1991	31DEC9999	Y	SCOLIOSIS, revision of failed scoliosis surgery, involving more than 1 of multiple osteotomy, fusion or instrumentation
48621	01DEC1991	31DEC9999	Y	SCOLIOSIS, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke, or similar) - not more than 4 levels
48624	01DEC1991	31DEC9999	Y	SCOLIOSIS, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - more than 4 levels
48627	01DEC1991	31DEC9999	Y	SCOLIOSIS, spinal fusion for, combined with segmental instrumentation (C D, Zielke or similar) down to and including pelvis
48630	01DEC1991	31DEC9999	Y	SCOLIOSIS, requiring anterior decompression of spinal cord with resection of vertebrae including bone graft and instrumentation in the presence of spinal cord involvement
48632	01JUL1993	31DEC9999	Y	SCOLIOSIS, congenital, vertebral resection and fusion for
48636	01DEC1991	30APR2003	N	PERCUTANEOUS LUMBAR DISCECTOMY, 1 or more levels
48636	01MAY2003	31OCT2006	N	PERCUTANEOUS LUMBAR DISCECTOMY, 1 or more levels not being a service associated with intradiscal electrothermal annuloplasty
48636	01NOV2006	31DEC9999	Y	PERCUTANEOUS LUMBAR PARTIAL OR TOTAL DISCECTOMY, 1 or more levels, not being a service associated with intradiscal electrothermal annuloplasty
48639	01DEC1991	31DEC9999	Y	VERTEBRAL BODY, total or subtotal excision of, including bone grafting or other form of fixation
48640	01JUL1998	31DEC9999	Y	VERTEBRAL BODY, disease of, excision and spinal fusion for, using segmental instrumentation, reconstruction utilising separate anterior and posterior approaches
48642	01DEC1991	31DEC9999	Y	SPINE, posterior, bone graft to, not being a service to which item 48648 or 48651 applies - 1 or 2 levels
48645	01DEC1991	31DEC9999	Y	SPINE, posterior, bone graft to, not being a service to which item 48648 or 48651 applies - more than 2 levels
48648	01DEC1991	31DEC9999	Y	SPINE, bone graft to, (postero-lateral fusion) - 1 or 2 levels
48651	01DEC1991	31DEC9999	Y	SPINE, bone graft to, (postero-lateral fusion) - more than 2 levels
48654	01DEC1991	31OCT2006	N	SPINAL FUSION (posterior interbody), with laminectomy, 1 level
48654	01NOV2006	31DEC9999	Y	SPINAL FUSION (posterior interbody), with partial or total laminectomy, 1 level
48657	01DEC1991	31OCT2006	N	SPINAL FUSION (posterior interbody), with laminectomy, more than 1 level
48657	01NOV2006	31DEC9999	Y	SPINAL FUSION (posterior interbody), with partial or total laminectomy, more than 1 level
48660	01DEC1991	31OCT2006	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level
48660	01NOV2006	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level, not being a service associated with artificial intervertebral total disc replacement
48660	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level
48663	01DEC1991	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level (where an assisting surgeon performs the approach) - principal surgeon
48663	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level - principal surgeon
48666	01DEC1991	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level (where an assisting surgeon performs the approach) - assisting surgeon
48666	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level - assisting surgeon
48669	01DEC1991	31OCT2006	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level
48669	01NOV2006	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level, not being a service associated with artificial intervertebral total disc replacement
48669	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level
48672	01DEC1991	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level (where an assisting surgeon performs the approach) - principal surgeon
48672	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level - principal surgeon
48675	01DEC1991	31DEC2013	N	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level (where an assisting surgeon performs the approach) - assisting surgeon
48675	01JAN2014	31DEC9999	Y	SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level - assisting surgeon
48678	01DEC1991	31DEC9999	Y	SPINE, simple internal fixation of, involving 1 or more of facetal screw, wire loop or similar, being a service associated with a service to which items 48642 to 48675 apply
48681	01DEC1991	31DEC9999	Y	SPINE, non-segmental internal fixation of (Harrington or similar), other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies
48684	01DEC1991	31OCT2006	N	SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels
48684	01NOV2006	31DEC2013	N	SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels, not being a service associated with artificial intervertebral total disc replacement
48684	01JAN2014	31DEC9999	Y	SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels
48687	01DEC1991	31DEC9999	Y	SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which items 48642 to 48675 apply - 3 or 4 levels
48690	01DEC1991	31DEC9999	Y	SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which items 48642 to 48675 apply - more than 4 levels
48691	01NOV2006	31DEC2013	N	LUMBAR ARTIFICIAL INTERVERTEBRAL TOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, with fluoroscopy
48691	01JAN2014	31DEC9999	Y	Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301
48692	01NOV2006	31DEC2013	N	LUMBAR ARTIFICIAL INTERVERTEBRAL TOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, with fluoroscopy (where an assisting surgeon performs the approach) - principal surgeon
48692	01JAN2014	31DEC9999	Y	Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301-principal surgeon
48693	01NOV2006	31DEC2013	N	LUMBAR ARTIFICIAL INTERVERTEBRAL TOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, (where an assisting surgeon performs the approach) - assisting surgeon
48693	01JAN2014	31DEC9999	Y	Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301-assisting surgeon
48694	01NOV2012	31DEC9999	Y	Cervical artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal surgery at the same cervical level; and (b) is skeletally mature; and (c) has symptomatic degenerative disc disease with radiculopathy; and (d) does not have vertebral osteoporosis; and (e) has failed conservative therapy; other than a service associated with item 40300 or 40301
48900	01DEC1991	30JUN2021	N	SHOULDER, excision of coraco-acromial ligament or removal of calcium deposit from cuff or both
48900	01JUL2021	31DEC9999	Y	Shoulder, excision of coraco-acromial ligament or removal of calcium deposit from cuff or both
48903	01DEC1991	31OCT1996	N	SHOULDER, decompression of subacromial space by acromionectomy, excision of coraco-acromial ligament and distal clavicle, or any combination
48903	01NOV1996	30JUN2021	N	SHOULDER, decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination
48903	01JUL2021	31DEC9999	Y	Shoulder, decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination (H)
48906	01DEC1991	30JUN2021	N	SHOULDER, repair of rotator cuff, including excision of coraco-acromial ligament or removal of calcium deposit from cuff, or both - not being a service associated with a service to which item 48900 applies
48906	01JUL2021	31DEC9999	Y	Shoulder, repair of rotator cuff, including excision of coraco-acromial ligament or removal of calcium deposit from cuff, or both-other than a service associated with a service to which item 48900 applies (H)
48909	01DEC1991	31OCT1996	N	SHOULDER, repair of rotator cuff, including decompression of subacromial space by acromionectomy, excision of coraco-acromial ligament and distal clavicle, or any combination, not being a service associated with a service to which item 48903 applies
48909	01NOV1996	30JUN2021	N	SHOULDER, repair of rotator cuff, including decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination, not being a service associated with a service to which item 48903 applies
48909	01JUL2021	31DEC9999	Y	Shoulder, repair of rotator cuff, including decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination, other than a service associated with a service to which item 48903 applies (H)
48912	01DEC1991	31DEC9999	Y	SHOULDER, arthrotomy of
48915	01DEC1991	30JUN2021	N	SHOULDER, hemi-arthroplasty of
48915	01JUL2021	31DEC9999	Y	Shoulder, hemi-arthroplasty of (H)
48918	01DEC1991	30JUN2021	N	SHOULDER, total replacement arthroplasty of, including any associated rotator cuff repair
48918	01JUL2021	31DEC9999	Y	Anatomic or reverse total shoulder replacement, including any of the following (if performed): (a) associated rotator cuff repair; (b) biceps tenodesis; (c) tuberosity osteotomy; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the shoulder region by open or arthroscopic means (H)
48919	01MAR2024	31DEC9999	Y	Anatomic or reverse total shoulder replacement with bone graft, including any of the following (if performed): (a) associated rotator cuff repair; (b) biceps tenodesis; (c) tuberosity osteotomy; other than a service associated with: (d) a service to which another item in this Schedule applies that is performed on the shoulder region by open or arthroscopic means; or (e) a service to which item 48245, 48248, 48251, 48254 or 48257 applies that is performed on the same joint (H)
48921	01DEC1991	30JUN2021	N	SHOULDER, total replacement arthroplasty, revision of
48921	01JUL2021	31DEC9999	Y	Shoulder, total replacement arthroplasty, revision of (H)
48924	01DEC1991	30JUN2021	N	SHOULDER, total replacement arthroplasty, revision of, requiring bone graft to scapula or humerus, or both
48924	01JUL2021	31DEC9999	Y	Revision of total shoulder replacement, including either or both of the following (if performed): (a) bone graft to humerus; (b) bone graft to scapula (H)
48925	01MAR2024	31DEC9999	Y	Arthroplasty of shoulder, other than: (a) a service to which another item applies; or (b) a service associated with a service to which any of items 48900 to 48909, 48948, 48951, or 48960 applies that is performed on the same joint (H)
48927	01DEC1991	30JUN2021	N	SHOULDER prosthesis, removal of
48927	01JUL2021	31DEC9999	Y	Shoulder prosthesis, removal of (H)
48930	01DEC1991	31OCT1996	N	SHOULDER, anterior stabilisation procedure for recurrent dislocation
48930	01NOV1996	31DEC9999	Y	SHOULDER, stabilisation procedure for recurrent anterior or posterior dislocation
48932	01MAR2024	31DEC9999	Y	Arthroplasty of acromioclavicular joint or sternoclavicular joint, other than: (a) a service to which another item applies; or (b) a service associated with a service to which another item in this Schedule applies that is performed on the same joint by arthroscopic means -one joint (H)
48933	01DEC1991	31OCT1996	N	SHOULDER, stabilisation procedure for multi-directional instability
48933	01NOV1996	31DEC9999	Y	SHOULDER, stabilisation procedure for multi-directional instability, including anterior or posterior (or both) repair when performed
48936	01DEC1991	31DEC9999	Y	SHOULDER, synovectomy of, as an independent procedure
48939	01DEC1991	30APR2009	N	SHOULDER, arthrodesis of
48939	01MAY2009	30JUN2021	N	SHOULDER, arthrodesis of, with synovectomy if performed
48939	01JUL2021	31DEC9999	Y	Shoulder, arthrodesis of, with synovectomy if performed (H)
48942	01DEC1991	30APR2009	N	SHOULDER, arthrodesis of, including removal of prosthesis, requiring bone grafting or internal fixation
48942	01MAY2009	30JUN2021	N	SHOULDER, arthrodesis of, with synovectomy if performed, with removal of prosthesis, requiring bone grafting or internal fixation
48942	01JUL2021	31DEC9999	Y	Arthrodesis of shoulder, with bone grafting or internal fixation, including either or both of the following (if performed): (a) removal of prosthesis; (b) synovectomy; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
48943	01MAR2024	31DEC9999	Y	Arthrodesis of acromioclavicular or sternoclavicular joint, including either or both of the following (if performed): (a) joint debridement; (b) synovectomy; -one joint (H)
48944	01MAR2024	31DEC9999	Y	Arthrodesis of scapulothoracic joint, including either or both of the following (if performed): (a) joint debridement; (b) synovectomy; -one joint (H)
48945	01DEC1991	30JUN2021	N	SHOULDER, diagnostic arthroscopy of (including biopsy) - not being a service associated with any other arthroscopic procedure of the shoulder region
48945	01JUL2021	31DEC9999	Y	SHOULDER, diagnostic arthroscopy of (including biopsy) - not being a service associated with any other arthroscopic procedure of the shoulder region (H)
48948	01DEC1991	31OCT1996	N	SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of loose bodies; debridement of labrum, synovium or rotator cuff; or chondroplasty - not being a service associated with any other arthroscopic procedure of the shoulder region
48948	01NOV1996	30JUN2021	N	SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of loose bodies; decompression of calcium deposit; debridement of labrum, synovium or rotator cuff; or chondroplasty - not being a service associated with any other arthroscopic procedure of the shoulder region
48948	01JUL2021	31DEC9999	Y	SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of loose bodies; decompression of calcium deposit; debridement of labrum, synovium or rotator cuff; or chondroplasty - not being a service associated with any other arthroscopic procedure of the shoulder region (H)
48951	01DEC1991	30JUN2021	N	SHOULDER, arthroscopic division of coraco-acromial ligament including acromioplasty - not being a service associated with any other arthroscopic procedure of the shoulder region
48951	01JUL2021	31DEC9999	Y	SHOULDER, arthroscopic division of coraco-acromial ligament including acromioplasty - not being a service associated with any other arthroscopic procedure of the shoulder region (H)
48952	01MAR2024	31DEC9999	Y	Surgery of acromioclavicular joint or sternoclavicular joint, by arthroscopic means, including any of the following (if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) excision of joint osteophytes; other than a service associated with a service to which another item in this Group applies that is performed on the same joint by arthroscopic means (H)
48953	01MAR2024	31DEC9999	Y	Surgery of scapulothoracic joint, by arthroscopic means, including any of the following (if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) excision of joint osteophytes; other than a service associated with a service to which another item in this Group applies that is performed on the same joint by arthroscopic means (H)
48954	01DEC1991	31OCT1996	N	SHOULDER, arthroscopic total synovectomy of - not being a service associated with any other arthroscopic procedure of the shoulder region
48954	01NOV1996	30JUN2021	N	SHOULDER, arthroscopic total synovectomy of, including release of contracture when performed - not being a service associated with any other arthroscopic procedure of the shoulder region
48954	01JUL2021	31DEC9999	Y	Synovectomy of shoulder, performed as an independent procedure, including release of contracture (if performed), other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the shoulder region by arthroscopic means (H)
48957	01DEC1991	31OCT1996	N	SHOULDER, arthroscopic stabilisation of, for recurrent instability - not being a service associated with any other arthroscopic procedure of the shoulder region
48957	01NOV1996	31DEC9999	Y	SHOULDER, arthroscopic stabilisation of, for recurrent instability including labral repair or reattachment when performed - not being a service associated with any other arthroscopic procedure of the shoulder region
48958	01JUL2021	31OCT2021	N	Joint stabilisation procedure for multi-directional instability of shoulder, anterior or posterior repair, by open or arthroscopic means, including labral repair or attachment (if performed), excluding bone grafting and removal of hardware, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the shoulder region by arthroscopic means (H)
48958	01NOV2021	31DEC9999	Y	Joint stabilisation procedure for multi-directional instability of shoulder, anterior or posterior repair, by open or arthroscopic means, including labral repair or reattachment (if performed), excluding bone grafting and removal of hardware, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the shoulder region by arthroscopic means (H)
48959	01MAR2024	31DEC9999	Y	Latarjet procedure by open or arthroscopic means, including any of the following (if performed) but excluding removal of hardware: (a) labral repair or reattachment; (b) bone grafting; (c) tendon transfer; other than a service associated with a service to which another item in this Schedule applies that is performed on the shoulder region by arthroscopic means (H)
48960	01DEC1991	31OCT1996	N	SHOULDER, arthroscopic reconstruction of, including repair of rotator cuff - not being a service associated with any other arthroscopic procedure of the shoulder region
48960	01NOV1996	30JUN2021	N	SHOULDER, reconstruction or repair of, including repair of rotator cuff by arthroscopic, arthroscopic assisted or mini open means; arthroscopic acromioplasty; or resection of acromioclavicular joint by separate approach when performed - not being a service associated with any other procedure of the shoulder region
48960	01JUL2021	31DEC9999	Y	SHOULDER, reconstruction or repair of, including repair of rotator cuff by arthroscopic, arthroscopic assisted or mini open means; arthroscopic acromioplasty; or resection of acromioclavicular joint by separate approach when performed - not being a service associated with any other procedure of the shoulder region (H)
48972	01JUL2021	31DEC9999	Y	Tenodesis of biceps, by open or arthroscopic means, performed as an independent procedure (H)
48980	01JUL2021	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the shoulder girdle (H)
48983	01JUL2021	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the elbow (H)
48986	01JUL2021	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the forearm (H)
49100	01DEC1991	30JUN2021	N	ELBOW, arthrotomy of, involving 1 or more of lavage, removal of loose body or division of contracture
49100	01JUL2021	31DEC9999	Y	ELBOW, arthrotomy of, involving 1 or more of lavage, removal of loose body or division of contracture (H)
49103	01DEC1991	31DEC9999	Y	ELBOW, ligamentous stabilisation of
49104	01JUL2021	31DEC9999	Y	Repair of one or more ligaments of the elbow, for acute instability-within 6 weeks after the time of injury (H)
49105	01JUL2021	31DEC9999	Y	Stabilisation of one or more ligaments of the elbow, for chronic instability, including harvesting of tendon graft-6 weeks or more after the time of injury (H)
49106	01DEC1991	30APR2009	N	ELBOW, arthrodesis of
49106	01MAY2009	31DEC9999	Y	ELBOW, arthrodesis of, with synovectomy if performed
49109	01DEC1991	30JUN2021	N	ELBOW, total synovectomy of
49109	01JUL2021	31DEC9999	Y	ELBOW, total synovectomy of (H)
49112	01DEC1991	30JUN2021	N	ELBOW, silastic or other replacement of radial head
49112	01JUL2021	31DEC9999	Y	Radial head replacement of elbow, other than a service associated with a service to which item 49115 applies (H)
49113	01MAR2024	31DEC9999	Y	Removal of radial head prosthesis (H)
49114	01MAR2024	31DEC9999	Y	Revision of radial head replacement (H)
49115	01DEC1991	30JUN2021	N	ELBOW, total joint replacement of
49115	01JUL2021	31DEC9999	Y	Total or hemi humeral arthroplasty of elbow, excluding isolated radial head replacement and ligament stabilisation procedures, other than a service associated with a service to which item 49112 applies (H)
49116	01NOV2006	30JUN2021	N	ELBOW, total replacement arthroplasty of, revision procedure, including removal of prosthesis
49116	01JUL2021	31DEC9999	Y	ELBOW, total replacement arthroplasty of, revision procedure, including removal of prosthesis (H)
49117	01NOV2006	30JUN2021	N	ELBOW, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis
49117	01JUL2021	31DEC9999	Y	Revision of total replacement arthroplasty of elbow, including bone grafting and removal of prosthesis (H)
49118	01DEC1991	30APR2009	N	ELBOW, diagnostic arthroscopy of, including biopsy
49118	01MAY2009	30JUN2021	N	ELBOW, diagnostic arthroscopy of, including biopsy and lavage, not being a service associated with any other arthroscopic procedure of the elbow
49118	01JUL2021	31DEC9999	Y	ELBOW, diagnostic arthroscopy of, including biopsy and lavage, not being a service associated with any other arthroscopic procedure of the elbow (H)
49121	01DEC1991	31OCT1996	N	ELBOW, arthroscopic surgery involving any 1 or more of drilling of defect, removal of loose body or chondroplasty - not being a service associated with any other arthroscopic procedure of the elbow joint
49121	01NOV1996	30JUN2021	N	ELBOW, arthroscopic surgery involving any 1 or more of: drilling of defect, removal of loose body; release of contracture or adhesions; chondroplasty; or osteoplasty - not being a service associated with any other arthroscopic procedure of the elbow
49121	01JUL2021	31DEC9999	Y	Surgery of the elbow, by arthroscopic means, including any of the following (if performed): (a) chondroplasty; (b) drilling of defect; (c) osteoplasty; (d) removal of loose bodies; (e) release of contracture or adhesions; (f) treatment of epicondylitis; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of an arthroscopic procedure of the elbow (H)
49124	01JUL2021	31DEC9999	Y	Excision of olecranon bursa, including bony prominence, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of an arthroscopic procedure of the elbow
49127	01MAR2024	31DEC9999	Y	Elbow joint, arthroplasty of, other than a service to which another item applies (H)
49200	01DEC1991	30APR2009	N	WRIST, arthrodesis of, including bone graft, with or without internal fixation of the radiocarpal joint
49200	01MAY2009	30JUN2021	N	WRIST, arthrodesis of, with synovectomy if performed, with or without bone graft and internal fixation of the radiocarpal joint
49200	01JUL2021	31DEC2021	N	Wrist, arthrodesis of, with synovectomy if performed, with or without bone graft and internal fixation of the radiocarpal joint (H)
49200	01JAN2022	31DEC9999	Y	Wrist, arthrodesis of, with synovectomy if performed, with or without internal fixation of the radiocarpal joint (H)
49203	01DEC1991	30APR2009	N	WRIST, limited arthrodesis of the intercarpal joint, including bone graft
49203	01MAY2009	30JUN2021	N	WRIST, limited arthrodesis of the intercarpal joint, with synovectomy if performed, with or without bone graft
49203	01JUL2021	31DEC9999	Y	Limited fusion of wrist, with or without bone graft, including each of the following: (a) ligament or tendon transfers; (b) partial or total excision of one or more carpal bones; (c) rebalancing procedures; (d) synovectomy (H)
49206	01DEC1991	31OCT1996	N	WRIST, excision arthroplasty of, with radial styloidectomy and proximal carpectomy
49206	01NOV1996	30JUN2021	N	WRIST, proximal carpectomy of, including styloidectomy when performed
49206	01JUL2021	31DEC9999	Y	Proximal row carpectomy of wrist, including either or both of the following (if performed): (a) styloidectomy; (b) synovectomy (H)
49209	01DEC1991	30JUN2021	N	WRIST, total replacement arthroplasty of
49209	01JUL2021	31DEC9999	Y	Prosthetic replacement of wrist or distal radioulnar joint, including either or both of the following (if performed): (a) ligament realignment; (b) tendon realignment (H)
49210	01NOV2006	30JUN2021	N	WRIST, total replacement arthroplasty of, revision procedure, including removal of prosthesis
49210	01JUL2021	31DEC9999	Y	Revision of total replacement arthroplasty of wrist or distal radioulnar joint, including any of the following (if performed): (a) ligament rebalancing; (b) removal of prosthesis; (c) tendon rebalancing (H)
49211	01NOV2006	31DEC9999	Y	WRIST, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis
49212	01DEC1991	30JUN2021	N	WRIST, arthrotomy of
49212	01JUL2021	31OCT2022	N	Arthrotomy of wrist or distal radioulnar joint, for infection, including any of the following (if performed): (a) joint debridement; (b) removal of loose bodies; (c) synovectomy (H)
49212	01NOV2022	31DEC9999	Y	Arthrotomy of wrist or distal radioulnar joint, including any of the following (if performed): (a) joint debridement; (b) removal of loose bodies; (c) synovectomy (H)
49213	01JUL2021	31DEC9999	Y	Sauve-Kapandji procedure of distal radioulnar joint, including any of the following (if performed): a) radioulnar fusion; b) osteotomy; c) soft tissue reconstruction
49215	01DEC1991	30JUN2021	N	WRIST, reconstruction of, including repair of single or multiple ligaments or capsules, including associated arthrotomy
49215	01JUL2021	31OCT2022	N	Reconstruction of single or multiple ligaments or capsules of wrist, by open procedure, including any of the following (if performed): (a) arthrotomy; (b) ligament harvesting and grafting; (c) synovectomy; (d) tendon harvesting and grafting; (e) insertion of synthetic ligament substitute (H)
49215	01NOV2022	31DEC9999	Y	Reconstruction of single or multiple ligaments or capsules of wrist, including any of the following (if performed): (a) arthrotomy; (b) ligament harvesting and grafting; (c) synovectomy; (d) tendon harvesting and grafting; (e) insertion of synthetic ligament substitute (H)
49218	01DEC1991	30JUN2021	N	WRIST, diagnostic arthroscopy of, including radiocarpal or midcarpal joints, or both (including biopsy) - not being a service associated with any other arthroscopic procedure of the wrist joint
49218	01JUL2021	31DEC9999	Y	Wrist, diagnostic arthroscopy of, including radiocarpal or midcarpal joints, or both (including biopsy)-other than a service associated with another arthroscopic procedure of the wrist joint (H)
49219	01JUL2021	29FEB2024	N	Diagnosis of carpometacarpal of thumb or joint of digit, by arthroscopic means, including biopsy (if performed) (H)
49219	01MAR2024	31DEC9999	Y	Diagnosis of carpometacarpal joint of thumb or joint of digit, by arthroscopic means, including biopsy (if performed) (H)
49220	01JUL2021	29FEB2024	N	Treatment of carpometacarpal of thumb or joint of digit, by arthroscopic means-one joint (H)
49220	01MAR2024	31DEC9999	Y	Treatment of carpometacarpal joint of thumb or joint of digit, by arthroscopic means-one joint (H)
49221	01DEC1991	31OCT1996	N	WRIST, arthroscopic surgery of, involving any 1 or more of drilling of defect, removal of loose body, local synovectomy or debridement - not being a service associated with any other arthroscopic procedure of the wrist joint
49221	01NOV1996	30JUN2021	N	WRIST, arthroscopic surgery of, involving any 1 or more of: drilling of defect; removal of loose body; release of adhesions; local synovectomy; or debridement of one area - not being a service associated with any other arthroscopic procedure of the wrist joint
49221	01JUL2021	31DEC9999	Y	Treatment of wrist, by arthroscopic means, including any of the following (if performed): (a) drilling of defect; (b) removal of loose bodies; (c) release of adhesions; (d) synovectomy; (e) debridement; (f) resection of dorsal or volar ganglia; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing an arthroscopic procedure of the wrist joint (H)
49224	01DEC1991	31OCT1996	N	WRIST, arthroscopic debridement of or total synovectomy of - not being a service associated with any other arthroscopic procedure of the wrist joint
49224	01NOV1996	30APR2009	N	WRIST, arthroscopic debridement of 2 or more distinct areas; or osteoplasty including excision of the distal ulna; or total synovectomy
49224	01MAY2009	30JUN2021	N	WRIST, arthroscopic debridement of 2 or more distinct areas; or osteoplasty including excision of the distal ulna; or total synovectomy, not being a service associated with any other arthroscopic procedure of the wrist
49224	01JUL2021	31DEC9999	Y	Osteoplasty of wrist, by arthroscopic means, including either or both of the following (if performed): (a) excision of the distal ulna; (b) total synovectomy; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing an arthroscopic procedure of the wrist joint-2 or more distinct areas (H)
49227	01DEC1991	31OCT1996	N	WRIST, arthroscopic pinning of osteochondral fragment - not being a service associated with any other arthroscopic procedure of the wrist joint
49227	01NOV1996	30JUN2021	N	WRIST, arthroscopic pinning of osteochondral fragment or stabilisation procedure for ligamentous disruption - not being a service associated with any other arthroscopic procedure of the wrist joint
49227	01JUL2021	31DEC9999	Y	Treatment of wrist by one of the following: (a) pinning of osteochondral fragment, by arthroscopic means; (b) stabilisation procedure for ligamentous disruption; (c) partial wrist fusion or carpectomy, by arthroscopic means; (d) fracture management; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing an arthroscopic procedure of the wrist joint (H)
49230	01JUL2021	29FEB2024	N	Total, hemi or interpositional prosthetic replacement of carpal bone of wrist, for trauma or emergency, including all of the following: (a) ligament and tendon rebalancing procedures; (b) limited wrist fusions; (c) limited bone grafting (H)
49230	01MAR2024	31DEC9999	Y	Total, hemi or interpositional prosthetic replacement of carpal bone of wrist, including any of the following (if performed): (a) ligament and tendon rebalancing procedures; (b) limited wrist fusions; (c) limited bone grafting (H)
49233	01JUL2021	29FEB2024	N	Excisional arthroplasty of single (or part of) carpal bone of wrist, when transfers of ligaments or tendons, or rebalancing procedures, are not required, including all of the following: (a) radial styloidectomy; (b) ulnar styloidectomy; (c) proximal hamate; (d) partial scaphoid; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a distal radial ulnar joint reconstruction, a proximal row carpectomy or another wrist procedure-applicable once for a single operation (H)
49233	01MAR2024	31DEC9999	Y	Excisional arthroplasty of single (or part of) carpal bone of wrist, when transfers of ligaments or tendons, or rebalancing procedures, are not required, including any of the following (if performed): (a) radial styloidectomy; (b) ulnar styloidectomy; (c) proximal hamate; (d) partial scaphoid; other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a distal radioulnar joint reconstruction, a proximal row carpectomy or a limited wrist fusion-applicable once for a single operation (H)
49236	01JUL2021	31OCT2022	N	Stabilisation of soft tissue of distal radioulnar joint, by open procedure, with or without ligament or tendon grafting, including either or both of the following (if performed): (a) graft harvest; (b) triangular fibrocartilage complex repair or reconstruction (H)
49236	01NOV2022	31DEC9999	Y	Stabilisation of soft tissue of distal radioulnar joint, with or without ligament or tendon grafting, including either or both of the following (if performed): (a) graft harvest; (b) triangular fibrocartilage complex repair or reconstruction (H)
49239	01JUL2021	29FEB2024	N	Excision of pisiform or hook of hamate, including release of ulnar nerve (if performed) (H)
49239	01MAR2024	31DEC9999	Y	Excision of pisiform or hook of hamate or sesamoid bone of hand, including release of ulnar nerve (if performed) (H)
49300	01DEC1991	30JUN2021	N	SACROILIAC JOINT arthrodesis of
49300	01JUL2021	31DEC9999	Y	Sacro-iliac joint-arthrodesis of (H)
49303	01DEC1991	31OCT2016	N	HIP, arthrotomy of, including lavage, drainage or biopsy when performed
49303	01NOV2016	30JUN2021	N	Hip, arthrotomy of, including lavage, drainage or biopsy when performed, other than a service associated with surgery for femoroacetabular impingement (H)
49303	01JUL2021	31DEC9999	Y	Arthrotomy of hip, by open procedure, including any of the following (if performed): (a) lavage; (b) drainage; (c) biopsy (H)
49306	01DEC1991	30APR2009	N	HIP arthrodesis of
49306	01MAY2009	30JUN2021	N	HIP arthrodesis of, with synovectomy if performed
49306	01JUL2021	31DEC9999	Y	Hip, arthrodesis of, with synovectomy if performed (H)
49309	01DEC1991	30JUN2021	N	HIP, arthrectomy or excision arthroplasty of, including removal of prosthesis (Austin Moore or similar (non cement ))
49309	01JUL2021	31DEC9999	Y	Arthrectomy or excision arthroplasty (Girdlestone) of hip, other than a service performed: (a) for the purpose of implant removal; or (b) as stage 1 of a 2-stage procedure (H)
49312	01DEC1991	31DEC9999	Y	HIP, arthrectomy or excision arthroplasty of, including removal of prosthesis (cemented, porous coated or similar)
49315	01DEC1991	30JUN2021	N	HIP, arthroplasty of, unipolar or bipolar
49315	01JUL2021	31DEC9999	Y	Hip, arthroplasty of, unipolar or bipolar (H)
49318	01DEC1991	30JUN2021	N	HIP, total replacement arthroplasty of, including minor bone grafting
49318	01JUL2021	31DEC9999	Y	Total arthroplasty of hip, including minor bone grafting (if performed), other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49319	01NOV1996	30JUN2021	N	HIP, total replacement arthroplasty of, including associated minor grafting, if performed - bilateral
49319	01JUL2021	31DEC9999	Y	Bilateral total arthroplasty of hip, including minor bone grafting (if performed), other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49321	01DEC1991	30JUN2021	N	HIP, total replacement arthroplasty of, including major bone grafting, including obtaining of graft
49321	01JUL2021	29FEB2024	N	Total arthroplasty of hip, with internal fixation, including either or both of the following (if performed): (a) structural bone graft; (b) insertion of synthetic substitutes or metal augments; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49321	01MAR2024	31DEC9999	Y	Complex primary arthroplasty of hip, with internal fixation, including either or both of the following (if performed): (a) structural bone graft; (b) insertion of synthetic substitutes or metal augments; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49324	01DEC1991	31DEC9999	Y	HIP, total replacement arthroplasty of, revision procedure including removal of prosthesis
49327	01DEC1991	31DEC9999	Y	HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to acetabulum, including obtaining of graft
49330	01DEC1991	31DEC9999	Y	HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to femur, including obtaining of graft
49333	01DEC1991	31DEC9999	Y	HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to both acetabulum and femur, including obtaining of graft
49336	01DEC1991	31DEC9999	Y	HIP, treatment of a fracture of the femur where revision total hip replacement is required as part of the treatment of the fracture (not including intra-operative fracture), being a service associated with a service to which items 49324 to 49333 apply
49339	01DEC1991	31DEC9999	Y	HIP, revision total replacement of, requiring anatomic specific allograft of proximal femur greater than 5 cm in length
49342	01DEC1991	31DEC9999	Y	HIP, revision total replacement of, requiring anatomic specific allograft of acetabulum
49345	01DEC1991	31DEC9999	Y	HIP, revision total replacement of, requiring anatomic specific allograft of both femur and acetabulum
49346	01MAY1994	31DEC9999	Y	HIP, revision arthroplasty with replacement of acetabular liner or ceramic head, not requiring removal of femoral component or acetabular shell
49348	01DEC1991	30JUN1993	N	HIP, congenital dislocation of, manipulation of, with application of cast (excluding aftercare)
49348	01JUL1993	31DEC9999	Y	HIP, congenital dislocation of, treatment of, by closed reduction
49351	01DEC1991	31DEC9999	Y	HIP, congenital dislocation of, treatment of, involving supervision of splint, harness or cast - each attendance
49354	01DEC1991	31DEC9999	Y	HIP, congenital dislocation of, open reduction of
49357	01JUL1993	31DEC9999	Y	HIP SPICA, initial application of, for congenital dislocation of hip (excluding aftercare)
49360	01MAY1994	30APR2009	N	HIP, diagnostic arthroscopy of
49360	01MAY2009	30JUN2021	N	HIP, diagnostic arthroscopy of, not being a service associated with any other arthroscopic procedure of the hip
49360	01JUL2021	31DEC9999	Y	Diagnostic arthroscopy of hip, other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing a procedure of the hip joint by arthroscopic means (H)
49363	01MAY1994	30APR2009	N	HIP, diagnostic arthroscopy of, with synovial biopsy
49363	01MAY2009	30JUN2021	N	HIP, diagnostic arthroscopy of, with synovial biopsy, not being a service associated with any other arthroscopic procedure of the hip
49363	01JUL2021	29FEB2024	N	Treatment of hip, by arthroscopic means, with synovial biopsy, including any procedures to treat bone or soft tissue in the same area (if performed), other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing: (a) a procedure of the hip joint by arthroscopic means; or (b) surgery for femoroacetabular impingement (H)
49363	01MAR2024	31DEC9999	Y	Diagnostic arthroscopy of hip, with synovial biopsy, other than a service associated with a service to which another item in this Schedule applies that is performed on the hip joint by arthroscopic means (H)
49366	01MAY1994	30APR2009	N	HIP, arthroscopic surgery of
49366	01MAY2009	31OCT2016	N	HIP, arthroscopic surgery of, not being a service associated with any other arthroscopic procedure of the hip
49366	01NOV2016	30JUN2021	N	Hip, arthroscopic surgery of, other than a service associated with another arthroscopic procedure of the hip, or a service associated with surgery for femoroacetabular impingement (H)
49366	01JUL2021	31DEC9999	Y	Treatment of hip, by arthroscopic means, including any procedures to treat bone or soft tissue in the same area (if performed), other than a service associated with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing: (a) a procedure of the hip joint by arthroscopic means; or (b) surgery for femoroacetabular impingement (H)
49369	01MAY1994	31DEC9999	Y	Historical item included for item mapping purposes
49372	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with exchange of head or liner (or both) (H)
49374	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with exchange of head and acetabular shell or cup, including minor bone grafting (if performed) (H)
49376	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with exchange of head and acetabular shell or cup, including major bone grafting (if performed) (H)
49378	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with revision of femoral component (if there is no requirement for femoral osteotomy), including minor bone grafting (if performed) (H)
49380	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with revision of femoral and acetabular components (if femoral osteotomy is not required), including minor bone grafting (if performed) (H)
49382	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with revision of femoral and acetabular components (if femoral osteotomy is not required), including major bone grafting (H)
49384	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, for pelvic discontinuity, with revision of acetabular component (H)
49386	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, with revision of femoral component with femoral osteotomy, including minor bone grafting (if performed) (H)
49388	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) revision of both of the following: (i) femoral component with femoral osteotomy; (ii) acetabular component; and (b) minor bone grafting (if performed) (H)
49390	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) revision of both of the following: (i) femoral component with femoral osteotomy; (ii) acetabular component; and (b) major bone grafting (H)
49392	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) either: (i) revision of femoral component with femoral osteotomy; or (ii) proximal femoral replacement; and (b) revision of acetabular component for pelvic discontinuity (H)
49394	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) replacement of proximal femur; and (b) revision of the acetabular component; and (c) bone grafting (if performed) (H)
49396	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) removal of prosthesis as stage 1 of a 2-stage revision arthroplasty or as a definitive stage procedure; and (b) insertion of temporary prosthesis (if performed) (H)
49398	01JUL2021	31DEC9999	Y	Revision arthroplasty of hip, including: (a) revision of femoral component for periprosthetic fracture; and (b) internal fixation; and (c) bone grafting (if performed) (H)
49500	01DEC1991	30JUN2021	N	KNEE, arthrotomy of, involving 1 or more of; capsular release, biopsy or lavage, or removal of loose body or foreign body
49500	01JUL2021	31DEC9999	Y	Knee, arthrotomy of, involving one or more of capsular release, biopsy or lavage, or removal of loose body or foreign body (H)
49503	01DEC1991	30JUN1993	N	KNEE, meniscectomy of, repair of collateral ligament, patellectomy of, chondroplasty of, osteoplasty of, or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 1 procedure
49503	01JUL1993	31OCT2006	N	KNEE, meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patello-femoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 1 procedure
49503	01NOV2006	30JUN2008	N	KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Groups applies) - any 1 procedure
49503	01JUL2008	30JUN2021	N	KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon (not being a service to which another item in this Group applies) - any 1 procedure
49503	01JUL2021	31DEC9999	Y	Arthrotomy of knee, including one of the following: (a) meniscal surgery; (b) repair of collateral or cruciate ligament; (c) patellectomy; (d) single transfer of ligament or tendon; (e) repair or replacement of chondral or osteochondral surface (excluding prosthetic replacement); other than a service associated with a service to which another item in this Group applies (H)
49506	01DEC1991	30JUN1993	N	KNEE, meniscectomy of, repair of collateral ligament, patellectomy of, chondroplasty of, osteoplasty of, or single transfer of ligament or tendon or any other procedure (not being a service to which another item in this Group applies) - any 2 or more procedures
49506	01JUL1993	31OCT2006	N	KNEE, meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patello-femoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 2 or more procedures
49506	01NOV2006	30JUN2008	N	KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Groups applies) - any 2 or more procedures (Anaes.) (Assist.)
49506	01JUL2008	30JUN2021	N	KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon (not being a service to which another item in this Group applies) - any 2 or more procedures
49506	01JUL2021	31DEC9999	Y	Arthrotomy of knee, including 2 or more of the following: (a) meniscal surgery; (b) repair of collateral or cruciate ligament; (c) patellectomy; (d) single transfer of ligament or tendon; (e) repair or replacement of chondral or osteochondral surface (excluding prosthetic replacement); other than a service associated with a service to which another item in this Group applies (H)
49509	01DEC1991	30JUN1993	N	KNEE, total synovectomy of, arthrodesis of, patello-femoral stabilisation or repair of cruciate ligament - any 1 procedure
49509	01JUL1993	30APR2009	N	KNEE, total synovectomy or arthrodesis of
49509	01MAY2009	30JUN2021	N	KNEE, total synovectomy or arthrodesis with synovectomy if performed
49509	01JUL2021	31DEC9999	Y	Total synovectomy of knee, by open procedure, other than a service performed in association with a service to which another item in this Schedule applies if the service described in the other item is for the purpose of performing an arthroplasty (H)
49512	01DEC1991	30APR2009	N	KNEE, arthrodesis of, with removal of prosthesis
49512	01MAY2009	30JUN2021	N	KNEE, arthrodesis of, with synovectomy if performed, with removal of prosthesis
49512	01JUL2021	31DEC9999	Y	Primary or revision arthrodesis of knee, including arthrodesis (H)
49515	01DEC1991	30JUN2021	N	KNEE, removal of prosthesis, cemented or uncemented, including associated cement, as the first stage of a 2 stage procedure
49515	01JUL2021	31DEC9999	Y	Removal of cemented or uncemented knee prosthesis, performed as the first stage of a 2-stage procedure; including: (a) removal of associated cement; and (b) insertion of spacer (if required) (H)
49516	01JUL2021	31DEC9999	Y	Bilateral unicompartmental arthroplasty of femur and proximal tibia of knee (H)
49517	01JUL1993	30JUN2021	N	KNEE, hemiarthroplasty of
49517	01JUL2021	31DEC9999	Y	Unicompartmental arthroplasty of femur and proximal tibia of knee (H)
49518	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of
49518	01JUL2021	29FEB2024	N	Total replacement arthroplasty of knee, including either or both of the following (if performed): (a) revision of patello-femoral joint replacement to total knee replacement; (b) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49518	01MAR2024	31DEC9999	Y	Total arthroplasty of knee, including either or both of the following (if performed): (a) revision of patello-femoral joint replacement to total knee replacement; (b) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49519	01NOV1996	30JUN2021	N	KNEE, total replacement arthroplasty of, including associated minor grafting, if performed - bilateral
49519	01JUL2021	29FEB2024	N	Bilateral total replacement arthroplasty of knee, including patellar resurfacing, other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49519	01MAR2024	31DEC9999	Y	Bilateral total arthroplasty of knee, including patellar resurfacing, other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49521	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of, requiring major bone grafting to femur or tibia, including obtaining of graft
49521	01JUL2021	29FEB2024	N	Complex primary arthroplasty of knee, with revision of components to femur or tibia, including either or both of the following (if performed): (a) ligament reconstruction; (b) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49521	01MAR2024	31DEC9999	Y	Complex primary arthroplasty of knee, using revision femoral or tibial components, including either or both of the following (if performed): (a) ligament reconstruction; (b) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49524	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of, requiring major bone grafting to femur and tibia, including obtaining of graft
49524	01JUL2021	29FEB2024	N	Complex primary arthroplasty of knee, with revision of components to femur and tibia, including either or both of the following (if performed): (a) ligament reconstruction; (b) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49524	01MAR2024	31DEC9999	Y	Complex primary arthroplasty of knee: (a) using revision femoral and tibial components; or (b) using revision femoral or tibial components including anatomic specific allograft of femur or tibia; including either or both of the following (if performed): (c) ligament reconstruction; (d) patellar resurfacing; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49525	01JUL2021	31DEC9999	Y	Revision of uni-compartmental arthroplasty of the knee, with femoral or tibial components (or both) with uni-compartmental implants, other than a service associated with a service to which: (a) item 48245, 48248, 48251, 48254 or 48257 applies; or (b) another item in this Group applies if the service described in the other item is for the purpose of performing surgery on a knee (H)
49527	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of, revision procedure, including removal of prosthesis
49527	01JUL2021	29FEB2024	N	Minor revision of total or partial replacement of knee, including either or both of the following: (a) exchange of polyethylene component (including uni); (b) insertion of patellar component; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49527	01MAR2024	31DEC9999	Y	Minor revision of total or partial arthroplasty of knee, including either or both of the following: (a) exchange of polyethylene component (including uni); (b) insertion of patellar component; other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49530	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of, revision procedure, requiring bone grafting to femur or tibia, including obtaining of graft and including removal of prosthesis
49530	01JUL2021	29FEB2024	N	Revision of total or partial replacement of knee, with exchange of femoral or tibial component: (a) excluding revision of unicompartmental with unicompartmental implants; and (b) including patellar resurfacing (if performed); other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49530	01MAR2024	31DEC9999	Y	Revision of total or partial arthroplasty of knee, with exchange of femoral or tibial component: (a) excluding revision of unicompartmental with unicompartmental implants; and (b) including patellar resurfacing (if performed); other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49533	01DEC1991	30JUN2021	N	KNEE, total replacement arthroplasty of, revision procedure, requiring bone grafting to both femur and tibia, including obtaining of graft and including removal of prosthesis
49533	01JUL2021	29FEB2024	N	Revision of total or partial replacement of knee, with exchange of femoral and tibial components, excluding revision of unicompartmental with unicompartmental implants, including patellar resurfacing (if performed), other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49533	01MAR2024	31DEC9999	Y	Revision of total or partial arthroplasty of knee, with exchange of femoral and tibial components, excluding revision of unicompartmental with unicompartmental implants, including patellar resurfacing (if performed), other than a service associated with a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49534	01NOV1996	30JUN2021	N	KNEE, patello-femoral joint of, total replacement arthroplasty as a primary procedure
49534	01JUL2021	29FEB2024	N	Replacement of patella and trochlea of patello-femoral joint of knee, performed as a primary procedure (H)
49534	01MAR2024	31DEC9999	Y	Arthroplasty of patella and trochlea of patello-femoral joint of knee, performed as a primary procedure (H)
49536	01DEC1991	31OCT1996	N	KNEE, repair or reconstruction of, for chronic instability involving either cruciate or collateral ligaments
49536	01NOV1996	30APR2009	N	KNEE, repair or reconstruction of, for chronic instability (open or arthroscopic, or both) involving either cruciate or collateral ligaments, including notchplasty when performed
49536	01MAY2009	30JUN2021	N	KNEE, repair or reconstruction of, for chronic instability (open or arthroscopic, or both) involving either cruciate or collateral ligaments, including notchplasty when performed, not being a service associated with any other arthroscopic procedure of the knee
49536	01JUL2021	31DEC9999	Y	Either: (a) repair of cruciate ligaments of knee; or (b) repair or reconstruction of collateral ligaments of knee; by open or arthroscopic means, including either or both of the following (if performed): (c) graft harvest; (d) intraarticular knee surgery; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49539	01DEC1991	31OCT1996	N	KNEE, reconstructive surgery of cruciate ligaments (open or arthroscopic, or both), including surgery to other internal derangements, not being a service to which another item in this Group applies
49539	01NOV1996	31OCT2006	N	KNEE, reconstructive surgery of cruciate ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies
49539	01NOV2006	30APR2009	N	KNEE, reconstructive surgery of cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies
49539	01MAY2009	31DEC9999	Y	KNEE, reconstructive surgery of cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies or a service associated with any other arthroscopic procedure of the knee
49542	01DEC1991	31OCT1996	N	KNEE, reconstructive surgery to cruciate ligaments (open or arthroscopic, or both), including meniscus repair, extracapsular procedure and debridement when performed
49542	01NOV1996	31OCT2006	N	KNEE, reconstructive surgery to cruciate ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed
49542	01NOV2006	30APR2009	N	KNEE, reconstructive surgery to cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed
49542	01MAY2009	30JUN2021	N	KNEE, reconstructive surgery to cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed, not being a service associated with any other arthroscopic procedure of the knee
49542	01JUL2021	31DEC9999	Y	Reconstruction of anterior or posterior cruciate ligament of knee, by open or arthroscopic means, including any of the following (if performed): (a) graft harvest; (b) donor site repair; (c) meniscal repair; (d) collateral ligament repair; (e) extra-articular tenodesis; (f) any other associated intra-articular surgery; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49544	01JUL2021	31DEC9999	Y	Reconstruction of 2 or more cruciate or collateral ligaments of knee, by open or arthroscopic means, including any of the following (if performed): (a) ligament repair; (b) graft harvest donor site repair; (c) meniscal repair; (d) any other associated intra-articular surgery; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49545	01DEC1991	30APR2009	N	KNEE, revision arthrodesis of
49545	01MAY2009	31DEC9999	Y	KNEE, revision arthrodesis of, with synovectomy if performed
49548	01DEC1991	30JUN2021	N	KNEE, revision of patello-femoral stabilisation
49548	01JUL2021	31DEC9999	Y	Knee, revision of patello-femoral stabilisation (H)
49551	01DEC1991	30JUN2021	N	KNEE, revision of procedures to which item 49536, 49539 or 49542 applies
49551	01JUL2021	31DEC9999	Y	Knee, revision of procedures to which item 49536 or 49542 applies (H)
49554	01DEC1991	30JUN2021	N	KNEE, revision of total replacement of, by anatomic specific allograft of tibia or femur
49554	01JUL2021	31DEC9999	Y	Revision of total replacement of knee, by anatomic specific allograft of tibia or femur, other than a service to which item 48245, 48248, 48251, 48254 or 48257 applies (H)
49557	01DEC1991	31OCT2011	N	KNEE, diagnostic arthroscopy of (including biopsy, simple trimming of meniscal margin or plica) - not being a service associated with any other arthroscopic procedure of the knee region
49557	01NOV2011	31DEC9999	Y	KNEE, diagnostic arthroscopy of (including biopsy, simple trimming of meniscal margin or plica) - not being a service associated with autologous chondrocyte implantation or matrix-induced autologous chondrocyte implantation or any other arthroscopic procedure of the knee region
49558	01NOV1996	31DEC9999	Y	KNEE, arthroscopic surgery of, involving 1 or more of: debridement, osteoplasty or chondroplasty - not associated with any other arthroscopic procedure of the knee region
49559	01NOV1996	31DEC9999	Y	KNEE, arthroscopic surgery of, involving chondroplasty requiring multiple drilling or carbon fibre (or similar) implant; including any associated debridement or oestoplasty - not associated with any other arthroscopic procedure of the knee region
49560	01DEC1991	31OCT1996	N	KNEE, arthroscopic surgery of, involving any 1 or more of: meniscectomy, removal of loose body, lateral release, or chondroplasty - not being a service associated with any other arthroscopic procedure of the knee region
49560	01NOV1996	31OCT2006	N	KNEE, arthroscopic surgery of, involving 1 or more of: meniscectomy, removal of loose body or lateral release - not being a service associated with any other arthroscopic procedure of the knee region
49560	01NOV2006	31DEC9999	Y	KNEE, arthroscopic surgery of, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release - not being a service associated with any other arthroscopic procedure of the knee region
49561	01NOV1996	31OCT2006	N	KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: meniscectomy, removal of loose body or lateral release; where the procedure includes associated debridement, osteoplasty or chrondoplasty - not associated with any other arthroscopic procedure of the knee region
49561	01NOV2006	31DEC9999	Y	KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release; where the procedure includes associated debridement, osteoplasty or chondroplasty - not associated with any other arthroscopic procedure of the knee region
49562	01NOV1996	31OCT2006	N	KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: meniscectomy, removal of loose body or lateral release; where the procedure includes chondroplasty requiring multiple drilling or carbon fibre (or similar) implant and associated debridement or osteoplasty - not associated with any other arthroscopic procedure of the knee region
49562	01NOV2006	31DEC9999	Y	KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release; where the procedure includes chondroplasty requiring multiple drilling or carbon fibre (or similar) implant and associated debridement or osteoplasty - not associated with any other arthroscopic procedure of the knee region
49563	01DEC1991	31OCT1996	N	KNEE, arthroscopic surgery of, involving meniscus repair or osteoplasty, or both
49563	01NOV1996	31OCT2011	N	KNEE, arthroscopic surgery of, involving 1 or more of: meniscus repair; osteochondral graft; or chondral graft - not associated with any other arthroscopic procedure of the knee region
49563	01NOV2011	31DEC9999	Y	KNEE, arthroscopic surgery of, involving 1 or more of: meniscus repair; osteochondral graft; or chondral graft (excluding autologous chondrocyte implantation or matrix-induced autologous chondrocyte implantation) -not associated with any other arthroscopic procedure of the knee region
49564	01MAY2000	30APR2009	N	KNEE, patello-femoral stabilisation of, combined arthroscopic and open procedure, including lateral release, medial capsulorrhaphy and tendon transfer
49564	01MAY2009	30JUN2021	N	KNEE, patello-femoral stabilisation of, combined arthroscopic and open procedure, including lateral release, medial capsulorrhaphy and tendon transfer, not being a service associated with any other arthroscopic procedure of the knee
49564	01JUL2021	30JUN2024	N	Stabilisation of patellofemoral joint of knee, by combined open and arthroscopic means, including either or both of the following (if performed): (a) medial soft tissue reconstruction and tendon transfer; (b) tibial tuberosity transfer with bone graft and internal fixation; other than a service associated a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49564	01JUL2024	31DEC9999	Y	Stabilisation of patellofemoral joint of knee, by combined open and arthroscopic means, including either or both of the following (if performed): (a) medial soft tissue reconstruction and tendon transfer; (b) tibial tuberosity transfer with bone graft and internal fixation; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49565	01JUL2021	30JUN2024	N	Reconstruction of patellofemoral joint of knee, by combined open and arthroscopic means, including: (a) both of the following: (i) medial soft tissue reconstruction; (ii) tibial tuberosity transfer; and (b) any of the following (if performed): (i) bone graft; (ii) internal fixation; (iii) trochleoplasty; other than a service associated a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49565	01JUL2024	31DEC9999	Y	Reconstruction of patellofemoral joint of knee, by combined open and arthroscopic means, including: (a) both of the following: (i) medial soft tissue reconstruction; (ii) tibial tuberosity transfer; and (b) any of the following (if performed): (i) bone graft; (ii) internal fixation; (iii) trochleoplasty; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the knee by arthroscopic means (H)
49566	01DEC1991	30APR2009	N	KNEE, arthroscopic total synovectomy of
49566	01MAY2009	31DEC9999	Y	KNEE, arthroscopic total synovectomy of, not being a service associated with any other arthroscopic procedure of the knee
49569	01MAY1994	30JUN2021	N	KNEE, mobilisation for post-traumatic stiffness, by multiple muscle or tendon release (quadricepsplasty)
49569	01JUL2021	31DEC9999	Y	Knee, mobilisation for post-traumatic stiffness, by multiple muscle or tendon release (quadricepsplasty) (H)
49570	01JUL2021	31DEC9999	Y	Diagnosis of knee, by arthroscopic means, when the pre-procedure diagnosis is undetermined, including either or both of the following (if performed): (a) biopsy; (b) lavage (H)
49572	01JUL2021	31DEC9999	Y	Partial meniscectomy of knee, by arthroscopic means, for atraumatic meniscus tear, other than a service to which another item of this Schedule applies if the service described in the other item is for the purpose of treating osteoarthritis (H)
49574	01JUL2021	31DEC9999	Y	Removal of loose bodies of knee, by arthroscopic means-one or more bodies (H)
49576	01JUL2021	31DEC9999	Y	Repair of chondral lesion of knee, by arthroscopic means, including either or both of the following (if performed): (a) microfracture; (b) microdrilling; other than a service performed in combination with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing chondral or osteochondral grafts (H)
49578	01JUL2021	31DEC9999	Y	Release of soft tissue, lateral release or osteoplasty of knee, by arthroscopic means, other than a service performed in combination with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of stabilising the patellofemoral joint of the knee (H)
49580	01JUL2021	31DEC9999	Y	Partial meniscectomy of knee, by arthroscopic means, for traumatic meniscus tear (H)
49582	01JUL2021	31DEC9999	Y	Meniscal repair of knee, by arthroscopic means (H)
49584	01JUL2021	31DEC9999	Y	Chondral, osteochondral or meniscal graft of knee, by arthroscopic means (H)
49586	01JUL2021	31DEC9999	Y	Synovectomy of knee, by arthroscopic means, for neoplasia or inflammatory arthropathy, other than a service to which another item of this Schedule applies if the service described in the other item is for the purpose of treating uncomplicated osteoarthritis
49590	01JUL2021	31DEC9999	Y	Excision of ganglion, cyst or bursa of knee, by open or arthroscopic means, performed as an independent procedure, other than a service associated with a service to which another item in this Group applies
49592	01MAR2024	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the hip, including pelvis and proximal femur (H)
49594	01MAR2024	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the knee, including distal femur, proximal fibula and proximal tibia (H)
49596	01MAR2024	31DEC9999	Y	Excision of heterotopic ossification, myositis ossificans or post-traumatic ossification in the lower leg, other than a service to which item 49594 applies (H)
49700	01DEC1991	31DEC9999	Y	ANKLE, diagnostic arthroscopy of, including biopsy
49703	01DEC1991	30APR2009	N	ANKLE, arthroscopic surgery of
49703	01MAY2009	30JUN2021	N	ANKLE, arthroscopic surgery of, not being a service associated with any other arthroscopic procedure of the ankle
49703	01JUL2021	31DEC9999	Y	Surgery of ankle joint, by arthroscopic means, including any of the following (if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) excision of joint osteophytes; other than a service associated with a service to which another item in this Group applies if the service described in the other item is for the purpose of performing a procedure on the ankle by arthroscopic means (H)
49706	01DEC1991	30JUN2021	N	ANKLE, arthrotomy of, involving 1 or more of: lavage, removal of loose body or division of contracture
49706	01JUL2021	30JUN2023	N	Arthrotomy of joint of ankle, for infection, including removal of loose bodies and joint debridement, including release of joint contracture (if performed) (H)
49706	01JUL2023	31DEC9999	Y	Arthrotomy of joint of ankle, including removal of loose bodies and joint debridement, including release of joint contracture (if performed) (H)
49709	01DEC1991	30JUN2021	N	ANKLE, ligamentous stabilisation of
49709	01JUL2021	31DEC9999	Y	Stabilisation of ligament of ankle or subtalar joint (or both), including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) joint debridement; -one ligament complex, each incision (H)
49712	01DEC1991	30APR2009	N	ANKLE, arthrodesis of
49712	01MAY2009	30JUN2021	N	ANKLE, arthrodesis of, with synovectomy if performed
49712	01JUL2021	31DEC9999	Y	Arthrodesis of ankle, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint (H)
49715	01DEC1991	30JUN2021	N	ANKLE, total joint replacement of
49715	01JUL2021	31DEC9999	Y	Total replacement of ankle, with prosthetic replacement of ankle joint, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint (H)
49716	01NOV2006	30JUN2021	N	ANKLE, total replacement arthroplasty of, revision procedure, including removal of prosthesis
49716	01JUL2021	29FEB2024	N	Revision of total ankle replacement: (a) including either: (i) exchange of tibial or talar components (or both) and plastic inserts; or (ii) removal of tibial or talar components (or both) and plastic inserts; and (b) including any of the following (if performed): (i) insertion of cement spacer for infection; (ii) capsulotomy; (iii) joint release; (iv) neurolysis; (v) debridement of cysts; (vi) synovectomy; (vii) joint debridement other than a service associated with a service to which 30023 applies. (H)
49716	01MAR2024	31DEC9999	Y	Revision of total ankle replacement: (a) including either: (i) exchange of tibial or talar components (or both) or plastic inserts; or (ii) removal of tibial or talar components (or both) and plastic inserts; and (b) including any of the following (if performed): (i) insertion of cement spacer for infection; (ii) capsulotomy; (iii) joint release; (iv) neurolysis; (v) debridement of cysts; (vi) synovectomy; (vii) joint debridement other than a service associated with a service to which item 30023 applies (H)
49717	01NOV2006	30JUN2021	N	ANKLE, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis
49717	01JUL2021	29FEB2024	N	Revision of total ankle replacement: (a) including either: (i) exchange of tibial and talar components; or (ii) removal of tibial and talar components and conversion to ankle arthrodesis; and (b) including both of the following (iii) internal or external fixation, by any means; (iv) major bone grafting; and (c) including any of the following (if performed): (i) capsulotomy; (ii) joint release; (iii) neurolysis; (iv) debridement and extensive grafting of cysts; (v) synovectomy; (vi) joint debridement; other than a service associated with a service to which item 30023, 48245, 48248, 48251, 48254 or 48257 applies (H)
49717	01MAR2024	31DEC9999	Y	Revision of total ankle replacement: (a) including either: (i) exchange of tibial and talar components; or (ii) removal of tibial and talar components and conversion to ankle arthrodesis; and (b) including both of the following (iii) internal or external fixation, by any means; (iv) major bone grafting; and (c) including any of the following (if performed): (i) capsulotomy; (ii) joint release; (iii) neurolysis; (iv) debridement and extensive grafting of cysts; (v) synovectomy; (vi) joint debridement; other than a service associated with a service to which item 30023, 48245, 48248, 48251, 48254 or 48257 applies that is performed at the same site (H)
49718	01DEC1991	30JUN2021	N	ANKLE, Achilles' tendon or other major tendon, repair of
49718	01JUL2021	31DEC9999	Y	Primary repair of major tendon of ankle, by any method, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy -one tendon (H)
49721	01DEC1991	31DEC9999	Y	ANKLE, Achilles' tendon rupture managed by non-operative treatment
49724	01DEC1991	30JUN2021	N	ANKLE, Achilles' tendon, secondary repair or reconstruction of
49724	01JUL2021	31DEC9999	Y	Reconstruction of major tendon of ankle, by any method, including any of the following (if performed): (a) synovial biopsy; (b) synovectomy; (c) adjacent tendon transfer; (d) turn down flaps; other than a service associated with a service to which item 49718 applies (H)
49727	01DEC1991	30JUN2021	N	ANKLE, Achilles' tendon, operation for lengthening
49727	01JUL2021	31DEC9999	Y	Lengthening of major tendon of ankle, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy (H)
49728	01NOV2006	30JUN2021	N	ANKLE, lengthening of the gastrocnemius aponeurosis and soleus fascia, for the correction of equinus deformity in children with cerebral palsy
49728	01JUL2021	31DEC9999	Y	Lengthening of Achilles tendon, by any method, with gastro-soleus lengthening for the correction of equinous deformity, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy; other than a service associated with a service to which item 49727 applies (H)
49730	01JUL2021	06AUG2021	N	Surgery of joint of hindfoot (other than ankle or first metatarsophalangeal joint), by arthroscopic means, including any of the following (if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) excision of joint osteophytes; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the ankle by arthroscopic means-one joint (H)
49730	07AUG2021	31DEC9999	Y	Surgery of joint of hindfoot (other than ankle) or first metatarsophalangeal joint, by arthroscopic means, including any of the following (if performed): (a) cartilage treatment; (b) removal of loose bodies; (c) synovectomy; (d) excision of joint osteophytes; other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of performing a procedure on the ankle by arthroscopic means-one joint (H)
49732	01JUL2021	31DEC9999	Y	Endoscopy of large tendons of foot, including any of the following (if performed): (a) debridement of tendon and sheath; (b) removal of loose bodies; (c) synovectomy; (d) excision of tendon impingement; other than a service associated with a service to which item 49718 or 49724 applies (H)
49734	01JUL2021	31OCT2022	N	Arthrotomy of hindfoot, midfoot or metatarsophalangeal joint, for infection, including: (a) removal of loose bodies; and (b) either or both of the following: (i) joint debridement; (ii) release of joint contracture; -each incision (H)
49734	01NOV2022	31DEC9999	Y	Arthrotomy of hindfoot, midfoot or metatarsophalangeal joint, including: (a) removal of loose bodies; and (b) either or both of the following: (i) joint debridement; (ii) release of joint contracture; -each incision (H)
49736	01JUL2021	31DEC9999	Y	Transfer of major tendon of foot and ankle, including: (a) split or whole transfer to contralateral side of foot; and (b) passage of posterior or anterior tendon to, or through, interosseous membrane; and (c) any of the following (if performed): (i) synovial biopsy; (ii) synovectomy; (iii) tendon lengthening; (iv) insetting of tendon (H)
49738	01JUL2021	31DEC9999	Y	Stabilisation of ligament of talonavicular or metatarsophalangeal joint, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement (H)
49740	01JUL2021	29FEB2024	N	Revision of arthrodesis of ankle, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which 30023 applies (H)
49740	01MAR2024	31DEC9999	Y	Revision of arthrodesis of ankle, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which item 30023 applies that is performed at the same site (H)
49742	01JUL2021	31DEC9999	Y	Arthrodesis of extended ankle and hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint (H)
49744	01JUL2021	29FEB2024	N	Revision of arthrodesis of extended ankle and hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which 30023 applies (H)
49744	01MAR2024	31DEC9999	Y	Revision of arthrodesis of extended ankle and hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which item 30023 applies that is performed at the same site (H)
49760	01JUL2021	31DEC9999	Y	Arthroereisis of subtalar joint, including any of the following (if performed): (a) capsulotomy; (b) synovectomy; (c) joint debridement (H)
49761	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsal, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -one metatarsal (H)
49762	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -2 metatarsals (H)
49763	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -3 metatarsals (H)
49764	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -4 metatarsals (H)
49765	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -5 metatarsals (H)
49766	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -6 metatarsals (H)
49767	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -7 metatarsals (H)
49768	01JUL2021	31DEC9999	Y	Stabilisation of metatarsophalangeal joint at metatarsals, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) osteotomy, with or without fixation; (e) local tendon transfer; (f) local tendon lengthening or release; (g) ligament repair; (h) joint debridement; -8 metatarsals (H)
49769	01JUL2021	31DEC9999	Y	Unilateral correction of hallux valgus or varus deformity, by osteotomy of first metatarsal and proximal phalanx of first toe, with internal fixation of both bones, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49770	01JUL2021	31DEC9999	Y	Bilateral correction of hallux valgus or varus deformity, by osteotomy of first metatarsal and proximal phalanx of first toe, with internal fixation of both bones, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49771	01JUL2021	29FEB2024	N	Synovectomy of major tendon of ankle, for extensive synovitis by any method, including any of the following (if performed): (a) tenolysis; (b) debridement of ligament or tendon (or both); (c) release of ligament or tendon (or both); (d) excision of tubercule or osteophyte; (e) reconstruction of tendon retinaculum; (f) neurolysis; other than a service associated with a service to which item 30023 applies-each incision (H)
49771	01MAR2024	31DEC9999	Y	Synovectomy of major tendon of ankle, for extensive synovitis by any method, including any of the following (if performed): (a) tenolysis; (b) debridement of ligament or tendon (or both); (c) release of ligament or tendon (or both); (d) excision of tubercule or osteophyte; (e) reconstruction of tendon retinaculum; (f) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-each incision (H)
49772	01JUL2021	31DEC9999	Y	Excision of rheumatoid nodules or gouty tophi, excluding aftercare, including any of the following (if performed): (a) capsulotomy; (b) debridement of ligament or tendon (or both); (c) release of ligament or tendon (or both); (d) excision of tubercle or osteophyte; -each incision (H)
49773	01JUL2021	29FEB2024	N	Revision of excision of intermetatarsal or digital neuroma, including any of the following (if performed): (a) release of tissues; (b) excision of bursae; (c) neurolysis; other than a service associated with a service to which item 30023 applies-one web space (H)
49773	01MAR2024	31DEC9999	Y	Revision of excision of intermetatarsal or digital neuroma, including any of the following (if performed): (a) release of tissues; (b) excision of bursae; (c) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one web space (H)
49774	01JUL2021	29FEB2024	N	Release of tarsal tunnel, including any of the following (if performed): (a) release of ligaments; (b) synovectomy; (c) neurolysis; other than a service associated with a service to which item 30023 applies-one foot (H)
49774	01MAR2024	31DEC9999	Y	Release of tarsal tunnel, including any of the following (if performed): (a) release of ligaments; (b) synovectomy; (c) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one foot (H)
49775	01JUL2021	29FEB2024	N	Revision of release of tarsal tunnel, including any of the following (if performed): (a) release of ligaments; (b) synovectomy; (c) neurolysis; other than a service associated with a service to which item 30023 applies-one foot (H)
49775	01MAR2024	31DEC9999	Y	Revision of release of tarsal tunnel, including any of the following (if performed): (a) release of ligaments; (b) synovectomy; (c) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one foot (H)
49776	01JUL2021	31OCT2021	N	Revision of arthrodesis of joint of hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which item 30023 applies (H)
49776	01NOV2021	29FEB2024	N	Revision of arthrodesis of joint of hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which item 30023 applies-may only be claimed once per joint (H)
49776	01MAR2024	31DEC9999	Y	Revision of arthrodesis of joint of hindfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; (e) removal of hardware; (f) neurolysis; (g) osteotomy of non-union or malunion; other than a service associated with a service to which item 30023 applies that is performed at the same site-may only be claimed once per joint (H)
49777	01JUL2021	31DEC9999	Y	Arthrodesis of joint of midfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint; -one joint (H)
49778	01JUL2021	31DEC9999	Y	Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints; -2 joints (H)
49779	01JUL2021	31DEC9999	Y	Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints; -3 joints (H)
49780	01JUL2021	31DEC9999	Y	Arthrodesis of joints of midfoot, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints; -4 joints (H)
49781	01JUL2021	31DEC9999	Y	Revision of arthrodesis of joint of midfoot, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of ostephytes at joint; (e) removal of hardware; (f) osteotomy of non-union or malunion; -one joint (H)
49782	01JUL2021	29FEB2024	N	Revision of total ankle replacement, including: (a) bone grafting of perioperative cysts to the tibia or talus (or both); and (b) retention of implants; and (c) any of the following (if performed): (i) capsulotomy; (ii) joint release; (iii) neurolysis; (iv) debridement and grafting of cysts; (v) synovectomy; (vi) joint debridement; other than a service associated with a service to which item 30023 applies (H)
49782	01MAR2024	31DEC9999	Y	Revision of total ankle replacement, including: (a) bone grafting of perioperative cysts to the tibia or talus (or both); and (b) retention of implants; and (c) any of the following (if performed): (i) capsulotomy; (ii) joint release; (iii) neurolysis; (iv) debridement and grafting of cysts; (v) synovectomy; (vi) joint debridement; other than a service associated with a service to which item 30023 applies that is performed at the same site (H)
49783	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -3 joints (H)
49784	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -4 joints (H)
49785	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -5 joints (H)
49786	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -6 joints (H)
49787	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -7 joints (H)
49788	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joints, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -8 joints (H)
49789	01JUL2021	31DEC9999	Y	Bilateral arthrodesis of first metatarsophalangeal joint, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint (H)
49790	01JUL2021	31DEC9999	Y	Revision of arthrodesis of first metatarsophalangeal joint, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of exostosis at joint; (e) removal of hardware; (f) osteotomy of non-union or malunion (H)
49791	01JUL2021	31DEC9999	Y	Arthrodesis of hallux interphalangeal or lesser metatarsophalangeal joint, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joint (H)
49792	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -one or 2 toes (H)
49793	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -3 toes (H)
49794	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -4 toes (H)
49795	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -5 toes (H)
49796	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -6 toes (H)
49797	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -7 toes (H)
49798	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal joint (or both) of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) joint release; (d) synovectomy; (e) removal of osteophytes at joints; -8 toes (H)
49800	01DEC1991	30JUN2021	N	FOOT, flexor or extensor tendon, primary repair of
49800	01JUL2021	31DEC9999	Y	Primary repair of flexor or extensor tendon of foot, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy; -one toe
49803	01DEC1991	30JUN2021	N	FOOT, flexor or extensor tendon, secondary repair of
49803	01JUL2021	31DEC9999	Y	Secondary repair of flexor or extensor tendon of foot, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy; -one toe
49806	01DEC1991	30JUN2021	N	FOOT, subcutaneous tenotomy of, 1 or more tendons
49806	01JUL2021	31DEC9999	Y	Subcutaneous tenotomy of foot, by small percutaneous incisions-one or more tendons
49809	01DEC1991	30JUN2021	N	FOOT, open tenotomy of, with or without tenoplasty
49809	01JUL2021	31DEC9999	Y	Open tenotomy or lengthening of foot, by open incision, with or without tenoplasty, including either or both of the following (if performed): (a) synovial biopsy; (b) synovectomy; -one toe
49812	01DEC1991	30JUN2021	N	FOOT, tendon or ligament transplantation of, not being a service to which another item in this Group applies
49812	01JUL2021	31DEC9999	Y	Advancement of tendon or ligament transfer of foot, including: (a) side to side transfer, harvesting and transfer for ligament or minor foot tendon reconstruction; and (b) either or both of the following (if performed): (i) synovial biopsy; (ii) synovectomy; -one major tendon or toe (H)
49814	01JUL2021	31DEC9999	Y	Reconstruction of major tendon of ankle, by any method, including: (a) osteotomy of hindfoot, with internal fixation; and (b) lengthening of major tendon of ankle; and (c) any of the following (if performed): (i) synovial biopsy; (ii) synovectomy; (iii) adjacent tendon transfer; (iv) turn down flaps; other than a service associated with a service to which item 49718 applies (H)
49815	01DEC1991	30APR2009	N	FOOT, triple arthrodesis of
49815	01MAY2009	30JUN2021	N	FOOT, triple arthrodesis of, with synovectomy if performed
49815	01JUL2021	31DEC9999	Y	Triple arthrodesis of hindfoot joints, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints (H)
49818	01DEC1991	30JUN2021	N	FOOT, excision of calcaneal spur
49818	01JUL2021	31DEC9999	Y	Release of plantar fascia, including excision of calcaneal spur (if performed) (H)
49821	01DEC1991	30JUN2021	N	FOOT, correction of hallux valgus or hallux rigidus by excision arthroplasty (Keller's or similar procedure) - unilateral
49821	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joint, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement -one joint (H)
49824	01DEC1991	30JUN2021	N	FOOT, correction of hallux valgus or hallux rigidus by excision arthroplasty (Keller's or similar procedure) - bilateral
49824	01JUL2021	31DEC9999	Y	Excisional or interpositional arthroplasty of metatarsophalangeal or tarsometatarsal joint, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) local tendon transfer; (e) joint debridement; -2 joints (H)
49827	01DEC1991	30APR2000	N	FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - unilateral
49827	01MAY2000	30JUN2021	N	FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - unilateral
49827	01JUL2021	31DEC9999	Y	Unilateral correction of hallux valgus or varus deformity of the foot, by local tendon transfer, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49830	01DEC1991	30APR2000	N	FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - bilateral
49830	01MAY2000	30JUN2021	N	FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - bilateral
49830	01JUL2021	31DEC9999	Y	Bilateral correction of hallux valgus or varus deformity of the foot, by local tendon transfer, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49833	01DEC1991	30JUN2011	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal including internal fixation where performed - unilateral
49833	01JUL2011	30JUN2021	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - unilateral
49833	01JUL2021	31OCT2021	N	Unilateral correction of hallus valgus or varus deformity of the foot, by osteotomy of first metatarsal, without internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49833	01NOV2021	31DEC9999	Y	Unilateral correction of hallux valgus or varus deformity of the foot, by osteotomy of first metatarsal, without internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49836	01DEC1991	30JUN2011	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal including internal fixation where performed - bilateral
49836	01JUL2011	30JUN2021	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - bilateral
49836	01JUL2021	31OCT2021	N	Bilateral correction of hallus valgus or varus deformity of the foot by osteotomy of first metatarsal, without internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49836	01NOV2021	31DEC9999	Y	Bilateral correction of hallux valgus or varus deformity of the foot by osteotomy of first metatarsal, without internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49837	01MAY2000	30JUN2011	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, including internal fixation where performed - unilateral
49837	01JUL2011	30JUN2021	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - unilateral
49837	01JUL2021	31OCT2021	N	Unilateral correction of hallus valgus or varus deformity of the foot, by osteotomy of first metatarsal, with internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49837	01NOV2021	31DEC9999	Y	Unilateral correction of hallux valgus or varus deformity of the foot, by osteotomy of first metatarsal, with internal fixation, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49838	01MAY2000	30JUN2011	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, including internal fixation where performed - bilateral
49838	01JUL2011	30JUN2021	N	FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - bilateral
49838	01JUL2021	31OCT2021	N	Bilateral correction of hallus valgus or varus deformity of the foot by osteotomy of first metatarsal, with internal fixation or arthrodesis of first metatarsophalangeal joint, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49838	01NOV2021	31DEC9999	Y	Bilateral correction of hallux valgus or varus deformity of the foot by osteotomy of first metatarsal, with internal fixation or arthrodesis of first metatarsophalangeal joint, including any of the following (if performed): (a) exostectomy; (b) removal of bursae; (c) synovectomy; (d) capsule repair; (e) capsule or tendon release or transfer (H)
49839	01DEC1991	30JUN2021	N	FOOT, correction of hallux rigidus or hallux valgus by prosthetic arthroplasty - unilateral
49839	01JUL2021	31DEC9999	Y	Total replacement of first metatarsophalangeal joint, with replacement of both joint surfaces, including any of the following (if performed): (a) capsulotomy; (b) synovectomy; (c) joint debridement (H)
49842	01DEC1991	31DEC9999	Y	FOOT, correction of hallux rigidus or hallux valgus by prosthetic arthroplasty - bilateral
49845	01DEC1991	30APR2009	N	FOOT, arthrodesis of, first metatarso-phalangeal joint
49845	01MAY2009	30JUN2021	N	FOOT, arthrodesis of, first metatarso-phalangeal joint, with synovectomy if performed
49845	01JUL2021	31DEC9999	Y	Unilateral arthrodesis of first metatarsophalangeal joint, by open or arthroscopic means, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints (H)
49848	01DEC1991	31DEC9999	Y	FOOT, correction of claw or hammer toe
49851	01DEC1991	30JUN2021	N	FOOT, correction of claw or hammer toe with internal fixation
49851	01JUL2021	31DEC9999	Y	Arthrodesis, osteotomy or interpositional arthroplasty of proximal or distal (or both) joints of lesser toe, including any of the following (if performed): (a) internal fixation, by any method; (b) capsulotomy; (c) tendon lengthening; (d) joint release; (e) synovectomy; (f) removal of osteophytes at joints; -one toe (H)
49854	01DEC1991	30JUN2021	N	FOOT, radical plantar fasciotomy or fasciectomy of
49854	01JUL2021	31DEC9999	Y	Radical plantar fasciotomy or fasciectomy, with extensive incision into foot and excision of fascia, including excision of calcaneal spur (if performed), other than a service associated with a service to which 49818 applies (H)
49857	01DEC1991	30JUN2021	N	FOOT, metatarso-phalangeal joint replacement
49857	01JUL2021	31DEC9999	Y	Hemi joint replacement of first or lesser metatarsophalangeal joint, including any of the following (if performed): (a) capsulotomy; (b) synovectomy; (c) joint debridement (H)
49860	01DEC1991	30JUN2021	N	FOOT, synovectomy of metatarso-phalangeal joint, single joint
49860	01JUL2021	31DEC9999	Y	Synovectomy of metatarsophalangeal joints, including any of the following (if performed): (a) capsulotomy; (b) debridement; (c) release of ligament or tendon (or both); -one or more joints on one foot (H)
49863	01DEC1991	31DEC9999	Y	FOOT, synovectomy of metatarso-phalangeal joint, 2 or more joints
49866	01DEC1991	30JUN2021	N	FOOT, neurectomy for plantar or digital neuritis (Morton's or Bett's syndrome)
49866	01JUL2021	29FEB2024	N	Excision of intermetatarsal or digital neuroma, including any of the following (if performed): (a) release of metatarsal or digital ligament; (b) excision of bursae; (c) neurolysis; other than a service associated with a service to which item 30023 applies-one web space (H)
49866	01MAR2024	31DEC9999	Y	Excision of intermetatarsal or digital neuroma, including any of the following (if performed): (a) release of metatarsal or digital ligament; (b) excision of bursae; (c) neurolysis; other than a service associated with a service to which item 30023 applies that is performed at the same site-one web space (H)
49869	01DEC1991	31DEC9999	Y	TALIPES EQUINOVARUS, posterior release of
49872	01DEC1991	31DEC9999	Y	TALIPES EQUINOVARUS, medial release of
49875	01DEC1991	31DEC9999	Y	TALIPES EQUINOVARUS, combined postero-medial release of
49878	01DEC1991	30JUN2021	N	TALIPES EQUINOVARUS, calcaneo valgus or metatarus varus, treatment by cast, splint or manipulation - each attendance
49878	01JUL2021	31DEC9999	Y	Talipes equinovarus, calcaneo valgus or metatarsus varus, treatment by cast, splint or manipulation-each attendance
49881	01JUL2021	29FEB2024	N	Complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of interphalangeal or metatarsophalangeal joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) skin closure, by any local method; other than a service associated with a service to which item 30023 applies-each incision (H)
49881	01MAR2024	31DEC9999	Y	Complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of interphalangeal or metatarsophalangeal joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) skin closure, by any local method; other than a service associated with a service to which item 30023 applies that is performed at the same site-each incision (H)
49884	01JUL2021	29FEB2024	N	Complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of ankle, hindoot or midfoot joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any method; other than a service associated with a service to which item 30023 applies-each incision (H)
49884	01MAR2024	31DEC9999	Y	Complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of ankle, hindoot or midfoot joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any method; other than a service associated with a service to which item 30023 applies that is performed at the same site-each incision (H)
49887	01JUL2021	29FEB2024	N	Revision of complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of interphalangeal or metatarsophalangeal joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) skin closure, by any method; other than a service associated with a service to which item 30023 or 49881 applies-each incision (H)
49887	01MAR2024	31DEC9999	Y	Revision of complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of interphalangeal or metatarsophalangeal joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) skin closure, by any method; other than a service associated with: (c) a service to which item 49881 applies; or (d) a service to which item 30023 applies that is performed at the same site -each incision (H)
49890	01JUL2021	29FEB2024	N	Revision of complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of ankle, hindoot or midfoot joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any method; other than a service associated with a service to which item 30023 or 49884 applies-each incision (H)
49890	01MAR2024	31DEC9999	Y	Revision of complete excision of one or more ganglia or bursae: (a) including excision of bony prominence or mucinous cyst of ankle, hindfoot or midfoot joint and surrounding tissues; and (b) including any of the following (if performed): (i) arthrotomy; (ii) synovectomy; (iii) osteophyte resections; (iv) neurolysis; (v) capsular or ligament repair; (vi) skin closure, by any method; other than a service associated with: (c) a service to which item 49884 applies; or (d) a service to which item 30023 applies that is performed at the same site -each incision (H)
50100	01DEC1991	31DEC9999	Y	JOINT, diagnostic arthroscopy of (including biopsy), not being a service to which another item in this Group applies and not being a service associated with any other arthroscopic procedure
50102	01NOV1996	31DEC9999	Y	JOINT, arthroscopic surgery of, not being a service to which another item in this Group applies
50103	01DEC1991	31DEC9999	Y	JOINT, arthrotomy of, not being a service to which another item in this Group applies
50104	01JUL1993	31DEC9999	Y	JOINT, synovectomy of, not being a service to which another item in this Group applies
50106	01DEC1991	31DEC9999	Y	JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Group applies
50107	01JUL2021	31DEC9999	Y	Stabilisation of joint of hip, by open means, including any of the following (if performed): (a) repair of capsule; (b) labrum; (c) capsulorraphy; (d) repair of ligament; (e) internal fixation; other than a service associated with a service to which another item in this Group applies (H)
50109	01DEC1991	30APR2009	N	JOINT, arthrodesis of, not being a service to which another item in this Group applies
50109	01MAY2009	31DEC9999	Y	JOINT, arthrodesis of, not being a service to which another item in this Group applies, with synovectomy if performed
50112	01DEC1991	31OCT1996	N	CICATRICIAL FLEXION CONTRACTURE OF JOINT, correction of, involving tissues deeper than skin and subcutaneous tissue
50112	01NOV1996	30JUN2021	N	CICATRICIAL FLEXION OR EXTENSION CONTRACTION OF JOINT, correction of, involving tissues deeper than skin and subcutaneous tissue, not being a service to which another item in this Group applies
50112	01JUL2021	31DEC9999	Y	Cicatricial flexion or extension contraction of joint, correction of, involving tissues deeper than skin and subcutaneous tissue, other than a service to which another item in this Group applies (H)
50115	01DEC1991	30JUN2021	N	JOINT or JOINTS, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies
50115	01JUL2021	31DEC9999	Y	Manipulation of one or more joints, excluding spine, other than a service associated with a service to which another item in this Group applies (H)
50118	01DEC1991	30APR2009	N	SUBTALAR JOINT, arthrodesis of
50118	01MAY2009	30JUN2021	N	SUBTALAR JOINT, arthrodesis of, with synovectomy if performed
50118	01JUL2021	31DEC9999	Y	Arthrodesis of joint of hindfoot, by any method, with internal or external fixation by any method, including any of the following (if performed): (a) capsulotomy; (b) joint release; (c) synovectomy; (d) removal of osteophytes at joints; -one joint (H)
50121	01DEC1991	31DEC9999	Y	GREATER TROCHANTER, transplantation of ileopsoas tendon to
50124	01DEC1991	31DEC9999	Y	JOINT or other SYNOVIAL CAVITY, aspiration of, injection into, or both of these procedures; payable on not more than 25 occasions in any 12 month period
50125	19JUN1997	31OCT1997	N	JOINT OR OTHER SYNOVIAL CAVITY, aspiration of, or injection into, or both of these procedures - where it can be demonstrated that a 26th or subsequent treatment (including any treatments to which item 50124 applies) is indicated in a 12 month period
50125	01NOV1997	31DEC9999	Y	JOINT OR OTHER SYNOVIAL CAVITY, aspiration of, or injection into, or both of these procedures - where it can be demonstrated that a 26th or subsequent treatment (including any treatments to which item 50124 applies) is indicated in a 12 month period
50127	01JUL1993	31DEC9999	Y	JOINT OR JOINTS, arthroplasty of, by any technique not being a service to which another item applies
50130	01JUL1993	30JUN2021	N	JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures
50130	01JUL2021	31DEC9999	Y	Joint or joints, application of external fixator to, other than for treatment of fractures (H)
50200	01DEC1991	30JUN2021	N	AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, biopsy of (not including aftercare)
50200	01JUL2021	31DEC9999	Y	Core needle biopsy of aggressive or potentially malignant bone or soft tissue tumour, excluding aftercare
50201	01NOV2004	30JUN2021	N	AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, involving neurovascular structures, open biopsy of (not including aftercare)
50201	01JUL2021	31DEC9999	Y	Incisional biopsy of aggressive or potentially malignant bone or soft tissue tumour, excluding aftercare
50203	01DEC1991	30JUN2021	N	BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR, lesional or marginal excision of
50203	01JUL2021	31DEC9999	Y	Intralesional or marginal excision of bone or soft tissue tumour
50206	01DEC1991	30JUN2021	N	BONE TUMOUR, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation
50206	01JUL2021	31DEC9999	Y	Intralesional or marginal excision of bone tumour, with at least one of the following: (a) autograft; (b) allograft; (c) cementation (H)
50209	01DEC1991	30JUN2021	N	BONE TUMOUR, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation
50209	01JUL2021	31DEC9999	Y	Intralesional or marginal excision of bone tumour, with at least 2 of the following: (a) autograft; (b) allograft; (c) cementation (H)
50212	01DEC1991	30JUN2021	N	MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR affecting the long bones of leg or arm, enbloc resection of, with compartmental or wide excision of soft tissue, without reconstruction
50212	01JUL2021	31DEC9999	Y	Wide excision of malignant or aggressive bone or soft tissue tumour (or both), affecting a limb, trunk or scapula (H)
50215	01DEC1991	30JUN2021	N	MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR affecting the long bones of leg or arm, enbloc resection of, with compartmental or wide excision of soft tissue, with intercalary reconstruction (prosthesis, allograft or autograft)
50215	01JUL2021	31DEC9999	Y	Wide excision of malignant or aggressive bone or soft tissue tumour (or both), with intercalary reconstruction of bone by prosthesis, allograft or autograft (H)
50218	01DEC1991	30APR2009	N	MALIGNANT TUMOUR of LONG BONE, enbloc resection of, with replacement or arthrodesis of adjacent joint
50218	01MAY2009	30JUN2021	N	MALIGNANT TUMOUR of LONG BONE, enbloc resection of, with replacement or arthrodesis of adjacent joint, with synovectomy if performed
50218	01JUL2021	31DEC9999	Y	Wide excision of malignant or aggressive bone or soft tissue tumour (or both), with reconstruction, replacement or arthrodesis of adjacent joint, by prosthesis, allograft or autograft (H)
50221	01DEC1991	30JUN2021	N	MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR of PELVIS, SACRUM or SPINE; or SCAPULA and SHOULDER, enbloc resection of
50221	01JUL2021	31DEC9999	Y	Wide excision of malignant or aggressive bone or soft tissue tumour (or both) of pelvis, sacrum or spine, without reconstruction (H)
50224	01DEC1991	30JUN2021	N	MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR of PELVIS, SACRUM or SPINE; or SCAPULA and SHOULDER, enbloc resection of, with reconstruction by prosthesis, allograft or autograft
50224	01JUL2021	31OCT2021	N	Wide excision of malignant or bone or soft tissue tumour (or both) of pelvis, sacrum or spine, with reconstruction of bone defect, or one or more joints, by any technique
50224	01NOV2021	31DEC9999	Y	Wide excision of malignant or aggressive bone or soft tissue tumour (or both) of pelvis, sacrum or spine, with reconstruction of bone defect, or one or more joints, by any technique
50227	01DEC1991	31DEC9999	Y	MALIGNANT BONE TUMOUR, enbloc resection of, with massive anatomic specific allograft or autograft, with or without prosthetic replacement
50230	01DEC1991	31DEC9999	Y	BENIGN TUMOUR, resection of, requiring anatomic specific allograft, with or without internal fixation
50233	01DEC1991	30JUN2021	N	MALIGNANT TUMOUR, amputation for, hemipelvectomy or interscapulo-thoracic
50233	01JUL2021	31DEC9999	Y	Treatment of malignant or aggressive bone or soft tissue tumour (or both) by hindquarter or forequarter amputation (H)
50236	01DEC1991	30JUN2021	N	MALIGNANT TUMOUR, amputation for, hip disarticulation, shoulder disarticulation or proximal third femur
50236	01JUL2021	31DEC9999	Y	Treatment of malignant or aggressive bone or soft tissue tumour (or both), by hip disarticulation, shoulder disarticulation or amputation through the proximal one third of the femur (H)
50239	01DEC1991	30JUN2021	N	MALIGNANT TUMOUR, amputation for, not being a service to which another item in this Group applies
50239	01JUL2021	31DEC9999	Y	Treatment of malignant or aggressive bone or soft tissue tumour (or both), by amputation, other than a service associated with a service to which item 50233 or 50236 applies (H)
50242	01JUL2021	31DEC9999	Y	Revision of endoprosthetic replacement, if item 50218 or 50224, or an item that describes a service substantially similar to either of those items, applied to the initial procedure: (a) including any of the following: (i) rebushing; (ii) patella resurfacing; (iii) polyethylene exchange or similar; and (b) excluding removal of prosthetic from bone (H)
50245	01JUL2021	31DEC9999	Y	Revision of reconstructive procedure, if item 50215, 50218 or 50224, or an item that describes a service substantially similar to any of those items, applied to the initial procedure, by any technique or combination of techniques (H)
50300	01JUL1995	30JUN2021	N	JOINT DEFORMITY, slow correction of, using ring fixator or similar device, including all associated attendances - payable only once in any 12 month period
50300	01JUL2021	31DEC9999	Y	Gradual correction of joint deformity, with application of external fixator (H)
50303	01JUL1995	31OCT2005	N	LIMB LENGTHENING, up to and including 5cm, requiring slow distraction under general anaesthesia in the operating theatre of a hospital or approved day-hospital facility, with or without application of a ring fixator or similar device, including all associated attendances - payable only once in any 12 month period
50303	01NOV2005	30JUN2021	N	LIMB LENGTHENING, 5cm or less, by gradual distraction, with application of an external fixator or intra-medullary device, in the operating theatre of a hospital - payable only once per limb in any 12 month period
50303	01JUL2021	31DEC9999	Y	Limb lengthening, by gradual distraction, with application of external fixator or intra-medullary device (H)
50306	01JUL1995	31OCT2005	N	LIMB LENGTHENING , where the lengthening is bipolar, or bone transport is performed or where the fixator is extended to correct an adjacent joint deformity
50306	01NOV2005	30JUN2021	N	LIMB LENGTHENING , where the lengthening is bipolar, or bone transport is performed or where the fixator is extended to correct an adjacent joint deformity, or where the lengthening is greater than 5cm
50306	01JUL2021	31DEC9999	Y	Bipolar limb lengthening: (a) with application of external fixator or intra-medullary device; and (b) by any of the following: (i) gradual distraction; (ii) bone transport; (iii) fixator extension, to correct for an adjacent joint deformity (H)
50309	01JUL1995	30JUN2021	N	RING FIXATOR OR SIMILAR DEVICE, adjustment of, with or without insertion or removal of fixation pins, performed under general anaesthesia in the operating theatre of a hospital, not being a service to which item 50303 or 50306 applies
50309	01JUL2021	31DEC9999	Y	Ring fixator or similar device, adjustment of, with or without insertion or removal of fixation pins, performed under general anaesthesia, other than a service to which item 50303 or 50306 applies (H)
50310	01JUL2021	31DEC9999	Y	Major adjustment of ring fixator or similar device, other than a service associated with a service to which item 50303, 50306, or 50309 applies
50312	01JUL1995	30APR2009	N	ANKLE, synovectomy of
50312	01MAY2009	30JUN2021	N	ANKLE, synovectomy of, by arthroscopic or open means - not associated with any other arthroscopic procedure of the ankle
50312	01JUL2021	31DEC9999	Y	Synovectomy or debridement, and microfracture, of ankle joint for osteochondral large defect greater than 1.5cm2, by arthroscopic or open means, including any of the following (if performed): (a) capsulotomy; (b) debridement or release of ligament; (c) debridement or release of tendon; other than a service associated with a service to which any of the following apply: (d) item 49703; (e) another item in this Schedule if the service described in the other item is for the purpose of performing an arthroscopic procedure of the ankle (H)
50315	01JUL1995	31DEC9999	Y	TALIPES EQUINOVARUS, posterior release of
50318	01JUL1995	31DEC9999	Y	TALIPES EQUINOVARUS, medial release of
50321	01JUL1995	30JUN2021	N	TALIPES EQUINOVARUS, combined postero-medial release of
50321	01JUL2021	31DEC9999	Y	Release of soft tissue of talipes equinovarus, by open means (H)
50324	01JUL1995	30JUN2021	N	TALIPES EQUINOVARUS, combined postero-medial release of, revision procedure
50324	01JUL2021	31DEC9999	Y	Revision of release of soft tissue of talipes equinovarus, by open means (H)
50327	01JUL1995	31DEC9999	Y	TALIPES EQUINOVARUS, bilateral procedures
50330	01JUL1995	30JUN2021	N	TALIPES EQUINOVARUS, or talus, vertical congenital - post operative manipulation and change of plaster, performed under general anaesthesia in the operating theatre of a hospital, not being a service to which item 50315, 50318, 50321, 50324 or 50327 applies
50330	01JUL2021	31DEC9999	Y	Post-operative manipulation, and change of plaster, of vertical, congenital talipes equinovarus or talus, other than a service to which item 50321 or 50324 applies (H)
50333	01JUL1995	30JUN2021	N	TARSAL COALITION, excision of, with interposition of muscle, fat graft or similar graft
50333	01JUL2021	31DEC9999	Y	Excision of tarsal coalition, with interposition of muscle, fat graft or similar graft, including any of the following (if performed): (a) capsulotomy; (b) synovectomy; (c) excision of osteophytes; -one coalition (H)
50335	01JUL2021	31DEC9999	Y	Treatment of vertical, congenital talus, by percutaneous or open stabilisation of talonavicular joint and Achilles tenotomy (H)
50336	01JUL1995	30JUN2021	N	TALUS, VERTICAL, CONGENITAL, combined anterior and posterior reconstruction
50336	01JUL2021	31DEC9999	Y	Talus, vertical, congenital, combined anterior and posterior reconstruction (H)
50339	01JUL1995	30JUN2021	N	FOOT AND ANKLE, tibialis anterior tendon (split or whole) transfer to lateral column
50339	01JUL2021	31DEC9999	Y	Tibialis anterior or tibialis posterior tendon transfer (split or whole) (H)
50342	01JUL1995	31DEC9999	Y	FOOT AND ANKLE, tibialis or tibialis posterior tendon transfer, through the interosseous membrane to anterior or posterior aspect of foot
50345	01JUL1995	30JUN2021	N	HYPEREXTENSION DEFORMITY OF TOE, release incorporating V-Y plasty of skin, lengthening of extensor tendons and release of capsule contracture
50345	01JUL2021	31DEC9999	Y	Hyperextension deformity of toe, release incorporating V-Y plasty of skin, lengthening of extensor tendons and release of capsule contracture (H)
50348	01JUL1995	30JUN2021	N	HIP, KNEE AND LEG PROCEDURES KNEE, deformity of, post-operative manipulation and change of plaster, performed under general anaesthesia in the operating theatre of a hospital
50348	01JUL2021	31DEC9999	Y	Knee, deformity of, post-operative manipulation and change of plaster, performed under general anaesthesia (H)
50349	01MAY2001	31DEC9999	Y	HIP, congenital dislocation of, treatment of, by closed reduction
50350	01MAY2001	31DEC9999	Y	HIP, congenital dislocation of, open reduction of
50351	01JUL1995	30APR2001	N	HIP, congenital or developmental dislocation of, open reduction of
50351	01MAY2001	30JUN2021	N	HIP, developmental dislocation of, open reduction of
50351	01JUL2021	31DEC9999	Y	Treatment of developmental dislocation of hip, by open reduction, including application of hip spica (H)
50352	01MAY2001	30JUN2021	N	HIP, congenital dislocation of, treatment of, involving supervision of splint, harness or cast - each attendance
50352	01JUL2021	31DEC9999	Y	Treatment of developmental dysplasia of hip, including supervision of initial application of splint, harness or cast, other than a service to which another item in this Group applies
50353	01MAY2001	31DEC9999	Y	HIP SPICA, initial application of, for congenital dislocation of hip (excluding aftercare)
50354	01JUL1995	30JUN2021	N	TIBIA, pseudarthrosis of, congenital, resection and internal fixation
50354	01JUL2021	31DEC9999	Y	Resection and fixation of congenital pseudarthrosis of tibia
50357	01JUL1995	30JUN2021	N	KNEE, LEG OR THIGH, rectus femoris tendon transfer, or medial or lateral hamstring tendon transfer
50357	01JUL2021	31DEC9999	Y	Transfer of tendon of rectus femoris or medial or lateral hamstring (H)
50360	01JUL1995	30JUN2021	N	KNEE, LEG OR THIGH, combined medial and lateral hamstring tendon transfer
50360	01JUL2021	31DEC9999	Y	Combined medial and lateral hamstring tendon transfer (H)
50363	01JUL1995	31DEC9999	Y	KNEE, contracture of, posterior release involving multiple tendon lengthening or tenotomies, unilateral
50366	01JUL1995	31DEC9999	Y	KNEE, contracture of, posterior release involving multiple tendon lengthening or tenotomies, bilateral
50369	01JUL1995	30JUN2021	N	KNEE, contracture of, posterior release involving multiple tendon lengthening with or without tenotomies and release of joint capsule with or without cruciate ligaments, unilateral
50369	01JUL2021	31DEC9999	Y	Unilateral posterior release of knee contracture, with multiple tendon lengthening or tenotomies, including release of joint capsule (if performed), other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of knee replacement (H)
50372	01JUL1995	30JUN2021	N	KNEE, contracture of, posterior release involving multiple tendon lengthening with or without tenotomies and release of joint capsule with or without cruciate ligaments, bilateral
50372	01JUL2021	31DEC9999	Y	Bilateral posterior release of knee contracture, with multiple tendon lengthening or tenotomies, including release of joint capsule (if performed), other than a service associated with a service to which another item of this Schedule applies if the service described in the other item is for the purpose of knee replacement (H)
50375	01JUL1995	30JUN2021	N	HIP, contracture of, medial release, involving lengthening of, or division of the adductors and psoas with or without division of the obturator nerve, unilateral
50375	01JUL2021	31DEC9999	Y	Unilateral medial release of hip contracture, with lengthening or division of the adductors and psoas, including division of obturator nerve (if performed) (H)
50378	01JUL1995	30JUN2021	N	HIP, contracture of, medial release, involving lengthening of, or division of the adductors and psoas with or without division of the obturator nerve, bilateral
50378	01JUL2021	31DEC9999	Y	Bilateral medial release of hip contracture, with lengthening or division of adductors and psoas, including division of obturator nerve (if performed) (H)
50381	01JUL1995	30JUN2021	N	HIP, contracture of, anterior release, involving lengthening of, or division of the hip flexors and psoas with or without division of the joint capsule, unilateral
50381	01JUL2021	31DEC9999	Y	Unilateral anterior release of hip contracture, with lengthening or division of hip flexors and psoas, including division of joint capsule (if performed) (H)
50384	01JUL1995	30JUN2021	N	HIP, contracture of, anterior release, involving lengthening of, or division of the hip flexors and psoas with or without division of the joint capsule, bilateral
50384	01JUL2021	31DEC9999	Y	Bilateral anterior release of hip contracture, with lengthening or division of hip flexors and psoas, including division of joint capsule (if performed) (H)
50387	01JUL1995	31DEC9999	Y	HIP, iliopsoas tendon transfer to greater trochanter, or transfer of abdominal musculature to greater trochanter, or transfer of adductors to ischium
50390	01JUL1995	30JUN2021	N	PERTHES, CEREBRAL PALSY, or other neuromuscular conditions, affecting hips or knees, application of cast under general anaesthesia, performed in the operating theatre of a hospital
50390	01JUL2021	31DEC9999	Y	Application of cast under general anaesthesia, for patient with perthes, cerebral palsy, or other neuromuscular conditions, affecting hips or knees (H)
50393	01JUL1995	30JUN2021	N	PELVIS, bone graft or shelf procedures for acetabular dysplasia
50393	01JUL2021	31DEC9999	Y	Acetabular shelf procedure, other than a service associated with a service to which another item of this Schedule applies if the service in the other item is for the purpose of performing arthroplasty on the hip (H)
50394	01JUL1998	30JUN2021	N	ACETABULAR DYSPLASIA, treatment of, by multiple peri-acetabular osteotomy, including internal fixation where performed
50394	01JUL2021	31DEC9999	Y	Multiple peri-acetabular osteotomy, including internal fixation (if performed) (H)
50395	01JUL2021	31DEC9999	Y	Osteotomy and distillation of greater trochanter, with internal fixation (H)
50396	01JUL1995	30JUN2021	N	SHOULDER, ARM AND FOREARM PROCEDURES HAND, congenital abnormalities or duplication of digits, amputation or splitting of phalanx or phalanges, with ligament or joint reconstruction
50396	01JUL2021	31DEC9999	Y	Amputation of congenital abnormalities or duplication of digits of the hand or foot, including any of the following (if performed): (a) splitting of phalanx or phalanges; (b) ligament reconstruction; (c) joint reconstruction (H)
50399	01JUL1995	30JUN2021	N	FOREARM, RADIAL APLASIA OR DYSPLASIA (radial club hand), centralisation or radialisation of
50399	01JUL2021	31DEC9999	Y	Forearm, radial aplasia or dysplasia (radial club hand), centralisation or radialisation of (H)
50402	01JUL1995	31DEC9999	Y	TORTICOLLIS, bipolar release of sternocleidomastoid muscle and associated soft tissue
50405	01JUL1995	31DEC9999	Y	ELBOW, flexorplasty, or tendon transfer to restore elbow function
50408	01JUL1995	31DEC9999	Y	SHOULDER, congenital or developmental dislocation, open reduction of
50411	01JUL1995	30JUN2021	N	AMPUTATIONS OR RECONSTRUCTIONS FOR CONGENITAL DEFORMITIES LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion
50411	01JUL2021	31DEC9999	Y	Lower limb deficiency, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion
50414	01JUL1995	30JUN2021	N	LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion and rotationplasty
50414	01JUL2021	31DEC9999	Y	Lower limb deficiency, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion and rotationplasty
50417	01JUL1995	30JUN2021	N	LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the tibia by reconstruction of the knee, involving transfer of fibula or tibia, and repair of quadriceps mechanism
50417	01JUL2021	31DEC9999	Y	Lower limb deficiency, treatment of congenital deficiency of the tibia by reconstruction of the knee, involving transfer of fibula or tibia, and repair of quadriceps mechanism
50420	01JUL1995	30JUN2021	N	PATELLA, congenital dislocation of, reconstruction of the quadriceps
50420	01JUL2021	31DEC9999	Y	Patella, congenital dislocation of, reconstruction of the quadriceps (H)
50423	01JUL1995	30JUN2021	N	TIBIA, FIBULA OR BOTH, congenital deficiency of, transfer of the fibula to tibia, with internal fixation
50423	01JUL2021	31DEC9999	Y	Tibia, fibula or both, congenital deficiency of, transfer of the fibula to tibia, with internal fixation
50426	01JUL1995	30JUN2021	N	TUMOROUS CONDITIONS DIAPHYSEAL ACLASIA, removal of lesion or lesions from bone - 1 approach
50426	01JUL2021	31DEC9999	Y	Removal of one or more lesions from bone, for osteochondroma occurring solitary or in association with hereditary multiple exotoses, with histological examination-one approach (H)
50428	01JUL2021	31DEC9999	Y	Percutaneous drilling of osteochondritis dessicans or other osteochondral lesion, for a patient: (a) with open growth plates; or (b) less than 18 years of age (H)
50450	01NOV2006	30APR2009	N	UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. ( Correction of femoral torsion by rotational osteotomy of the femur. ( Correction of tibial torsion by rotational osteotomy of the tibia. ( Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis or os calcis lengthening. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50450	01MAY2009	30JUN2021	N	UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of femoral torsion by rotational osteotomy of the femur. (d) Correction of tibial torsion by rotational osteotomy of the tibia. (e) Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis, with synovectomy if performed, or os calcis lengthening. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50450	01JUL2021	31DEC9999	Y	Unilateral single event multilevel surgery, for a patient less than 18 years of age with hemiplegic cerebral palsy, comprising 3 or more of the following: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; (b) correction of muscle imbalance by transfer of a tendon or tendons; (c) correction of femoral torsion by rotational osteotomy of the femur; (d) correction of tibial torsion by rotational osteotomy of the tibia; (e) correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis with synovectomy if performed, or os calcis lengthening; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50451	01NOV2006	30APR2009	N	UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of femoral torsion by rotational osteotomy of the femur. (d) Correction of tibial torsion by rotational osteotomy of the tibia. (e) Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis or os calcis lengthening. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50451	01MAY2009	30JUN2021	N	UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of femoral torsion by rotational osteotomy of the femur. (d) Correction of tibial torsion by rotational osteotomy of the tibia. (e) Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis, with synovectomy if performed, or os calcis lengthening. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50451	01JUL2021	31DEC9999	Y	Unilateral single event multilevel surgery, for a patient less than 18 years of age with hemiplegic cerebral palsy, comprising 3 or more of the following: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; (b) correction of muscle imbalance by transfer of a tendon or tendons; (c) correction of femoral torsion by rotational osteotomy of the femur; (d) correction of tibial torsion by rotational osteotomy of the tibia; (e) correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis with synovectomy if performed, or os calcis lengthening; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50455	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises: ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50455	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50456	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises: (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50456	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50460	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery and bilateral femoral osteotomies. ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. ( Correction of torsional abnormality of the femur by rotational osteotomy and internal fixation. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50460	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery and bilateral femoral osteotomies, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of torsional abnormality of the femur by rotational osteotomy and internal fixation; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50461	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery and bilateral femoral osteotomies. (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of torsional abnormality of the femur by rotational osteotomy and internal fixation. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50461	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery and bilateral femoral osteotomies, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of torsional abnormality of the femur by rotational osteotomy and internal fixation; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50465	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies. ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. ( Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. ( Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50465	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of abnormal torsion of the femur by rotational osteotomy with internal fixation; and (d) correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50466	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies. (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (d) Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50466	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of abnormal torsion of the femur by rotational osteotomy with internal fixation; and (d) correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50470	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation. ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. ( Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. ( Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. ( Correction of bilateral pes valgus by os calcis lengthening or subtalar fusion. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50470	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with cerebral palsy, that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of abnormal torsion of the femur by rotational osteotomy with internal fixation; and (d) correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation; and (e) correction of bilateral pes valgus by os calcis lengthening or subtalar fusion; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50471	01NOV2006	30JUN2021	N	BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation. (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (d) Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. (e) Correction of bilateral pes valgus by os calcis lengthening or subtalar fusion. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50471	01JUL2021	31DEC9999	Y	Bilateral single event multilevel surgery, for a patient less than 18 years of age with cerebral palsy, that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation, with: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of abnormal torsion of the femur by rotational osteotomy with internal fixation; and (d) correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation; and (e) correction of bilateral pes valgus by os calcis lengthening or subtalar fusion; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50475	01NOV2006	30JUN2021	N	SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy for the correction of crouch gait including: ( Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. ( Correction of muscle imbalance by tendon transfer/transfers. ( Correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation. ( Correction of patella alta and quadriceps insufficiency by patella tendon shortening/reconstruction. ( Correction of tibial torsion by rotational osteotomy of the tibia with internal fixation. ( Correction of foot instability by os calcis lengthening or subtalar fusion. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare
50475	01JUL2021	31DEC9999	Y	Single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, for the correction of crouch gait, including: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation; and (d) correction of patella alta and quadriceps insufficiency by patella tendon shortening or reconstruction; and (e) correction of tibial torsion by rotational osteotomy of the tibia with internal fixation; and (f) correction of foot instability by os calcis lengthening or subtalar fusion; conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare (H)
50476	01NOV2006	30JUN2021	N	SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy for the correction of crouch gait including: (a) Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) Correction of muscle imbalance by tendon transfer/transfers. (c) Correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation. (d) Correction of patella alta and quadriceps insufficiency by patella tendon shortening/reconstruction. (e) Correction of tibial torsion by rotational osteotomy of the tibia with internal fixation. (f) Correction of foot instability by os calcis lengthening or subtalar fusion. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare
50476	01JUL2021	14JUL2021	N	Single event multilevel surgery for patients less than 18 years of age with diplegic cerebral palsy for the correction of crouch gait including: (a) lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b) correction of muscle imbalance by tendon transfer/transfers. (c) correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation. (d) correction of patella alta and quadriceps insufficiency by patella tendon shortening/reconstruction. (e) correction of tibial torsion by rotational osteotomy of the tibia with internal fixation. (f) correction of foot instability by os calcis lengthening or subtalar fusion. conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50476	15JUL2021	31DEC9999	Y	Single event multilevel surgery, for a patient less than 18 years of age with diplegic cerebral palsy, for the correction of crouch gait including: (a) lengthening of a contracted muscle tendon unit or units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening; and (b) correction of muscle imbalance by transfer of a tendon or tendons; and (c) correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation; and (d) correction of patella alta and quadriceps insufficiency by patella tendon shortening or reconstruction; and (e) correction of tibial torsion by rotational osteotomy of the tibia with internal fixation; and (f) correction of foot instability by os calcis lengthening or subtalar fusion; conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare (H)
50500	01NOV2006	31DEC9999	Y	RADIUS OR ULNA, distal end of, with open growth plate, treatment of fracture of, by closed reduction
50504	01NOV2006	31DEC9999	Y	RADIUS OR ULNA, distal end of, with open growth plate, treatment of fracture of, by open reduction
50508	01NOV2006	30JUN2021	N	RADIUS, distal end of, with open growth plate, treatment of Colles', Smith's or Barton's fracture, by closed reduction
50508	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius or ulna (or both), by closed reduction, for a patient with open growth plates
50512	01NOV2006	30JUN2021	N	RADIUS, distal end of, with open growth plate, treatment of Colles', Smith's or Barton's fracture of, by open reduction
50512	01JUL2021	31DEC9999	Y	Treatment of fracture of distal end of radius or ulna (or both), by open or closed reduction, with internal fixation, for a patient with open growth plates (H)
50516	01NOV2006	31DEC9999	Y	RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital
50520	01NOV2006	31DEC9999	Y	RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, by open reduction
50524	01NOV2006	30JUN2021	N	RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by closed reduction undertaken in the operating theatre of a hospital
50524	01JUL2021	31DEC9999	Y	Radius or ulna, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by closed reduction (H)
50528	01NOV2006	30JUN2021	N	RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by reduction with or without internal fixation by open or percutaneous means
50528	01JUL2021	31DEC9999	Y	Radius or ulna, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by reduction with or without internal fixation by open or percutaneous means (H)
50532	01NOV2006	30JUN2021	N	RADIUS AND ULNA, shafts of, with open growth plates, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital
50532	01JUL2021	31DEC9999	Y	Treatment of fracture of shafts of radius or ulna (or both), by closed reduction, for a patient with open growth plate (H)
50536	01NOV2006	30JUN2021	N	RADIUS AND ULNA, shafts of, with open growth plates, treatment of fracture of, by open reduction
50536	01JUL2021	31DEC9999	Y	Treatment of fracture of shafts of radius or ulna (or both), by open or closed reduction, with internal fixation, for a patient with open growth plate (H)
50540	01NOV2006	30JUN2021	N	OLECRANON, with open growth plate, treatment of fracture of, by open reduction
50540	01JUL2021	31DEC9999	Y	Olecranon, with open growth plate, treatment of fracture of, by open reduction (H)
50544	01NOV2006	30JUN2021	N	RADIUS, with open growth plate, treatment of fracture of head or neck of, by closed reduction of
50544	01JUL2021	31DEC9999	Y	Radius, with open growth plate, treatment of fracture of head or neck of, by closed reduction of
50548	01NOV2006	30JUN2021	N	RADIUS, with open growth plate, treatment of fracture of head or neck of, by reduction with or without internal fixation by open or percutaneous means
50548	01JUL2021	31DEC9999	Y	Radius, with open growth plate, treatment of fracture of head or neck of, by reduction with or without internal fixation by open or percutaneous means (H)
50552	01NOV2006	30JUN2021	N	HUMERUS, proximal, with open growth plate, treatment of fracture of, by closed reduction, undertaken in the operating theatre, neonatal unit or nursery of a hospital
50552	01JUL2021	31DEC9999	Y	Humerus, proximal, with open growth plate, treatment of fracture of, by closed reduction (H)
50556	01NOV2006	30JUN2021	N	HUMERUS, proximal, with open growth plate, treatment of fracture of, by open reduction
50556	01JUL2021	31DEC9999	Y	Treatment of fracture of proximal humerus, by open or closed reduction, with internal fixation, for a patient with open growth plate (H)
50560	01NOV2006	30JUN2021	N	HUMERUS, shaft of, with open growth plate, treatment of fracture of, by closed reduction, undertaken in the operating theatre, neonatal unit or nursery of a hospital
50560	01JUL2021	31DEC9999	Y	Humerus, shaft of, with open growth plate, treatment of fracture of, by closed reduction (H)
50564	01NOV2006	30JUN2021	N	HUMERUS, shaft of, with open growth plate, treatment of fracture of, by internal or external fixation
50564	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of humerus, by open or closed reduction, with internal or external fixation, for a patient with open growth plate (H)
50568	01NOV2006	30JUN2021	N	HUMERUS, with open growth plate, supracondylar or condylar, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital
50568	01JUL2021	31DEC9999	Y	Humerus, with open growth plate, supracondylar or condylar, treatment of fracture of, by closed reduction (H)
50572	01NOV2006	30JUN2021	N	HUMERUS, with open growth plate, supracondylar or condylar, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means, undertaken in the operating theatre of a hospital
50572	01JUL2021	31DEC9999	Y	Humerus, with open growth plate, supracondylar or condylar, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means (H)
50576	01NOV2006	30JUN2021	N	FEMUR, with open growth plate, treatment of fracture of, by closed reduction or traction
50576	01JUL2021	31DEC9999	Y	Treatment of fracture of femur, by closed reduction or traction, including application of hip spica (if performed), for a patient with open growth plate
50580	01NOV2006	30JUN2021	N	TIBIA, with open growth plate, plateau or condyles, medial or lateral, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means
50580	01JUL2021	31DEC9999	Y	Tibia, with open growth plate, plateau or condyles, medial or lateral, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means (H)
50584	01NOV2006	30JUN2021	N	TIBIA, distal, with open growth plate, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means
50584	01JUL2021	31DEC9999	Y	Tibia, distal, with open growth plate, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means (H)
50588	01NOV2006	30JUN2021	N	TIBIA AND FIBULA, with open growth plates, treatment of fracture of, by internal fixation
50588	01JUL2021	31DEC9999	Y	Tibia and fibula, with open growth plates, treatment of fracture of, by internal fixation (H)
50592	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of femur, by open or closed reduction, with internal or external fixation, for a patient with open growth plate (H)
50596	01JUL2021	31DEC9999	Y	Treatment of fracture of shaft of tibia, by open or closed reduction, including casting, for a patient with open growth plate (H)
50600	01NOV2006	30JUN2021	N	SCOLIOSIS OR KYPHOSIS, in a growing child, manipulation of deformity and application of a localiser cast, under general anaesthesia, in a hospital
50600	01JUL2021	31DEC9999	Y	Scoliosis or kyphosis, in a child, manipulation of deformity and application of a localiser cast, under general anaesthesia, in a hospital (H)
50604	01NOV2006	30JUN2021	N	SCOLIOSIS or KYPHOSIS, in a child or adolescent, spinal fusion for (without instrumentation)
50604	01JUL2021	31DEC9999	Y	Scoliosis or kyphosis, in a child or adolescent, spinal fusion for (without instrumentation) (H)
50608	01NOV2006	31OCT2018	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, treatment by segmental instrumentation and fusion of the spine, not being a service to which item 48642 to 48675 applies
50608	01NOV2018	30JUN2021	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, treatment by segmental instrumentation and fusion of the spine, not being a service to which item 51011 to 51171 applies
50608	01JUL2021	31DEC9999	Y	Scoliosis or kyphosis, in a child or adolescent, treatment by segmental instrumentation and fusion of the spine, other than a service to which any of items 51011 to 51171 apply (H)
50612	01NOV2006	31OCT2018	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, with spinal deformity, treatment by segmental instrumentation, utilising separate anterior and posterior approaches, not being a service to which item 48642 to 48675 applies
50612	01NOV2018	30JUN2021	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, with spinal deformity, treatment by segmental instrumentation, utilising separate anterior and posterior approaches, not being a service to which item 51011 to 51171 applies
50612	01JUL2021	31DEC9999	Y	Scoliosis or kyphosis, in a child or adolescent, with spinal deformity, treatment by segmental instrumentation, utilising separate anterior and posterior approaches, other than a service to which any of items 51011 to 51171 apply (H)
50616	01NOV2006	30JUN2021	N	SCOLIOSIS, in a child or adolescent, re-exploration for adjustment or removal of segmental instrumentation used for correction of spine deformity
50616	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, re-exploration for adjustment or removal of segmental instrumentation used for correction of spine deformity (H)
50620	01NOV2006	31OCT2018	N	SCOLIOSIS, in a child or adolescent, revision of failed scoliosis surgery, involving more than 1 of osteotomy, fusion, removal of instrumentation or instrumentation, not being a service to which item 48642 to 48675 applies
50620	01NOV2018	30JUN2021	N	SCOLIOSIS, in a child or adolescent, revision of failed scoliosis surgery, involving more than 1 of osteotomy, fusion, removal of instrumentation or instrumentation, not being a service to which item 51011 to 51171 applies
50620	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, revision of failed scoliosis surgery, involving more than one of osteotomy, fusion, removal of instrumentation or instrumentation, other than a service to which any of items 51011 to 51171 apply (H)
50624	01NOV2006	30JUN2021	N	SCOLIOSIS, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - not more than 4 levels
50624	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - not more than 4 levels (H)
50628	01NOV2006	30JUN2021	N	SCOLIOSIS, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - more than 4 levels
50628	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar)-more than 4 levels (H)
50632	01NOV2006	31OCT2018	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, requiring segmental instrumentation and fusion of the spine down to and including the pelvis or sacrum, not being a service to which item 48642 to 48675 applies
50632	01NOV2018	30JUN2021	N	SCOLIOSIS OR KYPHOSIS, in a child or adolescent, requiring segmental instrumentation and fusion of the spine down to and including the pelvis or sacrum, not being a service to which item 51011 to 51171 applies
50632	01JUL2021	31DEC9999	Y	Scoliosis or kyphosis, in a child or adolescent, requiring segmental instrumentation and fusion of the spine down to and including the pelvis or sacrum, other than a service to which any of items 51011 to 51171 apply (H)
50636	01NOV2006	31OCT2018	N	SCOLIOSIS, in a child or adolescent, requiring anterior decompression of the spinal cord with vertebral resection and instrumentation in the presence of spinal cord involvement, not being a service to which item 48642 to 48675 applies
50636	01NOV2018	30JUN2021	N	SCOLIOSIS, in a child or adolescent, requiring anterior decompression of the spinal cord with vertebral resection and instrumentation in the presence of spinal cord involvement, not being a service to which item 51011 to 51171 applies
50636	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, requiring anterior decompression of the spinal cord with vertebral resection and instrumentation in the presence of spinal cord involvement, other than a service to which any of items 51011 to 51171 apply (H)
50640	01NOV2006	31OCT2018	N	SCOLIOSIS, in a child or adolescent, congenital, resection and fusion of abnormal vertebra via an anterior or posterior approach, not being a service to which item 48642 to 48675 applies
50640	01NOV2018	30JUN2021	N	SCOLIOSIS, in a child or adolescent, congenital, resection and fusion of abnormal vertebra via an anterior or posterior approach, not being a service to which item 51011 to 51171 applies
50640	01JUL2021	31DEC9999	Y	Scoliosis, in a child or adolescent, congenital, resection and fusion of abnormal vertebra via an anterior or posterior approach, other than a service to which any of items 51011 to 51171 apply (H)
50644	01NOV2006	30JUN2021	N	SPINE, bone graft to, for a child or adolescent, associated with surgery for correction of scoliosis or kyphosis or both
50644	01JUL2021	31DEC9999	Y	Spine, bone graft to, for a child or adolescent, associated with surgery for correction of scoliosis or kyphosis or both (H)
50650	01NOV2006	31DEC9999	Y	HIP DYSPLASIA or DISLOCATION, in a child, examination, manipulation and arthrography of the hip under anaesthesia
50654	01NOV2006	30JUN2021	N	HIP DYSPLASIA or DISLOCATION, in a child, application or reapplication of a hip spica, including examination of the hip
50654	01JUL2021	29FEB2024	N	Treatment of hip dysplasia or dislocation, for a patient under the age of 18 years, by examination or closed reduction (or both), with or without arthrography of the hip under anaesthesia, and with application or reapplication of a hip spica (H)
50654	01MAR2024	30JUN2024	N	Examination or closed reduction (or both) of hip for a patient under the age of 18 years, including any of the following (if performed): (a) diagnostic injection; (b) arthrography; (c) application or reapplication of a hip spica (H)
50654	01JUL2024	31DEC9999	Y	Examination or closed reduction (or both) of hip under anaesthesia for a patient under the age of 18 years, including any of the following (if performed): (a) diagnostic injection; (b) arthrography; (c) application or reapplication of a hip spica (H)
50658	01NOV2006	31DEC9999	Y	HIP DYSPLASIA or DISLOCATION, in a child, examination and manipulation of the hip under anaesthesia
50950	01MAY2004	31OCT2017	N	NONRESECTABLE HEPATOCELLULAR CARCINOMA, destruction of, by percutaneous radiofrequency ablation, including any associated imaging services, not being a service associated with a service to which item 30419 or 50952 applies
50950	01NOV2017	30JUN2021	N	Unresectable primary malignant tumour of the liver, destruction of, by percutaneous radiofrequency ablation or percutaneous microwave tissue ablation (including any associated imaging services), other than a service associated with a service to which item 30419 or 50952 applies
50950	01JUL2021	31DEC9999	Y	Unresectable primary malignant tumour of the liver, destruction of, by percutaneous ablation (including any associated imaging services), other than a service associated with a service to which item 30419 or 50952 applies
50952	01MAY2004	31OCT2017	N	NONRESECTABLE HEPATOCELLULAR CARCINOMA, destruction of, by open or laparoscopic radiofrequency ablation, where a multi-disciplinary team has assessed that percutaneous radiofrequency ablation cannot be performed or is not practical because of one or more of the following clinical circumstances: - percutaneous access cannot be achieved; - vital organs/tissues are at risk of damage from the percutaneous RFA procedure; or - resection of one part of the liver is possible however there is at least one primary liver tumour in a non-resectable region of the liver which is suitable for radiofrequency ablation, including any associated imaging services, not being a service associated with a service to which item 30419 or 50950 applies
50952	01NOV2017	30JUN2021	N	Unresectable primary malignant tumour of the liver, destruction of, by open or laparoscopic radiofrequency ablation or open or laparoscopic microwave tissue ablation (including any associated imaging services), if a multi-disciplinary team has assessed that percutaneous radiofrequency ablation or percutaneous microwave tissue ablation cannot be performed or is not practical because of one or more of the following clinical circumstances: (a) percutaneous access cannot be achieved; (b) vital organs or tissues are at risk of damage from the percutaneous radiofrequency ablation or percutaneous microwave tissue ablation procedure; (c) resection of one part of the liver is possible, however there is at least one primary liver tumour in an unresectable portion of the liver that is suitable for radiofrequency ablation or microwave tissue ablation; other than a service associated with a service to which item 30419 or 50950 applies.
50952	01JUL2021	31DEC9999	Y	Unresectable primary malignant tumour of the liver, destruction of, by open or laparoscopic ablation (including any associated imaging services), if a multi-disciplinary team has assessed that percutaneous ablation cannot be performed or is not practical because of one or more of the following clinical circumstances:(a) percutaneous access cannot be achieved;(b) vital organs or tissues are at risk of damage from the percutaneous ablation procedure;(c) resection of one part of the liver is possible, however there is at least one primary liver tumour in an unresectable portion of the liver that is suitable for ablation;other than a service associated with a service to which item 30419 or 50950 applies
51011	01NOV2018	31OCT2021	N	Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, one motion segment, not being a service associated with a service to which item 51012, 51013, 51014 or 51015 applies
51011	01NOV2021	31DEC9999	Y	Direct spinal decompression or exposure (via a partial or a total laminectomy or a partial vertebrectomy), or a posterior spinal release, one motion segment, not being a service associated with a service to which item 51012, 51013, 51014 or 51015 applies (H)
51012	01NOV2018	31OCT2021	N	Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 2 motion segments, not being a service associated with a service to which item 51011, 51013, 51014 or 51015 applies
51012	01NOV2021	31DEC9999	Y	Direct spinal decompression or exposure (via a partial or a total laminectomy or a partial vertebrectomy), or a posterior spinal release, 2 motion segments, not being a service associated with a service to which item 51011, 51013, 51014 or 51015 applies (H)
51013	01NOV2018	31OCT2021	N	Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 3 motion segments, not being a service associated with a service to which item 51011, 51012, 51014 or 51015 applies
51013	01NOV2021	31DEC9999	Y	Direct spinal decompression or exposure (via a partial or a total laminectomy or a partial vertebrectomy), or a posterior spinal release, 3 motion segments, not being a service associated with a service to which item 51011, 51012, 51014 or 51015 applies (H)
51014	01NOV2018	31OCT2021	N	Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51015 applies
51014	01NOV2021	31DEC9999	Y	Direct spinal decompression or exposure (via a partial or a total laminectomy or a partial vertebrectomy), or a posterior spinal release, 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51015 applies (H)
51015	01NOV2018	31OCT2021	N	Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, more than 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51014 applies
51015	01NOV2021	31DEC9999	Y	Direct spinal decompression or exposure (via a partial or a total laminectomy or a partial vertebrectomy), or a posterior spinal release, more than 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51014 applies (H)
51020	01NOV2018	31DEC9999	Y	Simple fixation of part of one vertebra (not motion segment) including pars interarticularis, spinous process or pedicle, or simple interspinous wiring between 2 adjacent vertebral levels, not being a service associated with: (a) interspinous dynamic stabilisation devices; or (b) a service to which item 51021, 51022, 51023, 51024, 51025 or 51026 applies
51021	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, one motion segment, not being a service associated with a service to which item 51020, 51022, 51023, 51024, 51025 or 51026 applies
51021	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, one motion segment, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51022, 51023, 51024, 51025 or 51026 applies (H)
51022	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 2 motion segments, not being a service associated with a service to which item 51020, 51021, 51023, 51024, 51025 or 51026 applies
51022	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 2 motion segments, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51021, 51023, 51024, 51025 or 51026 applies (H)
51023	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 3 or 4 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51024, 51025 or 51026 applies
51023	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 3 or 4 motion segments, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51021, 51022, 51024, 51025 or 51026 applies (H)
51024	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 5 or 6 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51025 or 51026 applies
51024	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 5 or 6 motion segments, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51025 or 51026 applies (H)
51025	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 7 to 12 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51026 applies
51025	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 7 to 12 motion segments, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51026 applies (H)
51026	01NOV2018	29FEB2024	N	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, more than 12 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51025 applies
51026	01MAR2024	31DEC9999	Y	Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, more than 12 motion segments, excluding vertebral body tethering for the treatment of scoliosis and not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51025 applies (H)
51031	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, one motion segment, not being a service associated with a service to which item 51032, 51033, 51034, 51035 or 51036 applies
51032	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, 2 motion segments, not being a service associated with a service to which item 51031, 51033, 51034, 51035 or 51036 applies
51033	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, 3 motion segments, not being a service associated with a service to which item 51031, 51032, 51034, 51035 or 51036 applies
51034	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, 4 to 7 motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51035 or 51036 applies
51035	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, 8 to 11 motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51034 or 51036 applies
51036	01NOV2018	31DEC9999	Y	Spine, posterior and/or posterolateral bone graft to, 12 or more motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51034 or 51035 applies
51041	01NOV2018	31DEC9999	Y	Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), one motion segment, not being a service associated with a service to which item 51042, 51043, 51044 or 51045 applies
51042	01NOV2018	31DEC9999	Y	Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 2 motion segments, not being a service associated with a service to which item 51041, 51043, 51044 or 51045 applies
51043	01NOV2018	31DEC9999	Y	Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 3 motion segments, not being a service associated with a service to which item 51041, 51042, 51044 or 51045 applies
51044	01NOV2018	31DEC9999	Y	Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 4 motion segments, not being a service associated with a service to which item 51041, 51042, 51043 or 51045 applies
51045	01NOV2018	31DEC9999	Y	Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 5 or more motion segments, not being a service associated with a service to which item 51041, 51042, 51043 or 51044 applies
51051	01NOV2018	31OCT2019	N	Pedicle subtraction osteotomy, one motion segment, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51052, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51051	01NOV2019	31DEC9999	Y	Pedicle subtraction osteotomy, one vertebra, not being a service associated with a service to which item 51052, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51052	01NOV2018	31OCT2019	N	Pedicle subtraction osteotomy, 2 motion segments, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51052	01NOV2019	31DEC9999	Y	Pedicle subtraction osteotomy, 2 vertebrae, not being a service associated with a service to which item 51051, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51053	01NOV2018	31OCT2019	N	Vertebral column resection osteotomy performed through single posterior approach, one motion segment, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51053	01NOV2019	31DEC9999	Y	Vertebral column resection osteotomy performed through single posterior approach, one vertebra, not being a service associated with a service to which item 51051, 51052, 51054, 51055, 51056, 51057, 51058 or 51059 applies
51054	01NOV2018	31DEC9999	Y	Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), one vertebra, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51055, 51056, 51057, 51058 or 51059 applies
51055	01NOV2018	31DEC9999	Y	Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), 2 vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 51056, 51057, 51058 or 51059 applies
51056	01NOV2018	31DEC9999	Y	Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), 3 or more vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 51055, 51057, 51058 or 51059 applies
51057	01NOV2018	31DEC9999	Y	Vertebral body, en bloc excision of (complete spondylectomy), one vertebra, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 51055, 51056, 51058 or 51059 applies
51058	01NOV2018	31DEC9999	Y	Vertebral body, en bloc excision of (complete spondylectomy), 2 vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 51055, 51056, 51057 or 51059 applies
51059	01NOV2018	31DEC9999	Y	Vertebral body, en bloc excision of (complete spondylectomy), 3 or more vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item 51051, 51052, 51053, 51054, 51055, 51056, 51057 or 51058 applies
51061	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at one motion segment, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51062, 51063, 51064, 51065 or 51066 applies
51061	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at one motion segment, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51062, 51063, 51064, 51065 or 51066 applies
51062	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at 2 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51063, 51064, 51065 or 51066 applies
51062	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at 2 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51063, 51064, 51065 or 51066 applies
51063	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at 3 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51064, 51065 or 51066 applies
51063	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at 3 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51064, 51065 or 51066 applies
51064	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at 4 to 7 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51065 or 51066 applies
51064	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at 4 to 7 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51065 or 51066 applies
51065	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at 8 to 11 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51066 applies
51065	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at 8 to 11 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51066 applies
51066	01NOV2018	31OCT2019	N	Spine fusion, anterior and posterior, including spinal instrumentation at 12 or more motion segments, posterior and/or posterolateral bone graft, and anterior column fusion not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51065 applies
51066	01NOV2019	31DEC9999	Y	Spinal fusion, anterior and posterior, including spinal instrumentation at 12 or more motion segments, posterior and/or posterolateral bone graft, and anterior column fusion not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51065 applies
51071	01NOV2018	31DEC2021	N	Removal of intradural lesion, not being a service associated with a service to which item 51072 or 51073 applies
51071	01JAN2022	31DEC9999	Y	Removal of intradural lesion, or primary extradural tumour or lesion, where the pathology is confirmed by histology - not including removal of synovial or juxtafacet cyst and not being a service associated with a service to which item 51072 or 51073 applies (H)
51072	01NOV2018	31DEC9999	Y	Craniocervical junction lesion, transoral approach for, not being a service associated with a service to which item 51071 or 51073 applies
51073	01NOV2018	31DEC9999	Y	Removal of intramedullary tumour or arteriovenous malformation, not being a service associated with a service to which item 51071 or 51072 applies
51102	01NOV2018	31DEC9999	Y	Thoracoplasty in combination with thoracic scoliosis correction-3 or more ribs
51103	01NOV2018	31DEC9999	Y	Odontoid screw fixation
51110	01NOV2018	31DEC9999	Y	Spine, treatment of fracture, dislocation or fracture dislocation, with immobilisation by calipers or halo, not including application of skull tongs or calipers as part of operative positioning
51111	01NOV2018	31DEC9999	Y	Skull calipers or halo, insertion of, as an independent procedure
51112	01NOV2018	31DEC9999	Y	Plaster jacket, application of, as an independent procedure
51113	01NOV2018	31DEC9999	Y	Halo, application of, in addition to spinal fusion for scoliosis, or other conditions
51114	01NOV2018	31DEC9999	Y	Halo thoracic orthosis-application of both halo and thoracic jacket
51115	01NOV2018	31DEC9999	Y	Halo femoral traction, as an independent procedure
51120	01NOV2018	31DEC9999	Y	Bone graft, harvesting of autogenous graft, via separate incision or via subcutaneous approach, in conjunction with spinal fusion, other than for the purposes of bone graft obtained from the cervical, thoracic, lumbar or sacral spine
51130	01NOV2018	31DEC9999	Y	Lumbar artificial intervertebral total disc replacement, at one motion segment only, including removal of disc and marginal osteophytes: (a) for a patient who: (i) has not had prior spinal fusion surgery at the same lumbar level; and (ii) does not have vertebral osteoporosis; and (iii) has failed conservative therapy; and (b) not being a service associated with a service to which item 51011, 51012, 51013, 51014 or 51015 applies
51131	01NOV2018	31DEC9999	Y	Cervical artificial intervertebral total disc replacement, at one motion segment only, including removal of disc and marginal osteophytes, for a patient who: (a) has not had prior spinal surgery at the same cervical level; and (b) is skeletally mature; and (c) has symptomatic degenerative disc disease with radiculopathy; and (d) does not have vertebral osteoporosis; and (e) has failed conservative therapy
51140	01NOV2018	31DEC9999	Y	Previous spinal fusion, re-exploration for, involving adjustment or removal of instrumentation up to 3 motion segments, not being a service associated with a service to which item 51141 applies
51141	01NOV2018	31DEC9999	Y	Previous spinal fusion, re-exploration for, involving adjustment or removal of instrumentation more than 3 motion segments, not being a service associated with a service to which item 51140 applies
51145	01NOV2018	31DEC9999	Y	Wound debridement or excision for post operative infection or haematoma following spinal surgery
51150	01NOV2018	31DEC9999	Y	Coccyx, excision of
51160	01NOV2018	31DEC9999	Y	Anterior exposure of thoracic or lumbar spine, one motion segment, not being a service to which item 51165 applies
51165	01NOV2018	29FEB2024	N	Anterior exposure of thoracic or lumbar spine, more than one motion segment, not being a service to which item 51160 applies
51165	01MAR2024	31DEC9999	Y	Anterior exposure of thoracic or lumbar spine, more than one motion segment, excluding vertebral body tethering for the treatment of scoliosis and not being a service to which item 51160 applies (H)
51170	01NOV2018	31DEC9999	Y	Syringomyelia or hydromyelia, craniotomy for, with or without duraplasty, intradural dissection, plugging of obex or local cerebrospinal fluid shunt
51171	01NOV2018	31DEC9999	Y	Syringomyelia or hydromyelia, treatment by direct cerebrospinal fluid shunt (for example, syringosubarachnoid shunt, syringopleural shunt or syringoperitoneal shunt)
51300	01DEC1991	31OCT1994	N	NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45
51300	01NOV1994	30JUN1995	N	NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45
51300	01JUL1995	31OCT1995	N	NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies
51300	01NOV1995	31OCT1996	N	NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $186.50 but does not exceed $331.30 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $186.50 but where the fee for the series or combination of operations does not exceed $331.30 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies
51300	01NOV1996	30APR1997	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $331.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $331.30"
51300	01MAY1997	31OCT1997	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $410.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $410.00"
51300	01NOV1997	31OCT1998	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $416.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $416.95"
51300	01NOV1998	31OCT1999	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $423.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $423.20"
51300	01NOV1999	31OCT2000	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $429.55 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $429.55"
51300	01NOV2000	31OCT2001	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65"
51300	01NOV2001	31OCT2002	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65"
51300	01NOV2002	31OCT2003	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $452.70 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $452.70"
51300	01NOV2003	31OCT2004	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $464.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $464.00"
51300	01NOV2004	31OCT2005	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $473.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $473.75"
51300	01NOV2005	31OCT2006	N	"NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $483.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $483.20"
51300	01NOV2006	31OCT2008	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $493.35 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $493.35"
51300	01NOV2008	31OCT2009	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $515.80 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $515.80"
51300	01NOV2009	31OCT2010	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $527.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $527.65"
51300	01NOV2010	31OCT2011	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $537.15 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $537.15"
51300	01NOV2011	31OCT2012	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $547.90 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $547.90"
51300	01NOV2012	30JUN2019	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $558.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $558.30"
51300	01JUL2019	30JUN2020	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $567.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $567.25"
51300	01JUL2020	30JUN2021	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $575.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $575.75"
51300	01JUL2021	30JUN2022	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $580.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $580.95"
51300	01JUL2022	30JUN2023	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $590.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $590.25"
51300	01JUL2023	31OCT2023	N	"Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $611.50 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $611.50"
51300	01NOV2023	30JUN2024	N	Assistance at any operation mentioned in an item in Group T8 that includes “(Assist.)” for which the fee does not exceed $614.55 or at a series or combination of operations mentioned in an item in Group T8 that include “(Assist.)” for which the aggregate fee does not exceed $614.55
51300	01JUL2024	31DEC9999	Y	Assistance at any operation mentioned in an item in Group T8 that includes “(Assist.)” for which the fee does not exceed $636.05 or at a series or combination of operations mentioned in an item in Group T8 that include “(Assist.)” for which the aggregate fee does not exceed $636.05
51303	01DEC1991	31OCT1994	N	Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20
51303	01NOV1994	30JUN1995	N	Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20
51303	01JUL1995	31OCT1995	N	Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies
51303	01NOV1995	31OCT1996	N	Assistance at any operation for which the fee exceeds $331.30 or at a combination of operations for which the aggregate fee exceeds $331.30 provided that the fee for at least 1 of the operations exceeds $186.50 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies
51303	01NOV1996	30APR1997	N	"Assistance at any operation identified by the word ""Assist."" for which the fees exceeds $331.30 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $331.30."
51303	01MAY1997	31OCT1997	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $410.00 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $410.00."
51303	01NOV1997	31OCT1998	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $416.95 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $416.95"
51303	01NOV1998	31OCT1999	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $423.20 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $423.20"
51303	01NOV1999	31OCT2000	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $429.55 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $429.55"
51303	01NOV2000	31OCT2001	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $441.65"
51303	01NOV2001	31OCT2002	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $441.65"
51303	01NOV2002	31OCT2003	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $452.70 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $452.70"
51303	01NOV2003	31OCT2004	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $464.00 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $464.00"
51303	01NOV2004	31OCT2005	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $473.75 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $473.75"
51303	01NOV2005	31OCT2006	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $483.20 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $483.20"
51303	01NOV2006	31OCT2008	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $493.35 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $493.35"
51303	01NOV2008	31OCT2009	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $515.80 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $515.80"
51303	01NOV2009	31OCT2010	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $527.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $527.65"
51303	01NOV2010	31OCT2011	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $537.15 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $537.15"
51303	01NOV2011	31OCT2012	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $547.90 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $547.90"
51303	01NOV2012	30JUN2019	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $558.30 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $558.30."
51303	01JUL2019	30JUN2020	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $567.25 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $567.25."
51303	01JUL2020	30JUN2021	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $575.75 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $575.75"
51303	01JUL2021	30JUN2022	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $580.95 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $580.95"
51303	01JUL2022	30JUN2023	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $590.25 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $590.25"
51303	01JUL2023	31OCT2023	N	"Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $611.50 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $611.50"
51303	01NOV2023	30JUN2024	N	Assistance at any operation mentioned in an item in Group T8 that includes “(Assist.)” for which the fee exceeds $614.55 or at a series or combination of operations mentioned in an item in Group T8 that include “(Assist.)” for which the aggregate fee exceeds $614.55
51303	01JUL2024	31DEC9999	Y	Assistance at any operation mentioned in an item in Group T8 that includes “(Assist.)” for which the fee exceeds $636.05 or at a series or combination of operations mentioned in an item in Group T8 that include “(Assist.)” for which the aggregate fee exceeds $636.05
51306	01DEC1991	31OCT2017	N	Assistance at a delivery involving Caesarean section
51306	01NOV2017	31DEC9999	Y	Assistance at a birth involving Caesarean section
51309	01DEC1991	31OCT1996	N	Assistance at a series or combination of operations, 1 of which is a delivery involving Caesarean section
51309	01NOV1996	31OCT2017	N	"Assistance at a series or combination of operations which have been identified by the word ""Assist."" and assistance at a delivery involving Caesarean section"
51309	01NOV2017	31DEC9999	Y	Assistance at a series or combination of operations that include “(Assist.)” and assistance at a birth involving Caesarean section
51312	01JUL1995	31OCT1995	N	Assistance at any interventional obstetric procedure described in items 16609, 16612, 16615 and 16633
51312	01NOV1995	31OCT2017	N	Assistance at any interventional obstetric procedure covered by items 16606, 16609, 16612, 16615, 16627 and 16633
51312	01NOV2017	31DEC9999	Y	Assistance at any interventional obstetric procedure covered by items 16606, 16609, 16612, 16615 and 16627
51315	01MAY1997	31OCT2012	N	Assistance at cataract and intraocular lens surgery covered by item 42698,42701, 42702, 42704 or 42707, when performed in association with services covered by item 42551 to 42569, 42653, 42656, 42746, 42749, 42752, 42776 or 42779
51315	01NOV2012	31DEC9999	Y	Assistance at cataract and intraocular lens surgery covered by item 42698, 42701, 42702, 42704 or 42707, when performed in association with services covered by item 42551 to 42569, 42653, 42656, 42725, 42746, 42749, 42752, 42776 or 42779
51318	01MAY1997	31DEC9999	Y	Assistance at cataract and intraocular lens surgery where patient has: - total loss of vision, including no potential for central vision, in the fellow eye; or - previous significant surgical complication in the fellow eye; or - pseudo exfoliation, subluxed lens, iridodonesis, phacodonesis, retinal detachment, corneal scarring, pre-existing uveitis, bound down miosed pupil, nanophthalmos, spherophakia, Marfan's syndrome, homocysteinuria or previous blunt trauma causing intraocular damage
51700	01DEC1991	31OCT1999	N	PROFESSIONAL ATTENDANCE (other than a second or subsequent attendance in a single course of treatment) BY AN APPROVED DENTAL PRACTITIONER where the patient is referred to the approved dental practitioner - an attendance related to a subsequent operative procedure described in an item in Groups O3 to O9 where that attendance is at consulting rooms, hospital or nursing home (The referral must be from a registered dental practitioner or a medical practitioner)
51700	01NOV1999	31OCT2000	N	APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by an approved dental practitioner in the practice of oral and maxillofacial surgery where the patient is referred to him or her) (The referral must be from a registered dental practitioner or a medical practitioner) - INITIAL attendance in a single course of treatment
51700	01NOV2000	31OCT2007	N	APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance at consulting rooms, hospital or residential aged care facility by an approved dental practitioner in the practice of oral and maxillofacial surgery where the patient is referred to him or her) (The referral must be from a registered dental practitioner or a medical practitioner) - INITIAL attendance in a single course of treatment
51700	01NOV2007	31DEC9999	Y	APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner, at consulting rooms, hospital or residential aged care facility where the patient is referred to him or her
51703	01DEC1991	31OCT1999	N	PROFESSIONAL ATTENDANCE BY AN APPROVED DENTAL PRACTITIONER where the patient is referred to the approved dental practitioner - each attendance related to an operative procedure described in an item in Groups O3 to O9 subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home (The referral must be from a registered dental practitioner or a medical practitioner)
51703	01NOV1999	31OCT2007	N	- Each attendance SUBSEQUENT to the first in a single course of treatment
51703	01NOV2007	31DEC9999	Y	Professional attendance by an approved dental practitioner, each attendance subsequent to the first in a single course of treatment at consulting rooms, hospital or residential aged care facility where the patient is referred to him or her
51800	01DEC1991	31OCT1994	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45
51800	01NOV1994	31OCT1995	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45
51800	01NOV1995	31OCT1996	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $186.50 but does not exceed $331.30 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $186.50 but where the fee for the series or combination of operations does not exceed $331.30
51800	01NOV1996	30APR1997	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $331.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $331.30"
51800	01MAY1997	31OCT1997	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $410.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $410.00"
51800	01NOV1997	31OCT1998	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $416.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $416.95"
51800	01NOV1998	31OCT1999	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $423.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $423.20"
51800	01NOV1999	31OCT2000	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $429.55 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $429.55"
51800	01NOV2000	31OCT2001	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65"
51800	01NOV2001	31OCT2002	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65"
51800	01NOV2002	31OCT2003	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $452.70 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $452.70"
51800	01NOV2003	31OCT2004	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $464.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $464.00"
51800	01NOV2004	31OCT2005	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $473.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $473.75"
51800	01NOV2005	31OCT2006	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $483.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $483.20"
51800	01NOV2006	31OCT2008	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $493.35 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $493.35"
51800	01NOV2008	31OCT2009	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $515.80 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $515.80"
51800	01NOV2009	31OCT2010	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $527.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $527.65"
51800	01NOV2010	31OCT2011	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $537.15 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $537.15"
51800	01NOV2011	31OCT2012	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $547.90 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $547.90"
51800	01NOV2012	30JUN2019	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $558.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $558.30"
51800	01JUL2019	30JUN2020	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $567.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $567.25"
51800	01JUL2020	30JUN2021	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $575.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $575.75"
51800	01JUL2021	30JUN2022	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $580.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $580.95"
51800	01JUL2022	30JUN2023	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $590.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $590.25"
51800	01JUL2023	31OCT2023	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $611.50 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $611.50"
51800	01NOV2023	30JUN2024	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation mentioned in an item that includes “(Assist.)” for which the fee does not exceed $614.55 or at a series or combination of operations mentioned in an item in Groups O3 to O9 that include “(Assist.)” for which the aggregate fee does not exceed $614.55
51800	01JUL2024	31DEC9999	Y	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation mentioned in an item that includes “(Assist.)” for which the fee does not exceed $636.05 or at a series or combination of operations mentioned in an item in Groups O3 to O9 that include “(Assist.)” for which the aggregate fee does not exceed $636.05
51803	01DEC1991	31OCT1994	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20
51803	01NOV1994	31OCT1995	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20
51803	01NOV1995	31OCT1996	N	ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $331.30 or at a combination of operations for which the aggregate fee exceeds $331.30 provided that the fee for at least 1 of the operations exceeds $186.50
51803	01NOV1996	30APR1997	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $331.30 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $331.30"
51803	01MAY1997	31OCT1997	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $410.00 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $410.00"
51803	01NOV1997	31OCT1998	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $416.95 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $416.95"
51803	01NOV1998	31OCT1999	N	"Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $423.20 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $423.20"
51803	01NOV1999	31OCT2000	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $429.55 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $429.55"
51803	01NOV2000	31OCT2001	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $434.70 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $434.70"
51803	01NOV2001	31OCT2002	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $441.65"
51803	01NOV2002	31OCT2003	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $452.70 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $452.70"
51803	01NOV2003	31OCT2004	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $464.00 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $464.00"
51803	01NOV2004	31OCT2005	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $473.75 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $473.75"
51803	01NOV2005	31OCT2006	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $483.20 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $483.20"
51803	01NOV2006	31OCT2008	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $493.35 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $493.35"
51803	01NOV2008	31OCT2009	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $515.80 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $515.80"
51803	01NOV2009	31OCT2010	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $527.65 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $527.65"
51803	01NOV2010	31OCT2011	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $537.15 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $537.15"
51803	01NOV2011	31OCT2012	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $547.90 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $547.90"
51803	01NOV2012	30JUN2019	N	"Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $558.30 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $558.30"
51803	01JUL2019	30JUN2020	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $567.25 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $567.25
51803	01JUL2020	30JUN2021	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $575.75 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $575.75
51803	01JUL2021	30JUN2022	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $580.95 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $580.95
51803	01JUL2022	30JUN2023	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $590.25 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $590.25
51803	01JUL2023	31OCT2023	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $611.50 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $611.50
51803	01NOV2023	30JUN2024	N	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation mentioned in an item that includes “(Assist.)” for which the fee exceeds $614.55 or at a series or combination of operations mentioned in an item that include “(Assist.)” if the aggregate fee exceeds $614.55
51803	01JUL2024	31DEC9999	Y	Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation mentioned in an item that includes “(Assist.)” for which the fee exceeds $636.05 or at a series or combination of operations mentioned in an item that include “(Assist.)” if the aggregate fee exceeds $636.05
51900	01NOV2000	31OCT2007	N	WOUND OF SOFT TISSUE IN THE ORAL AND MAXILLOFACIAL REGION, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed
51900	01NOV2007	31DEC9999	Y	WOUND OF SOFT TISSUE, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed
51902	01NOV2000	31OCT2007	N	WOUNDS, OF THE ORAL AND MAXILLOFACIAL REGION, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in Groups O3 to O9 applies
51902	01NOV2007	31DEC9999	Y	WOUNDS, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in Groups O3 to O9 applies
51904	01NOV2000	30APR2001	N	LIPECTOMY - wedge excision of skin or fat - 1 EXCISION
51904	01MAY2001	31OCT2007	N	LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 1 EXCISION
51904	01NOV2007	31DEC9999	Y	LIPECTOMY - wedge excision of skin or fat - 1 EXCISION
51906	01NOV2000	30APR2001	N	LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 2 OR MORE EXCISIONS
51906	01MAY2001	31OCT2007	N	LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 2 OR MORE EXCISIONS
51906	01NOV2007	31DEC9999	Y	LIPECTOMY - wedge excision of skin or fat - 2 OR MORE EXCISIONS
52000	01DEC1991	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CM LONG), superficial
52001	01NOV1992	31DEC9999	Y	OPERATIVE PROCEDURE ON TISSUE, ORGAN OR REGION not being a service to which another item in Groups O3 to O9 applies, including any consultation on the same occasion
52003	01DEC1991	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue
52006	01DEC1991	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CM LONG), superficial
52009	01DEC1991	31DEC9999	Y	SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue
52010	01NOV2000	31DEC9999	Y	FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with accurate apposition of each layer of tissue
52012	01DEC1991	30APR2001	N	SUPERFICIAL FOREIGN BODY, removal of, as an independent procedure
52012	01MAY2001	31OCT2007	N	SUPERFICIAL FOREIGN BODY, in the oral and maxillofacial region, removal of, as an independent procedure
52012	01NOV2007	31DEC9999	Y	SUPERFICIAL FOREIGN BODY, removal of, as an independent procedure
52015	01DEC1991	30APR2001	N	SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and suture, as an independent procedure
52015	01MAY2001	31OCT2007	N	SUBCUTANEOUS FOREIGN BODY, in the oral and maxillofacial region, removal of, requiring incision and suture, as an independent procedure
52015	01NOV2007	31DEC9999	Y	SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and suture, as an independent procedure
52018	01DEC1991	30APR2001	N	FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure
52018	01MAY2001	31OCT2007	N	FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, in the oral and maxillofacial region, removal of, as an independent procedure
52018	01NOV2007	31DEC9999	Y	FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure
52021	01DEC1991	31DEC9999	Y	ASPIRATION BIOPSY of 1 or MORE JAW CYSTS as an independent procedure to obtain material for diagnostic purposes and not being a service associated with an operative procedure on the same day
52024	01DEC1991	30APR2001	N	BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure
52024	01MAY2001	31OCT2007	N	BIOPSY OF SKIN OR MUCOUS MEMBRANE, in the oral and maxillofacial region, as an independent procedure
52024	01NOV2007	31DEC9999	Y	BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure
52025	01NOV2000	31DEC9999	Y	LYMPH NODE OF NECK, biopsy of
52027	01DEC1991	31OCT2000	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure
52027	01NOV2000	30APR2001	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies
52027	01MAY2001	31OCT2007	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, in the oral and maxillofacial region, as an independent procedure and not being a service to which item 52025 applies
52027	01NOV2007	31OCT2019	N	BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies
52027	01NOV2019	31DEC9999	Y	BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies
52030	01DEC1991	30APR2001	N	SINUS, excision of, involving superficial tissue only
52030	01MAY2001	31OCT2007	N	SINUS, in the oral and maxillofacial region, excision of, involving superficial tissue only
52030	01NOV2007	31DEC9999	Y	SINUS, excision of, involving superficial tissue only
52031	01NOV2000	31DEC9999	Y	PRE-AURICULAR SINUS, excision of
52033	01DEC1991	30APR2001	N	SINUS, excision of, involving muscle and deep tissue
52033	01MAY2001	31OCT2007	N	SINUS, in the oral and maxillofacial region, excision of, involving muscle and deep tissue
52033	01NOV2007	31DEC9999	Y	SINUS, excision of, involving muscle and deep tissue
52034	01MAY1997	31OCT2000	N	PREMALIGNANT LESIONS of the oral mucous, treatment by liquid nitrogen cryotherapy
52034	01NOV2000	31DEC9999	Y	PREMALIGNANT LESIONS of the oral mucous, treatment by cryotherapy, diathermy or carbon dioxide laser
52035	01NOV2000	30APR2001	N	ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the upper aerodigestive tract
52035	01MAY2001	31OCT2001	N	ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the upper aerodigestive tract in the practice of oral and maxillofacial surgery
52035	01NOV2001	31DEC9999	Y	ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions of the oral cavity
52036	01DEC1991	30APR2001	N	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies
52036	01MAY2001	31OCT2007	N	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation),in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies
52036	01NOV2007	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies
52039	01DEC1991	30APR2001	N	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions
52039	01MAY2001	31OCT2007	N	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions
52039	01NOV2007	31DEC9999	Y	TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions
52042	01DEC1991	30APR2001	N	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
52042	01MAY2001	31OCT2007	N	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
52042	01NOV2007	31DEC9999	Y	TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane
52045	01DEC1991	31OCT1992	N	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in Groups O3 to O9, involving muscle, bone, or other deep tissue
52045	01NOV1992	30APR2001	N	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue
52045	01MAY2001	31OCT2007	N	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue
52045	01NOV2007	31DEC9999	Y	TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue
52048	01DEC1991	31OCT1992	N	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in Groups O3 to O9
52048	01NOV1992	30APR2001	N	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies
52048	01MAY2001	31OCT2007	N	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), in the oral and maxillofacial region, removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies
52048	01NOV2007	31DEC9999	Y	TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies
52051	01DEC1991	30APR2001	N	TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft
52051	01MAY2001	31OCT2007	N	TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft
52051	01NOV2007	31DEC9999	Y	TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft
52054	01DEC1991	30APR2001	N	TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft
52054	01MAY2001	31OCT2007	N	TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft
52054	01NOV2007	31DEC9999	Y	TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft
52055	01NOV1992	31OCT2000	N	HAEMATOMA, SMALL ABSCESS OR CELLULITIS IN THE ORAL AND MAXILLOFACIAL REGION, not requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding after care)
52055	01NOV2000	31OCT2007	N	HAEMATOMA, SMALL ABSCESS OR CELLULITIS IN THE ORAL AND MAXILLOFACIAL REGION, not requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding after care)
52055	01NOV2007	31DEC9999	Y	HAEMATOMA, SMALL ABSCESS OR CELLULITIS, not requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding after care)
52056	01NOV2000	31OCT2007	N	HAEMATOMA IN THE ORAL AND MAXILLOFACIAL REGION, aspiration of
52056	01NOV2007	31DEC9999	Y	HAEMATOMA, aspiration of
52057	01DEC1991	31OCT2000	N	LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, INCISION WITH DRAINAGE OF (excluding aftercare), where undertaken in the operating theatre of a hospital or approved day-hospital facility
52057	01NOV2000	31OCT2007	N	LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion IN THE ORAL AND MAXILLOFACIAL REGION, requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding aftercare)
52057	01NOV2007	31DEC9999	Y	LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding aftercare)
52058	01NOV2000	31OCT2007	N	PERCUTANEOUS DRAINAGE OF DEEP ABSCESS IN THE ORAL AND MAXILLOFACIAL REGION, using interventional imaging techniques - but not including imaging
52058	01NOV2007	31DEC9999	Y	PERCUTANEOUS DRAINAGE OF DEEP ABSCESS, using interventional imaging techniques - but not including imaging
52059	01NOV2000	31OCT2007	N	ABSCESS IN THE ORAL AND MAXILLOFACIAL REGION DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging
52059	01NOV2007	31DEC9999	Y	ABSCESS, DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging
52060	01DEC1991	31OCT2000	N	MUSCLE, excision of
52060	01NOV2000	31OCT2007	N	MUSCLE IN THE ORAL AND MAXILLOFACIAL REGION, excision of
52060	01NOV2007	31DEC9999	Y	MUSCLE, excision of
52061	01NOV2000	31OCT2007	N	MUSCLE, IN THE ORAL AND MAXILLOFACIAL REGION, RUPTURED, repair of (limited), not associated with external wound
52061	01NOV2007	31DEC9999	Y	MUSCLE, RUPTURED, repair of (limited), not associated with external wound
52062	01NOV2000	31OCT2007	N	MUSCLE, IN THE ORAL AND MAXILLOFACIAL REGION, RUPTURED, repair of (extensive), not associated with external wound
52062	01NOV2007	31DEC9999	Y	MUSCLE, RUPTURED, repair of (extensive), not associated with external wound
52063	01DEC1991	31OCT2000	N	BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies
52063	01NOV2000	31OCT2007	N	BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies
52063	01NOV2007	31DEC9999	Y	BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies
52064	01NOV2000	31OCT2007	N	BONE CYST IN THE ORAL AND MAXILLOFACIAL REGION, injection into or aspiration of
52064	01NOV2007	31DEC9999	Y	BONE CYST, injection into or aspiration of
52066	01DEC1991	31DEC9999	Y	SUBMANDIBULAR GLAND, extirpation of
52069	01DEC1991	31DEC9999	Y	SUBLINGUAL GLAND, extirpation of
52072	01DEC1991	31DEC9999	Y	SALIVARY GLAND, DILATATION OR DIATHERMY of duct
52073	01NOV2000	31DEC9999	Y	SALIVARY GLAND, repair of CUTANEOUS FISTULA OF
52075	01DEC1991	31DEC9999	Y	SALIVARY GLAND, removal of CALCULUS from duct or meatotomy or marsupialisation, 1 or more such procedures
52078	01DEC1991	31DEC9999	Y	TONGUE, partial excision of
52081	01DEC1991	31DEC9999	Y	TONGUE TIE, division or excision of frenulum
52084	01DEC1991	30JUN2021	N	TONGUE TIE, MANDIBULAR FRENULUM OR MAXILLARY FRENULUM, division or excision of frenulum, in a person aged not less than 2 years
52084	01JUL2021	31DEC9999	Y	TONGUE TIE, MANDIBULAR FRENULUM OR MAXILLARY FRENULUM, division or excision of frenulum, in a patient aged not less than 2 years
52087	01DEC1991	31DEC9999	Y	RANULA OR MUCOUS CYST OF MOUTH, removal of
52090	01DEC1991	31OCT1992	N	OPERATION (FOR ACUTE OSTEOMYLITIS) ON MANDIBLE OR MAXILLA (other than alveolar margins) ONE BONE
52090	01NOV1992	31OCT2000	N	OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for osteomyelitis - 1 bone
52090	01NOV2000	31DEC9999	Y	OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for chronic osteomyelitis - 1 bone or in combination with adjoining bones
52092	01NOV1992	31DEC9999	Y	OPERATION on SKULL for OSTEOMYELITIS
52093	01DEC1991	31DEC9999	Y	OPERATION (FOR CHRONIC OSTEOMYELITIS) ON MANDIBLE OR MAXILLA OR MANDIBLE AND MAXILLA (other than alveolar margins)
52094	01NOV2000	31OCT2007	N	OPERATION ON ANY COMBINATION OF ADJOINING BONES IN THE ORAL AND MAXILLOFACIAL REGION, being bones referred to in item 52092
52094	01NOV2007	31DEC9999	Y	OPERATION ON ANY COMBINATION OF ADJOINING BONES, being bones referred to in item 52092
52095	01NOV2000	31OCT2007	N	BONE GROWTH STIMULATOR IN THE ORAL AND MAXILLOFACIAL REGION, insertion of
52095	01NOV2007	31DEC9999	Y	BONE GROWTH STIMULATOR, insertion of
52096	01DEC1991	31DEC9999	Y	ORTHOPAEDIC PIN OR WIRE, insertion of, into maxilla or mandible or zygoma, as an independent procedure
52097	01NOV2000	31OCT2007	N	EXTERNAL FIXATION IN THE ORAL AND MAXILLOFACIAL REGION, removal of, in the operating theatre of a hospital or approved day-hospital facility
52097	01NOV2007	31DEC9999	Y	EXTERNAL FIXATION, removal of, in the operating theatre of a hospital
52098	01NOV2000	31OCT2007	N	EXTERNAL FIXATION IN THE ORAL AND MAXILLOFACIAL REGION, removal of, in conjunction with operations involving internal fixation or bone grafting or both
52098	01NOV2007	31DEC9999	Y	EXTERNAL FIXATION, removal of, in conjunction with operations involving internal fixation or bone grafting or both
52099	01DEC1991	31DEC9999	Y	BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, per bone, not being a service associated with a service to which item 52102 or 52105 applies
52102	01DEC1991	31OCT2007	N	BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, where undertaken in the operating theatre of a hospital or approved day-hospital facility, per bone
52102	01NOV2007	31DEC9999	Y	BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, where undertaken in the operating theatre of a hospital, per bone
52105	01DEC1991	31DEC9999	Y	PLATE, 1 or more of, and associated screw and wire which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, per bone, not being a service associated with a service to which item 52099 or 52102 applies
52106	01MAY1997	31OCT2007	N	ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital or approved day-hospital facility
52106	01NOV2007	31DEC9999	Y	ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital
52108	01DEC1991	31DEC9999	Y	LIP, full thickness wedge excision of, with repair by direct sutures
52111	01DEC1991	31DEC9999	Y	VERMILIONECTOMY
52114	01DEC1991	31DEC9999	Y	MANDIBLE or MAXILLA, segmental resection of, for tumours or cysts
52117	01DEC1991	31DEC9999	Y	MANDIBLE, including lower border, or MAXILLA, sub-total resection of
52120	01DEC1991	31DEC9999	Y	MANDIBLE, hemimandiblectomy of, including condylectomy where performed
52122	01NOV1992	30APR1997	N	MANDIBLE, HEMI-MANDIBULAR RECONSTRUCTION with BONE GRAFT, not being a service associated with a service to which item 52123 applies
52122	01MAY1997	31DEC9999	Y	MANDIBLE, hemi-mandibular reconstruction of, OR MAXILLA, reconstruction of, with BONE GRAFT, PLATE, TRAY OR ALLOPLAST, not being a service associated with a service to which item 52123 applies
52123	01DEC1991	31DEC9999	Y	MANDIBLE, total resection of both sides, including condylectomies where performed
52126	01DEC1991	31DEC9999	Y	MAXILLA, total resection of
52129	01DEC1991	31DEC9999	Y	MAXILLA, total resection of both maxillae
52130	01NOV2000	31OCT2007	N	BONE GRAFT IN THE ORAL AND MAXILLOFACIAL REGION, not being a service to which another item in Groups O3 to O9 applies
52130	01NOV2007	31DEC9999	Y	BONE GRAFT, not being a service to which another item in Groups O3 to O9 applies
52131	01NOV2000	31OCT2007	N	BONE GRAFT WITH INTERNAL FIXATION, IN THE ORAL AND MAXILLOFACIAL REGION, not being a service to which another item in Groups O3 to O9 applies
52131	01NOV2007	31OCT2008	N	BONE GRAFT WITH INTERNAL FIXATION, not being a service to which an item in the range 51900 to 53070 or the range 53203 to 53460 applies
52131	01NOV2008	31DEC9999	Y	BONE GRAFT WITH INTERNAL FIXATION, not being a service to which an item in the range (a) 51900 to 52186; or (b) 52303 to 53460 applies
52132	01DEC1991	31DEC9999	Y	TRACHEOSTOMY
52133	01NOV2000	31DEC9999	Y	CRICOTHYROSTOMY by direct stab or Seldinger technique, using Minitrach or similar device
52135	01DEC1991	31OCT2007	N	POST-OPERATIVE or POST-NASAL HAEMORRHAGE, or both, control of, where undertaken in the operating theatre of a hospital or approved day-hospital facility
52135	01NOV2007	31DEC9999	Y	POST-OPERATIVE or POST-NASAL HAEMORRHAGE, or both, control of, where undertaken in the operating theatre of a hospital
52136	01NOV2000	30APR2001	N	ARTERIAL OR VENOUS ANASTOMOSIS, as an independent procedure
52136	01MAY2001	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS, as an independent procedure in the practice of oral and maxillofacial surgery
52137	01NOV2000	30APR2001	N	ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item applies, when performed in combination with another vascular operation (including graft to graft anastomosis)
52137	01MAY2001	31DEC9999	Y	ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item applies, when performed in combination with another vascular operation (including graft to graft anastomosis) in the practice of oral and maxillofacial surgery
52138	01DEC1991	31DEC9999	Y	MAXILLARY ARTERY, ligation of
52141	01DEC1991	31DEC9999	Y	FACIAL, MANDIBULAR or LINGUAL ARTERY or VEIN or ARTERY and VEIN, ligation of, not being a service to which item 52138 applies
52144	01DEC1991	30APR2001	N	FOREIGN BODY, deep, removal of using interventional imaging techniques
52144	01MAY2001	31OCT2007	N	FOREIGN BODY, in the oral and maxillofacial region, deep, removal of using interventional imaging techniques
52144	01NOV2007	31DEC9999	Y	FOREIGN BODY, deep, removal of using interventional imaging techniques
52147	01DEC1991	31DEC9999	Y	DUCT OF MAJOR SALIVARY GLAND, transposition of
52148	01NOV1992	31DEC9999	Y	PAROTID DUCT, repair of, using micro-surgical techniques
52150	01NOV2000	31DEC9999	Y	PAROTID GLAND, total extirpation of
52152	01NOV2000	31DEC9999	Y	PAROTID GLAND, total extirpation of, with preservation of facial nerve
52154	01NOV2000	31DEC9999	Y	RECURRENT PAROTID TUMOUR, excision of, with preservation of facial nerve
52156	01NOV2000	31DEC9999	Y	PAROTID GLAND, SUPERFICIAL LOBECTOMY OF, with exposure of facial nerve
52158	01NOV2000	31DEC9999	Y	SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling
52160	01NOV2000	31DEC9999	Y	RADICAL EXCISION OF INTRA-ORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH GLANDS OF NECK (commando-type operation)
52166	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck
52168	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, selective dissection of 3 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck
52170	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, selective dissection of 4 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve
52172	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, bilateral dissection of levels I, II and III (bilateral supraomohyoid dissections)
52174	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck
52176	01NOV2000	31DEC9999	Y	LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve
52180	01NOV2000	31OCT2007	N	MALIGNANT DISEASE AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, biopsy of (not including aftercare)
52180	01NOV2007	31DEC9999	Y	MALIGNANT DISEASE AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, biopsy of (not including aftercare)
52182	01NOV2000	31OCT2007	N	BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of
52182	01NOV2007	31DEC9999	Y	BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR, lesional or marginal excision of
52184	01NOV2000	31OCT2007	N	BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation
52184	01NOV2007	31DEC9999	Y	BONE TUMOUR, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation
52186	01NOV2000	31OCT2007	N	BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation
52186	01NOV2007	31DEC9999	Y	BONE TUMOUR, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation
52300	01DEC1991	30APR2001	N	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with skin or mucosa
52300	01MAY2001	31OCT2007	N	SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, with skin or mucosa
52300	01NOV2007	31DEC9999	Y	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with skin or mucosa
52303	01DEC1991	30APR2001	N	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with buccal pad of fat
52303	01MAY2001	31OCT2007	N	SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, with buccal pad of fat
52303	01NOV2007	31DEC9999	Y	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with buccal pad of fat
52306	01DEC1991	30APR2001	N	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, using temporalis muscle
52306	01MAY2001	31OCT2007	N	SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, using temporalis muscle
52306	01NOV2007	31DEC9999	Y	SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, using temporalis muscle
52309	01DEC1991	30APR2001	N	FREE GRAFTING (mucosa or split skin) of a granulating area
52309	01MAY2001	31OCT2007	N	FREE GRAFTING (mucosa or split skin) of a granulating area in the oral and maxillofacial region,
52309	01NOV2007	31DEC9999	Y	FREE GRAFTING (mucosa or split skin) of a granulating area
52312	01DEC1991	31OCT1995	N	FREE GRAFTING (mucosa or split skin) to 1 defect, including elective dissection
52312	01NOV1995	30APR2001	N	FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect including elective dissection
52312	01MAY2001	31OCT2007	N	FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect in the oral and maxillofacial region, including elective dissection
52312	01NOV2007	31DEC9999	Y	FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect, including elective dissection
52315	01DEC1991	30APR2001	N	FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin)
52315	01MAY2001	31OCT2007	N	FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin) in the oral and maxillofacial region
52315	01NOV2007	31DEC9999	Y	FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin)
52318	01DEC1991	31MAR1992	N	HARVESTING OF BONE GRAFT via separate incision, associated with any other item in Groups O3 to O9 - autogenous
52318	01APR1992	31DEC9999	Y	BONE GRAFT, harvesting of, via separate incision, being a service associated with a service to which another item in Groups O3 to O9 applies - Autogenous - small quantity
52319	01APR1992	31DEC9999	Y	BONE GRAFT, harvesting of, via separate incision, being a service associated with a service to which another item in Groups O3 to O9 applies - Autogenous - large quantity
52320	01NOV2000	31DEC9999	Y	VASCULARISED PEDICLE BONE GRAFT TO BE USED IN THE ORAL AND MAXILLOFACIAL REGION, harvesting of, in conjunction with another service
52321	01DEC1991	30APR2001	N	FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies
52321	01MAY2001	31OCT2007	N	FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of in the oral and maxillofacial region, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies
52321	01NOV2007	31DEC9999	Y	FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies
52324	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, using tongue, first stage
52327	01DEC1991	31DEC9999	Y	DIRECT FLAP REPAIR, using tongue, second stage
52330	01DEC1991	31DEC9999	Y	PALATAL DEFECT (oro-nasal fistula), plastic closure of, including services to which item 52300, 52303, 52306 or 52324 applies
52333	01DEC1991	31DEC9999	Y	CLEFT PALATE, primary repair
52336	01DEC1991	31DEC9999	Y	CLEFT PALATE, secondary repair, closure of fistula using local flaps
52337	01MAY1997	31DEC9999	Y	ALVEOLAR CLEFT (congenital) unilateral, grafting of, including plastic closure of associated oro-nasal fistulae and ridge augmentation
52339	01DEC1991	31DEC9999	Y	CLEFT PALATE, secondary repair, lengthening procedure
52342	01DEC1991	31DEC9999	Y	MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
52345	01DEC1991	31OCT2000	N	MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52345	01NOV2000	31DEC9999	Y	MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52348	01DEC1991	31DEC9999	Y	MANDIBLE or MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site
52351	01DEC1991	31OCT2000	N	MANDIBLE or MAXILLA, bilateral osteotomy of osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52351	01NOV2000	31DEC9999	Y	MANDIBLE or MAXILLA, bilateral osteotomy of osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52354	01DEC1991	31DEC9999	Y	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site
52357	01DEC1991	31OCT2000	N	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52357	01NOV2000	31DEC9999	Y	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52360	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site
52360	01JUL1998	31DEC9999	Y	MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site
52363	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52363	01JUL1998	31OCT2000	N	MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52363	01NOV2000	31DEC9999	Y	MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52366	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site
52366	01JUL1998	31DEC9999	Y	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site
52369	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52369	01JUL1998	31OCT2000	N	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52369	01NOV2000	31DEC9999	Y	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52372	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site
52372	01JUL1998	31DEC9999	Y	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site
52375	01DEC1991	30JUN1998	N	MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52375	01JUL1998	31OCT2000	N	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52375	01NOV2000	31DEC2014	N	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52375	01JAN2015	31DEC9999	Y	MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H)
52378	01DEC1991	31DEC9999	Y	GENIOPLASTY including transposition of nerves and vessels and bone grafts taken from the same site
52379	01NOV1992	31DEC9999	Y	FACE, contour reconstruction of 1 region, using autogenous bone or cartilage graft
52380	01NOV1992	31DEC9999	Y	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site
52382	01NOV1992	31OCT2000	N	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both
52382	01NOV2000	31DEC9999	Y	MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination
52420	01NOV1992	31DEC9999	Y	MANDIBLE, fixation by intermaxillary wiring, excluding wiring for obesity
52424	01NOV2000	31OCT2007	N	DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) IN THE ORAL AND MAXILLOFACIAL REGION
52424	01NOV2007	31DEC9999	Y	DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection)
52430	01NOV2000	31OCT2007	N	MICROVASCULAR REPAIR OF THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit
52430	01NOV2007	31DEC9999	Y	MICROVASCULAR REPAIR OF, using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit
52432	01NOV2000	31DEC9999	Y	MICROVASCULAR ANASTOMOSIS of artery or vein IN THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques, for free transfer of tissue including setting in of free flap
52434	01NOV2000	31DEC9999	Y	MICRO-ARTERIAL OR MICRO-VENOUS GRAFT IN THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques
52440	01NOV2000	31DEC9999	Y	CLEFT LIP, unilateral - primary repair, 1 stage, without anterior palate repair
52442	01NOV2000	31DEC9999	Y	CLEFT LIP, unilateral - primary repair, 1 stage, with anterior palate repair
52444	01NOV2000	31DEC9999	Y	CLEFT LIP, bilateral - primary repair, 1 stage, without anterior palate repair
52446	01NOV2000	31DEC9999	Y	CLEFT LIP, bilateral - primary repair, 1 stage, with anterior palate repair
52448	01NOV2000	31DEC9999	Y	CLEFT LIP, lip adhesion procedure, unilateral or bilateral
52450	01NOV2000	31DEC9999	Y	CLEFT LIP, partial revision, including minor flap revision alignment and adjustment, including revision of minor whistle deformity if performed
52452	01NOV2000	31DEC9999	Y	CLEFT LIP, total revision, including major flap revision, muscle reconstruction and revision of major whistle deformity
52454	01NOV2000	31DEC9999	Y	CLEFT LIP, primary columella lengthening procedure, bilateral
52456	01NOV2000	31DEC9999	Y	CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first stage
52458	01NOV2000	31DEC9999	Y	CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second stage
52460	01NOV2000	31DEC9999	Y	VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for
52470	01NOV2000	31DEC9999	Y	FACIAL NERVE PALSY, excision of tissue for
52476	01NOV2000	31DEC9999	Y	EYELID closure in facial nerve paralysis, insertion of foreign implant for
52478	01NOV2000	31DEC9999	Y	EYELID, WHOLE THICKNESS RECONSTRUCTION OF other than by direct suture only
52480	01NOV2000	31DEC9999	Y	COMPOSITE GRAFT (Chondro-cutaneous or chondro-mucosal) to nose, ear or eyelid
52482	01NOV2000	31DEC9999	Y	MACROCHEILIA or macroglossia, operation for
52484	01NOV2000	31DEC9999	Y	MACROSTOMIA, operation for
52600	01DEC1991	31DEC9999	Y	MANDIBULAR OR PALATAL EXOSTOSIS, excision of
52603	01DEC1991	31DEC9999	Y	MYLOHYOID RIDGE, reduction of
52606	01DEC1991	31DEC9999	Y	MAXILLARY TUBEROSITY, reduction of
52609	01DEC1991	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - less than 5 lesions
52612	01DEC1991	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - 5 to 20 lesions
52615	01DEC1991	31DEC9999	Y	PAPILLARY HYPERPLASIA OF THE PALATE, removal of - more than 20 lesions
52618	01DEC1991	31DEC9999	Y	VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral
52621	01DEC1991	31DEC9999	Y	FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral
52624	01DEC1991	31DEC9999	Y	ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral
52626	01NOV1992	31DEC9999	Y	ALVEOLAR RIDGE AUGMENTATION - unilateral, insertion of tissue expanding device into maxillary or mandibular alveolar ridge region for
52627	01DEC1991	30APR2001	N	OSSEO-INTEGRATION PROCEDURE - extra oral implantation of titanium fixture
52627	01MAY2001	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial surgery, extra oral implantation of titanium fixture
52630	01DEC1991	30APR2001	N	OSSEO-INTEGRATION PROCEDURE - fixation of transcutaneous abutment
52630	01MAY2001	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial surgery, fixation of transcutaneous abutment
52633	01MAY1997	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE - intra-oral implantation of titanium fixture to facilitate restoration of the dentition following resection of part of the maxilla or mandible for benign or malignant tumours
52636	01MAY1997	31DEC9999	Y	OSSEO-INTEGRATION PROCEDURE - fixation of transmucosal abutment to fixtures placed following resection of part of the maxilla or mandible for benign or malignant tumours
52800	01DEC1991	30APR2001	N	NEUROLYSIS BY OPEN OPERATION, without transposition, not being a service associated with a service to which item 52803 applies
52800	01MAY2001	31OCT2007	N	NEUROLYSIS BY OPEN OPERATION, in the oral and maxillofacial region, without transposition, not being a service associated with a service to which item 52803 applies
52800	01NOV2007	31DEC9999	Y	NEUROLYSIS BY OPEN OPERATION, without transposition, not being a service associated with a service to which item 52803 applies
52803	01DEC1991	30APR2001	N	NERVE TRUNK, internal (interfascicular), NEUROLYSIS of, using microsurgical techniques
52803	01MAY2001	31OCT2007	N	NERVE TRUNK, internal (interfascicular), in the oral and maxillofacial region, NEUROLYSIS of, using microsurgical techniques
52803	01NOV2007	31DEC9999	Y	NERVE TRUNK, internal (interfascicular), NEUROLYSIS of, using microsurgical techniques
52806	01DEC1991	30APR2001	N	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve
52806	01MAY2001	31OCT2007	N	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve in the oral and maxillofacial region
52806	01NOV2007	31DEC9999	Y	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve
52809	01DEC1991	30APR2001	N	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve
52809	01MAY2001	31OCT2007	N	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve in the oral and maxillofacial region
52809	01NOV2007	31DEC9999	Y	NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve
52812	01DEC1991	30APR2001	N	NERVE TRUNK, PRIMARY repair of, using microsurgical techniques
52812	01MAY2001	31OCT2007	N	NERVE TRUNK, in the oral and maxillofacial region, PRIMARY repair of, using microsurgical techniques
52812	01NOV2007	31DEC9999	Y	NERVE TRUNK, PRIMARY repair of, using microsurgical techniques
52815	01DEC1991	30APR2001	N	NERVE TRUNK, SECONDARY repair of, using microsurgical techniques
52815	01MAY2001	31OCT2007	N	NERVE TRUNK, in the oral and maxillofacial region, SECONDARY repair of, using microsurgical techniques
52815	01NOV2007	31DEC9999	Y	NERVE TRUNK, SECONDARY repair of, using microsurgical techniques
52818	01DEC1991	30APR2001	N	NERVE, TRANSPOSITION OF
52818	01MAY2001	31OCT2007	N	NERVE, in the oral and maxillofacial region, TRANSPOSITION OF
52818	01NOV2007	31DEC9999	Y	NERVE, TRANSPOSITION OF
52821	01DEC1991	30APR2001	N	NERVE GRAFT TO NERVE TRUNK (cable graft) including harvesting of nerve graft using microsurgical techniques
52821	01MAY2001	31OCT2007	N	NERVE GRAFT TO NERVE TRUNK in the oral and maxillofacial region (cable graft) including harvesting of nerve graft using microsurgical techniques
52821	01NOV2007	31DEC9999	Y	NERVE GRAFT TO NERVE TRUNK, (cable graft) including harvesting of nerve graft using microsurgical techniques
52824	01DEC1991	31DEC9999	Y	PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief
52826	01NOV2000	31DEC9999	Y	INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance
52828	01NOV2000	30APR2001	N	CUTANEOUS NERVE, primary repair of, using microsurgical techniques
52828	01MAY2001	31OCT2007	N	CUTANEOUS NERVE, in the oral and maxillofacial region, primary repair of, using microsurgical techniques
52828	01NOV2007	31DEC9999	Y	CUTANEOUS NERVE, primary repair of, using microsurgical techniques
52830	01NOV2000	30APR2001	N	CUTANEOUS NERVE, secondary repair of, using microsurgical techniques
52830	01MAY2001	31OCT2007	N	CUTANEOUS NERVE, in the oral and maxillofacial region, secondary repair of, using microsurgical techniques
52830	01NOV2007	31DEC9999	Y	CUTANEOUS NERVE, secondary repair of, using microsurgical techniques
52832	01NOV2000	30APR2001	N	CUTANEOUS NERVE, nerve graft to, using microsurgical techniques
52832	01MAY2001	31OCT2007	N	CUTANEOUS NERVE, in the oral and maxillofacial region, nerve graft to, using microsurgical techniques
52832	01NOV2007	31DEC9999	Y	CUTANEOUS NERVE, nerve graft to, using microsurgical techniques
53000	01DEC1991	31DEC9999	Y	MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF
53003	01DEC1991	31OCT2000	N	MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF, where undertaken in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which another item in Groups O3 to O9 applies
53003	01NOV2000	31DEC9999	Y	MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia (requiring admission to hospital) not being a service associated with a service to which another item in Groups O3 to O9 applies
53004	01NOV2000	31DEC9999	Y	MAXILLARY ANTRUM, LAVAGE OF - each attendance at which the procedure is performed, including any associated consultation
53006	01DEC1991	31DEC9999	Y	ANTROSTOMY (RADICAL)
53007	01NOV2000	31DEC9999	Y	ANTROSTOMY (RADICAL) with transantral ethmoidectomy or transantral vidian neurectomy
53009	01DEC1991	31DEC9999	Y	ANTRUM, intranasal operation on, or removal of foreign body from
53012	01DEC1991	31DEC9999	Y	ANTRUM, drainage of, through tooth socket
53015	01DEC1991	31DEC9999	Y	ORO-ANTRAL FISTULA, plastic closure of
53016	01MAY1997	31DEC9999	Y	NASAL SEPTUM, septoplasty, submucous resection or closure of septal perforation
53017	01NOV2000	31DEC9999	Y	NASAL SEPTUM, reconstruction of
53018	01DEC1991	31DEC9999	Y	TURBINECTOMY or TURBINECTOMIES, partial or total, unilateral
53019	01NOV1992	31DEC9999	Y	MAXILLARY SINUS, BONE GRAFT to floor of maxillary sinus following elevation of mucosal lining (sinus lift procedure), (unilateral)
53050	01NOV2000	31DEC9999	Y	LATERAL RHINOTOMY with removal of tumour
53052	01NOV2000	31DEC9999	Y	POST-NASAL SPACE, direct examination of, with or without biopsy
53054	01NOV2000	31OCT2001	N	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures
53054	01NOV2001	31DEC9999	Y	NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX one or more of these procedures
53056	01NOV2000	31DEC9999	Y	EXAMINATION OF NASAL CAVITY or POST-NASAL SPACE, or NASAL CAVITY AND POST-NASAL SPACE, UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies
53058	01NOV2000	31DEC9999	Y	NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding aftercare)
53060	01NOV2000	31OCT2001	N	CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES OR PHARYNX FOR OBSTRUCTION OR HAEMORRHAGE SECONDARY TO SURGERY (OR TRAUMA) - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose
53060	01NOV2001	31DEC9999	Y	CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES FOR OBSTRUCTION OR HAEMORRHAGE SECONDARY TO SURGERY (OR TRAUMA) - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose
53062	01NOV2000	31DEC9999	Y	POST SURGICAL NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both
53064	01NOV2000	31DEC9999	Y	CRYOTHERAPY TO NOSE in the treatment of nasal haemorrhage
53066	01NOV2000	31DEC9999	Y	DISLOCATION OF TURBINATE OR TURBINATES, 1 or both sides, not being a service associated with a service to which another item in this Group applies
53068	01NOV2000	31DEC9999	Y	TURBINECTOMY or TURBINECTOMIES, partial or total, unilateral
53070	01NOV2000	31DEC9999	Y	TURBINATES, submucous resection of, unilateral
53200	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of a dislocation of, not requiring open reduction
53203	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of a dislocation of, requiring open reduction
53206	01DEC1991	31OCT2007	N	TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital or approved day-hospital facility, not being a service associated with a service to which another item in Groups O3 to O9 applies
53206	01NOV2007	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in Groups O3 to O9 applies
53209	01DEC1991	31DEC9999	Y	GLENOID FOSSA, ZYGOMATIC ARCH and TEMPORAL BONE, reconstruction of (Obwegeser technique)
53212	01DEC1991	31DEC9999	Y	ABSENT CONDYLE and ASCENDING RAMUS in hemifacial microsomia, construction of, not including harvesting of graft material
53215	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthroscopy of, with or without biopsy, not being a service associated with any other arthroscopic procedure of that joint
53218	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedures
53220	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthrotomy of, not being a service to which another item in this Group applies
53221	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without microsurgical techniques
53224	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with condylectomy or condylotomy, with or without microsurgical techniques
53225	01NOV1992	31DEC9999	Y	ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 cannuli into the appropriate joint space(s)
53226	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, synovectomy of, not being a service to which another item in this Group applies
53227	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including meniscectomy when performed, with or without microsurgical techniques
53230	01DEC1991	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular and condylar head surgery, with or without microsurgical techniques
53233	01DEC1991	31OCT2000	N	TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 53224, 53227 and 53230 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques
53233	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 53224, 53226, 53227 and 53230 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques
53236	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Group applies
53239	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT, arthrodesis of, not being a service to which another item in this Group applies
53242	01NOV2000	31DEC9999	Y	TEMPOROMANDIBULAR JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures
53400	01DEC1991	31DEC9999	Y	MAXILLA, unilateral or bilateral, treatment of fracture of, not requiring splinting
53403	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of fracture of, not requiring splinting
53406	01DEC1991	31DEC9999	Y	MAXILLA, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation
53409	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation
53410	01DEC1991	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, not requiring surgical reduction
53411	01DEC1991	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach
53412	01DEC1991	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at 1 site
53413	01DEC1991	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 2 sites
53414	01DEC1991	31DEC9999	Y	ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 3 sites
53415	01DEC1991	31MAR1992	N	MAXILLA, treatment of fracture of, requiring open operation
53415	01APR1992	31DEC9999	Y	MAXILLA, treatment of fracture of, requiring open reduction
53416	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of fracture of, requiring open reduction
53418	01DEC1991	31MAR1992	N	MAXILLA, treatment of fracture of, requiring internal fixation not involving plate(s)
53418	01APR1992	31DEC9999	Y	MAXILLA, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s)
53419	01DEC1991	31MAR1992	N	MANDIBLE, treatment of fracture of, requiring internal fixation not involving plate(s)
53419	01APR1992	31DEC9999	Y	MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s)
53422	01DEC1991	31MAR1992	N	MAXILLA, treatment of fracture of, requiring internal fixation involving plate(s)
53422	01APR1992	31DEC9999	Y	MAXILLA, treatment of fracture of, requiring open reduction and internal fixation involving plate(s)
53423	01DEC1991	31MAR1992	N	MANDIBLE, treatment of fracture of, requiring internal fixation involving plate(s)
53423	01APR1992	31DEC9999	Y	MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation involving plate(s)
53424	01DEC1991	31DEC9999	Y	MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s)
53425	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s)
53427	01DEC1991	31DEC9999	Y	MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s)
53429	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s)
53439	01DEC1991	31DEC9999	Y	MANDIBLE, treatment of a closed fracture of, involving a joint surface
53453	01NOV1992	31DEC9999	Y	ORBITAL CAVITY, reconstruction of a wall or floor with or without foreign implant
53455	01NOV1992	31DEC9999	Y	ORBITAL CAVITY, bone or cartilage graft to orbital wall or floor including reduction of prolapsed or entrapped orbital contents
53458	01MAY1997	31DEC9999	Y	NASAL BONES, treatment of fracture of, not being a service to which item 53459 or 53460 applies
53459	01MAY1997	31DEC9999	Y	NASAL BONES, treatment of fracture of, by reduction
53460	01MAY1997	31DEC9999	Y	NASAL BONES, treatment of fractures of, by open reduction involving osteotomies
53600	01NOV2000	31DEC9999	Y	SKIN SENSITIVITY TESTING for allergens to anaesthetics and materials used in OMS surgery, USING 1 TO 20 ALLERGENS
53700	01NOV2000	31DEC9999	Y	(Note. Where an anaesthetic combines a regional nerve block with a general anaesthetic for an operative procedure, benefits will be paid only under the anaesthetic item relevant to the operation. The items in this Group are to be used in the practice of oral and maxillofacial surgery and are not to be used for dental procedures (eg. restorative dentistry or dental extraction.)) TRIGEMINAL NERVE, primary division of, injection of an anaesthetic agent
53702	01NOV2000	31DEC9999	Y	TRIGEMINAL NERVE, peripheral branch of, injection of an anaesthetic agent
53704	01NOV2000	31DEC9999	Y	FACIAL NERVE, injection of an anaesthetic agent
53706	01NOV2000	31OCT2007	N	NERVE BRANCH IN THE ORAL AND MAXILLOFACIAL REGION, destruction by a neurolytic agent, not being a service to which any other item in this Group applies
53706	01NOV2007	31DEC9999	Y	NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies
54001	22MAY2020	31DEC9999	Y	Telehealth attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient is referred to the approved dental practitioner
54002	22MAY2020	31DEC9999	Y	Telehealth attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient is referred to the approved dental practitioner
54003	22MAY2020	31DEC9999	Y	Phone attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient is referred to the approved dental practitioner
54004	22MAY2020	31DEC9999	Y	Phone attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient is referred to the approved dental practitioner
54006	15SEP2021	31DEC2021	N	Telehealth attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient is referred to the approved dental practitioner
54006	01JAN2022	31DEC9999	Y	Telehealth attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient to whom the service is provided is: (a) referred to the approved dental practitioner; and (b) admitted to hospital
54007	15SEP2021	31DEC2021	N	Telehealth attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient is referred to the approved dental practitioner
54007	01JAN2022	31DEC9999	Y	Telehealth attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient to whom the service is provided is: (a) referred to the approved dental practitioner; and (b) admitted to hospital
54011	15SEP2021	31DEC2021	N	Phone attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient is referred to the approved dental practitioner
54011	01JAN2022	31DEC9999	Y	Phone attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner in the practice of oral and maxillofacial surgery, if the patient to whom the service is provided is: (a) referred to the approved dental practitioner; and (b) admitted to hospital
54012	15SEP2021	31DEC2021	N	Phone attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient is referred to the approved dental practitioner
54012	01JAN2022	31DEC9999	Y	Phone attendance by an approved dental practitioner in the practice of oral and maxillofacial surgery, each attendance after the first in a single course of treatment, if the patient to whom the service is provided is: (a) referred to the approved dental practitioner; and (b) admitted to hospital
55000	01DEC1991	31OCT1992	N	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not associated with Item 55003, 55006 or 55009 where the patient is not referred by a medical practitioner for ultrasonic examination each ultrasonic examination not exceeding two examinations in any one pregnancy (NR)
55000	01NOV1992	31DEC9999	Y	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not being a service associated with a service to which item 55003, 55004, 55006, 55102, 55105, 55112, 55118, 55124, 55130, 55201, 55204, 55225, 55231, 55234 or 55237 applies, if the patient is not referred by a medical practitioner for ultrasonic examination each ultrasonic examination not exceeding 2 examinations in 1 pregnancy (NR)
55003	01DEC1991	31OCT1992	N	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 55000, 55006 or 55009 and where the referring medical practitioner is not a member of a group of practitioners of which the firstmentioned practitioner is a member (R)
55003	01NOV1992	31DEC9999	Y	Ultrasonic crosssectional echography, performed by, or on behalf of, a medical practitioner, if: (a) the patient is referred by a medical practitioner for ultrasonic examination, not being a service associated with a service to which item 55004, 55006, 55102, 55105, 55112, 55118, 55124, 55130, 55201, 55204, 55225, 55231, 55234 or 55237 applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member (R)
55004	01NOV1992	31DEC9999	Y	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this category applies (R)
55005	01JUL2011	31DEC9999	Y	HEAD, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55006	01DEC1991	31OCT1992	N	ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not associated with Item 55000, 55003 or 55009 (NR)
55006	01NOV1992	31DEC9999	Y	ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not being a service associated with a service to which item 55003, 55004, 55102, 55105, 55112, 55201, 55204, 55225, 55231, 55234 or 55237 applies (NR)
55007	01JUL2011	31DEC9999	Y	HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55008	01JUL2011	31DEC9999	Y	ORBITAL CONTENTS, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55009	01DEC1991	31DEC9999	Y	ECHOCARDIOGRAPHY, not covered by Item 55000 or 55003 (R)
55010	01JUL2011	31DEC9999	Y	ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55011	01JUL2011	31DEC9999	Y	NECK, 1 or more structures of, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55012	01DEC1991	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries), peripheral vessels or intrathoracic or intraabdominal vascular structures (excluding cardiac and pregnancy related studies), (not associated with Item 55003) one examination and report (R)
55013	01JUL2011	31DEC9999	Y	NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55014	01JUL2011	30JUN2014	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service to which an item in Subgroup 4,applies, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55017, 55020, 55038, 55044, 55731 or 55732 on the same patient within 24 hours (R) (NK)
55014	01JUL2014	31DEC9999	Y	Abdomen, ultrasound scan of (including scan of urinary tract when performed), if: (a) the patient is referred by a medical practitioner or participating nurse practitioner; and (b) if the patient is referred by a medical practitioner-the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) if the patient is referred by a participating nurse practitioner-the nurse practitioner does not have a business or financial arrangement with the providing practitioner; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (e) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (f) within 24 hours of the service, a service mentioned in item 55017, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK)
55015	01DEC1991	31DEC9999	Y	two or more examinations of the kind referred to in Item 55012 and report (not associated with Item 55003) (R)
55016	01JUL2011	31DEC9999	Y	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service to which an item in Subgroup 4,applies where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55017	01JUL2011	30JUN2014	N	URINARY TRACT, ultrasound scan of but not being a service associated with the service to which an item in Subgroup 4,applies,,where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55041, 55020, 55036, 55044, 55731 or 55732 on the same patient within 24 hours (R) (NK)
55017	01JUL2014	31DEC9999	Y	Urinary tract, ultrasound scan of, if: (a) the patient is referred by a medical practitioner; and (b) the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (e) within 24 hours of the service, a service mentioned in item 55014, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK)
55018	01DEC1991	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not associated with Item 55003) examination and report (R)
55019	01JUL2011	31DEC9999	Y	URINARY TRACT, ultrasound scan of, but not being a service associated with the service to which an item in Subgroup 4,applies, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55020	01JUL2011	31DEC9999	Y	PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service to which an item in Subgroup 4,applies, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R) (NK)
55021	01DEC1991	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography (not associated with Item 55003) examination and report (R)
55022	01JUL2011	31DEC9999	Y	PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service to which an item in Subgroup 4,applies, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55023	01JUL2011	31DEC9999	Y	SCROTUM, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55024	01DEC1991	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by Item 11603, 11606 or 11609 (not associated with Item 55003) examination and report (R)
55025	01JUL2011	31DEC9999	Y	SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK)
55026	01JUL2011	31DEC9999	Y	ULTRASONIC CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this Group applies (R) (NK)
55027	01DEC1991	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by Item 11612 (not associated with Item 55003) examination and report (R)
55028	01JUL1993	31OCT1993	N	HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55028	01NOV1993	31JAN2000	N	HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55028	01FEB2000	31OCT2001	N	HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55028	01NOV2001	30APR2020	N	HEAD, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55028	01MAY2020	31DEC9999	Y	Head, ultrasound scan of (R)
55029	01JUL1993	31OCT1993	N	HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55029	01NOV1993	31JAN2000	N	HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55029	01FEB2000	30APR2020	N	HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55029	01MAY2020	31DEC9999	Y	Head, ultrasound scan of (NR)
55030	01JUL1993	31OCT1993	N	ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55030	01NOV1993	31JAN2000	N	ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55030	01FEB2000	31OCT2001	N	ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55030	01NOV2001	30APR2020	N	ORBITAL CONTENTS, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55030	01MAY2020	31DEC9999	Y	Orbital contents, ultrasound scan of (R)
55031	01JUL1993	31OCT1993	N	ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55031	01NOV1993	31JAN2000	N	ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55031	01FEB2000	30APR2020	N	ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55031	01MAY2020	31DEC9999	Y	Orbital contents, ultrasound scan of (NR)
55032	01JUL1993	31OCT1993	N	NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55032	01NOV1993	31JAN2000	N	NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55032	01FEB2000	31OCT2001	N	NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55032	01NOV2001	30APR2020	N	NECK, 1 or more structures of, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55032	01MAY2020	31DEC9999	Y	Neck, one or more structures of, ultrasound scan of (R)
55033	01JUL1993	31OCT1993	N	NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55033	01NOV1993	31JAN2000	N	NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55033	01FEB2000	30APR2020	N	NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55033	01MAY2020	31DEC9999	Y	Neck, one or more structures of, ultrasound scan of (NR)
55034	01JUL1993	31OCT1993	N	BREAST, 1 or both, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55034	01NOV1993	31DEC9999	Y	BREAST, 1 or both, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55035	01JUL1993	31OCT1993	N	BREAST, 1 or both, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55035	01NOV1993	31DEC9999	Y	BREAST, 1 or both, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55036	01JUL1993	31OCT1993	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55036	01NOV1993	31AUG1999	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55036	01SEP1999	31JAN2000	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55042 or 55044 on the same patient within 24 hours (R)
55036	01FEB2000	31OCT2000	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R)
55036	01NOV2000	31OCT2001	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R)
55036	01NOV2001	31OCT2011	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R)
55036	01NOV2011	30JUN2014	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where: (a) the patient is referred by a referring practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R)
55036	01JUL2014	30APR2020	N	Abdomen, ultrasound scan of (including scan of urinary tract when performed), if: (a) the patient is referred by a medical practitioner or participating nurse practitioner for ultrasonic examination; and (b) if the patient is referred by a medical practitioner-the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) if the patient is referred by a participating nurse practitioner-the nurse practitioner does not have a business or financial arrangement with the providing practitioner; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (e) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (f) within 24 hours of the service, a service mentioned in item 55017, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (K)
55036	01MAY2020	31DEC9999	Y	Abdomen, ultrasound scan of (including scan of urinary tract when performed), for morphological assessment, if: (a) the service is not solely a transrectal ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder base;(iii) urethra; and(b) within 24 hours of the service, a service mentioned in item 55038 is not performed on the same patient by the providing practitioner (R)
55037	01JUL1993	31OCT1993	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55037	01NOV1993	31JAN2000	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55037	01FEB2000	31OCT2000	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55037	01NOV2000	30APR2020	N	ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55037	01MAY2020	31DEC9999	Y	Abdomen, ultrasound scan of (including scan of urinary tract when performed), for morphological assessment, if the service is not solely a transrectal ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder base;(iii) urethra (NR)
55038	01JUL1993	31OCT1993	N	URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55038	01NOV1993	31JAN2000	N	URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55038	01FEB2000	31OCT2000	N	URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R)
55038	01NOV2000	31OCT2001	N	URINARY TRACT, ultrasound scan of but not being a service associated with the service described in item 55600 or item 55603, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R)
55038	01NOV2001	30JUN2014	N	URINARY TRACT, ultrasound scan of but not being a service associated with the service described in item 55600 or item 55603, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R)
55038	01JUL2014	30APR2020	N	Urinary tract, ultrasound scan of, if: (a) the patient is referred by a medical practitioner for ultrasonic examination; and (b) the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (e) within 24 hours of the service, a service mentioned in item 55017, 55036, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (K)
55038	01MAY2020	31DEC9999	Y	Urinary tract, ultrasound scan of, if: (a) the service is not solely a transrectal ultrasonic examination of any of the following: (i) prostate gland; (ii) bladder base; (iii) urethra; and (b) within 24 hours of the service, a service mentioned in item 55036 or 55065 is not performed on the same patient by the providing practitioner (R)
55039	01JUL1993	31OCT1993	N	URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55039	01NOV1993	31JAN2000	N	URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55039	01FEB2000	31OCT2000	N	URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55039	01NOV2000	30APR2020	N	URINARY TRACT, ultrasound scan of, but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55039	01MAY2020	31DEC9999	Y	Urinary tract, ultrasound scan of, if the service is not solely a transrectal ultrasonic examination of any of the following: (a) prostate gland; (b) bladder base; (c) urethra (NR)
55040	01JUL1993	31OCT1993	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55040	01NOV1993	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55041	01JUL1993	31OCT1993	N	TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION including real time colour flow mapping or power doppler and report when indicated in the assessment of a known fetal anomaly where the service is performed by, or on behalf of, a medical; practitioner: (a) with recordings on videotape; and (b) not being a service associated with a service to which an item in this Groupo applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member, payable once in any one pregnancy (R)
55041	01NOV1993	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner for ultrasonic examination - each ultrasonic examination, not exceeding 2 examinations in any 1 pregnancy, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55042	01JUL1993	31OCT1993	N	PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55042	01NOV1993	31AUG1999	N	PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55042	01SEP1999	31DEC9999	Y	PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55036 on the same patient within 24 hours (R)
55043	01JUL1993	31OCT1993	N	PELVIS, female, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55043	01NOV1993	31DEC9999	Y	PELVIS, female, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55044	01JUL1993	31OCT1993	N	PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55044	01NOV1993	31AUG1999	N	PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55044	01SEP1999	31JAN2000	N	PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55036 on the same patient within 24 hours (R)
55044	01FEB2000	31OCT2000	N	PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R)
55044	01NOV2000	31OCT2001	N	PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R)
55044	01NOV2001	31DEC9999	Y	PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R)
55045	01JUL1993	31OCT1993	N	PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55045	01NOV1993	31JAN2000	N	PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55045	01FEB2000	31OCT2000	N	PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55045	01NOV2000	31DEC9999	Y	PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55046	01SEP1999	31DEC9999	Y	PELVIS, female, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasound examination not being a service associated with a service to which an item in subgroup 2 or 3 of this group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R).
55047	01SEP1999	31DEC9999	Y	PELVIS, female, ultrasound scan of, in association with saline infusion of the endometrial cavity by any or all approaches, where: (a) the patient is not referred by a medical practitioner and the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and (b) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR).
55048	01JUL1993	31OCT1993	N	SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55048	01NOV1993	31JAN2000	N	SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55048	01FEB2000	31OCT2001	N	SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55048	01NOV2001	30APR2020	N	SCROTUM, ultrasound scan of, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55048	01MAY2020	31DEC9999	Y	Scrotum, ultrasound scan of (R)
55049	01JUL1993	31OCT1993	N	SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55049	01NOV1993	31JAN2000	N	SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55049	01FEB2000	30APR2020	N	SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55049	01MAY2020	31DEC9999	Y	Scrotum, ultrasound scan of (NR)
55050	01JUL1993	31OCT1993	N	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55050	01NOV1993	31JAN2000	N	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55050	01FEB2000	31DEC9999	Y	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55051	01JUL1993	31OCT1993	N	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55051	01NOV1993	31JAN2000	N	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55051	01FEB2000	31DEC9999	Y	MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55052	01JUL1993	31OCT1993	N	JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55052	01NOV1993	31JAN2000	N	JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55052	01FEB2000	31DEC9999	Y	JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55053	01JUL1993	31OCT1993	N	JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR)
55053	01NOV1993	31JAN2000	N	JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR)
55053	01FEB2000	31DEC9999	Y	JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR)
55054	01JUL1993	31OCT1993	N	ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this Group applies (R)
55054	01NOV1993	30APR2020	N	ULTRASONIC CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this Group applies (R)
55054	01MAY2020	31DEC9999	Y	Ultrasonic cross-sectional echography, in conjunction with a surgical procedure (other than a procedure to which item 55848 or 55850 applies) using interventional techniques, not being a service associated with a service to which any other item in this Group applies (R)
55055	01JUL1993	31DEC9999	Y	ORBITAL CONTENTS, ultrasonic echography of, unidimensional, not being a service associated with a service to which another item in this Group applies (NR)
55056	01JUL1993	31OCT1993	N	ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which another item in this Group applies (R)
55056	01NOV1993	31DEC9999	Y	ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which item 55055 or an item in Subgroups 2 or 3 of this Group applies (R)
55057	01JUL1993	31OCT1993	N	ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which another item in this Group applies (NR)
55057	01NOV1993	31DEC9999	Y	ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which item 55055 or an item in Subgroups 2 or 3 of this Group applies (NR)
55058	01JUL1995	31DEC9999	Y	MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - examination and report (R)
55059	01JUL2011	31DEC9999	Y	BREAST, one, ultrasound scan of, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55060	01JUL2011	31DEC9999	Y	BREAST, one, ultrasound scan of, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK)
55061	01JUL2011	31DEC9999	Y	BREASTS, both, ultrasound scan of, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55062	01JUL2011	31DEC9999	Y	BREASTS, both, ultrasound scan of, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK)
55063	01JUL2011	30JUN2014	N	URINARY BLADDER, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of the Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55600, 55601, 55603, 55604, 55014, 55017, 55020, 55036, 55038, 55044, 55731, 55732 or 11917 on the same date of service (R) (NK)
55063	01JUL2014	31DEC9999	Y	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is referred by a medical practitioner for ultrasonic examination; and (b) the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) within 24 hours of the service, a service mentioned in item 11917, 55014, 55017, 55036, 55038, 55600, 55601, 55603, 55604, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK)
55064	01JUL2011	30JUN2014	N	URINARY BLADDER, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 applies; and the service is not performed with item 55600, 55601, 55603, 55604, 55016, 55019, 55022, 55037, 55039, 55045, 55733, 55734 or 11917 on the same date of service (NR) (NK)
55064	01JUL2014	31DEC2014	N	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c) within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55022, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (NK)
55064	01JAN2015	31DEC9999	Y	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c) within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (NK)
55065	01JUL2014	30APR2020	N	PELVIS, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2, or 3, applies; and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (d) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (e) the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R)(K)
55065	01MAY2020	31OCT2021	N	Pelvis, ultrasound scan of, by any or all approaches, if:(a) the service is not solely: (i) a service to which an item in Subgroup 5 of this Group applies, or (ii) a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and(b) within 24 hours of the service, a service mentioned in item 55038 is not performed on the same patient by the providing practitioner (R)
55065	01NOV2021	31DEC9999	Y	Pelvis, ultrasound scan of, by any or all approaches, if:(a) the service is not solely a service to which an item (other than item 55736 or 55739) in Subgroup 5 of this Group applies or a transrectal ultrasonic examination of any of the following: prostate gland; bladder base; urethra; and (b) within 24 hours of the service, a service mentioned in item 55038 is not performed on the same patient by the providing practitioner (R)
55066	01MAY2020	31DEC9999	Y	Breasts, both, ultrasound scan, in conjunction with a surgical procedure using interventional techniques, if:(a) the request for the scan indicates that an ultrasound guided breast intervention be performed; and(b) the service is not performed in conjunction with any other item in this Group (R)
55067	01JUL2014	31DEC9999	Y	PELVIS, ultrasound scan of, by any or all approaches, where: a) the patient is referred by a medical practitioner; and b) the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and d) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and e) within 24 hours of the service, a service mentioned in item 55014, 55017, 55036 or 55038 is not performed on the same patient by the providing practitioner (R) (NK)
55068	01JUL2014	30APR2020	N	PELVIS, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this Group applies; and (c) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs (NR)(K)
55068	01MAY2020	31OCT2021	N	Pelvis, ultrasound scan of, by any or all approaches, if the service is not solely a service to which an item in Subgroup 5 of this Group applies or a transrectal ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder base;(iii) urethra (NR)
55068	01NOV2021	31DEC9999	Y	Pelvis, ultrasound scan of, by any or all approaches, if the service is not solely a service to which an item (other than item 55736 or 55739) in Subgroup 5 of this Group applies or a transrectal ultrasonic examination of any of the following:(i) prostate gland;(ii) bladder base;(iii) urethra (NR)
55069	01JUL2014	31DEC9999	Y	PELVIS, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this Group applies; and (c) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs (NR) (NK)
55070	01FEB2000	31OCT2001	N	BREAST, one, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55070	01NOV2001	31OCT2011	N	BREAST, one, ultrasound scan of, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55070	01NOV2011	30APR2020	N	BREAST, one, ultrasound scan of, where: (a) the patient is referred by a referring practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55070	01MAY2020	31DEC9999	Y	Breast, one, ultrasound scan of (R)
55071	01MAY2020	31DEC9999	Y	Breast, one, ultrasound scan, in conjunction with a surgical procedure using interventional techniques, if:(a) the request for the scan indicates that an ultrasound guided breast intervention be performed; and(b) the service is not performed in conjunction with any other item in this group (R)
55073	01FEB2000	30APR2020	N	BREAST, one, ultrasound scan of, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR)
55073	01MAY2020	31DEC9999	Y	Breast, one, ultrasound scan of (NR)
55076	01FEB2000	31OCT2001	N	BREASTS, both, ultrasound scan of, performed by or on behalf of a medical practitioner where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55076	01NOV2001	31OCT2011	N	BREASTS, both, ultrasound scan of, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55076	01NOV2011	30APR2020	N	BREASTS, both, ultrasound scan of, where: (a) the patient is referred by a referring practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55076	01MAY2020	31DEC9999	Y	Breasts, both, ultrasound scan of, including an ultrasound scan for post mastectomy surveillance (R)
55079	01FEB2000	30APR2020	N	BREASTS, both, ultrasound scan of, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR)
55079	01MAY2020	31DEC9999	Y	Breasts, both, ultrasound scan of, including an ultrasound scan for post mastectomy surveillance (NR)
55084	01MAY2004	30JUN2014	N	URINARY BLADDER, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of the Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55600, 55603, 55036, 55038, 55044, 55731 or 11917 on the same date of service (R)
55084	01JUL2014	30APR2020	N	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is referred by a medical practitioner; and (b) the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) within 24 hours of the service, a service mentioned in item 11917, 55014, 55017, 55036, 55038, 55600, 55601, 55603, 55604, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (K)
55084	01MAY2020	31DEC9999	Y	Urinary bladder, ultrasound scan of, by any or all approaches, if within 24 hours of the service, a service mentioned in item 11917, 55036, 55038, 55065, 55600 or 55603 is not performed on the same patient by the providing practitioner (R)
55085	01MAY2004	30JUN2014	N	URINARY BLADDER, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 applies; and the service is not performed with item 55600, 55603, 55037, 55039, 55045, 55733 or 11917 on the same date of service (NR)
55085	01JUL2014	31DEC2014	N	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c) within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55022, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (K)
55085	01JAN2015	30APR2020	N	Urinary bladder, ultrasound scan of, by any or all approaches, if: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c) within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (K)
55085	01MAY2020	31DEC9999	Y	Urinary bladder, ultrasound scan of, by any or all approaches, if within 24 hours of the service, a service mentioned in item 11917, 55037, 55039, 55068, 55600 or 55603 is not performed on the same patient by the providing practitioner (NR)
55100	01DEC1991	31DEC9999	Y	TWO DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, not associated with any other echocardiographic examination (R)
55102	01NOV1992	30JUN1993	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST 2 THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R)
55102	01JUL1993	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST 2 THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55103	01DEC1991	31DEC9999	Y	TWO DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, associated with another echocardiographic examination (R)
55105	01NOV1992	30JUN1993	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of cardiac dimensions, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R)
55105	01JUL1993	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of cardiac dimensions, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55106	01DEC1991	31DEC9999	Y	M-MODE AND TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST TWO THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not associated with Items 55000, 55003, or 55009 (R)
55112	01NOV1992	30JUN1993	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, together with real time colour flow mapping from at least 2 thoracic windows, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R)
55112	01JUL1993	31OCT2000	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 thoracic windows, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55112	01NOV2000	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3 of this Group applies (R)
55113	01JUL2001	30APR2002	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R)
55113	01MAY2002	30APR2020	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R)
55113	01MAY2020	31DEC9999	Y	M-mode and two-dimensional real time echocardiographic examination of the heart from at least 2 acoustic windows for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain, if:(a) the service involves all of the following:(i) measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques;(ii) real time colour flow mapping from at least 2 acoustic windows;(iii) recordings on video tape or digital media; and(b) the service is not associated with a service to which another item in this Subgroup (except items 55118 and 55130), applies (R)
55114	01JUL2001	30APR2002	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R)
55114	01MAY2002	30APR2020	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R)
55114	01MAY2020	31DEC9999	Y	M-mode and two dimensional real time echocardiographic examination of the heart from at least 2 acoustic windows for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic or embolic disease or heart tumour, if:(a) the service involves all of the following:(i) measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques;(ii) real time colour flow mapping from at least 2 acoustic windows;(iii) recordings on video tape or digital media; and(b) the service is not associated with a service to which another item in this Subgroup (except items 55118 and 55130), applies (R)
55115	01JUL2001	30APR2002	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of symptoms or signs of congenital heart disease (R)
55115	01MAY2002	30APR2020	N	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of symptoms or signs of congenital heart disease (R)
55115	01MAY2020	31DEC9999	Y	M-mode and two dimensional real time echocardiographic examination of the heart from at least 2 acoustic windows for the investigation of symptoms or signs of congenital heart disease, if:(a) the service involves all of the following:(i) measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques;(ii) real time colour flow mapping from at least 2 acoustic windows;(iii) recordings on video tape or digital media; and(b) the service is not associated with a service to which another item in this Subgroup (except items 55118 and 55130), applies (R)
55116	01NOV2000	30JUN2001	N	EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55116	01JUL2001	30APR2002	N	EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55116	01MAY2002	30APR2020	N	EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup applies (with the exception of items 55118 and 55130). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55116	01MAY2020	31DEC9999	Y	Exercise stress echocardiography performed in conjunction with a service mentioned in item 11712, if:(a) the service involves all of the following:(i) two dimensional recordings before exercise (baseline) from at least 3 acoustic windows;(ii) matching recordings from the same windows at, or immediately after, peak exercise;(iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and(b) the service is not associated with a service to which another item in this Subgroup (except items 55118 and 55130), applies (R)
55117	01NOV2000	30JUN2001	N	PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose or immediately after, peak exercise. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55117	01JUL2001	30APR2002	N	PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55117	01MAY2002	30APR2020	N	PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies (with the exception of items 55118 and 55130). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R)
55117	01MAY2020	31DEC9999	Y	Pharmacological stress echocardiography performed in conjunction with a service mentioned in item 11712, if:(a) the service involves all of the following:(i) two dimensional recordings before drug infusion (baseline) from at least 3 acoustic windows;(ii) matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose;(iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and(b) the service is not associated with a service to which another item in this Subgroup (except items 55118 and 55130), applies (R)
55118	01NOV1992	30JUN1993	N	2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, not being a service associated with another echocardiographic examination (R)
55118	01JUL1993	31OCT2000	N	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least 2 oesophageal windows: (i) performed using a mechanical sector scanner or phased array transducer; with (a) measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous Doppler techniques; (b) real time colour flow mapping from at least 2 oesophageal windows; and (c) recordings on video tape; and (ii) not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55118	01NOV2000	30APR2002	N	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a) pulsed wave Doppler examination; (b) real time colour flow mapping; and (c) recordings on video tape or digital medium; and not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies (R)
55118	01MAY2002	31MAY2003	N	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a) pulsed wave Doppler examination; (b) real time colour flow mapping; and (c) recordings on video tape or digital medium; and not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R)
55118	01JUN2003	30APR2004	N	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a) pulsed wave Doppler examination; (b) real time colour flow mapping; and (c) recordings on video tape or digital medium; and not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R)
55118	01MAY2004	30APR2020	N	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level: (a) with: (i) real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii) recordings on video tape or digital medium; and (b) not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R)
55118	01MAY2020	28FEB2021	N	Heart, two dimensional real time transoesophageal examination of, from at least 2 levels, and in more than one plane at each level, if:(a) the service includes:(i) real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and(ii) recordings on video tape or digital medium; and(b) the service is not an intra operative service (R) (Anaes.)
55118	01MAR2021	30JUN2021	N	Heart, two dimensional real time transoesophageal examination of, from at least 2 levels, and in more than one plane at each level, if: (a) the service includes: (i) real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii) recordings on video tape or digital medium; and (b) the service is not: (i) an intra operative service; or (ii) a service associated with a service to which an item in Subgroup 3 of this Group applies (R)
55118	01JUL2021	31DEC9999	Y	Heart, two-dimensional or three-dimensional real time transoesophageal examination of, from at least 2 levels, and in more than one plane at each level, if: (a) the service includes: (i) real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii) recordings on digital media; and (b) the service is not an intra-operative service; and (c) not being a service associated with a service to which an item in Subgroup 3 applies.(R)
55119	01JUL2011	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R) (NK)
55120	01JUL2011	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R) (NK)
55121	01JUL2011	31DEC9999	Y	M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of symptoms or signs of congenital heart disease (R) (NK)
55122	01JUL2011	31DEC9999	Y	EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup applies (with the exception of items 55118, 55125, 55130 and 55131). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) (NK)
55123	01JUL2011	31DEC9999	Y	PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup, applies (with the exception of items 55118, 55125, 55130 and 55131). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) (NK)
55124	01NOV1992	31DEC9999	Y	2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, being a service associated with another echocardiographic examination (R)
55125	01JUL2011	31DEC9999	Y	HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level: (a) with: (i) real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii) recordings on video tape or digital medium; and (b) not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, applies (R) (NK)
55126	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Initial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media: (a) for the investigation of any of the following: (i) symptoms or signs of cardiac failure; or (ii) suspected or known ventricular hypertrophy or dysfunction; or (iii) pulmonary hypertension; or (iv) valvular, aortic, pericardial, thrombotic or embolic disease; or (v) heart tumour; or (vi) symptoms or signs of congenital heart disease; or (vii) other rare indications; and (b) if the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146) or an item in Subgroup 2 (except items 55118 and 55130) applies; and (d) cannot be claimed within 24 months if a service associated with a service to which item 55127, 55128, 55129, 55132, 55133 or 55134 is provided For any particular patient, applicable not more than once in 24 months (R)
55126	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Initial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media: (a) for the investigation of any of the following: (i) symptoms or signs of cardiac failure; or (ii) suspected or known ventricular hypertrophy or dysfunction; or (iii) pulmonary hypertension; or (iv) valvular, aortic, pericardial, thrombotic or embolic disease; or (v) heart tumour; or (vi) symptoms or signs of congenital heart disease; or (vii) other rare indications; and (b) if the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130), or an item in Subgroup 3 applies; and (d) cannot be claimed within 24 months if a service associated with a service to which item 55127, 55128, 55129, 55132, 55133 or 55134 is provided For any particular patient, applicable not more than once in 24 months (R)
55126	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Initial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of any of the following: (i) symptoms or signs of cardiac failure; (ii) suspected or known ventricular hypertrophy or dysfunction; (iii) pulmonary hypertension; (iv) valvular, aortic, pericardial, thrombotic or embolic disease; (v) heart tumour; (vi) symptoms or signs of congenital heart disease; (vii) other rare indications; and (b) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R)
55127	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a specialist or consultant physician; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146) or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55127	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a specialist or consultant physician; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130), or an item in Subgroup 3 applies (R)
55127	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Repeat serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of known valvular dysfunction; and (b) is requested by a specialist or consultant physician; and (c) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55128	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a medical practitioner (other than a specialist or consultant physician) at, or from, a practice location in: (i) a Modified Monash 3 area; or (ii) a Modified Monash 4 area; or (iii) a Modified Monash 5 area; or (iv) a Modified Monash 6 area; or (v) a Modified Monash 7 area; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146) or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55128	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of known valvular dysfunction, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a medical practitioner (other than a specialist or consultant physician) at, or from, a practice location in: (i) a Modified Monash 3 area; or (ii) a Modified Monash 4 area; or (iii) a Modified Monash 5 area; or (iv) a Modified Monash 6 area; or (v) a Modified Monash 7 area; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55128	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Repeat serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of known valvular dysfunction; and (b) is requested by a medical practitioner (other than a specialist or consultant physician) at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55129	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, excluding valvular dysfunction (when valvular dysfunction is the primary condition): (a) for the investigation of any of the following: (i) symptoms or signs of cardiac failure; or (ii) suspected or known ventricular hypertrophy or dysfunction; or (iii) pulmonary hypertension; or (iv) aortic, thrombotic, embolic disease or pericardial disease (excluding isolated pericardial effusion or pericarditis); or (v) heart tumour; or (vi) structural heart disease; or (vii) other rare indications; and (b) if the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation if present; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures when possible; and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146) or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55129	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Repeat serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, excluding valvular dysfunction (when valvular dysfunction is the primary condition): (a) for the investigation of any of the following: (i) symptoms or signs of cardiac failure; or (ii) suspected or known ventricular hypertrophy or dysfunction; or (iii) pulmonary hypertension; or (iv) aortic, thrombotic, embolic disease or pericardial disease (excluding isolated pericardial effusion or pericarditis); or (v) heart tumour; or (vi) structural heart disease; or (vii) other rare indications; and (b) if the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation if present; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures when possible; and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55129	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Repeat serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, if: (a) valvular dysfunction is not the primary issue for the patient (although it may be a secondary issue); and (b) the service is for the investigation of any of the following: (i) symptoms or signs of cardiac failure; (ii) suspected or known ventricular hypertrophy or dysfunction; (iii) pulmonary hypertension; (iv) aortic, thrombotic, embolic disease or pericardial disease (excluding isolated pericardial effusion or pericarditis); (v) heart tumour; (vi) structural heart disease; (vii) other rare indications; and (c) the service is requested by a specialist or consultant physician; and (d) the service is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55130	01NOV1992	31OCT2000	N	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure (R)
55130	01NOV2000	30APR2004	N	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure (R)
55130	01MAY2004	30APR2020	N	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure - not associated with item 55135 (R)
55130	01MAY2020	30JUN2021	N	Intra-operative two-dimensional real time transoesophageal echocardiography incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure, not being a service associated with a service to which item 55135 applies (R) (Anaes.)
55130	01JUL2021	31DEC9999	Y	Intraoperative two-dimensional or three-dimensional real time transoesophageal echocardiography, if the service: (a) includes Doppler techniques with colour flow mapping and recordings on digital media; and (b) is performed during cardiac surgery; and (c) incorporates sequential assessment of cardiac function before and after the surgical procedure; and (d) is not associated with a service to which item 55135, or an item in Subgroup 3, applies (R)
55131	01JUL2011	31DEC9999	Y	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure - not associated with items 55135 and 55136 (R) (NK)
55132	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, for the investigation of a patient who is under 17 years of age, or a patient of any age with complex congenital heart disease, if: (a) the service involves the all of the following, where possible: (i) assessment of ventricular structure and function including quantification of systolic function (if the ventricular configuration allows accurate quantification) using at least one of M-mode, 2-dimensional or 3-dimensional imaging; and (ii) assessment of diastolic function; and (iii) assessment of atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant Doppler techniques with quantification; and (vii) subxiphoid views where recommended for congenital heart lesions; and (viii) additional haemodynamic parameters relevant to the clinical condition under review; and (b) the service is performed by a specialist or consultant physician practising in the speciality of cardiology; and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146) or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55132	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, for the investigation of a patient who is under 17 years of age, or a patient of any age with complex congenital heart disease, if: (a) the service involves the all of the following, where possible: (i) assessment of ventricular structure and function including quantification of systolic function (if the ventricular configuration allows accurate quantification) using at least one of M-mode, 2-dimensional or 3-dimensional imaging; and (ii) assessment of diastolic function; and (iii) assessment of atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant Doppler techniques with quantification; and (vii) subxiphoid views where recommended for congenital heart lesions; and (viii) additional haemodynamic parameters relevant to the clinical condition under review; and (b) the service is performed by a specialist or consultant physician practising in the speciality of cardiology; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55132	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of a patient who: (i) is under 17 years of age; or (ii) has complex congenital heart disease; and (b) is performed by a specialist or consultant physician practising in the speciality of cardiology; and (c) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55133	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2Frequent repetition serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media: (a) for the investigation of a patient: (i) with isolated pericardial effusion or pericarditis; or (ii) who has commenced medication for non-cardiac purposes that have cardiotoxic side effects, and if the patient has a normal baseline study which requires echocardiograms to comply with the requirements of the Pharmaceutical Benefits Scheme; and (b) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55133	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2Frequent repetition serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media: (a) for the investigation of a patient: (i) with isolated pericardial effusion or pericarditis; or (ii) who has commenced medication for non-cardiac purposes that have cardiotoxic side effects, and if the patient has a normal baseline study which requires echocardiograms to comply with the requirements of the Pharmaceutical Benefits Scheme; and (b) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55133	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2 Frequent repetition serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of a patient who: (i) has an isolated pericardial effusion or pericarditis; or (ii) has a normal baseline study, and has commenced medication for non-cardiac purposes that has cardiotoxic side effects and is a pharmaceutical benefit (within the meaning of Part VII of the National Health Act 1953) for the writing of a prescription for the supply of which under that Part an echocardiogram is required; and (b) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55134	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2Repeat real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for rare cardiac pathologies, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a specialist or consultant physician; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55134	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2Repeat real time echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for rare cardiac pathologies, if: (a) the service involves all of the following, where possible: (i) assessment of left ventricular structure and function including quantification of systolic function using M-mode, 2-dimensional or 3-dimensional imaging and diastolic function; and (ii) assessment of right ventricular structure and function with quantitative assessment; and (iii) assessment of left and right atrial structure including quantification of atrial sizes; and (iv) assessment of vascular connections of the heart including the great vessels and systemic venous structures; and (v) assessment of pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (vi) assessment of all present valves including structural assessment and measurement of blood flow velocities across the valves using pulsed wave and continuous wave Doppler techniques with quantification of stenosis or regurgitation; and (vii) assessment of additional haemodynamic parameters including the assessment of pulmonary pressures; and (b) the service is requested by a specialist or consultant physician; and (c) not being a service associated with a service to which another item in this Subgroup (except items 55137, 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55134	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets one or more of the following and the requirements of Note: IR.1.2 Repeat real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 3 acoustic windows, with recordings on digital media, for the investigation of rare cardiac pathologies, if the service: (a) is requested by a specialist or consultant physician; and (b) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55137, 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); or (iii) an item in Subgroup 3 applies (R)
55135	01MAY2004	30APR2020	N	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac valve surgery (repair or replacement) incorporating sequential assessment of cardiac function and valve competence before and after the surgical procedure - not associated with item 55130 (R)
55135	01MAY2020	30JUN2021	N	Intra-operative two-dimensional real time transoesophageal echocardiography incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac valve surgery (replacement or repair) incorporating sequential assessment of cardiac function and valve competence before and after the surgical procedure, not being a service associated with a service to which item 55130 applies (R) (Anaes.)
55135	01JUL2021	29FEB2024	N	Intraoperative two-dimensional or three-dimensional real time transoesophageal echocardiography, if the service: (a) is provided on the same day as a service to which item 38477, 38484, 38499, 38516 or 38517 applies; and (b) includes Doppler techniques with colour flow mapping and recordings on digital media; and (c) is performed during cardiac valve surgery (replacement or repair); and (d) incorporates sequential assessment of cardiac function and valve competence before and after the surgical procedure; and (e) is not associated with a service to which item 55130, or an item in Subgroup 3, applies (R)
55135	01MAR2024	31DEC9999	Y	Intraoperative two-dimensional or three-dimensional real time transoesophageal echocardiography, if the service: (a) is provided on the same day as a service to which item 38477, 38484, 38499, 38516 or 38517 applies; and (b) includes Doppler techniques with colour flow mapping and recordings on digital media; and (c) is performed during cardiac valve surgery (replacement or repair); and (d) incorporates sequential assessment of cardiac function and valve competence before and after the surgical procedure; and (e) is not associated with a service to which item 22054, 55130, or an item in Subgroup 3, applies (R)
55136	01JUL2011	31DEC9999	Y	INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac valve surgery (repair or replacement) incorporating sequential assessment of cardiac function and valve competence before and after the surgical procedure - not associated with items 55130 and 55131 (R) (NK)
55137	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media:(a) for the investigation of a fetus with suspected or confirmed of one or more of the following: (i) complex congenital heart disease; or (ii) functional heart disease; or (iii) fetal cardiac arrhythmia; or (iv) cardiac structural abnormality requiring confirmation; and (b) the service involves the assessment all of the following, where possible: (i) ventricular structure and function; and (ii) atrial structure; and (iii) vascular connections of the heart including the great vessels and systemic venous structures; and (iv) pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (v) all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant Doppler techniques with quantification; and (c) the service is performed by a specialist or consultant physician practising in the speciality of cardiology with advanced training and expertise in fetal cardiac imaging; and (d) not being a service associated with a service to which another item in this Subgroup (except items 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) applies (R)
55137	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2Serial real time echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media: (a) for the investigation of a fetus with suspected or confirmed of one or more of the following: (i) complex congenital heart disease; or (ii) functional heart disease; or (iii) fetal cardiac arrhythmia; or (iv) cardiac structural abnormality requiring confirmation; and (b) the service involves the assessment all of the following, where possible: (i) ventricular structure and function; and (ii) atrial structure; and (iii) vascular connections of the heart including the great vessels and systemic venous structures; and (iv) pericardium and assessment of any haemodynamic consequences of pericardial abnormalities; and (v) all present valves including structural assessment and measurement of blood flow velocities across the valves using relevant Doppler techniques with quantification; and (c) the service is performed by a specialist or consultant physician practising in the speciality of cardiology with advanced training and expertise in fetal cardiac imaging; and (d) not being a service associated with a service to which another item in this Subgroup (except items 55141, 55143, 55145 and 55146), or an item in Subgroup 2 (except items 55118 and 55130) or an item in Subgroup 3 applies (R)
55137	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of a fetus with suspected or confirmed: (i) complex congenital heart disease; or (ii) functional heart disease; or (iii) fetal cardiac arrhythmia; or (iv) cardiac structural abnormality requiring confirmation; and (b) is performed by a specialist or consultant physician practising in the speciality of cardiology with advanced training and expertise in fetal cardiac imaging; and (c) is not associated with a service to which: (i) another item in this Subgroup applies (except items 55141, 55143, 55145 and 55146); or (ii) an item in Subgroup 2 applies (except items 55118 and 55130); applies; or (iii) an item in Subgroup 3 applies (R)
55137	01JUL2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.1.2 Serial real time transthoracic echocardiographic examination of the heart with real time colour flow mapping from at least 4 acoustic windows, with recordings on digital media, if the service: (a) is for the investigation of a fetus with suspected or confirmed: (i) complex congenital heart disease; or (ii) functional heart disease; or (iii) fetal cardiac arrhythmia; or (iv) cardiac structural abnormality requiring confirmation; and (b) is performed by a specialist or consultant physician practising in the speciality of cardiology with advanced training and expertise in fetal cardiac imaging; and (c) is not associated with a service to which: (i) an item in Subgroup 2 applies (except items 55118 and 55130); or (ii) an item in Subgroup 3 applies (R)
55141	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Exercise stress echocardiography focused study if; (a) the service involves all of the following: (i) two-dimensional recordings before exercise (baseline) from at least 2 acoustic windows; and (ii) matching recordings at or immediately after peak exercise, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) cannot be claimed if a service associated with a service to which item 55143, 55145 or 55146 applies is provided in the previous 24 months; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies For any particular patient, applicable not more than once in 24 months (R)
55141	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Exercise stress echocardiography focused study if; (a) the service involves all of the following: (i) two-dimensional recordings before exercise (baseline) from at least 2 acoustic windows; and (ii) matching recordings at or immediately after peak exercise, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) cannot be claimed if a service associated with a service to which item 55143, 55145 or 55146 applies is provided in the previous 24 months; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (d) not being a service associated with a service to which an item in Subgroup 3 applies For any particular patient, applicable not more than once in 24 months (R)
55141	01MAR2021	30NOV2022	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2 Exercise stress echocardiography focused study, other than a service associated with a service to which: (a) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (b) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R)
55141	01DEC2022	31DEC2022	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2 and does not apply to a service provided to a patient if, in the previous 24 months, a service associated with a service to which item 55143 or 55146 applies has been provided to the patient. Exercise stress echocardiography focused study, other than a service associated with a service to which: (a) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (b) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R)
55141	01JAN2023	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2 and does not apply to a service provided to a patient if, in the previous 24 months, a service associated with a service to which item 55143, 55145 or 55146 applies has been provided to the patient. Exercise stress echocardiography focused study, other than a service associated with a service to which: (a) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (b) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R)
55143	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 Repeat pharmacological or exercise stress echocardiography if: (a) the patient has had a service associated with a service to which item 55141, 55145 or 55146 applies provided in the previous 24 months; and (b) the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies For any particular patient, applicable not more than once in 12 months (R)
55143	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 Repeat pharmacological or exercise stress echocardiography if: (a) the patient has had a service associated with a service to which item 55141, 55145 or 55146 applies provided in the previous 24 months; and (b) the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (e) not being a service associated with a service to which an item in Subgroup 3 applies For any particular patient, applicable not more than once in 12 months (R)
55143	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 Repeat pharmacological or exercise stress echocardiography if: (a) a service to which item 55141, 55145 or 55146 applies has been performed on the patient in the previous 24 months; and (b) the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which: (i) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (ii) an item in Subgroup 3 applies Applicable not more than once in a 12 month period (R)
55143	01JUL2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1, IR.1.1 and IR.1.2 Repeat pharmacological or exercise stress echocardiography if: (a) a service to which item 55141, 55145, 55146, or this item, applies has been performed on the patient in the previous 24 months; and (b) the patient has symptoms of ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which: (i) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (ii) an item in Subgroup 3 applies Applicable not more than once in a 12 month period (R)
55145	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Pharmacological stress echocardiography if: (a) the service involves all of the following: (i) two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and (ii) matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) a service to which item 55141, 55146 or 55143 applies has not been provided in the previous 24 months; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies For any particular patient, applicable not more than once in 24 months (R)
55145	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Pharmacological stress echocardiography if: (a) the service involves all of the following: (i) two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and (ii) matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) a service to which item 55141, 55146 or 55143 applies has not been provided in the previous 24 months; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (d) not being a service associated with a service to which an item in Subgroup 3 applies For any particular patient, applicable not more than once in 24 months (R)
55145	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2 Pharmacological stress echocardiography, other than a service associated with a service to which: (a) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (b) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R) Note: this item does not apply to a service provided to a patient if, in the previous 24 months, a service associated with a service to which item 55141, 55143 or 55146 applies has been provided to the patient.
55146	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Pharmacological stress echocardiography if: (a) the service involves all of the following: (i) two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and (ii) matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) the patient has had a service performed under item 55141 in the previous 4 weeks and the test has failed due to an inadequate heart rate response; and (c) a service to which item 55143 or 55145 applies has not been provided in the previous 24 months; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies For any particular patient, applicable not more than once in 24 months (R)
55146	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2Pharmacological stress echocardiography if: (a) the service involves all of the following: (i) two-dimensional recordings before drug infusion (baseline) from at least 2 acoustic windows; and (ii) matching recordings at least twice during drug infusion, including a recording at the peak drug dose, which include at least parasternal short and long axis views, and apical 4-chamber and 2 chamber views; and (iii) recordings on digital media with equipment permitting display of baseline and matching peak images on the same screen; and (iv) resting electrocardiogram and continuous multi-channel electrocardiogram monitoring and recording during stress; and (v) blood pressure monitoring and the recording of other parameters (including heart rate); and (b) the patient has had a service performed under item 55141 in the previous 4 weeks and the test has failed due to an inadequate heart rate response; and (c) a service to which item 55143 or 55145 applies has not been provided in the previous 24 months; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (e) not being a service associated with a service to which an item in Subgroup 3 applies For any particular patient, applicable not more than once in 24 months (R)
55146	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.0.1 and IR.1.2 Pharmacological stress echocardiography if: (a) a service to which item 55141 applies has been performed on the patient in the previous 4 weeks, and the test has failed due to an inadequate heart rate response; and (b) the service is not associated with a service to which: (i) item 11704, 11705, 11707, 11714, 11729 or 11730 applies; or (ii) an item in Subgroup 3 applies Applicable not more than once in a 24 month period (R) Note: this item does not apply to a service provided to a patient if, in the previous 24 months, a service associated with a service to which item 55143 or 55145 applies has been provided to the patient.
55201	01NOV1992	30NOV1992	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which item 55000, 55003 or 55006 applies - 1 examination and report (R)
55201	01DEC1992	30JUN1993	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which item 55000, 55003 or 55006 applies - 1 examination and report (R)
55201	01JUL1993	30JUN1996	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55201	01JUL1996	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis) (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55204	01NOV1992	30JUN1993	N	- 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R)
55204	01JUL1993	30JUN1996	N	- 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55204	01JUL1996	31DEC9999	Y	- 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R)
55207	01JUL1996	31OCT1996	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, urology or general surgery (sub-specialising in vascular surgery) attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R)
55207	01NOV1996	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R)
55208	01JAN1997	30APR2020	N	Confidential Item mapped to 55238
55208	01MAY2020	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent to confirm a diagnosis of vascular aetiology for impotence (R). Note: This item is only available for services rendered by Dr Christopher McMahon, provider number 045449 of Australian Centre for Sexual Health, Berry Road Medical Centre, St Leonards NSW 2065.
55209	01JAN1997	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent to confirm a diagnosis of vascular aetiology for impotence (R)(NK).
55210	01JUL1996	31OCT1996	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, urology or general surgery (sub-specialising in vascular surgery) attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and report is prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R).
55210	01NOV1996	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R).
55211	01JAN1997	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism, or (b) fibrosis of any type, or (c) fracture of the tunica, or (d) arteriovenous malformations (R)(K).
55211	01MAY2020	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations (R) Note: This items is only available for Dr Christopher McMahon, provider number 045449 of Australian Centre for Sexual Health, Berry Road Medical Centre, St Leonards NSW 2065
55212	01JAN1997	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism, or (b) fibrosis of any type, or (c) fracture of the tunica, or (d) arteriovenous malformations (R)(NK).
55220	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55221	01JUL2011	30JUN2019	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55221	01JUL2019	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which item 55222 or 55246 or an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) (NK)
55222	01JUL2011	30JUN2019	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55222	01JUL2019	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which item 55221 or 55244 or an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) (NK)
55223	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55224	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55225	01NOV1992	30JUN1993	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not being a service associated with a service to which item 55000, 55003 or 55006 applies) - examination and report (R)
55225	01JUL1993	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R)
55226	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies (R) (NK)
55227	01JUL2011	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55228	01JUL2011	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55229	01JUL2011	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55230	01JUL2011	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55231	01NOV1992	30JUN1993	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography (not being a service associated with a service to which item 55000, 55003 or 55006 applies) examination and report (R)
55231	01JUL1993	30JUN1996	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies examination and report (R)
55231	01JUL1996	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis) and carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies examination and report (R)
55232	01JUL2011	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies (R) (NK)
55233	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access graft in the upper or lower limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK)
55234	01NOV1992	30JUN1993	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including a service referred to in item 11603, 11606 or 11609 (not being a service associated with a service to which item 55000, 55003 or 55006 applies) examination and report (R)
55234	01JUL1993	30JUN1996	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies examination and report (R)
55234	01JUL1996	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis), including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies examination and report (R)
55235	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or veins OR arteries and veins, for mapping of bypass conduit prior to vascular surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) (NK)
55236	01JUL2011	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow spectral analysis and marking of veins in the lower limb below the inguinal ligament prior to varicose vein surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) (NK)
55237	01NOV1992	30JUN1993	N	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels before measured exercise using treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral), (not being a service associated with a service to which item 55000, 55003 or 55006 applies) examination and report (R)
55237	01JUL1993	31DEC9999	Y	DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels before measured exercise using treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies examination and report (R)
55238	01NOV1997	31OCT2001	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55238	01NOV2001	30APR2020	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R)
55238	01MAY2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb or of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55240	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, including a service referred to in item 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - 1 examination and report (R)
55242	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, including a service referred to in item 11612, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55244	01NOV1997	31OCT2001	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55244	01NOV2001	30JUN2019	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55244	01JUL2019	30APR2020	N	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which item 55222, 55246 or an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) (K)
55244	01MAY2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with any of the following:(a) a service to which item 55246 applies;(b) a service to which an item in Subgroup 4 applies;(c) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55245	01NOV1998	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55246	01NOV1997	31OCT2001	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55246	01NOV2001	30JUN2019	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55246	01JUL2019	30APR2020	N	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which item 55221 or 55244 or an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) (K)
55246	01MAY2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with any of the following:(a) a service to which item 55244 applies;(b) a service to which an item in Subgroup 4 applies;(c) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55247	01NOV1998	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55248	01NOV1997	31OCT2001	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55248	01NOV2001	30JUN2019	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55248	01JUL2019	30APR2020	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R) (K)
55248	01MAY2020	31OCT2020	N	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb or of arteries and bypass grafts in the upper limb, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55248	01NOV2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb or of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55250	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55252	01NOV1997	31OCT2001	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 ( with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55252	01NOV2001	30APR2020	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R)
55252	01MAY2020	31OCT2020	N	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55252	01NOV2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroup 4 applies (R).
55254	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55256	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - 1 examination and report (R)
55256	01NOV2001	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - (R)
55258	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55260	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, including a service referred to in item 11612, not being a service associated with a service to which an item in Subgroups 1 (with exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55262	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55262	01NOV2001	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55263	01NOV1998	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55264	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55264	01NOV2001	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55265	01NOV1998	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55266	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55266	01NOV2001	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55268	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55270	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55270	01NOV2001	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55272	01NOV1997	31DEC9999	Y	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception o f item 55054) or 4 of this Group applies - 1 examination and report (R)
55274	01NOV1997	31OCT2001	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - 1 examination and report (R)
55274	01NOV2001	30APR2020	N	DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - (R)
55274	01MAY2020	31OCT2020	N	Duplex scanning, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri orbital Doppler examination, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55274	01NOV2020	31DEC9999	Y	Duplex scanning, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri orbital Doppler examination, not being a service associated with a service to which an item in Subgroup 4 applies (R).
55276	01NOV1997	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55276	01NOV2001	30APR2002	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55276	01MAY2002	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55276	01MAY2020	31OCT2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins or of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with any of the following: (a) a service to which an item in Subgroup 4 applies; (b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55276	01NOV2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins or of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55277	01NOV1998	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55277	01NOV2001	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55278	01NOV1997	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55278	01NOV2001	30APR2002	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55278	01MAY2002	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R)
55278	01MAY2020	31OCT2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels or of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55278	01NOV2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels or of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55279	01NOV1998	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55279	01NOV2001	31DEC9999	Y	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55280	01NOV1997	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R)
55280	01NOV2001	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R)
55280	01MAY2020	31OCT2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra cranial vessels, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55280	01NOV2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra cranial vessels, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55282	01NOV1997	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vasular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R)
55282	01NOV2001	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated doppler flow measurements: (a) by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent; and (b) performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence; and (c) where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at thepractice location where the service is performed, immediately before or for a period during the performance of the service; and (d) where that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R)
55282	01MAY2020	31OCT2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements:(a) by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent; and(b) performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence; and(c) if a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is performed, immediately before or for a period during the performance of the service; and(d) if the specialist or consultant physician interprets the results and prepares a report, not being a service associated with any of the following:(i) a service to which an item in Subgroup 4 applies;(ii) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55282	01NOV2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements:(a) by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent; and(b) performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence; and(c) if a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is performed, immediately before or for a period during the performance of the service; and(d) if the specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55284	01NOV1997	31OCT2001	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - 1 examination and report (R)
55284	01NOV2001	30APR2020	N	DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies - (R)
55284	01MAY2020	31OCT2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements:(a) by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis; and(b) if indicated, assess the progress and management of:(i) priapism; or(ii) fibrosis of any type; or(iii) fracture of the tunica; or(iv) arteriovenous malformations; and(c) if a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is performed, immediately before or for a period during the performance of the service; and(d) if the specialist or consultant physician interprets the results and prepares a report, not being a service associated with any of the following:(i) a service to which an item in Subgroup 4 applies;(ii) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55284	01NOV2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements:(a) by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis; and(b) if indicated, assess the progress and management of:(i) priapism; or(ii) fibrosis of any type; or(iii) fracture of the tunica; or(iv) arteriovenous malformations; and(c) if a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is performed, immediately before or for a period during the performance of the service; and(d) if the specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55286	01NOV1997	31DEC9999	Y	Note: For this item, the scanned area must be specified on the account or patient assignment form. DUPLEX SCANNING, unilateral or bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of vessels not otherwise specified (excluding the cavernosal artery and the dorsal artery of the penis), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), 3 or 4 of this Group applies - 1 examination and report (R)
55288	01NOV1997	31OCT1998	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. - TWO examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276 and 55278, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55288	01NOV1998	31AUG1999	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. - TWO examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55288	01SEP1999	31OCT2001	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. - TWO examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55288	01NOV2001	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. - TWO examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238 and 55256; block (b) - item 55244, 55246, 55262, and 55264; block (c) - item 55248, and 55266; block (d) - item 55252 and 55270; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - (R)
55290	01NOV1997	31OCT1998	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. THREE examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276 and 55278, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55290	01NOV1998	31AUG1999	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. THREE examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55290	01SEP1999	31OCT2001	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. THREE examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R)
55290	01NOV2001	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. THREE examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238 and 55256, block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248 and 55266; block (d) - item 55252 and 55270; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - (R)
55292	01NOV2001	30APR2020	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access graft in the upper or lower limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R)
55292	01MAY2020	31OCT2020	N	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access grafts in the upper or lower limbs, not being a service associated with any of the following:(a) a service to which an item in Subgroup 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55292	01NOV2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access grafts in the upper or lower limbs, not being a service associated with a service to which an item in Subgroup 4 applies (R)
55294	01NOV2001	30APR2020	N	DUPLEX SCANNING, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or veins OR arteries and veins, for mapping of bypass conduit prior to vascular surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R)
55294	01MAY2020	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or veins, or both, including any associated skin marking, for mapping of bypass conduit before vascular surgery, not being a service associated with any of the following:(a) a service to which an item in Subgroup 3 or 4 applies; (b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55296	01NOV2001	30APR2020	N	DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow spectral analysis and marking of veins in the lower limb below the inguinal ligament prior to varicose vein surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R)
55296	01MAY2020	31DEC9999	Y	Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow spectral analysis and marking of veins in the lower limbs below the inguinal ligament before varicose vein surgery, including any associated skin marking, not being a service associated with any of the following:(a) a service to which an item in Subgroup 3 or 4 applies;(b) a service to which item 55880, 55881, 55882, 55883, 55884, 55885, 55886, 55887, 55888, 55889, 55890, 55891, 55892, 55893, 55894 or 55895 applies (R)
55300	01JUL1993	31OCT1993	N	PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a) personally by a medical practitioner using a transducer probe or probes able to operate within a frequency range of 7 to 7.5 megahertz and able to obtain both transverse and longitudinal scans; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist surgeon or consultant physician who has: (i) examined the patient in the 60 days prior to the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R)
55300	01NOV1993	31DEC9999	Y	PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R)
55303	01NOV1993	31DEC9999	Y	PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a) personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequecies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R)
55600	01NOV1998	30JUN2011	N	PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R)
55600	01JUL2011	31OCT2011	N	PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K)
55600	01NOV2011	30JUN2014	N	PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a referring practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K)
55600	01JUL2014	30JUN2018	N	Prostate, bladder base and urethra, l ultrasound scan of, if performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that: (i) have a nominal frequency of 7 to 7.5 MHz or a nominal frequency range that includes frequencies of 7 to 7.5 MHz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology, a consultant physician in medical oncology, who has: (i) examined the patient in the 60 days before the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R) (K)
55600	01JUL2018	30APR2020	N	Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patients current prostatic disease (R) (K)
55600	01MAY2020	31DEC9999	Y	Prostate, bladder base and urethra, ultrasound scan of, if performed:(a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and(b) after a digital rectal examination of the prostate by that medical practitioner; and(c) on a patient who has been assessed by:(i) a specialist in urology, radiation oncology or medical oncology; or(ii) a consultant physician in medical oncology; who has:(iii) examined the patient in the 60 days before the scan; and(iv) recommended the scan for the management of the patients current prostatic disease(R)
55601	01JUL2011	30JUN2018	N	PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i) examined the patient in the 60 days prior to the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R) (NK)
55601	01JUL2018	31DEC9999	Y	Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patients current prostatic disease (R) (NK)
55603	01NOV1998	30JUN2011	N	PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a) personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R)
55603	01JUL2011	30JUN2018	N	PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K)
55603	01JUL2018	30APR2020	N	Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner who made the assessment mentioned in paragraph (c) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patients current prostatic disease (R) (K)
55603	01MAY2020	31DEC9999	Y	Prostate, bladder base and urethra, ultrasound scan of, if performed:(a) personally by a medical practitioner who made the assessment mentioned in paragraph (c) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and(b) after a digital rectal examination of the prostate by that medical practitioner; and(c) on a patient who has been assessed by:(i) a specialist in urology, radiation oncology or medical oncology; or(ii) a consultant physician in medical oncology; who has:(iii) examined the patient in the 60 days before the scan; and(iv) recommended the scan for the management of the patients current prostatic disease(R)
55604	01JUL2011	30JUN2018	N	PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i) examined the patient in the 60 days prior to the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R) (NK)
55604	01JUL2018	31DEC9999	Y	Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner who made the assessment mentioned in paragraph (c) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patients current prostatic disease (R) (NK)
55700	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) gross maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55700	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55700	01NOV2001	31OCT2005	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55700	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55707 (R). Fee is payable only for item 55700 or item 55707, not both items.
55700	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, if: (a) the patient is referred by a medical practitioner or participating midwife; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) 1 or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 (R). Fee is payable only for item 55700 or item 55707, not both items.
55700	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, for determining the gestation, location, viability or number of foetuses, if the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation (R)
55700	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the gestation, location, viability or number of fetuses, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is less than 12 weeks of gestation; and (b) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55704, 55705, 55707, 55708, 55740, 55741, 55742 or 55743 (R)
55701	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 or 55714 (R) (NK). Fee is payable only for item 55700 or 55701, or, or item 55707 or 55714, not both items
55702	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55708 or 55716 (R) (NK). Fee is payable only for item 55702 or 55703, or, item 55707 or 55714, not both items
55703	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) gross maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical imcompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR)
55703	01NOV2000	31OCT2005	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR)
55703	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55708 (R). Fee is payable only for item 55703 or item 55707, not both items.
55703	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55708 (R). Fee is payable only for item 55703 or item 55707, not both items.
55703	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, for determining the gestation, location, viability or number of foetuses, if the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation (NR)
55703	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the gestation, location, viability or number of fetuses, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is less than 12 weeks of gestation; and (b) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55704, 55705, 55707, 55708, 55740, 55741, 55742 or 55743 (NR)
55704	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) gross maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55704	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55704	01NOV2001	31OCT2005	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R)
55704	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55707 (R). Fee is payable only for item 55704 or item 55707, not both items.
55704	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if: (a)the patient is referred by a medical practitioner or participating midwife; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife -- the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormalityFootnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 (r). fee is payable only for item 55704 or item 55707, not both items.
55704	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of foetuses, if the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation (R)
55704	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of fetuses, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (b) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55705	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) gross maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical imcompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR)
55705	01NOV2000	31OCT2005	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR)
55705	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55708 (R). Fee is payable only for item 55705 or item 55708, not both items.
55705	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner;and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum;(ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR)
55705	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of foetuses, if the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation (NR)
55705	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of fetuses, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (b) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55706	01FEB2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) the service is not performed in the same pregnancy as item 55709 (R)
55706	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the patient is referred by a medical practitioner or participating midwife; and (b) the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner - the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) the service is not performed in the same pregnancy as item 55709 (R)
55706	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if:(a) the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and(b) the service is not performed in the same pregnancy as item 55709 (R)
55706	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the dating for the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55709; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55706	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the dating for the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55709; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55707	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a) the patient is referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 80mm; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the conditions mentioned in subparagraphs (e) (i) to (xxx) of item 55704 are present; and (f) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (g) the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (R)
55707	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, if; (a) the patient is referred by a medical practitioner or participating midwife; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner - the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) at least 1 condition mentioned in paragraph (f) of item 55704 is present; and (g) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (h) the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (R)
55707	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) the pregnancy (as confirmed by ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and(b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and(c) the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (R)
55707	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if:(a) the pregnancy (as confirmed by the current ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and(b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and(c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55707	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the pregnancy (as confirmed by the current ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and (b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55708	01NOV2005	31OCT2007	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a) the patient is not referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 80mm; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the conditions in subparagraphs (e) (i) to (xxx) of item 55704 are present; and (e) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f) the service is not performed in conjunction with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (NR)
55708	01NOV2007	30APR2020	N	PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84 mm; and (c) the service is not associated with a service to which an item in subgroup 2 or 3 applies; and (d) at least 1 condition mentioned in paragraph (e) of item 55704 is present; and (e) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f) the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (nr) (item is subject to subrule 11 (2))
55708	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84 mm; and(b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and(c) the service is not performed with item 55700, 55703, 55704 or 55705, on the same patient within 24 hours (NR)
55708	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if:(a) the pregnancy (as confirmed by the current ultrasound) is dated by a crown rump length of 45 to 84 mm; and(b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and(c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55708	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the pregnancy (as confirmed by the current ultrasound) is dated by a crown rump length of 45 to 84 mm; and (b) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55709	01FEB2000	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the service is not performed in the same pregnancy as item 55706 or 55713 (NR)
55709	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if:(a) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and(b the service is not performed in the same pregnancy as item 55706 (NR)
55709	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55706; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55709	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55706; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55710	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where:(a) the patient is referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and(e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (r)Footnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item 55704 or 55707 (r) (nk). Fee is payable only for item 55704 or 55710, or, item 55707 or 55714, not both items
55711	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where:(a) the patient is not referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) one or more of the following conditions are present: (i) hyperemesis gravidarum (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (nr)Footnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item 55708 or 55716 (r) (nk). Fee is payable only for item 55705 or 55711, or, item 55708 or 55716, not both items
55712	01FEB2000	30APR2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R)
55712	01MAY2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R)
55712	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R)
55712	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if:(a) the service is requested by a medical practitioner who:(i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and(c) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709 (R)
55712	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the current ultrasound is requested by a medical practitioner who: (i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (c) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55712	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the current ultrasound is requested by a medical practitioner who: (i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or (ii) has a Diploma of Obstetrics; or (iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or (iv) has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (c) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55713	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner; and (b) the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) the service is not performed in the same pregnancy as item 55709 or 55717 (R) (NK)
55714	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a) the patient is referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) one or more of the conditions mentioned in subparagraphs (e) (i) to (xxx) of item 55704 or 55710 are present; and (f) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (g) the service is not performed with item 55700, 55701, 55702, 55703, 55704, 55705, 55710 or 55711 on the same patient within 24 hours (R) (NK)
55715	01FEB2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (NR)
55715	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (NR)
55715	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if:(a) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and(b) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709 (NR)
55715	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55715	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (b) further examination is clinically indicated after performance, in the same pregnancy, of a scan mentioned in item 55706 or 55709; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55716	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a) the patient is not referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) one or more of the conditions in subparagraphs (e) (i) to (xxx) of item 55704 or 55710 are present; and (e) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f) the service is not performed in conjunction with item 55700, 55701, 55702, 55703, 55704, 55705, 55710 or 55711 on the same patient within 24 hours (NR) (NK)
55717	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the service is not performed in the same pregnancy as item 55706 or 55713 (NR) (NK)
55718	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) the service is not performed in the same pregnancy as item 55723; and (f) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) multiple pregnancy; (xx) fetal infection; (xxi) pregnancy after assisted reproduction; (xxii) trauma; (xxiii) diabetes mellitus; (xxiv) hypertension; (xxv) toxaemia of pregnancy; (xxvi) liver or renal disease; (xxvii) autoimmune disease; (xxviii) cardiac disease; (xxix) alloimmunisation; (xxx) maternal infection; (xxxi) inflammatory bowel disease; (xxxii) bowel stoma; (xxxiii) abdominal wall scarring; (xxxiv) previous spinal or pelvic trauma or disease; (xxxv) drug dependency; (xxxvi) thrombophilia; (xxxvii) gross maternal obesity; (xxxviii) advanced maternal age; (xxxix) abdominal pain or mass (R)
55718	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner where: (a) the patient is referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) the service is not performed in the same pregnancy as item 55723; and (f) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (R)
55718	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, if:(a) the patient is referred by a medical practitioner or participating midwife; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife -- the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) the service is not performed in the same pregnancy as item 55723; and (g) 1 or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (r)
55718	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(b) the service is not performed in the same pregnancy as item 55723 (R)
55718	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55723; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55718	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55723; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55719	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55706, 55709, 55713 or 55717 applies (R) (NK)
55720	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55706, 55709, 55713 or 55717 applies (NR) (NK)
55721	01FEB2000	30APR2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R)
55721	01MAY2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R)
55721	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, where:(a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55718, 55722, 55723 or 55726 (R) (K)
55721	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) the service is requested by a medical practitioner who:(i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(d) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R)
55721	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the current ultrasound is requested by a medical practitioner who: (i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (c) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55721	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the current ultrasound is requested by a medical practitioner who: (i) is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or (ii) has a Diploma of Obstetrics; or (iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of Obstetrics; or (iv) has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by current ultrasound) is after 22 weeks of gestation; and (c) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55722	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where:(a) the patient is referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member;and(e) the service is not performed in the same pregnancy as item 55723 or 55726; and(f) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (r) (nk)
55723	01FEB2000	31OCT2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the service is not performed in the same pregnancy as item 55718; and (e) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) multiple pregnancy; (xx) fetal infection; (xxi) pregnancy after assisted reproduction; (xxii) trauma; (xxiii) diabetes mellitus; (xxiv) hypertension; (xxv) toxaemia of pregnancy; (xxvi) liver or renal disease; (xxvii) autoimmune disease; (xxviii) cardiac disease; (xxix) alloimmunisation; (xxx) maternal infection; (xxxi) inflammatory bowel disease; (xxxii) bowel stoma; (xxxiii) abdominal wall scarring; (xxxiv) previous spinal or pelvic trauma or disease; (xxxv) drug dependency; (xxxvi) thrombophilia; (xxxvii) gross maternal obesity; (xxxviii) advanced maternal age; (xxxix) abdominal pain or mass (NR)
55723	01NOV2000	30APR2020	N	PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in subgroup 2 or 3 applies; and (d) the service is not performed in the same pregnancy as item 55718; and (e) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetalcardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy;(xviii) premature labour;(xix) fetal infection;(xx) pregnancy after assisted reproduction;(xxi) trauma;(xxii) diabetes mellitus;(xxiii) hypertension;(xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) gross maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (nr)(item is subject to subrule 11 (2))
55723	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(b) the service is not performed in the same pregnancy as item 55718 (NR)
55723	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55718; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55723	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) the current ultrasound: (i) is not performed in the same pregnancy as item 55718; and (ii) is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55724	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) further examination is clinically indicated in the same pregnancy to which item 55718, 55722, 55723 or 55726 applies (R) NK)
55725	01FEB2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricans and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (NR)
55725	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (NR)
55725	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if:(a) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(b) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (NR)
55725	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55725	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55726	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where:(a) the patient is not referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) the service is not performed in the same pregnancy as item 55718 or 55722; and(e) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (nr) (nk)
55727	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) further examination is clinically indicated in the same pregnancy to which item 55718, 55722, 55723 or 55726 applies (NR) (NK)
55728	01FEB2000	30APR2000	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R)
55728	01MAY2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e) it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R)
55728	01NOV2001	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R)
55729	01NOV2000	31OCT2001	N	MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - examination and report (R)
55729	01NOV2001	31OCT2004	N	MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - (R)
55729	01NOV2004	30APR2020	N	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of the umbilical artery, and measured assessment of amniotic fluid volume after the 24th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - (R)
55729	01MAY2020	31DEC9999	Y	Duplex scanning, if:(a) the service involves:(i) B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of the umbilical artery; and(ii) measured assessment of amniotic fluid volume after the 24th week of gestation; and(b) there is reason to suspect intrauterine growth retardation or a significant risk of fetal death;-examination and report (R)
55730	01JUL2011	31DEC9999	Y	Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of the umbilical artery, and measured assessment of amniotic fluid volume after the 24th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies (R) (NK)
55731	01FEB2000	31OCT2001	N	PELVIS, FEMALE, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (d) the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R)
55731	01NOV2001	31DEC9999	Y	PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (d) the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R)
55732	01JUL2011	31DEC9999	Y	PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (d) the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R) (NK)
55733	01FEB2000	31DEC9999	Y	PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR)
55734	01JUL2011	31DEC9999	Y	PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK)
55735	01JUL2011	31DEC2013	N	PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) (NK)
55735	01JAN2014	31DEC9999	Y	PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) (NK)
55736	01FEB2000	31OCT2001	N	PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, performed by or on behalf of a medical practitioner where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of medical practitioners of which the first mentioned practitioner is a member; and (d) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R)
55736	01NOV2001	31DEC2013	N	PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R)
55736	01JAN2014	30APR2020	N	PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R)
55736	01MAY2020	31DEC9999	Y	Pelvis, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, if a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R)
55737	01JUL2011	31DEC2013	N	PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) (NK)
55737	01JAN2014	31DEC9999	Y	PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) (NK)
55739	01FEB2000	31DEC2013	N	PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR)
55739	01JAN2014	30APR2020	N	PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c) a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR)
55739	01MAY2020	31DEC9999	Y	Pelvis, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, if a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR)
55740	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of fetuses, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55741	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, for determining the structure, gestation, location, viability or number of fetuses, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 12 to 16 weeks of gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55742	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the pregnancy (as confirmed by the current ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and (c) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55743	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the pregnancy (as confirmed by the current ultrasound) is dated by a fetal crown rump length of 45 to 84 mm; and (c) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55757	01NOV2022	31DEC2023	N	Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical length assessment for risk of preterm labour, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) the patient has a history indicating high-risk of preterm labour or birth or second trimester fetal loss; (ii) the patient has symptoms suggestive of threatened preterm labour or second trimester fetal loss; (iii) the patients cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55757	01JAN2024	31DEC9999	Y	Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical length assessment for risk of preterm labour, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) the patient has a history indicating high risk of preterm labour or birth or second trimester fetal loss; (ii) the patient has symptoms suggestive of threatened preterm labour or second trimester fetal loss; (iii) the patients cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (R)
55758	01NOV2022	31DEC2023	N	Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical length assessment for risk of preterm labour, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) the patient has a history indicating high-risk of preterm labour or birth or second trimester fetal loss; (ii) the patient has symptoms suggestive of threatened preterm labour or second trimester fetal loss; (iii) the patients cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55758	01JAN2024	31DEC9999	Y	Pelvis or abdomen, ultrasound (the current ultrasound) scan of, for cervical length assessment for risk of preterm labour, by any or all approaches, if: (a) the dating of the pregnancy (as confirmed by the current ultrasound) is between 14 and 30 weeks of gestation; and (b) any of the following apply: (i) the patient has a history indicating high risk of preterm labour or birth or second trimester fetal loss; (ii) the patient has symptoms suggestive of threatened preterm labour or second trimester fetal loss; (iii) the patients cervical length is less than 25 mm on an ultrasound before 28 weeks gestation; and (c) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in another item in this Subgroup (NR)
55759	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the first mentioned practitioner is a member; and (f) the service is not performed in conjunction with item 55706, 55709, 55712, or 55715 during the same pregnancy (R)
55759	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f) the service is not performed in conjunction with item 55706, 55709, 55712, 55715 or 55762 during the same pregnancy (R)
55759	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if:(a) ultrasound of the same pregnancy confirms a multiple pregnancy; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and(c) the service mentioned in item 55706, 55709, 55712, 55715 or 55762 is not performed in conjunction with the scan during the same pregnancy (R)
55759	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks gestation; and (c) the service mentioned in item 55706, 55709, 55712, 55715 or 55762 is not performed in conjunction with the current ultrasound during the same pregnancy; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55760	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f) the service is not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719, 57721, 55762 or 55763 during the same pregnancy (R) (NK)
55762	01NOV2000	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is not referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not performed in conjunction with item 55706, 55709, 55712, 55715 or 55759during the same pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies (NR)
55762	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (c) the service mentioned in item 55706, 55709, 55712, 55715 or 55759 is not performed in conjunction with the scan during the same pregnancy (NR)
55762	01NOV2022	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks gestation; and (c) the service mentioned in item 55706, 55709, 55712, 55715 or 55759 is not performed in conjunction with the current ultrasound during the same pregnancy; and (d) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55763	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is not referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719, 55720, 55759 or 55760 during the same pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies (NR) (NK)
55764	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the first mentioned practitioner is a member; and (f) further examination is clinically indicated in the same pregnancy to which item 55759 or 55762 has been performed; and (g) not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (R)
55764	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f) further examination is clinically indicated in the same pregnancy to which item 55759 or 55762 has been performed; and (g) not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (R)
55764	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, if:(a) the service is requested by a medical practitioner who:(i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and(b) ultrasound of the same pregnancy confirms a multiple pregnancy; and(c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and(d) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and(e) the service mentioned in item 55706, 55709, 55712 or 55715 is not performed in conjunction with the scan during the same pregnancy (R)
55764	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the service is requested by a medical practitioner who: (i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and (b) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks gestation; and (d) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and (e) the service mentioned in item 55706, 55709, 55712 or 55715 is not performed in conjunction with the current ultrasound during the same pregnancy; and (f) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55764	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a) the service is requested by a medical practitioner who: (i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or (ii) has a Diploma of Obstetrics; or (iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or (iv) has obstetric privileges at a non-metropolitan hospital; and (b) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks gestation; and (d) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and (e) the service mentioned in item 55706, 55709, 55712 or 55715 is not performed in conjunction with the current ultrasound during the same pregnancy; and (f) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55765	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e) the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f) further examination is clinically indicated in the same pregnancy to which item 55759, 55760, 55762 or 55763 has been performed; and (g) not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719 during the same pregnancy (R) (NK)
55766	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e) further examination is clinically indicated in the same pregnancy to which item 55759, or 55762 has been performed; and (f) not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (NR)
55766	01NOV2001	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e) further examination is clinically indicated in the same pregnancy to which item 55759, or 55762 has been performed; and (f) not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (NR)
55766	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if:(a) ultrasound of the same pregnancy confirms a multiple pregnancy; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and(c) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and(d) the service mentioned in item 55706, 55709, 55712 or 55715, is not performed in conjunction with the scan during the same pregnancy (NR)
55766	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (c) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and (d) the service mentioned in item 55706, 55709, 55712 or 55715 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55766	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) an ultrasound of the same pregnancy confirms a multiple pregnancy; and (b) the dating of the pregnancy (as confirmed by the current ultrasound) is 17 to 22 weeks of gestation; and (c) further examination is clinically indicated in the same pregnancy in which item 55759 or 55762 has been performed; and (d) the service mentioned in item 55706, 55709, 55712 or 55715 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55767	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) the patient is not referred by a medical practitioner; and (b) ultrasound of the same pregnancy confirms a multiple pregnancy; and (c) the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d) the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e) further examination is clinically indicated in the same pregnancy to which item 55759, 55760, 55762 or 55763 has been performed; and (f) not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719 or 55720 during the same pregnancy (NR) (NK)
55768	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b) the ultrasound confirms a multiple pregnancy; and (c) the patient is referred by a medical practitioner; and (d) the service is not performed in the same pregnancy as item 55770; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R)
55768	01NOV2001	31OCT2006	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b) the ultrasound confirms a multiple pregnancy; and (c) the patient is referred by a medical practitioner; and (d) the service is not performed in the same pregnancy as item 55770; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R)
55768	01NOV2006	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner; and (d)the service is not performed in the same pregnancy as item 55770 or 55771; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, or 55725, 55726 or 55727 during the same pregnancy (R)
55768	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(b) the ultrasound confirms a multiple pregnancy; and(c) the service is not performed in the same pregnancy as item 55770; and(d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the scan during the same pregnancy (R)
55768	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) an ultrasound confirms a multiple pregnancy; and (c) the service is not performed in the same pregnancy as item 55770; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55768	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) an ultrasound confirms a multiple pregnancy; and (c) the service is not performed in the same pregnancy as item 55770; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55769	01JUL2011	31OCT2011	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b) the ultrasound confirms a multiple pregnancy; and (c) the patient is referred by a medical practitioner or participating nurse practitioner; and (d) the service is not performed in the same pregnancy as item 55770 or 55771; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK)
55769	01NOV2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b) the ultrasound confirms a multiple pregnancy; and (c) the patient is referred by a medical practitioner; and (d) the service is not performed in the same pregnancy as item 55770 or 55771; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK)
55770	01NOV2000	31OCT2006	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) the service is not performed in the same pregnancy as item 55768; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (NR)
55770	01NOV2006	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) the service is not performed in the same pregnancy as item 55768; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721, 55723 or 55725 during the same pregnancy (NR)
55770	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(b) the ultrasound confirms a multiple pregnancy; and(c) the service is not performed in the same pregnancy as item 55768; and(d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the scan during the same pregnancy (NR)
55770	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) an ultrasound confirms a multiple pregnancy; and (c) the service is not performed in the same pregnancy as item 55768; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55770	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy (as confirmed by the current ultrasound) is after 22 weeks of gestation; and (b) an ultrasound confirms a multiple pregnancy; and (c) the service is not performed in the same pregnancy as item 55768; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55771	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) the service is not performed in the same pregnancy as item 55768 or 55759; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721, 55723, 55724,,55725, 55726 or 55727 during the same pregnancy (NR) (NK)
55772	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R)
55772	01NOV2001	31OCT2006	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstericians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R)
55772	01NOV2006	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55723 or 55725 during the same pregnancy (R)
55772	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if:(a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and(b) the service is requested by a medical practitioner who:(i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and(c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and(d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and(e) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the scan during the same pregnancy (R)
55772	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy as confirmed by the current ultrasound is after 22 weeks of gestation; and (b) the service is requested by a medical practitioner who: (i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or(ii) has a Diploma of Obstetrics; or(iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or(iv) has obstetric privileges at a non metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by an ultrasound is a multiple pregnancy; and (e) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (f) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55772	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, if: (a) dating of the pregnancy as confirmed by the current ultrasound is after 22 weeks of gestation; and (b) the service is requested by a medical practitioner who: (i) is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists; or (ii) has a Diploma of Obstetrics; or (iii) has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of Obstetrics; or (iv) has obstetric privileges at a non-metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by an ultrasound is a multiple pregnancy; and (e) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (f) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (R)
55773	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c) further examination is clinically indicated in the same pregnancy to which item 55768, 55769, 55770 or 55771 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g) the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK)
55774	01NOV2000	31OCT2001	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721 55723, 55725 or 55728 during the same pregnancy (NR)
55774	01NOV2001	31OCT2006	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed ;and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721 55723, 55725 or 55728 during the same pregnancy (NR)
55774	01NOV2006	30APR2020	N	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed ;and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721 55723 or 55725 during the same pregnancy (NR)
55774	01MAY2020	31OCT2022	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if:(a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and(b) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and(c) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and(d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the scan during the same pregnancy (NR)
55774	01NOV2022	31DEC2023	N	Pelvis or abdomen, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) dating of the pregnancy as confirmed by the current ultrasound is after 22 weeks of gestation; and (b) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (c) the pregnancy as confirmed by an ultrasound is a multiple pregnancy; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55774	01JAN2024	31DEC9999	Y	Pelvis or abdomen, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound (the current ultrasound) scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, if: (a) dating of the pregnancy as confirmed by the current ultrasound is after 22 weeks of gestation; and (b) further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (c) the pregnancy as confirmed by an ultrasound is a multiple pregnancy; and (d) the service mentioned in item 55718, 55721, 55723 or 55725 is not performed in conjunction with the current ultrasound during the same pregnancy; and (e) the current ultrasound is not performed on the same patient within 24 hours of a service mentioned in item 55757 or 55758 (NR)
55775	01JUL2011	31DEC9999	Y	PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a) dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b) the patient is not referred by a medical practitioner; and (c) further examination is clinically indicated in the same pregnancy to which item 55768, 55769, 55770 or 5571 has been performed; and (d) the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f) the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (NR) (NK)
55800	01NOV2000	31OCT2001	N	HAND OR WRIST, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55800	01NOV2001	31DEC9999	Y	HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55801	01JUL2011	31DEC9999	Y	HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55802	01NOV2000	31OCT2001	N	HAND OR WRIST, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55802	01NOV2001	31DEC9999	Y	HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55803	01JUL2011	31DEC9999	Y	HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55804	01NOV2000	31OCT2001	N	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55804	01NOV2001	31DEC9999	Y	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55805	01JUL2011	31DEC9999	Y	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55806	01NOV2000	31OCT2001	N	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55806	01NOV2001	31DEC9999	Y	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55807	01JUL2011	31DEC9999	Y	FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55808	01NOV2000	31OCT2001	N	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member. (R)
55808	01NOV2001	30APR2003	N	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member. (R)
55808	01MAY2003	31DEC9999	Y	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: - evaluation of injury to tendon, muscle or muscle/tendon junction; or - rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or - biceps subluxation; or - capsulitis and bursitis; or - evaluation of mass including ganglion; or - occult fracture; or - acromioclavicular joint pathology.(R)
55809	01JUL2011	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific shoulder pain alone. SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: - evaluation of injury to tendon, muscle or muscle/tendon junction; or - rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or - biceps subluxation; or - capsulitis and bursitis; or - evaluation of mass including ganglion; or - occult fracture; or - acromioclavicular joint pathology (R) (NK)
55810	01NOV2000	31OCT2001	N	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55810	01NOV2001	30APR2003	N	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55810	01MAY2003	31DEC9999	Y	SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: - evaluation of injury to tendon, muscle or muscle/tendon junction; or - rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or - biceps subluxation; or - capsulitis and bursitis; or - evaluation of mass including ganglion; or - occult fracture; or - acromioclavicular joint pathology.(NR)
55811	01JUL2011	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific shoulder pain alone. SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: - evaluation of injury to tendon, muscle or muscle/tendon junction; or - rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or - biceps subluxation; or - capsulitis and bursitis; or - evaluation of mass including ganglion; or - occult fracture; or - acromioclavicular joint pathology (NR) (NK)
55812	01NOV2000	31OCT2001	N	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55812	01NOV2001	30APR2020	N	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55812	01MAY2020	31DEC9999	Y	Chest or abdominal wall, one or more areas, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55070, 55073, 55076 or 55079 (R)
55813	01JUL2011	31DEC9999	Y	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55814	01NOV2000	31OCT2001	N	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55814	01NOV2001	30APR2020	N	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55814	01MAY2020	31DEC9999	Y	Chest or abdominal wall, one or more areas, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55070, 55073, 55076 or 55079 (NR)
55815	01JUL2011	31DEC9999	Y	CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55816	01NOV2000	31OCT2001	N	HIP OR GROIN, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55816	01NOV2001	31DEC9999	Y	HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55817	01JUL2011	31DEC9999	Y	HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55818	01NOV2000	31OCT2001	N	HIP OR GROIN, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (c) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (d) the patient is not referred by a medical practitioner (NR)
55818	01NOV2001	31DEC9999	Y	HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (b) the patient is not referred by a medical practitioner (NR)
55819	01JUL2011	31DEC9999	Y	HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (b) the patient is not referred by a medical practitioner (NR) (NK)
55820	01NOV2000	31OCT2001	N	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (c) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55820	01NOV2001	31DEC9999	Y	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55821	01JUL2011	31DEC9999	Y	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55822	01NOV2000	31OCT2001	N	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (f) the patient is not referred by a medical practitioner (NR)
55822	01NOV2001	31DEC9999	Y	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55823	01JUL2011	31DEC9999	Y	PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55824	01NOV2000	31DEC9999	Y	BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55825	01JUL2011	31DEC9999	Y	BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55826	01NOV2000	31OCT2001	N	BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55826	01NOV2001	31DEC9999	Y	BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55827	01JUL2011	31DEC9999	Y	BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55828	01NOV2000	31OCT2001	N	KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55828	01NOV2001	30APR2003	N	KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55828	01MAY2003	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: - meniscal and cruciate ligament tears - assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: - abnormality of tendons or bursae about the knee; or - meniscal cyst, popliteal fossa cyst, mass or pseudomass; or - nerve entrapment, nerve or nerve sheath tumour; or - injury of collateral ligaments.(R)
55829	01JUL2011	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: - meniscal and cruciate ligament tears - assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: - abnormality of tendons or bursae about the knee; or - meniscal cyst, popliteal fossa cyst, mass or pseudomass; or - nerve entrapment, nerve or nerve sheath tumour; or - injury of collateral ligaments (R) (NK)
55830	01NOV2000	31OCT2001	N	KNEE, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55830	01NOV2001	30APR2003	N	KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55830	01MAY2003	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: - meniscal and cruciate ligament tears - assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: - abnormality of tendons or bursae about the knee; or - meniscal cyst, popliteal fossa cyst, mass or pseudomass; or - nerve entrapment, nerve or nerve sheath tumour; or - injury of collateral ligaments.(NR)
55831	01JUL2011	31DEC9999	Y	Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: - meniscal and cruciate ligament tears - assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: - abnormality of tendons or bursae about the knee; or - meniscal cyst, popliteal fossa cyst, mass or pseudomass; or - nerve entrapment, nerve or nerve sheath tumour; or - injury of collateral ligaments (NR) (NK)
55832	01NOV2000	31OCT2001	N	LOWER LEG, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55832	01NOV2001	31DEC9999	Y	LOWER LEG, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55833	01JUL2011	31DEC9999	Y	LOWER LEG, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55834	01NOV2000	31OCT2001	N	LOWER LEG, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55834	01NOV2001	31DEC9999	Y	LOWER LEG, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55835	01JUL2011	31DEC9999	Y	LOWER LEG, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55836	01NOV2000	31OCT2001	N	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where (a) the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55836	01NOV2001	31OCT2013	N	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a) the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55836	01NOV2013	31DEC9999	Y	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55837	01JUL2011	31DEC9999	Y	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a) the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55838	01NOV2000	31OCT2001	N	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55838	01NOV2001	31DEC9999	Y	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55839	01JUL2011	31DEC9999	Y	ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55840	01NOV2000	31OCT2001	N	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55840	01NOV2001	31DEC9999	Y	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55841	01JUL2011	31DEC9999	Y	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55842	01NOV2000	31OCT2001	N	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55842	01NOV2001	31DEC9999	Y	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55843	01JUL2011	31DEC9999	Y	MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55844	01NOV2000	31OCT2001	N	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55844	01NOV2001	30APR2020	N	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55844	01MAY2020	31DEC9999	Y	Assessment of a mass associated with the skin or subcutaneous structures, not being a part of the musculoskeletal system, one or more areas, ultrasound scan of (R)
55845	01JUL2011	31DEC9999	Y	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55846	01NOV2000	31OCT2001	N	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55846	01NOV2001	30APR2020	N	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR)
55846	01MAY2020	31DEC9999	Y	Assessment of a mass associated with the skin or subcutaneous structures, not being a part of the musculoskeletal system, one or more areas, ultrasound scan of (NR)
55847	01JUL2011	31DEC9999	Y	ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the patient is not referred by a medical practitioner (NR) (NK)
55848	01NOV2000	30APR2020	N	MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this group applies, and not performed in conjunction with item 55054 (R)
55848	01MAY2020	31DEC9999	Y	Musculoskeletal ultrasound, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this group applies, and not performed in conjunction with a service mentioned in item 55054 (R)
55849	01JUL2011	31DEC9999	Y	MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this group applies, and not performed in conjunction with item 55054 or 55026 (R) (NK)
55850	01NOV2000	31OCT2001	N	MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a) the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b) the service is not performed in conjunction with items 55054, or 55800 to 55848, and (c) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55850	01NOV2001	30APR2020	N	MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a) the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b) the service is not performed in conjunction with items 55054, or 55800 to 55848, and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55850	01MAY2020	31DEC9999	Y	Musculoskeletal ultrasound, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, if:(a) the medical practitioner or nurse practitioner has indicated on a request for a musculoskeletal ultrasound that an ultrasound guided intervention be performed if clinically indicated; and(b) the service is not performed in conjunction with a service mentioned in item 55054 or any other item in this Subgroup (R)
55851	01JUL2011	31DEC9999	Y	MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a) the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b) the service is not performed in conjunction with items 55026, 55054, or 55800 to 55849, and (c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55852	01MAY2001	31OCT2001	N	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, performed by or on behalf of a medical practitioner, where: a) the patient is referred by a medical practitioner b) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R)
55852	01NOV2001	31OCT2011	N	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a) the patient is referred by a medical practitioner b) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55852	01NOV2011	30APR2020	N	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a) the patient is referred by a referring practitioner b) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R)
55852	01MAY2020	31DEC9999	Y	Paediatric spine, spinal cord and overlying subcutaneous tissues, ultrasound scan of (R)
55853	01JUL2011	31DEC9999	Y	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a) the patient is referred by a medical practitioner b) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK)
55854	01MAY2001	31OCT2001	N	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, performed by or on behalf of a medical practitioner, where: a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and b) the patient is not referred by a medical practitioner (NR)
55854	01NOV2001	30APR2020	N	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and b) the patient is not referred by a medical practitioner (NR)
55854	01MAY2020	31DEC9999	Y	Paediatric spine, spinal cord and overlying subcutaneous tissues, ultrasound scan of (NR)
55855	01JUL2011	31DEC9999	Y	PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a) the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and b) the patient is not referred by a medical practitioner (NR) (NK)
55856	01MAY2020	31DEC9999	Y	Hand or wrist or both, left or right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55858 (R)
55857	01MAY2020	31DEC9999	Y	Hand or wrist, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55859 (NR)
55858	01MAY2020	31DEC9999	Y	Hand or wrist, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55856 (R)
55859	01MAY2020	31DEC9999	Y	Hand or wrist, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55857 (NR)
55860	01MAY2020	31DEC9999	Y	Forearm or elbow, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55862 (R)
55861	01MAY2020	31DEC9999	Y	Forearm or elbow, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55863 (NR)
55862	01MAY2020	31DEC9999	Y	Forearm or elbow, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55860 (R)
55863	01MAY2020	31DEC9999	Y	Forearm or elbow, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55861 (NR)
55864	01MAY2020	31DEC9999	Y	Shoulder or upper arm, or both, left or right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) an injury to a muscle, tendon or muscle/tendon junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult fracture;(vii) acromioclavicular joint pathology; and(b) the service is not performed in conjunction with a service mentioned in item 55866 (R)
55865	01MAY2020	31DEC9999	Y	Shoulder or upper arm, or both, left or right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) an injury to a muscle, tendon or muscle/tendon junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult fracture;(vii) acromioclavicular joint pathology; and(b) the service is not performed in conjunction with a service mentioned in item 55867 (NR)
55866	01MAY2020	31DEC9999	Y	Shoulder or upper arm, or both, left and right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) an injury to a muscle, tendon or muscle/tendon junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult fracture;(vii) acromioclavicular joint pathology; and(b) the service is not performed in conjunction with a service mentioned in item 55864 (R)
55867	01MAY2020	31DEC9999	Y	Shoulder or upper arm, or both, left and right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) an injury to a muscle, tendon or muscle/tendon junction;(ii) rotator cuff tear, calcification or tendinosis (biceps, subscapular, supraspinatus or infraspinatus);(iii) biceps subluxation;(iv) capsulitis and bursitis;(v) a mass, including a ganglion;(vi) an occult fracture;(vii) acromioclavicular joint pathology; and(b) the service is not performed in conjunction with a service mentioned in item 55865 (NR)
55868	01MAY2020	31DEC9999	Y	Hip or groin, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55870 (R)
55869	01MAY2020	31DEC9999	Y	Hip or groin, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55871 (NR)
55870	01MAY2020	31DEC9999	Y	Hip or groin, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55868 (R)
55871	01MAY2020	31DEC9999	Y	Hip or groin, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with a service mentioned in item 55869 (NR)
55872	01MAY2020	31DEC9999	Y	Paediatric hip examination for dysplasia, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55874 (R)
55873	01MAY2020	31DEC9999	Y	Paediatric hip examination for dysplasia, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55875 (NR)
55874	01MAY2020	31DEC9999	Y	Paediatric hip examination for dysplasia, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55872 (R)
55875	01MAY2020	31DEC9999	Y	Paediatric hip examination for dysplasia, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55873 (NR)
55876	01MAY2020	31DEC9999	Y	Buttock or thigh, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55878 (R)
55877	01MAY2020	31DEC9999	Y	Buttock or thigh or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55879 (NR)
55878	01MAY2020	31DEC9999	Y	Buttock or thigh, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55876 (R)
55879	01MAY2020	31DEC9999	Y	Buttock or thigh, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55877 (NR)
55880	01MAY2020	31DEC9999	Y	Knee, left or right, ultrasound scan of, if: (a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve or nerve sheath tumour;(iv) an injury of collateral ligaments; and (b) the service is not performed in conjunction with item 55882 (R)
55881	01MAY2020	31DEC9999	Y	Knee, left or right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions: (i) abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the service is not performed in conjunction with item 55883 (NR)
55882	01MAY2020	31DEC9999	Y	Knee, left and right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions:(i) abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the service is not performed in conjunction with a service mentioned in item 55880 (R)
55883	01MAY2020	31DEC9999	Y	Knee, left and right, ultrasound scan of, if:(a) the service is used for the assessment of one or more of the following suspected or known conditions: (i) abnormality of tendons or bursae about the knee;(ii) a meniscal cyst, popliteal fossa cyst, mass or pseudomass;(iii) a nerve entrapment or a nerve or nerve sheath tumour;(iv) an injury of collateral ligaments; and(b) the service is not performed in conjunction with item 55881 (NR)
55884	01MAY2020	31DEC9999	Y	Lower leg, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55886 (R)
55885	01MAY2020	31DEC9999	Y	Lower leg, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55887 (NR)
55886	01MAY2020	31DEC9999	Y	Lower leg, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55884 (R)
55887	01MAY2020	31DEC9999	Y	Lower leg, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55885 (NR)
55888	01MAY2020	31DEC9999	Y	Ankle or hind foot, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55890 (R)
55889	01MAY2020	31DEC9999	Y	Ankle or hind foot, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55891 (NR)
55890	01MAY2020	31DEC9999	Y	Ankle or hind foot, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55888 (R)
55891	01MAY2020	31DEC9999	Y	Ankle or hind foot, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55889 (NR)
55892	01MAY2020	31DEC9999	Y	Mid foot or fore foot, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55894 (R)
55893	01MAY2020	31DEC9999	Y	Mid foot or fore foot, or both, left or right, ultrasound scan of, if the service is not performed in conjunction with item 55895 (NR)
55894	01MAY2020	31DEC9999	Y	Mid foot or fore foot, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55892 (R)
55895	01MAY2020	31DEC9999	Y	Mid foot or fore foot, or both, left and right, ultrasound scan of, if the service is not performed in conjunction with item 55893 (NR)
56000	01DEC1991	31DEC9999	Y	Computerised tomography - scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (not covered by item 57000 or 57100) (R) (A)
56001	01NOV1996	28FEB1999	N	HEAD COMPUTERISED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R)
56001	01MAR1999	30JUN2018	N	HEAD COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) (K) (Anaes.)
56001	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) (K) (Anaes.)
56001	01MAY2020	31DEC9999	Y	Computed tomography-scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) (Anaes.)
56003	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF BRAIN with or without scan of internal auditory meatus with intravenous contrast medium (not being a service to which item 57003 or 57103 applies) (R)
56006	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF BRAIN with or without scan of internal auditory meatus without intravenous contrast medium (minimum of 8 slices) with intravenous contrast medium (not being a service to which item 57006 or 57106 applies) (R)
56007	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R)
56007	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R)
56007	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R) (K) (Anaes.)
56007	01MAY2020	31DEC9999	Y	Computed tomography-scan of brain with intravenous contrast medium and with any scans of the brain before intravenous contrast injection, when performed, not being a service to which item 57007 applies (R) (Anaes.)
56009	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF PITUITARY FOSSA by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R)
56010	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R)
56010	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K) (Anaes.)
56010	01MAY2020	31DEC9999	Y	Computed tomography-scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when performed (R) (Anaes.)
56012	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF ORBITS by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R)
56013	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R)
56013	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K) (Anaes.)
56013	01MAY2020	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) (Anaes.)
56015	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF MIDDLE EAR AND TEMPORAL BONE, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R)
56016	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R)
56016	01MAR1999	31JAN2000	N	COMPUTED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K)
56016	01FEB2000	30APR2020	N	COMPUTED TOMOGRAPHY - scan of petrous bones in axial and coronal planes in 1 mm or 2 mm sections, with or without intravenous contrast medium, with or without scan of brain (R) (K) (Anaes.)
56016	01MAY2020	31DEC9999	Y	Computed tomography-scan of petrous bones in axial and coronal planes in 1 mm or 2 mm sections, with or without intravenous contrast medium, with or without scan of brain (R) (Anaes.)
56018	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF TEMPORAL BONES WITH AIR STUDY (including reconstructions), including intrathecal injection, but not including an associated brain scan (R)
56019	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of temporal bones with air study (including reconstructions), with intrathecal injection but not including an associated brain scan (R)
56019	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of temporal bones with air study (including reconstructions), with intrathecal injection but not including an associated brain scan (R) (K)
56021	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF FACIAL BONES, sinuses and salivary glands scan of 1 or more regions without intravenous contrast medium (R)
56022	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R)
56022	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) (K) (Anaes.)
56022	01MAY2020	31DEC9999	Y	Computed tomography-scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) (Anaes.)
56024	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF FACIAL BONES, sinuses and salivary glands scan of 1 or more regions with intravenous contrast medium (R)
56025	01JUL2011	31DEC9999	Y	CONE BEAM COMPUTED TOMOGRAPHY of teeth and supporting bone structures (R) (K)
56026	01JUL2011	31DEC9999	Y	CONE BEAM COMPUTED TOMOGRAPHY of teeth and supporting bone structures (R) (NK)
56027	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF FACIAL BONES, sinuses and salivary glands scan of 1 or more regions without and with intravenous contrast medium (R)
56028	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken (R)
56028	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R)
56028	01MAR1999	31OCT2001	N	COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (K)
56028	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (K) (Anaes.)
56028	01MAY2020	31DEC9999	Y	Computed tomography-scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both before intravenous contrast injection, when performed (R) (Anaes.)
56030	01FEB2000	30APR2020	N	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (K) (Anaes.)
56030	01MAY2020	31DEC9999	Y	Computed tomography-scan of facial bones, para nasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (Anaes.)
56033	01FEB2000	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (NK)
56036	01FEB2000	30APR2020	N	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a) a scan without intravenous contrast medium has been undertaken; and (b) the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (K) (Anaes.)
56036	01MAY2020	31DEC9999	Y	Computed tomography-scan of facial bones, para nasal sinuses or both, with scan of brain, with intravenous contrast medium, if:(a) a scan without intravenous contrast medium has been performed; and(b) the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (Anaes.)
56039	01FEB2000	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a) a scan without intravenous contrast medium has been undertaken; and (b) the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (NK)
56041	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57041 applies (R) (NK) (Anaes.)
56047	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57047 applies (R) (NK) (Anaes.)
56050	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK) (Anaes.)
56053	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK) (Anaes.)
56056	01MAR1999	31JAN2000	N	COMPUTED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK)
56056	01FEB2000	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of petrous bones in axial and coronal planes in 1 mm or 2 mm sections, with or without intravenous contrast medium, with or without scan of brain (R) (NK) (Anaes.)
56059	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of temporal bone, with air study (including reconstructions) with intrathecal injection but not including an associated brain scan (R) (NK)
56062	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) (NK) (Anaes.)
56068	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (NK) (Anaes.)
56070	01MAY2000	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (NK) (Anaes.)
56076	01MAY2000	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a) a scan without intravenous contrast medium has been undertaken; and (b) the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (NK) (Anaes.)
56100	01DEC1991	31DEC9999	Y	NECK COMPUTERISED TOMOGRAPHY SCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine) scan of 1 or more regions without intravenous contrast medium (not being a service to which item 56900 applies) (R)
56101	01NOV1996	28FEB1999	N	NECK COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R)
56101	01MAR1999	30JUN2018	N	NECK COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) (K) (Anaes.)
56101	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) (K) (Anaes.)
56101	01MAY2020	31DEC9999	Y	Computed tomography-scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) (Anaes.)
56103	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine) scan of 1 or more regions with intravenous contrast medium (not being a service to which item 56903 applies) (R)
56106	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine) scan of 1 or more regions without and with intravenous contrast medium (not being a service to which item 56906 applies) (R)
56107	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken, not being a service to which item 56807 applies (R)
56107	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56807 applies (R)
56107	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56807 applies (R) (K) (Anaes.)
56107	01MAY2020	31DEC9999	Y	Computed tomography-scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine)-with intravenous contrast medium and with any scans of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) before intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56807 applies (R) (Anaes.)
56141	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56841 applies (R) (NK) (Anaes.)
56147	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56847 applies (R) (NK) (Anaes.)
56200	01DEC1991	31DEC9999	Y	SPINE COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 25 slices or less without intravenous contrast medium (R)
56203	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 25 slices or less with intravenous contrast medium (R)
56206	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 25 slices or less without and with intravenous contrast medium (R)
56209	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 26 or more slices without intravenous contrast medium (R)
56210	01NOV1996	31OCT1997	N	SPINE COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56210	01NOV1997	28FEB1999	N	SPINE COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R)
56210	01MAR1999	31DEC9999	Y	SPINE COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56212	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 26 or more slices with intravenous contrast medium (R)
56215	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions, 26 or more slices without and with intravenous contrast medium (R)
56216	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56216	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56216	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56218	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF SPINE, 1 or more regions with intrathecal contrast medium, not including the preparation by intrathecal injection of contrast medium (R)
56219	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724, 59727 or 59730 applies and not in association with item 60957 (R)
56219	01MAR1999	30JUN2018	N	SPINE COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (K) (Anaes.)
56219	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (K) (Anaes.)
56219	01MAY2020	31OCT2023	N	Computed tomography-scan of spine, one or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X rays, not being a service to which item 59724 or 59275 applies (R) (Anaes.)
56219	01NOV2023	31DEC9999	Y	Computed tomography-scan of spine, one or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X rays, not being a service to which item 59724 applies (R)
56220	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, cervical region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56220	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, cervical region, without intravenous contrast medium (R) (Anaes.)
56221	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, thoracic region, without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56221	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, thoracic region, without intravenous contrast medium (R) (Anaes.)
56223	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56223	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, lumbosacral region, without intravenous contrast medium (R) (Anaes.)
56224	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, cervical region, with intravenous contrast medium and with any scans of the cervical region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56224	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, cervical region, with intravenous contrast medium and with any scans of the cervical region of the spine before intravenous contrast injection when undertaken (R) (Anaes.)
56225	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, thoracic region, with intravenous contrast medium and with any scans of the thoracic region of the spine prior to intravenous contrast injection when undertaken, only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56225	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, thoracic region, with intravenous contrast medium and with any scans of the thoracic region of the spine before intravenous contrast injection when undertaken (R) (Anaes.)
56226	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, with intravenous contrast medium and with any scans of the lumbosacral region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56226	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, lumbosacral region, with intravenous contrast medium and with any scans of the lumbosacral region of the spine prior to intravenous contrast injection when undertaken (R) (Anaes.)
56227	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, cervical region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56228	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, thoracic region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56229	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56230	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, cervical region, with intravenous contrast medium, and with any scans to the cerival region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56231	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, thoracic region, with intravenous contrast medium and with any scans of the thoracic region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56232	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, with intravenous contrast medium and with any scans of the lumbosacral region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56233	01NOV2001	30APR2020	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56220, 56221 and 56223 without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56233	01MAY2020	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Computed tomography-scan of spine, 2 examinations of the kind referred to in items 56220, 56221 and 56223, without intravenous contrast medium (R) (Anaes.)
56234	01NOV2001	30APR2020	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56224, 56225 and 56226 with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56234	01MAY2020	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Computed tomography-scan of spine, 2 examinations of the kind referred to in items 56224, 56225 and 56226, with intravenous contrast medium and with any scans of these regions of the spine before intravenous contrast injection when undertaken (R) (Anaes.)
56235	01NOV2001	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56227, 56228 and 56229 without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56236	01NOV2001	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56230, 56231 and 56232 with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56237	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56237	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, 3 regions cervical, thoracic and lumbosacral, without intravenous contrast medium (R) (Anaes.)
56238	01NOV2001	30APR2020	N	COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit, payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56238	01MAY2020	31DEC9999	Y	Computed tomography-scan of spine, 3 regions, cervical, thoracic and lumbosacral, with intravenous contrast medium and with any scans of these regions of the spine before intravenous contrast injection when undertaken (R) (Anaes.)
56239	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56240	01NOV2001	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit, payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56250	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56256	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56259	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (NK) (Anaes.)
56300	01DEC1991	31DEC9999	Y	CHEST COMPUTERISED TOMOGRAPHY SCAN OF CHEST, including lungs, mediastinum and pleura, without intravenous contrast medium (not being a service to which item 56700, 56800, 56900, 57000 or 57100 applies) (R)
56301	01NOV1996	28FEB1999	N	CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R)
56301	01MAR1999	30APR2006	N	CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.)
56301	01MAY2006	30JUN2018	N	CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56301	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56301	01MAY2020	31DEC9999	Y	Computed tomography-scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
56303	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST, including lungs, mediastinum and pleura, with intravenous contrast medium (not being a service to which item 56703, 56803, 56903, 57003 or 57103 applies) (R)
56306	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST, including lungs, mediastinum and pleura, without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906, 57006 or 57106 applies) (R)
56307	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken, not being a service to which item 56807 or 57007 applies (R)
56307	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R)
56307	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies and not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.)
56307	01MAY2006	30APR2020	N	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56307	01MAY2020	31DEC9999	Y	Computed tomography-scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest, including lungs, mediastinum, chest wall or pleura and upper abdomen before intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
56341	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56841 or 57041 applies and not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.)
56341	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56841 or 57041 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
56347	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies and not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.)
56347	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
56400	01DEC1991	31DEC9999	Y	UPPER ABDOMEN COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (not being a service to which item 56700, 56800, 56900 or 57100 applies) (R)
56401	01NOV1996	28FEB1999	N	UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R)
56401	01MAR1999	30JUN2018	N	UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) (K) (Anaes.)
56401	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) (K) (Anaes.)
56401	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) (Anaes.)
56403	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not being a service to which item 56703, 56803, 56903 or 57103 applies) (R)
56406	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906 or 57106 applies) (R)
56407	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R)
56407	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R)
56407	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R) (K) (Anaes.)
56407	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper abdomen only (diaphragm to iliac crest), with intravenous contrast medium, and with any scans of upper abdomen (diaphragm to iliac crest) before intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R) (Anaes.)
56409	01NOV1996	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium not being a service associated with a service to which item 56401 applies (R)
56409	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium not being a service associated with a service to which item 56401 applies (R) (K) (Anaes.)
56409	01MAY2020	31DEC9999	Y	Computed tomography-scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium not being a service associated with a service to which item 56401 applies (R) (Anaes.)
56412	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis), with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R)
56412	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis), with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R)
56412	01MAR1999	30APR2020	N	COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R) (K) (Anaes.)
56412	01MAY2020	31DEC9999	Y	Computed tomography-scan of pelvis only (iliac crest to pubic symphysis), with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) before intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R) (Anaes.)
56441	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), without intravenous contrast medium, not being a service to which item 56341, 56541, 56841 or 57041 applies (R) (NK) (Anaes.)
56447	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) with intravenous contrast medium, and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56347, 56547, 56847 or 57047 applies (R) (NK) (Anaes.)
56449	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium, not being a service to which item 56441 applies (R) (NK) (Anaes.)
56452	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) with intravenous contrast medium, and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56447 applies (R) (NK) (Anaes.)
56500	01DEC1991	31DEC9999	Y	UPPER ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (not being a service to which item 56700, 56800, 56900 or 57100 applies) (R)
56501	01NOV1996	28FEB1999	N	UPPER ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R)
56501	01MAR1999	30APR2004	N	UPPER ABDOMEN AND PELVIS COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.)
56501	01MAY2004	30JUN2018	N	UPPER ABDOMEN AND PELVIS COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.)
56501	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.)
56501	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy and not being a service to which item 56801 or 57001 applies(R) (Anaes.)
56503	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN AND PELVIS with intravenous contrast medium (not being a service to which item 56703, 56803, 56903 or 57103 applies) (R)
56506	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906 or 57106 applies) (R)
56507	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R)
56507	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R)
56507	01MAR1999	30APR2004	N	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R) (K) (Anaes.)
56507	01MAY2004	30APR2020	N	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not for the purposes of virtual colonoscopy, not being a service to which item 56807 or 57007 applies (R) (K) (Anaes.)
56507	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis before intravenous contrast injection, when performed, not for the purposes of virtual colonoscopy and not being a service to which item 56807 or 57007 applies (R) (Anaes.)
56541	01MAR1999	30APR2004	N	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56841 or 57041 applies (R) (NK) (Anaes.)
56541	01MAY2004	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56841 or 57041 applies (R) (NK) (Anaes.)
56547	01MAR1999	30APR2004	N	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium, and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies (R) (NK) (Anaes.)
56547	01MAY2004	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium, and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not for the purposes of virtual colonoscopy, not being a service to which item 56847 or 57047 applies (R) (NK) (Anaes.)
56549	01MAY2005	31DEC9999	Y	COMPUTED TOMOGRAPHY OF COLON, following incomplete colonoscopy in the preceding 3 months, where the patient is referred by the specialist or consultant physician who performed the incomplete colonoscopy, not being a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K)
56551	01MAY2005	31DEC9999	Y	COMPUTED TOMOGRAPHY OF COLON, where the patient is referred by a specialist or consultant physician and where (a) one of the following conditions is present: (i) fistulous disease (ii) obstructed colon (iii) megacolon and where (b) the request specifies the condition; not being a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K)
56552	01JUL2007	31DEC9999	Y	COMPUTED TOMOGRAPHY OF COLON for exclusion of colorectal neoplasia in symptomatic or high risk patients if: (a) the patient has had an incomplete colonoscopy in the 3 months before the scan; and (b) the date of incomplete colonoscopy is set out on the request for scan; and (c) the service is not a service to which items 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K)
56553	01SEP2015	30APR2020	N	Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if: (a) one [or more] of the following applies: (i) the patient has had an incomplete colonoscopy in the 3 months before the scan; (ii) there is a high-grade colonic obstruction; (iii) the patient is referred by a specialist or consultant physician who performs colonoscopies [in the practice of his or her speciality]; and (b) the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies; and (c) the service has not been performed on the patient in the 36 months before the scan (R) (K) (Anaes.)
56553	01MAY2020	31OCT2021	N	Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if:(a) one or more of the following applies:(i) the patient has had an incomplete colonoscopy in the 3 months before the scan;(ii) there is a high grade colonic obstruction;(iii) the service is requested by a specialist or consultant physician who performs colonoscopies in the practice of the specialists or consultant physicians speciality; and(b) the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies; and(c) the service has not been performed on the patient in the 36 months before the scan (R) (Anaes.)
56553	01NOV2021	31DEC9999	Y	Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if:(a) one or more of the following applies:(i) the patient has had an incomplete colonoscopy in the 3 months before the scan;(ii) there is a high grade colonic obstruction;(iii) the service is requested by a specialist or consultant physician who performs colonoscopies in the practice of the specialists or consultant physicians speciality; and(b) the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R)
56554	01JUL2007	31DEC9999	Y	COMPUTED TOMOGRAPHY OF COLON for exclusion of colorectal neoplasia in symptomatic or high risk patients if: (a) the request for scan states that one of the following contraindications to colonoscopy is present: (i) suspected perforation of the colon; (ii) complete or high-grade obstruction that will not allow passage of the scope; and (b) the service must not be a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K)
56555	01SEP2015	31DEC9999	Y	Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if: (a) one [or more] of the following applies: (i) the patient has had an incomplete colonoscopy in the 3 months before the scan; (ii) there is a high-grade colonic obstruction; (iii) the patient is referred by a specialist or consultant physician who performs colonoscopies [in the practice of his or her speciality]; and (b) the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies; and (c) the service has not been performed on the patient in the 36 months before the scan (R) (NK) (Anaes.)
56600	01DEC1991	31DEC9999	Y	EXTREMITIES COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices without intravenous contrast medium (R)
56603	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices with intravenous contrast medium (R)
56606	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices without and with intravenous contrast medium (R)
56609	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices without intravenous contrast medium (R)
56612	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices with intravenous contrast medium (R)
56615	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium (R)
56618	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices without intravenous contrast medium (R)
56619	01NOV1996	31OCT1997	N	EXTREMITIES COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56619	01NOV1997	28FEB1999	N	EXTREMITIES COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R)
56619	01MAR1999	30JUN2018	N	EXTREMITIES COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56619	01JUL2018	31OCT2018	N	COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56619	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), without intravenous contrast medium. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56620, 56626, 56660 or 56666 apply (R) (K) (Anaes.)
56620	01NOV2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of knee, without intravenous contrast medium. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56619, 56625, 56659 or 56665 apply (R) (K) (Anaes.)
56620	01MAY2020	31DEC9999	Y	Computed tomography-scan of knee, without intravenous contrast medium, not being a service to which item 56622 or 56629 applies (R) (Anaes.)
56621	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices with intravenous contrast medium (R)
56622	01MAY2020	31DEC9999	Y	Computed tomography-scan of lower limb, left or right or both, one region (other than knee), or more than one region (which may include knee), without intravenous contrast medium, not being a service to which item 56620 applies (R) (Anaes.)
56623	01MAY2020	31DEC9999	Y	Computed tomography-scan of lower limb, left or right or both, one region (other than knee), or more than one region (which may include knee), with intravenous contrast medium and with any scans of the lower limb before intravenous contrast injection, when performed, not being a service to which item 56626 applies (R) (Anaes.)
56624	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices without and with intravenous contrast medium (R)
56625	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56625	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R)
56625	01MAR1999	31OCT2018	N	COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.)
56625	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), with intravenous contrast medium and with any scans of extremities before intravenous contrast injection, when performed. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56620, 56626, 56660 or 56666 apply. (R) (K) (Anaes.)
56626	01NOV2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of the knee, with intravenous contrast medium and with any scans of the knee prior to intravenous contrast injection, when undertaken. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56619, 56625, 56659 or 56665 apply (R) (K) (Anaes.).
56626	01MAY2020	31DEC9999	Y	Computed tomography-scan of knee, with intravenous contrast medium and with any scans of the knee before intravenous contrast injection, when performed, not being a service to which items 56623 or 56630 apply (R) (Anaes.)
56627	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper limb, left or right or both, any one region, or more than one region, without intravenous contrast medium (R) (Anaes.)
56628	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper limb, left or right or both, any one region, or more than one region, with intravenous contrast medium and with any scans of the upper limb before intravenous contrast injection, when performed (R) (Anaes.)
56629	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper limb and lower limb, left or right or both, any one region (other than knee), or more than one region (which may include knee) without intravenous contrast medium not being a service to which item 56620 applies (R) (Anaes.)
56630	01MAY2020	31DEC9999	Y	Computed tomography-scan of upper limb and lower limb, left or right or both, any one region (other than knee), or more than one region (which may include knee) with intravenous contrast medium with any scans of the limbs before intravenous contrast injection, when performed, not being a service to which item 56626 applies (R)
56659	01MAR1999	31OCT2018	N	COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete (R) (NK) (Anaes.)
56659	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), without intravenous contrast medium. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56620, 56626, 56660 or 56666 apply (R) (NK) (Anaes.).
56660	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of the knee, without intravenous contrast medium. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56619, 56625, 56659 or 56665 apply (R) (NK) (Anaes.)
56665	01MAR1999	31OCT2018	N	COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium, and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.)
56665	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), with intravenous contrast medium and with any scans of extremities before intravenous contrast injection, when performed. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56620, 56626, 56660 or 56666 apply (R) (NK) (Anaes.).
56666	01NOV2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of knee, with intravenous contrast medium, and with any scans of the knee prior to intravenous contrast injection, when performed. Payable once only whether one or more attendances are required to complete the service, not being a service to which any of items 56619, 56625, 56659 or 56665 apply (R) (NK) (Anaes.)
56700	01DEC1991	31DEC9999	Y	CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without intravenous contrast medium (not being a service to which item 56800, 56900 or 57100 applies) (R)
56703	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) with intravenous contrast medium (not being a service to which item 56803, 56903 or 57103 applies) (R)
56706	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without and with intravenous contrast medium (not being a service to which item 56806, 56906 or 57106 applies) (R)
56800	01DEC1991	31DEC9999	Y	CHEST, ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHY SCAN OF CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (not being a service to which item 56900 applies) (R)
56801	01NOV1996	28FEB1999	N	CHEST, ABDOMEN, PELVIS AND NECK COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium (R)
56801	01MAR1999	30APR2006	N	CHEST, ABDOMEN, PELVIS AND NECK COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.)
56801	01MAY2006	30JUN2018	N	CHEST, ABDOMEN, PELVIS AND NECK COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56801	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56801	01MAY2020	31DEC9999	Y	Computed tomography-scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
56803	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (not being a service to which item 56903 applies) (R)
56806	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium (not being a service to which item 56906 applies) (R)
56807	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken (R)
56807	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken (R)
56807	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.)
56807	01MAY2006	30APR2020	N	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
56807	01MAY2020	31DEC9999	Y	Computed tomography-scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck before intravenous contrast injection, when performed, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
56841	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.)
56841	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
56847	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.)
56847	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
56900	01DEC1991	31DEC9999	Y	NECK, CHEST, ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHY SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (R)
56903	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF NECK, CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (R)
56906	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium (R)
57000	01DEC1991	31DEC9999	Y	BRAIN AND CHEST COMPUTERISED TOMOGRAPHY SCAN OF BRAIN AND CHEST without intravenous contrast medium (R)
57001	01NOV1996	28FEB1999	N	BRAIN, CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium (R)
57001	01MAR1999	30APR2006	N	BRAIN, CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.)
57001	01MAY2006	30JUN2018	N	BRAIN, CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
57001	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
57001	01MAY2020	31DEC9999	Y	Computed tomography-scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
57003	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF BRAIN AND CHEST with intravenous contrast medium (R)
57006	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF BRAIN AND CHEST without and with intravenous contrast medium (R)
57007	01NOV1996	31OCT1997	N	COMPUTERISED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans prior to intravenous contrast injwection, when undertaken (R)
57007	01NOV1997	28FEB1999	N	COMPUTERISED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken (R)
57007	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification(R) (K) (Anaes.)
57007	01MAY2006	30APR2020	N	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.)
57007	01MAY2020	31DEC9999	Y	Computed tomography-scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen before intravenous contrast injection, when performed, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (Anaes.)
57041	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification(R) (NK) (Anaes.)
57041	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
57047	01MAR1999	30APR2006	N	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification(R) (NK) (Anaes.)
57047	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.)
57100	01DEC1991	31DEC9999	Y	CHEST AND UPPER ABDOMEN AND BRAIN COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without intravenous contrast medium (R)
57103	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN with intravenous contrast medium (R)
57106	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without and with intravenous contrast medium (R)
57200	01DEC1991	31DEC9999	Y	PELVIMETRY COMPUTERISED TOMOGRAPHY PELVIMETRY (R)
57201	01NOV1996	28FEB1999	N	PELVIMETRY COMPUTERISED TOMOGRAPHY - PELVIMETRY (R)
57201	01MAR1999	30JUN2018	N	PELVIMETRY COMPUTED TOMOGRAPHY - PELVIMETRY (R) (K) (Anaes.)
57201	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY - PELVIMETRY (R) (K) (Anaes.)
57201	01MAY2020	31DEC9999	Y	Computed tomography-pelvimetry (R) (Anaes.)
57247	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY - PELVIMETRY (R) (NK) (Anaes.)
57300	01DEC1991	31DEC9999	Y	DYNAMIC SCAN OF REGION COMPUTERISED TOMOGRAPHY DYNAMIC SCAN OF REGION not being a service associated with a service to which another item in this Group applies (R)
57303	01DEC1991	31DEC9999	Y	COMPUTERISED TOMOGRAPHY DYNAMIC SCAN OF REGION being a service associated with a service to which another item in this Group applies (R)
57340	01NOV1992	31DEC9999	Y	INTERVENTIONAL TECHNIQUES COMPUTERISED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R)
57341	01NOV1996	28FEB1999	N	INTERVENTIONAL TECHNIQUES COMPUTERISED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R)
57341	01MAR1999	30JUN2018	N	INTERVENTIONAL TECHNIQUES COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (K) (Anaes.)
57341	01JUL2018	30APR2020	N	COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (K) (Anaes.)
57341	01MAY2020	31DEC2023	N	Computed tomography, in conjunction with a surgical procedure using interventional techniques (R) (Anaes.)
57341	01JAN2024	31DEC9999	Y	Computed tomography, in conjunction with a surgical procedure using interventional techniques (R)
57345	01MAR1999	31DEC9999	Y	COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (NK) (Anaes.)
57350	01NOV1996	28FEB1999	N	SPIRAL ANGIOGRAPHY COMPUTERISED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, including multiple projections, not being a service to which another item in this group applies (R)
57350	01MAR1999	31OCT2000	N	SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service is not performed on the same patient within 12 months (R) (K)
57350	01NOV2000	30APR2006	N	SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months (R) (K) (Anaes.)
57350	01MAY2006	30JUN2018	N	SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (K) (Anaes.)
57350	01JUL2018	31DEC9999	Y	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (K) (Anaes.)
57351	01NOV2001	30APR2006	N	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; acute ruptured aneurysm; or acute dissection of the aorta, carotid or vertebral artery; and (c) the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months. (R) (K) (Anaes.)
57351	01MAY2006	30APR2020	N	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; acute ruptured aneurysm; or acute dissection of the aorta, carotid or vertebral artery; and (c) the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (K) (Anaes.)
57351	01MAY2020	30JUN2020	N	Computed tomography-angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (a) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a general practitioner and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (b) the service is not a service to which another item in this group applies; and (c) the service is performed for the exclusion of acute or recurrent pulmonary embolism, acute symptomatic arterial occlusion, post-operative complication of arterial surgery, acute ruptured aneurysm, or acute dissection of the aorta, carotid or vertebral artery; and (d) a service to which item 57352, 57353 or 57354 applies has been performed on the same patient within the previous 12 months; and (e) the service is not a study performed to image the coronary arteries (R) (Anaes.)
57351	01JUL2020	30JUN2021	N	Computed tomography-angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of acute or recurrent pulmonary embolism, acute symptomatic arterial occlusion, post-operative complication of arterial surgery, acute ruptured aneurysm, or acute dissection of the aorta, carotid or vertebral artery; and (c) a service to which item 57352, 57353 or 57354 applies has been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R)
57351	01JUL2021	31DEC9999	Y	Computed tomography-angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of acute or recurrent pulmonary embolism, acute symptomatic arterial occlusion, post-operative complication of arterial surgery, acute ruptured aneurysm, or acute dissection of the aorta, carotid or vertebral artery; and (c) a service to which item 57352, 57353, 57354 or 57357 applies has been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R)
57352	01MAY2020	28FEB2021	N	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the arch of the aorta; or (b) the carotid arteries; or (c) the vertebral arteries and their branches (head and neck); including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (d) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a general practitioner and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (e) the service is not a service to which another item in this group applies; and (f) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (g) the service is not a study performed to image the coronary arteries (R) (Anaes.)
57352	01MAR2021	31DEC9999	Y	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the arch of the aorta; or (b) the carotid arteries; or (c) the vertebral arteries and their branches (head and neck); including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (d) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a medical practitioner (other than a specialist or consultant physician) and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (e) the service is not a service to which another item in this group applies; and (f) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (g) the service is not a study performed to image the coronary arteries (R)
57353	01MAY2020	28FEB2021	N	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the ascending and descending aorta; or (b) the common iliac and abdominal branches including upper limbs (chest, abdomen and upper limbs); including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (c) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a general practitioner and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (d) the service is not a service to which another item in this group applies; and (e) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (f) the service is not a study performed to image the coronary arteries (R) (Anaes.)
57353	01MAR2021	31DEC9999	Y	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the ascending and descending aorta; or (b) the common iliac and abdominal branches including upper limbs (chest, abdomen and upper limbs); including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (c) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a medical practitioner (other than a specialist or consultant physician) and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (d) the service is not a service to which another item in this group applies; and (e) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (f) the service is not a study performed to image the coronary arteries (R)
57354	01MAY2020	28FEB2021	N	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the descending aorta; or (b) the pelvic vessels (aorto-iliac segment) and lower limbs; including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (c) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a general practitioner and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (d) the service is not a service to which another item in this group applies; and (e) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (f) the service is not a study performed to image the coronary arteries (R) (Anaes.)
57354	01MAR2021	31DEC9999	Y	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of: (a) the descending aorta; or (b) the pelvic vessels (aorto-iliac segment) and lower limbs; including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: (c) either: (i) the service is requested by a specialist or consultant physician; or (ii) the service is requested by a medical practitioner (other than a specialist or consultant physician) and the request indicates that the patients case has been discussed with a specialist or consultant physician; and (d) the service is not a service to which another item in this group applies; and (e) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (f) the service is not a study performed to image the coronary arteries (R)
57355	01MAR1999	31OCT2000	N	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, including multiple projections, not being a service to which another item in this group applies (R) (NK)
57355	01NOV2000	30APR2006	N	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months (R) (NK) (Anaes.)
57355	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (NK) (Anaes.)
57356	01NOV2001	30APR2006	N	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: a) the service is not a service to which another item in this group applies; and b) the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; or acute ruptured aneurysm; acute dissection of the aorta, carotid or vertebral artery; and c) the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months. (R) (NK) (Anaes.)
57356	01MAY2006	31DEC9999	Y	COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: a) the service is not a service to which another item in this group applies; and b) the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; or acute ruptured aneurysm; acute dissection of the aorta, carotid or vertebral artery; and (c) the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (NK) (Anaes.)
57357	01NOV2020	31DEC9999	Y	Computed tomography-angiography with intravenous contrast medium of any or all, or any part, of the pulmonary arteries and their branches, including any scans performed before intravenous contrast injection-one or more data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy or digital recording of multiple projections, if: the service is not a service to which another item in this group applies; and the service is not a study performed to image the coronary arteries; and the service is:(i) performed for the exclusion of pulmonary arterial stenosis, occlusion, aneurysm or embolism and is requested by a specialist or consultant physician; or(ii) performed for the exclusion of pulmonary arterial stenosis, occlusion or aneurysm and is requested by a medical practitioner (other than a specialist or consultant physician) and the request indicates that the patients case has been discussed with a specialist or consultant physician; or (iii) for the exclusion of pulmonary embolism and is requested be a medical practitioner (other than a specialist or consultant physician) (R)
57360	01JUL2011	30APR2020	N	COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES performed on a minimum of a 64 slice (or equivalent) scanner, where the request is made by a specialist or consultant physician, and: a) the patient has stable symptoms consistent with coronary ischaemia, is at low to intermediate risk of coronary artery disease and would have been considered for coronary angiography; or b) the patient requires exclusion of coronary artery anomaly or fistula; or c) the patient will be undergoing non-coronary cardiac surgery (R) (K)
57360	01MAY2020	30JUN2021	N	Computed tomography of the coronary arteries performed on a minimum of a 64 slice (or equivalent) scanner if:(a) the request is made by a specialist or consultant physician; and(b) one of the following subparagraphs applies to the patient:(i) the patient has stable symptoms consistent with coronary ischaemia, is at low to intermediate risk of coronary artery disease and would have been considered for coronary angiography;(ii) the patient requires exclusion of coronary artery anomaly or fistula;(iii) the patient will be undergoing non coronary cardiac surgery (R)
57360	01JUL2021	31OCT2021	N	Computed tomography of the coronary arteries performed on a minimum of a 64 slice (or equivalent) scanner if: (a) the request is made by a specialist or consultant physician; and (b) for a patient not known to have coronary artery disease who: (i) has stable or acute symptoms consistent with coronary ischaemia; and (ii) is at low to intermediate risk of an acute coronary event, including having no significant cardiac biomarker elevation and no electrocardiogram changes indicating acute ischaema Applicable not more than once in a 5 year period (R)
57360	01NOV2021	31DEC9999	Y	Computed tomography of the coronary arteries performed on a minimum of a 64 slice (or equivalent) scanner if: (a) the request is made by a specialist or consultant physician; and (b) the patient has stable or acute symptoms consistent with coronary ischaemia; and (c) the patient is at low to intermediate risk of an acute coronary event, including having no significant cardiac biomarker elevation and no electrocardiogram changes indicating acute ischaemia (R) Note: See explanatory note IN.2.2 for claiming restrictions for this item.
57361	01JUL2011	31DEC9999	Y	COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES performed on a minimum of a 64 slice (or equivalent) scanner, where the request is made by a specialist or consultant physician, and: a) the patient has stable symptoms consistent with coronary ischaemia, is at low to intermediate risk of coronary artery disease and would have been considered for coronary angiography; or b) the patient requires exclusion of coronary artery anomaly or fistula; or c) the patient will be undergoing non-coronary cardiac surgery (R) (NK)
57362	01NOV2014	30APR2020	N	Dental & temporo-mandibular joint imaging for diagnosis and management of mandibular and dento-alveolar fractures, dental implant planning, orthodontics, endodontic, periodontal and temporo-mandibular joint conditions: without contrast medium. Restricted to requesting by dental specialists and medical practitioners and must be performed on equipment located in practices accredited under the Diagnostic Imaging Accreditation Scheme using dedicated (rather than hybrid) CBCT units. Claims for more than one CBCT per patient per day are excluded. Claiming with two-dimensional imaging in the same episode (items 57959-57969) and with CT in the same episode (items 56001-57361) are also excluded. (K)
57362	01MAY2020	31DEC9999	Y	Cone beam computed tomography-dental and temporo mandibular joint imaging (without contrast medium) for diagnosis and management of any of the following:(a) mandibular and dento alveolar fractures;(b) dental implant planning;(c) orthodontics;(d) endodontic conditions;(e) periodontal conditions;(f) temporo mandibular joint conditionsApplicable once per patient per day, not being for a service to which any of items 57960 to 57969 apply, and not being a service associated with another service in Group I2 (R) (Anaes.)
57363	01NOV2014	31DEC9999	Y	Dental & temporo-mandibular joint imaging for diagnosis and management of mandibular and dento-alveolar fractures, dental implant planning, orthodontics, endodontic, periodontal and temporo-mandibular joint conditions: without contrast medium. Restricted to requesting by dental specialists and medical practitioners and must be performed on equipment located in practices accredited under the Diagnostic Imaging Accreditation Scheme using dedicated (rather than hybrid) CBCT units. Claims for more than one CBCT per patient per day are excluded. Claiming with two-dimensional imaging in the same episode (items 57959-57969) and with CT in the same episode (items 56001-57361) are also excluded. (NK)
57364	01JUL2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: TR.8.3 (item 38247), TR.8.2 (item 38249) or item 38252 if subclause (iv) applies. Computed tomography of the coronary arteries performed on a minimum of a 64 slice (or equivalent) scanner, if: (a) the service is requested by a specialist or consultant physician; and (b) at least one of the following apply to the patient: (i) the patient has stable symptoms and newly recognised left ventricular systolic dysfunction of unknown aetiology; (ii) the patient requires exclusion of coronary artery anomaly or fistula; (iii) the patient will be undergoing non-coronary cardiac surgery; (iv) the patient meets the criteria to be eligible for a service to which item 38247, 38249 or 38252 applies, but as an alternative to selective coronary angiography will require an assessment of the patency of one or more bypass grafts (R)
57400	01DEC1991	31DEC9999	Y	Computerised tomography - scan of brain without intravenous contrast medium (R) (A)
57403	01DEC1991	31DEC9999	Y	THORACIC CAVITY, aspiration of, for diagnostic purposes, not associated with Item 6941 intravenous contrast medium (R) (A)
57406	01DEC1991	31DEC9999	Y	Computerised tomography - scan of brain without and with intravenous contrast medium (R) (A)
57500	01DEC1991	31DEC9999	Y	DIGITS OR PHALANGES - all or any of either hand or either foot (NR)
57503	01DEC1991	31DEC9999	Y	DIGITS OR PHALANGES - all or any of either hand or either foot (R)
57506	01DEC1991	31OCT1996	N	HAND, WRIST, FOREARM, ELBOW OR ARM (elbow to shoulder) (NR)
57506	01NOV1996	31OCT1997	N	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR)
57506	01NOV1997	30APR2020	N	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR)
57506	01MAY2020	31DEC9999	Y	Hand, wrist, forearm, elbow or humerus (NR)
57509	01DEC1991	31OCT1996	N	HAND, WRIST, FOREARM, ELBOW OR ARM (elbow to shoulder) (R)
57509	01NOV1996	31OCT1997	N	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R)
57509	01NOV1997	30APR2020	N	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R)
57509	01MAY2020	31DEC9999	Y	Hand, wrist, forearm, elbow or humerus (R)
57512	01DEC1991	31OCT1996	N	HAND, WRIST AND LOWER FOREARM OR UPPER FOREARM AND ELBOW OR ELBOW AND ARM (elbow to shoulder) (NR)
57512	01NOV1996	31OCT1997	N	HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (NR)
57512	01NOV1997	30APR2005	N	HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (NR)
57512	01MAY2005	30APR2020	N	HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (NR)
57512	01MAY2020	31DEC9999	Y	Hand and wrist, or hand, wrist and forearm, or forearm and elbow, or elbow and humerus (NR)
57515	01DEC1991	31OCT1996	N	HAND, WRIST AND LOWER FOREARM OR UPPER FOREARM AND ELBOW OR ELBOW AND ARM (elbow to shoulder) (R)
57515	01NOV1996	31OCT1997	N	HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (R)
57515	01NOV1997	30APR2005	N	HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (R)
57515	01MAY2005	30APR2020	N	HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (R)
57515	01MAY2020	31DEC9999	Y	Hand and wrist, or hand, wrist and forearm, or forearm and elbow, or elbow and humerus (R)
57518	01DEC1991	31OCT1996	N	FOOT, ANKLE, LOWER LEG, UPPER LEG, KNEE OR THIGH (femur) (NR)
57518	01NOV1996	31OCT1997	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (NR)
57518	01NOV1997	31OCT2018	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (NR)
57518	01NOV2018	30APR2020	N	FOOT, ANKLE, LEG, OR FEMUR (NR)(K)
57518	01MAY2020	31DEC9999	Y	Foot, ankle, leg or femur (NR)
57521	01DEC1991	31OCT1996	N	FOOT, ANKLE, LOWER LEG, UPPER LEG, KNEE OR THIGH (femur) (R)
57521	01NOV1996	31OCT1997	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (R)
57521	01NOV1997	31OCT2018	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (R)
57521	01NOV2018	30APR2020	N	FOOT, ANKLE, LEG, OR FEMUR (R)(K)
57521	01MAY2020	31DEC9999	Y	Foot, ankle, leg or femur (R)
57522	01NOV2018	30APR2020	N	Knee (NR)(K)
57522	01MAY2020	31DEC9999	Y	Knee (NR)
57523	01NOV2018	30APR2020	N	Knee (R)(K)
57523	01MAY2020	31DEC9999	Y	Knee (R)
57524	01DEC1991	31OCT1996	N	FOOT, ANKLE AND LOWER LEG OR UPPER LEG AND KNEE (NR)
57524	01NOV1996	31OCT1997	N	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR)
57524	01NOV1997	30APR2020	N	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR)
57524	01MAY2020	31DEC9999	Y	Foot and ankle, or ankle and leg, or leg and knee, or knee and femur (NR)
57527	01DEC1991	31OCT1996	N	FOOT, ANKLE AND LOWER LEG OR UPPER LEG AND KNEE (R)
57527	01NOV1996	31OCT1997	N	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R)
57527	01NOV1997	30APR2020	N	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R)
57527	01MAY2020	31DEC9999	Y	Foot and ankle, or ankle and leg, or leg and knee, or knee and femur (R)
57529	01JUL2011	31DEC9999	Y	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR) (NK)
57530	01JUL2011	31DEC9999	Y	HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R) (NK)
57532	01JUL2011	31DEC9999	Y	HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (NR) (NK)
57533	01JUL2011	31DEC9999	Y	HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (R) (NK)
57535	01JUL2011	31OCT2018	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (NR) (NK)
57535	01NOV2018	31DEC9999	Y	FOOT, ANKLE, LEG, OR FEMUR (NR) (NK)
57536	01JUL2011	31OCT2018	N	FOOT, ANKLE, LEG, KNEE OR FEMUR (R) (NK)
57536	01NOV2018	31DEC9999	Y	FOOT, ANKLE, LEG, OR FEMUR (R) (NK)
57537	01NOV2018	31DEC9999	Y	Knee (NR)(NK)
57538	01JUL2011	31DEC9999	Y	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR) (NK)
57539	01JUL2011	31DEC9999	Y	FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R) (NK)
57540	01NOV2018	31DEC9999	Y	Knee (R)(NK)
57541	01NOV2019	30JUN2021	N	Fee for a service rendered using first eligible x-ray procedure carried out during attendance at residential aged care facility, where the service has been requested by a medical practitioner who has attended the patient in person and the request identifies one or more of the following indications: the patient has experienced a fall and one or more of the following items apply to the service 57509, 57515, 57521, 57527, 57530, 57533, 57539, 57703, 57705, 57709, 57711, 57712, 57714, 57715, 57717, 58521, 58523, 58524, 58526, 58527, 58529, 57536; or pneumonia or heart failure is suspected and item 58503 or 58505 applies to the service; or acute abdomen or bowel obstruction is suspected and item 58903 or 58905 applies to the service. This call-out fee can be claimed once only per visit at a residential aged care facility irrespective of the number of patients attended. NOTE: If the service is bulked billed 95% of the fee is payable. The multiple services rule does not apply to this item. (R)
57541	01JUL2021	31DEC9999	Y	Fee for a service rendered using first eligible x-ray procedure carried out during attendance at residential aged care facility, where the service has been requested by a medical practitioner who has attended the patient in person and the request identifies one or more of the following indications: the patient has experienced a fall and one or more of the following items apply to the service 57509, 57515, 57521, 57527, 57703, 57709, 57712, 57715, 58521, 58524, 58527; or pneumonia or heart failure is suspected and item 58503 applies to the service; or acute abdomen or bowel obstruction is suspected and item 58903 applies to the service. This call-out fee can be claimed once only per visit at a residential aged care facility irrespective of the number of patients attended. NOTE: If the service is bulked billed 95% of the fee is payable. The multiple services rule does not apply to this item. (R)
57700	01DEC1991	30APR2020	N	SHOULDER OR SCAPULA (NR)
57700	01MAY2020	31DEC9999	Y	Shoulder or scapula (NR)
57702	01JUL2011	31DEC9999	Y	SHOULDER OR SCAPULA (NR) (NK)
57703	01DEC1991	30APR2020	N	SHOULDER OR SCAPULA (R)
57703	01MAY2020	31DEC9999	Y	Shoulder or scapula (R)
57705	01JUL2011	31DEC9999	Y	SHOULDER OR SCAPULA (R) (NK)
57706	01DEC1991	30APR2020	N	CLAVICLE (NR)
57706	01MAY2020	31DEC9999	Y	Clavicle (NR)
57708	01JUL2011	31DEC9999	Y	CLAVICLE (NR) (NK)
57709	01DEC1991	30APR2020	N	CLAVICLE (R)
57709	01MAY2020	31DEC9999	Y	Clavicle (R)
57711	01JUL2011	31DEC9999	Y	CLAVICLE (R) (NK)
57712	01DEC1991	30APR2020	N	HIP JOINT (R)
57712	01MAY2020	31DEC9999	Y	Hip joint (R)
57714	01JUL2011	31DEC9999	Y	HIP JOINT (R) (NK)
57715	01DEC1991	30APR2020	N	PELVIC GIRDLE (R)
57715	01MAY2020	31DEC9999	Y	Pelvic girdle (R)
57717	01JUL2011	31DEC9999	Y	PELVIC GIRDLE (R) (NK)
57718	01DEC1991	31DEC9999	Y	SACROILIAC JOINTS (R)
57721	01DEC1991	30APR2020	N	FEMUR, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (R)
57721	01MAY2020	31DEC9999	Y	Femur, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (R)
57723	01JUL2011	31DEC9999	Y	FEMUR, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (R) (NK)
57900	01DEC1991	31OCT1996	N	SKULL (calvarium) (R)
57900	01NOV1996	31DEC9999	Y	SKULL OR CEPHALOMETRY (R)
57901	01NOV1998	30APR2020	N	SKULL, not in association with item 57902 (R)
57901	01MAY2020	31DEC9999	Y	Skull, not in association with item 57902 (R)
57902	01NOV1998	30APR2020	N	CEPHALOMETRY, not in association with item 57901 (R)
57902	01MAY2020	31DEC9999	Y	Cephalometry, not in association with item 57901 (R)
57903	01DEC1991	31DEC9999	Y	SINUSES (R)
57905	01MAY2020	31DEC9999	Y	Mastoids or petrous temporal bones (R)
57906	01DEC1991	31DEC9999	Y	MASTOIDS (R)
57907	01MAY2020	31DEC9999	Y	Sinuses or facial bones - orbit, maxilla or malar, any or all (R)
57909	01DEC1991	31DEC9999	Y	PETROUS TEMPORAL BONES (R)
57911	01JUL2011	31DEC9999	Y	SKULL, not in association with item 57902 or 57914 (R) (NK)
57912	01DEC1991	31DEC9999	Y	FACIAL BONES orbit, maxilla or malar, any or all (R)
57914	01JUL2011	31DEC9999	Y	CEPHALOMETRY, not in association with item 57901 or 57911 (R) (NK)
57915	01DEC1991	31OCT1996	N	MANDIBLE (R)
57915	01NOV1996	30APR2020	N	MANDIBLE, not by orthopantomography technique (R)
57915	01MAY2020	31DEC9999	Y	Mandible, not by orthopantomography technique (R)
57917	01JUL2011	31DEC9999	Y	SINUSES (R) (NK)
57918	01DEC1991	31OCT1996	N	SALIVARY CALCULUS (R)
57918	01NOV1996	30APR2020	N	SALIVARY CALCULUS (R)
57918	01MAY2020	31DEC9999	Y	Salivary calculus (R)
57920	01JUL2011	31DEC9999	Y	MASTOIDS (R) (NK)
57921	01DEC1991	30APR2020	N	NOSE (R)
57921	01MAY2020	31DEC9999	Y	Nose (R)
57923	01JUL2011	31DEC9999	Y	PETROUS TEMPORAL BONES (R) (NK)
57924	01DEC1991	30APR2020	N	EYE (R)
57924	01MAY2020	31DEC9999	Y	Eye (R)
57926	01JUL2011	31DEC9999	Y	FACIAL BONES orbit, maxilla or malar, any or all (R) (NK)
57927	01DEC1991	30APR2020	N	TEMPOROMANDIBULAR JOINTS (R)
57927	01MAY2020	31DEC9999	Y	Temporo mandibular joints (R)
57929	01JUL2011	31DEC9999	Y	MANDIBLE, not by orthopantomography technique (R) (NK)
57930	01DEC1991	30APR2020	N	TEETH SINGLE AREA (R)
57930	01MAY2020	31DEC9999	Y	Teeth-single area (R)
57932	01JUL2011	31DEC9999	Y	SALIVARY CALCULUS (R) (NK)
57933	01DEC1991	30APR2020	N	TEETH FULL MOUTH (R)
57933	01MAY2020	31DEC9999	Y	Teeth - full mouth (R)
57935	01JUL2011	31DEC9999	Y	NOSE (R) (NK)
57936	01DEC1991	31DEC9999	Y	TEETH, ORTHOPANTOMOGRAPHY (R)
57938	01JUL2011	31DEC9999	Y	EYE (R) (NK)
57939	01DEC1991	30APR2020	N	PALATOPHARYNGEAL STUDIES with fluoroscopic screening (R)
57939	01MAY2020	31DEC9999	Y	Palato pharyngeal studies with fluoroscopic screening (R)
57941	01JUL2011	31DEC9999	Y	TEMPOROMANDIBULAR JOINTS (R) (NK)
57942	01DEC1991	30APR2020	N	PALATOPHARYNGEAL STUDIES without fluoroscopic screening (R)
57942	01MAY2020	31DEC9999	Y	Palato pharyngeal studies without fluoroscopic screening (R)
57944	01JUL2011	31DEC9999	Y	TEETH SINGLE AREA (R) (NK)
57945	01DEC1991	31OCT1996	N	LARYNX (R)
57945	01NOV1996	30APR2020	N	LARYNX, LATERAL AIRWAYS AND SOFT TISSUES OF THE NECK, not being a service associated with a service to which item 57939 or 57942 applies (R)
57945	01MAY2020	31DEC9999	Y	Larynx, lateral airways and soft tissues of the neck, not being a service associated with a service to which item 57939 or 57942 applies (R)
57947	01JUL2011	31DEC9999	Y	TEETH FULL MOUTH (R) (NK)
57948	01NOV2001	31DEC9999	Y	Teeth, Orthopantomography, for diagnostic survey of the mandible OR of the maxilla OR of the mandible and the maxilla, and the associated dental structures (R)
57950	01JUL2011	31DEC9999	Y	PALATOPHARYNGEAL STUDIES with fluoroscopic screening (R) (NK)
57951	01NOV2001	31DEC9999	Y	Teeth, Orthopantomography, for exclusion of a fracture following significant trauma, infection or tumour of the mandible OR of the maxilla OR of the mandible and the maxilla (R)
57953	01JUL2011	31DEC9999	Y	PALATOPHARYNGEAL STUDIES without fluoroscopic screening (R) (NK)
57954	01NOV2001	31DEC9999	Y	Teeth, Orthopantomography, for further investigation or monitoring of a fracture, infection, or tumour of the mandible OR of the maxilla OR of the mandible and the maxilla (R)
57956	01JUL2011	31DEC9999	Y	LARYNX, LATERAL AIRWAYS AND SOFT TISSUES OF THE NECK, not being a service associated with a service to which item 57939, 57942, 57950 or 57953 applies (R) (NK)
57957	01NOV2001	31DEC9999	Y	Teeth, Orthopantomography, for monitoring following surgery to the mandible OR of the maxilla OR of the mandible and the maxilla OR to associated dental structures (R)
57959	01JUL2011	31DEC9999	Y	Orthopantomography, for diagnosis and/or management of trauma, infection, tumours, congenital conditions or surgical conditions of the teeth or maxillofacial region (R) (NK)
57960	01NOV2002	30APR2020	N	Orthopantomography, for diagnosis and/or management of trauma, infection, tumours, congenital conditions or surgical conditions of the teeth or maxillofacial region (R)
57960	01MAY2020	31DEC9999	Y	Orthopantomography for diagnosis or management (or both) of trauma, infection, tumour or a congenital or surgical condition of the teeth or maxillofacial region (R)
57962	01JUL2011	31DEC9999	Y	Orthopantomography, for diagnosis and/or management of impacted teeth, caries, periodontal or peripical pathology where signs or symptoms of those conditions are evident (R) (NK)
57963	01NOV2002	30APR2020	N	Orthopantomography, for diagnosis and/or management of impacted teeth, caries, periodontal or peripical pathology where signs or symptoms of those conditions are evident (R)
57963	01MAY2020	31DEC9999	Y	Orthopantomography for diagnosis or management (or both) of any of the following conditions, if the signs and symptoms of the condition is present:(a) impacted teeth;(b) caries;(c) periodontal pathology;(d) periapical pathology (R)
57965	01JUL2011	31DEC9999	Y	Orthopantomography, for diagnosis and/or management of missing or crowded teeth, or developmental anomalies of the teeth or jaws (R) (NK)
57966	01NOV2002	30APR2020	N	Orthopantomography, for diagnosis and/or management of missing or crowded teeth, or developmental anomalies of the teeth or jaws (R)
57966	01MAY2020	31DEC9999	Y	Orthopantomography for diagnosis or management (or both) of missing or crowded teeth, or developmental anomalies of the teeth or jaws (R)
57968	01JUL2011	31DEC9999	Y	Orthopantomography, for diagnosis and/or management of temporomandibular joint arthroses or dysfunction (R) (NK)
57969	01NOV2002	30APR2020	N	Orthopantomography, for diagnosis and/or management of temporomandibular joint arthroses or dysfunction (R)
57969	01MAY2020	31DEC9999	Y	Orthopantomography for diagnosis or management (or both) of temporo mandibular joint arthroses or dysfunction (R)
58100	01DEC1991	30APR2020	N	SPINE CERVICAL (R)
58100	01MAY2020	31DEC9999	Y	Spine-cervical (R)
58102	01JUL2011	31DEC9999	Y	SPINE CERVICAL (R) (NK)
58103	01DEC1991	30APR2020	N	SPINE THORACIC (R)
58103	01MAY2020	31DEC9999	Y	Spine-thoracic (R)
58105	01JUL2011	31DEC9999	Y	SPINE THORACIC (R) (NK)
58106	01DEC1991	30APR2020	N	SPINE LUMBOSACRAL (R)
58106	01MAY2020	31DEC9999	Y	Spine-lumbosacral (R)
58108	01NOV2001	30APR2020	N	Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R)
58108	01MAY2020	31DEC9999	Y	Spine-4 regions, cervical, thoracic, lumbosacral and sacrococcygeal (R)
58109	01DEC1991	30APR2020	N	SPINE SACROCOCCYGEAL (R)
58109	01MAY2020	31DEC9999	Y	Spine-sacrococcygeal (R)
58111	01JUL2011	31DEC9999	Y	SPINE LUMBOSACRAL (R) (NK)
58112	01DEC1991	30APR2020	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, two examinations of the kind referred to in items 58100, 58103, 58106 and 58109 (R)
58112	01MAY2020	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine-2 examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R)
58114	01JUL2011	31DEC9999	Y	Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R) (NK)
58115	01DEC1991	31OCT2002	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examiniations performed under this item SPINE 3 OR MORE REGIONS (R)
58115	01NOV2002	30APR2020	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R)
58115	01MAY2020	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine-3 examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R)
58117	01JUL2011	31DEC9999	Y	SPINE SACROCOCCYGEAL (R) (NK)
58118	01DEC1991	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind referred to in items 58100, 58103, 58106 and 58109 (R)
58120	01JAN2010	30APR2020	N	Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R), if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year
58120	01MAY2020	31DEC9999	Y	Spine-4 regions, cervical, thoracic, lumbosacral and sacrococcygeal, if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year (R)
58121	01JAN2010	30APR2020	N	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R), if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year
58121	01MAY2020	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine-3 examinations of the kind mentioned in items 58100, 58103, 58106 and 58109, if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year (R)
58123	01JUL2011	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, two examinations of the kind referred to in items 58100, 58102, 58103, 58105, 58106, 58109, 58111 and 58117 (R) (NK)
58124	01JUL2011	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58102, 58103, 58105, 58106, 58109, 58111 and 58117 (R) (NK)
58126	01JUL2011	31DEC9999	Y	Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal, if the service to which item 58120, 58121, 58126 or 58127 applies has not been performed on the same patient within the same calendar year (R) (NK)
58127	01JUL2011	31DEC9999	Y	NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58102, 58103, 58105, 58106 and 58109, 58111 and 58117 if the service to which item 58120, 58121, 58126 or 58127 applies has not been performed on the same patient within the same calendar year (R) (NK)
58300	01DEC1991	19JAN1997	N	BONE AGE STUDY, WRIST AND KNEE (R)
58300	20JAN1997	30APR2020	N	BONE AGE STUDY (R)
58300	01MAY2020	31DEC9999	Y	Bone age study (R)
58302	01JUL2011	31DEC9999	Y	BONE AGE STUDY (R) (NK)
58303	01DEC1991	31DEC9999	Y	BONE AGE STUDY, WRIST (R)
58306	01DEC1991	31OCT1996	N	SKELETAL SURVEY INVOLVING 4 OR MORE REGIONS (R)
58306	01NOV1996	30APR2020	N	SKELETAL SURVEY (R)
58306	01MAY2020	31DEC9999	Y	Skeletal survey (R)
58308	01JUL2011	31DEC9999	Y	SKELETAL SURVEY (R) (NK)
58500	01DEC1991	30APR2020	N	CHEST (lung fields) by direct radiography (NR)
58500	01MAY2020	31DEC9999	Y	Chest (lung fields) by direct radiography (NR)
58502	01JUL2011	31DEC9999	Y	CHEST (lung fields) by direct radiography (NR) (NK)
58503	01DEC1991	30APR2020	N	CHEST (lung fields) by direct radiography (R)
58503	01MAY2020	31DEC9999	Y	Chest (lung fields) by direct radiography (R)
58505	01JUL2011	31DEC9999	Y	CHEST (lung fields) by direct radiography (R) (NK)
58506	01DEC1991	30APR2020	N	CHEST (lung fields) by direct radiography with fluoroscopic screening (R)
58506	01MAY2020	31DEC9999	Y	Chest (lung fields) by direct radiography with fluoroscopic screening (R)
58508	01JUL2011	31DEC9999	Y	CHEST (lung fields) by direct radiography with fluoroscopic screening (R) (NK)
58509	01DEC1991	30APR2020	N	THORACIC INLET OR TRACHEA (R)
58509	01MAY2020	31DEC9999	Y	Thoracic inlet or trachea (R)
58511	01JUL2011	31DEC9999	Y	THORACIC INLET OR TRACHEA (R) (NK)
58512	01DEC1991	31DEC9999	Y	CHEST, BY MINIATURE RADIOGRAPHY (R)
58515	01DEC1991	31DEC9999	Y	CARDIAC EXAMINATION (including barium swallow) (NR)
58518	01DEC1991	31DEC9999	Y	CARDIAC EXAMINATION (including barium swallow) (R)
58521	01DEC1991	31OCT1996	N	STERNUM OR RIBS ON 1 SIDE (R)
58521	01NOV1996	30APR2020	N	LEFT RIBS, RIGHT RIBS OR STERNUM (R)
58521	01MAY2020	31DEC9999	Y	Left ribs, right ribs or sternum (R)
58523	01JUL2011	31DEC9999	Y	LEFT RIBS, RIGHT RIBS OR STERNUM (R) (NK)
58524	01DEC1991	31OCT1996	N	STERNUM AND RIBS ON 1 SIDE OR RIBS ON BOTH SIDES (R)
58524	01NOV1996	30APR2020	N	LEFT AND RIGHT RIBS, LEFT RIBS AND STERNUM, OR RIGHT RIBS AND STERNUM (R)
58524	01MAY2020	31DEC9999	Y	Left and right ribs, left ribs and sternum, or right ribs and sternum (R)
58526	01JUL2011	31DEC9999	Y	LEFT AND RIGHT RIBS, LEFT RIBS AND STERNUM, OR RIGHT RIBS AND STERNUM (R) (NK)
58527	01DEC1991	31OCT1996	N	STERNUM AND RIBS ON BOTH SIDES (R)
58527	01NOV1996	30APR2020	N	LEFT RIBS, RIGHT RIBS AND STERNUM (R)
58527	01MAY2020	31DEC9999	Y	Left ribs, right ribs and sternum (R)
58529	01JUL2011	31DEC9999	Y	LEFT RIBS, RIGHT RIBS AND STERNUM (R) (NK)
58700	01DEC1991	30APR2020	N	PLAIN RENAL ONLY (R)
58700	01MAY2020	31DEC9999	Y	Plain renal only (R)
58702	01JUL2011	31DEC9999	Y	PLAIN RENAL ONLY (R) (NK)
58703	01DEC1991	31DEC9999	Y	DRIPINFUSION PYELOGRAPHY (R)
58706	01DEC1991	31OCT1997	N	INTRAVENOUS PYELOGRAPHY, including preliminary plain film (R)
58706	01NOV1997	31OCT2001	N	INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R)
58706	01NOV2001	30APR2020	N	INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R)
58706	01MAY2020	31DEC9999	Y	Intravenous pyelography, with or without preliminary plain films and with or without tomography (R)
58708	01JUL2011	31DEC9999	Y	INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R) (NK)
58709	01DEC1991	31DEC9999	Y	INTRAVENOUS PYELOGRAPHY, including preliminary plain film and limited tomography, involving up to 3 tomographic cuts (R)
58712	01DEC1991	31DEC9999	Y	INTRAVENOUS PYELOGRAPHY, including preliminary plain film with delayed examination for the CYSTOURETERIC REFLUX (R)
58715	01DEC1991	31OCT1997	N	ANTEGRADE OR RETROGRADE PYELOGRAPHY including preliminary plain film (R)
58715	01NOV1997	31OCT2001	N	ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R)
58715	01NOV2001	30APR2020	N	ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R)
58715	01MAY2020	31DEC9999	Y	Antegrade or retrograde pyelography with or without preliminary plain films and with preparation and contrast injection, one side (R)
58717	01JUL2011	31DEC9999	Y	ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R) (NK)
58718	01DEC1991	31OCT1997	N	RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY (R)
58718	01NOV1997	31OCT2001	N	RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R)
58718	01NOV2001	30APR2020	N	RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R)
58718	01MAY2020	31DEC9999	Y	Retrograde cystography or retrograde urethrography with or without preliminary plain films and with preparation and contrast injection (R)
58720	01JUL2011	31DEC9999	Y	RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
58721	01DEC1991	31OCT1997	N	RETROGRADE MICTURATING CYSTOURETHROGRAPHY (R)
58721	01NOV1997	31OCT2001	N	RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R)
58721	01NOV2001	30APR2020	N	RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R)
58721	01MAY2020	31DEC9999	Y	Retrograde micturating cysto urethrography, with preparation and contrast injection (R)
58723	01JUL2011	31DEC9999	Y	RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R) (NK)
58724	01DEC1991	31DEC9999	Y	RETROPERITONEAL PNEUMOGRAM (R)
58900	01DEC1991	31OCT1996	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (NR)
58900	01NOV1996	30JUN2016	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (NR)
58900	01JUL2016	30APR2020	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912 or 58915 applies (NR)
58900	01MAY2020	31DEC9999	Y	Plain abdominal only, not being a service associated with a service to which item 58909, 58912 or 58915 applies (NR)
58902	01JUL2011	30JUN2016	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915, 58917, 58924 or 58926 applies (NR) (NK)
58902	01JUL2016	31DEC9999	Y	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915 or 58917 applies (NR) (NK)
58903	01DEC1991	31OCT1996	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (R)
58903	01NOV1996	30JUN2016	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (R)
58903	01JUL2016	30APR2020	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912 or 58915 applies (R)
58903	01MAY2020	31DEC9999	Y	Plain abdominal only, not being a service associated with a service to which item 58909, 58912 or 58915 applies (R)
58905	01JUL2011	30JUN2016	N	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915, 58917, 58924 or 58926 applies (R) (NK)
58905	01JUL2016	31DEC9999	Y	PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915 or 58917 applies (R) (NK)
58906	01DEC1991	31DEC9999	Y	OESOPHAGUS, with or without examination for foreign body or barium swallow (R)
58909	01DEC1991	31OCT1997	N	BARIUM or other opaque meal OF OESOPHAGUS, STOMACH AND DUODENUM, with or without screening of chest, with or without preliminary plain film (R)
58909	01NOV1997	31OCT2001	N	BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR ABDOMEN, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939 or 57942 or 57945 applies - (R)
58909	01NOV2001	30APR2020	N	BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR DUODENUM, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939 or 57942 or 57945 applies - (R)
58909	01MAY2020	31DEC9999	Y	Barium or other opaque meal of one or more of pharynx, oesophagus, stomach or duodenum, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939, 57942 or 57945 applies (R)
58911	01JUL2011	31DEC9999	Y	BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR DUODENUM, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939, 57942, 57945, 57950, 57953 or 57956 applies - (R) (NK)
58912	01DEC1991	30APR2020	N	BARIUM or other opaque meal OF OESOPHAGUS, STOMACH, DUODENUM AND FOLLOW THROUGH TO COLON, with or without screening of chest, with or without preliminary plain film (R)
58912	01MAY2020	31DEC9999	Y	Barium or other opaque meal of oesophagus, stomach, duodenum and follow through to colon, with or without screening of chest and with or without preliminary plain film (R)
58914	01JUL2011	31DEC9999	Y	BARIUM or other opaque meal OF OESOPHAGUS, STOMACH, DUODENUM AND FOLLOW THROUGH TO COLON, with or without screening of chest, with or without preliminary plain film (R) (NK)
58915	01DEC1991	30APR2020	N	BARIUM or other opaque meal, SMALL BOWEL SERIES ONLY, with or without preliminary plain film (R)
58915	01MAY2020	31DEC9999	Y	Barium or other opaque meal, small bowel series only, with or without preliminary plain film (R)
58916	01NOV1997	31OCT2001	N	SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R)
58916	01NOV2001	30APR2020	N	SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R)
58916	01MAY2020	31DEC9999	Y	Small bowel enema, barium or other opaque study of the small bowel, including duodenal intubation, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies (R)
58917	01JUL2011	31DEC9999	Y	BARIUM or other opaque meal, SMALL BOWEL SERIES ONLY, with or without preliminary plain film (R) (NK)
58918	01DEC1991	31DEC9999	Y	OPAQUE ENEMA (R)
58920	01JUL2011	31DEC9999	Y	SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R) (NK)
58921	01DEC1991	31OCT1997	N	OPAQUE ENEMA, including air contrast study (R)
58921	01NOV1997	31OCT2001	N	OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - examination and report (R)
58921	01NOV2001	30APR2020	N	OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - (R)
58921	01MAY2020	31DEC9999	Y	Opaque enema, with or without air contrast study and with or without preliminary plain films (R)
58923	01JUL2011	31DEC9999	Y	OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - (R) (NK)
58924	01DEC1991	31OCT1997	N	GRAHAM'S TEST (cholecystography), including preliminary abdominal radiography (R)
58924	01NOV1997	31OCT2001	N	GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - examination and report (R)
58924	01NOV2001	31DEC9999	Y	GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - (R)
58926	01JUL2011	31DEC9999	Y	GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - (R) (NK)
58927	01DEC1991	31OCT1997	N	CHOLEGRAPHY DIRECT operative or postoperative (R)
58927	01NOV1997	31OCT2001	N	CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - examination and report (R)
58927	01NOV2001	30APR2020	N	CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - (R)
58927	01MAY2020	31DEC9999	Y	Cholegraphy direct, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies (R)
58929	01JUL2011	31DEC9999	Y	CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - (R) (NK)
58930	01DEC1991	31DEC9999	Y	CHOLEGRAPHY intravenous (R)
58933	01DEC1991	31OCT1997	N	CHOLEGRAPHY percutaneous transhepatic (R)
58933	01NOV1997	31OCT2001	N	CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R)
58933	01NOV2001	30APR2020	N	CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R)
58933	01MAY2020	31DEC9999	Y	Cholegraphy, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection (R)
58935	01JUL2011	31DEC9999	Y	CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
58936	01DEC1991	31OCT1997	N	CHOLEGRAPHY drip infusion (R)
58936	01NOV1997	31OCT2001	N	CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R)
58936	01NOV2001	30APR2020	N	CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R)
58936	01MAY2020	31DEC9999	Y	Cholegraphy, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography (R)
58938	01JUL2011	31DEC9999	Y	CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R) (NK)
58939	01NOV1996	18FEB1997	N	DEFAECOGRAM, paediatric (R)
58939	19FEB1997	30APR2020	N	DEFAECOGRAM (R)
58939	01MAY2020	31DEC9999	Y	Defaecogram (R)
58941	01JUL2011	31DEC9999	Y	DEFAECOGRAM (R) (NK)
59100	01DEC1991	31DEC9999	Y	FOREIGN BODY IN EYE (special method, Sweet's or other) (R)
59103	01DEC1991	31OCT2009	N	FOREIGN BODY, LOCALISATION OF AND REPORT, not being a service to which another item in this Group applies (R)
59103	01NOV2009	31DEC9999	Y	Localisation of foreign body, if provided in conjunction with a service described in Subgroups 1 to 12 of Group I3 (R)
59104	01JUL2011	31DEC9999	Y	Localisation of foreign body, if provided in conjunction with a service described in Subgroups 1 to 12 of Group I3 (R) (NK)
59300	01DEC1991	31OCT2001	N	(Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, (with or without thermography) and report if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59300	01NOV2001	31OCT2003	N	(Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, (with or without thermography) if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59300	01NOV2003	30APR2004	N	(Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59300	01MAY2004	30APR2020	N	(Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) MAMMOGRAPHY OF BOTH BREASTS, if there is a reason to suspect the presence of malignancy because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner. Unless otherwise indicated, mammography includes both breasts (R)
59300	01MAY2020	31DEC9999	Y	Mammography of both breasts if there is reason to suspect the presence of malignancy because of:(a) the past occurrence of breast malignancy in the patient; or(b) significant history of breast or ovarian malignancy in the patients family; or(c) symptoms or indications of breast disease found on examination of the patient by a medical practitioner (R) (Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients)
59301	01JUL2011	31DEC9999	Y	(Note: These items are intended for use in the investigation of a clinical abnormality of the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) MAMMOGRAPHY OF BOTH BREASTS, if there is a reason to suspect the presence of malignancy because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner. Unless otherwise indicated, mammography includes both breasts (R) (NK)
59302	01NOV2018	30APR2020	N	Three dimensional tomosynthesis of both breasts, not being a service associated with item 59300 or 59301, if there is reason to suspect the presence of malignancy because of: the past occurrence of breast malignancy in the patient or members of the patients family; or symptoms or indications of malignancy found on examination of the patient by a medical practitioner (R) (K)
59302	01MAY2020	31DEC9999	Y	Three dimensional tomosynthesis of both breasts, if there is reason to suspect the presence of malignancy because of: a) the past occurrence of breast malignancy in the patient; or b) significant history of breast or ovarian malignancy in the patients family; or c) symptoms or indications of breast disease found on examination of the patient by a medical practitioner Not being a service to which item 59300 applies (R)
59303	01DEC1991	31OCT2001	N	RADIOGRAPHIC EXAMINATION OF 1 BREAST, (with or without thermography) and report if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59303	01NOV2001	31OCT2003	N	RADIOGRAPHIC EXAMINATION OF 1 BREAST, (with or without thermography) if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59303	01NOV2003	30APR2004	N	RADIOGRAPHIC EXAMINATION OF 1 BREAST, if: (a) the patient is referred with a specific request for this procedure; and (b) there is reason to suspect the presence of malignancy in the breasts because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59303	01MAY2004	30APR2020	N	MAMMOGRAPHY OF ONE BREAST, if: (a) the patient is referred with a specific request for a unilateral mammogram; and (b) there is reason to suspect the presence of malignancy because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R)
59303	01MAY2020	31DEC9999	Y	Mammography of one breast if: (a) the service is specifically requested for a unilateral mammogram; and(b) there is reason to suspect the presence of malignancy because of:(i) the past occurrence of breast malignancy in the patient; or(ii) significant history of breast or ovarian malignancy in the patients family; or(iii) symptoms or indications of breast disease found on examination of the patient by a medical practitioner (R)
59304	01JUL2011	31DEC9999	Y	MAMMOGRAPHY OF ONE BREAST, if: (a) the patient is referred with a specific request for a unilateral mammogram; and (b) there is reason to suspect the presence of malignancy because of: (i) the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) (NK)
59305	01NOV2018	30APR2020	N	Three dimensional tomosynthesis of one breast, not being a service associated with item 59303 or 59304, if there is reason to suspect the presence of malignancy because of: the past occurrence of breast malignancy in the patient or members of the patients family; or symptoms or indications of malignancy found on examination of the patient by a medical practitioner (R) (K)
59305	01MAY2020	31DEC9999	Y	Three dimensional tomosynthesis of one breast, if there is reason to suspect the presence of malignancy because of: a) the past occurrence of breast malignancy in the patient; or b) significant history of breast or ovarian malignancy in the patients family; or c) symptoms or indications of breast disease found on examination of the patient by a medical practitioner Not being a service to which item 59303 applies (R)
59306	01DEC1991	31DEC9999	Y	MAMMARY DUCTOGRAM (galactography) - 1 breast (R)
59307	01JUL2011	31DEC9999	Y	MAMMARY DUCTOGRAM (galactography) - 1 breast (R) (NK)
59309	01DEC1991	31DEC9999	Y	MAMMARY DUCTOGRAM (galactography) - 2 breasts (R)
59310	01JUL2011	31DEC9999	Y	MAMMARY DUCTOGRAM (galactography) - 2 breasts (R) (NK)
59312	01NOV1997	31OCT2001	N	RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - examination and report (R)
59312	01NOV2001	30APR2020	N	RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - (R)
59312	01MAY2020	31DEC9999	Y	Radiographic examination of both breasts, in conjunction with a surgical procedure on each breast, using interventional techniques (R)
59313	01JUL2011	31DEC9999	Y	RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - (R) (NK)
59314	01NOV1997	31OCT2001	N	RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - examination and report (R)
59314	01NOV2001	30APR2020	N	RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - (R)
59314	01MAY2020	31DEC9999	Y	Radiographic examination of one breast, in conjunction with a surgical procedure using interventional techniques (R)
59315	01JUL2011	31DEC9999	Y	RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - (R) (NK)
59318	01NOV1997	31OCT2001	N	RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 30361 - examination and report (R)
59318	01NOV2001	31OCT2003	N	RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 30361 - (R)
59318	01NOV2003	30APR2020	N	RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 31536 - (R)
59318	01MAY2020	31DEC9999	Y	Radiographic examination of excised breast tissue to confirm satisfactory excision of one or more lesions in one breast or both following pre-operative localisation in conjunction with a service under item 31536 (R)
59319	01JUL2011	31DEC9999	Y	RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 31536 - (R) (NK)
59500	01DEC1991	31DEC9999	Y	PREGNANT UTERUS (R)
59503	01DEC1991	31OCT1996	N	PELVIMETRY OR PLACENTOGRAPHY (R)
59503	01NOV1996	28FEB1999	N	PELVIMETRY, not being a service associated with a service to which item 57201 applies (R)
59503	01MAR1999	31DEC9999	Y	PELVIMETRY, not being a service associated with a service to which item 57201 applies (R)
59504	01JUL2011	31DEC9999	Y	PELVIMETRY, not being a service associated with a service to which item 57201 or 57247 applies (R) (NK)
59506	01DEC1991	31DEC9999	Y	CONTROL XRAYS IN CONJUNCTION WITH INTRAUTERINE FOETAL BLOOD TRANSFUSION (R)
59700	01DEC1991	31OCT1997	N	DISCOGRAPHY 1 disc (R)
59700	01NOV1997	31OCT2001	N	DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59700	01NOV2001	30APR2020	N	DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - (R)
59700	01MAY2020	31DEC9999	Y	Discography, each disc, with or without preliminary plain films and with preparation and contrast injection (R) (Anaes.)
59701	01JUL2011	31DEC9999	Y	DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59703	01DEC1991	31OCT1997	N	DACRYOCYSTOGRAPHY 1 side (R)
59703	01NOV1997	31OCT2001	N	DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - examination and report (R)
59703	01NOV2001	30APR2020	N	DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - (R)
59703	01MAY2020	31DEC9999	Y	Dacryocystography, one side, with or without preliminary plain film and with preparation and contrast injection (R)
59704	01JUL2011	31DEC9999	Y	DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - (R) (NK)
59706	01DEC1991	31DEC9999	Y	ENCEPHALOGRAPHY (R)
59709	01DEC1991	31DEC9999	Y	CEREBRAL VENTRICULOGRAPHY (R)
59712	01DEC1991	31OCT1997	N	HYSTEROSALPINGOGRAPHY (R)
59712	01NOV1997	31OCT2001	N	HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59712	01NOV2001	30APR2020	N	HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - (R)
59712	01MAY2020	31DEC9999	Y	Hysterosalpingography, with or without preliminary plain films and with preparation and contrast injection (R)(Anaes.)
59713	01JUL2011	31DEC9999	Y	HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59715	01DEC1991	31OCT1997	N	BRONCHOGRAPHY 1 side (R)
59715	01NOV1997	31OCT2001	N	BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59715	01NOV2001	30JUN2016	N	BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R)
59715	01JUL2016	30APR2020	N	BRONCHOGRAPHY, one side, with or without preliminary plain films and with preparation and contrast injection, on a person under 16 years of age - (R) (K)
59715	01MAY2020	31DEC9999	Y	Bronchography, one side, with or without preliminary plain films and with preparation and contrast injection, on a person under 16 years of age (R) (Anaes.)
59716	01JUL2011	30JUN2016	N	BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59716	01JUL2016	31DEC9999	Y	BRONCHOGRAPHY, one side, with or without preliminary plain films and with preparation and contrast injection, on a person under 16 years of age - (R) (NK)
59718	01DEC1991	31OCT1997	N	PHLEBOGRAPHY 1 side (R)
59718	01NOV1997	31OCT2001	N	PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59718	01NOV2001	30APR2020	N	PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R)
59718	01MAY2020	31DEC9999	Y	Phlebography, one side, with or without preliminary plain films and with preparation and contrast injection (R) (Anaes.)
59719	01JUL2011	31DEC9999	Y	PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59721	01DEC1991	31DEC9999	Y	SPLENOGRAPHY (R)
59724	01DEC1991	31OCT1996	N	MYELOGRAPHY, 1 region (R)
59724	01NOV1996	31OCT1997	N	MYELOGRAPHY, 1 region, not being a service associated with a service to which item 56219 applies (R)
59724	01NOV1997	31OCT2001	N	MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 applies - examination and report (R)
59724	01NOV2001	30APR2020	N	MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 applies - (R)
59724	01MAY2020	31DEC9999	Y	Myelography, one or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 applies (R)(Anaes.)
59725	01JUL2011	31DEC9999	Y	MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 or 56259 applies - (R) (NK)
59727	01DEC1991	31OCT1996	N	MYELOGRAPHY, 2 regions (R)
59727	01NOV1996	31DEC9999	Y	MYELOGRAPHY, 2 regions, not being a service associated with a service to which item 56219 applies (R)
59730	01DEC1991	31OCT1996	N	MYELOGRAPHY, 3 regions (R)
59730	01NOV1996	31DEC9999	Y	MYELOGRAPHY, 3 regions, not being a service associated with a service to which item 56219 applies (R)
59733	01DEC1991	31OCT1997	N	SIALOGRAPHY 1 side (R)
59733	01NOV1997	31OCT2001	N	SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 applies - examination and report (R)
59733	01NOV2001	30APR2020	N	SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 applies - (R)
59733	01MAY2020	31DEC9999	Y	Sialography, one side, with preparation and contrast injection, not being a service associated with a service to which item 57918 applies (R)
59734	01JUL2011	31DEC9999	Y	SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 or 57932 applies - (R) (NK)
59736	01DEC1991	31OCT1997	N	VASOEPIDIDYMOGRAPHY 1 side (R)
59736	01NOV1997	31OCT2001	N	VASOEPIDIDYMOGRAPHY, 1 side, for other than an investigation for reversal of previous sterilisation - examination and report (R)
59736	01NOV2001	30JUN2008	N	VASOEPIDIDYMOGRAPHY, 1 side, for other than an investigation for reversal of previous sterilisation - (R)
59736	01JUL2008	31DEC9999	Y	VASOEPIDIDYMOGRAPHY, 1 side, - (R)
59737	01JUL2011	31DEC9999	Y	VASOEPIDIDYMOGRAPHY, 1 side, - (R) (NK)
59739	01DEC1991	31OCT1997	N	SINUSES AND FISTULAE (R)
59739	01NOV1997	31OCT2001	N	SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59739	01NOV2001	30APR2020	N	SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - (R)
59739	01MAY2020	31DEC9999	Y	Sinogram or fistulogram, one or more regions, with or without preliminary plain films and with preparation and contrast injection (R)
59740	01JUL2011	31DEC9999	Y	SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59742	01DEC1991	31DEC9999	Y	LARYNGOGRAPHY with contrast media (R)
59745	01DEC1991	31DEC9999	Y	PNEUMOARTHROGRAPHY (R)
59748	01DEC1991	31DEC9999	Y	ARTHROGRAPHY contrast (R)
59751	01DEC1991	19JAN1997	N	ARTHROGRAPHY double contrast (R)
59751	20JAN1997	31OCT1997	N	ARTHROGRAPHY double contrast (R)
59751	01NOV1997	31OCT2001	N	ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - examination and report (R)
59751	01NOV2001	30APR2020	N	ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - (R)
59751	01MAY2020	31DEC9999	Y	Arthrography, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection (R)
59752	01JUL2011	31DEC9999	Y	ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - (R) (NK)
59754	01DEC1991	31OCT1997	N	LYMPHANGIOGRAPHY, including follow up radiography (R)
59754	01NOV1997	31OCT2001	N	LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - examination and report(R)
59754	01NOV2001	30APR2020	N	LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - (R)
59754	01MAY2020	31DEC9999	Y	Lymphangiography, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection (R)
59755	01JUL2011	31DEC9999	Y	LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - (R) (NK)
59757	01DEC1991	31DEC9999	Y	PNEUMOMEDIASTINUM (R)
59760	01NOV1996	31DEC9999	Y	PERITONEOGRAM (herniography) with or without contrast medium including preparation - performed on a person over 14 years of age (R)
59761	01JUL2011	31DEC9999	Y	PERITONEOGRAM (herniography) with or without contrast medium including preparation - performed on a person over 14 years of age (R) (NK)
59763	01NOV1996	30APR2020	N	AIR INSUFFLATION during video - fluoroscopic imaging including associated consultation (R)
59763	01MAY2020	31DEC9999	Y	Air insufflation during video-fluoroscopic imaging including associated consultation (R)
59764	01JUL2011	31DEC9999	Y	AIR INSUFFLATION during video - fluoroscopic imaging including associated consultation (R) (NK)
59900	01DEC1991	31DEC9999	Y	BY FILM OR OTHER TECHNIQUE SERIAL ANGIOCARDIOGRAPHY (rapid cassette changing) each series (R)
59903	01DEC1991	30JUN1993	N	SERIAL ANGIOCARDIOGRAPHY (SINGLE PLAIN, direct rollfilm method) each series (R)
59903	01JUL1993	30JUN2001	N	SERIAL ANGIOCARDIOGRAPHY (SINGLE PLANE) each series (R)
59903	01JUL2001	30NOV2015	N	ANGIOCARDIOGRAPHY including the service described in item 59970, 59974 or 61109, not being a service to which item 59912 or 59925 applies (R) (K)
59903	01DEC2015	30APR2020	N	Angiocardiography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59912 or 59925 applies (R) (K) (Anaes.)
59903	01MAY2020	31DEC9999	Y	Angiocardiography, including the service mentioned in item 59970 or 61109, not being a service to which item 59912 or 59925 applies (R) (Anaes.)
59906	01DEC1991	30JUN1993	N	SERIAL ANGIOCARDIOGRAPHY (BIPLANE, direct rollfilm method) each series (R)
59906	01JUL1993	31DEC9999	Y	SERIAL ANGIOCARDIOGRAPHY (BIPLANE) each series (R)
59909	01DEC1991	31DEC9999	Y	SERIAL ANGIOCARDIOGRAPHY (indirect rollfilm method) each series (R)
59912	01DEC1991	30JUN2001	N	SELECTIVE CORONARY ARTERIOGRAPHY (R)
59912	01JUL2001	30NOV2015	N	SELECTIVE CORONARY ARTERIOGRAPHY (R) (K), including the services described in item 59970, 59974 or 61109, not being a service to which item 59903 or 59925 applies (Anaes.)
59912	01DEC2015	30APR2020	N	Selective coronary arteriography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59903 or 59925 applies (R) (K) (Anaes.)
59912	01MAY2020	31DEC9999	Y	Selective coronary arteriography, including the service mentioned in item 59970 or 61109, not being a service to which item 59903 or 59925 applies (R) (Anaes.)
59915	01DEC1991	31DEC9999	Y	CEREBRAL ANGIOGRAPHY 1 side (R)
59918	01DEC1991	31DEC9999	Y	ARTERIOGRAPHY, PERIPHERAL 1 side (R)
59921	01DEC1991	31DEC9999	Y	AORTOGRAPHY (R)
59924	01DEC1991	30JUN1993	N	SELECTIVE ARTERIOGRAPHY each injection and film run (R)
59924	01JUL1993	31DEC9999	Y	SELECTIVE ARTERIOGRAPHY per injection and film or data acquisition run (R)
59925	01JUL2001	30NOV2015	N	SELECTIVE CORONARY ARTERIOGRAPHY AND ANGIOCARDIOGRAPHY, including the services described in items 59903, 59912, 59970, 59974 or 61109 (R) (K)
59925	01DEC2015	30APR2020	N	Selective coronary arteriography and angiocardiography, including a service mentioned in item 59903, 59912, 59970, 59974, 61109 or 61110 (R) (K) (Anaes.)
59925	01MAY2020	31DEC9999	Y	Selective coronary arteriography and angiocardiography, including a service mentioned in item 59903, 59912, 59970 or 61109 (R) (Anaes.)
59970	01NOV1996	31OCT1998	N	ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, one or more regions including any preliminary plain films, preparation and contrast injection (R)
59970	01NOV1998	30JUN2001	N	ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R)
59970	01JUL2001	30APR2020	N	ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R) (K) (Anaes.)
59970	01MAY2020	31DEC2024	N	Angiography or digital subtraction angiography, or both, with fluoroscopy and image acquisition, using a mobile image intensifier, including any preliminary plain films, preparation and contrast injection-one or more regions (R) (Anaes.)
59970	01JAN2025	31DEC9999	Y	Angiography or digital subtraction angiography, or both, with fluoroscopy and image acquisition, using a mobile image intensifier, including any preliminary plain films, preparation and contrast injection-one or more regions (R)
59971	01JUL2001	30NOV2015	N	ANGIOCARDIOGRAPHY including the service described in item 59970, 59974 or 61109, not being a service to which item 59972 or 59973 applies (R) (NK)
59971	01DEC2015	31DEC9999	Y	Angiocardiography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59972 or 59973 applies (R) (NK) (Anaes.)
59972	01JUL2001	30NOV2015	N	SELECTIVE CORONARY ARTERIOGRAPHY (R) (NK), including the service described in item 59970, 59974 or 61109, not being a service to which item 59971 or 59973 applies (Anaes.)
59972	01DEC2015	31DEC9999	Y	Selective coronary arteriography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59971 or 59973 applies (R) (NK) (Anaes.)
59973	01JUL2001	30NOV2015	N	SELECTIVE CORONARY ARTERIOGRAPHY AND ANGIOCARDIOGRAPHY, including the services described in items 59970, 59971, 59972, 59974 or 61109 (R) (NK)
59973	01DEC2015	31DEC9999	Y	Selective coronary arteriography and angiocardiography, including a service mentioned in item 59970, 59971, 59972, 59974, 61109 or 61110 (R) (NK) (Anaes.)
59974	01JUL2001	31DEC9999	Y	ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R) (NK) (Anaes.)
60000	01NOV1992	31DEC2014	N	BY DIGITAL SUBTRACTION TECHNIQUE DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (Anaes.)
60000	01JAN2015	30APR2020	N	BY DIGITAL SUBTRACTION TECHNIQUE DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60000	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography-1 to 3 data acquisition runs (R) (Anaes.)
60001	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60003	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (Anaes.)
60003	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60003	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography-4 to 6 data acquisition runs (R) (Anaes.)
60004	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60006	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (Anaes.)
60006	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60006	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography-7 to 9 data acquisition runs (R) (Anaes.)
60007	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60009	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (Anaes.)
60009	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (K) (Anaes.)
60009	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography-10 or more data acquisition runs (R) (Anaes.)
60010	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (NK) (Anaes.)
60012	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 1 to 3 data acquisition runs (R) (Anaes.)
60012	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60012	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of thorax-1 to 3 data acquisition runs (R) (Anaes.)
60013	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of thorax - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60015	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 4 to 6 data acquisition runs (R) (Anaes.)
60015	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60015	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of thorax-4 to 6 data acquisition runs (R) (Anaes.)
60016	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of thorax - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60018	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 7 to 9 data acquisition runs (R) (Anaes.)
60018	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60018	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of thorax-7 to 9 data acquisition runs (R) (Anaes.)
60019	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of thorax - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60021	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 10 or more data acquisition runs (R) (Anaes.)
60021	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 10 or more data acquisition runs (R) (K) (Anaes.)
60021	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of thorax-10 or more data acquisition runs (R) (Anaes.)
60022	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of thorax - 10 or more data acquisition runs (R) (NK) (Anaes.)
60024	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 1 to 3 data acquisition runs (R) (Anaes.)
60024	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60024	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of abdomen-1 to 3 data acquisition runs (R) (Anaes.)
60024	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of abdomen-1 to 3 data acquisition runs (R)
60025	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of abdomen - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60027	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 4 to 6 data acquisition runs (R) (Anaes.)
60027	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60027	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of abdomen-4 to 6 data acquisition runs (R) (Anaes.)
60027	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of abdomen-4 to 6 data acquisition runs (R)
60028	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of abdomen - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60030	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 7 to 9 data acquisition runs (R) (Anaes.)
60030	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60030	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of abdomen-7 to 9 data acquisition runs (R) (Anaes.)
60030	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of abdomen-7 to 9 data acquisition runs (R)
60031	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of abdomen - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60033	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 10 or more data acquisition runs (R) (Anaes.)
60033	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 10 or more data acquisition runs (R) (K) (Anaes.)
60033	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of abdomen-10 or more data acquisition runs (R) (Anaes.)
60033	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of abdomen-10 or more data acquisition runs (R)
60034	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of abdomen - 10 or more data acquisition runs (R) (NK) (Anaes.)
60036	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.)
60036	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60036	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs-1 to 3 data acquisition runs (R) (Anaes.)
60037	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60039	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.)
60039	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60039	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs-4 to 6 data acquisition runs (R) (Anaes.)
60040	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60042	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.)
60042	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60042	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs-7 to 9 data acquisition runs (R) (Anaes.)
60043	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60045	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 10 or more data acquisition runs (R) (Anaes.)
60045	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.)
60045	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs-10 or more data acquisition runs (R) (Anaes.)
60046	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of upper limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.)
60048	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.)
60048	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60048	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of lower limb or limbs-1 to 3 data acquisition runs (R) (Anaes.)
60048	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs-1 to 3 data acquisition runs (R)
60049	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60051	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.)
60051	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60051	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of lower limb or limbs-4 to 6 data acquisition runs (R) (Anaes.)
60051	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs-4 to 6 data acquisition runs (R)
60052	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60054	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.)
60054	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60054	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of lower limb or limbs-7 to 9 data acquisition runs (R) (Anaes.)
60054	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs-7 to 9 data acquisition runs (R)
60055	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60057	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 10 or more data acquisition runs (R) (Anaes.)
60057	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.)
60057	01MAY2020	31DEC2024	N	Digital subtraction angiography, examination of lower limb or limbs-10 or more data acquisition runs (R) (Anaes.)
60057	01JAN2025	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs-10 or more data acquisition runs (R)
60058	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of lower limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.)
60060	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.)
60060	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.)
60060	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs-1 to 3 data acquisition runs (R) (Anaes.)
60061	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.)
60063	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.)
60063	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.)
60063	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs-4 to 6 data acquisition runs (R) (Anaes.)
60064	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.)
60066	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.)
60066	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.)
60066	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs-7 to 9 data acquisition runs (R) (Anaes.)
60067	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.)
60069	01NOV1992	31DEC2014	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (Anaes.)
60069	01JAN2015	30APR2020	N	DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.)
60069	01MAY2020	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs-10 or more data acquisition runs (R) (Anaes.)
60070	01JAN2015	31DEC9999	Y	Digital subtraction angiography, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.)
60072	01NOV1992	31DEC2014	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 1 vessel (NR) (Anaes.)
60072	01JAN2015	30APR2020	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 1 vessel (NR) (K) (Anaes.)
60072	01MAY2020	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique-one vessel (NR) (Anaes.)
60073	01JAN2015	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique - one vessel (NR) (NK) (Anaes.)
60075	01NOV1992	31DEC2014	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 2 vessels (NR) (Anaes.)
60075	01JAN2015	30APR2020	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 2 vessels (NR) (K) (Anaes.)
60075	01MAY2020	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique-2 vessels (NR) (Anaes.)
60076	01JAN2015	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique - 2 vessels (NR) (NK) (Anaes.)
60078	01NOV1992	31DEC2014	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 3 or more vessels (NR) (Anaes.)
60078	01JAN2015	30APR2020	N	SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 3 or more vessels (NR) (K) (Anaes.)
60078	01MAY2020	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique-3 or more vessels (NR) (Anaes.)
60079	01JAN2015	31DEC9999	Y	Selective arteriography or selective venography by digital subtraction angiography technique - 3 or more vessels (NR) (NK) (Anaes.)
60100	01DEC1991	31OCT2001	N	TOMOGRAPHY OF ANY REGION AND REPORT (R)
60100	01NOV2001	31DEC9999	Y	TOMOGRAPHY OF ANY REGION (R) (Anaes.)
60101	01JUL2011	31DEC9999	Y	TOMOGRAPHY OF ANY REGION (R) (NK)
60300	01DEC1991	31DEC9999	Y	STEREOSCOPIC EXAMINATION AND REPORT (R)
60500	01DEC1991	18FEB1997	N	FLUOROSCOPY, with general anaesthesia (R)
60500	19FEB1997	30APR2020	N	FLUOROSCOPY, with general anaesthesia (not being a service associated with a radiographic examination) (R)
60500	01MAY2020	31DEC9999	Y	Fluoroscopy, with general anaesthesia (not being a service associated with a radiographic examination) (R)
60501	01JUL2011	31DEC9999	Y	FLUOROSCOPY, with general anaesthesia (not being a service associated with a radiographic examination) (R) (NK)
60503	01DEC1991	18FEB1997	N	FLUOROSCOPY, without general anaesthesia (R)
60503	19FEB1997	30APR2020	N	FLUOROSCOPY, without general anaesthesia (not being a service associated with a radiographic examination) (R)
60503	01MAY2020	31DEC9999	Y	Fluoroscopy, without general anaesthesia (not being a service associated with a radiographic examination) (R)
60504	01JUL2011	31DEC9999	Y	FLUOROSCOPY, without general anaesthesia (not being a service associated with a radiographic examination) (R) (NK)
60506	01NOV1992	31OCT1997	N	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Category applies (R)
60506	01NOV1997	30APR2020	N	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Table applies (R)
60506	01MAY2020	31DEC9999	Y	Fluoroscopy using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Group applies (R)
60507	01JUL2011	31DEC9999	Y	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Table applies (R) (NK)
60509	01NOV1992	31OCT1997	N	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Category applies (R)
60509	01NOV1997	30APR2020	N	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Table applies (R)
60509	01MAY2020	31DEC9999	Y	Fluoroscopy using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Group applies (R)
60510	01JUL2011	31DEC9999	Y	FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Table applies (R) (NK)
60700	01DEC1991	31DEC9999	Y	Radiographic examination of any part and report not covered by another item in this Group (R)
60900	01DEC1991	31DEC9999	Y	"Note: In this Subgroup, ""preparation"" means the injection of opaque or contrast media or the removal of fluid and its replacement by air, oxygen or other similar preparation ENCEPHALOGRAPHY (NR)"
60903	01DEC1991	31OCT1997	N	CEREBRAL ANGIOGRAPHY (one side) percutaneous, catheter or open exposure (NR)
60903	01NOV1997	31DEC9999	Y	CEREBRAL ANGIOGRAPHY, 1 side percutaneous, catheter or open exposure, when used in association with a service to which items 59900, 59903,59906, 59912, 59915, 59918, 59921, 59924 or 59970 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60906	01DEC1991	31DEC9999	Y	CEREBRAL VENTRICULOGRAPHY (NR)
60909	01DEC1991	31DEC9999	Y	DACRYOCYSTOGRAPHY 1 side (NR)
60912	01DEC1991	31DEC9999	Y	BRONCHOGRAPHY 1 or both sides (NR)
60915	01DEC1991	31OCT1997	N	AORTOGRAPHY (NR)
60915	01NOV1997	31DEC9999	Y	AORTOGRAPHY, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918 59921, 59924 or 59970 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60918	01DEC1991	31OCT1997	N	ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY 1 vessel (NR)
60918	01NOV1997	30JUN2001	N	ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY 1 vessel, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918, 59921 or 59924 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60918	01JUL2001	31DEC2014	N	ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY 1 vessel, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60918	01JAN2015	30APR2020	N	ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY 1 vessel, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60079 inclusive apply (NR)
60918	01MAY2020	30JUN2021	N	Arteriography (peripheral) or phlebography-one vessel, when used in association with a service to which item 59903, 59912, 59925 or 59970 applies, not being a service associated with a service to which any of items 60000 to 60078 apply (NR)
60918	01JUL2021	31DEC9999	Y	Arteriography (peripheral) or phlebography-one vessel, when used in association with a service to which item 59970 applies, not being a service associated with a service to which any of items 60000 to 60078 apply (NR)
60921	01DEC1991	31DEC9999	Y	SPLENOGRAPHY (NR)
60924	01DEC1991	31DEC9999	Y	RETROPERITONEAL PNEUMOGRAM (NR)
60927	01DEC1991	31OCT1997	N	SELECTIVE ARTERIOGRAM or PHLEBOGRAM (NR)
60927	01NOV1997	30JUN2001	N	SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918, 59921 or 59924 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60927	01JUL2001	31DEC2014	N	SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR)
60927	01JAN2015	30APR2020	N	SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60079 inclusive apply (NR)
60927	01MAY2020	30JUN2021	N	Selective arteriogram or phlebogram, when used in association with a service to which item 59903, 59912, 59925 or 59970 applies, not being a service associated with a service to which any of items 60000 to 60078 apply (NR)
60927	01JUL2021	31DEC9999	Y	Selective arteriogram or phlebogram, when used in association with a service to which item 59970 applies, not being a service associated with a service to which any of items 60000 to 60078 apply (NR)
60930	01DEC1991	31DEC9999	Y	PERCUTANEOUS INJECTION of radioopaque material into RENAL CYST (including aspiration) or RENAL PELVIS for antegrade pyelography (NR)
60933	01DEC1991	31DEC9999	Y	PNEUMOARTHROGRAPHY or PNEUMOPERITONEUM (NR)
60936	01DEC1991	31DEC9999	Y	ARTHROGRAPHY, single or double contrast, excluding arthrography of the joints between articular processes of the vertebrae (NR)
60939	01DEC1991	31OCT1996	N	DRIPINFUSION PYELOGRAPHY OR CHOLEGRAPHY (NR)
60939	01NOV1996	31DEC9999	Y	DRIPINFUSION CHOLEGRAPHY (NR)
60942	01DEC1991	31DEC9999	Y	RETROGRADE MICTURATING CYSTOURETHROGRAPHY (NR)
60945	01DEC1991	31DEC9999	Y	HYSTEROSALPINGOGRAPHY (NR)
60948	01DEC1991	31DEC9999	Y	DISCOGRAPHY 1 disc (NR)
60951	01DEC1991	31DEC9999	Y	DISCOGRAPHY using Metrizamide contrast medium (NR)
60954	01DEC1991	31DEC9999	Y	INTRAOSSEOUS VENOGRAPHY (NR)
60957	01DEC1991	30JUN1995	N	MYELOGRAPHY not being a service to which item 60960 applies (NR)
60957	01JUL1995	31DEC9999	Y	MYELOGRAPHY (NR)
60960	01DEC1991	31DEC9999	Y	MYELOGRAPHY, using Metrizamide contrast medium (NR)
60963	01DEC1991	31DEC9999	Y	CISTERNAL PUNCTURE (NR)
60966	01DEC1991	31DEC9999	Y	SINUS OR FISTULA, INJECTION INTO (NR)
60969	01DEC1991	31DEC9999	Y	SIALOGRAPHY (NR)
60972	01DEC1991	31DEC9999	Y	LYMPHANGIOGRAPHY 1 side (NR)
60975	01DEC1991	31DEC9999	Y	LARYNGOGRAPHY (NR)
60978	01DEC1991	31DEC9999	Y	PNEUMOMEDIASTINUM (NR)
60981	01DEC1991	31DEC9999	Y	CHOLEGRAM (CHOLANGIOGRAM) percutaneous transhepatic (NR)
61109	01NOV1992	31OCT1997	N	FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R)
61109	01NOV1997	30APR2020	N	FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R)
61109	01MAY2020	31DEC9999	Y	Fluoroscopy in an angiography suite with image intensification, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this Group applies (R)
61110	01JUL2011	31DEC9999	Y	FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R) (NK)
61200	01DEC1991	31DEC9999	Y	Magnetic resonance imaging - examination of any part or parts of the body (R) (HR)
61300	01DEC1991	31DEC9999	Y	NOTE (This note should be read in conjunction with explanatory notes for this Category). Benefits for a nuclear scanning service are only payable when the preliminary examination of the patient, estimation and administration of the dosage and the performance of the scan, are undertaken by a medical practitioner, or on behalf of a medical practitioner in the practitioner's presence, and the compilation of the final report is undertaken by the medical practitioner. Additional benefits will only be attracted for a specialist physician or consultant physician attendance under Category 1 of the Schedule where there is a request for a full medical examination accompanied by a letter or note of referral. MYOCARDIAL PERFUSION STUDY USING THALLIUM single study for stress or reperfusion (R)
61301	01DEC1991	31DEC9999	Y	MYOCARDIAL PERFUSION STUDY USING THALLIUM single study for stress or reperfusion (R)
61302	01NOV1996	31OCT1997	N	NOTE Benefits for a nuclear medicine scanning service are only payable when the preliminary examination of the patient, estimation and administration of the dosage and the performance of the scan, are undertaken by a medical specialist, or on behalf of the medical specialist in the specialist's presence, and the compilation of the report is undertaken by the medical specialist. Additional benefits will only be attracted for a specialist or consultant physician attendance under Category 1 of the Schedule where there is a request for a full medical examination accompanied by a letter or note of referral. SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY with thallium or sestamibi - planar imaging (R)
61302	01NOV1997	30APR2020	N	SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - planar imaging (R)
61302	01MAY2020	31DEC9999	Y	Single stress or rest myocardial perfusion study-planar imaging (R)
61303	01NOV1996	31OCT1997	N	SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY with thallium or sestamibi - with single photon emission tomography and with planar imaging when undertaken (R)
61303	01NOV1997	30APR2020	N	SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - with single photon emission tomography and with planar imaging when undertaken (R)
61303	01MAY2020	31DEC9999	Y	Single stress or rest myocardial perfusion study-with single photon emission tomography and with planar imaging when performed (R)
61304	01DEC1991	31DEC9999	Y	MYOCARDIAL PERFUSION STUDY USING THALLIUM combined study for stress and reperfusion (R)
61305	01DEC1991	31DEC9999	Y	MYOCARDIAL PERFUSION STUDY USING THALLIUM combined study for stress and reperfusion (R)
61306	01NOV1996	31OCT1997	N	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study with thallium or sestamibi, or thallium and sestamibi, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R)
61306	01NOV1997	30APR2020	N	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R)
61306	01MAY2020	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-planar imaging (R)
61307	01NOV1996	31OCT1997	N	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study with thallium or sestamibi, or thallium and sestamibi, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R)
61307	01NOV1997	30APR2020	N	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R)
61307	01MAY2020	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with single photon emission tomography and with planar imaging when performed (R)
61308	01DEC1991	31DEC9999	Y	MYOCARDIAL INFARCTAVID IMAGING STUDY (R)
61309	01DEC1991	31DEC9999	Y	MYOCARDIAL INFARCTAVID IMAGING STUDY (R)
61310	01NOV1996	30APR2020	N	MYOCARDIAL INFARCT-AVID-STUDY, with planar imaging and single photon emission tomography, OR planar imaging or single photon emission tomography (R)
61310	01MAY2020	31DEC9999	Y	Myocardial infarct avid study (R)
61311	14SEP2019	09JAN2020	N	Single stress or rest myocardial perfusion study-with PET (R)
61311	10JAN2020	30NOV2020	N	Single stress or rest myocardial perfusion study-with PET (R) Item 61311 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61311	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with PET if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61394, 61398, 61380, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R)
61311	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with PET if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61394, 61398, 61380, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R) Item 61311 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61312	01DEC1991	31DEC9999	Y	GATED CARDIAC BLOOD POOL (equilibrium) STUDY (R)
61313	01NOV1996	30APR2020	N	GATED CARDIAC BLOOD POOL STUDY, (equilibrium), with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R)
61313	01MAY2020	31DEC9999	Y	Gated cardiac blood pool study, (equilibrium) (R)
61314	01NOV1996	30APR2020	N	GATED CARDIAC BLOOD POOL STUDY, and first pass blood flow or cardiac shunt study, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R)
61314	01MAY2020	31DEC9999	Y	Gated cardiac blood pool study, with or without intervention, and first pass blood flow or cardiac shunt study (R)
61315	01DEC1991	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY with intervention (R)
61316	01NOV1996	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, with intervention, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R)
61317	01NOV1996	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, with intervention and first pass blood flow study or cardiac shunt study, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R)
61318	01DEC1991	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY (not being a service associated with a service to which another item in this Group applies (R)
61319	01DEC1991	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY (not being a service associated with a service to which another item in this Group applies (R)
61320	01NOV1996	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY OR CARDIAC SHUNT STUDY, not being a service to which another item in this Group applies (R)
61321	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2Single rest myocardial perfusion study for the assessment of extent and severity of viable and non-viable myocardium - with single photon emission tomography and with planar imaging, when performed on a patient who has left ventricular systolic dysfunction and probable or confirmed coronary artery disease, if: (a) using a single rest technetium-99m (Tc-99m) protocol; and (b) the service is requested by a specialist or a consultant physician; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61325, 61329 or 61345 applies (R)
61321	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of extent and severity of viable and non-viable myocardium - with single photon emission tomography, which can include planar imaging, when performed on a patient who has left ventricular systolic dysfunction and probable or confirmed coronary artery disease, if: (a) using a single rest technetium-99m (Tc-99m) protocol; and (b) the service is requested by a specialist or a consultant physician; and (c) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61325, 61329, 61345, 61398 or 61406 applies (R)
61321	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses a single rest technetium-99m (Tc-99m) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61325, 61329, 61345, 61398 or 61406 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61321	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses a single rest technetium-99m (Tc-99m) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61325, 61329, 61332, 61345, 61380, 61398, 61406 or 61422 applies; and (e) if the patient is 17 years or older-a service to which this item, or item 61325, 61329, 61332, 61345, 61380, 61398, 61406 or 61422, applies has not been provided to the patient in the previous 24 months (R)
61321	01NOV2023	31DEC9999	Y	Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses a single rest technetium-99m (Tc-99m) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61325, 61329, 61345, 61398 or 61406 applies; and (e) if the patient is 17 years or older-a service to which this item, or item 61325, 61329, 61345, 61398 or 61406 applies has not been provided to the patient in the previous 24 months (R)
61322	01DEC1991	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY being a service associated with a service to which another item in this Group applies (R)
61323	01DEC1991	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY being a service associated with a service to which another item in this Group applies (R)
61324	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1Single stress myocardial perfusion study - with single photon emission tomography and with planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which items 55141, 55143, 55145 or 55146 applies; or (iv) the patient has had an assessment of undue exertional dyspnoea of uncertain aetiology; and (b) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345 or 61357 applies (R)
61324	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study - with single photon emission tomography, which can include planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which items 55141, 55143, 55145 or 55146 applies; and (b) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61324	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61324	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61325, 61329, 61332, 61377, 61345, 61357, 61380, 61394, 61398, 61406, 61414 or 61422 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61311, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61324	01NOV2023	31DEC9999	Y	Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting ECG, continuous ECG monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61329, 61345, 61357, 61394, 61398, 61406, 61410 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61325	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2Single rest myocardial perfusion study for the assessment of extent and severity of viable and non-viable myocardium - with single photon emission tomography and with planar imaging, when performed on a patient with left ventricular systolic dysfunction and probable or confirmed coronary artery disease, if: (a) using an initial rest study followed by redistribution study on the same day; and (b) using a thallous chloride-201 (Tl-201) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61329 or 61345 applies (R)
61325	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of extent and severity of viable and non-viable myocardium - with single photon emission tomography, which can include planar imaging, when performed on a patient with left ventricular systolic dysfunction and probable or confirmed coronary artery disease, if: (a) using an initial rest study followed by redistribution study on the same day; and (b) using a thallous chloride-201 (Tl-201) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61329, 61345, 61398 or 61406 applies (R)
61325	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses: (i) an initial rest study followed by a redistribution study on the same day; and (ii) a thallous chloride-201 (Tl-201) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61329, 61345, 61398 or 61406 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than twice each 24 months. (R)
61325	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses: (i) an initial rest study followed by a redistribution study on the same day; and (ii) a thallous chloride-201 (Tl-201) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61329, 61332, 61345, 61380, 61398, 61406 or 61422 applies; and (e) if the patient is 17 years or older: (i) a service to which item 61321, 61329, 61332, 61345, 61380, 61398, 61406 or 61442, applies has not been provided to the patient in the previous 24 months; and (ii) the service is applicable only twice each 24 months (R)
61325	01NOV2023	31DEC9999	Y	Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with single photon emission tomography, with or without planar imaging, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) the service uses: (i) an initial rest study followed by a redistribution study on the same day; and (ii) a thallous chloride-201 (Tl-201) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61329, 61345, 61398 or 61406 applies; and (e) if the patient is 17 years or older: (i) a service to which item 61321, 61329, 61345, 61398 or 61406 applies has not been provided to the patient in the previous 24 months; and (ii) the service is applicable only twice each 24 months (R)
61326	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY (R)
61327	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY (R)
61328	01NOV1996	30APR2020	N	LUNG PERFUSION STUDY, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R)
61328	01MAY2020	31DEC9999	Y	Lung perfusion study (R)
61329	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which item 55141, 55143, 55145 or 55146 applies; and (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61345 or 61357 applies (R)
61329	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography, which can include planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which item 55141, 55143, 55145 or 55146 applies; and (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61329	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61345, 61357, 61394, 61398, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61329	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406, 61414 or 61422 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61311, 61321, 61324, 61325, 61332, 61345, 61357, 61380, 61394, 61398, 61406, 61414 or 61422, applies has not been provided to the patient in the previous 24 months (R)
61329	01NOV2023	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61345, 61357, 61394, 61398, 61406 or 61414 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61321, 61324, 61325, 61345, 61357, 61394, 61398, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61330	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using Xe127 gas (R)
61331	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using Xe127 gas (R)
61332	14SEP2019	09JAN2020	N	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with PET (R)
61332	10JAN2020	30NOV2020	N	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with PET (R) Item 61332 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61332	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61345, 61357, 61377, 61380, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R)
61332	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61345, 61357, 61377, 61380, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R) Item 61332 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61333	14SEP2019	09JAN2020	N	Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R)
61333	10JAN2020	28FEB2021	N	Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R) Item 61333 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61333	01MAR2021	31OCT2022	N	Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R) Item 61333 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61333	01NOV2022	31DEC9999	Y	Lung ventilation study using Galligas and lung perfusion study using gallium-68 macro aggregated albumin (68Ga-MAA), with PET, if the service is performed because the service to which item 61348 applies cannot be performed due to unavailability of technetium-99m (R)
61334	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using Xe133 gas (R)
61335	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using Xe133 gas (R)
61336	14SEP2019	09JAN2020	N	Cerebral perfusion study, with PET (R)
61336	10JAN2020	28FEB2021	N	Cerebral perfusion study, with PET (R) Item 61336 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61336	01MAR2021	31OCT2022	N	Cerebral perfusion study, with PET (R) Item 61336 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61336	01NOV2022	31DEC9999	Y	Cerebral study, with PET, if the service is performed because the service to which item 61402 applies cannot be performed due to unavailability of technetium-99m (R)
61337	14SEP2019	09JAN2020	N	Bone study-whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61337	10JAN2020	28FEB2021	N	Bone study-whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61337 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61337	01MAR2021	31DEC9999	Y	Bone study-whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61337 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61338	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using aerosol (R)
61339	01DEC1991	31DEC9999	Y	LUNG VENTILATION STUDY using aerosol (R)
61340	01NOV1996	30APR2020	N	LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R)
61340	01MAY2020	31DEC9999	Y	Lung ventilation study using aerosol, technegas or xenon gas (R)
61341	14SEP2019	09JAN2020	N	Bone study-whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61341	10JAN2020	28FEB2021	N	Bone study-whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61341 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61341	01MAR2021	31OCT2022	N	Bone study-whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61341 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61341	01NOV2022	31DEC9999	Y	Bone study - whole body with PET, with delayed imaging when undertaken, if the service is performed because the services to which item 61421 or 61425 apply cannot be performed due to unavailability of technetium-99m (R)
61342	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using either Xe127 or Xe133 gas (R)
61343	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using either Xe127 or Xe133 gas (R)
61344	14SEP2019	09JAN2020	N	Computed tomography performed at the same time and covering the same body area as positron emission tomography covered by items 61311, 61332, 61333, 61336, 61337 and 61341, for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued (R)
61344	10JAN2020	28FEB2021	N	Computed tomography performed at the same time and covering the same body area as positron emission tomography covered by items 61311, 61332, 61333, 61336, 61337 and 61341, for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued (R) Item 61344 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information.
61344	01MAR2021	31DEC9999	Y	Computed tomography performed at the same time and covering the same body area as positron emission tomography covered by items 61311, 61332, 61333, 61336, 61337 and 61341, for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued (R) Item 61344 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61345	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which item 55141, 55143, 55145 or 55146 applies; or (iv) the patient has had an assessment of undue exertional dyspnoea of uncertain aetiology; and (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329 or 61357 applies (R)
61345	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography, which can include planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which item 55141, 55143, 55145 or 55146 applies; and (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a specialist or consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414 applies (R)
61345	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61345	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61357, 61377, 61380, 61394, 61398, 61406, 61414 or 61422 applies (R); and (f) if the patient is 17 years or older-a service to which this item, or item 61311, 61321, 61324, 61325, 61329, 61332, 61357, 61377, 61380, 61394, 61398, 61406, 61414 or 61422, applies has not been provided to the patient in the previous 24 months (R)
61345	01NOV2023	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a specialist or consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414 applies (R); and (f) if the patient is 17 years or older-a service to which this item, or item 61321, 61324, 61325, 61329, 61357, 61394, 61398, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61346	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol (R)
61347	01DEC1991	31DEC9999	Y	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol (R)
61348	01NOV1996	30APR2020	N	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R)
61348	01MAY2020	31DEC9999	Y	Lung perfusion study and lung ventilation study using aerosol, technegas or xenon gas (R)
61349	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with single photon emission tomography and with planar imaging, if: (a) in the previous 24 months, the patient has had a single stress or combined rest and stress myocardial perfusion study performed under item 61324, 61329, 61345 or 61357 and has undergone a revascularisation procedure; and (b) the patient has one or more of the following symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy, where at least one of the following applies; (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under service to which item 55141, 55143, 55145 or 55146 applies; or (iv) the patient has had an assessment of undue exertional dyspnoea of uncertain aetiology; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and For any particular patient, applicable not more than once in 12 months (R)
61349	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with single photon emission tomography, which can include planar imaging, if: (a) in the previous 24 months, the patient has had a single stress or combined rest and stress myocardial perfusion study performed under item 61324, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 and has undergone a revascularisation procedure; and (b) the patient has one or more of the following symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy, where at least one of the following applies; (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under service to which item 55141, 55143, 55145 or 55146 applies; and (c) the service is requested by a specialist or a consultant physician; and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730 or 61410 applies; and For any particular patient, applicable not more than once in 12 months (R)
61349	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) in the previous 24 months, the patient has had a service performed to which item 61324, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730 or 61410 applies Applicable not more than once in 12 months (R)
61349	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) both: (i) a service has been provided to the patient in the previous 24 months to which this item, or item 61311, 61324, 61329, 61332, 61337, 61345, 61357, 61365, 61380, 61394, 61398, 61406, 61410, 61414 or 61418, applies; and (ii) the patient has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61365, 61410 or 61418 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61365, 61410 or 61418, applies has not been provided to the patient in the previous 12 months (R)
61349	01NOV2023	31DEC9999	Y	Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) both: (i) a service has been provided to the patient in the previous 24 months to which this item, or item 61324, 61329, 61345, 61357, 61394, 61398, 61406, 61410 or 61414 applies; and (ii) the patient has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730 or 61410 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61410, applies has not been provided to the patient in the previous 12 months (R)
61350	01DEC1991	31DEC9999	Y	LIVER AND SPLEEN STUDY (colloid) (R)
61351	01DEC1991	31DEC9999	Y	LIVER AND SPLEEN STUDY (colloid) (R)
61352	01NOV1996	31DEC9999	Y	LIVER AND SPLEEN STUDY (colloid) - planar imaging (R)
61353	01NOV1996	30APR2020	N	LIVER AND SPLEEN STUDY (colloid), with single photon emission tomography and with planar imaging when undertaken (R)
61353	01MAY2020	31DEC9999	Y	Liver and spleen study (colloid) (R)
61354	01DEC1991	31DEC9999	Y	RED BLOOD CELL SPLEEN OR LIVER STUDY (R)
61355	01DEC1991	31DEC9999	Y	RED BLOOD CELL SPLEEN OR LIVER STUDY (R)
61356	01NOV1996	30APR2020	N	RED BLOOD CELL SPLEEN OR LIVER STUDY, including single photon emission tomography when undertaken (R)
61356	01MAY2020	31DEC9999	Y	Red blood cell spleen or liver study (R)
61357	01AUG2020	14SEP2020	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1Single stress myocardial perfusion study - with single photon emission tomography and with planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which items 55141, 55143, 55145 or 55146 applies; or (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329 or 61345 applies (R)
61357	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study - with single photon emission tomography, which can include planar imaging, if: (a) the patient has symptoms of cardiac ischaemia where at least one of the following applies: (i) the patient has body habitus or other physical condition/s (including heart rhythm disturbance) to the extent where a stress echocardiography would not provide adequate information; or (ii) the patient is unable to exercise to the extent where a stress echocardiography would not provide adequate information; or (iii) the patient has had a failed stress echocardiography provided under a service to which items 55141, 55143, 55145 or 55146 applies; and (b) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (c) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (d) not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61394, 61398, 61406 or 61414 applies (R)
61357	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which items 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61394, 61398, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61357	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which items 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61377, 61380, 61394, 61398, 61406, 61414 or 61422 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61311, 61324, 61329, 61332, 61345, 61377, 61380, 61394, 61398, 61406, or 61414, applies has not been provided to the patient in the previous 24 months (R)
61357	01NOV2023	31DEC9999	Y	Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) at least one of the following applies: (i) the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; (ii) the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; (iii) the patient has had a failed stress echocardiography provided in a service to which items 55141, 55143, 55145 or 55146 applies; and (c) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (d) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61394, 61398, 61406 or 61414 applies; and (f) if the patient is 17 years or older-a service to which this item, or item 61324, 61329, 61345, 61394, 61398, 61406, or 61414, applies has not been provided to the patient in the previous 24 months (R)
61358	01DEC1991	31DEC9999	Y	HEPATOBILIARY STUDY (R)
61359	01DEC1991	31DEC9999	Y	HEPATOBILIARY STUDY (R)
61360	01NOV1996	26NOV2013	N	HEPATOBILIARY STUDY, including morphine administration or pre-treatment with cholecystokinin (CCK) when undertaken (R)
61360	27NOV2013	30APR2020	N	HEPATOBILIARY STUDY, including morphine administration or pre-treatment with a cholagogue when performed (R) (K)
61360	01MAY2020	31DEC9999	Y	Hepatobiliary study, including morphine administration or pre-treatment with a cholagogue when performed (R)
61361	01NOV1996	26NOV2013	N	HEPATOBILIARY STUDY with formal quantification following baseline imaging, using an infusion of cholecystokinin (CCK) (R)
61361	27NOV2013	30APR2020	N	HEPATOBILIARY STUDY with formal quantification following baseline imaging, using a cholagogue (R) (K)
61361	01MAY2020	31DEC9999	Y	Hepatobiliary study with formal quantification following baseline imaging, using a cholagogue (R)
61362	01DEC1991	31DEC9999	Y	BOWEL HAEMORRHAGE STUDY (R)
61363	01DEC1991	31DEC9999	Y	BOWEL HAEMORRHAGE STUDY (R)
61364	01NOV1996	30APR2020	N	BOWEL HAEMORRHAGE STUDY (R)
61364	01MAY2020	31DEC9999	Y	Bowel haemorrhage study (R)
61365	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61410 or 61418 applies Applicable not more than once in 12 months (R)
61365	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) at least one of the following applies: the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information; the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information; the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61410 or 61418 applies Applicable not more than once in 12 months (R) Item 61365 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61366	01DEC1991	31DEC9999	Y	MECKEL'S DIVERTICULUM STUDY (R)
61367	01DEC1991	31DEC9999	Y	MECKEL'S DIVERTICULUM STUDY (R)
61368	01NOV1996	30APR2020	N	MECKEL'S DIVERTICULUM STUDY (R)
61368	01MAY2020	31DEC9999	Y	Meckels diverticulum study (R)
61369	01NOV1999	31OCT2004	N	INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a) there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination)(R)
61369	01NOV2004	30JUN2010	N	INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a) there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination) (R)
61369	01JUL2010	30APR2020	N	INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a) there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (R)
61369	01MAY2020	31DEC9999	Y	Indium-labelled octreotide study (including single photon emission tomography when undertaken), if:(a) a gastro-entero-pancreatic endocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or(b) both:(i) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified on the basis of conventional techniques; and(ii) the study is to exclude additional disease sites (R)
61370	01DEC1991	31DEC9999	Y	SALIVARY STUDY (R)
61371	01DEC1991	31DEC9999	Y	SALIVARY STUDY (R)
61372	01NOV1996	30APR2020	N	SALIVARY STUDY (R)
61372	01MAY2020	31DEC9999	Y	Salivary study (R)
61373	01NOV1996	30APR2020	N	GASTRO-OESOPHAGEAL REFLUX STUDY, including delayed imaging on a separate occasion when undertaken (R)
61373	01MAY2020	31DEC9999	Y	Gastro-oesophageal reflux study, including delayed imaging on a separate occasion when performed (R)
61374	01DEC1991	31DEC9999	Y	GASTROOESOPHAGEAL REFLUX STUDY (R)
61375	01DEC1991	31DEC9999	Y	GASTROOESOPHAGEAL REFLUX STUDY (R)
61376	01NOV1996	30APR2020	N	OESOPHAGEAL CLEARANCE STUDY (R)
61376	01MAY2020	31DEC9999	Y	Oesophageal clearance study (R)
61377	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61380, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R)
61377	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61380, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R) Item 61377 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61378	01DEC1991	31DEC9999	Y	OESOPHAGEAL CLEARANCE STUDY (R)
61379	01DEC1991	31DEC9999	Y	OESOPHAGEAL CLEARANCE STUDY (R)
61380	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R)
61380	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61394, 61398, 61406, 61414 or 61422 applies Applicable not more than once in 24 months (R) Item 61380 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61381	01NOV1996	30APR2020	N	GASTRIC EMPTYING STUDY, using single tracer (R)
61381	01MAY2020	31DEC9999	Y	Gastric emptying study, using single tracer (R)
61382	01DEC1991	31DEC9999	Y	GASTRIC EMPTYING STUDY using single tracer (R)
61383	01NOV1996	30APR2020	N	COMBINED SOLID AND LIQUID GASTRIC EMPTYING STUDY using dual isotope technique or the same isotope on separate days (R)
61383	01MAY2020	31DEC9999	Y	Combined solid and liquid gastric emptying study using dual isotope technique or the same isotope on separate days (R)
61384	01NOV1996	30APR2020	N	RADIONUCLIDE COLONIC TRANSIT STUDY (R)
61384	01MAY2020	31DEC9999	Y	Radionuclide colonic transit study (R)
61385	01DEC1991	31DEC9999	Y	GASTRIC EMPTYING STUDY using dual tracer (R)
61386	01NOV1996	30APR2020	N	RENAL STUDY, including perfusion and renogram images and computer analysis OR cortical study with planar imaging (R)
61386	01MAY2020	31DEC9999	Y	Renal study, including perfusion and renogram images and computer analysis or cortical study with planar imaging (R)
61387	01NOV1996	30APR2020	N	RENAL CORTICAL STUDY, with single photon emission tomography and planar quantification (R)
61387	01MAY2020	31DEC9999	Y	Renal cortical study, with single photon emission tomography and planar quantification (R)
61388	01DEC1991	31DEC9999	Y	RENAL STUDY WITH OR WITHOUT DYNAMIC FLOW STUDY AND WITH OR WITHOUT COMPUTER EXTRACTION OF functional parameters (R)
61389	01NOV1996	30APR2020	N	SINGLE RENAL STUDY with pre-procedural administration of a diuretic or angiotensin converting enzyme (ACE) inhibitor (R)
61389	01MAY2020	31DEC9999	Y	Single renal study with pre-procedural administration of a diuretic or angiotensin converting enzyme (ACE) inhibitor (R)
61390	01NOV1996	30APR2020	N	RENAL STUDY with diuretic administration following a baseline study (R)
61390	01MAY2020	31DEC9999	Y	Renal study with diuretic administration after a baseline study (R)
61391	01DEC1991	31DEC9999	Y	RENAL STUDY WITH INTERVENTION (R)
61392	01DEC1991	31DEC9999	Y	RENAL STUDY WITH INTERVENTION (R)
61393	01NOV1996	30APR2020	N	COMBINED EXAMINATION INVOLVING A RENAL STUDY following angiotensin converting enzyme (ACE) inhibitor provocation and a baseline study, in either order and related to a single referral episode (R)
61393	01MAY2020	31DEC9999	Y	Combined examination involving a renal study following angiotensin converting enzyme (ACE) inhibitor provocation and a baseline study, in either order and related to a single referral episode (R)
61394	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study - with single photon emission tomography, which can include planar imaging, if: the patient has symptoms of cardiac ischaemia; and the service is provided at, or from, a practice location in: a Modified Monash 3 area; or a Modified Monash 4 area; or a Modified Monash 5 area; or a Modified Monash 6 area; or a Modified Monash 7 area; and a stress echocardiography service is not available in the Modified Monash area where the service is provided; and the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and the service is requested by a specialist or consultant physician; and not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61394	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61398, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61394	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61398, 61406, 61414 or 61422 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61398, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61394	01NOV2023	31DEC9999	Y	Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61398, 61406 or 61414 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61324, 61329, 61345, 61357, 61398, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61395	01DEC1991	31DEC9999	Y	CYSTOURETEROGRAM (R)
61396	01DEC1991	31DEC9999	Y	CYSTOURETEROGRAM (R)
61397	01NOV1996	30APR2020	N	CYSTOURETEROGRAM (R)
61397	01MAY2020	31DEC9999	Y	Cystoureterogram (R)
61398	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography, which can include planar imaging, if: the patient has symptoms of cardiac ischaemia; and the service is provided at, or from, a practice location in: a Modified Monash 3 area; or a Modified Monash 4 area; or a Modified Monash 5 area; or a Modified Monash 6 area; or a Modified Monash 7 area; and a stress echocardiography service is not available in the Modified Monash area where the services is provided; and the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and the service is requested by a medical practitioner (other than a specialist or consultant physician); and not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61398	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61406 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61398	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61406, 61414 or 61422 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61406, 61414 or 61422, applies has not been provided to the patient in the previous 24 months (R)
61398	01NOV2023	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61406 or 61414 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61406 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61399	01DEC1991	31DEC9999	Y	TESTICULAR STUDY (R)
61400	01DEC1991	31DEC9999	Y	TESTICULAR STUDY (R)
61401	01NOV1996	31DEC9999	Y	TESTICULAR STUDY (R)
61402	01NOV1996	31OCT1998	N	BRAIN STUDY USING TC-EXAMETAZINE, with single photon emission tomogrophy and with planar imaging when undertaken (R)
61402	01NOV1998	30APR2020	N	CEREBRAL PERFUSION STUDY, with single photon emission tomography and with planar imaging when undertaken (R)
61402	01MAY2020	31DEC9999	Y	Cerebral perfusion study, with single photon emission tomography and with planar imaging when performed (R)
61403	01DEC1991	31DEC9999	Y	BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT (R)
61404	01DEC1991	31DEC9999	Y	BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT (R)
61405	01NOV1996	31DEC9999	Y	BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R)
61406	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography, which can include planar imaging, if: the patient has symptoms of cardiac ischaemia; and the service is provided at, or from, a practice location in: a Modified Monash 3 area; or a Modified Monash 4 area; or a Modified Monash 5 area; or a Modified Monash 6 area; or a Modified Monash 7 area; and a stress echocardiography service is not available in the Modified Monash area where the services is provided; and the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and the service is requested by a specialist or consultant physician; and not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61406	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398 or 61414 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61406	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61377, 61345, 61357, 61380, 61394, 61398, 61414 or 61422 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61414 or 61422, applies has not been provided to the patient in the previous 24 months (R)
61406	01NOV2023	31DEC9999	Y	Combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a specialist or consultant physician; and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398 or 61414 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398 or 61414, applies has not been provided to the patient in the previous 24 months (R)
61407	01DEC1991	31DEC9999	Y	CEREBROSPINAL FLUID TRANSPORT STUDY (R)
61408	01DEC1991	31DEC9999	Y	CEREBROSPINAL FLUID TRANSPORT STUDY (R)
61409	01NOV1996	30APR2020	N	CEREBRO-SPINAL FLUID TRANSPORT STUDY, with imaging on 2 or more separate occasions (R)
61409	01MAY2020	30JUN2023	N	Cerebro spinal fluid transport study, with imaging on 2 or more separate occasions (R)
61409	01JUL2023	31DEC9999	Y	Cerebro-spinal fluid transport study using technetium 99m, with imaging on 2 or more separate occasions (R)
61410	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion-with single photon emission tomography, which can include planar imaging, if: in the previous 24 months, the patient has had a single stress or combined rest and stress myocardial perfusion study performed under item 61324, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 and has undergone a revascularisation procedure; and the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and the service is provided at, or from, a practice location in: a Modified Monash 3 area; or a Modified Monash 4 area; or a Modified Monash 5 area; or a Modified Monash 6 area; or a Modified Monash 7 area; and a stress echocardiography service is not available in the Modified Monash area where the services is provided; and not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies For any particular patient, applicable not more than once in 12 months (R)
61410	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) in the previous 24 months, the patient has had a service performed to which item 61324, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies, and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies Applicable not more than once in 12 months (R)
61410	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) both: (i) a service has been provided to the patient in the previous 24 months to which this item, or item 61311, 61324, 61329, 61332, 61345, 61349, 61357, 61365, 61377, 61380, 61394, 61398, 61406, 61414 or 61418, applies; and (ii) the patient has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730 or 61418 applies; and (f) if the patient is 17 years or older-a service to which item 61349, 61365 or 61418 applies has not been provided to the patient in the previous 12 months
61410	01NOV2023	31DEC9999	Y	Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with single photon emission tomography, with or without planar imaging, if: (a) both: (i) a service has been provided to the patient in the previous 24 months to which this item, or item 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406 or 61414 applies; and (ii) the patient has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (f) if the patient is 17 years or older-a service to which item 61349 applies has not been provided to the patient in the previous 12 months
61411	01DEC1991	31DEC9999	Y	CEREBROSPINAL FLUID SHUNT PATENCY STUDY (R)
61412	01DEC1991	31DEC9999	Y	CEREBROSPINAL FLUID SHUNT PATENCY STUDY (R)
61413	01NOV1996	30APR2020	N	CEREBRO-SPINAL FLUID SHUNT PATENCY STUDY (R)
61413	01MAY2020	31DEC9999	Y	Cerebro spinal fluid shunt patency study (R)
61414	15SEP2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study - with single photon emission tomography, which can include planar imaging, if: the patient has symptoms of cardiac ischaemia; and the service is provided at, or from, a practice location in: a Modified Monash 3 area; or a Modified Monash 4 area; or a Modified Monash 5 area; or a Modified Monash 6 area; or a Modified Monash 7 area; and a stress echocardiography service is not available in the Modified Monash area where the services is provided; and the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and the service is requested by a medical practitioner (other than a specialist or consultant physician); and not being a service associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398, 61406 or 61414 applies (R)
61414	01MAR2021	30JUN2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398 or 61406 applies Note: this item applies to a service provided to a patient who is 17 years or older not more than once each 24 months. (R)
61414	01JUL2021	31OCT2023	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61422 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61398 or 61406, applies has not been provided to the patient in the previous 24 months (R)
61414	01NOV2023	31DEC9999	Y	Single stress myocardial perfusion study, with single photon emission tomography, with or without planar imaging, if: (a) the patient has symptoms of cardiac ischaemia; and (b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (e) the service is requested by a medical practitioner (other than a specialist or consultant physician); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61321, 61324, 61325, 61329, 61345, 61357, 61394, 61398 or 61406 applies; and (g) if the patient is 17 years or older-a service to which this item, or item 61324, 61329, 61345, 61357, 61398 or 61406, applies has not been provided to the patient in the previous 24 months (R)
61415	01DEC1991	31DEC9999	Y	DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (not being a service associated with a service to which another item in this Group applies) (R)
61416	01DEC1991	31DEC9999	Y	DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (not being a service associated with a service to which another item in this Group applies) (R) (NC)
61417	01NOV1996	31DEC9999	Y	DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY, not being a service associated with a service to which another item in this Group applies (R)
61418	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies, and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (e) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61365 or 61410 applies Applicable not more than once in 12 months (R)
61418	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1 Repeat combined stress and rest, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion, with PET, if: (a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies, and has subsequently undergone a revascularisation procedure; and (b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and (c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and (d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and (e) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and (f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61365 or 61410 applies Applicable not more than once in 12 months (R) Item 61418 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61419	01DEC1991	31DEC9999	Y	BONE STUDY whole body (R)
61420	01DEC1991	31DEC9999	Y	BONE STUDY whole body (R)
61421	01NOV1996	30APR2020	N	BONE STUDY - whole body, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61421	01MAY2020	31DEC9999	Y	Bone study-whole body, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61422	01DEC2020	28FEB2021	N	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with PET, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) technetium is not available and the service uses an equivalent protocol to the single rest technetium-99m (Tc-99m) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies Applicable not more than once in 24 months (R)
61422	01MAR2021	31DEC9999	Y	Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2 Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non-viable myocardium, with PET, if: (a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (b) technetium is not available and the service uses an equivalent protocol to the single rest technetium-99m (Tc-99m) protocol; and (c) the service is requested by a specialist or a consultant physician; and (d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies Applicable not more than once in 24 months (R) Item 61422 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.
61423	01DEC1991	31DEC9999	Y	BONE STUDY whole body and DYNAMIC BLOOD FLOW OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (R)
61424	01DEC1991	31DEC9999	Y	BONE STUDY whole body and DYNAMIC BLOOD FLOW OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (R)
61425	01NOV1996	30APR2020	N	BONE STUDY - whole body and single photon emission tomography, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61425	01MAY2020	31DEC9999	Y	Bone study-whole body and single photon emission tomography, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)
61426	01NOV1996	30APR2020	N	WHOLE BODY STUDY using iodine (R)
61426	01MAY2020	31DEC9999	Y	Whole body study using iodine (R)
61427	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING IODINE (R)
61428	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING IODINE (R)
61429	01NOV1996	30APR2020	N	WHOLE BODY STUDY using gallium (R)
61429	01MAY2020	31DEC9999	Y	Whole body study using gallium (R)
61430	01NOV1996	30APR2020	N	WHOLE BODY STUDY using gallium, with single photon emission tomography (R)
61430	01MAY2020	31DEC9999	Y	Whole body study using gallium, with single photon emission tomography (R)
61431	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING GALLIUM (R)
61432	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING GALLIUM (R)
61433	01NOV1996	30APR2020	N	WHOLE BODY STUDY using cells labelled with technetium (R)
61433	01MAY2020	31DEC9999	Y	Whole body study using cells labelled with technetium (R)
61434	01NOV1996	30APR2020	N	WHOLE BODY STUDY using cells labelled with technetium, with single photon emission tomography (R)
61434	01MAY2020	31DEC9999	Y	Whole body study using cells labelled with technetium, with single photon emission tomography (R)
61435	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING CELLS LABELLED WITH TECHNETIUM (R)
61436	01DEC1991	31DEC9999	Y	WHOLE BODY STUDY USING CELLS LABELLED WITH TECHNETIUM (R)
61437	01NOV1996	31DEC9999	Y	WHOLE BODY STUDY using thallium (R)
61438	01NOV1996	30APR2020	N	WHOLE BODY STUDY using thallium, with single photon emission tomography (R)
61438	01MAY2020	31DEC9999	Y	Whole body study using thallium (R)
61439	01DEC1991	31DEC9999	Y	BONE MARROW STUDY whole body (R)
61440	01DEC1991	31DEC9999	Y	BONE MARROW STUDY whole body (R)
61441	01NOV1996	31OCT1999	N	BONE MARROW STUDY - whole body (R)
61441	01NOV1999	30APR2020	N	BONE MARROW STUDY - whole body using technetium labelled bone marrow agents (R)
61441	01MAY2020	31DEC9999	Y	Bone marrow study-whole body using technetium labelled bone marrow agents (R)
61442	01NOV1997	30APR2020	N	WHOLE BODY STUDY, using gallium - with single photon emission tomography of 2 or more body regions acquired separately (R)
61442	01MAY2020	31DEC9999	Y	Whole body study, using gallium-with single photon emission tomography of 2 or more body regions acquired separately (R)
61443	01DEC1991	31DEC9999	Y	REPEAT OF A WHOLE BODY STUDY on a different occasion using the same administration of radiopharmaceutical (R)
61444	01DEC1991	31DEC9999	Y	REPEAT OF A WHOLE BODY STUDY on a different occasion using the same administration of radiopharmaceutical (R) (NC)
61445	01NOV1999	30APR2020	N	BONE MARROW STUDY - localised using technetium labelled agent (R)
61445	01MAY2020	31DEC9999	Y	Bone marrow study-localised using technetium labelled agent (R)
61446	01NOV1996	30APR2020	N	LOCALISED BONE OR JOINT STUDY, including when undertaken, blood flow, blood pool and repeat imaging on a separate occasion (R)
61446	01MAY2020	31DEC9999	Y	Regional scintigraphic study, using an approved bone scanning agent, including when undertaken, blood flow imaging, blood pool imaging and repeat imaging on a separate occasion (R)
61447	01DEC1991	31DEC9999	Y	LOCALISED BONE OR JOINT STUDY including FLOW AND BLOOD POOL STUDIES (R)
61448	01DEC1991	31DEC9999	Y	LOCALISED BONE OR JOINT STUDY including FLOW AND BLOOD POOL STUDIES (R)
61449	01NOV1996	30APR2020	N	LOCALISED BONE OR JOINT STUDY and single photon emission tomography, including when undertaken, blood flow, blood pool and imaging on a separate occasion (R)
61449	01MAY2020	31DEC9999	Y	Regional scintigraphic study, using an approved bone scanning agent and single photon emission tomography, including when undertaken, blood flow imaging, blood pool imaging and repeat imaging on a separate occasion (R)
61450	01NOV1996	30APR2020	N	LOCALISED STUDY using gallium (R)
61450	01MAY2020	31DEC9999	Y	Localised study using gallium (R)
61451	01DEC1991	31DEC9999	Y	LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using gallium (R)
61452	01DEC1991	31DEC9999	Y	LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using gallium (R)
61453	01NOV1996	30APR2020	N	LOCALISED STUDY using gallium, with single photon emission tomography (R)
61453	01MAY2020	31DEC9999	Y	Localised study using gallium, with single photon emission tomography (R)
61454	01NOV1996	30APR2020	N	LOCALISED STUDY using cells labelled with technetium (R)
61454	01MAY2020	31DEC9999	Y	Localised study using cells labelled with technetium (R)
61455	01DEC1991	31DEC9999	Y	LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using cells labelled with technetium (R)
61456	01DEC1991	31DEC9999	Y	LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using cells labelled with technetium (R)
61457	01NOV1996	30APR2020	N	LOCALISED STUDY using cells labelled with technetium, with single photon emission tomography (R)
61457	01MAY2020	31DEC9999	Y	Localised study using cells labelled with technetium, with single photon emission tomography (R)
61458	01NOV1996	31DEC9999	Y	LOCALISED STUDY using thallium (R)
61459	01DEC1991	31DEC9999	Y	REPEAT OF A LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY on a different occasion using the same administration of radiopharmaceutical (R)
61460	01DEC1991	31DEC9999	Y	REPEAT OF A LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY on a different occasion using the same administration of radiopharmaceutical (R) (NC)
61461	01NOV1996	30APR2020	N	LOCALISED STUDY using thallium, with single photon emission tomography (R)
61461	01MAY2020	31DEC9999	Y	Localised study using thallium (R)
61462	01NOV1996	19JAN1997	N	REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING OR REPEAT PLANAR OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on a separate occasion using the same administration of radiopharmaceutical, not being a service associated with items 61373, 61409, 61421, 61425, 61446, 61449, 61484 or 61485 (R)
61462	20JAN1997	31JAN2009	N	REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R)
61462	01FEB2009	30APR2020	N	REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, 61484 or 61485 where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R)
61462	01MAY2020	31DEC9999	Y	Repeat planar and single photon emission tomography imaging, or repeat planar imaging or single photon emission tomography imaging on an occasion subsequent to the performance of item 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469 or 61485, if there is no additional administration of radiopharmaceutical and if the previous radionuclide scan was abnormal or equivocal (R)
61463	01DEC1991	31DEC9999	Y	VENOGRAPHY (including blood pool study, active uptake study or dynamic blood flow study) (R)
61464	01DEC1991	31DEC9999	Y	VENOGRAPHY (including blood pool study, active uptake study or dynamic blood flow study) (R)
61465	01NOV1996	31DEC9999	Y	VENOGRAPHY (R)
61466	01JUL2023	31DEC9999	Y	Cerebro-spinal fluid transport study using indium-111, with imaging on 2 or more separate occasions (R)
61467	01DEC1991	31DEC9999	Y	LYMPHOSCINTIGRAPHY (R)
61468	01DEC1991	31DEC9999	Y	LYMPHOSCINTIGRAPHY (R)
61469	01NOV1996	30APR2020	N	LYMPHOSCINTIGRAPHY (R)
61469	01MAY2020	31DEC9999	Y	Lymphoscintigraphy (R)
61470	01JUL2023	30JUN2024	N	Whole body or localised study using thallium-201, or single rest myocardial perfusion study using thallium-201, if all of the following apply: (a) The service is bulk billed; (b) The service is performed in conjunction with a service described in items 61438, 61461 or 61325.
61470	01JUL2024	31DEC9999	Y	Whole body or localised study using thallium-201, or single rest myocardial perfusion study using thallium-201, if all of the following apply: a) the service is bulk billed; and b) the service is performed in conjunction with a service described in item 61438, 61461 or 61325
61471	01DEC1991	31DEC9999	Y	THYROID STUDY (R)
61472	01DEC1991	31DEC9999	Y	THYROID STUDY (R)
61473	01NOV1996	30APR2020	N	THYROID STUDY including uptake measurement when undertaken (R)
61473	01MAY2020	31DEC9999	Y	Thyroid study (R)
61475	01DEC1991	31DEC9999	Y	THYROID UPTAKE STUDY PERFORMED ON GAMMA CAMERA (R)
61476	01DEC1991	31DEC9999	Y	THYROID UPTAKE STUDY PERFORMED ON GAMMA CAMERA (R)
61477	08NOV2022	31DEC9999	Y	Whole body or localised study using gallium, if all of the following apply: (a) the service is bulk-billed; (b) the service is performed in conjunction with a service described in items 61429, 61430, 61442, 61450 or 61453
61479	01DEC1991	31DEC9999	Y	PARATHYROID (R)
61480	01NOV1996	30APR2020	N	PARATHYROID STUDY, planar imaging and single photon emission tomography when undertaken (R)
61480	01MAY2020	31DEC9999	Y	Parathyroid study (R)
61482	01DEC1991	31DEC9999	Y	ADRENAL STUDY USING SELENOCHOLESTEROL (R)
61483	01DEC1991	31DEC9999	Y	ADRENAL STUDY USING SELENOCHOLESTEROL (R) (NC)
61484	01NOV1996	31JAN2009	N	ADRENAL STUDY, with imaging on 2 or more separate occasions (R)
61484	01FEB2009	31DEC9999	Y	ADRENAL STUDY (R)
61485	01NOV1996	31JAN2009	N	ADRENAL STUDY, with imaging on 2 or more occasions and renal localisation and single photon emission tomography when undertaken (R)
61485	01FEB2009	30APR2020	N	ADRENAL STUDY, with single photon emission tomography (R)
61485	01MAY2020	31DEC9999	Y	Adrenal study, with single photon emission tomography (R)
61486	01DEC1991	31DEC9999	Y	ADRENAL STUDY (not being a service to which item 61482 or 61483 applies) (R)
61487	01DEC1991	31DEC9999	Y	ADRENAL STUDY (not being a service to which item 61482 or 61483 applies) (R) (NC)
61490	01DEC1991	31DEC9999	Y	SINGLE PHOTON EMISSION TOMOGRAPHY being a service associated with a service to which another item in this Group applies (R)
61493	01DEC1991	31DEC9999	Y	TEAR DUCT STUDY (R)
61494	01DEC1991	31DEC9999	Y	TEAR DUCT STUDY (R)
61495	01NOV1996	30APR2020	N	TEAR DUCT STUDY (R)
61495	01MAY2020	31DEC9999	Y	Tear duct study (R)
61497	01DEC1991	31DEC9999	Y	PARTICLE PERFUSION STUDY (INTRAARTERIAL) OR LE VEEN SHUNT STUDY (R)
61498	01DEC1991	31DEC9999	Y	PARTICLE PERFUSION STUDY (INTRAARTERIAL) OR LE VEEN SHUNT STUDY (R)
61499	01NOV1996	30APR2020	N	PARTICLE PERFUSION STUDY (intra-arterial) or Le Veen shunt study (R)
61499	01MAY2020	31DEC9999	Y	Particle perfusion study (infra arterial) or Le Veen shunt study (R)
61501	01DEC1991	31DEC9999	Y	STUDY OF REGION OR ORGAN not being a service to which another item in this Group applies (R)
61502	01DEC1991	31DEC9999	Y	Study of region or organ not being a service to which another item in this Group applies (R) (NC)
61503	01NOV1996	31DEC9999	Y	STUDY OF REGION OR ORGAN not being a service to which another item in this Group applies (R)
61505	01MAY2007	30APR2020	N	CT scan performed at the same time and covering the same body area as single photon emission tomography for the purpose of anatomic localisation or attenuation correction where no separate diagnostic CT report is issued and only in association with items 61302 - 61650 (R)
61505	01MAY2020	31JUL2020	N	CT scan performed at the same time and covering the same body area as single photon emission tomography or positron emission tomography for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued and only in association with items 61302 to 61647 (R)
61505	01AUG2020	28FEB2021	N	CT scan performed at the same time and covering the same body area as single photon emission tomography or positron emission tomography for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued and only in association with items 61310 to 61647 (R)
61505	01MAR2021	31DEC9999	Y	CT scan performed at the same time and covering the same body area as single photon emission tomography or positron emission tomography for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued and performed in association with a service to which an item in Subgroup 1 or 2 of Group I4 applies (R)
61506	04DEC1999	31DEC9999	Y	Test item reserved for ITEM FEE MAP - DO NOT USE FOR ANY PROCEDURE
61507	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61508	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61509	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61510	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61511	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61512	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61513	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61514	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61515	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61516	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61517	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61518	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61519	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61520	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61521	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61522	01OCT1997	31DEC9999	Y	POSITRON EMISSION TOMOGRAPHY - location specific
61523	01OCT2001	21DEC2005	N	Whole body FDG PET study, performed for evaluation of a solitary pulmonary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration, or for which an attempt at pathological characterisation has failed.
61523	22DEC2005	31DEC9999	Y	Whole body FDG PET study, performed for evaluation of a solitary pulmonary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration biopsy, or for which an attempt at pathological characterisation has failed.(R)
61524	01NOV2019	31DEC9999	Y	Whole body FDG PET study, performed for the staging of locally advanced (Stage III) breast cancer, for a patient who is considered suitable for active therapy (R)
61525	01NOV2019	31DEC9999	Y	Whole body FDG PET study, performed for the evaluation of suspected metastatic or suspected locally or regionally recurrent breast carcinoma, for a patient who is considered suitable for active therapy (R)
61526	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for evaluation of a solitary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration, or for which an attempt at pathological characterisation has failed, with catheterisation of the bladder
61527	01AUG2022	31DEC9999	Y	Whole body study using PET, if the service is performed because the services to which items 61429, 61430, 61442, 61450 or 61453 apply cannot be performed due to unavailability of gallium-67 (R)
61529	01OCT2001	21DEC2005	N	Whole body FDG PET study, performed for the primary staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned
61529	22DEC2005	31DEC9999	Y	Whole body FDG PET study, performed for the staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned (R)
61532	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the primary staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned, with catheterisation of the bladder
61535	01OCT2001	31DEC9999	Y	FDG PET study of the brain performed for the evaluation of a suspected primary brain tumour to guide surgical biopsy of the lesion and to assist in treatment planning
61538	01OCT2001	30JUN2011	N	FDG PET study of the brain performed for the evaluation of a residual structural brain lesion based on anatomical imaging findings, after definitive therapy for glioma
61538	01JUL2011	31DEC9999	Y	FDG PET study of the brain for evaluation of suspected residual or recurrent malignant brain tumour based on anatomical imaging findings, after definitive therapy (or during ongoing chemotherapy) in patients who are considered suitable for further active therapy. (R)
61541	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed in a symptomatic patient for the evaluation of a residual structural lesion, after definitive therapy for colorectal cancer
61541	01DEC2008	30JUN2011	N	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy
61541	01JUL2011	31DEC9999	Y	Whole body FDG PET study, following initial therapy, for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy (R)
61544	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed in a symptomatic patient for the evaluation of a residual structural lesion after definitive therapy for colorectal cancer, with catheterisation of the bladder
61544	01DEC2008	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy, with catheterisation of the bladder.
61547	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the evaluation of apparently isolated liver or pulmonary metastases, following previous therapy for colorectal carcinoma, where surgical resection is planned
61550	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the evaluation of apparently isolated liver or pulmonary metastases, following previous therapy for colorectal carcinoma, where surgical resection is planned, with catheterisation of the bladder
61553	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed for the evaluation of apparently limited metastatic disease from malignant melanoma, where surgical resection is planned
61553	01DEC2008	30JUN2011	N	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy
61553	01JUL2011	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy (R)
61556	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed for the evaluation of apparently limited metastatic disease from malignant melanoma, where surgical resection is planned, with catheterisation of the bladder
61556	01DEC2008	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy, with catheterisation of the bladder
61559	01OCT2001	21DEC2005	N	FDG PET study of the brain, performed for the evaluation of refractory epilepsy which is being evaluated for surgery, where results of standard assessment are inconclusive for localisation of the epileptogenic focus
61559	22DEC2005	31DEC9999	Y	FDG PET study of the brain, performed for the evaluation of refractory epilepsy which is being evaluated for surgery (R)
61560	01NOV2021	31DEC2021	N	FDG PET study of the brain, performed for the diagnosis of Alzheimers disease, if: clinical evaluation of the patient by a specialist, or in consultation with a specialist, is equivocal; and the service includes a quantitative comparison of the results of the study with the results of an FDG PET study of a normal brain from a reference database; and a service to which this item applies has not been performed on the patient in the previous 12 months; and a service to which item 61402 applies has not been performed on the patient in the previous 12 months for the diagnosis or management of Alzheimers disease Applicable not more than 3 times per lifetime
61560	01JAN2022	31DEC9999	Y	FDG PET study of the brain, performed for the diagnosis of Alzheimers disease, if: clinical evaluation of the patient by a specialist, or in consultation with a specialist, is equivocal; and the service includes a quantitative comparison of the results of the study with the results of an FDG PET study of a normal brain from a reference database; and a service to which this item applies has not been performed on the patient in the previous 12 months; and a service to which item 61402 applies has not been performed on the patient in the previous 12 months for the diagnosis or management of Alzheimers disease Applicable not more than 3 times per lifetime (R)
61562	01OCT2001	31DEC9999	Y	FDG PET study of the heart, performed for the evaluation of ischaemic heart disease and impaired left ventricular function, where revascularisation surgery is being considered and standard myocardial viability tests are negative or equivocal for ischaemia
61563	01JUL2022	31DEC9999	Y	Whole body prostate-specific membrane antigen PET study performed for the initial staging of intermediate to high-risk prostate adenocarcinoma, for a previously untreated patient who is considered suitable for locoregional therapy with curative intent Applicable once per lifetime (R)
61564	01JUL2022	31DEC9999	Y	Whole body prostate-specific membrane antigen PET study performed for the restaging of recurrent prostate adenocarcinoma, for a patient who:(a) has undergone prior locoregional therapy; and(b) is considered suitable for further locoregional therapy to determine appropriate therapeutic pathways and timing of treatment initiation Applicable twice per lifetime (R)
61565	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed for the evaluation of epithelial ovarian carcinoma with suspected tumour recurrence following initial therapy, based on equivocal anatomical imaging findings or an elevation of CA-125
61565	01DEC2008	30JUN2011	N	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy.
61565	01JUL2011	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. (R)
61568	01OCT2001	30NOV2008	N	Whole body FDG PET study, performed for the evaluation of epithelial ovarian carcinoma with suspected tumour recurrence following initial therapy, based on equivocal anatomical imaging findings or an elevation of CA-125, with catheterisation of the bladder
61568	01DEC2008	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy with curative intent, with catheterisation of the bladder.
61571	01OCT2001	30JUN2011	N	Whole body FDG PET study, performed for the primary staging of proven carcinoma of the uterine cervix, prior to planned radical radiation therapy or combined modality therapy
61571	01JUL2011	31DEC9999	Y	Whole body FDG PET study, for the further primary staging of patients with histologically proven carcinoma of the uterine cervix, at FIGO stage IB2 or greater by conventional staging, prior to planned radical radiation therapy or combined modality therapy with curative intent. (R)
61574	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the primary staging of proven carcinoma of the uterine cervix, prior to planned radical radiation therapy or combined modality therapy, with catheterisation of the bladder
61575	01JUL2011	31DEC9999	Y	Whole body FDG PET study, for the further staging of patients with confirmed local recurrence of carcinoma of the uterine cervix considered suitable for salvage pelvic chemoradiotherapy or pelvic exenteration with curative intent. (R)
61577	01OCT2001	31AUG2009	N	Whole body FDG PET study, performed for the staging of proven oesophageal carcinoma, where curative surgery or chemoradiation is planned
61577	01SEP2009	31DEC9999	Y	Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy (R).
61580	01OCT2001	31AUG2009	N	Whole body FDG PET study, performed for the staging of proven oesophageal carcinoma, where curative surgery or chemoradiation is planned, with catheterisation of the bladder
61580	01SEP2009	31DEC9999	Y	Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy, with catheterisation of the bladder (R).
61583	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the staging of proven gastric carcinoma, where curative surgery is planned
61586	01OCT2001	31DEC9999	Y	Whole body FDG PET study, performed for the staging of proven gastric carcinoma, where curative surgery is planned, with catheterisation of the bladder
61589	01OCT2001	31DEC9999	Y	FDG PET study for follow-up of a cancer shown to be positive by an earlier FDG PET service (the earlier service), if (a) the earlier service was eligible for Medicare benefit because of Health Insurance Determination HS/3/1997, (B) the service is not eligible for Medicare benefit otherwise than because of Health Insurance Determination HS/02/2001, and (c) the service is required to assess response to treatment or possible tumour recurrence
61592	01OCT2001	31DEC9999	Y	FDG PET study, with catheterisation of the bladder, for follow-up of a cancer shown to be positive by an earlier FDG PET service (the earlier service), if (a) the earlier service was eligible for Medicare benefit because of Health Insurance Determination HS/3/1997, (B) the service is not eligible for Medicare benefit otherwise than because of Health Insurance Determination HS/02/2001, and (c) the service is required to assess response to treatment or possible tumour recurrence
61595	14JAN2002	31DEC9999	Y	FDG PET study for the primary staging of carcinoma of the head and neck
61598	14JAN2002	31AUG2009	N	Whole body FDG PET study for the primary staging of carcinoma of the head and neck
61598	01SEP2009	31DEC9999	Y	Whole body FDG PET study performed for the staging of biopsy-proven newly diagnosed or recurrent head and neck cancer (R).
61601	14JAN2002	31DEC9999	Y	FDG PET study for the further investigation of suspected residual or recurrent carcinoma of the head and neck
61604	14JAN2002	31AUG2009	N	Whole body FDG PET study for the further investigation of suspected residual or recurrent carcinoma of the head and neck
61604	01SEP2009	31DEC9999	Y	Whole body FDG PET study performed for the evaluation of patients with suspected residual head and neck cancer after definitive treatment, and who are suitable for active therapy (R).
61607	14JAN2002	31DEC9999	Y	FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site
61610	14JAN2002	31AUG2009	N	Whole body FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site
61610	01SEP2009	31DEC9999	Y	Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma of unknown primary site involving cervical nodes (R).
61612	01NOV2022	31DEC9999	Y	Whole body FDG PET study for the initial staging of eligible cancer types, for a patient who is considered suitable for active therapy, if: (a) the eligible cancer type is: (i) a rare or uncommon cancer (less than 12 cases per 100,000 persons per year); and (ii) a typically FDG-avid cancer; and (b) there is at least a 10% likelihood that the PET study result will inform a significant change in management for the patient Applicable once per cancer diagnosis (R)
61613	14JAN2002	31AUG2009	N	Whole body FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site, with catherterisation of the bladder
61613	01SEP2009	31DEC9999	Y	Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma from an unknown primary site involving cervical nodes, with catherterisation of the bladder (R).
61614	01NOV2024	31DEC9999	Y	Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent cancer in a patient who is undergoing, or is suitable for, active therapy, if the cancer is:(a) a rare or uncommon cancer (less than 12 cases per 100,000 persons per year); and(b) a typically FDG-avid cancer (R)
61616	14JAN2002	30JUN2011	N	Whole body FDG PET study for staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma
61616	01JUL2011	31DEC9999	Y	Whole body FDG PET study for the initial staging of indolent non-Hodgkin's lymphoma where clinical, pathological and imaging findings indicate that the stage is I or IIA and the proposed management is definitive radiotherapy with curative intent. (R)
61619	14JAN2002	31DEC9999	Y	Whole body FDG PET study for staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder
61620	01JUL2011	31OCT2017	N	Whole body FDG PET study for the initial staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma. (R)
61620	01NOV2017	31DEC9999	Y	Whole body FDG PET study for the initial staging of newly diagnosed or previously untreated Hodgkin or non-Hodgkin lymphoma (R)
61622	14JAN2002	30JUN2011	N	Whole body FDG PET study for evaluation of a residual mass after treatment of Hodgkin's or non-Hodgkin's lymphoma
61622	01JUL2011	31OCT2017	N	Whole body FDG PET study to assess response to first line therapy either during treatment or within three months of completing definitive first line treatment for Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma), (R)
61622	01NOV2017	31DEC9999	Y	Whole body FDG PET study to assess response to first line therapy either during treatment or within three months of completing definitive first line treatment for Hodgkin or non-Hodgkin lymphoma (R)
61625	14JAN2002	31DEC9999	Y	Whole body FDG PET study for evaluation of a residual mass after treatment of Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder
61628	14JAN2002	30JUN2011	N	Whole body FDG PET study for restaging of suspected recurrent or residual Hodgkin's or non-Hodgkin's lymphoma
61628	01JUL2011	31OCT2017	N	Whole body FDG PET study for restaging following confirmation of recurrence of Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma). (R)
61628	01NOV2017	31DEC9999	Y	Whole body FDG PET study for restaging following confirmation of recurrence of Hodgkin or non-Hodgkin lymphoma (R)
61631	14JAN2002	31DEC9999	Y	Whole body FDG PET study for restaging of suspected recurrent or residual Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder
61632	01JUL2011	31OCT2017	N	Whole body FDG PET study to assess response to second-line chemotherapy when stem cell transplantation is being considered, for Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma). (R)
61632	01NOV2017	31DEC9999	Y	Whole body FDG PET study to assess response to second-line chemotherapy if haemopoietic stem cell transplantation is being considered for Hodgkin or non-Hodgkin lymphoma (R)
61634	14JAN2002	31DEC9999	Y	Whole body FDG PET study to guide biopsy of a suspected bone or soft tissue sarcoma, where structural imaging suggests lesional heterogeneity
61637	14JAN2002	31DEC9999	Y	Whole body FDG PET study to guide biopsy of a suspected bone or soft tissue sarcoma, where structural imaging suggests lesional heterogeneity, with catheterisation of the bladder
61640	14JAN2002	30JUN2011	N	Whole body FDG PET study for staging of biopsy-proven bone or soft tissue sarcoma being considered for resection of the primary or limited metastatic disease
61640	01JUL2011	31DEC9999	Y	Whole body FDG PET study for initial staging of patients with biopsy-proven bone or soft tissue sarcoma (excluding gastrointestinal stromal tumour) considered by conventional staging to be potentially curable. (R)
61643	14JAN2002	31DEC9999	Y	Whole body FDG PET study for staging of biopsy-proven bone or soft tissue sarcoma being considered for resection of the primary or limited metastatic disease, with catheterisation of the bladder
61644	01APR2022	30JUN2023	N	Single rest myocardial perfusion study for the assessment of the extent and severity of non-viable myocardium, with PET, if: (a) the service is performed because the service to which item 61325 applies cannot be performed due to unavailability of thallous chloride 201 (Tl-201); and (b) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (c) the service is performed in conjunction with a rest myocardial perfusion study using technetium-99m; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (f) this service and item 61325 are applicable only twice each 24 months (R) Item 61644 is a substitute item that may only be used during periods of national shortage of Tl-201. See IN.4.4 of explanatory notes to this Category for further information.
61644	01JUL2023	31DEC9999	Y	Single rest myocardial perfusion study for the assessment of the extent and severity of non-viable myocardium, with PET, if: (a) the service is performed because the service to which item 61325 applies cannot be performed due to unavailability of thallous chloride 201 (Tl-201); and (b) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and (c) the service is performed in conjunction with a rest myocardial perfusion study using technetium-99m; and (d) the service is requested by a specialist or a consultant physician; and (e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729 or 11730 applies; and (f) this service and item 61325 are applicable only twice each 24 months (R)
61646	14JAN2002	30JUN2011	N	Whole body FDG PET study for the evaluation of suspected residual or recurrent sarcoma on structural imaging after definitive therapy
61646	01JUL2011	31DEC9999	Y	Whole body FDG PET study for the evaluation of patients with suspected residual or recurrent sarcoma (excluding gastrointestinal stromal tumour) after the initial course of definitive therapy to determine suitability for subsequent therapy with curative intent. (R)
61647	01MAY2018	30APR2020	N	Whole body 68Ga-DOTA-peptide PET study (including any associated computed tomography scans for anatomic localisation and attenuation correction), if: (a) a gastro-entero-pancreatic neuroendocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or (b) both: (i) a surgically amenable gastro-entero-pancreatic neuroendocrine tumour has been identified on the basis of conventional techniques; and (ii) the study is for excluding additional disease sites (R)
61647	01MAY2020	31DEC9999	Y	Whole body 68Ga DOTA peptide PET study, if:(a) a gastro entero pancreatic neuroendocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or(b) both:(i) a surgically amenable gastro entero pancreatic neuroendocrine tumour has been identified on the basis of conventional techniques; and(ii) the study is for excluding additional disease sites (R)
61649	14JAN2002	31DEC9999	Y	Whole body FDG PET study for the evaluation of suspected residual or recurrent sarcoma on structural imaging after definitive therapy, with catheterisation of the bladder
61650	01JUN2004	30JUN2010	N	LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (Ministerial Determination) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection
61650	01JUL2010	30APR2020	N	LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (R) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection
61650	01MAY2020	31DEC9999	Y	LeukoScan study of the long bones and feet for suspected osteomyelitis, if:(a) the patient does not have access to ex vivo white blood cell scanning; and(b) the patient is not being investigated for other sites of infection (R)
61651	01JUL2011	31DEC9999	Y	SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - planar imaging (R) (NK)
61652	01JUL2011	31DEC9999	Y	SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - with single photon emission tomography and with planar imaging when undertaken (R) (NK)
61653	01JUL2011	31DEC9999	Y	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R) (NK)
61654	01JUL2011	31DEC9999	Y	COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R) (NK)
61655	01JUL2011	31DEC9999	Y	MYOCARDIAL INFARCT-AVID-STUDY, with planar imaging and single photon emission tomography, OR planar imaging or single photon emission tomography (R) (NK)
61656	01JUL2011	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, (equilibrium), with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R) (NK)
61657	01JUL2011	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, and first pass blood flow or cardiac shunt study, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK)
61658	01JUL2011	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, with intervention, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK)
61659	01JUL2011	31DEC9999	Y	GATED CARDIAC BLOOD POOL STUDY, with intervention and first pass blood flow study or cardiac shunt study, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) (NK)
61660	01JUL2011	31DEC9999	Y	CARDIAC FIRST PASS BLOOD FLOW STUDY OR CARDIAC SHUNT STUDY, not being a service to which another item in this Group applies (R) (NK)
61661	01JUL2011	31DEC9999	Y	LUNG PERFUSION STUDY, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) (NK)
61662	01JUL2011	31DEC9999	Y	LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R) (NK)
61663	01JUL2011	31DEC9999	Y	LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK)
61664	01JUL2011	31DEC9999	Y	LIVER AND SPLEEN STUDY (colloid) - planar imaging (R) (NK)
61665	01JUL2011	31DEC9999	Y	LIVER AND SPLEEN STUDY (colloid), with single photon emission tomography and with planar imaging when undertaken (R) (NK)
61666	01JUL2011	31DEC9999	Y	RED BLOOD CELL SPLEEN OR LIVER STUDY, including single photon emission tomography when undertaken (R) (NK)
61667	01JUL2011	26NOV2013	N	HEPATOBILIARY STUDY, including morphine administration or pre-treatment with cholecystokinin (CCK) when undertaken (R) (NK)
61667	27NOV2013	31DEC9999	Y	HEPATOBILIARY STUDY, including morphine administration or pre-treatment with a cholagogue when performed (R) (NK)
61668	01JUL2011	26NOV2013	N	HEPATOBILIARY STUDY with formal quantification following baseline imaging, using an infusion of cholecystokinin (CCK) (R) (NK)
61668	27NOV2013	31DEC9999	Y	HEPATOBILIARY STUDY with formal quantification following baseline imaging, using a cholagogue (R) (NK)
61669	01JUL2011	31DEC9999	Y	BOWEL HAEMORRHAGE STUDY (R) (NK)
61670	01JUL2011	31DEC9999	Y	MECKEL'S DIVERTICULUM STUDY (R) (NK)
61671	01JUL2011	31DEC9999	Y	INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a) there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination) (R) (NK)
61672	01JUL2011	31DEC9999	Y	SALIVARY STUDY (R) (NK)
61673	01JUL2011	31DEC9999	Y	GASTRO-OESOPHAGEAL REFLUX STUDY, including delayed imaging on a separate occasion when undertaken (R) (NK)
61674	01JUL2011	31DEC9999	Y	OESOPHAGEAL CLEARANCE STUDY (R) (NK)
61675	01JUL2011	31DEC9999	Y	GASTRIC EMPTYING STUDY, using single tracer (R) (NK)
61676	01JUL2011	31DEC9999	Y	COMBINED SOLID AND LIQUID GASTRIC EMPTYING STUDY using dual isotope technique or the same isotope on separate days (R) (NK)
61677	01JUL2011	31DEC9999	Y	RADIONUCLIDE COLONIC TRANSIT STUDY (R) (NK)
61678	01JUL2011	31DEC9999	Y	RENAL STUDY, including perfusion and renogram images and computer analysis OR cortical study with planar imaging (R) (NK)
61679	01JUL2011	31DEC9999	Y	RENAL CORTICAL STUDY, with single photon emission tomography and planar quantification (R) (NK)
61680	01JUL2011	31DEC9999	Y	SINGLE RENAL STUDY with pre-procedural administration of a diuretic or angiotensin converting enzyme (ACE) inhibitor (R) (NK)
61681	01JUL2011	31DEC9999	Y	RENAL STUDY with diuretic administration following a baseline study (R) (NK)
61682	01JUL2011	31DEC9999	Y	COMBINED EXAMINATION INVOLVING A RENAL STUDY following angiotensin converting enzyme (ACE) inhibitor provocation and a baseline study, in either order and related to a single referral episode (R) (NK)
61683	01JUL2011	31DEC9999	Y	CYSTOURETEROGRAM (R) (NK)
61684	01JUL2011	31DEC9999	Y	TESTICULAR STUDY (R) (NK)
61685	01JUL2011	31DEC9999	Y	CEREBRAL PERFUSION STUDY, with single photon emission tomography and with planar imaging when undertaken (R) (NK)
61686	01JUL2011	31DEC9999	Y	BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK)
61687	01JUL2011	31DEC9999	Y	CEREBRO-SPINAL FLUID TRANSPORT STUDY, with imaging on 2 or more separate occasions (R) (NK)
61688	01JUL2011	31DEC9999	Y	CEREBRO-SPINAL FLUID SHUNT PATENCY STUDY (R) (NK)
61689	01JUL2011	31DEC9999	Y	DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY, not being a service associated with a service to which another item in this Group applies (R) (NK)
61690	01JUL2011	31DEC9999	Y	BONE STUDY - whole body, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) (NK)
61691	01JUL2011	31DEC9999	Y	BONE STUDY - whole body and single photon emission tomography, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) (NK)
61692	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using iodine (R) (NK)
61693	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using gallium (R) (NK)
61694	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using gallium, with single photon emission tomography (R) (NK)
61695	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using cells labelled with technetium (R) (NK)
61696	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using cells labelled with technetium, with single photon emission tomography (R) (NK)
61697	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using thallium (R) (NK)
61698	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY using thallium, with single photon emission tomography (R) (NK)
61699	01JUL2011	31DEC9999	Y	BONE MARROW STUDY - whole body using technetium labelled bone marrow agents (R) (NK)
61700	01JUL2011	31DEC9999	Y	WHOLE BODY STUDY, using gallium - with single photon emission tomography of 2 or more body regions acquired separately (R) (NK)
61701	01JUL2011	31DEC9999	Y	BONE MARROW STUDY - localised using technetium labelled agent (R) (NK)
61702	01JUL2011	31DEC9999	Y	LOCALISED BONE OR JOINT STUDY, including when undertaken, blood flow, blood pool and repeat imaging on a separate occasion (R) (NK)
61703	01JUL2011	31DEC9999	Y	LOCALISED BONE OR JOINT STUDY and single photon emission tomography, including when undertaken, blood flow, blood pool and imaging on a separate occasion (R) (NK)
61704	01JUL2011	31DEC9999	Y	LOCALISED STUDY using gallium (R) (NK)
61705	01JUL2011	31DEC9999	Y	LOCALISED STUDY using gallium, with single photon emission tomography (R) (NK)
61706	01JUL2011	31DEC9999	Y	LOCALISED STUDY using cells labelled with technetium (R) (NK)
61707	01JUL2011	31DEC9999	Y	LOCALISED STUDY using cells labelled with technetium, with single photon emission tomography (R) (NK)
61708	01JUL2011	31DEC9999	Y	LOCALISED STUDY using thallium (R) (NK)
61709	01JUL2011	31DEC9999	Y	LOCALISED STUDY using thallium, with single photon emission tomography (R) (NK)
61710	01JUL2011	31DEC9999	Y	REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, 61484, 61485, 61669, 61692, 61693, 61694, 61700, 61704, 61705, 61712, 61715 or 61716 where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R) (NK)
61711	01JUL2011	31DEC9999	Y	VENOGRAPHY (R) (NK)
61712	01JUL2011	31DEC9999	Y	LYMPHOSCINTIGRAPHY (R) (NK)
61713	01JUL2011	31DEC9999	Y	THYROID STUDY including uptake measurement when undertaken (R) (NK)
61714	01JUL2011	31DEC9999	Y	PARATHYROID STUDY, planar imaging and single photon emission tomography when undertaken (R) (NK)
61715	01JUL2011	31DEC9999	Y	ADRENAL STUDY (R) (NK)
61716	01JUL2011	31DEC9999	Y	ADRENAL STUDY, with single photon emission tomography (R) (NK)
61717	01JUL2011	31DEC9999	Y	TEAR DUCT STUDY (R) (NK)
61718	01JUL2011	31DEC9999	Y	PARTICLE PERFUSION STUDY (intra-arterial) or Le Veen shunt study (R) (NK)
61719	01JUL2011	31DEC9999	Y	CT scan performed at the same time and covering the same body area as single photon emission tomography for the purpose of anatomic localisation or attenuation correction where no separate diagnostic CT report is issued and only in association with items 61302 - 61729 (R) (NK)
61729	01JUL2011	31DEC9999	Y	LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (Ministerial Determination) (NK) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection
63000	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included in Subgroup 1 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for the exclusion of: - tumour of the brain or meninges (R) (Anaes.)
63001	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - tumour of the brain or meninges (R) (Contrast)
63001	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for tumour of the brain or meninges (R) (Anaes.) (Contrast)
63002	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for tumour of the brain or meninges (R) (Contrast)
63003	01SEP1998	31DEC9999	Y	- skull base or orbital tumour (R) (Anaes.)
63004	01AUG2004	30APR2020	N	- inflammation of the brain or meninges (R) (Contrast)
63004	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for inflammation of brain or meninges (R) (Anaes.) (Contrast)
63005	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for inflammation of brain or meninges (R) (Contrast)
63006	01SEP1998	31DEC9999	Y	- acoustic neuroma (R) (Anaes.)
63007	01AUG2004	30APR2020	N	- skull base or orbital tumour (R) (Contrast)
63007	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for skull base or orbital tumour (R) (Anaes.) (Contrast)
63008	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for skull base or orbital tumour (R) (Contrast)
63009	01SEP1998	31DEC9999	Y	- pituitary tumour (R) (Anaes.)
63010	01AUG2004	30APR2020	N	- stereotactic scan of brain, with Fiducials in place, for the sole purpose to allow planning for stereotactic neurosurgery (R) (Contrast)
63010	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for stereotactic scan of brain, with fiducials in place, for the sole purpose of allowing planning for stereotactic neurosurgery (R) (Anaes.) (Contrast)
63011	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for stereotactic scan of brain, with fiducials in place, for the sole purpose of allowing planning for stereotactic neurosurgery (R) (Contrast)
63012	01SEP1998	31DEC9999	Y	- inflammation of brain or meninges (R) (Anaes.)
63013	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - tumour of the brain or meninges (R) (NK) (Contrast)
63014	01JUL2011	31DEC9999	Y	- inflammation of the brain or meninges (R) (NK) (Contrast)
63015	01SEP1998	31DEC9999	Y	- toxic or metabolic or ischaemic encephalopathy (R) (Anaes.)
63016	01JUL2011	31DEC9999	Y	- skull base or orbital tumour (R) (NK) (Contrast)
63017	01JUL2011	31DEC9999	Y	- stereotactic scan of brain, with Fiducials in place, for the sole purpose to allow planning for stereotactic neurosurgery (R) (NK) (Contrast)
63018	01SEP1998	31DEC9999	Y	- demyelinating disease of the brain (R) (Anaes.)
63019	01MAR2024	31DEC9999	Y	MRI-scan of head (including MRA if performed) for the assessment of suitability for the treatment of medically refractory essential tremor with magnetic resonance imaging-guided focused ultrasound Applicable once per patient per lifetime (R) (Contrast)
63020	01MAR2024	31DEC9999	Y	MRI-scan of head (including MRA if performed) for the post-procedure assessment of the patient following magnetic resonance imaging-guided focused ultrasound for the treatment of medically refractory essential tremor Applicable once per patient per lifetime (R) (Contrast)
63021	01SEP1998	31DEC9999	Y	- congenital malformation of brain or meninges (R)
63024	01SEP1998	31DEC9999	Y	- venous sinus thrombosis (R) (Anaes.)
63040	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 2 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - acoustic neuroma (R) (Contrast)
63040	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for acoustic neuroma (R) (Anaes.) (Contrast)
63041	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for acoustic neuroma (R) (Contrast)
63042	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for pituitary tumour (R) (Contrast)
63043	01AUG2004	30APR2020	N	- pituitary tumour (R) (Contrast)
63043	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for pituitary tumour (R) (Anaes.) (Contrast)
63044	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for toxic or metabolic or ischaemic encephalopathy (R) (Contrast)
63045	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for demyelinating disease of the brain (R) (Contrast)
63046	01AUG2004	30APR2020	N	- toxic or metabolic or ischaemic encephalopathy (R) (Contrast)
63046	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for toxic or metabolic or ischaemic encephalopathy (R) (Anaes.) (Contrast)
63047	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for congenital malformation of the brain or meninges (R) (Contrast)
63048	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for venous sinus thrombosis (R) (Contrast)
63049	01AUG2004	30APR2020	N	- demyelinating disease of the brain (R) (Contrast)
63049	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for demyelinating disease of the brain (R) (Anaes.) (Contrast)
63050	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 2 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for the exclusion of: - tumour of the central nervous system or meninges (R) (Anaes.)
63051	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for head trauma (R) (Contrast)
63052	01AUG2004	30APR2020	N	- congenital malformation of the brain or meninges (R) (Contrast)
63052	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for congenital malformation of the brain or meninges (R) (Anaes.) (Contrast)
63053	01SEP1998	31DEC9999	Y	- inflammation of the central nervous system or meninges (R) (Anaes.)
63054	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for epilepsy (R) (Contrast)
63055	01AUG2004	30APR2020	N	- venous sinus thrombosis (R) (Contrast)
63055	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for venous sinus thrombosis (R) (Anaes.) (Contrast)
63056	01SEP1998	31DEC9999	Y	- demyelinating disease of the central nervous system (R) (Anaes.)
63057	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for stroke (R) (Contrast)
63058	01AUG2004	30APR2020	N	- head trauma (R) (Contrast)
63058	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for head trauma (R) (Anaes.) (Contrast)
63059	01SEP1998	31DEC9999	Y	- congenital malformation of the central nervous system or meninges (R) (Anaes.)
63060	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for carotid or vertebral artery dissection (R) (Contrast)
63061	01AUG2004	30APR2020	N	- epilepsy (R) (Contrast)
63061	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for epilepsy (R) (Anaes.) (Contrast)
63062	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63063	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for intracranial aneurysm (R) (Contrast)
63064	01AUG2004	30APR2020	N	- stroke (R) (Contrast)
63064	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for stroke (R) (Anaes.) (Contrast)
63065	01JUL2006	31DEC9999	Y	MRI - scan of head (including MRA, if performed) for intracranial arteriovenous malformation (R) (Contrast)
63067	01AUG2004	30APR2020	N	- carotid or vertebral artery desection (R) (Contrast)
63067	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for carotid or vertebral artery dissection (R) (Anaes.) (Contrast)
63070	01AUG2004	30APR2020	N	- intracranial aneurysm (R) (Contrast)
63070	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for intracranial aneurysm (R) (Anaes.) (Contrast)
63073	01AUG2004	30APR2020	N	- intracranial arteriovenous malformation (R) (Contrast)
63073	01MAY2020	31DEC9999	Y	MRI-scan of head (including MRA, if performed) for intracranial arteriovenous malformation (R) (Anaes.) (Contrast)
63074	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 2 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - acoustic neuroma (R) (NK) (Contrast)
63075	01JUL2011	31DEC9999	Y	- pituitary tumour (R) (NK) (Contrast)
63076	01JUL2011	31DEC9999	Y	- toxic or metabolic or ischaemic encephalopathy (R) (NK) (Contrast)
63077	01JUL2011	31DEC9999	Y	- demyelinating disease of the brain (R) (NK) (Contrast)
63078	01JUL2011	31DEC9999	Y	- congenital malformation of the brain or meninges (R) (NK) (Contrast)
63079	01JUL2011	31DEC9999	Y	- venous sinus thrombosis (R) (NK) (Contrast)
63080	01JUL2011	31DEC9999	Y	- head trauma (R) (NK) (Contrast)
63081	01JUL2011	31DEC9999	Y	- epilepsy (R) (NK) (Contrast)
63082	01JUL2011	31DEC9999	Y	- stroke (R) (NK) (Contrast)
63083	01JUL2011	31DEC9999	Y	- carotid or vertebral artery desection (R) (NK) (Contrast)
63084	01JUL2011	31DEC9999	Y	- intracranial aneurysm (R) (NK) (Contrast)
63085	01JUL2011	31DEC9999	Y	- intracranial arteriovenous malformation (R) (NK) (Contrast)
63100	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 3 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for further investigation of: - tumour of the brain or meninges (R) (Anaes.)
63101	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 3 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE ANGIOGRAPHY of extra and/or intracranial circulation, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and neck vessels for: - stroke (R) (Contrast)
63101	01MAY2020	31DEC9999	Y	MRI and MRA of extracranial or intracranial circulation (or both)-scan of head and neck vessels for stroke (R) (Anaes.) (Contrast)
63102	01JUL2006	31DEC9999	Y	MRI and MRA of extracranial or intracranial circulation (or both) - scan of head and neck vessels for stroke (R) (Contrast)
63103	01SEP1998	31DEC9999	Y	- skull base or orbital tumour (R) (Anaes.)
63104	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 3 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE ANGIOGRAPHY of extra and/or intracranial circulation, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and neck vessels for: - stroke (R) (NK) (Contrast)
63106	01SEP1998	31DEC9999	Y	- acoustic neuroma (R) (Anaes.)
63109	01SEP1998	31DEC9999	Y	- pituitary tumour (R) (Anaes.)
63111	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - tumour of the central nervous system or meninges (R) (Contrast)
63111	01MAY2020	31DEC9999	Y	MRI-scan of head and cervical spine (including MRA, if performed) for tumour of the central nervous system or meninges (R) (Anaes.) (Contrast)
63112	01SEP1998	31DEC9999	Y	- inflammation of the brain or meninges (R) (Anaes.)
63113	01JUL2006	31DEC9999	Y	MRI - scan of head and cervical spine (including MRA, if performed) for tumour of the central nervous system or meninges (R) (Contrast)
63114	01AUG2004	30APR2020	N	- inflammation of the central nervous system or meninges (R) (Contrast)
63114	01MAY2020	31DEC9999	Y	MRI-scan of head and cervical spine (including MRA, if performed) for inflammation of the central nervous system or meninges (R) (Anaes.) (Contrast)
63115	01SEP1998	31DEC9999	Y	- toxic or metabolic or ischaemic encephalopathy (R) (Anaes.)
63116	01JUL2006	31DEC9999	Y	MRI - scan of head and cervical spine (including MRA, if performed) for inflammation of the central nervous system or meninges (R) (Contrast)
63117	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - tumour of the central nervous system or meninges (R) (NK) (Contrast)
63118	01SEP1998	31DEC9999	Y	- demyelinating disease of the brain (R) (Anaes.)
63119	01JUL2011	31DEC9999	Y	- inflammation of the central nervous system or meninges (R) (NK) (Contrast)
63121	01SEP1998	31DEC9999	Y	- congenital malformation of the brain or meninges (R) (Anaes.)
63124	01SEP1998	31DEC9999	Y	- head trauma (R) (Anaes.)
63125	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 5 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - demyelinating disease of the central nervous system (R) (Contrast)
63125	01MAY2020	31DEC9999	Y	MRI-scan of head and cervical spine (including MRA, if performed) for demyelinating disease of the central nervous system (R) (Anaes.) (Contrast)
63126	01JUL2006	31DEC9999	Y	MRI - scan of head and cervical spine (including MRA, if performed) for demyelinating disease of the central nervous system (R) (Contrast)
63127	01SEP1998	31DEC9999	Y	- epilepsy (R) (Anaes.)
63128	01AUG2004	30APR2020	N	- congenital malformation of the central nervous system or meninges (R) (Contrast)
63128	01MAY2020	31DEC9999	Y	MRI-scan of head and cervical spine (including MRA, if performed) for congenital malformation of the central nervous system or meninges (R) (Anaes.) (Contrast)
63129	01JUL2006	31DEC9999	Y	MRI - scan of head and cervical spine (including MRA, if performed) for congenital malformation of the central nervous system or meninges (R) (Contrast)
63130	01SEP1998	31DEC9999	Y	- stroke (R) (Anaes.)
63131	01AUG2004	30APR2020	N	- syrinx (congenital or acquired) (R) (Contrast)
63131	01MAY2020	31DEC9999	Y	MRI-scan of head and cervical spine (including MRA, if performed) for syrinx (congenital or acquired) (R) (Anaes.) (Contrast)
63132	01JUL2006	31DEC9999	Y	MRI - scan of head and cervical spine (including MRA, if performed) for syrinx (congenital or acquired) (R) (Contrast)
63133	01SEP1998	31DEC9999	Y	- venous sinus thrombosis (R) (Anaes.)
63134	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 5 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - demyelinating disease of the central nervous system (R) (NK) (Contrast)
63135	01JUL2011	31DEC9999	Y	- congenital malformation of the central nervous system or meninges (R) (NK) (Contrast)
63136	01JUL2011	31DEC9999	Y	- syrinx (congenital or acquired) (R) (NK) (Contrast)
63150	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 4 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for further investigation of: - tumour of the central nervous system or meninges (R) (Anaes.)
63151	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - infection (R) (Contrast)
63151	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for infection (R) (Anaes.) (Contrast)
63152	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for infection (R) (Contrast)
63153	01SEP1998	31DEC9999	Y	- inflammation of the central nervous system or meninges (R) (Anaes.)
63154	01AUG2004	30APR2020	N	- tumour (R) (Contrast)
63154	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for tumour (R) (Anaes.) (Contrast)
63155	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for tumour (R) (Contrast)
63156	01SEP1998	31DEC9999	Y	- demyelinating disease of the central nervous system (R) (Anaes.)
63157	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - infection (R) (NK) (Contrast)
63158	01JUL2011	31DEC9999	Y	- tumour (R) (NK) (Contrast)
63159	01SEP1998	31DEC9999	Y	- congenital malformation of the central nervous system or meninges (R) (Anaes.)
63161	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 7 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - demyelinating (R) (Contrast)
63161	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for demyelinating disease (R) (Anaes.) (Contrast)
63162	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63163	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for demyelinating disease (R) (Contrast)
63164	01AUG2004	30APR2020	N	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast)
63164	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) (Contrast)
63165	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or th emeninges (R) (Contrast)
63167	01AUG2004	30APR2020	N	myelopathy (R) (Contrast)
63167	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for myelopathy (R) (Anaes.) (Contrast)
63168	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for myelopathy (R) (Contrast)
63169	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for syrinx (congenital or acquired) (R) (Contrast)
63170	01AUG2004	30APR2020	N	- syrinx (congenital or acquired) (R) (Contrast)
63170	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for syrinx (congenital or acquired) (R) (Anaes.) (Contrast)
63171	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for cervical radiculopathy (R) (Contrast)
63172	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for sciatica (R) (Contrast)
63173	01AUG2004	30APR2020	N	- cervical radiculopathy (R) (Contrast)
63173	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for cervical radiculopathy (R) (Anaes.) (Contrast)
63174	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for spinal canal stenosis (R) (Contrast)
63175	01JUL2006	31DEC9999	Y	MRI - scan or 1 region or 2 contiguous regions of the spine for previous spinal surgery (R) (Contrast)
63176	01AUG2004	30APR2020	N	- sciatica (R) (Contrast)
63176	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for sciatica (R) (Anaes.) (Contrast)
63177	01JUL2006	31DEC9999	Y	MRI - scan of 1 region or 2 contiguous regions of the spine for trauma (R)
63179	01AUG2004	30APR2020	N	- spinal canal stenosis (R) (Contrast)
63179	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for spinal canal stenosis (R) (Anaes.) (Contrast)
63182	01AUG2004	30APR2020	N	- previous spinal surgery (R) (Contrast)
63182	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for previous spinal surgery (R) (Anaes.) (Contrast)
63185	01AUG2004	30APR2020	N	- trauma (R)
63185	01MAY2020	31DEC9999	Y	MRI-scan of one region or 2 contiguous regions of the spine for trauma (R) (Anaes.)
63186	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 7 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - demyelinating (R) (NK) (Contrast)
63187	01JUL2011	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (NK) (Contrast)
63188	01JUL2011	31DEC9999	Y	- myelopathy (R) (NK) (Contrast)
63189	01JUL2011	31DEC9999	Y	- syrinx (congenital or acquired) (R) (NK) (Contrast)
63190	01JUL2011	31DEC9999	Y	- cervical radiculopathy (R) (NK) (Contrast)
63191	01JUL2011	31DEC9999	Y	- sciatica (R) (NK) (Contrast)
63192	01JUL2011	31DEC9999	Y	- spinal canal stenosis (R) (NK) (Contrast)
63193	01JUL2011	31DEC9999	Y	- previous spinal surgery (R) (NK) (Contrast)
63194	01JUL2011	31DEC9999	Y	- trauma (R) (NK)
63200	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 5 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for monitoring of: - acoustic neuroma (R) (Anaes.)
63201	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - infection (R) (Contrast)
63201	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for infection (R) (Anaes.) (Contrast)
63202	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for infection (R) (Contrast)
63203	01SEP1998	31DEC9999	Y	- pituitary tumour (R) (Anaes.)
63204	01AUG2004	30APR2020	N	- tumour (R) (Contrast)
63204	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for tumour (R) (Anaes.) (Contrast)
63205	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous of 2 non-contiguous regions of the spine for tumour (R) (Contrast)
63206	01SEP1998	31DEC9999	Y	- demyelinating disease of the brain (R) (Anaes.)
63207	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - infection (R) (NK) (Contrast)
63208	01JUL2011	31DEC9999	Y	- tumour (R) (NK) (Contrast)
63209	01SEP1998	31DEC9999	Y	- congenital malformation of brain or meninges (R) (Anaes.)
63212	01SEP1998	31DEC9999	Y	- head trauma (R) (Anaes.)
63215	01SEP1998	31DEC9999	Y	- epilepsy (R) (Anaes.)
63218	01SEP1998	31DEC9999	Y	- stroke (R) (Anaes.)
63219	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 9 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - demyelinating disease (R) (Contrast)
63219	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for demyelinating disease (R) (Anaes.) (Contrast)
63220	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine of rdemyelinating disease (R) (Contrast)
63221	01SEP1998	31DEC9999	Y	- toxic or metabolic or ischaemic encephalopathy (R) (Anaes.)
63222	01AUG2004	30APR2020	N	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast)
63222	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) (Contrast)
63223	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast)
63224	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for myelopathy (R) (Contrast)
63225	01AUG2004	30APR2020	N	- myelopathy (R) (Contrast)
63225	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for myelopathy (R) (Anaes.) (Contrast)
63226	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for syrinx (congenital or acquired) (R) (Contrast)
63227	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for cervial radiculopathy (R) (Contrast)
63228	01AUG2004	30APR2020	N	- syrinx (congenital or acquired ) (R) (Contrast)
63228	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for syrinx (congenital or acquired) (R) (Anaes.) (Contrast)
63229	27JUN2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for sciatica (R) (Contrast)
63230	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for spinal canal stenosis (R) (Contrast)
63231	01AUG2004	30APR2020	N	- cervical radiculopathy (R) (Contrast)
63231	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for cervical radiculopathy (R) (Anaes.) (Contrast)
63232	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for previous spinal surgery (R) (Contrast)
63234	01AUG2004	30APR2020	N	- sciatica (R) (Contrast)
63234	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for sciatica (R) (Anaes.) (Contrast)
63237	01AUG2004	30APR2020	N	- spinal canal stenosis (R) (Contrast)
63237	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for spinal canal stenosis (R) (Anaes.) (Contrast)
63240	01AUG2004	30APR2020	N	- previous spinal surgery (R) (Contrast)
63240	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for previous spinal surgery (R) (Anaes.) (Contrast)
63243	01AUG2004	30APR2020	N	- trauma (R)
63243	01MAY2020	31DEC9999	Y	MRI-scan of 3 contiguous or 2 non contiguous regions of the spine for trauma (R) (Anaes.)
63244	01JUL2006	31DEC9999	Y	MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for trauma (R)
63250	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 6 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for monitoring of: - demyelinating disease of the central nervous system (R) (Anaes.)
63253	01SEP1998	31DEC9999	Y	- congenital malformation of the central nervous system or meninges (R) (Anaes.)
63256	01SEP1998	31DEC9999	Y	-syrinx (congenital or acquired) (R) (Anaes.)
63257	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 9 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - demyelinating disease (R) (NK) (Contrast)
63258	01JUL2011	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (NK) (Contrast)
63259	01JUL2011	31DEC9999	Y	- myelopathy (R) (NK) (Contrast)
63260	01JUL2011	31DEC9999	Y	- syrinx (congenital or acquired ) (R) (NK) (Contrast)
63261	01JUL2011	31DEC9999	Y	- cervical radiculopathy (R) (NK) (Contrast)
63262	01JUL2011	31DEC9999	Y	- sciatica (R) (NK) (Contrast)
63263	01JUL2011	31DEC9999	Y	- spinal canal stenosis (R) (NK) (Contrast)
63264	01JUL2011	31DEC9999	Y	- previous spinal surgery (R) (NK) (Contrast)
63265	01JUL2011	31DEC9999	Y	- trauma (R) (NK)
63270	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for monitoring of: - tumour of the brain or meninges (R) (Anaes.)
63271	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 10 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cervical spine and brachial plexus for: - tumour (R) (Contrast)
63271	01MAY2020	31DEC9999	Y	MRI-scan of cervical spine and brachial plexus for tumour (R) (Anaes.) (Contrast)
63272	01JUL2006	31DEC9999	Y	MRI - scan of cervial spine and brachial plexus for tumour (R) (Contrast)
63273	01SEP1998	31DEC9999	Y	- skull base or orbital tumour (R) (Anaes.)
63274	01AUG2004	30APR2020	N	- trauma (R) (Contrast)
63274	01MAY2020	31DEC9999	Y	MRI-scan of cervical spine and brachial plexus for trauma (R) (Anaes.) (Contrast)
63275	01JUL2006	31DEC9999	Y	MRI - scan of cervical spine and brachial plexus for trauma (R) (Contrast)
63276	01SEP1998	31DEC9999	Y	- inflammation of brain or meninges (R) (Anaes.)
63277	01AUG2004	30APR2020	N	- cervical radiculopathy (R) (Contrast)
63277	01MAY2020	31DEC9999	Y	MRI-scan of cervical spine and brachial plexus for cervical radiculopathy (R) (Anaes.) (Contrast)
63278	01JUL2006	31DEC9999	Y	MRI - scan of cervical spine and brachial plexus for cervical radiculopathy (R) (Contrast)
63279	01SEP1998	31DEC9999	Y	- venous sinus thrombosis (R) (Anaes.)
63280	01AUG2004	30APR2020	N	- previous surgery (R) (Contrast)
63280	01MAY2020	31DEC9999	Y	MRI-scan of cervical spine and brachial plexus for previous surgery (R) (Anaes.) (Contrast)
63281	01JUL2006	31DEC9999	Y	MRI - scan of cervical spine and brachial plexus for previous surgery (R) (Contrast)
63282	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 10 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cervical spine and brachial plexus for: - tumour (R) (NK) (Contrast)
63283	01JUL2011	31DEC9999	Y	- trauma (R) (NK) (Contrast)
63284	01JUL2011	31DEC9999	Y	- cervical radiculopathy (R) (NK) (Contrast)
63285	01JUL2011	31DEC9999	Y	- previous surgery (R) (NK) (Contrast)
63290	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for monitoring of: - tumour of the central nervous system or meninges (R) (Anaes.)
63293	01SEP1998	31DEC9999	Y	- inflammation of the central nervous system or meninges (R) (Anaes.)
63300	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 9 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for the exclusion of: - infection (R) (Anaes.)
63301	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - tumour arising in bone or musculoskeletal system, this excludes tumours arising in breast, prostate or rectum (R) (Contrast)
63301	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for tumour arising in bone or musculoskeletal system, excluding tumours arising in breast, prostate or rectum (R) (Anaes.) (Contrast)
63302	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for tumour arising, in bone or musculoskeletal system, excluding tumours arising in breast, prostate or rectum (R) (Contrast)
63303	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63304	01AUG2004	30APR2020	N	- infection arising in bone or musculoskeletal system, this excludes infection arising in breast, prostate or rectum (R) (Contrast)
63304	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for infection arising in bone or musculoskeletal system, excluding infection arising in breast, prostate or rectum (R) (Anaes.) (Contrast)
63305	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for infection arising in bone or musculoskeletal system, excluding infection arising in breast, prostate or rectum (R) (Contrast)
63306	01SEP1998	31DEC9999	Y	- demyelinating disease (R) (Anaes.)
63307	01AUG2004	30APR2020	N	- osteonecrosis (R) (Contrast)
63307	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for osteonecrosis (R) (Anaes.) (Contrast)
63308	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for osteonecrosis (R) (Contrast)
63309	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63310	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - tumour arising in bone or musculoskeletal system, this excludes tumours arising in breast, prostate or rectum (R) (NK) (Contrast)
63311	01JUL2011	31DEC9999	Y	- infection arising in bone or musculoskeletal system, this excludes infection arising in breast, prostate or rectum (R) (NK) (Contrast)
63312	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63313	01JUL2011	31DEC9999	Y	- osteonecrosis (R) (NK) (Contrast)
63315	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63322	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 12 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - derangement of hip or its supporting structures (R) (Contrast)
63322	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of hip or its supporting structures (R) (Anaes.) (Contrast)
63323	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of hip or its supporting structures (R) (Contrast)
63324	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of shoulder its supporting structures (R) (Contrast)
63325	01AUG2004	30APR2020	N	- derangment of shoulder or its supporting structures (R) (Contrast)
63325	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of shoulder or its supporting structures (R) (Anaes.) (Contrast)
63326	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of knee or its supporting structures (R) (Contrast)
63327	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of ankle or foot (or both) or its supporting structures (R) (Contrast)
63328	01AUG2004	30APR2020	N	- derangment of knee or its supporting structures (R) (Contrast)
63328	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of knee or its supporting structures (R) (Anaes.) (Contrast)
63329	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of 1 or both temporomandibular joints or their supporting structures (R) (Contrast)
63330	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of wrist or hand (or both) or its supporting structures (R) (Contrast)
63331	01AUG2004	30APR2020	N	- derangment of ankle and/or foot or its supporting structures (R) (Contrast)
63331	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of ankle or foot (or both) or its supporting structures (R) (Anaes.) (Contrast)
63332	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for derangement of elbow or its supporting structures (R) (Contrast)
63334	01AUG2004	30APR2020	N	- derangment of one or both temporomandibular joints or their supporting structures (R) (Contrast)
63334	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of one or both temporomandibular joints or their supporting structures (R) (Anaes.) (Contrast)
63337	01AUG2004	30APR2020	N	- derangment of wrist and/or hand or its supporting structures (R) (Contrast)
63337	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of wrist or hand (or both) or its supporting structures (R) (Anaes.) (Contrast)
63340	01AUG2004	30APR2020	N	- derangment of elbow or its supporting structures (R) (Contrast)
63340	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for derangement of elbow or its supporting structures (R) (Anaes.) (Contrast)
63341	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 12 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - derangement of hip or its supporting structures (R) (NK) (Contrast)
63342	01JUL2011	31DEC9999	Y	- derangement of shoulder or its supporting structures (R) (NK) (Contrast)
63343	01JUL2011	31DEC9999	Y	- derangement of knee or its supporting structures (R) (NK) (Contrast)
63345	01JUL2011	31DEC9999	Y	- derangement of ankle and/or foot or its supporting structures (R) (NK) (Contrast)
63346	01JUL2011	31DEC9999	Y	- derangement of one or both temporomandibular joints or their supporting structures (R) (NK) (Contrast)
63347	01JUL2011	31DEC9999	Y	- derangement of wrist and/or hand or its supporting structures (R) (NK) (Contrast)
63348	01JUL2011	31DEC9999	Y	- derangement of elbow or its supporting structures (R) (NK) (Contrast)
63350	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 10 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for the exclusion of: - infection (R) (Anaes.)
63353	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63356	01SEP1998	31DEC9999	Y	- demyelinating disease (R) (Anaes.)
63359	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63361	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 13 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - Gaucher disease (R)
63361	01MAY2020	31DEC9999	Y	MRI-scan of musculoskeletal system for Gaucher disease (R) (Anaes.)
63362	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63363	01JUL2006	31DEC9999	Y	MRI - scan of musculoskeletal system for Gaucher disease (R)
63364	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 13 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - Gaucher disease (R) (NK)
63365	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63385	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 14 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cardiovascular system for: - congenital disease of the heart or a great vessel (R) (Contrast)
63385	01MAY2020	31DEC9999	Y	MRI-scan of cardiovascular system for congenital disease of the heart or a great vessel (R) (Anaes.) (Contrast)
63386	01JUL2006	31DEC9999	Y	MRI - scan of cardiovascular system for congenital disease of the heart or a great vessel (R) (Contrast)
63387	01JUL2006	31DEC9999	Y	MRI - scan of cardiovascular system for tumour of the heart or a great vessel (R) (Contrast)
63388	01AUG2004	30APR2020	N	- tumour of the heart or a great vessel (R) (Contrast)
63388	01MAY2020	31DEC9999	Y	MRI-scan of cardiovascular system for tumour of the heart or a great vessel (R) (Anaes.) (Contrast)
63389	01JUL2006	31DEC9999	Y	MRI - scan of cardiovascular system for abnormality of thoracic aorta (R) (Contrast)
63390	01JAN2025	31DEC9999	Y	MRI - scan of the cardiovascular system for the assessment of myocardial structure and function and characterisation, if the service is requested by a specialist or consultant physician who has assessed the patient, and the request for the scan indicates:(a) acute onset (less than 3 months) heart failure caused by suspected myocarditis which would otherwise require endomyocardial biopsy to confirm the diagnosis of myocarditis; or(b) unexplained arrhythmia caused by suspected myocarditis which would otherwise require endomyocardial biopsy to confirm the diagnosis of myocarditis; or(c) suspected drug-induced myocarditis, where the results from the following examinations are inconclusive to form a diagnosis: i. troponin; andii. chest x-ray, andiii. transthoracic echocardiogram.(R)(Contrast)
63391	01AUG2004	30APR2020	N	- abnormality of thoracic aorta (R) (Contrast)
63391	01MAY2020	31DEC9999	Y	MRI-scan of cardiovascular system for abnormality of thoracic aorta (R) (Anaes.) (Contrast)
63392	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 14 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cardiovascular system for: - congenital disease of the heart or a great vessel (R) (NK) (Contrast)
63393	01JUL2011	31DEC9999	Y	- tumour of the heart or a great vessel (R) (NK) (Contrast)
63394	01JUL2011	31DEC9999	Y	- abnormality of thoracic aorta (R) (NK) (Contrast)
63395	01MAY2018	02AUG2018	N	MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (K) (Contrast)
63395	03AUG2018	09AUG2018	N	MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI, for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (K) (Contrast)
63395	10AUG2018	30APR2020	N	MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (K) (Contrast)
63395	01MAY2020	31DEC9999	Y	MRI-scan of cardiovascular system for assessment of myocardial structure and function involving:(a) dedicated right ventricular views; and(b) 3D volumetric assessment of the right ventricle; and(c) reporting of end diastolic and end systolic volumes, ejection fraction and BSA indexed values;if the request for the scan indicates that:(d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or(e) investigative findings in relation to the patient are consistent with ARVC(R) (Contrast)
63396	01MAY2018	02AUG2018	N	MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (NK) (Contrast)
63396	03AUG2018	09AUG2018	N	MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI, for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (NK) (Contrast)
63396	10AUG2018	31DEC9999	Y	MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable once in 12 months (R) (NK) (Contrast)
63397	01MAY2018	02AUG2018	N	MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (K) (Contrast)
63397	03AUG2018	09AUG2018	N	MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI, for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (K) (Contrast)
63397	10AUG2018	30APR2020	N	MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (K) (Contrast)
63397	01MAY2020	31DEC9999	Y	MRI-scan of cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and(b) 3D volumetric assessment of the right ventricle; and(c) reporting of end diastolic and end systolic volumes, ejection fraction and BSA indexed values;if the request for the scan indicates that the patient:(d) is asymptomatic; and(e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC)(R) (Contrast)
63398	01MAY2018	02AUG2018	N	MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (NK) (Contrast)
63398	03AUG2018	09AUG2018	N	MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI, for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (NK) (Contrast)
63398	10AUG2018	31DEC9999	Y	MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end-diastolic and end-systolic volumes, ejection fraction and BSA-indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable once in 36 months (R) (NK) (Contrast)
63399	01JAN2022	31DEC9999	Y	MRI-scan of cardiovascular system for the assessment of myocardial structure and function, if the service is requested by a consultant physician who has assessed the patient, and the request for the scan indicates: the patient has suspected myocarditis after receiving a mRNA COVID-19 vaccine; and the patient had symptom onset within 21 days of a mRNA COVID-19 vaccine administration; and the results from the following examinations are inconclusive to form a diagnosis of myocarditis:(i) echocardiogram; and(ii) troponin; and(iii) chest X-ray. Applicable not more than once in a patients lifetime (R) (Contrast)
63400	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 11 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for further investigation of: - infection (R) (Anaes.)
63401	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 15 on three occasions only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for: - vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Contrast)
63401	01MAY2020	31DEC9999	Y	MRA-if the request for the scan specifically identifies the clinical indication for the scan-scan of cardiovascular system for vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Contrast)
63402	01JUL2006	31DEC9999	Y	MRA - if the request for the scan specifically identifies the clinical identification for the scan - scan of cardiovascular system for vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Contrast)
63403	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63404	01AUG2004	30APR2020	N	- obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Contrast)
63404	01MAY2020	31DEC9999	Y	MRA-if the request for the scan specifically identifies the clinical indication for the scan-scan of cardiovascular system for obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Contrast)
63405	01JUL2006	31DEC9999	Y	MRA - if the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Contrast)
63406	01SEP1998	31DEC9999	Y	- demyelinating disease (R) (Anaes.)
63407	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 15 on three occasions only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for: - vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (NK) (Contrast)
63408	01JUL2011	31DEC9999	Y	- obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (NK) (Contrast)
63409	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63412	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63415	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63416	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 16 on one occasion only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Contrast)
63416	01MAY2020	31DEC9999	Y	MRA-scan of person under the age of 16 for the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Contrast)
63417	01JUL2006	31DEC9999	Y	MRA - scan of person under the age of 16 for the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Contrast)
63418	01SEP1998	31DEC9999	Y	- cervical radiculopathy (R) (Anaes.)
63419	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 16 on one occasion only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) NK) (Contrast)
63421	01SEP1998	31DEC9999	Y	- sciatica (R) (Anaes.)
63424	01SEP1998	31DEC9999	Y	- spinal canal stenosis (R) (Anaes.)
63425	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 17 on two occasions only in any 12 month period, for previously diagnosed conditions MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - post-inflammatory or post-traumatic physeal fusion (R)
63425	01MAY2020	31DEC9999	Y	MRI-scan of person under the age of 16 for post inflammatory or post traumatic physeal fusion (R)
63426	01JUL2006	31DEC9999	Y	MRI - scan of person under the age of 16 for post-inflammatory or post-traumatic physeal fusion (R)
63427	01SEP1998	31DEC9999	Y	- previous spinal surgery (R) (Anaes.)
63428	01AUG2004	30APR2020	N	- Gaucher disease (R)
63428	01MAY2020	31DEC9999	Y	MRI-scan of person under the age of 16 for Gaucher disease (R)
63429	01JUL2006	31DEC9999	Y	MRI - scan of person under the age of 16 for Gaucher disease (R)
63430	01SEP1998	31DEC9999	Y	- trauma (R) (Anaes.)
63432	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 17 on two occasions only in any 12 month period, for previously diagnosed conditions MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - post-inflammatory or post-traumatic physeal fusion (R) (NK)
63433	01JUL2011	31DEC9999	Y	- Gaucher disease (R) (NK)
63440	01AUG2004	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - pelvic or abdominal mass (R) (Contrast)
63440	01MAY2020	31DEC9999	Y	MRI-scan of person under the age of 16 for pelvic or abdominal mass (R) (Contrast)
63441	01JUL2006	31DEC9999	Y	MRI - scan of person under the age of 16 for pelvic or abdominal mass (R) (Contrast)
63442	01JUL2006	31DEC9999	Y	MRI - scan of person under the age of 16 for mediastinal mass (R) (Contrast)
63443	01AUG2004	30APR2020	N	- mediastinal mass (R) (Contrast)
63443	01MAY2020	31DEC9999	Y	MRI-scan of person under the age of 16 for mediastinal mass (R) (Contrast)
63444	01JUL2006	31DEC9999	Y	MRI - scan of person under the age of 16 for congenital uterine or anorectal abnormality (R) (Contrast)
63446	01AUG2004	30APR2020	N	- congenital uterine or anorectal abnormality (R) (Contrast)
63446	01MAY2020	31DEC9999	Y	MRI-scan of person under the age of 16 for congenital uterine or anorectal abnormality (R) (Contrast)
63447	01JUL2011	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - pelvic or abdominal mass (R) (NK) (Contrast)
63448	01JUL2011	31DEC9999	Y	- mediastinal mass (R) (NK) (Contrast)
63449	01JUL2011	31DEC9999	Y	- congenital uterine or anorectal abnormality (R) (NK) (Contrast)
63450	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 12 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for further investigation of: - infection (R) (Anaes.)
63453	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63454	01MAY2019	31JUL2019	N	MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where: (a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected and diagnosis is indeterminate; and(d) further examination is clinically indicated in the same pregnancy to which item 55712 or 55715 or 55719 or 55720 or 55721 or 55724 or 55725 or 55727 applies. (R) (K) (Anaes.) (Contrast)
63454	01AUG2019	30APR2020	N	MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where:(a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected; and (d) an ultrasound provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, has been performed and diagnosis is indeterminate or requires further examination. (R) (K) (Contrast)
63454	01MAY2020	30JUN2021	N	MRI - scan of the pelvis or abdomen, if: (a) the pregnancy is at, or after, 18 weeks gestation; and(b) fetal central nervous system abnormality is suspected; and(c) an ultrasound has been performed and is provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics; and(d) the diagnosis is indeterminate or requires further examination; and(e) the service is requested by a specialist practising in the specialty of obstetrics (R) (Contrast)
63454	01JUL2021	31OCT2022	N	MRI - scan of the pelvis or abdomen, for a patient who is pregnant, if: (a) the pregnancy is at, or after, 18 weeks gestation; and(b) fetal central nervous system abnormality is suspected; and(c) an ultrasound has been performed and is provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics; and(d) the diagnosis is indeterminate or requires further examination; and(e) the service is requested by a specialist practising in the specialty of obstetrics (R) (Contrast)
63454	01NOV2022	31DEC9999	Y	MRI scan of the pelvis or abdomen, for a patient who is pregnant, if: (a) the pregnancy is at, or after, 18 weeks gestation; and (b) fetal abnormality is suspected; and (c) an ultrasound has been performed and is provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics; and (d) the diagnosis of fetal abnormality as a result of the ultrasound is indeterminate or requires further examination; and (e) the MRI service is requested by a specialist practising in the specialty of obstetrics (R) (Contrast)
63455	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of body for: - adrenal mass in a patient with malignancy which is otherwise resectable (R) (NK)
63456	01SEP1998	31DEC9999	Y	- demyelinating disease (R) (Anaes.)
63457	01JUL2011	31DEC2013	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period (NK)
63457	01JAN2014	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the person is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period (NK)
63458	01JUL2011	31DEC2013	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 or 63457 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1: Benefits are payable on one occasion only in any 12 month period NOTE 2: This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 or 63457 (NK)
63458	01JAN2014	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the person has had an abnormality detected as a result of a service described in item 63464 or 63457 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1: Benefits are payable on one occasion only in any 12 month period NOTE 2: This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 or 63457 (NK)
63459	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63460	01MAY2019	31JUL2019	N	MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where: (a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected and diagnosis is indeterminate; and(d) further examination is clinically indicated in the same pregnancy to which item 55712 or 55715 or 55719 or 55720 or 55721 or 55724 or 55725 or 55727 applies. (R) (NK) (Anaes.) (Contrast)
63460	01AUG2019	31DEC9999	Y	MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where:(a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected; and (d) an ultrasound provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, has been performed and diagnosis is indeterminate or requires further examination. (R) (NK) (Contrast)
63461	01AUG2004	30APR2020	N	NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of body for: - adrenal mass in a patient with malignancy which is otherwise resecetable (R)
63461	01MAY2020	31DEC9999	Y	MRI-scan of the body for adrenal mass in a patient with a malignancy that is otherwise resectable (R)
63462	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63463	01JUL2006	31DEC9999	Y	MRI - scan of the body for adrenal mass in a patient with a malignancy that is otherwise resectable (R)
63464	01FEB2009	16APR2009	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63464	17APR2009	31DEC2009	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63464	01JAN2010	31DEC2013	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63464	01JAN2014	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the person is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63464	01MAY2020	31OCT2022	N	MRI-scan of both breasts for the detection of cancer, if a dedicated breast coil is used, the request for the scan identifies that the person is asymptomatic and is younger than 50 years of age, and the request for the scan identifies: (a) that the patient is at high risk of developing breast cancer, due to one of the following:(i) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer;(ii) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the relatives has been diagnosed with bilateral breast cancer, had onset of breast cancer before the age of 40 years, had onset of ovarian cancer before the age of 50 years, has been diagnosed with breast and ovarian cancer (at the same time or at different times), has Ashkenazi Jewish ancestry or is a male relative who has been diagnosed with breast cancer;(iii) one first or second degree relative diagnosed with breast cancer at age 45 years or younger, and another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or(b) that genetic testing has identified the presence of a high risk breast cancer gene mutation (R)
63464	01NOV2022	31DEC9999	Y	MRI scan of both breasts for the detection of cancer in a patient, if: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient is asymptomatic and is younger than 60 years of age; and (c) the request for the scan identifies that the patient is at high risk of developing breast cancer due to one or more of the following: (i) genetic testing has identified the presence of a high risk breast cancer gene mutation in the patient or in a first degree relative of the patient; (ii) both: (A) one of the patients first or second degree relatives was diagnosed with breast cancer at age 45 years or younger; and (B) another first or second degree relative on the same side of the patients family was diagnosed with bone or soft tissue sarcoma at age 45 years or younger; (iii) the patient has a personal history of breast cancer before the age of 50 years; (iv) the patient has a personal history of mantle radiation therapy; (v) the patient has a lifetime risk estimation greater than 30% or a 10 year absolute risk estimation greater than 5% using a clinically relevant risk evaluation algorithm; and (d) the service is not performed in conjunction with item 55076 or 55079 Applicable not more than once in a 12 month period (R) (Contrast)
63465	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63466	01FEB2009	16APR2009	N	NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R)
63466	17APR2009	31DEC2009	N	NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C)1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63466	01JAN2010	31DEC9999	Y	NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii) that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period
63467	01FEB2009	31DEC2013	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1: Benefits are payable on one occasion only in any 12 month period NOTE 2: This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464
63467	01JAN2014	30APR2020	N	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the person has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1: Benefits are payable on one occasion only in any 12 month period NOTE 2: This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464
63467	01MAY2020	31DEC9999	Y	MRI-scan of both breasts for the detection of cancer, if:(a) a dedicated breast coil is used; and(b) the person has had an abnormality detected as a result of a service mentioned in item 63464 performed in the previous 12 months (R)
63468	01SEP1998	31DEC9999	Y	- cervical radiculopathy (R) (Anaes.)
63469	01FEB2009	31DEC9999	Y	MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1: Benefits are payable on one occasion only in any 12 month period NOTE 2: This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63466
63470	01AUG2004	31OCT2010	N	NOTE: Benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a) the patient is referred by a specialist or by a consultant physician and (b) the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast)
63470	01NOV2010	30APR2020	N	NOTE: Benefits are payable for a service under items 63470 and 63473 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a) the patient is referred by a specialist or by a consultant physician and (b) the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast)
63470	01MAY2020	31DEC9999	Y	MRI-scan of the pelvis for the staging of histologically diagnosed cervical cancer at FIGO stage 1B or greater, if the request for scan identifies that: (a) a histological diagnosis of carcinoma of the cervix has been made; and(b) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater (R) (Contrast)
63471	01SEP1998	31DEC9999	Y	- sciatica (R) (Anaes.)
63472	01JUL2006	31DEC9999	Y	MRI - if: (a) the patient is referred by a specialist or by a consultant physician; and (b) the request for scan identifies that: (i) a histological diagnosis of carcinoma of the cervix has been made; and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater - scan of pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast)
63473	01AUG2004	30APR2020	N	- Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast)
63473	01MAY2020	31DEC9999	Y	MRI-scan of the pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stage 1B or greater, if the request for the scan identifies that: (a) a histological diagnosis of carcinoma of the cervix has been made; and(b) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater (R) (Contrast)
63474	01SEP1998	31DEC9999	Y	- spinal canal stenosis (R) (Anaes.)
63475	01JUL2006	31DEC9999	Y	MRI - if: (a) the patient is referred by a specialist or by a consultant physician; and (b) the request for scan identifies that: (i) a histological diagnosis of carcinoma of the cervix has been made; and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater - scan of pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast)
63476	01JUL2009	31OCT2010	N	NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast)
63476	01NOV2010	30APR2020	N	NOTE: benefits are payable for a service under item 63476 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast)
63476	01MAY2020	31OCT2024	N	MRI-scan of the pelvis for the initial staging of rectal cancer, if: (a) a phased array body coil is used; and(b) the request for the scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum) (R) (Contrast)
63476	01NOV2024	31DEC9999	Y	MRI-scan of the pelvis for the initial staging, restaging or follow up of rectal cancer, if: (a) a high resolution T2 technique is used; and (b) the request for the scan identifies that the indication is for: (i) the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum); or (ii) the initial assessment of response to chemotherapy or chemoradiotherapy; or (iii) the assessment of possible recurrent tumour after complete response to neoadjuvant therapy, within an active surveillance program; or (iv) the assessment of recurrent disease prior to treatment planning (R) (Contrast)
63477	01SEP1998	31DEC9999	Y	- previous spinal surgery (R) (Anaes.)
63478	01JUL2009	31DEC9999	Y	NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast)
63479	01JUL2011	31DEC9999	Y	NOTE: Benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a) the patient is referred by a specialist or by a consultant physician and (b) the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (NK) (Contrast)
63480	01SEP1998	31DEC9999	Y	- trauma (R) (Anaes.)
63481	01JUL2011	31DEC9999	Y	- Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (NK) (Contrast)
63482	01JAN2006	31OCT2012	N	NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R) (Contrast)
63482	01NOV2012	30APR2020	N	NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R)
63482	01MAY2020	31DEC9999	Y	MRI-scan of pancreas and biliary tree for suspected biliary or pancreatic pathology (R)
63483	01JUL2006	31DEC9999	Y	MRI - scan of pancreas and biliary tree for suspected biliary or pancreatic pathology (R)
63484	01JUL2011	31DEC9999	Y	NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (NK) (contrast)
63486	01JUL2011	31DEC9999	Y	NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R) (NK)
63487	01NOV2016	30APR2020	N	MRI-performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has been diagnosed with metastatic cancer restricted to the regional lymph nodes; and (ii) clinical examination and conventional imaging have failed to identify the primary cancer (R) (K) (Anaes)
63487	01MAY2020	31DEC9999	Y	MRI-scan of both breasts, if:(a) a dedicated breast coil is used; and(b) the request for the scan identifies that:(i) the patient has been diagnosed with metastatic cancer restricted to the regional lymph nodes; and(ii) clinical examination and conventional imaging have failed to identify the primary cancer (R) (Anaes.)
63488	01NOV2016	31DEC9999	Y	MRI-performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has been diagnosed with metastatic cancer restricted to the regional lymph nodes; and (ii) clinical examination and conventional imaging have failed to identify the primary cancer (R) (NK) (Anaes)
63489	01NOV2016	30APR2020	N	MRI-guided biopsy, performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has a suspicious lesion seen on MRI but not on conventional imaging; and (ii) the lesion is not amenable to biopsy guided by conventional imaging; and (d) a repeat ultrasound scan of the affected breast is performed: (i) before the guided biopsy is performed; and (ii) as part of the service under this item (R) (K) (Anaes.)
63489	01MAY2020	31OCT2021	N	MRI-guided biopsy, if:(a) the request for the scan identifies that the patient has a suspicious lesion seen on MRI but not on conventional imaging; and(b) an ultrasound scan of the affected breast, performed immediately before the biopsy, confirms that the lesion is not amenable to biopsy guided by conventional imaging; and(c) a dedicated breast coil is used (R) (Anaes.)
63489	01NOV2021	31DEC9999	Y	MRI-scan of one breast, performed in conjunction with a biopsy procedure on that breast and an ultrasound scan of that breast, if: (a) the request for the MRI scan identifies that the patient has a suspicious lesion seen on MRI but not on conventional imaging; and (b) the ultrasound scan is performed immediately before the MRI scan and confirms that the lesion is not amenable to biopsy guided by conventional imaging; and (c) a dedicated breast coil is used (R)
63490	01NOV2016	31DEC9999	Y	MRI-guided biopsy performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has a suspicious lesion seen on MRI but not on conventional imaging; and (ii) the lesion is not amenable to biopsy guided by conventional imaging; and (d) a repeat ultrasound scan of the affected breast is performed: (i) before the guided biopsy is performed; and (ii) as part of the service under this item (R) (NK) (Anaes.)
63491	01AUG2004	31OCT2012	N	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item)
63491	01NOV2012	30APR2020	N	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the service requested by a medical practitioner. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item)
63491	01MAY2020	31DEC9999	Y	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if: (a) the service is performed on a person in accordance with clause 2.5.1; and(b) the item for the service includes in its description ‘(Contrast); and(c) the service is performed using a contrast agent
63492	01JUL2006	31OCT2012	N	MRI or MRA service to which an item in the Group (other than an item in this Subgroup) applies if: (a) the item for the service includes in its description '(Contrast)'; and (b) the service is performed using a contrast agent
63492	01NOV2012	31DEC9999	Y	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the service is requested by a medical practitioner. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item)
63493	01JUL2006	31OCT2012	N	MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if the service is performed on a person using intravenous or intra muscular sedation
63493	01NOV2012	31DEC9999	Y	- involves use of intravenous or intramuscular sedation on a patient
63494	01AUG2004	30APR2020	N	- involves use of intravenous or intramuscular sedation on a patient
63494	01MAY2020	31DEC9999	Y	MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if: (a) the service is performed on a person in accordance with clause 2.5.1; and(b) the service is performed using intravenous or intra muscular sedation
63495	01JUL2006	31OCT2012	N	MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if the service is performed on a person under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic
63495	01NOV2012	31DEC9999	Y	- on a patient under anaesthetic in the presence of a medical practitioner qualified to perform an anaesthetic
63496	01MAY2019	30APR2020	N	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying item for use with MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the service requested by a specialist or by a consultant and the scan performed involves the use of HEPATOBILIARY SPECIFIC contrast agent, as clinically indicated for eligible MRI items 64545 and 64546.
63496	01MAY2020	31DEC9999	Y	NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. MRI service to which item 63545 or 63546 applies if: (a) the service is performed on a person under the supervision of an eligible provider; and(b) the service is performed using an hepatobiliary specific contrast agent
63497	01AUG2004	30APR2020	N	- on a patient under anaesthetic in the presence of a medical practitioner qualified to perform an anaesthetic
63497	01MAY2020	31DEC9999	Y	MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if: (a) the service is performed on a person in accordance with clause 2.5.1; and(b) the service is performed under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic
63498	12MAR2012	30JUN2023	N	MRI service to which item 63501, 63502, 63504 or 63505 applies if: (a) the service is performed in accordance with the determination; and (b) the service is performed on a person using intravenous or intra muscular sedation
63498	01JUL2023	31DEC9999	Y	MRI service to which item 63501, 63502, 63504 or 63505 applies, if the service is performed on a person using intravenous or intra muscular sedation
63499	12MAR2012	30JUN2023	N	MRI service to which item 63501, 63502, 63504 or 63505 applies if: (a) the service is performed in accordance with the determination; and (b) the service is performed on a person under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic.
63499	01JUL2023	31DEC9999	Y	MRI service to which item 63501, 63502, 63504 or 63505 applies, if the service is performed on a person under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic
63500	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 13 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for monitoring of: - demyelinating disease (R) (Anaes.)
63501	12MAR2012	30APR2020	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan confirms a loss of integrity of the implant (R) Note: Benefits are payable on one occasion only in any 12 Month Period
63501	01MAY2020	30JUN2023	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and(b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and(ii) the result of the scan confirms a loss of integrity of the implant. (R) Note: Benefits are payable on one occasion only in any 24 Month Period
63501	01JUL2023	31DEC9999	Y	MRI-scan of one or both breasts for the evaluation of implant integrity, if: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan confirms a loss of integrity of the implant (R)
63502	12MAR2012	30APR2020	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan does not demonstrate a loss of integrity of the implant (R) Note: Benefits are payable on one occasion only in any 12 Month Period
63502	01MAY2020	30JUN2023	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan does not demonstrate a loss of integrity of the implant (R) Note: Benefits are payable on one occasion only in any 24 Month Period
63502	01JUL2023	31DEC9999	Y	MRI-scan of one or both breasts for the evaluation of implant integrity, if: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan does not demonstrate a loss of integrity of the implant (R)
63503	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63504	12MAR2012	30JUN2023	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan confirms a loss of integrity of the implant (R)
63504	01JUL2023	31DEC9999	Y	MRI-scan of one or both breasts for the evaluation of implant integrity, if: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan confirms a loss of integrity of the implant (R)
63505	12MAR2012	30JUN2023	N	MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan does not demonstrate a loss of integrity of the implant (R)
63505	01JUL2023	31DEC9999	Y	MRI-scan of one or both breasts for the evaluation of implant integrity, if: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan does not demonstrate a loss of integrity of the implant (R)
63506	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63507	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.); or - unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or - paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.)
63507	01OCT2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient under 16 years for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.); or - unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or - paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.)
63507	01MAY2020	31DEC9999	Y	MRI-scan of head for a patient under 16 years if the service is for:(a) an unexplained seizure; or(b) an unexplained headache if significant pathology is suspected; or(c) paranasal sinus pathology that has not responded to conservative therapy (R) (Contrast)
63508	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: - unexplained seizure(s) (R) (NK) (Contrast) (Anaes.); or - unexplained headache where significant pathology is suspected (R) (NK) (Contrast) (Anaes.); or - paranasal sinus pathology which has not responded to conservative therapy (R) (NK) (Contrast) (Anaes.)
63508	01OCT2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient under 16 years for any of the following: - unexplained seizure(s) (R) (NK) (Contrast) (Anaes.); or - unexplained headache where significant pathology is suspected (R) (NK) (Contrast) (Anaes.); or - paranasal sinus pathology which has not responded to conservative therapy (R) (NK) (Contrast) (Anaes.)
63509	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63510	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any of the following: - significant trauma (R) (Contrast) (Anaes.); or - unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or - unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.)
63510	01OCT2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient under 16 years following radiographic examination for: - significant trauma (R) (Contrast) (Anaes.); or - unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or - unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.)
63510	01MAY2020	31DEC9999	Y	MRI-scan of spine following radiographic examination for a patient under 16 years if the service is for: (a) significant trauma; or(b) unexplained neck or back pain with associated neurological signs; or(c) unexplained back pain if significant pathology is suspected (R) (Contrast)
63511	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any of the following: - significant trauma (R) (NK) (Contrast) (Anaes.); or - unexplained neck or back pain with associated neurological signs (R) (NK) (Contrast) (Anaes.); or - unexplained back pain where significant pathology is suspected (R) (NK) (Contrast) (Anaes.)
63511	01OCT2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient under 16 years following radiographic examination for: - significant trauma (R) (NK) (Contrast) (Anaes.); or - unexplained neck or back pain with associated neurological signs (R) (NK) (Contrast) (Anaes.); or - unexplained back pain where significant pathology is suspected (R) (NK) (Contrast) (Anaes.)
63512	01SEP1998	31DEC9999	Y	- cervical radiculopathy (R) (Anaes.)
63513	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (Contrast) (Anaes.)
63513	01OCT2013	31OCT2018	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient under 16 years following radiographic examination for internal joint derangement (R) (Contrast) (Anaes.)
63513	01NOV2018	30APR2020	N	MRI - referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient aged under 16 years for internal joint derangement (R) (K) (Contrast) (Anaes.)
63513	01MAY2020	31DEC9999	Y	MRI-scan of knee for internal joint derangement for a patient under 16 years (R) (Contrast)
63514	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (NK) (Contrast) (Anaes.)
63514	01OCT2013	31OCT2018	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient under 16 years following radiographic examination for internal joint derangement (R) (NK) (Contrast) (Anaes.)
63514	01NOV2018	31DEC9999	Y	MRI - referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient aged under 16 years for internal joint derangement (R) (NK) (Contrast) (Anaes.)
63515	01SEP1998	31DEC9999	Y	- sciatica (R) (Anaes.)
63516	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: - suspected septic arthritis (R) (Contrast) (Anaes.); or - suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); or - suspected Perthes disease (R) (Contrast) (Anaes.)
63516	01OCT2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip for a patient under 16 years following radiographic examination for: - suspected septic arthritis (R) (Contrast) (Anaes.); or - suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); or - suspected Perthes disease (R) (Contrast) (Anaes.)
63516	01MAY2020	31DEC9999	Y	MRI-scan of hip following radiographic examination for a patient under 16 years if any of the following is suspected: (a) septic arthritis;(b) slipped capital femoral epiphysis;(c) Perthes disease (R) (Contrast)
63517	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: - suspected septic arthritis (R) (NK) (Contrast) (Anaes.); or - suspected slipped capital femoral epiphysis (R) (NK) (Contrast) (Anaes.); or - suspected Perthes disease (R) (NK) (Contrast) (Anaes.)
63517	01OCT2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip for a patient under 16 years following radiographic examination for: - suspected septic arthritis (R) (NK) (Contrast) (Anaes.); or - suspected slipped capital femoral epiphysis (R) (NK) (Contrast) (Anaes.); or - suspected Perthes disease (R) (NK) (Contrast) (Anaes.)
63518	01SEP1998	31DEC9999	Y	- spinal canal stenosis (R) (Anaes.)
63519	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (Contrast) (Anaes.)
63519	01OCT2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow for a patient under 16 years following radiographic examination where a significant fracture or avulsion injury is suspected that will change management (R) (Contrast) (Anaes.)
63519	01MAY2020	31DEC9999	Y	MRI-scan of elbow following radiographic examination for a patient under 16 years if a significant fracture or avulsion injury, which would change the way in which the patient is managed, is suspected (R) (Contrast)
63520	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (NK) (Contrast) (Anaes.)
63520	01OCT2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow for a patient under 16 years following radiographic examination where a significant fracture or avulsion injury is suspected that will change management (R) (NK) (Contrast) (Anaes.)
63521	01SEP1998	31DEC9999	Y	- previous spinal surgery (R) (Anaes.)
63522	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.)
63522	01OCT2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist for a patient under 16 years following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.)
63522	01MAY2020	31DEC9999	Y	MRI-scan of wrist following radiographic examination for a patient under 16 years if a scaphoid fracture is suspected (R) (Contrast)
63523	01NOV2012	30SEP2013	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (NK) (Contrast) (Anaes.)
63523	01OCT2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist for a patient under 16 years following radiographic examination where scaphoid fracture is suspected (R) (NK) (Contrast) (Anaes.)
63524	01SEP1998	31DEC9999	Y	- trauma (R) (Anaes.)
63525	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.); or - unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or - paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.)
63526	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any or the following: - significant trauma (R) (Contrast) (Anaes.); or - unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or - unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.)
63527	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (Contrast) (Anaes.)
63528	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: - suspected septic arthritis (R) (Contrast) (Anaes.); - suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); - suspected Perthes disease (R) (Contrast) (Anaes.)
63529	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (Contrast) (Anaes.)
63530	01NOV2012	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.)
63531	01NOV2019	30APR2020	N	MRI - scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has a breast lesion; and the results of conventional imaging are inconclusive for the presence of breast cancer; and biopsy has not been possible. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (K) (Anaes.) (Contrast)
63531	01MAY2020	31DEC9999	Y	MRI-scan of both breasts, if: (a) a dedicated breast coil is used; and(b) the request for the scan identifies that:(i) the patient has a breast lesion; and(ii) the results of conventional imaging are inconclusive for the presence of breast cancer; and(iii) biopsy has not been possible (R) (Contrast)
63532	01NOV2019	31DEC9999	Y	MRI - scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has a breast lesion; and the results of conventional imaging are inconclusive for the presence of breast cancer; and biopsy has not been possible. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (NK) (Anaes.) (Contrast)
63533	01NOV2019	30APR2020	N	MRI - scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has been diagnosed with a breast cancer; and there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and the results of breast MRI imaging may alter treatment planning. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (K) (Anaes.) (Contrast)
63533	01MAY2020	31DEC9999	Y	MRI-scan of both breasts, if: (a) a dedicated breast coil is used; and(b) the request for the scan identifies that:(i) the patient has been diagnosed with a breast cancer; and(ii) there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and(c) the results of breast MRI imaging may alter treatment planning (R) (Contrast)
63534	01NOV2019	31DEC9999	Y	MRI - scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has been diagnosed with a breast cancer;and there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and the results of breast MRI imaging may alter treatment planning. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (NK) (Anaes.) (Contrast)
63539	01JUL2024	31DEC9999	Y	MRI-scan of the abdomen, requested by a specialist or consultant physician, to assess the development or growth of renal tumours in a patient with a confirmed clinical or molecular diagnosis of a genetic disorder associated with an increased risk of developing renal tumours, other than a service to which item 63540 applies Applicable once in any 12 month period (R) (Contrast)
63540	01JUL2024	31DEC9999	Y	MRI-scan of the abdomen, requested by a specialist or consultant physician, to assess a patient with one or more known renal tumours and with a confirmed clinical or molecular diagnosis of a genetic disorder associated with an increased risk of developing renal tumours, if the service is performed: (a) to evaluate changes in clinical condition or suspected complications of the known renal tumours; or (b) where a disease specific line of treatment has been initiated and an assessment of patient responsiveness to the treatment is required Applicable once in any 3 month period (R) (Contrast)
63541	01JUL2018	30JUN2020	N	Multiparametric Magnetic Resonance Imaging scan of the prostate for the detection of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and the request for the scan identifies:that the patient is suspected of developing prostate cancer, due to one of the following: (i) a digital rectal examination which is suspicious for prostate cancer; or (ii) in a person under 70 years, at least two prostate specific antigen (PSA) tests performed within an interval of 1- 3 months are greater than 3.0 ng/ml, and the free/total PSA ratio is less than 25% or the repeat PSA exceeds 5.5 ng/ml; or (iii) in a person under 70 years, whose risk of developing prostate cancer based on relevant family history is at least double the average risk, at least two PSA tests performed within an interval of 1- 3 months are greater than 2.0 ng/ml, and the free/total PSA ratio is less than 25%; or (iv) in a person 70 years or older, at least two PSA tests performed within an interval of 1- 3 months are greater than 5.5ng/ml and the free/total PSA ratio is less than 25%.using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated) (R) (K) Note: Benefits are payable on one occasion only in any 12 month period. Relevant family history is a first degree relative with prostate cancer, or suspected of carrying a BRCA 1 or BRCA 2 mutation.
63541	01JUL2020	31OCT2021	N	Multiparametric Magnetic Resonance Imaging scan of the prostate for the detection of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and the request for the scan identifies: that the patient is suspected of developing prostate cancer, due to one of the following: (i) a digital rectal examination which is suspicious for prostate cancer; or (ii) in a person under 70 years, at least two prostate specific antigen (PSA) tests performed within an interval of 1- 3 months are greater than 3.0 ng/ml, and the free/total PSA ratio is less than 25% or the repeat PSA exceeds 5.5 ng/ml; or (iii) in a person under 70 years, whose risk of developing prostate cancer based on relevant family history is at least double the average risk, at least two PSA tests performed within an interval of 1- 3 months are greater than 2.0 ng/ml, and the free/total PSA ratio is less than 25%; or (iv) in a person 70 years or older, at least two PSA tests performed within an interval of 1- 3 months are greater than 5.5ng/ml and the free/total PSA ratio is less than 25%.using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated) (R) Note: Benefits are payable on one occasion only in any 12 month period. Relevant family history is a first degree relative with prostate cancer, or suspected of carrying a BRCA 1 or BRCA 2 mutation.
63541	01NOV2021	31DEC9999	Y	Multiparametric MRI-scan of the prostate for the detection of cancer, requested by a specialist in the speciality of urology, radiation oncology or medical oncology: (a) if the request for the scan identifies that the patient is suspected of developing prostate cancer: (i) on the basis of a digital rectal examination; or (ii) in the circumstances mentioned in clause 2.5.9A; and (b) using a standardised image acquisition protocol involving: (i) T2-weighted imaging; and (ii) diffusion-weighted imaging; and (iii) (unless contraindicated) dynamic contrast enhancement (R) Note: See explanatory note IN.5.1 for the meaning of Clause 2.5.9 in the descriptor for this item and the claiming limitations.
63542	01JUL2018	31DEC9999	Y	Multiparametric Magnetic Resonance Imaging scan of the prostate for the detection of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and the request for the scan identifies:that the patient is suspected of developing prostate cancer, due to one of the following: (i) a digital rectal examination which is suspicious for prostate cancer; or (ii) in a person under 70 years, at least two prostate specific antigen (PSA) tests performed within an interval of 1- 3 months are greater than 3.0 ng/ml, and the free/total PSA ratio is less than 25% or the repeat PSA exceeds 5.5 ng/ml; or (iii) in a person under 70 years, whose risk of developing prostate cancer based on relevant family history is at least double the average risk, at least two PSA tests performed within an interval of 1- 3 months are greater than 2.0 ng/ml, and the free/total PSA ratio is less than 25%; or (iv) in a person 70 years or older, at least two PSA tests performed within an interval of 1- 3 months are greater than 5.5ng/ml and the free/total PSA ratio is less than 25%.using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated) (R) (NK) Note: Benefits are payable on one occasion only in any 12 month period. Relevant family history is a first degree relative with prostate cancer, or suspected of carrying a BRCA 1 or BRCA 2 mutation.
63543	01JUL2018	30JUN2020	N	Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and: the request for the scan identifies: (i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) the patient is not planning or undergoing treatment for prostate cancer. using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)(R) (K) Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression. This item is not to be used for the purposes of treatment planning or for monitoring after treatment.
63543	01JUL2020	31OCT2021	N	Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and: the request for the scan identifies: (i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) the patient is not planning or undergoing treatment for prostate cancer. using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)(R) Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression. This item is not to be used for the purposes of treatment planning or for monitoring after treatment.
63543	01NOV2021	31DEC9999	Y	Multiparametric MRI-scan of the prostate for the assessment of cancer, requested by a specialist in the speciality of urology, radiation oncology or medical oncology: (a) if the request for the scan identifies that the patient: (i) is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) is not undergoing, or planning to undergo, treatment for prostate cancer; and (b) using a standardised image acquisition protocol involving: (i) T2-weighted imaging; and (ii) diffusion-weighted imaging; and (iii) (unless contraindicated) dynamic contrast enhancement (R) Note: See explanatory note IN.5.2 for claiming restrictions for this item.
63544	01JUL2018	31DEC9999	Y	Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and: the request for the scan identifies: (i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) the patient is not planning or undergoing treatment for prostate cancer. using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)(R) (NK) Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression. This item is not to be used for the purposes of treatment planning or for monitoring after treatment
63545	01MAY2019	30APR2020	N	Note: Benefits are payable on only one occasion in any 12-month period MAGNETIC RESONANCE IMAGING with a contrast agent - multiphase scans of the liver (including delayed imaging, when performed) - performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or consultant physician - for characterisation or intervention planning, in a patient with: known colorectal carcinoma; and known, suspected, or possible liver metastasis; and previous computed tomography or ultrasound imaging has identified a mass lesion in the liver. For use with HEPATOBILIARY-SPECIFIC CONTRAST AGENT (item 63496). If a patient has known or suspected clinical indication/s considered by a specialist or consultant physician to indicate the need for imaging with an extracellular contrast agent, the modifying MRI item 63491 can be used with this item. Fee: $550 Benefit: 75% = $412.50 85% = $467.50 (R) (K) (Anaes.) (See IN.0.18, IN.0.19 of explanatory notes to this category)
63545	01MAY2020	31OCT2022	N	MRI - multiphase scans of liver (including delayed imaging, if performed) with a contrast agent, for characterisation or intervention planning, if:(a) the patient has: (i) known colorectal carcinoma; and(ii) known, suspected, or possible liver metastasis; and(b) computed tomography, or ultrasound imaging, has identified a mass lesion in patients liver.For any particular patient-applicable not more than once in a 12 month period (R) (Contrast)
63545	01NOV2022	30JUN2023	N	MRI-multiphase scans of liver (including delayed imaging, if performed) with a contrast agent, for staging where surgical resection or interventional techniques are under consideration to treat any liver metastases detected, if: (a) the patient has a confirmed extra-hepatic primary malignancy (other than hepatocellular carcinoma), with no persistent extra-hepatic disease; and (b) computed tomography of the patients liver is negative or inconclusive for metastatic disease; and (c) the identification of liver metastases would change the patients treatment planning Applicable not more than once in a 12 month period (R) (Contrast)
63545	01JUL2023	31DEC9999	Y	MRI - multiphase scans of liver (including delayed imaging, if performed) with a contrast agent, for characterisation, or staging where surgical resection or interventional techniques are under consideration, if: (a) the patient has a confirmed extra-hepatic primary malignancy (other than hepatocellular carcinoma); and (b) computed tomography is negative or inconclusive for hepatic metastatic disease; and (c) the identification of liver metastases would change the patients treatment planning Applicable not more than once in a 12 month period (R) (Contrast)
63546	01MAY2019	30APR2020	N	Note: Benefits are payable on only one occasion in any 12-month period MAGNETIC RESONANCE IMAGING with a contrast agent - multiphase scans of the liver (including delayed imaging, when performed) - performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or consultant physician - for diagnosis or staging, in a patient with known or suspected hepatocellular carcinoma, and: chronic liver disease, that has been confirmed by a specialist or consultant physician; and liver function identified as Child-Pugh class A or B; and an identified hepatic lesion over 10 mm in diameter. For use with HEPATOBILIARY-SPECIFIC CONTRAST AGENT (item 63496). If a patient has known or suspected clinical indication/s considered by a specialist or consultant physician to indicate the need for imaging with an extracellular contrast agent, the modifying MRI item 63491 can be used with this item. Fee: $550 Benefit: 75% = $412.50 85% = $467.50 (R) (K) (Anaes.) (See IN.0.18, IN.0.19 of explanatory notes to this category)
63546	01MAY2020	31DEC9999	Y	MRI - multiphase scans of the liver (including delayed imaging, if performed) with a contrast agent, for diagnosis or staging, if: (a) the patient has:(i) known or suspected hepatocellular carcinoma; and(ii) chronic liver disease that has been confirmed by a specialist or consultant physician; and(b) the patients liver function has been identified as Child Pugh class A or B; and(c) the patient has an identified hepatic lesion over 10 mm in diameter.For any particular patient-applicable not more than once in a 12 month period (R) (Contrast)
63547	01MAY2018	30APR2020	N	MRI scan of both breasts for the detection of cancer, if (a) a dedicated breast coil is used; and (b) the request for the scan identifies that: (i) the patient has a breast implant in situ; and (ii) anaplastic large cell lymphoma has been diagnosed NOTE: benefits are payable once in a patient's lifetime (R) (K) (Contrast)
63547	01MAY2020	31DEC9999	Y	MRI-scan of both breasts for the detection of cancer, if: (a) a dedicated breast coil is used; and(b) the request for the scan identifies that:(i) the patient has a breast implant in situ; and(ii) anaplastic large cell lymphoma has been diagnosed(R) (Contrast)
63548	01MAY2018	31DEC9999	Y	MRI scan of both breasts for the detection of cancer, if (a) a dedicated breast coil is used; and (b) the request for the scan identifies that: (i) the patient has a breast implant in situ; and (ii) anaplastic large cell lymphoma has been diagnosed NOTE: benefits are payable once in a patient's lifetime (R) (NK) (Contrast)
63549	01NOV2022	31DEC9999	Y	MRI scan of the pelvis or abdomen, for a patient with a multiple pregnancy, if: (a) the multiple pregnancy is at, or after, 18 weeks gestation; and (b) fetal abnormality is suspected; and (c) an ultrasound has been performed and is provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics; and (d) the diagnosis of fetal abnormality as a result of the ultrasound is indeterminate or requires further examination; and (e) the MRI service is requested by a specialist practising in the specialty of obstetrics (R) (Contrast)
63550	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 14 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for monitoring of: - demyelinating disease (R) (Anaes.)
63551	01NOV2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient 16 years or older for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.) - unexplained chronic headache with suspected intracranial pathology (R) (Contrast) (Anaes.)
63551	01MAY2020	30JUN2020	N	Scan of head for a patient 16 years or older, after a request by a medical practitioner (other than a specialist or consultant physician), for any of the following: (a) unexplained seizure(s);(b) unexplained chronic headache with suspected intracranial pathology (R) (Contrast)
63551	01JUL2020	31DEC9999	Y	MRI - scan of head for a patient 16 years or older, after a request by a medical practitioner (other than a specialist or consultant physician), for any of the following: (a) unexplained seizure(s);(b) unexplained chronic headache with suspected intracranial pathology (R) (Contrast)
63552	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient 16 years or older for any of the following: - unexplained seizure(s) (R) (NK) (Contrast) (Anaes.) - unexplained chronic headache with suspected intracranial pathology (R) (NK) (Contrast) (Anaes.)
63553	01SEP1998	31DEC9999	Y	- congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.)
63554	01NOV2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical radiculopathy (R) (Contrast) (Anaes.)
63554	01MAY2020	30JUN2020	N	Scan of spine for a patient 16 years or older, after referral by a medical practitioner (other than a specialist or consultant physician), for suspected cervical radiculopathy (R) (Contrast)
63554	01JUL2020	31DEC9999	Y	MRI - scan of spine for a patient 16 years or older, after referral by a medical practitioner (other than a specialist or consultant physician), for suspected cervical radiculopathy (R) (Contrast)
63555	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical radiculopathy (R) (NK) (Contrast) (Anaes.)
63556	01SEP1998	31DEC9999	Y	- myelopathy (R) (Anaes.)
63557	01NOV2013	30APR2020	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical spine trauma (R) (Contrast) (Anaes.)
63557	01MAY2020	30JUN2020	N	Scan of spine for a patient 16 years or older, after referral by a medical practitioner (other than a specialist or consultant physician), for suspected cervical spinal trauma (R) (Contrast)
63557	01JUL2020	31DEC9999	Y	MRI - scan of spine for a patient 16 years or older, after referral by a medical practitioner (other than a specialist or consultant physician), for suspected cervical spinal trauma (R) (Contrast)
63558	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical spine trauma (R) (NK) (Contrast) (Anaes.)
63559	01SEP1998	31DEC9999	Y	- syrinx (congenital or acquired) (R) (Anaes.)
63560	01NOV2013	31OCT2018	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: - inability to extend the knee suggesting the possibility of acute meniscal tear (R) (Contrast) (Anaes.); or - clinical findings suggesting acute anterior cruciate ligament tear. (R) (Contrast) (Anaes.)
63560	01NOV2018	30APR2020	N	MRI - scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient aged 16 to 49 years with: inability to extend the knee suggesting the possibility of acute meniscal tear; or clinical findings suggesting acute anterior cruciate ligament tear. (R) (K) (Contrast) (Anaes.)
63560	01MAY2020	30JUN2020	N	Scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient 16 to 49 years with: (a) inability to extend the knee suggesting the possibility of acute meniscal tear; or(b) clinical findings suggesting acute anterior cruciate ligament tear (R) (Contrast)
63560	01JUL2020	31DEC9999	Y	MRI - scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient 16 to 49 years with: (a) inability to extend the knee suggesting the possibility of acute meniscal tear; or(b) clinical findings suggesting acute anterior cruciate ligament tear (R) (Contrast)
63561	01NOV2013	31OCT2018	N	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: - inability to extend the knee suggesting the possibility of acute meniscal tear (R) (NK) (Contrast) (Anaes.); or - clinical findings suggesting acute anterior cruciate ligament tear. (R) (NK) (Contrast) (Anaes.)
63561	01NOV2018	31DEC9999	Y	MRI - scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient aged 16 to 49 years with: inability to extend the knee suggesting the possibility of acute meniscal tear; or clinical findings suggesting acute anterior cruciate ligament tear. (R) (NK) (Contrast) (Anaes.)
63562	01SEP1998	31DEC9999	Y	- cervical radiculopathy (R) (Anaes.)
63563	01NOV2022	31DEC9999	Y	MRI scan of the pelvis or abdomen, if the request for the scan identifies that the investigation is for: (a) sub-fertility that requires one or more of the following: (i) an investigation of suspected Mullerian duct anomaly seen in pelvic ultrasound or hysterosalpingogram; (ii) an assessment of uterine mass identified on pelvic ultrasound before consideration of surgery; (iii) an investigation of recurrent implantation failure in IVF (2 or more embryo transfer cycles without viable pregnancy); or (b) surgical planning of a patient with known or suspected deep endometriosis involving the bowel, bladder or ureter (or any combination of the bowel, bladder or ureter), where the results of pelvic ultrasound are inconclusive Applicable not more than once in a 2 year period (R) (Contrast)
63564	01MAR2023	31DEC9999	Y	Note: the requirements for services provided under item 63564 are detailed under note IN.5.4 MRI - whole body scan for the early detection of cancer: a) requested by a specialist or consultant physician in consultation with a clinical geneticist in a familial cancer or genetic clinic; and b) the request identifies that the patient has a high risk of developing cancer malignancy due to heritable TP53 - related cancer (hTP53rc) syndrome (R)
63565	01SEP1998	31DEC9999	Y	- sciatica (R) (Anaes.)
63568	01SEP1998	31DEC9999	Y	- spinal canal stenosis (R) (Anaes.)
63571	01SEP1998	31DEC9999	Y	- previous spinal surgery (R) (Anaes.)
63574	01SEP1998	31DEC9999	Y	- trauma (R) (Anaes.)
63580	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for monitoring of: - infection (R) (Anaes.)
63583	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63584	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient 16 years or older for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.) - unexplained chronic headache with suspected intracranial pathology (R) (Contrast) (Anaes.)
63585	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical radiculopathy (R) (Contrast) (Anaes.)
63586	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical spine trauma (R) (Contrast) (Anaes.)
63587	01NOV2013	31DEC9999	Y	referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: - inability to extend the knee suggesting the possibility of acute meniscal tear (R) (Contrast) (Anaes.); or - clinical findings suggesting acute anterior cruciate ligament tear (R) (Contrast) (Anaes.)
63590	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for monitoring of: - infection (R) (Anaes.)
63593	01SEP1998	31DEC9999	Y	- tumour (R) (Anaes.)
63600	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 17 on one occasion only in a 12 month period for one service per item per episode MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for the exclusion of: - tumour arising in bone or other connective tissue (R) (Anaes.)
63603	01SEP1998	31DEC9999	Y	- infection arising in bone or other connective tissue (R) (Anaes.)
63606	01SEP1998	31DEC9999	Y	- osteonecrosis (R) (Anaes.)
63609	01SEP1998	31DEC9999	Y	- derangement of hip or its supporting structures (R) (Anaes.)
63612	01SEP1998	31DEC9999	Y	- derangement of shoulder or its supporting structures (R) (Anaes.)
63615	01SEP1998	31DEC9999	Y	- derangement of knee or its supporting structures (R) (Anaes.)
63618	01SEP1998	31DEC9999	Y	- derangement of ankle or its supporting structures (R) (Anaes.)
63621	01SEP1998	31DEC9999	Y	- derangement of temporomandibular joint or its supporting structures (R) (Anaes.)
63624	01SEP1998	31DEC9999	Y	- derangement of wrist or its supporting structures (R) (Anaes.)
63627	01SEP1998	31DEC9999	Y	- derangement of elbow or its supporting structures (R) (Anaes.)
63650	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 18 on one occasion only in a 12 month period, for one service per item per episode. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for further investigation of: - tumour arising in bone or other connective tissue (R) (Anaes.)
63653	01SEP1998	31DEC9999	Y	- infection arising in bone or other connective tissue (R) (Anaes.)
63656	01SEP1998	31DEC9999	Y	- osteonecrosis (R) (Anaes.))
63659	01SEP1998	31DEC9999	Y	- derangement of hip or its supporting structures (R) (Anaes.)
63662	01SEP1998	31DEC9999	Y	- derangement of shoulder or its supporting structures (R) (Anaes.)
63665	01SEP1998	31DEC9999	Y	- derangement of knee or its supporting structures (R) (Anaes.)
63668	01SEP1998	31DEC9999	Y	- derangement of ankle or its supporting structures (R) (Anaes.)
63671	01SEP1998	31DEC9999	Y	- derangement of temporomandibular joint or its supporting structures (R) (Anaes.)
63674	01SEP1998	31DEC9999	Y	- derangement of wrist or its supporting structures (R) (Anaes.)
63677	01SEP1998	31DEC9999	Y	- derangement of elbow or its supporting structures (R) (Anaes.)
63680	01SEP1998	31DEC9999	Y	- post-inflammatory or post-traumatic physeal fusion in a person under 16 years of age (R) (Anaes.)
63700	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in a 12 month period, for one service per item per episode. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for monitoring of: - derangement of hip or its supporting structures (R) (Anaes.)
63703	01SEP1998	31DEC9999	Y	- derangement of shoulder or its supporting structures (R) (Anaes.)
63706	01SEP1998	31DEC9999	Y	- derangement of knee or its supporting structures (R) (Anaes.)
63709	01SEP1998	31DEC9999	Y	- derangement of ankle or its supporting structures (R) (Anaes.)
63712	01SEP1998	31DEC9999	Y	- derangement of temporomandibular joint or its supporting structures (R) (Anaes.)
63715	01SEP1998	31DEC9999	Y	- derangement of wrist or its supporting structures (R) (Anaes.)
63718	01SEP1998	31DEC9999	Y	- derangement of elbow or its supporting structures (R) (Anaes.)
63721	01SEP1998	31DEC9999	Y	- post-inflammatory or post-traumatic physeal fusion in a person under 16 years of age (R) (Anaes.)
63736	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for monitoring of: - osteonecrosis (R) (Anaes.)
63739	01SEP1998	31DEC9999	Y	- tumour arising in bone or other connective tissue (R) (Anaes.)
63740	01NOV2014	30APR2020	N	MRI to evaluate small bowel Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients: (a) Evaluation of disease extent at time of initial diagnosis of Crohn's disease (b) Evaluation of exacerbation/suspected complications of known Crohn's disease (c) Evaluation of known or suspected Crohn's disease in pregnancy (d) Assessment of change to therapy in patients with small bowel Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (K) (Contrast)
63740	01MAY2020	31DEC9999	Y	MRI-scan to evaluate small bowel Crohns disease if the service is provided to a patient for: (a) evaluation of disease extent at time of initial diagnosis of Crohns disease; or(b) evaluation of exacerbation, or suspected complications, of known Crohns disease; or(c) evaluation of known or suspected Crohns disease in pregnancy; or(d) assessment of change to therapy in a patient with small bowel Crohns disease (R) (Contrast)
63741	01NOV2014	30APR2020	N	MRI enteroclysis for Crohn's disease. Medicare benefits are only payable for this item if the service is related to item 63740. (R) (K)
63741	01MAY2020	31DEC9999	Y	MRI-scan with enteroclysis for Crohns disease if the service is related to item 63740 (R)
63742	01SEP1998	31DEC9999	Y	- infection arising in bone or other connective tissue (R) (Anaes.)
63743	01NOV2014	30APR2020	N	MRI for fistulising perianal Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients for: - Evaluation of pelvic sepsis and fistulas associated with established or suspected Crohn's disease - Assessment of change to therapy of pelvis sepsis and fistulas from Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (K) (Contrast)
63743	01MAY2020	31DEC9999	Y	MRI-scan for fistulising perianal Crohns disease if the service is provided to a patient for:(a) evaluation of pelvic sepsis and fistulas associated with established or suspected Crohns disease; or(b) assessment of change to therapy of pelvis sepsis and fistulas from Crohns disease (R) (Contrast)
63744	01NOV2014	31DEC9999	Y	MRI to evaluate small bowel Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients: (a) Evaluation of disease extent at time of initial diagnosis of Crohn's disease (b) Evaluation of exacerbation/suspected complications of known Crohn's disease (c) Evaluation of known or suspected Crohn's disease in pregnancy (d) Assessment of change to therapy in patients with small bowel Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (NK) (Contrast)
63745	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 21 on two occasions only in a 12 month period, and for a maximum of one service per item per episode of care. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for further investigation or monitoring of: - Gaucher disease (R) (Anaes.)
63746	01NOV2014	31DEC9999	Y	MRI enteroclysis for Crohn's disease. Medicare benefits are only payable for this item if the service is related to item 63744. (R) (NK)
63747	01NOV2014	31DEC9999	Y	MRI for fistulising perianal Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients for: - Evaluation of pelvic sepsis and fistulas associated with established or suspected Crohn's disease - Assessment of change to therapy of pelvis sepsis and fistulas from Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (NK) (Contrast)
63750	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 22 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for further investigation of: - congenital disease of the heart or a great vessel (R) (Anaes.)
63753	01SEP1998	31DEC9999	Y	- tumour of the heart or a great vessel (R) (Anaes.)
63756	01SEP1998	31DEC9999	Y	- abnormality of thoracic aorta (R) (Anaes.)
63800	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 23 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for monitoring of: - congenital disease of the heart or a great vessel (R) (Anaes.)
63803	01SEP1998	31DEC9999	Y	- tumour of the heart or a great vessel (R) (Anaes.)
63806	01SEP1998	31DEC9999	Y	- abnormality of the thoracic aorta (R) (Anaes.)
63850	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 24 on two occasions only in a 12 month period MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for exclusion of or further investigation of: - stroke (R) (Anaes.)
63853	01SEP1998	31DEC9999	Y	- carotid or vertebral artery dissection (R) (Anaes.)
63856	01SEP1998	31DEC9999	Y	- intracranial aneurysm (R) (Anaes.)
63859	01SEP1998	31DEC9999	Y	- intracranial arteriovenous malformation (R) (Anaes.)
63862	01SEP1998	31DEC9999	Y	- venous sinus thrombosis (R) (Anaes.)
63865	01SEP1998	31DEC9999	Y	- vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Anaes.)
63868	01SEP1998	31DEC9999	Y	- obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Anaes.)
63870	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 25 on one occasion only in a 12 month period MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system of a person under the age of 16 years for further investigation of: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Anaes.)
63880	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for monitoring of: - carotid or vertebral artery dissection (R) (Anaes.)
63883	01SEP1998	31DEC9999	Y	- venous sinus thrombosis (R) (Anaes.)
63900	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for each service included by Subgroup 27 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for further investigation of: - pelvic or abdominal mass (R) (Anaes.)
63903	01SEP1998	31DEC9999	Y	- mediastinal mass (R) (Anaes.)
63906	01SEP1998	31DEC9999	Y	- congenital uterine or anorectal abnormality (R) (Anaes.)
63909	01SEP1998	31DEC9999	Y	- Gaucher disease (R) (Anaes.)
63920	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for the each service included by item 63920 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body for further investigation of: - adrenal mass in a patient with a malignancy which is otherwise resectable (R) (Anaes.)
63930	01SEP1998	31DEC9999	Y	NOTE: Benefits are payable for the each service included by item 63930 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for monitoring of: - congenital uterine or anorectal abnormality (R) (Anaes.)
63940	01SEP1998	31DEC9999	Y	MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for monitoring of: - mediastinal mass (R) (Anaes.)
63943	01SEP1998	31DEC9999	Y	- pelvic or abdominal mass (R) (Anaes.)
63946	01SEP1998	31DEC9999	Y	- Gaucher disease (R) (Anaes.)
63960	01MAY2004	31DEC9999	Y	Note: Benefits are payable for each service included by Subgroup 31 on one occasion only. Magnetic Resonance Imaging, performed under the professional supervision of an eligible provider at an eligible location where: (a) the patient is referred by a specialist or by a consultant physician; and (b) the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater. Scan for the further investigation of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R)
63963	01MAY2004	31DEC9999	Y	- Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R)
64990	01FEB2004	31DEC2021	N	A diagnostic imaging service to which an item in this table (other than this item or item 64991) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
64990	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64991, 64992, 64993, 64994 or 64995) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
64991	01MAY2004	31AUG2004	N	A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital or day-hospital facility: and (d) the service is bulk-billed in respect of the fees for: (i) this item: and (ii) the other item in this table applying to the service (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania
64991	01SEP2004	31DEC2019	N	A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC)
64991	01JAN2020	31DEC2021	N	A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location within Modified Monash areas 2 to 7.
64991	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64990, 64992, 64993, 64994 or 64995) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 2 area
64992	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64990, 64991, 64993, 64994 or 64995) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a Modified Monash 3 are; or (ii) a Modified Monash 4 area
64993	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64990, 64991, 64992, 64994 or 64995) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 5 area
64994	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64990, 64991, 64992, 64993 or 64995) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 6 area
64995	01JAN2022	31DEC9999	Y	A diagnostic imaging service to which an item in this table (other than this item or item 64990, 64991, 64992, 64993 or 64994) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 7 area
65001	01DEC1991	30JUN1994	N	Blood count consisting of erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count 1 or 2 procedures
65001	01JUL1994	31DEC9999	Y	Erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, or reticulocyte count 1 or 2 tests
65002	01DEC1991	31DEC9999	Y	Blood count consisting of erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count one or two procedures.
65003	01DEC1991	30JUN1994	N	3 or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices
65003	01JUL1994	31DEC9999	Y	3 or more tests described in 65001, and calculation or measurement of cell index or indices
65004	01DEC1991	31DEC9999	Y	Three or more procedures to which item 65001/65002 applies, including any calculation or measurement of erythrocyte or other indices
65005	01DEC1991	30JUN1994	N	Examination of blood film, with or without 5 part differential cell count, or 5 part differential cell count with or without examination of blood film, and if performed, any of these additional services Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alphanaphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027
65005	01JUL1994	19MAR1997	N	Examination of blood film, or 5 part differential cell count, or both 5 part differential cell count and examination of blood film, including (if performed): (a) a service described in item 65027; and (b) any of the following services: (i) examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron; (ii) examination of a blood film with alphanaphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff or Sudan Black stains; (iii) Kleihauer test for HbF on blood film
65005	20MAR1997	31DEC9999	Y	Examination of: (a) a blood film by special stains to demonstrate Heinz bodies, parasites or iron; or (b) a blood film by enzyme cytochemistry for neutrophil alkaline phosphatese, alphanaphthyl acetate esterase or chloroacetate esterase; or (c) a blood film using any other special staining methods including periodic acid Schiff and Sudan black; or (d) a urinary sediment for haemosiderin including a service described in item 65072
65006	01DEC1991	31DEC9999	Y	Examination of blood film, with or without five part differential cell count, or five part differential cell count with or without examination of blood film, and if performed, any of these additional services Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alphanaphthylacetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027/65028
65007	01DEC1991	30JUN1994	N	Full blood examination consisting of items 65003 and 65005
65007	01JUL1994	31DEC9999	Y	Full blood examination (consisting of the services described in items 65003 and 65005)
65008	01DEC1991	31DEC9999	Y	Full blood examination consisting of items 65003/65004 and 65005/65006
65009	01DEC1991	30JUN1994	N	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine 1 or more procedures
65009	01JUL1994	31DEC9999	Y	Haemolysis or metabolic enzymes - assessment by: (a) erythrocyte autohaemolysis test; (b) erythrocyte fragility test; (c) sugar water test; (d) erythrocyte metabolic enzyme test; (e) heat denaturation test; (f) isopropanol precipitation test; (g) acid haemolysis test;and (h) quantitation of muramidase in serum or urine; 1 or more tests
65010	01DEC1991	31DEC9999	Y	Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine one or more procedures
65011	01DEC1991	30JUN1994	N	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005, and 65007
65011	01JUL1994	31DEC9999	Y	Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential count including any services in item 65060 or 65072 2 or more instrument generated results from a single sample
65012	01DEC1991	31DEC9999	Y	Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the following examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008
65013	01DEC1991	30JUN1994	N	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015
65013	01JUL1994	31DEC9999	Y	Bone marrow trephine biopsy - histopathological examination of sections of bone marrow, including (if performed): (a) examination of aspirated material; and (b) special stains or immunochemical techniques (if any); and (c) a service described in item 65001, 65003, 65005, 65007 or 65015
65014	01DEC1991	31DEC9999	Y	Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001/65002, 65003/65004, 65005/65006, 65007/65008 and 65015/65016
65015	01DEC1991	30JUN1994	N	Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007
65015	01JUL1994	31DEC9999	Y	Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): (a) special stains or immunochemical techniques (if any); and (b) a service described in item 65001, 65003, 65005 or 65007
65016	01DEC1991	31DEC9999	Y	Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008
65017	01DEC1991	30JUN1994	N	Blood grouping, including backgrouping when performed ABO and Rh (D antigen)
65017	01JUL1994	31DEC9999	Y	Blood grouping (including backgrouping if performed) ABO and Rh (D antigen)
65018	01DEC1991	31DEC9999	Y	Blood grouping, including backgrouping when performed ABO and Rh (D antigen).
65019	01DEC1991	30JUN1994	N	Blood grouping Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system 1 or more systems, including any services specified in item 65017
65019	01JUL1994	31DEC9999	Y	Blood grouping Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system 1 or more systems, including a service described in item 65017 (if performed)
65020	01DEC1991	31DEC9999	Y	Blood grouping Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system one or more systems, including any services specified in item 65017/65018
65021	01DEC1991	30JUN1994	N	Blood grouping, including backgrouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007
65021	01JUL1994	31DEC9999	Y	Blood grouping (including backgrouping if performed), and examination of serum for Rh and other blood group antibodies, including: (a) identification and quantitation of any antibodies detected; and (b) (if performed) a service described in item 65001, 65003, 65005 or 65007
65022	01DEC1991	31DEC9999	Y	Blood grouping, including backgrouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008
65023	01DEC1991	30JUN1994	N	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any 1 day
65023	01JUL1994	31DEC9999	Y	Compatibility tests - all tests performed on any 1 day, including: (a) all grouping checks of patient and donor; and (b) examination for antibodies, and, if necessary, quantitation of any antibodies detected; and (c) a service described in item 65001, 65003, 65005, 65007, 65017 or 65021 (if performed)
65024	01DEC1991	31DEC9999	Y	Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001/65002, 65003/65004, 65005/65006, 65007/65008, 65017/65018 and 65021/65022 including all testing performed on any one day
65025	01DEC1991	30JUN1994	N	Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected
65025	01JUL1994	31DEC9999	Y	Examination of serum for blood group antibodies (including identification and, if necessary, quantitation of any antibodies detected)
65026	01DEC1991	31DEC9999	Y	Examination of serum for blood group antibodies including identification and, if necessary, quantative estimation of any antibodies detected
65027	01DEC1991	30JUN1994	N	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including those services specified in items 65005 and 65007 1 or more tests
65027	01JUL1994	31DEC9999	Y	1 or more of the following tests (a) direct Coombs test; (b) qualitative or quantitative test for cold agglutinins or heterophile antibodies; (c) qualitative spectroscopic examination of blood for abnormal haemoglobins; (d) qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test)
65028	01DEC1991	31DEC9999	Y	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examinations of blood for abnormal haemoglobins, qua;itative test for red cell porphyrins and detected of metalbumin (Schumm's test) including those services specified in items 65005/65006 and 65007/65008 - one or more tests
65029	01DEC1991	30JUN1994	N	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of fibrinogen degradation products, fibrin monomer or Ddimer 1 estimation
65029	01JUL1994	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of: fibrinogen degradation products, fibrin monomer or Ddimer 1 test
65030	01DEC1991	31DEC9999	Y	Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one of fibrinogen degradation products, fibrin monomer or Ddimer one estimation
65031	01DEC1991	30JUN1994	N	2 estimations specified in item 65029
65031	01JUL1994	31DEC9999	Y	2 tests described in item 65029
65032	01DEC1991	31DEC9999	Y	Two estimations specified in item 65029/65030
65033	01DEC1991	30JUN1994	N	3 estimations specified in item 65029
65033	01JUL1994	31DEC9999	Y	3 tests described in item 65029
65034	01DEC1991	31DEC9999	Y	Three estimations specified in item 65029/65030
65035	01DEC1991	30JUN1994	N	4 or more estimations specified in item 65029
65035	01JUL1994	31DEC9999	Y	4 or more tests described in item 65029
65036	01DEC1991	31DEC9999	Y	Four or more estimations specified in item 65029/65030
65037	01DEC1991	30JUN1994	N	Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant 1 estimation
65037	01JUL1994	31DEC9999	Y	Quantitation, by 1 or more techniques, of: plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant 1 to 3 tests
65038	01DEC1991	31DEC9999	Y	Quantitative assay, by one or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, Euglobulin clot lysis time and test for lupus anticoagulant one estimation.
65039	01DEC1991	30JUN1994	N	4 or more estimations specified in item 65037
65039	01JUL1994	31DEC9999	Y	4 or more tests described in item 65037
65040	01DEC1991	31DEC9999	Y	Four or more estimations specified in item 65037/65038
65041	01DEC1991	30JUN1994	N	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance 1 or more estimations
65041	01JUL1994	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance 1 or more tests
65042	01DEC1991	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance one or more estimations
65043	01DEC1991	30JUN1994	N	Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin 1 or more estimations
65043	01JUL1994	31DEC9999	Y	Heparin quantitation when monitoring a patient on subcutaneous heparin or low molecular weight heparin 1 or more tests
65044	01DEC1991	31DEC9999	Y	Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin one or more estimations
65045	01DEC1991	30JUN1994	N	Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor 1 estimation
65045	01JUL1994	31DEC9999	Y	Quantitation of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, or Passovy factor 1 test
65046	01DEC1991	31DEC9999	Y	Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor one estimation
65047	01DEC1991	30JUN1994	N	2 estimations specified in item 65045
65047	01JUL1994	31DEC9999	Y	2 tests described in item 65045
65048	01DEC1991	31DEC9999	Y	Two estimations as specified in item 65045/65046
65049	01DEC1991	30JUN1994	N	3 or more estimations specified in item 65045
65049	01JUL1994	31DEC9999	Y	3 or more tests described in item 65045
65050	01DEC1991	31DEC9999	Y	Three or more estimations as specified in item 65045/65046
65052	20MAR1997	31DEC9999	Y	Examination of a maternal blood film for the presence of fetal red blood cells (Kleihauer test) including any service described in item 65005 (if performed)
65053	20MAR1997	31DEC9999	Y	Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell surface antigens using flow cytometric methods including any service described in item 65007 or 65052 (if performed)
65060	01NOV1998	31DEC9999	Y	Haemoglobin, erythrocyte sedimentation rate, blood viscosity - 1 or more tests
65063	01NOV1998	31OCT1999	N	Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential count including any services in item 65060 or 65072 2 or more instrument generated results from a single sample
65063	01NOV1999	31DEC9999	Y	Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential count - not being a service where haemoglobin only is requested including any services in item 65060 or 65072 - 1 or more instrument generated results from a single sample
65066	01NOV1998	31DEC9999	Y	Examination of: (a) a blood film by special stains to demonstrate Heinz bodies, parasites or iron; or (b) a blood film by enzyme cytochemistry for neutrophil alkaline phosphatase, alpha-naphthyl acetate esterase or chloroacetate esterase; or (c) a blood film using any other special staining methods including periodic acid Schiff and Sudan Black; or (d) a urinary sediment for haemosiderin including a service described in item 65072
65069	01NOV1998	31DEC9999	Y	Full blood examination consisting of: (a) a morphological assessment of a blood film; (b) item 65063; and (c) (if performed) any test in item 65060 or 65072
65070	01NOV2000	30JUN2020	N	Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and manual or instrument generated differential count - not being a service where haemoglobin only is requested - one or more instrument generated set of results from a single sample; and (if performed) (a) a morphological assessment of a blood film; (b) any service in item 65060 or 65072
65070	01JUL2020	31DEC9999	Y	Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and manual or instrument generated differential count - not being a service where haemoglobin only is requested - one or more instrument generated sets of results from a single sample; and (if performed) (a) a morphological assessment of a blood film; (b) any service in item 65060 or 65072
65072	01NOV1998	30APR2005	N	Examination for reticulocytes including a reticulocyte count by any method - 1 or more tests in any episode
65072	01MAY2005	31DEC9999	Y	Examination for reticulocytes including a reticulocyte count by any method - 1 or more tests
65075	01NOV1998	31DEC9999	Y	Haemolysis or metabolic enzymes - assessment by: (a) erythrocyte autohaemolysis test; or (b) erythrocyte osmotic fragility test; or (c) sugar water test; or (d) G-6-P D (qualitative or quantitative) test; or (e) pyruvate kinase (qualitative or quantitative) test; or (f) acid haemolysis test; or (g) quantitation of muramidase in serum or urine; or (h) Donath Landsteiner antibody test; or (i) other erythrocyte metabolic enzyme tests 1 or more tests
65078	01NOV1998	30APR2008	N	Tests for the diagnosis of thalassaemia when indicated on the basis of an abnormal full blood examination or by the clinical need for family studies, consisting of haemoglobin electrophoresis or chromatography and at least 2 of: (a) examination for HbH; or (b) quantitation of HbA2; or (c) quantitation of HbF; including (if performed) any service described in item 65060 or 65070
65078	01MAY2008	31DEC9999	Y	Tests for the diagnosis of thalassaemia consisting of haemoglobin electrophoresis or chromatography and at least 2 of: (a) examination for HbH; or (b) quantitation of HbA2; or (c) quantitation of HbF; including (if performed) any service described in item 65060 or 65070
65079	01MAY2007	31DEC9999	Y	Tests described in item 65078 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
65081	01NOV1998	30APR2008	N	Tests for the investigation of haemoglobinopathy (including S, C, D, E), other than thalassaemia, when indicated on the basis of an abnormal full blood examination or by the clinical need for family studies, consisting of haemoglobin electrophoresis or chromatography and at least 1 of: (a) heat denaturation test; or (b) isopropanol precipitation test; or (c) tests for the presence of haemoglobin S; or (d) quantitation of any haemoglobin fraction (including S, C, D, E); including (if performed) any service described in item 65060, 65070 or 65078
65081	01MAY2008	31DEC9999	Y	Tests for the investigation of haemoglobinopathy consisting of haemoglobin electrophoresis or chromatography and at least 1 of: (a) heat denaturation test; or (b) isopropanol precipitation test; or (c) tests for the presence of haemoglobin S; or (d) quantitation of any haemoglobin fraction (including S, C, D, E); including (if performed) any service described in item 65060, 65070 or 65078
65082	01MAY2007	31DEC9999	Y	Tests described in item 65081 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
65084	01NOV1998	30APR2008	N	Bone marrow trephine biopsy - histopathological examination of sections of bone marrow and examination of aspirated material (including clot sections where necessary), including (if performed): (a) special stains or immunohistochemical techniques (if any); and (b) any test described in item 65060, 65066 or 65070
65084	01MAY2008	31DEC9999	Y	Bone marrow trephine biopsy - histopathological examination of sections of bone marrow and examination of aspirated material (including clot sections where necessary), including (if performed): any test described in item 65060, 65066 or 65070
65087	01NOV1998	30APR2008	N	Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): (a) special stains or immunohistochemical techniques (if any); and (b) any test described in item 65060, 65066 or 65070
65087	01MAY2008	31DEC9999	Y	Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): any test described in item 65060, 65066 or 65070
65090	01NOV1998	31DEC9999	Y	Blood grouping (including back-grouping if performed) - ABO and Rh (D antigen)
65093	01NOV1998	31DEC9999	Y	Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - 1 or more systems, including item 65090 (if performed)
65096	01NOV1998	31DEC9999	Y	Blood grouping (including back-grouping if performed), and examination of serum for Rh and other blood group antibodies, including: (a) identification and quantitation of any antibodies detected; and (b) (if performed) any test described in item 65060 or 65070
65099	01NOV1998	31OCT1999	N	Compatibility tests by crossmatch all tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies, and if necessary identification of any antibodies detected; and (c) any tests described in item 65060, 65063, 65069, 65090 or 65096 (if performed)
65099	01NOV1999	30JUN2020	N	Compatibility tests by crossmatch - all tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies, and if necessary identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090 or 65096 (Item is subject to rule 5)
65099	01JUL2020	31DEC9999	Y	Compatibility tests by crossmatch - all tests performed on any 1 day for up to 6 units, including: (a) direct testing of donor red cells from each unit against the serum of the patient by one or more accepted crossmatching techniques; and (b) all grouping checks of the patient and donor; and (c) examination for antibodies, and if necessary identification of any antibodies detected; and (d) (if performed) any tests described in item 65060, 65070, 65090 or 65096 (Item is subject to rule 5)
65102	01NOV1998	30JUN2020	N	Compatibility tests by crossmatch - all tests performed on any one day in excess of 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies, and if necessary identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105 (Item is subject to rule 5)
65102	01JUL2020	31DEC9999	Y	Compatibility tests by crossmatch - all tests performed on any 1 day in excess of 6 units, including: (a) direct testing of donor red cells from each unit against serum of the patient by one or more accepted crossmatching techniques; and (b) all grouping checks of the patient and donor; and (c) examination for antibodies, and if necessary identification of any antibodies detected; and (d) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105 (Item is subject to rule 5)
65105	01NOV1998	31OCT1999	N	Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion all tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies, and if necessary identification of any antibodies detected; and (c) any tests described in item 65060, 65063, 65069, 65090 or 65096 (if performed)
65105	01NOV1999	31DEC9999	Y	Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion - all tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies and, if necessary, identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090 or 65096 (Item is subject to rule 5)
65108	01NOV1998	31DEC9999	Y	Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion - all tests performed on any one day in excess of 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies and, if necessary, identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105 (Item is subject to rule 5)
65109	01MAY2007	31DEC9999	Y	Release of fresh frozen plasma or cryoprecipitate for the use in a patient for the correction of a coagulopathy - 1 release.
65110	01MAY2007	31DEC9999	Y	Release of compatible fresh platelets for the use in a patient for platelet support as prophylaxis to minimize bleeding or during active bleeding - 1 release.
65111	01NOV1998	31DEC9999	Y	Examination of serum for blood group antibodies (including identification and, if necessary, quantitation of any antibodies detected)
65114	01NOV1998	31DEC9999	Y	1 or more of the following tests: (a) direct Coombs (antiglobulin) test; (b) qualitative or quantitative test for cold agglutinins or heterophil antibodies
65117	01NOV1998	30APR2003	N	1 or more of the following tests: (a) qualitative spectroscopic examination of blood for chemically altered haemoglobins; (b) detection of methaemalbumin (Schumm's test)
65117	01MAY2003	31DEC9999	Y	1 or more of the following tests: (a) Spectroscopic examination of blood for chemically altered haemoglobins; (b) detection of methaemalbumin (Schumm's test)
65120	01NOV1998	31DEC9999	Y	Prothrombin time (including INR where appropriate), activated partial thromboplastin time, thrombin time (including test for the presence of heparin), test for factor XIII deficiency (qualitative), Echis test, Stypven test, reptilase time, fibrinogen, or 1 of fibrinogen degradation products, fibrin monomer or D-dimer - 1 test
65123	01NOV1998	31DEC9999	Y	2 tests described in item 65120
65126	01NOV1998	31DEC9999	Y	3 tests described in item 65120
65129	01NOV1998	31DEC9999	Y	4 or more tests described in item 65120
65132	01NOV1998	30APR2000	N	Quantitation, by 1 or more techniques, of antithrombin III, Protein C, Protein S, heparin cofactor II, plasminogen, euglobulin clot lysis time and test for lupus anticoagulant 1 to 3 tests
65132	01MAY2000	31OCT2000	N	Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where any request for the test by a medical practitioner specifically identifies in writing a history of venous thromboembolism or arterial thrombosis - quantitation by 1 or more techniques - 1 test
65132	01NOV2000	31OCT2003	N	Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - if the request for the test specifically identifies in writing a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test
65132	01NOV2003	31DEC9999	Y	Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where the request for the test(s) specifically identifies that the patient has a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test
65133	01MAY2000	31DEC9999	Y	2 tests described in item 65132
65134	01MAY2000	31DEC9999	Y	3 tests described in item 65132
65135	01MAY2000	31DEC9999	Y	4 tests described in item 65132
65136	01MAY2000	31DEC9999	Y	5 tests described in item 65132
65137	01MAY2000	31OCT2000	N	Test for the presence of lupus anticoagulant not being a service associated with any service to which item 65132 applies
65137	01NOV2000	31OCT2007	N	Test for the presence of lupus anticoagulant not being a service associated with any service to which items 65132, 65133, 65134, 65135 and 65136 apply
65137	01NOV2007	31DEC9999	Y	Test for the presence of lupus anticoagulant not being a service associated with any service to which items 65175, 65176, 65177, 65178 and 65179 apply
65138	01NOV1998	31DEC9999	Y	4 or more tests described in item 65132
65139	01MAY2000	31DEC9999	Y	Quantitation of plasminogen - 1 test
65140	01MAY2000	31DEC9999	Y	Quantitation of euglobulin clot lysis time - 1 test
65141	01NOV1998	31DEC9999	Y	Test for Activated Protein C resistance for a patient with a history of venous thrombosis or pulmonary thromboembolism where any request for the test by a medical practitioner specifically identifies in writing a history of venous thrombosis or pulmonary thromboembolism
65142	01MAY2000	31OCT2000	N	Confirmation or characterisation of an abnormal or indeterminate results using a separate specimen collected on a different day using tests described in item 65132 - 1 or more tests
65142	01NOV2000	31OCT2007	N	Confirmation or clarification of an abnormal or indeterminate result from a test described in item 65132, by testing a specimen collected on a different day - 1 or more tests
65142	01NOV2007	31DEC9999	Y	Confirmation or clarification of an abnormal or indeterminate result from a test described in item 65175, by testing a specimen collected on a different day - 1 or more tests
65144	01NOV1998	31DEC9999	Y	Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or other substances; or heparin, low molecular weight heparins, heparinoid or other drugs - 1 or more tests
65147	01NOV1998	31DEC9999	Y	Quantitation of anti-Xa activity when monitoring is required for a patient receiving a low molecular weight heparin or heparinoid - 1 test
65150	01NOV1998	30APR2007	N	Quantitation of von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor assay), von Willebrand factor collagen binding activity, factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating coagulation factor inhibitors other than by Bethesda assay - 1 test
65150	01MAY2007	31DEC9999	Y	Quantitation of von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor assay), von Willebrand factor collagen binding activity, factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating coagulation factor inhibitors other than by Bethesda assay - 1 test (Item is subject to rule 6 )
65153	01NOV1998	30APR2007	N	2 tests described in item 65150
65153	01MAY2007	31DEC9999	Y	2 tests described in item 65150 (Item is subject to rule 6 )
65156	01NOV1998	30APR2007	N	3 or more tests described in item 65150
65156	01MAY2007	31DEC9999	Y	3 or more tests described in item 65150 (Item is subject to rule 6 )
65157	01MAY2007	31DEC9999	Y	A test described in item 65150, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
65158	01MAY2007	31DEC9999	Y	Tests described in item 65150, other than that described in 65157, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18)
65159	01NOV1998	31DEC9999	Y	Quantitation of circulating coagulation factor inhibitors by Bethesda assay - 1 test
65162	01NOV1998	31DEC9999	Y	Examination of a maternal blood film for the presence of fetal red blood cells (Kleihauer test)
65165	01NOV1998	31OCT2003	N	Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell surface antigens using flow cytometric methods including (if performed) any test described in item 65070 or 65162
65165	01NOV2003	31DEC9999	Y	Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell antigens using flow cytometric methods including (if performed) any test described in item 65070 or 65162
65166	01MAY2007	31DEC9999	Y	A test described in item 65165 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
65168	01MAY2000	31DEC9999	Y	Characterisation of the genotype of a patient for Factor V Leiden gene mutation, or detection of other relevant mutations in the investigation of proven venous thrombosis or pulmonary embolism - 1 or more tests
65171	01MAY2000	31DEC9999	Y	Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency or activated protein C resistance in a first degree relative of a person who has a proven defect of any of the above - 1 or more tests
65174	01MAY2000	31DEC9999	Y	Characterisation of the genotype of a person who is a first degree relative of a person who has been proven to have 1 or more abnormal genotypes under item 65168 - 1 or more tests
65175	01MAY2007	31DEC9999	Y	Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where the request for the test(s) specifically identifies that the patient has a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test (Item is subject to Rule 6)
65176	01MAY2007	31DEC9999	Y	2 tests described in item 65175 (Item is subject to rule 6)
65177	01MAY2007	31DEC9999	Y	3 tests described in item 65175 (Item is subject to rule 6)
65178	01MAY2007	31DEC9999	Y	4 tests described in item 65175 (Item is subject to rule 6)
65179	01MAY2007	31DEC9999	Y	5 tests described in item 65175 (Item is subject to rule 6)
65180	01MAY2007	31DEC9999	Y	A test described in item 65175, if rendered by a receiving APA, where no tests in the item have been rendered by the referring APA - 1 test (Item is subject to rule 6 and 18)
65181	01MAY2007	30JUN2020	N	Tests described in item 65175, other than that described in 65180, if rendered by a receiving APA - each test to a maximum of 4 tests (Item is subject to rule 6 and 18)
65181	01JUL2020	31DEC9999	Y	A test described in item 65175, if rendered by a receiving APP, if one or more tests described in the item have been rendered by the referring APP - one test (Item is subject to rule 6 and 18)
65200	09AUG2004	31DEC9999	Y	Characterisation of gene rearrangement by nucleic acid amplification in the diagnosis and monitoring of patients with laboratory evidence of: (a) acute myeloid leukaemia; or (b) acute promyelocytic leukaemia; or (c) acute lymphoid leukaemia; or (d) chronic myeloid leukaemia; each test to a maximum of 4 tests in a 12 month period
66201	01DEC1991	30JUN1993	N	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea 1 estimation
66201	01JUL1993	31OCT1993	N	Quantitative in serum, plasma, urine or other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis, when not performed as specified in item 66331, of alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, or urea 1 estimation
66201	01NOV1993	30JUN1994	N	Quantitative estimation in serum, plasma, urine or other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, urea 1 estimation
66201	01JUL1994	30JUN1995	N	Quantitation in serum, plasma, urine or other body fluid, by any method except reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, or urea 1 test
66201	01JUL1995	31OCT1995	N	Quantitation in serum, plasma, urine or other body fluid, by any method except reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate or urea 1 test
66201	01NOV1995	31DEC9999	Y	Quantitation in serum, plasma, urine or other body fluid, by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate or urea 1 test
66202	01DEC1991	31DEC9999	Y	Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245/66246), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea one estimation
66203	01DEC1991	30JUN1994	N	2 estimations specified in item 66201
66203	01JUL1994	31DEC9999	Y	2 tests described in item 66201
66204	01DEC1991	31DEC9999	Y	Two estimations specified in item 66201/66202
66205	01DEC1991	30JUN1994	N	3 estimations specified in item 66201
66205	01JUL1994	31DEC9999	Y	3 tests described in item 66201
66206	01DEC1991	31DEC9999	Y	Three estimations specified in item 66201/66202
66207	01DEC1991	30JUN1994	N	4 estimations specified in item 66201
66207	01JUL1994	31DEC9999	Y	4 tests described in item 66201
66208	01DEC1991	31DEC9999	Y	Four estimations specified in item 66201/66202
66209	01DEC1991	30JUN1994	N	5 estimations specified in item 66201
66209	01JUL1994	31DEC9999	Y	5 tests described in item 66201
66210	01DEC1991	31DEC9999	Y	Five estimations specified in item 66201/66202
66211	01DEC1991	30JUN1994	N	6 or more estimations specified in item 66201
66211	01JUL1994	31DEC9999	Y	6 or more tests described in item 66201
66212	01DEC1991	31DEC9999	Y	Six or more estimations specified in item 66201/66202
66213	01DEC1991	30JUN1994	N	Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations
66213	01JUL1994	31DEC9999	Y	Test by any method (except reagent strip or dip-stick): (a) for the presence of: (i) the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen; or (ii) cryoglobulins or cryofibrinogen in plasma; or (b) of pH of body fluids other than urine (not including urine acidification test); 1 or more tests
66214	01DEC1991	31DEC9999	Y	Qualitative estimation by any method, except by reagent strip or dipstick of the following urine constituents bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrin, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma one or more estimations
66215	01SEP1992	30JUN1994	N	Quantitative estimation of cryoglobulins or cryofibrinogen after a positive result for cryoglobulin is obtained in any service specified in item 66213 (including provision of that service) - 1 or more estimations
66215	01JUL1994	31DEC9999	Y	Quantitation of cryoglobulins or cryofibrinogen following their detection in a test described in item 66213, including that service - 1 or more tests
66217	01DEC1991	30JUN1994	N	Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituents haemoglobin, porphyrins, reducing substances each estimation, to a maximum of 3 estimations, taken on separate days
66217	01JUL1994	31DEC9999	Y	Tests by any chemical method (except reagent strip or dipstick) for the following faecal constituents haemoglobin, porphyrins, reducing substances each test, to a maximum of 3 tests taken on separate days
66218	01DEC1991	31DEC9999	Y	Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituents haemoglobin, porphyrins, reducing substances each estimation, to a maximum of three estimations, taken on separate days
66219	01DEC1991	31AUG1992	N	Immunological detection of human haemoglobin in faeces, including any additional services specified in items 66217 - 1 estimation in any 28 day period
66219	01SEP1992	30JUN1994	N	Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217 - 1 estimation in any 28 day period
66219	01JUL1994	31DEC9999	Y	Identification of human haemoglobin in faeces, including a service (if performed) described in item 66217 - 1 test in a 28 - day period
66220	01DEC1991	31DEC9999	Y	Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217/66218 - one estimation in any twenty eight day period
66221	01NOV1994	31DEC9999	Y	Test for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a) an immunological method; and (b) a chemical method (except reagent strip or dip-stick); each test, to a maximum of 3 tests taken on separate days in a 28 day period
66223	01DEC1991	30JUN1994	N	Osmolality, estimation by osmometer, in serum or in urine 1 or more estimations
66223	01JUL1994	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine 1 or more tests
66224	01DEC1991	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine one or more estimations
66225	01DEC1991	30JUN1994	N	Quantitative estimation of blood gases including tests performed from pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen 1 or more estimations on 1 specimen
66225	01JUL1994	31DEC9999	Y	Quantitation of: (a) blood gases (including pO2, oxygen saturation and pCO2; and (b) bicarbonate and pH; including any other measurement (eg., haemoglobin or potassium) or calculation performed on the same specimen 1 or more tests on 1 specimen
66226	01DEC1991	31DEC9999	Y	Quantitative estimation of blood gases including tests performed from pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen one or more estimations on one specimen
66227	01DEC1991	30JUN1994	N	Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day
66227	01JUL1994	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day
66228	01DEC1991	31DEC9999	Y	Estimation of blood gases as specified in items 66225/66226 on each specimen in excess of 1 to a maximum of 6 specimens within any one day
66229	01DEC1991	30JUN1994	N	Calculus, analysis of 1 or more
66229	01JUL1994	31DEC9999	Y	Calculus, analysis of 1 or more
66230	01DEC1991	31DEC9999	Y	Calculus, analysis of one or more
66231	01DEC1991	31OCT1993	N	Drug or chemical assays including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances 1 or more assays
66231	01NOV1993	30JUN1994	N	Drug or chemical assays including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances or the monitoring of patients participating in a drug abuse treatment program
66231	01JUL1994	31DEC9999	Y	All qualitative and quantitative tests on blood, urine or other body fluid for: (a) a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b) ingested or absorbed toxic chemicals; including a service described in item 66235, 66237 or 66239 (if performed), but excluding: (c) the surveillance of sports people and athletes for performance improving substances; and (d) the monitoring of patients participating in a drug abuse treatment program
66232	01DEC1991	31DEC9999	Y	Drug or chemical assays including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235/66236, 66237/66238 and 66239/66240, but excluding the surveillance of sports people and athletes for performance improving substances one or more assays.
66233	01DEC1991	30JUN1993	N	Drug assays including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes each assay to a maximum of 4 assays within any 28 day period
66233	01JUL1993	31DEC9999	Y	Drug assays  including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug, or drugs, of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment program, being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs  each assay to a maximum of 21 assays in any 12 month period
66234	01DEC1991	31DEC9999	Y	Drug assays including all qualitative and quantitative estimations on blood, urine orother body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes each assay to a maximum of four assays within any twenty eight day period
66235	01DEC1991	30JUN1993	N	Drug assay quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule 1 estimation
66235	01JUL1993	30JUN1994	N	Drug assay quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule 1 estimation (This fee applies where a laboratory performs the only drug assay specified on the request form or performs 1 assay and refers the rest to the laboratory of a separate APA)
66235	01JUL1994	31DEC9999	Y	Quantitation, not elsewhere described in this Table by any method or methods, in blood or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where a laboratory performs the only drug assay specified on the request form or performs 1 assay refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66236	01DEC1991	31DEC9999	Y	Drug assay quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule one estimation
66237	01DEC1991	30JUN1993	N	2 estimations specified in item 66235
66237	01JUL1993	30JUN1994	N	2 estimations specified in item 66235 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the drug assays specified on the request form and refers the remainder to the laboratory of a separate APA.)
66237	01JUL1994	31DEC9999	Y	2 tests described in item 66235 (This fee applies where 1 laboratory performs the only drug assay specified on the request form or performs 2 assay and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66238	01DEC1991	31DEC9999	Y	Two estimations specified in item 66235/66236
66239	01DEC1991	30JUN1994	N	3 or more estimations specified in item 66235
66239	01JUL1994	31DEC9999	Y	3 or more tests described in item 66235
66240	01DEC1991	31DEC9999	Y	Three or more estimations specified in item 66235/66236
66241	01SEP1992	30JUN1993	N	Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3 - each estimation to a maximum of 2 estimations
66241	01JUL1993	30JUN1994	N	"Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3 - each estimation to a maximum of 2 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the drug assays specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
66241	01JUL1994	31OCT1994	N	"Tests described in any of items 66235 to 66237 (inclusive), if the number of tests relating to the same patient episode does not exceed 3 - each test to a maximum of 2 tests (Item is subject to Rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the drug assays specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
66241	01NOV1994	31OCT1995	N	Tests described in item 66235, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item is subject to Rule 6)
66241	01NOV1995	31DEC9999	Y	Tests described in item 66235, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to Rule 6)
66243	01DEC1991	30JUN1994	N	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid 1 or more examinations or estimations
66243	01JUL1994	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, and quantitation of : (a) lecithin/sphingomyelin ratio; or (b) palmitic acid, phosphatidylglycerol or lamellar body phospholipid; 1 or more tests
66244	01DEC1991	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid, phosphatidylglycerol or lamellar body phospholipid - one or more examinations or estimations
66245	01DEC1991	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the cholesterol is >6.5 mmol/l and triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity 1 examination to a maximum of 2 examinations in any 12 month period
66246	01DEC1991	31DEC9999	Y	Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5 mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity one examination to a maximum of two examinations in any twelve month period
66247	01DEC1991	31DEC9999	Y	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin or of total rele'/ant enzyme activity - 2 or more examinations
66248	01DEC1991	31DEC9999	Y	Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity two or more examinations
66249	01JUL1994	31DEC9999	Y	Electrophoresis, quantitative or qualitative, of serum, urine or other body fluid to demonstrate: (a) protein classes; or (b) presence and amount of paraprotein; or (c) the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase; including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity
66250	01JUL1994	31DEC9999	Y	Electrophoresis, quantitation or qualitative, of serum, for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >3.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - each episode to a maximum of 2 episodes in a 12 month period
66251	01DEC1991	31DEC9999	Y	Alphafeto protein, Alpha1 antitrypsin, Alpha2 macroglobulin, beta2 microglobulin, C1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in items 66263), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in items 66263), and, in the follow up of proven malignancy, Mucinlike carcinoma associated antigen, CA125 antigen, CA19.9 antigen, CA15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specificenolase, Thyroglobulin quantitative estimation in serum, urine or other body fluid 1 estimation
66252	01DEC1991	31DEC9999	Y	Alphafeto protein, Alpha1 antitrypsin, Alpha2 macroglobulin, beta2 microglobulin, C1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in items 66263/66264), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in items 66263/66264), and, in the follow up of proven malignancy, Mucinlike carcinoma associated antigen, CA125 antigen, CA19.9 antigen, CA15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, Thyroglobulin quantitative estimation in serum, urine or other body fluid one estimation
66253	01DEC1991	31DEC9999	Y	Two or more estimations specified in item 66251
66254	01DEC1991	31DEC9999	Y	Two or more estimations specified in item 66251/66252
66255	01SEP1992	30JUN1994	N	Alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, quantitative estimation in serum, urine or other body fluid - 1 or more estimations
66255	01JUL1994	31DEC9999	Y	Alpha-1-acid glycoprotein, alpha-1-antitrypsin, or alpha-2-macroglobulin - quantitation in serum, urine or other body fluid - 1 or more tests
66257	01SEP1992	30JUN1994	N	C-1 esterase inhibitor, quantitative estimation
66257	01JUL1994	31DEC9999	Y	C-1 esterase inhibitor, quantitation
66258	01SEP1992	31DEC9999	Y	C-1 esterase inhibitor, functional assay
66259	01SEP1992	31DEC9999	Y	Alpha-fetoprotein, beta-2-microglobulin, caeruloplasmin, ferritin (except when part of item 66263), haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin, prostate specific antigen, prostatic acid phosphatase, transferrin (except when part of item 66263) - quantitative estimation in serum, urine or other body fluid - 1 estimation
66260	01SEP1992	31DEC9999	Y	2 or more estimations as specified in item 66259
66261	01SEP1992	30JUN1994	N	CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy, quantitative estimation - 1 estimation
66261	01JUL1994	31DEC9999	Y	CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy - quantitation - 1 test
66262	01SEP1992	30JUN1994	N	2 or more estimations specified in item 66261
66262	01JUL1994	31DEC9999	Y	2 or more tests described in item 66261
66263	01DEC1991	30JUN1994	N	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin
66263	01JUL1994	31DEC9999	Y	Iron studies consisting of quantitation of: (a) serum iron; (b) transferrin or iron binding capacity; and (c) ferritin
66264	01DEC1991	31DEC9999	Y	Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin
66265	01DEC1991	30JUN1994	N	Serum B12, serum folate 1 or more estimations within any 28 day period
66265	01JUL1994	31DEC9999	Y	Serum B12 or serum folate 1 or more tests within a 28 - day period
66266	01DEC1991	31DEC9999	Y	Serum B12, serum folate one or more estimations within any twenty eight day period
66267	01DEC1991	30JUN1994	N	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period
66267	01JUL1994	31DEC9999	Y	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 episodes in a 12 month period
66268	01DEC1991	31DEC9999	Y	Red cell folate and serum B12 add, if required, serum folate, to a maximum of three estimations in any twelve month period
66269	01DEC1991	30JUN1994	N	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of vitamins A, B1, B2, B3, B6, C, and E 1 or more estimations within any 6 month period
66269	01JUL1994	31DEC9999	Y	Vitamins - quantitation of vitamins A, B1, B2, B3, B6, C, and E in blood, urine or other body fluid - 1 or more tests within a 6 month period
66270	01DEC1991	31DEC9999	Y	Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E one or more estimations within any six month period
66271	01DEC1991	30JUN1994	N	Vitamin D or D fractions 1 or more estimations
66271	01JUL1994	31DEC9999	Y	Vitamin D or D fractions 1 or more tests
66272	01DEC1991	31DEC9999	Y	Vitamin D or D fractions one or more estimations
66273	01DEC1991	31DEC9999	Y	Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc 1 quantitative estimation
66274	01DEC1991	31DEC9999	Y	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, serotonin, xylose, zinc one quantitative estimation
66275	01DEC1991	31DEC9999	Y	2 or more estimations specified in item 66273
66276	01DEC1991	31DEC9999	Y	Two or more estimations specified in item 66273/66274
66277	01DEC1991	30JUN1994	N	Aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, in blood, urine or other body fluid or tissue - 1 or more estimations in any 6 month period
66277	01JUL1994	31DEC9999	Y	Quantitation of aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, or strontium, in blood, urine or other body fluid or tissue - 1 or more tests in a 6 month period
66278	01DEC1991	31DEC9999	Y	Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six months
66279	01DEC1991	30JUN1994	N	Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period each estimation
66279	01JUL1994	31DEC9999	Y	Blood lead quantitation (other than for occupational health screening purposes) to a maximum of 3 tests in a 6 month period each test
66280	01DEC1991	31DEC9999	Y	Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month period each estimation
66281	01DEC1991	30JUN1994	N	Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA) quantitative including any qualitative estimations 1 or more estimations
66281	01JUL1994	31DEC9999	Y	Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), or phenylacetic acid (PAA) quantitation 1 or more tests
66282	01DEC1991	31DEC9999	Y	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) quantitative including any qualitative estimations one or more estimations
66283	01DEC1991	30JUN1994	N	Faecal fat, breath hydrogen measurements in response to loading with disaccharides 1 or more quantitative estimations within any 28 day period
66283	01JUL1994	31DEC9999	Y	Quantitation of: (a) faecal fat; or (b) breath hydrogen in response to loading with disaccharides; 1 or more tests within a 28 day period
66284	01DEC1991	31DEC9999	Y	Faecal Fat, Breath Hydrogen measurements in response to loading with disaccharides one or more quantitative estimations within any twenty eight day period
66285	01DEC1991	30JUN1994	N	Solid tissue or tissues excluding blood elements assay of 1 or 2 enzymes
66285	01JUL1994	31DEC9999	Y	Enzymes - quantitation of 1 or 2 in solid tissue or tissues other than blood elements
66286	01DEC1991	31DEC9999	Y	Solid tissue or tissues excluding blood elements assay of one or two enzymes
66287	01DEC1991	30JUN1994	N	Assay of 3 to 5 enzymes specified in item 66285
66287	01JUL1994	31DEC9999	Y	Quantitation of 3 to 5 enzymes as described in item 66285
66288	01DEC1991	31DEC9999	Y	Assay of three to five enzymes as specified in item 66285/66286
66289	01DEC1991	30JUN1994	N	Assay of 6 or more enzymes specified in item 66285
66289	01JUL1994	31DEC9999	Y	Quantitation of 6 or more enzymes as described in item 66285
66290	01DEC1991	31DEC9999	Y	Assay of six or more enzymes as specified in item 66285/66286
66291	01DEC1991	30JUN1994	N	Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin
66291	01JUL1994	31DEC9999	Y	Thyroid function tests, including thyrotrophin (TSH) and 1 or more of the following tests free thyroxine index, free thyroxine, free T3, total T3, thyroxine-binding globulin
66292	01DEC1991	31DEC9999	Y	Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following tests free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin
66293	01DEC1991	30JUN1994	N	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones
66293	01JUL1994	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and quantitation of hormones
66294	01DEC1991	31DEC9999	Y	Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones
66295	01DEC1991	30JUN1994	N	Growth hormone suppression by glucose loading, growth hormone stimulation by exercise, dexamethasone suppression test, Ldopa stimulation of growth hormone, where physically performed by a recognised pathologist 1 or more procedures
66295	01JUL1994	31DEC9999	Y	Personal performance by a recognised pathologist of 1 or more of the following: (a) growth hormone suppression by glucose loading; (b) growth hormone stimulation by exercise; (c) dexamethasone suppression test; (d) Ldopa stimulation of growth hormone
66296	01DEC1991	31DEC9999	Y	Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, LDopa stimulation of growth hormone, where physically performed by a recognised pathologist one or more procedures
66297	01DEC1991	30JUN1994	N	Gonadotrophin releasing hormone stimulation test, synacthen stimulation test, glucagon stimulation test with Cpeptide measurement, pentagastrin stimulation of thyrocalcitonin release, secretin stimulation of gastrin release, insulin hypoglycaemia, arginine infusion, where physically performed by a recognised pathologist 1 procedure
66297	01JUL1994	31DEC9999	Y	Personal performance by a recognised pathologist of 1 of the following: (a) gonadotrophin releasing hormone stimulation test; (b) synacthen stimulation test; (c) glucagon stimulation test with Cpeptide measurement; (d) pentagastrin stimulation of thyrocalcitonin release; (e) secretin stimulation of gastrin release; (f) insulin hypoglycaemia; (g) arginine infusion
66298	01DEC1991	31DEC9999	Y	Gonadotrophin releasing stimulation test, Synacthen stimulation test, Glucagon stimulation test with Cpeptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist one procedure
66299	01DEC1991	30JUN1994	N	2 or more tests specified in item 66297
66299	01JUL1994	31DEC9999	Y	Personal performance by a recognised pathologist of 2 or more tests described in item 66297
66300	01DEC1991	31DEC9999	Y	Two or more procedures specified in item 66297/66298
66301	01DEC1991	30JUN1993	N	Hormones and hormone binding proteins, quantitative estimation by any method of ACTH, aldosterone, androstenedione, Cpeptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (anti diuretic hormone) 1 estimation
66301	01JUL1993	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of ACTH, aldosterone, androstenedione, Cpeptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) 1 estimation (This fee applies where a laboratory performs the only hormone estimation specified on the request form or performs 1 estimation and refers the rest to the laboratory of a separate APA)
66302	01DEC1991	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of ACTH, Aldosterone, Androstenedione, Cpeptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone) one estimation
66303	01DEC1991	30JUN1993	N	2 estimations specified in item 66301
66303	01JUL1993	31DEC9999	Y	2 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.)
66304	01DEC1991	31DEC9999	Y	Two estimations specified in item 66301/66302
66305	01DEC1991	30JUN1993	N	3 estimations specified in item 66301
66305	01JUL1993	31DEC9999	Y	3 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.)
66306	01DEC1991	31DEC9999	Y	Three estimations specified in item 66301/66302
66307	01DEC1991	30JUN1993	N	4 estimations specified in item 66301
66307	01JUL1993	31DEC9999	Y	4 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.)
66308	01DEC1991	31DEC9999	Y	Four estimations specified in item 66301/66302
66309	01DEC1991	30JUN1993	N	5 estimations specified in item 66301
66309	01JUL1993	31DEC9999	Y	5 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the hormone estimations specified on the request form refers the remainder to the laboratory of a separate APA.)
66310	01DEC1991	31DEC9999	Y	Five estimations specified in item 66301/66302
66311	01DEC1991	31DEC9999	Y	6 or more estimations specified in item 66301
66312	01DEC1991	31DEC9999	Y	Six or more estimations specified in item 66301/66302
66313	01SEP1992	30JUN1993	N	Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations
66313	01JUL1993	31DEC9999	Y	"Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the hormone estimations specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
66315	01DEC1991	30JUN1994	N	Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast 1 or more assays
66315	01JUL1994	31DEC9999	Y	Quantitation of hormone receptors on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast 1 or more tests
66316	01DEC1991	31DEC9999	Y	Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast one or more assays
66317	01DEC1991	31OCT1993	N	HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1 each estimation to a maximum of 4 estimations in any 12 month period
66317	01NOV1993	30JUN1994	N	HDL cholesterol or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1 each episode to a maximum of 4 episodes in any 12 month period
66317	01JUL1994	31OCT1994	N	Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a) has a serum cholesterol level >5.5mmol/l; or (b) is on prescribed lipid lowering drugs; or (c) has a fasting serum triglyceride level > 2.0 mmol/1; each episode to a maximum of 4 episodes in a 12 - month period
66317	01NOV1994	31DEC9999	Y	Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a) has a serum cholesterol level >5.5mmol/L; or (b) has a fasting serum triglyceride level > 2.0 mmol/L; or (c) is on a lipid lowering drug prescribed by a medical practitioner; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9)
66318	01DEC1991	31DEC9999	Y	HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs each estimation to a maximum of four estimations in any twelve month period
66319	01DEC1991	30JUN1994	N	Glycosylated haemoglobin only when performed in the management of established diabetes each estimation to a maximum of 4 estimations in any 12 month period
66319	01JUL1994	31DEC9999	Y	Quantitation of glycosylated haemoglobin performed in the management of established diabetes each test to a maximum of 4 tests in a 12 month period
66320	01DEC1991	31DEC9999	Y	Glycosylated haemoglobin only when performed in the management of established diabetes each estimation to a maximum of four estimations in any twelve month period
66321	01MAR1992	31OCT1993	N	Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66353, 66373, 73527 or 73529 - 1 patient episode in that pregnancy
66321	01NOV1993	30JUN1994	N	Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66353, 66373, 73527 or 73529 - 1 patient episode in that pregnancy
66321	01JUL1994	31DEC9999	Y	Quantitation in the 2nd trimester of pregnancy, of alpha-fetoprotein, human chorionic gonadotrophin, oestriol and any other substance to detect foetal abnormality, including a service described in 1 or more of items 66353, 66373, 73527 and 73529 (if performed) - 1 patient episode in a pregnancy
66322	20MAR1997	31DEC9999	Y	Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - each test to a maximum of 6 tests in a 12 month period which includes the whole pregnancy, including a service in item 66319 (if performed)
66323	01SEP1992	30JUN1994	N	Estimation of tryptic activity in faeces for the investigation of diarrhoea of greater than 4 weeks duration in children less than 6 years of age
66323	01JUL1994	31DEC9999	Y	Test for tryptic activity in faeces in the investigation of diarrhoea of longer than 4 weeks duration in children under 6 years old
66325	01SEP1992	30JUN1994	N	Estimation of serum aluminium in a patient in a renal dialysis program - each estimation
66325	01JUL1994	31DEC9999	Y	Quantitation of serum aluminium in a patient in a renal dialysis program - each test
66327	01NOV1994	19MAR1997	N	TSH - quantitation, requested as a preliminary test to thyroid function testing
66327	20MAR1997	31DEC9999	Y	TSH quantitation
66329	01NOV1994	31OCT1995	N	Thyroid function tests (comprising the service described in item 66327 and 1 or more of the following tests - estimation of free thyroxine index, free thryoxine, free T3, total T3, thyroxine binding globulin) in respect of a patient, if at least one of the following conditions is satisfied: (a) the patient has an abnormal level of TSH; (b) the test are performed for the purpose of: (i) monitoring thyroid disease in the patient; or (ii) if the patient is in a hospital - investigating thyroid function in the patient; or (iii) investigating dementia or psychiatric illness of the patient; or (iv) investigating amenorrhoea or infertility of the patient (c) the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d) the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 7B)
66329	01NOV1995	31DEC9999	Y	Thyroid function tests (comprising the service described in item 66327 and 1 or more of the following tests - estimation of free thyroxine index, free thryoxine, free T3, total T3, thyroxine binding globulin) in respect of a patient, if at least one of the following conditions is satisfied: (a) the patient has an abnormal level of TSH; (b) the tests are performed for the purpose of: (i) monitoring thyroid disease in the patient; or (ii) if the patient is an admitted patient -investigating the sick euthyroid syndrome; or (iii) investigating dementia or psychiatric illness of the patient; or (iv) investigating amenorrhoea or infertility of the patient (c) the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d) the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 10)
66331	01JUL1993	30JUN1994	N	Quantitative estimation in serum, plasma, urine or other body fluid of cholesterol or triglycerides or both, except by reagent strip with or without reflectance meter or electrophoresis
66331	01JUL1994	31DEC9999	Y	Quantitation (except by reagent strip with or without reflectance meter or electrophoresis) of cholesterol or triglycerides or both in serum, plasma, urine or other body fluid
66335	01JUL1993	30JUN1994	N	Services specified in item 66331 and 1 estimation specified in item 66201
66335	01JUL1994	31DEC9999	Y	A service described in item 66331 and 1 test described in item 66201
66337	01JUL1993	30JUN1994	N	Services specified in item 66331 and 2 estimations specified in item 66201
66337	01JUL1994	31DEC9999	Y	A service described in item 66331 and 2 tests described in item 66201
66339	01JUL1993	30JUN1994	N	Services specified in item 66331 and 3 estimations specified in item 66201
66339	01JUL1994	31DEC9999	Y	A service described in item 66331 and 3 tests described in item 66201
66341	01JUL1993	30JUN1994	N	Services specified in item 66331 and 4 or more estimations specified in item 66201
66341	01JUL1994	31DEC9999	Y	A service described in item 66331 and 4 or more tests described in item 66201
66343	01JUL1993	30JUN1994	N	Drug assays including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug, or drugs, of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment program, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs each assay to a maximum of 21 assays in any 12 month period
66343	01JUL1994	31DEC9999	Y	Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient: (a) participating in a drug abuse treatment program; or (b) being treated for drug effects; including all tests on blood, urine or other body fluid - each episode, to a maximum of 21 episodes in a 12 month period
66353	01NOV1993	30JUN1994	N	Alpha-fetoprotein (where not requested as part of item 66321) - quantitative estimation in serum or other body fluids
66353	01JUL1994	31DEC9999	Y	Quantitation in serum or other body fluids of alpha fetoprotein, except if requested as part of item 66321
66355	01NOV1993	30JUN1994	N	Ferritin (where not requested as part of iron studies) - quantitative estimation
66355	01JUL1994	31DEC9999	Y	Ferritin - quantitation, except if requested as part of iron studies
66357	01NOV1993	30JUN1994	N	Prostate specific antigen, prostatic acid phosphatase, in the monitoring or confirmation of malignancy - quantitative estimation - 1 estimation
66357	01JUL1994	31DEC9999	Y	Prostate specific antigen or prostatic acid phosphatase - quantitation in the confirmation or monitoring of malignancy - 1 test
66359	01NOV1993	30JUN1994	N	2 estimations specified in item 66357
66359	01JUL1994	31DEC9999	Y	2 tests described in item 66357
66361	01NOV1993	30JUN1994	N	Beta-2-microglobulin, caeruloplasmin, haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin - quantitative estimation in serum, urine or other body fluids - 1 estimation
66361	01JUL1994	31DEC9999	Y	Beta-2-microglobulin, caeruloplasmin, haptoglobins, microalbumin in proven diabetes mellitus, or prealbumin - quantitation in serum, urine or other body fluids - 1 test
66363	01NOV1993	30JUN1994	N	2 or more estimations specified in item 66361
66363	01JUL1994	31DEC9999	Y	2 or more tests described in item 66361
66365	01NOV1993	30JUN1994	N	Neonatal bilirubin (1 or more fractions) - quantitative estimation
66365	01JUL1994	31DEC9999	Y	Neonatal bilirubin (1 or more fractions) - quantitation
66367	01NOV1993	30JUN1994	N	Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation
66367	01JUL1994	31OCT1996	N	Quantitation of acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, oxalate, pyruvate, serotonin, xylose, or zinc - 1 test
66367	01NOV1996	31DEC9999	Y	Quantitation of acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline (except if performed as part of item 66425 or 66426), lactate, oxalate, pyruvate, serotonin, xylose, or zinc - 1 test
66369	01NOV1993	30JUN1994	N	2 or more estimations specified in item 66367
66369	01JUL1994	31DEC9999	Y	2 or more tests described in item 66367
66371	01NOV1993	30JUN1994	N	TSH (where not requested as part of thyroid function test or in association with other hormones or hormone binding proteins specified in item 66377) - quantitative estimation
66371	01JUL1994	31DEC9999	Y	TSH - quantitation, except if requested as part of thyroid function test or in association with other hormones or hormone binding proteins described in item 66405
66373	01NOV1993	30JUN1994	N	Human placental lactogen, oestriol (where not requested as part of item 66321 - quantitative estimation by any method - 1 estimation
66373	01JUL1994	31DEC9999	Y	Human placental lactogen or oestriol - quantitation, except if requested as part of item 66321 - 1 test
66375	01NOV1993	30JUN1994	N	2 estimations specified in item 66373
66375	01JUL1994	31DEC9999	Y	2 tests described in item 66373
66377	01NOV1993	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - androstenedione, DHEAS, dihydrotestosterone, FSH, hydroxyprogesterone, LH, oestradiol, oestrone, progesterone, prolactin, sex hormone binding globulin, free or total testosterone, TSH (where it is not requested on its own or as part of a thyroid function test) - 1 estimation
66379	01NOV1993	31DEC9999	Y	2 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66381	01NOV1993	31DEC9999	Y	3 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66383	01NOV1993	31DEC9999	Y	4 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66385	01NOV1993	31DEC9999	Y	5 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66387	01NOV1993	31DEC9999	Y	6 or more estimations specified in item 66377
66389	01NOV1993	31DEC9999	Y	"Estimations specified in any of items 66377 to 66387 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
66391	01NOV1993	31DEC9999	Y	Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, aldosterone, C-peptide, calcitonin, cortisol, cyclic AMP, 11-deoxycortisol, gastrin, glucagon, growth hormone, insulin, PTH, renin, somatomedin C(IgF1), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (anti-diuretic hormone) - 1 estimation
66393	01NOV1993	31DEC9999	Y	2 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66395	01NOV1993	31DEC9999	Y	3 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66397	01NOV1993	31DEC9999	Y	4 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66399	01NOV1993	31DEC9999	Y	5 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
66401	01NOV1993	31DEC9999	Y	6 or more estimations specified in item 66391
66403	01NOV1993	31DEC9999	Y	"Estimations specified in any of items 66391 to 66401 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
66405	01JUL1994	19MAR1997	N	Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(1gF1), free or total testosterone, TSH (where not requested on its own or as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test (This fee applies where a laboratory performs the only hormone test specified on the request form or performs 1 test and refers the rest to a laboratory of a separate APA) (Item is subject to rule 6)
66405	20MAR1997	31DEC9999	Y	Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test
66407	01JUL1994	31DEC9999	Y	2 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 2 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
66409	01JUL1994	31DEC9999	Y	3 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 3 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
66411	01JUL1994	31DEC9999	Y	4 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 4 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
66413	01JUL1994	31DEC9999	Y	5 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 5 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
66415	01JUL1994	31DEC9999	Y	6 or more tests described in item 66405
66417	01JUL1994	31OCT1994	N	"Tests described in any of items 66405 to 66413 (inclusive), if the number of tests relating to the same patient episode does not exceed 6 - each test to a maximum of 5 tests (Item subject to Rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the hormone tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"")."
66417	01NOV1994	31OCT1995	N	Tests described in item 66405, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item subject to Rule 6)
66417	01NOV1995	31DEC9999	Y	Tests described in item 66405, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to Rule 6)
66419	01NOV1994	30JUN1995	N	Oral glucose test that includes the following: (a) administration of glucose; (b) at least 3 estimations of blood glucose; (c) 1 or more of the tests (other than those described in paragraph (a) or (b) described in item 66405
66419	01JUL1995	31DEC9999	Y	Oral glucose test for the diagnosis of diabetes mellitus that includes the following: (a) administration of glucose; (b) at least 3 estimations of blood glucose; (c) if performed, any test described in item 66405
66421	01NOV1995	31DEC9999	Y	Tests for reducing substances in faeces by any method (except reagent strip or dipstick)
66422	01JUL1996	31DEC9999	Y	Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a) an immunological method; and (b) a chemical method (except reagent strip or dip stick); with a maximum of 3 examinations on specimens collected on separate days in a 28 day period - 1 examination by both methods
66423	01JUL1996	31DEC9999	Y	2 examinations by both methods described in item 66422 performed on separately collected and identified specimens
66424	01JUL1996	31DEC9999	Y	3 examinations by both methods described in item 66422 performed on separately collected and identified specimens
66425	01NOV1996	31DEC9999	Y	Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66367 - 1 or more tests (Low bone densitometry is defined in paragraph D1.14 of explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule)
66426	01NOV1996	31DEC9999	Y	Quantitation of products of collagen breakdown for the monitoring of patients with metabolic bone disease, and if performed, a service described in item 66367 - 1 or more tests
66427	20MAR1997	31DEC9999	Y	TSH quantitation described in item 66327 and 1 test described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66428	20MAR1997	31DEC9999	Y	TSH quantitation described in item 66327 and 2 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 tests specified on the request form or performs 3 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66429	20MAR1997	31DEC9999	Y	TSH quantitation described in item 66327 and 3 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66430	20MAR1997	31DEC9999	Y	TSH quantitation described in item 66327 and 4 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 tests specified on the request form or performs 5 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66431	20MAR1997	31DEC9999	Y	TSH quantitation described in item 66327 and 5 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 6 or more tests specified on the request form) (Item is subject to rule 6)
66432	20MAR1997	31DEC9999	Y	Tests described in items 66327 and 66405, if rendered under a request mentioned in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to Rule 6)
66435	01JUL1998	31DEC9999	Y	Detection of the C282Y genetic mutation for haemochromatosis where: a) the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or b) the patient has a first degree relative with haemochromatosis or with homozygosity for the C282Y genetic mutation. Not exceeding 1 episode in a 3 year period.
66500	01NOV1998	31OCT2001	N	Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea 1 test
66500	01NOV2001	30APR2002	N	Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test
66500	01MAY2002	31OCT2008	N	Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test
66500	01NOV2008	31DEC9999	Y	Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter) of: acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test
66503	01NOV1998	31DEC9999	Y	2 tests described in item 66500
66506	01NOV1998	31DEC9999	Y	3 tests described in item 66500
66509	01NOV1998	31DEC9999	Y	4 tests described in item 66500
66512	01NOV1998	30JUN2008	N	5 tests described in item 66500
66512	01JUL2008	31DEC9999	Y	5 or more tests described in item 66500
66515	01NOV1998	31DEC9999	Y	6 or more tests described in item 66500
66517	01NOV2007	30JUN2020	N	Quantitation of bile acids in blood in pregnancy. To a maximum of 3 tests in a pregnancy.
66517	01JUL2020	31DEC9999	Y	Quantitation of bile acids in blood in pregnancy. Applicable not more than 3 times in a pregnancy.
66518	01NOV1998	31OCT2001	N	Investigation of cardiac or skeletal muscle damage by measurement of creatine kinase isoenzymes (by any method), troponin or myoglobin in plasma or serum - 1 or more tests in a 24 hour period
66518	01NOV2001	31OCT2004	N	Investigation of cardiac or skeletal muscle damage by measurement of creatine kinase isoenzymes (by any method), troponin or myoglobin in plasma or serum - testing on 1 specimen in a 24 hour period
66518	01NOV2004	30APR2005	N	Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 1 specimen in a 24 hour period
66518	01MAY2005	31DEC9999	Y	Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 1 specimen in a 24 hour period
66519	01NOV2001	31OCT2004	N	Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 2 or more specimens in a 24 hour period
66519	01NOV2004	30APR2005	N	Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 2 or more specimens in a 24 hour period
66519	01MAY2005	31DEC9999	Y	Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 2 or more specimens in a 24 hour period
66521	01NOV1998	31DEC9999	Y	Quantitation (except by reagent strip with or without reflectance meter or electrophoresis) of cholesterol or triglycerides or both in serum, plasma, urine or other body fluid
66522	01NOV2021	31DEC9999	Y	Faecal calprotectin test for the diagnosis of inflammatory bowel disease, if all the following apply: the patient is under 50 years of age; the patient has gastrointestinal symptoms suggestive of inflammatory or functional bowel disease of more than 6 weeks duration; infectious causes have been excluded; the likelihood of malignancy has been assessed as low; no relevant clinical alarms are present
66523	01NOV2021	31DEC9999	Y	Faecal calprotectin test for the diagnosis of inflammatory bowel disease, if all the following apply: the results of a service to which item 66522 applies were inconclusive for the patient (that is, the results showed a faecal calprotectin level of more than 50 -g/g but not more than 100 -g/g); the patient has ongoing gastrointestinal symptoms suggestive of inflammatory or functional bowel disease; the service is requested by a specialist or consultant physician practising as a specialist gastroenterologist; the request indicates that an endoscopic examination is not initially required; no relevant clinical alarms are present
66524	01NOV1998	31DEC9999	Y	A service described in item 66521 and 1 test described in item 66500
66527	01NOV1998	31DEC9999	Y	A service described in item 66521 and 2 tests described in item 66500
66530	01NOV1998	31DEC9999	Y	A service described in item 66521 and 3 tests described in item 66500
66533	01NOV1998	31DEC9999	Y	A service described in item 66521 and 4 or more tests described in item 66500
66536	01NOV1998	31OCT2000	N	Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a) has a serum cholesterol level >5.5mmol/L; or (b) has a fasting serum triglyceride level > 2.0 mmol/L; or (c) is on a lipid lowering drug prescribed by a medical practitioner; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9)
66536	01NOV2000	31OCT2001	N	Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a) has a serum cholesterol level >5.5mmol/L; or (b) has a fasting serum triglyceride level > 2.0 mmol/L; or (c) is on a lipid lowering drug prescribed by a medical practitioner; or (d) has a serum cholesterol level >4.0 mmol/L and has a history of ischaemic heart disease; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9)
66536	01NOV2001	31DEC9999	Y	Quantitation of HDL cholesterol
66539	01NOV1998	30APR2005	N	Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - each episode to a maximum of 2 episodes in a 12 month period
66539	01MAY2005	30APR2007	N	Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - 1 of this item to a maximum of 2 in a 12 month period
66539	01MAY2007	31DEC9999	Y	Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - (Item is subject to rule 25)
66542	01NOV1998	30APR2000	N	Oral glucose tolerence test for the diagnosis of diabetes mellitus that includes the following: (a) administration of glucose; (b) at least 3 estimations of blood glucose; and if performed (c) any test described in item 66695
66542	01MAY2000	31DEC9999	Y	Oral glucose tolerance test for the diagnosis of diabetes mellitus that includes: (a) administration of glucose; and (b) at least 2 measurements of blood glucose; and (c) (if performed) any test described in item 66695
66545	01NOV1998	31OCT1999	N	Oral glucose challenge test in pregnancy for the detection of gestational diabetes that includes: (a) administration of glucose; (b) 1 or 2 measurements of blood glucose; and (c) any test in item 66695 (if performed) 1 patient episode in a pregnancy
66545	01NOV1999	31DEC9999	Y	Oral glucose challenge test in pregnancy for the detection of gestational diabetes that includes: (a) administration of glucose; and (b) 1 or 2 measurements of blood glucose; and (c) (if performed) any test in item 66695
66548	01NOV1998	31OCT1999	N	Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a) administration of glucose; (b) at least 3 measurements of blood glucose; and (c) any test in item 66695 (if performed) 1 patient episode in a pregnancy
66548	01NOV1999	31OCT2001	N	Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a) administration of glucose; and (b) at least 3 measurements of blood glucose; and (c) (if performed) any test in item 66695
66548	01NOV2001	31DEC9999	Y	Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a) administration of glucose; and (b) at least 3 measurements of blood glucose; and (c) any test in item 66695 (if performed)
66551	01NOV1998	30APR2007	N	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period
66551	01MAY2007	31OCT2014	N	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - (Item is subject to rule 25)
66551	01NOV2014	31DEC2021	N	Quantitation of glycated haemoglobin performed in the management of established diabetes - (Item is subject to rule 25)
66551	01JAN2022	31DEC9999	Y	Quantitation of glycated haemoglobin performed in the management of established diabetes (See para PR.2.2 of explanatory notes to this Category)
66554	01NOV1998	30APR2007	N	Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - each test to a maximum of 6 tests in a 12 month period which includes the whole pregnancy, including a service in item 66551 (if performed)
66554	01MAY2007	31OCT2014	N	Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - including a service in item 66551 (if performed) (Item is subject to rule 25)
66554	01NOV2014	31DEC9999	Y	Quantitation of glycated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - including a service in item 66551 (if performed) - (Item is subject to rule 25)
66557	01NOV1998	31DEC9999	Y	Quantitation of fructosamine performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period
66560	01NOV1998	31OCT2000	N	Microalbumin in proven diabetes mellitus quantitation in urine 1 or more tests
66560	01NOV2000	31DEC9999	Y	Microalbumin - quantitation in urine
66563	01NOV1998	31DEC9999	Y	Osmolality, estimation by osmometer, in serum or in urine - 1 or more tests
66566	01NOV1998	31OCT2008	N	Quantitation of: (a) blood gases (including pO2, oxygen saturation and pCO2) ; and (b) bicarbonate and pH; including any other measurement (eg. haemoglobin, potassium or ionised calcium) or calculation performed on the same specimen - 1 or more tests on 1 specimen
66566	01NOV2008	31DEC9999	Y	Quantitation of: (a) blood gases (including pO2, oxygen saturation and pCO2) ; and (b) bicarbonate and pH; including any other measurement (eg. haemoglobin, lactate, potassium or ionised calcium) or calculation performed on the same specimen - 1 or more tests on 1 specimen
66569	01NOV1998	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 2 specimens performed within any 1 day
66572	01NOV1998	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 3 specimens performed within any 1 day
66575	01NOV1998	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 4 specimens performed within any 1 day
66578	01NOV1998	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5 specimens performed within any 1 day
66581	01NOV1998	31DEC9999	Y	Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 6 or more specimens performed within any 1 day
66584	01NOV1998	31DEC9999	Y	Quantitation of ionised calcium (except if performed as part of item 66566) - 1 test
66585	01NOV2023	31DEC9999	Y	Quantification of laboratory-based BNP or NT-proBNP testing in a patient with systemic sclerosis (scleroderma) to assess risk of pulmonary arterial hypertension Maximum of 2 tests in a 12 month period
66586	01JUL2024	31DEC9999	Y	Quantification of BNP or NT-proBNP testing in a patient with diagnosed pulmonary arterial hypertension to monitor for disease progression Applicable 4 times in any 12-month period
66587	01NOV1998	31DEC9999	Y	Urine acidification test for the diagnosis of renal tubular acidosis including the administration of an acid load, and pH measurements on 4 or more urine specimens and at least 1 blood specimen
66590	01NOV1998	31DEC9999	Y	Calculus, analysis of 1 or more
66593	01NOV1998	31DEC9999	Y	Ferritin - quantitation, except if requested as part of iron studies
66596	01NOV1998	31DEC9999	Y	Iron studies, consisting of quantitation of: (a) serum iron; and (b) transferrin or iron binding capacity; and (c) ferritin
66599	01NOV1998	28FEB1999	N	Serum B12 or red cell folate and, if required, serum folate (Item is subject to rule 23)
66599	01MAR1999	31DEC9999	Y	Serum B12 or red cell folate and, if required, serum folate (Item is subject to Rule 21)
66602	01NOV1998	28FEB1999	N	Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 episodes in a 12 month period
66602	01MAR1999	31DEC9999	Y	Serum B12 and red cell folate and, if required, serum folate (Item is subject to rule 21)
66605	01NOV1998	30APR2009	N	Vitamins - quantitation of vitamins A, B1, B2, B3, B6, C and E in blood, urine or other body fluid - 1 or more tests within a 6 month period
66605	01MAY2009	30JUN2011	N	Vitamins - quantitation of vitamins B1, B2, B3, B6 and C in blood, urine or other body fluid - 1 or more tests within a 6 month period
66605	01JUL2011	31DEC9999	Y	Vitamins - quantitation of vitamins B1, B2, B3, B6 or C in blood, urine or other body fluid - 1 or more tests
66606	01MAY2007	31DEC9999	Y	A test described in item 66605 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 25)
66607	01MAY2009	30JUN2011	N	Vitamins - quantitation of vitamins A and E in blood, urine or other body fluid - 1 or more tests within a 6 month period
66607	01JUL2011	31DEC9999	Y	Vitamins - quantitation of vitamins A or E in blood, urine or other body fluid - 1 or more tests within a 6 month period
66608	01NOV1998	31DEC9999	Y	Vitamin D or D fractions - 1 or more tests
66609	01MAY2007	31DEC9999	Y	A test described in item 66608 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66610	01JUL2011	31DEC9999	Y	A test described in item 66607 if rendered by a receiving APP - 1 or more tests
66611	01NOV1998	31DEC9999	Y	Quantitation, not elsewhere described in this Table by any method or methods, in blood or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where 1 laboratory performs the only test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66614	01NOV1998	31DEC9999	Y	2 tests described in item 66611 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66617	01NOV1998	31DEC9999	Y	3 or more tests described in item 66611 (Item is subject to rule 6)
66620	01NOV1998	31DEC9999	Y	Tests described in item 66611, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to rule 6)
66623	01NOV1998	31OCT2003	N	All qualitative and quantitative tests on blood, urine or other body fluid for: (a) a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b) ingested or absorbed toxic chemicals; including a service described in item 66611, 66614 or 66617 (if performed), but excluding: (c) the surveillance of sports people and athletes for performance improving substances; and (d) the monitoring of patients participating in a drug abuse treatment program
66623	01NOV2003	31DEC9999	Y	All qualitative and quantitative tests on blood, urine or other body fluid for: (a) a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b) ingested or absorbed toxic chemicals; including a service described in item 66800, 66803, 66806, 66812 or 66815 (if performed), but excluding: (c) the surveillance of sports people and athletes for performance improving substances; and (d) the monitoring of patients participating in a drug abuse treatment program
66626	01NOV1998	30APR2002	N	Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient: (a) participating in a drug abuse treatment program; or (b) being monitored for drug effects; but excluding (c) the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid - each episode, to a maximum of 21 episodes in a 12 month period
66626	01MAY2002	30APR2005	N	Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid - each episode, to a maximum of 36 episodes in a 12 month period
66626	01MAY2005	30APR2007	N	Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid
66626	01MAY2007	31DEC9999	Y	Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid (Item is subject to rule 25)
66629	01NOV1998	31DEC9999	Y	Beta-2-microglobulin - quantitation in serum, urine or other body fluids - 1 or more tests
66632	01NOV1998	31DEC9999	Y	Caeruloplasmin, haptoglobins, or prealbumin - quantitation in serum, urine or other body fluids - 1 or more tests
66635	01NOV1998	31DEC9999	Y	Alpha-1-antitrypsin - quantitation in serum, urine or other body fluid - 1 or more tests
66638	01NOV1998	31DEC9999	Y	Isoelectric focussing or similar methods for determination of alpha-1-antitrypsin phenotype in serum - 1 or more tests
66639	01MAY2007	31DEC9999	Y	A test described in item 66638 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66641	01NOV1998	31DEC9999	Y	Electrophoresis of serum or other body fluid to demonstrate: (a) the isoenzymes of lactate dehydrogenase; or (b) the isoenzymes of alkaline phosphatase; including the preliminary quantitation of total relevant enzyme activity - 1 or more tests
66642	01MAY2007	31DEC9999	Y	A test described in item 66641 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66644	01NOV1998	31DEC9999	Y	C-1 esterase inhibitor - quantitation
66647	01NOV1998	31DEC9999	Y	C-1 esterase inhibitor - functional assay
66650	01NOV1998	31OCT1999	N	Alphafetoprotein, CA15.3 antigen (CA15.3), CA125 antigen (CA125), CA19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy quantitation 1 test
66650	01NOV1999	30APR2003	N	Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of gestational trophoblastic disease - quantitation - 1 test
66650	01MAY2003	30APR2007	N	Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test
66650	01MAY2007	31OCT2008	N	Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test (Item is subject to rule 6)
66650	01NOV2008	31DEC9999	Y	Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), neuron specific enolase (NSE), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test (Item is subject to rule 6)
66651	01MAY2007	31DEC9999	Y	A test described in item 66650 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
66652	01MAY2007	31DEC9999	Y	A test described in item 66650 if rendered by a receiving APP - other than that described in 66651, if rendered by a receiving APP, 1 test (Item is subject to rule 6 and 18)
66653	01NOV1998	30APR2007	N	2 or more tests described in item 66650
66653	01MAY2007	31DEC9999	Y	2 or more tests described in item 66650 (Item is subject to rule 6)
66654	01NOV2023	31DEC9999	Y	Prostate specific antigen - quantitation in the monitoring of high-risk patients For any particular patient, applicable not more than once in 11 months
66655	01MAY2001	30APR2002	N	Prostate specific antigen - quantitation in the assessment of clinically suspected prostatic disease - 1 patient episode in a 12 month period
66655	01MAY2002	30APR2005	N	Prostate specific antigen - quantitation - 1 patient episode in a 12 month period
66655	01MAY2005	30APR2007	N	Prostate specific antigen - quantitation - 1 of this item in a 12 month period
66655	01MAY2007	31OCT2023	N	Prostate specific antigen - quantitation - 1 of this item in a 12 month period (Item is subject to rule 25)
66655	01NOV2023	31DEC9999	Y	Prostate specific antigen-quantitation For any particular patient, applicable not more than once in 23 months
66656	01NOV1998	30APR2001	N	Prostate specific antigen or prostate acid phosphatase - quantitation in the confirmation or monitoring of malignancy - 1 test
66656	01MAY2001	31OCT2002	N	Prostate specific antigen - quantitation in the monitoring of previously diagnosed prostatic disease (including a test described in item 66655) - each patient episode to a maximum of 4 patient episodes in a 12 month period
66656	01NOV2002	31OCT2023	N	Prostate specific antigen - quantitation in the monitoring of previously diagnosed prostatic disease (including a test described in item 66655)
66656	01NOV2023	31DEC9999	Y	Prostate specific antigen (PSA) quantitation in the monitoring of previously diagnosed prostatic disease (including prostate cancer, prostatitis or a premalignant condition such as atypical small acinar proliferation)
66659	01NOV1998	30APR2001	N	2 tests described in item 66656
66659	01MAY2001	30APR2005	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 patient episode in a 12 month period
66659	01MAY2005	30APR2007	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 of this item in a 12 month period
66659	01MAY2007	30APR2009	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 of this item in a 12 month period (Item is subject to rule 25)
66659	01MAY2009	30JUN2009	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies above the age related median but below the age related, method specific 97.5% reference limit - 1 of this item in a 12 month period (Item is subject to rule 25)
66659	01JUL2009	31OCT2023	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result that lies at or above the age related median but below the age related, method specific 97.5% reference limit - 1 of this item in a 12 month period (Item is subject to rule 25)
66659	01NOV2023	31DEC9999	Y	Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA and any derived index, including, if performed, a test described in item 66656, in the follow up of a PSA result under item 66654 or 66655 that lies at: (a) more than 2.0 ug/L but less than or equal to 5.5 ug/L for patients with a family history of prostate cancer; or (b) more than 3.0 ug/L but less than or equal to 5.5 ug/L for patients who are at least 50 years of age but under 70 years of age; or (c) more than 5.5 ug/L but less than or equal to 10.0 ug/L for patients who are at least 70 years of age For any particular patient, applicable not more than once in 11 months
66660	01MAY2009	30JUN2009	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result which lies above the age related, method specific 97.5% reference limit, but below a value of 10 ug/L - 4 of this item in a 12 month period. (Item is subject to rule 25)
66660	01JUL2009	31OCT2023	N	Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result that lies at or above the age related, method specific 97.5% reference limit, but below a value of 10 ug/L - 4 of this item in a 12 month period. (Item is subject to rule 25)
66660	01NOV2023	31DEC9999	Y	Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA and any derived index, in the monitoring of previously diagnosed prostatic disease, including, if performed, a test described in item 66656, if the current PSA level lies at: (a) more than 2.0 ug/L but less than or equal to 5.5 ug/L for patients with a family history of prostate cancer; or (b) more than 3.0 ug/L but less than or equal to 5.5 ug/L for patients who are at least 50 years of age but under 70 years of age; or (c) more than 5.5 ug/L but less than or equal to 10.0 ug/L for patients who are at least 70 years of age For any particular patient, applicable not more than 4 times in 11 months
66662	01NOV1998	31DEC9999	Y	Quantitation of hormone receptors on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast - 1 or more tests
66663	01MAY2007	31DEC9999	Y	A test described in item 66662 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66665	01NOV1998	31DEC9999	Y	Lead quantitation in blood or urine (other than for occupational health screening purposes) to a maximum of 3 tests in a 6 month period - each test
66666	01MAY2007	31DEC9999	Y	A test described in item 66665 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66667	01NOV2000	31DEC9999	Y	Quantitation of serum zinc in a patient receiving intravenous alimentation - each test
66668	01NOV1998	31DEC9999	Y	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, or zinc, in blood, urine or other body fluid or tissue - 1 or more tests in a 6 month period
66669	01NOV2000	30APR2005	N	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22)
66669	01MAY2005	31DEC9999	Y	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22)
66670	01NOV2000	30APR2005	N	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22)
66670	01MAY2005	31DEC9999	Y	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22)
66671	01NOV1998	31DEC9999	Y	Quantitation of serum aluminium in a patient in a renal dialysis program - each test
66672	01NOV2000	30APR2005	N	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22)
66672	01MAY2005	31DEC9999	Y	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22)
66673	01NOV2000	30APR2005	N	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22)
66673	01MAY2005	31DEC9999	Y	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22)
66674	01NOV1998	31DEC9999	Y	Quantitation of: (a) faecal fat; or (b) breath hydrogen in response to loading with disaccharides; 1 or more tests within a 28 day period
66677	01NOV1998	31DEC9999	Y	Test for tryptic activity in faeces in the investigation of diarrhoea of longer than 4 weeks duration in children under 6 years old
66680	01NOV1998	31DEC9999	Y	Quantitation of disaccharidases and other enzymes in intestinal tissue - 1 or more tests
66683	01NOV1998	31DEC9999	Y	Enzymes - quantitation in solid tissue or tissues other than blood elements or intestinal tissue - 1 or more tests
66686	01NOV1998	31DEC9999	Y	Performance of 1 or more of the following procedures: (a) growth hormone suppression by glucose loading; (b) growth hormone stimulation by exercise; (c) dexamethasone suppression test; (d) sweat collection by iontophoresis for chloride analysis; (e) pharmacological stimulation of growth hormone
66689	01NOV1998	31DEC9999	Y	Personal performance by a recognised pathologist of 1 of the following procedures: (a) gonadotrophin releasing hormone stimulation test; (b) synacthen stimulation test; (c) glucagon stimulation test with C-peptide measurement; (d) pentagastrin or calcium stimulation of thyrocalcitonin release; (e) secretin or calcium stimulation of gastrin release; (f) insulin hypoglycaemia; (g) arginine infusion; (h) thyrotrophin releasing hormone (TRH) test
66692	01NOV1998	31DEC9999	Y	Personal performance by a recognised pathologist of 2 or more tests described in item 66689
66695	01NOV1998	31OCT2004	N	Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test
66695	01NOV2004	30APR2007	N	Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test
66695	01MAY2007	31OCT2008	N	Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test (Item is subject to rule 6)
66695	01NOV2008	31DEC9999	Y	Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, - 1 test (Item is subject to rule 6)
66696	01MAY2007	31DEC9999	Y	A test described in item 66695, if rendered by a receiving APP - where no tests in the item have been rendered by the referring APP (Item is subject to rule 6 and 18)
66697	01MAY2007	31OCT2008	N	Tests described in item 66695, other than that described in 66696, if rendered by a receiving APP - each test to a maximum of 5 tests (Item is subject to rule 6 and 18)
66697	01NOV2008	31DEC9999	Y	Tests described in item 66695, other than that described in 66696, if rendered by a receiving APP - each test to a maximum of 4 tests (Item is subject to rule 6 and 18)
66698	01NOV1998	31DEC9999	Y	2 tests described in item 66695 (Item is subject to rule 6)
66701	01NOV1998	31DEC9999	Y	3 tests described in item 66695 (Item is subject to rule 6)
66704	01NOV1998	31DEC9999	Y	4 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66707	01NOV1998	30JUN2008	N	5 tests described in item 66695 (Item is subject to rule 6)
66707	01JUL2008	31DEC9999	Y	5 or more tests described in item 66695 (Item is subject to rule 6)
66710	01NOV1998	31DEC9999	Y	6 or more tests described in item 66695 (Item is subject to rule 6)
66711	01NOV2005	30APR2007	N	Quantitation in saliva of cortisol in: (a) the investigation of Cushing's syndrome; or (b) the management of children with congenital adrenal hyperplasia
66711	01MAY2007	31DEC9999	Y	Quantitation in saliva of cortisol in: (a) the investigation of Cushing's syndrome; or (b) the management of children with congenital adrenal hyperplasia (Item is subject to rule 6)
66712	01NOV2005	30APR2007	N	Two tests described in item 66711
66712	01MAY2007	31DEC9999	Y	Two tests described in item 66711 (Item is subject to rule 6)
66713	01NOV1998	31DEC9999	Y	Tests described in item 66695, if rendered under a request referred to in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6)
66714	01MAY2007	31DEC9999	Y	A test described in item 66711, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP (Item is subject to rule 6 and 18)
66715	01MAY2007	31DEC9999	Y	Tests described in item 66711, other than that described in 66714, if rendered by a receiving APP, each test to a maximum of 1 test (Item is subject to rule 6 and 18)
66716	01NOV1998	31DEC9999	Y	TSH quantitation
66719	01NOV1998	31OCT2008	N	Thyroid function tests (comprising the service described in item 66716 and 1 or more of the following tests - estimation of free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin) for a patient, if at least 1 of the following conditions is satisfied: (a) the patient has an abnormal level of TSH; (b) the tests are performed: (i) for the purpose of monitoring thyroid disease in the patient; or (ii) to investigate the sick euthyroid syndrome if the patient is an admitted patient; or (iii) to investigate dementia or psychiatric illness of the patient; or (iv) to investigate amenorrhoea or infertility of the patient; (c) the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d) the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 9)
66719	01NOV2008	30JUN2020	N	Thyroid function tests (comprising the service described in item 66716 and 1 or more of the following tests - free thyroxine, free T3, for a patient, if at least 1 of the following conditions is satisfied: (a) the patient has an abnormal level of TSH; (b) the tests are performed: (i) for the purpose of monitoring thyroid disease in the patient; or (ii) to investigate the sick euthyroid syndrome if the patient is an admitted patient; or (iii) to investigate dementia or psychiatric illness of the patient; or (iv) to investigate amenorrhoea or infertility of the patient; (c) the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d) the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 9)
66719	01JUL2020	31DEC9999	Y	Thyroid function tests (comprising the service described in item 66716 and either or both of a test for free thyroxine and a test for free T3) for a patient, if: (a) the patient has a level of TSH that is outside the normal reference range for the particular method of assay used to determine the level; or (b) the request from the requesting medical practitioner indicates that the tests are performed: (i) for the purpose of monitoring thyroid disease in the patient; or (ii) to investigate the sick euthyroid syndrome if the patient is an admitted patient; or (iii) to investigate dementia or psychiatric illness of the patient; or (iv) to investigate amenorrhoea or infertility of the patient; or (c) the request from the requesting medical practitioner indicates that the medical practitioner suspects the patient has a pituitary dysfunction; or (d) the request from the requesting medical practitioner indicates that the patient is on drugs that interfere with thyroid hormone metabolism or function
66722	01NOV1998	31DEC9999	Y	TSH quantitation described in item 66716 and 1 test described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66723	01MAY2007	31DEC9999	Y	Tests described in item 66722, that is, TSH quantitation and 1 test described in 66695, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
66724	01MAY2007	31DEC9999	Y	Tests described in item 66722, if rendered by a receiving APP, other than that described in 66723. It is to include a quantitation of TSH - each test to a maximum of 4 tests described in item 66695 (Item is subject to rule 6 and 18)
66725	01NOV1998	31DEC9999	Y	TSH quantitation described in item 66716 and 2 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 tests specified on the request form or performs 3 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66728	01NOV1998	31DEC9999	Y	TSH quantitation described in item 66716 and 3 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66731	01NOV1998	31DEC9999	Y	TSH quantitation described in item 66716 and 4 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 tests specified on the request form or performs 5 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66734	01NOV1998	31DEC9999	Y	TSH quantitation described in item 66716 and 5 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 6 or more tests specified on the request form) (Item is subject to rule 6)
66737	01NOV1998	31DEC9999	Y	Tests described in items 66716 and 66695, if rendered under a request mentioned in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6)
66740	01NOV1998	31DEC9999	Y	Quantitation, in pregnancy, of alpha-fetoprotein, human chorionic gonadotrophin, oestriol and any other substance to detect fetal abnormality, including a service described in 1 or more of items 66743, 66746, 73527 and 73529 (if performed) - 1 patient episode in a pregnancy
66743	01NOV1998	30APR2003	N	Quantitation of alpha-fetoprotein in serum or other body fluids during pregnancy except if requested as part of item 66740
66743	01MAY2003	31DEC9999	Y	Quantitation of alpha-fetoprotein in serum or other body fluids during pregnancy except if requested as part of items 66750 or 66751
66746	01NOV1998	31DEC9999	Y	Human placental lactogen or oestriol - quantitation, except if requested as part of item 66740 - 1 test
66749	01NOV1998	31DEC9999	Y	Amniotic fluid, spectrophotometric examination of, and quantitation of: (a) lecithin/sphingomyelin ratio; or (b) palmitic acid, phosphatidylglycerol or lamellar body phospholipid; or (c) bilirubin, including correction for haemoglobin 1 or more tests
66750	01MAY2003	30APR2005	N	Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - 1 patient episode in a pregnancy
66750	01MAY2005	30APR2007	N	Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - 1 of this item in a pregnancy
66750	01MAY2007	30JUN2020	N	Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - (Item is subject to rule 25)
66750	01JUL2020	31DEC9999	Y	Quantitation, in pregnancy, of any 2 of the following to detect foetal abnormality - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - including (if performed) a service described in item 73527 or 73529 - Applicable not more than once in a pregnancy
66751	01MAY2003	30APR2007	N	Quantitation, in pregnancy, of any three or more tests described in 66750
66751	01MAY2007	31DEC9999	Y	Quantitation, in pregnancy, of any three or more tests described in 66750 (Item is subject to rule 25)
66752	01NOV1998	30APR2007	N	Quantitation of citrate, oxalate, total free fatty acids or amino acids including cysteine, homocysteine, cystine and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test
66752	01MAY2007	31OCT2008	N	Quantitation of citrate, oxalate, total free fatty acids, cysteine, homocysteine, cystine or other amino acids and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test
66752	01NOV2008	31DEC9999	Y	Quantitation of acetoacetate, beta-hydroxybutyrate, citrate, oxalate, total free fatty acids, cysteine, homocysteine, cystine, lactate, pyruvate or other amino acids and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test
66755	01NOV1998	31DEC9999	Y	2 or more tests described in item 66752
66756	01MAY2007	31DEC9999	Y	Quantitation of 10 or more amino acids for the diagnosis of inborn errors of metabolism - up to 4 tests in a 12 month period on specimens of plasma, CSF and urine.
66757	01MAY2007	31DEC9999	Y	Quantitation of 10 or more amino acids for monitoring of previously diagnosed inborn errors of metabolism in 1 tissue type.
66758	01NOV1998	31DEC9999	Y	Quantitation of angiotensin converting enzyme, or cholinesterase - 1 or more tests
66761	01NOV1998	31DEC9999	Y	Test for reducing substances in faeces by any method (except reagent strip or dipstick)
66764	01NOV1998	31OCT2008	N	Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a) an immunological method; and (b) a chemical method (except reagent strip or dip stick); with a maximum of 3 examinations on specimens collected on separate days in a 28 day period - 1 examination by both methods
66764	01NOV2008	31DEC9999	Y	Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces except by reagent strip or dip stick methods) with a maximum of 3 examinations on specimens collected on separate days in a 28 day period
66767	01NOV1998	31OCT2008	N	2 examinations by both methods described in item 66764 performed on separately collected and identified specimens
66767	01NOV2008	31DEC9999	Y	2 examinations described in item 66764 performed on separately collected and identified specimens
66770	01NOV1998	31OCT2008	N	3 examinations by both methods described in item 66764 performed on separately collected and identified specimens
66770	01NOV2008	31DEC9999	Y	3 examinations described in item 66764 performed on separately collected and identified specimens
66773	01NOV1998	31OCT2001	N	Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in paragraph D1.15 of explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule)
66773	01NOV2001	31OCT2007	N	Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in the explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule)
66773	01NOV2007	31DEC9999	Y	Quantitation of products of collagen breakdown or formation for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in the explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule)
66776	01NOV1998	31OCT2007	N	Quantitation of products of collagen breakdown for the monitoring of patients with metabolic bone disease or Paget's disease of bone, and if performed, a service described in item 66752 - 1 or more tests
66776	01NOV2007	31DEC9999	Y	Quantitation of products of collagen breakdown or formation for the monitoring of patients with metabolic bone disease or Paget's disease of bone, and if performed, a service described in item 66752 - 1 or more tests
66779	01NOV1998	31DEC9999	Y	Adrenaline, noradrenaline, dopamine, histamine, hydroxyindoleacetic acid (5HIAA), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA) or serotonin quantitation - 1 or more tests
66780	01MAY2007	31DEC9999	Y	A test described in item 66779 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66782	01NOV1998	31DEC9999	Y	Porphyrins or porphyrins precursors - detection in plasma, red cells, urine or faeces - 1 or more tests
66783	01MAY2007	31DEC9999	Y	A test described in item 66782 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66785	01NOV1998	30APR2007	N	Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 1 test
66785	01MAY2007	31DEC9999	Y	Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 1 test (Item is subject to rule 6)
66788	01NOV1998	30APR2007	N	Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 2 or more tests
66788	01MAY2007	31DEC9999	Y	Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 2 or more tests (Item is subject to rule 6)
66789	01MAY2007	31DEC9999	Y	A test described in item 66785 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
66790	01MAY2007	31DEC9999	Y	A test described in item 66785 other than that described in 66789, if rendered by a receiving APP - to a maximum of 1 test (Item is subject to rule 6 and 18)
66791	01NOV1998	31DEC9999	Y	Porphyrin biosynthetic enzymes - measurement of activity in blood cells or other tissues - 1 or more tests
66792	01MAY2007	31DEC9999	Y	A test described in item 66791 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
66794	01NOV1998	31OCT1999	N	Detection of the C282Y genetic mutation for haemochromatosis where: (a) the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b) the patient has a first degree relative with haemochromatosis or with homozygosity for the C282Y genetic mutation; not exceeding 1 episode in a 3 year period (Item is subject to rule 22)
66794	01NOV1999	31DEC9999	Y	Detection of the C282Y genetic mutation of the HFE gene and, if performed, detection of other mutations for haemochromatosis where: (a) the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b) the patient has a first degree relative with haemochromatosis; or (c) the patient has a first degree relative with homozygosity for the C282Y genetic mutation, or with compound heterozygosity for recognised genetic mutations for haemochromatosis (Item is subject to rule 20)
66800	01NOV2003	31DEC9999	Y	Quantitation in blood, urine or other body fluid by any method (except reagent tablet or reagent strip) of any of the following being used therapeutically by the patient from whom the specimen was taken: amikacin, carbamazepine, digoxin, disopyramide, ethanol, ethosuximide, gentamicin, lithium, lignocaine, netilmicin, paracetamol, phenobarbitone, primidone, phenytoin, procainamide, quinidine, salicylate, theophylline, tobramycin, valproate or vancomycin - 1 test (Item to be subject to rule 6)
66803	01NOV2003	31DEC9999	Y	2 tests described in item 66800 (Item is subject to rule 6)
66804	01MAY2007	31DEC9999	Y	A test described in item 66800 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
66805	01MAY2007	31DEC9999	Y	A test described in item 66800 other than that described in 66804, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18)
66806	01NOV2003	31DEC9999	Y	3 tests described in item 66800 (Item is subject to rule 6)
66809	01NOV2003	31DEC9999	Y	Tests described in item 66800, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to rule 6)
66812	01NOV2003	31DEC9999	Y	Quantitation, not elsewhere described in this Table by any method or methods, in blood, urine or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where 1 laboratory performs the only test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66815	01NOV2003	31DEC9999	Y	2 tests described in item 66812 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
66816	01MAY2007	31DEC9999	Y	A test described in item 66812 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
66817	01MAY2007	31DEC9999	Y	A test described in item 66812, other than that described in 66816, if rendered by a receiving APP - to a maximum of 1 test (Item is subject to rule 6 and 18)
66818	01NOV2003	31DEC9999	Y	Tests described in item 66812, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 1 test (Item is subject to rule 6)
66819	01MAY2007	31OCT2008	N	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25)
66819	01NOV2008	31DEC9999	Y	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid - 1 test. (Item is subject to rule 6, 22 and 25)
66820	01MAY2007	31DEC9999	Y	A test described in item 66819 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6, 18, 22 and 25)
66821	01MAY2007	31DEC9999	Y	A test described in item 66819 other than that described in 66820 if rendered by a receiving APP to a maximum of 1 test (Item is subject to rule 6, 18, 22 and 25)
66822	01MAY2007	31OCT2008	N	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25)
66822	01NOV2008	31DEC9999	Y	Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid - 2 or more tests. (Item is subject to rule 6, 22 and 25)
66825	01MAY2007	31DEC9999	Y	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25)
66826	01MAY2007	31DEC9999	Y	A test described in item 66825 if rendered by a receiving APP where no tests have been rendered by the referring APP - 1 test (Item is subject to rules 6, 18, 22 and 25 )
66827	01MAY2007	31DEC9999	Y	A test described in item 66825, other than that described in 66826, if rendered by a receiving APP to a maximum of 1 test (Item is subject to rules 6, 18, 22 and 25)
66828	01MAY2007	31DEC9999	Y	Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25)
66829	01NOV2024	31DEC9999	Y	Quantitation of BNP or NT-proBNP for the exclusion of a diagnosis of heart failure in a patient presenting in a non-hospital setting to assist in decision-making regarding the clinical necessity of an echocardiogram, where heart failure is suspected based on signs and symptoms but diagnosis is uncertain Applicable once in any 12 month period
66830	01JUL2008	31DEC9999	Y	Quantitation of BNP or NT-proBNP for the diagnosis of heart failure in patients presenting with dyspnoea to a hospital Emergency Department (Item is subject to rule 25)
66831	01NOV2008	31DEC9999	Y	Quantitation of copper or iron in liver tissue biopsy
66832	01NOV2008	31DEC9999	Y	A test described in item 66831 if rendered by a receiving APP (Item is subject to rule 18A and 22)
66833	01NOV2014	31DEC9999	Y	25-hydroxyvitamin D, quantification in serum, for the investigation of a patient who: (a) has signs or symptoms of osteoporosis or osteomalacia; or (b) has increased alkaline phosphatase and otherwise normal liver function tests; or (c) has hyperparathyroidism, hypo- or hypercalcaemia, or hypophosphataemia; or (d) is suffering from malabsorption (for example, because the patient has cystic fibrosis, short bowel syndrome, inflammatory bowel disease or untreated coeliac disease, or has had bariatric surgery); or (e) has deeply pigmented skin, or chronic and severe lack of sun exposure for cultural, medical, occupational or residential reasons; or (f) is taking medication known to decrease 25OH-D levels (for example, anticonvulsants); or (g) has chronic renal failure or is a renal transplant recipient; or (h) is less than 16 years of age and has signs or symptoms of rickets; or (i) is an infant whose mother has established vitamin D deficiency; or (j) is a exclusively breastfed baby and has at least one other risk factor mentioned in a paragraph in this item; or (k) has a sibling who is less than 16 years of age and has vitamin D deficiency
66834	01NOV2014	31DEC9999	Y	A test described in item 66833 if rendered by a receiving APP (Item is subject to Rule 18)
66835	01NOV2014	31DEC9999	Y	1, 25-dihydroxyvitamin D - quantification in serum, if the request for the test is made by, or on advice of, the specialist or consultant physician managing the treatment of the patient
66836	01NOV2014	31DEC9999	Y	1, 25-dihydroxyvitamin D-quantification in serum, if: (a) the patient has hypercalcaemia; and (b) the request for the test is made by a general practitioner managing the treatment of the patient
66837	01NOV2014	31DEC9999	Y	A test described in item 66835 or 66836 if rendered by a receiving APP (Item is subject to Rule 18)
66838	01NOV2014	31DEC9999	Y	Serum vitamin B12 test (Item is subject to Rule 25)
66839	01NOV2014	31DEC9999	Y	Quantification of vitamin B12 markers such as holoTranscobalamin or methylmalonic acid, where initial serum vitamin B12 result is low or equivocal
66840	01NOV2014	31DEC9999	Y	Serum folate test and, if required, red cell folate test for a patient at risk of folate deficiency, including patients with malabsorption conditions, macrocytic anaemia or coeliac disease
66841	01NOV2014	31DEC9999	Y	Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk. (Item is subject to rule 25)
66900	01MAY2009	31DEC9999	Y	CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, including the measurement of exhaled 13CO2 or 14CO2 (except if item 12533 applies) for either:- (a) the confirmation of Helicobacter pylori colonisation OR (b) the monitoring of the success of eradication of Helicobacter pylori.
69201	01DEC1991	30JUN1994	N	Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains 1 or more examinations
69201	01JUL1994	31DEC9999	Y	Microscopy of wet film material other than blood, from 1 or more sites, obtained directly from a patient (not cultures) including: (a) differential cell count (if performed); or (b) examination for dermatophytes; or (c) dark ground illumination; or (d) stained preparation or preparations using any relevant stain or stains; 1 or more tests
69202	01DEC1991	31DEC9999	Y	Microscopic examination of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultures wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains one or more examinations
69203	01DEC1991	30JUN1994	N	Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any services specified in item 69201 each estimation
69203	01JUL1994	31DEC9999	Y	Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) to a maximum of 3 tests taken on separate days, including a service (if performed) described in item 69201 each test
69204	01DEC1991	31DEC9999	Y	Microscopic examination of faeces forparasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 69201/69202 each estimation
69205	01DEC1991	30JUN1994	N	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201 1 or more sites
69205	01JUL1994	31DEC9999	Y	Culture and (if performed) microscopy to detect pathogenic micro-organisms (including fungi but excluding viruses), from nasal swabs, throat swabs, eye swabs and ear swabs, including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) the detection of antigens not elsewhere described in this Table; or (c) a service described in item 69201; specimens from 1 or more sites
69206	01DEC1991	31DEC9999	Y	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic microorganisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201 one or more sites
69207	01DEC1991	31OCT1993	N	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 69205 1 or more examinations on 1 or more specimens
69207	01NOV1993	30JUN1994	N	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 73810 1 or more examinations on 1 or more specimens
69207	01JUL1994	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms, including fungi but excluding viruses, from: (a) skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens); or (b) specimens of sputum (except when part of item 69213); including (if performed): (c) the detection of antigens not elsewhere specified in this Table; or (d) pathogenic identification and antibiotic susceptibility testing; or (e) a service described in item 69201, 69205 and 73810; 1 or more tests on 1 or more specimens
69208	01DEC1991	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic microorganisms, including fungi but excluding viruses, from the following sites skin or other superficial sites, urethra, vagina, cervix, or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213/69214), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201/69202, 69205/69206 one or more examinations on one or more specimens
69209	01DEC1991	30JUN1994	N	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 69207 1 or more sites
69209	01JUL1994	31DEC9999	Y	Microscopy and culture of postoperative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms (including fungi but excluding viruses) involving aerobic and anaerobic culture and the use of different culture media, and including (if performed); (a) pathogen identification and antibiotic susceptibility testing; (b) the detection of antigens not elsewhere specified in this Table; or (c) a service described in item 69201, 69205 or 69207; specimens from 1 or more sites
69210	01DEC1991	31DEC9999	Y	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic microorganisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201/69202, 69205/69206 and 69207/69208 one or more sites
69211	01DEC1991	30JUN1994	N	Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of 3 specimens in any 7 day period each examination
69211	01JUL1994	31DEC9999	Y	Culture of faeces for faecal pathogens, involving the use of at least 2 selective or enrichment media and culture in at least 2 different atmospheres and including (if performed): (a) pathogen identification and antibiotic susceptibility testing; (b) the detection of clostridial toxins or antigens not elsewhere specified in this Table; or (c) a service described in item 69201; to a maximum of 3 specimens in any 7-day period each test
69212	01DEC1991	31DEC9999	Y	Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201/69202, to a maximum of three specimens in any seven day period each examination
69213	01DEC1991	30JUN1994	N	Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201
69213	01JUL1994	31DEC9999	Y	Microscopy with appropriate stains and culture of 3 specimens of sputum, urine or other body fluids for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; and (c) a service described in item 69201
69214	01DEC1991	31DEC9999	Y	Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201/69202
69215	01DEC1991	30JUN1994	N	Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets
69215	01JUL1994	31DEC9999	Y	Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a) identification of any cultured pathogen; and (b) necessary antibiotic susceptibility testing; each set of cultures to a maximum of 3 sets
69216	01DEC1991	31DEC9999	Y	Blood culture to determine the presence or absence of pathogenic microorganisms excluding viruses, including serial cultures and subcultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing each set of cultures to a maximum of three sets
69217	01DEC1991	30JUN1994	N	Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (simple culture by dip slide is excluded from this item)
69217	01JUL1994	31DEC9999	Y	Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a) cell count; and (b) culture; and (c) colony count (if performed); and (d) stained preparations; and (e) identification of cultured pathogens; and (f) antibiotic susceptibility testing; and (g) any examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts
69218	01DEC1991	31DEC9999	Y	Urine examination including serial examination,with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (Simple culture by dip slide is excluded from this item)
69219	01DEC1991	30JUN1994	N	Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed 1 or more estimations
69219	01JUL1994	31OCT1996	N	Detection of: (a) the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus, respiratory syncytial virus, cryptococcal antigens or Varicella zoster; or (b) Clostridium difficile toxin (except if the service described in item 69211 has been performed); 1 or more tests
69219	01NOV1996	31DEC9999	Y	Detection of: (a) the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus, respiratory syncytial virus, cryptococcal antigens or Varicella zoster; or (b) Clostridium difficile toxin (except if a service described in item 69289 to 69291 has been performed); 1 or more tests
69220	01DEC1991	31DEC9999	Y	Direct detection of the antigens of Heamophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF andurine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211/69212 has been performed one or more estimations
69221	01DEC1991	30JUN1994	N	Direct detection of Chlamydia from clinical material, not cultures 1 or more estimations
69221	01JUL1994	31DEC9999	Y	Detection of Chlamydia from material obtained directly from a patient (not cultures) - 1 or more tests
69222	01DEC1991	31DEC9999	Y	Direct detection of Chlamydia from clinical material, not cultures one or more estimations
69223	01DEC1991	30JUN1994	N	Direct detection of herpes simplex virus from clinical material, not cultures 1 or more estimations
69223	01JUL1994	31DEC9999	Y	Detection of herpes simplex virus from material obtained directly from a patient (not cultures) 1 or more tests
69224	01DEC1991	31DEC9999	Y	Direct detection of Herpes simplex from clinical material, not cultures one or more estimations
69225	01DEC1991	31DEC9999	Y	Investigation for herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any services specified in items 69221 and 69223
69226	01DEC1991	31DEC9999	Y	Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 69221/69222 and 69223/69224
69227	01DEC1991	31DEC9999	Y	All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69229, 69243 and 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
69228	01DEC1991	31DEC9999	Y	All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69230, 69244 and 69246, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
69229	01DEC1991	30JUN1993	N	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule estimation of 1 antibody
69229	01JUL1993	30JUN1994	N	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule estimation of 1 antibody (This fee applies where a laboratory performs the only antibody estimation specified on the request form or performs 1 estimation and refers the rest to the laboratory of a separate APA)
69229	01JUL1994	31DEC9999	Y	Quantitation of 1 antibody to microbial or exogenous antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
69230	01DEC1991	31DEC9999	Y	Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule estimation of one antibody
69231	01DEC1991	30JUN1993	N	2 estimations specified in item 69229
69231	01JUL1993	30JUN1994	N	2 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
69231	01JUL1994	31DEC9999	Y	2 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
69232	01DEC1991	31DEC9999	Y	Two estimations specified in item 69229/69230
69233	01DEC1991	30JUN1993	N	3 estimations specified in item 69229
69233	01JUL1993	30JUN1994	N	3 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
69233	01JUL1994	31DEC9999	Y	3 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
69234	01DEC1991	31DEC9999	Y	Three estimations specified in item 69229/69230
69235	01DEC1991	30JUN1993	N	4 estimations specified in item 69229
69235	01JUL1993	30JUN1994	N	4 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.)
69235	01JUL1994	31DEC9999	Y	4 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
69236	01DEC1991	31DEC9999	Y	Four estimations specified in item 69229/69230
69237	01DEC1991	30JUN1993	N	5 estimations specified in item 69229
69237	01JUL1993	31DEC9999	Y	5 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6)
69238	01DEC1991	31DEC9999	Y	Five estimations specified in item 69229/69230
69239	01DEC1991	30JUN1994	N	6 or more estimations specified in item 69229
69239	01JUL1994	31DEC9999	Y	6 or more tests described in item 69229
69240	01DEC1991	31DEC9999	Y	Six or more estimations specified in item 69229/69230
69241	01SEP1992	30JUN1993	N	Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations
69241	01JUL1993	30JUN1994	N	"Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the antibody estimations specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
69241	01JUL1994	31OCT1994	N	"Tests described in any of items 69229 to 69237, if the number of tests relating to the same patient episode does not exceed 6 - each tests to a maximum of 5 tests (Item is subject to rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the antibody tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)"
69241	01NOV1994	31OCT1995	N	Tests described in item 69229, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item is subject to rule 6)
69241	01NOV1995	31DEC9999	Y	Tests described in item 69229, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6)
69243	01DEC1991	31DEC9999	Y	Hepatitis B surface antigen test
69244	01DEC1991	31DEC9999	Y	Hepatitis B surface antigen test
69245	01DEC1991	30JUN1994	N	Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249
69245	01JUL1994	31DEC9999	Y	Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody test, and including a service described in item 69243, 69247 or 69249 (if performed)
69246	01DEC1991	31DEC9999	Y	Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 69243/69244, 69247/69248 and 69249/69250
69247	01DEC1991	30JUN1994	N	All serological tests performed for the identification of the agent causing acute hepatitis, which must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249
69247	01JUL1994	31DEC9999	Y	Serological tests to identify the agent causing acute hepatitis (must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody test and the services described in item 69243, 69245 and 69249)
69248	01DEC1991	31DEC9999	Y	All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 69243/69244, 69245/69246 and 69249/69250
69249	01DEC1991	30JUN1994	N	All tests performed in the follow up of a patient with proven hepatitis B, including hepatitis B surface antigen and either hepatitis B antigen or hepatitis B surface antibody tests, including services specified in items 69243 and 69245
69249	01JUL1994	31DEC9999	Y	Tests performed in the follow-up of a patient with proven hepatitis B, including: (a) hepatitis B surface antigen test; and (b) either: (i) hepatitis Be antigen test; or (ii) hepatitis B surface antibody test, and (c) (if performed) services described in item 69243 and 69245
69250	01DEC1991	31DEC9999	Y	All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 69243/69244 and 69245/69246
69251	01DEC1991	30JUN1994	N	Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent 1 or more estimations
69251	01JUL1994	31DEC9999	Y	Antibiotics or antimicrobial chemotherapeutic agents in serum, urine or other body fluid - quantitation 1 or more tests
69252	01DEC1991	31DEC9999	Y	Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent one or more estimations
69253	01SEP1992	30JUN1994	N	All microbiological serology during a pregnancy, which must include the determination of 1 of the following - rubella immune status, specific syphilis serology or hepatitis B surface antigen - including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
69253	01JUL1994	19MAR1997	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 1 of the following: rubella immune status, specific syphilis serology, hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed)
69253	20MAR1997	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 1 of the following: rubella immune status, specific syphilis serology, hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed)
69255	01SEP1992	30JUN1994	N	All microbiological serology during a pregnancy, which must include the determination of 2 of the following - rubella immune status, specific syphilis serology or hepatitis B surface antigen and including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
69255	01JUL1994	31OCT1995	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B surface antigen; (b) a service described in 1 or more of items 69229, 69243 and 69245 (if performed)
69255	01NOV1995	19MAR1997	N	Microbiological serology during a pregnancy (except in the investigation of a clinically intercurrent microbial illness during that pregnancy) including: (a) the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B antigen; (b) a service described in 1 or more of items 69229, 69266 to 69281 (if performed)
69255	20MAR1997	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed)
69257	01SEP1992	30JUN1994	N	All microbiological serology during a pregnancy, which must include the determination of all 3 of the following - rubella immune status, specific syphilis serology and hepatitis B surface antigen - including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy
69257	01JUL1994	31OCT1996	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a) the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69243 and 69245 (if performed)
69257	01NOV1996	19MAR1997	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a) the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69266 to 69281 (if performed)
69257	20MAR1997	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a) the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b) a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed)
69259	01JUL1998	31DEC9999	Y	Quantitation of HIV viral RNA load in plasma, serum or cerebrospinal fluid in the monitoring of a HIV sero-positive patient, who is not on antiretroviral therapy. 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 6 episodes in a 12 month period
69260	01JUL1998	31DEC9999	Y	Quantitation of HIV viral RNA load in plasma, serum or cerebrospinal fluid in the monitoring of antiretroviral therapy in a HIV sero-positive patient. 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 6 episodes in a 12 month period
69261	01JUL1993	30JUN1994	N	Examination for chlamydia by culture or by the demonstration of chlamydial nucleic acid using a DNA probe in material collected directly from a patient, including a service specified in item 69221, 69223 or 69263
69261	01JUL1994	31DEC9999	Y	Examination for Chlamydia (by culture or by the demonstration of chlamydial nucleic acid using a DNA probe) in material obtained directly from a patient, including a service specified in item 69221, 69223 or 69263 (if performed)
69262	01JUL1996	31DEC9999	Y	Detection of chlamydia by any method in specimens from 1 or more sites
69263	01JUL1993	30JUN1994	N	Examination for herpes simplex virus of 1 or more types in material collected directly from a patient by culture, including a service specified in item 69221, 69223 or 69261
69263	01JUL1994	31DEC9999	Y	Examination for herpes simplex virus of 1 or more types by culture in material obtained directly from a patient, including a service described in item 69221, 69223 or 69261 (if performed)
69264	01JUL1996	31DEC9999	Y	Examination for Herpes simplex virus of 1 or more types by culture in material obtained directly from a patient, including a service described in items 69223, 69262 or 69282 (if performed)
69265	01JUL1993	30JUN1994	N	Determination of antibodies to hepatitis C
69265	01JUL1994	31DEC9999	Y	Hepatitis C antibody test
69266	01JUL1996	19MAR1997	N	Investigation for acute Hepatitis A - Hepatitis A IgM antibody test (Item is subject to rule 12)
69266	20MAR1997	31DEC9999	Y	Investigation for acute Hepatitis A using: Hepatitis A IgM antibody test (Item is subject to rule 12)
69267	01JUL1996	19MAR1997	N	Determination of immune status to Hepatitis A - Hepatitis A IgG antibody test (Item is subject to rule 12)
69267	20MAR1997	31DEC9999	Y	Determination of immune status to Hepatitis A using: Hepatitis A IgG antibody test (Item is subject to rule 12)
69268	01JUL1996	19MAR1997	N	Investigation for acute or resolving Hepatitis B, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B core antibody test; and (c) Hepatitis B e antibody test (if the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12)
69268	20MAR1997	31DEC9999	Y	Investigation for acute or resolving Hepatitis B, or testing of close, recent contacts of proven Hepatitis B infection, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B core antibody test; and (c) Hepatitis B e antibody test (if the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12)
69269	01JUL1996	19MAR1997	N	Investigation for resolving Hepatitis B if Hepatitis B core antibody test is positive and Hepatitis B surface antigen test is negative, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B core antibody test; and (c) Hepatitis B surface antibody test (Item is subject to rule 12)
69269	20MAR1997	31DEC9999	Y	Investigation for resolution of Hepatitis B if the Hepatitis B core antibody test is positive and the Hepatitis B surface antigen test is negative, including: (a) Hepatitis B core antibody test; and (b) Hepatitis B surface antigen test; and (c) Hepatitis B surface antibody test (Item is subject to rule 12)
69270	01JUL1996	19MAR1997	N	Determination of immune status to Hepatitis B (post exposure) - Hepatitis B core antibody test (Item is subject to rule 12)
69270	20MAR1997	31DEC9999	Y	Determination of immune status to Hepatitis B (post exposure) using: Hepatitis B core antibody test (Item is subject to rule 12)
69271	01JUL1996	19MAR1997	N	Determination of immune status to Hepatitis B (post vaccination) - Hepatitis B surface antibody test (Item is subject to rule 12)
69271	20MAR1997	31DEC9999	Y	Determination of immune status to Hepatitis B (post vaccination) using: Hepatitis B surface antibody test (Item is subject to rule 12)
69272	01JUL1996	19MAR1997	N	Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen - Hepatitis B surface antigen test (Item is subject to rule 12)
69272	20MAR1997	31DEC9999	Y	Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen using: Hepatitis B surface antigen test (Item is subject to rule 12)
69273	01JUL1996	31DEC9999	Y	Investigation for chronic Hepatitis B or carriage of Hepatitis B antigen if the Hepatitis B surface antigen test is positive, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B e antigen test (Item is subject to rule 12)
69274	01JUL1996	19MAR1997	N	Investigation for Hepatitis C - Hepatitis C antibody test (Item is subject to rule 12)
69274	20MAR1997	31DEC9999	Y	Testing for Hepatitis C using: Hepatitis C antibody test (Item is subject to rule 12)
69275	01JUL1996	19MAR1997	N	Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test - Hepatitis D antibody test (Item is subject to rule 12)
69275	20MAR1997	31DEC9999	Y	Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test using: Hepatitis D antibody test (Item is subject to rule 12)
69276	01JUL1996	31DEC9999	Y	Determination of immune status to Hepatitis A and Hepatitis B, including: (a) Hepatitis A IgG antibody test; and (b) Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12)
69277	01JUL1996	19MAR1997	N	Investigation for chronic viral hepatitis, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis C antibody test (Item is subject to rule 12)
69277	20MAR1997	31DEC9999	Y	Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis C antibody test (Item is subject to rule 12)
69278	01JUL1996	19MAR1997	N	Investigation for chronic viral hepatitis if Hepatitis B surface antigen test is positive, including: (a) Hepatitis C antibody test; and (b) Hepatitis B surface antigen test; and (c) Hepatitis B e antigen test (Item is subject to rule 12)
69278	20MAR1997	31DEC9999	Y	Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, if Hepatitis B surface antigen test is positive, including: (a) Hepatitis C antibody test; and (b) Hepatitis B surface antigen test; and (c) Hepatitis B e antigen test (Item is subject to rule 12)
69279	01JUL1996	19MAR1997	N	Investigation for acute Hepatitis A, Hepatitis B or Hepatitis C in a patient with a currently elevated transaminase level, including: (a) Hepatitis A IgM antibody test; and (b) Hepatitis C antibody test; and (c) Hepatitis B surface antigen test; and (d) Hepatitis B core antibody test; and (e) Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12)
69279	20MAR1997	31DEC9999	Y	Investigation for acute Hepatitis A, Hepatitis B, Hepatitis C and Hepatitis D in a patient with a currently elevated transaminase level, including: (a) Hepatitis A IgM antibody test; and (b) Hepatitis C antibody test; and (c) Hepatitis B surface antigen test; and (d) Hepatitis B core antibody test; and (e) Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed); and (f) Hepatitis D antibody test (if Hepatitis B surface antigen test is positive) (if performed) (Item is subject to rule 12)
69280	20MAR1997	31DEC9999	Y	Determination of immune status to Hepatitis B and testing for Hepatitis C, including: (a) Hepatitis C antibody test; and (b) Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12)
69281	01JUL1996	31DEC9999	Y	Syphilis serology and any 1 of items 69273, 69274 or 69277 (Item is subject to rule 12)
69282	01JUL1996	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms, including the detection of chlamydia by any method from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in item 69201, 69205, 69207, 69223, 69262, 69264 or 73810; 1 or more tests on 1 or more specimens
69283	20MAR1997	31DEC9999	Y	Investigation for acute Hepatitis A and Hepatitis C in a patient with a currently elevated transaminase level, including: (a) Hepatitis A IgM antibody test; and (b) Hepatitis C antibody test (Item is subject to rule 12)
69284	01JUL1998	31DEC9999	Y	Detection of Hepatitis C viral RNA if at least one of the following criteria is satisfied: a) the patient is Hepatitis C sero-positive and has normal liver function tests on two occasions six months apart; b) the patient's serological status is uncertain after testing; c) the test is performed for the purpose of: (i) determining the Hepatitis C status in immunosuppressed in an immunocompromised patient; or (ii) the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient. Not exceeding 1 episode in a 12 month period.
69285	01JUL1996	31DEC9999	Y	Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days, including a service (if performed) described in item 69201 - 1 examination
69286	01JUL1996	31DEC9999	Y	2 examinations described in item 69285 performed on separately collected and identified specimens
69287	01JUL1996	31DEC9999	Y	3 examinations described in item 69285 performed on separately collected and identified specimens
69289	01JUL1996	31DEC9999	Y	Culture of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a) pathogen identification and antibiotic susceptibility testing; and (b) the detection of clostridial toxins or antigens not elsewhere specified in this Table; and (c) a service described in item 69201; with a maximum of 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination
69290	01JUL1996	31DEC9999	Y	2 examinations described in item 69289 performed on separately collected and identified specimens
69291	01JUL1996	31DEC9999	Y	3 examinations described in item 69289 performed on separately collected and identified specimens
69293	01JUL1996	31DEC9999	Y	Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a) identification of any cultured pathogen; and (b) necessary antibiotic susceptibility testing; to a maximum of 3 sets of cultures - 1 set of cultures
69294	01JUL1996	31DEC9999	Y	2 sets of cultures described in item 69293
69295	01JUL1996	31DEC9999	Y	3 sets of cultures described in item 69293
69300	01NOV1998	31DEC9999	Y	Microscopy of wet film material other than blood, from 1 or more sites, obtained directly from a patient (not cultures) including: (a) differential cell count (if performed); or (b) examination for dermatophytes; or (c) dark ground illumination; or (d) stained preparation or preparations using any relevant stain or stains; 1 or more tests
69303	01NOV1998	31OCT2005	N	Culture and (if performed) microscopy to detect pathogenic micro-organisms (including fungi but excluding viruses) from nasal swabs, throat swabs, eye swabs and ear swabs (excluding swabs taken for epidemiological surveillance), including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) the detection of antigens not elsewhere described in this Table; or (c) a service described in item 69300; specimens from 1 or more sites
69303	01NOV2005	31DEC9999	Y	Culture and (if performed) microscopy to detect pathogenic micro-organisms from nasal swabs, throat swabs, eye swabs and ear swabs (excluding swabs taken for epidemiological surveillance), including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) a service described in item 69300; specimens from 1 or more sites
69306	01NOV1998	31OCT2005	N	Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from skin or other superficial sites, including (if performed): (a) the detection of antigens not elsewhere specified in this Table; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69312, 69318 and 73810; 1 or more tests on 1 or more specimens
69306	01NOV2005	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms from skin or other superficial sites, including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) a service described in items 69300, 69303, 69312, 69318; 1 or more tests on 1 or more specimens
69309	01NOV1998	31OCT2005	N	Microscopy and culture to detect dermatophytes and other fungi causing cutaneous disease from skin scrapings, skin biopsies, hair and nails (excluding swab specimens) and including (if performed): (a) the detection of antigens not elsewhere specified in this Table; or (b) a service described in items 69300, 69303, 69306, 69312, 69318 and 73810; 1 or more tests on 1 or more specimens
69309	01NOV2005	30JUN2020	N	Microscopy and culture to detect dermatophytes and other fungi causing cutaneous disease from skin scrapings, skin biopsies, hair and nails (excluding swab specimens) and including (if performed): (a) the detection of antigens not elsewhere specified in this Table; or (b) a service described in items 69300, 69303, 69306, 69312, 69318; 1 or more tests on 1 or more specimens
69309	01JUL2020	31DEC9999	Y	Microscopy and culture to detect dermatophytes and other fungi causing cutaneous disease from skin scrapings, skin biopsies, hair and nails (excluding swab specimens) and including (if performed): (a) the detection of antigens not elsewhere specified in this Schedule; or (b) a service described in items 69300, 69303, 69306, 69312, 69318; 1 or more tests on 1 or more specimens
69312	01NOV1998	31OCT2005	N	Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from urethra, vagina, cervix or rectum (except for faecal pathogens), including (if performed): (a) the detection of antigens not elsewhere specified in this Table; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69306 and 69318; 1 or more tests on 1 or more specimens
69312	01NOV2005	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms from urethra, vagina, cervix or rectum (except for faecal pathogens), including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) a service described in items 69300, 69303, 69306 and 69318; 1 or more tests on 1 or more specimens
69315	01NOV1998	31OCT1999	N	Microscopy and culture to detect pathogenic microorganisms, including the detection of chlamydia by any method from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in item 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69372, 69375 or 73810 1 or more tests on 1 or more specimens
69315	01NOV1999	31OCT2000	N	Microscopy and culture to detect pathogenic microorganisms, and the detection of chlamydia from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in item 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69372, 69375 or 73810; 1 or more tests on 1 or more specimens
69315	01NOV2000	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms, and the detection of chlamydia from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69370, 69372, 69375 or 73810; 1 or more tests on 1 or more specimens
69316	01MAY2007	31DEC9999	Y	Detection of Chlamydia trachomatis by any method - 1 test (Item is subject to rule 26)
69317	01MAY2007	31DEC9999	Y	1 test described in item 69494 and a test described in 69316. (Item is subject to rule 26)
69318	01NOV1998	30APR2003	N	Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a) the detection of antigens not elsewhere specified in this Table; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens
69318	01MAY2003	31OCT2005	N	Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a) the detection of antigens (from any type of specimen) not elsewhere specified in this Table including item 69372; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens
69318	01NOV2005	31DEC9999	Y	Microscopy and culture to detect pathogenic micro-organisms from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens
69319	01MAY2007	31DEC9999	Y	2 tests described in item 69494 and a test described in 69316. (Item is subject to rule 26)
69321	01NOV1998	31OCT2005	N	Microscopy and culture of post-operative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms (including fungi but excluding viruses) involving aerobic and anaerobic cultures and the use of different culture media, and including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) the detection of antigens not elsewhere specified in this Table; or (c) a service described in item 69300, 69303, 69306, 69312 or 69318; specimens from 1 or more sites
69321	01NOV2005	31DEC9999	Y	Microscopy and culture of post-operative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms involving aerobic and anaerobic cultures and the use of different culture media, and including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b) a service described in item 69300, 69303, 69306, 69312 or 69318; specimens from 1 or more sites
69324	01NOV1998	30APR2000	N	Microscopy with appropriate stains and culture of 1 specimen of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300
69324	01MAY2000	31OCT2000	N	Microscopy with appropriate stains and culture of 1 specimen of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300
69324	01NOV2000	30JUN2020	N	Microscopy (with appropriate stains) and culture for mycobacteria - 1 specimen of sputum, urine, or other body fluid or 1 operative or biopsy specimen, including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300
69324	01JUL2020	31DEC9999	Y	Microscopy (with appropriate stains) and culture for mycobacteria - 1 specimen of sputum, urine, or other body fluid or 1 operative or biopsy specimen, including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300
69325	01MAY2007	31DEC9999	Y	A test described in item 69324 if rendered by a receiving APP (Item is subject to rule 18)
69327	01NOV1998	31OCT2000	N	Microscopy with appropriate stains and culture of 2 specimens of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300
69327	01NOV2000	31DEC9999	Y	Microscopy (with appropriate stains) and culture for mycobacteria - 2 specimens of sputum, urine, or other body fluid or 2 operative or biopsy specimens, including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300
69328	01MAY2007	31DEC9999	Y	A test described in item 69327 if rendered by a receiving APP (Item is subject to rule 18)
69330	01NOV1998	31OCT2000	N	Microscopy with appropriate stains and culture of 3 specimens of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300
69330	01NOV2000	31DEC9999	Y	Microscopy (with appropriate stains) and culture for mycobacteria - 3 specimens of sputum, urine, or other body fluid or 3 operative or biopsy specimens, including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300
69331	01MAY2007	31DEC9999	Y	A test described in item 69330 if rendered by a receiving APP (Item is subject to rule 18)
69333	01NOV1998	30JUN2011	N	Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a) cell count; and (b) culture; and (c) colony count; and (d) (if performed) stained preparations; and (e) (if performed) identification of cultured pathogens; and (f) (if performed) antibiotic suseptibility testing; and (g) (if performed) examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts
69333	01JUL2011	30JUN2020	N	Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a) cell count; and (b) culture; and (c) colony count; and (d) (if performed) stained preparations; and (e) (if performed) identification of cultured pathogens; and (f) (if performed) antibiotic susceptibility testing; and (g) (if performed) examination for pH, specific gravity, blood, protein, urobilinogen, sugar, acetone or bile salts
69333	01JUL2020	31DEC9999	Y	Urine examination (including serial examinations) by any means other than simple culture by dip slide, including: (a) cell count; and (b) culture; and (c) colony count; and (d) (if performed) stained preparations; and (e) (if performed) identification of cultured pathogens; and (f) (if performed) antibiotic susceptibility testing; and (g) (if performed) examination for pH, specific gravity, blood, protein, urobilinogen, sugar, acetone or bile salts
69336	01NOV1998	30APR2000	N	Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days, including (if performed) a service described in item 69300 - 1 examination
69336	01MAY2000	31OCT2000	N	Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days in any 7 day period, including (if performed) a service described in item 69300 - 1 examination
69336	01NOV2000	30APR2003	N	Microscopy of faeces for ova, cysts and parasites using concentration techniques (including the use of appropriate stains) with no more than 3 examinations on specimens collected on separate days in any 7 day period, including (if performed) a service mentioned in item 69300 - 1 examination
69336	01MAY2003	31OCT2003	N	Microscopy of faeces for ova, cysts and parasites using concentration techniques and including use of fixed stains for cryptosporidia and giardia - 1 examination in any 7 day period
69336	01NOV2003	30APR2005	N	Microscopy of faeces for ova, cysts and parasites using concentration techniques including use of fixed stains or antigen detection for cryptosporidia and giardia - including (if performed) a service mentioned in item 69300 - 1 examination in any 7 day period
69336	01MAY2005	30JUN2020	N	Microscopy of faeces for ova, cysts and parasites that must include a concentration technique, and the use of fixed stains or antigen detection for cryptosporidia and giardia - including (if performed) a service mentioned in item 69300 - 1 of this item in any 7 day period
69336	01JUL2020	31DEC9999	Y	Microscopy of faeces for ova, cysts and parasites that must include a concentration technique, and the use of fixed stains or antigen detection for cryptosporidia and giardia - including (if performed) a service described in item 69300 - 1 of this item in any 7 day period
69339	01NOV1998	30APR2003	N	2 examinations described in item 69336 performed on separately collected and identified specimens
69339	01MAY2003	31DEC9999	Y	Microscopy of faeces for ova, cysts and parasites using concentration techniques examined subsequent to item 69336 on a separately collected and identified specimen collected within 7 days of the examination described in 69336 - 1 examination in any 7 day period
69342	01NOV1998	31DEC9999	Y	3 examinations described in item 69336 performed on separately collected and identified specimens
69345	01NOV1998	31OCT2000	N	Culture of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a) pathogen identification and antibiotic susceptibility testing; and (b) the detection of clostridial toxins or antigens not elsewhere specified in this Table; and (c) a service described in item 69300; with a maximum of 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination
69345	01NOV2000	30APR2002	N	Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a) pathogen identification and antibiotic susceptibility testing; and (b) the detection of clostridial toxins or antigens not elsewhere specified in this Table; and (c) a service described in item 69300; with no more than 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination
69345	01MAY2002	30APR2003	N	Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a) pathogen identification and antibiotic susceptibility testing; and (b) the detection of clostridial toxins or antigens not elsewhere specified in this Table; and (c) a service described in item 69300; with no more than 3 examinations performed on separately identified specimens, collected at different times in any 7 day period - 1 examination
69345	01MAY2003	31DEC9999	Y	Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a) pathogen identification and antibiotic susceptibility testing; and (b) the detection of clostridial toxins; and (c) a service described in item 69300; - 1 examination in any 7 day period
69348	01NOV1998	31DEC9999	Y	2 examinations described in item 69345 performed on separately collected and identified specimens
69351	01NOV1998	31DEC9999	Y	3 examinations described in item 69345 performed on separately collected and identified specimens
69354	01NOV1998	31DEC9999	Y	Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a) identification of any cultured pathogen; and (b) necessary antibiotic susceptibility testing; to a maximum of 3 sets of cultures - 1 set of cultures
69357	01NOV1998	31DEC9999	Y	2 sets of cultures described in item 69354
69360	01NOV1998	31DEC9999	Y	3 sets of cultures described in item 69354
69363	01NOV1998	31OCT2001	N	Detection of clostridium difficile or clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369 or 69372 has been performed) - 1 or more tests
69363	01NOV2001	31OCT2002	N	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369 or 69372 has been performed) - 1 or more tests
69363	01NOV2002	30APR2003	N	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369, 69370 or 69372 has been performed) - 1 or more tests
69363	01MAY2003	30APR2004	N	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69369, 69370 or 69372 has been performed) - 1 or more tests
69363	01MAY2004	31OCT2005	N	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in items 69345, 69369, 69370, 69372, 69373 or 69375 has been performed) - 1 or more tests
69363	01NOV2005	31OCT2014	N	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in items 69345, 69369, 69370, 69373 or 69375 has been performed) - 1 or more tests
69363	01NOV2014	31DEC9999	Y	Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345 has been performed) - one or more tests
69364	01NOV2005	30APR2006	N	Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subjuect to rule 25)
69364	01MAY2006	31DEC9999	Y	Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subject to rule 26)
69365	01NOV2005	30APR2006	N	2 or more tests described in 69364 (Item is subject to rule 25)
69365	01MAY2006	31OCT2006	N	2 or more tests described in 69364 (Item is subject to rule 26)
69365	01NOV2006	31DEC9999	Y	2 tests described in 69364 (Item is subject to rule 26)
69366	01NOV1998	31DEC9999	Y	Test for Helicobacter pylori in faeces, for either: (a) the confirmation of Helicobacter pylori colonisation; where (i) suitable biopsy material for diagnosis cannot be obtained at endoscopy in patients with peptic ulcer disease, or where the diagnosis of peptic ulcer has been made on barium meal; or (ii) in patients with a history of peptic ulcer disease or gastric neoplasia, where endoscopy is not indicated; or (b) the monitoring of the success of eradication therapy for Helicobacter pylori in patients with peptic ulcer disease; where any request for the test by a medical practitioner specifically identifies in writing one or more of the clinical indications for the test
69367	01NOV2006	31DEC9999	Y	3 or more tests described in 69364 (Item is subject to rule 26)
69369	01NOV1998	31DEC9999	Y	Detection of chlamydia by any method in specimens from 1 or more sites
69370	01NOV1999	31DEC9999	Y	Detection of chlamydia by any method and Neisseria gonorrhoeae by nucleic acid amplification techniques in specimens from 1 or more sites
69372	01NOV1998	31OCT2000	N	Detection of microbial antigens (except if the service described in item 69369 has been performed) 1 or more tests
69372	01NOV2000	31OCT2002	N	Detection of microbial antigens (except if the service described in item 69369 or 69370 has been performed) - 1 or more tests
69372	01NOV2002	30APR2004	N	Detection of microbial antigens or nucleic acids (except if the service described in item 69369 or 69370 has been performed) - 1 or more tests
69372	01MAY2004	31DEC9999	Y	Detection of microbial antigens or nucleic acids (not elsewhere described in this table) - 1 or more tests
69373	01MAY2004	31DEC9999	Y	Detection of a virus or microbial antigen or nucleic acid from a respiratory tract specimen - 1 test
69374	01MAY2004	31DEC9999	Y	2 or more tests described in 69373
69375	01NOV1998	28FEB1999	N	Examination for Herpes simplex virus, varicella zoster virus and cytomegalovirus by culture, including a service described in item 69315, 69369 or 69372 (if performed)
69375	01MAR1999	31OCT2001	N	Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture, including a service described in item 69369 or 69372 (if performed) - 1 or more tests
69375	01NOV2001	31OCT2002	N	Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by nucleic acid amplification technique, including a service described in item 69369 or 69372 (if performed) - 1 or more tests
69375	01NOV2002	30APR2004	N	Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by nucleic acid amplification technique, including a service described in item 69369, 69370 or 69372 (if performed) - 1 or more tests
69375	01MAY2004	31DEC9999	Y	Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by detection of microbial antigen or nucleic acid, including a service described in item 69363, 69369, 69370, 69372 or 69373 (if performed) - 1 test
69376	01MAY2004	31DEC9999	Y	2 or more tests described in 69375
69378	01NOV1998	28FEB1999	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV seropositive patient, who is not on antiretroviral therapy 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20)
69378	01MAR1999	30JUN1999	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV seropositive patient, who is not on antiretroviral therapy 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20)
69378	01JUL1999	30APR2005	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more assays on 1 or more specimens in any 1 episode
69378	01MAY2005	30APR2008	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more tests on 1 or more specimens
69378	01MAY2008	31DEC9999	Y	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more tests
69379	01MAY2007	31DEC9999	Y	A test described in item 69378 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
69380	01JUL2011	31DEC9999	Y	Genotypic testing for HIV antiretroviral resistance in a patient with confirmed HIV infection if the patient's viral load is greater than 1,000 copies per ml at any of the following times: (a) at presentation; or (b) before antiretroviral therapy: or (c) when treatment with combination antiretroviral agents fails; maximum of 2 tests in a 12 month period
69381	01NOV1998	28FEB1999	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV seropositive patient 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20)
69381	01MAR1999	30JUN1999	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV seropositive patient 1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20)
69381	01JUL1999	30APR2005	N	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode
69381	01MAY2005	31DEC9999	Y	Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV sero-positive patient - 1 or more tests on 1 or more specimens
69382	01MAR1999	30JUN1999	N	Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode (Item is not subject to rule 20)
69382	01JUL1999	30APR2005	N	Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode
69382	01MAY2005	31DEC9999	Y	Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more tests on 1 or more specimens
69383	01MAY2007	31DEC9999	Y	A test described in item 69381 if rendered by a receiving APP - 1 or more tests on 1 or more specimens (Item is subject to rule 18)
69384	01NOV1998	31OCT2007	N	Quantitation of 1 antibody to microbial or exogenous antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
69384	01NOV2007	31DEC9999	Y	Quantitation of 1 antibody to microbial antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6)
69387	01NOV1998	31DEC9999	Y	2 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 estimations specified on the request form or performs 2 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6)
69390	01NOV1998	31DEC9999	Y	3 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 estimations specified on the request form or performs 3 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6)
69393	01NOV1998	31DEC9999	Y	4 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 estimations specified on the request form or performs 4 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6)
69396	01NOV1998	30JUN2008	N	5 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 estimations specified on the request form or performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6)
69396	01JUL2008	31DEC9999	Y	5 or more tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 estimations specified on the request form or performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6)
69399	01NOV1998	30APR2007	N	6 or more tests described in item 69384
69399	01MAY2007	31DEC9999	Y	6 or more tests described in item 69384 (Item is subject to rule 6)
69400	01MAY2007	31DEC9999	Y	A test described in item 69384, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rules 6 and 18)
69401	01MAY2007	31OCT2008	N	A test described in item 69384, other than that described in 69400, if rendered by a receiving APP - each test to a maximum of 5 tests (Item is subject to rule 6 and 18)
69401	01NOV2008	31DEC9999	Y	A test described in item 69384, other than that described in 69400, if rendered by a receiving APP - each test to a maximum of 4 tests (Item is subject to rule 6, 18 and 18A)
69402	01NOV1998	31DEC9999	Y	Tests described in item 69384, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6)
69405	01NOV1998	31OCT2002	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 1 of the following - rubella immune status, specific syphilis serology, hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465
69405	01NOV2002	30APR2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 1 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493
69405	01MAY2003	31OCT2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 1 of the following - rubella immune status, specific syphilis serology, or carriage of Hepatitis B; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69487, 69490 and 69493
69405	01NOV2003	31OCT2005	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 1 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69405	01NOV2005	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 1 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69408	01NOV1998	31OCT2002	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of 2 of the following - rubella immune status, specific syphilis serology or, hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465
69408	01NOV2002	30APR2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 2 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493
69408	01MAY2003	31OCT2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody test; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69408	01NOV2003	31OCT2005	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69408	01NOV2005	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69411	01NOV1998	31OCT2002	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a) the determination of all 3 of the following - rubella immune status, specific syphilis serology and, hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465
69411	01NOV2002	30APR2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of all 3 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493
69411	01MAY2003	31OCT2003	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of all 3 of the following - rubella immune status, specific syphilis serology, and carriage of Hepatitis B; and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69487, 69490 and 69493
69411	01NOV2003	31OCT2005	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 3 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69411	01NOV2005	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 3 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69413	01NOV2003	31OCT2005	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of all 4 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69413	01NOV2005	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of 4 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69414	01NOV1998	31DEC9999	Y	Investigation for acute Hepatitis A using: Hepatitis A IgM antibody test (Item is subject to rule 11)
69415	01NOV2005	30APR2008	N	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of all 5 of the following - rubella immune status, specific syphillis serology, carriage of Hepatitus B, Hepatitus C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69415	01MAY2008	31DEC9999	Y	Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a) the determination of all 5 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b) (if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481
69417	01NOV1998	31DEC9999	Y	Determination of immune status to Hepatitis A using: Hepatitis A IgG antibody test (Item is subject to rule 11)
69418	01MAY2007	31DEC9999	Y	A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade squamous intraepithelial lesions (HSIL) of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for HSIL of the cervix; or - is already undergoing annual cytological review for the follow-up of a previously treated HSIL. - to a maximum of 2 of this item in a 24 month period (Item is subject to rule 25)
69419	01MAY2007	31DEC9999	Y	A test described in item 69418 if rendered by a receiving APP - 1 test (Item is subject to rule 18 and 25 )
69420	01NOV1998	31DEC9999	Y	Investigation for acute or resolving Hepatitis B, or testing of close, recent contacts of proven Hepatitis B infection, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B core antibody test; and (c) (if performed,) Hepatitis B e antibody test (where the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (Item is subject to rule 11)
69421	01JUL2024	31DEC9999	Y	Detection of respiratory pathogen nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample; Testing of 4 pathogens
69422	01JUL2024	31DEC9999	Y	Detection of respiratory pathogen nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in item 69421; Testing of 5 or more pathogens
69423	01NOV1998	31DEC9999	Y	Investigation for resolution of Hepatitis B if the Hepatitis B core antibody test is positive and the Hepatitis B surface antigen test is negative, including: (a) Hepatitis B core antibody test; and (b) Hepatitis B surface antigen test; and (c) Hepatitis B surface antibody test (Item is subject to rule 11)
69426	01NOV1998	31DEC9999	Y	Determination of immune status to Hepatitis B (post exposure) using: Hepatitis B core antibody test (Item is subject to rule 11)
69429	01NOV1998	31DEC9999	Y	Determination of immune status to Hepatitis B (post vaccination) using: Hepatitis B surface antibody test (Item is subject to rule 11)
69432	01NOV1998	31DEC9999	Y	Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen using: Hepatitis B surface antigen test (Item is subject to rule 11)
69435	01NOV1998	31DEC9999	Y	Investigation for chronic Hepatitis B or carriage of Hepatitis B antigen if the Hepatitis B surface antigen test is positive, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis B e antigen test (Item is subject to rule 11)
69438	01NOV1998	31DEC9999	Y	Testing for Hepatitis C using: Hepatitis C antibody test (Item is subject to rule 11)
69441	01NOV1998	31DEC9999	Y	Supplementary testing for Hepatitis C antibodies using a different Hepatitis C antibody assay on the specimen which has a reactive result on the initial Hepatitis C antibody test. (Item is not subject to rule 11)
69442	01NOV2000	07DEC2003	N	Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation for antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - not exceeding 1 episode in a 12 month period (Item is subject to rule 19)
69442	08DEC2003	30APR2005	N	Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - not more than 2 tests in a 12 month period
69442	01MAY2005	31DEC9999	Y	Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - To a maximum of 2 of this item in a 12 month period
69443	01NOV2000	31OCT2001	N	Nucleic acid amplification and determination of hepatitis C virus (HCV) genotype provided: (a) the patient is HCV RNA positive; and (b) the patient is being evaluated for antiviral therapy of chronic HCV hepatitis; where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis - not exceeding 1 episode
69443	01NOV2001	30APR2005	N	Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a) the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b) the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; No more than 1 episode in a 12 month period
69443	01MAY2005	31DEC9999	Y	Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a) the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b) the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; To a maximum of 1 of this item in a 12 month period
69444	01NOV1998	30APR2004	N	Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a) the patient is Hepatitis C seropositive and has normal liver function tests on 2 occasions at least 6 months apart; (b) the patient's serological status is uncertain after testing; (c) the test is performed for the purpose of: (i) determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii) the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; Not exceeding 1 episode in a 12 month period (Item is subject to rule 19)
69444	01MAY2004	30APR2005	N	Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a) the patient is Hepatitis C seropositive; (b) the patient's serological status is uncertain after testing; (c) the test is performed for the purpose of: (i) determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii) the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; Not exceeding 1 episode in a 12 month period (Item is subject to rule 19)
69444	01MAY2005	31DEC9999	Y	Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a) the patient is Hepatitis C seropositive; (b) the patient's serological status is uncertain after testing; (c) the test is performed for the purpose of: (i) determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii) the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; To a maximum of 1 of this item in a 12 month period (Item is subject to rule 19)
69445	01NOV2000	30APR2005	N	Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - not exceeding 4 episodes in a 12 month period (Item is subject to rule 19)
69445	01MAY2005	30APR2007	N	Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 19)
69445	01MAY2007	31OCT2007	N	Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 25)
69445	01NOV2007	31DEC9999	Y	Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69499) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 25)
69447	01NOV1998	31DEC9999	Y	Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test using: Hepatitis D antibody test (Item is subject to rule 11)
69450	01NOV1998	31DEC9999	Y	Determination of immune status to Hepatitis A and Hepatitis B, including: (a) Hepatitis A IgG antibody test; and (b) Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 11)
69451	01MAY2007	31DEC9999	Y	A test described in item 69445 if rendered by a receiving APP - 1 test. (Item is subject to rule 18 and 25)
69453	01NOV1998	31DEC9999	Y	Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, including: (a) Hepatitis B surface antigen test; and (b) Hepatitis C antibody test (Item is subject to rule 11)
69456	01NOV1998	31DEC9999	Y	Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, if Hepatitis B surface antigen test is positive, including: (a) Hepatitis C antibody test; and (b) Hepatitis B surface antigen test; and (c) Hepatitis B e antigen test (Item is subject to rule 11)
69459	01NOV1998	31DEC9999	Y	Investigation for acute Hepatitis A, Hepatitis B, Hepatitis C and Hepatitis D in a patient with a currently elevated transaminase level, including: (a) Hepatitis A IgM antibody test; and (b) Hepatitis C antibody test; and (c) Hepatitis B surface antigen test; and (d) Hepatitis B core antibody test; and (e) (if performed) Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive); and (f) ( if performed) Hepatitis D antibody test (if Hepatitis B surface antigen test is positive) (Item is subject to rule 11)
69462	01NOV1998	31OCT2000	N	Determination of immune status to Hepatitis B and testing for Hepatitis C, including: (a) Hepatitis C antibody test; and (b) Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12)
69462	01NOV2000	31DEC9999	Y	Determination of Hepatitis B status and testing for Hepatitis C, including: (a) Hepatitis C antibody test; and (b) Hepatitis B core antibody test and if this is positive; (c) Hepatitis B surface antigen test (Item is subject to rule 11)
69465	01NOV1998	31DEC9999	Y	Syphilis serology and any 1 of items 69435, 69438 or 69453 (Item is subject to rule 11)
69468	01NOV1998	31DEC9999	Y	Investigation for acute Hepatitis A and Hepatitis C in a patient with a currently elevated transaminase level, including: (a) Hepatitis A IgM antibody test; and (b) Hepatitis C antibody test (Item subject to rule 11)
69471	01NOV1998	31OCT2008	N	Test of cell-mediated immunity in blood for the detection of active tuberculosis or atypical mycobacterial infection in an immunosuppressed or immunocompromised patient - 1 test
69471	01NOV2008	30APR2017	N	Test of cell-mediated immunity in blood for the detection of latent tuberculosis in an immunosuppressed or immunocompromised patient - 1 test
69471	01MAY2017	31DEC9999	Y	Test of cell-mediated immune response in blood for the detection of latent tuberculosis by interferon gamma release assay (IGRA) in the following people: (a) a person who has been exposed to a confirmed case of active tuberculosis; (b) a person who is infected with human immunodeficiency virus; (c) a person who is to commence, or has commenced, tumour necrosis factor (TNF) inhibitor therapy; (d) a person who is to commence, or has commenced, renal dialysis; (e) a person with silicosis; (f) a person who is, or is about to become, immunosuppressed because of a disease, or a medical treatment, not mentioned in paragraphs (a) to (e)
69472	01NOV2001	31DEC9999	Y	Detection of antibodies to Epstein Barr Virus using specific serology - 1 test
69474	01NOV2001	31DEC9999	Y	Detection of antibodies to Epstein Barr Virus using specific serology - 2 or more tests
69475	01NOV2002	30APR2008	N	One test for hepatitis antigen or antibodies to determine immune status or viral carriage following exposure or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D including: (a) One test for antibodies to Hepatitis A; or (b) One test for antibodies to or antigens of Hepatitis B; or (c) One test for antibodies to Hepatitis C; or (d) One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11)
69475	01MAY2008	31DEC9999	Y	One test for hepatitis antigen or antibodies to determine immune status or viral carriage following exposure or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D (Item subject to rule 11)
69476	13MAR2020	30MAR2020	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where: (a) the person was a private patient in a recognised hospital; or (b) the person received the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485
69476	31MAR2020	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where: (a) the person was a private patient in a recognised hospital; or (b) the person received the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485
69477	13MAR2020	30MAR2020	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020: (a) the person was not a private patient in a recognised hospital; or (b) the person did not receive the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485
69477	31MAR2020	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020: (a) the person was not a private patient in a recognised hospital; or (b) the person did not receive the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485
69478	01NOV2002	30APR2008	N	Two tests for hepatitis antigens or antibodies to determine immune status or viral carriage following exposure to, or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D including: (a) One test for antibodies to Hepatitis A; or (b) One test for surface or core antibodies to Hepatitis B; or (c) One test for surface antigen of Hepatitis B; or (d) One test for 'e' antibodies to or 'e' antigen of Hepatitis B; or (e) One test for antibodies to Hepatitis C; or (f) One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11)
69478	01MAY2008	31DEC9999	Y	2 tests described in 69475 (Item subject to rule 11)
69479	01APR2020	18MAY2020	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Where the service is bulk-billed.
69479	19MAY2020	31DEC2021	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory as described in 4.1 of the Pathology Services Table Where the service is bulk-billed.
69479	01JAN2022	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is a private patient in a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service from a prescribed laboratory as described in 4.1 of the Pathology Services Table
69480	01APR2020	31DEC2021	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the service is not covered by item 69479 Where the service is bulk billed
69480	01JAN2022	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is a private patient in a hospital other than a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service not covered by item 69479
69481	01NOV2002	30APR2008	N	Three tests for the investigation of infectious causes of acute or chronic hepatitis including: (a) One test for antibodies to Hepatitis A; or (b) One test for core antibodies to Hepatitis B; or (c) One test for 'e' antibodies to or 'e' antigens of Hepatitis B; or (d) One test for surface antibodies to or surface antigen of Hepatitis B; or (e) One test for antibodies to Hepatitis C; or (f) One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11)
69481	01MAY2008	31DEC9999	Y	Investigation of infectious causes of acute or chronic hepatitis - 3 tests for hepatitis antibodies or antigens, (Item subject to rule 11)
69482	01JUL2008	31DEC9999	Y	Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface antigen positive and have chronic hepatitis B, but are not receiving antiviral therapy - 1 test (Item is subject to rule 25)
69483	01JUL2008	31DEC9999	Y	Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface antigen positive and who have chronic hepatitis B and are receiving antiviral therapy - 1 test (Item is subject to rule 25)
69484	01NOV2002	30APR2008	N	Supplementary testing for Hepatitis B surface antigen or Hepatitis C antibody using a different assay on the specimen which yielded a reactive result on initial testing (Item is not subject to rule 11)
69484	01MAY2008	31DEC9999	Y	Supplementary testing for Hepatitis B surface antigen or Hepatitis C antibody using a different assay on the specimen which yielded a reactive result on initial testing (Item is subject to rule 18)
69485	13MAR2020	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service is bulk-billed.(See PN.3.5 of explanatory notes to this Category)
69486	01NOV2005	30APR2006	N	A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade intraepithelial abnormalities of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for high grade intraepithelial abnormalities of the cervix - to a maximum of 2 of this item in a 24 month period
69486	01MAY2006	31DEC9999	Y	A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade squamous intraepithelial lesions (HSIL) of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for HSIL of the cervix; or - is already undergoing annual cytological review for the follow-up of a previously treated HSIL. - to a maximum of 2 of this item in a 24 month period
69487	01NOV2002	31DEC9999	Y	One test referred to in 69475 and a supplementary test described in 69484 (Item subject to rule 11)
69488	01MAY2007	30NOV2017	N	Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69499 or 69445) (Item is subject to rule 18 and 25)
69488	01DEC2017	31DEC9999	Y	Quantitation of HCV RNA load in plasma or serum in: (a) the pre-treatment evaluation, of a patient with chronic HCV hepatitis, for antiviral therapy; or (b) the assessment of efficacy of antiviral therapy for such a patient (including a service in item 69499 or 69445) (Item is subject to rule 18 and 25)
69489	01MAY2007	31DEC9999	Y	A test described in item 69488 if rendered by a receiving APP (Item is subject to rule 18 and 25)
69490	01NOV2002	31DEC9999	Y	Two tests referred to in 69478 and a supplementary test described in 69484 (Item subject to rule 11)
69491	01MAY2007	30NOV2017	N	Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a) the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b) the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; To a maximum of 1 of this item in a 12 month period
69491	01DEC2017	31DEC9999	Y	Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis. To a maximum of 1 of this item in a 12 month period
69492	01MAY2007	31DEC9999	Y	A test described in item 69491 if rendered by a receiving APP - 1 test (Item is subject to rule 18 and 25)
69493	01NOV2002	31DEC9999	Y	Three tests referred to in 69481 and a supplementary test described in 69484 (Item subject to rule 11)
69494	01MAY2007	31DEC9999	Y	Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subject to rule 6 and 26)
69495	01MAY2007	31DEC9999	Y	2 tests described in 69494 (Item is subject to rule 6 and 26)
69496	01MAY2007	31DEC9999	Y	3 or more tests described in 69494 (Item is subject to rule 6 and 26)
69497	01MAY2007	31DEC9999	Y	A test described in item 69494, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6, 18 and 26)
69498	01MAY2007	31DEC9999	Y	A test described in item 69494, other than that described in 69497, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6, 18 and 26)
69499	01MAY2007	31DEC9999	Y	Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a) the patient is Hepatitis C seropositive; (b) the patient's serological status is uncertain after testing; (c) the test is performed for the purpose of: (i) determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii) the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; To a maximum of 1 of this item in a 12 month period (Item is subject to rule 19 and 25)
69500	01MAY2007	31DEC9999	Y	A test described in item 69499 if rendered by a receiving APP - 1 test (Item is subject to rule 18,19 and 25)
69501	28JUL2020	02AUG2020	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: the person is employed, hired, retained or contracted by an approved provider, or works in an aged care service, in Victoria; and the person is informed of the results of the tests within 24 hours of receipt of the specimen at an accredited pathology laboratory; and the results of the test are reported to all appropriate authorities in accordance with Victorian legislation or regulations within 24 hours of receipt of the specimen at an accredited pathology laboratory; and the person is not a private patient in a recognised hospital; and the person is not an admitted patient of a hospital; and the service is not performed in a prescribed laboratory. Where the service is bulk-billed.
69501	03AUG2020	21SEP2020	N	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is employed, hired, retained or contracted; (i) by an approved provider, or works in an aged care service, in Victoria; or (ii) to travel interstate as a driver of a heavy vehicle; and (b) the person is informed of the results of the tests within 24 hours of receipt of the specimen at an accredited pathology laboratory; and (c) the results of the test are reported in adherence with the applicable State or Territory reporting requirements within 24 hours of receipt of the specimen at an accredited pathology laboratory; and (d) the person is not a private patient in a recognised hospital; and (e) the person is not an admitted patient of a hospital; and (f) the service is not performed in a prescribed laboratory as described in 4.1 of the pathology services table Other than a service to which an item in this instrument or an item in the pathology services tables applies. Where the service is bulk billed.
69501	22SEP2020	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is employed, hired, retained or contracted; (i) by an approved provider, or works in an aged care service, in Victoria; or (ii) to travel interstate as a driver of a heavy vehicle; or (iii) to travel interstate as a rail crew member; and (b) the person is informed of the results of the tests within 24 hours of receipt of the specimen at an accredited pathology laboratory; and (c) the results of the test are reported in adherence with the applicable State or Territory reporting requirements within 24 hours of receipt of the specimen at an accredited pathology laboratory; and (d) the person is not a private patient in a recognised hospital; and (e) the person is not an admitted patient of a hospital; and (f) the service is not performed in a prescribed laboratory as described in 4.1 of the pathology services table Other than a service to which item 69476, 69477, 69479 or 69480 applies, or an item in the pathology services tables applies. Where the service is bulk billed.
69505	01JUL2023	31DEC9999	Y	Sequencing and analysis of the genome of mycobacterium tuberculosis complex from an isolate or nucleic acid extract: (a) to speciate the organism: (i) at the time of a patients initial diagnosis and commencement of initial empiric therapy; or (ii) following recurrence of a patients symptoms or a patients failure to respond to treatment within the expected timeframe; and (b) for the purpose of: (i) genome-wide determination of the antimicrobial resistance markers (resistome) of the isolate; and (ii) individualising the patients treatment Applicable once at initial diagnosis and once per episode of disease recurrence
69506	01OCT2022	31DEC2022	N	Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient in a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service from a prescribed laboratory
69506	01JAN2023	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient in a recognised hospital; or (b) the person receives a bulk-billed service from a prescribed laboratory
69507	01OCT2022	31DEC2022	N	Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in 69506, if: (a) the person is a private patient in a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service from a prescribed laboratory 2 to 4 tests
69507	01JAN2023	31DEC9999	Y	Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in 69506, if: (a) the person is a private patient in a recognised hospital; or (b) the person receives a bulk-billed service from a prescribed laboratory 2 to 4 tests
69508	01OCT2022	31DEC9999	Y	5 to 8 tests described in 69507
69509	01OCT2022	31DEC9999	Y	9 to 12 tests described in 69507
69510	01OCT2022	31DEC9999	Y	13 or more tests described in item 69507
69511	01OCT2022	31DEC2022	N	Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient in a hospital other than a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service not covered by item 69506
69511	01JAN2023	31DEC2023	N	Detection of a SARS-CoV-2 nucleic acid if: (a) the person is a private patient in a hospital other than a recognised hospital; or (b) the person receives a bulk-billed service not covered by item 69506
69511	01JAN2024	31DEC9999	Y	Detection of a SARS-CoV-2 nucleic acid if the person receives a bulk billed service
69512	01OCT2022	31DEC2022	N	Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in 69511, if: (a) the person is a private patient in a hospital other than a recognised hospital and the fee charged for the service does not exceed the schedule fee; or (b) the person receives a bulk-billed service not covered by item 69507 2 to 4 tests
69512	01JAN2023	31DEC2023	N	Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in 69511, if: (a) the person is a private patient in a hospital other than a recognised hospital; or (b) the person receives a bulk-billed service not covered by item 69507 2 to 4 tests
69512	01JAN2024	31DEC9999	Y	Detection of a viral, fungal, atypical pneumonia pathogen or Bordetella species nucleic acid from a nasal swab, throat swab, nasopharyngeal aspirate and/or lower respiratory tract sample, including a service described in 69511, if the person receives a bulk billed service 2 to 4 tests
69513	01OCT2022	31DEC9999	Y	5 to 8 tests described in 69512
69514	01OCT2022	31DEC9999	Y	9 to 12 tests described in 69512
69515	01OCT2022	31DEC9999	Y	13 or more tests described in item 69512
71001	01DEC1991	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation 1 or more procedures
71002	01DEC1991	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245/66246, 66247/66248 or 71005/71006), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation one or more procedures
71003	01DEC1991	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005) on serum and urine concurrently collected 2 or more procedures
71004	01DEC1991	31DEC9999	Y	Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245/66246, 66247/66248 or 71005/71006) on serum and urine concurrently collected two or more procedures
71005	01DEC1991	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method estimation of 1 immunoglobin
71006	01DEC1991	31DEC9999	Y	Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method estimation of one immunoglobin
71007	01DEC1991	31DEC9999	Y	2 estimations specified in item 71005
71008	01DEC1991	31DEC9999	Y	Two estimations specified in item 71005/71006
71009	01DEC1991	31DEC9999	Y	3 or more estimations specified in item 71005
71010	01DEC1991	31DEC9999	Y	Three or more estimations specified in item 71005/71006
71011	01DEC1991	31DEC9999	Y	Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA 1 or more estimations
71012	01DEC1991	31DEC9999	Y	Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA one or more estimation
71013	01DEC1991	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period
71014	01DEC1991	31DEC9999	Y	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period
71015	01DEC1991	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens 1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period
71016	01DEC1991	31DEC9999	Y	Specific IgG or IgE antibodies to potential allergens one or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period
71017	01DEC1991	31DEC9999	Y	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required
71018	01DEC1991	31DEC9999	Y	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required
71019	01DEC1991	31DEC9999	Y	Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1 in 40 or greater has been obtained
71020	01DEC1991	31DEC9999	Y	Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1 in 40 or greater has been obtained
71021	01DEC1991	31DEC9999	Y	Antibodies to extractable nuclear antigens, detection of in serum or other body fluids
71022	01DEC1991	31DEC9999	Y	Antibodies to extractable nuclear antigens, detection of in serum or other body fluids
71023	01DEC1991	31DEC9999	Y	Characterisation of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021
71024	01DEC1991	31DEC9999	Y	Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021/71022
71025	01DEC1991	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule estimation of 1 antibody
71026	01DEC1991	31DEC9999	Y	Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule estimation of one antibody
71027	01DEC1991	31DEC9999	Y	2 estimations specified in item 71025
71028	01DEC1991	31DEC9999	Y	Two estimations specified in item 71025/71026
71029	01DEC1991	31DEC9999	Y	3 estimations specified in item 71025
71030	01DEC1991	31DEC9999	Y	Three estimations specified in item 71025/71026
71031	01DEC1991	31DEC9999	Y	4 or more estimations specified in item 71025
71032	01DEC1991	31DEC9999	Y	Four or more estimations specified in item 71025/71026
71033	01DEC1991	31DEC9999	Y	Rheumatoid factor, detection of by any technique
71034	01DEC1991	31DEC9999	Y	Rheumatoid factor, detection of by any technique.
71035	01DEC1991	31DEC9999	Y	Quantitation of Rheumatoid factor where detected, including services specified in item 71033
71036	01DEC1991	31DEC9999	Y	Quantitation of Rheumatoid factor where detected, including services specified in item 71033/71034
71037	01DEC1991	31DEC9999	Y	Complement total and components 1 quantitative estimation
71038	01DEC1991	31DEC9999	Y	Complement total and components one quantitative estimation
71039	01DEC1991	31DEC9999	Y	2 estimations specified in item 71037
71040	01DEC1991	31DEC9999	Y	2 estimations specified in item 71037/71038
71041	01DEC1991	31DEC9999	Y	3 or more estimations specified in item 71037
71042	01DEC1991	31DEC9999	Y	Three or more estimations specified in item 71037/71038
71043	01DEC1991	31DEC9999	Y	Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests
71044	01DEC1991	31DEC9999	Y	Leucocyte fractionation as a preliminary toleucocyte marker or leucocyte function tests
71045	01DEC1991	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in the HAEMATOLOGY GROUP of the Schedule
71046	01DEC1991	31DEC9999	Y	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in the HAEMATOLOGY DIVISION of the Schedule
71047	01DEC1991	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any services in item 71049 1 or more estimations
71048	01DEC1991	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 71049/71050 one or more estimations
71049	01DEC1991	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any services in item 71047 1 or more estimations
71050	01DEC1991	31DEC9999	Y	Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of seven monoclonal antibodies, including any services in item 71047/71048 one or more estimations
71051	01DEC1991	31DEC9999	Y	HLA typing comprising A, B, C and DR phenotypes
71052	01DEC1991	31DEC9999	Y	HLA typing comprising A, B, C and DR phenotypes
71053	01DEC1991	31DEC9999	Y	HLA typing, excluding any services specified in item 71051 1 or more antigens
71054	01DEC1991	31DEC9999	Y	HLA typing, excluding any services specified in item 71051/71052 one or more antigens
71055	01DEC1991	31DEC9999	Y	Mantoux test
71056	01DEC1991	31DEC9999	Y	Mantoux test
71057	01NOV1998	31DEC9999	Y	Electrophoresis, quantitative and qualitative, of serum, urine or other body fluid all collected within a 28 day period, to demonstrate: (a) protein classes; or (b) presence and amount of paraprotein; including the preliminary quantitation of total protein, albumin and globulin - 1 specimen type
71058	01NOV1998	31DEC9999	Y	Examination as described in item 71057 of 2 or more specimen types
71059	01NOV1998	31OCT2000	N	Electrophoresis and immunofixation or immuno electrophoresis or isoelectric focussing of: (a) urine for detection of Bence Jones proteins; and (b) serum, plasma or other body fluid; and characterisation, if detected, of a paraprotein or cryoglobulin not previously characterised - examination of 1 specimen type (eg. serum, urine or CSF)
71059	01NOV2000	30JUN2011	N	Electrophoresis and immunofixation or immunoelectrophoresis or isoelectric focussing of: (a) urine for detection of Bence Jones proteins; or (b) serum, plasma or other body fluid; and characterisation, if detected, of a paraprotein or cryoglobulin not previously characterised - examination of 1 specimen type (eg. serum, urine or CSF)
71059	01JUL2011	31DEC9999	Y	Immunofixation or immunoelectrophoresis or isoelectric focusing of: (a) urine for detection of Bence Jones proteins; or (b) serum, plasma or other body fluid; and characterisation of a paraprotein or cryoglobulin - examination of 1 specimen type (eg. serum, urine or CSF)
71060	01NOV1998	31DEC9999	Y	Examination as described in item 71059 of 2 or more specimen types
71061	01SEP1992	30JUN1994	N	Examination for, and characterisation of, a paraprotein or cryoglobulin not previously characterised on serum, urine or other body fluid by immunoelectrophoresis or immunofixation - 1 or more procedures
71061	01JUL1994	31DEC9999	Y	Immunoelectrophoresis or immunofixation, of serum, urine or other body fluid, and characterisation of, a paraprotein or cryoglobulin not previously characterised, including a service described in 1 or both of items 66213 and 66215 (if performed ) - 1 or more tests
71062	01NOV1998	31DEC9999	Y	Electrophoresis and immunofixation or immunoelectrophoresis or isoelectric focussing of CSF for the detection of oligoclonal bands and including if required electrophoresis of the patient's serum for comparison purposes - 1 or more tests
71063	01SEP1992	31DEC9999	Y	Examination for, and characterisation of, a paraprotein not previously characterised, by immunoelectrophoresis or immunofixation on serum and urine collected concurrently - 2 or more procedures
71064	01NOV1998	31DEC9999	Y	Detection and quantitation of cryoglobulins or cryofibrinogen - 1 or more tests
71065	01SEP1992	30JUN1994	N	Examination of CSF and serum concurrently for the presence of oligoclonal proteins - 2 or more procedures
71065	01JUL1994	31DEC9999	Y	Examination of CSF and serum concurrently collected for the presence of oligoclonal proteins - 2 or more tests
71066	01NOV2002	31DEC9999	Y	Quantitation of total immunoglobulin A by any method in serum, urine or other body fluid - 1 test
71067	01SEP1992	30JUN1994	N	Immunoglobulins A, G, M or D, quantitative estimation by any method in serum, urine or other body fluid - 1 estimation
71067	01JUL1994	31DEC9999	Y	Quantitation of total immunoglobulins A, G, M or D by any method in serum, urine or other body fluid - 1 test
71068	01NOV2002	31DEC9999	Y	Quantitation of total immunoglobulin G by any method in serum, urine or other body fluid - 1 test
71069	01SEP1992	30JUN1994	N	2 estimations specified in item 71067
71069	01JUL1994	31OCT2002	N	2 tests described in item 71067
71069	01NOV2002	31DEC9999	Y	2 tests described in items 71066, 71068, 71072 or 71074
71071	01SEP1992	30JUN1994	N	3 or more estimations specified in item 71067
71071	01JUL1994	31OCT2002	N	3 or more tests described in item 71067
71071	01NOV2002	31DEC9999	Y	3 or more tests described in items 71066, 71068, 71072 or 71074
71072	01NOV2002	31DEC9999	Y	Quantitation of total immunoglobulin M by any method in serum, urine or other body fluid - 1 test
71073	01SEP1992	30JUN1994	N	Immunoglobulin G subclasses, quantitative estimation of all 4 subclasses with a maximum of 2 patient episodes in any 12 month period - each patient episode
71073	01JUL1994	31OCT1997	N	Quantitation of all 4 immunoglobulin G subclasses, with a maximum of 2 patient episodes in a 12-month period - each patient episode
71073	01NOV1997	30APR2005	N	Quantitation of all 4 immunoglobulin G subclasses - each patient episode
71073	01MAY2005	31DEC9999	Y	Quantitation of all 4 immunoglobulin G subclasses
71074	01NOV2002	31DEC9999	Y	Quantitation of total immunoglobulin D by any method in serum, urine or other body fluid - 1 test
71075	01SEP1992	30JUN1994	N	Immunoglobulin E (total), quantitative estimation with a maximum of 2 patient episodes in any 12 month period - each patient episode
71075	01JUL1994	30APR2005	N	Quantitation of immunoglobulin E (total), with a maximum of 2 patient episodes in any 12 month period - each patient episode
71075	01MAY2005	30APR2007	N	Quantitation of immunoglobulin E (total), 1 test. To a maximum of 2 of this item in a 12 month period
71075	01MAY2007	31DEC9999	Y	Quantitation of immunoglobulin E (total), 1 test. (Item is subject to rule 25)
71076	01MAY2007	31DEC9999	Y	A test described in item 71073 if rendered by a receiving APP - 1 test (Item is subject to rule 18)
71077	01SEP1992	30JUN1994	N	Immunoglobulin E (total), quantitative estimation in the follow up of a patient with proven immunoglobulin E secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in any 12 month period - each patient episode
71077	01JUL1994	30APR2005	N	Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in a 12 month period - each patient episode
71077	01MAY2005	30APR2007	N	Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, 1 test. To a maximum of 6 of this item in a 12 month period
71077	01MAY2007	31DEC9999	Y	Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, 1 test. (Item is subject to rule 25)
71079	01SEP1992	30JUN1994	N	Estimation of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in any 12 month period - each patient episode
71079	01JUL1994	30APR2005	N	Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in a 12 month period - each patient episode
71079	01MAY2005	30APR2007	N	Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, 1 of this item to a maximum of 4 in a 12 month period
71079	01MAY2007	31OCT2007	N	Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, 1 test (Item is subject to rule 25)
71079	01NOV2007	31DEC9999	Y	Detection of specific immunoglobulin E antibodies to single or multiple potential allergens, 1 test (Item is subject to rule 25)
71081	01SEP1992	30JUN1994	N	Total haemolytic complement, quantitative estimation
71081	01JUL1994	31DEC9999	Y	Quantitation of total haemolytic complement
71083	01SEP1992	30JUN1994	N	Complement components C3, C4 or properdin factor B, quantitative estimation - 1 estimation
71083	01JUL1994	31DEC9999	Y	Quantitation of complement components C3 and C4 or properdin factor B - 1 test
71085	01SEP1992	30JUN1994	N	2 estimations specified in item 71083
71085	01JUL1994	31DEC9999	Y	2 tests described in item 71083
71087	01SEP1992	30JUN1994	N	3 or more estimations specified in item 71083
71087	01JUL1994	31DEC9999	Y	3 or more tests described in item 71083
71089	01SEP1992	30JUN1994	N	Complement components or breakdown products of complement proteins not elsewhere specified in an item in this Schedule, quantitative estimation - 1 estimation
71089	01JUL1994	30APR2007	N	Quantitation of complement components or breakdown products of complement proteins not elsewhere described in an item in this Schedule - 1 test
71089	01MAY2007	31DEC9999	Y	Quantitation of complement components or breakdown products of complement proteins not elsewhere described in an item in this Schedule - 1 test (Item is subject to rule 6)
71090	01MAY2007	31DEC9999	Y	A test described in item 71089, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
71091	01SEP1992	30JUN1994	N	2 estimations specified in item 71089
71091	01JUL1994	30APR2007	N	2 tests described in item 71089
71091	01MAY2007	31DEC9999	Y	2 tests described in item 71089 (Item is subject to rule 6)
71092	01MAY2007	31DEC9999	Y	Tests described in item 71089, other than that described in 71090, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18)
71093	01SEP1992	30JUN1994	N	3 or more estimations specified in item 71089
71093	01JUL1994	30APR2007	N	3 or more tests described in item 71089
71093	01MAY2007	31DEC9999	Y	3 or more tests described in item 71089 (Item is subject to rule 6)
71095	01NOV1997	31DEC9999	Y	Quantitation of serum or plasma eosinophil cationic protein, or both, to a maximum of 3 assays in 1 year, for monitoring the response to therapy in corticosteroid treated asthma, in a child aged less than 12 years
71096	01MAY2007	31DEC9999	Y	A test described in item 71095 if rendered by a receiving APP. (Item is subject to rule 18)
71097	01SEP1992	30JUN1994	N	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required
71097	01JUL1994	31DEC9999	Y	Antinuclear antibodies - detection in serum or other body fluids, including quantitation if required
71099	01SEP1992	30JUN1994	N	Double-stranded DNA antibodies, quantitative estimation by 1 or more methods other than the Crithidia method
71099	01JUL1994	31DEC9999	Y	Double-stranded DNA antibodies - quantitation by 1 or more methods other than the Crithidia method
71101	01SEP1992	30JUN1994	N	Antibodies to 1 or more extractable nuclear antigens, detection in serum or other body fluids
71101	01JUL1994	31DEC9999	Y	Antibodies to 1 or more extractable nuclear antigens - detection in serum or other body fluids
71103	01SEP1992	30JUN1994	N	Antibodies to 1 or more extractable nuclear antigens, characterisation after a positive result is obtained by a service specified in item 71101, including that service
71103	01JUL1994	31DEC9999	Y	Characterisation of an antibody detected in a service described in item 71101 (including that service)
71105	01SEP1992	31DEC9999	Y	Rheumatoid factor, detection by any technique
71106	01JUL1994	31DEC9999	Y	Rheumatoid factor - detection by any technique in serum or other body fluids, including quantitation if required
71107	01SEP1992	31DEC9999	Y	Quantitation of rheumatoid factor if detected, during a service specified in item 71105, including that service
71109	01SEP1992	30JUN1994	N	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, glomerular basement membrane, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, neutrophil cytoplasm, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome, thyroid stimulating hormone receptor), qualitative or quantitative - estimation of 1 antibody
71109	01JUL1994	30APR2001	N	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody
71109	01MAY2001	31DEC9999	Y	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody
71113	01SEP1992	30JUN1994	N	Estimation of 2 antibodies specified in item 71109
71113	01JUL1994	31DEC9999	Y	Detection of 2 antibodies described in item 71109
71115	01SEP1992	30JUN1994	N	Estimation of 3 antibodies specified in item 71109
71115	01JUL1994	31DEC9999	Y	Detection of 3 antibodies described in item 71109
71117	01SEP1992	30JUN1994	N	Estimation of 4 antibodies specified in item 71109
71117	01JUL1994	31OCT2001	N	Detection of 4 antibodies described in item 71109
71117	01NOV2001	31DEC9999	Y	Detection of 4 or more antibodies described in item 71109
71119	01SEP1992	30JUN1994	N	Antibodies to tissue antigens not elsewhere specified in an item in this Schedule, qualitative or quantitative - estimation of 1 antibody
71119	01JUL1994	31DEC9999	Y	Antibodies to tissue antigens not elsewhere specified in this Table - detection, including quantitation if required, of 1 antibody
71121	01SEP1992	30JUN1994	N	Estimation of 2 antibodies specified in item 71119
71121	01JUL1994	31DEC9999	Y	Detection of 2 antibodies specified in item 71119
71123	01SEP1992	30JUN1994	N	Estimation of 3 antibodies specified in item 71119
71123	01JUL1994	31DEC9999	Y	Detection of 3 antibodies specified in item 71119
71125	01SEP1992	30JUN1994	N	Estimation of 4 or more antibodies specified in item 71119
71125	01JUL1994	31DEC9999	Y	Detection of 4 or more antibodies specified in item 71119
71127	01SEP1992	30JUN1994	N	Functional tests for lymphocytes - estimation of proliferation induced by 1 or more mitogens, estimation of proliferation induced by 1 or more antigens or estimation of 1 or more mixed lymphocyte reactions, other than quantitation by microscopy - including a test specified in item 65005, with a maximum of 2 patient episodes in any 12 month period - each patient episode
71127	01JUL1994	30APR2005	N	Functional tests for lymphocytes - quantitation other than by microscopy of: (a) proliferation induced by 1 or more mitogens; or (b) proliferation induced by 1 or more antigens; or (c) estimation of 1 or more mixed lymphocyte reactions; including a test described in item 65066 or 65070 (if performed), with a maximum of 2 patient episodes in a 12 month period - each patient episode
71127	01MAY2005	31DEC9999	Y	Functional tests for lymphocytes - quantitation other than by microscopy of: (a) proliferation induced by 1 or more mitogens; or (b) proliferation induced by 1 or more antigens; or (c) estimation of 1 or more mixed lymphocyte reactions; including a test described in item 65066 or 65070 (if performed), 1 of this item to a maximum of 2 in a 12 month period
71129	01SEP1992	30JUN1994	N	2 estimations specified in item 71127
71129	01JUL1994	31DEC9999	Y	2 tests described in item 71127
71131	01SEP1992	30JUN1994	N	3 or more estimations specified in item 71127
71131	01JUL1994	31DEC9999	Y	3 or more tests described in item 71127
71133	01NOV2002	31DEC9999	Y	Investigation of recurrent infection by qualitative assessment for the presence of defects in oxidative pathways in neutrophils by the nitroblue tetrazolium (NBT) reduction test
71134	01NOV2002	31DEC9999	Y	Investigation of recurrent infection by quantitative assessment of oxidative pathways by flow cytometric techniques, including a test described in 71133 (if performed)
71135	01SEP1992	30JUN1994	N	Determination of neutrophil function - comprising at least 2 of neutrophil chemotaxis, neutrophil phagocytosis, neutrophil oxidative metabolism, neutrophil bactericidal activity - including any test specified in item 65005 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in any 12 month period - each patient episode
71135	01JUL1994	31OCT2002	N	Quantitation of neutrophil function, comprising at least 2 of the following: (a) chemotaxis; (b) phagocytosis; (c) oxidative metabolism; (d) bactericidal activity; including any test described in item 65066 or 65070 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in a 12 month period - each patient episode
71135	01NOV2002	30APR2005	N	Quantitation of neutrophil function, comprising at least 2 of the following: (a) chemotaxis; (b) phagocytosis; (c) oxidative metabolism; (d) bactericidal activity; including any test described in items 65066, 65070, 71133 or 71134 (if performed), with a maximum of 2 patient episodes in a 12 month period - each patient episode
71135	01MAY2005	31DEC9999	Y	Quantitation of neutrophil function, comprising at least 2 of the following: (a) chemotaxis; (b) phagocytosis; (c) oxidative metabolism; (d) bactericidal activity; including any test described in items 65066, 65070, 71133 or 71134 (if performed), 1 of this item to a maximum of 2 in a 12 month period
71137	01SEP1992	30JUN1994	N	Determination of cell mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in any 12 month period - each patient episode
71137	01JUL1994	30APR2005	N	Quantitation of cell-mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in a 12 month period - each patient episode
71137	01MAY2005	31DEC9999	Y	Quantitation of cell-mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, 1 of this item to a maximum of 2 in a 12 month period
71139	01SEP1992	30JUN1994	N	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more specimens of blood, CSF or serous fluid
71139	01JUL1994	30APR2004	N	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations, including a total lymphocyte count by any method, on 1 or more specimens of blood, CSF or serous fluid
71139	01MAY2004	31DEC9999	Y	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations, including a total lymphocyte count or total leucocyte count by any method, on 1 or more specimens of blood, CSF or serous fluid
71141	01SEP1992	31DEC9999	Y	Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more disaggregated tissue specimens
71143	01SEP1992	30JUN1994	N	Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139 or 71141, on a specimen of blood, CSF, serous fluid or disaggregated tissue
71143	01JUL1994	31OCT1999	N	Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis of an immunological or haematological malignancy, including a service described in 1 or both of items 71139 and 71141 (if performed), on a specimen of blood, CSF, serous fluid or disaggregated tissue
71143	01NOV1999	31DEC9999	Y	Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis (but not monitoring) of an immunological or haematological malignancy, including a service described in 1 or both of items 71139 and 71141 (if performed), on a specimen of blood, CSF, serous fluid or disaggregated tissue
71145	01SEP1992	30JUN1994	N	Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139, 71141 or 71143, on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF, serous fluid
71145	01JUL1994	31OCT1999	N	Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis of an immunological or haematological malignancy, including a service described in 1 or more of items 71139, 71141 and 71143 (if performed), on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid
71145	01NOV1999	31DEC9999	Y	Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis (but not monitoring) of an immunological or haematological malignancy, including a service described in 1 or more of items 71139, 71141 and 71143 (if performed), on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid
71146	01MAY2004	30APR2006	N	Enumeration of CD34+ cells, only for the purposes of autologous or directed allogeneic haemopoietic stem cell transplantation, including a total white cell count
71146	01MAY2006	31DEC9999	Y	Enumeration of CD34+ cells, only for the purposes of autologous or directed allogeneic haemopoietic stem cell transplantation, including a total white cell count on the pherisis collection
71147	01SEP1992	30APR2007	N	HLA-B27 typing
71147	01MAY2007	31DEC9999	Y	HLA-B27 typing (Item is subject to rule 27)
71148	01MAY2007	31DEC9999	Y	A test described in item 71147 if rendered by a receiving APP. (Item is subject to rule 18 and 27)
71149	01SEP1992	30JUN1994	N	Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including any service specified in item 71147
71149	01JUL1994	31DEC9999	Y	Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including (if performed) a service described in item 71147
71151	01SEP1992	31DEC9999	Y	Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any separation of leucocytes) - phenotyping or genotyping of 2 or more antigens
71153	01MAY2001	30APR2007	N	Investigations in the assessment or diagnosis of systemic inflammatory disease or vasculitis - antineutrophil cytoplasmic antibody immunofluorescence (ANCA test), antineutrophil proteinase 3 antibody (PR-3 ANCA test), antimyeloperoxidase antibody (MPO ANCA test) or antiglomerular basement membrane antibody (GBM test) - detection of 1 antibody (Item is subject to rule 23)
71153	01MAY2007	31DEC9999	Y	Investigations in the assessment or diagnosis of systemic inflammatory disease or vasculitis - antineutrophil cytoplasmic antibody immunofluorescence (ANCA test), antineutrophil proteinase 3 antibody (PR-3 ANCA test), antimyeloperoxidase antibody (MPO ANCA test) or antiglomerular basement membrane antibody (GBM test) - detection of 1 antibody (Item is subject to rule 6 and 23)
71154	01MAY2007	31DEC9999	Y	A test described in item 71153, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test. (Item is subject to rule 6, 18 and 23)
71155	01MAY2001	30APR2007	N	Detection of 2 antibodies described in item 71153 (Item is subject to rule 23)
71155	01MAY2007	31DEC9999	Y	Detection of 2 antibodies described in item 71153 (Item is subject to rule 6 and 23)
71156	01MAY2007	31DEC9999	Y	Tests described in item 71153, other than that described in 71154, if rendered by a receiving APP - each test to a maximum of 3 tests (Item is subject to rule 6, 18 and 23)
71157	01MAY2001	30APR2007	N	Detection of 3 antibodies described in item 71153 (Item is subject to rule 23)
71157	01MAY2007	31DEC9999	Y	Detection of 3 antibodies described in item 71153 (Item is subject to rule 6 and 23)
71159	01MAY2001	30APR2007	N	Detection of 4 or more antibodies described in item 71153 (Item is subject to rule 23)
71159	01MAY2007	31DEC9999	Y	Detection of 4 or more antibodies described in item 71153 (Item is subject to rule 6 and 23)
71160	01NOV2002	31DEC9999	Y	Detection of antibodies for the monitoring of established coeliac disease or other gluten hypersensitivity syndromes, including: a) IgA antibody to gliadin; or b) IgG antibody to gliadin; or c) Antibody to endomysium; or d) Antibody to tissue transglutaminase; or e) IgA antibody to tissue transglutaminase; or f) IgG antibody to tissue transglutaminase One test
71161	01NOV2002	31DEC9999	Y	Two or more tests described in 71160 for the monitoring of established coeliac disease or other gluten hypersensitivity syndrome
71162	01NOV2002	31DEC9999	Y	Three or more tests described in 71160 for the diagnosis of coeliac disease or other gluten hypersensitivity syndrome. To a maximum of 2 patient episodes in a 12 month period - each patient episode (Item subject to rule 24)
71163	01NOV2003	31DEC9999	Y	Detection of one of the following antibodies (of 1 or more class or isotype) in the assessment or diagnosis of coeliac disease or other gluten hypersensitivity syndromes and including a service described in item 71066 (if performed): a) Antibodies to gliadin; or b) Antibodies to endomysium; or c) Antibodies to tissue transglutaminase; - 1 test
71164	01NOV2003	31DEC9999	Y	Two or more tests described in 71163 and including a service described in 71066 (if performed)
71165	01MAY2007	31OCT2007	N	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody (Item is subject to rule 6)
71165	01NOV2007	31DEC9999	Y	Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody (Item is subject to rule 6)
71166	01MAY2007	31DEC9999	Y	Detection of 2 antibodies described in item 71165 (Item is subject to rule 6)
71167	01MAY2007	31DEC9999	Y	Detection of 3 antibodies described in item 71165 (Item is subject to rule 6)
71168	01MAY2007	31DEC9999	Y	Detection of 4 or more antibodies described in item 71165 (Item is subject to rule 6)
71169	01MAY2007	31DEC9999	Y	A test described in item 71165, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18)
71170	01MAY2007	31DEC9999	Y	Tests described in item 71165, other than that described in 71169, if rendered by a receiving APP - each test to a maximum of 3 tests (Item is subject to rule 6 and 18)
71175	01NOV2021	31DEC9999	Y	A test, requested by a specialist or consultant physician, to diagnose neuromyelitis optica spectrum disorder (NMOSD) or myelin oligodendrocyte glycoprotein antibody-related demyelination (MARD), by the detection of one or more antibodies, for a patient: suspected of having NMOSD or MARD; and with any of the following: recurrent, bilateral or severe optic neuritis; recurrent longitudinal extensive transverse myelitis (LETM); area postrema syndrome (unexplained hiccups, nausea or vomiting); acute brainstem syndrome; symptomatic narcolepsy or acute diencephalic clinical syndrome with typical NMOSD magnetic resonance imaging lesions; symptomatic cerebral syndrome with typical NMOSD magnetic resonance imaging lesions; monophasic neuromyelitis optica (no recurrence, and simultaneous or closely related optic neuritis and LETM within 30 days of each other); acute disseminated encephalomyelitis; aseptic meningitis and encephalomyelitis; poor recovery from multiple sclerosis relapses Applicable not more than 4 times in 12 months
71180	01NOV2007	31DEC9999	Y	Antibody to cardiolipin or beta-2 glycoprotein I - detection, including quantitation if required; one antibody specificity (IgG or IgM)
71183	01NOV2007	31DEC9999	Y	Detection of two antibodies described in item 71180
71186	01NOV2007	31DEC9999	Y	Detection of three or more antibodies described in item 71180
71189	01NOV2007	31DEC9999	Y	Detection of specific IgG antibodies to 1 or more respiratory disease allergens not elsewhere specified.
71192	01NOV2007	31DEC9999	Y	2 items described in item 71189.
71195	01NOV2007	31DEC9999	Y	3 or more items described in item 71189.
71198	01NOV2007	31DEC9999	Y	Estimation of serum tryptase for the evaluation of unexplained acute hypotension or suspected anaphylactic event, assessment of risk in stinging insect anaphylaxis, exclusion of mastocytosis, monitoring of known mastocytosis.
71200	01NOV2007	30APR2009	N	Detection and quantitation, if present, of free kappa or lambda light chains in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma cell dyscrasias.
71200	01MAY2009	31DEC9999	Y	Detection and quantitation, if present, of free kappa and lambda light chains in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma cell dyscrasias.
71202	01NOV2023	31DEC9999	Y	Measurable residual disease (MRD) testing by flow cytometry, performed on bone marrow from a patient diagnosed with acute lymphoblastic leukaemia, for the purpose of determining baseline MRD, or facilitating the determination of MRD following combination chemotherapy or after salvage therapy, requested by a specialist or consultant physician practising as a haematologist or oncologist
71203	01NOV2007	31DEC9999	Y	Determination of HLAB5701 status by flow cytometry or cytotoxity assay prior to the initiation of Abacavir therapy including item 73323 if performed.
72801	01DEC1991	30JUN1994	N	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions
72801	01JUL1994	31DEC9999	Y	Examination of biopsy material (gross and microscopic) including all tissue processing, staining, and except as provided for in 72805 and 72807 - all professional opinions
72802	01DEC1991	31DEC9999	Y	Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions
72803	01DEC1991	30JUN1994	N	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination
72803	01JUL1994	31DEC9999	Y	Intraoperative frozen section diagnosis of biopsy material, including any other tissue pathology service in Group P5
72804	01DEC1991	31DEC9999	Y	Immediate frozen section diagnosis of biopsy material, including any other histopathology examination
72805	01DEC1991	30JUN1994	N	Immunohistochemical investigation of biopsy material by 1 or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination
72805	01JUL1994	31DEC9999	Y	Immunohistochemical staining of biopsy material by 1 or more labelled antibody techniques (including immunofluorescence and immunoperoxidase) and including any other tissue pathology service in Group P5
72806	01DEC1991	31DEC9999	Y	Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination
72807	01DEC1991	30JUN1994	N	Electron microscopy of biopsy material including any other histopathology examination
72807	01JUL1994	31DEC9999	Y	Electron microscopy of biopsy material including any other tissue pathology service in Group P5
72808	01DEC1991	31DEC9999	Y	Electron microscopy of biopsy material including any other histopathology examination
72813	20MAR1997	31DEC9999	Y	Examination of complexity level 2 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13)
72814	01NOV2018	31OCT2021	N	Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer, to determine if the requirements relating to PD-L1 status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled.
72814	01NOV2021	30SEP2022	N	Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer.
72814	01OCT2022	31AUG2023	N	Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer or recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx.
72814	01SEP2023	31DEC9999	Y	Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with: (a) non-small cell lung cancer; or (b) recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx; or (c) locally recurrent unresectable or metastatic triple-negative breast cancer.
72816	20MAR1997	31DEC9999	Y	Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 separately identified specimen (Item is subject to rule 13)
72817	20MAR1997	31OCT2002	N	Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 or more separately identified specimens (Item is subject to rule 13)
72817	01NOV2002	31DEC9999	Y	Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 to 4 separately identified specimens (Item is subject to rule 13)
72818	01NOV2002	31DEC9999	Y	Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 or more separately identified specimens (Item is subject to rule 13)
72823	20MAR1997	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 separately identified specimen (Item is subject to rule 13)
72824	20MAR1997	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 to 4 separately identified specimens (Item is subject to rule 13)
72825	20MAR1997	31OCT2002	N	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 or more separately identified specimens (Item is subject to rule 13)
72825	01NOV2002	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 to 7 separately identified specimens (Item is subject to rule 13)
72826	01NOV2002	31OCT2008	N	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 8 or more separately identified specimens (Item is subject to rule 13)
72826	01NOV2008	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 8 to 11 separately identified specimens (Item is subject to rule 13)
72827	01NOV2008	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 12 to 17 separately identified specimens (Item is subject to Rule 13)
72828	01NOV2008	31DEC9999	Y	Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 18 or more separately identified specimens (Item is subject to Rule 13)
72830	20MAR1997	31DEC9999	Y	Examination of complexity level 5 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13)
72836	20MAR1997	31DEC9999	Y	Examination of complexity level 6 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13)
72838	01NOV2007	31DEC9999	Y	Examination of complexicity level 7 biopsy material with multiple tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens. (Item is subject to rule 13)
72844	01NOV1998	31DEC9999	Y	Enzyme histochemistry of skeletal muscle for investigation of primary degenerative or metabolic muscle diseases or of muscle abnormalities secondary to disease of the central or peripheral nervous system - 1 or more tests
72846	20MAR1997	31OCT2003	N	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies (Item is subject to rule 13)
72846	01NOV2003	31DEC9999	Y	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 72848 (Item is subject to rule 13)
72847	20MAR1997	31OCT2008	N	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies (Item is subject to rule 13)
72847	01NOV2008	30JUN2009	N	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4-6 or more antibodies (Item is subject to rule 13)
72847	01JUL2009	31DEC9999	Y	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4-6 antibodies (Item is subject to rule 13)
72848	01NOV2003	31DEC9999	Y	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13)
72849	01NOV2008	31DEC9999	Y	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7-10 antibodies (Item is subject to rule 13)
72850	01NOV2008	31DEC9999	Y	Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13)
72851	20MAR1997	31DEC9999	Y	Electron microscopic examination of biopsy material - 1 separately identified specimen (Item is subject to rule 13)
72852	20MAR1997	31DEC9999	Y	Electron microscopic examination of biopsy material - 2 or more separately identified specimens (Item is subject to rule 13)
72855	20MAR1997	31OCT2001	N	Intraoperative frozen section diagnosis of biopsy material - 1 separately identified specimen (Item is subject to rule 14)
72855	01NOV2001	31DEC9999	Y	Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 1 separately identified specimen (Item is subject to rule 13)
72856	20MAR1997	31OCT2001	N	Intraoperative frozen section diagnosis of biopsy material - 2 or more separately identified specimens (Item is subject to rule 14)
72856	01NOV2001	31OCT2003	N	Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 2 or more separately identified specimens (Item is subject to rule 13)
72856	01NOV2003	31DEC9999	Y	Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 2 to 4 separately identified specimens (Item is subject to rule 13)
72857	01NOV2003	31DEC9999	Y	Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 5 or more separately identified specimens (Item is subject to rule 13)
72858	01NOV2015	31DEC9999	Y	A second opinion, provided in a written report, where the opinion and report together require no more than 30 minutes to complete, on a patient specimen, requested by a treating practitioner, where further information is needed for accurate diagnosis and appropriate patient management.
72859	01NOV2015	31DEC9999	Y	A second opinion, provided in a written report, where the opinion and report together require more than 30 minutes to complete, on a patient specimen, requested by a treating practitioner, where further information is needed for accurate diagnosis and appropriate patient management.
72860	01MAY2019	30APR2020	N	Retrieval and review of archived formalin fixed paraffin embedded block(s) to determine the appropriate sample(s) for the purpose of conducting further genetic testing. For any particular patient, this item is applicable for a maximum of one retrieval per subsequent patient episode.
72860	01MAY2020	28FEB2021	N	Retrieval and review of one or more archived formalin fixed paraffin embedded block(s) to determine the appropriate sample(s) for the purpose of conducting genetic testing
72860	01MAR2021	31DEC9999	Y	Retrieval and review of one or more archived formalin fixed paraffin embedded blocks to determine the appropriate samples for the purpose of conducting genetic testing, other than: (a) a service associated with a service to which item 72858 or 72859 applies; or (b) a service associated with, and rendered in the same patient episode as, a service to which an item in Group P5, P6, P10 or P11 applies Applicable not more than once in a patient episode
73043	01DEC1991	30JUN1994	N	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes 1 or more examinations
73043	01JUL1994	31DEC9999	Y	Cytology (including serial examinations) of nipple discharge or smears from skin, lip, mouth, nose or anus for detection of precancerous or cancerous changes 1 or more tests
73044	01DEC1991	31DEC9999	Y	Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes one or more examinations
73045	01DEC1991	29FEB1992	N	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043 and any histopathological service performed on that cytology specimen one or more examinations
73045	01MAR1992	30JUN1994	N	Cytological examination, other than an examination mentioned in item 73053, for malignancy, including serial examinations and histological services performed on the resulting specimens from washings or brushings from sites not specified in item 73043, or performed on a single specimen of sputum or urine or on 1 or more specimens of other body fluids - 1 or more examinations
73045	01JUL1994	30NOV2017	N	Cytology (including serial examinations) for malignancy (other than an examination mentioned in item 73053); and including any Group P5 service, if performed on: (a) specimens resulting from washings or brushings from sites not specified in item 73043; or (b) a single specimen of sputum or urine; or (c) 1 or more specimens of other body fluids; 1 or more tests
73045	01DEC2017	31DEC9999	Y	Cytology (including serial examinations) for malignancy (other than an examination mentioned in item 73076); and including any Group P5 service, if performed on: (a) specimens resulting from washings or brushings from sites not specified in item 73043; or (b) a single specimen of sputum or urine; or (c) 1 or more specimens of other body fluids; 1 or more tests
73046	01DEC1991	31DEC9999	Y	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043/73044 and any histopathological service performed on that cytology specimen one or more examinations
73047	01DEC1991	30JUN1994	N	Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells
73047	01JUL1994	31DEC9999	Y	Cytology of a series of 3 sputum or urine specimens for malignant cells
73048	01DEC1991	31DEC9999	Y	Cytological examination including examination of a series of three sputum or urine specimens for malignant cells
73049	01DEC1991	30JUN1994	N	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues
73049	01JUL1994	30APR2000	N	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues
73049	01MAY2000	30APR2009	N	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues
73049	01MAY2009	31DEC9999	Y	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues - 1 identified site
73050	01DEC1991	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues
73051	01DEC1991	30JUN1994	N	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance
73051	01JUL1994	30APR2000	N	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues if: (a) the aspiration is performed by a recognised pathologist; or (b) a recognised pathologist attends the aspiration and performs cytological examination during the attendance
73051	01MAY2000	30JUN2011	N	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues if: (a) the aspiration is performed by a recognised pathologist; or (b) a recognised pathologist attends the aspiration and performs cytological examination during the attendance
73051	01JUL2011	31DEC9999	Y	Cytology of material obtained directly from a patient at one identified site by fine needle aspiration of solid tissue or tissues if a recognized pathologist: (a) performs the aspiration; or (b) attends the aspiration and performs cytological examination during the attendance
73052	01DEC1991	31DEC9999	Y	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance
73053	01DEC1991	30JUN1994	N	Routine cytological examination of smears from cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination
73053	01JUL1994	19MAR1997	N	Cytology of smears from cervix: (a) for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia; or (b) due to an unsatisfactory smear taken in the circumstances defined in para (a) above; each examination
73053	20MAR1997	31OCT2001	N	Cytology of smears from cervix: (a) for detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia; or (b) due to an unsatisfactory smear taken in the circumstances defined in para (a) above; or (c) if there is inadequate information provided to use item 73055; each examination
73053	01NOV2001	31DEC9999	Y	Cytology of a smear from cervix where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each examination (a) for the detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia, or (b) if a further specimen is taken due to an unsatisfactory smear taken for the purposes of paragraph (a); or (c) if there is inadequate information provided to use item 73055;
73054	01DEC1991	31DEC9999	Y	Routine cytological examination of smears from the cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination
73055	01DEC1991	30JUN1994	N	Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with item 73053 - each examination
73055	01JUL1994	31OCT2001	N	Cytology not associated with item 73053, of smears from cervix in association with: (a) the management of previously detected abnormalities including precancerous or cancerous conditions; or (b) the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia; each test
73055	01NOV2001	30APR2017	N	Cytology of a smear from cervix, not associated with item 73053, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test (a) for the management of previously detected abnormalities including precancerous or cancerous conditions; or (b) for the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia;
73055	01MAY2017	31DEC9999	Y	Cytology of a smear from cervix, not associated with item 73053, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test: (a) for the management of previously detected abnormalities including precancerous or cancerous conditions; or (b) for the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia.
73056	01DEC1991	31DEC9999	Y	Cytological examination of smears from cervix in association with the management of previously detected abnormalities including pre-cancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with Item 73054 - each examination
73057	01DEC1991	30JUN1994	N	Cytological examination of smears from vagina, not associated with items 73053 or 73055 - each examination
73057	01JUL1994	31OCT2001	N	Cytology of smears from vagina, not associated with item 73053 or 73055 nor to monitor hormone replacement therapy - each test
73057	01NOV2001	31DEC9999	Y	Cytology of smears from vagina, not associated with item 73053 or 73055 and not to monitor hormone replacement therapy, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test
73058	01DEC1991	31DEC9999	Y	Cytological examination of smears from vagina, not associated with Items 73054 or 73056 - each examination
73059	01NOV1997	31OCT2003	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies
73059	01NOV2003	30APR2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13)
73059	01MAY2009	30JUN2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13)
73059	01JUL2009	31DEC2013	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13)
73059	01JAN2014	31DEC9999	Y	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13)
73060	01NOV1997	31OCT2003	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies
73060	01NOV2003	30APR2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies (Item is subject to rule 13)
73060	01MAY2009	30JUN2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6 antibodies (Item is subject to rule 13)
73060	01JUL2009	31DEC2013	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6 antibodies (Item is subject to rule 13)
73060	01JAN2014	31DEC9999	Y	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6 antibodies (Item is subject to rule 13)
73061	01NOV2003	30APR2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13)
73061	01MAY2009	30JUN2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13)
73061	01JUL2009	31DEC2013	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13)
73061	01JAN2014	31DEC9999	Y	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13)
73062	01MAY2009	31DEC9999	Y	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues - 2 or more separately identified sites.
73063	01MAY2009	30JUN2011	N	Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues, where an employee of the APA also attends the aspiration for confirmation of sample adequacy.
73063	01JUL2011	31DEC9999	Y	Cytology of material obtained directly from a patient at one identified site by fine needle aspiration of solid tissue or tissues if an employee of an approved pathology authority attends the aspiration for confirmation of sample adequacy
73064	01MAY2009	30JUN2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13)
73064	01JUL2009	31DEC2013	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13)
73064	01JAN2014	31DEC9999	Y	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13)
73065	01MAY2009	30JUN2009	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13)
73065	01JUL2009	31DEC2013	N	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13)
73065	01JAN2014	31DEC9999	Y	Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13)
73066	01JUL2011	31DEC9999	Y	Cytology of material obtained directly from a patient at 2 or more separately identified sites by fine needle aspiration of solid tissue or tissues if a recognized pathologist: (a) performs the aspiration; or (b) attends the aspiration and performs cytological examination during the attendance
73067	01JUL2011	31DEC9999	Y	Cytology of material obtained directly from a patient at 2 or more separately identified sites by fine needle aspiration of solid tissue or tissues if an employee of an approved pathology authority attends the aspiration for confirmation of sample adequacy
73069	01MAY2017	31DEC9999	Y	Cytology of a specimen obtained from cervix or vagina, not associated with item 73053, 73055 or 73057, where the slide is prepared by liquid based preparation techniques, and the slide is microscopically examined by or on behalf of a pathologist using manual or semi-automated image analysis methods.
73070	01DEC2017	31DEC9999	Y	73070 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer or cancer: (a) performed on a liquid based cervical specimen; and (b) for an asymptomatic patient who is at least 24 years and 9 months of age For any particular patient, once only in a 57 month period
73071	01DEC2017	30JUN2022	N	73071 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer or cancer: (a) performed on a self-collected vaginal specimen; and (b) for an asymptomatic patient who is at least 30 years of age For any particular patient, once only in a 7 year period
73071	01JUL2022	31DEC9999	Y	A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre-cancer or cancer, if performed: (a) on a self-collected vaginal specimen; and (b) for an asymptomatic patient who is at least 24 years and 9 months of age For any particular patient, applicable once in 57 months
73072	01DEC2017	31OCT2022	N	A test, including partial genotyping, for oncogenic human papillomavirus, performed on a liquid based cervical specimen: (a) for the investigation of a patient in a specific population that appears to have a higher risk of cervical pre-cancer or cancer; or (b) for the follow-up management of a patient with a previously detected oncogenic human papillomavirus infection or cervical pre-cancer or cancer; or (c) for the investigation of a patient with symptoms suggestive of cervical cancer; or (d) for the follow-up management of a patient after treatment of high grade squamous intraepithelial lesions or adenocarcinoma in situ of the cervix; or (e) for the follow-up management of a patient with glandular abnormalities; or (f) for the follow-up management of a patient exposed to diethylstilboestrol in utero
73072	01NOV2022	31DEC9999	Y	A test, including partial genotyping, for oncogenic human papillomavirus: (a) for the investigation of a patient in a specific population that appears to have a higher risk of cervical pre-cancer or cancer; or (b) for the follow-up management of a patient with a previously detected oncogenic human papillomavirus infection or cervical pre-cancer or cancer; or (c) for the investigation of a patient with symptoms suggestive of cervical cancer; or (d) for the follow-up management of a patient after treatment of high grade squamous intraepithelial lesions or adenocarcinoma in situ of the cervix; or (e) for the follow-up management of a patient with glandular abnormalities; or (f) for the follow-up management of a patient exposed to diethylstilboestrol in utero; or (g) for a patient previously treated for a genital tract malignancy when performed as a co-test for both human papillomavirus (HPV) and liquid-based cytology (LBC).
73073	01DEC2017	30JUN2022	N	A test, including partial genotyping, for oncogenic human papillomavirus: (a) performed on a self-collected vaginal specimen; and (b) for the follow-up management of a patient with oncogenic human papillomavirus infection or cervical pre-cancer or cancer that was detected by a test to which item 73071 applies For any particular patient, once only in a 21 month period
73073	01JUL2022	31DEC9999	Y	A test, including partial genotyping, for oncogenic human papillomavirus: (a) performed on a self-collected vaginal specimen; and (b) for the follow-up management of a patient with oncogenic human papillomavirus infection or cervical pre-cancer or cancer that was detected by a test to which item 73071 applies
73074	01DEC2017	31OCT2022	N	A test, including partial genotyping, for oncogenic human papillomavirus: (a) performed on a liquid based vaginal vault specimen; and (b) for the investigation of a patient following a total hysterectomy
73074	01NOV2022	31DEC9999	Y	A test, including partial genotyping, for oncogenic human papillomavirus, for the investigation of a patient following a total hysterectomy.
73075	01DEC2017	31OCT2022	N	A test, including partial genotyping, for oncogenic human papillomavirus, if: (a) the test is a repeat of a test to which item 73070, 73071, 73072, 73073, 73074 or this item applies; and (b) the specimen collected for the previous test is unsatisfactory
73075	01NOV2022	31DEC9999	Y	A test, including partial genotyping, for oncogenic human papillomavirus, if: (a) the test is a repeat of a test to which item 73070, 73071, 73072, 73074 or this item applies; and (b) the specimen collected for the previous test is unsatisfactory
73076	01DEC2017	31OCT2022	N	Cytology of a liquid-based cervical or vaginal vault specimen, where the stained cells are examined microscopically or by automated image analysis by or on behalf of a pathologist, if: (a) the cytology is associated with the detection of oncogenic human papillomavirus infection by: (i) a test to which item 73070, 73071, 73073, 73074 or 73075 applies; or (ii) a test to which item 73072 applies for a patient mentioned in paragraph (a) or (b) of that item; or (b) the cytology is associated with a test to which item 73072 applies for a patient mentioned in paragraph (c), (d), (e) or (f) of that item; or (c) the cytology is associated with a test to which item 73074 applies; or (d) the test is a repeat of a test to which this item applies, if the specimen collected for the previous test is unsatisfactory; or (e) the cytology is for the follow-up management of a patient treated for endometrial adenocarcinoma
73076	01NOV2022	31DEC9999	Y	Cytology of a liquid-based cervical or vaginal vault specimen, where the stained cells are examined microscopically or by automated image analysis by or on behalf of a pathologist, if: (a) the cytology is associated with the detection of oncogenic human papillomavirus infection by: (i) a test to which item 73070, 73071, 73074 or 73075 applies; or (ii) a test to which item 73072 applies for a patient mentioned in paragraph (a) or (b) of that item; or (b) the cytology is associated with a test to which item 73072 applies for a patient mentioned in paragraph (c), (d), (e) or (f) of that item; or (c) the cytology is associated with a test to which item 73074 applies; or (d) the test is a repeat of a test to which this item applies, if the specimen collected for the previous test is unsatisfactory; or (e) the cytology is for the follow-up management of a patient treated for endometrial adenocarcinoma
73281	01DEC1991	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood 1 or more estimations
73282	01DEC1991	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood one or more estimations
73283	01DEC1991	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood
73284	01DEC1991	31DEC9999	Y	Chromosome studies, including preparation, count and karyotyping of blood
73285	01DEC1991	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile Xsite determination 1 or more identifications
73286	01DEC1991	31DEC9999	Y	Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile Xsite determination one or more identifications
73287	01JUL1993	30JUN1994	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid except blood - 1 or more estimations
73287	01JUL1994	30APR2003	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or fragile X-site determination of 1 or more of any tissue or fluid except blood - 1 or more tests
73287	01MAY2003	31OCT2008	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques of 1 or more of any tissue or fluid except blood - 1 or more tests
73287	01NOV2008	30APR2010	N	Chromosome studies, (karyotype), by cytogenetic or other comparable techniques, of 1 or more of any tissue or fluid except blood - 1 or more tests
73287	01MAY2010	31DEC9999	Y	The study of the whole of every chromosome by cytogenetic or other techniques, performed on 1 or more of any tissue or fluid except blood (including a service mentioned in item 73293, if performed) - 1 or more tests
73288	01NOV2018	31DEC9999	Y	Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer, to determine if the requirements relating to PD-L1 status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled.
73289	01JUL1993	30JUN1994	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of blood - 1 or more estimations
73289	01JUL1994	30APR2003	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or fragile X-site determination of blood - 1 or more tests
73289	01MAY2003	31OCT2008	N	Chromosome studies, including preparation, count, karyotyping and identification by banding techniques of blood - 1 or more tests
73289	01NOV2008	30APR2010	N	Chromosome studies, (karyotype), by cytogenetic or other comparable techniques of blood - 1 or more tests
73289	01MAY2010	31DEC9999	Y	The study of the whole of every chromosome by cytogenetic or other techniques, performed on blood (including a service mentioned in item 73293, if performed) - 1 or more tests
73290	01MAY2010	31DEC9999	Y	The study of the whole of each chromosome by cytogenetic or other techniques, performed on blood or bone marrow, in the diagnosis and monitoringof haematological malignancy (including a service in items 73287 or 73289, if performed). - 1 or more tests.
73291	01MAY2010	31DEC9999	Y	Analysis of one or more chromosome regions for specific constitutional genetic abnormalities of blood or fresh tissue in a) diagnostic studies of a person with developmental delay, intellectual disability, autism, or at least two congenital abnormalities, in whom cytogenetic studies (item 73287 or 73289) are either normal or have not been performed; or b) studies of a relative for an abnormality previously identified in such an affected person. - 1 or more tests.
73292	01MAY2010	31DEC9999	Y	Analysis of chromosomes by genome-wide micro-array including targeted assessment of specific regions for constitutional genetic abnormalities in diagnostic studies of a person with developmental delay, intellectual disability, autism, or at least two congenital abnormalities (including a service in items 73287, 73289 or 73291, if performed) - 1 or more tests.
73293	01MAY2010	31DEC9999	Y	Analysis of one or more regions on all chromosomes for specific constitutional genetic abnormalities of fresh tissue in diagnostic studies of the products of conception, including exclusion of maternal cell contamination. - 1 or more tests.
73294	01MAY2010	31DEC9999	Y	Analysis of the PMP22 gene for constitutional genetic abnormalities causing peripheral neuropathy, either as: a) diagnostic studies of an affected person; or b) studies of a relative for an abnormality previously identified in an affected person - 1 or more tests.
73295	01FEB2017	31JUL2020	N	Detection of germline BRCA1 or BRCA2 gene mutations, in a patient with platinum-sensitive relapsed ovarian, fallopian tube or primary peritoneal cancer with high grade serous features or a high grade serous component, and who has responded to subsequent platinum-based chemotherapy, requested by a specialist or consultant physician, to determine whether the eligibility criteria for olaparib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. Maximum one test per lifetime
73295	01AUG2020	31AUG2022	N	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, in a patient with advanced (FIGO III-IV) high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer for whom testing of tumour tissue is not feasible, requested by a specialist or consultant physician, to determine eligibility for olaparib under the Pharmaceutical Benefits Scheme (PBS) Maximum of one test per patients lifetime
73295	01SEP2022	30JUN2024	N	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, in a patient with advanced (FIGO III-IV) high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer for whom testing of tumour tissue is not feasible, requested by a specialist or consultant physician, to determine eligibility for treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor under the Pharmaceutical Benefits Scheme (PBS) Maximum of one test per patients lifetime
73295	01JUL2024	31DEC2024	N	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, requested by a specialist or consultant physician, to determine eligibility for treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor under the Pharmaceutical Benefits Scheme (PBS), in a patient with: (a) advanced (FIGO III-IV) high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer for whom testing of tumour tissue is not feasible; or (b) triple negative early breast cancer; or (c) hormone receptor positive, HER2-negative, early breast cancer with one or more high-risk characteristics. Applicable once per lifetime.
73295	01JAN2025	31DEC9999	Y	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, requested by a specialist or consultant physician, to determine eligibility for a relevant treatment under the Pharmaceutical Benefits Scheme (PBS), in a patient with: (a) advanced (FIGO III-IV) high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer for whom testing of tumour tissue is not feasible; or (b) breast cancer. Applicable once per lifetime
73296	01NOV2017	28FEB2021	N	Characterisation of germline gene mutations, requested by a specialist or consultant physician, including copy number variation in BRCA1 and BRCA2 genes and one or more of the following genes STK11, PTEN, CDH1, PALB2, or TP53 in a patient with breast or ovarian cancer for whom clinical and family history criteria, as assessed by the specialist or consultant physician who requests the service using a quantitative algorithm, place the patient at >10% risk of having a pathogenic mutation identified in one or more of the genes specified above.
73296	01MAR2021	31OCT2023	N	Characterisation of germline gene variants: (a) including copy number variation in: (i) BRCA1 genes; and (ii) BRCA2 genes; and (iii) one or more of the genes STK11, PTEN, CDH1, PALB2 and TP53; and (b) in a patient: (i) with breast, ovarian, fallopian tube or primary peritoneal cancer; and (ii) for whom clinical and family history criteria (as assessed, by the specialist or consultant physician who requests the service, using a quantitative algorithm) place the patient at greater than 10% risk of having a pathogenic or likely pathogenic gene variation identified in one or more of the genes specified in subparagraphs (a)(i), (ii) and (iii); requested by a specialist or consultant physician
73296	01NOV2023	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician: (a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which must include at least: (i) BRCA1 and BRCA 2 genes; and (ii) one or more STK11, PTEN, CDH1, PALB2 and TP53 genes; and (b) in a patient: (i) with breast, ovarian, fallopian tube or primary peritoneal cancer; and (ii) for whom clinical and family history criteria place the patient at greater than 10% risk of having a pathogenic or likely pathogenic gene associated with breast, ovarian, fallopian tube or primary peritoneal cancer Once per cancer diagnosis
73297	01NOV2017	28FEB2021	N	Characterisation of germline gene mutations, requested by a specialist or consultant physician, including copy number variation in BRCA1 and BRCA2 genes and one or more of the following genes STK11, PTEN, CDH1, PALB2, or TP53 in a patient who is a biological relative of a patient who has had a pathogenic mutation identified in one or more of the genes specified above, and has not previously received a service under item 73296.
73297	01MAR2021	31OCT2021	N	Characterisation of germline gene variations: (a) including copy number variation in: (i) BRCA1 genes; and (ii) BRCA2 genes; and (iii) one or more of the genes STK11, PTEN, CDH1, PALB2 and TP53; and (b) in a patient who: (i) is a biological relative of a patient who has had a pathogenic or likely pathogenic gene variation identified in one or more of the genes mentioned in subparagraphs (a)(i), (ii) and (iii); and (ii) has not previously received a service to which item 73295, 73296 or 73297 applies; requested by a specialist or consultant physician
73297	01NOV2021	31OCT2023	N	Characterisation of germline gene variants, including copy number variation: in one or more of the following genes: BRCA1; BRCA2; STK11; PTEN; CDH1; PALB2; TP53; and in a patient who: is a biological relative of a patient who has had a pathogenic or likely pathogenic gene variant identified in one or more of the genes mentioned in paragraph (a); and has not previously received a service to which item 73295, 73296 or 73302 applies; requested by a specialist or consultant physician
73297	01NOV2023	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician: (a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which may include the following genes: (i) BRCA1 or BRCA2; (ii) STK11, PTEN, CDH1, PALB2 and TP53; and (b) in a patient: (i) who has a biological relative who has had a pathogenic or likely pathogenic gene variant identified in one or more of the genes mentioned in paragraph (a); or (ii) who has not previously received a service to which item 73295, 73296 or 73302 applies Once per variant
73298	01MAY2019	31DEC9999	Y	Characterisation of germline gene variants in the following genes: (a) COL4A3; and (b) COL4A4; and (c) COL4A5; in a patient for whom clinical and relevant family history criteria have been assessed by a specialist or consultant physician, who requests the service to be strongly suggestive of Alport syndrome.
73299	01MAY2019	31DEC9999	Y	Characterisation of germline gene variants: (a) in the following genes: (i) COL4A3; and (ii) COL4A4; and (iii) COL4A5; (b) in a patient who: (i) is a first degree biological relative of a patient who has had a pathogenic mutation identified in one or more of the genes mentioned in subparagraphs (a)(i), (ii) and (iii); and (ii) has not previously received a service which item 73298 applies; requested by a specialist or consultant physician.
73300	01MAY2003	31OCT2003	N	Detection of genetic mutation of the FMR1 gene by nucleic acid amplification (NAA) where: (a) the patient exhibits the specific clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a first or second degree relative with a fragile X (A) mutation 1 or more tests
73300	01NOV2003	31OCT2008	N	Detection of genetic mutation of the FMR1 gene by nucleic acid amplification (NAA) where: (a) the patient exhibits one or more of the clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a relative with a fragile X (A) mutation 1 or more tests
73300	01NOV2008	30APR2009	N	Detection of mutation of the FMR1 gene where: (a) the patient exhibits one or more of the clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a relative with a fragile X (A) mutation 1 or more tests
73300	01MAY2009	31DEC9999	Y	Detection of mutation of the FMR1 gene where: (a) the patient exhibits intellectual disability, ataxia, neurodegeneration, or premature ovarian failure consistent with an FMRI mutation; or (b) the patient has a relative with a FMR1 mutation 1 or more tests
73301	01AUG2020	31AUG2022	N	A test of tumour tissue from a patient with advanced (FIGO III-IV), high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to olaparib under the Pharmaceutical Benefits Scheme (PBS). Applicable once per primary tumour diagnosis
73301	01SEP2022	31DEC9999	Y	A test of tumour tissue from a patient with advanced (FIGO III-IV), high grade serous or high grade epithelial ovarian, fallopian tube or primary peritoneal cancer, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor under the Pharmaceutical Benefits Scheme (PBS) Applicable once per primary tumour diagnosis
73302	01AUG2020	31DEC9999	Y	Characterisation of germline gene variants including copy number variants, in BRCA1 or BRCA2 genes, in a patient who has had a pathogenic or likely pathogenic variant identified in either gene by tumour testing and who has not previously received a service to which items 73295, 73296 or 73297 applies, requested by a specialist or consultant physician. Applicable once per primary tumour diagnosis
73303	01APR2022	31DEC2024	N	A test of tumour tissue from a patient with metastatic castration-resistant prostate cancer, including subsequent characterisation of germline gene variants should tumour tissue testing undertaken during the same service be inconclusive, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to olaparib under the Pharmaceutical Benefits Scheme. Applicable once per primary tumour diagnosis
73303	01JAN2025	31DEC9999	Y	A test of tumour tissue from a patient with metastatic castration-resistant prostate cancer, including subsequent characterisation of germline gene variants should tumour tissue testing undertaken during the same service be inconclusive, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to a relevant treatment under the Pharmaceutical Benefits Scheme; Applicable once per primary tumour diagnosis
73304	01APR2022	31DEC2024	N	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, in a patient with metastatic castration-resistant prostate cancer, for whom testing of tumour tissue is not clinically feasible, requested by a specialist or consultant physician, to determine eligibility for olaparib under the Pharmaceutical Benefits Scheme. Applicable once per lifetime
73304	01JAN2025	31DEC9999	Y	Detection of germline BRCA1 or BRCA2 pathogenic or likely pathogenic gene variants, in a patient with metastatic castration-resistant prostate cancer, for whom testing of tumour tissue is not clinically feasible, requested by a specialist or consultant physician, to determine eligibility for a relevant treatment under the Pharmaceutical Benefits Scheme; Applicable once per lifetime
73305	01MAY2003	31OCT2008	N	Detection of genetic mutation of the FMR1 gene by Southern Blot where the results in item 73300 are inconclusive
73305	01NOV2008	31DEC9999	Y	Detection of mutation of the FMR1 gene by Southern Blot analysis where the results in item 73300 are inconclusive
73306	01NOV2023	31DEC9999	Y	Gene expression profiling testing using EndoPredict, for the purpose of profiling gene expression in formalin-fixed, paraffin-embedded primary breast cancer tissue from core needle biopsy or surgical tumour sample to estimate the risk of distant recurrence of breast cancer within 10 years, if: (a) the sample is from a new primary breast cancer, which is suitable for adjuvant chemotherapy; and (b) the sample has been determined to be oestrogen receptor positive and HER2 negative by IHC and ISH respectively on surgically removed tumour; and (c) the sample is axillary node negative or positive (up to 3 nodes) with a tumour size of at least 1 cm and no more than 5 cm determined by histopathology on surgically removed tumour; and (d) the sample has no evidence of distal metastasis; and (e) pre-testing of intermediate risk of distant metastases has shown that the tumour is defined by at least one of the following characteristics: (i) histopathological grade 2 or 3; (ii) one to 3 lymph nodes involved in metastatic disease (including micrometastases but not isolated tumour cells); and (f) the service is not administered for the purpose of altering treatment decisions Applicable once per new primary breast cancer diagnosis for any particular patient
73307	01JAN2024	31DEC9999	Y	A test of tumour tissue from a patient with advanced (FIGO III-IV), high-grade serous or other high-grade ovarian, fallopian tube or primary peritoneal carcinoma, requested by a specialist or consultant physician, if the test is: (a) to determine eligibility with respect to homologous recombination deficiency (HRD) status, including BRCA1 or BRCA2 status, to provide access to poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor therapy under the Pharmaceutical Benefits Scheme; and (b) including a service described in item 73301 Applicable once per primary tumour diagnosis
73308	01MAY2006	31DEC9999	Y	Characterisation of the genotype of a patient for Factor V Leiden gene mutation, or detection of the other relevant mutations in the investigation of proven venous thrombosis or pulmonary embolism - 1 or more tests
73309	01MAY2007	31DEC9999	Y	A test described in item 73308, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
73310	01NOV2023	31DEC9999	Y	Measurable residual disease (MRD) testing by next-generation sequencing, performed on bone marrow (or a peripheral blood sample if bone marrow cannot be collected) from a patient diagnosed with acute lymphoblastic leukaemia, for the purpose of determining baseline MRD, or facilitating the determination of MRD following combination chemotherapy or after salvage therapy, requested by a specialist or consultant physician practising as a haematologist or oncologist
73311	01MAY2006	31DEC9999	Y	Characterisation of the genotype of a person who is a first degree relative of a person who has proven to have 1 or more abnormal genotypes under item 73308 - 1 or more tests
73312	01MAY2007	31DEC9999	Y	A test described in item 73311, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
73313	01JUL2024	31DEC9999	Y	Development of a quantitative patient-specific molecular assay for measurable residual disease (MRD) testing performed on bone marrow (or a peripheral blood sample if bone marrow cannot be collected) from a patient diagnosed with acute lymphoblastic leukaemia treated with combination chemotherapy or after salvage therapy, including the first service described in item 73316 performed on that bone marrow or peripheral blood sample, requested by a specialist or consultant physician practising as a haematologist or oncologist Applicable once per patient per episode of disease or per relapse
73314	01MAY2006	31OCT2008	N	Characterisation of gene rearrangement by nucleic acid amplification in the diagnosis and monitoring of patients with laboratory evidence of: (a) acute myeloid leukaemia; or (b) acute promyelocytic leukaemia; or (c) acute lymphoid leukaemia; or (d) chronic myeloid leukaemia; each test to a maximum of 4 tests in a 12 month period
73314	01NOV2008	30APR2009	N	Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of: (a) acute myeloid leukaemia; or (b) acute promyelocytic leukaemia; or (c) acute lymphoid leukaemia; or (d) chronic myeloid leukaemia; (Item is subject to Rule 25)
73314	01MAY2009	31DEC9999	Y	Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of: (a) acute myeloid leukaemia; or (b) acute promyelocytic leukaemia; or (c) acute lymphoid leukaemia; or (d) chronic myeloid leukaemia;
73315	01MAY2007	30APR2009	N	A test described in item 73314, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 25)
73315	01MAY2009	31DEC9999	Y	A test described in item 73314, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18)
73316	01JUL2024	31DEC9999	Y	Measurable residual disease (MRD) testing by a quantitative patient-specific molecular assay performed on bone marrow (or, in a patient with T-cell acute lymphoblastic leukaemia, performed on a peripheral blood sample if bone marrow cannot be collected) from a patient diagnosed with acute lymphoblastic leukaemia treated with combination chemotherapy or after salvage therapy, requested by a specialist or consultant physician practising as a haematologist or oncologist, other than a service associated with a service to which item 73313 applies
73317	01MAY2006	31DEC9999	Y	Detection of the C282Y genetic mutation of the HFE gene and, if performed, detection of other mutations for haemochromatosis where: (a) the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b) the patient has a first degree relative with haemochromatosis; or (c) the patient has a first degree relative with homozygosity for the C282Y genetic mutation, or with compound heterozygosity for recognised genetic mutations for haemochromatosis (Item is subject to rule 20)
73318	01MAY2007	31DEC9999	Y	A test described in item 73317, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 20)
73320	01MAY2006	31OCT2006	N	Detection of HLA-B27 by nucleic acid amplification
73320	01NOV2006	31DEC9999	Y	Detection of HLA-B27 by nucleic acid amplification includes a service described in 71147 unless the service in item 73320 is rendered as a pathologist determinable service. (Item is subject to rule 27)
73321	01MAY2007	31DEC9999	Y	A test described in item 73320, if rendered by a receiving APP - 1 or more tests. (Item is subject to rule 18 and 27)
73323	01NOV2007	31OCT2008	N	Determination of HLAB5701 status by molecular techniques or cytotoxity assay prior to the initiation of Abacavir therapy including item 71203 if performed.
73323	01NOV2008	31DEC9999	Y	Determination of HLAB5701 status by molecular techniques prior to the initiation of Abacavir therapy including item 71203 if performed.
73324	01NOV2008	31DEC9999	Y	A test described in item 73323 if rendered by a receiving APP 1 or more tests (Item is subject to Rule 18)
73325	01JUL2011	30JUN2022	N	Characterisation of mutations in: (a) the JAK2 gene; or (b) the MPL gene; or (c) both genes; in the diagnostic work-up, by, or on behalf of, the specialist or consultant physician, of a patient with clinical and laboratory evidence of: a) polycythaemia vera; or b) essential thrombocythaemia; 1 or more tests
73325	01JUL2022	31DEC9999	Y	Determination of JAK2 V617F variant allele frequency in the diagnostic work-up by, or on behalf of, a specialist or consultant physician, for a patient with clinical and laboratory evidence of a myeloproliferative neoplasm
73326	01JUL2011	31DEC9999	Y	Characterisation of the gene rearrangement FIP1L1-PDGFRA in the diagnostic work-up and management of a patient with laboratory evidence of: a) mast cell disease; or b) idiopathic hypereosinophilic syndrome; or c) chronic eosinophilic leukaemia;. 1 or more tests
73327	01JUL2011	31DEC9999	Y	Detection of genetic polymorphisms in the Thiopurine S-methyltransferase gene for the prevention of dose-related toxicity during treatment with thiopurine drugs; including (if performed) any service described in item 65075. 1 or more tests
73328	01MAY2012	31DEC9999	Y	A test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to gefitinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73330	01MAY2012	31DEC9999	Y	A test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73332	01MAY2012	30NOV2012	N	An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer (other than in the neoadjuvant setting) requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene mutation status for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled.
73332	01DEC2012	31DEC9999	Y	An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer requested by, or on the advice of, a specialist or consultant physician who manages the treatment of the patient to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene amplification for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled.
73333	01NOV2012	30JAN2023	N	Detection of germline mutations of the von Hippel-Lindau (VHL) gene: (a) in a patient who has a clinical diagnosis of VHL syndrome and: (i) a family history of VHL syndrome and one of the following: (A) haemangioblastoma (retinal or central nervous system); (B) phaeochromocytoma; (C) renal cell carcinoma; or (i) 2 or more haemangioblastomas; or (ii) one haemangioblastoma and a tumour or a cyst of: (A) the adrenal gland; or (B) the kidney; or (C) the pancreas; or (D) the epididymis; or (E) a broad ligament (other than epididymal and single renal cysts, which are common in the general population); or (a) in a patient presenting with one or more of the following clinical features suggestive of VHL syndrome: (i) haemangioblastomas of the brain, spinal cord, or retina; (ii) phaeochromocytoma; (iii) functional extra-adrenal paraganglioma
73333	31JAN2023	31DEC9999	Y	Detection of germline mutations of the von Hippel-Lindau (VHL) gene: (a) in a patient who has a clinical diagnosis of VHL syndrome and: (i) a family history of VHL syndrome and one of the following: (A) haemangioblastoma (retinal or central nervous system); (B) phaeochromocytoma; (C) renal cell carcinoma; or (ii) 2 or more haemangioblastomas; or (iii) one haemangioblastoma and a tumour or a cyst of: (A) the adrenal gland; or (B) the kidney; or (C) the pancreas; or (D) the epididymis; or (E) a broad ligament (other than epididymal and single renal cysts, which are common in the general population); or (b) in a patient presenting with one or more of the following clinical features suggestive of VHL syndrome: (i) haemangiblastomas of the brain, spinal cord, or retina; (ii) phaeochromocytoma; (iii) functional extra-adrenal paraganglioma
73334	01NOV2012	31DEC9999	Y	Detection of germline mutations of the von Hippel-Lindau (VHL) gene in biological relatives of a patient with a known mutation in the VHL gene
73335	01NOV2012	31DEC9999	Y	Detection of somatic mutations of the von Hippel-Lindau (VHL) gene in a patient with: (a) 2 or more tumours comprising: (i) 2 or more haemangioblastomas, or (ii) one haemangioblastoma and a tumour of: (A) the adrenal gland; or (B) the kidney; or (C) the pancreas; or (D) the epididymis; and (b) no germline mutations of the VHL gene identified by genetic testing
73336	01DEC2013	30APR2017	N	A test of tumour tissue from a patient with unresectable stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib under Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73336	01MAY2017	31OCT2019	N	A test of tumour tissue from a patient with unresectable stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib or vemurafenib under the Pharmaceutical Benefits Scheme are fulfilled.
73336	01NOV2019	31MAR2020	N	A test of tumour tissue from a patient with stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib or vemurafenib under the Pharmaceutical Benefits Scheme are fulfilled.
73336	01APR2020	31DEC9999	Y	A test of tumour tissue from a patient with stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib, vemurafenib or encorafenib under the Pharmaceutical Benefits Scheme are fulfilled.
73337	01JAN2014	30JUN2018	N	A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to erlotinib or gefitinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73337	01JUL2018	31DEC2020	N	A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to erlotinib, gefitinib or afatinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73337	01JAN2021	31OCT2021	N	A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to an EGFR tyrosine kinase inhibitor listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73337	01NOV2021	31OCT2022	N	A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine: if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to an EGFR tyrosine kinase inhibitor under the Pharmaceutical Benefits Scheme are fulfilled; or if the requirements relating to EGFR status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled.
73337	01NOV2022	31OCT2023	N	A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine: if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to an EGFR tyrosine kinase inhibitor under the Pharmaceutical Benefits Scheme are fulfilled; or if the requirements relating to EGFR status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme are fulfilled.
73337	01NOV2023	31DEC9999	Y	A test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) to determine if requirements relating to epidermal growth factor receptor (EGFR) gene status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled; and (b) not associated with a service to which item 73437 or 73438 applies
73338	01APR2014	31DEC2014	N	A test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab or panitumumab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73338	01JAN2015	31DEC2021	N	A test of tumour tissue from a patient with metastatic colorectal cancer (stage IV), requested by a specialist or consultant physician, to determine if the requirements relating to rat sarcoma oncogene (RAS) gene mutation status for access to cetuximab or panitumumab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled, if: (a) the test is conducted for all clinically relevant mutations on KRAS exons 2, 3 and 4 and NRAS exons 2, 3, and 4; or (b) a RAS mutation is found.
73338	01JAN2022	31DEC9999	Y	A test of tumour tissue from a patient with metastatic colorectal cancer (stage IV), requested by a specialist or consultant physician, to determine if: (a) requirements relating to rat sarcoma oncogene (RAS) gene variant status for access to cetuximab or panitumumab under the Pharmaceutical Benefits Scheme are fulfilled, if: the test is conducted for all clinically relevant mutations on KRAS exons 2, 3 and 4 and NRAS exons 2, 3, and 4; or a clinically-relevant RAS variant is detected; and, in cases where no RAS variant is detected (b) the requirements relating to BRAF V600 gene variant status for access to encorafenib under the Pharmaceutical Benefits Scheme are fulfilled.
73339	01NOV2014	31DEC9999	Y	Detection of germline mutations in the RET gene in patients with a suspected clinical diagnosis of multiple endocrine neoplasia type 2 (MEN2) requested by a specialist or consultant physician who manages the treatment of the patient. One test. (Item is subject to rule 25)
73340	01NOV2014	31DEC9999	Y	Detection of a known mutation in the RET gene in an asymptomatic relative of a patient with a documented pathogenic germline RET mutation requested by a specialist or consultant physician who manages the treatment of the patient. One test. (Item is subject to rule 25)
73341	01JUL2015	31JAN2017	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.
73341	01FEB2017	05FEB2018	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib or ceritinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled
73341	06FEB2018	30APR2020	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib, ceritinib or alectinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled
73341	01MAY2020	31OCT2021	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to an anaplastic lymphoma kinase inhibitor under the Pharmaceutical Benefits Scheme (PBS) are fulfilled
73341	01NOV2021	31OCT2022	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician, to determine: if requirements relating to ALK gene rearrangement status for access to an anaplastic lymphoma kinase inhibitor under the Pharmaceutical Benefits Scheme are fulfilled; or if requirements relating to ALK status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled.
73341	01NOV2022	31OCT2023	N	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician, to determine: if requirements relating to ALK gene rearrangement status for access to an anaplastic lymphoma kinase inhibitor under the Pharmaceutical Benefits Scheme are fulfilled; or if requirements relating to ALK status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme are fulfilled.
73341	01NOV2023	31DEC9999	Y	Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with a new diagnosis of locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician, if the test is: (a) to determine if requirements relating to ALK gene rearrangement status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled; and (b) not associated with a service to which item 73437 or 73439 applies
73342	01JAN2016	31DEC9999	Y	An in situ hybridisation (ISH) test of tumour tissue from a patient with metastatic adenocarcinoma of the stomach or gastro-oesophageal junction, with documented evidence of human epidermal growth factor receptor 2 (HER2) overexpression by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+ on the same tumour tissue sample, requested by, or on the advice of, a specialist or consultant physician who manages the treatment of the patient to determine if the requirements relating to HER2 gene amplification for access to trastuzumab under the Pharmaceutical Benefits Scheme are fulfilled.
73343	01SEP2017	30NOV2017	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib on the Pharmaceutical Benefits Scheme are fulfilled.
73343	01DEC2017	28FEB2019	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib or ibrutinib on the Pharmaceutical Benefits Scheme are fulfilled.
73343	01MAR2019	31AUG2020	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib, ibrutinib or venetoclax on the Pharmaceutical Benefits Scheme are fulfilled.
73343	01SEP2020	31OCT2021	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib, ibrutinib, venetoclax or acalabrutinib on the Pharmaceutical Benefits Scheme are fulfilled.
73343	01NOV2021	30JUN2023	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation or genome wide micro-array, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib, ibrutinib, venetoclax or acalabrutinib on the Pharmaceutical Benefits Scheme are fulfilled. For any particular patient, applicable not more than once in 12 months.
73343	01JUL2023	31OCT2023	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation or genome wide micro-array, in a patient with chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node sample, requested by a specialist or consultant physician. For any particular patient at initial diagnosis, at disease relapse, or on disease progression only where initiation of, or change in therapy is anticipated.
73343	01NOV2023	31OCT2024	N	Detection of 17p chromosomal deletions by fluorescence in situ hybridisation or genome wide micro-array, in a patient with chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node sample, requested by a specialist or consultant physician For any particular patient: (a) at initial diagnosis; or (b) at disease relapse; or (c) on disease progression; but only where initiation of, or change in, therapy is anticipated
73343	01NOV2024	31DEC9999	Y	Detection of 17p chromosomal deletions, in a patient with chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node sample, requested by a specialist or consultant physician For any particular patient: (a) at initial diagnosis; or (b) at disease relapse; or (c) on disease progression; but only where initiation of, or change in, therapy is anticipated
73344	01JAN2019	31JUL2020	N	Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer (NSCLC), which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician to determine if requirements relating to ROS1 gene rearrangement status for access to crizotinib under the Pharmaceutical Benefits Scheme are fulfilled.
73344	01AUG2020	31OCT2021	N	Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer (NSCLC), which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician to determine if requirements relating to ROS1 gene rearrangement status for access to crizotinib or entrectinib under the Pharmaceutical Benefits Scheme are fulfilled.
73344	01NOV2021	31OCT2022	N	Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician, to determine: if requirements relating to ROS1 gene arrangement status for access to crizotinib or entrectinib under the Pharmaceutical Benefits Scheme are fulfilled; or if requirements relating to ROS1 status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled.
73344	01NOV2022	31OCT2023	N	Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician, to determine: if requirements relating to ROS1 gene arrangement status for access to crizotinib or entrectinib under the Pharmaceutical Benefits Scheme are fulfilled; or if requirements relating to ROS1 status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme are fulfilled.
73344	01NOV2023	31DEC9999	Y	Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with a new diagnosis of locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician, if the test is: (a) to determine if requirements relating to ROS1 gene arrangement status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled: and (b) not associated with a service to which item 73437 or 73439 applies
73345	01JUL2018	31DEC9999	Y	Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of investigating, making or excluding a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73347, 73348, or 73349 applies. The patient must have clinical or laboratory findings suggesting there is a high probability suggestive of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder.
73346	01JUL2018	31DEC9999	Y	Testing of a pregnant patient whose carrier status for pathogenic cystic fibrosis transmembrane conductance regulator variants, as well as their reproductive partner carrier status is unknown, for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus, in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73350 applies. The fetus must have ultrasonic findings of echogenic gut, with unknown familial cystic fibrosis transmembrane conductance regulator variants.
73347	01JUL2018	31DEC9999	Y	Testing of a prospective parent for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the risk of their fetus having pathogenic cystic fibrosis transmembrane conductance regulator variants. This is indicated when the fetus has ultrasonic evidence of echogenic gut when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73348, or 73349 applies.
73348	01JUL2018	31DEC2019	N	Testing of a patient with a laboratory-established family history of pathogenic cystic fibrosis transmembrane conductance regulator variants, for the purpose of determining whether the patient is an asymptomatic genetic carrier of the pathogenic cystic fibrosis transmembrane conductance regulator variants that have been laboratory established in the family history when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73347, or 73349 applies. The patient must have a positive family history, confirmed by laboratory findings of pathogenic cystic fibrosis transmembrane conductance regulator variants, with a personal risk of being a heterozygous genetic carrier of at least 6%. (This includes family relatedness of: parents, children, full-siblings, half-siblings, grand-parents, grandchildren, aunts, uncles, first cousins, and first cousins once-removed, but excludes relatedness of second cousins or more distant relationships).
73348	01JAN2020	31DEC9999	Y	Testing of a patient with a laboratory-established family history of pathogenic cystic fibrosis transmembrane conductance regulator variants, for the purpose of determining whether the patient is an asymptomatic genetic carrier of the pathogenic cystic fibrosis transmembrane conductance regulator variants that have been laboratory established in the family history, not being a service associated with a service to which item 73345, 73347, or 73349 applies. The patient must have a positive family history, confirmed by laboratory findings of pathogenic cystic fibrosis transmembrane conductance regulator variants, with a personal risk of being a heterozygous genetic carrier of at least 6%. (This includes family relatedness of: parents, children, full-siblings, half-siblings, grand-parents, grandchildren, aunts, uncles, first cousins, and first cousins once-removed, but excludes relatedness of second cousins or more distant relationships).
73349	01JUL2018	31DEC9999	Y	Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the reproductive risk of the patient with their reproductive partner because their reproductive partner is already known to have pathogenic cystic fibrosis transmembrane conductance regulator variants requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73347, or 73348 applies.
73350	01JUL2018	31DEC9999	Y	Testing of a pregnant patient, where one or both prospective parents are known to be a genetic carrier of pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus, when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73346 applies. The fetus must be at 25% or more risk of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder because of known familial cystic fibrosis transmembrane conductance regulator variants.
73351	01FEB2019	31DEC9999	Y	A test of tumour tissue that is derived from a new sample from a patient with locally advanced (Stage IIIb) or metastatic (Stage IV) non-small cell lung cancer (NSCLC), who has progressed on or after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI). The test is to be requested by a specialist or consultant physician, to determine if the requirements relating to EGFR T790M gene status for access to osimertinib under the Pharmaceutical Benefits Scheme are fulfilled.
73352	01MAY2020	31DEC9999	Y	Characterisation of germline variants causing familial hypercholesterolaemia (which must include the LDLR, PCSK9 and APOB genes), requested by a specialist or consultant physician, for a patient: (a) for whom no familial mutation has been identified; and (b) who has any of the following: (i) a Dutch Lipid Clinic Network score of at least 6; (ii) an LDL-cholesterol level of at least 6.5 mmol/L in the absence of secondary causes; (iii) an LDL-cholesterol level of between 5.0 and 6.5 mmol/L with signs of premature or accelerated atherogenesis Applicable only once per lifetime
73353	01MAY2020	31DEC9999	Y	Detection of a familial mutation for a patient who has a first- or second-degree relative with a documented pathogenic germline gene variant for familial hypercholesterolaemia Applicable only once per lifetime
73354	01MAY2020	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation, in the MLH1, MSH2, MSH6, PMS2 and EPCAM genes, requested by a specialist or consultant physician, for:(a) a patient with suspected Lynch syndrome following immunohistochemical examination of neoplastic tissue that has demonstrated loss of expression of one or more mismatch repair proteins; or (b) a patient: (i) who has endometrial cancer; and (ii) who is assessed by the specialist or consultant physician as being at a risk of more than 10% of having Lynch syndrome, on the basis of clinical and family history criteria
73355	01MAY2020	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation, in the APC and MUTYH genes, requested by a specialist or consultant physician, for a patient: (a) who has adenomatous polyposis; and (b) who is assessed by the specialist or consultant physician as being at a risk of more than 10% of having either of the following, on the basis of clinical and family history criteria: (i) familial adenomatous polyposis; (ii) MUTYH-associated polyposis
73356	01MAY2020	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation, in the SMAD4, BMPR1A, STK11 and GREM1 genes, requested by a specialist or consultant physician, for a patient: (a) who has non-adenomatous polyposis; and (b) who is assessed by the specialist or consultant physician as being at a risk of more than 10% of having any of the following, on the basis of clinical and family history criteria: (i) juvenile polyposis syndrome; (ii) Peutz-Jeghers syndrome; (iii) hereditary mixed polyposis syndrome
73357	01MAY2020	28FEB2021	N	Characterisation of germline gene variants, including copy number variation, in the genes mentioned in item 73354, 73355 or 73356, requested by a specialist or consultant physician, for a patient: (a) who has a first-degree relative with a pathogenic mutation identified in one or more of those genes; and (b) who has not previously received a service to which any of items 73354, 73355 and 73356 apply
73357	01MAR2021	31DEC9999	Y	Characterisation of germline gene variants, including copy number variation, in the genes mentioned in item 73354, 73355 or 73356, requested by a specialist or consultant physician, for a patient: (a) who has a biological relative with a pathogenic mutation identified in one or more of those genes; and (b) who has not previously received a service to which any of items 73354, 73355 and 73356 apply
73358	01MAY2020	31DEC9999	Y	Characterisation, via whole exome or genome sequencing and analysis, of germline variants known to cause monogenic disorders, if: (a) the characterisation is: (i) requested by a consultant physician practising as a clinical geneticist; or (ii) requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and (b) the patient is aged 10 years or younger and is strongly suspected of having a monogenic condition, based on the presence of: (i) dysmorphic facial appearance and one or more major structural congenital anomalies; or (ii) intellectual disability or global developmental delay of at least moderate severity, as determined by a specialist paediatrician; and (c) the characterisation is performed following the performance for the patient of a service to which item 73292 applies for which the results were non-informative; and (d) the characterisation is not performed in conjunction with a service to which item 73359 applies Applicable only once per lifetime
73359	01MAY2020	31DEC9999	Y	Characterisation, via whole exome or genome sequencing and analysis, of germline variants known to cause monogenic disorders, if: (a) the characterisation is: (i) requested by a consultant physician practising as a clinical geneticist; or (ii) requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and (b) the request for the characterisation states that singleton testing is inappropriate; and (c) the patient is aged 10 years or younger and is strongly suspected of having a monogenic condition, based on the presence of: (i) dysmorphic facial appearance and one or more major structural congenital anomalies; or (ii) intellectual disability or global developmental delay of at least moderate severity, as determined by a specialist paediatrician; and (d) the characterisation is performed following the performance for the patient of a service to which item 73292 applies for which the results were non-informative; and (e) the characterisation is performed using a sample from the patient and a sample from each of the patients biological parents; and (f) the characterisation is not performed in conjunction with a service to which item 73358 applies Applicable only once per lifetime
73360	01MAY2020	31DEC9999	Y	Re-analysis of whole exome or genome data obtained in performing a service to which item 73358 or 73359 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if: (a) the re-analysis is: (i) requested by a consultant physician practising as a clinical geneticist; or (ii) requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and (b) the patient is aged 15 years or younger and is strongly suspected of having a monogenic condition; and (c) the re-analysis is performed at least 18 months after: (i) a service to which item 73358 or 73359 applies; or (ii) a service to which this item applies Applicable only twice per lifetime
73361	01MAY2020	31OCT2021	N	Detection of a single gene variant for diagnostic purposes, if: (a) the detection is: (i) requested by a consultant physician practising as a clinical geneticist; or (ii) requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and (b) the patient has a biological sibling with a known monogenic condition; and (c) a service to which item 73358, 73359 or 73360 applies has identified the causative variant for the siblings condition; and (d) the results of the testing performed for the sibling are made available for the purpose of providing the detection for the patient; and (e) the detection is not performed in conjunction with a service to which item 73362 or 73363 applies Applicable only once per variant per lifetime
73361	01NOV2021	31DEC9999	Y	Testing of a person (the person tested) for the detection of a single gene variant for diagnostic purposes, if: the person tested has a biological sibling (the sibling) with a known monogenic condition; and a service described in item 73358, 73359 or 73360 has identified the causative variant for the siblings condition; and the results of the testing performed for the sibling are made available for the purpose of providing the detection for the person tested; and the detection is: requested by a consultant physician practising as a clinical geneticist; or requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and the detection is not performed in conjunction with a service to which item 73362 or 73363 applies Applicable only once per variant per lifetime
73362	01MAY2020	31OCT2021	N	Detection of a single gene variant for the purpose of reproductive decision making, if: (a) the detection is requested by a consultant physician or specialist; and (b) the patient has a first-degree relative with a known monogenic condition; and (c) a service to which item 73358, 73359 or 73360 applies has identified the causative variant for the relative; and (d) the results of the testing performed for the relative are made available for the purpose of providing the detection for the patient; and (e) the detection is not performed in conjunction with item 73361 or 73363 Applicable only once per variant per lifetime
73362	01NOV2021	31DEC9999	Y	Testing of a person (the person tested) for the detection of a single gene variant for the purpose of reproductive decision making, if: the person tested has a first-degree relative (the relative) with a known monogenic condition; and a service described in item 73358, 73359 or 73360 has identified the causative variant for the relatives condition; and the results of the testing performed for the relative are made available for the purpose of providing the detection for the person tested; and the detection is requested by a consultant physician or specialist; and the detection is not performed in conjunction with item 73359, 73361 or 73363 Applicable only once per variant per lifetime
73363	01MAY2020	31OCT2021	N	Detection of a single gene variant for segregation purposes in relation to a person, if: (a) the detection is: (i) requested by a consultant physician practising as a clinical geneticist; or (ii) requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and (b) the patient: (i) is a biological parent or other biological relative of the person and has a known phenotype of the person; or (ii) is a biological parent of the person and has a suspected monogenic condition; and (c) a sample has not previously been tested for the patient for a service to which item 73359 applies; and (d) a service to which item 73358, 73359 or 73360 applies has identified a potentially causative variant for the person; and (e) the results of the testing performed for the patient are made available for the purpose of providing the detection for the person; and (f) the detection is not performed in conjunction with item 73361 or 73362 Applicable only once per variant per lifetime
73363	01NOV2021	31DEC9999	Y	Testing of a person (the person tested) for the detection of a single gene variant for segregation analysis in relation to another person (the patient), if: the patient has a known phenotype of a suspected monogenic condition; and a service described in item 73358 or 73360 has identified a potentially causative variant for the patient; and the person tested is a biological parent or other biological relative of the patient; and a sample from the person tested has not previously been tested in relation to the patient for a service to which item 73359 applies; and the results of the testing of the person tested for this service are made available for the purpose of providing the detection for the patient; and the detection is: requested by a consultant physician practising as a clinical geneticist; or requested by a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist; and the detection is not performed in conjunction with item 73361 or 73362 Applicable only once per variant per lifetime
73364	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for: (i) the characterisation of MYC gene rearrangement; and (ii) if the results of the characterisation mentioned in subparagraph (i) are positive-the characterisation of either or both of BCL2 gene rearrangement and BCL6 gene rearrangement; and (b) is for a patient: (i) for whom MYC immunohistochemistry is non-negative; and (ii) with clinical or laboratory evidence, including morphological features, of diffuse large B-cell lymphoma or high grade B-cell lymphoma; and (c) is not performed in conjunction with item 73365 Applicable only once per lifetime
73365	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of MYC gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of Burkitt lymphoma; and (c) is not performed in conjunction with item 73364 Applicable only once per lifetime
73366	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of either or both of the following: (i) CCND1 gene rearrangement; (ii) CCND2 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of mantle cell lymphoma Applicable only once per lifetime
73367	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the presence of isochromosome 7q; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of hepatosplenic T-cell lymphoma Applicable only once per lifetime
73368	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of either or both of the following: (i) DUSP22 gene rearrangement; (ii) TP63 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of ALK negative anaplastic large cell lymphoma Applicable only once per lifetime
73369	01MAY2020	31DEC9999	Y	Analysis of blood or bone marrow, requested by a specialist or consultant physician, that: (a) is for the characterisation of either or both of the following: (i) TCL1A gene rearrangement; (ii) MTCP1 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of T-cell prolymphocytic leukaemia Applicable only once per lifetime
73370	01MAY2020	31DEC9999	Y	Analysis of blood or bone marrow, requested by a specialist or consultant physician, that: (a) is for the characterisation of the following: (i) chromosome translocations t(4;14), t(14;16), t(14;20); (ii) 1q gain; (iii) 17p deletion; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of plasma cell myeloma Applicable only once per lifetime
73371	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the detection of chromosome 1p/19q co-deletion; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of glial neoplasm with probable oligodendroglial component Applicable only once per lifetime
73372	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the identification of IDH1/2 pathological variant status; and (b) is for a patient with: (i) negative IDH1 (R132H) immunohistochemistry; and (ii) clinical or laboratory evidence, including morphological features, of glial neoplasm Applicable only once per lifetime
73373	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of MGMT promoter methylation status; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of glioblastoma Applicable only once per lifetime
73374	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of copy number changes, gene rearrangements, or other molecular changes in one of the following genes: (i) MDM2 CNV; (ii) FUS; (iii) DDIT3; (iv) EWSR1; (v) ETV6; (vi) NTRK1; (vii) NTRK3; (viii) COL1A1; (ix) PDGFB; (x) STAT6; (xi) PAX3; (xii) PAX7; (xiii) SS18; (xiv) BCOR; (xv) CIC; (xvi) HEY1; (xvii) ALK; (xviii) USP6; (xix) NR4A3; (xx) NCOA2; (xxi) FOXO1; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of sarcoma Applicable only once per lifetime
73375	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of copy number changes, gene rearrangements, or other molecular changes, in 2 or 3 of the genes mentioned in item 73374; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of sarcoma Applicable only once per lifetime
73376	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of copy number changes, gene rearrangements, or other molecular changes, in 4 or more of the genes mentioned in item 73374; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of sarcoma Applicable only once per lifetime
73377	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the detection of FOXL2.402C>G status; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of granulosa cell ovarian tumour Applicable only once per lifetime
73378	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of NUTM1 gene status at 15q14; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of midline NUT carcinoma Applicable only once per lifetime
73379	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of ETV6-NTRK3 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of secretory carcinoma of the breast Applicable only once per lifetime
73380	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of MAML2 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of mucoepidermoid carcinoma Applicable only once per lifetime
73381	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of ETV6-NTRK3 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of mammary analogue secretory carcinoma of the salivary gland Applicable only once per lifetime
73382	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of EWSR1 gene rearrangement, with or without PLAG1 gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of hyalinising clear cell carcinoma of the salivary gland Applicable only once per lifetime
73383	01MAY2020	31DEC9999	Y	Analysis of tumour tissue, requested by a specialist or consultant physician, that: (a) is for the characterisation of either or both of the following: (i) TFE3 gene rearrangement; (ii) TFEB gene rearrangement; and (b) is for a patient with clinical or laboratory evidence, including morphological features, of renal cell carcinoma Applicable only once per lifetime
73384	01NOV2021	31DEC9999	Y	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the pathology services table (see PR.7.1), of samples from the patient and (if relevant) the patients reproductive partner, for the purpose of providing an assay for pre-implantation genetic testing, requested by a specialist or consultant physician Applicable not more than once per patient episode per disorder (of a kind described in clause 2.7.3A (PR.7.1)) per reproductive relationship
73385	01NOV2021	30JUN2022	N	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the pathology services table (see PR.7.1), of embryonic tissue from a sample from one embryo, if the analysis is: (a) for the purpose of providing a pre-implantation genetic test; and (b) requested by a specialist or consultant physician; and (c) performed in the assisted reproductive treatment cycle in which the embryo was produced Applicable not more than once per embryo
73385	01JUL2022	31DEC9999	Y	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the Pathology Services Table (see PR.7.1), of embryonic tissue from a sample from one embryo, if: (a) the analysis is: (i) requested by a specialist or consultant physician; and (ii) for the purpose of providing a pre-implantation genetic test; and (iii) performed on an embryo that was produced in a single assisted reproductive treatment cycle; and (b) the service is not a service to which item 73386 or 73387 applies for the same assisted reproductive treatment cycle Applicable not more than once per embryo
73386	01NOV2021	30JUN2022	N	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the pathology services table (see PR.7.1), of embryonic tissue from samples from 2 embryos, if the analysis is: (a) for the purpose of providing a pre-implantation genetic test; and (b) requested by a specialist or consultant physician; and (c) performed in the assisted reproductive treatment cycle in which the embryos were produced Applicable not more than once per assisted reproductive treatment cycle, and not more than once for the 2 embryos tested
73386	01JUL2022	31DEC9999	Y	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the Pathology Services Table (see PR.7.1), of embryonic tissue from samples from 2 embryos, if: (a) the analysis is: (i) requested by a specialist or consultant physician; and (ii) for the purpose of providing a pre-implantation genetic test; and (iii) performed on embryos that were produced in a single assisted reproductive treatment cycle; and (b) the service is not a service to which item 73385 or 73387 applies for the same assisted reproductive treatment cycle Applicable not more than once per assisted reproductive treatment cycle for the 2 embryos tested
73387	01NOV2021	30JUN2022	N	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the pathology services table (see PR.7.1), of embryonic tissue from samples from 3 or more embryos, if the analysis is: (a) for the purpose of providing a pre-implantation genetic test; and (b) requested by a specialist or consultant physician; and (c) performed in the assisted reproductive treatment cycle in which the embryos were produced Applicable not more than once per assisted reproductive treatment cycle for the 3 or more embryos tested
73387	01JUL2022	31DEC9999	Y	Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A of the Pathology Services Table (see PR.7.1), of embryonic tissue from samples from 3 or more embryos, if: (a) the analysis is: (i) requested by a specialist or consultant physician; and (ii) for the purpose of providing a pre-implantation genetic test; and (iii) performed on embryos that were produced in a single assisted reproductive treatment cycle; and (b) the service is not a service to which item 73385 or 73386 applies for the same assisted reproductive treatment cycle Applicable not more than once per assisted reproductive treatment cycle for the 3 or more embryos tested
73388	01NOV2021	31DEC9999	Y	Analysis of chromosomes by genome-wide microarray, of a sample from amniocentesis or chorionic villus sampling, including targeted assessment of specific regions for constitutional genetic abnormalities in diagnostic studies of a fetus, if one or more major fetal structural abnormalities have been detected on ultrasound; or nuchal translucency was greater than 3.5 mm Applicable only once per fetus
73389	01NOV2021	31DEC9999	Y	Analysis of products of conception from a patient with suspected hydatidiform mole for the characterisation of ploidy status Applicable once per pregnancy
73391	01NOV2021	31DEC9999	Y	Analysis of chromosomes by genome-wide microarray in diagnostic studies of a patient with multiple myeloma Applicable once per lifetime
73392	01JUL2022	31DEC9999	Y	Characterisation of pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician: (a) in at least the following genes: (i) MYBPC3; (ii) MYH7; (iii) TNNI3; (iv) TNNT2; (v) TPM1; (vi) ACTC1; (vii) MYL2; (viii) MYL3; (ix) PRKAG2; (x) LAMP2; (xi) GLA; (xii) LMNA; (xiii) SCN5A; (xiv) TTN; (xv) RBM20; (xvi) PLN; (xvii) DSP; (xviii) DSC2; (xix) DSG2; (xx) JUP; (xxi) PKP2; (xxii) TMEM43; and (b) for a patient for whom clinical history, family history or laboratory findings suggest there is a high probability of one or more of the following heritable cardiomyopathies in the patient: (i) hypertrophic cardiomyopathy; (ii) dilated cardiomyopathy; (iii) arrhythmogenic cardiomyopathy Applicable once per lifetime
73393	01JUL2022	31DEC9999	Y	Characterisation of one or more pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician, if: (a) a service described in item 73392 has not previously been performed for the patient; and (b) the patient is a first-degree biological relative (or a second-degree biological relative if a first-degree biological relative is unavailable) of a person who has a pathogenic or likely pathogenic germline gene variant that is confirmed by laboratory findings; and (c) the service is performed for the purpose of assessing present or future risk of any of the following heritable cardiomyopathies in the patient: (i) hypertrophic cardiomyopathy; (ii) dilated cardiomyopathy; (iii) arrhythmogenic cardiomyopathy Applicable once per variant per lifetime
73394	01JUL2022	31DEC9999	Y	Characterisation of one or more recessive pathogenic or likely pathogenic germline genes, requested by a specialist or consultant physician, for the purpose of determining the reproductive risk of heritable cardiomyopathy in a patient: (a) who is a reproductive partner of a known carrier of a pathogenic or likely pathogenic germline gene that is confirmed by laboratory findings ; and (b) for whom carrier status of a pathogenic or likely pathogenic germline gene is unknown; and (c) who has a clinical history, family history or laboratory findings suggesting there is a low probability of heritable cardiomyopathy Applicable once per gene per lifetime
73395	01JUL2022	31DEC9999	Y	Re-analysis of whole exome or genome data that is obtained in performing a service to which item 73392 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if: (a) the re-analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and (b) the patient is strongly suspected of having a heritable cardiomyopathy; and (c) the re-analysis is performed at least 18 months after a service to which item 73392 or this item applies is performed for the patient Applicable twice per lifetime
73396	01JUL2022	31DEC9999	Y	Characterisation of variants in the JAK2 exon 12 in the diagnostic work-up of a patient with clinical and laboratory evidence of polycythaemia vera, requested by a specialist or consultant physician
73397	01JUL2022	31DEC9999	Y	Characterisation of variants in both the CALR and MPL genes in the diagnostic work-up of a patient with clinical and laboratory evidence of essential thrombocythaemia or primary myelofibrosis, requested by a specialist or consultant physician
73398	01JUL2022	31DEC9999	Y	Characterisation of variants in at least 8 genes, which must include all of the following genes: (a) JAK2 (including exons 12 and 14); (b) CALR; (c) MPL; in the diagnostic work-up of a patient with clinical and laboratory evidence of polycythaemia vera or essential thrombocythaemia, requested by a specialist or consultant physician Applicable to one test per diagnostic episode
73399	01JUL2022	31DEC9999	Y	Characterisation of variants in at least 20 genes, which must include all of the following genes: (a) JAK2 (including exons 12 and 14); (b) CALR; (c) MPL; in the diagnostic work-up of a patient, with clinical and laboratory evidence of primary myelofibrosis, who is eligible for a stem cell transplant, requested by a specialist or consultant physician Applicable to one test per diagnostic episode
73401	01JUL2022	31DEC9999	Y	Characterisation, by whole exome or genome sequencing and analysis, of germline gene variants in one or more of the genes implicated in heritable cystic kidney disease, if: (a) the service is requested by a consultant physician practising as: (i) a clinical geneticist; or (ii) a specialist nephrologist; and (b) the patient has a renal abnormality and is strongly suspected of having a monogenic condition Applicable once per lifetime
73402	01JUL2022	31DEC9999	Y	Characterisation, by whole exome or genome sequencing and analysis, of germline gene variants in one or more of the genes implicated in heritable kidney disease, if: (a) the service is requested by a consultant physician practising as: (i) a clinical geneticist; or (ii) a specialist nephrologist; and (b) the patient has chronic kidney disease (other than cystic disease or Alport syndrome) and is strongly suspected of having a monogenic condition Applicable once per lifetime
73403	01JUL2022	31DEC9999	Y	Re-analysis of genetic data obtained in performing a service to which item 73401 or 73402 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if: (a) the re-analysis is requested by a consultant physician practising as a clinical geneticist or a specialist paediatrician; and (b) the patient has a strong clinical suspicion of a monogenic condition; and (c) a service to which item 73401, 73402 or this item applies has not been performed for the patient in the previous 18 months Applicable twice per lifetime
73404	01JUL2022	31DEC9999	Y	Detection of a single gene variant in a patient, if: (a) the service is requested by: (i) a clinical geneticist; or (ii) a specialist or consultant physician providing professional genetic counselling services; and (b) the patient has a first-degree relative with a known monogenic cause of kidney disease; and (c) a service described in item 73401, 73402, or 73403 has identified the causative variant for the disease for the relative Applicable once per variant per lifetime
73405	01JUL2022	31DEC9999	Y	Detection of one or more variants of a single gene known to cause heritable kidney disease, for the purpose of reproductive decision making, if: (a) the detection is requested by a consultant physician practising as: (i) a clinical geneticist; or (ii) a specialist nephrologist; and (b) the patient is the reproductive partner of an individual known to be a carrier of a pathogenic variant that causes heritable kidney disease that has a recessive mode of inheritance; and (c) a service described in item 73401, 73402, 73403 or 73404 has identified the causative gene for the patients partner; and (d) the detection test methodology has sufficient diagnostic range and sensitivity to detect at least 95% of pathogenic variants likely to be present in the patient
73406	01JUL2022	31DEC9999	Y	Testing of a pregnant patient, for the purpose of determining whether monogenic variants are present in the fetus, if: (a) the service is requested by a consultant physician practising as: (i) a clinical geneticist; or (ii) a specialist nephrologist; and (b) the patient or the patients reproductive partner (or both) are known to be affected by, or are carriers of, a known pathogenic variant that causes heritable kidney disease; and (c) the fetus is at risk, of at least 25%, of inheriting a monogenic variant known to cause kidney disease
73410	01JUL2022	31OCT2022	N	Deletion testing of HBA1 and HBA2 for: (a) the diagnosis of alpha thalassaemia in a patient of reproductive age: (i) who has abnormal red cell indices; and (ii) for whom thalassaemia screening for beta-thalassaemia was not conclusive; and (iii) who does not have a concurrent iron deficiency (or who, irrespective of iron status, is pregnant); and (iv) who has no historic normal cell indices; or (b) the determination of carrier status in a person: (i) who is a reproductive partner of a person of child-bearing potential with diagnosed alpha thalassaemia; and (ii) who has abnormal red cell indices; and (iii) who does not have a concurrent iron deficiency (See para PN.7.5 of explanatory notes to this Category)
73410	01NOV2022	30JUN2024	N	Deletion testing of HBA1 and HBA2 for: (a) the diagnosis of alpha thalassaemia in a patient of reproductive age: (i) who has abnormal red cell indices; and (ii) for whom thalassaemia screening was suggestive of thalassaemia; and (iii) who does not have a concurrent iron deficiency (or who, irrespective of iron status, is pregnant); and (iv) who has no historic normal cell indices; or (b) the determination of carrier status in a person: (i) who is a reproductive partner of a person of child-bearing potential with diagnosed alpha thalassaemia; and (ii) who has abnormal red cell indices; and (iii) who does not have a concurrent iron deficiency (See para PN.7.5 of explanatory notes to this Category)
73410	01JUL2024	31DEC9999	Y	Deletion testing of HBA1 and HBA2 for: (a) the diagnosis of alpha thalassaemia in a patient of reproductive age: (i) who has abnormal red cell indices; and (ii) for whom thalassaemia screening was suggestive of thalassaemia; and (iii) who does not have a concurrent iron deficiency (or who, irrespective of iron status, is pregnant); and (iv) who has no historic normal cell indices; or (b) the determination of carrier status in a person: (i) who is a reproductive partner of a person with alpha thalassaemia; and (ii) who has abnormal red cell indices; and (iii) who does not have a concurrent iron deficiency; or (c) the determination of carrier status in a person: (i) who is a reproductive partner of a person with alpha thalassaemia and heterozygous 2-gene deletion; and (ii) who has normal red cell indices
73411	01JUL2022	30JUN2024	N	Sequencing of HBA1 or HBA2, if the results of deletion testing described in item 73410 were inconclusive and a less common or rare variant is suspected, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or (b) for the determination of carrier status in a reproductive partner of a person of child-bearing potential with diagnosed alpha thalassaemia Applicable once per gene per lifetime
73411	01JUL2024	31DEC9999	Y	Sequencing of HBA1 or HBA2, if the results of deletion testing described in item 73410 were inconclusive and a less common or rare variant is suspected, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or (b) for the determination of carrier status in a reproductive partner of a person with alpha thalassaemia Applicable once per gene per lifetime
73412	01JUL2022	30JUN2024	N	Deletion testing of HBA1 and HBA2, if the results of deletion testing described in item 73410 were inconclusive and a large deletion variant is suspected, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or (b) for the determination of carrier status in a reproductive partner of a person of child-bearing potential with diagnosed alpha thalassaemia
73412	01JUL2024	31DEC9999	Y	Deletion testing of HBA1 and HBA2, if the results of deletion testing described in item 73410 were inconclusive and a large deletion variant is suspected, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or (b) for the determination of carrier status in a reproductive partner of a person with alpha thalassaemia
73413	01JUL2022	30JUN2024	N	Non-deletion testing of HBA1 and HBA2 using techniques other than sequencing, if the results of deletion testing described in item 73410 were inconclusive, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age ; or (b) for the determination of carrier status in a reproductive partner of a person of child-bearing potential with diagnosed alpha thalassaemia
73413	01JUL2024	31DEC9999	Y	Non-deletion testing of HBA1 and HBA2 using techniques other than sequencing, if the results of deletion testing described in item 73410 were inconclusive, either: (a) for the diagnosis of alpha thalassaemia in a patient of reproductive age ; or (b) for the determination of carrier status in a reproductive partner of a person with alpha thalassaemia
73416	01JUL2022	31DEC9999	Y	Detection of germline gene variants, including copy number variation, requested by a specialist or consultant physician: (a) in at least the following genes: (i) KCNQ1; (ii) KCNH2; (iii) SCN5A; (iv) KCNE1; (v) KCNE2; (vi) KCNJ2; (vii) CACNA1C; (viii) RYR2; (ix) CASQ2; (x) CAV3; (xi) SCN4B; (xii) AKAP9; (xiii) SNTA1; (xiv) KCNJ5; (xv) ALG10; (xvi) CALM1; (xvii) CALM2; (xviii) ANK2; (xix) TECRL; (xx) TRDN; and (b) for a patient for whom clinical or family history criteria is suggestive of inherited cardiac arrhythmias or channelopathies that place the patient at greater than 10% risk of having a pathogenic variant Applicable once per lifetime
73417	01JUL2022	31DEC9999	Y	Characterisation of one or more pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician, if: (a) the patient is a first-degree or second-degree biological relative of a person with a pathogenic or likely pathogenic germline gene variant that is confirmed by laboratory findings; and (b) the service is performed for the purpose of assessing present or future risk of a cardiac arrhythmia or channelopathy; and (c) a service to which item 73416 applies has not previously been performed for the patient Applicable once per variant per lifetime
73418	01JUL2022	31OCT2023	N	Characterisation of one or more recessive pathogenic or likely pathogenic germline genes, requested by a specialist or consultant physician, for the purpose of determining the reproductive risk of cardiac arrhythmia or channelopathy in a patient: (a) who is a reproductive partner of a person who is a known carrier of a pathogenic or likely pathogenic germline gene variant of a gene confirmed by laboratory findings; and (b) for whom a service to which item 73416 applies has not previously been performed; and (c) for whom carrier status of a pathogenic or likely pathogenic germline gene variant is unknown; and (d) who has a clinical history, family history or laboratory findings suggesting there is a low probability of cardiac arrhythmia or channelopathy Applicable once per variant per lifetime
73418	01NOV2023	31DEC9999	Y	Characterisation of one or more recessive pathogenic or likely pathogenic germline genes, requested by a specialist or consultant physician, for the purpose of determining the reproductive risk of cardiac arrhythmia or channelopathy in a patient: (a) who is a reproductive partner of a person who is a known carrier of a pathogenic or likely pathogenic germline gene variant of a gene confirmed by laboratory findings; and (b) for whom a service to which item 73416 applies has not previously been performed; and (c) for whom carrier status of a pathogenic or likely pathogenic germline gene variant is unknown; and (d) who has a clinical history, family history or laboratory findings suggesting there is a low probability of cardiac arrhythmia or channelopathy Applicable once per gene per lifetime
73419	01JUL2022	31DEC9999	Y	Re-analysis of whole exome or genome data that was obtained in performing a service to which item 73416 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if: (a) the re-analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and (b) the patient is strongly suspected of having inheritable cardiac arrhythmia or channelopathies; and (c) the service is performed at least 18 months after a service to which item 73416 or this item applies was performed for the patient Applicable twice per lifetime
73420	01JUL2022	31OCT2024	N	Non-invasive prenatal testing of blood from an RhD negative pregnant patient for the detection of the RHD gene from fetal DNA circulating in maternal blood
73420	01NOV2024	31DEC9999	Y	Non-invasive prenatal testing of blood from an RhD negative pregnant patient for the detection of the RHD gene from fetal DNA circulating in maternal blood, if the patient has not been previously alloimmunised against RhD
73421	01JUL2022	31OCT2024	N	Non-invasive prenatal testing of blood from an RhD negative pregnant patient (in a singleton pregnancy) for the detection of the RHD gene from fetal DNA circulating in maternal blood, if the patient is alloimmunised with immune Anti-D
73421	01NOV2024	31DEC9999	Y	Non-invasive prenatal testing of blood from an RhD negative pregnant patient for the detection of the RHD gene from fetal DNA circulating in maternal blood, if the patient has been previously alloimmunised against RhD
73422	01NOV2022	31OCT2024	N	Characterisation of a gene variant or gene variants using a gene panel, in a patient presenting with clinical signs and symptoms suggestive of a genetic neuromuscular disorder (other than signs and symptoms associated with variants that are not detected by massively parallel sequencing), if the service is requested: (a) by a specialist or consultant physician; and (b) after exclusion of non-genetic causes Applicable once per lifetime
73422	01NOV2024	31DEC9999	Y	Characterisation of a gene variant or gene variants using a gene panel, in a patient presenting with clinical signs and symptoms suggestive of a genetic neuromuscular disorder (other than signs and symptoms associated with variants that are not detectable by massively parallel sequencing), if the service is requested: (a) by a specialist or consultant physician; and (b) after exclusion of non-genetic causes Applicable once per lifetime
73423	01NOV2022	31DEC9999	Y	Detection of a single identified gene variant, in a biological relative of a person with a germline gene variant for a neuromuscular disorder identified by a service described in item 73422, 73425 or 73426, if the service is requested by a specialist or consultant physician Applicable once per variant
73424	01NOV2022	31OCT2024	N	Prenatal detection of an actionable pathogenic familial gene variant or gene variants (including maternal cell contamination assessment), requested by a specialist or consultant physician, for a genetic neuromuscular disorder previously identified in an index person in the patients family as a result of a service described in item 73422 Applicable once per pregnancy
73424	01NOV2024	31DEC9999	Y	Prenatal detection of an actionable pathogenic familial gene variant or gene variants (including maternal cell contamination assessment), requested by a specialist or consultant physician, for a genetic neuromuscular disorder previously identified in an index person in the patients family as a result of a service described in item 73422, 73434 or 73435 Applicable once per pregnancy
73425	01NOV2022	31DEC9999	Y	Prenatal detection of unknown gene variants (including maternal cell contamination assessment) using a gene panel, if: (a) the service is requested: (i) by a specialist or consultant physician, for a suspected genetic neuromuscular disorder; and (ii) after exclusion of non-genetic causes; and (b) the service is performed using a sample from the fetus; and (c) the service is not performed in conjunction with a service to which item 73426 applies Applicable once per pregnancy
73426	01NOV2022	31DEC9999	Y	Prenatal detection of unknown gene variants (including maternal cell contamination assessment) using a gene panel, if: (a) the service is requested: (i) by a specialist or consultant physician; and (ii) for a suspected genetic neuromuscular disorder; and (iii) after exclusion of non-genetic causes; and (b) the request states that singleton testing is inappropriate; and (c) the service is performed using a sample from the fetus and a sample from each of the fetuss biological parents; and (d) the service is not performed in conjunction with a service to which item 73425 applies Applicable once per pregnancy
73427	01NOV2022	30JUN2023	N	Single gene testing for the characterisation of a germline gene variant or germline gene variants, if requested by a specialist or consultant physician, within the same gene in which the patients reproductive partner has a documented pathogenic germline recessive gene variant for a neuromuscular disorder identified by a service described in item 73422, 73425 or 73426 Applicable once per gene
73427	01JUL2023	31DEC9999	Y	Single gene testing for the characterisation of a germline gene variant or germline gene variants: (a) if requested by a specialist or consultant physician; and (b) within the same gene in which the patients reproductive partner has a documented pathogenic germline recessive gene variant for a neuromuscular disorder identified by a service described in: (i) item 73422, 73425 or 73426; or (ii) item 73434, if the patient has been provided a service described in item 73434 and that service has not identified a relevant variant Applicable once per gene
73428	01NOV2022	31DEC9999	Y	Re-analysis of whole genome or exome data obtained in performing a service described in item 73422, 73425 or 73426, for characterisation of previously unreported gene variants related to the clinical phenotype, if the re-analysis is requested by: (a) a consultant physician practicing as a clinical geneticist; or (b) a consultant physician practising as a specialist paediatrician, following consultation with a clinical geneticist Applicable twice per lifetime
73429	01JUL2023	31OCT2024	N	Genetic testing (including characterisation of single nucleotide variants, structural variants, fusions and copy number alterations) in a single gene panel, requested by a specialist or consultant physician, for a patient with clinical or laboratory evidence of a glioma, glioneuronal tumour or glioblastoma, to aid diagnosis and classification of the relevant tumour, including assessments of at least the following kinds: (a) IDH1, IDH2-variant testing; (b) 1p/19q-co-deletion assessment; (c) H3F3A-variant status; (d) TERT-promoter variant status; (e) EGFR-amplification; (f) CDKN2A/B-deletion; (g) BRAF-variants Applicable to one test per diagnostic episode
73429	01NOV2024	31DEC9999	Y	Genetic testing (including characterisation of single nucleotide variants, structural variants, fusions and copy number alterations) in a gene panel, requested by a specialist or consultant physician, for a patient with clinical or laboratory evidence of a glioma, glioneuronal tumour or glioblastoma, to aid diagnosis and classification of the relevant tumour, including assessments of at least the following kinds: (a) IDH1, IDH2-variant testing; (b) 1p/19q-co-deletion assessment; (c) H3F3A-variant status; (d) TERT-promoter variant status; (e) EGFR-amplification; (f) CDKN2A/B-deletion; (g) BRAF-variants Applicable to one test per diagnostic episode
73430	01JUL2022	31DEC9999	Y	Fluorescence in-situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic solid tumour, if: (a) the tumour is at risk of being caused by a neurotrophic receptor tyrosine kinase (NTRK) gene fusion as determined by either: (i) occurring in a child less than 18 years of age; or (ii) being mammary analogue secretory carcinoma of the salivary gland; or (iii) being secretory breast carcinoma; and (b) the test is requested by a specialist or consultant physician to determine if requirements relating to NTRK gene fusion status for access to a tropomyosin receptor kinase (Trk) inhibitor under the Pharmaceutical Benefits Scheme are fulfilled This item cannot be claimed if item 73433 has been claimed for the same patient during the same cancer diagnosis Applicable only once per cancer diagnosis
73431	01JUL2022	31DEC9999	Y	Two tests described in item 73430
73432	01JUL2022	31DEC9999	Y	Three or more tests described in item 73430
73433	01JUL2022	31DEC9999	Y	Next generation sequencing (NGS) test for neurotrophic receptor tyrosine kinase (NTRK1, NTRK2, NTRK3) fusions by RNA or DNA in tumour tissue from a patient with locally advanced or metastatic solid tumour, if: (a) the tumour is at risk of being caused by an NTRK gene fusion as determined by either: (i) occurring in a child less than 18 years of age; or (ii) being mammary analogue secretory carcinoma of the salivary gland; or (iii) being secretory breast carcinoma; (b) the test is requested by a specialist or consultant physician to determine if requirements relating to NTRK gene fusion status for access to a tropomyosin receptor kinase (Trk) inhibitor under the Pharmaceutical Benefits Scheme are fulfilled This item cannot be claimed if item 73430 has been claimed for the same patient during the same cancer diagnosis Applicable only once per cancer diagnosis
73434	01JUL2023	31OCT2024	N	Detection of pathogenic or likely pathogenic gene variants, requested by a specialist or consultant physician, for any of the following: (a) a patient with a suspected neuromuscular disorder; (b) a relative of a patient with a pathogenic or likely pathogenic germline gene variant associated with a neuromuscular disorder (confirmed by laboratory findings); (c) the reproductive partner of a patient with a recessive pathogenic or likely pathogenic germline gene variant associated with a neuromuscular disorder (confirmed by laboratory findings) Applicable once per gene per lifetime
73434	01NOV2024	31DEC9999	Y	Detection of pathogenic or likely pathogenic gene variants, requested by a specialist or consultant physician, for any of the following: (a) a patient with a suspected neuromuscular disorder, being a neuromuscular disorder with signs and symptoms associated with variants that are not detectable by massively parallel sequencing; (b) a relative of a patient with a pathogenic or likely pathogenic germline gene variant associated with a neuromuscular disorder (confirmed by laboratory findings); (c) the reproductive partner of a patient with a recessive pathogenic or likely pathogenic germline gene variant associated with a neuromuscular disorder (confirmed by laboratory findings) Applicable once per gene per lifetime
73435	01JUL2023	31DEC9999	Y	Detection of pathogenic or likely pathogenic DUX4 gene variants, requested by a specialist or consultant physician, for: (a) a patient with a suspected neuromuscular disorder; or (b) a relative of a patient with a pathogenic or likely pathogenic germline gene variant associated with a neuromuscular disorder (confirmed by laboratory findings) Applicable once per gene per lifetime
73436	01NOV2022	31OCT2023	N	A test of tumour tissue from a patient diagnosed with locally advanced or metastatic non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to MET proto-oncogene, receptor tyrosine kinase (MET) exon 14 skipping alterations (METex14sk) status for access to tepotinib are fulfilled under the Pharmaceutical Benefits Scheme
73436	01NOV2023	31DEC9999	Y	A test of tumour tissue from a patient with a new diagnosis of locally advanced or metastatic non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) to determine if the requirements relating to MET proto-oncogene, receptor tyrosine kinase (MET) exon 14 skipping alterations (METex14sk) status for access to an immunotherapy listed under the Pharmaceutical Benefits Scheme (PBS) are fulfilled: and (b) not associated with a service to which item 73437 or 73438 applies
73437	01NOV2023	31DEC9999	Y	A nucleic acid-based multi-gene panel test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) to detect variants in at least EGFR, BRAF, KRAS and MET exon 14 to determine access to specific therapies relevant to these variants listed on the Pharmaceutical Benefits Scheme (PBS); and (b) to detect the fusion status of at least ALK, ROS1, RET, NTRK1, NTRK2 and NTRK3; and (i) to determine access to specific therapies relevant to these variants listed on the PBS; or (ii) determine if the requirements relating to EGFR, ALK and ROS1 status for access immunotherapies listed on the PBS are fulfilled; and (c) not associated with a service to which item 73438, 73439, 73337, 73341, 73344, 73436 or 73351 applies
73438	01NOV2023	31DEC9999	Y	A DNA-based multi-gene panel test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) to detect variants in at least EGFR, BRAF, KRAS and MET exon 14; and (b) to determine access to specific therapies relevant to these variants listed on the Pharmaceutical Benefits Scheme (PBS); or (c) to determine if the requirements relating to EGFR status for access to immunotherapies listed on the PBS are fulfilled; and (d) not associated with a service to which item 73437, 73337, 73436 or 73351 applies
73439	01NOV2023	31DEC9999	Y	A nucleic acid-based multi-gene panel test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer and with documented absence of activating variants of the EGFR gene, KRAS, BRAF and MET exon14, requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) to determine the fusion status of at least ALK, ROS1, RET, NTRK1, NTRK2, and NTRK3 to determine access to specific therapies relevant to these variants listed on the Pharmaceutical Benefits Scheme (PBS) are fulfilled; or (b) to determine if the requirements relating to ALK and ROS1 status for access to immunotherapies listed on the PBS are fulfilled; and (c) not associated with a service to which item 73437, 73341, 73344 or 73351 applies
73440	01NOV2023	31DEC9999	Y	Genomic testing and copy number variant analysis of genes known to be causative or likely causative of childhood hearing loss in a patient, if:(a) the testing and analysis is requested by a specialist or consultant physician; and(b) the patient has congenital or childhood onset hearing loss that presented before the patient was 18 years of age and is permanent moderate, severe, or profound (>40 dB in the worst ear over 3 frequencies) and classified as sensorineural, auditory neuropathy or mixed; and(c) the patient is not eligible for a service to which item 73358 or 73359 applies; and(d) the testing and analysis is not associated with a service to which item 73441 applies Applicable once per lifetime
73441	01NOV2023	31OCT2024	N	Genomic testing and copy number variant analysis of relevant genes known to be causative or likely causative of childhood hearing loss in a patient, if:(a) the testing and analysis is requested by a specialist or consultant physician; and(b) the patient has congenital or childhood onset hearing loss that presented before the patient was 18 years of age and is permanent bilateral moderate, severe, or profound (>40 dB in the worst ear over 3 frequencies) and classified as sensorineural, auditory neuropathy or mixed; and(c) the testing and analysis is performed using a sample from the patient and a sample from each of the patients biological parents; and(d) the patient is not eligible for a service to which item 73358 or 73359 applies; and(e) the testing and analysis is not associated with a service to which item 73440 applies Applicable once per lifetime
73441	01NOV2024	31DEC9999	Y	Genomic testing and copy number variant analysis of relevant genes known to be causative or likely causative of childhood hearing loss in a patient, if:(a) the testing and analysis is requested by a specialist or consultant physician; and(b) the patient has congenital or childhood onset hearing loss that presented before the patient was 18 years of age and is permanent moderate, severe, or profound (>40 dB in the worst ear over 3 frequencies) and classified as sensorineural, auditory neuropathy or mixed; and(c) the testing and analysis is performed using a sample from the patient and a sample from each of the patients biological parents; and(d) the patient is not eligible for a service to which item 73358 or 73359 applies; and(e) the testing and analysis is not associated with a service to which item 73440 applies Applicable once per lifetime
73442	01NOV2023	31DEC9999	Y	Re-analysis of whole exome or genome data obtained under a service to which item 73440 or 73441 applies, for characterisation of previously unreported germline gene variants for childhood hearing loss in a patient, if:(a) the re-analysis is requested by a specialist or consultant physician; and(b) the re-analysis is performed at least 24 months after:(i) the service to which items 73440 or 73441 applies has been provided to the patient; or(ii) a service to which this item applies is performed for the patient Applicable twice per lifetime
73443	01NOV2023	31DEC9999	Y	Characterisation of one or more familial germline gene variants known to be causative or likely causative of childhood hearing loss in a person, if:(a) the person tested is a biological relative of a patient with a germline gene variant known to be causative or likely causative of hearing loss confirmed by laboratory findings; and(b) the result of a previous proband testing is made available to the laboratory undertaking the characterisation
73444	01NOV2023	31DEC9999	Y	Characterisation of all germline variants in one or more genes known to cause hearing loss in a person, if:(a) the characterisation is requested by a specialist or consultant physician; and(b) the characterisation is for the reproductive partner of a patient with a pathogenic or likely pathogenic recessive germline gene variant known to cause hearing loss confirmed by laboratory findings; and(c) the result of the patients previous testing is made available to the laboratory undertaking the characterisation
73445	01NOV2023	31DEC9999	Y	Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
73446	01NOV2023	31DEC9999	Y	Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
73447	01NOV2023	31DEC9999	Y	Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
73448	01NOV2023	31DEC9999	Y	Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
73451	01NOV2023	31OCT2024	N	Testing of a patient who is pregnant, or planning pregnancy, to identify carrier status for pathogenic or likely pathogenic variants in the following genes, for the purpose of determining reproductive risk of cystic fibrosis, spinal muscular atrophy or fragile X syndrome: CFTR; SMN1; FMR1 One test per lifetime.
73451	01NOV2024	31DEC2024	N	Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine: (a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene-reproductive risk of cystic fibrosis; (b) for the survival motor neuron 1 (SMN1) gene-reproductive risk of spinal muscular atrophy; (c) for the fragile X mental retardation 1 (FMR1) gene-reproductive risk of fragile X syndrome; (other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies) One test per lifetime
73451	01JAN2025	31DEC9999	Y	Testing of a patient (who is pregnant or planning pregnancy) to identify carrier status for pathogenic or likely pathogenic variants in a gene mentioned in paragraph (a), (b) or (c), to determine: (a) for the cystic fibrosis transmembrane conductance regulator (CFTR) gene-reproductive risk of cystic fibrosis; (b) for the survival motor neuron 1 (SMN1) gene-reproductive risk of spinal muscular atrophy; (c) for the fragile X messenger ribonucleoprotein 1 (FMR1) gene-reproductive risk of fragile X syndrome; (other than a service associated with a service to which item 73300, 73305, 73345, 73346, 73347, 73348, 73349 or 73350 applies) One test per lifetime
73452	01NOV2023	31DEC9999	Y	Testing of the reproductive partner of a patient who has been found to be a carrier of a pathogenic or likely pathogenic variant in the CFTR or SMN1 gene identified by testing under item 73451, for the purpose of determining the couples reproductive risk of cystic fibrosis or spinal muscular atrophy One test per condition per lifetime
73453	01NOV2023	31DEC9999	Y	Characterisation of germline pathogenic or likely pathogenic gene variants: (a) in at least the following genes: (i) ASPA; (ii) BLM; (iii) CFTR; (iv) ELP1; (v) FANCA; (vi) FANCC; (vii) FANCG; (viii) FMR1; (ix) G6PC1; (x) GBA1; (xi) HEXA; (xii) MCOLN1; (xiii) SLC37A4; (xiv) SMN1; (xv) SMPD1; and (b) in a patient of reproductive age who is of Ashkenazi Jewish descent for the purpose of ascertaining the patients carrier status for the following: (i) Bloom syndrome (ii) Canavan disease (iii) Cystic fibrosis (iv) Familial dysautonomia (v) Fanconi anaemia type C (vi) Fragile-X syndrome (vii) Gaucher disease (viii) Glycogen storage disease type I (ix) Mucolipidosis type IV (x) Niemann-Pick disease type A 7 (xi) Spinal muscular atrophy (xii) Tay-Sachs disease Applicable once per lifetime
73454	01NOV2023	31DEC9999	Y	Whole gene sequencing of a gene or genes described in item 73453, in a patient who is the reproductive partner of an individual who is affected by, or is a known genetic carrier of, one or more conditions described in item 73453 (other than cystic fibrosis, fragile-X syndrome or spinal muscular atrophy), for the purpose of determining the couples combined reproductive risk of the conditions, if: (a) the patient is not eligible for a service to which item 73453 applies; and (b) the patient has not received a service to which item 73453 applies; and (c) the patient has not received a service to which this item applies for the purpose of determining the patients reproductive risk with the patients current reproductive partner Applicable once per couple per lifetime
73455	01NOV2023	31DEC9999	Y	Testing of a pregnant patient, if at least one prospective parent is known to be affected by, or is a genetic carrier of, one or more conditions described in item 73453, for the purpose of determining whether a familial variant or variants are present in the fetus, if: (a) the testing is requested by a specialist or consultant physician; and (b) there is at least a 25% risk of the fetus inheriting a condition described in paragraph (b) of item 73453
73456	01NOV2023	31DEC9999	Y	Characterisation by whole genome sequencing, or by either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is requested by a specialist or consultant physician; and (b) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease, or any of the above; and (c) the service is not a service associated with a service to which item 73358, 73359 or 73457 applies Applicable only once per lifetime
73457	01NOV2023	31DEC9999	Y	Characterisation by whole genome sequencing, or either or both whole exome sequencing and mitochondrial DNA sequencing, of germline variants present in nuclear DNA and in mitochondrial DNA, of a patient with a strong suspicion of a mitochondrial disease, if: (a) the characterisation is performed using a sample from the patient and a sample from each of the patients biological parents; and (b) the request for the characterisation states that singleton testing is inappropriate; and (c) the characterisation is requested by a specialist or consultant physician; and (d) the characterisation is requested because of the onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or “failure to thrive” in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (e) the service is not a service associated with a service to which item 73358, 73359 or 73456 applies Applicable only once per lifetime
73458	01NOV2023	31DEC9999	Y	Re-analysis of whole genome or whole exome or mitochondrial DNA data obtained in performing a service to which item 73456 or 73457 applies, for characterisation of previously unreported germline variants related to the clinical phenotype, if: (a) the re-analysis is requested by a specialist or consultant physician; and (b) the patient is strongly suspected of having a monogenic mitochondrial disease; and (c) the re-analysis is performed at least 24 months after: (i) the service to which item 73456 or 73457 applies; or (ii) a service to which this item applies Applicable twice per lifetime
73459	01NOV2023	31DEC9999	Y	Testing for diagnostic purposes of a pregnant patient, for detection in the fetus of a gene variant or variants present in the parents, if: (a) the gene variant or variants are: (i) a variant or variants in the mitochondrial genome identified in the oocyte donating parent; or (ii) autosomal recessive variants identified in both biological parents within the same gene; or (iii) an autosomal dominant or X-linked variant identified in either biological parent; or (iv) identified in a biological sibling of the fetus; and (b) the causative variant or variants for the condition of the fetus first-degree relative have been confirmed by laboratory findings; and (c) the detection is requested by a specialist or consultant physician; and (d) the service is not a service associated with a service to which item 73361, 73362, 73363 or 73462 applies
73460	01NOV2023	31DEC9999	Y	Characterisation of mitochondrial DNA deletion or variant for diagnostic purposes in a patient suspected to have mitochondrial disease, if: (a) the characterisation is requested by the specialist or consultant physician managing the patients treatment; and (b) the patient displays onset of one or more clinical features indicative of mitochondrial disease, including at least one or more of the following: (i) meeting the clinical criteria of a probable indicator of mitochondrial disease on a relevant scoring system; (ii) evident mitochondrial dysfunction or decompensation; (iii) unexplained hypotonia or weakness, profound hypoglycaemia or ‘failure to thrive in the presence of a metabolic acidosis; (iv) unexplained single or multi-organ dysfunction or fulminant failure (including, but not limited to, neuropathies, myopathies, hepatopathy, pancreatic and/or bone marrow failure); (v) refractory or atypical seizures, developmental delays or cognitive regression, or progressive encephalopathy or progressive encephalomyopathy; (vi) cardiomyopathy and/or cardiac arrythmias; (vii) rapid hearing or painless visual loss or ptosis; (viii) stroke-like episodes or nonvasculitic strokes; (ix) ataxia, encephalopathy, seizures, muscle fatigue or weakness; (x) external ophthalmoplegia; (xi) hearing loss, diabetes, unexplained short stature, or endocrinopathy; (xii) family history of mitochondrial disease; and (c) the service is performed following a service to which items 73292, 73358, 73359, 73456 or 73457 applies for the same patient if the results were non-informativeApplicable 3 times per lifetime
73461	01NOV2023	31DEC9999	Y	Whole gene testing of a person for the characterisation of all germline gene variants within the same gene in which the persons reproductive partner has a pathogenic or likely pathogenic germline recessive gene variant for mitochondrial disease, if: (a) the partners germline recessive gene variant is confirmed by laboratory findings; and (b) the characterisation is requested by a specialist or consultant physician
73462	01NOV2023	31DEC9999	Y	Testing of a person for the detection of a single gene variant, if: (a) the person tested has a biological relative with a known pathogenic or likely pathogenic mitochondrial disease variant confirmed by laboratory findings; and (b) the testing is requested by a specialist or consultant physician; and (c) the service is not a service associated with a service to which item 73361, 73362 or 73363 applies
73521	01DEC1991	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test)
73522	01DEC1991	31DEC9999	Y	Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test)
73523	01DEC1991	30JUN1994	N	Semen examination (excluding post vasectomy semen examination), involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period
73523	01JUL1994	30APR2005	N	Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; with a maximum of 4 episodes in a 12 month period - each episode
73523	01MAY2005	30APR2007	N	Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; 1 of this item to a maximum of 4 in a 12 month period
73523	01MAY2007	31DEC9999	Y	Semen examination (other than post-vasectomy semen examination), including: (a) measurement of volume, sperm count and motility; and (b) examination of stained preparations; and (c) morphology; and (if performed) (d) differential count and 1 or more chemical tests; (Item is subject to rule 25)
73524	01DEC1991	31DEC9999	Y	Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period
73525	01DEC1991	30JUN1994	N	Sperm antibodies, sperm penetrating ability 1 or more tests
73525	01JUL1994	31DEC9999	Y	Sperm antibodies - sperm-penetrating ability - 1 or more tests
73526	01DEC1991	31DEC9999	Y	Sperm antibodies, sperm penetrating ability one or more tests
73527	01DEC1991	30JUN1994	N	Chorionic gonadotrophin (betaHCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy 1 or more estimations
73527	01JUL1994	30APR2002	N	Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods, including serial dilution (if performed) for diagnosis of pregnancy 1 or more tests
73527	01MAY2002	31DEC9999	Y	Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods for diagnosis of pregnancy - 1 or more tests
73528	01DEC1991	31DEC9999	Y	Chorionic gonadotrophin (beta HCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy one or more estimations
73529	01DEC1991	30JUN1994	N	Chorionic gonadotrophin (betaHCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG secreting neoplasm, threatened abortion or followup of abortion
73529	01JUL1994	31OCT1995	N	Chorionic gonadotrophin (betaHCG), quantitation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG secreting neoplasm, or threatened abortion, or followup of abortion or diagnosis of ectopic pregnancy, including any services performed in 73527 - 1 test
73529	01NOV1995	31OCT1999	N	Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or followup of abortion or diagnosis of ectopic pregnancy, including any services performed in 73527 - 1 test
73529	01NOV1999	31DEC9999	Y	Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or follow up of abortion or diagnosis of ectopic pregnancy, including any services performed in item 73527 - 1 test
73530	01DEC1991	31DEC9999	Y	Chorionic gonadotrophin (betaHCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG secreting neoplasm, threatened abortion or follow up of abortion
73801	01DEC1991	30JUN1994	N	Seminal examination for presence of spermatozoa
73801	01JUL1994	31DEC9999	Y	Semen examination for presence of spermatozoa
73802	01DEC1991	30JUN1993	N	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count 1 procedure
73802	01JUL1993	30JUN1994	N	Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin estimation, haematocrit estimation or erythrocyte count 1 procedure
73802	01JUL1994	31DEC9999	Y	Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count - 1 test
73803	01DEC1991	30JUN1994	N	2 procedures specified in item 73802
73803	01JUL1994	31DEC9999	Y	2 tests described in item 73802
73804	01DEC1991	30JUN1994	N	3 or more procedures specified in item 73802
73804	01JUL1994	31DEC9999	Y	3 or more tests described in item 73802
73805	01DEC1991	30JUN1993	N	Microscopical examination of urine
73805	01JUL1993	30JUN1994	N	Urine - microscopical examination of, or catalase test for, bacteria and cells, whether stained or not
73805	01JUL1994	31OCT2018	N	Microscopy of urine, whether stained or not, or catalase test
73805	01NOV2018	31DEC9999	Y	Microscopy of urine, excluding dipstick testing.
73806	01DEC1991	30JUN1994	N	Pregnancy test by 1 or more immunochemical methods
73806	01JUL1994	31DEC9999	Y	Pregnancy test by 1 or more immunochemical methods
73807	01DEC1991	30JUN1993	N	Microscopical examination of wet film other than urine
73807	01JUL1993	30JUN1994	N	Microscopical examination of wet film other than urine, including any relevant stain
73807	01JUL1994	31DEC9999	Y	Microscopy for wet film other than urine, including any relevant stain
73808	01DEC1991	30JUN1993	N	Microscopical examination of gram stained film
73808	01JUL1993	30JUN1994	N	Microscopical examination of Gram stained film, including any examination specified in items 73805 and 73807
73808	01JUL1994	31DEC9999	Y	Microscopy of Gram-stained film, including (if performed) a service described in item 73805 or 73807
73809	01DEC1991	31DEC9999	Y	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method
73810	01DEC1991	30JUN1994	N	Microscopical examination screening for fungi in skin, hair or nails 1 or more sites
73810	01JUL1994	31DEC9999	Y	Microscopy for fungi in skin, hair or nails - 1 or more sites
73811	01DEC1991	31JAN1992	N	Mantoux test
73811	01FEB1992	31DEC9999	Y	Mantoux test
73812	01NOV2021	30JUN2023	N	Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes when performed: (a) as a point-of-care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited against the point of care testing accreditation module under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%). Applicable not more than 3 times per 12 months per patient.
73812	01JUL2023	31DEC9999	Y	Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed: (a) as a point-of-care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point-of-care testing under the National General Practice Accreditation Scheme; and (c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient
73813	01NOV2024	31DEC9999	Y	Detection performed by, or on behalf of, a medical practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection
73815	01MAY2003	31DEC9999	Y	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period - where: (a) the health service is provided in a designated general practice participating in PoCT trials; and (b) the service is rendered as part of a consultation; and (c) the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes.
73818	01MAY2003	31DEC9999	Y	Quantitation of fasting HDL cholesterol, total cholesterol and triglyceride levels in patients undergoing lipid lowering therapy - each episode to a maximum of 4 episodes in a 12 month period - where: (a) the health service is provided in a designated general practice participating in PoCT trials; and (b) the service is rendered as part of a consultation; and (c) the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes.
73821	01MAY2003	31DEC9999	Y	Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in insulin dependent diabetic patients over 12 years of age and non-insulin dependent diabetic patients under 70 years of age - each test to a maximum of one test in a 12 month period - where: (a) the health service is provided in a designated general practice participating in PoCT trials; and (b) the service is rendered as part of a consultation; and (c) the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes.
73824	01MAY2003	31DEC9999	Y	Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in diabetic patients with established microalbuminuria - each test to a maximum of 4 tests in a 12 month period - where: (a) the health service is provided in a designated general practice participating in PoCT trials; and (b) the service is rendered as part of a consultation; and (c) the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes.
73825	01NOV2024	31DEC9999	Y	Detection performed by a participating nurse practitioner of: (a) chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) via molecular point-of-care testing for the diagnosis of CT or NG infection; and (b) trichomonas vaginalis (TV) via molecular point-of-care testing for the diagnosis of TV infection
73826	01NOV2021	31OCT2023	N	Quantitation of glycated haemoglobin (HbA1c) performed by a participating nurse practitioner in the management of established diabetes when performed: (a) as a point-of-care test; and (b) by a nurse practitioner who works in a general practice that is accredited against the point of care testing accreditation module under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%). Applicable not more than 3 times per 12 months per patient.
73826	01NOV2023	31DEC9999	Y	Quantitation of glycated haemoglobin (HbA1c) performed by a participating nurse practitioner in the management of established diabetes when performed: (a) as a point-of-care test; (b) by a nurse practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point-of-care testing under the National General Practice Accreditation Scheme; and (c) using a method and instrument certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrument has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient
73827	01MAY2003	31DEC9999	Y	Determination of INR in patients undergoing anticoagulant therapy - where: (a) the health service is provided in a designated general practice participating in PoCT trials; and (b) the service is rendered as part of a consultation; and (c) the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes.
73828	01NOV2011	31DEC9999	Y	Semen examination for presence of spermatozoa by a participating nurse practitioner
73829	01NOV2011	31DEC9999	Y	Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count by a participating nurse practitioner - 1 test
73830	01NOV2011	31DEC9999	Y	2 tests described in item 73829 by a participating nurse practitioner
73831	01NOV2011	31DEC9999	Y	3 or more tests described in item 73829 by a participating nurse practitioner
73832	01NOV2011	31OCT2019	N	Microscopy of urine, whether stained or not, or catalase test by a participating nurse practitioner
73832	01NOV2019	31DEC9999	Y	Microscopy of urine, excluding dipstick testing by a participating nurse practitioner.
73833	01NOV2011	31DEC9999	Y	Pregnancy test by 1 or more immunochemical methods by a participating nurse practitioner
73834	01NOV2011	31DEC9999	Y	Microscopy for wet film other than urine, including any relevant stain by a participating nurse practitioner
73835	01NOV2011	31DEC9999	Y	Microscopy of Gram-stained film, including (if performed) a service described in item 73832 or 73834 by a participating nurse practitioner
73836	01NOV2011	31DEC9999	Y	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method by a participating nurse practitioner
73837	01NOV2011	31DEC9999	Y	Microscopy for fungi in skin, hair or nails by a participating nurse practitioner - 1 or more sites
73839	01DEC2015	15MAR2018	N	Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period.
73839	16MAR2018	31DEC9999	Y	Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period. (Item is subject to restrictions in rule PR.9.1 of explanatory notes to this category)
73840	01DEC2000	31DEC2005	N	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period - where: (a) the health service is provided in a Commonwealth funded aboriginal and Torres strait Islander health and medical service; and (b) the Aboriginal and Torres Strait Islander health and medical service participates in a recognised quality assurance program.
73840	01JAN2006	15MAR2018	N	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period.
73840	16MAR2018	31DEC9999	Y	Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period. (Item is subject to restrictions in rule PR.9.1 of explanatory notes to this category)
73844	01JAN2006	15MAR2018	N	Quantitation of urinary microalbumin as determined by urine albumin extretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in the management of established diabetes.
73844	16MAR2018	31OCT2021	N	Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in the management of established diabetes. (Item is subject to restrictions in rule PR.9.1 of explanatory notes to this category)
73844	01NOV2021	31DEC9999	Y	Quantitation of urinary albumin/creatine ratio in urine on a random spot collection in the management of patients with established diabetes or patients at risk of microalbuminuria.
73899	01NOV2015	31DEC9999	Y	Initiation of a patient episode that consists of a service described in item 72858 or 72859 in circumstances other than those mentioned in item 73900
73900	01NOV2015	31DEC9999	Y	Initiation of a patient episode that consists of a service described in item 72858 or 72859 if the service is rendered in a prescribed laboratory.
73901	01FEB1992	30JUN1994	N	Initiation of a patient episode which consists only of a service specified in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory
73901	01JUL1994	31DEC9999	Y	Initiation of a patient episode that consists only of a service described in item 73053, 73055 or 73057 from a person who is not in a recognised hospital or a prescribed laboratory
73902	01NOV2007	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in item 72838 (in circumstances other than those described in item 73904) from a person who is an in-patient of a hospital
73903	01FEB1992	30JUN1994	N	Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital
73903	01JUL1994	19MAR1997	N	Initiation of a patient episode that consists only of a service described in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital
73903	20MAR1997	31OCT2003	N	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72823, 72824, 72825, 72830 and 72836 from a person who is an in-patient of a hospital other than a recognised hospital
73903	01NOV2003	31DEC9999	Y	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is an in-patient of a hospital other than a recognised hospital
73904	01NOV2007	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in item 72838 if the person is: (a) a private patient of a recognised hospital; or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory
73905	01FEB1992	30JUN1994	N	Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital
73905	01JUL1994	19MAR1997	N	Initiation of a patient episode that consists only of a service described in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital
73905	20MAR1997	31OCT2003	N	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72823, 72824, 72825, 72830 and 72836 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital
73905	01NOV2003	31DEC9999	Y	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital
73906	01NOV2007	31DEC9999	Y	Initiation of a patient episode that consists only of 1 or more services described in item 72838 (in circumstances other than those described in item 73908) from a person who is not a patient of a hospital
73907	01FEB1992	30JUN1994	N	Initiation of a patient episode by collection of specimen for a service other than a service specified in Items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre
73907	01JUL1994	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected in an approved collection centre
73908	01NOV2007	31DEC9999	Y	Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in item 72838 from a person who is not a patient of a hospital
73909	01FEB1992	30JUN1994	N	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital
73909	01JUL1994	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital
73910	20MAR1997	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing
73911	01FEB1992	30JUN1994	N	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution
73911	01JUL1994	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing or in a nursing home or institution
73912	20MAR1997	31OCT2000	N	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a nursing home or institution
73912	01NOV2000	31OCT2001	N	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care facility or institution
73912	01NOV2001	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care home or institution
73913	01FEB1992	30JUN1994	N	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907, 73917 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person
73913	01JUL1994	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or 73907 or items in Group P9) if the specimen is collected from the person by the person
73914	01NOV2007	31OCT2008	N	Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73916) from a person who is an in-patient of a hospital
73914	01NOV2008	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73916) from a person who is an in-patient of a hospital
73915	01FEB1992	30JUN1994	N	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner
73915	01JUL1994	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service (other than a service described in items 73901, 73903 or 73905 or items in Group P9) if the specimen is collected by or on behalf of the treating practitioner
73916	01NOV2008	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 if the person is: (a) a private patient of a recognised hospital; or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory
73917	01FEB1992	31DEC9999	Y	Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre
73918	01NOV2008	31DEC9999	Y	Initiation of a patient episode that consists only of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73919) from a person who is not a patient of a hospital
73919	01NOV2008	31DEC9999	Y	Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in items 72827, 72828 and 72838 from a person who is not a patient of a hospital
73920	01JUL2008	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre that the APA operates in the same premises as it operates a category GX or GY pathology laboratory
73921	01FEB1992	30JUN1994	N	Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority
73921	01JUL1994	30JUN1995	N	Referral of a specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority (Item is subject to subrule 11(9))
73921	01JUL1995	31OCT1999	N	Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to subrule 15(9))
73921	01NOV1999	30APR2004	N	Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to subrule 14(9) and 16(3))
73921	01MAY2004	31DEC9999	Y	Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to rules 14, 15 and 16)
73922	01MAY2007	30APR2012	N	Initiation of a patient episode that consists only of a service described in item 73053, 73055 or 73057. Unless item 73923 applies
73922	01MAY2012	30APR2017	N	Initiation of a patient episode that consists of a service described in item 73053, 73055 or 73057 (in circumstances other than those described in item 73923).
73922	01MAY2017	30NOV2017	N	Initiation of a patient episode that consists of a service described in item 73053, 73055, 73057 or 73069 (in circumstances other than those described in item 73923).
73922	01DEC2017	31OCT2022	N	Initiation of a patient episode that consists of a service described in item 73070, 73071, 73072, 73073, 73074, 73075 or 73076 (in circumstances other than those described in item 73923).
73922	01NOV2022	31DEC9999	Y	Initiation of a patient episode that consists of a service described in item 73070, 73071, 73072, 73074, 73075 or 73076 (in circumstances other than those described in item 73923)
73923	01MAY2007	30APR2012	N	Initiation of a patient episode that consists only of a service described in items 73053, 73055 or 73057 from a person who is a private patient in a recognised hospital or the service is rendered by a prescribed laboratory
73923	01MAY2012	30APR2017	N	Initiation of a patient episode that consists of a service described in items 73053, 73055 or 73057 if: (a) the person who is a private patient in a recognised hospital: or (b) the person receives the service from a prescribed laboratory
73923	01MAY2017	30NOV2017	N	Initiation of a patient episode that consists of a service described in items 73053, 73055, 73057 or 73069 if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory
73923	01DEC2017	31OCT2022	N	Initiation of a patient episode that consists of a service described in items 73070, 73071, 73072, 73073, 73074, 73075 or 73076 if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory
73923	01NOV2022	31DEC9999	Y	Initiation of a patient episode that consists of a service described in items 73070, 73071, 73072, 73074, 73075 or 73076 if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory
73924	01MAY2007	30APR2012	N	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is an in-patient of a hospital. Unless item 73925 applies
73924	01MAY2012	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73925) from a person who is an in-patient of a hospital.
73925	01MAY2007	30APR2012	N	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is a private patient in a recognised hospital or the service is rendered to a private patient in a hospital by a prescribed laboratory
73925	01MAY2012	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 if the person is: (a) a private patient of a recognised hospital; or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory.
73926	01MAY2007	30APR2012	N	Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not an in-patient of a private hospital. Unless item 73927 applies.
73926	01MAY2012	31DEC9999	Y	Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73927) from a person who is not a patient of a hospital.
73927	01MAY2007	30APR2012	N	Initiation by a prescribed laboratory of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not a private patient in a recognised hospital nor a patient in a private hospital
73927	01MAY2012	31DEC9999	Y	Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in items, 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 from a person who is not a patient of a hospital.
73928	01MAY2007	30JUN2008	N	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre. Unless item 73929 applies
73928	01JUL2008	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre. Unless item 73920 or 73929 applies
73929	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, if the specimen is collected in an approved pathology collection centre
73930	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for a service for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital. Unless item 73931 applies
73931	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if: () the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person who is a private patient in a hospital or () the person is a private patient in a recognised hospital and the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority
73932	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing. Unless item 73933 applies
73933	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person in the place where the person is residing
73934	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 and 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care home or institution. Unless 73935 applies
73935	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person in a residential aged care home or institution
73936	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected from the person by the person.
73937	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926), if the specimen is collected from the person by the person and if: () the service is performed in a prescribed laboratory or () the person is a private patient in a recognised hospital
73938	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by or on behalf of the treating practitioner. Unless item 73939 applies
73939	01MAY2007	31DEC9999	Y	Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926), if the specimen is collected by or on behalf of the treating practitioner and if: () the service is performed in a prescribed laboratory or () the person is a private patient in a recognised hospital
73940	01MAY2007	30JUN2023	N	Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to rules 14, 15 and 16)
73940	01JUL2023	31DEC9999	Y	Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of another approved pathology authority
74990	01FEB2004	31DEC2021	N	A pathology service to which an item in this table (other than this item or item 74991) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
74990	01JAN2022	31DEC9999	Y	A pathology service to which an item in this table (other than this item or item 74991, 75861, 75862, 75863 or 75864) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service
74991	01MAY2004	31AUG2004	N	A pathology service to which an item in this table (other than this item or item 74990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c) the person is not an admitted patient of a hospital or day-hospital facility: and (d) the service is bulk-billed in respect of the fees for: (i) this item: and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania (iii) A geographical area included in any of the following SSD spatial units: Beaudesert Shire Part A Belconnen Darwin City Eastern Outer Melbourne East Metropolitan Frankston City Gosford-Wyong Greater Geelong City Part A Gungahlin-Hall Ipswich City (Part in BSD) Litchfield Shire Melton-Wyndham Mornington Peninsula Shire Newcastle North Canberra Palmerston-East Arm Pine Rivers Shire Queanbeyan South Canberra South Eastern Outer Melbourne Southern Adelaide South West Metropolitan Thuringowa City Part A Townsville City Part A Tuggeranong Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or l the geographical area included in the SLA spatial unit of Palm Island (AC)
74991	01SEP2004	31DEC2019	N	A pathology service to which an item in this table (other than this item or item 74990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a regional, rural or remote area; or (ii) Tasmania; or (iii) A geographical area included in any of the following SSD spatial units: (A) Beaudesert Shire Part A (B) Belconnen (C) Darwin City (D) Eastern Outer Melbourne (E) East Metropolitan, Perth (F) Frankston City (G) Gosford-Wyong (H) Greater Geelong City Part A (I) Gungahlin-Hall (J) Ipswich City (part in BSD) (K) Litchfield Shire (L) Melton-Wyndham (M) Mornington Peninsula Shire (N) Newcastle (O) North Canberra (P) Palmerston-East Arm (Q) Pine Rivers Shire (R) Queanbeyan (S) South Canberra (T) South Eastern Outer Melbourne (U) Southern Adelaide (V) South West Metropolitan, Perth (W) Thuringowa City Part A (X) Townsville City Part A (Y) Tuggeranong (Z) Weston Creek-Stromlo (ZA) Woden Valley (ZB) Yarra Ranges Shire Part A; or (iv) the geographical area included in the SLA spatial unit of Palm Island (AC)
74991	01JAN2020	31DEC2021	N	A pathology service to which an item in this table (other than this item or item 74990) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location within Modified Monash areas 2 to 7.
74991	01JAN2022	31DEC9999	Y	A pathology service to which an item in this table (other than this item or items 74990, 75861, 75862, 75863 or 75864) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 2 area.
74992	01NOV2009	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73920.
74993	01NOV2009	30APR2012	N	A payment when the episode is bulk billed and includes item 73918, 73922 or 73926.
74993	01MAY2012	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73922 or 73926.
74994	01NOV2009	30APR2012	N	A payment when the episode is bulk billed and includes item 73914 or 73924.
74994	01MAY2012	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73924.
74995	01NOV2009	31OCT2015	N	A payment when the episode is bulk billed and includes item 73928, 73930 or 73936.
74995	01NOV2015	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73899, 73900, 73928, 73930 or 73936.
74996	01NOV2009	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73932 or 73940.
74997	01NOV2009	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73934.
74998	01NOV2009	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73938.
74999	01NOV2009	30APR2012	N	A payment when the episode is bulk billed and includes item 73916, 73919, 73923, 73925,73927, 73929, 73931, 73933, 73935, 73937 or 73939.
74999	01MAY2012	31DEC9999	Y	A payment when the episode is bulk billed and includes item 73923, 73925, 73927, 73929, 73931, 73933, 73935, 73937 or 73939.
75000	01DEC1991	31DEC9999	Y	CONSULTATION BY AN ACCREDITED ORTHODONTIST not being a service to which item 75003 applies
75001	01JUL1995	31OCT2012	N	Note: In this Group, benefit is only payable where the service has been rendered to a patient by a dental practitioner who has been accredited by the Minister to provide orthodontic services, except for the services covered by Items 75009-75023 which may also be rendered by a dental practitioner approved by the Minister to provide oral surgical services. CONSULTATIONS INITIAL PROFESSIONAL ATTENDANCE in a single course of treatment by an accredited orthodontist
75001	01NOV2012	31DEC9999	Y	Note: In this Group, benefit is only payable where the service has been rendered to a patient by a dental practitioner who is registered in the specialty of orthodontics, except for the services covered by Items 75009-75023 which may also be rendered by a medical practitioner who is a specialist in the practice of his or her specialty of oral and maxillofacial surgery. CONSULTATIONS INITIAL PROFESSIONAL ATTENDANCE in a single course of treatment by an eligible orthodontist (AO)
75002	01MAR2024	31DEC9999	Y	Initial professional attendance, in a single course of treatment (other than a service associated with a service to which item 75009, 75012, 75015 or 75023 applies)
75003	01DEC1991	31DEC9999	Y	CONSULTATION BY AN ACCREDITED ORTHODONTIST and treatment planning where treatment is deferred
75004	01JUL1995	31OCT2012	N	PROFESSIONAL ATTENDANCE by an accredited orthodontist subsequent to the first professional attendance by the orthodontist in a single course of treatment
75004	01NOV2012	31DEC9999	Y	PROFESSIONAL ATTENDANCE by an eligible orthodontist subsequent to the first professional attendance by the orthodontist in a single course of treatment (AO)
75005	01MAR2024	31DEC9999	Y	Subsequent professional attendance in a single course of treatment (other than a service associated with a service to which item 75009, 75012, 75015 or 75023 applies)
75006	01DEC1991	30JUN1995	N	PRODUCTION OF DENTAL STUDY MODELS not being a service associated with a service to which item 75003 applies or not being a service to which item 75024, 75027, 75030, 75033, 75036, 75039, 75042, 75045, 75048 or 75051 applies
75006	01JUL1995	31DEC9999	Y	PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75004 applies) prior to provision of a service to which: (a) item 75030, 75033, 75034, 75036, 75037, 75039, 75045 or 75051 applies; or (b) an item in Group T8 or Groups 03 to 09 applies; in a single course of treatment
75007	01MAR2024	31DEC9999	Y	Production of dental study models (other than a service associated with a service to which item 75002 or 75005 applies) prior to provision of a service to which: (a) item 75030, 75032, 75039, 75045 or 75051 apply; or (b) an item in Group T8 or Groups O3 to O9 apply; or (c) item 52321, 53212 or 75618 apply; or (d) any of items 52330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 apply; in a single treatment
75009	01DEC1991	30JUN1995	N	ORTHODONTIC RADIOGRAPHY orthopantomography (panoramic radiography)
75009	01JUL1995	29FEB2024	N	RADIOGRAPHY ORTHODONTIC RADIOGRAPHY orthopantomography (panoramic radiography), including any consultation on the same occasion
75009	01MAR2024	31DEC9999	Y	Orthodontic radiography-orthopantomography (panoramic radiography), including any consultation on the same occasion
75012	01DEC1991	30JUN1995	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings OR LATERAL CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings
75012	01JUL1995	29FEB2024	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings OR LATERAL CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings including any consultation on the same occasion
75012	01MAR2024	31DEC9999	Y	Orthodontic anteroposterior cephalometric radiography with cephalometric tracings or lateral cephalometric radiography with cephalometric tracings, including any consultation on the same occasion
75015	01DEC1991	30JUN1995	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings
75015	01JUL1995	29FEB2024	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings including any consultation on the same occasion
75015	01MAR2024	31DEC9999	Y	Radiography anteroposterior and lateral cephalometric radiography with cephalometric tracings, including any consultation on the same occasion
75018	01DEC1991	30JUN1995	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings and orthopantomography
75018	01JUL1995	31DEC9999	Y	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings and orthopantomography including any consultation on the same occasion
75021	01DEC1991	30JUN1995	N	ORTHODONTIC RADIOGRAPHY ANTEROPOSTERIOR AND LATERAL CEPHALOMETIC RADIOGRAPHY, with cephalometric tracings, orthopantomography and hand-wrist studies (including growth prediction)
75021	01JUL1995	31DEC9999	Y	ORTHODONTIC RADIOGRAPHY hand-wrist studies (including growth prediction) including any consultation on the same occasion
75023	01JUL1995	29FEB2024	N	INTRAORAL RADIOGRAPHY - single area, periapical or bitewing film
75023	01MAR2024	31DEC9999	Y	Intraoral radiography-single area, periapical or bitewing film
75024	01DEC1991	30JUN1995	N	PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all associated consultations WHERE 1 APPLIANCE IS USED
75024	01JUL1995	29FEB2024	N	PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all adjustments of appliances and supervision - WHERE 1 APPLIANCE IS USED
75024	01MAR2024	31DEC9999	Y	Pre-surgical infant maxillary arch repositioning including nasoalveolar moulding, supply of appliances and all adjustments of appliances, and supervision of all components of the service-if 1 appliance is used
75027	01DEC1991	30JUN1995	N	PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all associated consultations WHERE 2 APPLIANCES ARE USED
75027	01JUL1995	29FEB2024	N	PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all adjustments of appliances and supervision WHERE 2 APPLIANCES ARE USED
75027	01MAR2024	31DEC9999	Y	Pre-surgical infant maxillary arch repositioning including nasoalveolar moulding, supply of appliances and all adjustments of appliances, and supervision of all components of the service-if 2 appliances are used
75030	01DEC1991	30JUN1995	N	DECIDUOUS DENTITION TREATMENT MAXILLARY ARCH EXPANSION including supply of appliances and all associated consultations, treatment planning and retention services beyond the period of active treatment
75030	01JUL1995	29FEB2024	N	DENTITION TREATMENT MAXILLARY ARCH EXPANSION not being a service associated with a service to which item 75039, 75042, 75045 or 75048 applies, including supply of appliances, all adjustments of the appliances, removal of the appliances and retention
75030	01MAR2024	31DEC9999	Y	Maxillary arch expansion (other than a service associated with a service to which item 75039, 75042, 75045 or 75048 applies), including supply of appliances and all adjustments of appliances, removal of appliances and retention
75032	01MAR2024	31DEC9999	Y	Mixed dentition treatment including incisor alignment (mandibular and/or maxillary) lateral arch expansion, including supply of appliances and all adjustments of appliances, removal of appliances and retention
75033	01DEC1991	30JUN1995	N	DECIDUOUS AND PERMANENT DENTITION TREATMENT INCISOR ALIGNMENT using fixed appliances in maxillary arch, including supply of appliances and all associated consultations, treatment planning and retention services beyond the period of active treatment
75033	01JUL1995	31DEC9999	Y	MIXED DENTITION TREATMENT - incisor alignment using fixed appliances in maxillary arch, including supply of appliances, all adjustments of appliances, removal of the appliances and retention
75034	01JUL1995	29FEB2024	N	MIXED DENTITION TREATMENT - incisor alignment with or without lateral arch expansion using a removable appliance in the maxillary arch, including supply of appliances, associated adjustments and retention
75034	01MAR2024	31DEC9999	Y	Mixed dentition treatment-incisor alignment with or without lateral arch expansion using a removable appliance in the maxillary arch, including supply of all appliances, and associated adjustments and retention
75036	01DEC1991	30JUN1995	N	DECIDUOUS AND PERMANENT DENTITION TREATMENT LATERAL ARCH EXPANSION AND INCISOR ALIGNMENT using fixed appliances in maxillary arch, including supply of appliances and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75033 applies
75036	01JUL1995	31DEC9999	Y	MIXED DENTITION TREATMENT - lateral arch expansion and incisor alignment using fixed appliances in maxillary arch, including supply of appliances, all adjustments of appliances, removal of appliances and retention
75037	01JUL1995	31DEC9999	Y	MIXED DENTITION TREATMENT - lateral arch expansion and incisor correction - 2 arch (maxillary and mandibular) using fixed appliances in both maxillary and mandibular arches, including supply of appliances, all adjustments of appliances, removal of appliances and retention
75039	01DEC1991	30JUN1995	N	PERMANENT DENTITION TREATMENT SINGLE ARCH (mandibular or maxillary) TREATMENT (correction and/or alignment) using fixed appliances, including supply of appliances, and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75045 or 75048 applies INITIAL 3 MONTHS of active treatment
75039	01JUL1995	29FEB2024	N	PERMANENT DENTITION TREATMENT SINGLE ARCH (mandibular or maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - initial 3 months of active treatment
75039	01MAR2024	31DEC9999	Y	Permanent dentition treatment-single arch (mandibular or maxillary) treatment (correction and alignment) using orthodontic fixed appliances or aligners, including supply of appliances and aligners-initial 3 months of active treatment
75042	01DEC1991	30JUN1995	N	EACH SUBSEQUENT 3 MONTHS of active treatment for a maximum of a further 33 months
75042	01JUL1995	29FEB2024	N	PERMANENT DENTITION TREATMENT - SINGLE ARCH (mandibular or maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - each 3 months of active treatment (including all adjustments and maintenance and removal of the appliances) after the first for a maximum of a further 33 months
75042	01MAR2024	31DEC9999	Y	Permanent dentition treatment-single arch (mandibular or maxillary) treatment (correction and alignment) using orthodontic fixed appliances or aligners, including supply of appliances and aligners-each subsequent 3 months of active treatment (including all adjustments and maintenance and removal of the appliances) after the initial three months of active treatment for a maximum of a further 33 months
75045	01DEC1991	30JUN1995	N	PERMANENT DENTITION TREATMENT 2 ARCH (mandibular and maxillary) TREATMENT (correction and/or alignment) using fixed appliances, including supply of appliances and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75039 or 75042 applies INITIAL 3 MONTHS OF ACTIVE TREATMENT
75045	01JUL1995	29FEB2024	N	PERMANENT DENTITION TREATMENT 2 ARCH (mandibular and maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - initial 3 months of active treatment
75045	01MAR2024	31DEC9999	Y	Permanent dentition treatment-2 arch (mandibular and maxillary) treatment (correction and alignment) using orthodontic fixed appliances or aligners, including supply of appliances or aligners-initial 3 months of active treatment
75048	01DEC1991	30JUN1995	N	EACH SUBSEQUENT 3 MONTHS of active treatment for a maximum of a further 33 months
75048	01JUL1995	29FEB2024	N	PERMANENT DENTITION TREATMENT - 2 ARCH (mandibular and maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - each subsequent 3 months of active treatment (including all adjustments and maintenance, and removal of the appliances) after the first for a maximum of a further 33 months
75048	01MAR2024	31DEC9999	Y	Permanent dentition treatment-2 arch (mandibular and maxillary) treatment (correction and alignment) using orthodontic fixed appliances or aligners, including supply of appliances or aligners-each subsequent 3 months of active treatment (including all adjustments and maintenance, and removal of the appliances) after the initial three months of active treatment for a maximum of a further 33 months
75049	01JUL1995	29FEB2024	N	RETENTION, FIXED OR REMOVABLE, single arch (mandibular or maxillary) - supply of retainer and supervision of retention
75049	01MAR2024	31DEC9999	Y	Retention, fixed or removable, single arch (mandibular or maxillary)-supply of retainer and supervision of retention
75050	01JUL1995	29FEB2024	N	RETENTION, FIXED OR REMOVABLE, 2-arch (mandibular and maxillary) - supply of retainers and supervision of retention
75050	01MAR2024	31DEC9999	Y	Retention, fixed or removable, 2-arch (mandibular and maxillary)-supply of retainers and supervision of retention
75051	01DEC1991	30JUN1995	N	PRESURGICAL OR POSTSURGICAL JAW GROWTH GUIDANCE using removable appliances, including supply of appliances, all associated consultations and treatment planning
75051	01JUL1995	29FEB2024	N	JAW GROWTH GUIDANCE JAW GROWTH guidance using removable or functional appliances, including supply of appliances and all adjustments to appliances
75051	01MAR2024	31DEC9999	Y	Jaw growth guidance using removable or functional appliances, including supply of appliances and all adjustments to appliances
75150	01JUL1995	31OCT2012	N	Note: (i) In this Group, benefit is only payable where the service has been rendered to a patient who has been referred by an accredited orthodontist. (ii)While benefit is payable for simple extractions performed by a registered dental practitioner, benefit is only payable for surgical extractions and other surgical procedures where the service is rendered by a dental practitioner who has been approved by the Minister to provide oral surgical services. (see para CB1.5) CONSULTATIONS INITIAL PROFESSIONAL attendance in a single course of treatment by an accredited oral and maxillofacial surgeon where the patient is referred to the surgeon by an accredited orthodontist
75150	01NOV2012	31DEC9999	Y	Note: (i) In this Group, benefit is only payable where the service has been rendered to a patient who has been referred by an eligible orthodontist. (ii)While benefit is payable for simple extractions performed by a registered dental practitioner, benefit is only payable for surgical extractions and other surgical procedures where the service is rendered by a medical practitioner who is a specialist in the practice of his or her speciality of oral and maxillofacial surgery. CONSULTATIONS INITIAL PROFESSIONAL attendance in a single course of treatment by an eligible oral and maxillofacial surgeon where the patient is referred to the surgeon by an eligible orthodontist (AOS)
75153	01JUL1995	31OCT2012	N	PROFESSIONAL ATTENDANCE by an accredited oral and maxillofacial surgeon subsequent to the first professional attendance by the surgeon in a single course of treatment where the patient is referred to the surgeon by an accredited orthodontist
75153	01NOV2012	31DEC9999	Y	PROFESSIONAL ATTENDANCE by an eligible oral and maxillofacial surgeon subsequent to the first professional attendance by the surgeon in a single course of treatment where the patient is referred to the surgeon by an eligible orthodontist
75156	01JUL1995	31OCT2012	N	PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75153 applies) prior to provision of a service: (a) to which item 52321, 53212 or 75618 applies; or (b) to which an item in the series 52330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 applies; in a single course of treatment
75156	01NOV2012	31DEC9999	Y	PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75153 applies) prior to provision of a service: (a) to which item 52321, 53212 or 75618 applies; or (b) to which an item in the series 52330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 applies; in a single course of treatment if the patient is referred by an eligible orthodontist (AOS)
75200	01DEC1991	31OCT2012	N	SIMPLE EXTRACTIONS REMOVAL OF TOOTH OR TOOTH FRAGMENT not being treatment to which item 75400, 75403, 75406, 75409, 75412 or 75415 applies
75200	01NOV2012	29FEB2024	N	SIMPLE EXTRACTIONS Removal of tooth or tooth fragment (other than treatment to which item 75400, 75403, 75406, 75409, 75412 or 75415 applies), if the patient is referred by an eligible orthodontist (AD)
75200	01MAR2024	31DEC9999	Y	Removal of tooth or tooth fragment (other than treatment to which item 75402 or 75405 applies)
75203	01DEC1991	31OCT2012	N	REMOVAL OF TOOTH OR TOOTH FRAGMENT under general anaesthesia
75203	01NOV2012	29FEB2024	N	REMOVAL OF TOOTH OR TOOTH FRAGMENT under general anaesthesia, if the patient is referred by an eligible orthodontist (AD)
75203	01MAR2024	31DEC9999	Y	Removal of tooth or tooth fragment under general anaesthesia
75206	01DEC1991	31OCT2012	N	REMOVAL OF EACH ADDITIONAL TOOTH OR TOOTH FRAGMENT at the same attendance at which a service to which item 75200 or 75203 applies is rendered
75206	01NOV2012	29FEB2024	N	Removal of each additional tooth or tooth fragment at the same attendance at which a service to which item 75200 or 75203 applies is rendered, if the patient is referred by an eligible orthodontist (AD)
75206	01MAR2024	31DEC9999	Y	Removal of each additional tooth or tooth fragment if provided in association with a service to which item 75200 or 75203 applies
75400	01DEC1991	31OCT2012	N	SURGICAL EXTRACTIONS Surgical removal of erupted tooth, if the patient is referred by an eligible orthodontist (AOS)
75400	01NOV2012	29FEB2024	N	SURGICAL EXTRACTIONS Surgical removal of erupted tooth, if the patient is referred by an eligible orthodontist (AOS)
75400	01MAR2024	31DEC9999	Y	Surgical removal of erupted tooth
75402	01MAR2024	31DEC9999	Y	Surgical removal of tooth, or tooth fragment requiring incision of soft tissue only
75403	01DEC1991	31OCT2012	N	SURGICAL REMOVAL OF TOOTH with soft tissue impaction
75403	01NOV2012	31DEC9999	Y	Surgical removal of tooth with soft tissue impaction, if the patient is referred by an eligible orthodontist (AOS)
75405	01MAR2024	31DEC9999	Y	Surgical removal of tooth, or tooth fragment requiring removal of bone, where the patient is referred by a referring dentist or medical practitioner
75406	01DEC1991	31OCT2012	N	SURGICAL REMOVAL OF TOOTH with partial bone impaction
75406	01NOV2012	31DEC9999	Y	Surgical removal of tooth with partial bone impaction, if the patient is referred by an eligible orthodontist (AOS)
75409	01DEC1991	31OCT2012	N	SURGICAL REMOVAL OF TOOTH with complete bone impaction
75409	01NOV2012	31DEC9999	Y	Surgical removal of tooth with complete bone impaction, if the patient is referred by an eligible orthodontist (AOS)
75412	01DEC1991	31OCT2012	N	SURGICAL REMOVAL OF TOOTH FRAGMENT involving soft tissue only
75412	01NOV2012	31DEC9999	Y	Surgical removal of tooth fragment requiring incision of soft tissue only, if the patient is referred by an eligible orthodontist (AOS)
75415	01DEC1991	31OCT2012	N	SURGICAL REMOVAL OF TOOTH FRAGMENT involving bone
75415	01NOV2012	31DEC9999	Y	Surgical removal of tooth fragment requiring removal of bone, if the patient is referred by an eligible orthodontist (AOS)
75600	01DEC1991	31OCT2012	N	OTHER SURGICAL PROCEDURES Surgical exposure, stimulation and packing of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS)
75600	01NOV2012	29FEB2024	N	OTHER SURGICAL PROCEDURES Surgical exposure, stimulation and packing of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS)
75600	01MAR2024	31DEC9999	Y	Surgical exposure and packing of unerupted tooth
75603	01DEC1991	31OCT2012	N	SURGICAL EXPOSURE OF UNERUPTED TOOTH for the purpose of fitting a traction device
75603	01NOV2012	29FEB2024	N	Surgical exposure of unerupted tooth for the purpose of fitting a traction device, if the patient is referred by an eligible orthodontist (AOS)
75603	01MAR2024	31DEC9999	Y	Surgical exposure of unerupted tooth for the purpose of fitting a traction device or placement of a temporary anchorage device
75606	01DEC1991	31OCT2012	N	SURGICAL REPOSITIONING OF UNERUPTED TOOTH
75606	01NOV2012	29FEB2024	N	Surgical repositioning of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS)
75606	01MAR2024	31DEC9999	Y	Surgical repositioning of unerupted tooth where the patient is referred by a referring dentist or medical practitioner
75609	01DEC1991	31OCT2012	N	TRANSPLANTATION OF TOOTH BUD
75609	01NOV2012	29FEB2024	N	Transplantation of tooth bud, if the patient is referred by an eligible orthodontist (AOS)
75609	01MAR2024	31DEC9999	Y	Transplantation of tooth bud where the patient is referred by a referring dentist or medical practitioner
75610	01MAR2024	31DEC9999	Y	Surgical procedure for intraoral implantation of an osseointegrated fixture and placement of transmucosal abutments where the patient is referred by a referring dentist or medical practitioner
75612	01JUL1995	31OCT2012	N	SURGICAL PROCEDURE for intra oral implantation of osseointegrated fixture (first stage)
75612	01NOV2012	31DEC9999	Y	Surgical procedure for intra oral implantation of osseointegrated fixture (first stage), if the patient is referred by an eligible orthodontist (AOS)
75615	01JUL1995	31OCT2012	N	SURGICAL PROCEDURE FOR FIXATION of trans-mucosal abutment (second stage of osseointegrated implant)
75615	01NOV2012	31DEC9999	Y	Surgical procedure for fixation of trans mucosal abutment (second stage of osseointegrated implant), if the patient is referred by an eligible orthodontist (AOS)
75618	01JUL1995	31OCT2012	N	PROVISION AND FITTING OF A BITE RISING APPLIANCE or DENTAL SPLINT for the management of temporomandibular joint dysfunction syndrome
75618	01NOV2012	29FEB2024	N	Provision and fitting of a bite rising appliance or dental splint for the management of temporomandibular joint dysfunction syndrome, if the patient is referred by an eligible orthodontist (AOS)
75618	01MAR2024	31DEC9999	Y	Fabrication and fitting of a bite rising appliance or dental splint for the management of temporomandibular joint dysfunction syndrome
75621	01JUL1995	31OCT2008	N	THE PROVISION AND FITTING OF SURGICAL TEMPLATE in conjuction with orthognathic surgical procedures in association with: (a) an item in the series 52342 to 52375; or (b) item 52380 or 52382
75621	01NOV2008	31OCT2012	N	THE PROVISION AND FITTING OF SURGICAL TEMPLATE in conjuction with orthognathic surgical procedures in association with an item in the range: (a) 45720 to 45754; or (b) 52342 to 52375; or (c) 52380 or 52382
75621	01NOV2012	30JUN2023	N	The provision and fitting of surgical template in conjunction with orthognathic surgical procedures in association with: (a) an item in the series: (i) 45720 to 45754; or (ii) 52342 to 52375; or (b) item 52380 or 52382; if the patient is referred by an eligible orthodontist (AOS)
75621	01JUL2023	29FEB2024	N	The provision and fitting of surgical template in conjunction with orthognathic surgical procedures in association with: (a) an item in the series: (i) 46150 to 46161; or (ii) 52342 to 52375; or (b) item 52380 or 52382; if the patient is referred by an eligible orthodontist (AOS)
75621	01MAR2024	31DEC9999	Y	The fabrication and fitting of surgical splint or guide in conjunction with orthognathic surgical procedures and implant treatment, if provided in association with a service to which: (a) any item in the following series applies: (i) any of items 46150 to 46161 apply; or (ii) any of items 52342 to 52375 apply; or (b) item 52380 or 52382 applies; (c) item 75610 applies
75800	01DEC1991	31OCT2012	N	Note: Benefit is payable for services listed in this Group where they are rendered by a State registered dental practitioner CONSULTATIONS ATTENDANCE BY AN ELIGIBLE DENTAL PRACTITIONER involving consultation, preventive treatment and prophylaxis, of not less than 30 minutes' duration each attendance to a maximum of 3 attendances in any period of 12 months
75800	01NOV2012	29FEB2024	N	Note: Benefit is payable for services listed in this Group where they are rendered by a registered dental practitioner CONSULTATIONS ATTENDANCE BY AN ELIGIBLE DENTAL PRACTITIONER involving consultation, preventive treatment and prophylaxis, of not less than 30 minutes' duration each attendance to a maximum of 3 attendances in any period of 12 months
75800	01MAR2024	31DEC9999	Y	Attendance involving consultation, preventive treatment and prophylaxis, of not less than 30 minutes in duration for each attendance to a maximum of 3 attendances in any 12 month period (other than a service associated with a service to which item 75009, 75012, 75015 or 75023 applies)
75802	01MAR2024	31DEC9999	Y	Fabrication and fitting of acrylic base partial denture, including retainers-1 to 4 teeth
75803	01DEC1991	31DEC9999	Y	PROSTHODONTIC PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 1 TOOTH
75806	01DEC1991	31OCT2010	N	2 TEETH
75806	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 2 TEETH
75809	01DEC1991	31OCT2010	N	3 TEETH
75809	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE. including retainers 3 TEETH
75812	01DEC1991	31OCT2010	N	4 TEETH
75812	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 4 TEETH
75815	01DEC1991	31OCT2010	N	5 TO 9 TEETH
75815	01NOV2010	29FEB2024	N	PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 5 TO 9 TEETH
75815	01MAR2024	31DEC9999	Y	Fabrication and fitting of acrylic base partial denture, including retainers-5 to 9 teeth
75818	01DEC1991	31OCT2010	N	10 TO 12 TEETH
75818	01NOV2010	29FEB2024	N	PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 10 TO 12 TEETH
75818	01MAR2024	31DEC9999	Y	Fabrication and fitting of acrylic base partial denture or complete denture or overdenture, including retainers-10 to 12 teeth
75820	01MAR2024	31DEC9999	Y	Fabrication and fitting of metal framework partial denture, including all components-1 to 4 teeth
75821	01DEC1991	31DEC9999	Y	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 1 TOOTH
75824	01DEC1991	31OCT2010	N	2 TEETH
75824	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 2 TEETH
75827	01DEC1991	31OCT2010	N	3 TEETH
75827	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 3 TEETH
75830	01DEC1991	31OCT2010	N	4 TEETH
75830	01NOV2010	31DEC9999	Y	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 4 TEETH
75833	01DEC1991	31OCT2010	N	5 TO 9 TEETH
75833	01NOV2010	29FEB2024	N	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 5 TO 9 TEETH
75833	01MAR2024	31DEC9999	Y	Fabrication and fitting of metal framework partial denture including all components-5 to 9 teeth
75836	01DEC1991	31OCT2010	N	10 TO 12 TEETH
75836	01NOV2010	29FEB2024	N	PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 10 TO 12 TEETH
75836	01MAR2024	31DEC9999	Y	Fabrication and fitting of metal framework partial denture or complete denture or overdenture including all components-10 to 12 teeth
75839	01DEC1991	31DEC9999	Y	PROVISION AND FITTING OF RETAINERS not being a service associated with a service to which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 75827, 75830, 75833 or 75836 applies each retainer
75842	01DEC1991	29FEB2024	N	ADJUSTMENT OF PARTIAL DENTURE not being a service associated with a service to which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 75827, 75830, 75833 or 75836 applies
75842	01MAR2024	31DEC9999	Y	Adjustment of denture (other than a service associated with a service to which item 75802, 75815, 75818, 75820, 75833 or 75836 applies)
75845	01DEC1991	29FEB2024	N	RELINING OF PARTIAL DENTURE by laboratory process and associated fitting
75845	01MAR2024	31DEC9999	Y	Relining of denture by laboratory process and associated fitting
75848	01DEC1991	29FEB2024	N	REMODELLING AND FITTING OF PARTIAL DENTURE of more than 4 teeth
75848	01MAR2024	31DEC9999	Y	Remodelling and fitting of denture of more than 4 teeth
75851	01DEC1991	29FEB2024	N	REPAIR TO CAST METAL BASE OF PARTIAL DENTURE 1 or more points
75851	01MAR2024	31DEC9999	Y	Repair to metal framework of denture-1 or more points
75854	01DEC1991	29FEB2024	N	ADDITION OF A TOOTH OR TEETH to a partial denture to replace extracted tooth or teeth including taking of necessary impression
75854	01MAR2024	31DEC9999	Y	Addition of a tooth or teeth to a denture to replace extracted tooth or teeth, including taking of necessary impression
75855	01JAN2022	31OCT2023	N	A medical service to which an item in this table (other than this item or item 10990, 10991, 10992, 75856, 75857 or 75858) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in: (i) a Modified Monash 3 area; or (ii) a Modified Monash 4 area
75855	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service; and(e) the service is provided at, or from, a practice location in:(i) a Modified Monash 3 area; or(ii) a Modified Monash 4 area;other than a service associated with a service:(f) to which another item in this Group applies; or(g) that is a general practice support service; or(h) that is a MyMedicare service
75856	01JAN2022	31OCT2023	N	A medical service to which an item in this table (other than this item or item 10990, 10991, 10992, 75855, 75857 or 75858) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 5 area
75856	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service; and(e) the service is provided at, or from, a practice location in a Modified Monash 5 area;other than a service associated with a service:(f) to which another item in this Group applies; or(g) that is a general practice support service; or(h) that is a MyMedicare service
75857	01JAN2022	31OCT2023	N	A medical service to which an item in this table (other than this item or item 10990, 10991, 10992, 75855, 75856 or 75858) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii) the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 6 area
75857	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service; and(e) the service is provided at, or from, a practice location in a Modified Monash 6 area;other than a service associated with a service:(f) to which another item in this Group applies; or(g) that is a general practice support service; or(h) that is a MyMedicare service
75858	01JAN2022	31OCT2023	N	A medical service to which an item in this table (other than this item or item 10990, 10991, 10992, 75855, 75856 or 75857) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital: and (d) the service is bulk-billed in respect of the fees for: (i) this item and (ii)the other item in this Schedule applying to the service; and (e) the service is provided at, or from, a practice location in a Modified Monash 7 area
75858	01NOV2023	31DEC9999	Y	A medical service to which an item in this Schedule (other than this item) applies, if:(a) the service is an unreferred service; and(b) the service is provided to a person who is:(i) under the age of 16; or(ii) a concessional beneficiary; and(c) the person is not an admitted patient of a hospital; and(d) the service is bulk-billed in relation to the fees for:(i) this item; and(ii) any other item in this Schedule applying to the service; and(e) the service is provided at, or from, a practice location in a Modified Monash 7 area;other than a service associated with a service:(f) to which another item in this Group applies; or(g) that is a general practice support service; or(h) that is a MyMedicare service
75861	01JAN2022	31DEC9999	Y	A pathology service to which an item in this table (other than this item or item 74990, 74991, 75862, 75863 or 75864) applies if: (a) the service is an unreferred service; and (b) the service is rendered to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in: (i) a Modified Monash 3 area; or (ii) a Modified Monash 4 area
75862	01JAN2022	31OCT2022	N	A pathology service to which an item in this table (other than this item or item 74990, 74991, 75861, 75862, or 75864) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 5 area
75862	01NOV2022	31DEC9999	Y	A pathology service to which an item in this Schedule (other than this item or item 74990, 74991, 75861, 75863, or 75864) applies if: (a) the service is an unreferred service; and (b) the service is rendered to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 5 area
75863	01JAN2022	31OCT2022	N	A pathology service to which an item in this table (other than this item or item 74990, 74991, 75861, 75862 or 75863) applies if: (a) the service is an unreferred service; and (b) the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 6 area
75863	01NOV2022	31DEC9999	Y	A pathology service to which an item in this Schedule (other than this item or item 74990, 74991, 75861, 75862 or 75864) applies if: (a) the service is an unreferred service; and (b) the service is rendered to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 6 area
75864	01JAN2022	31OCT2022	N	A pathology service to which an item in this table (other than this item or item 74990, 74991, 75862 or 75863 ) applies if: (a) the service is an unreferred service; and (b) the service is rendered to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in respect of the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 7 area
75864	01NOV2022	31DEC9999	Y	A pathology service to which an item in this Schedule (other than this item or item 74990, 74991, 75861, 75862 or 75863) applies if: (a) the service is an unreferred service; and (b) the service is rendered to a person who is under the age of 16 or is a concessional beneficiary; and (c) the person is not an admitted patient of a hospital; and (d) the service is bulk-billed in relation to the fees for: (i) this item; and (ii) the other item in this Schedule applying to the service; and (e) the service is rendered at, or from, a practice location in a Modified Monash 7 area
75870	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75871	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 2 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75872	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) if:(a) item 763, 766, 769, 776, 788, 789, 2198, 2200, 5023, 5028, 5043, 5049, 5063, 5067, 5076, 5077, 5223, 5227, 5228, 5261, 5263, 5265, 5267 or 5262 applies; and(b) the attendance service is an unreferred service; and(c) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(d) the patient is not an admitted patient of a hospital; and(e) the attendance service is not provided in consulting rooms; and(f) the attendance service is provided in any of the following areas:(i) a Modified Monash 2 area;(ii) a Modified Monash 3 area;(iii) a Modified Monash 4 area;(iv) a Modified Monash 5 area;(v) a Modified Monash 6 area;(vi) a Modified Monash 7 area; and(g) the attendance service is provided by, or on behalf of, a general practitioner, a medical practitioner or a prescribed medical practitioner whose practice location is not in an area mentioned in paragraph (f); and(h) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) an item mentioned in paragraph (a) that applies to the service
75873	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in:(i) a Modified Monash 3 area; or(ii) a Modified Monash 4 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75874, 75875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75874	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 5 area;other than an attendance service associated with a service which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75875, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75875	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 6 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75876, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75876	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a general practice support service is provided, if:(a) the attendance service is provided to a patient who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the general practice support service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 7 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75880, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 2NOTE: this item can be claimed with face to face level B, C, D and E general attendance items, and level B telehealth and telephone general attendance items.
75880	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75881, 75882, 75883, 75884 or 75885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
75881	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 2 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75882, 75883, 75884 or 75885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
75882	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in:(i) a Modified Monash 3 area; or(ii) a Modified Monash 4 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75883, 75884 or 75885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
75883	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 5 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 75884 or 75885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
75884	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 6 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 75883 or 75885 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
75885	01NOV2023	31DEC9999	Y	Professional attendance (the attendance service) by a general practitioner, a medical practitioner or a prescribed medical practitioner, at which a MyMedicare service is provided, if:(a) the attendance service is provided to a patient:(i) who is enrolled in MyMedicare at the general practice through which the attendance service is provided; and(ii) who is under the age of 16 or who is a concessional beneficiary; and(b) the patient is not an admitted patient of a hospital; and(c) the attendance service is bulk-billed in relation to the fees for:(i) this item; and(ii) the MyMedicare service item applying to the attendance service; and(d) the attendance service is provided at, or from, a practice location in a Modified Monash 7 area;other than an attendance service associated with a service to which item 10990, 10991, 10992, 75855, 75856, 75857, 75858, 75870, 75871, 75872, 75873, 75874, 75875, 75876, 75880, 75881, 75882, 75883 or 75884 applies Subgroup 3NOTE: this item can be claimed with level C, D, and E telehealth general attendance items, and level C and D telephone general attendance items, where the patient is registered with MyMedicare.
80000	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80000	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80000	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80000	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80000	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80000	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80000	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80000	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80000	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80000	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient in consulting rooms by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 30 minutes but less than 50 minutes duration
80001	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80001	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80002	01MAR2023	31DEC9999	Y	Psychological therapy health service provided in consulting rooms by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 30 minutes but less than 50 minutes
80005	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the service requirements outlined for item 80000.
80005	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 30 minutes but less than 50 minutes duration
80006	01MAR2023	31DEC9999	Y	Psychological therapy health service provided at a place other than consulting rooms by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 30 minutes but less than 50 minutes
80010	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80010	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80010	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80010	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80010	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80010	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80010	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80010	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80010	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80010	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient in consulting rooms by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80011	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance , at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80011	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance , at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80012	01MAR2023	31DEC9999	Y	Psychological therapy health service provided in consulting rooms by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
80015	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms As per the service requirements outlined for item 80010.
80015	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80016	01MAR2023	31DEC9999	Y	Psychological therapy health service provided at a place other than consulting rooms by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
80020	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP PSYCHOTHERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP PSYCHOTHERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01NOV2011	30SEP2017	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80020	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80020	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration
80021	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Group psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face-to-face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80021	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Group psychological therapy services delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80021	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80021	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 60 minutes duration
80022	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is referred for a course of treatment by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80022	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred for a course of treatment by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 90 minutes duration
80023	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80023	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 90 minutes duration
80024	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is referred for a course of treatment by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80024	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred for a course of treatment by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 120 minutes duration
80025	01NOV2022	29FEB2024	N	Psychological therapy health service provided to a person as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80025	01MAR2024	31DEC9999	Y	Psychological therapy health service provided to a patient as part of a group of 4 to 10 patients by an eligible clinical psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 120 minutes duration
80100	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80100	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80100	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80100	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80100	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80100	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80100	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80100	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80100	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80100	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80101	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80101	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80102	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80105	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the psychologist service requirements outlined for item 80100.
80105	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80106	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80110	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80110	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80110	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80110	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80110	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80110	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80110	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80110	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80110	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80110	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80111	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80111	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80112	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
80115	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the psychologist service requirements outlined for item 80110.
80115	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80116	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
80120	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01NOV2011	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80120	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80120	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration
80121	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face-to-face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80121	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80121	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80121	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (e) the service is at least 60 minutes duration
80122	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80122	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 90 minutes duration
80123	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80123	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (e) the service is at least 90 minutes duration
80125	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80125	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80125	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional services at consulting rooms)
80125	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional services at consulting rooms)
80125	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms)
80125	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional services at consulting rooms)
80125	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms)
80125	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms)
80125	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms)
80125	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80126	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80126	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80127	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80127	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 120 minutes duration
80128	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80128	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible psychologist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (e) the service is at least 120 minutes duration
80129	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80130	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the occupational therapist service requirements outlined for item 80125.
80130	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80131	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80135	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80135	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80135	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80135	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80135	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80135	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80135	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80135	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80135	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80135	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80136	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80136	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80137	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 50 minutes
80140	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the occupational therapist service requirements outlined for item 80135.
80140	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80141	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 50 minutes
80145	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01NOV2011	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80145	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80145	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration
80146	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face-to-face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80146	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80146	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (f) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80146	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (e) the service is at least 60 minutes duration
80147	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80147	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 90 minutes duration
80148	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (f) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80148	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (e) the service is at least 90 minutes duration
80150	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80150	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80150	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80150	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80150	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80150	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80150	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80150	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80150	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80150	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80151	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80151	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80152	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80152	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 120 minutes duration
80153	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (f) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80153	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible occupational therapist if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist; and (e) the service is at least 120 minutes duration
80154	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80155	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the social worker service requirements outlined for item 80150.
80155	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
80156	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
80160	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80160	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply.
80160	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80160	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms)
80160	01NOV2011	29FEB2012	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80160	01MAR2012	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms)
80160	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80160	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80160	01SEP2018	29FEB2024	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms)
80160	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80161	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80161	01SEP2018	31DEC9999	Y	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply.
80162	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided in consulting rooms by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 50 minutes
80165	01NOV2006	29FEB2024	N	Professional attendance at a place other than consulting rooms. As per the social worker service requirements outlined for item 80160.
80165	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided to the patient individually and in person; and (c) at the completion of a course of treatment, the referring practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring practitioner on assessments carried out, treatment provided and recommendations on future management of the patients condition; and (e) the service is at least 50 minutes duration
80166	01MAR2023	31DEC9999	Y	Focussed psychological strategies health service provided at a place other than consulting rooms by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 50 minutes
80170	01NOV2006	30APR2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01MAY2007	31OCT2007	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01NOV2007	31JUL2009	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01AUG2009	31OCT2011	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01NOV2011	30SEP2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01OCT2017	31OCT2017	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80170	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80170	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by referring practitioner; and (b) the service is provided in person; and (c) the service is at least 60 minutes duration
80171	01NOV2017	31AUG2018	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face-to-face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80171	01SEP2018	31OCT2022	N	Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT
80171	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the eligible social worker; and (f) the service is at least 60 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80171	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker; and (e) the service is at least 60 minutes duration
80172	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80172	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 90 minutes duration
80173	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker; and (f) the service is at least 90 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80173	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker; and (e) the service is at least 90 minutes duration
80174	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided in person; and (c) the patient is not an admitted patient; and (d) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80174	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the service is provided in person; and (c) the service is at least 120 minutes duration
80175	01NOV2022	29FEB2024	N	Focussed psychological strategies health service provided to a person as part of a group of 4 to 10 patients by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker; and (f) the service is at least 120 minutes duration Further information on the requirements for this item are available in the explanatory notes to this Category.
80175	01MAR2024	31DEC9999	Y	Focussed psychological strategies health service provided to a patient as part of a group of 4 to 10 patients by an eligible social worker if: (a) the patient is referred by a referring practitioner; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker; and (e) the service is at least 120 minutes duration
80176	01JUL2023	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes
80177	01JUL2023	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes
80178	01JUL2023	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a mental health case conference if the conference lasts for at least 40 minutes
81000	01NOV2006	31DEC2013	N	Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible psychologist, where the patient is referred to the psychologist by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a psychologist who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a psychologist who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001
81000	01JAN2014	29FEB2024	N	Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible psychologist, where the patient is referred to the psychologist by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a psychologist who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a psychologist who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001
81000	01MAR2024	31DEC9999	Y	Non-directive pregnancy support counselling health service provided to a patient who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible psychologist if: (a) the patient is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the patient is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the eligible psychologist does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005 or 81010, items 792 or 4001 in the general medical services table, or items 92136, 92138, 93026, 93029, 92137 or 92139 in the Telehealth and Telephone Determination apply) for each pregnancy
81005	01NOV2006	31DEC2013	N	Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible social worker, where the patient is referred to the social worker by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a social worker who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a social worker who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001
81005	01JAN2014	29FEB2024	N	Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible social worker, where the patient is referred to the social worker by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a social worker who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a social worker who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001
81005	01MAR2024	31DEC9999	Y	Non-directive pregnancy support counselling health service provided to a patient, who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible social worker if: (a) the patient is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the patient is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the eligible social worker does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005 or 81010, items 792 or 4001 in the general medical services table, or items 92136, 92138, 93026, 93029, 92137 or 92139 in the Telehealth and Telephone Determination apply) for each pregnancy
81010	01NOV2006	31DEC2013	N	Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible mental health nurse, where the patient is referred to the mental health nurse by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a mental health nurse who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a mental health nurse who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 81000, 81005, 81010 and 4001
81010	01JAN2014	29FEB2024	N	Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible mental health nurse, where the patient is referred to the mental health nurse by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a mental health nurse who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service. It may not be provided by a mental health nurse who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 81000, 81005, 81010 and 4001
81010	01MAR2024	31DEC9999	Y	Non-directive pregnancy support counselling health service provided to a patient, who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible mental health nurse if: (a) the patient is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the patient is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005 or 81010, items 792 or 4001 in the general medical services table, or items 92136, 92138, 93026, 93029, 92137 or 92139 in the Telehealth and Telephone Determination apply) for each pregnancy
81100	01MAY2007	31OCT2009	N	DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81100	01NOV2009	30APR2010	N	DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81100	01MAY2010	30SEP2017	N	DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81100	01OCT2017	09DEC2020	N	DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81100	10DEC2020	29FEB2024	N	DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan or, if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110, 81120, 93284, 93286, 93606, 93607 and 93608 apply).
81100	01MAR2024	31DEC9999	Y	Diabetes education health service provided to a patient by an eligible diabetes educator for assessing the patients suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the patient for the group services if: (a) the patient has type 2 diabetes; and (b) the patient is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (c) the patient is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the patient individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services in items 81100, 81110 and 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination)
81105	01MAY2007	31OCT2010	N	DIABETES EDUCATION SERVICE - GROUP SERVICE Diabetes education health service provided to a person by an eligible diabetes educator, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible diabetes educator; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible diabetes educator prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible diabetes educator; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81105	01NOV2010	09DEC2020	N	DIABETES EDUCATION SERVICE - GROUP SERVICE Diabetes education health service provided to a person by an eligible diabetes educator, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible diabetes educator; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible diabetes educator prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible diabetes educator; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81105	10DEC2020	29FEB2024	N	DIABETES EDUCATION SERVICE - GROUP SERVICE Diabetes education health service provided to a person by an eligible diabetes educator, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible diabetes educator; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115, 81125, 93285, 93613, 93614 or 93615 the eligible diabetes educator prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible diabetes educator; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115, 81125, 93285, 93613, 93614 and 93615 apply) in a calendar year.
81105	01MAR2024	31DEC9999	Y	Diabetes education health service provided to a patient by an eligible diabetes educator, as a group service for the management of type 2 diabetes if: (a) the patient has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination; and (b) the service is provided to a patient who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the patient under item 81105, 81115 or 81125 or item 93285 of the Telehealth and Telephone Determination, the eligible diabetes educator prepares, or contributes to, a written report to be provided to the referring medical practitioner; and (f) an attendance record for the group is maintained by the eligible diabetes educator; to a maximum of 8 group services in a calendar year (including services in items 81105, 81115 and 81125 or item 93285 of the Telehealth and Telephone Determination)
81110	01MAY2007	31OCT2009	N	EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUP SERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81110	01NOV2009	30APR2010	N	EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUP SERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81110	01MAY2010	30SEP2017	N	EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUP SERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732, or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81110	01OCT2017	09DEC2020	N	EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUP SERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732, or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply).
81110	10DEC2020	29FEB2024	N	EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUP SERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan or, if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110, 81120, 93284, 93286, 93606, 93607 and 93608 apply).
81110	01MAR2024	31DEC9999	Y	Exercise physiology health service provided to a person by an eligible exercise physiologist for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services in items 81100, 81110 and 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination)
81115	01MAY2007	31OCT2010	N	EXERCISE PHYSIOLOGY SERVICE - GROUP SERVICE Exercise physiology health service provided to a person by an eligible exercise physiologist, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 8100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible exercise physiologist; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible exercise physiologist prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible exercise physiologist; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81115	01NOV2010	09DEC2020	N	EXERCISE PHYSIOLOGY SERVICE - GROUP SERVICE Exercise physiology health service provided to a person by an eligible exercise physiologist, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible exercise physiologist; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible exercise physiologist prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible exercise physiologist; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81115	10DEC2020	29FEB2024	N	EXERCISE PHYSIOLOGY SERVICE - GROUP SERVICE Exercise physiology health service provided to a person by an eligible exercise physiologist, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible exercise physiologist; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115, 81125, 93285, 93613, 93614 or 93615, the eligible exercise physiologist prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible exercise physiologist; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115, 81125, 93285, 93613, 93614 and 93615 apply) in a calendar year.
81115	01MAR2024	31DEC9999	Y	Exercise physiology health service provided to a person by an eligible exercise physiologist, as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the person under item 81105, 81115 or 81125 or item 93285 of the Telehealth and Telephone Determination, the eligible exercise physiologist prepares, or contributes to, a written report to be provided to the referring medical practitioner; and (f) an attendance record for the group is maintained by the eligible exercise physiologist; to a maximum of 8 group services in a calendar year (including services in items 81105, 81115 and 81125 or item 93285 of the Telehealth and Telephone Determination)
81120	01MAY2007	31OCT2009	N	DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply).
81120	01NOV2009	30APR2010	N	DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply).
81120	01MAY2010	30SEP2017	N	DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply).
81120	01OCT2017	09DEC2020	N	DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply).
81120	10DEC2020	29FEB2024	N	DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a) the service is provided to a person who has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan or, if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all components of the form issued by the Department; and (d) the person is not an admitted patient of a hospital; and (e) the service is provided to the person individually and in person; and (f) the service is of at least 45 minutes duration; and (g) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110, 81120, 93284, 93286, 93606, 93607 and 93608 apply).
81120	01MAR2024	31DEC9999	Y	Dietetics health service provided to a person by an eligible dietitian for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services in items 81100, 81110 and 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination)
81125	01MAY2007	31OCT2010	N	DIETETICS SERVICE - GROUP SERVICE Dietetics health service provided to a person by an eligible dietitian, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible dietitian; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible dietitian prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible dietitian; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81125	01NOV2010	09DEC2020	N	DIETETICS SERVICE - GROUP SERVICE Dietetics health service provided to a person by an eligible dietitian, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible dietitian; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible dietitian prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible dietitian; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year.
81125	10DEC2020	29FEB2024	N	DIETETICS SERVICE - GROUP SERVICE Dietetics health service provided to a person by an eligible dietitian, as a GROUP SERVICE for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible dietitian; and (e) the service is of at least 60 minutes duration; and (f) after the last service in the group services program provided to the person under items 81105, 81115, 81125, 93285, 93613, 93614 or 93615, the eligible dietitian prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible dietitian; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115, 81125, 93285, 93613, 93614 and 93615 apply) in a calendar year.
81125	01MAR2024	31DEC9999	Y	Dietetics health service provided to a person by an eligible dietitian, as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120 or items 93284 or 93286 of the Telehealth and Telephone Determination; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the person under item 81105, 81115 or 81125 or item 93285 of the Telehealth and Telephone Determination, the eligible dietitian prepares, or contributes to, a written report to be provided to the referring medical practitioner; and (f) an attendance record for the group is maintained by the eligible dietitian; to a maximum of 8 group services in a calendar year (including services to which items 81105, 81115 and 81125 or item 93285 of the Telehealth and Telephone Determination apply)
81300	01NOV2008	30APR2010	N	ABORIGINAL OR TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible Aboriginal health worker if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible Aboriginal health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of 5 services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81300	01MAY2010	30JUN2012	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible Aboriginal health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81300	01JUL2012	30SEP2017	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81300	01OCT2017	09DEC2020	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81300	10DEC2020	29FEB2024	N	ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81300	01MAR2024	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a patient of Aboriginal or Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81305	01NOV2008	30SEP2017	N	DIABETES EDUCATION HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if: (a) a medical practitioner has identified a need for follow-up allied health services; and (b) the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81305	01OCT2017	09DEC2020	N	DIABETES EDUCATION HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if: (a) either: a medical practitioner has identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81305	10DEC2020	29FEB2024	N	DIABETES EDUCATION HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if: (a) either: a medical practitioner has identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81305	01MAR2024	31DEC9999	Y	Diabetes education health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81310	01NOV2008	30SEP2017	N	AUDIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81310	01OCT2017	09DEC2020	N	AUDIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81310	10DEC2020	29FEB2024	N	AUDIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81310	01MAR2024	31DEC9999	Y	Audiology health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81315	01NOV2008	30SEP2017	N	EXERCISE PHYSIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81315	01OCT2017	09DEC2020	N	EXERCISE PHYSIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81315	10DEC2020	29FEB2024	N	EXERCISE PHYSIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81315	01MAR2024	31DEC9999	Y	Exercise physiology health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81320	01NOV2008	30SEP2017	N	DIETETICS HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81320	01OCT2017	09DEC2020	N	DIETETICS HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81320	10DEC2020	29FEB2024	N	DIETETICS HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81320	01MAR2024	31DEC9999	Y	Dietetics health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81325	01NOV2008	30SEP2017	N	MENTAL HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81325	01OCT2017	09DEC2020	N	MENTAL HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81325	10DEC2020	29FEB2024	N	MENTAL HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81325	01MAR2024	31DEC9999	Y	Mental health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81330	01NOV2008	30SEP2017	N	OCCUPATIONAL THERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81330	01OCT2017	09DEC2020	N	OCCUPATIONAL THERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81330	10DEC2020	29FEB2024	N	OCCUPATIONAL THERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81330	01MAR2024	31DEC9999	Y	Occupational therapy health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81335	01NOV2008	30SEP2017	N	PHYSIOTHERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81335	01OCT2017	09DEC2020	N	PHYSIOTHERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81335	10DEC2020	29FEB2024	N	PHYSIOTHERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81335	01MAR2024	31DEC9999	Y	Physiotherapy health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81340	01NOV2008	30SEP2017	N	PODIATRY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81340	01OCT2017	09DEC2020	N	PODIATRY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81340	10DEC2020	29FEB2024	N	PODIATRY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81340	01MAR2024	31DEC9999	Y	Podiatry health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81345	01NOV2008	30SEP2017	N	CHIROPRACTIC HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81345	01OCT2017	09DEC2020	N	CHIROPRACTIC HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81345	10DEC2020	29FEB2024	N	CHIROPRACTIC HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81345	01MAR2024	31DEC9999	Y	Chiropractic health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81350	01NOV2008	30SEP2017	N	OSTEOPATHY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81350	01OCT2017	09DEC2020	N	OSTEOPATHY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81350	10DEC2020	29FEB2024	N	OSTEOPATHY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81350	01MAR2024	31DEC9999	Y	Osteopathy health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81355	01NOV2008	30SEP2017	N	PSYCHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81355	01OCT2017	09DEC2020	N	PSYCHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81355	10DEC2020	29FEB2024	N	PSYCHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81355	01MAR2024	31DEC9999	Y	Psychology health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
81360	01NOV2008	30SEP2017	N	SPEECH PATHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81360	01OCT2017	09DEC2020	N	SPEECH PATHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360 inclusive apply) in a calendar year
81360	10DEC2020	29FEB2024	N	SPEECH PATHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if: (a) either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c) the person is not an admitted patient of a hospital; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of five services (including services to which items 81300 to 81360, 93048, 93061, 93546 to 93558 and 93579 to 93593 inclusive apply) in a calendar year
81360	01MAR2024	31DEC9999	Y	Speech pathology health service provided to a patient who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if the service is of at least 20 minutes duration and: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; to a maximum of 10 services (including any services to which this item or any other item in this Group or Subgroup 1 of Group M3 or item 93000, 93013, 93048 or 93061 of the Telehealth and Telephone Determination applies) in a calendar year
82000	01JUL2008	30JUN2011	N	PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010
82000	01JUL2011	31DEC2012	N	PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82000	01JAN2013	28FEB2023	N	PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82000	01MAR2023	29FEB2024	N	Psychology health service provided to a patient aged under 25 years by an eligible psychologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82005, 82010, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82000	01MAR2024	31DEC9999	Y	Psychology health service provided to a patient aged under 25 years by an eligible psychologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82005, 82010, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day
82001	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a community case conference if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which another item in this Group applies)
82002	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a community case conference if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which another item in this Group applies)
82003	01NOV2021	31DEC9999	Y	Attendance by an eligible allied health practitioner, as a member of a multidisciplinary case conference team, to participate in a community case conference if the conference lasts for at least 40 minutes (other than a service associated with a service to which another item in this Group applies)
82005	01JUL2008	30JUN2011	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010
82005	01JUL2011	31DEC2012	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner: and (d) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82005	01JAN2013	28FEB2023	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner: and (d) the speech pathologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82005	01MAR2023	29FEB2024	N	Speech pathology health service provided to a patient aged under 25 years by an eligible speech pathologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82010, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82005	01MAR2024	31DEC9999	Y	Speech pathology health service provided to a patient aged under 25 years by an eligible speech pathologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82010, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day
82010	01JUL2008	30JUN2011	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010
82010	01JUL2011	31DEC2012	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82010	01JAN2013	28FEB2023	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the occupational therapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82010	01MAR2023	29FEB2024	N	Occupational therapy health service provided to a patient aged under 25 years by an eligible occupational therapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82010	01MAR2024	31DEC9999	Y	Occupational therapy health service provided to a patient aged under 25 years by an eligible occupational therapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82030, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day
82015	01JUL2008	30JUN2011	N	PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible psychologist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025
82015	01JUL2011	31DEC2012	N	PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible psychologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82015	01JAN2013	28FEB2023	N	PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible psychologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82015	01MAR2023	29FEB2024	N	Psychology health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible psychologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 30 minutes duration; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82020, 82025, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82015	01MAR2024	31DEC9999	Y	Psychology health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible psychologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82020, 82025, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day
82020	01JUL2008	30JUN2011	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible speech pathologist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025
82020	01JUL2011	31DEC2012	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible speech pathologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82020	01JAN2013	28FEB2023	N	SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible speech pathologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the speech pathologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82020	01MAR2023	29FEB2024	N	Speech pathology health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible speech pathologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 30 minutes duration; and (e) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82025, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category.
82020	01MAR2024	31DEC9999	Y	Speech pathology health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible speech pathologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82025, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day
82025	01JUL2008	30JUN2011	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible occupational therapist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025
82025	01JUL2011	31DEC2012	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible occupational therapist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82025	01JAN2013	28FEB2023	N	OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible occupational therapist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the occupational therapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82025	01MAR2023	29FEB2024	N	Occupational therapy health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible occupational therapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 30 minutes duration; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82025	01MAR2024	31DEC9999	Y	Occupational therapy health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible occupational therapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82035, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day
82030	01JUL2011	31DEC2012	N	AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 13 years, by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82030	01JAN2013	28FEB2023	N	AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 13 years, by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030
82030	01MAR2023	29FEB2024	N	Audiology, optometry, orthoptic or physiotherapy health service provided to a patient aged under 25 years by an eligible audiologist, optometrist, orthoptist or physiotherapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82030	01MAR2024	31DEC9999	Y	Audiology, optometry, orthoptic or physiotherapy health service provided to a patient aged under 25 years by an eligible audiologist, optometrist, orthoptist or physiotherapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 93032, 93033, 93040 or 93041 apply may be provided to the same patient on the same day
82035	01JUL2011	31DEC2012	N	AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child has been diagnosed with PDD or eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82035	01JAN2013	28FEB2023	N	AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child has been diagnosed with PDD or eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035
82035	01MAR2023	29FEB2024	N	Audiology, optometry, orthoptic or physiotherapy health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the patient is not an admitted patient; and (c) the service is provided to the patient individually and in person; and (d) the service is at least 30 minutes duration; and (e) on the completion of the course of treatment, the eligible audiologist, optometrist, orthoptist or physiotherapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
82035	01MAR2024	31DEC9999	Y	Audiology, optometry, orthoptic or physiotherapy health service provided to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible audiologist, optometrist, orthoptist or physiotherapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 93035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day
82100	01NOV2010	31OCT2018	N	Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a) taking a detailed patient history; (b) performing a comprehensive examination; (c) performing a risk assessment; (d) based on the risk assessment - arranging referral or transfer of the patient's care to an obstetrician; (e) requesting pathology and diagnostic imaging services, when necessary; (f) discussing with the patient the collaborative arrangements for her maternity care and recording the arrangements in the midwife's written records in accordance with section 2E of the Health Insurance Regulations 1975. Payable once only for any pregnancy.
82100	01NOV2018	31DEC2023	N	Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a) taking a detailed patient history; (b) performing a comprehensive examination; (c) performing a risk assessment; (d) based on the risk assessment - arranging referral or transfer of the patient's care to an obstetrician; (e) requesting pathology and diagnostic imaging services, when necessary; (f) discussing with the patient the collaborative arrangements for her maternity care and recording the arrangements in the midwife's written records in accordance with section 6 of the Health Insurance Regulations 2018. Payable once only for any pregnancy.
82100	01JAN2024	31OCT2024	N	Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a) taking a detailed patient history; (b) performing a comprehensive examination; (c) performing a risk assessment; (d) based on the risk assessment - arranging referral or transfer of the patients care to an obstetrician; (e) requesting pathology and diagnostic imaging services, when necessary; (f) discussing with the patient the collaborative arrangements for her maternity care and recording the arrangements in the midwifes written records in accordance with section 6 of the Health Insurance Regulations 2018 Payable only once for any pregnancy
82100	01NOV2024	31DEC9999	Y	Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a) taking a detailed patient history; (b) performing a comprehensive examination; (c) performing a risk assessment; (d) based on the risk assessment - arranging referral or transfer of the patients care to an obstetrician; (e) requesting pathology and diagnostic imaging services, when necessary Payable only once for any pregnancy
82105	01NOV2010	31DEC2023	N	Short antenatal professional attendance by a participating midwife, lasting up to 40 minutes.
82105	01JAN2024	31DEC9999	Y	Short antenatal professional attendance by a participating midwife, lasting up to 40 minutes
82110	01NOV2010	31DEC2023	N	Long antenatal professional attendance by a participating midwife, lasting at least 40 minutes.
82110	01JAN2024	31DEC9999	Y	Long antenatal professional attendance by a participating midwife, lasting at least 40 minutes
82115	01NOV2010	28FEB2022	N	Professional attendance by a participating midwife, lasting at least 90 minutes, for assessment and preparation of a maternity care plan for a patient whose pregnancy has progressed beyond 20 weeks, if: (a) the patient is not an admitted patient of a hospital; and (b) the participating midwife undertakes a comprehensive assessment of the patient; and (c) the participating midwife develops a written maternity care plan that contains: · outcomes of the assessment; and · details of agreed expectations for care during pregnancy, labour and delivery; and · details of any health problems or care needs; and · details of collaborative arrangements that apply for the patient; and · details of any medication taken by the patient during the pregnancy, and any additional medication that may be required by the patient; and · details of any referrals or requests for pathology services or diagnostic imaging services for the patient during the pregnancy, and any additional referrals or requests that may be required for the patient; and (d) the maternity care plan is explained and agreed with the patient; and (e) the fee does not include any amount for the management of the labour and delivery. (Includes any antenatal attendance provided on the same occasion). Payable once only for any pregnancy.
82115	01MAR2022	31OCT2024	N	Professional attendance by a participating midwife, lasting at least 90 minutes, for assessment and preparation of a maternity care plan for a patient whose pregnancy has progressed beyond 28 weeks, where the participating midwife has had at least 2 antenatal attendances with the patient in the preceding 6 months, if: (a) the patient is not an admitted patient of a hospital; and (b) the participating midwife undertakes a comprehensive assessment of the patient; and (c) the participating midwife develops a written maternity care plan that contains: (i) outcomes of the assessment; and (ii) details of agreed expectations for care during pregnancy, labour and birth; and (iii) details of any health problems or care needs; and (iv) details of collaborative arrangements that apply to the patient; and (v) details of any medication taken by the patient during the pregnancy, and any additional medication that may be required by the patient; and (vi) details of any referrals or requests for pathology services or diagnostic imaging services for the patient during the pregnancy, and any additional referrals or requests that may be required for the patient; and (d) the maternity care plan is explained and agreed with the patient; and (e) the fee does not include any amount for the management of labour and birth; (Includes any antenatal attendance provided on the same occasion) Payable only once for any pregnancy; This item cannot be claimed if items 16590 or 16591 have previously been claimed during a single pregnancy, except in exceptional circumstances
82115	01NOV2024	31DEC9999	Y	Professional attendance by a participating midwife, lasting at least 90 minutes, for assessment and preparation of a maternity care plan for a patient whose pregnancy has progressed beyond 28 weeks, where the participating midwife has had at least 2 antenatal attendances with the patient in the preceding 6 months, if: (a) the patient is not an admitted patient of a hospital; and (b) the participating midwife undertakes a comprehensive assessment of the patient; and (c) the participating midwife develops a written maternity care plan that contains: (i) outcomes of the assessment; and (ii) details of agreed expectations for care during pregnancy, labour and birth; and (iii) details of any health problems or care needs; and (iv) details of any medication taken by the patient during the pregnancy, and any additional medication that may be required by the patient; and (v) details of any referrals or requests for pathology services or diagnostic imaging services for the patient during the pregnancy, and any additional referrals or requests that may be required for the patient; and (d) the maternity care plan is explained and agreed with the patient; and (e) the fee does not include any amount for the management of labour and birth; (Includes any antenatal attendance provided on the same occasion) Payable only once for any pregnancy; This item cannot be claimed if items 16590 or 16591 have previously been claimed during a single pregnancy, except in exceptional circumstances
82116	01MAR2022	31DEC9999	Y	Management of labour for up to 6 hours, not including birth, at a place other than a hospital if: (a) the attendance is by the participating midwife who: (i) provided the patient's antenatal care or (ii) is a member of a practice that has provided the patient's antenatal care; and (b) the total attendance time is documented in the patient notes; This item does not apply if birth is performed during the attendance; Only claimable once per pregnancy
82118	01MAR2022	31DEC9999	Y	Management of labour for up to 6 hours total attendance, including birth where performed or attendance and immediate post-birth care at an elective caesarean section if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by the first participating midwife who: (i) assisted or provided the patient's antenatal care; or (ii) is a member of a practice that has provided the patient's antenatal care; and (c) the total attendance time is documented in the patient notes. (Includes all hospital attendances related to the labour by the first participating midwife) Only claimable once per pregnancy; Not being a service associated with a service to which item 82120 applies (H)
82120	01NOV2010	28FEB2022	N	Management of confinement for up to 12 hours, including delivery (if undertaken), if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by a participating midwife who: (i) provided the patient's antenatal care; or (ii) is a member of a practice that provided the patient's antenatal care. (Includes all attendances related to the confinement by the participating midwife) Payable once only for any pregnancy
82120	01MAR2022	31DEC9999	Y	Management of labour between 6 and 12 hours total attendance, including birth where performed, if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by the first participating midwife who: (i) assisted or provided the patients antenatal care; or (ii) is a member of a practice that provided the patients antenatal care; and (c) the total attendance time is documented in the patient notes; (Includes all hospital attendances related to the labour by the first participating midwife) Only claimable once per pregnancy; Not being a service associated with a service to which item 82118 applies (H)
82123	01MAR2022	31DEC9999	Y	Management of labour for up to 6 hours total attendance, including birth where performed if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by the second participating midwife who either: (i) assisted or provided the patient's antenatal care; or (ii) is a member of a practice that has provided the patient's antenatal care; and (c) the total attendance time is documented in the patient notes; (Includes all hospital attendances related to the labour by the second participating midwife) Only claimable once per pregnancy; Not being a service associated with a service to which item 82125 applies (H)
82125	01NOV2010	28FEB2022	N	Management of confinement, including delivery (if undertaken) when care is transferred from 1 participating midwife to another participating midwife (the second participating midwife), if:(a) the patient is an admitted patient of a hospital; and (b) the patient's confinement is for longer than 12 hours; (c) the second participating midwife: (i) has provided the patient's antenatal care; or (ii) is a member of a practice that has provided the patient's antenatal care. (Includes all attendances related to the confinement by the second participating midwife) Payable one only for any pregnancy.
82125	01MAR2022	31DEC9999	Y	Management of labour between 6 and 12 hours total attendance, including birth where performed, if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by the second participating midwife who either: (i) assisted or provided the patients antenatal care; or (ii) is a member of a practice that provided the patients antenatal care; and (c) the total attendance time is documented in the patient notes; (Includes all hospital attendances related to the labour by the second participating midwife) Only claimable once per pregnancy; Not being a service associated with a service to which item 82123 or 82127 applies (H)
82127	01MAR2022	31DEC9999	Y	Management of labour for up to 6 hours total attendance, including birth where performed if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by a third participating midwife who either: (i) assisted or provided the patient's antenatal care; or (ii) is a member of a practice that has provided the patient's antenatal care; and (c) an attendance to which item 82123 applies has been provided by a second participating midwife who is a member of a practice that has provided the patient's antenatal care; and (d) the total attendance time is documented in the patient notes; (Includes all hospital attendances related to the labour by the third participating midwife) Only claimable once per pregnancy; Not being a service associated with a service to which item 82125 applies (H)
82130	01NOV2010	28FEB2022	N	Short Postnatal Attendance Short postnatal professional attendance by a participating midwife, lasting up to 40 minutes, within 6 weeks after delivery.
82130	01MAR2022	31DEC2023	N	Short Postnatal Attendance Short postnatal professional attendance by a participating midwife, lasting up to 40 minutes, within 6 weeks after birth.
82130	01JAN2024	31DEC9999	Y	Short postnatal professional attendance by a participating midwife, lasting up to 40 minutes, within 6 weeks after birth
82135	01NOV2010	28FEB2022	N	Long Postnatal Attendance Long postnatal professional attendance by a participating midwife, lasting at least 40 minutes, within 6 weeks after delivery.
82135	01MAR2022	31DEC2023	N	Long Postnatal Attendance Long postnatal professional attendance by a participating midwife, lasting at least 40 minutes, within 6 weeks after birth.
82135	01JAN2024	31DEC9999	Y	Long postnatal professional attendance by a participating midwife, lasting at least 40 minutes, within 6 weeks after birth
82140	01NOV2010	28FEB2022	N	Six Week Postnatal Attendance Postnatal professional attendance by a participating midwife on a patient not less than 6 weeks but not more than 7 weeks after delivery of a baby, including: (a) a comprehensive examination of patient and baby to ensure normal postnatal recovery; and (b) referral of the patient to a general practitioner for the ongoing care of the patient and baby Payable once only for any pregnancy.
82140	01MAR2022	31DEC2023	N	Six Week Postnatal Attendance Postnatal professional attendance by a participating midwife on a patient not less than 6 weeks but not more than 7 weeks after birth of a baby, including: (a) a comprehensive examination of patient and baby to ensure normal postnatal recovery; and (b) referral of the patient to a general practitioner for the ongoing care of the patient and baby Payable once only for any pregnancy.
82140	01JAN2024	31DEC9999	Y	Postnatal professional attendance by a participating midwife on a patient, not less than 6 weeks but not more than 7 weeks after birth of a baby, including: (a) a comprehensive examination of the patient and baby to ensure normal postnatal recovery; and (b) referral of the patient to a general practitioner for the ongoing care of the patient and baby Payable only once for any pregnancy
82150	01JUL2011	31OCT2012	N	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics.
82150	01NOV2012	31DEC2012	N	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82150	01JAN2013	31DEC9999	Y	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82151	01JUL2011	31OCT2012	N	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics.
82151	01NOV2012	31DEC2012	N	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82151	01JAN2013	31DEC9999	Y	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82152	01JUL2011	31OCT2012	N	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics.
82152	01NOV2012	31DEC2012	N	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82152	01JAN2013	31DEC9999	Y	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82200	01NOV2010	30JUN2024	N	Professional attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management.
82200	01JUL2024	31DEC9999	Y	Professional attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management
82205	01NOV2010	30JUN2024	N	Professional attendance by a participating nurse practitioner lasting less than 20 minutes and including any of the following: a) taking a history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation.
82205	01JUL2024	31DEC9999	Y	Professional attendance by a participating nurse practitioner lasting less than 20 minutes and including any of the following: a) taking a history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; for 1 or more health related issues, with appropriate documentation
82210	01NOV2010	30JUN2024	N	Professional attendance by a participating nurse practitioner lasting at least 20 minutes and including any of the following: a) taking a detailed history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation.
82210	01JUL2024	31DEC9999	Y	Professional attendance by a participating nurse practitioner lasting at least 20 minutes and including any of the following: a) taking a detailed history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; for 1 or more health related issues, with appropriate documentation
82215	01NOV2010	30JUN2024	N	Professional attendance by a participating nurse practitioner lasting at least 40 minutes and including any of the following: a) taking an extensive history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation.
82215	01JUL2024	31DEC9999	Y	Professional attendance by a participating nurse practitioner lasting at least 40 minutes and including any of the following: a) taking an extensive history; b) undertaking clinical examination; c) arranging any necessary investigation; d) implementing a management plan; e) providing appropriate preventive health care; for 1 or more health related issues, with appropriate documentation
82220	01JUL2011	31OCT2012	N	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
82220	01NOV2012	31DEC2012	N	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located:(i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82220	01JAN2013	31DEC9999	Y	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82221	01JUL2011	31OCT2012	N	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
82221	01NOV2012	31DEC2012	N	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82221	01JAN2013	31DEC9999	Y	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82222	01JUL2011	31OCT2012	N	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) located outside an inner metropolitan area, not being an admitted patient; or b) at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician.
82222	01NOV2012	31DEC2012	N	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82222	01JAN2013	31DEC9999	Y	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies.
82223	01JUL2011	31OCT2012	N	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician.
82223	01NOV2012	31DEC9999	Y	A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i) is a care recipient receiving care in a residential care service; or (ii) is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit.
82224	01JUL2011	31OCT2012	N	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician.
82224	01NOV2012	31DEC9999	Y	A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i) is a care recipient receiving care in a residential care service; or (ii) is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit
82225	01JUL2011	31OCT2012	N	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a) a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b) at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician
82225	01NOV2012	31DEC9999	Y	A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i) is a care recipient receiving care in a residential care service; or (ii) is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit
82226	01MAR2024	31DEC9999	Y	Burns, involving 1% or more but less than 3% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, by a participating nurse practitioner-each attendance at which the procedure is performed Not applicable for skin reactions secondary to radiotherapy
82227	01MAR2024	31DEC9999	Y	Burns, involving 3% or more but less than 10% of total body surface, dressing of (including redressing of any related donor site, if required), without anaesthesia, by a participating nurse practitioner-each attendance at which the procedure is performed Not applicable for skin reactions secondary to radiotherapy
82228	01MAR2024	31DEC9999	Y	Nipple or areola or both, intradermal colouration of, by a participating nurse practitioner, following breast reconstruction after mastectomy or for congenital absence of nipple
82300	01NOV2012	28FEB2023	N	Audiology health service, consisting of BRAIN STEM EVOKED RESPONSE AUDIOMETRY, performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is a specialist in the specialty of otolaryngology head and neck surgery; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11300 applies has not been performed on the person on the same day.
82300	01MAR2023	29FEB2024	N	Audiology health service, consisting of brain stem evoked response audiometry, performed on a patient by an eligible audiologist if: (a) the service is not for the purposes of programming either an auditory implant or the sound processors of an auditory implant; and (b) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (c) the service is not performed for the purpose of a hearing screening; and (d) the patient is not an admitted patient; and (e) the service is performed on the patient individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (g) a service to which item 11300 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82300	01MAR2024	31DEC9999	Y	Audiology health service, consisting of brain stem evoked response audiometry, performed on a patient by an eligible audiologist if: (a) the service is not for the purposes of programming either an auditory implant or the sound processors of an auditory implant; and (b) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (c) the service is not performed for the purpose of a hearing screening; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11300 applies has not been performed on the patient on the same day
82301	01MAR2023	29FEB2024	N	Audiology health service, consisting of programming an auditory implant or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the patient is not an admitted patient; and (b) the service is performed on the patient individually and in person; and (c) a service to which item 11302, 11342 or 11345 applies has not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 82302 or item 82304 applies on the same day This item is subject to section 9
82301	01MAR2024	31DEC9999	Y	Audiology health service, consisting of programming an auditory implant or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the service is performed on the patient individually and in person; and (b) a service to which item 11302, 11342 or 11345 applies has not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 82302 or item 82304 applies on the same day
82302	01MAR2022	28FEB2023	N	Audiology health service by telehealth for programming of an auditory implant, or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the service is not performed for the purpose of a hearing screening; and (b) a service to which item 11300, 11342 or 11345 applies has not been performed on the person on the same day. Applicable up to a total of 4 services to which this item or item 82300 or 82304 apply on the same day
82302	01MAR2023	31DEC9999	Y	Audiology health service by telehealth for programming of an auditory implant, or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the service is not performed for the purpose of a hearing screening; and (b) a service to which item 11302, 11342 or 11345 applies not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 82301 or item 82304 applies on the same day
82304	01MAR2022	28FEB2023	N	Audiology health service by phone for programming of an auditory implant, or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the service is not performed for the purpose of a hearing screening; and (b) a service to which item 11300, 11342 or 11345 applies has not been performed on the person on the same day. Applicable up to a total of 4 services to which this item or item 82300 or 82302 apply on the same day
82304	01MAR2023	31DEC9999	Y	Audiology health service by phone for programming of an auditory implant, or the sound processor of an auditory implant, unilateral, performed on a patient by an eligible audiologist if: (a) the service is not performed for the purpose of a hearing screening; and (b) a service to which item 11302, 11342 or 11345 applies not been performed on the patient on the same day Applicable up to a total of 4 services to which this item, item 82301 or item 82302 applies on the same day
82306	01NOV2012	28FEB2023	N	Audiology health service, consisting of NON-DETERMINATE AUDIOMETRY performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is a specialist in the specialty of otolaryngology head and neck surgery; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11306 applies has not been performed on the person on the same day.
82306	01MAR2023	29FEB2024	N	Audiology health service, consisting of non-determinate audiometry performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11306 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82306	01MAR2024	31DEC9999	Y	Audiology health service, consisting of non-determinate audiometry performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11306 applies has not been performed on the patient on the same day
82309	01NOV2012	28FEB2023	N	Audiology health service, consisting of an AIR CONDUCTION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11309 applies has not been performed on the person on the same day.
82309	01MAR2023	29FEB2024	N	Audiology health service, consisting of an air conduction audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11309 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82309	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an air conduction audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11309 applies has not been performed on the patient on the same day
82312	01NOV2012	28FEB2023	N	Audiology health service, consisting of an AIR AND BONE CONDUCTION AUDIOGRAM OR AIR CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11312 applies has not been performed on the person on the same day.
82312	01MAR2023	29FEB2024	N	Audiology health service, consisting of an air and bone conduction audiogram or air conduction and speech discrimination audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11312 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82312	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an air and bone conduction audiogram or air conduction and speech discrimination audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11312 applies has not been performed on the patient on the same day
82315	01NOV2012	28FEB2023	N	Audiology health service, consisting of an AIR AND BONE CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11315 applies has not been performed on the person on the same day.
82315	01MAR2023	29FEB2024	N	Audiology health service, consisting of an air and bone conduction and speech discrimination audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11315 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82315	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an air and bone conduction and speech discrimination audiogram performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11315 applies has not been performed on the patient on the same day
82318	01NOV2012	28FEB2023	N	Audiology health service, consisting of an AIR AND BONE CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM WITH OTHER COCHLEAR TESTS performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11318 applies has not been performed on the person on the same day.
82318	01MAR2023	29FEB2024	N	Audiology health service, consisting of an air and bone conduction and speech discrimination audiogram with other cochlear tests performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11318 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82318	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an air and bone conduction and speech discrimination audiogram with other cochlear tests performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11318 applies has not been performed on the patient on the same day
82324	01NOV2012	28FEB2023	N	Audiology health service, consisting of an IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed on a person by an eligible audiologist (not being a service associated with a service to which item 82309, 82312, 82315 or 82318 applies) if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11324 applies has not been performed on the person on the same day.
82324	01MAR2023	29FEB2024	N	Audiology health service, consisting of an impedance audiogram involving tympanometry and measurement of static compliance and acoustic reflex performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11324 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82324	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an impedance audiogram involving tympanometry and measurement of static compliance and acoustic reflex performed on a patient by an eligible audiologist if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is not performed for the purpose of a hearing screening; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11324 applies has not been performed on the patient on the same day
82327	01NOV2012	31DEC9999	Y	Audiology health service, consisting of an IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed on a person by an eligible audiologist (being a service associated with a service to which item 82309, 82312, 82315 or 82318 applies) if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11327 applies has not been performed on the person on the same day.
82332	01NOV2012	28FEB2023	N	Audiology health service, consisting of an OTO-ACOUSTIC EMISSION AUDIOMETRY for the detection of permanent congenital hearing impairment, performed by an eligible audiologist on an infant or child in circumstances in which: (a) the service is performed pursuant to a written request made by an eligible practitioner who is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (b) the infant or child is at risk due to 1 or more of the following factors: (i) admission to a neonatal intensive care unit; (ii) family history of hearing impairment; (iii) intra-uterine or perinatal infection (either suspected or confirmed); (iv) birthweight less than 1.5kg; (v) craniofacial deformity; (vi) birth asphyxia; (vii) chromosomal abnormality, including Down Syndrome; (viii) exchange transfusion; and (c) middle ear pathology has been excluded by specialist opinion; and (d) the infant or child is not an admitted patient of a hospital; and (e) the service is performed on the infant or child individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11332 applies has not been performed on the infant or child on the same day.
82332	01MAR2023	29FEB2024	N	Audiology health service, consisting of an oto-acoustic emission audiometry for the detection of outer hair cell functioning in the cochlear, performed by an eligible audiologist, when middle ear pathology has been excluded, if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is performed: (i) on an infant or child who is at risk of permanent hearing impairment; or (ii) on a patient who is at risk of oto-toxicity due to medications or medical intervention; or (iii) on a patient at risk of noise induced hearing loss; or (iv) to assist in the diagnosis of auditory neuropathy; and (c) the patient is not an admitted patient; and (d) the service is performed on the patient individually and in person; and (e) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (f) a service to which item 11332 applies has not been performed on the patient on the same day This item is subject to sections 9 and 12
82332	01MAR2024	31DEC9999	Y	Audiology health service, consisting of an oto-acoustic emission audiometry for the detection of outer hair cell functioning in the cochlea, performed by an eligible audiologist, when middle ear pathology has been excluded, if: (a) the service is performed pursuant to a written request made by a medical practitioner to assist in the diagnosis, treatment or management of ear disease or a related disorder in the patient; and (b) the service is performed: (i) on an infant or child who is at risk of permanent hearing impairment; or (ii) on a patient who is at risk of oto-toxicity due to medications or medical intervention; or (iii) on a patient at risk of noise induced hearing loss; or (iv) to assist in the diagnosis of auditory neuropathy; and (c) the service is performed on the patient individually and in person; and (d) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the medical practitioner who requested the service; and (e) a service to which item 11332 applies has not been performed on the patient on the same day
82350	01NOV2019	29FEB2024	N	Dietetics health service provided to an eligible patient by an eligible dietitian if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is of at least 20 minutes in duration
82350	01MAR2024	31DEC9999	Y	Dietetics health service provided to an eligible patient by an eligible dietitian if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is of at least 20 minutes in duration
82351	01NOV2019	31DEC9999	Y	Dietetics health service provided to an eligible patient by an eligible dietitian if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the dietitian; and (f) the service is of at least 20 minutes duration
82352	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 30 minutes but less than 50 minutes in duration.
82352	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes but less than 50 minutes in duration
82353	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 30 minutes but less than 50 minutes in duration.
82354	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and the service is at least 30 minutes but less than 50 minutes in duration.
82354	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes but less than 50 minutes in duration
82355	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82355	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82356	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 50 minutes in duration.
82357	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82357	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82358	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration.
82358	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided in person; and (c) the service is at least 60 minutes in duration
82359	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration.
82359	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 60 minutes in duration
82360	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration.
82360	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82361	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration.
82362	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration.
82362	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82363	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82363	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82364	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration.
82365	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82365	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82366	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration.
82366	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided in person; and (c) the service is at least 60 minutes in duration
82367	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration.
82367	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 60 minutes in duration
82368	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration.
82368	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82369	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration.
82370	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration.
82370	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82371	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82371	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82372	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration.
82373	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82373	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82374	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration
82374	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided in person; and (c) the service is at least 60 minutes in duration
82375	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration.
82375	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 60 minutes in duration
82376	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration
82376	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82377	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration
82378	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration.
82378	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes in duration
82379	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration.
82379	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82380	01NOV2019	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration.
82381	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration
82381	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes in duration
82382	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to a person as part of a group of 6 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration.
82382	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided in person; and (c) the service is at least 60 minutes in duration
82383	01NOV2019	29FEB2024	N	Eating disorder psychological treatment service provided to a person as part of a group of 6 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration.
82383	01MAR2024	31DEC9999	Y	Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the attendance is by video conference; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (e) the service is at least 60 minutes in duration
85011	01NOV2007	31DEC9999	Y	Comprehensive oral examination Evaluation of all teeth, their supporting tissues and the oral tissues in order to record the condition of these structures. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of one (1) per provider every 2 years.
85012	01NOV2007	31DEC9999	Y	Periodic oral examination An evaluation performed on a patient of record to determine any changes in the patient's dental and medical health status since a previous comprehensive or periodic examination. Limit of one (1) per provider every 6 months.
85013	01NOV2007	31DEC9999	Y	Oral examination - limited A limited problem-focused oral evaluation carried out immediately prior to required treatment. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of three (3) per 3 month period.
85022	01NOV2007	31DEC9999	Y	Intraoral periapical or bitewing radiograph - per exposure Limit of six (6) per day.
85025	01NOV2007	31DEC9999	Y	Intraoral radiograph - occlusal, maxillary or mandibular - per exposure
85031	01NOV2007	31DEC9999	Y	Extraoral radiograph - maxillary, mandibular - per exposure
85037	01NOV2007	31DEC9999	Y	Panoramic radiograph - per exposure
85039	01NOV2007	31DEC9999	Y	Tomography of the skull or parts thereof Limit of one (1) per 12 month period.
85047	01NOV2007	31DEC9999	Y	Caries activity screening test Limit one (1) per 12 month period.
85051	01NOV2007	31DEC9999	Y	Biopsy of tissue
85071	01NOV2007	31DEC9999	Y	Diagnostic model - per model
85111	01NOV2007	31DEC9999	Y	Removal of plaque and/or stain. Limit of one (1) per 6 month period.
85113	01NOV2007	31DEC9999	Y	Recontouring pre-existing restoration(s)
85114	01NOV2007	31DEC9999	Y	Removal of calculus - first visit Limit of one (1) per 6 month period.
85115	01NOV2007	31DEC9999	Y	Removal of calculus - subsequent visit Limit of two (2) per 12 month period.
85117	01NOV2007	31DEC9999	Y	Bleaching, internal - per tooth For non-vital discoloured tooth.
85121	01NOV2007	31DEC9999	Y	Topical application of remineralising agent - one treatment Limit of one (1) per 6 month period.
85123	01NOV2007	31DEC9999	Y	Concentrated remineralising agent, application - single tooth Limit of one (1) per day.
85131	01NOV2007	31DEC9999	Y	Dietary advice Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period.
85141	01NOV2007	31DEC9999	Y	Oral hygiene instruction Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period.
85161	01NOV2007	31DEC9999	Y	Fissure sealing - per tooth
85165	01NOV2007	31DEC9999	Y	Desensitizing procedure - per visit
85171	01NOV2007	31DEC9999	Y	Odontoplasty - per tooth
85213	01NOV2007	31DEC9999	Y	Treatment of acute periodontal infection - per visit Limit of two (2) per 12 month period.
85221	01NOV2007	31DEC9999	Y	Clinical periodontal analysis and recording Limit of one (1) per 12 month period.
85222	01NOV2007	31DEC9999	Y	Root planing and subgingival curettage - per eight teeth or less Limit of two (2) per day.
85225	01NOV2007	31DEC9999	Y	Non-surgical periodontal treatment where not otherwise specified - per visit Limit of one (1) per 12 month period.
85231	01NOV2007	31DEC9999	Y	Gingivectomy - per eight teeth or less Limit of four (4) per 12 month period.
85232	01NOV2007	31DEC9999	Y	Periodontal flap surgery - per eight teeth or less Limit of four (4) per 12 month period.
85233	01NOV2007	31DEC9999	Y	Osseous surgery - per eight teeth or less Limit of four (4) per 12 month period.
85234	01NOV2007	31DEC9999	Y	Osseous graft - per tooth or implant Limit of two (2) per 12 month period.
85238	01NOV2007	31DEC9999	Y	Periodontal flap surgery for crown lengthening - per tooth
85241	01NOV2007	31DEC9999	Y	Root resection - per root
85245	01NOV2007	31DEC9999	Y	Periodontal surgery involving one tooth or an implant Limit of one (1) per 12 month period.
85311	01NOV2007	31DEC9999	Y	Removal of a tooth or part(s) thereof 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 85316. Limit of one (1) per day.
85314	01NOV2007	31DEC9999	Y	Sectional removal of a tooth 1st sectional removal. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 85316. Limit of one (1) per day.
85316	01NOV2007	31DEC9999	Y	Additional extraction requiring removal of a tooth or part(s) thereof, or sectional removal of a tooth To be used for additional extractions on the same day in conjunction with items 85311 or 85314.
85322	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment not requiring removal of bone or tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day.
85323	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment requiring removal of bone 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day.
85324	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment requiring both removal of bone and tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day.
85326	01NOV2007	31DEC9999	Y	Additional extraction requiring surgical removal of a tooth or tooth fragment. To be used for additional surgical extractions on the same day in conjunction with items 85322, 85323 or 85324.
85331	01NOV2007	31DEC9999	Y	Alveolectomy - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
85337	01NOV2007	31DEC9999	Y	Reduction of fibrous tuberosity Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately
85338	01NOV2007	31DEC9999	Y	Reduction of flabby ridge - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately
85341	01NOV2007	31DEC9999	Y	Removal of hyperplastic tissue Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
85377	01NOV2007	31DEC9999	Y	Removal or repair of soft tissue (not elsewhere defined) Includes insertion of sutures, normal post-operative care and suture removal.
85378	01NOV2007	31DEC9999	Y	Surgical removal of foreign body Includes insertion of sutures, normal post-operative care and suture removal.
85381	01NOV2007	31DEC9999	Y	Surgical exposure of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal.
85384	01NOV2007	31DEC9999	Y	Repositioning of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal.
85386	01NOV2007	31DEC9999	Y	Splinting of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal.
85387	01NOV2007	31DEC9999	Y	Replantation and splinting of a tooth Includes insertion of sutures, normal post-operative care and suture removal.
85391	01NOV2007	31DEC9999	Y	Frenectomy Includes insertion of sutures, normal post-operative care and suture removal
85392	01NOV2007	31DEC9999	Y	Incision and drainage of abscess or cyst Includes insertion of sutures, normal post-operative care and suture removal.
85411	01NOV2007	31DEC9999	Y	Direct pulp capping
85412	01NOV2007	31DEC9999	Y	Incomplete endodontic therapy (inoperable or fractured)
85414	01NOV2007	31DEC9999	Y	Pulpotomy
85415	01NOV2007	31DEC9999	Y	Complete chemo-mechanical preparation of root canal - one canal
85416	01NOV2007	31DEC9999	Y	Complete chemo-mechanical preparation of root canal - each additional canal on the same tooth. To be claimed in conjunction with item 85415.
85417	01NOV2007	31DEC9999	Y	Root canal obturation - one canal
85418	01NOV2007	31DEC9999	Y	Root canal obturation - each additional canal on the same tooth To be claimed in conjunction with item 85417.
85419	01NOV2007	31DEC9999	Y	Extirpation of pulp or debridement of root canal(s) - emergency or palliative
85431	01NOV2007	31DEC9999	Y	Periapical curettage - per root
85432	01NOV2007	31DEC9999	Y	Apicectomy - per root Includes curettage.
85433	01NOV2007	31DEC9999	Y	Exploratory periradicular surgery Limit of one (1) per 12 month period. Not claimable if services for the following items 85431, 85432, 85434, 85436, 85437 and 85438 are provided on the same day
85434	01NOV2007	31DEC9999	Y	Apical seal - per canal Includes apicectomy and periapical curettage.
85436	01NOV2007	31DEC9999	Y	Sealing of perforation
85437	01NOV2007	31DEC9999	Y	Surgical treatment and repair of an external root resorption - per tooth
85438	01NOV2007	31DEC9999	Y	Hemisection
85445	01NOV2007	31DEC9999	Y	Exploration for a calcified root canal - per canal
85451	01NOV2007	31DEC9999	Y	Removal of root filling - per canal
85452	01NOV2007	31DEC9999	Y	Removal of cemented root canal post or post crown
85453	01NOV2007	31DEC9999	Y	Removal or bypassing fractured endodontic instrument
85455	01NOV2007	31DEC9999	Y	Additional visit for irrigation and/or dressing of the root canal system - per tooth Cannot be paid with items 85415, 85416, 85417 or 85418 on the same day.
85457	01NOV2007	31DEC9999	Y	Obturation of resorption defect or perforation (non-surgical)
85458	01NOV2007	31DEC9999	Y	Interim therapeutic root filling - per tooth Limit of three (3) in a 12 month period.
85511	01NOV2007	31DEC9999	Y	Metallic restoration - one surface - direct
85512	01NOV2007	31DEC9999	Y	Metallic restoration - two surfaces - direct
85513	01NOV2007	31DEC9999	Y	Metallic restoration - three surfaces - direct
85514	01NOV2007	31DEC9999	Y	Metallic restoration - four surfaces - direct
85515	01NOV2007	31DEC9999	Y	Metallic restoration - five surfaces - direct
85521	01NOV2007	31DEC9999	Y	Adhesive restoration - one surface - anterior tooth - direct Limit of five (5) single-surface adhesive restorations (85521 or 85531) per day.
85522	01NOV2007	31DEC9999	Y	Adhesive restoration - two surfaces - anterior tooth - direct
85523	01NOV2007	31DEC9999	Y	Adhesive restoration - three surfaces - anterior tooth - direct
85524	01NOV2007	31DEC9999	Y	Adhesive restoration - four surfaces - anterior tooth - direct
85525	01NOV2007	31DEC9999	Y	Adhesive restoration - five surfaces - anterior tooth - direct
85531	01NOV2007	31DEC9999	Y	Adhesive restoration - one surface - posterior tooth - direct Limit of five (5) single-surface adhesive restorations (85521 or 85531) per day.
85532	01NOV2007	31DEC9999	Y	Adhesive restoration - two surfaces - posterior tooth - direct
85533	01NOV2007	31DEC9999	Y	Adhesive restoration - three surfaces - posterior tooth - direct
85534	01NOV2007	31DEC9999	Y	Adhesive restoration - four surfaces - posterior tooth - direct
85535	01NOV2007	31DEC9999	Y	Adhesive restoration - five surfaces - posterior tooth - direct
85541	01NOV2007	31DEC9999	Y	Metallic restoration - one surface - indirect
85542	01NOV2007	31DEC9999	Y	Metallic restoration - two surfaces - indirect
85543	01NOV2007	31DEC9999	Y	Metallic restoration - three surfaces - indirect
85544	01NOV2007	31DEC9999	Y	Metallic restoration - four surfaces - indirect
85545	01NOV2007	31DEC9999	Y	Metallic restoration - five surfaces - indirect
85551	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - one surface - indirect
85552	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - two surfaces - indirect
85553	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - three surfaces - indirect
85554	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - four surfaces - indirect
85555	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - five surfaces - indirect
85572	01NOV2007	31DEC9999	Y	Provisional (intermediate/ temporary) restoration Not claimable if services for endodontic items (85411 to 85458 inclusive) except 85419 are provided on the same day. Limit of three (3) per 3 month period.
85574	01NOV2007	31DEC9999	Y	Metal band The cementation of a metal band for diagnostic, protective purposes or for the placement of a provisional (intermediate) restoration.
85575	01NOV2007	31DEC9999	Y	Pin retention - per pin
85576	01NOV2007	31DEC9999	Y	Stainless steel crown
85577	01NOV2007	31DEC9999	Y	Cusp capping - per cusp
85578	01NOV2007	31DEC9999	Y	Restoration of an incisal corner - per corner
85595	01NOV2007	31DEC9999	Y	Removal of inlay/onlay
85596	01NOV2007	31DEC9999	Y	Recementing of inlay/onlay
85597	01NOV2007	31DEC9999	Y	Post - direct Insertion of a post into a prepared root canal to provide an anchor for an artificial crown or other restoration.
85613	01NOV2007	31DEC9999	Y	Full crown - non metallic - indirect
85615	01NOV2007	31DEC9999	Y	Full crown - veneered - indirect
85618	01NOV2007	31DEC9999	Y	Full crown - metallic - indirect
85625	01NOV2007	31DEC9999	Y	Core for crown including post - indirect
85627	01NOV2007	31DEC9999	Y	Preliminary restoration for crown - direct
85629	01NOV2007	31DEC9999	Y	Post and root cap - indirect
85631	01NOV2007	31DEC9999	Y	Provisional crown
85632	01NOV2007	31DEC9999	Y	Provisional bridge - per pontic
85642	01NOV2007	31DEC9999	Y	Bridge pontic - direct - per pontic
85643	01NOV2007	31DEC9999	Y	Bridge pontic - indirect - per pontic
85644	01NOV2007	31DEC9999	Y	Semi-fixed attachment
85645	01NOV2007	31DEC9999	Y	Precision or magnetic attachment
85649	01NOV2007	31DEC9999	Y	Retainer for bonded fixture - indirect - per tooth
85651	01NOV2007	31DEC9999	Y	Recementing crown or veneer
85652	01NOV2007	31DEC9999	Y	Recementing bridge or splint - per abutment
85653	01NOV2007	31DEC9999	Y	Rebonding of bridge or splint where retreatment of bridge surface is required
85655	01NOV2007	31DEC9999	Y	Removal of crown
85656	01NOV2007	31DEC9999	Y	Removal of bridge or splint
85658	01NOV2007	31DEC9999	Y	Repair of crown, bridge or splint - indirect. Inclusive of labour and laboratory costs.
85659	01NOV2007	31DEC9999	Y	Repair of crown, bridge or splint - direct.
85661	01NOV2007	31DEC9999	Y	Fitting of implant abutment - per abutment
85669	01NOV2007	31DEC9999	Y	Removal and reattachment of prosthesis fixed to implant(s) - per implant
85671	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - non metallic - indirect
85672	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - veneered - indirect
85673	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - metallic - indirect
85711	01NOV2007	31DEC9999	Y	Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85712	01NOV2007	31DEC9999	Y	Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85716	01NOV2007	31DEC9999	Y	Metal palate or plate Additional to items 85711, 85712 or 85719.
85719	01NOV2007	31DEC9999	Y	Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85721	01NOV2007	31DEC9999	Y	Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with item 85733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period
85722	01NOV2007	31DEC9999	Y	Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 85733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85727	01NOV2007	31DEC9999	Y	Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 85733 for each additional tooth and item 85739 for each metal backing. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85728	01NOV2007	31DEC9999	Y	Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 85733 for each additional tooth and item 85739 for each metal backing. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
85731	01NOV2007	31DEC9999	Y	Retainer - per tooth Additional to items 85721 and 85722.
85732	01NOV2007	31DEC9999	Y	Occlusal rest - per rest Additional to items 85721 and 85722.
85733	01NOV2007	31DEC9999	Y	Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 85721, 85722, 85727 or 85728. Limit of twelve (12) per base.
85735	01NOV2007	31DEC9999	Y	Precision or magnetic attachment
85736	01NOV2007	31DEC9999	Y	Immediate tooth replacement - per tooth
85737	01NOV2007	31DEC9999	Y	Resilient lining
85738	01NOV2007	31DEC9999	Y	Wrought bar A wrought bar joining sections of a partial prosthesis.
85739	01NOV2007	31DEC9999	Y	Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated. To be claimed with items 85727 or 85728.
85741	01NOV2007	31DEC9999	Y	Adjustment of a denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture.
85743	01NOV2007	31DEC9999	Y	Relining - complete denture - processed For soft relines, use items 85743 and 85737.
85744	01NOV2007	31DEC9999	Y	Relining - partial denture - processed For soft relines, use items 85744 and 85737.
85745	01NOV2007	31DEC9999	Y	Remodelling - complete denture
85746	01NOV2007	31DEC9999	Y	Remodelling - partial denture
85751	01NOV2007	31DEC9999	Y	Relining - complete denture - direct Chair-side only. Either hard or soft material.
85752	01NOV2007	31DEC9999	Y	Relining - partial denture - direct
85753	01NOV2007	31DEC9999	Y	Cleaning and polishing of pre-existing denture Limit of one (1) per 2 year period.
85761	01NOV2007	31DEC9999	Y	Reattaching pre-existing tooth or clasp to denture. Inclusive of labour and laboratory costs
85762	01NOV2007	31DEC9999	Y	Replacing clasp on denture
85763	01NOV2007	31DEC9999	Y	Repairing broken base of a complete denture. Inclusive of labour and laboratory costs.
85764	01NOV2007	31DEC9999	Y	Repairing broken base of a partial denture. Inclusive of labour and laboratory costs.
85765	01NOV2007	31DEC9999	Y	Replacing first tooth on denture
85767	01NOV2007	31DEC9999	Y	Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day. Inclusive of labour and laboratory costs.
85768	01NOV2007	31DEC9999	Y	Adding tooth to partial denture to replace an extracted or decoronated tooth - per tooth
85769	01NOV2007	31DEC9999	Y	Repair or addition to metal casting
85771	01NOV2007	31DEC9999	Y	Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period.
85772	01NOV2007	31DEC9999	Y	Splint - resin - indirect
85773	01NOV2007	31DEC9999	Y	Splint - metal - indirect
85776	01NOV2007	31DEC9999	Y	Impression where required for denture repair/modification
85777	01NOV2007	31DEC9999	Y	Identification Marking a dental appliance with a patient's name or other form of enduring patient identification.
85811	01NOV2007	31DEC9999	Y	Passive removable appliance - per arch
85821	01NOV2007	31DEC9999	Y	Active removable appliance - per arch
85823	01NOV2007	31DEC9999	Y	Functional orthopaedic appliance
85829	01NOV2007	31DEC9999	Y	Partial banding - per arch
85831	01NOV2007	31DEC9999	Y	Full arch banding - per arch
85911	01NOV2007	31DEC9999	Y	Palliative care Interim care to relieve pain, infection, bleeding or other problems not associated with other treatment.
85926	01NOV2007	31DEC9999	Y	Individually made tray - medicaments A tray made for the application of medicaments to the teeth or supporting tissues. Not to be claimed for bleaching.
85927	01NOV2007	31DEC9999	Y	Provision of medication/ medicament The supply, prescription or administration of appropriate medications and medicaments required for dental treatment. Limit of one (1) per three month period.
85949	01NOV2007	31DEC9999	Y	Treatment under general anaesthesia A specialist anaesthetist must administer the anaesthetic.
85963	01NOV2007	31DEC9999	Y	Clinical occlusal analysis including muscle and joint palpation Limit of one (1) per three year period.
85964	01NOV2007	31DEC9999	Y	Registration and mounting of casts for occlusal analysis Limit of one (1) per three year period.
85965	01NOV2007	31DEC9999	Y	Occlusal splint
85966	01NOV2007	31DEC9999	Y	Adjustment of pre-existing occlusal splint - per visit
85968	01NOV2007	31DEC9999	Y	Occlusal adjustment following occlusal analysis - per visit
85971	01NOV2007	31DEC9999	Y	Adjunctive physical therapy for temporomandibular joint and associated structures Limit of four (4) per 12 month period
85972	01NOV2007	31DEC9999	Y	Repair/addition - occlusal splint
85981	01NOV2007	31DEC9999	Y	Splinting and stabilisation - direct - per tooth
85986	01NOV2007	31DEC9999	Y	Post-operative care where not otherwise included In normal circumstances, dentists provide post-operative care following dental treatment. However, where a patient requires unforeseen post-operative care or is seen by a dentist who did not provide the initial treatment, this item can be used. Limit of two (2) per 12 month period.
86012	01NOV2007	31DEC9999	Y	Periodic oral examination An evaluation performed on a patient of record to determine any changes in the patient's dental and medical health status since a previous periodic examination. Limit of one (1) per provider every 6 months.
86013	01NOV2007	31DEC9999	Y	Oral examination - limited A limited problem-focused oral evaluation carried out immediately prior to required treatment. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of three (3) per 3 month period.
86014	01NOV2007	31DEC9999	Y	Consultation A consultation to seek advice or discuss treatment options regarding a specific dental or oral condition. This consultation includes recording an appropriate medical history and any other relevant information.
86015	01NOV2007	31DEC9999	Y	Consultation - extended (30 mins) An extended consultation to seek advice or discuss treatment options regarding a specific dental or oral complaint. This consultation includes recording an appropriate medical history and any other relevant information. Limit of one (1) per provider per 12 month period.
86022	01NOV2007	31DEC9999	Y	Intraoral periapical or bitewing radiograph - per exposure Limit of six (6) per day.
86025	01NOV2007	31DEC9999	Y	Intraoral radiograph - occlusal, maxillary or mandibular - per exposure
86031	01NOV2007	31DEC9999	Y	Extraoral radiograph - maxillary, mandibular - per exposure
86035	01NOV2007	31DEC9999	Y	Radiograph of temporomandibular joint - per exposure
86036	01NOV2007	31DEC9999	Y	Cephalometric radiograph - lateral, antero-posterior, postero-anterior or submento-vertex - per exposure Limit of one (1) per 12 month period.
86037	01NOV2007	31DEC9999	Y	Panoramic radiograph - per exposure
86038	01NOV2007	31DEC9999	Y	Hand-wrist radiograph for skeletal age assessment Limit of one (1) per provider per 12 month period.
86039	01NOV2007	31DEC9999	Y	Tomography of the skull or parts thereof Limit of one (1) per 12 month period.
86047	01NOV2007	31DEC9999	Y	Caries activity screening test Limit one (1) per 12 month period.
86051	01NOV2007	31DEC9999	Y	Biopsy of tissue
86071	01NOV2007	31DEC9999	Y	Diagnostic model - per model
86082	01NOV2007	31DEC9999	Y	Tooth-jaw size prediction analysis Limit of one (1) per provider per 12 month period.
86111	01NOV2007	31DEC9999	Y	Removal of plaque and/or stain Limit of one (1) per 6 month period.
86113	01NOV2007	31DEC9999	Y	Recontouring pre-existing restoration(s)
86114	01NOV2007	31DEC9999	Y	Removal of calculus - first visit Limit of one (1) per 6 month period.
86115	01NOV2007	31DEC9999	Y	Removal of calculus - subsequent visit Limit of two (2) per 12 month period.
86117	01NOV2007	31DEC9999	Y	Bleaching, internal - per tooth For non-vital discoloured tooth.
86121	01NOV2007	31DEC9999	Y	Topical application of remineralising agent - one treatment Limit of one (1) per 6 month period.
86123	01NOV2007	31DEC9999	Y	Concentrated remineralising agent, application - single tooth Limit of one (1) per day.
86131	01NOV2007	31DEC9999	Y	Dietary advice Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period.
86141	01NOV2007	31DEC9999	Y	Oral hygiene instruction Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period.
86161	01NOV2007	31DEC9999	Y	Fissure sealing - per tooth
86165	01NOV2007	31DEC9999	Y	Desensitizing procedure - per visit
86171	01NOV2007	31DEC9999	Y	Odontoplasty - per tooth
86213	01NOV2007	31DEC9999	Y	Treatment of acute periodontal infection - per visit Limit of two (2) per 12 month period.
86221	01NOV2007	31DEC9999	Y	Clinical periodontal analysis and recording Limit of one (1) per 12 month period.
86222	01NOV2007	31DEC9999	Y	Root planning and subgingival curettage - per eight teeth or less Limit of two (2) per day.
86225	01NOV2007	31DEC9999	Y	Non-surgical periodontal treatment where not otherwise specified - per visit Limit of one (1) per 12 month period.
86231	01NOV2007	31DEC9999	Y	Gingivectomy - per eight teeth or less Limit of four (4) per 12 month period.
86232	01NOV2007	31DEC9999	Y	Periodontal flap surgery - per eight teeth or less Limit of four (4) per 12 month period.
86233	01NOV2007	31DEC9999	Y	Osseous surgery - per eight teeth or less Limit of four (4) per 12 month period.
86234	01NOV2007	31DEC9999	Y	Osseous graft - per tooth or implant Limit of two (2) per 12 month period.
86235	01NOV2007	31DEC9999	Y	Gingival graft - per tooth or implant Limit of two (2) per 12 month period.
86236	01NOV2007	31DEC9999	Y	Guided tissue regeneration - per tooth or implant
86237	01NOV2007	31DEC9999	Y	Guided tissue regeneration - membrane removal
86238	01NOV2007	31DEC9999	Y	Periodontal flap surgery for crown lengthening - per tooth
86241	01NOV2007	31DEC9999	Y	Root resection - per root
86245	01NOV2007	31DEC9999	Y	Periodontal surgery involving one tooth or an implant Limit of one (1) per 12 month period.
86311	01NOV2007	31DEC9999	Y	Removal of a tooth or part(s) thereof 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 86316. Limit of one (1) per day.
86314	01NOV2007	31DEC9999	Y	Sectional removal of a tooth 1st sectional removal. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 86316. Limit of one (1) per day.
86316	01NOV2007	31DEC9999	Y	Additional extraction requiring removal of a tooth or part(s) thereof, or sectional removal of a tooth To be used for additional extractions on the same day in conjunction with items 86311 or 86314.
86322	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment not requiring removal of bone or tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day.
86323	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment requiring removal of bone 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day.
86324	01NOV2007	31DEC9999	Y	Surgical removal of a tooth or tooth fragment requiring both removal of bone and tooth division. 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day.
86326	01NOV2007	31DEC9999	Y	Additional extraction requiring surgical removal of a tooth or tooth fragment. To be used for additional surgical extractions on the same day in conjunction with items 86322, 86323 or 86324.
86331	01NOV2007	31DEC9999	Y	Alveolectomy - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86332	01NOV2007	31DEC9999	Y	Ostectomy - per jaw Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86337	01NOV2007	31DEC9999	Y	Reduction of fibrous tuberosity Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86338	01NOV2007	31DEC9999	Y	Reduction of flabby ridge - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86341	01NOV2007	31DEC9999	Y	Removal of hyperplastic tissue Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86343	01NOV2007	31DEC9999	Y	Repositioning of muscle attachment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86344	01NOV2007	31DEC9999	Y	Vestibuloplasty Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86345	01NOV2007	31DEC9999	Y	Vestibuloplasty with skin or mucosal graft Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately.
86371	01NOV2007	31DEC9999	Y	Removal of tumour, cyst or scar - cutaneous, subcutaneous or in mucous membrane. Includes insertion of sutures, normal post-operative care and suture removal.
86373	01NOV2007	31DEC9999	Y	Removal of tumour, cyst or scar involving muscle, bone or other deep tissue. Includes insertion of sutures, normal post-operative care and suture removal.
86375	01NOV2007	31DEC9999	Y	Surgery to salivary duct Includes insertion of sutures, normal post-operative care and suture removal.
86376	01NOV2007	31DEC9999	Y	Surgery to salivary gland Includes insertion of sutures, normal post-operative care and suture removal.
86377	01NOV2007	31DEC9999	Y	Removal or repair of soft tissue (not elsewhere defined) Includes insertion of sutures, normal post-operative care and suture removal.
86378	01NOV2007	31DEC9999	Y	Surgical removal of foreign body Includes insertion of sutures, normal post-operative care and suture removal.
86379	01NOV2007	31DEC9999	Y	Marsupialisation of cyst Includes insertion of sutures, normal post-operative care and suture removal.
86381	01NOV2007	31DEC9999	Y	Surgical exposure of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal.
86382	01NOV2007	31DEC9999	Y	Surgical exposure and attachment of device for orthodontic traction Includes insertion of sutures, normal post-operative care and suture removal.
86384	01NOV2007	31DEC9999	Y	Repositioning of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal.
86385	01NOV2007	31DEC9999	Y	Surgical repositioning of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal.
86386	01NOV2007	31DEC9999	Y	Splinting of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal.
86387	01NOV2007	31DEC9999	Y	Replantation and splinting of a tooth Includes insertion of sutures, normal post-operative care and suture removal.
86388	01NOV2007	31DEC9999	Y	Transplantation of tooth or tooth bud Includes insertion of sutures, normal post-operative care and suture removal.
86389	01NOV2007	31DEC9999	Y	Surgery to isolate and preserve neurovascular tissue Includes insertion of sutures, normal post-operative care and suture removal.
86391	01NOV2007	31DEC9999	Y	Frenectomy Includes insertion of sutures, normal post-operative care and suture removal.
86392	01NOV2007	31DEC9999	Y	Incision and drainage of abscess or cyst Includes insertion of sutures, normal post-operative care and suture removal.
86393	01NOV2007	31DEC9999	Y	Surgery involving the maxillary antrum Includes insertion of sutures, normal post-operative care and suture removal.
86394	01NOV2007	31DEC9999	Y	Surgery for osteomylitis Includes insertion of sutures, normal post-operative care and suture removal.
86395	01NOV2007	31DEC9999	Y	Repair of nerve trunk Includes insertion of sutures, normal post-operative care and suture removal.
86411	01NOV2007	31DEC9999	Y	Direct pulp capping
86412	01NOV2007	31DEC9999	Y	Incomplete endodontic therapy (inoperable or fractured)
86414	01NOV2007	31DEC9999	Y	Pulpotomy
86415	01NOV2007	31DEC9999	Y	Complete chemo-mechanical preparation of root canal - one canal
86416	01NOV2007	31DEC9999	Y	Complete chemo-mechanical preparation of root canal - each additional canal on the same tooth. To be claimed in conjunction with item 86415.
86417	01NOV2007	31DEC9999	Y	Root canal obturation - one canal
86418	01NOV2007	31DEC9999	Y	Root canal obturation - each additional canal on the same tooth To be claimed in conjunction with item 86417.
86419	01NOV2007	31DEC9999	Y	Extirpation of pulp or debridement of root canal(s) - emergency or palliative
86431	01NOV2007	31DEC9999	Y	Periapical curettage - per root
86432	01NOV2007	31DEC9999	Y	Apicectomy - per root Includes curettage.
86433	01NOV2007	31DEC9999	Y	Exploratory periradicular surgery Limit of one (1) per 12 month period. Not claimable if services for the following items 86431, 86432, 86434, 86436, 86437 and 86438 are provided on the same day.
86434	01NOV2007	31DEC9999	Y	Apical seal - per canal Included apicectomy and periapical curettage.
86436	01NOV2007	31DEC9999	Y	Sealing of perforation
86437	01NOV2007	31DEC9999	Y	Surgical treatment and repair of an external root resorption - per tooth
86438	01NOV2007	31DEC9999	Y	Hemisection
86445	01NOV2007	31DEC9999	Y	Exploration for a calcified root canal - per canal
86451	01NOV2007	31DEC9999	Y	Removal of root filling - per canal
86452	01NOV2007	31DEC9999	Y	Removal of cemented root canal post or post crown
86453	01NOV2007	31DEC9999	Y	Removal or bypassing fractured endodontic instrument
86455	01NOV2007	31DEC9999	Y	Additional visit for irrigation and/or dressing of the root canal system - per tooth Cannot be paid with items 86415, 86416, 86417 or 86418 on the same day.
86457	01NOV2007	31DEC9999	Y	Obturation of resorption defect or perforation (non-surgical)
86458	01NOV2007	31DEC9999	Y	Interim therapeutic root filling - per tooth Limit of three (3) in a 12 month period.
86511	01NOV2007	31DEC9999	Y	Metallic restoration - one surface - direct
86512	01NOV2007	31DEC9999	Y	Metallic restoration - two surfaces - direct
86513	01NOV2007	31DEC9999	Y	Metallic restoration - three surfaces - direct
86514	01NOV2007	31DEC9999	Y	Metallic restoration - four surfaces - direct
86515	01NOV2007	31DEC9999	Y	Metallic restoration - five surfaces - direct
86521	01NOV2007	31DEC9999	Y	Adhesive restoration - one surface - anterior tooth - direct Limit of five (5) single-surface adhesive restorations (86521 or 86531) per day.
86522	01NOV2007	31DEC9999	Y	Adhesive restoration - two surfaces - anterior tooth - direct
86523	01NOV2007	31DEC9999	Y	Adhesive restoration - three surfaces - anterior tooth - direct
86524	01NOV2007	31DEC9999	Y	Adhesive restoration - four surfaces - anterior tooth - direct
86525	01NOV2007	31DEC9999	Y	Adhesive restoration - five surfaces - anterior tooth - direct
86531	01NOV2007	31DEC9999	Y	Adhesive restoration - one surface - posterior tooth - direct Limit of five (5) single-surface adhesive restorations (86521 or 86531) per day.
86532	01NOV2007	31DEC9999	Y	Adhesive restoration - two surfaces - posterior tooth - direct
86533	01NOV2007	31DEC9999	Y	Adhesive restoration - three surfaces - posterior tooth - direct
86534	01NOV2007	31DEC9999	Y	Adhesive restoration - four surfaces - posterior tooth - direct
86535	01NOV2007	31DEC9999	Y	Adhesive restoration - five surfaces - posterior tooth - direct
86541	01NOV2007	31DEC9999	Y	Metallic restoration - one surface - indirect
86542	01NOV2007	31DEC9999	Y	Metallic restoration - two surfaces - indirect
86543	01NOV2007	31DEC9999	Y	Metallic restoration - three surfaces - indirect
86544	01NOV2007	31DEC9999	Y	Metallic restoration - four surfaces - indirect
86545	01NOV2007	31DEC9999	Y	Metallic restoration - five surfaces - indirect
86551	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - one surface - indirect
86552	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - two surfaces - indirect
86553	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - three surfaces - indirect
86554	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - four surfaces - indirect
86555	01NOV2007	31DEC9999	Y	Tooth-coloured restoration - five surfaces - indirect
86572	01NOV2007	31DEC9999	Y	Provisional (intermediate/ temporary) restoration Not claimable if services for endodontic items (86411 to 86458 inclusive) except 86419 are provided on the same day. Limit of three (3) per three month period.
86574	01NOV2007	31DEC9999	Y	Metal band The cementation of a metal band for diagnostic, protective purposes or for the placement of a provisional (intermediate) restoration.
86575	01NOV2007	31DEC9999	Y	Pin retention - per pin
86576	01NOV2007	31DEC9999	Y	Stainless steel crown
86577	01NOV2007	31DEC9999	Y	Cusp capping - per cusp
86578	01NOV2007	31DEC9999	Y	Restoration of an incisal corner - per corner
86595	01NOV2007	31DEC9999	Y	Removal of inlay/onlay
86596	01NOV2007	31DEC9999	Y	Recementing of inlay/onlay
86597	01NOV2007	31DEC9999	Y	Post - direct Insertion of a post into a prepared root canal to provide an anchor for an artificial crown or other restoration.
86613	01NOV2007	31DEC9999	Y	Full crown - non metallic - indirect
86615	01NOV2007	31DEC9999	Y	Full crown - veneered - indirect
86618	01NOV2007	31DEC9999	Y	Full crown - metallic - indirect
86625	01NOV2007	31DEC9999	Y	Core for crown including post - indirect
86627	01NOV2007	31DEC9999	Y	Preliminary restoration for crown - direct
86629	01NOV2007	31DEC9999	Y	Post and root cap - indirect
86631	01NOV2007	31DEC9999	Y	Provisional crown
86632	01NOV2007	31DEC9999	Y	Provisional bridge - per pontic
86642	01NOV2007	31DEC9999	Y	Bridge pontic - direct - per pontic
86643	01NOV2007	31DEC9999	Y	Bridge pontic - indirect - per pontic
86644	01NOV2007	31DEC9999	Y	Semi-fixed attachment
86645	01NOV2007	31DEC9999	Y	Precision or magnetic attachment
86649	01NOV2007	31DEC9999	Y	Retainer for bonded fixture - indirect - per tooth
86651	01NOV2007	31DEC9999	Y	Recementing crown or veneer
86652	01NOV2007	31DEC9999	Y	Recementing bridge or splint - per abutment
86653	01NOV2007	31DEC9999	Y	Rebonding of bridge or splint where retreatment of bridge surface is required
86655	01NOV2007	31DEC9999	Y	Removal of crown
86656	01NOV2007	31DEC9999	Y	Removal of bridge or splint
86658	01NOV2007	31DEC9999	Y	Repair of crown, bridge or splint - indirect Inclusive of labour and laboratory costs.
86659	01NOV2007	31DEC9999	Y	Repair of crown, bridge or splint - direct
86661	01NOV2007	31DEC9999	Y	Fitting of implant abutment - per abutment
86663	01NOV2007	31DEC9999	Y	Removal of implant
86664	01NOV2007	31DEC9999	Y	Fitting of bar for denture - per abutment
86666	01NOV2007	31DEC9999	Y	Prosthesis with metal frame attached to implants - per tooth
86669	01NOV2007	31DEC9999	Y	Removal and reattachment of prosthesis fixed to implant(s) - per implant
86671	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - non metallic - indirect
86672	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - veneered - indirect
86673	01NOV2007	31DEC9999	Y	Full crown attached to osseointegrated implant - metallic - indirect
86679	01NOV2007	31DEC9999	Y	Surgical implant guide
86684	01NOV2007	31DEC9999	Y	Insertion of first stage of two-stage endosseous implant - per implant Includes cost of hardware.
86688	01NOV2007	31DEC9999	Y	Insertion of one-stage endosseous implant - per implant Includes cost of hardware.
86691	01NOV2007	31DEC9999	Y	Second stage surgery of two stage endosseous implant - per implant Includes the cost of hardware.
86711	01NOV2007	31DEC9999	Y	Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86712	01NOV2007	31DEC9999	Y	Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86716	01NOV2007	31DEC9999	Y	Metal palate or plate Additional to items 86711, 86712 or 86719
86719	01NOV2007	31DEC9999	Y	Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86721	01NOV2007	31DEC9999	Y	Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with items 86733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86722	01NOV2007	31DEC9999	Y	Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 86733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86727	01NOV2007	31DEC9999	Y	Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 86733 for each additional tooth and item 86739 for each metal backing Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86728	01NOV2007	31DEC9999	Y	Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 86733 for each additional tooth and item 86739 for each metal backing Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
86731	01NOV2007	31DEC9999	Y	Retainer - per tooth Additional to items 86721 and 86722.
86732	01NOV2007	31DEC9999	Y	Occlusal rest - per rest Additional to items 86721 and 86722.
86733	01NOV2007	31DEC9999	Y	Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 86721, 86722, 86727 or 86728. Limit of twelve (12) per base.
86735	01NOV2007	31DEC9999	Y	Precision or magnetic attachment
86736	01NOV2007	31DEC9999	Y	Immediate tooth replacement - per tooth
86737	01NOV2007	31DEC9999	Y	Resilient lining
86738	01NOV2007	31DEC9999	Y	Wrought bar A wrought bar joining sections of a partial prosthesis.
86739	01NOV2007	31DEC9999	Y	Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated. To be claimed with items 86727 or 86728.
86741	01NOV2007	31DEC9999	Y	Adjustment of a denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture.
86743	01NOV2007	31DEC9999	Y	Relining - complete denture - processed For soft relines, use items 86743 and 86737.
86744	01NOV2007	31DEC9999	Y	Relining - partial denture - processed For soft relines, use items 86744 and 86737.
86745	01NOV2007	31DEC9999	Y	Remodelling- complete denture
86746	01NOV2007	31DEC9999	Y	Remodelling - partial denture
86751	01NOV2007	31DEC9999	Y	Relining - complete denture - direct Chair-side only. Either hard or soft material.
86752	01NOV2007	31DEC9999	Y	Relining - partial denture - direct
86753	01NOV2007	31DEC9999	Y	Cleaning and polishing of pre-existing denture Limit of one (1) per two year period.
86761	01NOV2007	31DEC9999	Y	Reattaching pre-existing tooth or clasp to denture Includes labour and laboratory costs.
86762	01NOV2007	31DEC9999	Y	Replacing clasp on denture
86763	01NOV2007	31DEC9999	Y	Repairing broken base of a complete denture Includes labour and laboratory costs.
86764	01NOV2007	31DEC9999	Y	Repairing broken base of a partial denture Includes labour and laboratory costs.
86765	01NOV2007	31DEC9999	Y	Replacing first tooth on denture
86767	01NOV2007	31DEC9999	Y	Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day Includes labour and laboratory costs.
86768	01NOV2007	31DEC9999	Y	Adding tooth to partial denture to replace an extracted or decoronated tooth - per tooth
86769	01NOV2007	31DEC9999	Y	Repair or addition to metal casting
86771	01NOV2007	31DEC9999	Y	Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period
86772	01NOV2007	31DEC9999	Y	Splint - resin - indirect
86773	01NOV2007	31DEC9999	Y	Splint - metal - indirect
86776	01NOV2007	31DEC9999	Y	Impression where required for denture repair/modification
86777	01NOV2007	31DEC9999	Y	Identification Marking a dental appliance with a patient's name or other form of enduring patient identification.
86811	01NOV2007	31DEC9999	Y	Passive removable appliance - per arch
86821	01NOV2007	31DEC9999	Y	Active removable appliance - per arch
86823	01NOV2007	31DEC9999	Y	Functional orthopaedic appliance
86829	01NOV2007	31DEC9999	Y	Partial banding - per arch
86831	01NOV2007	31DEC9999	Y	Full arch banding - per arch
86862	01NOV2007	31DEC9999	Y	Bonding of attachment for application of orthodontic force
86911	01NOV2007	31DEC9999	Y	Palliative care Interim care to relieve pain, infection, bleeding or other problems not associated with other treatment.
86926	01NOV2007	31DEC9999	Y	Individually made tray - medicaments A tray made for the application of medicaments to the teeth or supporting tissues. Not to be claimed for bleaching.
86927	01NOV2007	31DEC9999	Y	Provision of medication/ medicament The supply, prescription or administration of appropriate medications and medicaments required for dental treatment. Limit of one (1) per three month period.
86949	01NOV2007	31DEC9999	Y	Treatment under general anaesthesia A specialist anaesthetist must administer the anaesthetic.
86963	01NOV2007	31DEC9999	Y	Clinical occlusal analysis including muscle and joint palpation Limit of one (1) per three year period.
86964	01NOV2007	31DEC9999	Y	Registration and mounting of casts for occlusal analysis Limit of one (1) per three year period.
86965	01NOV2007	31DEC9999	Y	Occlusal splint
86966	01NOV2007	31DEC9999	Y	Adjustment of pre-existing occlusal splint - per visit
86968	01NOV2007	31DEC9999	Y	Occlusal adjustment following occlusal analysis - per visit
86971	01NOV2007	31DEC9999	Y	Adjunctive physical therapy for temporomandibular joint and associated structures Limit of four (4) per 12 month period.
86972	01NOV2007	31DEC9999	Y	Repair/addition - occlusal splint
86981	01NOV2007	31DEC9999	Y	Splinting and stabilisation - direct - per tooth
86986	01NOV2007	31DEC9999	Y	Post-operative care where not otherwise included In normal circumstances, dental specialists provide post-operative care following dental treatment. However, where a patient requires unforeseen post-operative care or is seen by a dental specialist who did not provide the initial treatment, this item can be used. Limit of two (2) per 12 month period
87011	01NOV2007	31DEC9999	Y	Initial denture examination Assessment of any existing dentures and any teeth, supporting tissues and oral tissues in order to construct a removable dental prosthesis or refer to an appropriate clinician. This assessment includes the recording an appropriate medical history and any other relevant information. Limit of one (1) per provider every 2 years.
87014	01NOV2007	31DEC9999	Y	Consultation A consultation to seek advice or discuss treatment options regarding removable dental prosthesis. This consultation includes the recording an appropriate medical history and any other relevant information.
87071	01NOV2007	31DEC9999	Y	Diagnostic model - per model
87711	01NOV2007	31DEC9999	Y	Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87712	01NOV2007	31DEC9999	Y	Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87716	01NOV2007	31DEC9999	Y	Metal palate or plate Additional to items 87711, 87712 or 87719.
87719	01NOV2007	31DEC9999	Y	Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87721	01NOV2007	31DEC9999	Y	Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with item 87733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87722	01NOV2007	31DEC9999	Y	Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 87733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87727	01NOV2007	31DEC9999	Y	Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 87733 for each additional tooth and item 87739 for each metal backing Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87728	01NOV2007	31DEC9999	Y	Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 87733 for each additional tooth and item 87739 for each metal backing Limit of one new set of dentures per patient every eight (8) years. In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period.
87731	01NOV2007	31DEC9999	Y	Retainer - per tooth Additional to items 87721 and 87722
87732	01NOV2007	31DEC9999	Y	Occlusal rest Additional to items 87721 and 87722
87733	01NOV2007	31DEC9999	Y	Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 87721, 87722, 87727 or 87728. Limit of twelve (12) per base
87736	01NOV2007	31DEC9999	Y	Immediate tooth replacement - per tooth
87737	01NOV2007	31DEC9999	Y	Resilient lining
87738	01NOV2007	31DEC9999	Y	Wrought bar A wrought bar joining sections of a partial prosthesis.
87739	01NOV2007	31DEC9999	Y	Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated. To be claimed with items 87727 or 87728.
87741	01NOV2007	31DEC9999	Y	Adjustment of pre-existing denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture.
87743	01NOV2007	31DEC9999	Y	Relining - complete denture - processed For soft relines, use items 87743 and 87737.
87744	01NOV2007	31DEC9999	Y	Relining - partial denture - processed For soft relines, use items 87744 and 87737.
87745	01NOV2007	31DEC9999	Y	Remodelling - complete denture
87746	01NOV2007	31DEC9999	Y	Remodelling - partial denture
87751	01NOV2007	31DEC9999	Y	Relining - complete denture - direct Chair-side only. Either hard or soft material.
87752	01NOV2007	31DEC9999	Y	Relining - partial denture - direct
87753	01NOV2007	31DEC9999	Y	Cleaning and polishing of pre-existing denture Limit of one (1) per 2 year period.
87761	01NOV2007	31DEC9999	Y	Reattaching pre-existing tooth or clasp to denture Includes labour and laboratory costs.
87762	01NOV2007	31DEC9999	Y	Replacing clasp on denture
87763	01NOV2007	31DEC9999	Y	Repairing broken base of a complete denture Includes labour and laboratory costs.
87764	01NOV2007	31DEC9999	Y	Repairing broken base of a partial denture Includes labour and laboratory costs.
87765	01NOV2007	31DEC9999	Y	Replacing first tooth on denture
87767	01NOV2007	31DEC9999	Y	Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day Includes labour and laboratory costs.
87768	01NOV2007	31DEC9999	Y	Adding tooth to partial denture to replace an extracted or decoronated tooth - per tooth
87769	01NOV2007	31DEC9999	Y	Repair or addition to metal casting
87771	01NOV2007	31DEC9999	Y	Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period.
87776	01NOV2007	31DEC9999	Y	Impression where required for denture repair
87777	01NOV2007	31DEC9999	Y	Identification Marking a dental appliance with a patient's name or other form of enduring patient identification.
90001	01MAR2019	09DEC2020	N	A flag fall service to which item 90020, 90035, 90043 or 90051 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90001	10DEC2020	31OCT2023	N	A flag fall service to which item 2733, 2735, 90020, 90035, 90043, 90051, 93287, 93288, 93400, 93401, 93402, 93403, 93421, 93469 or 93470 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90001	01NOV2023	30JUN2024	N	For the first patient attended during one attendance by a general practitioner at one residential aged care facility on one occasion, the fee for the medical service described in whichever of items 90020, 90035, 90043, 90051 or 90054 applies is the amount listed in the item plus $60.55.
90001	01JUL2024	31DEC9999	Y	For the first patient attended during one attendance by a general practitioner at one residential aged care facility on one occasion, the fee for the medical service described in whichever of items 90020, 90035, 90043, 90051 or 90054 applies is the amount listed in the item plus $62.65.
90002	01MAR2019	09DEC2020	N	A flag fall service to which item 90092, 90093, 90095, 90096, 90183, 90188, 90202 or 90212 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90002	10DEC2020	31OCT2023	N	A flag fall service to which item 941, 942, 90092, 90093, 90095, 90096, 90183, 90188, 90202, 90212, 93291, 93292, 93431, 93432, 93433, 93434, 93451, 93475 and 93479 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90002	01NOV2023	30JUN2024	N	For the first patient attended during one attendance by a medical practitioner at one residential aged care facility on one occasion, the fee for the medical service described in whichever of items 90092, 90093, 90095, 90096, 90098, 90183, 90188, 90202, 90212 or 90215 applies is the amount listed in the item plus $43.95.
90002	01JUL2024	31DEC9999	Y	For the first patient attended during one attendance by a medical practitioner at one residential aged care facility on one occasion, the fee for the medical service described in whichever of items 90092, 90093, 90095, 90096, 90098, 90183, 90188, 90202, 90212 or 90215 applies is the amount listed in the item plus $45.50.
90003	10DEC2020	31DEC9999	Y	A flag fall service to which item 93312, 93313, 93316, 93319, 93322, 93323, 93326, 93327, 93375, 93376, 93381, 93382, 93383, 93384, 93385 and 93386 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90004	10DEC2020	31DEC9999	Y	A flag fall service to which any item in the following groups apply: Group M29 (other than 93537 and 93538) Group M30 (other than 93592 and 93593) Group M31 For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on.
90005	14JUN2021	31DEC2021	N	A flag fall service to which item 93624, 93625, 93626, 93627, 93634, 93635, 93636, 93637, 93644, 93645, 93646, 93647, 93653, 93654, 93655 or 93656 applies. For the first patient attended during one attendance by a general practitioner or by a medical practitioner (other than a general practitioner) at: a. one residential aged care facility, or at consulting rooms situated within such a complex, on one occasion; orb. one residential disability setting facility, or at consulting rooms situated within such a complex, on one occasion; or c. a persons place of residence (other than a residential aged care facility) on one occasion.
90005	01JAN2022	31JAN2023	N	A flag fall service to which item 93624, 93625, 93626, 93627, 93634, 93635, 93636, 93637, 93644, 93645, 93646, 93647, 93653, 93654, 93655, 93656, 93660 or 93661 applies. For the first patient attended during one attendance by a general practitioner or by a medical practitioner (other than a general practitioner) at: a. one residential aged care facility, or at consulting rooms situated within such a complex, on one occasion; orb. one residential disability setting facility, or at consulting rooms situated within such a complex, on one occasion; or c. a persons place of residence (other than a residential aged care facility) on one occasion.
90005	01FEB2023	31DEC9999	Y	A flag fall service to which item 93644, 93645, 93646, 93647, 93653, 93654, 93655, 93656, 93660 or 93661 applies. For the first patient attended during one attendance by a general practitioner or by a medical practitioner (other than a general practitioner) at: (a) one residential aged care facility, or at consulting rooms situated within such a complex, on one occasion; or (b) one residential disability setting facility, or at consulting rooms situated within such a complex, on one occasion; or (c) a persons place of residence (other than a residential aged care facility) on one occasion.
90020	01MAR2019	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in a residential aged care facility (other than accommodation in a self-contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-an attendance on one or more patients at one residential aged care facility on one occasion - each patient.
90035	01MAR2019	31OCT2023	N	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
90035	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner, on care recipients in a residential aged care facility, other than a service to which another item applies, lasting at least 6 minutes and less than 20 minutes and including any of the following that are clinically relevant:(a) taking a patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient (subject to clause 2.30.1)
90043	01MAR2019	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
90051	01MAR2019	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient
90054	01NOV2023	31DEC9999	Y	Professional attendance by a general practitioner, on care recipients in a residential aged care facility, other than a service to which another item applies, lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) performing a clinical examination;(c) arranging any necessary investigation;(d) implementing a management plan;(e) providing appropriate preventive health care;for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient (subject to clause 2.30.1)
90092	01MAR2019	31OCT2019	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies.
90092	01NOV2019	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner who is not a general practitioner.
90093	01MAR2019	31OCT2019	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies.
90093	01NOV2019	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner who is not a general practitioner.
90095	01MAR2019	31OCT2019	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies.
90095	01NOV2019	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner who is not a general practitioner.
90096	01MAR2019	31OCT2019	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies.
90096	01NOV2019	31OCT2023	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner who is not a general practitioner.
90096	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is a care recipient in the facility who is not a resident of a self-contained unit, lasting more than 45 minutes, but less than 60 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient (subject to clause 2.30.1), by a medical practitioner who is not a general practitioner
90098	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms within such a complex, if the patient is a care recipient in the facility who is not a resident of a self-contained unit, lasting more than 60 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a medical practitioner who is not a general practitioner-each patient (subject to subclause 2.30.1(2))
90183	01MAR2019	31OCT2023	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by medical practitioner in an eligible area.
90183	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms within such a complex, if the patient is a care recipient in the facility who is not a resident of a self contained unit, lasting not more than 5 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a prescribed medical practitioner in an eligible area-each patient (subject to subclause 2.30.1(2))
90188	01MAR2019	31OCT2023	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area.
90188	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms within such a complex, if the patient is a care recipient in the facility who is not a resident of a self contained unit, lasting more than 5 minutes but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a prescribed medical practitioner in an eligible area-each patient (subject to subclause 2.30.1(2))
90202	01MAR2019	31OCT2023	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area.
90202	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms within such a complex, if the patient is a care recipient in the facility who is not a resident of a self contained unit, lasting more than 25 minutes but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a prescribed medical practitioner in an eligible area-each patient (subject to subclause 2.30.1(2))
90212	01MAR2019	31OCT2023	N	Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by a medical practitioner in an eligible area.
90212	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is a care recipient in the facility who is not a resident of a self-contained unit, lasting more than 45 minutes but not more than 60 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a prescribed medical practitioner in an eligible area-each patient (subject to subclause 2.30.1(2))
90215	01NOV2023	31DEC9999	Y	Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is a care recipient in the facility who is not a resident of a self-contained unit, lasting more than 60 minutes-an attendance on one or more patients at one residential aged care facility on one occasion by a prescribed medical practitioner in an eligible area-each patient (subject to subclause 2.30.1(2))
90250	01NOV2019	28FEB2021	N	Professional attendance by a general practitioner who has not undertaken mental health skills training (not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90250	01MAR2021	31DEC9999	Y	Professional attendance by a general practitioner to prepare an eating disorder treatment and management plan, lasting at least 20 minutes but less than 40 minutes.
90251	01NOV2019	28FEB2021	N	Professional attendance by a general practitioner who has not undertaken mental health skills training (not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90251	01MAR2021	31DEC9999	Y	Professional attendance by a general practitioner to prepare an eating disorder treatment and management plan, lasting at least 40 minutes
90252	01NOV2019	28FEB2021	N	Professional attendance by a general practitioner who has undertaken mental health skills training (not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90252	01MAR2021	31DEC9999	Y	Professional attendance by a general practitioner to prepare an eating disorder treatment and management plan, lasting at least 20 minutes but less than 40 minutes, if the practitioner has successfully completed mental health skills training.
90253	01NOV2019	28FEB2021	N	Professional attendance by a general practitioner who has undertaken mental health skills training (not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90253	01MAR2021	31DEC9999	Y	Professional attendance by a general practitioner to prepare an eating disorder treatment and management plan, lasting at least 40 minutes, if the practitioner has successfully completed mental health skills training.
90254	01NOV2019	28FEB2021	N	Professional attendance by a medical practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if:(a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90254	01MAR2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner, specialist or consultant physician) to prepare an eating disorder treatment and management plant, lasting at least 20 minutes but less than 40 minutes.
90255	01NOV2019	28FEB2021	N	Professional attendance by a medical practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90255	01MAR2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner, specialist or consultant physician) to prepare an eating disorder treatment and management plan, lasting at least 40 minutes.
90256	01NOV2019	28FEB2021	N	Professional attendance by a medical practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90256	01MAR2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner, specialist or consultant physician) to prepare an eating disorder treatment and management plan, lasting at least 20 minutes but less than 40 minutes, if the practitioner has successfully completed mental health skills training.
90257	01NOV2019	28FEB2021	N	Professional attendance by a medical practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90257	01MAR2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner, specialist or consultant physician) to prepare an eating disorder treatment and management plan, lasting at least 40 minutes, if the practitioner has successfully completed mental health skills training.
90260	01NOV2019	28FEB2021	N	Professional attendance of at least 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
90260	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a consultant physician in the practice of the physicians specialty of psychiatry to prepare an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance lasts at least 45 minutes
90261	01NOV2019	28FEB2021	N	Professional attendance of at least 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
90261	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a consultant physician in the practice of the physicians specialty of paediatrics to prepare an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance lasts at least 45 minutes
90262	01NOV2019	28FEB2021	N	Professional attendance of at least 45 minutes in duration by video conference by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
90262	01MAR2021	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the physicians specialty of psychiatry to prepare an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance is by video conference and lasts at least 45 minutes
90263	01NOV2019	28FEB2021	N	Professional attendance of at least 45 minutes in duration by video conference by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
90263	01MAR2021	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the physicians specialty of paediatrics to prepare an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance is by video conference and lasts at least 45 minutes
90264	01NOV2019	28FEB2021	N	Professional attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
90264	01MAR2021	31DEC9999	Y	Professional attendance by a general practitioner to review an eating disorder treatment and management plan.
90265	01NOV2019	28FEB2021	N	Professional attendance by a medical practitioner to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
90265	01MAR2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner, specialist or consultant physician) to review an eating disorder treatment and management plan.
90266	01NOV2019	28FEB2021	N	Professional attendance of at least 30 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to:: (A) the patient; and (B) is the patients carer (if any), if the patient agrees.
90266	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a consultant physician in the practice of the physicians specialty of psychiatry to review an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance lasts at least 30 minutes
90267	01NOV2019	28FEB2021	N	Professional attendance of at least 20 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patients carer (if any), if the patient agrees.
90267	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a consultant physician in the practice of the physicians specialty of paediatrics to review an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance lasts at least 20 minutes
90268	01NOV2019	28FEB2021	N	Professional attendance of at least 30 minutes in duration by video conference by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patients carer (if any), if the patient agrees.
90268	01MAR2021	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the physicians specialty of psychiatry to review an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance is by video conference and lasts at least 30 minutes
90269	01NOV2019	28FEB2021	N	Professional attendance of at least 20 minutes in duration by video conference by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patients carer (if any), if the patient agrees.
90269	01MAR2021	31DEC9999	Y	Professional attendance by a consultant physician in the practice of the physicians specialty of paediatrics to review an eating disorder treatment and management plan, if: (a) the patient is referred; and (b) the attendance is by video conference and lasts at least 20 minutes
90271	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90271	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes.
90272	01NOV2019	28FEB2021	N	Professional attendance at a place other than consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan
90272	01MAR2021	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes.
90273	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90273	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes.
90274	01NOV2019	28FEB2021	N	Professional attendance at a place other than consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90274	01MAR2021	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes.
90275	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90275	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes.
90276	01NOV2019	28FEB2021	N	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90276	01MAR2021	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes.
90277	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90277	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes.
90278	01NOV2019	28FEB2021	N	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
90278	01MAR2021	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes.
90279	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner.
90279	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes, if the attendance is by video conference .
90280	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner
90280	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes, if the attendance is by video conference.
90281	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if:(a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner.
90281	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 30 minutes but less than 40 minutes, if the attendance is by video conference.
90282	01NOV2019	28FEB2021	N	Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if:(a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner.
90282	01MAR2021	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (other than a general practitioner, specialist or consultant physician) to provide treatment under an eating disorder treatment and management plan, lasting at least 40 minutes, if the attendance is by video conference.
90300	01JUL2021	31DEC2021	N	Professional attendance by a cardiothoracic surgeon in the practice of the surgeons speciality, if: (a) the service is performed in conjunction with a service (the lead extraction service) to which item 38358 applies; and (b) the surgeon is: (i) either performing, or providing surgical backup for the provider (who is not a cardiothoracic surgeon) who is performing, the lead extraction service; and (i) present for the duration of the lead extraction service, other than during the low risk pre and post extraction phases; and (iii) able to immediately scrub in and perform a thoracotomy if major complications occur (H)
90300	01JAN2022	31OCT2023	N	Professional attendance by a cardiothoracic surgeon in the practice of the surgeons speciality, if: (a) the service is performed in conjunction with a service (the lead extraction service) to which item 38358 applies; and (b) the surgeon is: (i) providing surgical backup for the provider (who is not a cardiothoracic surgeon) who is performing, the lead extraction service; and (ii) present for the duration of the lead extraction service, other than during the low risk pre and post extraction phases; and (iii) able to immediately scrub in and perform a thoracotomy if major complications occur (H)
90300	01NOV2023	31OCT2024	N	Professional attendance by a cardiothoracic surgeon in the practice of the surgeons speciality, if: (a) the service is: (i) performed in conjunction with a service (the lead extraction service) to which item 38358 applies; or (ii) performed in conjunction with a service (the leadless pacemaker extraction service) to which item 38373 or 38374 applies; and (b) the surgeon: (i) is providing surgical backup for the provider (who is not a cardiothoracic surgeon) who is performing the lead extraction service or the leadless pacemaker extraction service; and (ii) is present for the duration of the lead extraction service or the leadless pacemaker extraction service, other than during the low risk pre and post extraction phases; and (iii) is able to immediately scrub in and perform a thoracotomy if major complications occur (H)
90300	01NOV2024	31DEC9999	Y	Professional attendance by a cardiothoracic surgeon in the practice of the surgeons speciality, if: (a) the service is: performed in conjunction with a service (the lead extraction service) to which item 38358 applies; or performed in conjunction with a service (the leadless pacemaker extraction service) to which item 38373 or 38374 applies; or performed in conjunction with a service (the TAVI intermediate or low surgical risk service) to which item 38514 or 38522 applies); and (b) the surgeon: is providing surgical backup for the provider (who is not a cardiothoracic surgeon) who is performing the lead extraction service, the leadless pacemaker extraction service or the TAVI intermediate or low surgical risk service; and is present for the duration of the lead extraction service, the leadless pacemaker extraction service or the TAVI intermediate or low surgical risk service, other than during the low risk pre and post extraction or transcatheter aortic valve implantation phases; and is able to immediately scrub in and perform a thoracotomy if major complications occur (H)
91000	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes but less than 50 minutes duration
91001	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 30 minutes but less than 50 minutes duration
91005	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist in accordance with the requirements of item 91000
91010	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration
91011	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 50 minutes duration
91015	17JAN2020	31DEC9999	Y	Psychological therapy health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist in accordance with the requirements of item 91010
91100	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes duration
91101	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 20 minutes but less than 50 minutes duration
91105	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist in accordance with the requirements of item 91100
91110	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration
91111	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 50 minutes duration
91115	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist in accordance with the requirements of item 91110
91125	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes duration
91126	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 20 minutes but less than 50 minutes duration
91130	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist in accordance with the requirements of item 91125
91135	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration
91136	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 50 minutes duration
91140	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist in accordance with the requirements of item 91135
91150	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes duration
91151	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 20 minutes but less than 50 minutes duration
91155	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker in accordance with the requirements of item 91150
91160	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration
91161	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c) the attendance is by video conference; and (d) the patient is not an admitted patient; and (e) the service is at least 50 minutes duration
91165	17JAN2020	31DEC9999	Y	Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker in accordance with the requirements of item 91160
91166	13MAR2020	29MAR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible clinical psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration; where the service is bulk-billed
91166	30MAR2020	05APR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration; where the service is bulk-billed
91166	06APR2020	19APR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91166	20APR2020	31DEC2021	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration.
91166	01JAN2022	31DEC9999	Y	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration
91167	13MAR2020	29MAR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible clinical psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration; where the service is bulk-billed
91167	30MAR2020	05APR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; where the service is bulk-billed
91167	06APR2020	19APR2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91167	20APR2020	31DEC2021	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91167	01JAN2022	31DEC9999	Y	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91168	01MAR2023	31DEC9999	Y	Telehealth attendance for a psychological therapy health service provided by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 30 minutes but less than 50 minutes
91169	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (g) the service is at least 20 minutes but less than 50 minutes duration; where the service is bulk-billed
91169	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration; where the service is bulk-billed
91169	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91169	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91169	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91170	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration; where the service is bulk-billed
91170	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; where the service is bulk-billed
91170	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91170	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91170	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91171	01MAR2023	31DEC9999	Y	Telehealth attendance for a psychological therapy health service provided by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
91172	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible occupational therapist is a health professional at risk of COVID-19 virus; and (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91172	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91172	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91172	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91172	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91173	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible occupational therapist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration where the service is bulk-billed
91173	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration where the service is bulk-billed
91173	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91173	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration.
91173	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration
91174	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
91175	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible social worker is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91175	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91175	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91175	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91175	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91176	13MAR2020	29MAR2020	N	91176Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible social worker is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration where the service is bulk-billed
91176	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration where the service is bulk-billed
91176	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91176	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91176	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91177	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
91178	13MAR2020	29MAR2020	N	Telehealth attendance by a participating nurse practitioner lasting less than 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventive health care; where the service is bulk-billed.
91178	30MAR2020	05APR2020	N	Telehealth attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91178	06APR2020	19APR2020	N	Telehealth attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91178	20APR2020	31DEC9999	Y	Telehealth attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91179	13MAR2020	29MAR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventive health care; where the service is bulk-billed.
91179	30MAR2020	05APR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91179	06APR2020	19APR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91179	20APR2020	31DEC9999	Y	Telehealth attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91180	13MAR2020	29MAR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 40 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventive health care; where the service is bulk-billed.
91180	30MAR2020	05APR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91180	06APR2020	19APR2020	N	Telehealth attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91180	20APR2020	31DEC9999	Y	Telehealth attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91181	13MAR2020	29MAR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible clinical psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration; where the service is bulk-billed
91181	30MAR2020	05APR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration; where the service is bulk-billed
91181	06APR2020	19APR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91181	20APR2020	31DEC2021	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration.
91181	01JAN2022	31DEC9999	Y	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 30 minutes but less than 50 minutes duration
91182	13MAR2020	29MAR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible clinical psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration; where the service is bulk-billed
91182	30MAR2020	05APR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; where the service is bulk-billed
91182	06APR2020	19APR2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91182	20APR2020	31DEC2021	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91182	01JAN2022	31DEC9999	Y	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91183	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (g) the service is at least 20 minutes but less than 50 minutes duration; where the service is bulk-billed
91183	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration; where the service is bulk-billed
91183	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91183	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91183	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91184	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible psychologist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration; where the service is bulk-billed
91184	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; where the service is bulk-billed
91184	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91184	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91184	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91185	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible occupational therapist is a health professional at risk of COVID-19 virus; and (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91185	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91185	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91185	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91185	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91186	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible occupational therapist is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration where the service is bulk-billed
91186	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration where the service is bulk-billed
91186	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91186	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration.
91186	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes in duration
91187	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible social worker is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91187	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration where the service is bulk-billed
91187	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91187	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration.
91187	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 20 minutes but less than 50 minutes duration
91188	13MAR2020	29MAR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the eligible social worker is a health professional at risk of COVID-19 virus; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration where the service is bulk-billed
91188	30MAR2020	05APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration where the service is bulk-billed
91188	06APR2020	19APR2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91188	20APR2020	31DEC2021	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan, or as part of a shared care plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration.
91188	01JAN2022	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; or (iii) a specialist or consultant physician specialising in the practice of his or her field of paediatrics; and (b) the service is provided to the person individually; and (c) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (d) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (e) the service is at least 50 minutes duration
91189	13MAR2020	29MAR2020	N	Phone attendance by a participating nurse practitioner lasting less than 20 minutes if: (a) The attendance is where: (i) The person is at risk of COVID-19 virus; or (ii) The participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) The attendance includes any of the following that are clinically relevant: (i) taking a history; (ii) undertaking clinical examination; (iii) arranging any necessary investigation; (iv) implementing a management plan; (v) providing appropriate preventive health care; where the service is bulk-billed.
91189	30MAR2020	05APR2020	N	Phone attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91189	06APR2020	19APR2020	N	Phone attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91189	20APR2020	31DEC9999	Y	Phone attendance by a participating nurse practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91190	13MAR2020	29MAR2020	N	Phone attendance by a participating nurse practitioner lasting at least 20 minutes if: (a) The attendance is where: (i) The person is at risk of COVID-19 virus; or (ii) The participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) The attendance includes any of the following that are clinically relevant: (i) taking a history; (ii) undertaking clinical examination; (iii) arranging any necessary investigation; (iv) implementing a management plan; (v) providing appropriate preventive health care; where the service is bulk-billed.
91190	30MAR2020	05APR2020	N	Phone attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91190	06APR2020	19APR2020	N	Phone attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91190	20APR2020	31DEC9999	Y	Phone attendance by a participating nurse practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91191	13MAR2020	29MAR2020	N	Phone attendance by a participating nurse practitioner lasting at least 40 minutes if: (a) The attendance is where: (i) The person is at risk of COVID-19 virus; or (ii) The participating nurse practitioner is a health professional at risk of COVID-19 virus; and (b) The attendance includes any of the following that are clinically relevant: (i) taking a history; (ii) undertaking clinical examination; (iii) arranging any necessary investigation; (iv) implementing a management plan; (v) providing appropriate preventive health care; where the service is bulk-billed.
91191	30MAR2020	05APR2020	N	Phone attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; where the service is bulk-billed
91191	06APR2020	19APR2020	N	Phone attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91191	20APR2020	31DEC9999	Y	Phone attendance by a participating nurse practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care.
91192	13MAR2020	29MAR2020	N	Telehealth attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management, if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the participating nurse practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91192	30MAR2020	05APR2020	N	Telehealth attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; where the service is bulk-billed
91192	06APR2020	19APR2020	N	Telehealth attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91192	20APR2020	31DEC9999	Y	Telehealth attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management.
91193	13MAR2020	29MAR2020	N	Phone attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management, if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the participating nurse practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91193	30MAR2020	05APR2020	N	Phone attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management, where the service is bulk-billed
91193	06APR2020	19APR2020	N	Phone attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91193	20APR2020	31DEC9999	Y	Phone attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management.
91194	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
91195	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 50 minutes
91196	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner and (c) the service lasts at least 20 minutes but less than 50 minutes
91197	01MAR2023	31DEC9999	Y	Telehealth attendance for a focussed psychological strategies health service provided by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 50 minutes
91198	01MAR2023	31DEC9999	Y	Phone attendance for a psychological therapy health service provided by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 30 minutes but less than 50 minutes
91199	01MAR2023	31DEC9999	Y	Phone attendance for a psychological therapy health service provided by an eligible clinical psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible clinical psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
91200	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
91201	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible psychologist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible psychologist by a referring practitioner; and (c) the service lasts at least 50 minutes
91202	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
91203	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible occupational therapist to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible occupational therapist by a referring practitioner; and (c) the service lasts at least 50 minutes
91204	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 20 minutes but less than 50 minutes
91205	01MAR2023	31DEC9999	Y	Phone attendance for a focussed psychological strategies health service provided by an eligible social worker to a person other than the patient, if: (a) the service is part of the patients treatment; (b) the patient has been referred to the eligible social worker by a referring practitioner; and (c) the service lasts at least 50 minutes
91211	13MAR2020	29MAR2020	N	Short antenatal telehealth attendance by a participating midwife, lasting up to 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91211	30MAR2020	05APR2020	N	Short antenatal telehealth attendance by a participating midwife, lasting up to 40 minutes, where the service is bulk-billed
91211	06APR2020	19APR2020	N	Short antenatal telehealth attendance by a participating midwife, lasting up to 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91211	20APR2020	31DEC9999	Y	Short antenatal telehealth attendance by a participating midwife, lasting up to 40 minutes.
91212	13MAR2020	29MAR2020	N	Long antenatal telehealth attendance by a participating midwife, lasting at least 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91212	30MAR2020	05APR2020	N	Long antenatal telehealth attendance by a participating midwife, lasting at least 40 minutes, where the service is bulk-billed
91212	06APR2020	19APR2020	N	Long antenatal telehealth attendance by a participating midwife, lasting at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91212	20APR2020	31DEC9999	Y	Long antenatal telehealth attendance by a participating midwife, lasting at least 40 minutes.
91214	13MAR2020	29MAR2020	N	Short postnatal telehealth attendance by a participating midwife, lasting up to 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91214	30MAR2020	05APR2020	N	Short postnatal telehealth attendance by a participating midwife, lasting up to 40 minutes, where the service is bulk-billed
91214	06APR2020	19APR2020	N	Short postnatal telehealth attendance by a participating midwife, lasting up to 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91214	20APR2020	31DEC9999	Y	Short postnatal telehealth attendance by a participating midwife, lasting up to 40 minutes.
91215	13MAR2020	29MAR2020	N	Long postnatal telehealth attendance by a participating midwife, lasting at least 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91215	30MAR2020	05APR2020	N	Long postnatal telehealth attendance by a participating midwife, lasting at least 40 minutes, where the service is bulk-billed
91215	06APR2020	19APR2020	N	Long postnatal telehealth attendance by a participating midwife, lasting at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91215	20APR2020	31DEC9999	Y	Long postnatal telehealth attendance by a participating midwife, lasting at least 40 minutes.
91218	13MAR2020	29MAR2020	N	Short antenatal phone attendance by a participating midwife, lasting up to 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91218	30MAR2020	05APR2020	N	Short antenatal phone attendance by a participating midwife, lasting up to 40 minutes, where the service is bulk-billed
91218	06APR2020	19APR2020	N	Short antenatal phone attendance by a participating midwife, lasting up to 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91218	20APR2020	31DEC9999	Y	Short antenatal phone attendance by a participating midwife, lasting up to 40 minutes.
91219	13MAR2020	29MAR2020	N	Long antenatal phone attendance by a participating midwife, lasting at least 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91219	30MAR2020	05APR2020	N	Long antenatal phone attendance by a participating midwife, lasting at least 40 minutes, where the service is bulk-billed
91219	06APR2020	19APR2020	N	Long antenatal phone attendance by a participating midwife, lasting at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91219	20APR2020	31DEC9999	Y	Long antenatal phone attendance by a participating midwife, lasting at least 40 minutes.
91221	13MAR2020	29MAR2020	N	Short postnatal phone attendance by a participating midwife, lasting up to 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91221	30MAR2020	05APR2020	N	Short postnatal phone attendance by a participating midwife, lasting up to 40 minutes, where the service is bulk-billed
91221	06APR2020	19APR2020	N	Short postnatal phone attendance by a participating midwife, lasting up to 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91221	20APR2020	31DEC9999	Y	Short postnatal phone attendance by a participating midwife, lasting up to 40 minutes.
91222	13MAR2020	29MAR2020	N	Long postnatal phone attendance by a participating midwife, lasting at least 40 minutes, if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the participating midwife is a health professional at risk of COVID-19 virus; and (b) the attendance is bulk-billed
91222	30MAR2020	05APR2020	N	Long postnatal phone attendance by a participating midwife, lasting at least 40 minutes, where the service is bulk-billed
91222	06APR2020	19APR2020	N	Long postnatal phone attendance by a participating midwife, lasting at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91222	20APR2020	31DEC9999	Y	Long postnatal phone attendance by a participating midwife, lasting at least 40 minutes.
91283	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration
91285	17JAN2020	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration
91286	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration
91287	17JAN2020	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration
91371	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the service is at least 30 minutes but less than 40 minutes duration
91372	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the service is at least 40 minutes duration
91721	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration
91723	17JAN2020	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration
91725	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration
91727	17JAN2020	31DEC9999	Y	Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration
91729	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the service is at least 30 minutes but less than 40 minutes duration
91731	17JAN2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the services is at least 40 minutes duration
91790	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91790	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; where the service is bulk-billed
91790	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91790	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and(b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91790	01OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91792	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner of not more than 5 minutes if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91792	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner of not more than 5 minutes; where the service is bulk-billed
91792	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91792	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91792	01OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91794	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner, in an eligible area, of not more than 5 minutes if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91794	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes; where the service is bulk-billed
91794	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91794	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91794	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91794	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of not more than 5 minutes NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91795	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91795	30MAR2020	05APR2020	N	Phone attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; where the service is bulk-billed
91795	06APR2020	19JUL2020	N	Phone attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91795	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91795	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91797	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner of not more than 5 minutes if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91797	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner of not more than 5 minutes; where the service is bulk-billed
91797	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91797	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91797	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner of not more than 5 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91799	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, in an eligible area, of not more than 5 minutes if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; where the service is bulk-billed
91799	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes; where the service is bulk-billed
91799	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91799	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91799	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91800	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner lasting less than 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91800	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91800	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91800	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91800	01OCT2020	31OCT2023	N	Telehealth attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91800	01NOV2023	31DEC9999	Y	Telehealth attendance by a general practitioner lasting at least 6 minutes but less than 20 minutes if the attendance includes any of the following that are clinically relevant:(a) taking a short patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventative health care
91801	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner lasting at least 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91801	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91801	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91801	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91801	01OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91802	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner lasting at least 40 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91802	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91802	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91802	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91802	01OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91803	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91803	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91803	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91803	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91803	01OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91804	13MAR2020	29MAR2020	N	TTelehealth attendance by a medical practitioner of more than 25 minutes in duration but not more than 45 minutes if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91804	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91804	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91804	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91804	01OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91805	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner of at least 45 minutes in duration if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91805	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91805	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91805	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91805	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91805	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner) of more than 45 minutes in duration but not more than 60 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91806	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner, in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91806	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91806	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91806	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91806	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91806	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91807	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner, in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91807	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91807	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91807	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91807	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91807	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91808	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner, in an eligible area, of at least 45 minutes in duration if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91808	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91808	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91808	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91808	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91808	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 45 minutes in duration but not more than 60 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91809	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner lasting less than 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91809	30MAR2020	05APR2020	N	Phone attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91809	06APR2020	19JUL2020	N	Phone attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91809	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; and (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91809	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner lasting less than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; and (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91810	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner lasting at least 20 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91810	30MAR2020	05APR2020	N	Phone attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91810	06APR2020	19JUL2020	N	Phone attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91810	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91810	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91811	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner lasting at least 40 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91811	30MAR2020	05APR2020	N	Phone attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91811	06APR2020	19JUL2020	N	Phone attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91811	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91811	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91812	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91812	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91812	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91812	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91812	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91813	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner of at least 25 minutes in duration but not more than 45 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91813	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner of at least 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91813	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner of at least 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91813	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner of at least 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91813	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner of at least 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91814	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner of at least 45 minutes in duration if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91814	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91814	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91814	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91814	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner of at least 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91815	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a short patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91815	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91815	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91815	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91815	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 25 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91816	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91816	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91816	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91816	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91816	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 25 minutes in duration but not more than 45 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91817	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, in an eligible area, of more than 45 minutes in duration if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the attendance includes any of the following that are clinically relevant: (i) taking an extensive patient history; (ii) arranging any necessary investigation (iii) implementing a management plan; (iv) providing appropriate preventative health care; where the service is bulk-billed
91817	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care; where the service is bulk-billed
91817	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91817	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that: (a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91817	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 45 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation (c) implementing a management plan; (d) providing appropriate preventative health care. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91818	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91818	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91818	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91818	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91818	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91818	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes.
91819	13MAR2020	29MAR2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes; where the service is bulk-billed
91819	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes; where the service is bulk-billed
91819	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91819	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91819	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91819	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes.
91820	13MAR2020	29MAR2020	N	Telehealth attendance by a medical practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91820	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91820	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91820	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91820	01OCT2020	30JUN2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91820	01JUL2021	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
91820	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes.
91820	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes
91821	13MAR2020	29MAR2020	N	91821Telehealth attendance by a medical practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes; where the service is bulk-billed
91821	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes; where the service is bulk-billed
91821	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91821	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91821	01OCT2020	30JUN2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91821	01JUL2021	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
91821	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes.
91821	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes
91822	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91822	30MAR2020	05APR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91822	06APR2020	19APR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91822	20APR2020	31DEC9999	Y	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91823	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is after the first attendance as part of a single course of treatment.
91823	30MAR2020	05APR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is after the first attendance as part of a single course of treatment.
91823	06APR2020	19APR2020	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is after the first attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91823	20APR2020	31DEC9999	Y	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is after the first attendance as part of a single course of treatment.
91824	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant physician is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91824	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91824	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91824	20APR2020	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91825	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant physician is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91825	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91825	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is not a minor attendance after the first as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91825	20APR2020	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91826	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91826	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91826	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is a minor attendance after the first as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91826	20APR2020	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91827	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was not more than 15 minutes duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91827	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; and (c) the service is bulk-billed.
91827	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91827	20APR2020	29FEB2024	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration.
91827	01MAR2024	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes in duration; if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306, 308, 91828 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91828	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91828	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (c) the service is bulk-billed.
91828	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91828	20APR2020	29FEB2024	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration.
91828	01MAR2024	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; if that attendance and another attendance to which item 296, 297, 299, or any of items 300, 302, 304, 306 to 308, 91827, 91829 to 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91829	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91829	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (c) the service is bulk-billed.
91829	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91829	20APR2020	29FEB2024	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration.
91829	01MAR2024	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration; if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827, 91828, 91830, 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91830	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91830	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (c) the service is bulk-billed.
91830	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91830	20APR2020	29FEB2024	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration.
91830	01MAR2024	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration; if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827 to 91829, 91831, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91831	13MAR2020	29MAR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 75 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91831	30MAR2020	05APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration; and (c) the service is bulk-billed.
91831	06APR2020	19APR2020	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91831	20APR2020	29FEB2024	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration.
91831	01MAR2024	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration; if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827 to 91830, 91837 to 91839 and 92437 applies have not exceeded 50 attendances in a calendar year.
91832	13MAR2020	29MAR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91832	30MAR2020	05APR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91832	06APR2020	19APR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91832	20APR2020	31DEC9999	Y	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91833	13MAR2020	29MAR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is after the first attendance as part of a single course of treatment.
91833	30MAR2020	05APR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is after the first attendance as part of a single course of treatment.
91833	06APR2020	19APR2020	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is after the first attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91833	20APR2020	31DEC9999	Y	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is after the first attendance as part of a single course of treatment.
91834	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant physician is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91834	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91834	06APR2020	19APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91834	20APR2020	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance was other than a second or subsequent attendance as part of a single course of treatment.
91835	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant physician is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91835	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91835	06APR2020	19APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is not a minor attendance after the first as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91835	20APR2020	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is not a minor attendance after the first as part of a single course of treatment.
91836	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the specialist is a health professional at risk of COVID-19 virus; and(b) the attendance follows referral of the patient to the specialist; and(c) the attendance was of more than 5 minutes in duration; and(d) the patient is not an admitted patient; and(e) the service is bulk-billed. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91836	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the service is bulk-billed. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91836	06APR2020	19APR2020	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is a minor attendance after the first as part of a single course of treatment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91836	20APR2020	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration. Where the attendance is a minor attendance after the first as part of a single course of treatment.
91837	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was not more than 15 minutes duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91837	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; and (c) the service is bulk-billed.
91837	06APR2020	19APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91837	20APR2020	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration.
91837	01JAN2022	29FEB2024	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; Where the attendance is after the first attendance as part of a single course of treatment
91837	01MAR2024	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; Where the attendance is after the first attendance as part of a single course of treatment, if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827 to 91831, 91838, 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91838	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91838	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (c) the service is bulk-billed
91838	06APR2020	19APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91838	20APR2020	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration.
91838	01JAN2022	29FEB2024	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; Where the attendance is after the first attendance as part of a single course of treatment
91838	01MAR2024	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; Where the attendance is after the first attendance as part of a single course of treatment, if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827 to 91831, 91837, 91839 and 92437 applies have not exceeded 50 attendances in a calendar year
91839	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant psychiatrist; if:(f) the attendance is where: (j) the person is a patient at risk of COVID-19 virus; or (jj) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (g) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (h) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (i) the patient is not an admitted patient; and (j) the service is bulk-billed.
91839	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (c) the service is bulk-billed.
91839	06APR2020	19APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91839	20APR2020	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration.
91839	01JAN2022	29FEB2024	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration Where the attendance is after the first attendance as part of a single course of treatment
91839	01MAR2024	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration Where the attendance is after the first attendance as part of a single course of treatment, if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306 to 308, 91827 to 91831, 91837, 91838 and 92437 applies have not exceeded 50 attendances in a calendar year
91840	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and (b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (c) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91840	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (c) the service is bulk-billed.
91840	06APR2020	19APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91840	20APR2020	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration.
91841	13MAR2020	29MAR2020	N	Phone attendance for a person by a consultant psychiatrist; if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the consultant psychiatrist is a health professional at risk of COVID-19 virus; and(b) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and(c) the attendance was at least 75 minutes in duration; and(d) the patient is not an admitted patient; and (e) the service is bulk-billed.
91841	30MAR2020	05APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration; and (c) the service is bulk-billed.
91841	06APR2020	19APR2020	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91841	20APR2020	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration.
91842	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91842	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91842	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91842	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91842	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91842	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes.
91843	13MAR2020	29MAR2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the general practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes; where the service is bulk-billed
91843	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes; where the service is bulk-billed
91843	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91843	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91843	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91843	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes.
91844	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91844	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes; where the service is bulk-billed
91844	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91844	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91844	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91844	21JUL2021	31OCT2023	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes.
91844	01NOV2023	31DEC9999	Y	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 30 minutes, but less than 40 minutes
91845	13MAR2020	29MAR2020	N	Phone attendance by a medical practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if:(a) the attendance is where: (i) the person is a patient at risk of COVID-19 virus; or (ii) the medical practitioner is a health professional at risk of COVID-19 virus; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes; where the service is bulk-billed
91845	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes; where the service is bulk-billed
91845	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91845	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
91845	01OCT2020	30JUN2021	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91845	01JUL2021	20JUL2021	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
91845	21JUL2021	31OCT2023	N	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes.
91845	01NOV2023	31DEC9999	Y	Phone attendance by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (b) the service lasts at least 40 minutes
91846	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
91846	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
91847	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is after the first attendance as part of a single course of treatment
91847	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is after the first attendance as part of a single course of treatment
91848	15SEP2021	31DEC2021	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
91848	01JAN2022	31DEC9999	Y	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
91849	15SEP2021	31DEC2021	N	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is after the first attendance as part of a single course of treatment
91849	01JAN2022	31DEC9999	Y	Phone attendance for a person by a specialist in the practice of the specialists specialty if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is after the first attendance as part of a single course of treatment
91850	13MAR2020	29MAR2020	N	Antenatal telehealth service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(b) the service is provided on behalf of, and under the supervision of, a medical practitioner; and(c) the service is provided at, or from, a practice location in a regional, rural or remote area; and(d) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and(e) the service is not provided for an admitted patient of a hospital or approved day facility; and (f) The service is bulk billed.
91850	30MAR2020	05APR2020	N	Antenatal telehealth service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and (d) the service is bulk billed.
91850	06APR2020	19APR2020	N	Antenatal telehealth service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91850	20APR2020	30APR2023	N	Antenatal telehealth service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner.
91850	01MAY2023	31DEC9999	Y	Antenatal telehealth service provided by a practice midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner.
91851	13MAR2020	29MAR2020	N	Postnatal telehealth attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(b) is between 4 and 8 weeks after the birth; and(c) lasts at least 20 minutes in duration; and(d) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and(e) is for a pregnancy in relation to which a service to which item 82140 applies is not provided; and (f) the service is bulk billed. Applicable once for a pregnancy
91851	30MAR2020	05APR2020	N	Postnatal telehealth attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided; and (e) the service is bulk billed. Applicable once for a pregnancy
91851	06APR2020	19APR2020	N	Postnatal telehealth attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided. Applicable once for a pregnancy NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91851	20APR2020	31DEC9999	Y	Postnatal telehealth attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided. Applicable once for a pregnancy
91852	13MAR2020	29MAR2020	N	Postnatal telehealth attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and(b) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(c) is between 1 week and 4 weeks after the birth; and(d) lasts at least 20 minutes; and(e) is for a patient who was privately admitted for the birth; and(f) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided; and (g) the service is bulk billed. Applicable once for a pregnancy
91852	30MAR2020	05APR2020	N	Postnatal telehealth attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided; and (f) the service is bulk billed. Applicable once for a pregnancy
91852	06APR2020	19APR2020	N	Postnatal telehealth attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided. Applicable once for a pregnancy NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91852	20APR2020	31DEC2022	N	Postnatal telehealth attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided. Applicable once for a pregnancy
91852	01JAN2023	31DEC2023	N	Postnatal telehealth attendance (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135, 82140, 91214, 91215, 91221 or 91222 is not provided. Applicable once for a pregnancy
91852	01JAN2024	31DEC9999	Y	Postnatal telehealth attendance (other than a service to which any other item applies) if: (a) the attendance is rendered by: (i) a practice midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 of the Health Insurance (Midwife and Nurse Practitioner) Determination 2015 or item 91214, 91215, 91221 or 91222 is not provided. Applicable once for a pregnancy
91853	13MAR2020	29MAR2020	N	Antenatal telehealth attendance if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and (b) the service is bulk billed.
91853	30MAR2020	05APR2020	N	Antenatal telehealth attendance if the service is bulk billed.
91853	06APR2020	19APR2020	N	Antenatal telehealth attendance. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91853	20APR2020	31DEC9999	Y	Antenatal telehealth attendance.
91855	13MAR2020	29MAR2020	N	Antenatal phone service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(b) the service is provided on behalf of, and under the supervision of, a medical practitioner; and(c) the service is provided at, or from, a practice location in a regional, rural or remote area; and(d) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and(e) the service is not provided for an admitted patient of a hospital or approved day facility; and (f) the service is bulk billed.
91855	30MAR2020	05APR2020	N	Antenatal phone service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner; and (d) the services is bulk billed.
91855	06APR2020	19APR2020	N	Antenatal phone service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91855	20APR2020	30APR2023	N	Antenatal phone service provided by a midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is provided at, or from, a practice location in a regional, rural or remote area; and (c) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner.
91855	01MAY2023	31DEC9999	Y	Antenatal phone service provided by a practice midwife, nurse or an Aboriginal and Torres Strait Islander health practitioner, to a maximum of 10 services per pregnancy, if: (a) the service is provided on behalf of, and under the supervision of, a medical practitioner; and (b) the service is not performed in conjunction with another antenatal attendance item in Group T4 for the same patient on the same day by the same practitioner.
91856	13MAR2020	29MAR2020	N	Postnatal phone attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(b) is between 4 and 8 weeks after the birth; and(c) lasts at least 20 minutes in duration; and(d) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and(e) is for a pregnancy in relation to which a service to which item 82140 applies is not provided; and (f) the service is bulk billed. Applicable once for a pregnancy
91856	30MAR2020	05APR2020	N	Postnatal phone attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided; and (e) the service is bulk billed. Applicable once for a pregnancy
91856	06APR2020	19APR2020	N	Postnatal phone attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided. Applicable once for a pregnancy NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91856	20APR2020	31DEC9999	Y	Postnatal phone attendance by an obstetrician or general practitioner (other than a service to which any other item applies) if: (a) is between 4 and 8 weeks after the birth; and (b) lasts at least 20 minutes in duration; and (c) includes a mental health assessment (including screening for drug and alcohol use and domestic violence) of the patient; and (d) is for a pregnancy in relation to which a service to which item 82140 applies is not provided. Applicable once for a pregnancy
91857	13MAR2020	29MAR2020	N	Postnatal phone attendance other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and(b) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and(c) is between 1 week and 4 weeks after the birth; and(d) lasts at least 20 minutes; and(e) is for a patient who was privately admitted for the birth; and(f) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided; and (g) the service is bulk billed.Applicable once for a pregnancy
91857	30MAR2020	05APR2020	N	Postnatal phone attendance other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided; and (f) the service is bulk billed. Applicable once for a pregnancy
91857	06APR2020	19APR2020	N	Postnatal phone attendance other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided. Applicable once for a pregnancy NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91857	20APR2020	31DEC2022	N	Postnatal phone attendance other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 applies is not provided. Applicable once for a pregnancy
91857	01JAN2023	31DEC2023	N	Postnatal phone attendance other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which any other item applies) if: (a) the attendance is rendered by: (i) a midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135, 82140, 91214, 91215, 91221 or 91222 is not provided. Applicable once for a pregnancy
91857	01JAN2024	31DEC9999	Y	Postnatal phone attendance (other than a service to which any other item applies) if: (a) the attendance is rendered by: (i) a practice midwife (on behalf of and under the supervision of the medical practitioner who attended the birth); or (ii) an obstetrician; or (iii) a general practitioner; and (b) is between 1 week and 4 weeks after the birth; and (c) lasts at least 20 minutes; and (d) is for a patient who was privately admitted for the birth; and (e) is for a pregnancy in relation to which a service to which item 82130, 82135 or 82140 of the Health Insurance (Midwife and Nurse Practitioner) Determination 2015 or item 91214, 91215, 91221 or 91222 is not provided. Applicable once for a pregnancy
91858	13MAR2020	29MAR2020	N	Antenatal phone attendance if: (a) the attendance is where: (i) the person is at risk of COVID-19 virus; or (ii) the practitioner rendering the service is a health professional at risk of COVID-19 virus; and (b) the service is bulk billed.
91858	30MAR2020	05APR2020	N	Antenatal phone attendance if the service is bulk billed.
91858	06APR2020	19APR2020	N	Antenatal phone attendance. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
91858	20APR2020	31DEC9999	Y	Antenatal phone attendance.
91859	01MAR2023	31DEC9999	Y	Telehealth attendance by a general practitioner (not including a specialist or a consultant physician), registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
91861	01MAR2023	31DEC9999	Y	Telehealth attendance by a general practitioner (not including a specialist or a consultant physician), registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
91862	01MAR2023	31DEC9999	Y	Telehealth attendance by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
91863	01MAR2023	31DEC9999	Y	Telehealth attendance by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
91864	01MAR2023	31DEC9999	Y	Phone attendance by a general practitioner (not including a specialist or a consultant physician), registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
91865	01MAR2023	31DEC9999	Y	Phone attendance by a general practitioner (not including a specialist or a consultant physician), registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
91866	01MAR2023	31DEC9999	Y	Phone attendance by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 30 minutes but less than 40 minutes
91867	01MAR2023	31DEC9999	Y	Phone attendance by a medical practitioner, registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service: (a) for providing focussed psychological strategies for assessed mental disorders to a person other than the patient, if the service is part of the patients treatment; and (b) lasting at least 40 minutes
91868	01MAR2024	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration, if that attendance and another attendance to which item 296, 297, 299, 92437 or any of items 300, 302, 304, 306, 308, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91869, 91870, 91871, 91872, 91873 or 91879 to 91881 applies exceed 50 attendances in a calendar year for the patient
91869	01MAR2024	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes but not more than 30 minutes in duration, if that attendance and another attendance to which item 296, 297, 299, 92437 or any of items 300, 302, 304, 306, 308, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91868, 91870, 91871, 91872, 91873 or 91879 to 91881 applies exceed 50 attendances in a calendar year for the patient
91870	01MAR2024	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes but not more than 45 minutes in duration, if that attendance and another attendance to which item 296, 297, 299, 92437 or any of items 300, 302, 304, 306, 308, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91868, 91869, 91871, 91872, 91873 or 91879 to 91881 applies exceed 50 attendances in a calendar year for the patient
91871	01MAR2024	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes but not more than 75 minutes in duration, if that attendance and another attendance to which item 296, 297, 299, 92437 or any of items 300, 302, 304, 306, 308, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91868, 91869, 91870, 91872, 91873 or 91879 to 91881 applies exceed 50 attendances in a calendar year for the patient
91872	01MAR2024	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration, if that attendance and another attendance to which item 296, 297, 299, 92437 or any of items 300, 302, 304, 306, 308, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91868, 91869, 91870, 91871, 91873, or 91879 to 91881 applies exceed 50 attendances in a calendar year for the patient
91873	01MAR2024	31DEC9999	Y	Telehealth attendance lasting at least 45 minutes by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the psychiatrist by a referring practitioner, where the formulation of the patients clinical presentation indicates intensive psychotherapy is a clinically appropriate and indicated treatment, if that attendance and another attendance to which any of items 296, 297, 299 or any of items 300, 302, 304, 306, 308, 319, 92437, 91827, 91828, 91829, 91830, 91831, 91837, 91838, 91839, 91868, 91869, 91870, 91871, 91872 or 91879 to 91881 applies has not exceeded 160 attendances in a calendar year for the patient
91874	01MAR2024	31DEC9999	Y	Telehealth attendance involving an interview, lasting not more than 15 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91875, 91876, 91877, 91878, 91882, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91875	01MAR2024	31DEC9999	Y	Telehealth attendance involving an interview, lasting more than 15 minutes but not more than 30 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874, 91876, 91877, 91878, 91882, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91876	01MAR2024	31DEC9999	Y	Telehealth attendance involving an interview, lasting more than 30 minutes but not more than 45 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874, 91875, 91877, 91878, 91882, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91877	01MAR2024	31DEC9999	Y	Telehealth attendance involving an interview, lasting more than 45 minutes but not more than 75 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874, 91875, 91876 91878, 91882, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91878	01MAR2024	31DEC9999	Y	Telehealth attendance involving an interview, lasting more than 75 minutes, of a person other than the patient, when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874, 91875, 91876, 91877, 91882, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91879	01MAR2024	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration, if that attendance and another attendance to which 296, 297, 299 or any of items 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 91868 to 91873, 91880, 91881 or 92437 applies exceed 50 attendances in a calendar year for the patient
91880	01MAR2024	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes but not more than 30 minutes in duration, if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 91868 to 91873, 91879, 91881 or 92437 applies exceed 50 attendances in a calendar year for the patient
91881	01MAR2024	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes but not more than 45 minutes in duration, if that attendance and another attendance to which item 296, 297, 299 or any of items 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 91868 to 91873, 91879, 91880 or 92437 applies exceed 50 attendances in a calendar year for the patient
91882	01MAR2024	31DEC9999	Y	Phone attendance involving an interview, lasting not more than 15 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874 to 91878, 91883 or 91884 applies have not exceeded 15 in a calendar year for the patient
91883	01MAR2024	31DEC9999	Y	Phone attendance involving an interview, lasting more than 15 minutes but not more than 30 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874 to 91878, 91882 or 91884 applies have not exceeded 15 in a calendar year for the patient
91884	01MAR2024	31DEC9999	Y	Phone attendance involving an interview, lasting more than 30 minutes but not more than 45 minutes, of a person other than the patient when the patient is not in attendance, by a consultant physician in the practice of the consultant physicians specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner for the purposes of: (a) initial diagnostic evaluation; or (b) continuing management of the patient; if that attendance and another attendance to which any of items 341, 343, 345, 347, 349, 91874 to 91878, 91882 or 91883 applies have not exceeded 15 in a calendar year for the patient
91890	01JUL2021	31DEC9999	Y	Phone attendance by a general practitioner lasting less than 6 minutes for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management
91891	01JUL2021	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 6 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care
91892	01JUL2021	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting less than 6 minutes for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management
91893	01JUL2021	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 6 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care
91894	01JAN2022	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 20 minutes, if: (a) the attendance is performed from a practice location in Modified Monash areas 6 or 7; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
91895	01JAN2022	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), of more than 25 minutes in duration but not more than 45 minutes, if: (a) the attendance is performed from a practice location in Modified Monash areas 6 or 7; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
91900	01NOV2023	31DEC2023	N	Phone attendance by a general practitioner to a patient registered under MyMedicare with the billing practice, lasting at least 20 minutes, if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; for one or more health related issues, with appropriate documentation
91900	01JAN2024	31DEC9999	Y	Phone attendance by a general practitioner to a patient registered under MyMedicare with the billing practice, lasting at least 20 minutes, if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; for one or more health related issues, with appropriate documentation
91903	01NOV2023	31DEC2023	N	Phone attendance by a medical practitioner (not including a general practitioner) to a patient registered under MyMedicare with the billing practice, of more than 25 minutes in duration but not more than 45 minutes, if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; for one or more health related issues, with appropriate documentation
91903	01JAN2024	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner) to a patient registered under MyMedicare with the billing practice, of more than 25 minutes in duration but not more than 45 minutes, if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventative health care; for one or more health related issues, with appropriate documentation
91906	01NOV2023	31DEC2023	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, to a patient registered under MyMedicare with the billing practice, of more than 25 minutes in duration but not more than 45 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation
91906	01JAN2024	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, to a patient registered under MyMedicare with the billing practice, of more than 25 minutes in duration but not more than 45 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking a detailed patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation
91910	01NOV2023	31DEC9999	Y	Phone attendance by a general practitioner, to a patient registered under MyMedicare with the billing practice, lasting at least 40 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation
91913	01NOV2023	31DEC2023	N	Phone attendance by a medical practitioner, to a patient registered under MyMedicare with the billing practice, of more than 45 minutes in duration but not more than 60 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking a detailed patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventative health care;for one or more health related issues, with appropriate documentation
91913	01JAN2024	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner), to a patient registered under MyMedicare with the billing practice, of more than 45 minutes in duration but not more than 60 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventative health care;for one or more health related issues, with appropriate documentation
91916	01NOV2023	31DEC2023	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, to a patient registered under MyMedicare with the billing practice, of more than 45 minutes in duration but not more than 60 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking a detailed patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventative health care;for one or more health related issues, with appropriate documentation
91916	01JAN2024	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, to a patient registered under MyMedicare with the billing practice, of more than 45 minutes in duration but not more than 60 minutes, if the attendance includes any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventative health care;for one or more health related issues, with appropriate documentation
91920	01NOV2023	31DEC9999	Y	Telehealth attendance by a general practitioner, lasting at least 60 minutes and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91923	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner), of more than 60 minutes in duration and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
91926	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 60 minutes in duration and including any of the following that are clinically relevant:(a) taking an extensive patient history;(b) arranging any necessary investigation;(c) implementing a management plan;(d) providing appropriate preventive health care;for one or more health related issues, with appropriate documentation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92004	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner for a health assessment of a patient. Where the service is bulk-billed.
92004	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner for a health assessment of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92004	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner for a health assessment of a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92004	01OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner for a health assessment of a patient - this item or items 93470 or 93479 not more than once in a 9 month period. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92011	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment. Where the service is bulk-billed.
92011	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92011	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92011	01OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment - this item or items 93470 or 93479 not more than once in a 9 month period. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92016	30MAR2020	05APR2020	N	Phone attendance by a general practitioner for a health assessment of a patient. Where the service is bulk-billed.
92016	06APR2020	19JUL2020	N	Phone attendance by a general practitioner for a health assessment of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92016	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner for a health assessment of a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92016	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner for a health assessment of a patient - this item or items 93470 or 93479 not more than once in a 9 month period. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92023	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment of a patient. Where the service is bulk-billed.
92023	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92023	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment of a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92023	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for a health assessment of a patient - this item or items 93470 or 93479 not more than once in a 9 month period. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92024	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92024	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92024	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92024	01OCT2020	31OCT2023	N	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92024	01NOV2023	29FEB2024	N	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 235 to 340 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92024	01MAR2024	31DEC9999	Y	Telehealth attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92025	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92025	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92025	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92025	01OCT2020	31OCT2023	N	Telehealth attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92025	01NOV2023	31DEC9999	Y	Telehealth attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92026	30MAR2020	05APR2020	N	Telehealth contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92026	06APR2020	19JUL2020	N	Telehealth contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92026	20JUL2020	30SEP2020	N	Telehealth contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92026	01OCT2020	31OCT2023	N	Telehealth contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92026	01NOV2023	31DEC9999	Y	Contribution by a general practitioner by telehealth, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92027	30MAR2020	05APR2020	N	Telehealth contribution by a general practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92027	06APR2020	19JUL2020	N	Telehealth contribution by a general practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92027	20JUL2020	30SEP2020	N	Telehealth contribution by a general practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92027	01OCT2020	31OCT2023	N	Telehealth contribution by a general practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92027	01NOV2023	31DEC9999	Y	Contribution by a general practitioner by telehealth to:(a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or(b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider.(other than a service associated with a service to which items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92028	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table, or item 229 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table, or item 230 or item 92025 or 92069 or items applies Where the service is bulk-billed.
92028	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table, or item 229 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table, or item 230 or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92028	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table, or item 229 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table, or item 230 or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92028	01OCT2020	31OCT2023	N	Telehealth attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table, or item 229 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table, or item 230 or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92028	01NOV2023	31DEC9999	Y	Telehealth attendance by a general practitioner to review or coordinate a review of:(a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which items 229 or 721 of the general medical services table, or item 92024, 92055, 92068 or 92099 applies;(b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which items 230 or 723 of the general medical services table, or item 92025 or 92069 applies NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92055	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92055	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92055	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92055	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92055	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92056	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034, or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92056	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034, or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92056	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034, or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and(b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92056	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034, or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92056	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92057	30MAR2020	05APR2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92057	06APR2020	19JUL2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92057	20JUL2020	30SEP2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92057	01OCT2020	31OCT2023	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92057	01NOV2023	31DEC9999	Y	Contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician) by telehealth to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92058	30MAR2020	05APR2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician),, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92058	06APR2020	19JUL2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician),, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92058	20JUL2020	30SEP2020	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician),, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92058	01OCT2020	30JUN2023	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician),, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92058	01JUL2023	31OCT2023	N	Telehealth contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92058	01NOV2023	31DEC9999	Y	Contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician) by telehealth to:(a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or(b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider(other than a service associated with a service to which items 235 to 240 or 735 to 758 of the general medical services table apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92059	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721 or item 229 or item 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies Where the service is bulk-billed.
92059	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721 or item 229 or item 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92059	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721 or item 229 or item 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92059	01OCT2020	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721 or item 229 or item 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92059	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review or coordinate a review of:(a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 721 or item 229 of the general medical services table or item 92024, 92055, 92068 or 92099 applies; or(b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which items 230 or 723 of the general medical services table or item 92025, 92056, 92069 or 92100 applies NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92068	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92068	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92068	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92068	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758, items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92069	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92069	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92069	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92069	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240 or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92070	30MAR2020	05APR2020	N	Phone contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240, or items 92074 to 92078 or items 92030 to 92034 apply) Where the service is bulk-billed.
92070	06APR2020	19JUL2020	N	Phone contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240, or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92070	20JUL2020	30SEP2020	N	Phone contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240, or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92070	01OCT2020	31DEC9999	Y	Phone contribution by a general practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758, or items 235 to 240, or items 92074 to 92078 or items 92030 to 92034 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92071	30MAR2020	05APR2020	N	Phone contribution by a general practitioner (not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 apply) Where the service is bulk-billed.
92071	06APR2020	19JUL2020	N	Phone contribution by a general practitioner (not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 235 to 240, or items 92074 to 92078 or 92030 to 92034 apply). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92071	20JUL2020	30SEP2020	N	Phone contribution by a general practitioner (not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 235 to 240, or items 92074 to 92078 or 92030 to 92034 apply). NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92071	01OCT2020	31DEC9999	Y	Phone contribution by a general practitioner (not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758, items 235 to 240, or items 92074 to 92078 or 92030 to 92034 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92072	30MAR2020	05APR2020	N	Phone attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table or item 229 or items 92074 to 92078 or 92030 to 92034 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table or item 92025 or 92069 or items applies Where the service is bulk-billed.
92072	06APR2020	19JUL2020	N	Phone attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table or item 229 or items 92074 to 92078 or 92030 to 92034 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92072	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table or item 229 or items 92074 to 92078 or 92030 to 92034 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92072	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 of the general medical services table or item 229 or items 92074 to 92078 or 92030 to 92034 or item 92024 or 92068 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 of the general medical services table or item 92025 or 92069 or items applies NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92099	30MAR2020	05APR2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92099	06APR2020	19JUL2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92099	20JUL2020	30SEP2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92099	01OCT2020	31DEC9999	Y	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92100	30MAR2020	05APR2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92100	06APR2020	19JUL2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92100	20JUL2020	30SEP2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92100	01OCT2020	31DEC9999	Y	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92101	30MAR2020	05APR2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92101	06APR2020	19JUL2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92101	20JUL2020	30SEP2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92101	01OCT2020	31DEC9999	Y	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 of the general medical services table or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92102	30MAR2020	05APR2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply) Where the service is bulk-billed.
92102	06APR2020	19JUL2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92102	20JUL2020	30SEP2020	N	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92102	01OCT2020	31DEC9999	Y	Telephone contribution by a medical practitioner (not including a general practitioner, specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 of the general medical services table, or items 92074 to 92078 or items 92030 to 92034 or items 235 to 240 in the Health Insurance (Section 3C General Medical Services - Other Medical Practitioner) Determination 2018 apply). NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92103	30MAR2020	05APR2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721, 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies Where the service is bulk-billed.
92103	06APR2020	19JUL2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721, 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92103	20JUL2020	30SEP2020	N	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721, 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92103	01OCT2020	31DEC9999	Y	Telephone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 229, 721, 92024, 92055, 92068 or 92099 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 230, 723, 92025, 92056, 92069 or 92100 applies. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92112	30MAR2020	05APR2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92112	06APR2020	19JUL2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92112	20JUL2020	30SEP2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92112	01OCT2020	30JUN2021	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92112	01JUL2021	20JUL2021	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92112	21JUL2021	31DEC9999	Y	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92113	30MAR2020	05APR2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92113	06APR2020	19JUL2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92113	20JUL2020	30SEP2020	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92113	01OCT2020	20JUL2021	N	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92113	21JUL2021	31DEC9999	Y	Telehealth attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92114	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Where the service is bulk-billed.
92114	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92114	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92114	01OCT2020	30JUN2021	N	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92114	01JUL2021	20JUL2021	N	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92114	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan.
92115	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Where the service is bulk-billed.
92115	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92115	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92115	01OCT2020	30JUN2021	N	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92115	01JUL2021	20JUL2021	N	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92115	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation.
92116	30MAR2020	05APR2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92116	06APR2020	19JUL2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92116	20JUL2020	30SEP2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92116	01OCT2020	20JUL2021	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92116	21JUL2021	31DEC9999	Y	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92117	30MAR2020	05APR2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92117	06APR2020	19JUL2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92117	20JUL2020	30SEP2020	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92117	01OCT2020	20JUL2021	N	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92117	21JUL2021	31DEC9999	Y	Telehealth attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92118	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92118	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92118	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92118	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92118	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92118	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
92119	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92119	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92119	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92119	01OCT2020	30JUN2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92119	01JUL2021	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92119	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92119	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
92120	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Where the service is bulk-billed.
92120	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92120	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92120	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92120	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan.
92120	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan
92121	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Where the service is bulk-billed.
92121	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92121	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92121	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92121	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation.
92121	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation
92122	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92122	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92122	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92122	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92122	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92122	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
92123	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92123	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92123	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92123	01OCT2020	30JUN2021	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92123	01JUL2021	20JUL2021	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92123	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient.
92123	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner, (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient
92124	30MAR2020	05APR2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92124	06APR2020	19JUL2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92124	20JUL2020	30SEP2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92124	01OCT2020	31DEC9999	Y	Phone attendance, by a general practitioner who has not undertaken mental health skills training (and not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92125	30MAR2020	05APR2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92125	06APR2020	19JUL2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92125	20JUL2020	30SEP2020	N	Phone attendance, by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92125	01OCT2020	31DEC9999	Y	Phone attendance, by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92126	30MAR2020	05APR2020	N	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Where the service is bulk-billed.
92126	06APR2020	19JUL2020	N	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92126	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92126	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92126	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan.
92127	30MAR2020	05APR2020	N	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Where the service is bulk-billed.
92127	06APR2020	19JUL2020	N	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92127	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92127	01OCT2020	30JUN2021	N	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92127	01JUL2021	20JUL2021	N	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply)
92127	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation.
92128	30MAR2020	05APR2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92128	06APR2020	19JUL2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92128	20JUL2020	30SEP2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92128	01OCT2020	31DEC9999	Y	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92129	30MAR2020	05APR2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92129	06APR2020	19JUL2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92129	20JUL2020	30SEP2020	N	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92129	01OCT2020	31DEC9999	Y	Phone attendance, by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92130	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92130	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92130	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92130	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92131	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92131	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92131	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92131	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92132	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Where the service is bulk-billed.
92132	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92132	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92132	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92132	21JUL2021	31OCT2023	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan.
92132	01NOV2023	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan
92133	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Where the service is bulk-billed.
92133	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92133	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92133	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92133	21JUL2021	31OCT2023	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation.
92133	01NOV2023	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation
92134	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92134	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92134	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92134	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92135	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Where the service is bulk-billed.
92135	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92135	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92135	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92136	30MAR2020	05APR2020	N	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92138, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. Where the service is bulk-billed.
92136	06APR2020	19JUL2020	N	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92138, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92136	20JUL2020	30SEP2020	N	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92138, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92136	01OCT2020	30JUN2021	N	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92138, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92136	01JUL2021	31OCT2023	N	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001 of the general medical services table, or item 792 of the Other Medical Practitioner Determination, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92137, 92138, 92139, 93026 or 93029 applies in relation to that pregnancy
92136	01NOV2023	31DEC9999	Y	Telehealth attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who:(a) is currently pregnant; or(b) has been pregnant in the 12 months preceding the provision of the first service to which this item or items 792 or 4001 of the general medical services table, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92137, 92138, 92139, 93026 or 93029 applies in relation to that pregnancy
92137	30MAR2020	05APR2020	N	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92139, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. Where the service is bulk-billed.
92137	06APR2020	19JUL2020	N	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92139, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92137	20JUL2020	30SEP2020	N	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92139, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92137	01OCT2020	30JUN2021	N	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92139, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92137	01JUL2021	31OCT2023	N	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001 of the general medical services table, or item 792 of the Other Medical Practitioner Determination, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92136, 92138, 92139, 93026 or 93029 applies in relation to that pregnancy
92137	01NOV2023	31DEC9999	Y	Telehealth attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician) who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who:(a) is currently pregnant; or(b) has been pregnant in the 12 months preceding the provision of the first service to which this item or items 792 or 4001 of the general medical services table, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92136, 92138, 92139, 93026 or 93029 applies in relation to that pregnancy
92138	30MAR2020	05APR2020	N	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. Where the service is bulk-billed.
92138	06APR2020	19JUL2020	N	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92138	20JUL2020	30SEP2020	N	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92138	01OCT2020	30JUN2021	N	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 792, 92139, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92138	01JUL2021	31OCT2023	N	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001 of the general medical services table, or item 792 of the Other Medical Practitioner Determination, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92136, 92137, 92139, 93026 or 93029 applies in relation to that pregnancy
92138	01NOV2023	31DEC9999	Y	Phone attendance of at least 20 minutes in duration by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who:(a) is currently pregnant; or(b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 792 or 4001 of the general medical services table, or item 81000, 81005 or 81010 of the Allied Health Determination, or item 92136, 92137, 92139, 93026 or 93029 applies in relation to that pregnancy
92139	30MAR2020	05APR2020	N	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. Where the service is bulk-billed.
92139	06APR2020	19JUL2020	N	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92139	20JUL2020	30SEP2020	N	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92139	01OCT2020	30JUN2021	N	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001, 92136, 92138, 792, 92137, 81000, 81005, 81010, 93029 or 93026 applies in relation to that pregnancy. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92139	01JUL2021	31OCT2023	N	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician), who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 4001 of the general medical services table, or item 792 of the Other Medical Practitioner Determination, or item 81000, 81005 or 81010 of the Allied Health Determination or item 92136, 92137, 92138, 93026 or 93029 applies in relation to that pregnancy
92139	01NOV2023	31DEC9999	Y	Phone attendance of at least 20 minutes in duration by a medical practitioner (not including a general practitioner, specialist or consultant physician) who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who:(a) is currently pregnant; or(b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 792 or 4001 of the general medical services table, or item 81000, 81005 or 81010 of the Allied Health Determination or item 92136, 92137, 92138, 93026 or 93029 applies in relation to that pregnancy
92140	30MAR2020	05APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner and one or more allied health providers, if appropriate, for the treatment of the patient Where the service is bulk-billed.
92140	06APR2020	19APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner and one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92140	20APR2020	28FEB2023	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner and one or more allied health providers, if appropriate, for the treatment of the patient.
92140	01MAR2023	31DEC9999	Y	Telehealth attendance lasting at least 45 minutes by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant paediatrician by a referring practitioner, for a patient aged under 25, if the consultant paediatrician: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of a complex neurodevelopmental disorder (such as autism spectrum disorder) is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92141, 92142 or 92434) Applicable only once per lifetime
92141	30MAR2020	05APR2020	N	Telehealth attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; Where the service is bulk-billed.
92141	06APR2020	19APR2020	N	Telehealth attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92141	20APR2020	31DEC2021	N	Telehealth attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient.
92141	01JAN2022	28FEB2023	N	Telehealth attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139 or 289)
92141	01MAR2023	31DEC9999	Y	Telehealth attendance lasting at least 45 minutes by a specialist or consultant physician (not including a general practitioner), following referral of the patient to the specialist or consultant physician by a referring practitioner, for a patient aged under 25, if the specialist or consultant physician: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of an eligible disability is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92142 or 92434) Applicable only once per lifetime
92142	30MAR2020	05APR2020	N	Telehealth attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient Where the service is bulk-billed.
92142	06APR2020	19JUL2020	N	Telehealth attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92142	20JUL2020	30SEP2020	N	Telehealth attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92142	01OCT2020	28FEB2023	N	Telehealth attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92142	01MAR2023	31DEC9999	Y	Telehealth attendance lasting at least 45 minutes by a general practitioner (not including a specialist or consultant physician), for a patient aged under 25, if the general practitioner: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of an eligible disability is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92141 or 92434) Applicable only once per lifetime
92143	30MAR2020	05APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient Where the service is bulk-billed.
92143	06APR2020	19APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92143	20APR2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient.
92144	30MAR2020	05APR2020	N	Phone attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient Where the service is bulk-billed.
92144	06APR2020	19APR2020	N	Phone attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92144	20APR2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration by a specialist or consultant physician following referral of the patient to the specialist or consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the specialist or consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient.
92145	30MAR2020	05APR2020	N	Phone attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient Where the service is bulk-billed.
92145	06APR2020	19JUL2020	N	Phone attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92145	20JUL2020	30SEP2020	N	Phone attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92145	01OCT2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration by a general practitioner for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92146	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92146	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92146	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92146	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92146	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92147	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92147	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92147	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92147	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92147	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92148	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92148	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92148	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92148	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92148	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92149	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92149	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92149	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92149	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92149	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92150	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92150	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92150	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92150	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92150	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92150	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
92151	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92151	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92151	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92151	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92151	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92151	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
92152	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92152	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92152	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92152	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92152	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92152	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
92153	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92153	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92153	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92153	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92153	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92153	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
92154	30MAR2020	05APR2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92154	06APR2020	19JUL2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92154	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92154	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92155	30MAR2020	05APR2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92155	06APR2020	19JUL2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92155	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92155	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92156	30MAR2020	05APR2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92156	06APR2020	19JUL2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92156	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92156	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92157	30MAR2020	05APR2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92157	06APR2020	19JUL2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92157	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92157	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92158	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92158	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92158	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92158	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92159	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92159	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92159	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92159	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92160	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92160	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92160	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92160	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92161	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92161	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92161	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92161	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patients eating disorder; and (b) the plan includes treatment options and recommendations to manage the patients condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92162	30MAR2020	05APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92162	06APR2020	19APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92162	20APR2020	31DEC9999	Y	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92163	30MAR2020	05APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92163	06APR2020	19APR2020	N	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92163	20APR2020	31DEC9999	Y	Telehealth attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92166	30MAR2020	05APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92166	06APR2020	19APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92166	20APR2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92167	30MAR2020	05APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92167	06APR2020	19APR2020	N	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92167	20APR2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92170	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92170	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92170	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92170	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92170	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92171	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92171	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the speciality of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the speciality of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92171	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the speciality of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the speciality of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92171	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the speciality of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the speciality of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92171	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the speciality of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the speciality of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92171	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the speciality of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the speciality of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder
92172	30MAR2020	05APR2020	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92172	06APR2020	19APR2020	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92172	20APR2020	31DEC9999	Y	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92173	30MAR2020	05APR2020	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92173	06APR2020	19APR2020	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92173	20APR2020	29FEB2024	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92173	01MAR2024	30JUN2024	N	Telehealth attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
92173	01JUL2024	31DEC9999	Y	Telehealth attendance of at least 20 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
92176	30MAR2020	05APR2020	N	Phone attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92176	06APR2020	19JUL2020	N	Phone attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92176	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92176	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92176	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner to review an eligible patients eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92177	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Where the service is bulk-billed.
92177	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92177	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92177	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92177	21JUL2021	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review an eligible patients eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the medical practitioner reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the medical practitioner offers the patient and the patients carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder.
92178	30MAR2020	05APR2020	N	Phone attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92178	06APR2020	19APR2020	N	Phone attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92178	20APR2020	31DEC9999	Y	Phone attendance of at least 30 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92179	30MAR2020	05APR2020	N	Phone attendance of at least 20 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees Where the service is bulk-billed.
92179	06APR2020	19APR2020	N	Phone attendance of at least 20 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92179	20APR2020	31DEC9999	Y	Phone attendance of at least 20 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacy of services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patients needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees.
92182	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92182	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92182	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92182	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92182	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92184	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92184	06APR2020	19JUL2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92184	20JUL2020	30SEP2020	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92184	01OCT2020	20JUL2021	N	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92184	21JUL2021	31DEC9999	Y	Telehealth attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92186	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92186	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92186	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92186	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92186	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92186	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan
92188	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92188	06APR2020	19JUL2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92188	20JUL2020	30SEP2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92188	01OCT2020	20JUL2021	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92188	21JUL2021	31OCT2023	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92188	01NOV2023	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan
92194	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92194	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92194	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92194	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92194	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92196	30MAR2020	05APR2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92196	06APR2020	19JUL2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92196	20JUL2020	30SEP2020	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92196	01OCT2020	20JUL2021	N	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92196	21JUL2021	31DEC9999	Y	Phone attendance by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92198	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92198	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92198	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92198	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92198	21JUL2021	31OCT2023	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92198	01NOV2023	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan
92200	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Where the service is bulk-billed.
92200	06APR2020	19JUL2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92200	20JUL2020	30SEP2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that:(a) this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply); and (b) the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided, for all other patients the service may be bulk-billed.
92200	01OCT2020	20JUL2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. NOTE: It is a legislative requirement that this service must be performed by the patients usual medical practitioner (please see Note AN.1.1 for the definition of ‘patients usual medical practitioner as some exemptions do apply).
92200	21JUL2021	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan.
92210	30MAR2020	05APR2020	N	Telehealth attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. Where the service is bulk-billed.
92210	06APR2020	30SEP2020	N	Telehealth attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92210	01OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment.
92211	30MAR2020	05APR2020	N	Telehealth attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. Where the service is bulk-billed.
92211	06APR2020	30SEP2020	N	Telehealth attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92211	01OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment.
92216	30MAR2020	05APR2020	N	Phone attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. Where the service is bulk-billed.
92216	06APR2020	30SEP2020	N	Phone attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92216	01OCT2020	31DEC9999	Y	Phone attendance by a general practitioner on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment.
92217	30MAR2020	05APR2020	N	Phone attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. Where the service is bulk-billed.
92217	06APR2020	30SEP2020	N	Phone attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92217	01OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion-each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patients medical condition requires urgent assessment.
92422	06APR2020	19APR2020	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) this item or item 132 or 92431 has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92422	20APR2020	31DEC2021	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) this item or item 132 or 92431 has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician.
92422	01JAN2022	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119 of the general medical services table or item 91824, 91825, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) this item, or item 132 of the general medical services table, has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician
92423	06APR2020	19APR2020	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) item 132, 92422 or 92431 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132, 92422 or 92431; and (f) this item or item 133 or 92432 has not applied more than twice in any 12 month period NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92423	20APR2020	31DEC2021	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) item 132, 92422 or 92431 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132, 92422 or 92431; and (f) this item or item 133 or 92432 has not applied more than twice in any 12 month period.
92423	01JAN2022	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119 of the general medical services table or 91824, 91825, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) item 132 of the general medical services table or item 92422 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132 of the general medical services table or 92422; and (f) this item, or item 133 of the general medical services table has not applied more than twice in any 12 month period
92425	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
92425	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
92426	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is not a minor attendance after the first as part of a single course of treatment
92426	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is not a minor attendance after the first as part of a single course of treatment
92427	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is a minor attendance after the first as part of a single course of treatment
92427	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is a minor attendance after the first as part of a single course of treatment
92431	06APR2020	19APR2020	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) this item or item 132 or 92422 has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92431	20APR2020	31DEC2021	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) this item or item 132 or 92422 has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician.
92431	01JAN2022	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations
92432	06APR2020	19APR2020	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) item 132, 92422 or 92431 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132, 92422 or 92431; and (f) this item or item 133 or 92423 has not applied more than twice in any 12 month period. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92432	20APR2020	31DEC2021	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116, 119, 91824, 91834, 91825, 91835, 91826 or 91836 applies did not take place on the same day by the same consultant physician; and (d) item 132, 92422 or 92431 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132, 92422 or 92431; and (f) this item or item 133 or 92423 has not applied more than twice in any 12 month period.
92432	01JAN2022	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations
92434	06APR2020	19APR2020	N	Telehealth attendance of at least 45 minutes in duration, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92143, 9214, 92144, 92142, 92145 or 92474). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92434	20APR2020	31DEC2021	N	Telehealth attendance of at least 45 minutes in duration, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92143, 9214, 92144, 92142, 92145 or 92474).
92434	01JAN2022	28FEB2023	N	Telehealth attendance of at least 45 minutes in duration, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item, or item 135, 137, 139, 289 of the general medical services table, or item 92140, 92141, 92142 or 92145)
92434	01MAR2023	31DEC9999	Y	Telehealth attendance lasting at least 45 minutes by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant psychiatrist by a referring practitioner, for a patient aged under 25, if the consultant psychiatrist: (a) undertakes, or has previously undertaken in prior attendances, a comprehensive assessment in relation to which a diagnosis of a complex neurodevelopmental disorder (such as autism spectrum disorder) is made (if appropriate, using information provided by an eligible allied health provider); and (b) develops a treatment and management plan, which must include: (i) documentation of the confirmed diagnosis; and (ii) findings of any assessments performed for the purposes of formulation of the diagnosis or contribution to the treatment and management plan; and (iii) a risk assessment; and (iv) treatment options (which may include biopsychosocial recommendations); and (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92141 or 92142) Applicable only once per lifetime
92435	06APR2020	19APR2020	N	Telehealth attendance of more than 45 minutes in by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which this item or item 291 or 92475 applies has not been provided. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92435	20APR2020	31DEC2021	N	Telehealth attendance of more than 45 minutes in by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which this item or item 291 or 92475 applies has not been provided.
92435	01JAN2022	29FEB2024	N	Telehealth attendance of more than 45 minutes in by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which this item or item 291 of the general medical services table applies has not been provided
92435	01MAR2024	31DEC9999	Y	Telehealth attendance lasting more than 45 minutes by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant, by a medical practitioner in general practice (including a general practitioner, but not a specialist or consultant physician) or a participating nurse practitioner for an assessment or management; and (b) during the attendance, the consultant: (i) if it is clinically appropriate to do so-uses an appropriate outcome tool; and (ii) carries out a mental state examination; and (iii) undertakes a comprehensive diagnostic assessment; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing management by the consultant and (d) within 2 weeks after the attendance, the consultant prepares and gives the referring practitioner a written report, which includes: (i) a comprehensive diagnostic assessment of the patient; and (ii) a management plan for the patient for the next 12 months for the patient that comprehensively evaluates the patients biopsychosocial factors and makes recommendations to the referring practitioner to manage the patients ongoing care in a biopsychosocial model; and (e) if clinically appropriate, the consultant explains the diagnostic assessment and management plan, and a gives a copy, to: (i) the patient; and (ii) the patients carer (if any), if the patient agrees; and (f) in the preceding 12 months, a service to which this item or item 291 of the general medical services table applies has not been provided
92436	06APR2020	19APR2020	N	Telehealth attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291, 92435, 92475; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291, 92435, 92475 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 or 92476 applies has not been provided NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92436	20APR2020	31DEC2021	N	Telehealth attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291, 92435, 92475; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291, 92435, 92475 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 or 92476 applies has not been provided
92436	01JAN2022	29FEB2024	N	Telehealth attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291 or 92435; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291 of the general medical services table or 92435 applies has been provided; and (f) in the preceding 12 months, a service to which this item, or item 293 of the general medical services table applies has not been provided
92436	01MAR2024	31DEC9999	Y	Telehealth attendance lasting more than 30 minutes, but not more than 45 minutes, by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291 or 92435; and (b) the attendance follows referral of the patient to the consultant, by the medical practitioner or participating nurse practitioner managing the patient, for review of the management plan and the associated comprehensive diagnostic assessment; and (c) during the attendance, the consultant: (i) if it is clinically appropriate to do so-uses an appropriate outcome tool; and (ii) carries out a mental state examination; and (iii) reviews the comprehensive diagnostic assessment and undertakes additional assessment as required; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant prepares and gives to the referring practitioner a written report, which includes: (i) a revised comprehensive diagnostic assessment of the patient; and (ii) a revised management plan including updated recommendations to the referring practitioner to manage the patients ongoing care in a biopsychosocial model; and (e) if clinically appropriate, the consultant explains the diagnostic assessment and the management plan, and gives a copy, to: (i) the patient; and (ii) the patients carer (if any), if the patient agrees; and (f) in the preceding 12 months, a service to which item 291 of the general medical services table or item 92435 applies has been provided; and (g) in the preceding 12 months, a service to which this item or item 293 of the general medical services table applies has not been provided
92437	06APR2020	19APR2020	N	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, item 296, 297, 299 or 92477, or any of items 300 to 346, 353 to 358, 361 to 370, 91827 to 91831 or 91837 to 91841, in the preceding 24 months. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92437	20APR2020	31DEC2021	N	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, item 296, 297, 299 or 92477, or any of items 300 to 346, 353 to 358, 361 to 370, 91827 to 91831, 91837 to 91841, 92455 to 93457 or 92495 to 92497 in the preceding 24 months.
92437	01JAN2022	29FEB2024	N	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, or item 91827 to 91831, 91837 to 91839, 92455 to 92457, or item 296, 297, 299 or 300 to 346 of the general medical services table, in the preceding 24 months
92437	01MAR2024	31DEC9999	Y	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, or item 91827 to 91831, 91837 to 91839, 92455 to 92457, 91868 to 91873, 91879 to 91881 or item 296, 297, 299, 300, 302, 304, 306 to 308, 310, 312, 314, 316, 318, 319, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 342, 344 or 346 of the general medical services table, in the preceding 24 months
92455	20APR2020	31DEC9999	Y	Telehealth attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a group of 2 to 9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92456	20APR2020	31DEC9999	Y	Telehealth attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a family group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92457	20APR2020	31DEC9999	Y	Telehealth attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a family group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92458	06APR2020	19APR2020	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed. .
92458	20APR2020	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient. .
92459	06APR2020	19APR2020	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92459	20APR2020	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient.
92460	06APR2020	19APR2020	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item or item 352 or 92500 applies have not exceeded 4 in a calendar year for the patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92460	20APR2020	31DEC2021	N	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item or item 352 or 92500 applies have not exceeded 4 in a calendar year for the patient.
92460	01JAN2022	31DEC9999	Y	Telehealth attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item or item 352 of the general medical services table applies have not exceeded 4 in a calendar year for the patient
92461	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration
92461	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; and (c) the patient to whom the service is provided is admitted to hospital
92462	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration
92462	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92463	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration
92463	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92464	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration
92464	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92465	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration
92465	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92466	15SEP2021	31DEC2021	N	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, or item 91827 to 91831, 91837 to 91841, 92455 to 92457, 92495 to 92497 or 92477, or item 296, 297, 299, 300 to 346, 353 to 358 or 361 to 370 of the general medical services table, in the preceding 24 months
92466	01JAN2022	31DEC9999	Y	Telehealth attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner, if the patient to whom the service is provided: (a) either: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) is admitted to hospital
92471	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
92471	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance was other than a second or subsequent attendance as part of a single course of treatment
92472	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is not a minor attendance after the first as part of a single course of treatment
92472	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is not a minor attendance after the first as part of a single course of treatment
92473	15SEP2021	31DEC2021	N	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; where the attendance is a minor attendance after the first as part of a single course of treatment
92473	01JAN2022	31DEC9999	Y	Telehealth attendance for a person by a consultant physician in the practice of the consultant physicians specialty (other than psychiatry) if: (a) the attendance follows referral of the patient to the specialist; and (b) the attendance was of more than 5 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital; where the attendance is a minor attendance after the first as part of a single course of treatment
92474	06APR2020	19APR2020	N	Phone attendance of at least 45 minutes in duration , by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient;(other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92143, 92141, 92144, 92142, 92145 or 92434). NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92474	20APR2020	31DEC9999	Y	Phone attendance of at least 45 minutes in duration , by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant physician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patients condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient;(other than attendance on a patient for whom payment has previously been made under this item or item 135, 137, 139, 289, 92140, 92143, 92141, 92144, 92142, 92145 or 92434).
92475	06APR2020	19APR2020	N	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which this item or item 291 or 92435 applies has not been provided. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92475	20APR2020	31DEC2021	N	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which this item or item 291 or 92435 applies has not been provided.
92475	01JAN2022	31DEC9999	Y	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patients diagnosis; and (C) comprehensively evaluates the patients biological, psychological and social issues; and (D) addresses the patients diagnostic psychiatric issues; and (E) makes management recommendations addressing the patients biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
92476	06APR2020	19APR2020	N	Phone attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291, 92435, 92475; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291, 92435 or 92475 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 or 92436 applies has not been provided. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92476	20APR2020	31DEC2021	N	Phone attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291, 92435, 92475; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291, 92435 or 92475 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 or 92436 applies has not been provided.
92476	01JAN2022	31DEC9999	Y	Phone attendance of more than 30 minutes but not more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291, 92435, 92475; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patients carer (if any), if the patient agrees
92477	06APR2020	19APR2020	N	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, item 296, 297, 299 or 92437, or any of items 300 to 346, 353 to 358, 361 to 370, 91827 to 91831 or 91837 to 91841, in the preceding 24 months. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92477	20APR2020	31DEC9999	Y	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, item 296, 297, 299 or 92437, or any of items 300 to 346, 353 to 358, 361 to 370, 91827 to 91831 or 91837 to 91841, in the preceding 24 months.
92478	01NOV2024	31DEC9999	Y	Telehealth attendance for an admitted patient by a consultant psychiatrist; if: (a) the attendance follows referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the patient is located at a hospital; and (c) the attendance is not more than 15 minutes duration; and (d) the patient has not received a service to which item 92479, 92480, 92481, 92482 or 92483 applies in the last seven days (H)
92479	01NOV2024	31DEC9999	Y	Telehealth attendance for an admitted patient by a consultant psychiatrist; if: (a) the attendance follows referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the patient is located at a hospital; and (c) the attendance is at least 15 minutes, but not more than 30 minutes in duration; and (d) the patient has not received a service to which item 92478, 92480, 92481, 92482 or 92483 applies in the last seven days (H)
92480	01NOV2024	31DEC9999	Y	Telehealth attendance for an admitted patient by a consultant psychiatrist; if: (a) the attendance follows referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the patient is located at a hospital; and (c) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (d) the patient has not received a service to which item 92478, 92479, 92481, 92482 or 92483 applies in the last seven days (H)
92481	01NOV2024	31DEC9999	Y	Telehealth attendance for an admitted patient by a consultant psychiatrist; if: (a) the attendance follows referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the patient is located at a hospital; and (c) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (d) the patient has not received a service to which item 92478, 92479, 92480, 92482 or 92483 applies in the last seven days (H)
92482	01NOV2024	31DEC9999	Y	Telehealth attendance for an admitted patient by a consultant psychiatrist; if: (a) the attendance follows referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the patient is located at a hospital; and (c) the attendance was at least 75 minutes in duration; and (d) the patient has not received a service to which item 92478, 92479, 92480, 92481 or 92483 applies in the last seven days (H)
92483	01NOV2024	31DEC9999	Y	Telehealth attendance of more than 45 minutes by a consultant psychiatrist following referral of the patient to the consultant psychiatrist by a referring practitioner - an attendance on a patient located at a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from the consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, or any of items 296, 297, 299, 300, 302, 304, 306, 308, 91827 to 91831, 91837 to 91839, 92437 and 92478 to 92482 has applied in the preceding 24 months (H)
92495	20APR2020	31DEC9999	Y	Phone attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a group of 2 to 9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92496	20APR2020	31DEC9999	Y	Phone attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a family group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92497	20APR2020	31DEC9999	Y	Phone attendance for group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted): (a) of not less than 1 hour in duration; and (b) given under the continuous direct supervision of a consultant physician in the practice of the consultant physicians specialty of psychiatry; and (c) involving a family group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner; -each patient
92498	06APR2020	19APR2020	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92498	20APR2020	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient.
92499	06APR2020	19APR2020	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92499	20APR2020	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient.
92500	06APR2020	19APR2020	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item or item 352 or 92460 applies have not exceeded 4 in a calendar year for the patient. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92500	20APR2020	31DEC2021	N	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item or item 352 or 92460 applies have not exceeded 4 in a calendar year for the patient.
92500	01JAN2022	31DEC9999	Y	Phone attendance by a consultant physician in the practice of the consultant physicians specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient
92501	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration
92501	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was not more than 15 minutes duration; and (c) the patient to whom the service is provided is admitted to hospital
92502	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration
92502	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner and (b) the attendance was at least 15 minutes, but not more than 30 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92503	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration
92503	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 30 minutes, but not more than 45 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92504	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration
92504	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 45 minutes, but not more than 75 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92505	15SEP2021	31DEC2021	N	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration
92505	01JAN2022	31DEC9999	Y	Phone attendance for a person by a consultant psychiatrist; if: (a) the attendance follows a referral of the patient to the consultant psychiatrist by a referring practitioner; and (b) the attendance was at least 75 minutes in duration; and (c) the patient to whom the service is provided is admitted to hospital
92506	15SEP2021	31DEC2021	N	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner: (a) if the patient: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) the patient has not received an attendance under this item, item 91827 to 91831, 91837 to 91841, 92455 to 92457, 92495 to 92497 or 92437, or item 296, 297, 299, 300 to 346, 353 to 358, or 361 to 370 of the general medical services table, in the preceding 24 months
92506	01JAN2022	31DEC9999	Y	Phone attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physicians speciality of psychiatry following referral of the patient to the consultant physician by a referring practitioner if the patient to whom the service is provided: (a) either: (i) is a new patient for this consultant physician; or (ii) has not received an attendance from this consultant physician in the preceding 24 months; and (b) is admitted to hospital
92513	20APR2020	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management.
92514	20APR2020	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92515	20APR2020	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation.
92516	20APR2020	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation.
92517	15SEP2021	31DEC2021	N	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management
92517	01JAN2022	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management: (a) if the patient to whom the service is provided is admitted to hospital
92518	15SEP2021	31DEC2021	N	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92518	01JAN2022	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92519	15SEP2021	31DEC2021	N	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92519	01JAN2022	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92520	15SEP2021	31DEC2021	N	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92520	01JAN2022	31DEC9999	Y	Telehealth attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92521	20APR2020	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management.
92521	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management; Where the attendance is not the first attendance for that particular clinical indication
92522	20APR2020	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation.
92522	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, where the attendance is not the first attendance for those particular health-related issues, with appropriate documentation
92523	20APR2020	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation.
92524	20APR2020	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation.
92525	15SEP2021	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management
92525	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine-attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited management: (a) if the patient to whom the service is provided is admitted to hospital
92526	15SEP2021	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92526	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92527	15SEP2021	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92527	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92528	15SEP2021	31DEC2021	N	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation
92528	01JAN2022	31DEC9999	Y	Phone attendance by a public health physician in the practice of the public health physicians specialty of public health medicine, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation; where the patient to whom the service is provided is admitted to hospital
92610	20APR2020	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment).
92611	20APR2020	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment.
92612	20APR2020	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration.
92613	20APR2020	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration.
92614	20APR2020	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration.
92615	15SEP2021	31DEC2021	N	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment)
92615	01JAN2022	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment): (a) if the patient to whom the service is provided is admitted to hospital
92616	15SEP2021	31DEC2021	N	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment
92616	01JAN2022	31DEC9999	Y	Telehealth attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment: (a) if the patient to whom the service is provided is admitted to hospital
92617	20APR2020	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment).
92618	20APR2020	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment.
92619	20APR2020	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration.
92620	20APR2020	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration.
92621	20APR2020	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration.
92623	06APR2020	19APR2020	N	Telehealth attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 92628 or 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92623	20APR2020	31DEC2021	N	Telehealth attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 92628 or 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months.
92623	01JAN2022	31DEC9999	Y	Telehealth attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116, 119 of the general medical services table or item, 91822, 91823, 91833, 91824, 91825, 91826 or 91836 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 145 of the general medical services table applies has not been provided to the patient by the same practitioner in the preceding 12 months
92624	06APR2020	19APR2020	N	Telehealth attendance of more than 30 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141, 92623, 92628 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patients health status is reassessed; and (ii) a management plan prepared under item 141, 92623, 92628 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patients family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141, 92623, 92628 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 92629 or 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patients clinical condition or care circumstances that requires a further review. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92624	20APR2020	31DEC2021	N	Telehealth attendance of more than 30 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141, 92623, 92628 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patients health status is reassessed; and (ii) a management plan prepared under item 141, 92623, 92628 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patients family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141, 92623, 92628 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 92629 or 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patients clinical condition or care circumstances that requires a further review.
92624	01JAN2022	31DEC9999	Y	Telehealth attendance of more than 30 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141, 92623 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patients health status is reassessed; and (ii) a management plan prepared under item 141, 92623 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patients family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116, 119 of the general medical services table or item 91822, 91823, 91833, 91824, 91825, 91826 or 91836 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 of the general medical services table or item 92623 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item, or item 147 of the general medical services table applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patients clinical condition or care circumstances that requires a further review
92625	15SEP2021	31DEC2021	N	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment)
92625	01JAN2022	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist (other than a second or subsequent attendance in a single course of treatment): (a) if the patient to whom the service is provided is admitted to hospital
92626	15SEP2021	31DEC2021	N	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment
92626	01JAN2022	31DEC9999	Y	Phone attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment: (a) if the patient to whom the service is provided is admitted to hospital
92628	06APR2020	19APR2020	N	Phone attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 92623 or 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92628	20APR2020	31DEC2021	N	Phone attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 92623 or 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months.
92628	01JAN2022	31DEC9999	Y	Phone attendance of more than 60 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) all relevant aspects of the patients health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patients various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patients general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patients family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patients family and any carers; and (v) the management plan is communicated in writing to the referring practitioner
92629	06APR2020	19APR2020	N	Phone attendance of more than 30 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141, 92623, 92628 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patients health status is reassessed; and (ii) a management plan prepared under item 141, 92623, 92628 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patients family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141, 92623, 92628 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 92624 or 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patients clinical condition or care circumstances that requires a further review. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
92629	20APR2020	31DEC9999	Y	Phone attendance of more than 30 minutes in duration by a consultant physician or specialist in the practice of the consultant physicians or specialists specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141, 92623, 92628 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patients health status is reassessed; and (ii) a management plan prepared under item 141, 92623, 92628 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patients family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116, 119, 91822, 91832, 91823, 91833, 91824, 91834, 91825, 91835, 91826 or 91836 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141, 92623, 92628 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 92624 or 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patients clinical condition or care circumstances that requires a further review.
92701	22MAY2020	31DEC9999	Y	Telehealth attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply)
92702	15SEP2021	31DEC2021	N	Telehealth attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply)
92702	01JAN2022	31DEC9999	Y	Telehealth attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply) : (a) if the patient to whom the service is provided is admitted to hospital
92712	22MAY2020	31DEC2021	N	Phone attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply)
92712	01JAN2022	31DEC9999	Y	Phone attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes
92713	15SEP2021	31DEC2021	N	Phone attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply)
92713	01JAN2022	31DEC9999	Y	Phone attendance by a medical practitioner in the practice of anaesthesia for a consultation on a patient undergoing advanced surgery or who has complex medical problems, involving a selective history and the formulation of a written patient management plan documented in the patient notes, and lasting more than 15 minutes (other than a service associated with a service to which any of items 2801 to 3000 of the general medical services table apply): (a) if the patient to whom the service is provided is admitted to hospital
92715	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92715	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92716	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92716	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92717	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92717	08OCT2021	31OCT2023	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92717	01NOV2023	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92718	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92718	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92719	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92719	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92720	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92720	08OCT2021	31OCT2023	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92720	01NOV2023	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92721	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92721	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92722	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92722	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92723	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92723	08OCT2021	31OCT2023	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92723	01NOV2023	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92724	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92724	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92725	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92725	08OCT2021	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92726	01JUL2021	07OCT2021	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92726	08OCT2021	31OCT2023	N	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92726	01NOV2023	31DEC9999	Y	Telehealth attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92731	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92731	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92732	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92732	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92733	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92733	08OCT2021	31OCT2023	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92733	01NOV2023	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of not more than 5 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a short patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92734	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92734	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92735	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92735	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92736	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92736	08OCT2021	31OCT2023	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92736	01NOV2023	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 5 minutes in duration but not more than 20 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92737	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92737	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92738	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92738	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92739	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92739	08OCT2021	31OCT2023	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92739	01NOV2023	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, of more than 20 minutes in duration but not more than 40 minutes if the attendance includes any of the following that are clinically relevant: (a) taking a detailed patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92740	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92740	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a general practitioner lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92741	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician) lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92741	08OCT2021	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92742	01JUL2021	07OCT2021	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a General Practitioner, Specialist or Consultant Physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care
92742	08OCT2021	31OCT2023	N	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items.
92742	01NOV2023	31DEC9999	Y	Phone attendance for the provision of services related to blood borne viruses, sexual or reproductive health by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 40 minutes in duration if the attendance includes any of the following that are clinically relevant: (a) taking an extensive patient history; (b) arranging any necessary investigation; (c) implementing a management plan; (d) providing appropriate preventive health care Note: Consultations related to assisted reproductive technology and antenatal care are outside the scope of these items and cannot be rendered under these items
92746	16JUL2021	31DEC2021	N	Phone attendance by a general practitioner lasting at least 20 minutes in duration, if; (a) the service is performed on: (i) a person who is in a COVID-19 Commonwealth declared hotspot; or (ii) a person who is in COVID-19 isolation because of a State or Territory public health order; or (iii) a person who is in COVID-19 quarantine because of a State or Territory public health order; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
92746	01JAN2022	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 20 minutes in duration, if; (a) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
92747	16JUL2021	31DEC2021	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 20 minutes in duration, if: (a) the service is performed on: (i) a person who is in a COVID-19 Commonwealth declared hotspot; or (ii) a person who is in COVID-19 isolation because of a State or Territory public health order; or (iii) a person who is in COVID-19 quarantine because of a State or Territory public health order; and (b) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
92747	01JAN2022	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 20 minutes in duration, if: (a) the attendance includes any of the following that are clinically relevant: (i) taking a detailed patient history; (ii) arranging any necessary investigation; (iii) implementing a management plan; (iv) providing appropriate preventative health care
93000	30MAR2020	05APR2020	N	Telehealth attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health telehealth practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health telehealth practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93013 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year. Where the service is bulk-billed.
93000	06APR2020	19APR2020	N	Telehealth attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93013 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93000	20APR2020	31DEC2021	N	Telehealth attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93013 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year.
93000	01JAN2022	29FEB2024	N	Telehealth attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements or multidisciplinary care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93013 or any item in Part 1 of the Schedule to the Allied Health Determination applies) in a calendar year
93000	01MAR2024	31DEC9999	Y	Telehealth attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements or multidisciplinary care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93013 or any item in Subgroup 1 of Group M3 of the Allied Health Determination applies) in a calendar year
93013	30MAR2020	05APR2020	N	Phone attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health telehealth practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health telehealth practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93000 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year. Where the service is bulk-billed.
93013	06APR2020	19APR2020	N	Phone attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93000 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93013	20APR2020	31DEC2021	N	Phone attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements, multidisciplinary care plan or shared care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93000 or any item in Part 1 of the Schedule to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year.
93013	01JAN2022	29FEB2024	N	Phone attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements or multidisciplinary care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93000 or any item in Part 1 of the Schedule to the Allied Health Determination applies) in a calendar year
93013	01MAR2024	31DEC9999	Y	Phone attendance by an eligible allied health practitioner if: (a) the service is provided to a person who has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (b) the service is recommended in the persons Team Care Arrangements or multidisciplinary care plan as part of the management of the persons chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (c): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of -in relation to those matters; to a maximum of 5 services (including any services to which this item, item 93000 or any item in Subgroup 1 of Group M3 of the Allied Health Determination applies) in a calendar year
93026	30MAR2020	05APR2020	N	Non-directive pregnancy support counselling health service provided to a person who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a telehealth attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the service is provided to the person individually; and (d) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (e) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93029 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate Where the service is bulk-billed.
93026	06APR2020	19APR2020	N	Non-directive pregnancy support counselling health service provided to a person who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a telehealth attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the service is provided to the person individually; and (d) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (e) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93029 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93026	20APR2020	31DEC2021	N	Non-directive pregnancy support counselling health service provided to a person who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a telehealth attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the service is provided to the person individually; and (d) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (e) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93029 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate
93026	01JAN2022	31DEC9999	Y	Non directive pregnancy support counselling health service provided to a person who is currently pregnant or who has been pregnant in the preceding 12 months by an eligible psychologist, eligible social worker or eligible mental health nurse as a telehealth attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the service is provided to the person individually; and (d) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (e) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Allied Health Determination, item 4001 of the general medical services table and item 93029, 92136 and 92138 apply) for each pregnancy. The service may be used to address any pregnancy related issues for which non directive counselling is appropriate
93029	30MAR2020	05APR2020	N	Non-directive pregnancy support counselling health service provided to a person, who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a phone attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (ba) the service is provided to the person individually; and (c) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93026 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate Where the service is bulk-billed.
93029	06APR2020	19APR2020	N	Non-directive pregnancy support counselling health service provided to a person, who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a phone attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (ba) the service is provided to the person individually; and (c) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93026 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93029	20APR2020	31DEC2021	N	Non-directive pregnancy support counselling health service provided to a person, who is currently pregnant or who has been pregnant in the preceding 12 months, (but not as an admitted patient of a hospital) by an eligible psychologist, eligible social worker or eligible mental health nurse as a phone attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (ba) the service is provided to the person individually; and (c) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (d) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Health Insurance (Allied Health Services) Determination 2014 and 4001 and item 93026 apply) for each pregnancy The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate
93029	01JAN2022	31DEC9999	Y	Non directive pregnancy support counselling health service provided to a person, who is currently pregnant or who has been pregnant in the preceding 12 months by an eligible psychologist, eligible social worker or eligible mental health nurse as a phone attendance if: (a) the person is concerned about a current pregnancy or a pregnancy that occurred in the 12 months preceding the provision of the first service; and (b) the person is referred by a medical practitioner who is not a specialist or consultant physician; and (c) the service is provided to the person individually; and (d) the eligible psychologist, eligible social worker or eligible mental health nurse does not have a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination; and (e) the service is at least 30 minutes duration; to a maximum of 3 services (including services to which items 81000, 81005, 81010 in the Allied Health Determination, item 4001 of the general medical services table and item 93026, 92136 and 92138 apply) for each pregnancy. The service may be used to address any pregnancy related issues for which non directive counselling is appropriate
93032	30MAR2020	05APR2020	N	Psychology health service provided by telehealth attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93033, 93040 and 93041 or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day Where the service is bulk-billed.
93032	06APR2020	19APR2020	N	Psychology health service provided by telehealth attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93033, 93040 and 93041 or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93032	20APR2020	31DEC2021	N	Psychology health service provided by telehealth attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93033, 93040 and 93041 or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day
93032	01JAN2022	28FEB2023	N	Psychology health service provided by telehealth attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93033, 93040 and 93041 or items 82000, 82005, 82010 and 82030 in the Allied Health Determination apply). Up to 4 services may be provided to the same child on the same day
93032	01MAR2023	31DEC9999	Y	Psychology health service provided by telehealth attendance to a patient aged under 25 years by an eligible psychologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 82030, 93033, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93033	30MAR2020	05APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93040 or 93041, or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day Where the service is bulk-billed.
93033	06APR2020	19APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93040 or 93041, or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93033	20APR2020	31DEC2021	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93040 or 93041, or items 82000, 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day
93033	01JAN2022	28FEB2023	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93040 or 93041, or items 82000, 82005, 82010 and 82030 in the Allied Health Determination apply). Up to 4 services may be provided to the same child on the same day
93033	01MAR2023	31DEC9999	Y	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a patient aged under 25 years by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 82030, 93032, 93040 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93035	30MAR2020	05APR2020	N	Psychology health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93036, 93043 and 93044, or items 82015, 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day Where the service is bulk-billed.
93035	06APR2020	19APR2020	N	Psychology health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93036, 93043 and 93044, or items 82015, 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93035	20APR2020	31DEC2021	N	Psychology health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93036, 93043 and 93044, or items 82015, 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day
93035	01JAN2022	28FEB2023	N	Psychology health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93036, 93043 and 93044, or items 82015, 82020, 82025 and 82035 in the Allied Health Determination apply). Up to 4 services may be provided to the same child on the same day
93035	01MAR2023	31DEC9999	Y	Psychology health service provided by telehealth attendance to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible psychologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 82035, 93036, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93036	30MAR2020	05APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, item 93035, 93043 and 93044, or items 82015, 82020 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Where the service is bulk-billed.
93036	06APR2020	19APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, item 93035, 93043 and 93044, or items 82015, 82020 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93036	20APR2020	31DEC2021	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, item 93035, 93043 and 93044, or items 82015, 82020 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply)
93036	01JAN2022	28FEB2023	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, item 93035, 93043 and 93044, or items 82015, 82020 82025 and 82035 in the Allied Health Determination apply)
93036	01MAR2023	31DEC9999	Y	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by telehealth attendance to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 82035, 93035, 93043 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93040	30MAR2020	05APR2020	N	Psychology health service provided by phone attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93033 and 93041, or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day Where the service is bulk-billed.
93040	06APR2020	19APR2020	N	Psychology health service provided by phone attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93033 and 93041, or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93040	20APR2020	31DEC2021	N	Psychology health service provided by phone attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93033 and 93041, or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day
93040	01JAN2022	28FEB2023	N	Psychology health service provided by phone attendance to a child aged under 13 years by an eligible psychologist if: (a) the child was referred to the eligible psychologist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93033 and 93041, or items 82005, 82010 and 82030 in the Allied Health Determination apply). Up to 4 services may be provided to the same child on the same day
93040	01MAR2023	31DEC9999	Y	Psychology health service provided by phone attendance to a patient aged under 25 years by an eligible psychologist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 82030, 93032, 93033 or 93041 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93041	30MAR2020	05APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93932, 93033 and 93040 or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day Where the service is bulk-billed.
93041	06APR2020	19APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93932, 93033 and 93040 or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93041	20APR2020	31DEC2021	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93932, 93033 and 93040 or items 82005, 82010 and 82030 in the Health Insurance (Allied Health Services) Determination 2014 apply) Up to 4 services may be provided to the same child on the same day
93041	01JAN2022	28FEB2023	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 13 years by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the child was referred to the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist by an eligible practitioner: (i) to assist with the diagnosis of the child by the practitioner; or (ii) to contribute to the childs PDD or disability treatment and management plan, developed by the practitioner; and (b) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; or (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (c) the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of that service; and (d) the service is provided to the child individually; and (e) the service is at least 50 minutes duration; to a maximum of 4 services (including services to which this item, items 93032, 93033 and 93040 or items 82005, 82010 and 82030 in the Allied Health Determination apply). Up to 4 services may be provided to the same child on the same day
93041	01MAR2023	31DEC9999	Y	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a patient aged under 25 years by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the patient was referred by an eligible medical practitioner, or by an eligible allied health practitioner following referral by an eligible medical practitioner, to: (i) assist the eligible medical practitioner with diagnostic formulation where the patient has a suspected complex neurodevelopmental disorder or eligible disability; or (ii) contribute to the patients treatment and management plan developed by the referring eligible medical practitioner where a complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability is confirmed; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes duration Up to 4 services to which this item or any of items 82000, 82005, 82010, 82030, 93032, 93033 or 93040 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93043	30MAR2020	05APR2020	N	Psychology health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93044, 93036, 93035 and 93932 or items 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Where the service is bulk-billed.
93043	06APR2020	19APR2020	N	Psychology health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93044, 93036, 93035 and 93932 or items 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93043	20APR2020	31DEC2021	N	Psychology health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93044, 93036, 93035 and 93932 or items 82020, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply)
93043	01JAN2022	28FEB2023	N	Psychology health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible psychologist, if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her field of specialty, or a general practitioner; and (e) the eligible psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (h) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93032, 93035, 93036 and 93044 or items 82020, 82025 and 82035 in the Allied Health Determination apply)
93043	01MAR2023	31DEC9999	Y	Psychology health service provided by phone attendance to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible psychologist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 82035, 93035, 93036 or 93044 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93044	30MAR2020	05APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93935, 93036 and 93043 or items 82015, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) Where the service is bulk-billed.
93044	06APR2020	19APR2020	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93935, 93036 and 93043 or items 82015, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply) NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93044	20APR2020	31DEC2021	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (h) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93935, 93036 and 93043 or items 82015, 82025 and 82035 in the Health Insurance (Allied Health Services) Determination 2014 apply)
93044	01JAN2022	28FEB2023	N	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a child aged under 15 years for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist if: (a) the child has been diagnosed with a PDD or an eligible disability; and (b) the child, while aged under 13 years, received a PDD or disability treatment and management plan as prepared by the eligible practitioner; and (c) the child was referred by an eligible practitioner for services consistent with the childs PDD or disability treatment and management plan; and (d) the eligible practitioner is: (i) for a child with PDD, a consultant physician specialising in the practice of his or her field of psychiatry or paediatrics; (ii) for a child with disability, a specialist or consultant physician practising in his or her specialty, or a general practitioner; and (e) the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for the provision of those services; and (f) on the completion of the course of treatment, the eligible speech pathologist gives a written report to the referring eligible practitioner on assessments carried out, treatment provided and recommendations on future management of the childs condition; and (g) the service is provided to the child individually; and (i) the service is at least 30 minutes duration; to a maximum of 20 services (including services to which this item, items 93035, 93036 and 93043 or items 82015, 82025 and 82035 in the Allied Health Determination apply).
93044	01MAR2023	31DEC9999	Y	Speech pathology, occupational therapy, audiology, optometry, orthoptic or physiotherapy health service provided by phone attendance to a patient aged under 25 years for the treatment of a diagnosed complex neurodevelopmental disorder (such as autism spectrum disorder) or eligible disability by an eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist, if: (a) the patient has a treatment and management plan in place and has been referred by an eligible medical practitioner for a course of treatment consistent with that treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes duration; and (d) on the completion of the course of treatment, the eligible speech pathologist, occupational therapist, audiologist, optometrist, orthoptist or physiotherapist gives a written report to the referring eligible medical practitioner on assessments (if performed), treatment provided and recommendations on future management of the patients condition Up to 4 services to which this item or any of items 82015, 82020, 82025, 82035, 93035, 93036 or 93043 apply may be provided to the same patient on the same day Further information on the requirements for this item are available in the explanatory notes to this Category
93048	30MAR2020	05APR2020	N	Telehealth attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or 93061 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year Where the service is bulk-billed.
93048	06APR2020	19APR2020	N	Telehealth attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or 93061 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93048	20APR2020	31DEC2021	N	Telehealth attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or 93061 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014 applies) in a calendar year
93048	01JAN2022	29FEB2024	N	Telehealth attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or 93061 or any item in Part 6 of Schedule 2 to the Allied Health Determination applies) in a calendar year
93048	01MAR2024	31DEC9999	Y	Telehealth attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has: (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 10 services (including any services to which this item or 93000, 93013 or 93061 or any item in Subgroup 1 of Group M3 or any item in Group M11 of the Allied Health Determination applies) in a calendar year
93061	30MAR2020	05APR2020	N	Phone attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or item 93060 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014applies) in a calendar year Where the service is bulk-billed.
93061	06APR2020	19APR2020	N	Phone attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or item 93060 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014applies) in a calendar year NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93061	20APR2020	31DEC2021	N	Phone attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) either: (i) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (ii) the persons shared care plan identifies the need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or item 93060 or any item in Part 6 of Schedule 2 to the Health Insurance (Allied Health Services) Determination 2014applies) in a calendar year
93061	01JAN2022	29FEB2024	N	Phone attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (c) the service is provided to the person individually; and (d) the service is of at least 20 minutes duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 5 services (including any services to which this item or item 93060 or any item in Part 6 of Schedule 2 to the Allied Health Determination applies) in a calendar year
93061	01MAR2024	31DEC9999	Y	Phone attendance provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible allied health practitioner if: (a) a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or (b) the patient has (i) a chronic condition; and (ii) complex care needs being managed by a medical practitioner (other than a specialist or consultant physician) under both a GP Management Plan and Team Care Arrangements or, if the patient is a resident of an aged care facility, the patients medical practitioner has contributed to a multidisciplinary care plan; and (iii) the service is recommended in the patients Team Care Arrangements or multidisciplinary care plan as part of the management of the patients chronic condition and complex care needs; and (c) the person is referred to the eligible allied health practitioner by a medical practitioner using a referral form issued by the Department or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 20 minutes duration; and (f) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or the last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters; to a maximum of 10 services (including any services to which this item or item 93000, 93013, 93048 or any item in Subgroup 1 of Group M3 or any item in Group M11 of the Allied Health Determination applies) in a calendar year
93074	30MAR2020	05APR2020	N	Dietetics health service provided by telehealth attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration. Where the service is bulk-billed.
93074	06APR2020	19APR2020	N	Dietetics health service provided by telehealth attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93074	20APR2020	31DEC9999	Y	Dietetics health service provided by telehealth attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration.
93076	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93076	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93076	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration.
93079	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93079	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93079	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93084	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93084	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93084	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93087	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93087	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93087	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93092	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93092	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93092	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93095	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93095	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93095	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93100	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93100	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93100	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93103	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93103	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93103	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by telehealth attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93108	30MAR2020	05APR2020	N	Dietetics health service provided by phone attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration. Where the service is bulk-billed.
93108	06APR2020	19APR2020	N	Dietetics health service provided by phone attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93108	20APR2020	31DEC9999	Y	Dietetics health service provided by phone attendance to an eligible patient by an eligible dietitian: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is of at least 20 minutes in duration.
93110	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93110	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93110	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 30 minutes but less than 50 minutes in duration.
93113	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93113	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93113	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93118	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93118	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93118	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93121	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93121	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93121	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93126	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93126	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93126	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually person; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93129	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93129	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93129	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93134	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. Where the service is bulk-billed.
93134	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93134	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 20 minutes but less than 50 minutes in duration.
93137	30MAR2020	05APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. Where the service is bulk-billed.
93137	06APR2020	19APR2020	N	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration. NOTE: It is a legislative requirement that the service must be bulk-billed where the service is provided to a concessional or vulnerable patient at the time the service is provided. For all other patients the service may be bulk-billed.
93137	20APR2020	31DEC9999	Y	Eating disorder psychological treatment service provided by phone attendance to an eligible patient by an eligible social worker if: (a) the service is recommended in the patients eating disorder treatment and management plan; and (b) the service is provided to the patient individually; and (c) the service is at least 50 minutes in duration.
93200	20APR2020	31DEC9999	Y	Follow-up telehealth attendance provided by a practice nurse or an Aboriginal and Torres Strait Islander health practitioner, on behalf of a medical practitioner, for an Indigenous person who has received a health check if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the service is consistent with the needs identified through the health assessment.
93201	20APR2020	31DEC9999	Y	Telehealth attendance provided by a practice nurse or an Aboriginal and Torres Strait Islander health practitioner to a person with a chronic disease if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the person has a GP management plan, team care arrangements or multidisciplinary care plan in place and the service is consistent with the plan or arrangements.
93202	20APR2020	31DEC9999	Y	Follow-up phone attendance provided by a practice nurse or an Aboriginal and Torres Strait Islander health practitioner, on behalf of a medical practitioner, for an Indigenous person who has received a health check if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the service is consistent with the needs identified through the health assessment.
93203	20APR2020	31DEC9999	Y	Phone attendance provided by a practice nurse or an Aboriginal and Torres Strait Islander health practitioner to a person with a chronic disease if: (a) the service is provided on behalf of and under the supervision of a medical practitioner; and (b) the person has a GP management plan, team care arrangements or multidisciplinary care plan in place and the service is consistent with the plan or arrangements.
93284	22MAY2020	31DEC2021	N	Telehealth attendance by an eligible dietitian to provide a dietetics health service to a person for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP management plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services to which this item, item 92386, or items 81100, 81110 and 81120 of the Allied Health Determination apply)
93284	01JAN2022	31DEC9999	Y	Telehealth attendance by an eligible dietitian to provide a dietetics health service to a person for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP management plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services to which this item, item 92386, or items 81100, 81110 and 81120 of the Allied Health Determination apply)
93285	22MAY2020	31DEC9999	Y	Telehealth attendance by an eligible dietitian to provide a dietetics health service, as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment items 81100, 81110 or 81120 of the Allied Health Determination or items 93284 or 93286; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is of at least 60 minutes duration; and (d) after the last service in the group services program provided to the person under this item or items 81105, 81115 or 81125 of the Allied Health Determination, the eligible dietitian prepares, or contributes to, a written report to be provided to the referring medical practitioner; and (e) an attendance record for the group is maintained by the eligible dietitian; to a maximum of 8 group services in a calendar year (including services to which this item or items 81105, 81115 and 81125 of the Allied Health Determination apply)
93286	22MAY2020	31DEC2021	N	Phone attendance by an eligible dietitian to provide a dietetics health service to a person for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP management plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services to which this item, item 92384, or in items 81100, 81110 and 81120 of the Allied Health Determination apply)
93286	01JAN2022	31DEC9999	Y	Phone attendance by an eligible dietitian to provide a dietetics health service to a person for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the person has type 2 diabetes; and (b) the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP management plan or, if the person is a resident of an aged care facility, the persons medical practitioner has contributed to a multidisciplinary care plan; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); payable once in a calendar year for this or any other assessment for group services item (including services to which this item, item 92384, or in items 81100, 81110 and 81120 of the Allied Health Determination apply)
93287	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93288	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 40 minutes
93291	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93292	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a care recipient in a residential aged care facility (but not as an admitted patient of a hospital); and (b) the service is clinically indicated under a GP mental health treatment plan or a psychiatrist assessment and management plan; and (c) the service lasts at least 40 minutes
93300	07AUG2020	08OCT2020	N	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and(b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93300	09OCT2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93301	07AUG2020	08OCT2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93301	09OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93302	07AUG2020	08OCT2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93302	09OCT2020	31DEC9999	Y	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93303	07AUG2020	08OCT2020	N	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93303	09OCT2020	31DEC9999	Y	Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93304	07AUG2020	08OCT2020	N	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93304	09OCT2020	31DEC9999	Y	Telehealth attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93305	07AUG2020	08OCT2020	N	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93305	09OCT2020	31DEC9999	Y	Phone attendance by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93306	07AUG2020	08OCT2020	N	Professional attendance at consulting rooms by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93306	09OCT2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93307	07AUG2020	08OCT2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93307	09OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93308	07AUG2020	08OCT2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93308	09OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 30 minutes, but less than 40 minutes
93309	07AUG2020	08OCT2020	N	Professional attendance at consulting rooms by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93309	09OCT2020	31DEC9999	Y	Professional attendance at consulting rooms by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if:(b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93310	07AUG2020	08OCT2020	N	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93310	09OCT2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93311	07AUG2020	08OCT2020	N	Phone attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the practitioner is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service; and (c) the service lasts at least 40 minutes
93311	09OCT2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician), for the purpose of providing focussed psychological strategies for assessed mental disorders if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service lasts at least 40 minutes
93312	10DEC2020	31DEC9999	Y	Psychological therapy health service provided to a person (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93313	10DEC2020	31DEC9999	Y	Psychological therapy health service provided to a person (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93316	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93319	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital), by an eligible psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93322	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93323	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93326	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93327	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93330	07AUG2020	08OCT2020	N	Psychological therapy health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services ; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93330	09OCT2020	31DEC9999	Y	Psychological therapy health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93331	07AUG2020	08OCT2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93331	09OCT2020	31DEC9999	Y	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93332	07AUG2020	08OCT2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93332	09OCT2020	31DEC9999	Y	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93333	07AUG2020	08OCT2020	N	Psychological therapy health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93333	09OCT2020	31DEC9999	Y	Psychological therapy health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93334	07AUG2020	08OCT2020	N	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93334	09OCT2020	31DEC9999	Y	Psychological therapy health service provided by telehealth attendance by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93335	07AUG2020	08OCT2020	N	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93335	09OCT2020	31DEC9999	Y	Psychological therapy health service provided by phone attendance by an eligible clinical psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93350	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93350	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93351	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93351	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93352	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93352	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93353	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93353	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital), by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93354	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93354	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93355	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93355	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible psychologist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93356	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93356	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93357	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93357	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93358	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93358	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93359	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93359	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93360	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration
93360	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration
93361	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders ; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration
93361	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible occupational therapist if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes in duration
93362	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93362	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93363	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93363	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93364	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93364	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93365	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93365	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93366	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93366	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by telehealth attendance by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93367	07AUG2020	08OCT2020	N	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (a) the person is a person with a mental health disorder subject to COVID-19 public health orders; and (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who: (i) determines the person is responding to mental health treatment, or may respond to additional mental health treatment; or (ii) determines it appropriate for the person to access additional mental health treatment services; or (iii) makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93367	09OCT2020	31DEC9999	Y	Focussed psychological strategies health service provided by phone attendance by an eligible social worker if: (b) the person is referred by a medical practitioner working in general practice, a psychiatrist or a paediatrician who makes a written record of the need for additional mental health treatment services; and (c) the service is provided to the person individually; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93375	10DEC2020	31DEC9999	Y	Psychological therapy health service provided to a person (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 30 minutes but less than 50 minutes duration
93376	10DEC2020	31DEC9999	Y	Psychological therapy health service provided to a person (but not as an admitted patient of a hospital), by an eligible clinical psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible clinical psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93381	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93382	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital), by an eligible psychologist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible psychologist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93383	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93384	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible occupational therapist gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93385	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 20 minutes but less than 50 minutes duration
93386	10DEC2020	31DEC9999	Y	Focussed psychological strategies health service provided to a person (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the person is a care recipient in a residential aged care facility; and (b) the person is referred by: (i) a medical practitioner, either as part of a GP Mental Health Treatment Plan or as part of a psychiatrist assessment and management plan; or (ii) a specialist or consultant physician specialising in the practice of his or her field of psychiatry; and (c) the service is provided to the person individually and in person; and (d) at the completion of a course of treatment, the referring medical practitioner reviews the need for a further course of treatment; and (e) on the completion of the course of treatment, the eligible social worker gives a written report to the referring medical practitioner on assessments carried out, treatment provided and recommendations on future management of the persons condition; and (f) the service is at least 50 minutes duration
93400	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes, but less than 40 minutes
93401	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93402	10DEC2020	31DEC9999	Y	Professional attendance, by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes, but less than 40 minutes
93403	10DEC2020	31DEC9999	Y	Professional attendance, by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93404	10DEC2020	31DEC9999	Y	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93405	10DEC2020	31DEC9999	Y	Telehealth attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93406	10DEC2020	31DEC9999	Y	Telehealth attendance by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93407	10DEC2020	31DEC9999	Y	Telehealth attendance by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93408	10DEC2020	31DEC9999	Y	Phone attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93409	10DEC2020	31DEC9999	Y	Phone attendance by a general practitioner who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93410	10DEC2020	31DEC9999	Y	Phone attendance by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93411	10DEC2020	31DEC9999	Y	Phone attendance by a general practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93421	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93422	10DEC2020	31DEC9999	Y	Telehealth attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93423	10DEC2020	31DEC9999	Y	Phone attendance by a general practitioner to review a GP mental health treatment plan which the general practitioner, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93431	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner who has not undertaken mental health skills training (not including a general practitioner, specialist or a consultant physician), for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes, but less than 40 minutes
93432	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner who has not undertaken mental health skills training (not including a general practitioner, specialist or a consultant physician), for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93433	10DEC2020	31DEC9999	Y	Professional attendance, by a medical practitioner who has undertaken mental health skills training (but not including a general practitioner, specialist or consultant physician), for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes, but less than 40 minutes
93434	10DEC2020	31DEC9999	Y	Professional attendance, by a medical practitioner who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93435	10DEC2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93436	10DEC2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93437	10DEC2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93438	10DEC2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93439	10DEC2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 20 minutes but less than 40 minutes
93440	10DEC2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has not undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93441	10DEC2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) of at least 20 minutes but less than 40 minutes
93442	10DEC2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician), who has undertaken mental health skills training, for the preparation of a GP mental health treatment plan for a patient (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) the service lasts at least 40 minutes
93451	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner to review a GP mental health treatment plan which the medical practitioner, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93452	10DEC2020	31DEC9999	Y	Telehealth attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review a GP mental health treatment plan which the medical practitioner, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93453	10DEC2020	31DEC9999	Y	Phone attendance by a medical practitioner (not including a general practitioner, specialist or consultant physician) to review a GP mental health treatment plan which the medical practitioner, or an associated medical practitioner has prepared, or to review a psychiatrist assessment and management plan (but not as an admitted patient of a hospital) if: (a) the person is a care recipient in a residential aged care facility; and (b) one of the following services has been provided to the patient: (i) a mental health treatment plan under items 93400 to 93411 or 93431 to 93442; or (ii) a psychiatrist assessment and management plan; and (c) the reviewing practitioner modifies the persons GP mental health treatment plan or psychiatrist assessment and management plan to record that they recommend the person have an additional number of better access treatment services
93469	10DEC2020	31DEC9999	Y	Professional attendance by a general practitioner at a residential aged care facility to contribute to a multidisciplinary care plan, prepared by that facility, or to a review of such a plan prepared by such a facility, if the practitioner performs any of the following as a face-to-face service: (a) prepares part of a multidisciplinary care plan and adding a copy of that part of the plan to the persons medical records; or (b) preparing amendments to part of a multidisciplinary care plan and adding a copy of the amendments to the persons medical records; (c) giving advice to a practitioner who prepares part of a multidisciplinary care plan and recording in writing, on the persons medical records, any advice provided to the practitioner; or (d) giving advice to a practitioner who reviews part of a multidisciplinary care plan and recording in writing, on the persons medical records, any advice provided to the practitioner not more than once in a 3 month period
93470	10DEC2020	31DEC9999	Y	Professional face-to-face attendance by a general practitioner at a residential aged care facility to perform a health assessment of a person who is: (a) of Aboriginal or Torres Strait Islander descent; and (b) a care recipient in a residential aged care facility not more than once in a 9 month period
93475	10DEC2020	31DEC9999	Y	Professional attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician) at a residential aged care facility to contribute to a multidisciplinary care plan, prepared by that facility, or to a review of such a plan prepared by such a facility, if the practitioner performs any of the following as a face-to-face service: (a) prepares part of a multidisciplinary care plan and adding a copy of that part of the plan to the persons medical records; or (b) preparing amendments to part of a multidisciplinary care plan and adding a copy of the amendments to the persons medical records; (c) giving advice to a practitioner who prepares part of a multidisciplinary care plan and recording in writing, on the persons medical records, any advice provided to the practitioner; or (d) giving advice to a practitioner who reviews part of a multidisciplinary care plan and recording in writing, on the persons medical records, any advice provided to the practitioner not more than once in a 3 month period
93479	10DEC2020	31DEC9999	Y	Professional face-to-face attendance by a medical practitioner (not including a general practitioner, specialist or a consultant physician) at a residential aged care facility to perform a health assessment of a person who is: (a) of Aboriginal or Torres Strait Islander descent; and (b) a care recipient in a residential aged care facility not more than once in a 9 month period
93501	10DEC2020	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs;(b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner not more than once in a calendar year
93502	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible diabetes educator if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner not more than once in a calendar year
93503	10DEC2020	31DEC9999	Y	Audiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible audiologist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible audiologist gives a written report to the referring medical practitioner not more than once in a calendar year
93504	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs;(b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner not more than once in a calendar year
93505	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible dietitian if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible dietitian by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner not more than once in a calendar year
93506	10DEC2020	31DEC9999	Y	Mental health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible mental health worker if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible mental health worker gives a written report to the referring medical practitioner not more than once in a calendar year
93507	10DEC2020	31DEC9999	Y	Occupational therapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner not more than once in a calendar year
93508	10DEC2020	31DEC9999	Y	Physiotherapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner not more than once in a calendar year
93509	10DEC2020	31DEC9999	Y	Podiatry health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible podiatrist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible podiatrist gives a written report to the referring medical practitioner not more than once in a calendar year
93510	10DEC2020	31DEC9999	Y	Chiropractic health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible chiropractor if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible chiropractor gives a written report to the referring medical practitioner not more than once in a calendar year
93511	10DEC2020	31DEC9999	Y	Osteopathy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible osteopath if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible osteopath gives a written report to the referring medical practitioner not more than once in a calendar year
93512	10DEC2020	31DEC9999	Y	Psychology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible psychologist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible psychologist gives a written report to the referring medical practitioner not more than once in a calendar year
93513	10DEC2020	31DEC9999	Y	Speech pathology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible speech pathologist if all of the following apply: (a) the persons chronic or complex care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (b) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner not more than once in a calendar year
93518	10DEC2020	14SEP2021	N	Additional exercise physiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M29 or Group M3 applied (in total for all items), in that calendar year; (b) the persons chronic or complex care needs are assessed as requiring additional exercise physiology therapy services in a calendar year; (c) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (d) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (e) the service is provided to the person individually and in person; and (f) the service is at least 20 minutes in duration; and (g) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93518	15SEP2021	31DEC9999	Y	Additional exercise physiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the persons chronic or complex care needs are assessed as requiring additional exercise physiology therapy services in a calendar year; (b) the service is provided to a person whose chronic or complex care needs are being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; (e) the service is at least 20 minutes in duration; (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93519	10DEC2020	14SEP2021	N	Additional occupational therapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M29 or Group M3 applied (in total for all items), in that calendar year; (b) the persons chronic or complex care needs are assessed as requiring additional occupational therapy services in a calendar year; (c) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (d) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (e) the service is provided to the person individually and in person; and (f) the service is at least 20 minutes in duration; and (g) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93519	15SEP2021	31DEC9999	Y	Additional occupational therapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the persons chronic or complex care needs are assessed as requiring additional occupational therapy services in a calendar year; (b) the service is provided to a person whose chronic or complex care needs are being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; (e) the service is at least 20 minutes in duration; (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93520	10DEC2020	14SEP2021	N	Additional physiotherapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M29 or Group M3 applied (in total for all items), in that calendar year; (b) the persons chronic or complex care needs are assessed as requiring additional physiotherapy services in a calendar year; (c) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (d) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (e) the service is provided to the person individually and in person; and (f) the service is at least 20 minutes in duration; and (g) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93520	15SEP2021	31DEC9999	Y	Additional physiotherapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the persons chronic or complex care needs are assessed as requiring additional physiotherapy services in a calendar year; (b) the service is provided to a person whose chronic or complex care needs are being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; (e) the service is at least 20 minutes in duration; (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93524	10DEC2020	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93525	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible diabetes educator if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93526	10DEC2020	31DEC9999	Y	Audiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible audiologist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible audiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93527	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93528	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible dietitian if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible dietitian by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible dietitian gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93529	10DEC2020	31DEC9999	Y	Mental health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible mental health worker if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible mental health worker gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93530	10DEC2020	31DEC9999	Y	Occupational therapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93531	10DEC2020	31DEC9999	Y	Physiotherapy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93532	10DEC2020	31DEC9999	Y	Podiatry health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible podiatrist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible podiatrist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93533	10DEC2020	31DEC9999	Y	Chiropractic health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible chiropractor if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible chiropractor gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93534	10DEC2020	31DEC9999	Y	Osteopathy health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible osteopath if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible osteopath gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93535	10DEC2020	31DEC9999	Y	Psychology health service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible psychologist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible psychologist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93536	10DEC2020	31DEC9999	Y	Speech pathology service provided to a care recipient in a residential aged care facility, at a residential aged care facility, by an eligible speech pathologist if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93537	10DEC2020	31DEC9999	Y	Telehealth attendance provided to a care recipient in a residential aged care facility, by an eligible allied health practitioner, if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93538	10DEC2020	31DEC9999	Y	Phone attendance provided to a care recipient in a residential aged care facility, by an eligible allied health practitioner, if all of the following apply: (a) the service is provided to a person whose chronic or complex care needs is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; (b) the person is referred to the eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible allied health practitioner gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93546	10DEC2020	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner not more than once in a calendar year
93547	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible diabetes educator if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner not more than once in a calendar year
93548	10DEC2020	31DEC9999	Y	Audiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible audiologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible audiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible audiologist gives a written report to the referring medical practitioner not more than once in a calendar year
93549	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner not more than once in a calendar year
93550	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible dietitian if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner not more than once in a calendar year
93551	10DEC2020	31DEC9999	Y	Mental health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible mental health worker if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible mental health worker gives a written report to the referring medical practitioner not more than once in a calendar year
93552	10DEC2020	31DEC9999	Y	Occupational therapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner not more than once in a calendar year
93553	10DEC2020	31DEC9999	Y	Physiotherapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner not more than once in a calendar year
93554	10DEC2020	31DEC9999	Y	Podiatry health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible podiatrist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible podiatrist gives a written report to the referring medical practitioner not more than once in a calendar year
93555	10DEC2020	31DEC9999	Y	Chiropractic health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible chiropractor if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible chiropractor gives a written report to the referring medical practitioner not more than once in a calendar year
93556	10DEC2020	31DEC9999	Y	Osteopathy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible osteopath if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible osteopath gives a written report to the referring medical practitioner not more than once in a calendar year
93557	10DEC2020	31DEC9999	Y	Psychology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible psychologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible psychologist gives a written report to the referring medical practitioner not more than once in a calendar year
93558	10DEC2020	31DEC9999	Y	Speech pathology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible speech pathologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the persons health care needs are assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; (c) the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 30 minutes in duration; and (f) after the service, the eligible speech pathologist gives a written report to the referring medical practitioner not more than once in a calendar year
93571	10DEC2020	14SEP2021	N	Additional exercise physiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M30 or Group M11 applied (in total for all items), in that calendar year; (b) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (c) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 20 minutes in duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93571	15SEP2021	31DEC9999	Y	Additional exercise physiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the persons health care needs are assessed as requiring additional exercise physiology therapy services in a calendar year; (b) the service is provided to a person: (i) whose need for allied health treatment services has been identified by: A. a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or B. a shared care plan; or (ii) who is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; (d) the service is at least 20 minutes in duration; (e) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93572	10DEC2020	14SEP2021	N	Additional occupational therapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M30 or Group M11 applied (in total for all items), in that calendar year; (b) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (c) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 20 minutes in duration; and (f) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93572	15SEP2021	31DEC9999	Y	Additional occupational therapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the persons health care needs are assessed as requiring additional occupational therapy services in a calendar year; (b) the service is provided to a person: (i) whose need for allied health treatment services has been identified by: A. a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or B. a shared care plan; or (ii) who is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; (d) the service is at least 20 minutes in duration; (e) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93573	10DEC2020	14SEP2021	N	Additional physiotherapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the person has received 5 services, to which an item in subgroup 1 or 3 of Group M30 or Group M11 applied (in total for all items), in that calendar year; (b) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (c) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (d) the service is provided to the person individually and in person; and (e) the service is at least 20 minutes in duration; and (f) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93573	15SEP2021	31DEC9999	Y	Additional physiotherapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the persons health care needs are assessed as requiring additional physiotherapy health services in a calendar year; (b) the service is provided to a person: (i) whose need for allied health treatment services has been identified by: A. a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or B. a shared care plan; or (ii) who is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; (d) the service is at least 20 minutes in duration; (e) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner: (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or last service under the referral - in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of - in relation to those matters
93579	10DEC2020	31DEC9999	Y	Aboriginal and Torres Strait Islander health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93580	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible diabetes educator if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93581	10DEC2020	31DEC9999	Y	Audiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible audiologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible audiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93582	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible exercise physiologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93583	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible dietitian if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible dietitian by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible dietitian gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93584	10DEC2020	31DEC9999	Y	Mental health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible mental health worker if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible mental health worker by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible mental health worker gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93585	10DEC2020	31DEC9999	Y	Occupational therapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible occupational therapist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible occupational therapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible occupational therapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93586	10DEC2020	31DEC9999	Y	Physiotherapy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible physiotherapist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible physiotherapist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible physiotherapist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93587	10DEC2020	31DEC9999	Y	Podiatry health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible podiatrist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible podiatrist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible podiatrist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93588	10DEC2020	31DEC9999	Y	Chiropractic health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible chiropractor if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible chiropractor by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible chiropractor gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93589	10DEC2020	31DEC9999	Y	Osteopathy health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible osteopath if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible osteopath by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible osteopath gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93590	10DEC2020	31DEC9999	Y	Psychology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an eligible psychologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the eligible psychologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the eligible psychologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93591	10DEC2020	31DEC9999	Y	Speech pathology health service provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an speech pathologist if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the speech pathologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the speech pathologist gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93592	10DEC2020	31DEC9999	Y	Telehealth attendance provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an by an eligible allied health practitioner if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the by an eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the by an eligible allied health practitioner gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93593	10DEC2020	31DEC9999	Y	Phone attendance provided to a care recipient in a residential aged care facility of Aboriginal or Torres Strait Islander descent, at a residential aged care facility, by an by an eligible allied health practitioner if all of the following apply: (a) the service is provided to a person whose need for allied health treatment services has been identified by: (i) a health assessment service to which items 228, 715, 92004, 92011, 92016, 92023, 93470 or 93479 applies; or (ii) a shared care plan; or (b) the person is referred to the by an eligible allied health practitioner by the medical practitioner using a referral form that has been issued by the Department or a referral form that contains all the components of the form issued by the Department; (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes in duration; and (e) after the service, the by an eligible allied health practitioner gives a written report to the referring medical practitioner (i) if the service is the only service under the referral-in relation to that service; or (ii) if the service is the first or last service under the referral-in relation to that service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably expect to be informed of-in relation to those matters
93606	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible diabetes educator for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the persons type 2 diabetes is assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; and (b) the service is provided to a person whose type 2 diabetes is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; and (c) the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible diabetes educator gives a written report to the referring medical practitioner
93607	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible exercise physiologist for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the persons type 2 diabetes is assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; and (b) the service is provided to a person whose type 2 diabetes is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; and (c) the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner not more than once in a calendar year
93608	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible dietitian for assessing the persons suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patients needs and preparing the person for the group services if: (a) the persons type 2 diabetes is assessed, including taking a comprehensive patient history and identifying an appropriate treatment program based on the persons needs; and (b) the service is provided to a person whose type 2 diabetes is being managed under: (i) a multidisciplinary care plan for a residential aged care recipient to which items 232, 731, 92027, 92058, 92071, 92102, 93469 or 93475 applies; or (ii) a shared care plan; or (iii) a GP Management Plan and Team Care Arrangements, where the chronic or complex condition was being treated prior to the person receiving residential care; and (c) the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department, or a referral form that contains all the components of the form issued by the Department; and (d) the service is provided to the person individually and in person; and (e) the service is of at least 45 minutes duration; and (f) after the service, the eligible dietitian gives a written report to the referring medical practitioner
93613	10DEC2020	31DEC9999	Y	Diabetes education health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible diabetes educator as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the person under item 81105, 81115, 81125, 93285, 93613, 93614, 93615 the eligible diabetes educator prepares, or contributes to, a written report to be provided to the referring medical practitioner
93614	10DEC2020	31DEC9999	Y	Exercise physiology health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible exercise physiologist as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the person under item 81105, 81115, 81125, 93285, 93613, 93614, 93615 the eligible exercise physiologist prepares, or contributes to, a written report to be provided to the referring medical practitioner
93615	10DEC2020	31DEC9999	Y	Dietetics health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible dietitian as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c) the service is provided in person; and (d) the service is of at least 60 minutes duration; and (e) after the last service in the group services program provided to the person under item 81105, 81115, 81125, 93285, 93613, 93614, 93615 the eligible dietitian prepares, or contributes to, a written report to be provided to the referring medical practitioner
93620	10DEC2020	31DEC9999	Y	Additional exercise physiology health service provided to a care recipient in a residential aged care facility with type 2 diabetes, at a residential aged care facility, by an eligible exercise physiologist as a group service for the management of type 2 diabetes if: (a) the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110, 81120, 93284, 93286, 93606, 93607 or 93608; and (b) the person has received 8 services, to which an item in subgroup 2 of Group M31 or 81105, 81115, 81125 applied (in total for all items), in that calendar year. (c) the service is provided to a person who is part of a group of between 2 and 12 patients; and (d) the service is provided in person; and (e) the service is of at least 60 minutes duration; and (f) after the last service to which this item applies was provided to a person in a calendar year, the eligible exercise physiologist gives a written report to the referring medical practitioner
93624	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area
93624	31MAY2021	01JUL2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93624	02JUL2021	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93625	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93625	31MAY2021	01JUL2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93625	02JUL2021	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93626	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area
93626	31MAY2021	01JUL2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93626	02JUL2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93627	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93627	31MAY2021	01JUL2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93627	02JUL2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93634	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area; (e) the service is rendered in an after-hours period
93634	31MAY2021	01JUL2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93634	02JUL2021	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93635	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (e) the service is rendered in an after-hours period
93635	31MAY2021	01JUL2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93635	02JUL2021	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93636	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area; (e) the service is rendered in an after-hours period
93636	31MAY2021	01JUL2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93636	02JUL2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93637	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (e) the service is rendered in an after-hours period
93637	31MAY2021	01JUL2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93637	02JUL2021	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the first dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93644	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area
93644	31MAY2021	29JUN2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93644	30JUN2021	31JAN2023	N	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93644	01FEB2023	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area
93645	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93645	31MAY2021	29JUN2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93645	30JUN2021	31JAN2023	N	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93645	01FEB2023	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93646	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area
93646	31MAY2021	29JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93646	30JUN2021	31JAN2023	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93646	01FEB2023	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area
93647	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93647	31MAY2021	29JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93647	30JUN2021	31JAN2023	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93647	01FEB2023	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93653	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area; (e) the service is rendered in an after-hours period
93653	31MAY2021	29JUN2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93653	30JUN2021	31JAN2023	N	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93653	01FEB2023	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period
93654	26FEB2021	30MAY2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (e) the service is rendered in an after-hours period
93654	31MAY2021	29JUN2021	N	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93654	30JUN2021	31JAN2023	N	Professional attendance by a general practitioner for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93654	01FEB2023	31DEC9999	Y	Professional attendance by a general practitioner for the purpose of assessing a patients suitability for a dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period
93655	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in a Modified Monash 1 area; (e) the service is rendered in an after-hours period
93655	31MAY2021	29JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93655	30JUN2021	31JAN2023	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93655	01FEB2023	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in a Modified Monash 1 area; (d) the service is rendered in an after-hours period
93656	26FEB2021	30MAY2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the patient is eligible for a COVID-19 vaccine; (c) the service is bulk-billed; (d) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (e) the service is rendered in an after-hours period
93656	31MAY2021	29JUN2021	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93656	30JUN2021	31JAN2023	N	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period Note: Effective 31 May 2021, age restrictions on the use of this item have been removed.
93656	01FEB2023	31DEC9999	Y	Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patients suitability for a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is provided at, or from, a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area; (d) the service is rendered in an after-hours period
93660	01JAN2022	31DEC9999	Y	Attendance by a relevant health professional on behalf of a medical practitioner for the purpose of assessing a patients suitability for a dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is not provided at a practice location; and (d) the service is provided from a practice location in a Modified Monash 1 area
93661	01JAN2022	31DEC9999	Y	Attendance by a relevant health professional on behalf of a medical practitioner for the purpose of assessing a patients suitability for a dose of a COVID-19 vaccine if all of the following apply: (a) one or both of the following is undertaken, where clinically relevant: (i) a short patient history; (ii) limited examination and management; (b) the service is bulk-billed; (c) the service is not provided at a practice location; and (d) the service is provided from a practice location in: (i) a Modified Monash 2 area; or (ii) a Modified Monash 3 area; or (iii) a Modified Monash 4 area; or (iv) a Modified Monash 5 area; or (v) a Modified Monash 6 area; or (vi) a Modified Monash 7 area
93666	23DEC2021	31DEC9999	Y	A medical service associated with a service to which item 93644, 93645, 93646, 93647, 93653, 93654, 93655 or 93656 applies, if: (a) the service is bulk-billed; and (b) the service is for a patient being assessed for their suitability for the booster dose of a COVID-19 vaccine
93680	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner at consulting rooms lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation
93681	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) at consulting rooms lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation
93682	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) at consulting rooms, in an eligible area, lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation
93683	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner at consulting rooms lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation
93684	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) at consulting rooms lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation
93685	21JUL2021	31DEC9999	Y	Professional attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) at consulting rooms, in an eligible area, lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93690	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93691	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93692	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93693	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93694	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93695	21JUL2021	31DEC9999	Y	Telehealth attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93700	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93701	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93702	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting less than 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93703	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a general practitioner lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93704	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician) lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93705	21JUL2021	31DEC9999	Y	Phone attendance for nicotine and smoking cessation counselling, care and advice by a medical practitioner (not including a general practitioner, specialist or consultant physician), in an eligible area, lasting at least 20 minutes and must include any of the following: (a) taking a patient history, aimed at identifying disease risk factors attributable to nicotine use and smoking dependence, and/or identifying barriers and enablers to cessation; and (b) completing an assessment of the patients nicotine dependence, including where clinically appropriate a basic physical examination; and (c) initiating interventions and referrals for the cessation of nicotine, if required; and (d) implementing a management plan for appropriate treatment; and (e) providing the patient with nicotine and smoking cessation advice and information, including modifiable lifestyle factors; with appropriate documentation.
93715	08NOV2021	17JAN2022	N	Attendance by a medical practitioner (other than a specialist or consultant physician) for the assessment and management of a person with COVID-19 infection of recent onset and confirmed by laboratory testing.
93715	18JAN2022	31DEC9999	Y	Attendance by a medical practitioner (other than a specialist or consultant physician) for the assessment and management of a person with COVID-19 infection of recent onset and confirmed by either: (a) laboratory testing; or (b) a COVID-19 rapid antigen self-test which has been approved for supply in Australia by the Therapeutic Goods Administration, where: (i) the treating practitioner makes a record in the patients notes that the relevant state and territory reporting requirements have been met, if applicable, and either: a. confirms the patient has reported the positive test result to the relevant state or territory public health unit where reporting requirements are in place from time to time; or b. assists the patient to report the positive result to the relevant state or territory public health unit where reporting requirements are in place from time to time.
93716	19JUL2022	31DEC9999	Y	Phone attendance by a general practitioner lasting at least 20 minutes for the assessment and management of a person with COVID-19 infection of recent onset, for the purposes of determining the patients eligibility for receiving a COVID-19 oral antiviral treatment, where the service includes any of the following that are clinically relevant: (a) taking a detailed patient history;(b) arranging any necessary investigation;(c) implementing a management plan, including follow up arrangements;(d) providing any necessary treatment, including prescribing a COVID-19 oral antiviral treatment;(e) providing appropriate preventive health care for one or more related issues; with appropriate documentation
93717	19JUL2022	31DEC9999	Y	Phone attendance by a medical practitioner (other than a general practitioner) lasting at least 25 minutes for the assessment and management of a person with COVID-19 infection of recent onset, for the purposes of determining the patients eligibility for receiving a COVID-19 oral antiviral treatment, where the service includes any of the following that are clinically relevant: (a) taking a detailed patient history;(b) arranging any necessary investigation;(c) implementing a management plan, including follow up arrangements;(d) providing any necessary treatment, including prescribing a COVID-19 oral antiviral treatment;(e)providing appropriate preventive health care for one or more related issues; with appropriate documentation